Citrus Sinensis ID: 016009

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------
Protein Sequence
MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGAKRFAIVFPVLGALLVSMTLVAIFILRKRNSDSGDRQRSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI
Secondary Structure (PSIPRED)
cccccEEEccccccccccccccccccccHHHHccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccEEEEEccccccHHHHHHHHcccccccEEEEccccEEEEEEcccccEEEEEEEcccccccccccHHHHHHHHHHHHccccccccccccEEEcccccEEEEcccccccHHHHHccccccccccHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccEEEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccEEcHHHHHHHHccccHccEEccccccEEEEEEcccccEEEEEEccccccccccccHHHHHHHHHHHHHHHHHHHHHEEEEEcccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEcccHcHEEccccccEEEccccHHHHccccccEEEEEEcccccccHHHHHccccccccHHHHHHHHHHHHHccccccHHHHHHHHHHHHHcccHHHHcccHHccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHcc
Coil and Loop (DISEMBL)
mhglsvidisdnqlqgpvpnstafRNASVEAlegnkglcggvkgmqpckgflshkqnsgakrfAIVFPVLGALLVSMTLVAIFILRKrnsdsgdrqrsnqnphglfSILNFEGKLVYDEIVRATndfdaqycigngghgsvyraelpsgqvVAIKKfhsplpsdqivdkkEFLTEVEALTEIRHRNIVKLYGfcsharhsFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSylhhdcfppivhrdissknllldlEFEAHVADFGiakflkpdssnwtefagtygyvapelAYTMkitekcdvySFGVLALEVikgkhprdflsSISSsflntdieldemldprlpapsrsvQEKLRSIVEVVFSClnespesrptmKIVSQQLQI
Flexible Loop (DISEMBL)
MHGLSVIdisdnqlqgpvPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGAKRFAIVFPVLGALLVSMTLVAIFILRkrnsdsgdrqrsnqnphglFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHsplpsdqivdkKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSClnespesrptmkivsqqlqi
Low Complexity Region (SEG)
MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGAKRFAIVFPVLGALLVSMTLVAIFILRKRNSDSGDRQRSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGslaailssdaaaQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI
Disordered region (IsUnstruct)
*******************************LEGNKGLCGGVKGMQPCKGFLSHKQNSGAKRFAIVFPVLGALLVSMTLVAIFILR*****************GLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDI*********************RSIVEVVFSCL*******************
Disordered Region (DISOPRED)
MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGG***********************IVFPVLGALLVSMTLVAIFILR*********************ILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSP**********EFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS*****IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI
Disordered Region (DISEMBL)
MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGAKRFAIVFPVLGALLVSMTLVAIFILRKR***********QNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNES****************
Disordered Region (DISPRO)
*HGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPC**********GAKRFAIVFPVLGALLVSMTLVAIFILRKRN*****************SILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPL***QIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESR************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGAKRFAIVFPVLGALLVSMTLVAIFILRKRNSDSGDRQRSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	397	2.2.26 [Sep-21-2011]
Q8VZG8	1045	Probable LRR receptor-lik	yes	no	0.979	0.372	0.497	1e-114
Q9LP24	1120	Probable leucine-rich rep	no	no	0.972	0.344	0.486	1e-106
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.969	0.349	0.365	1e-68
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.944	0.340	0.378	2e-66
O49318	1124	Probable leucine-rich rep	no	no	0.964	0.340	0.360	1e-61
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.972	0.308	0.330	2e-61
C0LGV1	1135	LRR receptor-like serine/	no	no	0.952	0.333	0.364	2e-61
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.949	0.301	0.330	4e-61
Q9LHP4	1141	Receptor-like protein kin	no	no	0.949	0.330	0.341	5e-59
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.962	0.377	0.353	5e-59

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  413 bits (1062), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 199/400 (49%), Positives = 282/400 (70%), Gaps = 11/400 (2%)

Query: 1    MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGV---KGMQPCKGFLSHKQN 57
            M  L+ +D+S N LQGP+P++ AFRNA  +A EGNK LCG V   +G++PC   ++  + 
Sbjct: 645  MLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCS--ITSSKK 702

Query: 58   SGAKRFAIVF---PVLGALLVSMTLVAIFILRKRNSDSGDRQRSNQNPHGLFSILNFEGK 114
            S   R  I++   P++GA+++      IFI  ++ +   +    +++     SI +F+GK
Sbjct: 703  SHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGK 762

Query: 115  LVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD--QIVDKKEF 172
            + Y EI++AT +FD +Y IG GGHG VY+A+LP+  ++A+KK +    S       K+EF
Sbjct: 763  VRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEF 821

Query: 173  LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN 232
            L E+ ALTEIRHRN+VKL+GFCSH R++FLVYE+++RGSL  +L +D  A++L W +R+N
Sbjct: 822  LNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRIN 881

Query: 233  VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA 292
            V+KGVA ALSY+HHD  P IVHRDISS N+LL  ++EA ++DFG AK LKPDSSNW+  A
Sbjct: 882  VVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVA 941

Query: 293  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML 352
            GTYGYVAPELAY MK+TEKCDVYSFGVL LEVIKG+HP D +S++SSS  +  + L  + 
Sbjct: 942  GTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSIS 1001

Query: 353  DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
            D RLP P+  ++E++  I++V   CL+  P++RPTM  +S
Sbjct: 1002 DHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  384 bits (987), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/399 (48%), Positives = 273/399 (68%), Gaps = 13/399 (3%)

Query: 1    MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGV--KGMQPCKGFLSHKQNS 58
            M  L+ +DIS+N+L+GP+P++  FR A+ +ALE N GLC  +  + ++PC+     K+N 
Sbjct: 724  MIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKN- 782

Query: 59   GAKRFAIVFPVLGALLVSMTLVA---IFILRKRNSDSGDRQRSNQNPHGLFSILNFEGKL 115
            G     I+ P+LG L++ +++ A    + +RKR   +G         +   SI + +GK 
Sbjct: 783  GNLVVWILVPILGVLVI-LSICANTFTYCIRKRKLQNGRNTDPETGEN--MSIFSVDGKF 839

Query: 116  VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD--QIVDKKEFL 173
             Y +I+ +TN+FD  + IG GG+  VYRA L    ++A+K+ H  +  +  + V K+EFL
Sbjct: 840  KYQDIIESTNEFDPTHLIGTGGYSKVYRANL-QDTIIAVKRLHDTIDEEISKPVVKQEFL 898

Query: 174  TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNV 233
             EV+ALTEIRHRN+VKL+GFCSH RH+FL+YE++++GSL  +L++D  A+ L W++R+NV
Sbjct: 899  NEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINV 958

Query: 234  IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG 293
            +KGVA ALSY+HHD   PIVHRDISS N+LLD ++ A ++DFG AK LK DSSNW+  AG
Sbjct: 959  VKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAG 1018

Query: 294  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD 353
            TYGYVAPE AYTMK+TEKCDVYSFGVL LE+I GKHP D +SS+SSS     + L  + D
Sbjct: 1019 TYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSS-PGEALSLRSISD 1077

Query: 354  PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
             R+  P    +EKL  +VE+   CL  +PESRPTM  +S
Sbjct: 1078 ERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  260 bits (665), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 149/408 (36%), Positives = 218/408 (53%), Gaps = 23/408 (5%)

Query: 1    MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQN--- 57
            +  L + +IS+N L G VP++  F+        GN GLC   +    C+  + H  +   
Sbjct: 667  LMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSH--CQPLVPHSDSKLN 724

Query: 58   ---SGAKR---FAIVFPVLGALLVSMTLVAIFILRKRNSDSGDRQRSNQNPHGLFSILNF 111
               +G++R     I   V+G++ + +T + +    KR   +         P  + S    
Sbjct: 725  WLINGSQRQKILTITCIVIGSVFL-ITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFP 783

Query: 112  EGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKE 171
            +    Y  +V AT +F     +G G  G+VY+AE+  G+V+A+KK +S    +       
Sbjct: 784  KKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSR--GEGASSDNS 841

Query: 172  FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM 231
            F  E+  L +IRHRNIVKLYGFC H   + L+YE++ +GSL   L        L W+ R 
Sbjct: 842  FRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARY 901

Query: 232  NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTE 290
             +  G A+ L YLHHDC P IVHRDI S N+LLD  F+AHV DFG+AK +    S + + 
Sbjct: 902  RIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSA 961

Query: 291  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-------RDFLSSISSSFLN 343
             AG+YGY+APE AYTMK+TEKCD+YSFGV+ LE+I GK P        D ++ +  S  N
Sbjct: 962  VAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRN 1021

Query: 344  TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIV 391
              I   EM D RL    +    ++  ++++   C + SP SRPTM+ V
Sbjct: 1022 M-IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  253 bits (645), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 153/404 (37%), Positives = 227/404 (56%), Gaps = 29/404 (7%)

Query: 8    DISDNQLQGPVPNSTAFRNASVEALEGNKGLCG----GVKGMQPCKGFLSHKQNSG---A 60
            + S N L GP+P     RN S+ +  GN+GLCG         QP     S  +  G   +
Sbjct: 680  NFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSS 736

Query: 61   KRFAIVFPVLGALLVSMTLVAIFI-LRKRNSDSGDRQRSNQNPHGLFSILNFEGK--LVY 117
            K  AI   V+G   VS+ L+A+ + L +R   +      +  P  +   + F  K    +
Sbjct: 737  KIIAITAAVIGG--VSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTF 794

Query: 118  DEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLP--SDQIVDKKEFLTE 175
             ++V AT++FD  + +G G  G+VY+A LP+G  +A+KK  S     ++  VD   F  E
Sbjct: 795  QDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNS-FRAE 853

Query: 176  VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIK 235
            +  L  IRHRNIVKL+GFC+H   + L+YE++ +GSL  IL   +    L WS+R  +  
Sbjct: 854  ILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIAL 911

Query: 236  GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK-PDSSNWTEFAGT 294
            G A  L+YLHHDC P I HRDI S N+LLD +FEAHV DFG+AK +  P S + +  AG+
Sbjct: 912  GAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGS 971

Query: 295  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-------RDFLSSISSSFLNTDIE 347
            YGY+APE AYTMK+TEK D+YS+GV+ LE++ GK P        D ++ +  S++  D  
Sbjct: 972  YGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWV-RSYIRRDAL 1030

Query: 348  LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIV 391
               +LD RL      +   + +++++   C + SP +RP+M+ V
Sbjct: 1031 SSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQV 1074

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  237 bits (605), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 146/405 (36%), Positives = 218/405 (53%), Gaps = 22/405 (5%)

Query: 8    DISDNQLQGPVPNSTAFRNASVEALEGNKGLCGG-VKGMQPCKGFLSH----KQNSGAKR 62
            + S N L G +P++  F+N ++ +  GNKGLCGG ++   P      H    K  S  + 
Sbjct: 692  NFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSARRG 751

Query: 63   FAIVFPVLGALLVSMTLVAIFILRKRNS-DSGDRQRSNQNPHGLFSILNF--EGKLVYDE 119
              I+        +S+ L+AI +   RN  +       ++ P    S + F  + +    +
Sbjct: 752  RIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKD 811

Query: 120  IVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKE---FLTEV 176
            I+ AT  F   Y +G G  G+VY+A +PSG+ +A+KK  S    +          F  E+
Sbjct: 812  ILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEI 871

Query: 177  EALTEIRHRNIVKLYGFCSH--ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVI 234
              L +IRHRNIV+LY FC H  +  + L+YE++ RGSL  +L     +  + W  R  + 
Sbjct: 872  LTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHG-GKSHSMDWPTRFAIA 930

Query: 235  KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK-PDSSNWTEFAG 293
             G A+ L+YLHHDC P I+HRDI S N+L+D  FEAHV DFG+AK +  P S + +  AG
Sbjct: 931  LGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAG 990

Query: 294  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDF------LSSISSSFLNTDIE 347
            +YGY+APE AYTMK+TEKCD+YSFGV+ LE++ GK P         L++ + + +     
Sbjct: 991  SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHSL 1050

Query: 348  LDEMLDPRLPAPSRSV-QEKLRSIVEVVFSCLNESPESRPTMKIV 391
              E+LDP L      V    + ++ ++   C   SP  RPTM+ V
Sbjct: 1051 TSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREV 1095

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  236 bits (603), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 141/426 (33%), Positives = 227/426 (53%), Gaps = 40/426 (9%)

Query: 1    MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGA 60
            M  L  +++S N L+G +     F     +A  GN GLCG    +  C    S  Q S +
Sbjct: 816  MKSLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAGLCG--SPLSHCNRAGSKNQRSLS 871

Query: 61   KRFAIVFPVLGALL-VSMTLVAIFILRKRNSDSGDRQRSN-----------QNPHGLFSI 108
             +  ++   + +L  +++ ++ I +  K+N D   + R             Q P  LFS 
Sbjct: 872  PKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAP--LFSN 929

Query: 109  LNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVD 168
               +  + +D+I+ AT+  + ++ IG+GG G VY+AEL +G+ +A+KK    L  D ++ 
Sbjct: 930  GGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI---LWKDDLMS 986

Query: 169  KKEFLTEVEALTEIRHRNIVKLYGFCSHARH--SFLVYEFLKRGSLAAILSSDAAAQE-- 224
             K F  EV+ L  IRHR++VKL G+CS      + L+YE++  GS+   L ++   ++  
Sbjct: 987  NKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKE 1046

Query: 225  -LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP 283
             LGW  R+ +  G+A  + YLH+DC PPIVHRDI S N+LLD   EAH+ DFG+AK L  
Sbjct: 1047 VLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTG 1106

Query: 284  DSSNWTE----FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS 339
            +    TE    FAG+YGY+APE AY++K TEK DVYS G++ +E++ GK P + +    +
Sbjct: 1107 NYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEET 1166

Query: 340  SFLN-TDIELD---------EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
              +   +  LD         +++D  L +     +E    ++E+   C    P+ RP+ +
Sbjct: 1167 DMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSR 1226

Query: 390  IVSQQL 395
              S+ L
Sbjct: 1227 QASEYL 1232

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1

 Score =  236 bits (602), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 154/423 (36%), Positives = 219/423 (51%), Gaps = 45/423 (10%)

Query: 1    MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPC-----------K 49
            +  L  ++IS N+  G +P+S  FR      +EGN GLC   KG + C           +
Sbjct: 658  LENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCS--KGFRSCFVSNSSQLTTQR 715

Query: 50   GFLSHKQNSGAKRFAIVFPVLGALLVSMTLVAIFILRKRN-SDSGDRQRSNQ-NPHGLFS 107
            G  SH+          V  VL  L V   + A  ++R  N S++G+   + Q  P   F 
Sbjct: 716  GVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTP---FQ 772

Query: 108  ILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIV 167
             LNF  + V   +V           IG G  G VY+AE+P+ +V+A+KK   P+    + 
Sbjct: 773  KLNFTVEHVLKCLVEGN-------VIGKGCSGIVYKAEMPNREVIAVKKLW-PVTVPNLN 824

Query: 168  DKKE-------FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDA 220
            +K +       F  EV+ L  IRH+NIV+  G C +     L+Y+++  GSL ++L   +
Sbjct: 825  EKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERS 884

Query: 221  AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF 280
                LGW  R  +I G A  L+YLHHDC PPIVHRDI + N+L+  +FE ++ DFG+AK 
Sbjct: 885  GVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKL 944

Query: 281  LK----PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSS 336
            +       SSN    AG+YGY+APE  Y+MKITEK DVYS+GV+ LEV+ GK P D   +
Sbjct: 945  VDDGDFARSSN--TIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPID--PT 1000

Query: 337  ISSSFLNTD----IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
            I       D    I   +++D  L A   S  E++   + V   C+N  PE RPTMK V+
Sbjct: 1001 IPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVA 1060

Query: 393  QQL 395
              L
Sbjct: 1061 AML 1063

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  235 bits (600), Expect = 4e-61,   Method: Compositional matrix adjust.
 Identities = 147/445 (33%), Positives = 224/445 (50%), Gaps = 68/445 (15%)

Query: 4    LSVIDISDNQLQGPVPNSTA----------------------FRNASVEALEGNKGLCGG 41
            L  +D+S NQL G VP S                        F     ++  GN GLCG 
Sbjct: 794  LETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCG- 852

Query: 42   VKGMQPCKGFLSHKQNSG-AKRFAIVFPVLGALLVS--MTLVAIFILRKRN--------- 89
               +  C    S+ +  G + R  ++   + AL     M LV     ++R+         
Sbjct: 853  -SPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHG 911

Query: 90   ----SDSGDRQRSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAE 145
                + S    ++   P  LF     +  + +++I+ AT++   ++ IG+GG G VY+AE
Sbjct: 912  STAYTSSSSSSQATHKP--LFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAE 969

Query: 146  LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH--SFLV 203
            L +G+ VA+KK    L  D ++  K F  EV+ L  IRHR++VKL G+CS      + L+
Sbjct: 970  LENGETVAVKKI---LWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLI 1026

Query: 204  YEFLKRGSLAAILSSDAAAQE-----LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDIS 258
            YE++K GS+   L  D    E     L W  R+ +  G+A  + YLHHDC PPIVHRDI 
Sbjct: 1027 YEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIK 1086

Query: 259  SKNLLLDLEFEAHVADFGIAKFL------KPDSSNWTEFAGTYGYVAPELAYTMKITEKC 312
            S N+LLD   EAH+ DFG+AK L        DS+ W  FA +YGY+APE AY++K TEK 
Sbjct: 1087 SSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTW--FACSYGYIAPEYAYSLKATEKS 1144

Query: 313  DVYSFGVLALEVIKGKHPRDFLSSISSS---FLNTDIEL-----DEMLDPRLPAPSRSVQ 364
            DVYS G++ +E++ GK P D +         ++ T +E+     D+++DP+L       +
Sbjct: 1145 DVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEE 1204

Query: 365  EKLRSIVEVVFSCLNESPESRPTMK 389
            +    ++E+   C   SP+ RP+ +
Sbjct: 1205 DAACQVLEIALQCTKTSPQERPSSR 1229

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  228 bits (582), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 146/427 (34%), Positives = 228/427 (53%), Gaps = 50/427 (11%)

Query: 1    MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGA 60
            +  L  ++IS N   G +P++  FR  S + LEGNK LC   +    C  FL++++ +G 
Sbjct: 657  IENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQ--DSC--FLTYRKGNGL 712

Query: 61   ----------KRFAIVFPVLGALLVSMTLVAIFILR-------KRNSDSGDRQRSNQNPH 103
                      K    +  ++   +V M L A+ ++R       +R+S+ G+  +    P 
Sbjct: 713  GDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQFTP- 771

Query: 104  GLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPS 163
              F  LNF      D+I+R   + +    IG G  G VYRA++ +G+V+A+KK    + +
Sbjct: 772  --FQKLNFS----VDQIIRCLVEPNV---IGKGCSGVVYRADVDNGEVIAVKKLWPAMVN 822

Query: 164  DQIVDKKE-----FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSS 218
                +K +     F  EV+ L  IRH+NIV+  G C +     L+Y+++  GSL ++L  
Sbjct: 823  GGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH- 881

Query: 219  DAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA 278
            +     L W  R  ++ G A  L+YLHHDC PPIVHRDI + N+L+ L+FE ++ADFG+A
Sbjct: 882  ERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLA 941

Query: 279  KFLKPDS----SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL 334
            K +        SN    AG+YGY+APE  Y+MKITEK DVYS+GV+ LEV+ GK P D  
Sbjct: 942  KLVDEGDIGRCSN--TVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPID-- 997

Query: 335  SSISSSFLNTDIELD-----EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
             ++       D         E+LD  L + + +  +++  ++     C+N SP+ RPTMK
Sbjct: 998  PTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMK 1057

Query: 390  IVSQQLQ 396
             V+  L+
Sbjct: 1058 DVAAMLK 1064

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  228 bits (581), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 146/413 (35%), Positives = 225/413 (54%), Gaps = 31/413 (7%)

Query: 4   LSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFL----SHKQNSG 59
           L ++++S N+L GPVP +   +  + + L GN GLCGGV  + PC  F     SH    G
Sbjct: 574 LELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGV--LPPCSKFQRATSSHSSLHG 631

Query: 60  AKRFAIVFPVLGALLV--SMTLVAIFILRKRNSDS--GDRQRS-NQNPHGL--FSILNFE 112
            +  A     + ++L    +T+V   + +K  S+   GD   S  + P  L  F  L F 
Sbjct: 632 KRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFT 691

Query: 113 GKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKE 171
              +    ++ +N       IG G  G VY+AE+  S  V+A+KK        +     +
Sbjct: 692 ASDIL-ACIKESN------MIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGD 744

Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLA-AILSSDAAAQEL-GWSQ 229
           F+ EV  L ++RHRNIV+L GF  + ++  +VYEF+  G+L  AI   +AA + L  W  
Sbjct: 745 FVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVS 804

Query: 230 RMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           R N+  GVA  L+YLHHDC PP++HRDI S N+LLD   +A +ADFG+A+ +       +
Sbjct: 805 RYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMMARKKETVS 864

Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPR--DFLSSIS-----SSFL 342
             AG+YGY+APE  YT+K+ EK D+YS+GV+ LE++ G+ P   +F  S+         +
Sbjct: 865 MVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKI 924

Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             +I L+E LDP +    R VQE++  ++++   C  + P+ RP+M+ V   L
Sbjct: 925 RDNISLEEALDPNV-GNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISML 976

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	397
147767326	1032	hypothetical protein VITISV_008862 [Viti	0.974	0.375	0.585	1e-135
359491509	1032	PREDICTED: probable LRR receptor-like se	0.974	0.375	0.582	1e-134
225456159	1038	PREDICTED: probable LRR receptor-like se	0.979	0.374	0.573	1e-129
147772402	996	hypothetical protein VITISV_022117 [Viti	0.969	0.386	0.567	1e-128
359491512	1078	PREDICTED: probable LRR receptor-like se	0.979	0.360	0.578	1e-128
225456161	1037	PREDICTED: probable LRR receptor-like se	0.977	0.374	0.571	1e-126
297734328	2131	unnamed protein product [Vitis vinifera]	0.931	0.173	0.554	1e-120
356577797	1204	PREDICTED: probable LRR receptor-like se	0.989	0.326	0.523	1e-117
356577829	986	PREDICTED: probable LRR receptor-like se	0.989	0.398	0.520	1e-117
255545702	1008	receptor protein kinase, putative [Ricin	0.989	0.389	0.545	1e-116

>gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera]

 Score =  488 bits (1255), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 234/400 (58%), Positives = 301/400 (75%), Gaps = 13/400 (3%)

Query: 1    MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGA 60
            MHGL  +DIS N LQG +PNS AF+N ++E L+GNKGLCG VKG+QPC+   + K    A
Sbjct: 637  MHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKA 696

Query: 61   KRFAIVFPVLGALLVSMTLVAIFILR--KRNSD---SGDRQRSNQNPHGLFSILNFEGKL 115
              F I+F +LGALL+    + I ++   +RN+    +GD Q  N     LFSI  F+G+ 
Sbjct: 697  -VFIIIFSLLGALLILSAFIGISLISQGRRNAKMEKAGDVQTEN-----LFSISTFDGRT 750

Query: 116  VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTE 175
             Y+ I+ AT DFD  YCIG GGHGSVY+AELPSG +VA+KK H       +  +K+F+ E
Sbjct: 751  TYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHRF--DIDMAHQKDFMNE 808

Query: 176  VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIK 235
            + ALTEI+HRNIVKL GFCSH+RHSFLVYE+L+RGSL  ILS +  A+E+GW  R+N+IK
Sbjct: 809  IRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIK 868

Query: 236  GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY 295
            GVA ALSYLHHDC PPIVHRDISS N+LLD ++EAHV+DFG AKFLK DSSNW+  AGTY
Sbjct: 869  GVAHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTY 928

Query: 296  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR 355
            GYVAPELAYTMK+TEKCDVYSFGVLALEV++G+HP D +SS+S+S    ++ L ++LDPR
Sbjct: 929  GYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSASPGKDNVVLKDVLDPR 988

Query: 356  LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            LP P+   + ++ S++++  +CLN SP+SRPTM++VSQ L
Sbjct: 989  LPPPTLRDEAEVMSVIQLATACLNGSPQSRPTMQMVSQML 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  484 bits (1247), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 233/400 (58%), Positives = 300/400 (75%), Gaps = 13/400 (3%)

Query: 1    MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGA 60
            MHGL  +DIS N LQG +PNS AF+N ++E L+GNKGLCG VKG+QPC+   + K    A
Sbjct: 637  MHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKA 696

Query: 61   KRFAIVFPVLGALLVSMTLVAIFILR--KRNSD---SGDRQRSNQNPHGLFSILNFEGKL 115
              F I+F +LGALL+    + I ++   +RN+    +GD Q  N     LFSI  F+G+ 
Sbjct: 697  -VFIIIFSLLGALLILSAFIGISLISQGRRNAKMEKAGDVQTEN-----LFSISTFDGRT 750

Query: 116  VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTE 175
             Y+ I+ AT DFD  YCIG GGHGSVY+AELPSG +VA+KK H       +  +K+F+ E
Sbjct: 751  TYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHRF--DIDMAHQKDFVNE 808

Query: 176  VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIK 235
            + ALTEI+HRNIVKL GFCSH+RHSFLVYE+L+RGSL  ILS +  A+E+GW  R+N+IK
Sbjct: 809  IRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIK 868

Query: 236  GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY 295
            GV+ ALSYLHHDC PPIVHRDISS N+LLD ++EAHV+DFG AKFLK DSSNW+  AGTY
Sbjct: 869  GVSHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTY 928

Query: 296  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR 355
            GYVAPELAYTMK+TEKCDVYSFGVLALEV++G+HP D +SS+S S    ++ L ++LDPR
Sbjct: 929  GYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSDSPGKDNVVLKDVLDPR 988

Query: 356  LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            LP P+   + ++ S++++  +CLN SP+SRPTM++VSQ L
Sbjct: 989  LPPPTFRDEAEVTSVIQLATACLNGSPQSRPTMQMVSQML 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  468 bits (1203), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 230/401 (57%), Positives = 304/401 (75%), Gaps = 12/401 (2%)

Query: 1    MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCK-GFLSHKQ--- 56
            M  LS +DIS NQLQGP+P+S AFRNA++E L+GNK LCG VKG+QPCK GF   +Q   
Sbjct: 640  MPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVK 699

Query: 57   NSGAKRFAIVFPVLGALLVSMTLVAIFILRKRNSDSGDRQRSN-QNPHGLFSILNFEGKL 115
             S    F I+FP+LGAL++    + IF++ +R   + + +  + QN   LFSI NF+G+ 
Sbjct: 700  KSHKVVFIIIFPLLGALVLLFAFIGIFLIAERRERTPEIEEGDVQN--DLFSISNFDGRT 757

Query: 116  VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD-QIVDKKEFLT 174
            +Y+EI++AT DFD  YCIG GGHGSVY+AELPS  +VA+KK H   PSD ++ ++K+FL 
Sbjct: 758  MYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH---PSDTEMANQKDFLN 814

Query: 175  EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVI 234
            E+ ALTEI+HRNIVKL GFCSH RH FLVYE+L+RGSLA ILS + A ++LGW+ R+N+I
Sbjct: 815  EIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSREEA-KKLGWATRVNII 873

Query: 235  KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT 294
            KGVA AL+Y+HHDC PPIVHRD+SS N+LLD ++EAH++DFG AK LK DSSN +  AGT
Sbjct: 874  KGVAHALAYMHHDCSPPIVHRDVSSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGT 933

Query: 295  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP 354
            +GY+APELAYTMK+TEK DV+SFGV+ALEVIKG+HP D + S+S S    +I L++MLDP
Sbjct: 934  FGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKDNIALEDMLDP 993

Query: 355  RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            RLP  +   + ++ +I++    CL  +P+SRPTM+ VSQ L
Sbjct: 994  RLPPLTPQDEGEVIAILKQAIECLKANPQSRPTMQTVSQML 1034

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera]

 Score =  464 bits (1195), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 230/405 (56%), Positives = 301/405 (74%), Gaps = 20/405 (4%)

Query: 1   MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGA 60
           M GLS +DIS NQLQGP+PNS AFR+A++EAL+GNKGLCG VK ++PCK      Q    
Sbjct: 598 MLGLSDVDISYNQLQGPIPNSKAFRDATIEALKGNKGLCGNVKRLRPCKYGSGVDQQPVK 657

Query: 61  KR----FAIVFPVLGALLVSMTLVAIFILRKRNSDSGDRQRSNQNPHG-----LFSILNF 111
           K     F I+FP+LGAL++    + IF++  R      R+R+ +   G     LFSI  F
Sbjct: 658 KSHKVVFIIIFPLLGALVLLFAFIGIFLIAAR------RERTPEIKEGEVQNDLFSISTF 711

Query: 112 EGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD-QIVDKK 170
           +G+ +Y+EI++AT DFD  YCIG GGHGSVY+AELPS  +VA+KK H   PSD ++ ++K
Sbjct: 712 DGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH---PSDTEMANQK 768

Query: 171 EFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQR 230
           +FL E+ ALTEI+HRNIVKL GFCSH RH FLVYE+L+RGSLA ILS + A ++LGW+ R
Sbjct: 769 DFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSREEA-KKLGWATR 827

Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE 290
           +N+IKGVA AL+Y+HHDC PPIVHRDISS N+LLD ++EAH++DFG AK LK DSSN + 
Sbjct: 828 VNIIKGVAHALAYMHHDCSPPIVHRDISSNNILLDSQYEAHISDFGTAKLLKLDSSNQSI 887

Query: 291 FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE 350
            AGT+GY+APELAYTMK+TEK DV+SFGV+ALEVIKG+HP D + S+S S    +I L++
Sbjct: 888 LAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKDNIALED 947

Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           MLDPRLP  +   + ++ +I++    CL  +P+SRPTM+ VSQ L
Sbjct: 948 MLDPRLPPLTPQDEGEVIAIIKQATECLKANPQSRPTMQTVSQML 992

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  464 bits (1195), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 232/401 (57%), Positives = 301/401 (75%), Gaps = 12/401 (2%)

Query: 1    MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGA 60
            M GLS IDIS NQLQGP+PNS AFR+A++E L+GNK LCG VKG+QPCK      Q    
Sbjct: 647  MRGLSDIDISYNQLQGPIPNSKAFRDATIELLKGNKDLCGNVKGLQPCKNDSGAGQQPVK 706

Query: 61   KR----FAIVFPVLGALLVSMTLVAIFILRKRNSDSGDRQRSN-QNPHGLFSILNFEGKL 115
            K     F IVFP+LGAL++    + IF++ +R   + + +  + QN   LFSI  F+G+ 
Sbjct: 707  KGHKIVFIIVFPLLGALVLLFAFIGIFLIAERTKRTPEIEEGDVQN--DLFSISTFDGRA 764

Query: 116  VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD-QIVDKKEFLT 174
            +Y+EI++AT DFD  YCIG GGHGSVY+AEL SG +VA+KK ++   SD  + ++++F  
Sbjct: 765  MYEEIIKATKDFDPMYCIGKGGHGSVYKAELSSGNIVAVKKLYA---SDIDMANQRDFFN 821

Query: 175  EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVI 234
            EV ALTEI+HRNIVKL GFCSH RHSFLVYE+L+RGSLAA+LS + A ++LGW+ R+N+I
Sbjct: 822  EVRALTEIKHRNIVKLLGFCSHPRHSFLVYEYLERGSLAAMLSREEA-KKLGWATRINII 880

Query: 235  KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT 294
            KGVA ALSY+HHDC PPIVHRDISS N+LLD ++E H++DFG AK LK DSSN +  AGT
Sbjct: 881  KGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEPHISDFGTAKLLKLDSSNQSALAGT 940

Query: 295  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP 354
            +GYVAPE AYTMK+TEK DVYSFGV+ LEVIKG+HP D + S+S S    +I L++MLDP
Sbjct: 941  FGYVAPEHAYTMKVTEKTDVYSFGVITLEVIKGRHPGDQILSLSVSPEKENIVLEDMLDP 1000

Query: 355  RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            RLP  +   + ++ SI+ +  +CL+ +PESRPTMKI+SQ L
Sbjct: 1001 RLPPLTAQDEGEVISIINLATACLSVNPESRPTMKIISQML 1041

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  458 bits (1178), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 229/401 (57%), Positives = 303/401 (75%), Gaps = 13/401 (3%)

Query: 1    MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCK-GFLSHKQ--- 56
            M  LS +DIS NQLQGP+P+S AFRNA++E L+GNK LCG VKG+QPCK GF   +Q   
Sbjct: 640  MPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVK 699

Query: 57   NSGAKRFAIVFPVLGALLVSMTLVAIFILRKRNSDSGDRQRSN-QNPHGLFSILNFEGKL 115
             S    F I+FP+LGAL++    + IF++ +R   + + +  + QN   L SI  F+G+ 
Sbjct: 700  KSHKVVFIIIFPLLGALVLLSAFIGIFLIAERRERTPEIEEGDVQN--NLLSISTFDGRA 757

Query: 116  VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQ-IVDKKEFLT 174
            +Y+EI++AT DFD  YCIG GGHGSVY+AELPSG +VA+KK H   PSD  + ++K+FL 
Sbjct: 758  MYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSGNIVAVKKLH---PSDMDMANQKDFLN 814

Query: 175  EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVI 234
            +V A+TEI+HRNIV+L GFCS+ RHSFLVYE+L+RGSLA ILS + A ++LGW+ R+ +I
Sbjct: 815  KVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSLATILSREEA-KKLGWATRVKII 873

Query: 235  KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT 294
            KGVA ALSY+HHDC PPIVHRDISS N+LLD ++EAH+++ G AK LK DSSN ++ AGT
Sbjct: 874  KGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEAHISNLGTAKLLKVDSSNQSKLAGT 933

Query: 295  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP 354
             GYVAPE AYTMK+TEK DVYSFGV+ALEVIKG+HP D + SIS S    +I L +MLDP
Sbjct: 934  VGYVAPEHAYTMKVTEKTDVYSFGVIALEVIKGRHPGDQILSISVSP-EKNIVLKDMLDP 992

Query: 355  RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            RLP  +   + ++ +I+++  +CLN +P+SRPTM+I+SQ L
Sbjct: 993  RLPPLTPQDEGEVVAIIKLATACLNANPQSRPTMEIISQML 1033

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297734328|emb|CBI15575.3| unnamed protein product [Vitis vinifera]

 Score =  438 bits (1126), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 219/395 (55%), Positives = 291/395 (73%), Gaps = 25/395 (6%)

Query: 1   MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGA 60
           M  LS +DIS NQLQGP+P+S AFRNA++E L+GNK LCG                NS  
Sbjct: 401 MPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCG----------------NSHK 444

Query: 61  KRFAIVFPVLGALLVSMTLVAIFILRKRNSDSGDRQRSN-QNPHGLFSILNFEGKLVYDE 119
             F I+FP+LGAL++    + IF++ +R   + + +  + QN   L SI  F+G+ +Y+E
Sbjct: 445 VVFIIIFPLLGALVLLSAFIGIFLIAERRERTPEIEEGDVQN--NLLSISTFDGRAMYEE 502

Query: 120 IVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQ-IVDKKEFLTEVEA 178
           I++AT DFD  YCIG GGHGSVY+AELPSG +VA+KK H   PSD  + ++K+FL +V A
Sbjct: 503 IIKATKDFDPMYCIGKGGHGSVYKAELPSGNIVAVKKLH---PSDMDMANQKDFLNKVRA 559

Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
           +TEI+HRNIV+L GFCS+ RHSFLVYE+L+RGSLA ILS + A ++LGW+ R+ +IKGVA
Sbjct: 560 MTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSLATILSREEA-KKLGWATRVKIIKGVA 618

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
            ALSY+HHDC PPIVHRDISS N+LLD ++EAH+++ G AK LK DSSN ++ AGT GYV
Sbjct: 619 HALSYMHHDCSPPIVHRDISSNNILLDSQYEAHISNLGTAKLLKVDSSNQSKLAGTVGYV 678

Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           APE AYTMK+TEK DVYSFGV+ALEVIKG+HP D + SIS S    +I L +MLDPRLP 
Sbjct: 679 APEHAYTMKVTEKTDVYSFGVIALEVIKGRHPGDQILSISVS-PEKNIVLKDMLDPRLPP 737

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ 393
            +   + ++ +I+++  +CLN +P+SRPTM+I+SQ
Sbjct: 738 LTPQDEGEVVAIIKLATACLNANPQSRPTMEIISQ 772

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356577797|ref|XP_003557009.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Glycine max]

 Score =  427 bits (1098), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 212/405 (52%), Positives = 287/405 (70%), Gaps = 12/405 (2%)

Query: 1    MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGA 60
            M  L+ IDIS NQ +GP+PN  AF NA +EAL  NKGLCG V G++PC        N   
Sbjct: 793  MTSLTSIDISYNQFEGPLPNILAFHNAKIEALRNNKGLCGNVTGLEPCSTSSGKSHNHMR 852

Query: 61   KRFAIV-FPV-LGALLVSMTLVAIFI-LRKRNSDSGDRQRSNQNPHGLFSILNFEGKLVY 117
            K+  IV  P+ LG L++++    ++  L + +++  D+  S Q P+ +F+I +F+GK+V+
Sbjct: 853  KKVMIVILPLTLGILILALFAFGVWYHLCQTSTNKEDQATSIQTPN-IFAIWSFDGKMVF 911

Query: 118  DEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE 177
            + I+ AT DFD ++ IG GG G VY+A LP+GQVVA+KK HS +P+ ++++ K F  E++
Sbjct: 912  ENIIEATEDFDDKHLIGVGGQGCVYKAVLPTGQVVAVKKLHS-VPNGEMLNLKAFTCEIQ 970

Query: 178  ALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGV 237
            ALTEIRHRNIVKLYGFCSH++ SFLV EFL+ GS+   L  D  A    W +R+NV+K V
Sbjct: 971  ALTEIRHRNIVKLYGFCSHSQFSFLVCEFLENGSVEKTLKDDGQAMAFDWYKRVNVVKDV 1030

Query: 238  ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGY 297
            A+AL Y+HH+C P IVHRDISSKN+LLD E+ AHV+DFG AKFL PDSSNWT F GT+GY
Sbjct: 1031 ANALCYMHHECSPRIVHRDISSKNVLLDSEYVAHVSDFGTAKFLNPDSSNWTSFVGTFGY 1090

Query: 298  VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDI--ELDEM---- 351
             APELAYTM++ EKCDVYSFGVLA E++ GKHP D +SS+  S  +T +   LD M    
Sbjct: 1091 AAPELAYTMEVNEKCDVYSFGVLAWEILVGKHPGDDISSLLGSSPSTLVASTLDHMALMD 1150

Query: 352  -LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             LDPRLP P++ + +++ SI ++  +CL ESP SRPTM+ V+ +L
Sbjct: 1151 KLDPRLPHPTKPIGKEVASIAKIAMACLTESPRSRPTMEQVANEL 1195

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356577829|ref|XP_003557024.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Glycine max]

 Score =  427 bits (1097), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 211/405 (52%), Positives = 284/405 (70%), Gaps = 12/405 (2%)

Query: 1   MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGA 60
           M  L+ IDIS NQ +GP+PN  AF NA +EAL  NKGLCG V G++PC        N   
Sbjct: 575 MTSLTSIDISYNQFEGPLPNILAFHNAKIEALRNNKGLCGNVTGLEPCSTSSGKSHNHMR 634

Query: 61  KRFAIVF--PVLGALLVSMTLVAI-FILRKRNSDSGDRQRSNQNPHGLFSILNFEGKLVY 117
           K+  IV   P LG L++++    + + L + +++  D+  S Q P+ +F+I +F+GK+V+
Sbjct: 635 KKVMIVILPPTLGILILALFAFGVSYHLCQTSTNKEDQATSIQTPN-IFAIWSFDGKMVF 693

Query: 118 DEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE 177
           + I+ AT DFD ++ IG GG G VY+A LP+GQVVA+KK HS +P+ ++++ K F  E++
Sbjct: 694 ENIIEATEDFDDKHLIGVGGQGCVYKAVLPTGQVVAVKKLHS-VPNGEMLNLKAFTCEIQ 752

Query: 178 ALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGV 237
           ALTEIRHRNIVKLYGFCSH++ SFLV EFL+ GS+   L  D  A    W +R+NV+K V
Sbjct: 753 ALTEIRHRNIVKLYGFCSHSQFSFLVCEFLENGSVEKTLKDDGQAMAFDWYKRVNVVKDV 812

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGY 297
           A+AL Y+HH+C P IVHRDISSKN+LLD E+ AHV+DFG AKFL PDSSNWT F GT+GY
Sbjct: 813 ANALCYMHHECSPRIVHRDISSKNVLLDSEYVAHVSDFGTAKFLNPDSSNWTSFVGTFGY 872

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSI--SSSFLNTDIELDEM---- 351
            APELAYTM++ EKCDVYSFGVLA E++ GKHP D +SS+  SS  +     LD M    
Sbjct: 873 AAPELAYTMEVNEKCDVYSFGVLAWEILIGKHPGDVISSLLESSPSILVASTLDHMALMD 932

Query: 352 -LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            LD RLP P++ + +++ SI ++  +CL ESP SRPTM+ V+ +L
Sbjct: 933 KLDQRLPHPTKPIGKEVASIAKIAMACLTESPRSRPTMEQVANEL 977

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis]

 Score =  425 bits (1093), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 218/400 (54%), Positives = 293/400 (73%), Gaps = 7/400 (1%)

Query: 1    MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGA 60
            MHGLS IDIS N+L+GPVP++ AF+N+S+EA +GNKGLCG V+G+QPCK   S +Q S  
Sbjct: 611  MHGLSSIDISYNKLEGPVPDNKAFQNSSIEAFQGNKGLCGHVQGLQPCKPS-STEQGSSI 669

Query: 61   KR-----FAIVFPVLGALLVSMTLVAIFILRKRNSDSGDRQRSNQNPHGLFSILNFEGKL 115
            K        I  P+ GA L+   L  +F   KR+ ++ + ++S+Q    +  I +F+GK 
Sbjct: 670  KFHKRLFLVISLPLFGAFLILSFLGVLFFQSKRSKEALEAEKSSQESEEILLITSFDGKS 729

Query: 116  VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTE 175
            ++DEI+ AT+ F+  YCIG GG GSVY+A+L SG  VA+KK H    + +   +KEF +E
Sbjct: 730  MHDEIIEATDSFNDIYCIGKGGCGSVYKAKLSSGSTVAVKKLHQSHDAWKPY-QKEFWSE 788

Query: 176  VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIK 235
            + ALTEI+HRNIVK YGFCS++ +SFLVYE +++GSLA IL  + AA+EL W +R N+IK
Sbjct: 789  IRALTEIKHRNIVKFYGFCSYSAYSFLVYECIEKGSLATILRDNEAAKELEWFKRANIIK 848

Query: 236  GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY 295
            GVA+ALSY+HHDC PPIVHRDISSKN+LLD E EA V+DFGIA+ L  DSS+ T  AGT+
Sbjct: 849  GVANALSYMHHDCSPPIVHRDISSKNILLDSENEARVSDFGIARILNLDSSHRTALAGTF 908

Query: 296  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR 355
            GY+APELAY++ +TEKCDVYSFGVLALEVI GKHP + +SSISSS     + L+ ++D R
Sbjct: 909  GYMAPELAYSIVVTEKCDVYSFGVLALEVINGKHPGEIISSISSSSSTRKMLLENIVDLR 968

Query: 356  LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            LP PS  VQ +L +I+ + F+CLN +P+ RPTM+++   L
Sbjct: 969  LPFPSPEVQVELVNILNLAFTCLNSNPQVRPTMEMICHML 1008

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	397
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.982	0.373	0.498	4e-106
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.972	0.344	0.473	8.7e-98
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.967	0.348	0.367	5.5e-66
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.947	0.341	0.359	5.7e-62
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.964	0.340	0.360	1.2e-61
TAIR|locus:2168907	966	XIP1 "XYLEM INTERMIXED WITH PH	0.952	0.391	0.383	1.6e-61
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.977	0.309	0.325	2.2e-61
TAIR|locus:2139885	1013	AT4G28650 [Arabidopsis thalian	0.962	0.377	0.341	1.1e-57
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.949	0.375	0.363	2.1e-57
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.964	0.335	0.342	2.5e-57

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 1015 (362.4 bits), Expect = 4.0e-106, Sum P(2) = 4.0e-106
 Identities = 199/399 (49%), Positives = 271/399 (67%)

Query:     1 MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGV---KGMQPCKGFLSHKQN 57
             M  L+ +D+S N LQGP+P++ AFRNA  +A EGNK LCG V   +G++PC    S K +
Sbjct:   645 MLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSH 704

Query:    58 SGAKRFA-IVFPVLGALLVSMTLVAIFI-LRKRNSDSGDRQRSNQNPHGLFSILNFEGKL 115
                     I+ P++GA+++      IFI  RKR     +   S      L SI +F+GK+
Sbjct:   705 KDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETL-SIFSFDGKV 763

Query:   116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD--QIVDKKEFL 173
              Y EI++AT +FD +Y IG GGHG VY+A+LP+  ++A+KK +    S       K+EFL
Sbjct:   764 RYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFL 822

Query:   174 TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNV 233
              E+ ALTEIRHRN+VKL+GFCSH R++FLVYE+++RG            ++L W +R+NV
Sbjct:   823 NEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINV 882

Query:   234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG 293
             +KGVA ALSY+HHD  P IVHRDISS N+LL  ++EA ++DFG AK LKPDSSNW+  AG
Sbjct:   883 VKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAG 942

Query:   294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD 353
             TYGYVAPELAY MK+TEKCDVYSFGVL LEVIKG+HP D +S++SSS  +  + L  + D
Sbjct:   943 TYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISD 1002

Query:   354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
              RLP P+  ++E++  I++V   CL+  P++RPTM  +S
Sbjct:  1003 HRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 941 (336.3 bits), Expect = 8.7e-98, Sum P(2) = 8.7e-98
 Identities = 189/399 (47%), Positives = 267/399 (66%)

Query:     1 MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGV--KGMQPCKGFLSHKQNS 58
             M  L+ +DIS+N+L+GP+P++  FR A+ +ALE N GLC  +  + ++PC+     K+N 
Sbjct:   724 MIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNG 783

Query:    59 GAKRFAIVFPVLGALLVSMTLVA---IFILRKRNSDSGDRQRSNQNPHGLFSILNFEGKL 115
                 + +V P+LG L++ +++ A    + +RKR   +G R    +    + SI + +GK 
Sbjct:   784 NLVVWILV-PILGVLVI-LSICANTFTYCIRKRKLQNG-RNTDPETGENM-SIFSVDGKF 839

Query:   116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD--QIVDKKEFL 173
              Y +I+ +TN+FD  + IG GG+  VYRA L    ++A+K+ H  +  +  + V K+EFL
Sbjct:   840 KYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFL 898

Query:   174 TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNV 233
              EV+ALTEIRHRN+VKL+GFCSH RH+FL+YE++++G            + L W++R+NV
Sbjct:   899 NEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINV 958

Query:   234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG 293
             +KGVA ALSY+HHD   PIVHRDISS N+LLD ++ A ++DFG AK LK DSSNW+  AG
Sbjct:   959 VKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAG 1018

Query:   294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD 353
             TYGYVAPE AYTMK+TEKCDVYSFGVL LE+I GKHP D +SS+SSS     + L  + D
Sbjct:  1019 TYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSS-PGEALSLRSISD 1077

Query:   354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
              R+  P    +EKL  +VE+   CL  +PESRPTM  +S
Sbjct:  1078 ERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 647 (232.8 bits), Expect = 5.5e-66, Sum P(2) = 5.5e-66
 Identities = 148/403 (36%), Positives = 213/403 (52%)

Query:     4 LSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKG-MQPCKGFLSHKQN---SG 59
             L + +IS+N L G VP++  F+        GN GLC   +   QP       K N   +G
Sbjct:   670 LLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLING 729

Query:    60 AKR---FAIVFPVLGALLVSMTLVAIFILRKRNSDSGDRQRSNQNPHGLFSILNFEGKLV 116
             ++R     I   V+G++ + +T + +    KR   +         P  + S    +    
Sbjct:   730 SQRQKILTITCIVIGSVFL-ITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFT 788

Query:   117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEV 176
             Y  +V AT +F     +G G  G+VY+AE+  G+V+A+KK +S    +       F  E+
Sbjct:   789 YQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSR--GEGASSDNSFRAEI 846

Query:   177 EALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG 236
               L +IRHRNIVKLYGFC H   + L+YE++ +G              L W+ R  +  G
Sbjct:   847 STLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALG 906

Query:   237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGTY 295
              A+ L YLHHDC P IVHRDI S N+LLD  F+AHV DFG+AK +    S + +  AG+Y
Sbjct:   907 AAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSY 966

Query:   296 GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-------RDFLSSISSSFLNTDIEL 348
             GY+APE AYTMK+TEKCD+YSFGV+ LE+I GK P        D ++ +  S  N  I  
Sbjct:   967 GYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNM-IPT 1025

Query:   349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIV 391
              EM D RL    +    ++  ++++   C + SP SRPTM+ V
Sbjct:  1026 IEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 624 (224.7 bits), Expect = 5.7e-62, Sum P(2) = 5.7e-62
 Identities = 145/403 (35%), Positives = 221/403 (54%)

Query:     8 DISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGM----QPCKGFLSHKQNSG---A 60
             + S N L GP+P     RN S+ +  GN+GLCG         QP     S  +  G   +
Sbjct:   680 NFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSS 736

Query:    61 KRFAIVFPVLGALLVSMTLVAIFILRKRNSDSGDRQRSNQNPHGLFSILNFEGK--LVYD 118
             K  AI   V+G + + +  + ++++R+         +  Q P  +   + F  K    + 
Sbjct:   737 KIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQ-PSEMSLDIYFPPKEGFTFQ 795

Query:   119 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLP--SDQIVDKKEFLTEV 176
             ++V AT++FD  + +G G  G+VY+A LP+G  +A+KK  S     ++  VD   F  E+
Sbjct:   796 DLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNS-FRAEI 854

Query:   177 EALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG 236
               L  IRHRNIVKL+GFC+H   + L+YE++ +G              L WS+R  +  G
Sbjct:   855 LTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIALG 912

Query:   237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK-PDSSNWTEFAGTY 295
              A  L+YLHHDC P I HRDI S N+LLD +FEAHV DFG+AK +  P S + +  AG+Y
Sbjct:   913 AAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSY 972

Query:   296 GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-------RDFLSSISSSFLNTDIEL 348
             GY+APE AYTMK+TEK D+YS+GV+ LE++ GK P        D ++ + S ++  D   
Sbjct:   973 GYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRS-YIRRDALS 1031

Query:   349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIV 391
               +LD RL      +   + +++++   C + SP +RP+M+ V
Sbjct:  1032 SGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQV 1074

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 616 (221.9 bits), Expect = 1.2e-61, Sum P(2) = 1.2e-61
 Identities = 146/405 (36%), Positives = 219/405 (54%)

Query:     8 DISDNQLQGPVPNSTAFRNASVEALEGNKGLCGG-VKGMQPCKGFLSHKQN--SGAKRFA 64
             + S N L G +P++  F+N ++ +  GNKGLCGG ++   P      H  +  +G+ R  
Sbjct:   692 NFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSARRG 751

Query:    65 IVFPVLGALL--VSMTLVAIFILRKRNS-DSGDRQRSNQNPHGLFSILNFEGK--LVYDE 119
              +  ++ +++  +S+ L+AI +   RN  +       ++ P    S + F  K      +
Sbjct:   752 RIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKD 811

Query:   120 IVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKK---EFLTEV 176
             I+ AT  F   Y +G G  G+VY+A +PSG+ +A+KK  S    +          F  E+
Sbjct:   812 ILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEI 871

Query:   177 EALTEIRHRNIVKLYGFCSH--ARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVI 234
               L +IRHRNIV+LY FC H  +  + L+YE++ RG              + W  R  + 
Sbjct:   872 LTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKS-HSMDWPTRFAIA 930

Query:   235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK-PDSSNWTEFAG 293
              G A+ L+YLHHDC P I+HRDI S N+L+D  FEAHV DFG+AK +  P S + +  AG
Sbjct:   931 LGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAG 990

Query:   294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSS---ISSSFLN--TDIEL 348
             +YGY+APE AYTMK+TEKCD+YSFGV+ LE++ GK P   L     +++   N   D  L
Sbjct:   991 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHSL 1050

Query:   349 -DEMLDPRLPAPSRSV-QEKLRSIVEVVFSCLNESPESRPTMKIV 391
               E+LDP L      V    + ++ ++   C   SP  RPTM+ V
Sbjct:  1051 TSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREV 1095

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 594 (214.2 bits), Expect = 1.6e-61, Sum P(2) = 1.6e-61
 Identities = 157/409 (38%), Positives = 221/409 (54%)

Query:     7 IDISDNQLQGPVPNSTAFRNASVEALEGNKGLC-GGVKGMQPCKGFLSHKQNSGAKRFAI 65
             I+ S N+L GP+P S   R   VE+   N  LC     G    K F   ++  G K+ + 
Sbjct:   536 INFSSNRLSGPIPVSL-IRGGLVESFSDNPNLCIPPTAGSSDLK-FPMCQEPHGKKKLSS 593

Query:    66 VFPVLGALLVSMTLVAIFILRKRNSDSG---DRQRSNQNPHGLFSILNFEGKLVYD--EI 120
             ++ +L ++ + +  V +F LR+R S +    ++  +  +    + + +F  ++ +D  EI
Sbjct:   594 IWAILVSVFILVLGVIMFYLRQRMSKNRAVIEQDETLASSFFSYDVKSFH-RISFDQREI 652

Query:   121 VRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIV-DK----KEFLTE 175
             + +  D   +  +G+GG G+VYR EL SG+VVA+KK  S    D    DK    KE  TE
Sbjct:   653 LESLVD---KNIVGHGGSGTVYRVELKSGEVVAVKKLWSQSNKDSASEDKMHLNKELKTE 709

Query:   176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
             VE L  IRH+NIVKL+ + S    S LVYE++  G             E  W  R  +  
Sbjct:   710 VETLGSIRHKNIVKLFSYFSSLDCSLLVYEYMPNGNLWDALHKGFVHLE--WRTRHQIAV 767

Query:   236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP--DSSNWTEFAG 293
             GVA  L+YLHHD  PPI+HRDI S N+LLD+ ++  VADFGIAK L+     S  T  AG
Sbjct:   768 GVAQGLAYLHHDLSPPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGKDSTTTVMAG 827

Query:   294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN---TDIE--- 347
             TYGY+APE AY+ K T KCDVYSFGV+ +E+I GK P D     + + +N   T I+   
Sbjct:   828 TYGYLAPEYAYSSKATIKCDVYSFGVVLMELITGKKPVDSCFGENKNIVNWVSTKIDTKE 887

Query:   348 -LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
              L E LD RL   S S +  + + + V   C + +P  RPTM  V Q L
Sbjct:   888 GLIETLDKRL---SESSKADMINALRVAIRCTSRTPTIRPTMNEVVQLL 933

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 593 (213.8 bits), Expect = 2.2e-61, Sum P(2) = 2.2e-61
 Identities = 138/424 (32%), Positives = 222/424 (52%)

Query:     1 MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGA 60
             M  L  +++S N L+G +     F     +A  GN GLCG    +  C    S  Q S +
Sbjct:   816 MKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGSP--LSHCNRAGSKNQRSLS 871

Query:    61 KRFAIVFPVLGALL-VSMTLVAIFILRKRNSD---------SGDRQRSNQNPHGLFSILN 110
              +  ++   + +L  +++ ++ I +  K+N D         S     S+ +   LFS   
Sbjct:   872 PKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGG 931

Query:   111 FEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKK 170
              +  + +D+I+ AT+  + ++ IG+GG G VY+AEL +G+ +A+KK    L  D ++  K
Sbjct:   932 AKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI---LWKDDLMSNK 988

Query:   171 EFLTEVEALTEIRHRNIVKLYGFCSHARH--SFLVYEFLKRGXXXXXXXXXXXXQE---L 225
              F  EV+ L  IRHR++VKL G+CS      + L+YE++  G            ++   L
Sbjct:   989 SFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVL 1048

Query:   226 GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS 285
             GW  R+ +  G+A  + YLH+DC PPIVHRDI S N+LLD   EAH+ DFG+AK L  + 
Sbjct:  1049 GWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNY 1108

Query:   286 SNWTE----FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF 341
                TE    FAG+YGY+APE AY++K TEK DVYS G++ +E++ GK P + +    +  
Sbjct:  1109 DTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDM 1168

Query:   342 LN-TDIELD---------EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIV 391
             +   +  LD         +++D  L +     +E    ++E+   C    P+ RP+ +  
Sbjct:  1169 VRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQA 1228

Query:   392 SQQL 395
             S+ L
Sbjct:  1229 SEYL 1232

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)]

 Score = 568 (205.0 bits), Expect = 1.1e-57, Sum P(2) = 1.1e-57
 Identities = 141/413 (34%), Positives = 215/413 (52%)

Query:     4 LSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFL----SHKQNSG 59
             L ++++S N+L GPVP +   +  + + L GN GLCGGV  + PC  F     SH    G
Sbjct:   574 LELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGV--LPPCSKFQRATSSHSSLHG 631

Query:    60 AKRFA-IVFPVLGALLVS-MTLVAIFILRK--RNSDSGDRQRSNQN-PHGL--FSILNFE 112
              +  A  +  +   L +  +T+V   + +K   N   GD   S    P  L  F  L F 
Sbjct:   632 KRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFT 691

Query:   113 GKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKE 171
                +    ++ +N       IG G  G VY+AE+  S  V+A+KK        +     +
Sbjct:   692 ASDIL-ACIKESN------MIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGD 744

Query:   172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQEL--GWSQ 229
             F+ EV  L ++RHRNIV+L GF  + ++  +VYEF+  G              L   W  
Sbjct:   745 FVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVS 804

Query:   230 RMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
             R N+  GVA  L+YLHHDC PP++HRDI S N+LLD   +A +ADFG+A+ +       +
Sbjct:   805 RYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMMARKKETVS 864

Query:   290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD--FLSSIS-----SSFL 342
               AG+YGY+APE  YT+K+ EK D+YS+GV+ LE++ G+ P +  F  S+         +
Sbjct:   865 MVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKI 924

Query:   343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
               +I L+E LDP +    R VQE++  ++++   C  + P+ RP+M+ V   L
Sbjct:   925 RDNISLEEALDPNV-GNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISML 976

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 564 (203.6 bits), Expect = 2.1e-57, Sum P(2) = 2.1e-57
 Identities = 149/410 (36%), Positives = 212/410 (51%)

Query:     1 MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCK------GFLSH 54
             M  L+ +D S N L G VP +  F   +  +  GN  LCG   G  PCK      G  SH
Sbjct:   574 MQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLG--PCKDGVAKGGHQSH 631

Query:    55 KQNSGAKRFAIVFPVLGALLVSMTLVAIFILRKRNSDSGDRQRSNQNPHGLFSILNFEGK 114
              +   +    ++  VLG L+ S+    + I++ R+       R+ +     F  L+F   
Sbjct:   632 SKGPLSASMKLLL-VLGLLVCSIAFAVVAIIKARSLKKASESRAWRLT--AFQRLDFTCD 688

Query:   115 LVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLT 174
              V D + +  N       IG GG G VY+  +P+G +VA+K+  + +      D   F  
Sbjct:   689 DVLDSL-KEDN------IIGKGGAGIVYKGVMPNGDLVAVKRL-AAMSRGSSHDHG-FNA 739

Query:   175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVI 234
             E++ L  IRHR+IV+L GFCS+   + LVYE++  G              L W  R  + 
Sbjct:   740 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH-LHWDTRYKIA 798

Query:   235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFA 292
                A  L YLHHDC P IVHRD+ S N+LLD  FEAHVADFG+AKFL+   ++   +  A
Sbjct:   799 LEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIA 858

Query:   293 GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-RDFLSSISS-SFLN--TDIEL 348
             G+YGY+APE AYT+K+ EK DVYSFGV+ LE++ G+ P  +F   +    ++   TD   
Sbjct:   859 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTDSNK 918

Query:   349 D---EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             D   ++LDPRL   S  + E +  +  V   C+ E    RPTM+ V Q L
Sbjct:   919 DSVLKVLDPRLS--SIPIHE-VTHVFYVAMLCVEEQAVERPTMREVVQIL 965

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 564 (203.6 bits), Expect = 2.5e-57, Sum P(2) = 2.5e-57
 Identities = 144/421 (34%), Positives = 228/421 (54%)

Query:     1 MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSG- 59
             +  L  ++IS N   G +P++  FR  S + LEGNK LC   +    C  FL++++ +G 
Sbjct:   657 IENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQ--DSC--FLTYRKGNGL 712

Query:    60 -----AKRFAIVFPVLGALLVSMTLV-----AIFILRKRNSDSGDRQRSNQNPHGLFSIL 109
                  A R   +   L ALL+++T+V     A+ ++R R +   +R  S       +   
Sbjct:   713 GDDGDASRTRKLRLTL-ALLITLTVVLMILGAVAVIRARRNIDNERD-SELGETYKWQFT 770

Query:   110 NFEGKLVY--DEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIV 167
              F+ KL +  D+I+R   + +    IG G  G VYRA++ +G+V+A+KK    + +    
Sbjct:   771 PFQ-KLNFSVDQIIRCLVEPNV---IGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHD 826

Query:   168 DKKE-----FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXX 222
             +K +     F  EV+ L  IRH+NIV+  G C +     L+Y+++  G            
Sbjct:   827 EKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGS 886

Query:   223 QELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL- 281
               L W  R  ++ G A  L+YLHHDC PPIVHRDI + N+L+ L+FE ++ADFG+AK + 
Sbjct:   887 S-LDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVD 945

Query:   282 KPDSSNWTE-FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS 340
             + D    +   AG+YGY+APE  Y+MKITEK DVYS+GV+ LEV+ GK P D   ++   
Sbjct:   946 EGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPID--PTVPEG 1003

Query:   341 FLNTD-IELD----EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
                 D +  +    E+LD  L + + +  +++  ++     C+N SP+ RPTMK V+  L
Sbjct:  1004 IHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAML 1063

Query:   396 Q 396
             +
Sbjct:  1064 K 1064

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	397
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-49
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-46
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-43
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-42
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-41
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-34
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-33
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-30
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-27
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-27
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-26
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-25
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-25
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-25
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-23
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-23
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-22
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-22
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-21
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-21
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-21
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-20
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-18
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-18
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-18
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-17
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-13
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-06
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	6e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	5e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.003

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  166 bits (423), Expect = 3e-49
 Identities = 80/261 (30%), Positives = 122/261 (46%), Gaps = 17/261 (6%)

Query: 132 CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL 190
            +G+G  G+VY+A    +G++VA+K       S++    +    E+  L  + H NIV+L
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKIL--KKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
                   H +LV E+ + G L   LS       L   +   +   +   L YLH +   
Sbjct: 64  IDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHSN--- 117

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKIT 309
            I+HRD+  +N+LLD      +ADFG+AK L   SS+ T F GT  Y+APE L       
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 310 EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIEL-DEMLDPRLPAPSRSVQEKLR 368
            K DV+S GV+  E++ GK P  F    S   +   ++L   +L P L            
Sbjct: 178 PKVDVWSLGVILYELLTGKPP--F----SGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231

Query: 369 SIVEVVFSCLNESPESRPTMK 389
              +++  CLN+ P  RPT +
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAE 252

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  165 bits (420), Expect = 3e-49
 Identities = 76/260 (29%), Positives = 116/260 (44%), Gaps = 54/260 (20%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G GG G+VY A    +G+ VAIK       S      +E L E+E L ++ H NIVKLY
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLY 57

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G      H +LV E+ + GSL  +L  +    +L   + + ++  + + L YLH +    
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSN---G 112

Query: 252 IVHRDISSKNLLLD-LEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKIT 309
           I+HRD+  +N+LLD    +  +ADFG++K L  D S      GT  Y+APE L      +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 310 EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS 369
           EK D++S GV+  E                                           L  
Sbjct: 173 EKSDIWSLGVILYE-------------------------------------------LPE 189

Query: 370 IVEVVFSCLNESPESRPTMK 389
           + +++   L + PE RP+ K
Sbjct: 190 LKDLIRKMLQKDPEKRPSAK 209

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  160 bits (406), Expect = 1e-46
 Identities = 77/264 (29%), Positives = 122/264 (46%), Gaps = 31/264 (11%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G VY A +  +G++VAIK            D++  L E++ L +++H NIV+LY
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIK---KKKIKKDRERILREIKILKKLKHPNIVRLY 63

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                    +LV E+ + G L  +L       E    +    ++ +  AL YLH      
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFYLRQILSALEYLHSKG--- 117

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           IVHRD+  +N+LLD +    +ADFG+A+ L P     T F GT  Y+APE+       + 
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLGKGYGKA 176

Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML------DPRLPAPSRSVQE 365
            D++S GV+  E++ GK P          F   D +L E+        P  P P   +  
Sbjct: 177 VDIWSLGVILYELLTGKPP----------FPG-DDQLLELFKKIGKPKPPFPPPEWDISP 225

Query: 366 KLRSIVEVVFSCLNESPESRPTMK 389
           + + ++      L + PE R T +
Sbjct: 226 EAKDLIR---KLLVKDPEKRLTAE 246

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  152 bits (386), Expect = 1e-43
 Identities = 78/281 (27%), Positives = 117/281 (41%), Gaps = 47/281 (16%)

Query: 133 IGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  G VY+  L          VA+K         QI   +EFL E   + ++ H NI
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI---EEFLREARIMRKLDHPNI 63

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           VKL G C+      +V E++  G L   L      +EL  S  ++    +A  + YL   
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN----------WTEFAGTYGY 297
                +HRD++++N L+       ++DFG+++ L  D             W         
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-------- 171

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDP-- 354
            APE     K T K DV+SFGVL  E+   G+ P   +S         + E+ E L    
Sbjct: 172 -APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS---------NAEVLEYLKKGY 221

Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           RLP P     E    + +++  C  E PE RPT   + + L
Sbjct: 222 RLPKPPNCPPE----LYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  150 bits (382), Expect = 3e-43
 Identities = 76/281 (27%), Positives = 120/281 (42%), Gaps = 48/281 (17%)

Query: 133 IGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  G VY+ +L          VA+K         QI   +EFL E   + ++ H N+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI---EEFLREARIMRKLDHPNV 63

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           VKL G C+     ++V E+++ G L + L       +L  S  ++    +A  + YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN----------WTEFAGTYGY 297
                +HRD++++N L+       ++DFG+++ L  D             W         
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-------- 170

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDP-- 354
            APE     K T K DV+SFGVL  E+   G+ P   +S         + E+ E L    
Sbjct: 171 -APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS---------NEEVLEYLKNGY 220

Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           RLP P     E    + +++  C  E PE RPT   + + L
Sbjct: 221 RLPQPPNCPPE----LYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  147 bits (373), Expect = 8e-42
 Identities = 82/271 (30%), Positives = 125/271 (46%), Gaps = 36/271 (13%)

Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
            F+    IG GG G VY+A    +G+ VAIK     L S +   K++ + E++ L + +H
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKE--KKEKIINEIQILKKCKH 56

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN------VIKGVA 238
            NIVK YG        ++V EF   GSL  +L S         +Q +       V K + 
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS--------TNQTLTESQIAYVCKELL 108

Query: 239 DALSYLH--HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
             L YLH        I+HRDI + N+LL  + E  + DFG++  L  D+       GT  
Sbjct: 109 KGLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPY 162

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           ++APE+        K D++S G+ A+E+ +GK P   L  + + F            P L
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-----PGL 217

Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
             P +   E  +  ++    CL ++PE RPT
Sbjct: 218 RNPEKWSDE-FKDFLK---KCLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  144 bits (367), Expect = 7e-41
 Identities = 69/287 (24%), Positives = 112/287 (39%), Gaps = 59/287 (20%)

Query: 133 IGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  G VY+  L      +   VA+K            +++EFL E   + ++ H NI
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSHPNI 63

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH-H 246
           V+L G C+     ++V E++  G L   L      ++L     + +   +A  + YL   
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH--GEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS-----------NWTEFAGTY 295
           +     VHRD++++N L+       ++DFG+++ +  D              W       
Sbjct: 122 NF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------ 171

Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVI-------KGKHPRDFLSSISSSFLNTDIEL 348
              APE     K T K DV+SFGVL  E+         G    + L  +           
Sbjct: 172 ---APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED--------- 219

Query: 349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
                 RLP P     E    + E++  C    PE RPT   + + L
Sbjct: 220 ----GYRLPRPENCPDE----LYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  150 bits (381), Expect = 9e-40
 Identities = 109/409 (26%), Positives = 192/409 (46%), Gaps = 54/409 (13%)

Query: 7   IDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVK--GMQPCKGFLSHKQNSGAKRFA 64
           ++IS N L G +P++ AF   +  A+ GN  LCGG    G+ PCK             + 
Sbjct: 576 VNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPS-----WWF 630

Query: 65  IVFPVLGALLVSMTLVA---IFILRKRNSDSGDRQRSNQNPHGLFSILNFEGK----LVY 117
            +   LGA LV + LVA   +FI  + N +     +  +N  G + +  F+ K    +  
Sbjct: 631 YITCTLGAFLV-LALVAFGFVFIRGRNNLEL----KRVENEDGTWELQFFDSKVSKSITI 685

Query: 118 DEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQ----VVAIKKFHSPLPSDQIVDKKEFL 173
           ++I+ +  +   +  I  G  G+ Y+ +         V  I   +S +PS +I D     
Sbjct: 686 NDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIAD----- 736

Query: 174 TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNV 233
                + +++H NIVKL G C   + ++L++E+++  +L+ +L +      L W +R  +
Sbjct: 737 -----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKI 785

Query: 234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG 293
             G+A AL +LH  C P +V  ++S + +++D + E H+    +   L  D+  +   A 
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA- 843

Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN------TDIE 347
              YVAPE   T  ITEK D+Y FG++ +E++ GK P D    +  S +       +D  
Sbjct: 844 ---YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH 900

Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           LD  +DP +       Q ++  ++ +   C    P +RP    V + L+
Sbjct: 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  140 bits (356), Expect = 3e-39
 Identities = 70/287 (24%), Positives = 121/287 (42%), Gaps = 50/287 (17%)

Query: 133 IGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G VY+ +L         VA+K   +        ++K+FL E   + ++ H N+V
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVK---TLKEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 189 KLYGFCSHARHSFLVYEFLKRGSL------AAILSSDAAAQELGWSQRMNVIKGVADALS 242
           +L G C+     +LV E+++ G L      +  +        L     ++    +A  + 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN-----------WTEF 291
           YL        VHRD++++N L+  +    ++DFG+++ +  D              W   
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-- 174

Query: 292 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDE 350
                  APE       T K DV+SFGVL  E+   G  P      +S    N ++ L+ 
Sbjct: 175 -------APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---YPGLS----NEEV-LEY 219

Query: 351 MLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +    RLP P     ++L  ++    SC    PE RPT   + ++L+
Sbjct: 220 LRKGYRLPKPE-YCPDELYELML---SCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  127 bits (322), Expect = 2e-34
 Identities = 74/275 (26%), Positives = 123/275 (44%), Gaps = 35/275 (12%)

Query: 132 CIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL 190
            +G G  GSVY A    +G+++A+K     L  D   + +    E+  L+ ++H NIV+ 
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKS--VELSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 191 YGFC-SHARHSFLVY-EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA----DALSYL 244
           YG      +++  ++ E++  GSL+++L       E        VI+       + L+YL
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAYL 117

Query: 245 H-HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE--FAGTYGYVAPE 301
           H +     IVHRDI   N+L+D +    +ADFG AK L    +        GT  ++APE
Sbjct: 118 HSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR 361
           +    +     D++S G   +E+  GK P   L +   + L       E   P +P    
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-PMAALYKIGSSGEP--PEIPE--- 227

Query: 362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            + E+ +  +     CL   P+ RPT     + LQ
Sbjct: 228 HLSEEAKDFLR---KCLRRDPKKRPT---ADELLQ 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  124 bits (314), Expect = 4e-33
 Identities = 77/269 (28%), Positives = 120/269 (44%), Gaps = 26/269 (9%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           +D +    +G G  G VY+    P+G++ A+KK H          +K+ L E++ L    
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVD---GDEEFRKQLLRELKTLRSCE 57

Query: 184 HRNIVKLYG-FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM--NVIKGVADA 240
              +VK YG F      S +V E++  GSLA     D   +     + +   + + +   
Sbjct: 58  SPYVVKCYGAFYKEGEIS-IVLEYMDGGSLA-----DLLKKVGKIPEPVLAYIARQILKG 111

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           L YLH      I+HRDI   NLL++ + E  +ADFGI+K L+        F GT  Y++P
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169

Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE--MLDPRLPA 358
           E       +   D++S G+  LE   GK P  FL     SF     EL +     P    
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFP--FLPPGQPSF----FELMQAICDGPPPSL 223

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPT 387
           P+     + R  +    +CL + P+ RP+
Sbjct: 224 PAEEFSPEFRDFIS---ACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  121 bits (304), Expect = 7e-32
 Identities = 76/264 (28%), Positives = 138/264 (52%), Gaps = 20/264 (7%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G+G  G V+     +   VAIK     L SD ++ +++F  EV+AL  +RH++++ L+ 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKI----LKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            CS     +++ E +++GSL A L S    Q L  +  +++   VA+ ++YL        
Sbjct: 70  VCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ---NS 125

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKC 312
           +HRD++++N+L+  +    VADFG+A+ +K D    ++    Y + APE A     + K 
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKS 185

Query: 313 DVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
           DV+SFG+L  E+   G+ P   ++       N ++        R+P P++  QE    I 
Sbjct: 186 DVWSFGILLYEMFTYGQVPYPGMN-------NHEVYDQITAGYRMPCPAKCPQE----IY 234

Query: 372 EVVFSCLNESPESRPTMKIVSQQL 395
           +++  C    PE RP+ K + ++L
Sbjct: 235 KIMLECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  123 bits (309), Expect = 1e-31
 Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 20/270 (7%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH-RNIVKLY 191
           +G G  G VY A     ++VA+K     L S    + + FL E++ L  + H  NIVKLY
Sbjct: 8   LGEGSFGEVYLARDR--KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLY 64

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
            F       +LV E++  GSL  +L        L  S+ + ++  +  AL YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121

Query: 252 IVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSSN------WTEFAGTYGYVAPELAY 304
           I+HRDI  +N+LLD +     + DFG+AK L    S        +   GT GY+APE+  
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 305 TM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP-- 359
            +     +   D++S G+   E++ G  P +   + S++     I + E+  P L +P  
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI-ILELPTPSLASPLS 240

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
             + +   ++  +++   L + P++R +  
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSSS 270

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 4e-30
 Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 22/260 (8%)

Query: 132 CIGNGGHGSVYRAE-LPSGQVVAIKKFH-SPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
            IG G  G VY+   L +G  VAIK+     +  + +   K  + E++ L  ++H NIVK
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL---KSIMQEIDLLKNLKHPNIVK 63

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
             G    +   +++ E+ + GSL  I+       E   S     +  V   L+YLH    
Sbjct: 64  YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE---SLVAVYVYQVLQGLAYLHEQ-- 118

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKIT 309
             ++HRDI + N+L   +    +ADFG+A  L   S +     GT  ++APE+      +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177

Query: 310 EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS 369
              D++S G   +E++ G  P   L+ +++ F    I  D+   P LP     +  +L+ 
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALF---RIVQDDH--PPLPE---GISPELK- 228

Query: 370 IVEVVFSCLNESPESRPTMK 389
             + +  C  + P  RPT K
Sbjct: 229 --DFLMQCFQKDPNLRPTAK 246

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 6e-30
 Identities = 78/267 (29%), Positives = 132/267 (49%), Gaps = 27/267 (10%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G+G  G V+  +      VAIK       S+      +F+ E + + ++ H N+V+LYG
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-----DFIEEAKVMMKLSHPNLVQLYG 66

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C+  R  F+V E++  G L   L       +LG    +++   V +A+ YL  + F   
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLR--ERKGKLGTEWLLDMCSDVCEAMEYLESNGF--- 121

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSNWTEFAGTYGYVAPELAYTMKIT 309
           +HRD++++N L+  +    V+DFG+A+++  D   SS  T+F     +  PE+    + +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFS 179

Query: 310 EKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
            K DV+SFGVL  EV  +GK P +  S       N+++        RL  P  +  E   
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFS-------NSEVVESVSAGYRLYRPKLAPTE--- 229

Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQL 395
            +  +++SC +E PE RP  K +  QL
Sbjct: 230 -VYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  114 bits (288), Expect = 3e-29
 Identities = 76/262 (29%), Positives = 118/262 (45%), Gaps = 32/262 (12%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G VY+A +  +G+ VAIKK    L       K+  + E+  + + +H NIV  Y
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMR--LRKQN---KELIINEILIMKDCKHPNIVDYY 81

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN------VIKGVADALSYLH 245
                    ++V E++  GSL  I++            RMN      V + V   L YLH
Sbjct: 82  DSYLVGDELWVVMEYMDGGSLTDIIT--------QNFVRMNEPQIAYVCREVLQGLEYLH 133

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
                 ++HRDI S N+LL  +    +ADFG A  L  + S      GT  ++APE+   
Sbjct: 134 SQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR 190

Query: 306 MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
                K D++S G++ +E+ +G+ P      + + FL T   +     P L  P +   E
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-----PPLKNPEKWSPE 245

Query: 366 KLRSIVEVVFSCLNESPESRPT 387
             +  +     CL + PE RP+
Sbjct: 246 -FKDFLN---KCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 1e-27
 Identities = 74/272 (27%), Positives = 123/272 (45%), Gaps = 30/272 (11%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G  G VY+  L     VA+K   S LP D    K++FL E E L +  H NIVKL G
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C   +  ++V E +  GSL   L        +   + + +    A  + YL        
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLESKN---C 114

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT----YGYVAPELAYTMKI 308
           +HRD++++N L+       ++DFG+++  + +   +T   G       + APE     + 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 309 TEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDP--RLPAPSRSVQE 365
           T + DV+S+G+L  E    G  P   +S         + +  E ++   R+PAP +   E
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMS---------NQQTRERIESGYRMPAP-QLCPE 222

Query: 366 KLRSIVEVVFSCLNESPESRPTMKIVSQQLQI 397
           ++  ++     C    PE+RP+   +  +LQI
Sbjct: 223 EIYRLML---QCWAYDPENRPSFSEIYNELQI 251

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 1e-27
 Identities = 76/263 (28%), Positives = 126/263 (47%), Gaps = 35/263 (13%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH---RNIV 188
           IG G +G+VYR   +P+G+VVA+K  +   P D + D +    EV  L+++R     NI 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR---EVALLSQLRQSQPPNIT 65

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           K YG        +++ E+ + GS+  ++     A  +       +I+ V  AL Y+H   
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHKV- 120

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI 308
              ++HRDI + N+L+       + DFG+A  L  +SS  + F GT  ++APE+     I
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV-----I 173

Query: 309 TE------KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
           TE      K D++S G+   E+  G  P   + +  +  L     + +   PRL     S
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-----IPKSKPPRLEDNGYS 228

Query: 363 VQEKLRSIVEVVFSCLNESPESR 385
                + + E V +CL+E P+ R
Sbjct: 229 -----KLLREFVAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  108 bits (272), Expect = 3e-27
 Identities = 68/210 (32%), Positives = 113/210 (53%), Gaps = 18/210 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLT-----EVEALTEIRHRN 186
           IG+G  GSVY      SG+++A+K+   P  S    D+K  +      E+  L E++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH 246
           IV+  G    A H  +  E++  GS+AA+L++  A +E   +   N ++ +   L+YLH+
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT------EFAGTYGYVAP 300
                I+HRDI   N+L+D +    ++DFGI+K L+ +S +           G+  ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+      T K D++S G L +E++ GKHP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 74/276 (26%), Positives = 132/276 (47%), Gaps = 41/276 (14%)

Query: 133 IGNGGHGSVYRA--ELPSGQV--VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G V R   +LP  +   VAIK   +     Q   + +FLTE   + +  H NI+
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ---RLDFLTEASIMGQFDHPNII 68

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + +R   ++ E+++ GSL   L  +    +    Q + +++G+A  + YL    
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG--YVAPE-LAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+   + +T   G     + APE +AY 
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 306 MKITEKCDVYSFGVLALEVIK-GKHP------RDFLSSISSSFLNTDIELDEMLDPRLPA 358
            K T   DV+SFG++  EV+  G+ P      +D + ++   +             RLP 
Sbjct: 184 -KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-------------RLPP 229

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTM-KIVSQ 393
           P         ++ +++  C  +    RPT  +IVS 
Sbjct: 230 PMDCPS----ALYQLMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  105 bits (263), Expect = 5e-26
 Identities = 79/265 (29%), Positives = 127/265 (47%), Gaps = 23/265 (8%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
             FD    +G G +GSVY+A    +GQVVAIK     +P ++  D +E + E+  L +  
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKV----VPVEE--DLQEIIKEISILKQCD 56

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
              IVK YG        ++V E+   GS++ I+      + L   +   ++      L Y
Sbjct: 57  SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEY 114

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH       +HRDI + N+LL+ E +A +ADFG++  L    +      GT  ++APE+ 
Sbjct: 115 LH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI 171

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
             +    K D++S G+ A+E+ +GK P   +  + + F+   I       P  P P+ S 
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM---I-------PNKPPPTLSD 221

Query: 364 QEKLRS-IVEVVFSCLNESPESRPT 387
            EK      + V  CL + PE RP+
Sbjct: 222 PEKWSPEFNDFVKKCLVKDPEERPS 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  104 bits (262), Expect = 8e-26
 Identities = 76/287 (26%), Positives = 117/287 (40%), Gaps = 47/287 (16%)

Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
            ++    IG G  G VY       G++  +K+    L +    ++++ L EV+ L ++ H
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKE--IDLSNMSEKEREDALNEVKILKKLNH 58

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQE-------LGW-SQRMNVIKG 236
            NI+K Y          +V E+   G L+  +       +       L W  Q       
Sbjct: 59  PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------- 111

Query: 237 VADALSYLH--HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT 294
           +  AL YLH        I+HRDI  +N+ L       + DFGI+K L           GT
Sbjct: 112 LCLALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGT 166

Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDF----LSSISSSFLNTDIELDE 350
             Y++PEL        K D++S G +  E+   KHP  F    L  ++   L        
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP--FEGENLLELALKILKGQYP--- 221

Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI 397
                 P PS+   E LR++V    S L + PE RP+   ++Q LQ 
Sbjct: 222 ------PIPSQYSSE-LRNLVS---SLLQKDPEERPS---IAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 9e-26
 Identities = 74/268 (27%), Positives = 131/268 (48%), Gaps = 26/268 (9%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+     +   VA+K           +D K+FL E + + ++RH  +++LY 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKP-----GTMDPKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C+     ++V E +K GSL   L   A    L   Q +++   VA  ++YL    +   
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQNY--- 124

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD++++N+L+       VADFG+A+ +K D     E A     + APE A   + + K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184

Query: 312 CDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--RLPAPSRSVQEKLR 368
            DV+SFG+L  E++  G+ P   +         T+ E+ + +D   R+P P    +E   
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGM---------TNAEVLQQVDQGYRMPCPPGCPKE--- 232

Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            + +++  C  E P+ RPT + +  +L+
Sbjct: 233 -LYDIMLDCWKEDPDDRPTFETLQWKLE 259

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 1e-25
 Identities = 80/286 (27%), Positives = 123/286 (43%), Gaps = 51/286 (17%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
            +      IG G  G V   +   GQ VA+K        D     + FL E   +T +RH
Sbjct: 6   KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCL-----KDDSTAAQAFLAEASVMTTLRH 59

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
            N+V+L G        ++V E++ +GSL   L S   A  +  +Q++     V + + YL
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYL 118

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSS----NWTEFAGTYGYV 298
               F   VHRD++++N+L+  +  A V+DFG+AK      DS      WT         
Sbjct: 119 EEKNF---VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------- 166

Query: 299 APELAYTMKITEKCDVYSFGVLALEVI---KGKHPRDFLSSISSSFLNTDIELDEMLDP- 354
           APE     K + K DV+SFG+L  E+    +  +PR              I L +++   
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR--------------IPLKDVVPHV 212

Query: 355 ----RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
               R+ AP     E    + +V+  C    P  RPT K + +QL 
Sbjct: 213 EKGYRMEAPEGCPPE----VYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 2e-25
 Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 43/277 (15%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
             F    CIG G  G VY+A +  + QVVAIK        D+I D      E++ L++ R
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED---IQQEIQFLSQCR 57

Query: 184 HRNIVKLYGFCSHARHSFL-------VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG 236
              I K YG       SFL       + E+   GS   +L       +L  +    +++ 
Sbjct: 58  SPYITKYYG-------SFLKGSKLWIIMEYCGGGSCLDLLKP----GKLDETYIAFILRE 106

Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
           V   L YLH +     +HRDI + N+LL  E +  +ADFG++  L    S    F GT  
Sbjct: 107 VLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF 163

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM----L 352
           ++APE+       EK D++S G+ A+E+ KG+ P                +L  M    L
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS--------------DLHPMRVLFL 209

Query: 353 DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            P+   PS    +  +   + V  CLN+ P+ RP+ K
Sbjct: 210 IPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAK 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  103 bits (258), Expect = 2e-25
 Identities = 74/269 (27%), Positives = 135/269 (50%), Gaps = 31/269 (11%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G+G  G V+  +  +   VAIK  +    S++     +F+ E + + ++ H  +V+LYG
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-----DFIEEAKVMMKLSHPKLVQLYG 66

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C+  +  ++V EF++ G L   L       +L     +++ + V + + YL  + F   
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNSF--- 121

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSNWTEFAGTYGYVAPELAYTMKIT 309
           +HRD++++N L+       V+DFG+ +++  D   SS+  +F     +  PE+    K +
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP--VKWSPPEVFNFSKYS 179

Query: 310 EKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL- 367
            K DV+SFGVL  EV  +GK P  F          ++ E+ EM+        R  + KL 
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMP--FEKK-------SNYEVVEMIS----RGFRLYRPKLA 226

Query: 368 -RSIVEVVFSCLNESPESRPTMKIVSQQL 395
             ++ EV++SC +E PE RPT   + + +
Sbjct: 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  102 bits (257), Expect = 3e-25
 Identities = 78/269 (28%), Positives = 122/269 (45%), Gaps = 18/269 (6%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           +D++    IG G    VY A  LP+ + VAIK+    L   Q     E   EV+A+++  
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRID--LEKCQT-SVDELRKEVQAMSQCN 57

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           H N+VK Y         +LV  +L  GSL  I+ S      L  +    V+K V   L Y
Sbjct: 58  HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW----TEFAGTYGYVA 299
           LH +     +HRDI + N+LL  +    +ADFG++  L             F GT  ++A
Sbjct: 118 LHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+   +     K D++SFG+ A+E+  G  P      +    + T ++ D    P L  
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLT-LQNDP---PSLET 229

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPT 387
                ++  +S  +++  CL + P  RPT
Sbjct: 230 -GADYKKYSKSFRKMISLCLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 4e-25
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A +  +G++VAIKK    L  +     K  L E++ L E+ H NI+KL 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIK--LRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH-HDCFP 250
               H    +LV+EF+    L  ++      + L  S   + +  +   L++ H H    
Sbjct: 65  DVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL- 120

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI-T 309
              HRD+  +NLL++ E    +ADFG+A+        +T +  T  Y APEL    K  +
Sbjct: 121 ---HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177

Query: 310 EKCDVYSFGVLALEVIKGK 328
              D++S G +  E++  +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  102 bits (255), Expect = 6e-25
 Identities = 63/225 (28%), Positives = 111/225 (49%), Gaps = 22/225 (9%)

Query: 171 EFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQR 230
           EF+ E + + ++ H  +V+LYG C+  R  ++V E++  G L   L      +    SQ 
Sbjct: 45  EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE--HGKRFQPSQL 102

Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSN 287
           + + K V + ++YL    F   +HRD++++N L+D +    V+DFG+++++  D   SS 
Sbjct: 103 LEMCKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159

Query: 288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI 346
            ++F   +    PE+    K + K DV++FGVL  EV   GK P +        F N++ 
Sbjct: 160 GSKFPVRWS--PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE-------RFNNSET 210

Query: 347 ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIV 391
                   RL  P          +  +++SC +E  E RPT + +
Sbjct: 211 VEKVSQGLRLYRP----HLASEKVYAIMYSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  101 bits (252), Expect = 1e-24
 Identities = 78/275 (28%), Positives = 133/275 (48%), Gaps = 43/275 (15%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G V+       + VAIK       S++     +F+ E + + ++ H  +V+LYG
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-----DFIEEAQVMMKLSHPKLVQLYG 66

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAA--AQELGWSQRMNVIKGVADALSYLHHDCFP 250
            C+      LV+EF++ G L+  L +     +QE      ++V +G+A    YL      
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA----YLESSNV- 121

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSNWTEFAGTYGYVAPELAYTMK 307
             +HRD++++N L+       V+DFG+ +F+  D   SS  T+F     + +PE+    K
Sbjct: 122 --IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP--VKWSSPEVFSFSK 177

Query: 308 ITEKCDVYSFGVLALEVI-KGKHPRD------FLSSISSSFLNTDIELDEMLDPRLPAPS 360
            + K DV+SFGVL  EV  +GK P +       + +I++ F         +  PRL +  
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--------RLYKPRLAS-- 227

Query: 361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
                  +S+ E++  C  E PE RP+  ++  QL
Sbjct: 228 -------QSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 99.8 bits (249), Expect = 6e-24
 Identities = 76/287 (26%), Positives = 129/287 (44%), Gaps = 43/287 (14%)

Query: 133 IGNGGHGSVYRAELPSGQ------VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G V+  E    +      +VA+K       +D    +K+F  E E LT  +H N
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA---RKDFEREAELLTNFQHEN 69

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSS-----------DAAAQELGWSQRMNVIK 235
           IVK YG C+      +V+E+++ G L   L S           D+   EL  SQ + +  
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            +A  + YL    F   VHRD++++N L+  +    + DFG+++ +   ++++    G  
Sbjct: 130 QIASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSRDVY--TTDYYRVGGHT 184

Query: 295 ---YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
                ++ PE     K T + DV+SFGV+  E+   GK P   LS       N   E+ E
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-------NE--EVIE 235

Query: 351 MLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +   RL    R+       + +++  C    P+ R  +K + ++LQ
Sbjct: 236 CITQGRLLQRPRTCP---SEVYDIMLGCWKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 67/214 (31%), Positives = 99/214 (46%), Gaps = 32/214 (14%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIK--KFHSPLPS--DQIVDKKEFLTEVEALTEIRHRNI 187
           IG G  G VY A  L +G+++A+K  +     P    +I D      E++ L  ++H N+
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD------EMKVLELLKHPNL 61

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA----DALSY 243
           VK YG   H    ++  E+   G+L  +L       E G     +VI+       + L+Y
Sbjct: 62  VKYYGVEVHREKVYIFMEYCSGGTLEELL-------EHGRILDEHVIRVYTLQLLEGLAY 114

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE----FAGTYGYVA 299
           LH      IVHRDI   N+ LD      + DFG A  LK +++   E     AGT  Y+A
Sbjct: 115 LHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171

Query: 300 PELAYTMKITEK---CDVYSFGVLALEVIKGKHP 330
           PE+    K        D++S G + LE+  GK P
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 82/277 (29%), Positives = 118/277 (42%), Gaps = 41/277 (14%)

Query: 133 IGNGGHGSV----YRAELPSGQV--VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  GSV    Y   + SG+   VA+K             KKEFL E   + ++ H  
Sbjct: 3   LGHGNFGSVVKGVYL--MKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPC 57

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH 246
           IV+L G C       LV E    G L   L      +E+  S    +   VA  ++YL  
Sbjct: 58  IVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLES 113

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG-----YVAPE 301
             F   VHRD++++N+LL    +A ++DFG+++ L   S  +   A T G     + APE
Sbjct: 114 KHF---VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPE 168

Query: 302 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--RLPA 358
                K + K DV+S+GV   E    G  P   +            E+  ML+   RLP 
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM---------KGAEVIAMLESGERLPR 219

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           P    QE    I  ++ SC    PE RPT   +    
Sbjct: 220 PEECPQE----IYSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 96.8 bits (242), Expect = 4e-23
 Identities = 76/266 (28%), Positives = 114/266 (42%), Gaps = 44/266 (16%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALTEIRHRNIV 188
           +G G  G V    +  +G++ A+K         +I+ +KE    LTE   L+ I H  IV
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKK----KKIIKRKEVEHTLTERNILSRINHPFIV 56

Query: 189 KL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVAD---ALSYL 244
           KL Y F +     +LV E+   G L + LS +    E   ++        A+   AL YL
Sbjct: 57  KLHYAFQTE-EKLYLVLEYAPGGELFSHLSKEGRFSE-ERARFY-----AAEIVLALEYL 109

Query: 245 H-HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           H       I++RD+  +N+LLD +    + DFG+AK L  + S    F GT  Y+APE+ 
Sbjct: 110 HSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL 165

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSS----ISSSFLNTDIELDEMLDPRLPAP 359
                 +  D +S GVL  E++ GK P  F +     I    L   +   E L P     
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPP--FYAEDRKEIYEKILKDPLRFPEFLSPE---- 219

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESR 385
                   R ++      L + P  R
Sbjct: 220 -------ARDLIS---GLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 97.0 bits (242), Expect = 4e-23
 Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 52/272 (19%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +  + FL E + + ++RH  +V+LY 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKP-----GTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            CS     ++V E++ +GSL   L S    ++L   Q +++   +A+ ++YL    +   
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNY--- 124

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN----------WTEFAGTYGYVAPEL 302
           +HRD++++N+L+       +ADFG+A+ ++ D             WT         APE 
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT---------APEA 175

Query: 303 AYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELDEMLDPR 355
           A   + T K DV+SFG+L  E++  G+ P      R+ L  +   +             R
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-------------R 222

Query: 356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
           +P P    +E    + +++  C ++ PE RPT
Sbjct: 223 MPRPPNCPEE----LYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 97.4 bits (242), Expect = 4e-23
 Identities = 73/258 (28%), Positives = 117/258 (45%), Gaps = 22/258 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G V++  +  + QVVAIK        D+I D ++   E+  L++     + K Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G        +++ E+L  GS   +L     A      Q   ++K +   L YLH +    
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---K 121

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
            +HRDI + N+LL  + +  +ADFG+A  L         F GT  ++APE+        K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181

Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            D++S G+ A+E+ KG+ P   +  +   F          L P+   P+    E  +   
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPMRVLF----------LIPKNNPPTL-TGEFSKPFK 230

Query: 372 EVVFSCLNESPESRPTMK 389
           E + +CLN+ P  RPT K
Sbjct: 231 EFIDACLNKDPSFRPTAK 248

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 96.9 bits (242), Expect = 5e-23
 Identities = 68/268 (25%), Positives = 124/268 (46%), Gaps = 19/268 (7%)

Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           D++    IG G  G+V +      G+++  K+      +++  +K++ ++EV  L E++H
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK--EKQQLVSEVNILRELKH 58

Query: 185 RNIVKLYG-FCSHARHS-FLVYEFLKRGSLAAILS-SDAAAQELGWSQRMNVIKGVADAL 241
            NIV+ Y      +  + ++V E+ + G LA ++       + +       ++  +  AL
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 242 SYLHH--DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              H+  D    ++HRD+   N+ LD      + DFG+AK L  DSS    + GT  Y++
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           PE    M   EK D++S G L  E+     P  F    + + L    ++ E    R+P  
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPP--FT---ARNQLQLASKIKEGKFRRIPY- 232

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPT 387
                 +L  +++   S LN  P+ RP+
Sbjct: 233 --RYSSELNEVIK---SMLNVDPDKRPS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 96.7 bits (241), Expect = 9e-23
 Identities = 72/266 (27%), Positives = 127/266 (47%), Gaps = 22/266 (8%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G+G  G VY+A+     + A  K       +++ D   F+ E++ L+E +H NIV LY 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECKHPNIVGLYE 69

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
              +    +++ EF   G+L +I+      + L   Q   V + + +AL++LH      +
Sbjct: 70  AYFYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH---KV 124

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY--TMKITE 310
           +HRD+ + N+LL L+ +  +ADFG++   K        F GT  ++APE+    T K   
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 311 ---KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL 367
              K D++S G+  +E+ + + P   L+ +        I   E   P L  PS+      
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHELNPMRVLL---KILKSE--PPTLDQPSKWS---- 235

Query: 368 RSIVEVVFSCLNESPESRPTMKIVSQ 393
            S  + + SCL + P+ RPT   + +
Sbjct: 236 SSFNDFLKSCLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 96.1 bits (239), Expect = 1e-22
 Identities = 70/237 (29%), Positives = 118/237 (49%), Gaps = 25/237 (10%)

Query: 133 IGNGGHGSVYRAEL-PSG---QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G V R  L   G     VAIK   S     Q   +++FL+E   + +  H NI+
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ---RRDFLSEASIMGQFDHPNII 68

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
            L G  + +R   ++ EF++ G+L + L  +    +    Q + +++G+A  + YL    
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN 126

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG-----YVAPELA 303
           +   VHRD++++N+L++      V+DFG+++FL+ D+S+ T  +   G     + APE  
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 304 YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP 359
              K T   DV+S+G++  EV+  G+ P   +S       N D+      D RLP P
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-------NQDVINAIEQDYRLPPP 233

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 96.5 bits (240), Expect = 1e-22
 Identities = 70/242 (28%), Positives = 115/242 (47%), Gaps = 37/242 (15%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRHRNIVKL 190
           IG G  G+VY A ++ +GQ VAIK+ +      Q   KKE +  E+  + E +H NIV  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNL---QQQ--PKKELIINEILVMRENKHPNIVNY 81

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
                     ++V E+L  GSL  +++ +    E    Q   V +    AL +LH +   
Sbjct: 82  LDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDE---GQIAAVCRECLQALEFLHSN--- 134

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            ++HRDI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 311 KCDVYSFGVLALEVIKGKHP-----------------------RDFLSSISSSFLNTDIE 347
           K D++S G++A+E+++G+ P                        + LS+I   FLN  +E
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 254

Query: 348 LD 349
           +D
Sbjct: 255 MD 256

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 94.5 bits (235), Expect = 3e-22
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)

Query: 126 DFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           DF+    IG G  G V++    +  +V A+K+    L      +++E + E   L ++  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQID--LSKMNRREREEAIDEARVLAKLDS 58

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAA---AQELGWSQRMNVIKGVADAL 241
             I++ Y          +V E+ + G L  +L         ++  W   + ++ G    L
Sbjct: 59  SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
           ++LH      I+HRDI S NL LD      + D G+AK L  +++      GT  Y++PE
Sbjct: 115 AHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRD 332
           L       EK DV++ GV+  E   GKHP D
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 39/274 (14%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +GNG  G V+         VA+K       S +      FL E + + ++RH  +V+LY 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-----SFLEEAQIMKKLRHDKLVQLYA 68

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +GSL   L  D   + L     +++   VA  ++Y+    +   
Sbjct: 69  VVSE-EPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIERMNY--- 123

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           +HRD+ S N+L+       +ADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 310 EKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E++ KG+ P      R+ L  +   +             R+P P   
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-------------RMPCP--- 225

Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            Q+   S+ E++  C  + PE RPT + +   L+
Sbjct: 226 -QDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 65/262 (24%), Positives = 112/262 (42%), Gaps = 23/262 (8%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V +    P+G+++A+K     +       +K+ L E++ L +     IV  Y
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE---AIQKQILRELDILHKCNSPYIVGFY 65

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G   +     +  E++  GSL  IL        +       +   V   L+YLH      
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKILKE--VQGRIPERILGKIAVAVLKGLTYLHEKH--K 121

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           I+HRD+   N+L++   +  + DFG++  L    +    F GT  Y+APE       + K
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVK 179

Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE-LDEMLD---PRLPAPSRSVQEKL 367
            D++S G+  +E+  G+ P    +       +   E L  +++   PRLP+   S     
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPP----DGIFELLQYIVNEPPPRLPSGKFS----- 230

Query: 368 RSIVEVVFSCLNESPESRPTMK 389
               + V  CL + P  RP+ K
Sbjct: 231 PDFQDFVNLCLIKDPRERPSYK 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 5e-22
 Identities = 79/283 (27%), Positives = 128/283 (45%), Gaps = 41/283 (14%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G +G V +     +G++VAIKKF      D+ V KK  L EV+ L ++RH NIV L 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKE-SEDDEDV-KKTALREVKVLRQLRHENIVNLK 66

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH-HDCFP 250
                    +LV+E+++R  L  +   +A+   L      + I  +  A++Y H H+   
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCHSHN--- 120

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLK-PDSSNWTEFAGTYGYVAPEL-----AY 304
            I+HRDI  +N+L+       + DFG A+ L+   +S  T++  T  Y APEL      Y
Sbjct: 121 -IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179

Query: 305 TMKITEKCDVYSFGVLALEVIK------GKHPRDFLSSISSSFLNTDIELDEML--DPR- 355
              +    DV++ G +  E++       G    D L  I            E+   +PR 
Sbjct: 180 GKPV----DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235

Query: 356 ----LPAPSR--SVQEKLRSIV-----EVVFSCLNESPESRPT 387
                P PS+  S++ +    V     + + +CL   P+ R T
Sbjct: 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 93.5 bits (232), Expect = 1e-21
 Identities = 71/271 (26%), Positives = 123/271 (45%), Gaps = 39/271 (14%)

Query: 130 QYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR 185
           Q  IG G  G V+R  L         VAIK         Q  D   FL+E   + +  H 
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD---FLSEASIMGQFSHH 66

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
           NI++L G  +  + + ++ E+++ G+L   L       E    Q + +++G+A  + YL 
Sbjct: 67  NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLS 124

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGTYG--YVAPEL 302
              +   VHRD++++N+L++   E  V+DFG+++ L+ D    +T   G     + APE 
Sbjct: 125 DMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181

Query: 303 AYTMKITEKCDVYSFGVLALEVIK-GKHP------RDFLSSISSSFLNTDIELDEMLDPR 355
               K T   DV+SFG++  EV+  G+ P       + + +I+  F             R
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-------------R 228

Query: 356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRP 386
           LPAP     +   ++ +++  C  +    RP
Sbjct: 229 LPAP----MDCPSAVYQLMLQCWQQDRARRP 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 81/270 (30%), Positives = 125/270 (46%), Gaps = 28/270 (10%)

Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPL-PSDQIVDKKEFLTEVEALTEIR 183
           D++    IG+G +G VY+A ++ +G++VAIK     L P D   D +    E+  L E R
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVI--KLEPGD---DFEIIQQEISMLKECR 58

Query: 184 HRNIVKLYGFCSHARHSFL--VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADAL 241
           H NIV  +G  S+ R   L  V E+   GSL  I         L   Q   V +     L
Sbjct: 59  HPNIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIAYVCRETLKGL 114

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
           +YLH       +HRDI   N+LL  + +  +ADFG++  L    +    F GT  ++APE
Sbjct: 115 AYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPE 171

Query: 302 LA---YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           +A          KCD+++ G+ A+E+ + + P   L  + + FL   I       P+L  
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL---ISKSNFPPPKLKD 228

Query: 359 PSR-SVQEKLRSIVEVVFSCLNESPESRPT 387
             + S         + +  CL + P+ RPT
Sbjct: 229 KEKWSPV-----FHDFIKKCLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 92.6 bits (230), Expect = 2e-21
 Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 17/197 (8%)

Query: 133 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G +G VY          VA+K        +  ++ +EFL E   + EI+H N+V+L 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G C+     +++ EF+  G+L   L  +   QE+     + +   ++ A+ YL    F  
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF-- 125

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPE-LAYTMK 307
            +HRD++++N L+       VADFG+++ +  D+  +T  AG      + APE LAY  K
Sbjct: 126 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-K 181

Query: 308 ITEKCDVYSFGVLALEV 324
            + K DV++FGVL  E+
Sbjct: 182 FSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.4 bits (229), Expect = 2e-21
 Identities = 72/274 (26%), Positives = 123/274 (44%), Gaps = 39/274 (14%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK       S +      FL E + + ++RH  +V+LY 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-----AFLQEAQVMKKLRHEKLVQLYA 68

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +GSL   L  +     L   Q +++   +A  ++Y+    +   
Sbjct: 69  VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNY--- 123

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           VHRD+ + N+L+       VADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 310 EKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P   
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPP-- 226

Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             E   S+ +++  C  + PE RPT + +   L+
Sbjct: 227 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 92.6 bits (230), Expect = 2e-21
 Identities = 72/266 (27%), Positives = 122/266 (45%), Gaps = 23/266 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIK--KFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G G   S Y+A ++ +G ++A+K   +     S+Q    +    E+  +  + H +I++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
           + G      H  L  E++  GS++ +LS   A +E   +  +N  + +   LSYLH +  
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122

Query: 250 PPIVHRDISSKNLLLDLEFE-AHVADFGIAKFLKPDSSNWTEFA----GTYGYVAPELAY 304
             I+HRD+   NLL+D   +   +ADFG A  L    +   EF     GT  ++APE+  
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 305 TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ 364
             +    CDV+S G + +E+   K P +     S+        L   +     AP  S+ 
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWN-AEKHSNHL-----ALIFKIASATTAP--SIP 233

Query: 365 EKLRSIV-EVVFSCLNESPESRPTMK 389
           E L   + +V   CL   PE RP  +
Sbjct: 234 EHLSPGLRDVTLRCLELQPEDRPPSR 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 92.1 bits (229), Expect = 4e-21
 Identities = 71/283 (25%), Positives = 108/283 (38%), Gaps = 50/283 (17%)

Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  G V           +G+ VA+K  +         D   F  E+E L  + H NI
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTLDHENI 68

Query: 188 VKLYGFC--SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
           VK  G C     R   L+ E+L  GSL   L        L   + +     +   + YL 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLG 126

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV------- 298
                  +HRD++++N+L++ E    ++DFG+AK L  D          Y YV       
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD--------YYYVKEPGESP 175

Query: 299 ----APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML-- 352
               APE   T K +   DV+SFGV   E+    +     S  +       I   +M+  
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELF--TYGDPSQSPPAEFLRMIGIAQGQMIVT 233

Query: 353 --------DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
                     RLP P     E    + +++  C    P+ RP+
Sbjct: 234 RLLELLKEGERLPRPPSCPDE----VYDLMKLCWEAEPQDRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 92.0 bits (228), Expect = 5e-21
 Identities = 78/288 (27%), Positives = 134/288 (46%), Gaps = 46/288 (15%)

Query: 133 IGNGGHGSVYRAEL----PSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G V+ AE     P+    +VA+K    P     +  +K+F  E E LT ++H +
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEH 68

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSS---DA----------AAQELGWSQRMNV 233
           IVK YG C       +V+E++K G L   L +   DA          A  ELG SQ +++
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG 293
              +A  + YL    F   VHRD++++N L+       + DFG+++ +   S+++    G
Sbjct: 129 ASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGG 183

Query: 294 ----TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIEL 348
                  ++ PE     K T + DV+SFGV+  E+   GK P      +S++ +   I  
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---WFQLSNTEVIECITQ 240

Query: 349 DEMLD-PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             +L+ PR+  P        + + +++  C    P+ R  +K + + L
Sbjct: 241 GRVLERPRV-CP--------KEVYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 91.2 bits (227), Expect = 5e-21
 Identities = 68/220 (30%), Positives = 95/220 (43%), Gaps = 19/220 (8%)

Query: 127 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKE----FLTEVEALTE 181
           F+    IG G  G V   +   + ++ A+K       + Q   +K      L E   L E
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYM-----NKQKCVEKGSVRNVLNERRILQE 56

Query: 182 IRHRNIVKL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADA 240
           + H  +V L Y F     + +LV + L  G L   LS      E    Q    I  +  A
Sbjct: 57  LNHPFLVNLWYSFQDE-ENMYLVVDLLLGGDLRYHLSQKVKFSE---EQVKFWICEIVLA 112

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           L YLH      I+HRDI   N+LLD +   H+ DF IA  + PD+   T  +GT GY+AP
Sbjct: 113 LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-TSTSGTPGYMAP 168

Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS 340
           E+      +   D +S GV A E ++GK P    S     
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 77/299 (25%), Positives = 117/299 (39%), Gaps = 67/299 (22%)

Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
            T  F+    IG G +G VY+A    +GQ+VAIK          I D++E     E   E
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI------IEDEEE-----EIKEE 52

Query: 182 IR-------HRNIVKLYGFCSHARHS------FLVYEFLKRGSLAAILSSDAAAQELGWS 228
                    H NI   YG              +LV E    GS+     +D         
Sbjct: 53  YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-----TDLVKGLRKKG 107

Query: 229 QRMN------VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK 282
           +R+       +++     L+YLH +    ++HRDI  +N+LL    E  + DFG++  L 
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164

Query: 283 PDSSNWTEFAGTYGYVAPELAYTMK-----ITEKCDVYSFGVLALEVIKGK------HPR 331
                   F GT  ++APE+    +        + DV+S G+ A+E+  GK      HP 
Sbjct: 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224

Query: 332 DFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL-RSIVEVVFSCLNESPESRPTMK 389
             L  I                PR P P+    E   +   + +  CL ++ E RP M+
Sbjct: 225 RALFKI----------------PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFME 267

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 91.7 bits (227), Expect = 6e-21
 Identities = 71/264 (26%), Positives = 126/264 (47%), Gaps = 23/264 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G+VY A ++ +GQ VAI++ +      Q   K+  + E+  + E ++ NIV   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                    ++V E+L  GSL  +++     +     Q   V +    AL +LH +    
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN---Q 136

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           ++HRDI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            D++S G++A+E+I+G+ P    + + + +L       E+ +P          EKL +I 
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP----------EKLSAIF 246

Query: 372 -EVVFSCLNESPESRPTMKIVSQQ 394
            + +  CL+   E R + K + Q 
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQH 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 90.8 bits (225), Expect = 7e-21
 Identities = 73/273 (26%), Positives = 127/273 (46%), Gaps = 43/273 (15%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G  G+V + E  +GQ VA+K           V  + FL E   +T++ H+N+V+L G
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
              H    ++V E + +G+L   L +   A  +   Q +     VA+ + YL       +
Sbjct: 67  VILH-NGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK---KL 121

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKF--LKPDSS----NWTEFAGTYGYVAPELAYTM 306
           VHRD++++N+L+  +  A V+DFG+A+   +  D+S     WT         APE     
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT---------APEALKHK 172

Query: 307 KITEKCDVYSFGVLALEVI---KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
           K + K DV+S+GVL  EV    +  +P+  L  +        +E    ++P    P+   
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-----VEKGYRMEPPEGCPA--- 224

Query: 364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                 +  ++ SC    P+ RP+   + ++L+
Sbjct: 225 -----DVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 91.3 bits (226), Expect = 1e-20
 Identities = 60/200 (30%), Positives = 104/200 (52%), Gaps = 14/200 (7%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRHRNIVKL 190
           IG G  G+V+ A ++ +GQ VAIK+ +      Q   KKE +  E+  + E+++ NIV  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINL-----QKQPKKELIINEILVMKELKNPNIVNF 81

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
                     F+V E+L  GSL  +++     +    +Q   V +    AL +LH +   
Sbjct: 82  LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDE----AQIAAVCRECLQALEFLHAN--- 134

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            ++HRDI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 311 KCDVYSFGVLALEVIKGKHP 330
           K D++S G++A+E+++G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 90.1 bits (223), Expect = 1e-20
 Identities = 75/288 (26%), Positives = 130/288 (45%), Gaps = 41/288 (14%)

Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA 178
           EI R +   D +  +G G  G V+         VAIK         +      FL E + 
Sbjct: 2   EIPRESLRLDVK--LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-----AFLQEAQI 54

Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
           + ++RH  +V LY   S     ++V EF+ +GSL   L  +   + L   Q +++   +A
Sbjct: 55  MKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIA 112

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---Y 295
           D ++Y+    +   +HRD+ + N+L+       +ADFG+A+ +  + + +T   G     
Sbjct: 113 DGMAYIERMNY---IHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPI 167

Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIEL 348
            + APE A   + T K DV+SFG+L  E++ KG+ P      R+ L  +   +       
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY------- 220

Query: 349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                 R+P P    Q    S+ E++  C  + P+ RPT + +   L+
Sbjct: 221 ------RMPCP----QGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 74/258 (28%), Positives = 117/258 (45%), Gaps = 22/258 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G VY+  +  + +VVAIK        D+I D ++   E+  L++     I + Y
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYY 68

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G        +++ E+L  GS   +L      +    +    ++KG    L YLH +    
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKG----LDYLHSE---R 121

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
            +HRDI + N+LL  + +  +ADFG+A  L         F GT  ++APE+        K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181

Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            D++S G+ A+E+ KG+ P   L  +   F          L P+   P+   Q   +   
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLF----------LIPKNSPPTLEGQYS-KPFK 230

Query: 372 EVVFSCLNESPESRPTMK 389
           E V +CLN+ P  RPT K
Sbjct: 231 EFVEACLNKDPRFRPTAK 248

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 90.4 bits (224), Expect = 1e-20
 Identities = 74/287 (25%), Positives = 129/287 (44%), Gaps = 43/287 (14%)

Query: 133 IGNGGHGSVYRAE----LPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G V+ AE    LP     +VA+K       S     +++F  E E LT ++H++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA----RQDFQREAELLTVLQHQH 68

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSS------------DAAAQELGWSQRMNVI 234
           IV+ YG C+  R   +V+E+++ G L   L S            D A  +L   Q + + 
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG- 293
             +A  + YL    F   VHRD++++N L+       + DFG+++ +   S+++    G 
Sbjct: 129 SQIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGR 183

Query: 294 ---TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELD 349
                 ++ PE     K T + D++SFGV+  E+   GK P   LS+  +  +    +  
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--IECITQGR 241

Query: 350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           E+  PR   P          +  ++  C    P+ R  +K +  +LQ
Sbjct: 242 ELERPRTCPP---------EVYAIMQGCWQREPQQRMVIKDIHSRLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 73/258 (28%), Positives = 117/258 (45%), Gaps = 22/258 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G V++  +  + +VVAIK        D+I D ++   E+  L++     + K Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G        +++ E+L  GS   +L        L  +Q   +++ +   L YLH +    
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---K 121

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
            +HRDI + N+LL    E  +ADFG+A  L         F GT  ++APE+        K
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181

Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            D++S G+ A+E+ KG+ P   L  +   FL        +     P    +  + L+  V
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFL--------IPKNNPPTLEGNYSKPLKEFV 233

Query: 372 EVVFSCLNESPESRPTMK 389
           E   +CLN+ P  RPT K
Sbjct: 234 E---ACLNKEPSFRPTAK 248

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 73/264 (27%), Positives = 122/264 (46%), Gaps = 25/264 (9%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLT---EVEALTEIRHRNIVK 189
           +G G +G+VY      GQ++A+K+      S+ +  +KE+     EV+ L  ++H NIV+
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELD-TSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
             G C       +  EF+  GS+++IL+      E  + +     K + D ++YLH++C 
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC- 122

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE------FAGTYGYVAPELA 303
             +VHRDI   N++L       + DFG A+ L     + T         GT  ++APE+ 
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
                  K D++S G    E+  GK P   +  +++ F    I     L PRLP    + 
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY---IGAHRGLMPRLPDSFSA- 236

Query: 364 QEKLRSIVEVVFSCLNESPESRPT 387
                + ++ V SCL      RP+
Sbjct: 237 -----AAIDFVTSCLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 87.8 bits (218), Expect = 7e-20
 Identities = 77/268 (28%), Positives = 115/268 (42%), Gaps = 36/268 (13%)

Query: 133 IGNGGHGSVYRAEL--PSGQV--VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G+G  G V R E     G+V  VA+K   S   SD + D   FL E   +  + H N++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD---FLKEAAIMHSLDHENLI 59

Query: 189 KLYGFCSHARHSF-LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           +LYG      H   +V E    GSL   L  DA       S   +    +A+ + YL   
Sbjct: 60  RLYGVV--LTHPLMMVTELAPLGSLLDRLRKDALG-HFLISTLCDYAVQIANGMRYLESK 116

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT-------EFAGTYGYVAP 300
            F   +HRD++++N+LL  + +  + DFG+ + L  +  ++         FA    + AP
Sbjct: 117 RF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA----WCAP 169

Query: 301 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           E   T   +   DV+ FGV   E+   G+ P   LS  S      D E +     RL  P
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-SQILKKIDKEGE-----RLERP 223

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPT 387
               Q+    I  V+  C   +P  RPT
Sbjct: 224 EACPQD----IYNVMLQCWAHNPADRPT 247

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 36/275 (13%)

Query: 133 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDK---KEFLTEVEALTEIRHRNIV 188
           I  G +G V+ A+  S G + AIK     +    ++ K    + LTE + L++ +   +V
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKV----IKKADMIRKNQVDQVLTERDILSQAQSPYVV 56

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           KLY      ++ +LV E+L  G LA++L +  +  E         I  +  AL YLH + 
Sbjct: 57  KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE---DVARIYIAEIVLALEYLHSN- 112

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKF--------LKPDSSNWTEFAGTYGYVAP 300
              I+HRD+   N+L+D      + DFG++K         L  D        GT  Y+AP
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLNTDIELDEMLDPRLPA 358
           E+      ++  D +S G +  E + G  P   +    I  + LN  IE  E  D  +  
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--DVEVSD 228

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ 393
            +  +  KL          L   PE R   K + +
Sbjct: 229 EAIDLISKL----------LVPDPEKRLGAKSIEE 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 88.4 bits (220), Expect = 8e-20
 Identities = 63/243 (25%), Positives = 95/243 (39%), Gaps = 59/243 (24%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDK---------KEFLT 174
           +DF     IG G   +V  A E  + +  AIK          I+DK         K    
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIK----------ILDKRQLIKEKKVKYVKI 50

Query: 175 EVEALTEI-RHRNIVKLYGFCSHARHS-FLVYEFLKRGSLAAILS-----SDAAAQELGW 227
           E E LT +  H  I+KLY +      + + V E+   G L   +       +   +    
Sbjct: 51  EKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR---- 105

Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
                    +  AL YLH      I+HRD+  +N+LLD +    + DFG AK L P+SS 
Sbjct: 106 ----FYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158

Query: 288 WTE--------------------FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG 327
            +                     F GT  YV+PEL       +  D+++ G +  +++ G
Sbjct: 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218

Query: 328 KHP 330
           K P
Sbjct: 219 KPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 88.6 bits (219), Expect = 8e-20
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 12/199 (6%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G+VY A ++ +GQ VAIK+ +      Q   K+  + E+  + E ++ NIV   
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 82

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                    ++V E+L  GSL  +++     +     Q   V +    AL +LH +    
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALDFLHSN---Q 135

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           ++HRDI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 312 CDVYSFGVLALEVIKGKHP 330
            D++S G++A+E+++G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 88.7 bits (220), Expect = 8e-20
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 29/261 (11%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDK-KEFLTEVEALTEIRHRNIVKL 190
           IG+G  G+VY A ++ + +VVAIKK        Q  +K ++ + EV  L ++RH N ++ 
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQQLRHPNTIE- 79

Query: 191 YGFCSHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
           Y  C    H+ +LV E+   GS + IL  +   + L   +   +  G    L+YLH    
Sbjct: 80  YKGCYLREHTAWLVMEYC-LGSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHE- 135

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM--- 306
              +HRDI + N+LL       +ADFG A  + P +S    F GT  ++APE+   M   
Sbjct: 136 --RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILAMDEG 189

Query: 307 KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
           +   K DV+S G+  +E+ + K P   ++++S+ +    I  ++       +P+ S  + 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQND-------SPTLSSNDW 239

Query: 367 LRSIVEVVFSCLNESPESRPT 387
                  V SCL + P+ RP+
Sbjct: 240 SDYFRNFVDSCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 29/209 (13%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEF----LTEVEALTEIRHRNI 187
           IG G +G VY+A    +G++VA+KK    +  +   +K+ F    + E++ L ++RH NI
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKK----IRMEN--EKEGFPITAIREIKLLQKLRHPNI 60

Query: 188 VKLYGFC-SHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
           V+L     S  + S ++V+E++    L  +L S     +   SQ    +K + + L YLH
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLH 117

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPEL-- 302
            +    I+HRDI   N+L++ +    +ADFG+A+     +S ++T    T  Y  PEL  
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174

Query: 303 ---AYTMKITEKCDVYSFGVLALEVIKGK 328
               Y  ++    D++S G +  E+  GK
Sbjct: 175 GATRYGPEV----DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 66/265 (24%), Positives = 118/265 (44%), Gaps = 22/265 (8%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+     +   VA+K       S Q      FL E   +  ++H  +V+LY 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-----AFLEEANLMKTLQHDKLVRLYA 68

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E++ +GSL   L SD   + L   + ++    +A+ ++Y+    +   
Sbjct: 69  VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY--- 124

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 312 CDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSI 370
            DV+SFG+L  E++  GK P   +S       N+D+        R+P       E    +
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMS-------NSDVMSALQRGYRMPRMENCPDE----L 233

Query: 371 VEVVFSCLNESPESRPTMKIVSQQL 395
            +++ +C  E  E RPT   +   L
Sbjct: 234 YDIMKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 23/204 (11%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G HG V++A +  +G+ VA+KK         I    + L E++AL   +H  +VKL 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI--PNQALREIKALQACQHPYVVKLL 65

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILS------SDAAAQELGWSQRMNVIKGVADALSYLH 245
               H     LV E++    L+ +L        +A  +      RM ++KGVA    Y+H
Sbjct: 66  DVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSY---MRM-LLKGVA----YMH 116

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPELAY 304
            +    I+HRD+   NLL+  +    +ADFG+A+    +    ++    T  Y APEL Y
Sbjct: 117 AN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173

Query: 305 -TMKITEKCDVYSFGVLALEVIKG 327
              K     D+++ G +  E++ G
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 65/212 (30%), Positives = 93/212 (43%), Gaps = 35/212 (16%)

Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDK---KEFLTEVEALTEIRHRNIV 188
           +G GG G V   ++    +  A+K          IV+    +   +E E L E  H  IV
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCV----KKRHIVETGQQEHIFSEKEILEECNHPFIV 56

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILS-----SDAAAQELGWSQRMNVIKGVADALSY 243
           KLY      ++ +++ E+   G L  IL       +  A+          I  V  A  Y
Sbjct: 57  KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFY--------IACVVLAFEY 108

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH+     I++RD+  +NLLLD      + DFG AK LK     WT F GT  YVAPE+ 
Sbjct: 109 LHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEI- 163

Query: 304 YTMKITEK-----CDVYSFGVLALEVIKGKHP 330
               I  K      D +S G+L  E++ G+ P
Sbjct: 164 ----ILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.9 bits (213), Expect = 6e-19
 Identities = 75/274 (27%), Positives = 115/274 (41%), Gaps = 42/274 (15%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  GSV +  L +  ++   K  +  P+  +  +K+ L E+E     +   IVK YG
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL--QKQILRELEINKSCKSPYIVKYYG 66

Query: 193 FCSHARHSFL--VYEFLKRGSLAAI----LSSDAAAQE--LGWSQRMNVIKGVADALSYL 244
                  S +    E+ + GSL +I            E  LG      + + V   LSYL
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSYL 121

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE--- 301
           H      I+HRDI   N+LL  + +  + DFG++  L   +S    F GT  Y+APE   
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFTGTSFYMAPERIQ 176

Query: 302 -LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML----DPRL 356
              Y++      DV+S G+  LEV + + P  F            IEL   +    +P L
Sbjct: 177 GKPYSI----TSDVWSLGLTLLEVAQNRFP--FPPEGEPPL--GPIELLSYIVNMPNPEL 228

Query: 357 ---PAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
              P       E+ +  ++    CL + P  RPT
Sbjct: 229 KDEPGNGIKWSEEFKDFIKQ---CLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 85.9 bits (212), Expect = 7e-19
 Identities = 78/286 (27%), Positives = 128/286 (44%), Gaps = 43/286 (15%)

Query: 133 IGNGGHGSVYRAEL----PSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G V+ AE     P     +VA+K       SD    +K+F  E E LT ++H +
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNA--RKDFHREAELLTNLQHEH 68

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSL----------AAILSSDAAAQELGWSQRMNVIKG 236
           IVK YG C       +V+E++K G L          A +++      EL  SQ +++ + 
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG--- 293
           +A  + YL    F   VHRD++++N L+       + DFG+++ +   S+++    G   
Sbjct: 129 IAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY--STDYYRVGGHTM 183

Query: 294 -TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEM 351
               ++ PE     K T + DV+S GV+  E+   GK P   LS+      N  IE   +
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIEC--I 235

Query: 352 LDPR-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              R L  P    +E    + +++  C    P  R  +K +   LQ
Sbjct: 236 TQGRVLQRPRTCPKE----VYDLMLGCWQREPHMRLNIKEIHSLLQ 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 85.5 bits (212), Expect = 8e-19
 Identities = 70/267 (26%), Positives = 115/267 (43%), Gaps = 32/267 (11%)

Query: 133 IGNGGHGSVYRAE-LPSGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G+G  G+VY+   +P G+     VAIK              KE L E   +  + H ++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN---KEILDEAYVMASVDHPHV 71

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL--H 245
           V+L G C  ++   L+ + +  G L   + +      +G    +N    +A  +SYL   
Sbjct: 72  VRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK 128

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELA 303
                 +VHRD++++N+L+       + DFG+AK L  D   +    G     ++A E  
Sbjct: 129 R-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 304 YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
                T K DV+S+GV   E++  G  P +    I +  +   +E  E    RLP P   
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE---GIPAVEIPDLLEKGE----RLPQPPIC 236

Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMK 389
             +    +  V+  C     ESRPT K
Sbjct: 237 TID----VYMVLVKCWMIDAESRPTFK 259

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 85.6 bits (212), Expect = 8e-19
 Identities = 87/292 (29%), Positives = 129/292 (44%), Gaps = 50/292 (17%)

Query: 133 IGNGGHGSVYRAEL--------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           +G G  GSV   EL         +G+VVA+KK             ++F  E+E L  ++H
Sbjct: 12  LGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHL----RDFEREIEILKSLQH 64

Query: 185 RNIVKLYGFC-SHARHSF-LVYEFLKRGSLAAILSS-----DAAAQELGWSQRMNVIKGV 237
            NIVK  G C S  R +  LV E+L  GSL   L       D     L  SQ   + KG 
Sbjct: 65  DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ---ICKG- 120

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF----AG 293
              + YL    +   VHRD++++N+L++ E    + DFG+ K L  D   +       + 
Sbjct: 121 ---MEYLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174

Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVI----KGKHP-RDFLSSISSSFLNTDI-- 346
            + Y APE     K +   DV+SFGV+  E+     K   P  +F+  + +      I  
Sbjct: 175 IFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY 233

Query: 347 ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            L E+L    RLPAP     E    I  ++  C N  P  RP+   ++ Q++
Sbjct: 234 HLIELLKNNGRLPAPPGCPAE----IYAIMKECWNNDPSQRPSFSELALQVE 281

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 84.8 bits (211), Expect = 1e-18
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 26/207 (12%)

Query: 132 CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL 190
            +G G +G VY+A +  +G++VA+KK       + I      L E+  L E++H NIVKL
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI--PSTALREISLLKELKHPNIVKL 63

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA----DALSYLHH 246
                  R  +LV+E+     L   L  D     L      N+IK +       L+Y H 
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPL----SPNLIKSIMYQLLRGLAYCHS 116

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL---- 302
                I+HRD+  +N+L++ +    +ADFG+A+        +T    T  Y APE+    
Sbjct: 117 HR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 303 -AYTMKITEKCDVYSFGVLALEVIKGK 328
             Y+  +    D++S G +  E+I GK
Sbjct: 174 KHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 70/262 (26%), Positives = 113/262 (43%), Gaps = 28/262 (10%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDK---KEFLTEVEALTEIRHRNIV 188
           +G+G  GSVY    L  G   A+K+    L  D    +   K+   E+  L++++H NIV
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKE--VSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           +  G      + ++  E +  GSLA +L    +  E          + +   L YLH   
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE---PVIRLYTRQILLGLEYLHDR- 121

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMK 307
               VHRDI   N+L+D      +ADFG+AK +  + S    F G+  ++APE +A    
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQGG 178

Query: 308 ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF--LNTDIELDEMLDPRLPAPSRSVQE 365
                D++S G   LE+  GK P   L  +++ F    +           LP     + +
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS---------KELPPIPDHLSD 229

Query: 366 KLRSIVEVVFSCLNESPESRPT 387
           + +   + +  CL   P  RPT
Sbjct: 230 EAK---DFILKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 26/219 (11%)

Query: 121 VRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHS-------PLPSDQIVDKKEF 172
            R+  +F+    IG G +G VYRA +  SG++VA+KK          P+ S         
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--------- 53

Query: 173 LTEVEALTEIRHRNIVKLYGFC--SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQR 230
           L E+  L  +RH NIV+L       H    FLV E+ ++  LA++L  D        SQ 
Sbjct: 54  LREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLL--DNMPTPFSESQV 110

Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE 290
             ++  +   L YLH +    I+HRD+   NLLL  +    +ADFG+A+     +   T 
Sbjct: 111 KCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167

Query: 291 FAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGK 328
              T  Y APEL       T   D+++ G +  E++  K
Sbjct: 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 84/273 (30%), Positives = 125/273 (45%), Gaps = 44/273 (16%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  GSV + + +P+G V+A K  H  + +   V +K+ L E++ + E R   IV  Y
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVH--IGAKSSV-RKQILRELQIMHECRSPYIVSFY 69

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQE--LGWSQRMNVIKGVADALSYL---HH 246
           G   +  +  +  EF+  GSL  I           LG      +   V + L+YL   H 
Sbjct: 70  GAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYNVHR 124

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM 306
                I+HRDI   N+L++   +  + DFG++  L    ++   F GT  Y++PE     
Sbjct: 125 -----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVGTSTYMSPERIQGG 177

Query: 307 KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM--LD----------P 354
           K T K DV+S G+  +E+  GK P  F      S ++ D + D M  LD          P
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAF------SNIDDDGQDDPMGILDLLQQIVQEPPP 231

Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
           RL  PS    E LR  V+    CL + P  RPT
Sbjct: 232 RL--PSSDFPEDLRDFVDA---CLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 14/200 (7%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRHRNIVKL 190
           IG G  G V  A E  SG+ VA+K     L   Q   ++E L  EV  + + +H+N+V++
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQ---RRELLFNEVVIMRDYQHQNVVEM 83

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y         +++ EFL+ G+L  I+S     +E    Q   V + V  AL YLH     
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE----QIATVCESVLQALCYLHSQ--- 136

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            ++HRDI S ++LL L+    ++DFG    +  D        GT  ++APE+        
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196

Query: 311 KCDVYSFGVLALEVIKGKHP 330
           + D++S G++ +E++ G+ P
Sbjct: 197 EVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 64/268 (23%), Positives = 125/268 (46%), Gaps = 27/268 (10%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E   + +++H  +V+LY 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQ-----GSMSPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ GSL   L +    + L  ++ +++   +A+ ++++    +   
Sbjct: 69  VVTQ-EPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNY--- 123

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 312 CDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--RLPAPSRSVQEKLR 368
            DV+SFG+L  E++  G+ P   +         T+ E+ + L+   R+P P    +E   
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGM---------TNPEVIQNLERGYRMPRPDNCPEE--- 231

Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            + E++  C  E PE RPT + +   L+
Sbjct: 232 -LYELMRLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 75/262 (28%), Positives = 127/262 (48%), Gaps = 26/262 (9%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G+G  G VY+A+      +A  K       +++ D   ++ E+E L    H  IVKL G
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED---YMVEIEILATCNHPYIVKLLG 76

Query: 193 FCSHARHSFLVYEFLKRGSLAAI-LSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                   +++ EF   G++ AI L  D    E    Q   + + + +AL YLH      
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLHSM---K 130

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGI-AKFLKPDSSNWTEFAGTYGYVAPELAY--TMKI 308
           I+HRD+ + N+LL L+ +  +ADFG+ AK +K        F GT  ++APE+    TMK 
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR-DSFIGTPYWMAPEVVMCETMKD 189

Query: 309 TE---KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
           T    K D++S G+  +E+ + + P   L+      +   +++ +   P L  PS+   E
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEPPTLSQPSKWSME 244

Query: 366 KLRSIVEVVFSCLNESPESRPT 387
             R  ++     L++ PE+RP+
Sbjct: 245 -FRDFLKTA---LDKHPETRPS 262

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.4 bits (206), Expect = 4e-18
 Identities = 67/241 (27%), Positives = 117/241 (48%), Gaps = 35/241 (14%)

Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G V   R +LP  +   VAIK   +     Q   +++FL+E   + +  H NI+
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ---RRDFLSEASIMGQFDHPNII 68

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
            L G  + ++   +V E+++ GSL A L       +    Q + +++G+A  + YL    
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG 126

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGTYG--YVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + APE    
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 306 MKITEKCDVYSFGVLALEVIK-GKHP------RDFLSSISSSFLNTDIELDEMLDPRLPA 358
            K T   DV+S+G++  EV+  G+ P      +D + +I   +             RLPA
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-------------RLPA 230

Query: 359 P 359
           P
Sbjct: 231 P 231

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 83.1 bits (205), Expect = 4e-18
 Identities = 70/278 (25%), Positives = 116/278 (41%), Gaps = 43/278 (15%)

Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G V+   L +    VA+K     LP D    K +FL E   L +  H NIV+L 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 59

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G C+  +  ++V E ++ G     L ++     L   + + +++  A  + YL       
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH--- 114

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG-----------YVAP 300
            +HRD++++N L+  +    ++DFG+++          E  G Y            + AP
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR---------EEEDGVYASTGGMKQIPVKWTAP 165

Query: 301 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISS-SFLNTDIELDEMLDPRLPA 358
           E     + + + DV+SFG+L  E    G  P   LS+  +   +   +        RLP 
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV--------RLPC 217

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           P        R    ++  C    P  RP+   V Q+LQ
Sbjct: 218 PELCPDAVYR----LMERCWEYDPGQRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 70/267 (26%), Positives = 129/267 (48%), Gaps = 25/267 (9%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE------FLTEVEALTEIRHR 185
           IG G +G VY A  + +G+++A+K+   P       D ++        +E+E L ++ H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQE-LGWSQRMNVIKGVADALSYL 244
           NIV+  GF +   +  +  E++  GS+ + L +    +E L       V++G    L+YL
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG----LAYL 124

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP--DSSNWTEFAGTYGYVAPEL 302
           H      I+HRD+ + NLL+D +    ++DFGI+K      D+       G+  ++APE+
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 303 --AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             +Y+   + K D++S G + LE+  G+ P     +I++ F     +L        P P 
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF-----KLGN-KRSAPPIPP 235

Query: 361 RSVQEKLRSIVEVVFSCLNESPESRPT 387
                     ++ + +C   +P++RPT
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 82.3 bits (203), Expect = 6e-18
 Identities = 71/275 (25%), Positives = 121/275 (44%), Gaps = 31/275 (11%)

Query: 126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR 185
           +      IG G  G V   +   G  VA+K   +   +      + FL E   +T++RH 
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA------QAFLAEASVMTQLRHS 59

Query: 186 NIVKLYGFCSHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
           N+V+L G     +   ++V E++ +GSL   L S   +  LG    +     V +A+ YL
Sbjct: 60  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 118

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
             + F   VHRD++++N+L+  +  A V+DFG+    K  SS          + APE   
Sbjct: 119 EANNF---VHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALR 172

Query: 305 TMKITEKCDVYSFGVLALEVI---KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR 361
             K + K DV+SFG+L  E+    +  +PR  L  +        +E    +D     P  
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDAPDGCPP- 226

Query: 362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                   + +V+  C +    +RP+   + +QL+
Sbjct: 227 -------VVYDVMKQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 82.5 bits (204), Expect = 8e-18
 Identities = 75/294 (25%), Positives = 128/294 (43%), Gaps = 57/294 (19%)

Query: 133 IGNGGHGSVYRAEL--PSGQ-------VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           +G G  G VY+ EL  P+ +       +  +K+   P          EF  E E +++++
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ------EFRQEAELMSDLQ 66

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAIL-----SSDAAAQE--------LGWSQR 230
           H NIV L G C+  + + +++E+L  G L   L      SD  A+         L  S  
Sbjct: 67  HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 231 MNVIKGVADALSYL--HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
           +++   +A  + YL  HH      VHRD++++N L+       ++DFG+++ +   S+++
Sbjct: 127 LHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY--SADY 179

Query: 289 TEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLN 343
                       ++ PE     K T + D++SFGV+  E+   G  P          F N
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY-------YGFSN 232

Query: 344 TDIELDEMLDPR--LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            ++   EM+  R  LP P          ++E    C NE P  RP  K +  +L
Sbjct: 233 QEVI--EMIRSRQLLPCPEDCPARVYALMIE----CWNEIPARRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPS-DQIVDKKEFLTEVEALTEIRHRNIVKL 190
           IG G +G V++     +GQ+VAIKKF   + S D  V KK  L E+  L +++H N+V L
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF---VESEDDPVIKKIALREIRMLKQLKHPNLVNL 65

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH-HDCF 249
                  R   LV+E+     L  +   +   + +       +I     A+++ H H+C 
Sbjct: 66  IEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC- 121

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
              +HRD+  +N+L+  + +  + DFG A+ L     ++T++  T  Y APEL
Sbjct: 122 ---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 74/277 (26%), Positives = 119/277 (42%), Gaps = 31/277 (11%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G +G V + +   +GQ+VAIKKF      D++V KK  + E+  L ++RH N+V L 
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLES-EDDKMV-KKIAMREIRMLKQLRHENLVNLI 66

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                 +  +LV+EF+    L  +   +     L  S+    +  +   + + H      
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSH---N 120

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY-TMKITE 310
           I+HRDI  +N+L+       + DFG A+ L      +T++  T  Y APEL     K   
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR 180

Query: 311 KCDVYSFGVLALEVIKGKHPR-------DFLSSISSSFLNTDIELDEMLDP-------RL 356
             D+++ G L  E++ G+ P        D L  I     N      E+          RL
Sbjct: 181 AVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239

Query: 357 PA-----PSRSVQEKLRSIV-EVVFSCLNESPESRPT 387
           P      P      KL  +V ++   CL   P+ RP+
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 76/265 (28%), Positives = 132/265 (49%), Gaps = 29/265 (10%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDK-KEFLTEVEALTEIRHRNIVKL 190
           IG+G  G+VY A ++ + +VVAIKK        Q  +K ++ + EV  L ++RH N ++ 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH-HDCF 249
            G       ++LV E+   GS + +L  +   + L   +   V  G    L+YLH H+  
Sbjct: 81  RGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 135

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM--- 306
             ++HRD+ + N+LL       + DFG A  + P +     F GT  ++APE+   M   
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEG 189

Query: 307 KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
           +   K DV+S G+  +E+ + K P   ++++S+ +      + +   P L   S    E 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HIAQNESPAL--QSGHWSEY 242

Query: 367 LRSIVEVVFSCLNESPESRPTMKIV 391
            R+ V+   SCL + P+ RPT +++
Sbjct: 243 FRNFVD---SCLQKIPQDRPTSEVL 264

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 76/260 (29%), Positives = 130/260 (50%), Gaps = 27/260 (10%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDK-KEFLTEVEALTEIRHRNIVKL 190
           IG+G  G+VY A ++ + +VVAIKK        Q  +K ++ + EV+ L  I+H N ++ 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKM--SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
            G       ++LV E+   GS + +L  +   + L   +   +  G    L+YLH     
Sbjct: 91  KGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSH--- 144

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM---K 307
            ++HRDI + N+LL    +  +ADFG A    P +S    F GT  ++APE+   M   +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQ 200

Query: 308 ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL 367
              K DV+S G+  +E+ + K P   ++++S+ +      + +   P L +   S  +  
Sbjct: 201 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HIAQNESPTLQSNEWS--DYF 253

Query: 368 RSIVEVVFSCLNESPESRPT 387
           R+ V+   SCL + P+ RPT
Sbjct: 254 RNFVD---SCLQKIPQDRPT 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.8 bits (203), Expect = 1e-17
 Identities = 68/224 (30%), Positives = 97/224 (43%), Gaps = 45/224 (20%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE---FLTEVEALT 180
           +DF+    +G G  G V       SG+  A+K     L   +IV  K+    L E   L 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKI----LSKAKIVKLKQVEHVLNEKRILQ 56

Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAIL------SSDA----AAQELGWSQR 230
            IRH  +V LYG      + +LV E++  G L + L              AAQ       
Sbjct: 57  SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ------- 109

Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE 290
                 V  AL YLH      IV+RD+  +NLLLD +    + DFG AK +K  +  +T 
Sbjct: 110 ------VVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT- 157

Query: 291 FAGTYGYVAPEL----AYTMKITEKCDVYSFGVLALEVIKGKHP 330
             GT  Y+APE+     Y   +    D ++ G+L  E++ G  P
Sbjct: 158 LCGTPEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 31/212 (14%)

Query: 133 IGNGGHGSVYR---AELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G VY      +  G+    VAIK  +    +  + ++ EFL E   + E    +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQE-------LGWSQRMNVIKGVAD 239
           +V+L G  S  + + +V E + +G L + L S     E           + + +   +AD
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG--- 296
            ++YL    F   VHRD++++N ++  +    + DFG+ + +       T++    G   
Sbjct: 131 GMAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDI-----YETDYYRKGGKGL 182

Query: 297 ----YVAPELAYTMKITEKCDVYSFGVLALEV 324
               ++APE       T K DV+SFGV+  E+
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 72/280 (25%), Positives = 125/280 (44%), Gaps = 32/280 (11%)

Query: 134 GNGGHGSVYR---AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL 190
           G+ G  S+Y    A   +G++VA+K            +   +  E+  L  + H NIVK 
Sbjct: 15  GHFGKVSLYCYDPANDGTGEMVAVKTLKR---ECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 191 YGFCSHA--RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
            G CS    +   L+ E++  GSL   L       +L  +Q +   + + + ++YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH 127

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA----GTYGYVAPELAY 304
           +   +HRD++++N+LLD +    + DFG+AK + P+   +            + A E   
Sbjct: 128 Y---IHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 305 TMKITEKCDVYSFGVLALEVI-----KGKHPRDFLSSIS-SSFLNTDIELDEMLD--PRL 356
             K +   DV+SFGV   E++     K   P+ F   I       T + L E+L+   RL
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243

Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           P P    QE +  +++   +C     + RPT + +   L+
Sbjct: 244 PCPKNCPQE-VYILMK---NCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 80.7 bits (200), Expect = 4e-17
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 20/204 (9%)

Query: 132 CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVK 189
            +G+G  GSVY A    +G++VAIKK      S    ++   L EV++L ++  H NIVK
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVK 62

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
           L          + V+E+++ G+L   L  D   +    S   ++I  +   L+++H   F
Sbjct: 63  LKEVFRENDELYFVFEYME-GNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL-----AY 304
               HRD+  +NLL+       +ADFG+A+ ++     +T++  T  Y APE+     +Y
Sbjct: 121 ---FHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYVSTRWYRAPEILLRSTSY 176

Query: 305 TMKITEKCDVYSFGVLALEVIKGK 328
           +  +    D+++ G +  E+   +
Sbjct: 177 SSPV----DIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 74/261 (28%), Positives = 127/261 (48%), Gaps = 29/261 (11%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDK-KEFLTEVEALTEIRHRNIVKL 190
           IG+G  G+VY A    + +VVA+KK        Q  +K ++ + EV+ L +++H N ++ 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKM--SYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 191 YGFCSHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
            G C    H+ +LV E+   GS + +L  +   + L   +   +  G    L+YLH    
Sbjct: 87  KG-CYLKEHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSHN- 141

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM--- 306
             ++HRDI + N+LL    +  +ADFG A    P +S    F GT  ++APE+   M   
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVILAMDEG 195

Query: 307 KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
           +   K DV+S G+  +E+ + K P   ++++S+ +    I  ++       +P+    E 
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQND-------SPTLQSNEW 245

Query: 367 LRSIVEVVFSCLNESPESRPT 387
             S    V  CL + P+ RP 
Sbjct: 246 TDSFRGFVDYCLQKIPQERPA 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.8 bits (197), Expect = 6e-17
 Identities = 75/280 (26%), Positives = 119/280 (42%), Gaps = 30/280 (10%)

Query: 124 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQI---VDKK---EFLTEV 176
             +F  +  IG G    VY+A  L  G+VVA+KK        QI   +D K   + L E+
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-------QIFEMMDAKARQDCLKEI 53

Query: 177 EALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM--NVI 234
           + L ++ H N++K            +V E    G L+ ++      Q+    +R      
Sbjct: 54  DLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKH-FKKQKRLIPERTIWKYF 112

Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT 294
             +  AL ++H      I+HRDI   N+ +       + D G+ +F    ++      GT
Sbjct: 113 VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169

Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-LNTDIELDEMLD 353
             Y++PE  +      K D++S G L  E+   + P  F     + + L   IE  +   
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEKCDY-- 225

Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ 393
           P LPA   S  E+LR +V     C+N  PE RP +  V Q
Sbjct: 226 PPLPADHYS--EELRDLVSR---CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 79.4 bits (196), Expect = 7e-17
 Identities = 68/277 (24%), Positives = 111/277 (40%), Gaps = 44/277 (15%)

Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           DF     +G G +GSVY+ + L   Q  A+K+      S +  ++++ + E+  L  + H
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK--EREDAVNEIRILASVNH 58

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAA-----QELGWSQRMNVIKGVAD 239
            NI+             +V E+   G L+  +S          ++  W   + +++G   
Sbjct: 59  PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG--- 115

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
            L  LH      I+HRD+ S N+LL       + D GI+K LK + +  T+  GT  Y+A
Sbjct: 116 -LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQI-GTPHYMA 169

Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL--- 356
           PE+      + K D++S G L  E+     P                E   M D R    
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPP---------------FEARSMQDLRYKVQ 214

Query: 357 -----PAPSRSVQEKLRSIVEVVFSCLNESPESRPTM 388
                P P    Q+    +   + S L   P+ RP  
Sbjct: 215 RGKYPPIPPIYSQD----LQNFIRSMLQVKPKLRPNC 247

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 79.4 bits (195), Expect = 9e-17
 Identities = 76/279 (27%), Positives = 126/279 (45%), Gaps = 38/279 (13%)

Query: 127 FDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RH 184
           F+    +GNG +G VY+   + +GQ+ AIK     +  D+   ++E   E+  L +   H
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDE---EEEIKQEINMLKKYSHH 62

Query: 185 RNIVKLYGFCSHAR------HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
           RNI   YG              +LV EF   GS+  ++  +     L       + + + 
Sbjct: 63  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK-NTKGNTLKEEWIAYICREIL 121

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
             LS+LH      ++HRDI  +N+LL    E  + DFG++  L         F GT  ++
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178

Query: 299 APELAYTMKITE-----KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD 353
           APE+    +  +     K D++S G+ A+E+ +G  P   +  + + F          L 
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----------LI 228

Query: 354 PRLPAP---SRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           PR PAP   S+   +K +S +E   SCL ++   RPT +
Sbjct: 229 PRNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPTTE 264

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 73/264 (27%), Positives = 121/264 (45%), Gaps = 37/264 (14%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRHRNIVKL 190
           IG G  G V  A +  +G+ VA+KK    L   Q   ++E L  EV  + + +H NIV++
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMD--LRKQQ---RRELLFNEVVIMRDYQHPNIVEM 81

Query: 191 YGFCSHARHSFLV-------YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           Y        S+LV        EFL+ G+L  I++     +E    Q   V   V  ALS+
Sbjct: 82  YS-------SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLAVLKALSF 130

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      ++HRDI S ++LL  +    ++DFG    +  +        GT  ++APE+ 
Sbjct: 131 LHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI 187

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
             +    + D++S G++ +E++ G+ P       +   L     + + L P+L    + V
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDGEPPY-----FNEPPLQAMKRIRDNLPPKLKNLHK-V 241

Query: 364 QEKLRSIVEVVFSCLNESPESRPT 387
             +LRS ++     L   P  R T
Sbjct: 242 SPRLRSFLD---RMLVRDPAQRAT 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 67/279 (24%), Positives = 119/279 (42%), Gaps = 45/279 (16%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V++  L     VA+K     LP +    K +FL+E   L +  H NIVKL G
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQEL---KIKFLSEARILKQYDHPNIVKLIG 59

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH-HDCFPP 251
            C+  +  ++V E +  G   + L       EL   Q +      A  ++YL   +C   
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESKNC--- 114

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG----------YVAPE 301
            +HRD++++N L+       ++DFG+++          E  G Y           + APE
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSR---------QEDDGIYSSSGLKQIPIKWTAPE 164

Query: 302 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--RLPA 358
                + + + DV+S+G+L  E    G  P   +         T+ +  E ++   R+  
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM---------TNQQAREQVEKGYRMSC 215

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI 397
           P +   +    + +V+  C +  PE+RP    + ++L  
Sbjct: 216 PQKCPDD----VYKVMQRCWDYKPENRPKFSELQKELAA 250

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 14/200 (7%)

Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRHRNIVKL 190
           IG G  G V  A +  SG++VA+KK    L   Q   ++E L  EV  + + +H N+V++
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQ---RRELLFNEVVIMRDYQHENVVEM 82

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y         ++V EFL+ G+L  I++     +E    Q   V   V  ALS LH     
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLKALSVLHAQ--- 135

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            ++HRDI S ++LL  +    ++DFG    +  +        GT  ++APEL   +    
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195

Query: 311 KCDVYSFGVLALEVIKGKHP 330
           + D++S G++ +E++ G+ P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 69/269 (25%), Positives = 126/269 (46%), Gaps = 25/269 (9%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G+G  G VY+A+     V+A  K       +++ D   ++ E++ L    H NIVKL  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED---YMVEIDILASCDHPNIVKLLD 69

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
              +  + +++ EF   G++ A++      + L   Q   V K   +AL+YLH +    I
Sbjct: 70  AFYYENNLWILIEFCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KI 124

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE-- 310
           +HRD+ + N+L  L+ +  +ADFG++            F GT  ++APE+       +  
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 311 ---KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL 367
              K DV+S G+  +E+ + + P   L+      +   +++ +   P L  PSR   E  
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEPPTLAQPSRWSSE-- 237

Query: 368 RSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
               + +  CL ++ ++R T    +Q LQ
Sbjct: 238 --FKDFLKKCLEKNVDARWT---TTQLLQ 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 75/274 (27%), Positives = 130/274 (47%), Gaps = 31/274 (11%)

Query: 133 IGNGGHGSVY--RAELPSGQVVAIKK--FHSP------LPSDQIVDKKEFLTEVEALTE- 181
           +G+G  G VY  R +     ++A+K+   H+P         D+ +     ++EV  + E 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGD--IVSEVTIIKEQ 65

Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM-NVIKGVADA 240
           +RH NIV+ Y         ++V + ++   L    +S    ++    +R+ N+   +  A
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           L YLH +    IVHRD++  N++L  + +  + DFG+AK  K   S  T   GT  Y  P
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSCP 182

Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
           E+       EK DV++FG +  ++   + P  F S+   S L T I ++ + +P      
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPP--FYSTNMLS-LATKI-VEAVYEP------ 232

Query: 361 RSVQEKLRS--IVEVVFSCLNESPESRPTMKIVS 392
             + E + S  + +V+ SCL    E+RP +  VS
Sbjct: 233 --LPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 77.8 bits (191), Expect = 3e-16
 Identities = 69/282 (24%), Positives = 127/282 (45%), Gaps = 29/282 (10%)

Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA 178
           EI R +   + +  +G G  G V+ A       VA+K      P    V+   FL E   
Sbjct: 2   EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA--FLAEANV 54

Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
           +  ++H  +VKL+   +     +++ EF+ +GSL   L SD    +    + ++    +A
Sbjct: 55  MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIA 112

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGY 297
           + ++++    +   +HRD+ + N+L+       +ADFG+A+ ++ +     E A     +
Sbjct: 113 EGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-- 354
            APE       T K DV+SFG+L +E++  G+ P   +S+          E+   L+   
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---------PEVIRALERGY 220

Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           R+P P    +E    +  ++  C    PE RPT + +   L 
Sbjct: 221 RMPRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 80/289 (27%), Positives = 126/289 (43%), Gaps = 52/289 (17%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           ND   Q  IG G  G V +A +    +    AIK+       D   D ++F  E+E L +
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 63

Query: 182 I-RHRNIVKLYGFCSHARHSFLVYEFLKRGSL------AAILSSDAA-------AQELGW 227
           +  H NI+ L G C H  + +L  E+   G+L      + +L +D A       A  L  
Sbjct: 64  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
            Q ++    VA  + YL    F   +HRD++++N+L+   + A +ADFG+++        
Sbjct: 124 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQ 174

Query: 288 WTEFAGTYG-----YVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSS 340
                 T G     ++A E L Y++  T   DV+S+GVL  E++  G  P   +      
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTPYCGM------ 227

Query: 341 FLNTDIELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
              T  EL E L    RL  P     E    + +++  C  E P  RP+
Sbjct: 228 ---TCAELYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPS 269

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 77/283 (27%), Positives = 119/283 (42%), Gaps = 40/283 (14%)

Query: 124 TNDFDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           T+ ++    IG G +G VY+      G + A+K        D I D  E   E+EA   I
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL------DPISDVDE---EIEAEYNI 71

Query: 183 -----RHRNIVKLYGFCSHARHS-----FLVYEFLKRGSLAAILSSD-AAAQELGWSQRM 231
                 H N+VK YG    A        +LV E    GS+  ++       Q L  +   
Sbjct: 72  LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131

Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
            ++ G    L +LH++    I+HRD+   N+LL  E    + DFG++  L          
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188

Query: 292 AGTYGYVAPEL-----AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDI 346
            GT  ++APE+      Y      +CDV+S G+ A+E+  G  P   +  + + F     
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF----- 243

Query: 347 ELDEMLDPRLPAPSRSVQEK-LRSIVEVVFSCLNESPESRPTM 388
                  PR P P+    EK  RS    +  CL +  E+RP++
Sbjct: 244 -----KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 73/257 (28%), Positives = 119/257 (46%), Gaps = 23/257 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRHRNIVKL 190
           IG G  G V  A E  +G+ VA+KK    L   Q   ++E L  EV  + +  H N+V +
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQ---RRELLFNEVVIMRDYHHENVVDM 84

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y         ++V EFL+ G+L  I++     +E    Q   V   V  ALSYLH+    
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLSVLRALSYLHNQ--- 137

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            ++HRDI S ++LL  +    ++DFG    +  +        GT  ++APE+   +    
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197

Query: 311 KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSI 370
           + D++S G++ +E+I G+ P       +   L     + + L PR+   S  V   LR  
Sbjct: 198 EVDIWSLGIMVIEMIDGEPP-----YFNEPPLQAMRRIRDNLPPRV-KDSHKVSSVLRGF 251

Query: 371 VEVVFSCLNESPESRPT 387
           ++++   L   P  R T
Sbjct: 252 LDLM---LVREPSQRAT 265

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 65/277 (23%), Positives = 119/277 (42%), Gaps = 46/277 (16%)

Query: 133 IGNGGHGSVYRAELPSG------QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G V+ A+           +V +K        D+ + + EF  E++   ++ H+N
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENL-QSEFRRELDMFRKLSHKN 69

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQE------LGWSQRMNVIKGVADA 240
           +V+L G C  A   +++ E+   G L   L +  +  E      L   Q++ +   +A  
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG---Y 297
           + +L +  F   VHRD++++N L+  + E  V+   ++K     +S + +         +
Sbjct: 130 MDHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRW 184

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEML---- 352
           +APE       + K DV+SFGVL  EV  +G+ P   LS             +E+L    
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD------------EEVLNRLQ 232

Query: 353 --DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
                LP P      +L  ++     C   +P+ RP+
Sbjct: 233 AGKLELPVPE-GCPSRLYKLMT---RCWAVNPKDRPS 265

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 70/258 (27%), Positives = 112/258 (43%), Gaps = 31/258 (12%)

Query: 148 SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH--ARHSFLVYE 205
           +G+ VA+K        + I D K+   E+E L  + H NIVK  G C+        L+ E
Sbjct: 32  TGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88

Query: 206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD 265
           FL  GSL   L  +     L   Q++     +   + YL    +   VHRD++++N+L++
Sbjct: 89  FLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVE 143

Query: 266 LEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKITEKCDVYSFGVLAL 322
            E +  + DFG+ K ++ D   +T   +      + APE     K     DV+SFGV   
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203

Query: 323 EVIKGKHPRDFLSSISSSFLN---------TDIELDEMLD--PRLPAPSRSVQEKLRSIV 371
           E++      D  SS  + FL          T   L  +L+   RLP P    +E    + 
Sbjct: 204 ELLTYC---DSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEE----VY 256

Query: 372 EVVFSCLNESPESRPTMK 389
           +++  C    P  R T +
Sbjct: 257 QLMRKCWEFQPSKRTTFQ 274

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 71/287 (24%), Positives = 116/287 (40%), Gaps = 46/287 (16%)

Query: 133 IGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IGNG  G V   E   G    +VV  +   S  P +Q+     FL EV+   E+ H N++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL----LFLQEVQPYRELNHPNVL 58

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIK---GVADALSYLH 245
           +  G C  +    LV EF   G L   L S+        +Q+  + +    VA  L +LH
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLH 117

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA------KFLKPDSSNWTEFAGTYGYVA 299
              F   +H D++ +N  L  +    + D+G+A       +      +         ++A
Sbjct: 118 QADF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLA 170

Query: 300 PELA-------YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSS---ISSSFLNTDIEL 348
           PEL             T+K +++S GV   E+      P   LS    +       DI+L
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL 230

Query: 349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            +   P+L        ++   +++  F  L   PE+RPT + V + L
Sbjct: 231 PK---PQLDLK---YSDRWYEVMQ--FCWL--DPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 75.0 bits (184), Expect = 2e-15
 Identities = 72/273 (26%), Positives = 124/273 (45%), Gaps = 31/273 (11%)

Query: 133 IGNGGHGSVYRA---ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G  G+V +       S + VA+K   +   ++    K E L E   + ++ +  IV+
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELLREANVMQQLDNPYIVR 60

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
           + G C  A    LV E  + G L   L  +    E   ++   ++  V+  + YL    F
Sbjct: 61  MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEETNF 116

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG-----YVAPELAY 304
              VHRD++++N+LL  +  A ++DFG++K L  D + +   A T+G     + APE   
Sbjct: 117 ---VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMN 171

Query: 305 TMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
             K + K DV+SFGVL  E    G+ P      +  + +   IE  E    R+  P R  
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP---YKGMKGNEVTQMIESGE----RMECPQRCP 224

Query: 364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            E    + +++  C     + RP   +V  +L+
Sbjct: 225 PE----MYDLMKLCWTYGVDERPGFAVVELRLR 253

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 43/216 (19%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEF--------LTEVEALTEIR 183
           +G G +  VY+A    +G++VAIKK        ++ ++KE         L E++ L E++
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKI-------KLGERKEAKDGINFTALREIKLLQELK 60

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVAD---- 239
           H NI+ L     H  +  LV+EF+    L  ++            +  +++   AD    
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVI------------KDKSIVLTPADIKSY 107

Query: 240 ------ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG 293
                  L YLH   +  I+HRD+   NLL+  +    +ADFG+A+     +   T    
Sbjct: 108 MLMTLRGLEYLH-SNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164

Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGK 328
           T  Y APEL +  +      D++S G +  E++   
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.5 bits (183), Expect = 4e-15
 Identities = 68/267 (25%), Positives = 113/267 (42%), Gaps = 32/267 (11%)

Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G +G VY A   S QV +AIK+    +P       +    E+   + ++HRNIV+  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKE----IPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G  S      +  E +  GSL+A+L S     +      +   K + + L YLH +    
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---Q 128

Query: 252 IVHRDISSKNLLLD-LEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           IVHRDI   N+L++       ++DFG +K L   +     F GT  Y+APE      + +
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE------VID 182

Query: 311 K--------CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
           K         D++S G   +E+  GK P   L    ++     +       P +P    S
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH---PEIP---ES 236

Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMK 389
           +  + ++    +  C    P+ R +  
Sbjct: 237 LSAEAKNF---ILRCFEPDPDKRASAH 260

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 74/276 (26%), Positives = 124/276 (44%), Gaps = 27/276 (9%)

Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           DF+    IG+G +G VY+A  + +G++ AIK        D  V ++E +     + + +H
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIM----MKDCKH 65

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
            NIV  +G        ++  EF   GSL  I        E   SQ   V +     L YL
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSE---SQIAYVSRETLQGLYYL 122

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
           H       +HRDI   N+LL       +ADFG++  +    +    F GT  ++APE+A 
Sbjct: 123 HSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179

Query: 305 TMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR 361
             +     + CD+++ G+ A+E+ + + P   L  + + FL T         P+L     
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP---PKL----- 231

Query: 362 SVQEKLR---SIVEVVFSCLNESPESRPTMKIVSQQ 394
             ++K++   S    V   L ++P+ RPT + + Q 
Sbjct: 232 --KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 67/261 (25%), Positives = 110/261 (42%), Gaps = 27/261 (10%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG+G  G+VY+    P+G++ A+K  +     +  V +++   E+E L ++ H N+VK +
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTV-RRQICREIEILRDVNHPNVVKCH 138

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
               H     ++ EF+  GSL     +D            +V + +   ++YLH      
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQ-------FLADVARQILSGIAYLHRR---H 188

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-----LAYTM 306
           IVHRDI   NLL++      +ADFG+++ L           GT  Y++PE     L +  
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGA 248

Query: 307 KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
                 D++S GV  LE   G+ P         + L   I    M  P  P    +   +
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CMSQP--PEAPATASRE 303

Query: 367 LRSIVEVVFSCLNESPESRPT 387
            R  +     CL   P  R +
Sbjct: 304 FRHFISC---CLQREPAKRWS 321

Length = 353

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 74.5 bits (184), Expect = 7e-15
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 37/216 (17%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG+G +G V  A    +G+ VAIKK       D ++D K  L E++ L  +RH NI+ L 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 192 G-FCSHARHSF----LVYEFLKRGSLAAILSSDAAAQELGWSQRM-----NVIKGVADAL 241
                 +   F    +V E +    L  ++ S    Q L     +      +++G    L
Sbjct: 66  DILRPPSPEDFNDVYIVTELM-ETDLHKVIKSP---QPLT-DDHIQYFLYQILRG----L 116

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS---NWTEFAGTYGYV 298
            YLH      ++HRD+   N+L++   +  + DFG+A+ + PD       TE+  T  Y 
Sbjct: 117 KYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 299 APEL-----AYTMKITEKCDVYSFGVLALEVIKGKH 329
           APEL      YT  I    D++S G +  E++  K 
Sbjct: 174 APELLLSSSRYTKAI----DIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 7e-15
 Identities = 63/261 (24%), Positives = 114/261 (43%), Gaps = 21/261 (8%)

Query: 132 CIGNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
            +G G  G VY   ++ +G+ +A+K+    P   +   +      E++ L  ++H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
            YG         +  E++  GS+   L +  A  E   +      + + + + YLH +  
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE---TVTRKYTRQILEGVEYLHSN-- 123

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTM 306
             IVHRDI   N+L D      + DFG +K L+   S+ T      GT  +++PE+    
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182

Query: 307 KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
               K DV+S G   +E++  K P     ++++ F    I      +P+LP+    V   
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF---KIATQPT-NPQLPS---HVSPD 235

Query: 367 LRSIVEVVFSCLNESPESRPT 387
            R+ +        E+ + RP+
Sbjct: 236 ARNFLR---RTFVENAKKRPS 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.8 bits (181), Expect = 8e-15
 Identities = 67/297 (22%), Positives = 121/297 (40%), Gaps = 53/297 (17%)

Query: 133 IGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G V +A             VA+K       S ++ D    L+E   L ++ H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD---LLSEFNLLKQVNHPH 64

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAIL--SSDAAAQELGWSQRMNVIK--------- 235
           ++KLYG CS      L+ E+ K GSL + L  S       LG     N            
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 236 GVADALSYLHHDCFP-------PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
            + D +S+               +VHRD++++N+L+    +  ++DFG+++ +  + S  
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 289 TEFAG--TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-------GKHPRDFLSSISS 339
               G     ++A E  +    T + DV+SFGVL  E++        G  P    + + +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT 244

Query: 340 SFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +             R+  P    +E       ++ +C  + P+ RPT   +S++L+
Sbjct: 245 GY-------------RMERPENCSEEMYN----LMLTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 73.7 bits (181), Expect = 8e-15
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 21/201 (10%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFH-----SPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           IG G +G VY+A    +G+VVA+KK         +PS  I        E+  L E+ H N
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-------REISLLKELNHPN 60

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH- 245
           IVKL          +LV+EFL +  L   + + +    +      + +  +   L++ H 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA-SPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
           H     ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE+   
Sbjct: 119 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 174

Query: 306 MKI-TEKCDVYSFGVLALEVI 325
            K  +   D++S G +  E++
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 70/274 (25%), Positives = 122/274 (44%), Gaps = 32/274 (11%)

Query: 127 FDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RH 184
           F+    +GNG +G VY+   + +GQ+ AIK     +  D+   ++E   E+  L +   H
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDE---EEEIKLEINMLKKYSHH 72

Query: 185 RNIVKLYGF------CSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
           RNI   YG         H    +LV EF   GS+   L  +     L       + + + 
Sbjct: 73  RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREIL 131

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
             L++LH      ++HRDI  +N+LL    E  + DFG++  L         F GT  ++
Sbjct: 132 RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188

Query: 299 APELAYTMKITE-----KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD 353
           APE+    +  +     + D++S G+ A+E+ +G  P   +  + + F          L 
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF----------LI 238

Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
           PR P P    ++  +  ++ +  CL ++  SRP+
Sbjct: 239 PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPS 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 38/284 (13%)

Query: 133 IGNGGHGSVYRA----ELPSG---QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR 185
           +G+G  G VY       L  G     VA+K            +KKEFL E   ++   H 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK---GATDQEKKEFLKEAHLMSNFNHP 59

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQE-----LGWSQRMNVIKGVADA 240
           NIVKL G C      +++ E ++ G L + L  DA  +      L   + +++   VA  
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 241 LSYLHHDCFPPIVHRDISSKNLLL-----DLEFEAHVADFGIAKFLKPDSSNWTEFAGTY 295
             YL    F   +HRD++++N L+     D +    + DFG+A+ +        E  G  
Sbjct: 119 CVYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 296 G--YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEML 352
              ++APE     K T + DV+SFGVL  E++  G+ P   L+       N ++      
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-------NQEVLQHVTA 228

Query: 353 DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             RL  P  +  +K+  ++    +C  + P  RPT   + + LQ
Sbjct: 229 GGRLQKP-ENCPDKIYQLMT---NCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 69/278 (24%), Positives = 111/278 (39%), Gaps = 34/278 (12%)

Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVD------KKEFLTEVEA 178
           +F  +  IG G    VYRA  L  G  VA+KK        QI D      + + + E++ 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKV-------QIFDLMDAKARADCIKEIDL 55

Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
           L ++ H N++K Y          +V E    G L+ ++      + L       V K   
Sbjct: 56  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL--IPEKTVWKYFV 113

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
              S L H     ++HRDI   N+ +       + D G+ +F    ++      GT  Y+
Sbjct: 114 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173

Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP---- 354
           +PE  +      K D++S G L  E          ++++ S F    + L  +       
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE----------MAALQSPFYGDKMNLYSLCKKIEQC 223

Query: 355 -RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIV 391
              P PS    E+LR +V +   C+N  PE RP +  V
Sbjct: 224 DYPPLPSDHYSEELRQLVNM---CINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 69/273 (25%), Positives = 123/273 (45%), Gaps = 31/273 (11%)

Query: 133 IGNGGHGSVYRA--ELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G  G V +   ++   Q+ VAIK   +    ++   + E + E E + ++ +  IV+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKN---ENEKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
           + G C  A    LV E    G L   LS      E+  S  + ++  V+  + YL    F
Sbjct: 60  MIGVC-EAEALMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG-----YVAPELAY 304
              VHRD++++N+LL  +  A ++DFG++K L  D S +   A + G     + APE   
Sbjct: 117 ---VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECIN 171

Query: 305 TMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
             K + + DV+S+G+   E    G+ P      +    + + IE  +    RL  P+   
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKP---YKKMKGPEVMSFIEQGK----RLDCPAECP 224

Query: 364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            E    +  ++  C     E RP    V ++++
Sbjct: 225 PE----MYALMKDCWIYKWEDRPNFAKVEERMR 253

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 72/270 (26%), Positives = 122/270 (45%), Gaps = 27/270 (10%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           +D++    +G+G +G VY+A  L +G++ A+K      P D   D      E+  + E +
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-PGD---DFSLIQQEIFMVKECK 64

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           H NIV  +G        ++  E+   GSL  I        EL   Q   V +     L+Y
Sbjct: 65  HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLAY 121

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH       +HRDI   N+LL    +  +ADFG+A  +    +    F GT  ++APE+A
Sbjct: 122 LHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178

Query: 304 YTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
              K     + CD+++ G+ A+E+ + + P   L  + + FL +         P+L    
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP---PKL---- 231

Query: 361 RSVQEKLR---SIVEVVFSCLNESPESRPT 387
              ++K +   +    V   L ++P+ RPT
Sbjct: 232 ---KDKTKWSSTFHNFVKISLTKNPKKRPT 258

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 35/211 (16%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR-----N 186
           I  G  GSVY A+   +G   AIK     L    ++ K + +T V+A   I         
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKV----LKKSDMIAKNQ-VTNVKAERAIMMIQGESPY 58

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELG-----WSQRMNVIKGVADAL 241
           + KLY       + +LV E+L  G  A+++      + LG     W++    I  V   +
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAK--QYIAEVVLGV 110

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVA 299
             LH      I+HRDI  +NLL+D      + DFG+++             F GT  Y+A
Sbjct: 111 EDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLA 161

Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE    +   +  D +S G +  E + G  P
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 68/251 (27%), Positives = 110/251 (43%), Gaps = 46/251 (18%)

Query: 126 DFDAQY----CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
           D  ++Y     IG+G +G V  A +  SG+ VAIKK   P   D     K  L E++ L 
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI--PHAFDVPTLAKRTLRELKILR 59

Query: 181 EIRHRNIVKLYGFC----SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN---- 232
             +H NI+ +        +  +  ++V + L    L  I+ SD    E    + +     
Sbjct: 60  HFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTE----EHIRYFLY 114

Query: 233 -VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL--KPD--SSN 287
            +++G    L Y+H      ++HRD+   NLL++ + E  + DFG+A+ L   P      
Sbjct: 115 QLLRG----LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167

Query: 288 WTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVI------KGKHPRDFLSSI--- 337
            TE+  T  Y APEL  ++ + T   D++S G +  E++       GK+    L  I   
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227

Query: 338 ----SSSFLNT 344
               S   LN 
Sbjct: 228 LGSPSEEVLNR 238

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 86/286 (30%), Positives = 125/286 (43%), Gaps = 50/286 (17%)

Query: 133 IGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKE---FLTEVEALTEIRHR 185
           IG G  G VY   L          A+K        ++I D +E   FL E   + +  H 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL------NRITDLEEVEQFLKEGIIMKDFSHP 56

Query: 186 NIVKLYGFCSHARHSFLV-YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG-------V 237
           N++ L G C  +  S LV   ++K G L   + S+              +K        V
Sbjct: 57  NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQV 107

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSS--NWTEFAG 293
           A  + YL    F   VHRD++++N +LD  F   VADFG+A+  + K   S  N T    
Sbjct: 108 AKGMEYLASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164

Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEML 352
              ++A E   T K T K DV+SFGVL  E++ +G  P   + S        DI +  + 
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-------DITVYLLQ 217

Query: 353 DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTM-KIVSQQLQI 397
             RL  P    +     + EV+ SC +  PE RPT  ++VS+  QI
Sbjct: 218 GRRLLQP----EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 72/289 (24%), Positives = 126/289 (43%), Gaps = 50/289 (17%)

Query: 133 IGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  GSV  A+L     S Q VA+K   + + S    D +EFL E   + E  H N++
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS--DIEEFLREAACMKEFDHPNVI 64

Query: 189 KLYGFCSHARHS------FLVYEFLKRGSLAAILSSDAAAQE---LGWSQRMNVIKGVAD 239
           KL G    +R         ++  F+K G L   L      +E   L     +  +  +A 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY---- 295
            + YL    F   +HRD++++N +L+      VADFG++K +         ++G Y    
Sbjct: 125 GMEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSKKI---------YSGDYYRQG 172

Query: 296 -------GYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIE 347
                   ++A E       T   DV++FGV   E++ +G+ P        +   N++I 
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP-------YAGVENSEIY 225

Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              +   RL  P   +++    + E++  C +  P+ RP+ + +  QL+
Sbjct: 226 NYLIKGNRLKQPPDCLED----VYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 63/268 (23%), Positives = 108/268 (40%), Gaps = 44/268 (16%)

Query: 152 VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGS 211
           VA+K      P      +++FL EV+ L+ +   NI +L G C+      ++ E+++ G 
Sbjct: 49  VAVKV---LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105

Query: 212 LAAILS------SDAAAQELGWSQR--MNVIKGVADALSYLHHDCFPPIVHRDISSKNLL 263
           L   L       S  A      S    + +   +A  + YL    F   VHRD++++N L
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF---VHRDLATRNCL 162

Query: 264 LDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV-----------APELAYTMKITEKC 312
           +   +   +ADFG+++ L         ++  Y  V           A E     K T K 
Sbjct: 163 VGKNYTIKIADFGMSRNL---------YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKS 213

Query: 313 DVYSFGVLALEVIK--GKHPRDFLSSISSSFLNTDIELDEMLDPR--LPAPSRSVQEKLR 368
           DV++FGV   E++    + P + L+      +            +  LP P    ++   
Sbjct: 214 DVWAFGVTLWEILTLCREQPYEHLT--DQQVIENAGHFFRDDGRQIYLPRPPNCPKD--- 268

Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            I E++  C     E RPT + +   LQ
Sbjct: 269 -IYELMLECWRRDEEDRPTFREIHLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 29/268 (10%)

Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVD-KKEFLTEVEALTEIR 183
           D   Q  +G+G  G+VY+A  L + +++A+K     +P D  V+ +K+ ++E+E L +  
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKV----IPLDITVELQKQIMSELEILYKCD 57

Query: 184 HRNIVKLYG-FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALS 242
              I+  YG F    R S +  EF+  GSL            LG   R+ V   V   L+
Sbjct: 58  SPYIIGFYGAFFVENRIS-ICTEFMDGGSLDVYRK--IPEHVLG---RIAV--AVVKGLT 109

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           YL       I+HRD+   N+L++   +  + DFG++  L   +S    + GT  Y+APE 
Sbjct: 110 YLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPER 164

Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD---PRLPAP 359
               +     DV+S G+  +E+  G+ P   +     S +   + L  ++D   P LP  
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVLP-- 221

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPT 387
              V +     V  +  C+ + P+ RP 
Sbjct: 222 ---VGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 23/237 (9%)

Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE---FLTEVEALTE 181
           D +    +G G  G V+   +  S    A+K    P    +++  K+      E   L E
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP----EVIRLKQEQHVHNEKRVLKE 57

Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG--VAD 239
           + H  I++L+      R  +++ E++  G L + L +        +S    +     +  
Sbjct: 58  VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-----FSNSTGLFYASEIVC 112

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           AL YLH      IV+RD+  +N+LLD E    + DFG AK L+     WT   GT  Y+A
Sbjct: 113 ALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWT-LCGTPEYLA 166

Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLNTDIELDEMLDP 354
           PE+  +    +  D ++ G+L  E++ G  P   D    I    L   +E    LD 
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDL 223

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 67/289 (23%), Positives = 117/289 (40%), Gaps = 58/289 (20%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V +AE            VA+K       +++  D  + ++E+E +  I +H+
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEK--DLSDLVSEMEMMKMIGKHK 76

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG--------- 236
           NI+ L G C+     ++V E+   G+L   L +     E          +          
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 237 ----VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA 292
               VA  + +L        +HRD++++N+L+  +    +ADFG+A+    D  +   + 
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYR 189

Query: 293 GT------YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTD 345
            T        ++APE  +    T + DV+SFGVL  E+   G  P               
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY------------PG 237

Query: 346 IELDEMLD-----PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           I ++E+        R+  P    QE    +  ++  C +E P  RPT K
Sbjct: 238 IPVEELFKLLKEGYRMEKPQNCTQE----LYHLMRDCWHEVPSQRPTFK 282

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 49/288 (17%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY               VA+K       S+Q  D+ +FL E   +++  H+N
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE-SCSEQ--DESDFLMEALIMSKFNHQN 70

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM----NVIKGVADALS 242
           IV+L G        F++ E +  G L + L  +    E   S  M       + VA    
Sbjct: 71  IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL  +     A +ADFG+A+ +    +++    G      
Sbjct: 131 YLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKGGRAMLPI 185

Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-------GKHPRDFLSSISSSFLNTDIEL 348
            ++ PE       T K DV+SFGVL  E+         G+  ++ +  ++          
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-------- 237

Query: 349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              LDP    P          +  ++  C   +PE RP    + +++Q
Sbjct: 238 -GRLDPPKGCPGP--------VYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.1 bits (175), Expect = 7e-14
 Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 32/210 (15%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIK--KFHS-----PLPSDQIVDKKEFLTEVEALTEIRH 184
           I  G +G VYRA +  +G++VA+K  K        P+ S         L E+  L +++H
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS---------LREINILLKLQH 63

Query: 185 RNIVKL----YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADA 240
            NIV +     G  S+    ++V E+++   L +++  +   Q    S+   ++  +   
Sbjct: 64  PNIVTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVKCLMLQLLSG 118

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA-KFLKPDSSNWTEFAGTYGYVA 299
           +++LH +    I+HRD+ + NLLL+      + DFG+A ++  P    +T+   T  Y A
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLVVTLWYRA 174

Query: 300 PELAY-TMKITEKCDVYSFGVLALEVIKGK 328
           PEL     + +   D++S G +  E++  K
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 70.7 bits (173), Expect = 7e-14
 Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 44/286 (15%)

Query: 133 IGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IGNG  G V   E+ SG    QVV +K+      S  + ++ +FL E +    ++H N++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVV-VKELRV---SASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQ----ELGWSQRMNVIKGVADALSYL 244
           +  G C+      LV EF   G L   L S   A+    +    QRM     +A  L +L
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHL 116

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-------FLKPDSSNWTEFAGTYGY 297
           H + F   +H D++ +N LL  +    + D+G++        ++ PD   W        +
Sbjct: 117 HKNNF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL-WVPLR----W 168

Query: 298 VAPELA-------YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELD 349
           +APEL          +  T++ +V+S GV   E+ + G  P   LS      L   +   
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS--DEQVLTYTVREQ 226

Query: 350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           ++   +LP P   +    R   EV+  C  + PE RP+ + V   L
Sbjct: 227 QL---KLPKPRLKLPLSDR-WYEVMQFCWLQ-PEQRPSAEEVHLLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 15/215 (6%)

Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN 232
           L E+  L+ ++H NI+  Y          +  E+   G+L   +      Q       + 
Sbjct: 47  LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIV-RQKGQLFEEEMVLW 105

Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA 292
            +  +  A+SY+H      I+HRDI + N+ L       + DFGI+K L  + S      
Sbjct: 106 YLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV 162

Query: 293 GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML 352
           GT  Y++PEL   +K   K D+++ G +  E++  K  R F ++ +   L   I    + 
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK--RTFDAT-NPLNLVVKI----VQ 215

Query: 353 DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
               P  S    E    ++ +V S L + PE RPT
Sbjct: 216 GNYTPVVSVYSSE----LISLVHSLLQQDPEKRPT 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 72.2 bits (177), Expect = 2e-13
 Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 26/196 (13%)

Query: 148 SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY--GFCSHARHSFLVYE 205
           +G  VAIK   +  P ++   +  F  E      + H NIV L   G        F V+E
Sbjct: 2   TGHEVAIKLLRTDAPEEE-HQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFE 59

Query: 206 FLKRGSLAAILSSDAA--AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLL 263
           ++   +L  +L++D A  A E G      ++  V DAL+  H+     IVHRD+  +N++
Sbjct: 60  YVPGRTLREVLAADGALPAGETG-----RLMLQVLDALACAHNQ---GIVHRDLKPQNIM 111

Query: 264 L---DLEFEAHVADFGIAKFLKPDSSNW--------TEFAGTYGYVAPELAYTMKITEKC 312
           +    +   A V DFGI   L P   +         TE  GT  Y APE      +T   
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS 170

Query: 313 DVYSFGVLALEVIKGK 328
           D+Y++G++ LE + G+
Sbjct: 171 DLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 69/228 (30%), Positives = 95/228 (41%), Gaps = 60/228 (26%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE---FLTEVEALTEIRHRN-- 186
           IG G  G+V +    PSG ++A+K+  S       VD+KE    L +++ +  +R  +  
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRS------TVDEKEQKRLLMDLDVV--MRSSDCP 63

Query: 187 -IVKLYG---------FC------SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQR 230
            IVK YG          C      S  +    VYE LK      IL   A A        
Sbjct: 64  YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA-------- 115

Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE 290
                    AL+YL  +    I+HRD+   N+LLD      + DFGI+  L  DS   T 
Sbjct: 116 ------TVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTR 166

Query: 291 FAGTYGYVAPELAYTMKITE--------KCDVYSFGVLALEVIKGKHP 330
            AG   Y+APE     +I          + DV+S G+   EV  GK P
Sbjct: 167 DAGCRPYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 17/178 (9%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR---HRNIV 188
           IG G +G+VY+A +L +G+ VA+KK   PL  + I      L E+  L ++    H NIV
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI--PLSTLREIALLKQLESFEHPNIV 64

Query: 189 KLYGFC-----SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           +L   C            LV+E + +  LA  LS       L      ++++ +   + +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK-CPKPGLPPETIKDLMRQLLRGVDF 122

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
           LH      IVHRD+  +N+L+  + +  +ADFG+A+    + +  T    T  Y APE
Sbjct: 123 LHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 12/207 (5%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           N F+    +G G +G V +     + ++VAIKKF     ++++  K+  L E++ L  ++
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEV--KETTLRELKMLRTLK 58

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILS-SDAAAQELGWSQRMNVIKGVADALS 242
             NIV+L          +LV+E++++  L  +    +    E   S    +IK    A+ 
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK----AIH 114

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS-SNWTEFAGTYGYVAPE 301
           + H +    IVHRDI  +NLL+       + DFG A+ L   S +N+TE+  T  Y +PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGK 328
           L       +  D++S G +  E+  G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 16/199 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V  A +  +GQ VAIKK   P  +   V  K    E++ L  +RH NI+ L 
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP--VLAKRTYRELKLLKHLRHENIISLS 75

Query: 192 G-FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
             F S     + V E L    L  +L+S    ++        +++G    L Y+H     
Sbjct: 76  DIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRG----LKYVHS---A 127

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKIT 309
            +VHRD+   N+L++   +  + DFG+A   +      T +  T  Y APE+  T  K  
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLA---RIQDPQMTGYVSTRYYRAPEIMLTWQKYD 184

Query: 310 EKCDVYSFGVLALEVIKGK 328
            + D++S G +  E+++GK
Sbjct: 185 VEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 21/208 (10%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDK--KEFLTEVE----ALTEIRHR 185
           +G+G  G+V++   +P G  + I     P+    I D+  ++   E+     A+  + H 
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKI-----PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
            IV+L G C  A    LV +    GSL   +     +  L   + +N    +A  + YL 
Sbjct: 70  YIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLE 126

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELA 303
                 +VHR+++++N+LL  +    +ADFG+A  L PD     ++E      ++A E  
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 304 YTMKITEKCDVYSFGVLALEVIK-GKHP 330
              + T + DV+S+GV   E++  G  P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 60/250 (24%), Positives = 110/250 (44%), Gaps = 23/250 (9%)

Query: 152 VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLKRG 210
           VA+K       S +   ++  ++E++ ++ +  H NIV L G C+      ++ E+   G
Sbjct: 68  VAVKMLKPTAHSSE---REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124

Query: 211 SLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEA 270
            L   L     +  L     ++    VA  +++L        +HRD++++N+LL      
Sbjct: 125 DLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIV 180

Query: 271 HVADFGIAKFLKPDSSNWTEFAGTY---GYVAPELAYTMKITEKCDVYSFGVLALEVIK- 326
            + DFG+A+ +  D SN+           ++APE  +    T + DV+S+G+L  E+   
Sbjct: 181 KICDFGLARDIMND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239

Query: 327 GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRP 386
           G +P   +  + S F     E   M  P   AP          I +++ +C +  P  RP
Sbjct: 240 GSNPYPGM-PVDSKFYKLIKEGYRMAQPEH-AP--------AEIYDIMKTCWDADPLKRP 289

Query: 387 TMKIVSQQLQ 396
           T K + Q + 
Sbjct: 290 TFKQIVQLIG 299

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.2 bits (166), Expect = 6e-13
 Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 26/267 (9%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFH----SPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  G VY   ++ +G+ +A K+      SP  S ++        E++ L  ++H  I
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEV---SALECEIQLLKNLQHERI 66

Query: 188 VKLYG-FCSHARHSFLVY-EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
           V+ YG     A  +  ++ E++  GS+   L +  A  E   S      + + + +SYLH
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE---SVTRKYTRQILEGMSYLH 123

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
            +    IVHRDI   N+L D      + DFG +K L+    + T      GT  +++PE+
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
                   K DV+S G   +E++  K P     ++++ F        +  +P+LP+    
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA----TQPTNPQLPS---H 233

Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMK 389
           + E  R  +  +F      P +   ++
Sbjct: 234 ISEHARDFLGCIFVEARHRPSAEELLR 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 18/228 (7%)

Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIV---DKKEFLTEVEALT-EIRHRNI 187
           +G G  G V+ AEL  + Q  AIK     L  D ++   D +  + E   L+    H  +
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKA----LKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 58

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
             LY       + F V E+L  G L   + S     +    +       +   L +LH  
Sbjct: 59  THLYCTFQTKENLFFVMEYLNGGDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK 307
               IV+RD+   N+LLD +    +ADFG+ K      +    F GT  Y+APE+    K
Sbjct: 116 ---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172

Query: 308 ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR 355
                D +SFGVL  E++ G+ P           L   I +D    PR
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP---FHGHDEEELFQSIRMDNPCYPR 217

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 58/299 (19%)

Query: 126 DFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEAL 179
           D   +  IG G  G V RA +       +  +  +K+F S        D ++F  E+E L
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE------NDHRDFAGELEVL 56

Query: 180 TEI-RHRNIVKLYGFCSHARHSFLVYEFLKRGSL------AAILSSDAA-------AQEL 225
            ++  H NI+ L G C +  + ++  E+   G+L      + +L +D A       A  L
Sbjct: 57  CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116

Query: 226 GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS 285
              Q +     VA  + YL    F   +HRD++++N+L+     + +ADFG+++      
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLSR------ 167

Query: 286 SNWTEFAGTYG-----YVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS 338
                   T G     ++A E L Y++  T K DV+SFGVL  E++  G  P   +    
Sbjct: 168 GEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGM---- 222

Query: 339 SSFLNTDIELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
                T  EL E L    R+  P     E    + E++  C  + P  RP    +S QL
Sbjct: 223 -----TCAELYEKLPQGYRMEKPRNCDDE----VYELMRQCWRDRPYERPPFAQISVQL 272

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 67.8 bits (165), Expect = 8e-13
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 27/210 (12%)

Query: 133 IGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR 185
           +G G  G VY   +  G V       VAIK  +    +  + ++ EFL E   + E    
Sbjct: 14  LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNE---AASMRERIEFLNEASVMKEFNCH 69

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG-------VA 238
           ++V+L G  S  + + ++ E + RG L + L S     E    Q    +K        +A
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---- 294
           D ++YL+ + F   VHRD++++N ++  +F   + DFG+ + +    +++    G     
Sbjct: 130 DGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLP 184

Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEV 324
             +++PE       T   DV+SFGV+  E+
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 39/278 (14%)

Query: 131 YC----IGNGGHGSV--YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           YC    +G G +G V   R      Q V IKK +    S +  ++K    E + L++++H
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYV-IKKLNLRNASRR--ERKAAEQEAQLLSQLKH 58

Query: 185 RNIVKLYGFCSHARHS--------FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG 236
            NIV         R S        ++V  F + G L   L  +   + L  +Q +     
Sbjct: 59  PNIVAY-------RESWEGEDGLLYIVMGFCEGGDLYHKLK-EQKGKLLPENQVVEWFVQ 110

Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
           +A AL YLH      I+HRD+ ++N+ L       V D GIA+ L+      +   GT  
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY 167

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           Y++PEL        K DV++ G    E+   KH      + ++  +N+ +    +++ +L
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKH------AFNAKDMNSLVY--RIIEGKL 219

Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
           P   +    +L    E++ + L++ PE RP++K + +Q
Sbjct: 220 PPMPKDYSPEL---GELIATMLSKRPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 76/263 (28%), Positives = 112/263 (42%), Gaps = 37/263 (14%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALTEIRHRNIV 188
           +G G  G V    E  +G+  A+K     L  + IV K E    LTE   L   RH  + 
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKI----LKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 189 KL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG-VADALSYLHH 246
            L Y F +H R  F V E+   G L   LS +    E     R       +  AL YLH 
Sbjct: 59  ALKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHS 113

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM 306
           +    +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  Y+APE+    
Sbjct: 114 E--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 171

Query: 307 KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD----IELDEMLDPRLPAPSRS 362
                 D +  GV+  E++ G+ P          F N D     EL  M + R P   R+
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHEKLFELILMEEIRFP---RT 218

Query: 363 VQEKLRSIVEVVFSCLNESPESR 385
           +  + +S++      L + P+ R
Sbjct: 219 LSPEAKSLLS---GLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 14/203 (6%)

Query: 133 IGNGGHGSVY--RAELP--SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V+  R      +GQ+ A+K       + ++ D+     E + L E+ H  IV
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA--TLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 189 KL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           KL Y F +  +  +L+ +FL+ G L   LS +    E         +  +A AL +LH  
Sbjct: 62  KLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYLAELALALDHLHS- 116

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK 307
               I++RD+  +N+LLD E    + DFG++K           F GT  Y+APE+     
Sbjct: 117 --LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 174

Query: 308 ITEKCDVYSFGVLALEVIKGKHP 330
            T+  D +SFGVL  E++ G  P
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 28/216 (12%)

Query: 128 DAQY----CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           D +Y     IG G +G V  A    + + VAIKK  +    D  +D K  L E++ L  +
Sbjct: 4   DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHL 61

Query: 183 RHRNIVKLYGFCS-HARHSF----LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGV 237
            H N++ +        R +F    +VYE L    L  I+ S   +Q L        +  +
Sbjct: 62  DHENVIAIKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRS---SQTLSDDHCQYFLYQL 117

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGY 297
              L Y+H      ++HRD+   NLLL+   +  + DFG+A+         TE+  T  Y
Sbjct: 118 LRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWY 174

Query: 298 VAPEL-----AYTMKITEKCDVYSFGVLALEVIKGK 328
            APEL      YT  I    DV+S G +  E++  K
Sbjct: 175 RAPELLLNCSEYTTAI----DVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 67/273 (24%), Positives = 120/273 (43%), Gaps = 32/273 (11%)

Query: 133 IGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G+G  G+VY+   +P G+ V    AIK  +        V   EF+ E   +  + H ++
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV---EFMDEALIMASMDHPHL 71

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           V+L G C       LV + +  G L   +        +G    +N    +A  + YL   
Sbjct: 72  VRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER 128

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYT 305
               +VHRD++++N+L+       + DFG+A+ L+ D   +    G     ++A E  + 
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185

Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--RLPAPSRS 362
            K T + DV+S+GV   E++  G  P D + +          E+ ++L+   RLP P   
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------REIPDLLEKGERLPQPPIC 236

Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             +    +  V+  C     +SRP  K ++ + 
Sbjct: 237 TID----VYMVMVKCWMIDADSRPKFKELAAEF 265

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 29/283 (10%)

Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVD------KKEFLTEVEA 178
           +F  +  IG G    VYRA  L   + VA+KK        QI +      +++ + E++ 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKV-------QIFEMMDAKARQDCVKEIDL 55

Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
           L ++ H N++K            +V E    G L+ ++      + L       V K   
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL--IPERTVWKYFV 113

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
              S + H     ++HRDI   N+ +       + D G+ +F    ++      GT  Y+
Sbjct: 114 QLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173

Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-LNTDIELDEMLDPRLP 357
           +PE  +      K D++S G L  E+   + P  F     + F L   IE  +   P  P
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLFSLCQKIEQCDY--P--P 227

Query: 358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ---QLQI 397
            P+    EKLR +V +   C+   P+ RP +  V Q   Q+ +
Sbjct: 228 LPTEHYSEKLRELVSM---CIYPDPDQRPDIGYVHQIAKQMHV 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A +  +G+ VAIKK +     + + D    L E++ L  +RH +IV++ 
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 192 GFC-----SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH 246
                      +  ++V+E ++      I ++D    E         +  +  AL Y+H 
Sbjct: 66  HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE----HHQFFLYQLLRALKYIHT 121

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK--FLK-PDSSNWTEFAGTYGYVAPEL- 302
                + HRD+  KN+L + + +  + DFG+A+  F   P +  WT++  T  Y APEL 
Sbjct: 122 ---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178

Query: 303 -AYTMKITEKCDVYSFGVLALEVIKGK 328
            ++  K T   D++S G +  EV+ GK
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 66/269 (24%), Positives = 116/269 (43%), Gaps = 43/269 (15%)

Query: 133 IGNGGHGSVYRA--ELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G + R   +LPS +   VAI    +     Q   ++ FL E   L +  H NIV
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ---RRGFLAEALTLGQFDHSNIV 69

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  +      +V E++  G+L + L       +L   Q M ++ G+A  + YL    
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG 127

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYG--YVAPELAY 304
           +   VH+ +++  +L++ +    ++ F     L+ D S   +T  +G     + APE   
Sbjct: 128 Y---VHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181

Query: 305 TMKITEKCDVYSFGVLALEVIK-GKHP------RDFLSSISSSFLNTDIELDEMLDPRLP 357
               +   DV+SFG++  EV+  G+ P      +D + ++   F             RLP
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF-------------RLP 228

Query: 358 APSRSVQEKLRSIVEVVFSCLNESPESRP 386
           AP R+    L    +++  C  +    RP
Sbjct: 229 AP-RNCPNLLH---QLMLDCWQKERGERP 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 47/278 (16%)

Query: 127 FDAQYCIGNGGHGSVY--RAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           ++    IG G  G +Y  +A+  S   V IK+    L    + +K+    EV  L +++H
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEID--LTKMPVKEKEASKKEVILLAKMKH 58

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSL--------AAILSSDAAAQELGWSQRMNVIKG 236
            NIV  +         F+V E+   G L          + S D   Q L W  ++++   
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED---QILSWFVQISL--- 112

Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSSNWTEFA--- 292
               L ++H      I+HRDI S+N+ L      A + DFGIA+ L    ++  E A   
Sbjct: 113 ---GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTC 162

Query: 293 -GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE- 350
            GT  Y++PE+        K D++S G +  E+   KHP +      ++     +++ + 
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE-----GNNLHQLVLKICQG 217

Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTM 388
              P  P  SR     LRS++  +F     SP  RP++
Sbjct: 218 YFAPISPNFSR----DLRSLISQLFKV---SPRDRPSI 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 78/289 (26%), Positives = 125/289 (43%), Gaps = 52/289 (17%)

Query: 133 IGNGGHGSVYRAELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIV 188
           IG G  G V +A +    +    AIK+       D   D ++F  E+E L ++  H NI+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCKLGHHPNII 59

Query: 189 KLYGFCSHARHSFLVYEFLKRGSL------AAILSSDAA-------AQELGWSQRMNVIK 235
            L G C H  + +L  E+   G+L      + +L +D A       A  L   Q ++   
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY 295
            VA  + YL    F   +HRD++++N+L+   + A +ADFG+++              T 
Sbjct: 120 DVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTM 170

Query: 296 G-----YVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIEL 348
           G     ++A E L Y++  T   DV+S+GVL  E++  G  P   +         T  EL
Sbjct: 171 GRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGM---------TCAEL 220

Query: 349 DEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            E L    RL  P     E    + +++  C  E P  RP+   +   L
Sbjct: 221 YEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 82

Query: 192 GFCSHARHSFLVYE--FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
              + AR S   +   +L    + A L++    Q+L       +I  +   L Y+H    
Sbjct: 83  DVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 138

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKI 308
             I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M  
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVATRWYRAPEIMLNWMHY 195

Query: 309 TEKCDVYSFGVLALEVIKGK 328
            +  D++S G +  E++ G+
Sbjct: 196 NQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 23/209 (11%)

Query: 132 CIGNGGHGSVYRA--ELPSGQV--VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           CIG G  G VY+     P  +   VA+K   +         +++FL E   + +  H +I
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS---VREKFLQEAYIMRQFDHPHI 69

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIK---GVADALSYL 244
           VKL G  +     ++V E    G L + L               ++I     ++ AL+YL
Sbjct: 70  VKLIGVITE-NPVWIVMELAPLGELRSYLQ-----VNKYSLDLASLILYSYQLSTALAYL 123

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPEL 302
               F   VHRDI+++N+L+       + DFG++++L+ D S +    G     ++APE 
Sbjct: 124 ESKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPES 179

Query: 303 AYTMKITEKCDVYSFGVLALEVIK-GKHP 330
               + T   DV+ FGV   E++  G  P
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 70/260 (26%), Positives = 113/260 (43%), Gaps = 32/260 (12%)

Query: 137 GHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           G GS  RA L     S Q  A+K+   P  S  + D ++   E   L +++H NIV    
Sbjct: 9   GEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAFKE 65

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAA-----QELGWSQRMNVIKGVADALSYLHHD 247
                 H ++V E+   G L   +             L W  +M +       + ++H  
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK 119

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK 307
               ++HRDI SKN+ L    +  + DFG A+ L    +    + GT  YV PE+   M 
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176

Query: 308 ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL 367
              K D++S G +  E+   KHP       ++S+ N  +++ +      P PS    E L
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQ-----ANSWKNLILKVCQ--GSYKPLPSHYSYE-L 228

Query: 368 RSIVEVVFSCLNESPESRPT 387
           RS+++ +F     +P SRP+
Sbjct: 229 RSLIKQMF---KRNPRSRPS 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 28/207 (13%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G+ VAIKK   P  S +I  K+ +  E+  L  ++H N++ L 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAY-RELTLLKHMQHENVIGLL 80

Query: 192 G-FCS----HARHSF-LVYEFLKRGSLAAILS---SDAAAQELGWSQRMNVIKGVADALS 242
             F S         F LV  ++ +  L  I+    S+   Q L +     ++ G    L 
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQYLVY----QMLCG----LK 131

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y+H      I+HRD+   NL ++ + E  + DFG+A+      +  T +  T  Y APE+
Sbjct: 132 YIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRAPEV 185

Query: 303 AYT-MKITEKCDVYSFGVLALEVIKGK 328
               M   +  D++S G +  E++ GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 69/293 (23%), Positives = 123/293 (41%), Gaps = 59/293 (20%)

Query: 133 IGNGGHGSVYRAELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G G  GSV   +L        VA+K     + +    + ++FL+E   + E  H N+++
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS--EMEDFLSEAVCMKEFDHPNVMR 64

Query: 190 LYGFC--SHARHSF----LVYEFLKRGSLAA-ILSSDAAAQELGWSQRMNV--IKGVADA 240
           L G C  +     +    ++  F+K G L + +L S           +M V  +  +A  
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY----- 295
           + YL    F   +HRD++++N +L+      VADFG++K +         + G Y     
Sbjct: 125 MEYLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKI---------YNGDYYRQGR 172

Query: 296 ------GYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLSSISSSFLNTDIEL 348
                  ++A E       T K DV+SFGV   E+  +G+ P               +E 
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY------------PGVEN 220

Query: 349 DEMLD-----PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            E+ D      RL  P     + L  +  ++ SC   +P+ RP+ + +  +L+
Sbjct: 221 SEIYDYLRQGNRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 61/271 (22%), Positives = 111/271 (40%), Gaps = 34/271 (12%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDK----KEFLTEVEAL 179
            DF     +G GG+G V+ A+   +G++VA+K+         ++ K    +  LTE + L
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRM-----KKSLLFKLNEVRHVLTERDIL 55

Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVAD 239
           T  +   +VKL        + +L  E++  G    +L++     E     R  + +    
Sbjct: 56  TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED--HARFYMAEMFE- 112

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA----GTY 295
           A+  LH       +HRD+  +N L+D      + DFG+       S     +A    G+ 
Sbjct: 113 AVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGL-------SKGIVTYANSVVGSP 162

Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD-P 354
            Y+APE+          D +S G +  E + G  P    S+ + ++ N      E L  P
Sbjct: 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENL-KYWKETLQRP 220

Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
               P  ++ ++   ++      +N+ P  R
Sbjct: 221 VYDDPRFNLSDEAWDLIT---KLIND-PSRR 247

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 81/303 (26%), Positives = 126/303 (41%), Gaps = 49/303 (16%)

Query: 115 LVYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL 173
           +++D     ++ ++    IG G +G V++     +G   A+K        D I D  E  
Sbjct: 8   IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL------DPIHDIDE-- 59

Query: 174 TEVEALTEI-----RHRNIVKLYGF-----CSHARHSFLVYEFLKRGSLAAILSSDAAAQ 223
            E+EA   I      H N+VK YG        +    +LV E    GS+     +D    
Sbjct: 60  -EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-----TDLVKG 113

Query: 224 ELGWSQRMN---VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF 280
            L   +RM    +   + +AL  L H      +HRD+   N+LL  E    + DFG++  
Sbjct: 114 FLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173

Query: 281 LKPDSSNWTEFAGTYGYVAPE-LAYTMKI----TEKCDVYSFGVLALEVIKGKHPRDFLS 335
           L           GT  ++APE +A   ++      +CDV+S G+ A+E+  G  P   L 
Sbjct: 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233

Query: 336 SISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS--IVEVVFSCLNESPESRPTMKIVSQ 393
            + + F            PR P P+   Q +L S    + +  CL +  E RPT   VS 
Sbjct: 234 PMRALF----------KIPRNPPPTLH-QPELWSNEFNDFIRKCLTKDYEKRPT---VSD 279

Query: 394 QLQ 396
            LQ
Sbjct: 280 LLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 75/271 (27%), Positives = 110/271 (40%), Gaps = 52/271 (19%)

Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLT---EVEAL--------- 179
           +G G  G V  AE   +G++ AIK             KK  +    EVE+L         
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIK-----------ALKKGDIIARDEVESLMCEKRIFET 55

Query: 180 -TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
               RH  +V L+       H   V E+   G L   + +D  ++     + +     V 
Sbjct: 56  ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE----PRAVFYAACVV 111

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYGY 297
             L YLH +    IV+RD+   NLLLD E    +ADFG+ K  +       T F GT  +
Sbjct: 112 LGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEF 167

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLNTDIELDEMLDPR 355
           +APE+      T   D +  GVL  E++ G+ P   D    +  S +N     DE+  PR
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPR 222

Query: 356 -LPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
            L   + S+  +L          L  +PE R
Sbjct: 223 FLSREAISIMRRL----------LRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 13/203 (6%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQI-VDKKEFLTEVEALTEIRHRNIVKL 190
           IG G +G+VY+A +  SG  VA+K        D + +     +  ++ L    H NIV+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 191 YGFCSHARHS-----FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
              C+ +R        LV+E + +  L   L        L      ++++     L +LH
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK-VPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
            +C   IVHRD+  +N+L+    +  +ADFG+A+      +  T    T  Y APE+   
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVLLQ 181

Query: 306 MKITEKCDVYSFGVLALEVIKGK 328
                  D++S G +  E+ + K
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 65.5 bits (159), Expect = 8e-12
 Identities = 74/250 (29%), Positives = 109/250 (43%), Gaps = 37/250 (14%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALTEIRHRNIV 188
           +G G  G V    E  SG+  A+K     L  + I+ K E    LTE   L   RH  + 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKI----LKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58

Query: 189 KL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG--VADALSYLH 245
            L Y F +  R  F V E++  G L   LS     +E  +S+      G  +  AL YLH
Sbjct: 59  SLKYSFQTKDRLCF-VMEYVNGGELFFHLS-----RERVFSEDRTRFYGAEIVSALDYLH 112

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
                 IV+RD+  +NL+LD +    + DFG+ K    D++    F GT  Y+APE+   
Sbjct: 113 SG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED 169

Query: 306 MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD----IELDEMLDPRLPAPSR 361
                  D +  GV+  E++ G+ P          F N D     EL  M D + P   R
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHEKLFELILMEDIKFP---R 216

Query: 362 SVQEKLRSIV 371
           ++    +S++
Sbjct: 217 TLSADAKSLL 226

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 39/219 (17%)

Query: 122 RATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE-----FLTE 175
           R  + FD    IG G +G VY+A +  +G++VA+KK        ++ ++KE      + E
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-------RLDNEKEGFPITAIRE 56

Query: 176 VEALTEIRHRNIVKLY----------GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQEL 225
           ++ L ++ HRNIV L            F       +LV+E++    L  +L S       
Sbjct: 57  IKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLV--HF 113

Query: 226 GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS 285
                 + +K + + L+Y H   F   +HRDI   N+LL+ + +  +ADFG+A+    + 
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 286 SN-WTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFG 318
           S  +T    T  Y  PEL      Y   I    DV+S G
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAI----DVWSCG 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 16/202 (7%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+     +GQ+VA+KK    L S++       + E+  L E++H NIV L 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIR--LESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                    +L++EFL    L   L S    Q +      + +  +   + + H      
Sbjct: 66  DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL-----AYTM 306
           ++HRD+  +NLL+D +    +ADFG+A+        +T    T  Y APE+      Y+ 
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181

Query: 307 KITEKCDVYSFGVLALEVIKGK 328
            +    D++S G +  E+   K
Sbjct: 182 PV----DIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 19/205 (9%)

Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEF---LTE--VEALTEIRHRN 186
           +G G  G V  AEL  + ++ A+K     L  D I+   +    +TE  V AL   +H  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKV----LKKDVILQDDDVECTMTEKRVLALAG-KHPF 57

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH- 245
           + +L+         F V E++  G L   +       E    +       +   L +LH 
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE---PRARFYAAEIVLGLQFLHE 114

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
                 I++RD+   N+LLD E    +ADFG+ K         + F GT  Y+APE+   
Sbjct: 115 RG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 306 MKITEKCDVYSFGVLALEVIKGKHP 330
                  D ++ GVL  E++ G+ P
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)

Query: 133 IGNGGHGSV-YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +G+V    +  +G  VAIKK + P  S+     K    E+  L  ++H N++ L 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFA--KRAYRELRLLKHMKHENVIGLL 80

Query: 192 GFCSHAR-----HSF-LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
              +        H F LV  F+    L  ++  +  +++        ++KG    L Y+H
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSEDRIQFLVYQMLKG----LKYIH 135

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
                 I+HRD+   NL ++ + E  + DFG+A   +   S  T +  T  Y APE+   
Sbjct: 136 A---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVVTRWYRAPEVILN 189

Query: 306 -MKITEKCDVYSFGVLALEVIKGK 328
            M  T+  D++S G +  E++ GK
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 32/210 (15%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFH-----SPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           IG G +G VY+A +  + + +A+KK         +PS  I        E+  L E++H N
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-------REISLLKEMQHGN 62

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM------NVIKGVADA 240
           IV+L       +  +LV+E+L    L      D++  +   + R+       +++G+A  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIA-- 116

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             Y H      ++HRD+  +NLL+D    A  +ADFG+A+        +T    T  Y A
Sbjct: 117 --YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRA 171

Query: 300 PE-LAYTMKITEKCDVYSFGVLALEVIKGK 328
           PE L  +   +   D++S G +  E++  K
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 41/223 (18%)

Query: 133 IGNGGHGSVYRAELP---SGQ---VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           IG G  G V++A  P     +   +VA+K       S  +  + +F  E   + E  H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADM--QADFQREAALMAEFDHPN 69

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQ-------------------ELGW 227
           IVKL G C+  +   L++E++  G L   L   +                       L  
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI------AKFL 281
           ++++ + K VA  ++YL    F   VHRD++++N L+       +ADFG+      A + 
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEV 324
           K   ++    A    ++ PE  +  + T + DV+++GV+  E+
Sbjct: 187 KASEND----AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 48/151 (31%), Positives = 80/151 (52%), Gaps = 10/151 (6%)

Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTY 295
           ++ AL+YLH      I++RD+   N+LLD E    + D+G+ K  L+P  +  + F GT 
Sbjct: 105 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTP 160

Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT-DIELDEMLDP 354
            Y+APE+          D ++ GVL  E++ G+ P D + S  +   NT D     +L+ 
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220

Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
           ++  P RS+  K  S+++   S LN+ P+ R
Sbjct: 221 QIRIP-RSLSVKAASVLK---SFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 66/242 (27%), Positives = 105/242 (43%), Gaps = 64/242 (26%)

Query: 127 FDAQYCIGNGGHGSVYRA---ELPSGQVVAIKKFHSPLPSDQIVDKKEFLT--------E 175
           ++ + CIG G +G VY+A       G+  AIKKF            KE  T        E
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD---------KEQYTGISQSACRE 52

Query: 176 VEALTEIRHRNIVKLYG-FCSHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRM-- 231
           +  L E++H N+V L   F  HA  S +L++++ +   L  I+     A+ +     M  
Sbjct: 53  IALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVK 111

Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH----VADFGIAKF----LKP 283
           +++  + + + YLH +    ++HRD+   N+L+  E        + D G+A+     LKP
Sbjct: 112 SLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168

Query: 284 DSSNWTEFAG------TYGYVAPELA-----YTMKITEKCDVYSFG-----VLALEVI-K 326
                   A       T  Y APEL      YT  I    D+++ G     +L LE I K
Sbjct: 169 -------LADLDPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLEPIFK 217

Query: 327 GK 328
           G+
Sbjct: 218 GR 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 37/212 (17%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFH-----SPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           IG G +G VY+A +  +G++VA+KK         +PS  I        E+  L E+ H N
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-------REISLLKELNHPN 59

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG----VADALS 242
           IV+L          +LV+EFL    L   + S   +   G    +  IK     +   ++
Sbjct: 60  IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDS---SPLTGLDPPL--IKSYLYQLLQGIA 113

Query: 243 YLH-HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
           Y H H     ++HRD+  +NLL+D E    +ADFG+A+        +T    T  Y APE
Sbjct: 114 YCHSHR----VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 169

Query: 302 L-----AYTMKITEKCDVYSFGVLALEVIKGK 328
           +      Y+  +    D++S G +  E++  +
Sbjct: 170 ILLGSRQYSTPV----DIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 29/229 (12%)

Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
            +     IG G +G V  A   P+G  VAIKK     P +     +  L E++ L   +H
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS---PFEHQTFCQRTLREIKILRRFKH 62

Query: 185 RNIVKLY------GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
            NI+ +        F S     ++V E ++   L  ++ +    Q L        +  + 
Sbjct: 63  ENIIGILDIIRPPSFESF-NDVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQIL 116

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTY 295
             L Y+H      ++HRD+   NLLL+   +  + DFG+A+   P+  +    TE+  T 
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 296 GYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            Y APE+    K  T+  D++S G +  E++       GK     L+ I
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI 222

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 65/269 (24%), Positives = 115/269 (42%), Gaps = 36/269 (13%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G +GSVY+    P+G  +A+K+    L   +     + + E++ L +     IV  Y
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF---NQIIMELDILHKAVSPYIVDFY 65

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G        ++  E++  GSL  + +   A + +       +   V   L +L  +    
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE---------- 301
           I+HRD+   N+L++   +  + DFG++  L    +      G   Y+APE          
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGPNQN 181

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD---PRLPA 358
             YT+    + DV+S G+  LE+  G++P         ++ N   +L  ++D   P LP 
Sbjct: 182 PTYTV----QSDVWSLGLSILEMALGRYPYP-----PETYANIFAQLSAIVDGDPPTLP- 231

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPT 387
              S   +     + V  CLN+ P  RPT
Sbjct: 232 SGYSDDAQ-----DFVAKCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 71/280 (25%), Positives = 123/280 (43%), Gaps = 33/280 (11%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFH---SPLPSDQIVDKKEFLTEVEALT 180
           +DF+    +G G  G V + +  PSG ++A K  H    P   +QI+       E++ L 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII------RELQVLH 58

Query: 181 EIRHRNIVKLYG-FCSHARHSFLVYEFLKRGSLAAIL-SSDAAAQELGWSQRMNVIKGVA 238
           E     IV  YG F S    S +  E +  GSL  +L  +    +E+     + V++G  
Sbjct: 59  ECNSPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG-- 115

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
             L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y+
Sbjct: 116 --LAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYM 169

Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSSISSSFLNTDIELDEML 352
           +PE       + + D++S G+  +E+  G++P      ++  +      ++ +      +
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSI 229

Query: 353 DPRLPAPSRSV------QEKLRSIVEVVFSCLNESPESRP 386
            PR   P R V           +I E++   +NE P   P
Sbjct: 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP 269

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 68/276 (24%), Positives = 115/276 (41%), Gaps = 41/276 (14%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEF--LTEVEALTEIRHRNIVK 189
           +G G  G V+        ++V IK+    +P +Q+   +      E + L  + H NI++
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQ----IPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
            Y      +   +V E+   G+LA  +     +          ++      L  LHH   
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS----LLDEDTILHFFVQILLALHHVHT 119

Query: 250 PPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI 308
             I+HRD+ ++N+LLD  +    + DFGI+K L   S  +T   GT  Y++PEL      
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEGKPY 178

Query: 309 TEKCDVYSFGVLALEVIKGKH-------PRDFLSSISSSFLNTDIELDEMLDPRLPAP-S 360
            +K D+++ G +  E+   K        P   L  +S +F                AP S
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF----------------APIS 222

Query: 361 RSVQEKLRSIVEVVFSCLNESPESRPTM-KIVSQQL 395
                 LR ++    S LN  P  RP + +I++Q +
Sbjct: 223 DRYSPDLRQLIL---SMLNLDPSKRPQLSQIMAQPI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 73/250 (29%), Positives = 109/250 (43%), Gaps = 37/250 (14%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALTEIRHRNIV 188
           +G G  G V    E  +G+  A+K     L  + I+ K E    LTE   L   RH  + 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKI----LKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 189 KL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG--VADALSYLH 245
            L Y F +H R  F V E+   G L   LS     +E  +S+      G  +  AL YLH
Sbjct: 59  ALKYSFQTHDRLCF-VMEYANGGELFFHLS-----RERVFSEDRARFYGAEIVSALGYLH 112

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
                 +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  Y+APE+   
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 169

Query: 306 MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD----IELDEMLDPRLPAPSR 361
                  D +  GV+  E++ G+ P          F N D     EL  M + R P   R
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHEKLFELILMEEIRFP---R 216

Query: 362 SVQEKLRSIV 371
           ++  + +S++
Sbjct: 217 TLSPEAKSLL 226

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 70/294 (23%), Positives = 125/294 (42%), Gaps = 60/294 (20%)

Query: 133 IGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  GSV   +L     S   VA+K     + +    + +EFL+E   + +  H N++
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS--EIEEFLSEAACMKDFDHPNVM 64

Query: 189 KLYGFC--SHARHSF----LVYEFLKRGSLAA-ILSSDAAAQELGWSQRMNV--IKGVAD 239
           KL G C  + +        ++  F+K G L + +L S           +  +  +  +A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY---G 296
            + YL +  F   +HRD++++N +L  +    VADFG++K           ++G Y   G
Sbjct: 125 GMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSK---------KIYSGDYYRQG 172

Query: 297 YVAPELAYTMKI--------TEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIE 347
            +A      + I        T K DV++FGV   E+  +G+ P               +E
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY------------PGVE 220

Query: 348 LDEMLD-----PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             E+ D      RL  P   + E    + ++++SC    P+ RPT   + + L+
Sbjct: 221 NHEIYDYLRHGNRLKQPEDCLDE----LYDLMYSCWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 62/289 (21%), Positives = 118/289 (40%), Gaps = 45/289 (15%)

Query: 133 IGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G    G +Y+  L        Q+VAIK         Q  +   F  E   + E+ H NI
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE---FQQEASLMAELHHPNI 69

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQR--------------MNV 233
           V L G  +  +   +++E+L +G L   L   +   ++G S                +++
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG 293
              +A  + YL    F   VH+D++++N+L+  +    ++D G+++ +   S+++     
Sbjct: 130 AIQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIY--SADYYRVQP 184

Query: 294 T----YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD 349
                  ++ PE     K +   D++SFGV+  E+        F   +   +  ++ E+ 
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI--------FSFGLQPYYGFSNQEVI 236

Query: 350 EMLDPR--LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           EM+  R  LP            + E    C  E P  RP  K +  +L+
Sbjct: 237 EMVRKRQLLPCSEDCPPRMYSLMTE----CWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 23/213 (10%)

Query: 125 NDFDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFH---SPLPSDQIVDKKEFLTEVEALT 180
           +DF+    +G G  G V++ +  PSG ++A K  H    P   +QI+       E++ L 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII------RELQVLH 58

Query: 181 EIRHRNIVKLYG-FCSHARHSFLVYEFLKRGSLAAILSSDAAAQE--LGWSQRMNVIKGV 237
           E     IV  YG F S    S +  E +  GSL  +L       E  LG    + VIKG 
Sbjct: 59  ECNSPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG- 115

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGY 297
              L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y
Sbjct: 116 ---LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSY 168

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           ++PE       + + D++S G+  +E+  G++P
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 68/281 (24%), Positives = 126/281 (44%), Gaps = 35/281 (12%)

Query: 120 IVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQ----VVAIKKFH---SPLPSDQIVDKKE 171
           I++ T +F     +G+G  G+VY+   +P G+     VAIK+     SP  + +I+D+  
Sbjct: 3   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM 231
            +  V+      + ++ +L G C  +    L+ + +  G L   +        +G    +
Sbjct: 62  VMASVD------NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLL 112

Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
           N    +A  ++YL       +VHRD++++N+L+       + DFG+AK L  D   +   
Sbjct: 113 NWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169

Query: 292 AGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIEL 348
            G     ++A E       T + DV+S+GV   E++  G  P D    I +S +++ +E 
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEK 226

Query: 349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            E    RLP P     +    +  ++  C     +SRP  +
Sbjct: 227 GE----RLPQPPICTID----VYMIMVKCWMIDADSRPKFR 259

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 75/263 (28%), Positives = 112/263 (42%), Gaps = 38/263 (14%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALTEIRHRNIV 188
           +G G  G V    E  +G+  A+K     L  + I+ K E    +TE   L   RH  + 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKI----LRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 189 KL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG-VADALSYLHH 246
            L Y F +H R  F V E+   G L   LS +    E    +R       +  AL YLH 
Sbjct: 59  ALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEYLHS 113

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM 306
                +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+APE+    
Sbjct: 114 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 170

Query: 307 KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD----IELDEMLDPRLPAPSRS 362
                 D +  GV+  E++ G+ P          F N D     EL  M + R P   R+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHERLFELILMEEIRFP---RT 217

Query: 363 VQEKLRSIVEVVFSCLNESPESR 385
           +  + +S++      L + P+ R
Sbjct: 218 LSPEAKSLLA---GLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 33/189 (17%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVD--KKEF----LTEVEALTEIRHR 185
           IG G  G V++A    + Q+VA+KK         +++  K+ F    L E++ L  ++H 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKV--------LMENEKEGFPITALREIKILQLLKHE 71

Query: 186 NIVKLYGFC-------SHARHSF-LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGV 237
           N+V L   C       +  + SF LV+EF +   LA +LS+      L   +++  +K +
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV--MKML 128

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAG--- 293
            + L Y+H      I+HRD+ + N+L+  +    +ADFG+A+ F    +S    +     
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 294 TYGYVAPEL 302
           T  Y  PEL
Sbjct: 186 TLWYRPPEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 72/283 (25%), Positives = 117/283 (41%), Gaps = 46/283 (16%)

Query: 133 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG GG G VY A  P   + VA+KK    L S+  + KK FL E +   ++ H  IV +Y
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP- 250
             CS     +    +++  +L ++L S    + L  S+ +     V   LS  H  C   
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKICATI 126

Query: 251 ------PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---------------SSNWT 289
                  ++HRD+   N+LL L  E  + D+G A F K +                S+ T
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186

Query: 290 ---EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD- 345
              +  GT  Y+APE    +  +E  D+Y+ GV+  +++          ++S  +     
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML----------TLSFPYRRKKG 236

Query: 346 --IELDE-MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
             I   + +L P   AP R +      + ++    L   P  R
Sbjct: 237 RKISYRDVILSPIEVAPYREIP---PFLSQIAMKALAVDPAER 276

Length = 932

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 72/302 (23%), Positives = 125/302 (41%), Gaps = 66/302 (21%)

Query: 133 IGNGGHGSVYRAEL----PSGQ----VVAIKKFHSPLPSDQIVDK--KEFLTEVEALTEI 182
           +G G  G V RAE      S       VA+K     +  D   DK   + ++E+E +  I
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK-----MLKDNATDKDLADLISEMELMKLI 74

Query: 183 -RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSS-------------DAAAQELGWS 228
            +H+NI+ L G C+     +++ E+  +G+L   L +                 ++L + 
Sbjct: 75  GKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134

Query: 229 QRMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK------FL 281
             ++    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+      + 
Sbjct: 135 DLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190

Query: 282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSS 340
           K  S+          ++APE  +    T + DV+SFG+L  E+   G  P          
Sbjct: 191 KKTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY--------- 237

Query: 341 FLNTDIELDEMLD-----PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
                I ++E+        R+  PS    E    + E    C +  P  RPT K + + L
Sbjct: 238 ---PGIPVEELFKLLREGHRMDKPSNCTHELYMLMRE----CWHAVPTQRPTFKQLVEAL 290

Query: 396 QI 397
             
Sbjct: 291 DK 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 39/225 (17%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFH-SPLPSDQIVDKKEF---------LTEVEALTE 181
           +G G +G V +A    +G++VAIKK     + +D   D++           L E++ + E
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 182 IRHRNIVKLYG-FCSHARHSF--LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
           I+H NI+ L   +       F  LV + +    L  ++       E   SQ   ++  + 
Sbjct: 77  IKHENIMGLVDVYVEG---DFINLVMDIMA-SDLKKVVDRKIRLTE---SQVKCILLQIL 129

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA-KFLKPDSS----------- 286
           + L+ LH   +   +HRD+S  N+ ++ +    +ADFG+A ++  P  S           
Sbjct: 130 NGLNVLH-KWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 287 --NWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLALEVIKGK 328
               T    T  Y APEL     K     D++S G +  E++ GK
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 62.8 bits (152), Expect = 8e-11
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 11/199 (5%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +    Q VA+KK   P  S  ++  +    E+  L  ++H N++ L 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIGLL 80

Query: 192 GFCSHARHSFLVYE-FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
              + A       E +L    + A L++    Q+L       +I  +   L Y+H     
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---A 137

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKIT 309
            I+HRD+   N+ ++ + E  + DFG+A   +      T +  T  Y APE+    M   
Sbjct: 138 GIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYRAPEIMLNWMHYN 194

Query: 310 EKCDVYSFGVLALEVIKGK 328
           +  D++S G +  E++KGK
Sbjct: 195 QTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 47/141 (33%), Positives = 66/141 (46%), Gaps = 10/141 (7%)

Query: 193 FCSHA--RHSFLVYEFLKRGSLA-AILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
           FC+     H F V E+L  G L   I SS    +         +I G    L +LH    
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKK-- 115

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKIT 309
             I++RD+   N+LLD +    +ADFG+ K         + F GT  Y+APE+    K  
Sbjct: 116 -GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN 174

Query: 310 EKCDVYSFGVLALEVIKGKHP 330
           E  D +SFGVL  E++ G+ P
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 42/219 (19%)

Query: 133 IGNGGHG---SVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR------ 183
           +G G +G   S   AE    + VAIKK  +       V  K+ L +  AL E++      
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITN-------VFSKKILAK-RALRELKLLRHFR 59

Query: 184 -HRNIVKLYG----FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
            H+NI  LY     F  +    +L YE L    L  I+ S    Q L  +   + I  + 
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSG---QPLTDAHFQSFIYQIL 115

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD----SSNWTEFAGT 294
             L Y+H      ++HRD+   NLL++ + E  + DFG+A+    +    +   TE+  T
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 295 YGYVAPEL-----AYTMKITEKCDVYSFGVLALEVIKGK 328
             Y APE+     +YT  I    DV+S G +  E++  K
Sbjct: 173 RWYRAPEIMLSFQSYTKAI----DVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 25/208 (12%)

Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA-LTEIRHRN--IV 188
           +G G  G V  AEL   G+  A+K     +    ++D     T VE  +  +   N  + 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDV---VLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADA------LS 242
            LY       H F V EFL  G L   +      Q+ G   R ++ +    A      L 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHI------QDKG---RFDLYRATFYAAEIVCGLQ 110

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           +LH      I++RD+   N++LD +    +ADFG+ K      +  + F GT  Y+APE+
Sbjct: 111 FLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI 167

Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHP 330
              +K T   D +SFGVL  E++ G+ P
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 72/298 (24%), Positives = 125/298 (41%), Gaps = 62/298 (20%)

Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K          + D    ++E+E +  I +
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 79

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAIL----------SSDAAA---QELGWSQR 230
           H+NI+ L G C+     +++ E+  +G+L   L          S D A    +++ +   
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    VA  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 140 VSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DVNNID 191

Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
            +  T        ++APE  +    T + DV+SFGVL  E+   G  P            
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----------- 240

Query: 343 NTDIELDEMLD-----PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
              I ++E+        R+  P+    E    +  ++  C +  P  RPT K + + L
Sbjct: 241 -PGIPVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAIPSHRPTFKQLVEDL 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 26/253 (10%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFH----SPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  G VY   +  +G+ +A+K+      SP  S ++        E++ L  + H  I
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEV---NALECEIQLLKNLLHERI 66

Query: 188 VKLYGFCSHARHSFL--VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
           V+ YG         L    E +  GS+   L S  A  E   +      + + + +SYLH
Sbjct: 67  VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE---NVTRKYTRQILEGVSYLH 123

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP---DSSNWTEFAGTYGYVAPEL 302
            +    IVHRDI   N+L D      + DFG +K L+      +      GT  +++PE+
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
                   K D++S G   +E++  K P     ++++ F        +  +P LP     
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA----TQPTNPVLPP---H 233

Query: 363 VQEKLRSIVEVVF 375
           V +  R  ++ +F
Sbjct: 234 VSDHCRDFLKRIF 246

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 27/227 (11%)

Query: 110 NFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV--VAIKKFHSPLPSDQIV 167
             + K+ Y+       DF+    +G G  G V  A   +     VAIK+F       +I+
Sbjct: 22  KRKNKMKYE-------DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEK----SKII 70

Query: 168 DKKEF---LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAA-AQ 223
            +K+     +E + L  I H   V LYG      + +LV EF+  G     L  +     
Sbjct: 71  KQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN 130

Query: 224 ELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP 283
           ++G      ++  + + L  L+      IV+RD+  +NLLLD +    + DFG AK +  
Sbjct: 131 DVGCFYAAQIVL-IFEYLQSLN------IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-- 181

Query: 284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           D+  +T   GT  Y+APE+   +   +  D ++ G+   E++ G  P
Sbjct: 182 DTRTYT-LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 53/234 (22%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKF-------HSPLPSDQIVD-------KKEFLTEVEA 178
           +G G  G V+  E+ + Q +   +F          L + +I+        + +FL EV+ 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSS----------------DAAA 222
           L+ ++  NI++L G C       ++ E+++ G L   LSS                    
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 223 QELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK 282
             + +S  ++V   +A  + YL    F   VHRD++++N L+       +ADFG+++ L 
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLNF---VHRDLATRNCLVGENLTIKIADFGMSRNL- 188

Query: 283 PDSSNWTEFAGTY-----------GYVAPELAYTMKITEKCDVYSFGVLALEVI 325
                   +AG Y            ++A E     K T   DV++FGV   E++
Sbjct: 189 --------YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 65/270 (24%), Positives = 116/270 (42%), Gaps = 38/270 (14%)

Query: 133 IGNGGHGSVYRA-ELPSGQ----VVAIKKFH---SPLPSDQIVDKKEFLTEVEALTEIRH 184
           +G+G  G+VY+   +P G+     VAIK      SP  +      KE L E   +  +  
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN------KEILDEAYVMAGVGS 68

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
             + +L G C  +    LV + +  G L   +  +     +G    +N    +A  +SYL
Sbjct: 69  PYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYL 125

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPEL 302
                  +VHRD++++N+L+       + DFG+A+ L  D + +    G     ++A E 
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182

Query: 303 AYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--RLPAP 359
               + T + DV+S+GV   E++  G  P D + +          E+ ++L+   RLP P
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---------REIPDLLEKGERLPQP 233

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
                +    +  ++  C     E RP  +
Sbjct: 234 PICTID----VYMIMVKCWMIDSECRPRFR 259

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 77/308 (25%), Positives = 127/308 (41%), Gaps = 63/308 (20%)

Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFH---SPLPSDQIVDKKEFLTEVEALTE 181
           DF+    +G G  G V +    PSG ++A K  H    P   +QI      + E++ L E
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQI------IRELKVLHE 55

Query: 182 IRHRNIVKLYG-FCSHARHSFLVYEFLKRGSLAAILSSDAAAQE--LGWSQRMNVIKGVA 238
                IV  YG F S    S  + E +  GSL  +L       E  LG      +   V 
Sbjct: 56  CNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENILG-----KISIAVL 109

Query: 239 DALSYLH--HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
             L+YL   H     I+HRD+   N+L++   E  + DFG++  L    +N   F GT  
Sbjct: 110 RGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRS 163

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-----RDFLSSISSSFLNTDIELD-- 349
           Y++PE       T + D++S G+  +E+  G++P        L ++    ++     +  
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223

Query: 350 -----------------EMLD-------PRLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
                            E+LD       P+LP+ + S         + V  CL ++P+ R
Sbjct: 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFS-----DEFQDFVDKCLKKNPKER 278

Query: 386 PTMKIVSQ 393
             +K +++
Sbjct: 279 ADLKELTK 286

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 61/255 (23%), Positives = 111/255 (43%), Gaps = 51/255 (20%)

Query: 168 DKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAIL---------- 216
           D  + ++E+E +  I +H+NI+ L G C+     +++ E+  +G+L   L          
Sbjct: 60  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY 119

Query: 217 SSDAAA---QELGWSQRMNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHV 272
           S D      ++L +   ++    VA  + YL    C    +HRD++++N+L+  +    +
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKI 175

Query: 273 ADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIK 326
           ADFG+A+    D  N   +  T        ++APE  +    T + DV+SFGVL  E+  
Sbjct: 176 ADFGLAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Query: 327 -GKHPRDFLSSISSSFLNTDIELDEMLD-----PRLPAPSRSVQEKLRSIVEVVFSCLNE 380
            G  P               I ++E+        R+  P+    E    +  ++  C + 
Sbjct: 232 LGGSPY------------PGIPVEELFKLLKEGHRMDKPANCTHE----LYMIMRECWHA 275

Query: 381 SPESRPTMKIVSQQL 395
            P  RPT K + + L
Sbjct: 276 VPSQRPTFKQLVEDL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 56/266 (21%), Positives = 110/266 (41%), Gaps = 39/266 (14%)

Query: 151 VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRG 210
           +VA+K   + +       + +FL E++ ++ +++ NI++L G C       ++ E+++ G
Sbjct: 46  LVAVKMLRADVTKTA---RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENG 102

Query: 211 SLAAILSSDAAAQELGWSQRMNVIK---------GVADALSYLHHDCFPPIVHRDISSKN 261
            L   LS          +  +  +           +A  + YL    F   VHRD++++N
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF---VHRDLATRN 159

Query: 262 LLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG----TYGYVAPELAYTMKITEKCDVYSF 317
            L+   +   +ADFG+++ L   S ++    G       ++A E     K T   DV++F
Sbjct: 160 CLVGNHYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217

Query: 318 GVLALEVIK--GKHPRDFLS------SISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS 369
           GV   E+     + P   LS      +    F N   ++     P  P+P          
Sbjct: 218 GVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSP---------- 267

Query: 370 IVEVVFSCLNESPESRPTMKIVSQQL 395
           + +++  C +   + RPT   +   L
Sbjct: 268 VFKLMMRCWSRDIKDRPTFNKIHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 27/209 (12%)

Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIV---DKKEFLTEVEALTEIR-HRNI 187
           +G G  G V  A L  SG++ A+K     L  D I+   D +  +TE   L+  R H  +
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKV----LKKDVILQDDDVECTMTEKRILSLARNHPFL 58

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG------VADAL 241
            +LY         F V EF+  G L   +           S+R +  +       +  AL
Sbjct: 59  TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK---------SRRFDEARARFYAAEITSAL 109

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
            +LH      I++RD+   N+LLD E    +ADFG+ K    +    + F GT  Y+APE
Sbjct: 110 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +   M      D ++ GVL  E++ G  P
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 63/248 (25%), Positives = 103/248 (41%), Gaps = 31/248 (12%)

Query: 97  RSNQNPHGLFSILNFEGKLVYDEIVR-------ATNDFDAQYCIGNGGHGSVYRAELPSG 149
           R N+N      I NF  +  Y++IVR          D+D    IG G  G V      S 
Sbjct: 16  RKNKN------IDNFLNR--YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSS 67

Query: 150 QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKR 209
           Q V   K  S     +  D   F  E + +       +V+L+      ++ ++V E++  
Sbjct: 68  QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127

Query: 210 GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE 269
           G L  ++S+    ++  W++       V  AL  +H      ++HRD+   N+LLD    
Sbjct: 128 GDLVNLMSNYDVPEK--WAKFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGH 180

Query: 270 AHVADFGIAKFLKPDSSNWTE---FAGTYGYVAPELAYTMK----ITEKCDVYSFGVLAL 322
             +ADFG    +K D +         GT  Y++PE+  +         +CD +S GV   
Sbjct: 181 LKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238

Query: 323 EVIKGKHP 330
           E++ G  P
Sbjct: 239 EMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.9 bits (142), Expect = 7e-10
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 21/209 (10%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE---FLTEVEALTEIRHRNIV 188
           +G G  G VY   +  +G+ +A+K+   P   D     KE      E++ L  +RH  IV
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQV--PFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 189 KLYGFC--SHARHSFLVY-EFLKRGSLAAILSSDAAAQE-LGWSQRMNVIKGVADALSYL 244
           + YG C          ++ E++  GS+   L +  A  E +       +++GV    SYL
Sbjct: 68  QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV----SYL 122

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPE 301
           H +    IVHRDI   N+L D      + DFG +K ++    + T      GT  +++PE
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +        K DV+S     +E++  K P
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 25/222 (11%)

Query: 119 EIVRATNDFDAQY----CIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFL 173
           E+ +   +   +Y     +G+G +G V  A    +G+ VAIKK   P  S   +  K   
Sbjct: 5   ELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTY 62

Query: 174 TEVEALTEIRHRNIVKLYG-FC-----SHARHSFLVYEFLKRGSLAAILSSDAAAQELGW 227
            E+  L  + H N++ L   F         +  +LV   +    L  I+      Q+L  
Sbjct: 63  RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKC----QKLSD 117

Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
                ++  +   L Y+H      I+HRD+   N+ ++ + E  + DFG+A   +     
Sbjct: 118 DHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDE 171

Query: 288 WTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 328
            T +  T  Y APE+    M   +  D++S G +  E++ GK
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 63/256 (24%), Positives = 96/256 (37%), Gaps = 67/256 (26%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE---FLTEVEALT 180
           +DF+    IG G  G V+   +  +GQV A+K     L    ++ + +      E + L 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKV----LRKSDMIKRNQIAHVRAERDILA 56

Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNV------- 233
           +     IVKLY       H +LV E++  G L            +    R +V       
Sbjct: 57  DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETAR 104

Query: 234 --IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAK---------- 279
             I  +  AL  +H   F   +HRDI   N+L+D   + H+  ADFG+ K          
Sbjct: 105 FYIAELVLALDSVHKLGF---IHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREY 159

Query: 280 ---------FLKPDSSNWTEF----------AGTYGYVAPELAYTMKITEKCDVYSFGVL 320
                    F         +            GT  Y+APE+        +CD +S GV+
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVI 219

Query: 321 ALEVIKGKHPRDFLSS 336
             E++ G  P  F S 
Sbjct: 220 LYEMLYGFPP--FYSD 233

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 24/219 (10%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
            DFD +  +G G  G V    E  +G + A+K          ++  +E ++  E   +I 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVM-----KKSVLLAQETVSFFEEERDIL 55

Query: 184 HRN----IVKL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
             +    I +L Y F     + +LV E+   G L ++L+      +   +Q    +  + 
Sbjct: 56  SISNSPWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--LAELV 112

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS-NWTEFAGTYGY 297
            A+  +H   +   VHRDI  +N+L+D      +ADFG A  L  +   N     GT  Y
Sbjct: 113 LAIHSVHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169

Query: 298 VAPELAYTMKITEK------CDVYSFGVLALEVIKGKHP 330
           +APE+  TM    K      CD +S GV+A E+I G+ P
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 63/268 (23%), Positives = 117/268 (43%), Gaps = 48/268 (17%)

Query: 152 VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLKRG 210
           VA+K   S      + D    ++E+E +  I +H+NI+ L G C+     +++ E+  +G
Sbjct: 53  VAVKMLKSDATEKDLSD---LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 109

Query: 211 SLAAILS-------------SDAAAQELGWSQRMNVIKGVADALSYL-HHDCFPPIVHRD 256
           +L   L              +    ++L +   ++    VA  + YL    C    +HRD
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC----IHRD 165

Query: 257 ISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTMKITE 310
           ++++N+L+  +    +ADFG+A+    D  +   +  T        ++APE  +    T 
Sbjct: 166 LAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221

Query: 311 KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDI-ELDEMLDP--RLPAPSRSVQEKL 367
           + DV+SFGVL  E+          +   S +    + EL ++L    R+  PS    E  
Sbjct: 222 QSDVWSFGVLLWEI---------FTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNE-- 270

Query: 368 RSIVEVVFSCLNESPESRPTMKIVSQQL 395
             +  ++  C +  P  RPT K + + L
Sbjct: 271 --LYMMMRDCWHAVPSQRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 55/243 (22%), Positives = 109/243 (44%), Gaps = 25/243 (10%)

Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSS--------DA 220
           + +FL E++ ++ ++  NI++L   C  +    ++ E+++ G L   LS          A
Sbjct: 63  RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122

Query: 221 AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF 280
               + +S  + +   +A  + YL    F   VHRD++++N L+   +   +ADFG+++ 
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNCLVGKNYTIKIADFGMSRN 179

Query: 281 LKPDSSNWTEFAG----TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK--GKHPRDFL 334
           L   S ++    G       +++ E     K T   DV++FGV   E++    + P   L
Sbjct: 180 LY--SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237

Query: 335 SSISSSFLNT-DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ 393
           S       NT +   D+     LP P+        S+ +++ SC   + + RP+ + +  
Sbjct: 238 SD-EQVIENTGEFFRDQGRQVYLPKPALCP----DSLYKLMLSCWRRNAKERPSFQEIHA 292

Query: 394 QLQ 396
            L 
Sbjct: 293 TLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 57.9 bits (141), Expect = 1e-09
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 32/177 (18%)

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           + N +KLY   +  +   L+ +++K G L  +L  +    E   ++   +I+ + +AL+ 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSE---AEVKKIIRQLVEALND 124

Query: 244 LH-HDCFPPIVHRDISSKNLLLD-LEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
           LH H+    I+H DI  +N+L D  +   ++ D+G+ K +   S     + GT  Y +PE
Sbjct: 125 LHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC----YDGTLDYFSPE 176

Query: 302 LAYTMKIT-EKCDVYSF-----GVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML 352
                KI     D  SF     GVL  E++ GKHP            + +++L+ +L
Sbjct: 177 -----KIKGHNYD-VSFDWWAVGVLTYELLTGKHPFK-------EDEDEELDLESLL 220

Length = 267

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 17/204 (8%)

Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT-EIRHRNI 187
           +G G  G V  AEL  + +V AIK     L  D I+   +    +TE   L    +H  +
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKV----LKKDVILQDDDVDCTMTEKRILALAAKHPFL 58

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH-H 246
             L+         F V E++  G L   +     +++    +       V  AL +LH H
Sbjct: 59  TALHCCFQTKDRLFFVMEYVNGGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM 306
                +++RD+   N+LLD E    +ADFG+ K    +    T F GT  Y+APE+   +
Sbjct: 116 G----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL 171

Query: 307 KITEKCDVYSFGVLALEVIKGKHP 330
           +     D ++ GVL  E++ G+ P
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 56/237 (23%), Positives = 103/237 (43%), Gaps = 41/237 (17%)

Query: 168 DKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAA--QEL 225
           +++E   EV  L+ ++H NIV+         + ++V ++ + G L   +++       E 
Sbjct: 42  EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE- 100

Query: 226 GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS 285
              Q ++    +  AL ++H      I+HRDI S+N+ L  +    + DFGIA+ L    
Sbjct: 101 --DQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL---- 151

Query: 286 SNWTEFA----GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD-------FL 334
           ++  E A    GT  Y++PE+        K D+++ G +  E+   KH  +        L
Sbjct: 152 NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211

Query: 335 SSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIV 391
             I  S+            P  P  S    + LR++V  +F     +P  RP++  +
Sbjct: 212 KIIRGSY------------P--PVSSHYSYD-LRNLVSQLF---KRNPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 15/213 (7%)

Query: 126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR 185
           DF+    IG G  G V   +L +   V   K  +     +  +   F  E + L    ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSLAAILS--SDAAAQELGWSQRMNVIKGVADALSY 243
            I  L+       + +LV ++   G L  +LS   D   +++       ++  + D++  
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVHQ 120

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA-GTYGYVAPEL 302
           LH+      VHRDI   N+L+D+     +ADFG    L  D +  +  A GT  Y++PE+
Sbjct: 121 LHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174

Query: 303 AYTM-----KITEKCDVYSFGVLALEVIKGKHP 330
              M     K   +CD +S GV   E++ G+ P
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 68/279 (24%), Positives = 120/279 (43%), Gaps = 57/279 (20%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH-RNIVKL 190
           +G G +G V +   +P+G ++A+K+  + + S    ++K  L +++           V  
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ---EQKRLLMDLDISMRSVDCPYTVTF 65

Query: 191 YG---------FCSHARHSFLVYEFLKRGSLAAILSSDAAAQE--LGWSQRMNVIKGVAD 239
           YG          C     + L  +F K+     +        E  LG   ++ V   +  
Sbjct: 66  YGALFREGDVWICMEVMDTSL-DKFYKK-----VYDKGLTIPEDILG---KIAV--SIVK 114

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           AL YLH      ++HRD+   N+L++   +  + DFGI+ +L  DS   T  AG   Y+A
Sbjct: 115 ALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMA 171

Query: 300 PEL--------AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM 351
           PE          Y +    K DV+S G+  +E+  G+ P D       S+     +L ++
Sbjct: 172 PERINPELNQKGYDV----KSDVWSLGITMIELATGRFPYD-------SWKTPFQQLKQV 220

Query: 352 LD---PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
           ++   P+LPA   S +       + V  CL ++ + RP 
Sbjct: 221 VEEPSPQLPAEKFSPE-----FQDFVNKCLKKNYKERPN 254

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 49/206 (23%), Positives = 96/206 (46%), Gaps = 25/206 (12%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFH----SPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G + +VY+     +G++VA+K+ H       PS  I        E+  + E++H NI
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-------REISLMKELKHENI 60

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           V+L+          LV+E++    L   + +      L  +   +    +   +++ H +
Sbjct: 61  VRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL----- 302
               ++HRD+  +NLL++   E  +ADFG+A+      + ++    T  Y AP++     
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176

Query: 303 AYTMKITEKCDVYSFGVLALEVIKGK 328
            Y+  I    D++S G +  E+I G+
Sbjct: 177 TYSTSI----DIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 71/276 (25%), Positives = 108/276 (39%), Gaps = 55/276 (19%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR--NIVK 189
           IG+G  G VY+     +G V+A+K+      +    + K  L +++ + +  H    IVK
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRR---TGNKEENKRILMDLDVVLK-SHDCPYIVK 78

Query: 190 LYGFCSHARHSFLVYE--------FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADAL 241
            YG+       F+  E         LKR      +        LG   +M V   +  AL
Sbjct: 79  CYGYFITDSDVFICMELMSTCLDKLLKR------IQGPIPEDILG---KMTV--AIVKAL 127

Query: 242 SYL--HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
            YL   H     ++HRD+   N+LLD      + DFGI+  L  DS   T  AG   Y+A
Sbjct: 128 HYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAKTRSAGCAAYMA 182

Query: 300 PELAYTMKITEK----CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM---- 351
           PE         K     DV+S G+  +E+  G+ P          + N   E + +    
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFP----------YKNCKTEFEVLTKIL 232

Query: 352 -LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRP 386
             +P    P+        S V+    CL +    RP
Sbjct: 233 QEEPPSLPPNEGFSPDFCSFVD---LCLTKDHRKRP 265

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           +DF+    IG G  G V   ++   + +   K         I++K E L   E       
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMK---------ILNKWEMLKRAETACFREE 51

Query: 185 RN---------IVKLYGFCSHARHSFLVYEFLKRGSLAAILS--SDAAAQELGWSQRMNV 233
           RN         I  L+       + +LV ++   G L  +LS   D   +++       +
Sbjct: 52  RNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEM 111

Query: 234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA- 292
           +  +  ++  LH+      VHRDI   N+LLD+     +ADFG    +  D +  +  A 
Sbjct: 112 VLAI-HSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV 164

Query: 293 GTYGYVAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHP 330
           GT  Y++PE+   M     K   +CD +S GV   E++ G+ P
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 69/266 (25%), Positives = 106/266 (39%), Gaps = 44/266 (16%)

Query: 133 IGNGGHGSVYRAELPSGQVV----AIKKFHSPLPSDQIVDKKEF---LTEVEALTEIRHR 185
           IG G  G V +      Q +     I+K H       IV + E    L E   L ++   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAH-------IVSRSEVTHTLAERTVLAQVNCP 53

Query: 186 NIVKL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
            IV L + F S  +  +LV  F+  G L   L  +        S+       +  AL  L
Sbjct: 54  FIVPLKFSFQSPEK-LYLVLAFINGGELFHHLQREGRFDL---SRARFYTAELLCALENL 109

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVA--DFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           H      +++RD+  +N+LLD  ++ H+A  DFG+ K    D      F GT  Y+APEL
Sbjct: 110 HK---FNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPEL 164

Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR- 361
                 T+  D ++ GVL  E++ G  P          F + ++  +EM    L  P R 
Sbjct: 165 LLGHGYTKAVDWWTLGVLLYEMLTGLPP----------FYDENV--NEMYRKILQEPLRF 212

Query: 362 --SVQEKLRSIVEVVFSCLNESPESR 385
                   + ++      L+  P  R
Sbjct: 213 PDGFDRDAKDLLI---GLLSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 24/209 (11%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G VY+  +  + ++ A+K     L   +IV KKE +        I  R ++   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKV----LSKKEIVAKKE-VAHTIGERNILVRTLLDES 55

Query: 192 GFCSHARHSF-------LVYEFLKRGSLAAILSSDAAAQELGWSQRMNV-IKGVADALSY 243
            F    + SF       LV +++  G L   L  +    E     R    I  +  AL +
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE----DRAKFYIAELVLALEH 111

Query: 244 LH-HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           LH +D    IV+RD+  +N+LLD      + DFG++K    D+     F GT  Y+APE+
Sbjct: 112 LHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167

Query: 303 AYTMK-ITEKCDVYSFGVLALEVIKGKHP 330
               K  T+  D +S GVL  E+  G  P
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 65/213 (30%), Positives = 90/213 (42%), Gaps = 25/213 (11%)

Query: 126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIK--KFHSPLPSDQIVDKKEFLTEVEALTEI 182
           DF+    +G G  G V  A+   +G+  AIK  K    L   Q+   +    E   L E+
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV---QHVAQEKSILMEL 75

Query: 183 RHRNIVKLY-GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIK----GV 237
            H  IV +   F    R  FL+ EF+  G L   L               +V K     +
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPN-------DVAKFYHAEL 127

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGY 297
             A  YLH      I++RD+  +NLLLD +    V DFG AK  K     +T   GT  Y
Sbjct: 128 VLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT-LCGTPEY 181

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +APE+  +    +  D ++ GVL  E I G  P
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 43/147 (29%), Positives = 75/147 (51%), Gaps = 8/147 (5%)

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 298
           AL++LH      I++RD+   N+LLD E    + D+G+ K  ++P  +  T F GT  Y+
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYI 163

Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           APE+          D ++ GVL  E++ G+ P D +    +   NT+  L +++  +   
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR 223

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESR 385
             RS+  K  S+++     LN+ P+ R
Sbjct: 224 IPRSLSVKASSVLK---GFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 59/296 (19%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G    G VY+  L         Q VAIK         +   ++EF  E    + ++H N
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPN 69

Query: 187 IVKLYG-------------FCSHAR-HSFLVYEFLKRGSLAAILSSD---AAAQELGWSQ 229
           IV L G             +CSH+  H FLV     R   + + S+D        L  + 
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVM----RSPHSDVGSTDDDKTVKSTLEPAD 125

Query: 230 RMNVIKGVADALSYL--HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
            ++++  +A  + +L  HH     +VH+D++++N+L+  +    ++D G+  F +  +++
Sbjct: 126 FVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGL--FREVYAAD 178

Query: 288 WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
           + +  G       +++PE     K +   D++S+GV+  EV   G  P          + 
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-------YCGYS 231

Query: 343 NTDIELDEMLDPR--LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           N D+   EM+  R  LP P          +  ++  C NE P  RP  K +  +L+
Sbjct: 232 NQDVI--EMIRNRQVLPCPDDCPA----WVYTLMLECWNEFPSRRPRFKDIHSRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 56.8 bits (137), Expect = 9e-09
 Identities = 46/154 (29%), Positives = 69/154 (44%), Gaps = 25/154 (16%)

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPE 301
           +HH     ++HRDI S N+LL       + DFG +K      S+     F GT  YVAPE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE------LDEMLDPR 355
           +      ++K D++S GVL  E++  K P D            ++E      L    DP 
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD----------GENMEEVMHKTLAGRYDPL 265

Query: 356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            P+ S  +Q       E+V + L+  P+ RP+  
Sbjct: 266 PPSISPEMQ-------EIVTALLSSDPKRRPSSS 292

Length = 496

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 56.2 bits (136), Expect = 9e-09
 Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 47/226 (20%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKF--HSPLPSDQIVDKKEF----LTEVEALTEIRHR 185
           +G G  G VY+A ++ +G+VVA+KK   H+        +K  F    L E++ L +++H 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHN--------EKDGFPITALREIKILKKLKHP 67

Query: 186 NIVKLY-------GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
           N+V L              R S  +        L+ +L + +   +L  SQ    +  + 
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--KLTESQIKCYMLQLL 125

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG----- 293
           + ++YLH +    I+HRDI + N+L+D +    +ADFG+A+       N     G     
Sbjct: 126 EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182

Query: 294 ------TYGYVAPELA-----YTMKITEKCDVYSFGVLALEVIKGK 328
                 T  Y  PEL      YT  +    D++  G +  E+   +
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 61/247 (24%), Positives = 98/247 (39%), Gaps = 53/247 (21%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSP--LPSDQIVDKKEFLTEVEALTE 181
           +DF++   IG G  G V   +   +G + A+K       L  +Q+   +    E + L E
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIR---AERDILVE 57

Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAIL-SSDAAAQELGWSQRMNVIKGVADA 240
                +VK++      R+ +L+ EFL  G +  +L   D  ++E         I     A
Sbjct: 58  ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE----ATQFYIAETVLA 113

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF--------- 291
           +  +H   F   +HRDI   NLLLD +    ++DFG+   LK   ++ TEF         
Sbjct: 114 IDAIHQLGF---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLK--KAHRTEFYRNLTHNPP 168

Query: 292 ----------------------------AGTYGYVAPELAYTMKITEKCDVYSFGVLALE 323
                                        GT  Y+APE+       + CD +S GV+  E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 324 VIKGKHP 330
           ++ G  P
Sbjct: 229 MLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)

Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALTEIRHRNIV 188
           +G GG G V   ++  +G++ A KK    L   ++  +K     L E + L ++  R IV
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK----LDKKRLKKRKGEQMALNEKKILEKVSSRFIV 56

Query: 189 KL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH-H 246
            L Y F +      LV   +  G L   + +     E G+ +   +           H H
Sbjct: 57  SLAYAFETKD-DLCLVMTLMNGGDLKYHIYN---VGEPGFPEARAIFYAAQIICGLEHLH 112

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM 306
                IV+RD+  +N+LLD      ++D G+A  L          AGT GY+APE+    
Sbjct: 113 QRR--IVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGE 169

Query: 307 KITEKCDVYSFGVLALEVIKGKHP 330
                 D ++ G    E+I G+ P
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 35/224 (15%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFL--TEVEALTE 181
           +DF+    IG G  G V   ++  +GQV A+K          I++K E L   E     E
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMK----------ILNKWEMLKRAETACFRE 50

Query: 182 IR-------HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSS--DAAAQELGWSQRMN 232
            R        R I  L+       + +LV ++   G L  +LS   D   +++       
Sbjct: 51  ERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAE 110

Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA 292
           ++  + D++  L +      VHRDI   N+LLD      +ADFG    L  D +  +  A
Sbjct: 111 MVLAI-DSVHQLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA 163

Query: 293 -GTYGYVAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHP 330
            GT  Y++PE+   M     +   +CD +S GV   E++ G+ P
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 64/297 (21%), Positives = 116/297 (39%), Gaps = 47/297 (15%)

Query: 105 LFSILNFEGKLV--YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKF-HSPL 161
           +  I   E   +  Y  ++   ND   Q  I  G             + V I+ F     
Sbjct: 9   INDIKCIESDDIDKYTSVLIKEND---QNSIYKGIFN---------NKEVIIRTFKKFHK 56

Query: 162 PSDQIVDKKEFLTEVEALTEIRHRNIVKLYGF----CSHARHSFLVYEFLKRGSLAAILS 217
               ++D  E   E++ L  I   NI+K+YGF            L+ E+  RG L  +L 
Sbjct: 57  GHKVLIDITE--NEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD 114

Query: 218 SDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI 277
            +   ++L +  ++++       L  L+     P  +++++S + L+   ++  +   G+
Sbjct: 115 KE---KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGL 169

Query: 278 AKFLKPDSSNWTEFAGTYGYVAPELAYTM--KITEKCDVYSFGVLALEVIKGKHPRDFLS 335
            K L         F     Y + ++   +  + T K D+YS GV+  E+  GK P + L+
Sbjct: 170 EKILSSPPFKNVNFMV---YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226

Query: 336 --SISSSFLNTDIELDEMLD-PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
              I    +N +  L   LD P            ++ IVE   +C +     RP +K
Sbjct: 227 TKEIYDLIINKNNSLKLPLDCPLE----------IKCIVE---ACTSHDSIKRPNIK 270

Length = 283

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 24/154 (15%)

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 298
           AL++LH      I++RD+   N+LLD +    + D+G+ K  L P  +  T F GT  Y+
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYI 163

Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML------ 352
           APE+    +     D ++ GVL  E++ G+ P D ++       N D+  ++ L      
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITD------NPDMNTEDYLFQVILE 217

Query: 353 DP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
            P R+P   R +  K   +++     LN+ P+ R
Sbjct: 218 KPIRIP---RFLSVKASHVLK---GFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 64/255 (25%), Positives = 104/255 (40%), Gaps = 54/255 (21%)

Query: 161 LPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDA 220
           L SD   D   F      ++++ H+++VKLYG C    +  +V E++K G L   L  + 
Sbjct: 38  LGSDH-RDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREK 95

Query: 221 AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL---DLEFE----AHVA 273
               L W  +++V K +A AL YL       +VH ++  KN+L+    L         ++
Sbjct: 96  NNVSLHW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150

Query: 274 DFGIAKFLKP-----DSSNWTEFAGTYGYVAPELAY--TMKITEKCDVYSFGVLALEVI- 325
           D GI   +       +   W         +APE        +T   D +SFG   LE+  
Sbjct: 151 DPGIPITVLSREERVERIPW---------IAPECIRNGQASLTIAADKWSFGTTLLEICS 201

Query: 326 KGKHPRDFLSSISSSFLNTDIELDEMLD-----PRLPAPSRSVQEKLRSIVEVVFSCLNE 380
            G+ P   LS++SSS         E         RLP P  +       +  ++  C   
Sbjct: 202 NGEEP---LSTLSSS---------EKERFYQDQHRLPMPDCA------ELANLINQCWTY 243

Query: 381 SPESRPTMKIVSQQL 395
            P  RP+ + + + L
Sbjct: 244 DPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 69/264 (26%), Positives = 117/264 (44%), Gaps = 32/264 (12%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKF--HSPLPSDQIVDKKEFLTEVEALTE 181
            DF+    I NG +G+VY      + Q  A+KK    + +  +QI   ++   E + LT 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQI---QQVFVERDILTF 57

Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAA-AQELGWSQRMNVIKGVADA 240
             +  +V ++      RH  +V E+++ G  A +L +  A   ++    RM   + V  A
Sbjct: 58  AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA---RMYFAETVL-A 113

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF-LKPDSSNWTE--------- 290
           L YLH+     IVHRD+   NLL+       + DFG++K  L   ++N  E         
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 291 -----FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLN 343
                  GT  Y+APE+       +  D ++ G++  E + G  P   D    +    ++
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230

Query: 344 TDIELDEMLDPRLPAPSRSVQEKL 367
            DIE  E  +  LPA ++ +  +L
Sbjct: 231 DDIEWPEGDEA-LPADAQDLISRL 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 33/97 (34%), Positives = 52/97 (53%), Gaps = 5/97 (5%)

Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTY 295
           +A  L +LH      I++RD+   N++LD E    +ADFG+ K  +    +  T F GT 
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165

Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD 332
            Y+APE+       +  D ++FGVL  E++ G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 55/245 (22%), Positives = 98/245 (40%), Gaps = 34/245 (13%)

Query: 165 QIVDKKE------FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSS 218
           +++DK        F      ++++ H+++V  YG C     S +V E++K GSL   L  
Sbjct: 33  KVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK 92

Query: 219 DAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA 278
           +     + W  ++ V K +A AL +L       + H ++ +KN+LL  E +    +    
Sbjct: 93  NKNLINISW--KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFI 147

Query: 279 KFLKPDSS------NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKG-KHP 330
           K   P  S                +V PE +     ++   D +SFG    E+  G   P
Sbjct: 148 KLSDPGISITVLPKEI--LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205

Query: 331 RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKI 390
              L S        D         +LPAP      K   +  ++  C++  P+ RP+ + 
Sbjct: 206 LSALDSQKKLQFYEDRH-------QLPAP------KWTELANLINQCMDYEPDFRPSFRA 252

Query: 391 VSQQL 395
           + + L
Sbjct: 253 IIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 61/248 (24%), Positives = 103/248 (41%), Gaps = 33/248 (13%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G  G V  A   + +     KF++     +++ KK  L + E    +  RN++    
Sbjct: 3   IGKGSFGKVLLARHKAEE-----KFYAV----KVLQKKAILKKKEEKHIMSERNVL---- 49

Query: 193 FCSHARHSFLV---YEFLKRGSLAAILSSDAAAQELGWSQRMNVI---------KGVADA 240
              + +H FLV   + F     L  +L      +     QR               +A A
Sbjct: 50  -LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA 108

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYGYVA 299
           L YLH      IV+RD+  +N+LLD +    + DFG+ K  ++ + +  T F GT  Y+A
Sbjct: 109 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLA 164

Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           PE+ +        D +  G +  E++ G  P  F S  ++   +  +     L P +   
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP--FYSRNTAEMYDNILNKPLQLKPNITNS 222

Query: 360 SRSVQEKL 367
           +R + E L
Sbjct: 223 ARHLLEGL 230

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 35/222 (15%)

Query: 126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIK--KFHSPLPSDQI------------VDKK 170
           DF+    +G G  G V  AE   + ++ AIK  K    +  D +             DK 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 171 EFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQR 230
            FLT++ +  +   R    LY    +     L+Y   + G      +   AA+       
Sbjct: 61  PFLTQLHSCFQTVDR----LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE------- 109

Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE 290
                 ++  L +LH      I++RD+   N++LD E    +ADFG+ K    D      
Sbjct: 110 ------ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160

Query: 291 FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD 332
           F GT  Y+APE+       +  D +++GVL  E++ G+ P D
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 20/205 (9%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G+V++A    + ++VA+K+    L  D        L E+  L E++H+NIV+LY
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 192 GFCSHARHSFLVYEF----LKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
                 +   LV+E+    LK+   +     D    +    Q   ++KG+A   S  H+ 
Sbjct: 66  DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ---LLKGLAFCHS--HN- 119

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYGYVAPELAYTM 306
               ++HRD+  +NLL++   E  +ADFG+A+ F  P      E   T  Y  P++ +  
Sbjct: 120 ----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGA 174

Query: 307 KI-TEKCDVYSFGVLALEVIKGKHP 330
           K+ +   D++S G +  E+     P
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 25/209 (11%)

Query: 133 IGNGGHGSVYRA---ELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G VY     ++  G+    VA+K  +    S  + ++ EFL E   +      +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE---SASLRERIEFLNEASVMKGFTCHH 70

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIK-------GVAD 239
           +V+L G  S  + + +V E +  G L + L S     E    +    ++        +AD
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT----Y 295
            ++YL+   F   VHRD++++N ++  +F   + DFG+ + +    +++    G      
Sbjct: 131 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 185

Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEV 324
            ++APE       T   D++SFGV+  E+
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 64/307 (20%), Positives = 109/307 (35%), Gaps = 80/307 (26%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           C  +     + + + P+  +VA+KK +  L S    D K    E+    +++H NI+  Y
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKIN--LDSCSKEDLKLLQQEIITSRQLQHPNILP-Y 64

Query: 192 GFCSHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRM--NVIKGVADALSYLHHDC 248
                     ++V   +  GS   +L +       G  +     ++K V +AL Y+H   
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPE---GLPELAIAFILKDVLNALDYIHSKG 121

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAK------------FLKPDSS----NWTEFA 292
           F   +HR + + ++LL  + +  ++    +                P SS     W    
Sbjct: 122 F---IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL--- 175

Query: 293 GTYGYVAPELAYT--MKITEKCDVYSFGVLA-------------------LEVIKGKHPR 331
                 +PE+         EK D+YS G+ A                   LE ++G  P 
Sbjct: 176 ------SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPC 229

Query: 332 -----------DFLSSISSSFLNTDIELDEMLDPRLPAPS-RSVQEKLRSIVEVVFSCLN 379
                      D +S   SS  + +          +  P  R+  E     VE+   CL 
Sbjct: 230 LLDKSTYPLYEDSMSQSRSSNEHPNNR------DSVDHPYTRTFSEHFHQFVEL---CLQ 280

Query: 380 ESPESRP 386
             PESRP
Sbjct: 281 RDPESRP 287

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 71/282 (25%), Positives = 119/282 (42%), Gaps = 37/282 (13%)

Query: 133 IGNGGHGSVYRAEL---PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IGNG  G V  +E+        V +K+  +   S +   + EFL + +    ++H NI++
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE---QNEFLQQGDPYRILQHPNILQ 59

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSS------DAAAQELGWSQRMNVIKGVADALSY 243
             G C  A    LV+E+ + G L + LS       ++    L   QRM     +A  +++
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL---QRMAC--EIAAGVTH 114

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG--YVAPE 301
           +H   F   +H D++ +N  L  +    V D+GI      +    TE        ++APE
Sbjct: 115 MHKHNF---LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171

Query: 302 LA-------YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD 353
           L         T + T+  +V++ GV   E+ +    P   LS      LN  I+  ++  
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--EVLNHVIKDQQV-- 227

Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            +L  P   +    R    + F  L  SPE R T + V + L
Sbjct: 228 -KLFKPQLELPYSERWYEVLQFCWL--SPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 3/96 (3%)

Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
           +A  L +LH      I++RD+   N++LD E    +ADFG+ K    D      F GT  
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD 332
           Y+APE+       +  D ++FGVL  E++ G+ P +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 14/204 (6%)

Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALTEIRHRNIV 188
           +G GG G V   ++  +G++ A KK    L   ++  +K +   + E   L ++  R IV
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK----LNKKRLKKRKGYEGAMVEKRILAKVHSRFIV 56

Query: 189 KL-YGFCSHARHSFLVYEFLKRGSLA-AILSSDAAAQELGWSQRMNVIKGVADALSYLHH 246
            L Y F +      LV   +  G L   I + D         +       +   L +LH 
Sbjct: 57  SLAYAFQTKTDLC-LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM 306
                I++RD+  +N+LLD +    ++D G+A  LK   S    +AGT G++APEL    
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE 172

Query: 307 KITEKCDVYSFGVLALEVIKGKHP 330
           +     D ++ GV   E+I  + P
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 14/225 (6%)

Query: 126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR 185
           D++    IG G  G V      S + V   K  S     +  D   F  E + +      
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
            +V+L+      R+ ++V E++  G L  ++S+    ++  W++       V  AL  +H
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALDAIH 159

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA-GTYGYVAPELAY 304
              F   +HRD+   N+LLD      +ADFG    +  +     + A GT  Y++PE+  
Sbjct: 160 SMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216

Query: 305 TMK----ITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLN 343
           +         +CD +S GV   E++ G  P   D L    S  +N
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 261

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 10/209 (4%)

Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           +G GG G V   ++  +G++ A KK        +  +K   L E E L ++    IV L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-EKEILEKVNSPFIVNLA 59

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y F S   H  LV   +  G L   +  +   + L   + ++    +   + +LH     
Sbjct: 60  YAFESKT-HLCLVMSLMNGGDLKYHIY-NVGERGLEMERVIHYSAQITCGILHLHS---M 114

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            IV+RD+  +N+LLD +    ++D G+A  L  D    T+ AGT GY+APE+      + 
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSY 173

Query: 311 KCDVYSFGVLALEVIKGKHP-RDFLSSIS 338
             D ++ G    E++ G+ P +D    ++
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVA 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 12/136 (8%)

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           I+HRD+ +KN+ L       + DFG+++ L       T F GT  Y++PE         K
Sbjct: 127 ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185

Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            D++S G +  E+    H     +    +FL+  + + E   P LP    +   +L SI+
Sbjct: 186 SDIWSLGCILYEMCCLAH-----AFEGQNFLSVVLRIVEGPTPSLP---ETYSRQLNSIM 237

Query: 372 EVVFSCLNESPESRPT 387
           +   S LN+ P  RP+
Sbjct: 238 Q---SMLNKDPSLRPS 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 23/204 (11%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG+G  G V  A +   G  VA+KK   P   +Q   K+ +  E+  L  + H+NI+ L 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAY-RELVLLKCVNHKNIISLL 86

Query: 192 GFCSHAR------HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
              +  +        +LV E +   +L  ++  +   + + +     ++  +   + +LH
Sbjct: 87  NVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSY-----LLYQMLCGIKHLH 140

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAPELA 303
                 I+HRD+   N+++  +    + DFG+A+      +N+  T +  T  Y APE+ 
Sbjct: 141 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVI 194

Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M   E  D++S G +  E++KG
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 53.7 bits (130), Expect = 6e-08
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 40/216 (18%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKL 190
           +G G +G V++A +  + +VVA+KK      +    D +    E+  L E+  H NIVKL
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT--DAQRTFREIMFLQELGDHPNIVKL 72

Query: 191 YGF--CSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGV---------AD 239
                  + +  +LV+E+++    A I              R N+++ V           
Sbjct: 73  LNVIKAENDKDIYLVFEYMETDLHAVI--------------RANILEDVHKRYIMYQLLK 118

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW-----TEFAGT 294
           AL Y+H      ++HRD+   N+LL+ +    +ADFG+A+ L     N      T++  T
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 295 YGYVAPE--LAYTMKITEKCDVYSFGVLALEVIKGK 328
             Y APE  L  T + T+  D++S G +  E++ GK
Sbjct: 176 RWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 49/186 (26%), Positives = 87/186 (46%), Gaps = 20/186 (10%)

Query: 216 LSSDAAAQELGWSQRMNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVAD 274
           L SD  ++ L     ++    VA  + +L   +C    VHRD++++N+LL       + D
Sbjct: 225 LLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICD 280

Query: 275 FGIAKFLKPDSSNWTEFAGTY---GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 330
           FG+A+ +  D SN+     T+    ++APE  +    T   DV+S+G+L  E+   G  P
Sbjct: 281 FGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339

Query: 331 RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKI 390
              +  + S+F N           R+  P  + QE    + +++  C N  PE RP+   
Sbjct: 340 YPGM-IVDSTFYNKIKS-----GYRMAKPDHATQE----VYDIMVKCWNSEPEKRPSFLH 389

Query: 391 VSQQLQ 396
           +S  ++
Sbjct: 390 LSDIVE 395

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 9/200 (4%)

Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE-IRHRNIVKL 190
           IG G  G V  A+    G+  A+K     +  ++  ++K  + E   L + ++H  +V L
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-KEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
           +         + V +F+  G L   L  + +  E    +       +A AL YLH     
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLHS---I 115

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            IV+RD+  +N+LLD +    + DFG+ K     S   T F GT  Y+APE+        
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 311 KCDVYSFGVLALEVIKGKHP 330
             D +  G +  E++ G  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 53.6 bits (129), Expect = 8e-08
 Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 25/208 (12%)

Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G V+    P  G+ VA+KK   P     +V  K    E++ L   +H N++   
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKM--PNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65

Query: 192 -----GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH 246
                         ++V E ++      I+S    + +        +++G    L YLH 
Sbjct: 66  DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG----LKYLHS 121

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPELA-- 303
                I+HRDI   NLL++      + DFG+A+  +PD S + T+   T  Y APE+   
Sbjct: 122 ---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178

Query: 304 ---YTMKITEKCDVYSFGVLALEVIKGK 328
              YT  +    D++S G +  E++  +
Sbjct: 179 SRHYTSAV----DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 41/123 (33%), Positives = 58/123 (47%), Gaps = 11/123 (8%)

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 298
           AL +LH      IV+RDI  +N+LLD E    + DFG++K FL  +      F GT  Y+
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 299 APELAYTMKITEKC-DVYSFGVLALEVIKGKHP------RDFLSSISSSFLNTDIELDEM 351
           APE+        K  D +S G+L  E++ G  P      R+  S +S   L  D      
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF 233

Query: 352 LDP 354
           + P
Sbjct: 234 IGP 236

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 55/247 (22%), Positives = 97/247 (39%), Gaps = 45/247 (18%)

Query: 149 GQVVAIKKFHSPLPSD-QIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV---- 203
           G+V    K   P P   +I  K   L E   L  + H +++++         + +V    
Sbjct: 80  GRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139

Query: 204 ----YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISS 259
               Y +L + S           + L   Q + + K + + L YLH      I+HRD+ +
Sbjct: 140 SSDLYTYLTKRS-----------RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKT 185

Query: 260 KNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 319
           +N+ ++   +  + D G A+F    +  +   AGT    APE+    K   K D++S G+
Sbjct: 186 ENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGI 244

Query: 320 LALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLN 379
           +  E++   +P       S+ F +     +E          +S    L  I+    S L 
Sbjct: 245 VLFEML--AYP-------STIFEDPPSTPEE--------YVKSCHSHLLKII----STLK 283

Query: 380 ESPESRP 386
             PE  P
Sbjct: 284 VHPEEFP 290

Length = 357

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 59/249 (23%)

Query: 126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSP--LPSDQ---IVDKKEFLTEVEAL 179
           DF++   IG G  G V   +   +G V A+K       L  +Q   I  +++ L E ++L
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAIL-SSDAAAQELGWSQRMNVIKGVA 238
                  +VK++       + +L+ EFL  G +  +L   D   +E    +    I    
Sbjct: 62  W------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE----ETQFYIAETV 111

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF------- 291
            A+  +H   F   +HRDI   NLLLD +    ++DFG+   LK   ++ TEF       
Sbjct: 112 LAIDSIHQLGF---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLK--KAHRTEFYRNLNHS 166

Query: 292 ------------------------------AGTYGYVAPELAYTMKITEKCDVYSFGVLA 321
                                          GT  Y+APE+       + CD +S GV+ 
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 322 LEVIKGKHP 330
            E++ G  P
Sbjct: 227 YEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)

Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE---FLTEVEALTE 181
           DFD    IG G  G V       S QV A+K     L   +++ + +   F  E + +  
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL----LSKFEMIKRSDSAFFWEERDIMAH 99

Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADAL 241
                IV+L+      ++ ++V E++  G L  ++S+    ++  W++       V  AL
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK--WARFY--TAEVVLAL 155

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA-GTYGYVAP 300
             +H   F   +HRD+   N+LLD      +ADFG    +  +     + A GT  Y++P
Sbjct: 156 DAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISP 212

Query: 301 ELAYTMKIT----EKCDVYSFGVLALEVIKGKHP 330
           E+  +         +CD +S GV   E++ G  P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 20/209 (9%)

Query: 130 QY-CIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKK---EFLTEVEALTEIRH 184
           QY  +G GG G V   ++  +G++ A KK    L   +I  +K     L E + L ++  
Sbjct: 4   QYRVLGKGGFGEVCACQVRATGKMYACKK----LEKKRIKKRKGESMALNEKQILEKVNS 59

Query: 185 RNIVKLYGFCSHARHSF-LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG--VADAL 241
           R +V L  +    + +  LV   +  G L   +     A   G+ +   V     +   L
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA---GFEEGRAVFYAAEICCGL 115

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
             LH +    IV+RD+  +N+LLD      ++D G+A  + P+        GT GY+APE
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMAPE 171

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +    + T   D ++ G L  E+I G+ P
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 24/209 (11%)

Query: 133 IGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G GG+G V++        +G++ A+K            D      E   L  ++H  IV
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 189 KL-YGFCSHARHSFLVYEFLKRGSL------AAILSSDAAAQELGWSQRMNVIKGVADAL 241
            L Y F +  +  +L+ E+L  G L        I   D A   L           ++ AL
Sbjct: 64  DLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFMEDTACFYLS---------EISLAL 113

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
            +LH      I++RD+  +N+LLD +    + DFG+ K    + +    F GT  Y+APE
Sbjct: 114 EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +       +  D +S G L  +++ G  P
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 18/215 (8%)

Query: 126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFL----TEVEALTE 181
           +F+    +G G +G V+     SG           L    IV K +      TE + L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 182 IRHRN-IVKL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG-VA 238
           IR    +V L Y F +  +   L+ +++  G L   LS     +E    Q + +  G + 
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLH-LILDYINGGELFTHLSQRERFKE----QEVQIYSGEIV 115

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYGY 297
            AL +LH      I++RDI  +N+LLD      + DFG++K F + +      F GT  Y
Sbjct: 116 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 298 VAPELAYTMKI--TEKCDVYSFGVLALEVIKGKHP 330
           +AP++         +  D +S GVL  E++ G  P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 20/165 (12%)

Query: 237 VADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
           VA  +S+L   +C    +HRD++++N+LL       + DFG+A+ ++ D SN+       
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRND-SNYVVKGNAR 277

Query: 295 --YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEM 351
               ++APE  +    T + DV+S+G+L  E+   G  P   +  + S F     E   M
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM-PVDSKFYKMIKEGYRM 336

Query: 352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           L P   APS         + +++ SC +  P  RPT K + Q ++
Sbjct: 337 LSPEC-APSE--------MYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)

Query: 133 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKE---FLTEVEALTE-IRHRNI 187
           IG G  G V  A+  S G   A+K          I+ KKE    + E   L + ++H  +
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQK----KTILKKKEQNHIMAERNVLLKNLKHPFL 58

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           V L+     A   + V +++  G L   L  +    E    +       VA A+ YLH  
Sbjct: 59  VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE---PRARFYAAEVASAIGYLHS- 114

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYGYVAPELAYTM 306
               I++RD+  +N+LLD +    + DFG+ K  ++P+ +  T F GT  Y+APE+    
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKE 171

Query: 307 KITEKCDVYSFGVLALEVIKGKHP 330
                 D +  G +  E++ G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 19/202 (9%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G + +VY+     +GQ+VA+K     + +++ V     + E   L  ++H NIV L+
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVIS--MKTEEGVPFTA-IREASLLKGLKHANIVLLH 69

Query: 192 GFCSHARHSF-LVYEFLKRGSLAAILSSDAAAQELGWSQRMNV---IKGVADALSYLHHD 247
               H + +   V+E++    LA  +      Q  G     NV   +  +   L+Y+H  
Sbjct: 70  DII-HTKETLTFVFEYMHT-DLAQYM-----IQHPGGLHPYNVRLFMFQLLRGLAYIHGQ 122

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTM 306
               I+HRD+  +NLL+    E  +ADFG+A+     S  ++    T  Y  P+ L    
Sbjct: 123 ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT 179

Query: 307 KITEKCDVYSFGVLALEVIKGK 328
             +   D++  G + +E+++G+
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 51.1 bits (122), Expect = 5e-07
 Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 8/156 (5%)

Query: 174 TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNV 233
           TE   L  I H +I++L G  ++ + + L+     +  L   L+   A + +     + +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLA---AKRNIAICDILAI 187

Query: 234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF-LKPDSSNWTEFA 292
            + V  A+ YLH +    I+HRDI ++N+ ++   +  + DFG A F +  +++ +  +A
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244

Query: 293 GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 328
           GT    APEL          D++S G++  E+    
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 60/249 (24%), Positives = 99/249 (39%), Gaps = 55/249 (22%)

Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHS-FLVYEFLKRGSLAAIL-----SSDAAAQEL 225
            L E   L  + H+NI+ +   C       F++Y ++  G+L   L           Q L
Sbjct: 55  LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114

Query: 226 GWSQRMNVIKG--VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP 283
             S +  V     +A  +SYLH      ++H+DI+++N ++D E +  + D  +++ L P
Sbjct: 115 --STQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169

Query: 284 -------DSSN----WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPR 331
                  D+ N    W         +A E     + +   DV+SFGVL  E++  G+ P 
Sbjct: 170 MDYHCLGDNENRPVKW---------MALESLVNKEYSSASDVWSFGVLLWELMTLGQTP- 219

Query: 332 DFLSSISSSFLNTDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTM 388
                    ++  D  E+   L    RL  P     E    +  V+  C    PE RP+ 
Sbjct: 220 ---------YVEIDPFEMAAYLKDGYRLAQPINCPDE----LFAVMACCWALDPEERPS- 265

Query: 389 KIVSQQLQI 397
                QL  
Sbjct: 266 ---FSQLVQ 271

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 50.2 bits (120), Expect = 6e-07
 Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 298
           AL +LH      I++RDI  +N+LLD E    + DFG++K FL  +      F GT  Y+
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173

Query: 299 APELAYTMKI--TEKCDVYSFGVLALEVIKGKHP 330
           APE+         +  D +S GVL  E++ G  P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.9 bits (119), Expect = 6e-07
 Identities = 35/130 (26%), Positives = 57/130 (43%), Gaps = 19/130 (14%)

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIA---KFLKPDSSNWTEFAGTYGYVAPE-LAYTMK 307
           +V+RD+   N+LLD      ++D G+A      KP +S      GT+GY+APE L   + 
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 172

Query: 308 ITEKCDVYSFGVLALEVIKGKHPRDFLSS-----ISSSFLNTDIELDEMLDPRLPAP--- 359
                D +S G +  ++++G  P     +     I    L   +EL +   P L +    
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 232

Query: 360 --SRSVQEKL 367
              R V  +L
Sbjct: 233 LLQRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 13/146 (8%)

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD++++N+LL       + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260

Query: 311 KCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS 369
           + DV+SFGVL  E+   G  P   +  I   F      L E    R+ AP  +  E    
Sbjct: 261 QSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCR---RLKE--GTRMRAPDYTTPE---- 310

Query: 370 IVEVVFSCLNESPESRPTMKIVSQQL 395
           + + +  C +  P  RPT   + + L
Sbjct: 311 MYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 1/79 (1%)

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           IV+RD+  +N+LLD      ++D G+A  + P+        GT GY+APE+    K T  
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKYTFS 181

Query: 312 CDVYSFGVLALEVIKGKHP 330
            D +  G L  E+I+G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 1/79 (1%)

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           IV+RD+  +N+LLD      ++D G+A  + P+        GT GY+APE+    + T  
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAPEVVKNERYTFS 181

Query: 312 CDVYSFGVLALEVIKGKHP 330
            D +  G L  E+I+GK P
Sbjct: 182 PDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 4/91 (4%)

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
            L  LH +     V+RD+  +N+LLD      ++D G+A  + P+  +     GT GY+A
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGYMA 169

Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+    + T   D +  G L  E+I+G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 44/151 (29%), Positives = 71/151 (47%), Gaps = 17/151 (11%)

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD++++N+LL       + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 311 KCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS 369
           + DV+SFGVL  E+   G  P   +  I   F      L E    R+ AP  +  E    
Sbjct: 255 QSDVWSFGVLLWEIFSLGASPYPGV-QIDEEFCR---RLKE--GTRMRAPEYATPE---- 304

Query: 370 IVEVVFSCLNESPESRPT----MKIVSQQLQ 396
           I  ++  C + +PE RPT    ++I+   LQ
Sbjct: 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 5/96 (5%)

Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM 231
           F      + ++ H++IV LYG C     + +V EF++ G L   +   +      W  + 
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108

Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE 267
            V K +A ALSYL       +VH ++ +KN+LL  E
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLARE 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)

Query: 237 VADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
           VA  + +L   +C    +HRD++++N+LL     A + DFG+A+ +  D SN+       
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMND-SNYVVKGNAR 275

Query: 295 --YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEM 351
               ++APE  +    T + DV+S+G+L  E+   GK P   +  ++S F        +M
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI-LVNSKFYKMVKRGYQM 334

Query: 352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             P    P          I  ++  C N  P  RPT   +SQ +Q
Sbjct: 335 SRPDFAPP---------EIYSIMKMCWNLEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 15/203 (7%)

Query: 133 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKE---FLTEVEALTE-IRHRNI 187
           IG G  G V  A+  + G+  A+K     L    I+ KKE    + E   L + ++H  +
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV----LQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           V L+     A   + V +++  G L   L  + +  E    +       +A AL YLH  
Sbjct: 59  VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLHS- 114

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK 307
               I++RD+  +N+LLD +    + DFG+ K     S   + F GT  Y+APE+     
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP 172

Query: 308 ITEKCDVYSFGVLALEVIKGKHP 330
                D +  G +  E++ G  P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 36/140 (25%), Positives = 63/140 (45%), Gaps = 17/140 (12%)

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD++++N+LL       + DFG+A+  +  PD            ++APE  +    T 
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255

Query: 311 KCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS 369
           + DV+SFGVL  E+   G  P               ++++E    RL   +R    +  +
Sbjct: 256 QSDVWSFGVLLWEIFSLGASPY------------PGVQINEEFCQRLKDGTRMRAPENAT 303

Query: 370 --IVEVVFSCLNESPESRPT 387
             I  ++ +C    P+ RPT
Sbjct: 304 PEIYRIMLACWQGDPKERPT 323

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 55/231 (23%), Positives = 101/231 (43%), Gaps = 44/231 (19%)

Query: 126 DFDAQYC----IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
           D  ++Y     +G G +G V+ A +    + VA+KK    +        K  L E++ + 
Sbjct: 2   DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKK----IVLTDPQSVKHALREIKIIR 57

Query: 181 EIRHRNIVKLY--------------GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELG 226
            + H NIVK+Y              G  +     ++V E+++   LA +L     ++E  
Sbjct: 58  RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHA 116

Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDS 285
                 +++G    L Y+H      ++HRD+   N+ ++ E     + DFG+A+ + P  
Sbjct: 117 RLFMYQLLRG----LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169

Query: 286 SN---WTEFAGTYGYVAPELA-----YTMKITEKCDVYSFGVLALEVIKGK 328
           S+    +E   T  Y +P L      YT  I    D+++ G +  E++ GK
Sbjct: 170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 31/233 (13%)

Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM 231
           F      ++++ H ++  ++G C     + +V EF++ G L   L  +     + W  ++
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT-- 289
            V + +A ALSYL       +VH ++ +KN+LL       +A+ G + F+K      +  
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLA---RLGLAE-GTSPFIKLSDPGVSFT 173

Query: 290 -----EFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLSSISSSFL 342
                E      ++APE +     ++   D +SFG   LE+   G+ P   L   + S  
Sbjct: 174 ALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP---LKERTPS-- 228

Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + E       RLP PS       + +  ++  CL   P  RP+ + + + L
Sbjct: 229 --EKERFYEKKHRLPEPS------CKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 23/205 (11%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG+G  G V  A +  +GQ VAIKK   P     +   K    E+  +  + H+NI+ L 
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 192 GFCSHAR------HSFLVYEFLKRGSLAAILSSDAAAQELGW--SQRMNVIKGVADALSY 243
              +  +        +LV E +   +L  ++  D   + + +   Q +  IK       +
Sbjct: 82  NVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIK-------H 133

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 134 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 189

Query: 304 YTMKITEKCDVYSFGVLALEVIKGK 328
             M   E  D++S G +  E+I+G 
Sbjct: 190 LGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 60/252 (23%), Positives = 111/252 (44%), Gaps = 34/252 (13%)

Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIS 80

Query: 190 LYGFCSHAR------HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +   +L  ++  +   + + +     ++  +   + +
Sbjct: 81  LLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKH 134

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 190

Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +        ++ E L    P   
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--------KVIEQLGTPCPEFM 242

Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 243 KKLQPTVRNYVE 254

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 15/161 (9%)

Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN 232
           + EV  L  ++H NIV L+      R   LV+E+L    L   L +       G    M+
Sbjct: 51  IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDN------CGNLMSMH 103

Query: 233 VIK----GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
            +K     +   LSY H      I+HRD+  +NLL++ + E  +ADFG+A+     +  +
Sbjct: 104 NVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160

Query: 289 TEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGK 328
           +    T  Y  P+ L  + + +   D++  G +  E+  G+
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 74/263 (28%)

Query: 125 NDFDAQYCIGNGGHGSVYR--AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA---- 178
           +DF++   IG G  G V R   +  +G + A+KK      S+ +  +KE +  V A    
Sbjct: 1   DDFESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKL---RKSEML--EKEQVAHVRAERDI 54

Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAA------ILSSDAAAQELGWSQRMN 232
           L E  +  +VKLY       + +L+ E+L  G +          + +          R  
Sbjct: 55  LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET--------RFY 106

Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA 292
           + + +  A+  +H   +   +HRDI   NLLLD +    ++DFG+   LK   S+ TEF 
Sbjct: 107 IAETIL-AIDSIHKLGY---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLK--KSHRTEFY 160

Query: 293 ----------------------------------------GTYGYVAPELAYTMKITEKC 312
                                                   GT  Y+APE+       ++C
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC 220

Query: 313 DVYSFGVLALEVIKGKHPRDFLS 335
           D +S GV+  E++ G  P  F S
Sbjct: 221 DWWSLGVIMYEMLVGYPP--FCS 241

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 49/192 (25%), Positives = 78/192 (40%), Gaps = 35/192 (18%)

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQE---LGWSQRMNVIKGVADALS 242
           N+V L+ +       FLV +  + G L + +S      E     W+  M V      AL 
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG------ 296
            LH +    IV RD++  N+LLD      +  F            W+E   +        
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFS----------RWSEVEDSCDGEAVEN 146

Query: 297 -YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR 355
            Y APE+    + TE CD +S G +  E++ GK     L     S +NT   L+  +   
Sbjct: 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKT----LVECHPSGINTHTTLN--IPEW 200

Query: 356 LPAPSRSVQEKL 367
           +   +RS+ ++L
Sbjct: 201 VSEEARSLLQQL 212

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 15/161 (9%)

Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN 232
           + EV  L +++H NIV L+      +   LV+E+L +  L   L       + G S  M+
Sbjct: 52  IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD------DCGNSINMH 104

Query: 233 VIK----GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
            +K     +   L+Y H      ++HRD+  +NLL++   E  +ADFG+A+     +  +
Sbjct: 105 NVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161

Query: 289 TEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGK 328
           +    T  Y  P+ L  +   + + D++  G +  E+  G+
Sbjct: 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 57/246 (23%), Positives = 87/246 (35%), Gaps = 71/246 (28%)

Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEF---------LTEVEALTEI 182
           +G G  G V+   L  +G++ A+K          ++DKKE          LTE E L  +
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALK----------VLDKKEMIKRNKVKRVLTEQEILATL 58

Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG------ 236
            H  +  LY       +  LV ++   G L  +L            Q    +        
Sbjct: 59  DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR----------QPGKCLSEEVARFY 108

Query: 237 ---VADALSYLHHDCFPPIVHRDISSKNLLL-----------DLEFEAHVAD---FGIAK 279
              V  AL YLH      IV+RD+  +N+LL           DL  ++ V         +
Sbjct: 109 AAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165

Query: 280 FLKPDSSNWTE---------------FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEV 324
                SS  +                F GT  Y+APE+          D ++ G+L  E+
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225

Query: 325 IKGKHP 330
           + G  P
Sbjct: 226 LYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.2 bits (114), Expect = 5e-06
 Identities = 47/198 (23%), Positives = 83/198 (41%), Gaps = 31/198 (15%)

Query: 175 EVEALTEIRHRNIVKL--------YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELG 226
           E+ AL  + H NI+K+          +    ++ F +Y F+   +       D   + L 
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPLL 266

Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA-KFLKPDS 285
              R  ++K +  A+ Y+H      ++HRDI  +N+ L+ + +  + DFG A  F K   
Sbjct: 267 KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322

Query: 286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK---------GKHPRDFLSS 336
           +    + GT    +PE+       E  D++S G++ L+++          G  P   L  
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382

Query: 337 ISSSFLNTDIELDEMLDP 354
           I  S    D   +E  DP
Sbjct: 383 IIDSLSVCD---EEFPDP 397

Length = 501

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 45.9 bits (109), Expect = 6e-06
 Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 30/183 (16%)

Query: 210 GSLAAILSSDAA---AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL 266
            SLA IL         +E+ W+    V      AL  LH         R   S N+LL  
Sbjct: 1   VSLADILEVRGRPLNEEEI-WA----VCLQCLGALRELH---------RQAKSGNILLT- 45

Query: 267 EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK 326
            ++  +   G   F  P+ S    +     ++APE+      TEK D+YS G+   E + 
Sbjct: 46  -WDGLLKLDGSVAFKTPEQSRPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYEALD 99

Query: 327 GKHPRDFLSSISSSFLNTDIELDEM--LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPES 384
            + P +    +S+     +I L+ M   DPR  +    V    RS  + +  C +  P+ 
Sbjct: 100 YELPYNEERELSAIL---EILLNGMPADDPRDRSNLEGVSA-ARSFEDFMRLCASRLPQR 155

Query: 385 RPT 387
           R  
Sbjct: 156 REA 158

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 46.5 bits (111), Expect = 9e-06
 Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 62/221 (28%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKK----FHSPLPSDQIVDKKEFLTEVEALTEIR-HRN 186
           IG G    V +A    +G+  AIK     F S    +Q+ +    L E++AL  +  H N
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS---LEQVNN----LREIQALRRLSPHPN 59

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNV---IKG------- 236
           I++L           L     K G LA +        EL     MN+   IKG       
Sbjct: 60  ILRL--------IEVLFDR--KTGRLALVF-------EL---MDMNLYELIKGRKRPLPE 99

Query: 237 ---------VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDS 285
                    +  +L ++H +    I HRDI  +N+L+  +    +ADFG  +  + KP  
Sbjct: 100 KRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP- 154

Query: 286 SNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVI 325
             +TE+  T  Y APE   T      K D+++ G +  E++
Sbjct: 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 69/297 (23%), Positives = 131/297 (44%), Gaps = 39/297 (13%)

Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEV 176
           YD+     N+++    IGNG  G V+  +    Q     K  S     +  +K + + EV
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEV 63

Query: 177 EALTEIRHRNIVKLYG-FCSHARHS-FLVYEFLKRGSLAA-ILSSDAAAQELGWSQRMNV 233
             + E++H+NIV+    F + A    +++ EF   G L+  I        ++     +++
Sbjct: 64  NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123

Query: 234 IKGVADALSYLHHDCFPP----IVHRDISSKNLLLDLEFE-----------------AHV 272
            + +  AL+Y H+    P    ++HRD+  +N+ L                      A +
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 273 ADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY--TMKITEKCDVYSFGVLALEVIKGKHP 330
            DFG++K +  +S   +   GT  Y +PEL    T    +K D+++ G +  E+  GK P
Sbjct: 184 GDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Query: 331 RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
             F  + + S L ++++      P LP     ++ K + +  ++ + LN S + RP+
Sbjct: 243 --FHKANNFSQLISELK----RGPDLP-----IKGKSKELNILIKNLLNLSAKERPS 288

Length = 1021

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 34/165 (20%)

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW---TEFAGTYG 296
           AL  +H      ++HRD+ S N+ L       + DFG +K    DS +    + F GT  
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVASSFCGTPY 236

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVI------KGKHPRDFLSSISSSFLNTDIELDE 350
           Y+APEL    + ++K D++S GV+  E++      KG   R+ +  +          L  
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV----------LYG 286

Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             DP  P P   V   ++++++ +   L+++P  RPT    +QQL
Sbjct: 287 KYDP-FPCP---VSSGMKALLDPL---LSKNPALRPT----TQQL 320

Length = 478

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 38/161 (23%), Positives = 74/161 (45%), Gaps = 15/161 (9%)

Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN 232
           + EV  L +++H NIV L+      +   LV+E+L +              + G    M+
Sbjct: 52  IREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-------DLKQYMDDCGNIMSMH 104

Query: 233 VIK----GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
            +K     +   L+Y H      ++HRD+  +NLL++   E  +ADFG+A+     +  +
Sbjct: 105 NVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161

Query: 289 TEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGK 328
           +    T  Y  P+ L  + + + + D++  G +  E+  G+
Sbjct: 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 25/161 (15%)

Query: 174 TEVEALTEIRHRNIVKL-YGF------CSHARH-SFLVYEFLKRGSLAAILSSDAAAQEL 225
            E++ L  I HR I+ L + +      C         ++ ++ R               L
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG------------PL 182

Query: 226 GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK--P 283
              Q + + + + +AL+YLH      I+HRD+ ++N+ LD    A + DFG A  L   P
Sbjct: 183 PLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239

Query: 284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEV 324
           D+     ++GT    +PEL        K D++S G++  E+
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 32/220 (14%)

Query: 127 FDAQYC-IGNGGHGSVYRAELPSG---QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           F+ + C +G G +G VY+A+   G   +  A+K+      S           E+  L E+
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS------MSACREIALLREL 55

Query: 183 RHRNIVKLYG-FCSHA-RHSFLVYEFLKRGSLAAILSSDAAAQ------ELGWSQRMNVI 234
           +H N++ L   F SHA R  +L++++ +   L  I+    A++      +L      +++
Sbjct: 56  KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLL 114

Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLE----FEAHVADFGIAKF----LKPDSS 286
             + D + YLH +    ++HRD+   N+L+  E        +AD G A+     LKP  +
Sbjct: 115 YQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP-LA 170

Query: 287 NWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVI 325
           +      T+ Y APEL    +  T+  D+++ G +  E++
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 32/116 (27%), Positives = 53/116 (45%), Gaps = 14/116 (12%)

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIA---KFLKPDSSNWTEFAGTYGYVAPE-LAYTMK 307
           +V+RD+   N+LLD      ++D G+A      KP +S      GT+GY+APE L     
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGTA 172

Query: 308 ITEKCDVYSFGVLALEVIKG-----KHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
                D +S G +  ++++G     +H       I    L  ++EL +   P L +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKS 228

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 45.5 bits (107), Expect = 3e-05
 Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 23/203 (11%)

Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFH------SPLPSDQIVDKKEFLTEVEALTEIRHR 185
           +G G + +VY+ +   +G++VA+K         +P  +         + E   L  ++H 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA---------IREASLLKGLKHA 63

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
           NIV L+          LV+E++       +   D     L        +  +   LSY+H
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
                 I+HRD+  +NLL+    E  +ADFG+A+     S  ++    T  Y  P++   
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG 177

Query: 306 MKITEKC-DVYSFGVLALEVIKG 327
                 C D++  G + +E+I+G
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 23/205 (11%)

Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIG 87

Query: 190 LYGFCSHARH------SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           L    +  +        ++V E +   +L  ++       EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKH 141

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197

Query: 304 YTMKITEKCDVYSFGVLALEVIKGK 328
             M   E  D++S G +  E+IKG 
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 28/158 (17%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFL---------TEVEALTEIR 183
           I  G  G VY         +  KK +S L + ++V K + +          E +AL   +
Sbjct: 12  ISRGAFGKVY---------LGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNV--IKGVADAL 241
              IV LY     A + +LV E+L  G + ++L       E      M V  I  VA AL
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE-----EMAVKYISEVALAL 117

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK 279
            YLH      I+HRD+   N+L+  E    + DFG++K
Sbjct: 118 DYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 34/162 (20%)

Query: 237 VADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY 295
           VA+ + +L   +C    VHRD++++N+L+       + DFG+A+ +  DS N+     T+
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDS-NYISKGSTF 302

Query: 296 ---GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP-------RDFLSSISSSFLNT 344
               ++APE  +    T   DV+SFG+L  E+   G  P         F ++I   +   
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY--- 359

Query: 345 DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRP 386
                     R+  P+ +  E    I E++  C  E  E RP
Sbjct: 360 ----------RMAKPAHASDE----IYEIMQKCWEEKFEIRP 387

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 35/215 (16%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN-IVKL 190
           IG G +G VY+A +  +G++VA+KK  + L  D+       L E+  L  +     IV+L
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKK--TRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66

Query: 191 YGFCSHARHS------FLVYEFLK----------RGSLAAILSSDAAAQELGWSQRMNVI 234
                H          +LV+E+L                  L +         S    ++
Sbjct: 67  LD-VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK-----SFMYQLL 120

Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAG 293
           KGVA    + H      ++HRD+  +NLL+D +     +AD G+ +       ++T    
Sbjct: 121 KGVA----HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 294 TYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKG 327
           T  Y APE L  +   +   D++S G +  E+ + 
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 26/210 (12%)

Query: 133 IGNGGHGSVYRAE--LPSGQVVAIKKF-----HSPLPSDQIVDKKEFLTEVEALTEIRHR 185
           IG G +G V++A      G+ VA+K+         +P   I +    +  +  L    H 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VAVLRHLETFEHP 64

Query: 186 NIVKLYGFCSHARHS-----FLVYEFLKRGSLAAILSSDAAAQELGWSQRM--NVIKGVA 238
           N+V+L+  C+ +R        LV+E + +  L   L       E G       +++  + 
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK---VPEPGVPTETIKDMMFQLL 120

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
             L +LH      +VHRD+  +N+L+    +  +ADFG+A+      +  T    T  Y 
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYR 176

Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGK 328
           APE+          D++S G +  E+ + K
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 64/232 (27%), Positives = 102/232 (43%), Gaps = 32/232 (13%)

Query: 112 EGKLVYDEIVRATN-DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDK 169
           E K++ ++I R+ N  +     IGNG  G VY A  + + + VAIKK    L   Q  ++
Sbjct: 52  EEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV---LQDPQYKNR 108

Query: 170 KEFLTEVEALTEIRHRNIVKL----YGFC--SHARHSFL--VYEFLKRGSLAAILSSDAA 221
                E+  +  + H NI+ L    Y  C   + ++ FL  V EF+ +     +      
Sbjct: 109 -----ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN 163

Query: 222 AQELGWSQRMNVIK----GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEA-HVADFG 276
              L     + ++K     +  AL+Y+H      I HRD+  +NLL+D       + DFG
Sbjct: 164 NHAL----PLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216

Query: 277 IAKFLKPDSSNWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLALEVIKG 327
            AK L     + +     + Y APEL       T   D++S G +  E+I G
Sbjct: 217 SAKNLLAGQRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 28/157 (17%)

Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKF----HSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G + +VY+     +GQ+VA+K+         P   I        E   L +++H NI
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-------REASLLKDLKHANI 65

Query: 188 VKLYGFCSHARHSF-LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIK----GVADALS 242
           V L+    H + +  LV+E+L    L   +         G    M+ ++     +   L+
Sbjct: 66  VTLHDII-HTKKTLTLVFEYLDT-DLKQYMDD------CGGGLSMHNVRLFLFQLLRGLA 117

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK 279
           Y H      ++HRD+  +NLL+    E  +ADFG+A+
Sbjct: 118 YCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 38/185 (20%), Positives = 65/185 (35%), Gaps = 42/185 (22%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV--KL 190
           +  G    VY         V   K +            +   EV  L  +  + +   K+
Sbjct: 6   LKGGLTNRVYLLGTKDEDYVL--KINPS-----REKGADREREVAILQLLARKGLPVPKV 58

Query: 191 YGFCSHARHSFLVYEFLKRGSL--AAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
                    S+L+ E+++  +L   +    +  A++L            A+ L+ LH   
Sbjct: 59  LASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQL------------AELLAKLHQ-- 104

Query: 249 FPPIV--HRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM 306
            P +V  H D+   N+L+D        D  I   +  D   W E+AG YG  A +LA  +
Sbjct: 105 LPLLVLCHGDLHPGNILVD--------DGKILGII--D---W-EYAG-YGPPAFDLAAAL 149

Query: 307 KITEK 311
                
Sbjct: 150 LFNLL 154

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 19/171 (11%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA----L 179
            DF     IG G  G V   +   +G++ A+K   + L S+    KK+ L  V+A    L
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK---TLLKSEMF--KKDQLAHVKAERDVL 55

Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAIL-SSDAAAQELGWSQRMNVIKGVA 238
            E     +V LY     A++ +L+ EFL  G L  +L   D  ++++    R  + + V 
Sbjct: 56  AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAECVL 112

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNW 288
            A+  +H   F   +HRDI   N+L+D      ++DFG++  F K   S +
Sbjct: 113 -AIEAVHKLGF---IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 5/106 (4%)

Query: 220 AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK 279
           A  + LG +Q   V + +  A+ Y+H +    I+HRDI ++N+L++   +  + DFG A 
Sbjct: 252 ARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAAC 308

Query: 280 FLKPDSSNWTEF--AGTYGYVAPELAYTMKITEKCDVYSFGVLALE 323
           F +   S    +  AGT    APE+      T   D++S G++  E
Sbjct: 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 33/222 (14%)

Query: 133 IGNGGHGSVYRAELPSGQVV---AIKKFHSPLPSDQIVDK---------KEFLTEVEALT 180
           IG GG G VY  +  S   +   A+ K  + L ++ IV +          + +   + + 
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKIEN-LENETIVMETLVYNNIYDIDKIALWKNIH 78

Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQR---MNVIKGV 237
            I H  I K YG C   +   + Y F+    L  + ++    + +    +    N++K +
Sbjct: 79  NIDHLGIPKYYG-CGSFKRCRMYYRFILLEKL--VENTKEIFKRIKCKNKKLIKNIMKDM 135

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL---------KPDSSNW 288
              L Y+H      I H DI  +N+++D     ++ D+GIA              +  + 
Sbjct: 136 LTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDL 192

Query: 289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
               GT  Y   +      +T + D+ S G   L+    K P
Sbjct: 193 HR--GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 56/257 (21%), Positives = 98/257 (38%), Gaps = 77/257 (29%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSP--LPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G G  G V  A ++ +  + A+K       L  +Q+   K    E + L E  +  +VK
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVK---AERDILAEADNEWVVK 65

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNV---------IKGVADA 240
           LY       + + V +++  G + ++L             RM V         I  +  A
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLI------------RMEVFPEVLARFYIAELTLA 113

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI---------AKF------LKPDS 285
           +  +H   F   +HRDI   N+L+DL+    + DFG+         +K+      ++ DS
Sbjct: 114 IESVHKMGF---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS 170

Query: 286 SNWTEF--------------------------------AGTYGYVAPELAYTMKITEKCD 313
              ++                                  GT  Y+APE+      T+ CD
Sbjct: 171 MEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230

Query: 314 VYSFGVLALEVIKGKHP 330
            +S GV+  E++ G+ P
Sbjct: 231 WWSVGVILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 52/248 (20%), Positives = 96/248 (38%), Gaps = 59/248 (23%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSP--LPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G G  G V  A ++ +  + A+K       L  +Q+   K    E + L E  +  +V+
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVK---AERDILAEADNEWVVR 65

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
           LY       + + V +++  G + ++L       E         I  +  A+  +H   F
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE---DLARFYIAELTCAVESVHKMGF 122

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGI---------AKF------LKPDSSNWT----- 289
              +HRDI   N+L+D +    + DFG+         +K+      ++ DS +++     
Sbjct: 123 ---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179

Query: 290 ---------------------------EFAGTYGYVAPELAYTMKITEKCDVYSFGVLAL 322
                                         GT  Y+APE+      T+ CD +S GV+  
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239

Query: 323 EVIKGKHP 330
           E++ G+ P
Sbjct: 240 EMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	397
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
PRK10345	210	hypothetical protein; Provisional	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
smart00090	237	RIO RIO-like kinase.	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.68
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.64
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
KOG1243	690	consensus Protein kinase [General function predict	99.43
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.42
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.35
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.32
KOG3087	229	consensus Serine/threonine protein kinase [General	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.28
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.21
COG4248	637	Uncharacterized protein with protein kinase and he	99.19
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.17
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.1
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.08
PRK09902	216	hypothetical protein; Provisional	99.0
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.93
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.89
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.85
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.82
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.61
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.6
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.58
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.58
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.52
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.38
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.37
PF01636	239	APH: Phosphotransferase enzyme family This family	98.34
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.34
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.33
PLN02876	822	acyl-CoA dehydrogenase	98.26
PRK10593	297	hypothetical protein; Provisional	98.15
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.09
PLN03150	623	hypothetical protein; Provisional	98.09
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.09
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.03
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.0
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.92
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.86
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.83
PRK05231	319	homoserine kinase; Provisional	97.72
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.7
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.67
KOG2270	520	consensus Serine/threonine protein kinase involved	97.56
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.53
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.47
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.42
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.28
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.27
PLN02756	418	S-methyl-5-thioribose kinase	97.19
PLN02236	344	choline kinase	97.15
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	97.13
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.07
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.89
PF00560	22	LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le	96.82
PRK12396	409	5-methylribose kinase; Reviewed	96.62
PLN03150	623	hypothetical protein; Provisional	96.58
COG2334	331	Putative homoserine kinase type II (protein kinase	96.51
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.45
PRK11768	325	serine/threonine protein kinase; Provisional	96.42
PRK06148	1013	hypothetical protein; Provisional	96.3
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.24
PTZ00384	383	choline kinase; Provisional	96.16
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.83
PF13504	17	LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO	95.72

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-60  Score=433.77  Aligned_cols=280  Identities=41%  Similarity=0.734  Sum_probs=237.5

Q ss_pred             CCcccHHHHHHHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeE
Q 016009          112 EGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY  191 (397)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~  191 (397)
                      ...|+++++..||++|+..+.||+|+||.||+|.+++|+.||||++.......    ..+|.+|++++.+++|||+|+++
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~Ll  137 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKLL  137 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccEE
Confidence            44689999999999999999999999999999999999999999876532211    35699999999999999999999


Q ss_pred             EEEecCC-eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcE
Q 016009          192 GFCSHAR-HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEA  270 (397)
Q Consensus       192 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  270 (397)
                      |||.+.+ +.+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||..+.++|+||||||+|||||+++++
T Consensus       138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            9999988 599999999999999999886644 79999999999999999999999998899999999999999999999


Q ss_pred             EEeeeccccccCCCCCCcccc-cccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccc----c---ccc
Q 016009          271 HVADFGIAKFLKPDSSNWTEF-AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS----S---SFL  342 (397)
Q Consensus       271 kl~Dfg~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~----~---~~~  342 (397)
                      ||+|||+++............ .||.+|+|||+...+..++|+||||||++|+|++||+.|.+......    .   ...
T Consensus       217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            999999997654312222222 89999999999999999999999999999999999998877433111    0   111


Q ss_pred             ccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .....+.+++|+.+........+....+.+++.+|++.+|++||+|.||+++|+
T Consensus       297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~  350 (361)
T KOG1187|consen  297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE  350 (361)
T ss_pred             HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence            223368899999986322221267778999999999999999999999999884

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.6e-52  Score=436.16  Aligned_cols=367  Identities=27%  Similarity=0.534  Sum_probs=258.4

Q ss_pred             CCCCCEEecCCCcccccCCCCCccccCCcccccCCCCCCCCCC--CCCCCCCCCCCCCCCCCceeEEEehhhHHHHHHHH
Q 016009            1 MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVK--GMQPCKGFLSHKQNSGAKRFAIVFPVLGALLVSMT   78 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~~~~~~~~~~~~~gN~~lcg~~~--~~~~c~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~   78 (397)
                      +++|++||||+|+|+|.||+..+|.+++..++.||+.+||..+  ...+|...     .+....+.++++++++++++++
T Consensus       570 l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----~~~~~~~~~~~~~~~~~~~~~~  644 (968)
T PLN00113        570 VESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-----RKTPSWWFYITCTLGAFLVLAL  644 (968)
T ss_pred             CcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc-----cccceeeeehhHHHHHHHHHHH
Confidence            4678899999999999999888888888899999999999643  23455321     1112223333333333333333


Q ss_pred             HHHhhhhhccCCCCCCccCCCCCCCCcceeecc----CCcccHHHHHHHhcCCCCCccccccCcEEEEEEEe-CCCCEEE
Q 016009           79 LVAIFILRKRNSDSGDRQRSNQNPHGLFSILNF----EGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVA  153 (397)
Q Consensus        79 ~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~va  153 (397)
                      ++++++++++++....++....  .+......+    ...+.++++.   ..|...+.||+|+||.||+|.. .++..||
T Consensus       645 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~va  719 (968)
T PLN00113        645 VAFGFVFIRGRNNLELKRVENE--DGTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFV  719 (968)
T ss_pred             HHHHHHHHHhhhcccccccccc--cccccccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEE
Confidence            3333333332221111111111  110110001    1123344433   4577788999999999999976 5789999


Q ss_pred             EEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHH
Q 016009          154 IKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNV  233 (397)
Q Consensus       154 vK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i  233 (397)
                      ||++.....        ....|++.+++++||||++++|+|.+.+..++||||+++|+|.++++      .++|.++.++
T Consensus       720 vK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i  785 (968)
T PLN00113        720 VKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKI  785 (968)
T ss_pred             EEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHH
Confidence            999864211        11346889999999999999999999999999999999999999994      3899999999


Q ss_pred             HHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchh
Q 016009          234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCD  313 (397)
Q Consensus       234 ~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D  313 (397)
                      +.|+|+||+|||+.+.++++||||||+||+++.++.+++. ||........    ....++..|+|||++.+..++.++|
T Consensus       786 ~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~sD  860 (968)
T PLN00113        786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETRETKDITEKSD  860 (968)
T ss_pred             HHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCcccccCCCCCcccc
Confidence            9999999999997766799999999999999999988875 6655432211    2236789999999999999999999


Q ss_pred             hHHHHHHHHHHHhCCCCCCcccccccc------ccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC
Q 016009          314 VYSFGVLALEVIKGKHPRDFLSSISSS------FLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT  387 (397)
Q Consensus       314 v~s~G~~l~el~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt  387 (397)
                      ||||||++|||+||+.|++........      ..........++|+.+........+...++.+++.+||+.||++|||
T Consensus       861 v~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt  940 (968)
T PLN00113        861 IYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPC  940 (968)
T ss_pred             hhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcC
Confidence            999999999999999998543221100      00111223344555554333333456678899999999999999999


Q ss_pred             HHHHHHHhc
Q 016009          388 MKIVSQQLQ  396 (397)
Q Consensus       388 ~~~vl~~Le  396 (397)
                      |+||+++|+
T Consensus       941 ~~evl~~L~  949 (968)
T PLN00113        941 ANDVLKTLE  949 (968)
T ss_pred             HHHHHHHHH
Confidence            999999986

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4e-53  Score=386.22  Aligned_cols=253  Identities=31%  Similarity=0.543  Sum_probs=208.1

Q ss_pred             CCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC-eeeEEEEe
Q 016009          128 DAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR-HSFLVYEF  206 (397)
Q Consensus       128 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  206 (397)
                      ...+.+|+|+||+||+|.+.....||||++.........  .++|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~--~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES--RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH--HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            334559999999999999965555999999864433322  679999999999999999999999998887 79999999


Q ss_pred             ccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceeccCCCCcEEeCCCC-cEEEeeeccccccCCC
Q 016009          207 LKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP-IVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPD  284 (397)
Q Consensus       207 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~  284 (397)
                      |++|+|.++++.. ....+++..+++++.+||+||.|||++   + ||||||||+|||++.++ ++||+|||+++.....
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999874 235799999999999999999999998   7 99999999999999998 9999999999876543


Q ss_pred             CCCcccccccccccCccccc--CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          285 SSNWTEFAGTYGYVAPELAY--TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ....+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||............    ......+.+  +.  
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v----~~~~~Rp~~--p~--  269 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV----VVGGLRPPI--PK--  269 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH----HhcCCCCCC--Cc--
Confidence            33334478999999999999  568999999999999999999999999866542211111    011111111  11  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        ++...+..++.+||+.||+.||++.+++..|+
T Consensus       270 --~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~  301 (362)
T KOG0192|consen  270 --ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLE  301 (362)
T ss_pred             --cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence              24456888999999999999999999999886

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-53  Score=371.03  Aligned_cols=254  Identities=28%  Similarity=0.426  Sum_probs=211.7

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC-eeeEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR-HSFLV  203 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv  203 (397)
                      +.+..+.||+|..|+|||+.++ +++.+|+|++....   +....+++.+|++++++.+||+||.++|.|.... ...++
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~---~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI---DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC---CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence            3444678999999999999765 78899999985422   2345789999999999999999999999999888 59999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      ||||++|||++.+...   +.+++...-+|+.+|++||.|||+.  .+||||||||+|||++..|++||+|||.+..+..
T Consensus       157 mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             hhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            9999999999999765   3599999999999999999999973  2999999999999999999999999999987765


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .  ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.....   .+...-+-+..+++...+..+.. 
T Consensus       232 S--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---~~~~~~~Ll~~Iv~~ppP~lP~~-  305 (364)
T KOG0581|consen  232 S--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---PYLDIFELLCAIVDEPPPRLPEG-  305 (364)
T ss_pred             h--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---CCCCHHHHHHHHhcCCCCCCCcc-
Confidence            4  44567999999999999999999999999999999999999999865411   11111223455555433322221 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .++.++.+++..||++||.+|||++|++++
T Consensus       306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             -cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             466779999999999999999999999864

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-52  Score=382.19  Aligned_cols=251  Identities=25%  Similarity=0.456  Sum_probs=214.7

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ..|...+.||+|+|+.+|.++. .+|+.||+|++.+..- ......+.+.+|+++.++|+|||||+++++|++.+..|+|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l-~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL-KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh-cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence            4688899999999999999976 8999999999875322 2234567899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      .|+|.+++|..++..+   +++++.+++.++.||+.||.|||+.   +|+|||||..|+|+++++++||+|||+|..+..
T Consensus        97 LELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999999999743   4699999999999999999999999   999999999999999999999999999999998


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      +.....+.+||+.|+|||++.....+..+||||+||+||-|++|++||+...-        .+....+.......|.   
T Consensus       171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--------kety~~Ik~~~Y~~P~---  239 (592)
T KOG0575|consen  171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV--------KETYNKIKLNEYSMPS---  239 (592)
T ss_pred             cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH--------HHHHHHHHhcCccccc---
Confidence            87777889999999999999999999999999999999999999999973211        1111222222222221   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .......+||.++|++||.+|||+++|+..
T Consensus       240 -~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  240 -HLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             233457789999999999999999999863

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-51  Score=374.82  Aligned_cols=249  Identities=29%  Similarity=0.525  Sum_probs=208.0

Q ss_pred             CCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      .+...+.||+|.||.||.|.+.....||+|.++..     ....++|.+|+++|++|+|+|||+++|+|..+..++||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            34456779999999999999988889999998753     1235789999999999999999999999999889999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      ||+.|+|.++|.... +..+...+.+.++.|||+||+||+++   ++|||||.++|||++++..+||+|||+++....+.
T Consensus       282 ~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             ecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            999999999998733 35689999999999999999999999   99999999999999999999999999999544333


Q ss_pred             CCc-ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc--CCCCCCCCc
Q 016009          286 SNW-TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEML--DPRLPAPSR  361 (397)
Q Consensus       286 ~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  361 (397)
                      ... ....-+..|.|||.+..+.++.|||||||||+||||+| |+.|+..+....         +-+.+  ..+++.|..
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---------v~~~le~GyRlp~P~~  428 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---------VLELLERGYRLPRPEG  428 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---------HHHHHhccCcCCCCCC
Confidence            222 22233668999999999999999999999999999999 999987554321         11112  234555544


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                          ++..+.+++..||..+|++|||++.+...|+
T Consensus       429 ----CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~  459 (468)
T KOG0197|consen  429 ----CPDEVYELMKSCWHEDPEDRPTFETLREVLE  459 (468)
T ss_pred             ----CCHHHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence                4456999999999999999999999888775

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-51  Score=360.28  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=210.7

Q ss_pred             cCCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcc---hhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQ---IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      +.|...+.||+|+||.|-+| ..++|+.||||.++.......   ........+|+++|++|+|||||++.+++..++..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            45677889999999999999 556899999999976333221   11233457999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC---CcEEEeeecc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE---FEAHVADFGI  277 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~  277 (397)
                      |+||||++||+|.+.+-.++.   +.+..-..++.|++.|+.|||++   ||+||||||+|||+..+   -.+||+|||+
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             EEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999977654   66677788999999999999999   99999999999999766   6799999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCCC---CcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKI---TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP  354 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
                      |+... ......+.+||+.|.|||++.+..+   ..+.|+||+||+||-+++|.+||.....-.       .-.+.+...
T Consensus       326 AK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------sl~eQI~~G  397 (475)
T KOG0615|consen  326 AKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------SLKEQILKG  397 (475)
T ss_pred             hhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-------cHHHHHhcC
Confidence            99876 4556677899999999999986653   347899999999999999999987432211       112333444


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +....+..+.....+..++|.++|..||++|||+.|++++
T Consensus       398 ~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  398 RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            4444455666777889999999999999999999999874

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-52  Score=346.46  Aligned_cols=259  Identities=23%  Similarity=0.332  Sum_probs=211.2

Q ss_pred             cCCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEE-EEecCCe-ee
Q 016009          125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG-FCSHARH-SF  201 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~  201 (397)
                      .+|.+.++||+|.||+||++ ...+|..+|.|.++-  ..-+...+++...|+.+|++|+|||||++++ .+..+++ ++
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f--~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF--GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch--hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            35677889999999999999 567999999999873  3344456788999999999999999999999 4445555 89


Q ss_pred             EEEEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          202 LVYEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFP-PIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      ||||||.+|+|..++...+ ..+.++++.+|+++.|++.||..+|+.... .|.||||||.||+++.+|.+||+|||+++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            9999999999999986543 335689999999999999999999994332 38999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ++.......+..+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.....     ......+.   ....++.
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-----~~L~~KI~---qgd~~~~  248 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-----LSLCKKIE---QGDYPPL  248 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH-----HHHHHHHH---cCCCCCC
Confidence            998777767788999999999999999999999999999999999999999864321     11111111   2222211


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      +  ...++..+..||..|+..||+.||+.-.++..+
T Consensus       249 p--~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  249 P--DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             c--HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            1  145677899999999999999999865555443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-50  Score=351.03  Aligned_cols=202  Identities=30%  Similarity=0.498  Sum_probs=179.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      ..+|...+.||+|.|++||+|++. ++..||||.+....-  .....+.+..|+.+|+.++|||||+++++++.++..||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            357888888999999999999764 689999999875321  22345678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC------CcEEEeeec
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE------FEAHVADFG  276 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfg  276 (397)
                      |||||.||+|.++++..+   .+++.....++.|+|.||++||++   +||||||||+||||+..      -.+||+|||
T Consensus        87 VMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            999999999999998765   599999999999999999999999   99999999999999765      458999999


Q ss_pred             cccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL  334 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~  334 (397)
                      +|+.+... ....+.+|++-|||||++..++|+.|+|+||+|+++|++++|+.||+..
T Consensus       161 fAR~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  161 FARFLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hhhhCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99988743 3446689999999999999999999999999999999999999999843

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-50  Score=347.77  Aligned_cols=245  Identities=26%  Similarity=0.394  Sum_probs=204.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..++||+|+||+||.++. ++++.+|+|++++..-.. ..+.+....|..+|.+++||.||+++-.|++++.+||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            45799999999999999999954 578999999997633222 2346778899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      |+||+.||.|..+|+..+   .+++..+.-++.+|+.||.|||+.   +||||||||+|||||++|+++|+|||+++...
T Consensus       103 Vld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999999997654   489999999999999999999999   99999999999999999999999999999765


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      .......+.+||+.|||||++.+..|+..+|+||+|+++|||++|.+||......        ...+.+.....+.++..
T Consensus       177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~--------~~~~~I~~~k~~~~p~~  248 (357)
T KOG0598|consen  177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK--------KMYDKILKGKLPLPPGY  248 (357)
T ss_pred             cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH--------HHHHHHhcCcCCCCCcc
Confidence            5555556689999999999999999999999999999999999999998643321        11222222222222221


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRP  386 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RP  386 (397)
                         ...+..+++...+..||++|.
T Consensus       249 ---ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  249 ---LSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ---CCHHHHHHHHHHhccCHHHhc
Confidence               223477888899999999995

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2e-49  Score=378.07  Aligned_cols=255  Identities=27%  Similarity=0.471  Sum_probs=209.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      .+....+.||+|.||+||+|+..      +.+.||||.++.....   ...++|.+|++++..++|||||+++|.|..++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~---~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN---QARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH---HHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            34445677999999999999643      3567999999864332   24789999999999999999999999999999


Q ss_pred             eeeEEEEeccCCCHHHhhccccc-------cC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAA-------AQ----ELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE  267 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~-------~~----~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  267 (397)
                      ..++|+|||..|+|.++|.....       +.    +|+..+.+.||.|||.||.||-++   .+|||||.++|+|+.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence            99999999999999999975431       12    388999999999999999999999   89999999999999999


Q ss_pred             CcEEEeeeccccccCCCCCCc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccc
Q 016009          268 FEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNT  344 (397)
Q Consensus       268 ~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~  344 (397)
                      ..+||+|||+++.....+...  ....-..+|||||.+..++||++||||||||+|||+++ |+.||.....        
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--------  711 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--------  711 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------
Confidence            999999999998655443322  13345779999999999999999999999999999998 9999764433        


Q ss_pred             ccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          345 DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ++.+..+-+..+-   ..++.++.++.+|+..||+.+|++||++.||-..|+
T Consensus       712 ~EVIe~i~~g~lL---~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~  760 (774)
T KOG1026|consen  712 QEVIECIRAGQLL---SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ  760 (774)
T ss_pred             HHHHHHHHcCCcc---cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence            2223333333332   222456677999999999999999999999998885

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.6e-48  Score=327.45  Aligned_cols=261  Identities=23%  Similarity=0.388  Sum_probs=208.1

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +.|+...++|+|+||+||+++.+ +|+.||||++...  .++..-++-.++|+++|++++|+|+|.++.+|..+..++||
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            35777888999999999999765 6999999999752  23344467789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      +|||+..-|.++- ...  ..++.+.+.+++.|+++|+.|+|++   +++||||||+|||++.++.+||+|||+|+.+..
T Consensus        80 FE~~dhTvL~eLe-~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   80 FEYCDHTVLHELE-RYP--NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             eeecchHHHHHHH-hcc--CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            9999886665543 332  2478899999999999999999999   999999999999999999999999999999887


Q ss_pred             CCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc----------------ccccc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF----------------LNTDI  346 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~----------------~~~~~  346 (397)
                      .....+..+.|-.|.|||.+.+ .+|....|||++||++.||++|.+-|...+.+..-+                .....
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            6677788889999999999887 789999999999999999999998876544432111                11111


Q ss_pred             ccccccCCCCCCCCc---chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          347 ELDEMLDPRLPAPSR---SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       347 ~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      ....+.-|....+..   ..+.....+.+++..|++.||++|++-+|++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            122222222211111   11122346889999999999999999999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-49  Score=367.89  Aligned_cols=263  Identities=25%  Similarity=0.522  Sum_probs=220.8

Q ss_pred             cccHHHHHHHhcCC---------CCCccccccCcEEEEEEEeC----CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHH
Q 016009          114 KLVYDEIVRATNDF---------DAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT  180 (397)
Q Consensus       114 ~~~~~~~~~~~~~~---------~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~  180 (397)
                      .++|+|--.|..+|         .+.++||.|.||.||+|+++    ....||||.++.....+   .+.+|+.|+.||.
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytek---qrrdFL~EAsIMG  685 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEK---QRRDFLSEASIMG  685 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHH---HHhhhhhhhhhcc
Confidence            56676665555554         46678999999999999765    23579999998755443   3688999999999


Q ss_pred             hccCCceeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCC
Q 016009          181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSK  260 (397)
Q Consensus       181 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~  260 (397)
                      +.+||||++|.|+.......++|.|||+||+|+.+|+.+.+  ++++.|+..++++||.||.||.+.   ++|||||.++
T Consensus       686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAAR  760 (996)
T KOG0196|consen  686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAAR  760 (996)
T ss_pred             cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhh
Confidence            99999999999999999999999999999999999988764  599999999999999999999998   9999999999


Q ss_pred             cEEeCCCCcEEEeeeccccccCCCCC-Ccccccc--cccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccc
Q 016009          261 NLLLDLEFEAHVADFGIAKFLKPDSS-NWTEFAG--TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSS  336 (397)
Q Consensus       261 Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g--~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~  336 (397)
                      |||++.+..+|++|||++++++.+.. ..+...|  ..+|.|||.+...++|.+|||||||++|||.++ |.+||.++..
T Consensus       761 NILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN  840 (996)
T KOG0196|consen  761 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN  840 (996)
T ss_pred             heeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence            99999999999999999998876553 2333334  468999999999999999999999999999887 9999876654


Q ss_pred             cccccccccccccccc-CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          337 ISSSFLNTDIELDEML-DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       337 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..        .+..+. +-+++.|.    +++..|.+|+..||++|-.+||++.+|+..|+
T Consensus       841 Qd--------VIkaIe~gyRLPpPm----DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lD  889 (996)
T KOG0196|consen  841 QD--------VIKAIEQGYRLPPPM----DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLD  889 (996)
T ss_pred             HH--------HHHHHHhccCCCCCC----CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHH
Confidence            22        122221 23455443    55667999999999999999999999999885

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=351.04  Aligned_cols=263  Identities=23%  Similarity=0.394  Sum_probs=213.3

Q ss_pred             HHHHHHHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec
Q 016009          117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH  196 (397)
Q Consensus       117 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  196 (397)
                      .++++...+++.....||+|.||+||+|.+..  .||||++.......  ...+.|.+|+.++++-+|.||+-+.|||.+
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~--~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTP--EQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCH--HHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            45666666677788899999999999999853  49999998654433  357899999999999999999999999988


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                      +.. ++|..+|+|-+|..+++..+  ..++..+.+.|+.|||+||.|||.+   +|||+|||+.||++.++++|||+|||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence            877 99999999999999998765  4688899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCC--CCCcccccccccccCcccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 016009          277 IAKFLKPD--SSNWTEFAGTYGYVAPELAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       277 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      ++..-..-  ........|...|||||+++..   +|+..+||||||+++|||+||..||.....-..-+..+.+.    
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~----  609 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGY----  609 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccc----
Confidence            99754332  2233455788899999998854   58999999999999999999999987322211111111110    


Q ss_pred             cCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         ..+........+.+++.+|+..||..++++||.+.+|+.+|+
T Consensus       610 ---l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~  651 (678)
T KOG0193|consen  610 ---LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE  651 (678)
T ss_pred             ---cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence               112222233456678999999999999999999999999765

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=350.15  Aligned_cols=250  Identities=25%  Similarity=0.444  Sum_probs=213.3

Q ss_pred             cCCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ..|.....||+|..|.||.+ +..+++.||||++...    ....++-+.+|+.+|+..+|+|||++++.|..++++|+|
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~----~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR----KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEec----cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            45677788999999999999 5568899999998752    223467789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      ||||+||+|.+.+...    .+++.++..|+.++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+..
T Consensus       349 MEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            9999999999998654    389999999999999999999999   999999999999999999999999999999887


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      ........+||+.|||||+.....|.+|.||||||++++||+-|.+||=...++..-++..     ..-.|.+..+    
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-----~ng~P~lk~~----  492 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-----TNGTPKLKNP----  492 (550)
T ss_pred             ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-----hcCCCCcCCc----
Confidence            7777788899999999999999999999999999999999999999975444433322221     1112222222    


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+.+++.+||+.||++||++.|+|++
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            2344568999999999999999999999974

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=333.88  Aligned_cols=262  Identities=27%  Similarity=0.407  Sum_probs=211.5

Q ss_pred             hcCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+...+||.|..++||+|. .+.++.||||++......   .+.+.+.+|+..++.++||||++++..|..+..+|+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            4578889999999999999994 567899999998753222   236889999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||.||.+||+.+.+...-. ..+++..+..|++++++||.|||++   |.||||+|+.|||++++|.+||+|||.+..+.
T Consensus       102 VmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            9999999999999976543 3489999999999999999999999   99999999999999999999999999887655


Q ss_pred             CCCCCc----ccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 016009          283 PDSSNW----TEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       283 ~~~~~~----~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      ......    ...+||+.|||||++..  ..|+.|+||||||++..||.+|..||..+.++..-....+.......  ..
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~--t~  255 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL--TS  255 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc--cc
Confidence            433221    45689999999999653  35999999999999999999999999877765422221111111000  00


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+.+.......++.+++..|+++||++|||++++++.
T Consensus       256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            11122223445689999999999999999999999863

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4e-47  Score=345.17  Aligned_cols=240  Identities=30%  Similarity=0.510  Sum_probs=202.6

Q ss_pred             CCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          129 AQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       129 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      ..+-||+|+-|.||+|++. ++.||||+++.           .-..+++.|++|+||||+.+.|+|......+||||||.
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~e-----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRE-----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhh-----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            3567999999999999994 57899999753           12367899999999999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      .|-|...|....   .++......|..+||.||.|||.+   .|||||||+-||||+.+..+||+|||-++..... ...
T Consensus       196 ~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STk  268 (904)
T KOG4721|consen  196 QGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STK  268 (904)
T ss_pred             cccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhh
Confidence            999999997654   588889999999999999999999   9999999999999999999999999999876543 445


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR  368 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
                      ..++||..|||||+++..+.++|+||||||||||||+||..||.+......-+-.....+      .++.|.    .++.
T Consensus       269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL------~LpvPs----tcP~  338 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSL------HLPVPS----TCPD  338 (904)
T ss_pred             hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcc------cccCcc----cCch
Confidence            568999999999999999999999999999999999999999876554332222221111      122222    3445


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 016009          369 SIVEVVFSCLNESPESRPTMKIVSQQLQI  397 (397)
Q Consensus       369 ~l~~l~~~cl~~~P~~RPt~~~vl~~Le~  397 (397)
                      .+.-|+++||+..|..||++++++.+|+|
T Consensus       339 GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  339 GFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             HHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            57778899999999999999999999986

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-46  Score=332.74  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=199.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC--eee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR--HSF  201 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~  201 (397)
                      .+|...+.||+|+||.||++... +|...|||.+.....    ...+.+.+|+.+|++++|||||+++|......  ..+
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~----~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS----PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc----hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            35667788999999999999665 599999999875311    11677899999999999999999999854444  689


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC-CCcEEEeeeccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKF  280 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~  280 (397)
                      +.|||+++|+|.+++...+.  .+++..+..++.||++||+|||++   +++||||||+|||++. ++.+||+|||++..
T Consensus        93 i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            99999999999999987664  599999999999999999999998   9999999999999999 79999999999987


Q ss_pred             cCCC---CCCcccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCcc-ccccccccccccccccccCCC
Q 016009          281 LKPD---SSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFL-SSISSSFLNTDIELDEMLDPR  355 (397)
Q Consensus       281 ~~~~---~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~  355 (397)
                      ....   ........||+.|||||++..+. ...++||||+||++.||+||+.||... .....       .........
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~-------~~~ig~~~~  240 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA-------LLLIGREDS  240 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH-------HHHHhccCC
Confidence            6631   12234578999999999999643 345999999999999999999998752 11110       011111111


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      .+.-+   ...+....+++.+|++.||++|||+++++++-
T Consensus       241 ~P~ip---~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  241 LPEIP---DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             CCCCC---cccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            11111   12334578889999999999999999999763

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-46  Score=339.23  Aligned_cols=254  Identities=26%  Similarity=0.381  Sum_probs=209.0

Q ss_pred             HHhcCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCe
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARH  199 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  199 (397)
                      +..++|.+.+.||.|+|++|++|+ ..+++.+|||++.+..-.. ....+.+..|-++|.+| .||.|++|+..|++...
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            334688899999999999999995 5579999999986532211 12234567788999999 89999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      +|+|+||+++|+|.+++...+   .+++...+.++.+|+.||+|||+.   |||||||||+|||||+||+++|+|||.++
T Consensus       149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence            999999999999999998764   599999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCC-----------c--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccc
Q 016009          280 FLKPDSSN-----------W--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDI  346 (397)
Q Consensus       280 ~~~~~~~~-----------~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~  346 (397)
                      .+.+....           .  ...+||..|.+||++.....+..+|+|+|||++|+|+.|++||......-        
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl--------  294 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL--------  294 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH--------
Confidence            87542111           1  44789999999999999999999999999999999999999997654421        


Q ss_pred             ccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....+++-....+...    +..+.+|+.+.|..||.+|+|.++|-++
T Consensus       295 iFqkI~~l~y~fp~~f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  295 IFQKIQALDYEFPEGF----PEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHHHhcccCCCCC----CHHHHHHHHHHHccCccccccHHHHhhC
Confidence            1223332222222222    2457889999999999999999998764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=340.11  Aligned_cols=254  Identities=23%  Similarity=0.350  Sum_probs=207.9

Q ss_pred             HhcCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcc-hhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCe
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQ-IVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARH  199 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  199 (397)
                      ..+.|...+.||+|+||+|+.|. ..++..||+|.+........ ....+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            34578889999999999999995 45789999997665311111 123456678999999998 9999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC-CcEEEeeeccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIA  278 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~  278 (397)
                      .++||||+.||+|.+++...   .++.+.....++.|++.|++|+|+.   +|+||||||+|||+|.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999873   3588899999999999999999999   99999999999999999 99999999999


Q ss_pred             cccCCCCCCcccccccccccCcccccCCC-CC-cchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 016009          279 KFLKPDSSNWTEFAGTYGYVAPELAYTMK-IT-EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       279 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      ...........+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.....        ....+.....
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~--------l~~ki~~~~~  240 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN--------LYRKIRKGEF  240 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH--------HHHHHhcCCc
Confidence            98753445567789999999999999877 76 78999999999999999999998633211        0111222222


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      ..+....   ..++.+++.+|++.||.+|+|+.+|++
T Consensus       241 ~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  241 KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            2222211   456889999999999999999999984

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.3e-46  Score=344.67  Aligned_cols=257  Identities=25%  Similarity=0.414  Sum_probs=200.9

Q ss_pred             HhcCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEe
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCS  195 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  195 (397)
                      +.++|.+.+.||+|+||.||+|..      .+++.||+|++.....   ....+.+.+|+.+++++ +||||++++++|.
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT---ASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc---hHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            456788899999999999999963      2356899999864322   22346789999999999 8999999999887


Q ss_pred             cC-CeeeEEEEeccCCCHHHhhccccc-----------------------------------------------------
Q 016009          196 HA-RHSFLVYEFLKRGSLAAILSSDAA-----------------------------------------------------  221 (397)
Q Consensus       196 ~~-~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  221 (397)
                      .. ...++||||+++|+|.+++.....                                                     
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            64 457899999999999999864321                                                     


Q ss_pred             ------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCC--cccccc
Q 016009          222 ------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG  293 (397)
Q Consensus       222 ------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g  293 (397)
                            ..++++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++........  .....+
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                  13478899999999999999999998   9999999999999999999999999999865432221  122345


Q ss_pred             cccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-CCCCCcchHHHHHHHH
Q 016009          294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPR-LPAPSRSVQEKLRSIV  371 (397)
Q Consensus       294 ~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~  371 (397)
                      +..|+|||++.+..++.++||||||+++|||++ |..||.......       .....+.+.. ...+    ......+.
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~----~~~~~~l~  307 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFCQRLKDGTRMRAP----ENATPEIY  307 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------HHHHHHhcCCCCCCC----CCCCHHHH
Confidence            678999999998899999999999999999997 999986432110       0001111111 1111    12234588


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          372 EVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       372 ~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +++.+||+.||++|||+.|+++.|+
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~  332 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILG  332 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-47  Score=334.16  Aligned_cols=250  Identities=29%  Similarity=0.439  Sum_probs=213.8

Q ss_pred             cCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ..|+..+.||+|.||.||+|. ..+++.||+|++.......   ..+++.+|+.+|.+++++||.+++|.+..+..++++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d---eIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED---EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcch---hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            356777889999999999994 5678999999997644333   357788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      ||||.||++.+.+....   .+.+....-++.++..|+.|||.+   +.+|||||+.||++..+|.+||+|||++.++..
T Consensus        90 Mey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             HHHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence            99999999999997654   347778888999999999999999   999999999999999999999999999998877


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      ......+.+||+.|||||++....|+.|+||||||++.+||++|.+|+....++..-+..         .+..+  +...
T Consensus       164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI---------pk~~P--P~L~  232 (467)
T KOG0201|consen  164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI---------PKSAP--PRLD  232 (467)
T ss_pred             hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec---------cCCCC--Cccc
Confidence            666667889999999999999889999999999999999999999998877664433322         11111  1122


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+...+.+++..|+++||+.|||+.+++++
T Consensus       233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            2566779999999999999999999999875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.9e-45  Score=305.67  Aligned_cols=262  Identities=24%  Similarity=0.350  Sum_probs=207.3

Q ss_pred             cCCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .+|...+.+|+|.||.||+| ..++|+.||||+++.....+.  -.....+|++.|+.++|+||+.++++|...+...||
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG--i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG--INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC--ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence            35777889999999999999 566899999999986422221  245678999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      +|||+. +|+..++...  ..++..++..++.++.+|++|||.+   .|+||||||.|+|++++|.+||+|||+++.+.+
T Consensus        80 fEfm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   80 FEFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             EEeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            999975 9999997655  4688999999999999999999999   999999999999999999999999999999887


Q ss_pred             CCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccc----------ccccccccccccc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS----------SFLNTDIELDEML  352 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~----------~~~~~~~~~~~~~  352 (397)
                      .....+..+-|-.|.|||.+.|. .|+...|+||.||++.||+-|.+-|...+.+.+          ........+..+-
T Consensus       154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            77666666889999999988865 599999999999999999999876654333210          0000000011110


Q ss_pred             C---C-CCCCC--CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          353 D---P-RLPAP--SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       353 ~---~-~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      |   - ..+.+  ............+|+..++..||.+|+|++|++++
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            0   0 01100  11222334557899999999999999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-46  Score=333.32  Aligned_cols=264  Identities=26%  Similarity=0.403  Sum_probs=206.6

Q ss_pred             HHhcCCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC--C
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--R  198 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~  198 (397)
                      +-.+.|+.++.||+|+||.||+| +..+|+.||+|+++.....  ........+|+.+|++|+||||+++.+.....  .
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~--~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK--EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC--CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence            33456778889999999999999 5678999999999863322  23356678999999999999999999998766  6


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA  278 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  278 (397)
                      .+|||+|||+. +|.-++....  -.++..++..++.|++.||+|+|++   +|.|||||.+|||||.+|.+||+|||+|
T Consensus       192 siYlVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  192 SIYLVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             eEEEEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccce
Confidence            89999999987 8888886543  3699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC-CcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccc--------------cccc
Q 016009          279 KFLKPDSS-NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSIS--------------SSFL  342 (397)
Q Consensus       279 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~--------------~~~~  342 (397)
                      +++..... ..+..+-|..|.|||.+.|. .|+.+.|+||.||+|.||++|++.+.....+.              ..|.
T Consensus       266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence            98876554 36778889999999988865 69999999999999999999999876433321              0111


Q ss_pred             ccccccccccCCCCCCCC---cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          343 NTDIELDEMLDPRLPAPS---RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      ...-.....+.+..+-..   +.........++|+..+|..||.+|.|+.++++
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            000000111111111000   011122356788999999999999999999875

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4e-46  Score=338.58  Aligned_cols=249  Identities=28%  Similarity=0.386  Sum_probs=209.4

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|.||.||||+. .+.+.||+|.+.+...  ...+.+.+.+|++++++++||||+.++++|++..+.++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr--~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR--NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC--chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            4677778899999999999954 4788999999876433  233467799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      .||+.| +|..++...+   .++++++..++.+++.||.|||+.   +|.|||+||.|||++.++++|++|||+++.+..
T Consensus        80 te~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             ehhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            999987 9999998765   499999999999999999999999   999999999999999999999999999998887


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .....+...||+.|||||...+..|+..+|.||+||++||+.+|++||-..+-     ..   -...+.......+    
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-----~~---Lv~~I~~d~v~~p----  220 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-----TQ---LVKSILKDPVKPP----  220 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-----HH---HHHHHhcCCCCCc----
Confidence            66666778999999999999999999999999999999999999999742111     00   0111111111111    


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+..++...+.+||.+|.|-.+++.+
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            2445568889999999999999998888753

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-44  Score=326.37  Aligned_cols=245  Identities=22%  Similarity=0.335  Sum_probs=196.6

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec----CCeeeEEEE
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH----ARHSFLVYE  205 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e  205 (397)
                      ...+|+|++|.||+|.. +|+.||||++..... ......+.+.+|++++++++||||++++|++.+    ....++|||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            35699999999999988 688999999875322 221224678899999999999999999999866    346789999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |+++|+|.+++....   .+++.....++.+++.||.|||+..  +++||||||+||++++++.+||+|||++.......
T Consensus       103 y~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        103 YCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             eCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999999997643   5899999999999999999999742  77899999999999999999999999988654322


Q ss_pred             CCcccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccccc--CCCCCCCCc
Q 016009          286 SNWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML--DPRLPAPSR  361 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  361 (397)
                         ....++..|+|||.+.+  ..++.++|||||||++|||++|+.||.......        ....+.  ..+.+.+. 
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~-  245 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--------IYDLIINKNNSLKLPL-  245 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhcCCCCCCCC-
Confidence               23467889999999876  679999999999999999999999987543211        011111  11111111 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         .....+.+++.+||+.||++|||++++++.|+
T Consensus       246 ---~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~  277 (283)
T PHA02988        246 ---DCPLEIKCIVEACTSHDSIKRPNIKEILYNLS  277 (283)
T ss_pred             ---cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence               23446889999999999999999999999886

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9.6e-45  Score=328.60  Aligned_cols=254  Identities=21%  Similarity=0.255  Sum_probs=199.8

Q ss_pred             CCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |+..+.||+|+||.||++.. .+|+.||+|.+...... .......+.+|++++++++|+|++++.+++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            66678899999999999965 57999999998642211 11223567899999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |+++|+|.+++..... ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999999988754332 3589999999999999999999998   99999999999999999999999999998654322


Q ss_pred             CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHH
Q 016009          286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE  365 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (397)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||........    .......+.......    ...
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~----~~~  227 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVKEDQEEY----SEK  227 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhhcccccC----Ccc
Confidence             22345789999999999999999999999999999999999999874322100    000000111111111    112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 016009          366 KLRSIVEVVFSCLNESPESRPT-----MKIVSQQ  394 (397)
Q Consensus       366 ~~~~l~~l~~~cl~~~P~~RPt-----~~~vl~~  394 (397)
                      ....+.+|+.+||+.||++||+     +++++++
T Consensus       228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            3345889999999999999997     7888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.5e-44  Score=329.00  Aligned_cols=261  Identities=23%  Similarity=0.351  Sum_probs=198.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeCC-----------------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCce
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPS-----------------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI  187 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  187 (397)
                      ++|...+.||+|+||.||++...+                 +..||+|.+.....   .....++.+|++++++++||||
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN---KNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC---HHHHHHHHHHHHHHhhcCCCCe
Confidence            467888999999999999996532                 33699999875322   2235679999999999999999


Q ss_pred             eeeEEEEecCCeeeEEEEeccCCCHHHhhcccc----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 016009          188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDA----------------AAQELGWSQRMNVIKGVADALSYLHHDCFPP  251 (397)
Q Consensus       188 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~  251 (397)
                      +++++++...+..++||||+++|+|.+++....                ....++|.+++.++.|++.||+|||+.   +
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~  158 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N  158 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence            999999999999999999999999999885432                112478899999999999999999998   9


Q ss_pred             ceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh--C
Q 016009          252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK--G  327 (397)
Q Consensus       252 ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t--g  327 (397)
                      ++||||||+||++++++.+||+|||++.........  .....++..|+|||++.++.++.++||||||+++|||++  +
T Consensus       159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            999999999999999999999999999765433211  122345778999999988899999999999999999987  5


Q ss_pred             CCCCCccccccccccccccccccc-cCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          328 KHPRDFLSSISSSFLNTDIELDEM-LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       328 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..||............ ....... .......+    ...+..+.+++.+||+.||++|||+++|.+.|+
T Consensus       239 ~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         239 EQPYGELTDEQVIENA-GEFFRDQGRQVYLFRP----PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCcCCHHHHHHHH-HHHhhhccccccccCC----CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            5666533221100000 0000000 00000011    122345889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=329.62  Aligned_cols=260  Identities=24%  Similarity=0.370  Sum_probs=206.7

Q ss_pred             hcCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCC-ee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHAR-HS  200 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~  200 (397)
                      .++|...+.||.|+||.||+|+ ..+|..||||+++......+   .-.=++|+..|+++. ||||+++.+++.+.+ .+
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e---e~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE---ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH---HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            4578888999999999999995 55799999999986444322   223468999999998 999999999997777 99


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++|||||+. +|.+++..+  .+.+++.++..|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+|+.
T Consensus        86 ~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence            999999965 999999876  36899999999999999999999999   999999999999999999999999999997


Q ss_pred             cCCCCCCcccccccccccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc--------------cccccc
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--------------SFLNTD  345 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--------------~~~~~~  345 (397)
                      .... ...+..+.|-.|+|||++. .+-|+.+.|+|++||+++|+.+-++-|......+.              .+.. .
T Consensus       160 v~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e-g  237 (538)
T KOG0661|consen  160 VRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE-G  237 (538)
T ss_pred             cccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh-H
Confidence            7643 3346678999999999765 66799999999999999999998887765443321              1110 0


Q ss_pred             cccccccCCCCCCCCc-----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          346 IELDEMLDPRLPAPSR-----SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       346 ~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+...++-.++....     .......+..+++.+|++.||++|||+.|.+++
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            1122222222221111     112345678899999999999999999999875

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=357.43  Aligned_cols=254  Identities=27%  Similarity=0.450  Sum_probs=207.2

Q ss_pred             CCCCCccccccCcEEEEEEEeC--CCC----EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP--SGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      ..+..+.||+|.||.||.|...  +|.    .||+|.+....+   .....+|++|..+|++++|||||+++|+|.+...
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~---~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS---EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC---HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            3445677999999999999664  343    499999876332   3457899999999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhccccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          200 SFLVYEFLKRGSLAAILSSDAA----AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                      .++++|||++|+|..+|++.+.    ...++....+.++.+||+|+.||+++   ++|||||.++|+||++...+||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence            9999999999999999987632    23588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCccc-c-cccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc
Q 016009          276 GIAKFLKPDSSNWTE-F-AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEML  352 (397)
Q Consensus       276 g~~~~~~~~~~~~~~-~-~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  352 (397)
                      |+|+.+......... . .-...|||||.+..+.++.|+|||||||++||++| |..||.........       .....
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~-------~~~~~  919 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL-------LDVLE  919 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH-------HHHHh
Confidence            999954433332221 1 23468999999999999999999999999999999 99998754432211       11222


Q ss_pred             CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          353 DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       353 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+++.|..    ++..+.+++..||+.+|++||++..++++++
T Consensus       920 ggRL~~P~~----CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~  959 (1025)
T KOG1095|consen  920 GGRLDPPSY----CPEKLYQLMLQCWKHDPEDRPSFRTIVEQDP  959 (1025)
T ss_pred             CCccCCCCC----CChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence            335555443    4456889999999999999999999999764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-45  Score=306.64  Aligned_cols=239  Identities=25%  Similarity=0.351  Sum_probs=200.0

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||.|+||.|.+++.+ +|..+|+|++....- ......+...+|..+|+.+.||.++++++.+.+.+.+++|
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v-VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV-VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH-HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            46778899999999999999655 688999999875221 1222345678899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||++||-|..+++..+   +++++.++-++.+|+.||+|||+.   +|++|||||+|||+|.+|.+||+|||+|+....
T Consensus       123 meyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            99999999999997654   599999999999999999999999   999999999999999999999999999997654


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .   .-+.+||+.|+|||.+....+..++|.|+|||++|||+.|.+||.......        .-+.++...+.-|..  
T Consensus       197 r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~--------iY~KI~~~~v~fP~~--  263 (355)
T KOG0616|consen  197 R---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ--------IYEKILEGKVKFPSY--  263 (355)
T ss_pred             c---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH--------HHHHHHhCcccCCcc--
Confidence            3   345799999999999999999999999999999999999999987544321        122333333333332  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCC
Q 016009          364 QEKLRSIVEVVFSCLNESPESR  385 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~R  385 (397)
                        ....+.+|+...++.|-.+|
T Consensus       264 --fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  264 --FSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCHHHHHHHHHHHhhhhHhh
Confidence              23347888889999998888

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-45  Score=339.16  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=206.7

Q ss_pred             CCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      -|+..+.||.|+-|.|-.|+ ..+|+.+|||.+..... ........+.+|+-+|+-+.|||++++++++++..++|+|.
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~-~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE-LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccc-cccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            46667889999999999995 56899999999876422 11223456889999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++|-|.+++-..+   ++++.+..+++.||+.|+.|+|..   +|+||||||+|+|||.++.+||+|||+|..-. +
T Consensus        92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-P  164 (786)
T ss_pred             EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-C
Confidence            9999999999997655   589999999999999999999999   99999999999999999999999999998543 4


Q ss_pred             CCCcccccccccccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKIT-EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      +....+.+|++.|.|||+++|.+|. .++||||.||+||.|+||+.||++..-            ..++.+-.......+
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi------------r~LLlKV~~G~f~MP  232 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI------------RVLLLKVQRGVFEMP  232 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH------------HHHHHHHHcCcccCC
Confidence            4555677999999999999999985 689999999999999999999984321            111111111111112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+.+..+|+.+|+..||++|.|++||+++
T Consensus       233 s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  233 SNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            2344558899999999999999999999986

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.8e-45  Score=336.97  Aligned_cols=245  Identities=23%  Similarity=0.280  Sum_probs=197.2

Q ss_pred             ccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccC
Q 016009          131 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKR  209 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  209 (397)
                      +.||+|+||.||++.. .+|+.||+|++..... ........+..|++++++++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            3599999999999965 4789999999864211 1112345678899999999999999999999999999999999999


Q ss_pred             CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcc
Q 016009          210 GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT  289 (397)
Q Consensus       210 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  289 (397)
                      |+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  153 (323)
T cd05571          80 GELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence            99999986543   589999999999999999999998   999999999999999999999999999875433333334


Q ss_pred             cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHH
Q 016009          290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS  369 (397)
Q Consensus       290 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (397)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......        .....+.......+.    .....
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~~~~~~~~~p~----~~~~~  221 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEEIRFPR----TLSPE  221 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcCCCCCCC----CCCHH
Confidence            567999999999999989999999999999999999999998532211        001111111111111    22345


Q ss_pred             HHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          370 IVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       370 l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                      +.+++.+||+.||++||     ++.+++++
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            88999999999999999     79988763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-45  Score=337.52  Aligned_cols=259  Identities=27%  Similarity=0.428  Sum_probs=205.3

Q ss_pred             HHHHhcCCCCCccccccCcEEEEEEEeCC--C--CE-EEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEE
Q 016009          120 IVRATNDFDAQYCIGNGGHGSVYRAELPS--G--QV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFC  194 (397)
Q Consensus       120 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  194 (397)
                      |+-.-++-...++||+|+||.||+|++..  +  .. ||||..+... ........+|++|++++++++|||||+++|++
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            33334455556889999999999996543  3  23 8999987522 22334578999999999999999999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEee
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVAD  274 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  274 (397)
                      .....+++|||+|+||+|.++|.....  .++..++..++.+.|+||+|||++   +++||||.++|+|++.++.+||+|
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCc
Confidence            999999999999999999999987653  699999999999999999999999   999999999999999999999999


Q ss_pred             eccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccc-c
Q 016009          275 FGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEM-L  352 (397)
Q Consensus       275 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~  352 (397)
                      ||+++....-........-...|+|||.+..+.++.++|||||||++||+.+ |..||........        ...+ .
T Consensus       306 FGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v--------~~kI~~  377 (474)
T KOG0194|consen  306 FGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV--------KAKIVK  377 (474)
T ss_pred             cccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH--------HHHHHh
Confidence            9998764311111111234678999999999999999999999999999999 8889876553211        1111 1


Q ss_pred             -CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          353 -DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       353 -~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       +-+.+.+.    ..+..+..++.+||..+|++||||.++.+.|+
T Consensus       378 ~~~r~~~~~----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~  418 (474)
T KOG0194|consen  378 NGYRMPIPS----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE  418 (474)
T ss_pred             cCccCCCCC----CCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence             11222222    22345777888999999999999999999886

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-45  Score=339.07  Aligned_cols=246  Identities=26%  Similarity=0.349  Sum_probs=205.1

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  200 (397)
                      ..++|...++||+|.||+|+++..+ +++.+|||++++..- ....+.+..+.|.+|+... +||.++.++.++++++++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I-l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI-LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce-eccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            3568999999999999999999765 688999999987432 2334567788899998888 599999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      |+||||+.||++..+.+.    +.+++..+.-++..|+.||+|||++   +||+||||.+|||||.+|.+||+|||+++.
T Consensus       445 ~fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence            999999999995444332    3599999999999999999999999   999999999999999999999999999997


Q ss_pred             cCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      .-......++.+||+.|||||++.+..|+...|.|||||+||||+.|..||....            .++++|.-+....
T Consensus       518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd------------Eee~FdsI~~d~~  585 (694)
T KOG0694|consen  518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD------------EEEVFDSIVNDEV  585 (694)
T ss_pred             cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC------------HHHHHHHHhcCCC
Confidence            6544556678899999999999999999999999999999999999999987322            2223332222222


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTM  388 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~  388 (397)
                      .++...+.+...++.+.+.++|++|.-+
T Consensus       586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            3333445668889999999999999765

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.6e-44  Score=337.57  Aligned_cols=255  Identities=24%  Similarity=0.421  Sum_probs=201.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEec
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSH  196 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  196 (397)
                      .++|+..+.||+|+||.||+|..      .++..||||+++....   ....+.+.+|+++++.+ +||||++++++|..
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC---cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            45788899999999999999953      2466899999864322   22356788999999999 89999999999999


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccc-------------------------------------------------------
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAA-------------------------------------------------------  221 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  221 (397)
                      .+..++||||+++|+|.+++.....                                                       
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            9999999999999999999864321                                                       


Q ss_pred             -----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          222 -----------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       222 -----------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                                       ...+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++......
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                             12478999999999999999999998   9999999999999999999999999999865433


Q ss_pred             CCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC--CCCC
Q 016009          285 SSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPR--LPAP  359 (397)
Q Consensus       285 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  359 (397)
                      ...  .....++..|+|||.+.+..++.++||||||+++|||++ |..||........        ....+...  ...+
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~  339 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--------FYKMIKEGYRMLSP  339 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--------HHHHHHhCccCCCC
Confidence            221  112334667999999999999999999999999999998 8888764321100        00111111  0011


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .    ....++.+++.+||+.||++|||+.||+++|+
T Consensus       340 ~----~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~  372 (375)
T cd05104         340 E----CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE  372 (375)
T ss_pred             C----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            1    11245889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-44  Score=332.63  Aligned_cols=242  Identities=24%  Similarity=0.320  Sum_probs=194.0

Q ss_pred             ccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCC
Q 016009          133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGS  211 (397)
Q Consensus       133 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  211 (397)
                      ||+|+||.||++... +++.||+|.+..... ........+..|++++++++||||+++++++...+..++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            699999999999654 688999999864211 112235678899999999999999999999999999999999999999


Q ss_pred             HHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcccc
Q 016009          212 LAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF  291 (397)
Q Consensus       212 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  291 (397)
                      |.+++....   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.............
T Consensus        80 L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  153 (312)
T cd05585          80 LFHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF  153 (312)
T ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence            999986543   589999999999999999999998   99999999999999999999999999998644333333445


Q ss_pred             cccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHH
Q 016009          292 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV  371 (397)
Q Consensus       292 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  371 (397)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||......        .....+.......+.    .....+.
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--------~~~~~~~~~~~~~~~----~~~~~~~  221 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--------EMYRKILQEPLRFPD----GFDRDAK  221 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCCCCCCC----cCCHHHH
Confidence            7899999999999999999999999999999999999998643211        011111111111111    2234588


Q ss_pred             HHHHHccCCCCCCCCC---HHHHHH
Q 016009          372 EVVFSCLNESPESRPT---MKIVSQ  393 (397)
Q Consensus       372 ~l~~~cl~~~P~~RPt---~~~vl~  393 (397)
                      +++.+||+.||++||+   +.+++.
T Consensus       222 ~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         222 DLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            9999999999999985   566654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-45  Score=299.33  Aligned_cols=252  Identities=27%  Similarity=0.412  Sum_probs=210.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|.||.||.|+. +++-.||+|++.+.. -......+++.+|+++-+.|+||||+++++++.+....||
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH-HHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            45788999999999999999965 478899999987532 2222335789999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ++||.++|++...|.+... .++++.....++.|+|.|+.|+|..   +|+||||||+|+|++.++..|++|||.+..-.
T Consensus       100 ilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999999986543 5688999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                        .....+.+||..|.+||...+...+...|+|++|++.||++.|.+||.....        ++...++..-++..|.  
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~etYkrI~k~~~~~p~--  243 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SETYKRIRKVDLKFPS--  243 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHHHHHHHHccccCCc--
Confidence              4455678999999999999999999999999999999999999999974431        1111222222222221  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        .......++|.+|+..+|.+|.+..|++.+
T Consensus       244 --~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  244 --TISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             --ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence              223457899999999999999999999875

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-45  Score=329.53  Aligned_cols=248  Identities=24%  Similarity=0.320  Sum_probs=200.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence            36888899999999999999764 789999999864211 1112346688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          80 MEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999999986543   588999999999999999999998   999999999999999999999999999886543


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .   .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.......        ....+.......+.   
T Consensus       154 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~~~~~~---  219 (291)
T cd05612         154 R---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--------IYEKILAGKLEFPR---  219 (291)
T ss_pred             C---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCcCCCc---
Confidence            2   223468999999999998889999999999999999999999986432210        01111111111111   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPT-----MKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt-----~~~vl~~  394 (397)
                       .....+.+++.+||+.||.+||+     +++++++
T Consensus       220 -~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         220 -HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence             11345889999999999999995     8888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.5e-44  Score=331.96  Aligned_cols=245  Identities=24%  Similarity=0.293  Sum_probs=197.1

Q ss_pred             ccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccC
Q 016009          131 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKR  209 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  209 (397)
                      +.||+|+||.||++.. .+|+.||+|++...... .......+.+|+++++.++||||+++.+++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            3589999999999965 47899999998642211 122356788999999999999999999999999999999999999


Q ss_pred             CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcc
Q 016009          210 GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT  289 (397)
Q Consensus       210 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  289 (397)
                      |+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++...........
T Consensus        80 g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  153 (328)
T cd05593          80 GELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK  153 (328)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence            99998886543   589999999999999999999998   999999999999999999999999999875433333334


Q ss_pred             cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHH
Q 016009          290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS  369 (397)
Q Consensus       290 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (397)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.......        ....+.......+.    .....
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--------~~~~~~~~~~~~p~----~~~~~  221 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMEDIKFPR----TLSAD  221 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--------HHHHhccCCccCCC----CCCHH
Confidence            4578999999999998899999999999999999999999986432110        01111111111111    22345


Q ss_pred             HHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          370 IVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       370 l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                      +.+++.+||+.||++||     ++.+++++
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            78899999999999997     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.8e-45  Score=331.21  Aligned_cols=254  Identities=21%  Similarity=0.331  Sum_probs=214.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe-ee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH-SF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~  201 (397)
                      .++|...+.+|+|+||.++.++.+ ++..+++|.+.......  ..++...+|+.++++++|||||.+.+.+..++. .+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~--~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE--PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc--hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            357888899999999999999654 67899999987543322  235578999999999999999999999998888 99


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||+|++||++.+.+...+ ...++++++..|+.|++.|+.|||++   .|+|||||+.|||++.++.++|+|||+|+.+
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             EEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhc
Confidence            9999999999999998766 35689999999999999999999988   9999999999999999999999999999999


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      .+.........||+.|+.||.+.+.+|..|+|||||||++|||++-+++|......        .-...+......+   
T Consensus       157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~--------~Li~ki~~~~~~P---  225 (426)
T KOG0589|consen  157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS--------ELILKINRGLYSP---  225 (426)
T ss_pred             CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH--------HHHHHHhhccCCC---
Confidence            87776667789999999999999999999999999999999999999998743321        1111122212111   


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....+..++..++..|++.+|+.||++.+++.+
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            113455679999999999999999999999875

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.2e-44  Score=331.74  Aligned_cols=245  Identities=23%  Similarity=0.283  Sum_probs=196.4

Q ss_pred             ccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccC
Q 016009          131 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKR  209 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  209 (397)
                      +.||+|+||.||++.. .+|+.||+|++...... .......+..|+++++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence            3599999999999965 47899999998642211 112345678899999999999999999999999999999999999


Q ss_pred             CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcc
Q 016009          210 GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT  289 (397)
Q Consensus       210 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  289 (397)
                      |+|..++....   .+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  153 (323)
T cd05595          80 GELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence            99998886543   589999999999999999999998   999999999999999999999999999875433333334


Q ss_pred             cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHH
Q 016009          290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS  369 (397)
Q Consensus       290 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (397)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||......        .....+.......+.    .....
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~~~~~~~~~p~----~~~~~  221 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILMEEIRFPR----TLSPE  221 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCCCCCC----CCCHH
Confidence            457899999999999989999999999999999999999998633211        011111111111111    22345


Q ss_pred             HHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          370 IVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       370 l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                      +.+++.+||+.||++||     ++.+++++
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             HHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            78999999999999998     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.4e-44  Score=335.73  Aligned_cols=258  Identities=26%  Similarity=0.416  Sum_probs=201.7

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEE
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGF  193 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  193 (397)
                      ....++|...+.||+|+||.||+|..      .++..||+|++......   .....+.+|+++++.+ +|+||++++++
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~il~~l~~h~nIv~~~~~  110 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT---DEREALMSELKILSHLGQHKNIVNLLGA  110 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH---HHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence            33455788899999999999999863      23457999998753221   2356788999999999 89999999999


Q ss_pred             EecCCeeeEEEEeccCCCHHHhhcccc-----------------------------------------------------
Q 016009          194 CSHARHSFLVYEFLKRGSLAAILSSDA-----------------------------------------------------  220 (397)
Q Consensus       194 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------  220 (397)
                      |...+..++||||+++|+|.+++....                                                     
T Consensus       111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence            999999999999999999999885321                                                     


Q ss_pred             --------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC
Q 016009          221 --------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS  286 (397)
Q Consensus       221 --------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  286 (397)
                                    ...++++.+++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++........
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                          012478899999999999999999998   999999999999999999999999999976543221


Q ss_pred             C--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC--CCCCc
Q 016009          287 N--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL--PAPSR  361 (397)
Q Consensus       287 ~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  361 (397)
                      .  .....++..|+|||++.+..++.++||||||+++|||++ |+.||.......        ..........  ..+. 
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--------~~~~~~~~~~~~~~~~-  338 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--------KFYKMVKRGYQMSRPD-  338 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--------HHHHHHHcccCccCCC-
Confidence            1  112234568999999998899999999999999999997 999986432210        0111111111  1111 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         ..+..+.+++.+||+.||++|||+.+|+++|+
T Consensus       339 ---~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~  370 (374)
T cd05106         339 ---FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ  370 (374)
T ss_pred             ---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence               11345889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-43  Score=318.29  Aligned_cols=252  Identities=23%  Similarity=0.389  Sum_probs=201.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeC----CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|.++....   ......+.+|+.++++++||||+++++++..++..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS---DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            46788899999999999999653    356899999875322   12246789999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            99999999999999987543  3589999999999999999999998   999999999999999999999999998765


Q ss_pred             cCCCCCC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCC
Q 016009          281 LKPDSSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLP  357 (397)
Q Consensus       281 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~  357 (397)
                      ....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.......        ....+.+. ..+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~~  228 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--------VIKAVEDGFRLP  228 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHCCCCCC
Confidence            3222111 112234678999999999999999999999999999875 999986443211        01111111 111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+    ...+..+.+++.+||+.+|++|||+++|++.|+
T Consensus       229 ~~----~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~  263 (266)
T cd05064         229 AP----RNCPNLLHQLMLDCWQKERGERPRFSQIHSILS  263 (266)
T ss_pred             CC----CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence            11    123456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.4e-44  Score=328.84  Aligned_cols=246  Identities=24%  Similarity=0.350  Sum_probs=196.9

Q ss_pred             ccccccCcEEEEEEEe----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEe
Q 016009          131 YCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEF  206 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  206 (397)
                      +.||+|+||.||++..    .+++.||+|.+..............+..|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5699999999999964    357899999986422111122345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC
Q 016009          207 LKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS  286 (397)
Q Consensus       207 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  286 (397)
                      +++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999986543   478889999999999999999998   999999999999999999999999999875433333


Q ss_pred             CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHH
Q 016009          287 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK  366 (397)
Q Consensus       287 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (397)
                      ......|++.|+|||++.+..++.++||||||+++|||++|+.||......        .....+.......+..    .
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~~~~~~~~~~~~~----~  223 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTIDKILKGKLNLPPY----L  223 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCCCC----C
Confidence            334457899999999999888999999999999999999999998643321        1112222222222221    2


Q ss_pred             HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          367 LRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       367 ~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                      ...+.+++.+||+.||++||     ++++++++
T Consensus       224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            34588999999999999999     78887753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.7e-44  Score=331.12  Aligned_cols=248  Identities=25%  Similarity=0.309  Sum_probs=200.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+.+|++++++++||||+++++++..++..++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            46888899999999999999765 689999999864211 1112346788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999987543   588899999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      ..   ....|++.|+|||++.+..++.++|||||||++|||++|+.||.......        ....+.......+..  
T Consensus       171 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------~~~~i~~~~~~~p~~--  237 (329)
T PTZ00263        171 RT---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR--------IYEKILAGRLKFPNW--  237 (329)
T ss_pred             Cc---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH--------HHHHHhcCCcCCCCC--
Confidence            22   23578999999999999889999999999999999999999986432211        011111222221111  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPT-----MKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt-----~~~vl~~  394 (397)
                        ....+.+++.+||+.||++||+     +++++++
T Consensus       238 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        238 --FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             --CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              1234788999999999999997     6887754

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-44  Score=325.53  Aligned_cols=259  Identities=24%  Similarity=0.380  Sum_probs=207.8

Q ss_pred             CCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      ...+.++||+|.||.|.++....+..||||+++....   .....+|.+|+++|.+++||||++++|+|..++.+++|+|
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~---~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT---KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccc---hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            4456788999999999999998889999999986433   2346899999999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      ||++|+|.+++..+.... +.-....+|+.|||.||+||.+.   ++|||||.++|+|+|.++++||+|||+++.+...+
T Consensus       616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence            999999999998875422 34556678999999999999998   99999999999999999999999999999766554


Q ss_pred             CCc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCccccccccccccccccccccCCC-CCCCC
Q 016009          286 SNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK--GKHPRDFLSSISSSFLNTDIELDEMLDPR-LPAPS  360 (397)
Q Consensus       286 ~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  360 (397)
                      ...  ...+-.++|||+|.+..++++++||||+||+++||+++  ...||..+......     +...++++.. ...-.
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv-----en~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV-----ENAGEFFRDQGRQVVL  766 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH-----HhhhhhcCCCCcceec
Confidence            433  23455789999999999999999999999999999875  78888755432100     0111111111 00000


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.-++..+.+++..||..|-++|||++++...|+
T Consensus       767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq  802 (807)
T KOG1094|consen  767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ  802 (807)
T ss_pred             cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence            111234456889999999999999999999998875

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-43  Score=317.72  Aligned_cols=255  Identities=29%  Similarity=0.545  Sum_probs=208.8

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ++..+|+..+.||.|+||.||+|...++..+++|.+....    ......+..|+++++.++|+||+++++++...+..+
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence            4556788899999999999999988889999999986522    223567899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++++|.+++..... ..+++.+++.++.+++.|++|||+.   +++|+||+|+||++++++.+||+|||.+...
T Consensus        79 lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             EEEeecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhc
Confidence            99999999999999976442 4689999999999999999999998   9999999999999999999999999999866


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCC
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLPAP  359 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  359 (397)
                      ...........++..|+|||...+..++.++||||||+++|+|++ |+.||.......        ....+... ..+.+
T Consensus       155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~  226 (261)
T cd05148         155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--------VYDQITAGYRMPCP  226 (261)
T ss_pred             CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--------HHHHHHhCCcCCCC
Confidence            433322233345778999999988889999999999999999998 899986433210        11111111 11111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                          ...+..+.+++.+||+.||++|||+.++++.|+
T Consensus       227 ----~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~  259 (261)
T cd05148         227 ----AKCPQEIYKIMLECWAAEPEDRPSFKALREELD  259 (261)
T ss_pred             ----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence                123356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.8e-43  Score=325.63  Aligned_cols=259  Identities=24%  Similarity=0.358  Sum_probs=202.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||++... +|..+|+|.+.....   ....+.+.+|++++++++||||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            357888999999999999999665 688899999865321   2235679999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|.+++....   .+++..+..++.|++.||.|||+.+  +++||||||+||+++.++.++|+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             EeecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            999999999999996543   4889999999999999999999852  69999999999999999999999999987654


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc------cccccccc---------
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------SFLNTDIE---------  347 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~------~~~~~~~~---------  347 (397)
                      ..  ......|+..|+|||.+.+..++.++|||||||++|||+||+.||........      ........         
T Consensus       156 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             cc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence            32  22335689999999999998999999999999999999999999864321100      00000000         


Q ss_pred             -----------------------cccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          348 -----------------------LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       348 -----------------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                                             ...+.....+  ..........+.+|+.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPP--KLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCc--CCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                   0000000000  00001234568999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.8e-43  Score=320.71  Aligned_cols=261  Identities=20%  Similarity=0.285  Sum_probs=198.9

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||+|... +++.||+|.++.....   .....+.+|++++++++||||+++++++...+..++|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC---CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            46888999999999999999654 7899999998643221   1235678999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++ +|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++.....
T Consensus        82 ~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          82 FEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             EeCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            999975 8988886543  3578999999999999999999998   999999999999999999999999999976543


Q ss_pred             CCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccc--------------ccc--cccc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--------------SFL--NTDI  346 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--------------~~~--~~~~  346 (397)
                      .........+++.|+|||.+.+ ..++.++||||+||++|||+||+.||........              .+.  ....
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence            3333344578999999998865 5689999999999999999999999864321100              000  0000


Q ss_pred             ccccccCCCCCCCC--cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ELDEMLDPRLPAPS--RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .......+......  ........+..+++.+|++.||.+|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00111111110000  0000112457899999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.7e-43  Score=319.59  Aligned_cols=250  Identities=22%  Similarity=0.289  Sum_probs=196.1

Q ss_pred             ccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCC
Q 016009          133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGS  211 (397)
Q Consensus       133 lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  211 (397)
                      ||+|+||+||++.. .+|+.||+|.+..... ......+.+..|+++++.++|+||+++.+++..+...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            69999999999965 4789999999864221 111223567889999999999999999999999999999999999999


Q ss_pred             HHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCccc
Q 016009          212 LAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE  290 (397)
Q Consensus       212 L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  290 (397)
                      |.+++.... ....+++.++..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++............
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            998874322 224689999999999999999999998   9999999999999999999999999999766544333344


Q ss_pred             ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHH
Q 016009          291 FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSI  370 (397)
Q Consensus       291 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  370 (397)
                      ..|++.|+|||.+.+..++.++||||||+++|||++|+.||.........    ......+.......+    ...+..+
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~----~~~~~~~  228 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRILNDSVTYP----DKFSPAS  228 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHHhhcccCCCCc----ccCCHHH
Confidence            57899999999999999999999999999999999999998643211000    000111111111111    2234568


Q ss_pred             HHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          371 VEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       371 ~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                      .+++.+||+.||++||     ++++++++
T Consensus       229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         229 KSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            8999999999999999     77777753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-44  Score=331.03  Aligned_cols=256  Identities=21%  Similarity=0.297  Sum_probs=202.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||+|... +++.||+|++..... ........+..|+++++.++||||+++++++...+..++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence            36888899999999999999765 689999999864211 1112346788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....   .+++.++..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          80 MEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999999996543   588999999999999999999998   999999999999999999999999999976543


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .........+....+   .
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~---~  226 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL-KYWKETLQRPVYDDP---R  226 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH-HhccccccCCCCCcc---c
Confidence               223457899999999999989999999999999999999999998643321100000 000000001111100   0


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+.+++.+||+.+|++||++++++++
T Consensus       227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            1234568899999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-44  Score=318.78  Aligned_cols=258  Identities=24%  Similarity=0.344  Sum_probs=203.5

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcc----------hhcHHHHHHHHHHHHhccCCceeee
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQ----------IVDKKEFLTEVEALTEIRHRNIVKL  190 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~~  190 (397)
                      +..++|+..+.||+|.||.|-+|.. .+++.||||++.+.....+          ....+...+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3457899999999999999999954 4799999999865322111          1123578999999999999999999


Q ss_pred             EEEEecC--CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC
Q 016009          191 YGFCSHA--RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF  268 (397)
Q Consensus       191 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  268 (397)
                      +.+..+.  +.+|||+|||..|.+...-.   ....+++.+.++++.++..||.|||.+   +||||||||+|+|++++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence            9998665  57899999999888754322   112389999999999999999999999   999999999999999999


Q ss_pred             cEEEeeeccccccCCC-----CCCcccccccccccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCccccccc
Q 016009          269 EAHVADFGIAKFLKPD-----SSNWTEFAGTYGYVAPELAYTMK----ITEKCDVYSFGVLALEVIKGKHPRDFLSSISS  339 (397)
Q Consensus       269 ~~kl~Dfg~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~  339 (397)
                      ++||+|||.+......     .......+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||-....+  
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~--  325 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL--  325 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--
Confidence            9999999999876332     12234478999999999887743    356889999999999999999998643321  


Q ss_pred             cccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          340 SFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                            +-.+.+++..+..|..  .+....+.+||.++|.+||++|.+..+|..+.
T Consensus       326 ------~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  326 ------ELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ------HHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                  1233444444443332  24456688999999999999999999987653

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.4e-44  Score=323.53  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=201.0

Q ss_pred             HhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ..++|+....||+|+||.||+++. .+|..+|+|++++..- ......+.+..|-.+|....+|+||+++-.|++...+|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M-~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM-LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH-HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            457899999999999999999954 5799999999986322 22234566888999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      |||||++||++..+|....   .|++.....++.+++.|+.-+|+.   |+|||||||+|+|||..|++||+|||++.-+
T Consensus       218 LiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999999997654   599999999999999999999999   9999999999999999999999999998532


Q ss_pred             CC-----------------------CCC----Cc--------------------ccccccccccCcccccCCCCCcchhh
Q 016009          282 KP-----------------------DSS----NW--------------------TEFAGTYGYVAPELAYTMKITEKCDV  314 (397)
Q Consensus       282 ~~-----------------------~~~----~~--------------------~~~~g~~~y~aPE~~~~~~~~~~~Dv  314 (397)
                      ..                       +..    ..                    ...+|||.|+|||++.+..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            11                       000    00                    13469999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC---HH
Q 016009          315 YSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT---MK  389 (397)
Q Consensus       315 ~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~  389 (397)
                      ||+||++|||+.|-+||....+..        ....+++  ..+..|..  .....+..+||.+|+. ||++|.-   ++
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~--------T~rkI~nwr~~l~fP~~--~~~s~eA~DLI~rll~-d~~~RLG~~G~~  440 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQE--------TYRKIVNWRETLKFPEE--VDLSDEAKDLITRLLC-DPENRLGSKGAE  440 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHhhhccCCCc--CcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence            999999999999999997544321        0111111  11111111  1222568899999999 9999964   66


Q ss_pred             HHHH
Q 016009          390 IVSQ  393 (397)
Q Consensus       390 ~vl~  393 (397)
                      ||-+
T Consensus       441 EIK~  444 (550)
T KOG0605|consen  441 EIKK  444 (550)
T ss_pred             HHhc
Confidence            6543

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.9e-43  Score=312.03  Aligned_cols=250  Identities=26%  Similarity=0.477  Sum_probs=201.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|+..+.||+|+||.||++...++..+|+|.+....     ...+++.+|++++++++||||+++++++...+..++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            4677888999999999999998888899999876321     22467899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++|+|.+++....  ..+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||.+......
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          79 EFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence            9999999999987543  2589999999999999999999998   9999999999999999999999999998765332


Q ss_pred             CCC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCc
Q 016009          285 SSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLPAPSR  361 (397)
Q Consensus       285 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  361 (397)
                      ... .....++..|+|||...+..++.++||||||+++|||++ |+.||.......        ....+... ....+. 
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--------~~~~i~~~~~~~~~~-  224 (256)
T cd05114         154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--------VVEMISRGFRLYRPK-  224 (256)
T ss_pred             ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCCCCCCC-
Confidence            211 122234568999999988889999999999999999999 899986433211        01111111 111111 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         .....+.+++.+||+.+|++|||+.++++.|.
T Consensus       225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               12345889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.6e-43  Score=330.19  Aligned_cols=248  Identities=24%  Similarity=0.369  Sum_probs=192.7

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|+||.||+|... +++.||+|++....   .......+.+|+++++.++|+||+++++++...+..++||
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            4556788999999999999654 78999999986422   1223567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++|+|.+..       ..++..+..++.||+.||+|||+.   +++||||||+|||+++++.+||+|||++......
T Consensus       152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            999999986532       356778889999999999999998   9999999999999999999999999999876543


Q ss_pred             CCCcccccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          285 SSNWTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ........|+..|+|||.+..     ...+.++|||||||++|||++|+.||.......  +.   .....+.....   
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~---~~~~~~~~~~~---  293 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WA---SLMCAICMSQP---  293 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HH---HHHHHHhccCC---
Confidence            333344578999999998743     224568999999999999999999986321100  00   00000000000   


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..........+.+++.+||+.||++|||+.|++++
T Consensus       294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01111234568899999999999999999999875

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.6e-43  Score=322.07  Aligned_cols=262  Identities=20%  Similarity=0.302  Sum_probs=198.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|... +++.||+|++......   .....+.+|+++++.++||||+++++++..+...++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE---GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc---ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            467889999999999999999765 7899999998643221   123457789999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||++ ++|.+++....  ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++....
T Consensus        81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             EEECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            999996 57877775543  3588899999999999999999998   99999999999999999999999999987554


Q ss_pred             CCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc--------cccc------c
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL--------NTDI------E  347 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~--------~~~~------~  347 (397)
                      ..........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...........        ....      .
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            33333344578999999998765 4578899999999999999999999975432110000        0000      0


Q ss_pred             cccccCCCCCC-CCcchH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          348 LDEMLDPRLPA-PSRSVQ------EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       348 ~~~~~~~~~~~-~~~~~~------~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ........... ......      .....+.+++.+|++.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            00000000000 000000      012457799999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-44  Score=294.22  Aligned_cols=260  Identities=25%  Similarity=0.358  Sum_probs=208.0

Q ss_pred             hcCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-----  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  197 (397)
                      .++|++.+.||+|||+-||.++ ..++..+|+|++.-+.    ..+.+..++|++..++++|||+++++++...+     
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            3578899999999999999995 6688999999987533    23467889999999999999999999987433     


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQ-ELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                      .+.||+++|...|+|.+.+......+ .+++.+.+.|+.++++||.+||+.. ++++||||||.||++++.+.+++.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence            45899999999999999997654433 6899999999999999999999973 359999999999999999999999999


Q ss_pred             cccccCCCCCC---------cccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccc
Q 016009          277 IAKFLKPDSSN---------WTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT  344 (397)
Q Consensus       277 ~~~~~~~~~~~---------~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~  344 (397)
                      .++...-....         +....-|..|.|||.+.   +...++++|||||||+||+|+.|..||+....      .+
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------~G  248 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------QG  248 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------cC
Confidence            98865322111         12345688999999876   44578999999999999999999999974332      11


Q ss_pred             ccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          345 DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..-.-.+.++.+..|....  ++..+.+++.+|++.||.+||++.+++..++
T Consensus       249 gSlaLAv~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~~d  298 (302)
T KOG2345|consen  249 GSLALAVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSKLD  298 (302)
T ss_pred             CeEEEeeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            1112233344444333322  5667999999999999999999999998875

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.5e-44  Score=319.58  Aligned_cols=248  Identities=34%  Similarity=0.553  Sum_probs=191.1

Q ss_pred             CccccccCcEEEEEEEeC-----CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          130 QYCIGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      .+.||.|.||.||+|.+.     .+..|+||.++..   ......+.+.+|++.+++++||||++++|++...+..++|+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeecccccccccccccccccccccccccccccc
Confidence            467999999999999765     3568999999642   22223688999999999999999999999999888899999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++|+|.+++.... ...+++.+++.|+.|+++||+|||+.   +++|+||+++||++++++.+||+|||++......
T Consensus        81 e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             E--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            9999999999998762 24689999999999999999999998   9999999999999999999999999999876322


Q ss_pred             CCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          285 SSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       285 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ...  .........|+|||.+....++.++||||||+++|||++ |+.|+.......        ....+.+....... 
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--------~~~~~~~~~~~~~~-  227 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--------IIEKLKQGQRLPIP-  227 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--------HHHHHHTTEETTSB-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccceec-
Confidence            111  123456778999999998889999999999999999999 788876442211        01111111111111 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                        ......+.+++..||+.||++|||++++++.|
T Consensus       228 --~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  228 --DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              12234588999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.6e-43  Score=313.66  Aligned_cols=260  Identities=20%  Similarity=0.291  Sum_probs=206.1

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+..... ........+.+|+++++.++|||++++++++...+..+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            4788899999999999999965 4789999998764221 2223356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          204 YEFLKRGSLAAILSSDAA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      +||+++++|.+++..... ...+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            999999999988854321 23578999999999999999999998   99999999999999999999999999988765


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..........++..|+|||.+.+..++.++|+||||+++|||++|+.|+.........      ....+.....+  ...
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~------~~~~~~~~~~~--~~~  229 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS------LCQKIEQCDYP--PLP  229 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH------HHHHHhcCCCC--CCC
Confidence            4333333456888999999998888999999999999999999999997532210000      00111111111  111


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .......+.+++.+||+.+|++||++.+|++.|+
T Consensus       230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~  263 (267)
T cd08228         230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK  263 (267)
T ss_pred             hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence            1234456899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.1e-43  Score=317.72  Aligned_cols=255  Identities=25%  Similarity=0.447  Sum_probs=202.9

Q ss_pred             cCCCCCccccccCcEEEEEEEeCC------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPS------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      ++|+..+.||+|+||.||+|....      ...|++|.+.....   ......+.+|++++++++||||+++++++....
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE---PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC---HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            467888999999999999996532      25799999864221   223567899999999999999999999999989


Q ss_pred             eeeEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD  265 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  265 (397)
                      ..+++|||+++++|.+++.....             ...+++.+++.++.|++.||+|||+.   +++|+||||+||+++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence            99999999999999999865421             13588999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccc
Q 016009          266 LEFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL  342 (397)
Q Consensus       266 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~  342 (397)
                      +++.++|+|||++........  ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......    
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~----  234 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE----  234 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence            999999999999876533221  1223456788999999988889999999999999999998 999976432210    


Q ss_pred             ccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                          ....+.......   .....+.++.+|+.+||+.||++||+++||+++|+
T Consensus       235 ----~~~~i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05048         235 ----VIEMIRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR  281 (283)
T ss_pred             ----HHHHHHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence                011111111111   11234567999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.1e-43  Score=320.33  Aligned_cols=262  Identities=24%  Similarity=0.345  Sum_probs=201.3

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||++... +++.||+|++......  ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence            46888899999999999999765 6889999998753221  22356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||++++++..+....   ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          79 FEYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             EecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            9999998777654322   3589999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc----------------cccc
Q 016009          284 DSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL----------------NTDI  346 (397)
Q Consensus       284 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~----------------~~~~  346 (397)
                      ... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...........                ....
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence            322 22345689999999999988899999999999999999999999864332110000                0000


Q ss_pred             ccccccCCCCCCCCc----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ELDEMLDPRLPAPSR----SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .......+....+..    ........+.+++.+||+.||++|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000000000000    001134568999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-43  Score=328.15  Aligned_cols=248  Identities=23%  Similarity=0.300  Sum_probs=199.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeCC--CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPS--GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      ++|...+.||+|+||.||+|...+  +..||+|++..... ......+.+.+|+++++.++||||+++++++...+..++
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            468888999999999999996543  36899998753211 111234568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|.+++....   .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus       109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999997543   589999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......        ....+.......+.. 
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--------~~~~i~~~~~~~p~~-  250 (340)
T PTZ00426        183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--------IYQKILEGIIYFPKF-  250 (340)
T ss_pred             CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--------HHHHHhcCCCCCCCC-
Confidence            32   234578999999999998889999999999999999999999986433211        011111211111111 


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                         ....+.+++.+|++.||++|+     ++++++++
T Consensus       251 ---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        251 ---LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ---CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence               123477899999999999995     89998764

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=337.81  Aligned_cols=250  Identities=22%  Similarity=0.338  Sum_probs=205.2

Q ss_pred             CCCCCccccccCcEEEEEEEeCCC-CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEE-EEe-----c-
Q 016009          126 DFDAQYCIGNGGHGSVYRAELPSG-QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYG-FCS-----H-  196 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~-~~~-----~-  196 (397)
                      +.++.+.|.+|||+.||.|....+ ..+|+|++...    +....+.+.+|+++|++|+ |+|||.+++ ...     . 
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            456778899999999999976655 99999998753    3445788999999999996 999999999 331     1 


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                      ..+.+|.||||.||+|-+++..+... .|++.++++|+.++++|+++||.. .++|||||||-+||||+.++..||||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence            24678999999999999999866543 499999999999999999999995 5689999999999999999999999999


Q ss_pred             cccccCCCCCCc---------ccccccccccCcccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccc
Q 016009          277 IAKFLKPDSSNW---------TEFAGTYGYVAPELA---YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT  344 (397)
Q Consensus       277 ~~~~~~~~~~~~---------~~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~  344 (397)
                      .+..........         -...-|+.|+|||++   .+...++|+|||+|||+||-|+...+||+...         
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------  262 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------  262 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc---------
Confidence            987543322111         123468999999975   47789999999999999999999999998432         


Q ss_pred             ccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          345 DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                         ...|++.....|..  +.+...|.+||..||+.||++||++-+|+..+
T Consensus       263 ---~laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  263 ---KLAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             ---ceeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence               23444545443332  46677899999999999999999999999876

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.1e-43  Score=329.31  Aligned_cols=258  Identities=23%  Similarity=0.392  Sum_probs=202.2

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEE
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFC  194 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~  194 (397)
                      ...++|.+.+.||+|+||.||+|...      .+..||||++.....   ....+.+.+|+++++++. ||||++++++|
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR---SSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            34567888899999999999999642      234799999865322   223567999999999996 99999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccccc-----------------------------------------------------
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAA-----------------------------------------------------  221 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  221 (397)
                      ......++||||+++|+|.+++.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            999999999999999999998864210                                                     


Q ss_pred             ----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCc
Q 016009          222 ----------------------------------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN  261 (397)
Q Consensus       222 ----------------------------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  261 (397)
                                                              ...+++.++..++.|++.||+|||+.   +++|+||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence                                                    12478889999999999999999998   99999999999


Q ss_pred             EEeCCCCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccc
Q 016009          262 LLLDLEFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS  338 (397)
Q Consensus       262 ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  338 (397)
                      |++++++.+||+|||++........  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            9999999999999999986543222  1122346778999999998889999999999999999997 999976432110


Q ss_pred             ccccccccccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          339 SSFLNTDIELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       339 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .       ....+... ....+    ......+.+++.+||+.||++|||+.+|.++|+
T Consensus       348 ~-------~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~  395 (400)
T cd05105         348 T-------FYNKIKSGYRMAKP----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE  395 (400)
T ss_pred             H-------HHHHHhcCCCCCCC----ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence            0       00000000 11111    123456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.6e-43  Score=316.44  Aligned_cols=257  Identities=22%  Similarity=0.380  Sum_probs=202.0

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH  196 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  196 (397)
                      .+++|+..+.||+|+||.||+|...      ++..||+|++....   ......++.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4678999999999999999998643      35679999875422   12235678999999999999999999999999


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAA-------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE  269 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  269 (397)
                      ....++||||+++++|.+++.....       ...+++.++..++.|++.||.|||+.   +++|+||||+||++++++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence            9999999999999999999865321       12468899999999999999999998   9999999999999999999


Q ss_pred             EEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 016009          270 AHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI  346 (397)
Q Consensus       270 ~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~  346 (397)
                      ++|+|||++.........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||......        .
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------~  229 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------Q  229 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------H
Confidence            999999998755432211  112345678999999998889999999999999999999 78887543221        0


Q ss_pred             ccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          347 ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ....+.........   ......+.+++.+||+.||++|||+.|++++|+
T Consensus       230 ~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         230 VLRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            11111111111111   122346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-44  Score=312.61  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=206.8

Q ss_pred             cCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .+|++.+.||+|.||.|-++. ...|+.||||.+++.. -....+.-.+.+|++||+.|+||||+.++.+|++.+...+|
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk-IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK-IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhh-cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            357777889999999999994 5789999999998633 33344556788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||..+|.|.+++.+.+   .+++.+.+.++.||..|+.|+|.+   +++|||||.+|||+|.|+++||+|||++..+. 
T Consensus       132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~-  204 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA-  204 (668)
T ss_pred             EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc-
Confidence            99999999999998765   599999999999999999999999   99999999999999999999999999998765 


Q ss_pred             CCCCcccccccccccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKIT-EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ......+++|++-|.+||+..+.+|. +..|.||||++||-|+.|..||+.-...   .+     +..+-......|.  
T Consensus       205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~l-----vrQIs~GaYrEP~--  274 (668)
T KOG0611|consen  205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RL-----VRQISRGAYREPE--  274 (668)
T ss_pred             cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HH-----HHHhhcccccCCC--
Confidence            33455778999999999999998874 6899999999999999999999843221   11     1112122222111  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         .+....-||.+||..+|++|.|+++|..+
T Consensus       275 ---~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  275 ---TPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ---CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence               11225568889999999999999999865

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4e-43  Score=323.73  Aligned_cols=248  Identities=26%  Similarity=0.343  Sum_probs=194.4

Q ss_pred             CCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHH---HhccCCceeeeEEEEecCCeeeE
Q 016009          127 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEAL---TEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      |++.+.||+|+||.||+|.. .+++.||||+++..... .....+.+..|.+++   +.++||||+++++++...+..++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence            55678899999999999965 47899999998642111 111235566676655   56689999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|..++..    ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        80 v~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          80 VMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            9999999999988854    3589999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..........|++.|+|||.+.+..++.++|||||||++|||++|+.||......        .....+.......+.  
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~~~~p~--  222 (324)
T cd05589         153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSIVNDEVRYPR--  222 (324)
T ss_pred             CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCC--
Confidence            3333334567899999999999989999999999999999999999998643221        011111111111111  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                        .....+.+++.+||+.||++||     ++.+++++
T Consensus       223 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         223 --FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             --CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence              1234578899999999999999     57777653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.6e-43  Score=326.62  Aligned_cols=245  Identities=23%  Similarity=0.286  Sum_probs=195.8

Q ss_pred             ccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccC
Q 016009          131 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKR  209 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  209 (397)
                      +.||+|+||.||++.. .+|+.||+|.+...... .......+..|+++++.++||||+++.+++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3599999999999964 57899999998642211 112345678899999999999999999999999999999999999


Q ss_pred             CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          210 GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       210 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      |+|.+++....   .+++.++..++.|++.||+|||+ .   +++||||||+|||++.++.+||+|||++..........
T Consensus        80 ~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  153 (325)
T cd05594          80 GELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM  153 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence            99999886543   58999999999999999999997 6   99999999999999999999999999987543333333


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR  368 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
                      ....||+.|+|||++.+..++.++|||||||++|||+||+.||......        .....+.......+.    ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~~~~~i~~~~~~~p~----~~~~  221 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEEIRFPR----TLSP  221 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------HHHHHHhcCCCCCCC----CCCH
Confidence            4457999999999999989999999999999999999999998532211        011111111111111    1234


Q ss_pred             HHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          369 SIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       369 ~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                      .+.+++.+||+.||++|+     ++.+++++
T Consensus       222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            588899999999999996     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.3e-43  Score=323.93  Aligned_cols=252  Identities=25%  Similarity=0.330  Sum_probs=195.5

Q ss_pred             ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||.||++... +++.||+|.+...... .....+.+..|+.++.++ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence            35999999999999754 6889999998753221 122345678899988877 89999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|..++...   ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..........
T Consensus        80 ~~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~  153 (329)
T cd05618          80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  153 (329)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence            99999888654   3589999999999999999999998   99999999999999999999999999987543333333


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccc-ccccccCCCCCCCCcchHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDI-ELDEMLDPRLPAPSRSVQEKL  367 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  367 (397)
                      ....||..|+|||++.+..++.++||||||+++|||++|+.||............... ....+.......+.    ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~~  229 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLS  229 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC----CCC
Confidence            4467899999999999999999999999999999999999998643221110000000 01111222222221    223


Q ss_pred             HHHHHHHHHccCCCCCCCCC------HHHHHH
Q 016009          368 RSIVEVVFSCLNESPESRPT------MKIVSQ  393 (397)
Q Consensus       368 ~~l~~l~~~cl~~~P~~RPt------~~~vl~  393 (397)
                      ..+.+++.+||+.||++||+      +.++++
T Consensus       230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            45789999999999999998      467654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.4e-43  Score=323.97  Aligned_cols=253  Identities=25%  Similarity=0.338  Sum_probs=196.8

Q ss_pred             ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||.||++... +++.||+|+++.... ......+.+..|..++..+ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            35999999999999654 688999999874221 1122345688899999998 79999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|.+++...   ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..........
T Consensus        80 ~g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~  153 (329)
T cd05588          80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT  153 (329)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence            99999888654   3589999999999999999999998   99999999999999999999999999987533223333


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccc-ccccccccCCCCCCCCcchHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT-DIELDEMLDPRLPAPSRSVQEKL  367 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  367 (397)
                      ....||+.|+|||++.+..++.++|||||||++|||+||+.||+............ ......+.......+.    ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~~  229 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLS  229 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC----CCC
Confidence            44678999999999999899999999999999999999999997432211000000 0011112222222222    123


Q ss_pred             HHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 016009          368 RSIVEVVFSCLNESPESRPT------MKIVSQQ  394 (397)
Q Consensus       368 ~~l~~l~~~cl~~~P~~RPt------~~~vl~~  394 (397)
                      ..+.+++.+||+.||++|||      +++++++
T Consensus       230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            45788999999999999997      6777653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-42  Score=311.51  Aligned_cols=252  Identities=27%  Similarity=0.479  Sum_probs=202.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeCC----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ++|+..+.||+|+||.||+|....    ...|++|.+.....   ......+..|+.++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS---DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC---hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            568889999999999999997642    45799998864322   22356789999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      +++|||+++++|.+++....  ..+++.+++.++.|++.|++|||+.   +++|+||||+||++++++.++|+|||++..
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          81 MIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            99999999999999997644  3689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCCc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CC
Q 016009          281 LKPDSSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RL  356 (397)
Q Consensus       281 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~  356 (397)
                      ........  ....++..|+|||...+..++.++||||||+++|||++ |..||.......        ....+.+. ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~  227 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--------VIKAVEDGYRL  227 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--------HHHHHHcCCCC
Confidence            65222211  12234578999999998899999999999999999998 999985432110        01111111 11


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+    ...+..+.+++.+||+.+|++||++++|+++|+
T Consensus       228 ~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~  263 (266)
T cd05033         228 PPP----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD  263 (266)
T ss_pred             CCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            111    123456889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-42  Score=309.81  Aligned_cols=252  Identities=26%  Similarity=0.383  Sum_probs=205.5

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|++|.||++... +++.|++|.+.....  .......+.+|++++++++|||++++++++...+..++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence            4677788999999999999654 689999999864221  2334678899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++.... ...+++.+++.++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        79 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          79 EYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             EeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999999997643 24689999999999999999999998   9999999999999999999999999998876544


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      ........+++.|+|||+..+..++.++|+||||++++||++|+.||.......        ....+.....+...   .
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~---~  223 (256)
T cd08529         155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--------LILKIIRGVFPPVS---Q  223 (256)
T ss_pred             cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCCCc---c
Confidence            433344568889999999999889999999999999999999999986433210        01111111111111   1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.+++.+||+.+|++||++.++++.
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            334568999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-43  Score=312.37  Aligned_cols=252  Identities=27%  Similarity=0.514  Sum_probs=204.1

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .++|+..+.||+|++|.||+|...+++.||+|.++...     ...+++.+|++++++++|||++++++++...+..+++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            45688889999999999999988778899999986422     1256789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++.... ...+++.++..++.+++.|+.|||+.   +++|+||||+||++++++.++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          80 TELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            99999999999997644 24689999999999999999999998   999999999999999999999999999987653


Q ss_pred             CCCC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCCC
Q 016009          284 DSSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-PRLPAPS  360 (397)
Q Consensus       284 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  360 (397)
                      .... ......+..|+|||...+..++.++||||||+++|||+| |+.||.......        ....+.. ...+.+ 
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~-  226 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--------VLQQVDQGYRMPCP-  226 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCCCC-
Confidence            2211 111223457999999998899999999999999999999 999986432210        0000000 011111 


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         ......+.+++.+|++.+|++||+++++++.||
T Consensus       227 ---~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~  259 (261)
T cd05068         227 ---PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE  259 (261)
T ss_pred             ---CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence               123356889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.8e-43  Score=323.11  Aligned_cols=244  Identities=25%  Similarity=0.358  Sum_probs=194.4

Q ss_pred             ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||.||+|... +++.||+|++..... ......+.+..|..++..+ +||||+++++++...+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence            35999999999999764 688999999864211 1112345677888888877 69999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..........
T Consensus        80 ~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~  153 (320)
T cd05590          80 GGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT  153 (320)
T ss_pred             CchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence            999999886543   589999999999999999999998   99999999999999999999999999987643333333


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR  368 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......        ....+.......+.    ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~~~~----~~~~  221 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAILNDEVVYPT----WLSQ  221 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--------HHHHHhcCCCCCCC----CCCH
Confidence            45678999999999998889999999999999999999999986433211        11111111111111    1234


Q ss_pred             HHHHHHHHccCCCCCCCCCH------HHHHH
Q 016009          369 SIVEVVFSCLNESPESRPTM------KIVSQ  393 (397)
Q Consensus       369 ~l~~l~~~cl~~~P~~RPt~------~~vl~  393 (397)
                      .+.+++.+|++.||++||++      +++++
T Consensus       222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~  252 (320)
T cd05590         222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILR  252 (320)
T ss_pred             HHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence            57899999999999999998      66654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-43  Score=317.88  Aligned_cols=255  Identities=22%  Similarity=0.272  Sum_probs=200.5

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|+||.||++.. .+++.||+|++...... .......+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence            367788999999999999965 47899999998642211 1122456788999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++|+|.+++..... ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          80 TLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             eccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999999988864332 4589999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      . ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||........     .......+....   .....
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~---~~~~~  226 (285)
T cd05605         156 E-TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-----REEVERRVKEDQ---EEYSE  226 (285)
T ss_pred             C-ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-----HHHHHHHhhhcc---cccCc
Confidence            2 22334689999999999988899999999999999999999999864321100     000111111111   11112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                      .....+.+++.+||+.||++||     ++++++++
T Consensus       227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            3345688999999999999999     88898764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.5e-43  Score=311.57  Aligned_cols=252  Identities=23%  Similarity=0.442  Sum_probs=203.9

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .++|+..+.||+|+||.||+|...++..||+|.+....     ...+.+.+|+.++++++|+||+++++++...+..+++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence            35788889999999999999988888899999876421     1357889999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++..... ..+++.+++.++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             EecCCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            999999999999865432 4588999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 016009          284 DSSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLPAPS  360 (397)
Q Consensus       284 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  360 (397)
                      .... .....++..|+|||+..+..++.++||||||+++|+|+| |+.||.......        ....+... ..+.. 
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~-  226 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--------VMSALQRGYRMPRM-  226 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--------HHHHHHcCCCCCCC-
Confidence            2211 122345678999999988889999999999999999998 999985332110        00100000 11111 


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         ...+..+.+++.+|++.+|++|||++++.+.|+
T Consensus       227 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  259 (261)
T cd05072         227 ---ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD  259 (261)
T ss_pred             ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence               122345889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.2e-43  Score=323.19  Aligned_cols=245  Identities=25%  Similarity=0.336  Sum_probs=195.7

Q ss_pred             ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||.||+|... +++.||+|++..... ......+.+..|.+++..+ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence            35999999999999764 678999999864211 1122345677899998876 79999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|.+.+....   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..........
T Consensus        80 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  153 (321)
T cd05591          80 GGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT  153 (321)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence            999999886543   588999999999999999999998   99999999999999999999999999987644333334


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR  368 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
                      ....|++.|+|||++.+..++.++||||||+++|||++|+.||......        .....+.......+..    ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~i~~~~~~~p~~----~~~  221 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESILHDDVLYPVW----LSK  221 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCCCC----CCH
Confidence            4557899999999999889999999999999999999999998743321        1111111111111111    224


Q ss_pred             HHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 016009          369 SIVEVVFSCLNESPESRP-------TMKIVSQQ  394 (397)
Q Consensus       369 ~l~~l~~~cl~~~P~~RP-------t~~~vl~~  394 (397)
                      .+.+++..||+.||++||       ++++++++
T Consensus       222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            578899999999999999       78888754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.3e-44  Score=298.11  Aligned_cols=256  Identities=23%  Similarity=0.387  Sum_probs=210.5

Q ss_pred             hcCCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchh----cHHHHHHHHHHHHhc-cCCceeeeEEEEecC
Q 016009          124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV----DKKEFLTEVEALTEI-RHRNIVKLYGFCSHA  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  197 (397)
                      -+.|...+.||.|..++|-++ ..++|.++|+|++..........    -.+.-.+|+.+|+++ .||+|+.+.++++++
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            346777888999999999888 45578999999986533322221    234557899999999 699999999999999


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...++|+|.|+.|.|.|+|...-   .++++..++|+.|+.+|++|||.+   +||||||||+|||+|++.+++|+|||+
T Consensus        96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence            99999999999999999996543   599999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYT------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      ++.+.++ ......+||++|+|||.+..      ..|+...|.|++|++||-|+.|.+||.--..+        ..+.-+
T Consensus       170 a~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm--------lMLR~I  240 (411)
T KOG0599|consen  170 ACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM--------LMLRMI  240 (411)
T ss_pred             eeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH--------HHHHHH
Confidence            9988755 44567899999999998864      35788999999999999999999997521111        112233


Q ss_pred             cCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...........+.+......+||.+|++.||.+|.|++|++++
T Consensus       241 meGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  241 MEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            3334444445566777789999999999999999999999864

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-42  Score=314.15  Aligned_cols=255  Identities=27%  Similarity=0.471  Sum_probs=203.3

Q ss_pred             cCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      ++|...+.||+|+||.||+|...      +++.||+|.+.....   ....+.+.+|+++++.++|+|++++++++....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS---NDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC---HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            46777889999999999999653      347899999865322   123578999999999999999999999999999


Q ss_pred             eeeEEEEeccCCCHHHhhccccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAA-----------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE  267 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  267 (397)
                      ..++||||+++++|.+++.....           ...+++.++..++.|++.|++|||+.   +++|+||||+||+++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence            99999999999999999975421           23578999999999999999999998   99999999999999999


Q ss_pred             CcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccc
Q 016009          268 FEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNT  344 (397)
Q Consensus       268 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~  344 (397)
                      +.++|+|||++........  ......+++.|+|||++.+..++.++||||||+++|||++ |..||.......      
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------  232 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------  232 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence            9999999999875432221  1123345778999999999999999999999999999998 999975432211      


Q ss_pred             ccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          345 DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        ....+.........   ......+.+++.+||+.||++|||++||++.|+
T Consensus       233 --~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         233 --VIECITQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             --HHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence              11111111111111   123355889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-42  Score=309.56  Aligned_cols=250  Identities=26%  Similarity=0.474  Sum_probs=201.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|+..+.||+|+||.||+|...++..+|+|.+....     ...+++.+|+.++++++||||+++++++......+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-----ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            3577788899999999999988777789999876421     12467899999999999999999999999888999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||.+......
T Consensus        79 e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          79 EYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            9999999999986543  2589999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-CCCCCc
Q 016009          285 SSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPR-LPAPSR  361 (397)
Q Consensus       285 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  361 (397)
                      ... .....++..|+|||...+..++.++||||||+++|||++ |+.||.......        ....+.... ...+. 
T Consensus       154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~-  224 (256)
T cd05113         154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--------TVEKVSQGLRLYRPH-  224 (256)
T ss_pred             ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHhcCCCCCCCC-
Confidence            211 112235678999999988889999999999999999999 999986433210        001111111 11111 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         .....+.+++.+||+.+|++|||+.++++.||
T Consensus       225 ---~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 ---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               12356889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.8e-43  Score=322.23  Aligned_cols=249  Identities=23%  Similarity=0.311  Sum_probs=196.8

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCC-ceeeeEEEEecCCeeeEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR-NIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv  203 (397)
                      +|+..+.||+|+||.||+|... +++.||+|++..... ......+.+..|.+++..++|+ +|+.+++++...+..++|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence            4777889999999999999654 678999999864221 1122356788899999999764 688899999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        80 ~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          80 MEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            99999999999986543   488999999999999999999998   999999999999999999999999999875433


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........||+.|+|||++.+..++.++||||+||++|||+||+.||......        .....+.......+.   
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~~~~~~---  222 (324)
T cd05587         154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHNVSYPK---  222 (324)
T ss_pred             CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCCC---
Confidence            333334457899999999999989999999999999999999999998643221        011111111111111   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTM-----KIVSQ  393 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~-----~~vl~  393 (397)
                       .....+.+++.+||+.||++||+.     +++++
T Consensus       223 -~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         223 -SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             -CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence             123457889999999999999976     56654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-42  Score=311.72  Aligned_cols=260  Identities=22%  Similarity=0.328  Sum_probs=206.0

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|++|.||++.. .+++.++||.+..... .......++.+|+++++.++||||+++++++..++..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            4677888999999999999964 5889999998764221 2223356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          204 YEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      |||+++++|.+++.... ....+++.+++.++.+++.||+|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            99999999999886422 224589999999999999999999998   99999999999999999999999999987665


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..........++..|+|||...+..++.++|+||||+++|+|++|..||..........   .........+..+     
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~-----  229 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKKIEQCDYPPLP-----  229 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH---hhhhhcCCCCCCC-----
Confidence            44333334568889999999988889999999999999999999999975322100000   0011111111111     


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .......+.+++.+||+.||++|||+.+|++.++
T Consensus       230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~  263 (267)
T cd08229         230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK  263 (267)
T ss_pred             cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence            1234456889999999999999999999988775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.2e-42  Score=319.75  Aligned_cols=200  Identities=26%  Similarity=0.403  Sum_probs=173.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||++... ++..+|+|.+.....   ......+.+|++++++++||||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            367889999999999999999765 688899998765321   2235678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|.+++....   .+++..+..++.+++.||.|||+..  +++|+||||+||+++.++.+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            999999999999996543   4889999999999999999999742  79999999999999999999999999987553


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDF  333 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~  333 (397)
                      ...  .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         156 DSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             hhc--cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            221  1234688999999999988899999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2e-43  Score=326.97  Aligned_cols=255  Identities=22%  Similarity=0.294  Sum_probs=197.7

Q ss_pred             CCCCCccccccCcEEEEEEEe----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCee
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  200 (397)
                      +|+..+.||+|+||.||++..    .+++.||+|++............+.+..|+++++++ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477788999999999999864    368899999986422112222345678899999999 599999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++|+|.+++....   .+++.++..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999986543   489999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCC-CcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 016009          281 LKPDSS-NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       281 ~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      ...... ......||..|+|||.+.+. .++.++|||||||++|||+||+.||.........    ......+.......
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~~~~~~  230 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILKCDPPF  230 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhcCCCCC
Confidence            543322 22345789999999998765 4788999999999999999999998633211000    00001111111111


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                      +.    .....+.+++.+||+.||++||     ++++++++
T Consensus       231 ~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         231 PS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            11    1234578899999999999999     77788754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.5e-43  Score=326.41  Aligned_cols=240  Identities=24%  Similarity=0.308  Sum_probs=188.8

Q ss_pred             ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHH-HHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVE-ALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||+||+|... +|+.||+|++....... ......+..|.. +++.++||||+++++++...+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            35999999999999664 78999999986421111 112344555554 5678899999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|.+++....   .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..........
T Consensus        80 ~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (323)
T cd05575          80 GGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT  153 (323)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence            999999986543   588999999999999999999998   99999999999999999999999999987543333333


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR  368 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......        .....+.......+.    ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~~~~~----~~~~  221 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--------EMYDNILNKPLRLKP----NISV  221 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcCCCCCCC----CCCH
Confidence            4457899999999999989999999999999999999999998643211        011111111111111    1234


Q ss_pred             HHHHHHHHccCCCCCCCCCHH
Q 016009          369 SIVEVVFSCLNESPESRPTMK  389 (397)
Q Consensus       369 ~l~~l~~~cl~~~P~~RPt~~  389 (397)
                      .+.+++.+|++.||++||++.
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         222 SARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHHhhcCHHhCCCCC
Confidence            588999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.2e-43  Score=321.91  Aligned_cols=244  Identities=23%  Similarity=0.318  Sum_probs=195.0

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +|...+.||+|+||.||+|... +++.||+|.+...... .....+.+..|..++..+ +|++|+.+++++...+..++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence            4777889999999999999655 6789999998752211 112245567788888877 589999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+.+....   .+++.++..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++.....
T Consensus        80 ~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          80 MEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             EcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            99999999999886543   488999999999999999999998   999999999999999999999999999875443


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........||+.|+|||++.+..++.++|||||||++|||+||+.||......        .....+.......+.   
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~~~~~~~p~---  222 (323)
T cd05616         154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHNVAYPK---  222 (323)
T ss_pred             CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCC---
Confidence            333334567899999999999999999999999999999999999998643321        111112222222111   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTM  388 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~  388 (397)
                       .....+.+++.+|++.||++|++.
T Consensus       223 -~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         223 -SMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -cCCHHHHHHHHHHcccCHHhcCCC
Confidence             223457889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.7e-43  Score=323.90  Aligned_cols=258  Identities=26%  Similarity=0.401  Sum_probs=199.6

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEe
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCS  195 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  195 (397)
                      +.++|++.+.||+|+||.||+|...      +++.||+|+++....   ....+.+..|+++++++ +|+||++++++|.
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT---ASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC---HHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            3457888999999999999999532      357899999874322   12346688999999999 8999999999886


Q ss_pred             c-CCeeeEEEEeccCCCHHHhhccccc-----------------------------------------------------
Q 016009          196 H-ARHSFLVYEFLKRGSLAAILSSDAA-----------------------------------------------------  221 (397)
Q Consensus       196 ~-~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  221 (397)
                      . +...+++|||+++++|.+++.....                                                     
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            5 4568899999999999998854211                                                     


Q ss_pred             -----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCC--ccccccc
Q 016009          222 -----AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGT  294 (397)
Q Consensus       222 -----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~  294 (397)
                           ..+++|.++..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||++..+......  .....++
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                 12689999999999999999999998   9999999999999999999999999999876433221  1233456


Q ss_pred             ccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHH
Q 016009          295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEV  373 (397)
Q Consensus       295 ~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  373 (397)
                      ..|+|||++.+..++.++|||||||++|||++ |..||.......        .....+......  .........+.++
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~--~~~~~~~~~~~~l  308 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--------EFCRRLKEGTRM--RAPEYATPEIYSI  308 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--------HHHHHHhccCCC--CCCccCCHHHHHH
Confidence            78999999999999999999999999999998 999985322100        000011000000  0001233468899


Q ss_pred             HHHccCCCCCCCCCHHHHHHHhc
Q 016009          374 VFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       374 ~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+||+.+|++||++.||+++|+
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~  331 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILG  331 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.1e-42  Score=310.46  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=201.5

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++.....    .....+.+|+.++++++||||+++++++..++..++|
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG----DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc----chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            4788899999999999999975 5788999999864221    2245678999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++....   .+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          85 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            99999999999986543   589999999999999999999998   999999999999999999999999999986643


Q ss_pred             CCCCcccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          284 DSSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      .........++..|+|||.+.   ...++.++||||||+++|||++|+.|+.............   ......+...   
T Consensus       159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~---  232 (267)
T cd06646         159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS---KSNFQPPKLK---  232 (267)
T ss_pred             cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee---cCCCCCCCCc---
Confidence            333233456888999999874   3457889999999999999999999975433211110000   0000111111   


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                       ........+.+++.+||+.+|++|||++++++.|
T Consensus       233 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 -DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             -cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence             1112345688999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.9e-43  Score=300.70  Aligned_cols=262  Identities=23%  Similarity=0.297  Sum_probs=203.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe--cCCee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS--HARHS  200 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~  200 (397)
                      .++|+..+.|++|+||.||+|+. ++++.||+|+++.......  -.-.-++|+.+|.+++|||||.+..+..  +-+..
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G--FPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG--FPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC--CcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            34677788999999999999965 5789999999986432221  1234589999999999999999998874  44679


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      |+|||||+. +|...+....  +++...++..++.|+++|++|||++   .|+|||||++|+|++..|.+||+|||+|+.
T Consensus       153 y~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence            999999987 8999987655  5799999999999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccc--------------cccccc
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--------------SFLNTD  345 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--------------~~~~~~  345 (397)
                      +.......+..+-|..|.|||.+.+. .|++..|+||+||++.||+++++-|...+...+              .+.. -
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg-~  305 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG-Y  305 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC-c
Confidence            98777777888999999999998875 589999999999999999999988754433210              0000 0


Q ss_pred             cccccccCCCCC-CCCcchH----H--HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          346 IELDEMLDPRLP-APSRSVQ----E--KLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       346 ~~~~~~~~~~~~-~~~~~~~----~--~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+..+-.-..+ .+.....    .  ....-++|+...+..||.+|.|++|.|++
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            000000000000 0000000    0  12456788889999999999999998864

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.3e-43  Score=322.21  Aligned_cols=243  Identities=26%  Similarity=0.356  Sum_probs=190.9

Q ss_pred             ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||.||+|... +++.||+|.++..... .....+.+..|..++... +||||+++++++..++..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            35999999999999764 6889999998642211 112244556677777655 89999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|.+++....   .+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..........
T Consensus        80 gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  153 (316)
T cd05592          80 GGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA  153 (316)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence            999999986543   589999999999999999999998   99999999999999999999999999997654333334


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR  368 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......        ....+.......+.    ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~----~~~~  221 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--------LFDSILNDRPHFPR----WISK  221 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCCCC----CCCH
Confidence            45678999999999998899999999999999999999999986432210        01111111111111    1234


Q ss_pred             HHHHHHHHccCCCCCCCCCHH-HHH
Q 016009          369 SIVEVVFSCLNESPESRPTMK-IVS  392 (397)
Q Consensus       369 ~l~~l~~~cl~~~P~~RPt~~-~vl  392 (397)
                      .+.+++.+||+.||++||++. +++
T Consensus       222 ~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         222 EAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCChHHHH
Confidence            578899999999999999875 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.3e-43  Score=325.19  Aligned_cols=260  Identities=25%  Similarity=0.405  Sum_probs=194.0

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-----Ce
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-----RH  199 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  199 (397)
                      +|+..+.||+|+||.||+|.. .+|+.||+|++.....  .......+.+|++++++++||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc--cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence            467788999999999999965 4789999999864222  122345788999999999999999999988543     34


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+. ++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus        79 ~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          79 IYVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence            799999995 68988886543   589999999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCC---CcccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------cccc--
Q 016009          280 FLKPDSS---NWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNTD--  345 (397)
Q Consensus       280 ~~~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~~--  345 (397)
                      .......   ......|+..|+|||++.+  ..++.++|||||||++|||+||+.||..........       ....  
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET  231 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6432211   1234578999999998865  578999999999999999999999986432210000       0000  


Q ss_pred             ------cccccc---cCCCCCCC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          346 ------IELDEM---LDPRLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       346 ------~~~~~~---~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                            ......   +.+..+.+ ..........+.+++.+||+.||++|||++|++++
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                  000000   00000000 00001123457899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-42  Score=315.75  Aligned_cols=261  Identities=21%  Similarity=0.345  Sum_probs=194.1

Q ss_pred             CCCCCccccccCcEEEEEEEe-C-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc---cCCceeeeEEEEe-----
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-P-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI---RHRNIVKLYGFCS-----  195 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----  195 (397)
                      +|+..+.||+|+||.||+|.. . +++.||+|.++......  .....+.+|+++++.+   +||||++++++|.     
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            688889999999999999965 3 46889999986533221  1234566777777766   6999999999985     


Q ss_pred             cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          196 HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       196 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                      .....++||||++ ++|.+++..... ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            3456899999996 589988865432 3589999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc--cc-----cccccc
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS--FL-----NTDIEL  348 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~--~~-----~~~~~~  348 (397)
                      |++...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||.........  ..     ......
T Consensus       155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             cceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            999765433 2233456899999999998888999999999999999999999998754321100  00     000000


Q ss_pred             -------ccccCCCCCCCC-cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 -------DEMLDPRLPAPS-RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 -------~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                             .....+....+. ....+....+.+++.+|++.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence                   000110000000 0001223457899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.3e-43  Score=329.34  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=194.8

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      .|+..+.||+|+||+||+|.. .+++.||+|++..... ........+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV-LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            577889999999999999954 5788999999864211 11123467889999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          81 DYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            9999999999986543   488899999999999999999998   9999999999999999999999999997543110


Q ss_pred             CC-----------------------------------------------CcccccccccccCcccccCCCCCcchhhHHH
Q 016009          285 SS-----------------------------------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSF  317 (397)
Q Consensus       285 ~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~  317 (397)
                      ..                                               ......||+.|+|||.+.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                               0112468999999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCCcchHHHHHHHHHHHHH--ccCCCCCCCCCHHHHHH
Q 016009          318 GVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFS--CLNESPESRPTMKIVSQ  393 (397)
Q Consensus       318 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~--cl~~~P~~RPt~~~vl~  393 (397)
                      ||++|||+||+.||.......        ....+.+  .....+..  .....++.+++.+  |+..+|..||+++++++
T Consensus       235 G~il~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~--~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTE--------TQLKVINWENTLHIPPQ--VKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHH--------HHHHHHccccccCCCCC--CCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            999999999999986433211        0011111  01111110  0122346677766  66667777999999986


Q ss_pred             H
Q 016009          394 Q  394 (397)
Q Consensus       394 ~  394 (397)
                      +
T Consensus       305 h  305 (381)
T cd05626         305 H  305 (381)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5e-42  Score=307.84  Aligned_cols=260  Identities=22%  Similarity=0.322  Sum_probs=207.1

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||+|... +|+.|++|.++.... ......+.+.+|++++++++|+|++++++++...+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            57888999999999999999765 899999998864221 2222356789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          204 YEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      |||+++++|.+++.... ....+++.+++.++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            99999999999986432 224589999999999999999999998   99999999999999999999999999987665


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..........++..|+|||.+.+..++.++||||||+++|+|++|+.||..........      ...+.....+.  ..
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~~~--~~  229 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL------CKKIEKCDYPP--LP  229 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH------HhhhhcCCCCC--CC
Confidence            43333344568889999999988889999999999999999999999975322100000      00000001110  00


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .......+.+++.+||+.+|++|||+.+|+++|+
T Consensus       230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~  263 (267)
T cd08224         230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK  263 (267)
T ss_pred             hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence            1133456889999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=330.14  Aligned_cols=252  Identities=25%  Similarity=0.356  Sum_probs=203.0

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||+|... +|+.||+|++...... .......+..|++++..++||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence            36888899999999999999765 7899999998642111 112356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++...   ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          80 MEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            9999999999999765   3589999999999999999999998   999999999999999999999999999986554


Q ss_pred             CC-----------------------------CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 016009          284 DS-----------------------------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL  334 (397)
Q Consensus       284 ~~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~  334 (397)
                      ..                             .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            33                             1223456899999999999999999999999999999999999998754


Q ss_pred             ccccccccccccccccccC--CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 016009          335 SSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT-MKIVSQQ  394 (397)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~~vl~~  394 (397)
                      ....        ....+..  .....+...  .....+.+++..|++ ||.+||+ +++++++
T Consensus       234 ~~~~--------~~~~i~~~~~~~~~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         234 TLQE--------TYNKIINWKESLRFPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CHHH--------HHHHHhccCCcccCCCCC--CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            3211        0111111  111111110  133458889999998 9999999 9999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-42  Score=319.48  Aligned_cols=250  Identities=24%  Similarity=0.451  Sum_probs=198.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCC----EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.++....   ....+++.+|+.+++.++||||++++|+|... .
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            46888999999999999999753 343    489999864221   22356788999999999999999999999764 5


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++++||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence            679999999999999997643  3588999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCCc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC--C
Q 016009          280 FLKPDSSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD--P  354 (397)
Q Consensus       280 ~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~--~  354 (397)
                      .........  ....++..|+|||.+.+..++.++||||||+++|||++ |+.||+......         ...+..  .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---------~~~~~~~~~  228 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGE  228 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHhCCC
Confidence            765433222  12234668999999999999999999999999999998 999986432211         011111  1


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+.    .+...+.+++.+||+.+|++|||+.+++..|.
T Consensus       229 ~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~  266 (316)
T cd05108         229 RLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  266 (316)
T ss_pred             CCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            111111    12345889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1e-42  Score=320.06  Aligned_cols=245  Identities=24%  Similarity=0.318  Sum_probs=195.4

Q ss_pred             ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||.||++... +++.||+|.++.... ........+..|.++++.+ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            35999999999999665 578999999864211 1112345677899999888 79999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|.+++....   .+++.++..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++..........
T Consensus        80 ~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  153 (318)
T cd05570          80 GGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT  153 (318)
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence            999999886543   589999999999999999999998   99999999999999999999999999987543333333


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR  368 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||.......        ....+.......+.    ....
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--------~~~~i~~~~~~~~~----~~~~  221 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--------LFQSILEDEVRYPR----WLSK  221 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCCCCC----cCCH
Confidence            44568999999999999999999999999999999999999986433211        01111111111111    1234


Q ss_pred             HHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 016009          369 SIVEVVFSCLNESPESRPTM-----KIVSQQ  394 (397)
Q Consensus       369 ~l~~l~~~cl~~~P~~RPt~-----~~vl~~  394 (397)
                      .+.+++.+||+.||++|||+     .+++++
T Consensus       222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             HHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            58899999999999999999     887653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-42  Score=334.86  Aligned_cols=251  Identities=20%  Similarity=0.213  Sum_probs=199.6

Q ss_pred             CCCCCccccccCcEEEEEEEeC-C-CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-S-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .|...+.||+|++|.||+|... + ++.||+|.+...    .......+..|+.+++.++||||+++++++..++..++|
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            3778889999999999999543 4 678888876431    122345678899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          204 YEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      |||+++|+|.+++.... ...++++.++..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            99999999999886432 234688999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          283 PDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       283 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......        .....+.........
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~~~~~~~~~  292 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVLYGKYDPFP  292 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCC
Confidence            3322  123456899999999999989999999999999999999999998643221        011111111111101


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ......+.+++.+||+.||++||++++++..
T Consensus       293 ---~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        293 ---CPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ---ccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence               1223458899999999999999999999753

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-45  Score=306.81  Aligned_cols=248  Identities=28%  Similarity=0.450  Sum_probs=216.9

Q ss_pred             CCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |.+..+||+|+||.||++. ..+|+.+|+|++...      .+.+++..|+.++++++.|++|+++|.|.....+|+|||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            5567789999999999994 458999999997642      247889999999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      ||..|+..+.++.++  +++++.++..++...++||+|||..   .-+|||||+.|||++.+|.+||+|||.+.++...-
T Consensus       109 YCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  109 YCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            999999999997665  5799999999999999999999998   88999999999999999999999999999887666


Q ss_pred             CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHH
Q 016009          286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE  365 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (397)
                      ....+..||+-|||||++..-.|+.++||||+|+...||..|++||.+..++..-+..         ....++....+.+
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---------PT~PPPTF~KPE~  254 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---------PTKPPPTFKKPEE  254 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---------cCCCCCCCCChHh
Confidence            6667789999999999999999999999999999999999999999877665433322         1222333445567


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          366 KLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       366 ~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ++.++.+++..|+.++|++|-|+.+++++
T Consensus       255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  255 WSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            88899999999999999999999998875

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.9e-43  Score=326.32  Aligned_cols=203  Identities=27%  Similarity=0.356  Sum_probs=173.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||+||++... +++.||+|++..... ........+..|+.++.+++|+||+++++.+.+....++|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence            47888999999999999999654 689999999864211 1122345678899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          80 MEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             EcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            99999999999997543   589999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCC-----------------------------------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC
Q 016009          284 DSS-----------------------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK  328 (397)
Q Consensus       284 ~~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~  328 (397)
                      ...                                   .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                   012347899999999999989999999999999999999999


Q ss_pred             CCCCcc
Q 016009          329 HPRDFL  334 (397)
Q Consensus       329 ~p~~~~  334 (397)
                      .||...
T Consensus       234 ~Pf~~~  239 (363)
T cd05628         234 PPFCSE  239 (363)
T ss_pred             CCCCCC
Confidence            998643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=308.66  Aligned_cols=256  Identities=27%  Similarity=0.461  Sum_probs=197.8

Q ss_pred             CCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc--cCCceeeeEEEEecCC----ee
Q 016009          127 FDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNIVKLYGFCSHAR----HS  200 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~----~~  200 (397)
                      ....+++|+|.||.||||.+. ++.||||++..       .+++.|.+|-+|.+..  +|+||++++++-....    +.
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            344567999999999999984 58999999863       3578899999988865  8999999999876655    88


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCceeccCCCCcEEeCCCCcEEEee
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC------FPPIVHRDISSKNLLLDLEFEAHVAD  274 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------~~~ivH~dlk~~Nill~~~~~~kl~D  274 (397)
                      +||+||.+.|+|.++|..+.    ++|....+++..+++||+|||+..      .++|+|||||++|||+..|+++.|+|
T Consensus       284 wLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             eEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            99999999999999997654    899999999999999999999864      36899999999999999999999999


Q ss_pred             eccccccCCCCC--CcccccccccccCcccccCCC-CC-----cchhhHHHHHHHHHHHhCCCCCC--cccccccc----
Q 016009          275 FGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMK-IT-----EKCDVYSFGVLALEVIKGKHPRD--FLSSISSS----  340 (397)
Q Consensus       275 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-~~-----~~~Dv~s~G~~l~el~tg~~p~~--~~~~~~~~----  340 (397)
                      ||+|..+.+...  .....+||.+|||||++.+.- +.     .+.||||+|.+||||++.....+  ........    
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            999998775433  234478999999999987642 22     37899999999999998654432  11111100    


Q ss_pred             --cccccc-----ccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          341 --FLNTDI-----ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       341 --~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                        ....-+     .+.+...|.++..+... ..+..+.+.+..||+.||+.|.|+.-|-+++
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~  500 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERM  500 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence              000001     12222334443322222 4467799999999999999999999887765

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-43  Score=329.79  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=198.0

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||+||++... +|+.||||++..... ........+.+|+++++.++||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM-LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence            47888999999999999999654 689999999864211 1112345678899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++..+..
T Consensus        80 ~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          80 MEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             ECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999999987543   489999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCC--------------------------------------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHH
Q 016009          284 DSS--------------------------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI  325 (397)
Q Consensus       284 ~~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~  325 (397)
                      ...                                      ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            110                                      001235899999999999989999999999999999999


Q ss_pred             hCCCCCCccccccccccccccccccccC--CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 016009          326 KGKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT---MKIVSQQ  394 (397)
Q Consensus       326 tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~~vl~~  394 (397)
                      +|..||........        ...+.+  ..+..+..  ......+.+++.+|+. +|.+|++   +++++++
T Consensus       234 ~G~~Pf~~~~~~~~--------~~~i~~~~~~~~~~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         234 VGYPPFCSDNPQET--------YRKIINWKETLQFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCCCCCHHHH--------HHHHHcCCCccCCCCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99999864432110        011110  11111111  0123357788889986 9999998   8888764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.1e-42  Score=309.76  Aligned_cols=252  Identities=25%  Similarity=0.434  Sum_probs=201.0

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .+|...+.||+|++|.||+|... +++.|++|.+...     .....++.+|++++++++|||++++++++...+..+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence            35777888999999999999654 6889999997642     12356789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++..... ..+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            999999999999865432 4589999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCCc-ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          284 DSSNW-TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       284 ~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ..... .....+..|+|||...+..++.++||||||+++|||++ |..|+........ .    ........+  ..+  
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~----~~~~~~~~~--~~~--  227 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-Y----ELLEKGYRM--ERP--  227 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-H----HHHHCCCCC--CCC--
Confidence            22111 11234568999999998899999999999999999998 8999753221100 0    000000111  111  


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        ...+..+.+++.+||+.||++|||+.+++++|+
T Consensus       228 --~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~  260 (263)
T cd05052         228 --EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE  260 (263)
T ss_pred             --CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence              122356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.9e-43  Score=329.88  Aligned_cols=254  Identities=23%  Similarity=0.320  Sum_probs=200.0

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ..++|+..+.||+|+||.||++... +++.||+|.+..... ........+..|+.+++.++||||+++++++.+++..+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            3567888999999999999999654 688999999853111 11123455788999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++|+|.+++...    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            999999999999998643    478888999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCCC-CcccccccccccCcccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC-
Q 016009          282 KPDSS-NWTEFAGTYGYVAPELAYTM----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR-  355 (397)
Q Consensus       282 ~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  355 (397)
                      ..... ......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.......        ....+.+.. 
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~  264 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMDHKN  264 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH--------HHHHHHcCCC
Confidence            43322 22345799999999988653    47889999999999999999999986433210        111111111 


Q ss_pred             -CCCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 016009          356 -LPAPSRSVQEKLRSIVEVVFSCLNESPES--RPTMKIVSQQ  394 (397)
Q Consensus       356 -~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~~vl~~  394 (397)
                       +..+.  .......+.+++.+|++.+|++  |||+++++++
T Consensus       265 ~~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         265 SLTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             cCCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence             11111  0122345888999999999998  9999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-42  Score=324.69  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=195.5

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||++.. .+++.||+|...          .+.+.+|++++++++||||+++++++......++|
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            5799999999999999999954 578999999743          24567899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      +|++. ++|..++...   ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus       162 ~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        162 LPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             EecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            99985 6888887654   3588999999999999999999998   999999999999999999999999999975432


Q ss_pred             C-CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc--------------------ccc
Q 016009          284 D-SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--------------------SFL  342 (397)
Q Consensus       284 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--------------------~~~  342 (397)
                      . ........||+.|+|||++.+..++.++|||||||++|||+||+.|+-.......                    .+.
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            2 1222345799999999999998999999999999999999999987532111000                    000


Q ss_pred             c-ccccccccc---------CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          343 N-TDIELDEML---------DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       343 ~-~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      . .........         .+..........+....+.+++.+||+.||++|||++|++++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0 000000000         000000011112334578899999999999999999999864

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.3e-42  Score=312.81  Aligned_cols=253  Identities=24%  Similarity=0.423  Sum_probs=200.3

Q ss_pred             cCCCCCccccccCcEEEEEEEe-----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      ++|+..+.||+|+||.||+|..     .++..+++|.+.....   ......+.+|++++++++||||+++++++..+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN---PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC---HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            4677788999999999999963     3567899999874222   2234678899999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhccccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC
Q 016009          200 SFLVYEFLKRGSLAAILSSDAA--------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD  265 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  265 (397)
                      .++||||+++++|.+++.....              ...+++.+++.++.|++.||+|||+.   +++|+||||+||+++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIG  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEc
Confidence            9999999999999999853221              13478999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccc
Q 016009          266 LEFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL  342 (397)
Q Consensus       266 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~  342 (397)
                      +++.+||+|||++........  ......++..|+|||++.+..++.++||||||+++|||++ |..||......     
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-----  233 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-----  233 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence            999999999999976543221  1223345678999999988889999999999999999998 99887532211     


Q ss_pred             ccccccccccCCC--CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          343 NTDIELDEMLDPR--LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       343 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                          ...+.++..  .+.+.    .....+.+++.+||+.||++||++.+|+++|.
T Consensus       234 ----~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         234 ----EVIEMVRKRQLLPCSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             ----HHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence                011111111  11111    22345888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.6e-43  Score=323.26  Aligned_cols=240  Identities=26%  Similarity=0.355  Sum_probs=192.8

Q ss_pred             ccccccCcEEEEEEEe----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEe
Q 016009          131 YCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEF  206 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  206 (397)
                      +.||+|+||.||++..    .+|+.||+|++.....  .......+..|++++++++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            5699999999999854    3688999999864211  112345677899999999999999999999999999999999


Q ss_pred             ccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC
Q 016009          207 LKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS  286 (397)
Q Consensus       207 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  286 (397)
                      +++|+|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++........
T Consensus        80 ~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          80 LRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            99999999986543   589999999999999999999998   999999999999999999999999999886544433


Q ss_pred             CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHH
Q 016009          287 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK  366 (397)
Q Consensus       287 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (397)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......        ....+.......+.    ..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--------~~~~i~~~~~~~p~----~~  221 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--------TMTMILKAKLGMPQ----FL  221 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--------HHHHHHcCCCCCCC----CC
Confidence            3344678999999999998889999999999999999999999986432211        11111111111111    12


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHH
Q 016009          367 LRSIVEVVFSCLNESPESRPTMKI  390 (397)
Q Consensus       367 ~~~l~~l~~~cl~~~P~~RPt~~~  390 (397)
                      ...+.+++.+||+.||++||++.+
T Consensus       222 ~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         222 SPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CHHHHHHHHHHhhcCHhHcCCCCC
Confidence            345788999999999999999443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.9e-42  Score=312.12  Aligned_cols=254  Identities=26%  Similarity=0.462  Sum_probs=200.6

Q ss_pred             cCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      ++|.+.+.||+|+||.||++..      .++..+|+|.+...    .....+.+.+|++++++++|||++++++++...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            4678889999999999999964      23456899987642    1223567899999999999999999999999999


Q ss_pred             eeeEEEEeccCCCHHHhhccccc----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAA----------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF  268 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  268 (397)
                      ..++||||+++++|.+++.....          ...+++.+++.++.|++.||+|||+.   +++||||||+||++++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            99999999999999999864321          13489999999999999999999998   999999999999999999


Q ss_pred             cEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 016009          269 EAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTD  345 (397)
Q Consensus       269 ~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~  345 (397)
                      .++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|||+| |..||.......       
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------  230 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------  230 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence            999999999876543221  1122345678999999998889999999999999999998 899976432210       


Q ss_pred             cccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          346 IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ....+..........   .....+.+++.+||+.||.+|||++++++.|+
T Consensus       231 -~~~~i~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~  277 (288)
T cd05093         231 -VIECITQGRVLQRPR---TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ  277 (288)
T ss_pred             -HHHHHHcCCcCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence             011111111111011   12345899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4e-42  Score=305.92  Aligned_cols=247  Identities=25%  Similarity=0.424  Sum_probs=195.5

Q ss_pred             cccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCC
Q 016009          132 CIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRG  210 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  210 (397)
                      .||+|+||.||+|.. .+++.+|+|.+.....   ......+.+|++++++++||||+++++++......++||||++++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLP---PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            599999999999965 4789999998764221   223567899999999999999999999999999999999999999


Q ss_pred             CHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc--
Q 016009          211 SLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW--  288 (397)
Q Consensus       211 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--  288 (397)
                      +|.+++....  ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++..........  
T Consensus        79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            9999986543  3589999999999999999999998   99999999999999999999999999987543221111  


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCcchHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL  367 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (397)
                      .....+..|+|||.+.++.++.++||||||+++|||++ |..|+.......         ....+......  ......+
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---------~~~~~~~~~~~--~~~~~~~  222 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---------TREAIEQGVRL--PCPELCP  222 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---------HHHHHHcCCCC--CCcccCC
Confidence            11123457999999998889999999999999999998 888876433211         01111111110  0011224


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 016009          368 RSIVEVVFSCLNESPESRPTMKIVSQQLQI  397 (397)
Q Consensus       368 ~~l~~l~~~cl~~~P~~RPt~~~vl~~Le~  397 (397)
                      ..+.+++.+|++.+|++|||+.+|+++|+.
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            568899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.2e-43  Score=320.24  Aligned_cols=242  Identities=27%  Similarity=0.374  Sum_probs=191.5

Q ss_pred             ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||.||+|... +++.||+|.++..... .......+..|..++... +||||+++++++.+.+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            35999999999999764 5789999998642211 111235567788888765 89999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|.+++...   ..+++.++..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..........
T Consensus        80 ~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05619          80 GGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT  153 (316)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence            99999998653   3588999999999999999999998   99999999999999999999999999987543333333


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccc--cCCCCCCCCcchHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM--LDPRLPAPSRSVQEK  366 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  366 (397)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.......        ....+  ..+..+  .    ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--------~~~~i~~~~~~~~--~----~~  219 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--------LFQSIRMDNPCYP--R----WL  219 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCC--c----cC
Confidence            44578999999999998899999999999999999999999986432110        00111  111111  1    12


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 016009          367 LRSIVEVVFSCLNESPESRPTMK-IVSQ  393 (397)
Q Consensus       367 ~~~l~~l~~~cl~~~P~~RPt~~-~vl~  393 (397)
                      ...+.+++.+||+.||++||++. ++.+
T Consensus       220 ~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         220 TREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            34578899999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.4e-43  Score=321.06  Aligned_cols=243  Identities=24%  Similarity=0.316  Sum_probs=191.6

Q ss_pred             ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||.||+|... +|+.||+|.++..... .......+..|..++... +||||+++++++...+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence            35999999999999765 6889999998642211 112245567788888765 89999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|.+++...   ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05620          80 GGDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA  153 (316)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence            99999988654   3588999999999999999999998   99999999999999999999999999987543333334


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR  368 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
                      ....||..|+|||++.+..++.++||||||+++|||++|+.||......        .....+.......+.    ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~~~~~~~----~~~~  221 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVDTPHYPR----WITK  221 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCC----CCCH
Confidence            4567899999999999999999999999999999999999998643221        001111111111111    1234


Q ss_pred             HHHHHHHHccCCCCCCCCCHH-HHH
Q 016009          369 SIVEVVFSCLNESPESRPTMK-IVS  392 (397)
Q Consensus       369 ~l~~l~~~cl~~~P~~RPt~~-~vl  392 (397)
                      .+.+++.+||+.||++||++. +++
T Consensus       222 ~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         222 ESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCChHHHH
Confidence            578899999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.5e-42  Score=311.43  Aligned_cols=248  Identities=23%  Similarity=0.295  Sum_probs=193.0

Q ss_pred             ccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCC
Q 016009          133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGS  211 (397)
Q Consensus       133 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  211 (397)
                      ||+|+||.||++..+ +|+.||+|.+...... .......+..|++++++++||||+++.+++..+...++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK-KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh-cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            699999999999654 6899999998642211 11123456679999999999999999999999999999999999999


Q ss_pred             HHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcccc
Q 016009          212 LAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF  291 (397)
Q Consensus       212 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  291 (397)
                      |.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++....... .....
T Consensus        80 L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~  154 (277)
T cd05607          80 LKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQR  154 (277)
T ss_pred             HHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeecc
Confidence            9988864432 3588999999999999999999998   99999999999999999999999999987654322 22335


Q ss_pred             cccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHH
Q 016009          292 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV  371 (397)
Q Consensus       292 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  371 (397)
                      .|+..|+|||++.+..++.++||||+||++|||++|+.||........    .................   ......+.
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~---~~~~~~~~  227 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRTLEDEVKFEH---QNFTEESK  227 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHhhcccccccc---ccCCHHHH
Confidence            688999999999988899999999999999999999999863221000    00001111111111111   12344588


Q ss_pred             HHHHHccCCCCCCCCCHHHHHH
Q 016009          372 EVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       372 ~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      +++.+||+.||++||+++|+++
T Consensus       228 ~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         228 DICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             HHHHHHhccCHhhCCCCccchh
Confidence            9999999999999999976554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.8e-43  Score=324.98  Aligned_cols=241  Identities=24%  Similarity=0.317  Sum_probs=189.3

Q ss_pred             ccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHH-HHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE-ALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||.||++.. .+|+.+|+|++...... .......+..|.. +++.++||||+++++++..++..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence            3599999999999965 47899999998642111 1122345556655 4677899999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|..++...   ..+++.++..++.||+.||+|||+.   +++||||||+||++++++.+||+|||++..........
T Consensus        80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  153 (325)
T cd05604          80 GGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT  153 (325)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence            99999888654   3589999999999999999999998   99999999999999999999999999987543333333


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR  368 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||.......        ....+.......+.    ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--------~~~~~~~~~~~~~~----~~~~  221 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--------MYDNILHKPLVLRP----GASL  221 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--------HHHHHHcCCccCCC----CCCH
Confidence            45678999999999999999999999999999999999999986432110        01111111111111    1234


Q ss_pred             HHHHHHHHccCCCCCCCCCHHH
Q 016009          369 SIVEVVFSCLNESPESRPTMKI  390 (397)
Q Consensus       369 ~l~~l~~~cl~~~P~~RPt~~~  390 (397)
                      .+.+++.+|++.+|++||++++
T Consensus       222 ~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         222 TAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             HHHHHHHHHhccCHHhcCCCCC
Confidence            5778999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-42  Score=306.02  Aligned_cols=250  Identities=27%  Similarity=0.471  Sum_probs=200.2

Q ss_pred             CCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      +|+..+.||+|+||.||++..+++..+|+|.+....     .....+.+|++++++++||||+++++++...+..++|||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-----MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            577888999999999999988777889999876421     124578899999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |+++++|.+++....  ..+++..++.++.|++.|++|||+.   +++|+||||+||++++++.+||+|||+++......
T Consensus        80 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          80 YMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             cCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            999999999987543  2589999999999999999999998   99999999999999999999999999987654221


Q ss_pred             CC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          286 SN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       286 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .. .....++..|+|||...+..++.++||||||+++|||++ |+.||+........     .........  ..+.   
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-----~~~~~~~~~--~~~~---  224 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-----ESVSAGYRL--YRPK---  224 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH-----HHHHcCCcC--CCCC---
Confidence            11 111223457999999998899999999999999999999 89998643221100     001111111  1111   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ..+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       225 -~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         225 -LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             -CCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence             23446889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.1e-42  Score=311.80  Aligned_cols=254  Identities=27%  Similarity=0.500  Sum_probs=201.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      .+|...+.||+|+||.||++...      ++..+++|.+...    .....+.+.+|++++++++|+||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            35777888999999999999632      3556889987642    2223467899999999999999999999999999


Q ss_pred             eeeEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD  265 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  265 (397)
                      ..++||||+++++|.+++.....             ...+++.+++.++.|++.|++|||++   +++|+||||+||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence            99999999999999999965431             23489999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccc
Q 016009          266 LEFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL  342 (397)
Q Consensus       266 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~  342 (397)
                      .++.++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.......    
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----  233 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----  233 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            999999999999976543221  1223456788999999998899999999999999999999 999976433211    


Q ss_pred             ccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                          ....+.........   ...+..+.+++.+||+.+|++|||+++|+++|+
T Consensus       234 ----~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~  280 (291)
T cd05094         234 ----VIECITQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH  280 (291)
T ss_pred             ----HHHHHhCCCCCCCC---ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence                01111111111111   122345889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4e-43  Score=323.93  Aligned_cols=241  Identities=23%  Similarity=0.293  Sum_probs=187.9

Q ss_pred             ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHH-HHHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEV-EALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||+||++... +++.||+|++........ .....+..|. .+++.++||||+++++++...+..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            35999999999999655 678899999864211111 1123444444 45678899999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|.+++....   .+++.....++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..........
T Consensus        80 ~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~  153 (325)
T cd05602          80 GGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT  153 (325)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence            999999986543   478888999999999999999998   99999999999999999999999999987543333333


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR  368 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......        ....+.......+.    ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~~~~~~----~~~~  221 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--------MYDNILNKPLQLKP----NITN  221 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--------HHHHHHhCCcCCCC----CCCH
Confidence            45679999999999999999999999999999999999999986432211        01111111111111    2234


Q ss_pred             HHHHHHHHccCCCCCCCCCHHH
Q 016009          369 SIVEVVFSCLNESPESRPTMKI  390 (397)
Q Consensus       369 ~l~~l~~~cl~~~P~~RPt~~~  390 (397)
                      .+.+++.+|++.||.+||++.+
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         222 SARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             HHHHHHHHHcccCHHHCCCCCC
Confidence            5888999999999999998774

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.6e-42  Score=310.62  Aligned_cols=254  Identities=27%  Similarity=0.428  Sum_probs=200.1

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecC--
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHA--  197 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--  197 (397)
                      .+++.|+..+.||+|+||.||+|... +++.||+|.+....     .....+..|+.+++++ +|+|++++++++...  
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   77 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence            45677888899999999999999654 68899999986421     2246788999999998 799999999998653  


Q ss_pred             ----CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEe
Q 016009          198 ----RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVA  273 (397)
Q Consensus       198 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  273 (397)
                          ...+++|||+++++|.+++..... ..+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          78 PGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             CCCCcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence                457899999999999999876432 4589999999999999999999998   99999999999999999999999


Q ss_pred             eeccccccCCCCCCcccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 016009          274 DFGIAKFLKPDSSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIEL  348 (397)
Q Consensus       274 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  348 (397)
                      |||++..............|+..|+|||++.     ...++.++|||||||++|||++|+.||............     
T Consensus       154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~-----  228 (272)
T cd06637         154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-----  228 (272)
T ss_pred             cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-----
Confidence            9999986544333334457889999999876     335788999999999999999999998644322111100     


Q ss_pred             ccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+...     .......+.+++.+||+.||++|||+.+++++
T Consensus       229 ~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 PRNPAPRLK-----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             hcCCCCCCC-----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            000001111     01223458899999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.6e-42  Score=304.72  Aligned_cols=250  Identities=30%  Similarity=0.459  Sum_probs=204.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||+|... +++.+++|.+....      ..+++.+|++++++++|||++++++++......+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence            57888999999999999999765 47899999986421      157899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      +||+++++|.+++....  ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          77 MEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            99999999999986533  4689999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........++..|+|||++.+..++.++||||||+++|+|++|+.|+...........     ......+..    ...
T Consensus       152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~----~~~  222 (256)
T cd06612         152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNKPPPTL----SDP  222 (256)
T ss_pred             CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-----hccCCCCCC----Cch
Confidence            43333445678899999999988899999999999999999999999874332111000     000001111    111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+.+++.+||+.||++|||++||+++
T Consensus       223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             hhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            2234568899999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.2e-43  Score=326.46  Aligned_cols=255  Identities=22%  Similarity=0.317  Sum_probs=198.7

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ...++|+..+.||+|+||.||++... +++.+|+|.+..... ......+.+.+|+.+++.++||||+++++++.+++..
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            34568999999999999999999765 688999999853111 1112345678999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++|+|.+++...    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++..
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence            9999999999999998643    478899999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCC-CcccccccccccCcccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 016009          281 LKPDSS-NWTEFAGTYGYVAPELAYTM----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR  355 (397)
Q Consensus       281 ~~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  355 (397)
                      ...... ......||+.|+|||++.+.    .++.++||||+||++|||++|+.||.......        ....+.+..
T Consensus       192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~--------~~~~i~~~~  263 (370)
T cd05621         192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG--------TYSKIMDHK  263 (370)
T ss_pred             cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC
Confidence            643222 22345799999999998754    37889999999999999999999986433211        111122111


Q ss_pred             --CCCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 016009          356 --LPAPSRSVQEKLRSIVEVVFSCLNESPES--RPTMKIVSQQ  394 (397)
Q Consensus       356 --~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~~vl~~  394 (397)
                        +..+.  .......+.+++..|++.+|.+  |||+.|++++
T Consensus       264 ~~~~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 NSLNFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cccCCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              11111  1122345778888999865544  8999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-42  Score=335.51  Aligned_cols=256  Identities=25%  Similarity=0.293  Sum_probs=201.7

Q ss_pred             HhcCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC---
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR---  198 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---  198 (397)
                      ..++|.+.+.||+|+||+||++. ..+|+.||||.+.....  .......+.+|+..+..++|+|++++.+.+....   
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34689999999999999999995 45799999999865322  2234567889999999999999999988764332   


Q ss_pred             -----eeeEEEEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEE
Q 016009          199 -----HSFLVYEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV  272 (397)
Q Consensus       199 -----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  272 (397)
                           ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence                 3689999999999999986532 234689999999999999999999998   9999999999999999999999


Q ss_pred             eeeccccccCCCC--CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 016009          273 ADFGIAKFLKPDS--SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE  350 (397)
Q Consensus       273 ~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  350 (397)
                      +|||+++.+....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......        ....
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--------~~~~  256 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--------VMHK  256 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHH
Confidence            9999998654321  12234578999999999999999999999999999999999999986432110        0111


Q ss_pred             ccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..........   ......+.+++.+||+.||++||++.+++++
T Consensus       257 ~~~~~~~~~~---~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        257 TLAGRYDPLP---PSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HhcCCCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111111000   1223458899999999999999999999864

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.8e-42  Score=307.51  Aligned_cols=252  Identities=23%  Similarity=0.455  Sum_probs=202.1

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .++|...++||+|+||.||+|..++++.||+|.+....     ....++.+|++++++++|+|++++++++. .+..+++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            35688889999999999999998889999999986422     23567899999999999999999999874 4578999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++..... ..+++.++..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          79 TEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            999999999999865443 4689999999999999999999998   999999999999999999999999999976553


Q ss_pred             CCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          284 DSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       284 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ... ......++..|+|||++.+..++.++||||||+++||+++ |+.||........  .   ......  ...+.+. 
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~---~~~~~~--~~~~~~~-  226 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV--I---QNLERG--YRMPRPD-  226 (260)
T ss_pred             CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--H---HHHHcC--CCCCCCC-
Confidence            221 1222345678999999988889999999999999999999 9999864332100  0   000000  0111111 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         ..+..+.+++.+|++.+|++|||++++++.|+
T Consensus       227 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         227 ---NCPEELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             ---CCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence               12345899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.5e-42  Score=298.55  Aligned_cols=264  Identities=24%  Similarity=0.315  Sum_probs=202.6

Q ss_pred             cCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc-eeeeEEEEecCC----
Q 016009          125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN-IVKLYGFCSHAR----  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~----  198 (397)
                      ..|...+.||+|+||+||+|+ ..+|+.||+|+++.....  ........+|+.+|++++|+| |+++.+++.+.+    
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            345566779999999999995 457899999999864332  112455689999999999999 999999998877    


Q ss_pred             --eeeEEEEeccCCCHHHhhcccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          199 --HSFLVYEFLKRGSLAAILSSDAAA-QELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       199 --~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                        ..++|+||++. +|.+++...... +.++...+..++.|+++||+|||++   +|+||||||+||+++++|.+||+||
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence              78999999965 999998765532 3466688999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccc----------ccccc
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS----------SFLNT  344 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~----------~~~~~  344 (397)
                      |+|+...-.....+..++|..|.|||++.+. .|+...||||+||++.||++++.-|........          .....
T Consensus       165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9999766555556777899999999999877 699999999999999999999888765443210          00000


Q ss_pred             ccccccccCCC--CCC---CCcchHHH---HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          345 DIELDEMLDPR--LPA---PSRSVQEK---LRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       345 ~~~~~~~~~~~--~~~---~~~~~~~~---~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ........+-.  .+.   +.......   .....+++.+|++.+|.+|.|++.++.+
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            00111111111  110   11111111   1367899999999999999999999875

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-42  Score=315.06  Aligned_cols=254  Identities=26%  Similarity=0.363  Sum_probs=215.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  201 (397)
                      ...|+..+.||+|.||.||++..+ +|+.+|+|.+........ .....+.+|+++|+++. |||||.+.+.+++....+
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~-~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK-EDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc-ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            346777789999999999999765 599999999976433221 24578999999999998 999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC----CcEEEeeecc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE----FEAHVADFGI  277 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~  277 (397)
                      +|||++.||.|.+.+...    .+++.....++.|++.++.|||+.   +++||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999765    289999999999999999999998   99999999999999543    5799999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      +..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||......        .....+....+.
T Consensus       186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~--------~~~~~i~~~~~~  256 (382)
T KOG0032|consen  186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF--------EIFLAILRGDFD  256 (382)
T ss_pred             ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh--------HHHHHHHcCCCC
Confidence            998876 55667789999999999999999999999999999999999999998754431        112233333334


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+........+++..++..||.+|+|+.+++++
T Consensus       257 f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  257 FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            3444555667778999999999999999999999975

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-43  Score=328.37  Aligned_cols=252  Identities=21%  Similarity=0.297  Sum_probs=195.5

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||++.. .+++.||+|++..... ......+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence            3688889999999999999964 5789999999854111 1112345688899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        80 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          80 MEFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999998654   3588999999999999999999998   999999999999999999999999999863321


Q ss_pred             CCC-----------------------------------------------CcccccccccccCcccccCCCCCcchhhHH
Q 016009          284 DSS-----------------------------------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYS  316 (397)
Q Consensus       284 ~~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s  316 (397)
                      ...                                               ......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            000                                               001246899999999999889999999999


Q ss_pred             HHHHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCCcchHHHHHHHHHHHHHccCCCCCCC---CCHHHH
Q 016009          317 FGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESR---PTMKIV  391 (397)
Q Consensus       317 ~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---Pt~~~v  391 (397)
                      |||++|||+||+.||........        ...+..  ..+..+..  ......+.+++.+|+. +|.+|   +|+.|+
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~--------~~~i~~~~~~~~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~  302 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHET--------YRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEI  302 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHHH--------HHHHHccCCccCCCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence            99999999999999864332110        011110  01111110  0123457888999997 67765   599998


Q ss_pred             HHH
Q 016009          392 SQQ  394 (397)
Q Consensus       392 l~~  394 (397)
                      +++
T Consensus       303 l~h  305 (377)
T cd05629         303 KSH  305 (377)
T ss_pred             hcC
Confidence            875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.7e-43  Score=322.37  Aligned_cols=240  Identities=23%  Similarity=0.316  Sum_probs=187.5

Q ss_pred             ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHH-HHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVE-ALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||.||+|... +++.||+|++....... ......+..|.. +++.++||||+++++++.+.+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            35999999999999764 68899999986421111 112344555554 6788999999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|...+...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++..........
T Consensus        80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (321)
T cd05603          80 GGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT  153 (321)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence            99999888643   3588899999999999999999998   99999999999999999999999999987543323333


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR  368 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||......        .....+.......+.    ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~----~~~~  221 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--------QMYDNILHKPLQLPG----GKTV  221 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--------HHHHHHhcCCCCCCC----CCCH
Confidence            4457899999999999888999999999999999999999998643211        011112222222121    2234


Q ss_pred             HHHHHHHHccCCCCCCCCCHH
Q 016009          369 SIVEVVFSCLNESPESRPTMK  389 (397)
Q Consensus       369 ~l~~l~~~cl~~~P~~RPt~~  389 (397)
                      .+.+++.+|++.||.+||+..
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         222 AACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHHccCCHhhcCCCC
Confidence            588999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.7e-42  Score=305.52  Aligned_cols=250  Identities=27%  Similarity=0.490  Sum_probs=201.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|++.+.||+|+||.||+|..+++..+|+|.+.....     ..+.+.+|+.++++++|+|++++++++. ....+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT   79 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence            46788899999999999999888888999999865221     2467899999999999999999999885 45689999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++..... ..+++.+++.++.+++.||+|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          80 EYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            99999999999875432 4589999999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCc
Q 016009          285 SSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLPAPSR  361 (397)
Q Consensus       285 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  361 (397)
                      ... .....++..|+|||...+..++.++||||||+++|||++ |..||.......        ....+... ..+.+  
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~--  225 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--------VLEQVERGYRMPCP--  225 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCCCC--
Confidence            211 122234568999999988889999999999999999999 889986432210        01111110 11111  


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        .+....+.+++.+|++.+|++|||+.++++.|+
T Consensus       226 --~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  258 (260)
T cd05070         226 --QDCPISLHELMLQCWKKDPEERPTFEYLQSFLE  258 (260)
T ss_pred             --CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence              123456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.4e-42  Score=311.00  Aligned_cols=250  Identities=25%  Similarity=0.402  Sum_probs=202.1

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .+|+..+.||+|++|.||+|.. .+++.|++|.+.....    ...+.+.+|+.+++.++|+|++++++++..+...++|
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            4678888999999999999964 5789999999864222    2356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++...    .+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            9999999999998542    478999999999999999999998   999999999999999999999999999876554


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........+++.|+|||.+.+..++.++||||||+++|+|++|+.||..........       .........  ....
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~~--~~~~  239 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-------LIATNGTPE--LQNP  239 (296)
T ss_pred             cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH-------HHhcCCCCC--CCCc
Confidence            3333344578899999999988889999999999999999999999986433211100       000011000  0111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+.+++.+||+.+|++|||+.++++.
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            2334558899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.1e-42  Score=317.52  Aligned_cols=244  Identities=23%  Similarity=0.319  Sum_probs=193.6

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeeeEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  203 (397)
                      +|+..+.||+|+||.||++.. .+|+.||+|++..... ......+.+..|..+++.+. |++|+++.+++...+..++|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence            366778999999999999965 4789999999864211 11123456778999998885 57788899999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....   .+++.++..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        80 ~Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          80 MEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            99999999999986543   589999999999999999999998   999999999999999999999999999875443


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........||+.|+|||++.+..++.++||||+|+++|||++|+.||......        .....+.......+.   
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~~~~p~---  222 (323)
T cd05615         154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHNVSYPK---  222 (323)
T ss_pred             CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCc---
Confidence            333334456899999999999888999999999999999999999998643321        111112222221111   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTM  388 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~  388 (397)
                       .....+.+++.+|++.+|.+|++.
T Consensus       223 -~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         223 -SLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -cCCHHHHHHHHHHcccCHhhCCCC
Confidence             223457889999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4e-42  Score=317.29  Aligned_cols=246  Identities=24%  Similarity=0.316  Sum_probs=191.8

Q ss_pred             ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||.||++... +++.||+|++..... ......+.+..|..++.++ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence            35999999999999654 678999999875321 1122345688999999988 69999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|..++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..........
T Consensus        80 ~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  153 (327)
T cd05617          80 GGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT  153 (327)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence            999998886543   589999999999999999999998   99999999999999999999999999987543333333


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR  368 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||+......... ........+.......+.    ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~p~----~~~~  228 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKPIRIPR----FLSV  228 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCCCCCCC----CCCH
Confidence            45678999999999999999999999999999999999999986432111000 000011111122222111    1224


Q ss_pred             HHHHHHHHccCCCCCCCCCH
Q 016009          369 SIVEVVFSCLNESPESRPTM  388 (397)
Q Consensus       369 ~l~~l~~~cl~~~P~~RPt~  388 (397)
                      .+.+++.+||+.||++||++
T Consensus       229 ~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         229 KASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             HHHHHHHHHhccCHHHcCCC
Confidence            47889999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.5e-43  Score=324.39  Aligned_cols=251  Identities=23%  Similarity=0.307  Sum_probs=199.6

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||++... +|+.||+|+++.... ......+.+..|+.+++.++|+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence            46888899999999999999654 789999999874221 1112346688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          80 MEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             ECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            99999999999997653  3589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCC-cccccccccccCccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccC---
Q 016009          284 DSSN-WTEFAGTYGYVAPELAY------TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD---  353 (397)
Q Consensus       284 ~~~~-~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---  353 (397)
                      .... .....||+.|+|||++.      ...++.++|||||||++|||++|+.||........        ...+..   
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--------~~~i~~~~~  226 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT--------YNNIMNFQR  226 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH--------HHHHHcCCC
Confidence            3322 23346899999999986      45678899999999999999999999864332110        011110   


Q ss_pred             -CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          354 -PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       354 -~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       ...+...    .....+.+++..|++ +|++|||+++++++
T Consensus       227 ~~~~~~~~----~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         227 FLKFPEDP----KVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ccCCCCCC----CCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence             0111111    123457888999998 99999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-42  Score=310.59  Aligned_cols=261  Identities=21%  Similarity=0.348  Sum_probs=198.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeCC---------------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPS---------------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK  189 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  189 (397)
                      ++|+..+.||+|+||.||++....               ...||+|.++....   ......+.+|++++++++|+|+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT---KTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCCcCe
Confidence            478888999999999999986532               23589999875322   223567999999999999999999


Q ss_pred             eEEEEecCCeeeEEEEeccCCCHHHhhccccc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCC
Q 016009          190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAA---------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSK  260 (397)
Q Consensus       190 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~  260 (397)
                      +++++...+..++||||+++++|.+++.....         ...+++.+++.++.|++.||+|||+.   +++|+||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence            99999999999999999999999999864321         12478999999999999999999998   9999999999


Q ss_pred             cEEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCcccc
Q 016009          261 NLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK--GKHPRDFLSS  336 (397)
Q Consensus       261 Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t--g~~p~~~~~~  336 (397)
                      ||++++++.+||+|||++.........  .....++..|+|||...++.++.++||||||+++|||++  |..||.....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            999999999999999998765432211  122344678999999998889999999999999999998  5667654322


Q ss_pred             ccccccccccccccccCCC-CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          337 ISSSFLNTDIELDEMLDPR-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ....... ........... ...+.    ..+..+.+++.+||+.||++|||+.+|++.|+
T Consensus       239 ~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 EQVIENT-GEFFRNQGRQIYLSQTP----LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHH-HHhhhhccccccCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1100000 00000000000 00011    12346999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.4e-43  Score=328.63  Aligned_cols=254  Identities=20%  Similarity=0.277  Sum_probs=195.1

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|++.+.||+|+||.||++.. .+++.||+|.+..... ........+.+|++++++++||||+++++.+..++..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence            3688899999999999999965 4689999999864211 1112345688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..+..
T Consensus        80 ~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          80 MDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            99999999999996543   488899999999999999999998   999999999999999999999999999753210


Q ss_pred             CC-------------------------------------------CCcccccccccccCcccccCCCCCcchhhHHHHHH
Q 016009          284 DS-------------------------------------------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVL  320 (397)
Q Consensus       284 ~~-------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~  320 (397)
                      ..                                           .......||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                           00112468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 016009          321 ALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRP---TMKIVSQQ  394 (397)
Q Consensus       321 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP---t~~~vl~~  394 (397)
                      +|||++|+.||...........     ... .......+.  .......+.+++.+|+ .+|.+|+   |+.+++++
T Consensus       234 lyell~G~~Pf~~~~~~~~~~~-----i~~-~~~~~~~~~--~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQLK-----VIN-WETTLHIPS--QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHHH-----Hhc-cCccccCCC--CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999999875432110000     000 000111111  0112334667777766 4999999   89998864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-41  Score=304.88  Aligned_cols=251  Identities=26%  Similarity=0.452  Sum_probs=200.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|++.+.||+|+||.||+|...++..||+|.+....     ...+.+.+|++++++++||||+++++++.. ...++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   79 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-----cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence            4688889999999999999987777789999986422     124678999999999999999999998754 5679999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++|+|.+++..... ..+++.++..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||.+......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          80 EYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EcCCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            99999999999975432 3579999999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          285 SSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       285 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ... .....++..|+|||...+..++.++||||||+++|||+| |..||.......        ....+.. ....  ..
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--------~~~~~~~-~~~~--~~  224 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVER-GYRM--PC  224 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--------HHHHHhc-CCCC--CC
Confidence            221 122345678999999988889999999999999999999 888876432110        0111111 0000  01


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+..+.+++.+|++.||++|||+.++++.|+
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~  258 (262)
T cd05071         225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE  258 (262)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            1234566889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=304.95  Aligned_cols=255  Identities=21%  Similarity=0.318  Sum_probs=202.2

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCc-chhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSD-QIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      ++|...+.||+|++|.||++.. .+++.+++|.+....... .....+.+.+|++++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688899999999999999965 478999999986432211 12234578899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      |+||+++++|.+++....   .+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999986543   488899999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCCc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          283 PDSSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       283 ~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ......   ....++..|+|||.+.+..++.++||||+|+++|||++|+.||.........        .........  
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--------~~~~~~~~~--  225 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI--------FKIATQPTN--  225 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH--------HHHhccCCC--
Confidence            321111   2345788999999999988999999999999999999999998643321100        000000000  


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      ..........+.+++.+||+.+|++|||+.+++++.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence            001112334588999999999999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.8e-42  Score=323.08  Aligned_cols=258  Identities=24%  Similarity=0.407  Sum_probs=202.2

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEE
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGF  193 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~  193 (397)
                      ....++|...+.||+|+||.||+|.+.      .+..||+|+++.....   ...+.+.+|++++.++. ||||++++++
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS---SEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh---hHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            334456778889999999999999753      3468999999753221   22457889999999997 9999999999


Q ss_pred             EecCCeeeEEEEeccCCCHHHhhccccc----------------------------------------------------
Q 016009          194 CSHARHSFLVYEFLKRGSLAAILSSDAA----------------------------------------------------  221 (397)
Q Consensus       194 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------  221 (397)
                      +...+..++||||+++|+|.++++....                                                    
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            9999999999999999999999864321                                                    


Q ss_pred             -------------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCC
Q 016009          222 -------------------------------------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDIS  258 (397)
Q Consensus       222 -------------------------------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk  258 (397)
                                                                 ...+++.+++.++.|++.||+|||+.   +++|||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlk  266 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLA  266 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCC
Confidence                                                       12467888999999999999999998   99999999


Q ss_pred             CCcEEeCCCCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccc
Q 016009          259 SKNLLLDLEFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLS  335 (397)
Q Consensus       259 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~  335 (397)
                      |+||++++++.+||+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999976532221  1122356788999999998889999999999999999998 888976432


Q ss_pred             cccccccccccccccccCC--CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          336 SISSSFLNTDIELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...        .....+..  +...+.    .....+.+++.+||+.+|++||+++||++.|+
T Consensus       347 ~~~--------~~~~~~~~~~~~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~  397 (401)
T cd05107         347 MNE--------QFYNAIKRGYRMAKPA----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG  397 (401)
T ss_pred             chH--------HHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            111        01111111  111111    12345889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.6e-42  Score=326.90  Aligned_cols=251  Identities=20%  Similarity=0.289  Sum_probs=192.8

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      .|+..+.||+|+||.||+|.. .+++.||+|++..... ........+.+|++++++++||||+++++.+.+++..++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            577889999999999999965 4788999999864211 11123457889999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          81 DYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            9999999999986543   488899999999999999999998   9999999999999999999999999997532100


Q ss_pred             C-----------------------------------------------CCcccccccccccCcccccCCCCCcchhhHHH
Q 016009          285 S-----------------------------------------------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSF  317 (397)
Q Consensus       285 ~-----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~  317 (397)
                      .                                               .......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                               00112468999999999999899999999999


Q ss_pred             HHHHHHHHhCCCCCCcccccccccccccccccccc--CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC---HHHHH
Q 016009          318 GVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML--DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT---MKIVS  392 (397)
Q Consensus       318 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~~vl  392 (397)
                      ||++|||++|+.||........        ...+.  ......+..  ........+++.+++ .+|++|++   +++++
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~--------~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  303 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLET--------QMKVINWQTSLHIPPQ--AKLSPEASDLIIKLC-RGPEDRLGKNGADEIK  303 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHH--------HHHHHccCCCcCCCCc--ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence            9999999999999864332110        01111  111111110  112234666676665 49999987   88876


Q ss_pred             HH
Q 016009          393 QQ  394 (397)
Q Consensus       393 ~~  394 (397)
                      ++
T Consensus       304 ~h  305 (382)
T cd05625         304 AH  305 (382)
T ss_pred             cC
Confidence            53

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.5e-42  Score=308.81  Aligned_cols=257  Identities=24%  Similarity=0.371  Sum_probs=197.0

Q ss_pred             CCCccccccCcEEEEEEEe-----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC--Cee
Q 016009          128 DAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--RHS  200 (397)
Q Consensus       128 ~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  200 (397)
                      ...+.||+|+||+||++..     .+++.||+|.+.....   ......+.+|++++++++||||+++++++...  ...
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG---QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            7788899999999988642     3678899999865321   12356788999999999999999999988653  467


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      +++|||+++++|.+++...    .+++.+++.++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence            8999999999999998643    489999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCCC---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc------ccccccccc
Q 016009          281 LKPDSSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL------NTDIELDEM  351 (397)
Q Consensus       281 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~  351 (397)
                      .......   .....++..|+|||...+..++.++||||||+++|||+||..|+...........      .........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            6533221   1122456679999999888899999999999999999999999754321100000      000011111


Q ss_pred             cCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+.....+  .....+..+.+++..||+.+|++|||+++|+++|+
T Consensus       237 ~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~  279 (283)
T cd05080         237 LERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK  279 (283)
T ss_pred             hhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            11111110  01123456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.9e-42  Score=309.77  Aligned_cols=254  Identities=24%  Similarity=0.421  Sum_probs=198.8

Q ss_pred             CCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      +|...+.||+|+||.||+|...      ....+++|.+.....   .....++.+|+++++.++||||+++++.+...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS---SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC---HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence            4667788999999999999642      235788888764222   2234678999999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhcccc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCC
Q 016009          200 SFLVYEFLKRGSLAAILSSDA---------------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDIS  258 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk  258 (397)
                      .++++||+.+++|.+++....                     ....+++.+++.++.|++.||+|||+.   +++|||||
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dik  154 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLA  154 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhh
Confidence            999999999999999875421                     123588999999999999999999998   99999999


Q ss_pred             CCcEEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccc
Q 016009          259 SKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLS  335 (397)
Q Consensus       259 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~  335 (397)
                      |+||++++++.++|+|||++.........  .....++..|+|||...+..++.++||||||+++|||+| |..||....
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            99999999999999999999765433221  122345678999999988889999999999999999999 999986432


Q ss_pred             cccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          336 SISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...         +..........+  ........+.+++.+||+.+|++||++.++++.|+
T Consensus       235 ~~~---------~~~~~~~~~~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~  284 (290)
T cd05045         235 PER---------LFNLLKTGYRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE  284 (290)
T ss_pred             HHH---------HHHHHhCCCCCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            211         111111111100  01122346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.5e-42  Score=309.90  Aligned_cols=254  Identities=20%  Similarity=0.331  Sum_probs=199.8

Q ss_pred             CCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      +|...+.||+|+||.||+|...      +++.||+|++.....   ....+.+..|+.+++.++||||+++++++.....
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE---GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            4566788999999999999653      357899999875322   1234678899999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhcccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC
Q 016009          200 SFLVYEFLKRGSLAAILSSDA-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL  266 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  266 (397)
                      .++++||+++++|.+++....             ....+++..+..++.|++.||+|||+.   +++||||||+||++++
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence            999999999999999985321             123488899999999999999999998   9999999999999999


Q ss_pred             CCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccc
Q 016009          267 EFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLN  343 (397)
Q Consensus       267 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~  343 (397)
                      ++.+||+|||+++........  .....+++.|+|||.+.++.++.++||||||+++|||++ |..||......      
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------  233 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------  233 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence            999999999998765432211  123345778999999988889999999999999999998 88887532211      


Q ss_pred             cccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          344 TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        .....+.+.......   .+.+..+.+++..||+.+|++||++++|++.|+
T Consensus       234 --~~~~~i~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         234 --DVIEMIRNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             --HHHHHHHcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence              111222222211111   123455889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.5e-41  Score=306.88  Aligned_cols=250  Identities=25%  Similarity=0.400  Sum_probs=195.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCC----EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      ++|+..+.||+|+||.||+|.+. +++    .+++|.+.....   .....++..|+..+++++||||+++++++.. ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG---RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc---hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence            46778899999999999999753 454    477787653211   1224567888889999999999999998854 45


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++++||+++|+|.+++....  ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccce
Confidence            788999999999999997543  3589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--
Q 016009          280 FLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--  354 (397)
Q Consensus       280 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  354 (397)
                      .......  ......++..|+|||...++.++.++||||||+++||+++ |+.||.......         ..+++..  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---------~~~~~~~~~  228 (279)
T cd05111         158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---------VPDLLEKGE  228 (279)
T ss_pred             eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHHCCC
Confidence            6543322  1233456778999999998899999999999999999998 999986433211         0111111  


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+.    .+...+.+++.+||+.||++|||+.|+++.|+
T Consensus       229 ~~~~~~----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~  266 (279)
T cd05111         229 RLAQPQ----ICTIDVYMVMVKCWMIDENVRPTFKELANEFT  266 (279)
T ss_pred             cCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            111111    12345788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-41  Score=303.99  Aligned_cols=243  Identities=26%  Similarity=0.453  Sum_probs=193.4

Q ss_pred             cccccCcEEEEEEEe---CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          132 CIGNGGHGSVYRAEL---PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      .||+|+||.||+|.+   .++..+|+|+++....  .....+++..|+.+++.++||||+++++++. .+..++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN--DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC--cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence            589999999999954   3578899999864322  2234577899999999999999999999885 456789999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|.+++....   .+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++..........
T Consensus        79 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          79 LGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            999999986543   589999999999999999999998   99999999999999999999999999998664432211


Q ss_pred             ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--CCCCCCcc
Q 016009          289 ---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--RLPAPSRS  362 (397)
Q Consensus       289 ---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  362 (397)
                         ....++..|+|||.+....++.++|+||||+++|||++ |+.||.......         ....+..  ..+.+.  
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---------~~~~i~~~~~~~~~~--  221 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---------VTQMIESGERMECPQ--  221 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHCCCCCCCCC--
Confidence               12233578999999988889999999999999999998 999987433211         0111111  111111  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        .....+.+++.+||+.||++||++.+|.+.|+
T Consensus       222 --~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~  253 (257)
T cd05116         222 --RCPPEMYDLMKLCWTYGVDERPGFAVVELRLR  253 (257)
T ss_pred             --CCCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence              22345889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=307.31  Aligned_cols=255  Identities=24%  Similarity=0.386  Sum_probs=202.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  197 (397)
                      .++|...+.||+|+||.||+|...      ++..|++|.+....   .......+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            357888899999999999999653      24689999976422   222356788999999999999999999999999


Q ss_pred             CeeeEEEEeccCCCHHHhhccccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcE
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAA-------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEA  270 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  270 (397)
                      ...++||||+++|+|.+++.....       ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence            999999999999999999865332       22478999999999999999999998   99999999999999999999


Q ss_pred             EEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 016009          271 HVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIE  347 (397)
Q Consensus       271 kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  347 (397)
                      ||+|||+++.......  ......++..|+|||.+.+..++.++||||||+++||++| |..||.......        .
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------~  230 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--------V  230 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--------H
Confidence            9999999876543321  1123346788999999988889999999999999999998 999986432211        0


Q ss_pred             cccccCCCC-CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          348 LDEMLDPRL-PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       348 ~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...+.+... ..+.    .....+.+++.+||+.+|++|||+.++++.|+
T Consensus       231 ~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         231 LKFVIDGGHLDLPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111111111 1111    12456889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.1e-42  Score=308.28  Aligned_cols=255  Identities=26%  Similarity=0.415  Sum_probs=200.1

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH  196 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  196 (397)
                      .+++|...+.||+|++|.||+|...      .+..|++|.+.....   ......+..|+.++++++|+||+++++++..
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS---EQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            3467888899999999999999764      356789998754221   2234678999999999999999999999998


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC---c
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAA----AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF---E  269 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~  269 (397)
                      ....++||||+++++|.+++.....    ...+++.++..++.|++.||+|||+.   +++|+||||+||+++.++   .
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcc
Confidence            8899999999999999999865432    12589999999999999999999998   999999999999998765   5


Q ss_pred             EEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 016009          270 AHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI  346 (397)
Q Consensus       270 ~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~  346 (397)
                      +||+|||+++........  ......+..|+|||++.+..++.++|||||||++|||++ |..||.......        
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--------  229 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--------  229 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------
Confidence            999999999865322211  112233568999999998899999999999999999997 999986432110        


Q ss_pred             ccccccC--CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          347 ELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       347 ~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ....+.  .....+.    ..+..+.+++.+||+.+|++|||+.+|+++|+
T Consensus       230 -~~~~~~~~~~~~~~~----~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         230 -VMEFVTGGGRLDPPK----GCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -HHHHHHcCCcCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             011111  1111111    22346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-41  Score=309.05  Aligned_cols=262  Identities=24%  Similarity=0.397  Sum_probs=201.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCC-----------------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPS-----------------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN  186 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n  186 (397)
                      ..+|+..+.||+|+||.||++...+                 +..||+|.+.....   ....+.+.+|++++++++|||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS---DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC---HHHHHHHHHHHHHHHhcCCCC
Confidence            3578889999999999999986542                 24589999875322   133578899999999999999


Q ss_pred             eeeeEEEEecCCeeeEEEEeccCCCHHHhhccccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCC
Q 016009          187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAA--------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDIS  258 (397)
Q Consensus       187 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk  258 (397)
                      ++++++++..++..+++|||+++++|.+++.....        ...+++..++.++.|++.||+|||+.   +++|+|||
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk  157 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA  157 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence            99999999999999999999999999999865431        12589999999999999999999998   99999999


Q ss_pred             CCcEEeCCCCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCcc
Q 016009          259 SKNLLLDLEFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK--GKHPRDFL  334 (397)
Q Consensus       259 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t--g~~p~~~~  334 (397)
                      |+||+++.++.++|+|||++........  ......++..|+|||...+..++.++||||||+++|||++  |..|+...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9999999999999999999876533221  1223345778999999988889999999999999999998  67776533


Q ss_pred             cccccccccccccccccc-CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          335 SSISSSFLNTDIELDEML-DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .....  ..   ...... +.............+.++.+++.+||+.||++|||+.+|++.|+
T Consensus       238 ~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         238 TDQQV--IE---NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ChHHH--HH---HHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            21110  00   000000 00000000001122346899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.6e-42  Score=311.45  Aligned_cols=256  Identities=23%  Similarity=0.388  Sum_probs=201.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEec
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSH  196 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  196 (397)
                      .++|...+.||+|+||.||++..      .++..||+|.++....   ....+.+.+|+++++++ +||||+++++++..
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH---SSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC---hHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            35788899999999999999953      1345799998865322   22346789999999999 79999999999999


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                      .+..+++|||+++|+|.+++..... ..+++.++..++.+++.||+|||+.   +++|+||||+||+++.++.++++|||
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence            9999999999999999999865432 3489999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC
Q 016009          277 IAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD  353 (397)
Q Consensus       277 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  353 (397)
                      ++.........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......        .......
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------~~~~~~~  258 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------KFYKLIK  258 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--------HHHHHHH
Confidence            99865433211  122345678999999998889999999999999999998 999976432210        0111111


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       354 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ......  ........+.+++.+||+.+|++|||+.|+++.|+
T Consensus       259 ~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~  299 (302)
T cd05055         259 EGYRMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG  299 (302)
T ss_pred             cCCcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            111100  00112345889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.6e-41  Score=304.89  Aligned_cols=259  Identities=24%  Similarity=0.350  Sum_probs=200.4

Q ss_pred             HHHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          120 IVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       120 ~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      ++.+++++.....||+|+||.||+|.. .++..|++|.+....    ....+.+.+|++++++++|+||+++++++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG   78 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence            345667777778899999999999965 467889999876422    223567899999999999999999999999999


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC-CCcEEEeeecc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL-EFEAHVADFGI  277 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~  277 (397)
                      ..++|+||+++++|.+++.........++..+..++.|++.||+|||+.   +++|+||||+||+++. ++.++|+|||+
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~  155 (268)
T cd06624          79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGT  155 (268)
T ss_pred             EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchh
Confidence            9999999999999999997543211227888999999999999999998   9999999999999976 67999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMK--ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR  355 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  355 (397)
                      +..............++..|+|||+..+..  ++.++||||||+++|+|++|+.|+............  .... -..+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~--~~~~-~~~~~  232 (268)
T cd06624         156 SKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK--VGMF-KIHPE  232 (268)
T ss_pred             heecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh--hhhh-ccCCC
Confidence            876543333333446789999999986543  788999999999999999999998643211100000  0000 00111


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ++      ......+.+++.+||+.+|++|||+.|++++
T Consensus       233 ~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         233 IP------ESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             CC------cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            11      1233458889999999999999999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=294.95  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=206.5

Q ss_pred             hcCCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      ++.|+.-++||+|.|+.||++ ..++|+.+|+|.+......  ..+.+++.+|+.|.+.++||||+++...+.+....|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~--~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc--cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            346777788999999999999 5668999999988643222  2357889999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC---CcEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE---FEAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~  279 (397)
                      |+|+|.|++|..-+-.+.   -.++..+-..+.||+++|.|+|.+   +|||||+||+|+++-..   .-+||+|||++.
T Consensus        88 vFe~m~G~dl~~eIV~R~---~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EEecccchHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            999999999976664432   367888889999999999999999   99999999999999543   358999999999


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      .+. +.......+|||+|||||+++..+|+..+|||+.|++||-|+.|.+||.......        -.+.+.......+
T Consensus       162 ~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--------lye~I~~g~yd~~  232 (355)
T KOG0033|consen  162 EVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYEQIKAGAYDYP  232 (355)
T ss_pred             EeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--------HHHHHhccccCCC
Confidence            888 5556677899999999999999999999999999999999999999986422210        0111222222222


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +..+.....+..+|+.+||..||.+|.|+.|.+++
T Consensus       233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            22334445567889999999999999999998865

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.4e-42  Score=339.09  Aligned_cols=259  Identities=27%  Similarity=0.432  Sum_probs=200.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||+|... +|+.||+|++...... .....+.+.+|++++++++||||+++++++.+++..+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~-~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSE-NPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccccc-CHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            46888899999999999999654 6899999998753322 223356799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhcccc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          204 YEFLKRGSLAAILSSDA--------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                      |||++||+|.+++....        ....+++..++.++.|+++||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence            99999999999886421        113467788899999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCC------------------CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccc
Q 016009          276 GIAKFLKPDS------------------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSI  337 (397)
Q Consensus       276 g~~~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~  337 (397)
                      |++.......                  .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9998652110                  0011246899999999999999999999999999999999999998642211


Q ss_pred             cccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhc
Q 016009          338 SSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRP-TMKIVSQQLQ  396 (397)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~~vl~~Le  396 (397)
                      ....      ...+.++....+   ..+.+..+.+++.+|++.||++|| +++++++.|+
T Consensus       238 ki~~------~~~i~~P~~~~p---~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le  288 (932)
T PRK13184        238 KISY------RDVILSPIEVAP---YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE  288 (932)
T ss_pred             hhhh------hhhccChhhccc---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            0000      011111111001   123345688999999999999996 5666666553

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.5e-42  Score=304.03  Aligned_cols=251  Identities=21%  Similarity=0.318  Sum_probs=202.4

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|+||.||++... +++.+++|.++....   ....+.+..|+.+++.++|+|++++.+.+..++..+++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS---SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc---hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            4677889999999999999654 788999999864222   223567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++..... ..+++..++.++.|++.||.|||+.   +++|+||||+||++++++.++++|||.+......
T Consensus        78 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          78 EYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             eeCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            99999999998865332 4578999999999999999999998   9999999999999999999999999999766543


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      ........++..|+|||+..+..++.++|+||||+++|+|++|+.||........        ...+.........   .
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~---~  222 (255)
T cd08219         154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--------ILKVCQGSYKPLP---S  222 (255)
T ss_pred             ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--------HHHHhcCCCCCCC---c
Confidence            3333445688899999999988899999999999999999999999864322110        0011111111001   1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.+++.+||+.||++|||+.+++..
T Consensus       223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            223458899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.3e-42  Score=309.62  Aligned_cols=258  Identities=22%  Similarity=0.366  Sum_probs=200.9

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS  195 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  195 (397)
                      ...++|++.+.||+|+||.||+|...      .+..||+|.+.....   ......+.+|+.+++.++||||+++++++.
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS---LRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            34568899999999999999999543      245799998764221   223456889999999999999999999999


Q ss_pred             cCCeeeEEEEeccCCCHHHhhccccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC
Q 016009          196 HARHSFLVYEFLKRGSLAAILSSDAA-------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF  268 (397)
Q Consensus       196 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  268 (397)
                      ..+..++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+.   +++||||||+||++++++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~  156 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCC
Confidence            99999999999999999999964321       23467888999999999999999998   999999999999999999


Q ss_pred             cEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 016009          269 EAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTD  345 (397)
Q Consensus       269 ~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~  345 (397)
                      .++|+|||+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||......        
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--------  228 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------  228 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence            9999999998765432211  112234678999999998889999999999999999998 78887532211        


Q ss_pred             cccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          346 IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .....+.+.......   ......+.+++.+|++.||++|||+.++++.|+
T Consensus       229 ~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~  276 (288)
T cd05061         229 QVLKFVMDGGYLDQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK  276 (288)
T ss_pred             HHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            111111111111111   122346899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-41  Score=305.71  Aligned_cols=259  Identities=29%  Similarity=0.453  Sum_probs=197.8

Q ss_pred             cCCCCCccccccCcEEEEEEEe-----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec--C
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH--A  197 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~  197 (397)
                      .+|+..+.||+|+||.||++..     .++..|++|.+...    .....+.+.+|++++++++||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            4677889999999999999964     35789999998642    12235678999999999999999999998743  3


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++|+||||+||++++++.++|+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence            46889999999999999986543  3589999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCCc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccc-------cc
Q 016009          278 AKFLKPDSSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD-------IE  347 (397)
Q Consensus       278 ~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~-------~~  347 (397)
                      +..........   ....++..|+|||...+..++.++||||||+++|||++|..|+..............       ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence            98765432211   112234569999999888899999999999999999998877543221100000000       00


Q ss_pred             cccccCC--CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          348 LDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       348 ~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+.+..  ..+.+    ......+.+++.+||+.+|++|||+++|++.|+
T Consensus       235 ~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05081         235 LIELLKNNGRLPAP----PGCPAEIYAIMKECWNNDPSQRPSFSELALQVE  281 (284)
T ss_pred             HHHHHhcCCcCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            0011111  11111    122345889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.5e-41  Score=301.81  Aligned_cols=246  Identities=25%  Similarity=0.425  Sum_probs=196.8

Q ss_pred             cccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCC
Q 016009          132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGS  211 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  211 (397)
                      .||+|+||.||+|...+++.+|+|.+.....   ......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP---QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            5899999999999888899999999865322   1234568899999999999999999999999999999999999999


Q ss_pred             HHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc-cc
Q 016009          212 LAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW-TE  290 (397)
Q Consensus       212 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~  290 (397)
                      |.+++....  ..+++.+++.++.+++.||.|+|+.   +++|+||+|+||++++++.++|+|||++.......... ..
T Consensus        79 L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          79 FLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            999986543  3588999999999999999999998   99999999999999999999999999987543222111 12


Q ss_pred             ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHH
Q 016009          291 FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS  369 (397)
Q Consensus       291 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (397)
                      ..++..|+|||+..+..++.++||||||+++||+++ |..||..........     .....  .....+.    ..+..
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-----~~~~~--~~~~~~~----~~~~~  222 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-----QVEKG--YRMSCPQ----KCPDD  222 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-----HHHcC--CCCCCCC----CCCHH
Confidence            234567999999998889999999999999999998 999986432211000     00000  0111111    22356


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          370 IVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       370 l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+++.+|++.+|++||++.+++++|.
T Consensus       223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         223 VYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.8e-41  Score=308.91  Aligned_cols=261  Identities=22%  Similarity=0.375  Sum_probs=199.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-----------------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCce
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-----------------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI  187 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  187 (397)
                      ++|++.+.||+|+||.||++...                 ++..+|+|.+.....   ....+++.+|++++++++|+||
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN---KNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCc
Confidence            46888999999999999998532                 234689999864321   2235688999999999999999


Q ss_pred             eeeEEEEecCCeeeEEEEeccCCCHHHhhccccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCC
Q 016009          188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAA--------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISS  259 (397)
Q Consensus       188 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~  259 (397)
                      +++++++...+..++||||+++++|.+++.....        ...+++.+++.++.|++.||+|||+.   +++|+||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp  158 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT  158 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence            9999999999999999999999999999865331        12478889999999999999999998   999999999


Q ss_pred             CcEEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCccc
Q 016009          260 KNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK--GKHPRDFLS  335 (397)
Q Consensus       260 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t--g~~p~~~~~  335 (397)
                      +||++++++.++|+|||++..+......  .....++..|+|||...++.++.++||||||+++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            9999999999999999998765432211  122334678999999888889999999999999999998  677875332


Q ss_pred             ccccccccccccccc-ccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          336 SISSSFLNTDIELDE-MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       336 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..... ......... ......+.+.    .++..+.+++.+||+.||++|||+.+|++.|+
T Consensus       239 ~~~~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         239 DEQVI-ENTGEFFRDQGRQVYLPKPA----LCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             hHHHH-HHHHHHHhhccccccCCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            21100 000000000 0000111111    12356889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=303.51  Aligned_cols=253  Identities=26%  Similarity=0.519  Sum_probs=204.8

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      ..++|.+.+.||+|+||.||++..++++.+++|.+....     ...+++.+|++++++++|+|++++++++......++
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            346788899999999999999988888899999987422     235678999999999999999999999999899999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++++|.+++..... ..+++.++..++.+++.|++|||+.   +++|+||||+||++++++.++|+|||++....
T Consensus        79 v~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             EEeccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceecc
Confidence            9999999999999976442 4689999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCC
Q 016009          283 PDSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLPAP  359 (397)
Q Consensus       283 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  359 (397)
                      .... ......++..|+|||.+.+..++.++|+||||++++|++| |+.||......        .....+... ..+.+
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~  226 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVERGYRMPRP  226 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC
Confidence            3211 1112234568999999998889999999999999999999 99998543211        011111110 11111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .    +.+..+.+++.+|++.+|++||+++++++.|+
T Consensus       227 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         227 P----NCPEELYDLMLQCWDKDPEERPTFEYLQSFLE  259 (261)
T ss_pred             C----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence            1    12345889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.7e-41  Score=302.62  Aligned_cols=244  Identities=25%  Similarity=0.419  Sum_probs=191.6

Q ss_pred             ccccCcEEEEEEEeC---CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccC
Q 016009          133 IGNGGHGSVYRAELP---SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKR  209 (397)
Q Consensus       133 lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  209 (397)
                      ||+|+||.||+|.+.   ++..||+|.+.....   ....+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccC---hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            899999999999653   355799999865321   2235678999999999999999999998864 568999999999


Q ss_pred             CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc-
Q 016009          210 GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW-  288 (397)
Q Consensus       210 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  288 (397)
                      ++|.+++....  ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.......... 
T Consensus        79 ~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          79 GPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            99999986533  3589999999999999999999998   99999999999999999999999999997654332211 


Q ss_pred             --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCcchHH
Q 016009          289 --TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE  365 (397)
Q Consensus       289 --~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (397)
                        ....++..|+|||...+..++.++||||||+++||+++ |..||...........     +...  .....+.    .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-----~~~~--~~~~~~~----~  222 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF-----IEQG--KRLDCPA----E  222 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-----HHCC--CCCCCCC----C
Confidence              11223568999999988889999999999999999996 9999865432110000     0000  0111111    2


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          366 KLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       366 ~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...++.+++.+||+.||++||++.+|.+.|+
T Consensus       223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~  253 (257)
T cd05115         223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMR  253 (257)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2346889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=301.94  Aligned_cols=249  Identities=27%  Similarity=0.452  Sum_probs=202.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .++|+..+.||+|+||.||+|... |+.|++|.+.....     ..+++.+|+.++++++|+|++++++++...+..++|
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence            357888899999999999999874 78999999875321     357899999999999999999999999989999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++..... ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccc
Confidence            999999999999875442 3589999999999999999999998   999999999999999999999999999986532


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ...   ....+..|+|||.+.+..++.++||||||+++||+++ |..||.......         +...+.....  ...
T Consensus       155 ~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---------~~~~~~~~~~--~~~  220 (256)
T cd05039         155 GQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPHVEKGYR--MEA  220 (256)
T ss_pred             ccc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---------HHHHHhcCCC--CCC
Confidence            221   2334668999999988889999999999999999997 999976332110         0000000000  000


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ....+..+.+++.+||+.+|++|||+.+++++|+
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  254 (256)
T cd05039         221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA  254 (256)
T ss_pred             ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence            1122356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3e-41  Score=301.68  Aligned_cols=250  Identities=27%  Similarity=0.477  Sum_probs=199.9

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|...+.||+|++|.||++...++..+++|.+....     ...+.+.+|++++++++|+|++++++++. .+..+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT   79 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence            3577788899999999999988777789999876421     12467889999999999999999999875 45688999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++..... ..+++..+..++.+++.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          80 EFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EcCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            99999999999975432 4589999999999999999999998   9999999999999999999999999999765432


Q ss_pred             CC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCc
Q 016009          285 SS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLPAPSR  361 (397)
Q Consensus       285 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  361 (397)
                      .. ......++..|+|||...+..++.++||||||+++|||+| |+.||.......        ....+... ..+.+  
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~--  225 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--------VLEQVERGYRMPCP--  225 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCC--
Confidence            21 1122345678999999988889999999999999999999 899986432211        00111110 11111  


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        ...+..+.+++.+||+.||++||++++|++.|+
T Consensus       226 --~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  258 (260)
T cd05069         226 --QGCPESLHELMKLCWKKDPDERPTFEYIQSFLE  258 (260)
T ss_pred             --cccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence              133456889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-41  Score=301.17  Aligned_cols=248  Identities=29%  Similarity=0.508  Sum_probs=201.8

Q ss_pred             ccccccCcEEEEEEEeCC----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEe
Q 016009          131 YCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEF  206 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  206 (397)
                      +.||+|+||.||++....    +..|++|.+.......   ..+.+.+|++.++.++|+|++++++++......++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE---ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh---HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            359999999999997653    7899999987533322   367899999999999999999999999999999999999


Q ss_pred             ccCCCHHHhhccccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          207 LKRGSLAAILSSDAA------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       207 ~~~g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      +++++|.+++.....      ...+++.+++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence            999999999976521      24689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCC--CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCC
Q 016009          281 LKPDS--SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-PRL  356 (397)
Q Consensus       281 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~  356 (397)
                      .....  .......++..|+|||.+....++.++||||+|+++|||++ |..||.......        ....+.+ ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~  226 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--------VLEYLRKGYRL  226 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCC
Confidence            65432  12233457889999999988889999999999999999999 699987543211        0111111 111


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+    ...+..+.+++.+||+.+|++|||+.|++++|+
T Consensus       227 ~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 PKP----EYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCC----ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            111    122456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=305.04  Aligned_cols=250  Identities=30%  Similarity=0.463  Sum_probs=203.0

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||.|++|.||+|... +++.|++|.+.....   ......+.+|+++++.++|+|++++.+++..+...++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA---EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc---chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence            35777888999999999999654 688999999864321   22346788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      +||+++++|.+++...    .+++..++.++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        78 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          78 MEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             EEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            9999999999998653    589999999999999999999998   999999999999999999999999999987764


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........++..|+|||.+.+..++.++||||||+++|||+||+.||...........     ......+.....    
T Consensus       151 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-----~~~~~~~~~~~~----  221 (274)
T cd06609         151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-----IPKNNPPSLEGN----  221 (274)
T ss_pred             cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-----hhhcCCCCCccc----
Confidence            43333445788899999999988899999999999999999999999864332110000     000011111110    


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .....+.+++.+||..+|++|||+++++++
T Consensus       222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             133458899999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.6e-41  Score=306.72  Aligned_cols=253  Identities=26%  Similarity=0.486  Sum_probs=199.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      +++...+.||+|+||.||++...      ++..+++|.+...    .....+.+.+|+++++.++|+||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            35667888999999999999532      3567899987642    2233568999999999999999999999999999


Q ss_pred             eeeEEEEeccCCCHHHhhccccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAA------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL  266 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  266 (397)
                      ..+++|||+++++|.+++.....            ...+++.+++.++.|++.|++|||+.   +++|+||||+||++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence            99999999999999999865431            12488999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccc
Q 016009          267 EFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLN  343 (397)
Q Consensus       267 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~  343 (397)
                      ++.++|+|||++.........  .....+++.|+|||...+..++.++||||||+++|||++ |+.||.......     
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----  232 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-----  232 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-----
Confidence            999999999998755432211  122334678999999998889999999999999999998 899975432211     


Q ss_pred             cccccccccCCC-CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          344 TDIELDEMLDPR-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       344 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         ....+.... ...+.    ..+..+.+++.+||+.||++||++++|++.|+
T Consensus       233 ---~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         233 ---AIECITQGRELERPR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ---HHHHHHcCccCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence               011111111 11111    22345889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.4e-41  Score=309.54  Aligned_cols=250  Identities=27%  Similarity=0.447  Sum_probs=202.3

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .+|+..+.||.|++|.||+|.. .+++.|++|.+....    ....+.+.+|+++++.++|||++++++++...+..++|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence            3588888999999999999964 578999999986422    22356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      +||+++++|.+++...    .+++.++..++.+++.|++|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          95 MEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            9999999999988542    489999999999999999999998   999999999999999999999999999886654


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........++..|+|||.+.+..++.++||||||+++|+|++|+.||...........     ......+....+    
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~-----~~~~~~~~~~~~----  238 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGTPELQNP----  238 (296)
T ss_pred             ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhcCCcccCCc----
Confidence            43333445688899999999988899999999999999999999999865432111000     000000111111    


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+.+++.+||+.||++|||+.+++.+
T Consensus       239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            1233458889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-41  Score=308.52  Aligned_cols=253  Identities=20%  Similarity=0.253  Sum_probs=197.1

Q ss_pred             CCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |+..+.||+|+||+||++.. .+++.+|+|.+..... ........+.+|++++++++|+|++++.+++..++..+++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI-KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh-hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            55667899999999999965 4789999999864221 111223457889999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          81 IMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             eccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999999988865432 3599999999999999999999998   99999999999999999999999999987654322


Q ss_pred             CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHH
Q 016009          286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE  365 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (397)
                       ......|+..|+|||.+.+..++.++|+||||+++|||++|..||.........    ......+......    ....
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~----~~~~~~~~~~~~~----~~~~  227 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR----EEVDRRVLETEEV----YSAK  227 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhhhccccc----cCcc
Confidence             223457899999999999888999999999999999999999998643211000    0000011111111    1112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 016009          366 KLRSIVEVVFSCLNESPESRPT-----MKIVSQ  393 (397)
Q Consensus       366 ~~~~l~~l~~~cl~~~P~~RPt-----~~~vl~  393 (397)
                      ....+.+|+..|++.||++||+     +.+++.
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            3345788999999999999999     667665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-41  Score=307.86  Aligned_cols=263  Identities=24%  Similarity=0.306  Sum_probs=198.5

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|++|.||+|... +++.||+|++......  ......+.+|+.++++++|||++++++++..++..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE--EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc--CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence            4677888999999999999764 7899999998653221  223467889999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||++ ++|.+++........+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence            9997 68888886544445689999999999999999999998   9999999999999999999999999998765433


Q ss_pred             CCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc-------cccc---cccccc-
Q 016009          285 SSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL-------NTDI---ELDEML-  352 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~-------~~~~---~~~~~~-  352 (397)
                      ........+++.|+|||.+.+. .++.++||||||+++|||+||+.||...........       ..+.   ...... 
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            3333334678899999987654 578899999999999999999999864322110000       0000   000000 


Q ss_pred             -CCCCCC-CC----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          353 -DPRLPA-PS----RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       353 -~~~~~~-~~----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .+..+. ..    ........++.+++.+||+.||++|||+++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             000000 00    0001123457899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.4e-41  Score=303.70  Aligned_cols=253  Identities=28%  Similarity=0.504  Sum_probs=201.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCC---EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQ---VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      .++|+..+.||+|+||.||+|... +++   .+++|.+.....   ....+.+..|++++++++|||++++.+++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT---EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC---HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            346788899999999999999764 333   799998864322   2235678999999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++|+||||+||++++++.++|+|||++.
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccce
Confidence            999999999999999986543  3589999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCCCc-c--cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-
Q 016009          280 FLKPDSSNW-T--EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-  354 (397)
Q Consensus       280 ~~~~~~~~~-~--~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  354 (397)
                      ......... .  ....+..|+|||++.+..++.++||||||+++|||++ |+.||......        .....+... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i~~~~  227 (268)
T cd05063         156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAINDGF  227 (268)
T ss_pred             ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhcCC
Confidence            654322211 1  1123457999999988889999999999999999998 99998543221        011111111 


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+    .+....+.+++.+||+.+|++||++.+|++.|+
T Consensus       228 ~~~~~----~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~  265 (268)
T cd05063         228 RLPAP----MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD  265 (268)
T ss_pred             CCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            11111    123456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.9e-42  Score=308.80  Aligned_cols=254  Identities=21%  Similarity=0.282  Sum_probs=198.9

Q ss_pred             CCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |+..+.||+|+||.||++.. .+++.||+|.+...... .......+..|+.++++++|+|++++++.+...+..++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            56678899999999999965 47899999998642221 12223567889999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |+++++|.+++..... ..+++.++..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999998854332 4589999999999999999999998   99999999999999999999999999987654322


Q ss_pred             CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHH
Q 016009          286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE  365 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (397)
                       ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........     .............   .....
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-----~~~~~~~~~~~~~---~~~~~  227 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-----REEVERLVKEVQE---EYSEK  227 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-----HHHHHhhhhhhhh---hcCcc
Confidence             22334789999999999998999999999999999999999999864321100     0001111110000   00112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 016009          366 KLRSIVEVVFSCLNESPESRPT-----MKIVSQQ  394 (397)
Q Consensus       366 ~~~~l~~l~~~cl~~~P~~RPt-----~~~vl~~  394 (397)
                      ....+.+++..||+.||++|||     ++|++++
T Consensus       228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            2345889999999999999999     8888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.6e-41  Score=303.21  Aligned_cols=252  Identities=25%  Similarity=0.419  Sum_probs=194.3

Q ss_pred             CCCccccccCcEEEEEEEeCC-CC--EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC------C
Q 016009          128 DAQYCIGNGGHGSVYRAELPS-GQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA------R  198 (397)
Q Consensus       128 ~~~~~lg~G~~g~vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  198 (397)
                      .+.+.||+|+||.||+|...+ +.  .+|+|.++.....  ....+.+..|+++++.++|+||+++++++...      .
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT--RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            456789999999999997654 33  5899988653222  23357789999999999999999999987432      2


Q ss_pred             eeeEEEEeccCCCHHHhhcccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          199 HSFLVYEFLKRGSLAAILSSDA---AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                      ..+++|||+++|+|.+++....   ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence            4689999999999998874322   123589999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc
Q 016009          276 GIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEML  352 (397)
Q Consensus       276 g~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  352 (397)
                      |++.........  .....+++.|+|||...+..++.++||||||+++|||++ |+.||.......        ....+.
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~  228 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--------IYDYLR  228 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHH
Confidence            999876433221  122345678999999998899999999999999999999 788886432210        001111


Q ss_pred             CC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          353 DP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       353 ~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .. ....+.    .....+.+++.+||+.||++|||+.++++.|+
T Consensus       229 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  269 (272)
T cd05075         229 QGNRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELE  269 (272)
T ss_pred             cCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            11 111111    22345889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-42  Score=310.00  Aligned_cols=255  Identities=30%  Similarity=0.513  Sum_probs=199.7

Q ss_pred             CCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |+..+.||+|+||+||++... +++.+|+|.+.....  ..........|+.++++++||||+++++++......++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhcccccccccccccccccccccccccccc
Confidence            456788999999999999765 566899999875322  22223344569999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |+++++|.+++...   ..+++..++.++.|+++||.+||+.   +++|+||||+||++++++.++|+|||.+.......
T Consensus        79 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   79 YCPGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             EETTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred             cccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            99999999999732   4589999999999999999999999   99999999999999999999999999997653333


Q ss_pred             CCcccccccccccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          286 SNWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      .......++..|+|||... +..++.++||||+|+++++|++|..||...........     .................
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  227 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI-----IEKILKRPLPSSSQQSR  227 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH-----HHHHHHTHHHHHTTSHT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh-----hhhcccccccccccccc
Confidence            4445567899999999998 88899999999999999999999999875411110000     00000000000000000


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.+++..||+.||++|||+.+++++
T Consensus       228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  228 EKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             TSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             hhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            112569999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.7e-41  Score=309.25  Aligned_cols=253  Identities=27%  Similarity=0.421  Sum_probs=196.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCC--EEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  200 (397)
                      ++|++.+.||+|+||.||+|..+ ++.  .+++|.++....   ....+.+.+|++++.++ +||||+++++++...+..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~   78 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS---ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL   78 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC---HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence            47888899999999999999765 333  478888763221   12346789999999999 799999999999999999


Q ss_pred             eEEEEeccCCCHHHhhcccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC
Q 016009          201 FLVYEFLKRGSLAAILSSDA-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE  267 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  267 (397)
                      ++++||+++++|.+++....             ....+++.+++.++.|++.||+|||+.   +++|+||||+||+++++
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~  155 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGEN  155 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCC
Confidence            99999999999999986532             113588999999999999999999998   99999999999999999


Q ss_pred             CcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 016009          268 FEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI  346 (397)
Q Consensus       268 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~  346 (397)
                      +.+||+|||++........ ......+..|+|||...+..++.++||||||+++|||++ |..||.......        
T Consensus       156 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--------  226 (297)
T cd05089         156 LASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------  226 (297)
T ss_pred             CeEEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------
Confidence            9999999999864321111 111223457999999988889999999999999999998 999986432211        


Q ss_pred             ccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          347 ELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       347 ~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ....+... ....+    ......+.+++.+||+.+|.+|||++++++.|+
T Consensus       227 ~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  273 (297)
T cd05089         227 LYEKLPQGYRMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLS  273 (297)
T ss_pred             HHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            00011100 11111    122345889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.3e-41  Score=300.70  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=205.1

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||.|+||.||.++. .+++.+++|.+.....  .....+++.+|++++++++|+||+++++++.+.+..+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence            477788999999999999954 4688999998764221  1233567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++.... ...+++.++..++.|++.|+.|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          79 EYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             EecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            9999999999997653 24589999999999999999999998   9999999999999999999999999999876544


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      ........+++.|+|||...+..++.++||||||+++|||++|..||......        .....+.........   .
T Consensus       155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~---~  223 (256)
T cd08221         155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--------NLVVKIVQGNYTPVV---S  223 (256)
T ss_pred             cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCCCCc---c
Confidence            43334457899999999998888899999999999999999999998642211        111111111111111   2


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      .....+.+++.+||+.+|++||+++++++++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            2345588999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-41  Score=311.21  Aligned_cols=261  Identities=18%  Similarity=0.285  Sum_probs=197.6

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||+|..+ +++.||+|.+......   .....+.+|++++++++||||+++++++..++..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC---CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            46888899999999999999654 6788999998653221   1234677899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++ +|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          83 FEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             EeCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            999975 8888775543  3588999999999999999999998   999999999999999999999999999976544


Q ss_pred             CCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccc-----cc--ccccccc------c
Q 016009          284 DSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS-----SF--LNTDIEL------D  349 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~-----~~--~~~~~~~------~  349 (397)
                      .........++..|+|||.+.+ ..++.++||||||+++|||+||+.||........     ..  .......      .
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence            3333344567899999998765 4588999999999999999999999864322100     00  0000000      0


Q ss_pred             cccCCCCCCC-C----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          350 EMLDPRLPAP-S----RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       350 ~~~~~~~~~~-~----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+...+.. .    .........+.+++.+|++.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            0000000000 0    0001123457899999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.4e-41  Score=307.17  Aligned_cols=256  Identities=23%  Similarity=0.368  Sum_probs=202.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCC-----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec-C
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPS-----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH-A  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~  197 (397)
                      .++|...+.||+|+||.||+|...+     +..|++|++....   .....+.+.+|+.++++++|+|++++++++.. +
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA---SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            4578888999999999999997655     6889999876422   22335778899999999999999999998865 5


Q ss_pred             CeeeEEEEeccCCCHHHhhcccccc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEE
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAA-----QELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV  272 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  272 (397)
                      ...++++||+++++|.+++......     ..+++.+++.++.+++.||+|||+.   +++|+||||+||++++++.+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence            6789999999999999998654322     4689999999999999999999998   9999999999999999999999


Q ss_pred             eeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccc
Q 016009          273 ADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELD  349 (397)
Q Consensus       273 ~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  349 (397)
                      +|||+++.+......  .....++..|+|||++.+..++.++||||||+++||+++ |+.||..........     ...
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-----~~~  233 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA-----YLK  233 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH-----HHH
Confidence            999999865433221  122345678999999988889999999999999999999 999986433211000     000


Q ss_pred             cccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .  ......+    ...+..+.+++.+||+.||++|||+.++++.|+
T Consensus       234 ~--~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  274 (280)
T cd05043         234 D--GYRLAQP----INCPDELFAVMACCWALDPEERPSFSQLVQCLT  274 (280)
T ss_pred             c--CCCCCCC----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            0  0011111    122346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.9e-42  Score=322.20  Aligned_cols=260  Identities=21%  Similarity=0.310  Sum_probs=200.8

Q ss_pred             HHHHHHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec
Q 016009          118 DEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH  196 (397)
Q Consensus       118 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  196 (397)
                      .++....++|+..+.||+|+||.||++... +++.+|+|.+..... ......+.+.+|+.+++.++||||+++++++..
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            344555689999999999999999999665 688999999753111 111224567889999999999999999999999


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                      ++..++||||+++|+|.+++...    .++...+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            99999999999999999998643    478888999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCC-CcccccccccccCcccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 016009          277 IAKFLKPDSS-NWTEFAGTYGYVAPELAYTM----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       277 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      ++........ ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.......        ....+
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i  259 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKI  259 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH--------HHHHH
Confidence            9987643322 22345799999999998754    37889999999999999999999987433211        01111


Q ss_pred             cCC--CCCCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHh
Q 016009          352 LDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPES--RPTMKIVSQQL  395 (397)
Q Consensus       352 ~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~~vl~~L  395 (397)
                      ...  .+..+.  .......+.+++..|++.++.+  ||++++++++.
T Consensus       260 ~~~~~~~~~~~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         260 MNHKNSLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HcCCCcccCCC--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            111  111111  1123445788899999844443  78999998763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.1e-41  Score=307.43  Aligned_cols=249  Identities=26%  Similarity=0.421  Sum_probs=202.0

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .+|+..+.||+|++|.||++.. .+++.||+|.+.....    ...+.+.+|+.+++.++|+|++++++++..++..++|
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            5788889999999999999965 5799999999864221    2346788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++..    ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          95 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             ecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            999999999999854    2478999999999999999999998   999999999999999999999999999876554


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........+++.|+|||...+..++.++|+||||+++|++++|+.||............     .....+...    ..
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-----~~~~~~~~~----~~  238 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----ATNGTPELQ----NP  238 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-----ccCCCCCCC----Cc
Confidence            433334456888999999999888999999999999999999999998643221110000     000001111    11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      ......+.+++.+||+.+|++||+++++++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            223345788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.8e-41  Score=305.05  Aligned_cols=251  Identities=24%  Similarity=0.377  Sum_probs=197.4

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+.....   ....+.+.+|++++++++|||++++++++...+..++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT---VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC---hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            577788999999999999964 5789999999864221   223467899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|..+.       .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            999999997542       377888999999999999999998   9999999999999999999999999999765432


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........... .......+.++..+...  ..
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~  223 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-PLQLLQCIVDEDPPVLP--VG  223 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-hHHHHHHHhccCCCCCC--CC
Confidence              22335789999999999988899999999999999999999999864322110000 00001111111111100  01


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.+++.+|++.+|++||+++|++++
T Consensus       224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         224 QFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            123458899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5e-41  Score=301.84  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=189.5

Q ss_pred             cccccCcEEEEEEEeCC---CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          132 CIGNGGHGSVYRAELPS---GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      .||+|+||.||+|...+   +..+++|.++....   ......+.+|+.++++++||||+++++++.+....++||||++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS---VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            58999999999997543   45799998865322   1234578899999999999999999999999999999999999


Q ss_pred             CCCHHHhhccccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC
Q 016009          209 RGSLAAILSSDAA--AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS  286 (397)
Q Consensus       209 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  286 (397)
                      +|+|.+++.....  ....++..+..++.|++.|++|||+.   +++|+||||+||+++.+++++|+|||++........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            9999999965432  23467788889999999999999998   999999999999999999999999999875432221


Q ss_pred             C--cccccccccccCcccccCC-------CCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 016009          287 N--WTEFAGTYGYVAPELAYTM-------KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       287 ~--~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      .  .....++..|+|||++.+.       .++.++|+||||+++|||++ |+.||.....................++..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL  235 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence            1  1224567889999987642       35789999999999999996 999986433211000000000011111111


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..      .....+.+++..|| .+|++|||++||++.|+
T Consensus       236 ~~------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         236 KL------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CC------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            10      12234778888999 58999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.8e-42  Score=310.95  Aligned_cols=257  Identities=25%  Similarity=0.426  Sum_probs=202.1

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEE
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFC  194 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  194 (397)
                      ...++|+..+.||+|+||.||++...      +...+|+|.+.....   ......+.+|+++++++ +|+||+++++++
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC---HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            34457888899999999999999653      236799998875322   12346688999999999 899999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCc
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSD-------------AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN  261 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  261 (397)
                      ..++..+++|||+++|+|.+++...             .....+++..++.++.|++.||+|||+.   +++|+||||+|
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N  162 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN  162 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence            9999999999999999999998643             1234689999999999999999999998   99999999999


Q ss_pred             EEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccc
Q 016009          262 LLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS  338 (397)
Q Consensus       262 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  338 (397)
                      |++++++.+||+|||++.........  .....++..|+|||...+..++.++|||||||++|||++ |..||.......
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            99999999999999999865433211  122234678999999988889999999999999999998 988875332111


Q ss_pred             ccccccccccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          339 SSFLNTDIELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       339 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .        ...+... ....+.    .....+.+++.+||+.||++|||+.|+++.|+
T Consensus       243 ~--------~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~  289 (293)
T cd05053         243 L--------FKLLKEGYRMEKPQ----NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD  289 (293)
T ss_pred             H--------HHHHHcCCcCCCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence            0        0000010 111111    22345889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-41  Score=307.76  Aligned_cols=264  Identities=24%  Similarity=0.391  Sum_probs=205.1

Q ss_pred             ccHHHHHHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEE
Q 016009          115 LVYDEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYG  192 (397)
Q Consensus       115 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~  192 (397)
                      +.++.+..+.++|+..+.||+|+||.||++.. .+++.+++|.+....     .....+..|+.+++++ +|||++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeee
Confidence            44566677889999999999999999999965 468899999875311     1235678899999999 6999999999


Q ss_pred             EEe-----cCCeeeEEEEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC
Q 016009          193 FCS-----HARHSFLVYEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL  266 (397)
Q Consensus       193 ~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  266 (397)
                      ++.     .++..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.   +++|+||||+||++++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~  159 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT  159 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence            883     3457899999999999999875422 224588999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeeeccccccCCCCCCcccccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc
Q 016009          267 EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF  341 (397)
Q Consensus       267 ~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~  341 (397)
                      ++.++|+|||++..............|+..|+|||++..     ..++.++||||+|+++|||++|+.|+..........
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~  239 (286)
T cd06638         160 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF  239 (286)
T ss_pred             CCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence            999999999998866543333344568999999998753     447889999999999999999999986443211100


Q ss_pred             cccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          342 LNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      .     ......+....+.    .....+.+++.+||+.||++|||+.|+++.+
T Consensus       240 ~-----~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 K-----IPRNPPPTLHQPE----LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             h-----ccccCCCcccCCC----CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            0     0000011111111    1234588999999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.1e-41  Score=307.40  Aligned_cols=256  Identities=24%  Similarity=0.417  Sum_probs=201.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  197 (397)
                      .++|+..+.||+|+||.||++...      ++..||+|.+.....   ....+++.+|+.++++++|||++++++++..+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC---HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            467888999999999999999753      467899999864222   22356789999999999999999999999999


Q ss_pred             CeeeEEEEeccCCCHHHhhcccc-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCC
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDA-------------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDIS  258 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk  258 (397)
                      ...++||||+++|+|.+++....                   ....+++.+++.++.|++.||+|||+.   +++|+|||
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~  157 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA  157 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence            99999999999999999986432                   112478899999999999999999998   99999999


Q ss_pred             CCcEEeCCCCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccc
Q 016009          259 SKNLLLDLEFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLS  335 (397)
Q Consensus       259 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~  335 (397)
                      |+||++++++.++|+|||++........  .......+..|+|||...+..++.++||||||+++|||++ |..||....
T Consensus       158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999875432221  1112234667999999988899999999999999999998 888875332


Q ss_pred             cccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          336 SISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..        .....+.+.......   ...+..+.+++.+||+.+|++|||+.|+++.||
T Consensus       238 ~~--------~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         238 HE--------EVIYYVRDGNVLSCP---DNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HH--------HHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            11        111111111111101   122356889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.5e-41  Score=303.46  Aligned_cols=252  Identities=26%  Similarity=0.470  Sum_probs=200.6

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-C---CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-S---GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      .+|++.+.||+|+||.||+|... +   +..+|+|.++....   ....+.+..|+.++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            46778899999999999999653 2   33799999864322   12356789999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++++|.+++....  ..+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.++++|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            99999999999999997543  3589999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCCc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-C
Q 016009          281 LKPDSSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-R  355 (397)
Q Consensus       281 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~  355 (397)
                      ........   ....++..|+|||.+.+..++.++|+||||+++||+++ |..||.......        ....+.+. .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~  227 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYR  227 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCCc
Confidence            65432211   11223568999999998889999999999999999887 999986433211        01111111 1


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+.+.    ..+..+.+++.+|++.+|++||++.++++.|+
T Consensus       228 ~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  264 (267)
T cd05066         228 LPAPM----DCPAALHQLMLDCWQKDRNERPKFEQIVSILD  264 (267)
T ss_pred             CCCCC----CCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence            11111    22345889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-43  Score=319.16  Aligned_cols=247  Identities=30%  Similarity=0.441  Sum_probs=202.8

Q ss_pred             CCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |...+.||.|+||.||.+. ..+.+.||||++.-..+. ....-++++.|+..|++++|||.+.+-|+|..+...|||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ-s~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccc-cHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4556779999999999995 457889999999753332 22335789999999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      ||- ||-.|++.-..  +++.+..+..|+.+.+.||+|||+.   +.||||||+.|||+++.|.+||+|||.+....+. 
T Consensus       107 YCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-  179 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-  179 (948)
T ss_pred             HHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence            995 58888876544  5788899999999999999999999   9999999999999999999999999999765543 


Q ss_pred             CCcccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          286 SNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                         ..++|||.|||||++.   .++|+-++||||||++..||...++|.-.+..+..-+..     ..--.|.+.     
T Consensus       180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-----AQNesPtLq-----  246 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-----AQNESPTLQ-----  246 (948)
T ss_pred             ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-----HhcCCCCCC-----
Confidence               3468999999999876   578999999999999999999999996555443322211     111122332     


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..++...+.+++..||++-|.+|||.++++++
T Consensus       247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            23667778999999999999999999999875

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2e-41  Score=310.22  Aligned_cols=256  Identities=25%  Similarity=0.394  Sum_probs=199.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC--------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFC  194 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  194 (397)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.+.....   .....++..|+++++.+ +||||+++++++
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC---hHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            357888899999999999999642        235799999875321   22356788999999999 799999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCc
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN  261 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  261 (397)
                      ...+..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+.   +++|+||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence            999999999999999999999975421             13489999999999999999999998   99999999999


Q ss_pred             EEeCCCCcEEEeeeccccccCCCCCCc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccc
Q 016009          262 LLLDLEFEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS  338 (397)
Q Consensus       262 ill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  338 (397)
                      |++++++.++|+|||.+..........  ....++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            999999999999999987654322111  11223568999999998889999999999999999998 888875322110


Q ss_pred             ccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          339 SSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                               ....+.....  ..........+.+++.+||+.+|++|||+.+|++.|+
T Consensus       251 ---------~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~  297 (307)
T cd05098         251 ---------LFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  297 (307)
T ss_pred             ---------HHHHHHcCCC--CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence                     0000100100  0001123346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-41  Score=299.06  Aligned_cols=253  Identities=24%  Similarity=0.298  Sum_probs=205.1

Q ss_pred             CCCCCccccccCcEEEEEEEeCC-CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||.|.-|+||++++.+ +..+|+|++.+..-. ......+...|.+||+.++||.++.+++.++.+...+|+|
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~-~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA-SRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh-hhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            45667889999999999998764 589999998753221 1223456788999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC-
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP-  283 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-  283 (397)
                      |||+||+|..+.+.+.. +.+++..++-++.+|+-||+|||-.   |||.|||||+|||+.++|++.|+||.++..... 
T Consensus       157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999998876554 6799999999999999999999999   999999999999999999999999998753210 


Q ss_pred             --------------------------------CCC-----------------------CcccccccccccCcccccCCCC
Q 016009          284 --------------------------------DSS-----------------------NWTEFAGTYGYVAPELAYTMKI  308 (397)
Q Consensus       284 --------------------------------~~~-----------------------~~~~~~g~~~y~aPE~~~~~~~  308 (397)
                                                      ...                       .....+||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                       0123468999999999999999


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC-
Q 016009          309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT-  387 (397)
Q Consensus       309 ~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-  387 (397)
                      +.++|+|+|||++|||+.|..||.....        .+.+..++-..+..+..  .+.+..+.+||.+.|.+||++|.. 
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~--------~~Tl~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNN--------KETLRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCc--------hhhHHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhcc
Confidence            9999999999999999999999864332        23344444444443322  145567999999999999999987 


Q ss_pred             ---HHHHHH
Q 016009          388 ---MKIVSQ  393 (397)
Q Consensus       388 ---~~~vl~  393 (397)
                         +.||-+
T Consensus       383 ~rGA~eIK~  391 (459)
T KOG0610|consen  383 KRGAAEIKR  391 (459)
T ss_pred             ccchHHhhc
Confidence               666644

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-41  Score=302.38  Aligned_cols=254  Identities=24%  Similarity=0.414  Sum_probs=197.6

Q ss_pred             CCCCccccccCcEEEEEEEeCC----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe---
Q 016009          127 FDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH---  199 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  199 (397)
                      |...+.||+|+||.||+|....    +..||+|.++.....  ......+.+|++.++.++||||+++++++.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT--YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence            4567889999999999996542    367999998753222  2235678999999999999999999998865544   


Q ss_pred             ---eeEEEEeccCCCHHHhhcccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEe
Q 016009          200 ---SFLVYEFLKRGSLAAILSSDA---AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVA  273 (397)
Q Consensus       200 ---~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  273 (397)
                         .++++||+++|+|..++....   ....+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence               799999999999999985432   223589999999999999999999998   99999999999999999999999


Q ss_pred             eeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccccccc
Q 016009          274 DFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE  350 (397)
Q Consensus       274 Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  350 (397)
                      |||+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......        ....
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--------~~~~  227 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--------IYDY  227 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHH
Confidence            99999865433221  112234678999999988889999999999999999999 888876432211        1111


Q ss_pred             ccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+.....   ........+.+++.+||+.||++|||+.|+++.|+
T Consensus       228 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~  270 (273)
T cd05035         228 LRHGNRLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE  270 (273)
T ss_pred             HHcCCCCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111110   01123456899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.9e-41  Score=304.19  Aligned_cols=253  Identities=28%  Similarity=0.403  Sum_probs=199.0

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||+|.. .+++.||+|.++....    .....+.+|+.+++.++||||+++++++...+..++|
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG----EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            4677788899999999999965 4688999999864221    2245678899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++....   .+++.+++.++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          85 MEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            99999999999986543   589999999999999999999998   999999999999999999999999999876544


Q ss_pred             CCCCcccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          284 DSSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      .........|+..|+|||.+.   ...++.++|||||||++|||++|..|+.............   ......+....  
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~~--  233 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT---KSNFQPPKLKD--  233 (267)
T ss_pred             cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh---ccCCCCCcccc--
Confidence            333334457899999999874   4568899999999999999999999975332211000000   00000111110  


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        .......+.+++.+|++.+|++|||+++|+++
T Consensus       234 --~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         234 --KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             --cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence              01123458899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3e-41  Score=304.88  Aligned_cols=251  Identities=24%  Similarity=0.458  Sum_probs=198.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCC----EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      .++|+..+.||+|+||+||+|.. .+|.    .||+|.+.....   ......+.+|+.+++.++||||+++++++... 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS---PKANKEILDEAYVMAGVGSPYVCRLLGICLTS-   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC---HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence            35788889999999999999964 4554    489999864322   22356788999999999999999999999754 


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA  278 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  278 (397)
                      ..++++||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence            5789999999999999987543  3589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCCc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-
Q 016009          279 KFLKPDSSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-  354 (397)
Q Consensus       279 ~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  354 (397)
                      +.........  ....++..|+|||...+..++.++||||||+++|||++ |..||+......         ....+.. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---------~~~~~~~~  227 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---------IPDLLEKG  227 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHHCC
Confidence            8765332221  12234678999999998889999999999999999998 899986432110         0111111 


Q ss_pred             -CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 -RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 -~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ..+.+    ......+.+++.+||+.||++||++.++++.|+
T Consensus       228 ~~~~~~----~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~  266 (279)
T cd05109         228 ERLPQP----PICTIDVYMIMVKCWMIDSECRPRFRELVDEFS  266 (279)
T ss_pred             CcCCCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence             11111    123456889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.6e-41  Score=299.91  Aligned_cols=252  Identities=25%  Similarity=0.348  Sum_probs=201.1

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec-CCeeeEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH-ARHSFLV  203 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv  203 (397)
                      +|+..+.||+|++|.||++... +++.|++|.+.....  .....+.+.+|++++++++|+|++++.+.+.. ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence            4777889999999999999654 678999999864221  12235678899999999999999999998764 4467899


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++.... ...+++.++..++.+++.|++|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 ~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          79 MGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            99999999999997543 24589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........+++.|+|||.+.+..++.++||||||+++++|++|+.||.......        ....+.....+..   .
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--------~~~~~~~~~~~~~---~  223 (257)
T cd08223         155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS--------LVYRIIEGKLPPM---P  223 (257)
T ss_pred             cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHhcCCCCC---c
Confidence            3333344568899999999999889999999999999999999999986322110        0011111111111   1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+.+++.+|++.||++|||+.+++++
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            2334568899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.4e-41  Score=301.99  Aligned_cols=248  Identities=27%  Similarity=0.431  Sum_probs=202.2

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      .|+..+.||.|+||.||+|... +++.||+|.+.....   ......+.+|++++++++|||++++++++.+....++||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            4666788999999999999754 688999998764221   123567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++..    .++++.++..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          82 EYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            99999999999864    2488899999999999999999998   9999999999999999999999999999766543


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      ........++..|+|||.+.+..++.++|+||||+++|||+||+.|+..........         ......  +.....
T Consensus       155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---------~~~~~~--~~~~~~  223 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF---------LIPKNN--PPTLTG  223 (277)
T ss_pred             ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh---------hhhcCC--CCCCch
Confidence            333334467889999999988889999999999999999999999986443211100         000000  111223


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.+++.+||+.+|++||++.++++.
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         224 EFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            455678899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-41  Score=310.43  Aligned_cols=253  Identities=27%  Similarity=0.438  Sum_probs=196.3

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCC--EEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  200 (397)
                      ++|++.+.||+|+||.||+|... ++.  .+++|.+....   .......+.+|++++.++ +||||+++++++...+..
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC---CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            57888899999999999999754 454  45777765321   122356788999999999 899999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC
Q 016009          201 FLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE  267 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  267 (397)
                      ++||||+++++|.+++.....             ...+++.+++.++.|++.|++|||+.   +++||||||+||+++++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence            999999999999999865421             12578999999999999999999998   99999999999999999


Q ss_pred             CcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 016009          268 FEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI  346 (397)
Q Consensus       268 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~  346 (397)
                      +.+||+|||++....... .......+..|+|||...+..++.++||||||+++|||+| |..||.......        
T Consensus       161 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------  231 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------  231 (303)
T ss_pred             CcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--------
Confidence            999999999986422111 1111234567999999988889999999999999999998 999985332110        


Q ss_pred             ccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          347 ELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       347 ~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ....+... ....+.    .....+.+++.+||+.+|++||++++++++|+
T Consensus       232 ~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~  278 (303)
T cd05088         232 LYEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLN  278 (303)
T ss_pred             HHHHHhcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            00011010 111111    12345889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.7e-41  Score=311.13  Aligned_cols=259  Identities=19%  Similarity=0.269  Sum_probs=192.5

Q ss_pred             Ccccccc--CcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEe
Q 016009          130 QYCIGNG--GHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEF  206 (397)
Q Consensus       130 ~~~lg~G--~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  206 (397)
                      .++||+|  +|++||++.. .+|+.||+|++......  ....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT--NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhcc--HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            4679999  7899999965 57899999998653221  12245677899999999999999999999999999999999


Q ss_pred             ccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC
Q 016009          207 LKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS  286 (397)
Q Consensus       207 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  286 (397)
                      +++|+|.+++..... ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++++||+..........
T Consensus        81 ~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          81 MAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             cCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999999865432 3589999999999999999999998   999999999999999999999999986543321111


Q ss_pred             -------CcccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccccc-----
Q 016009          287 -------NWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML-----  352 (397)
Q Consensus       287 -------~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----  352 (397)
                             ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.....................     
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                   0112346778999999875  45889999999999999999999998643221100000000000000     


Q ss_pred             --------------CCCC----------C-----CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          353 --------------DPRL----------P-----APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       353 --------------~~~~----------~-----~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                                    +...          +     ............+.+++.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                          0000          0     0000112234568899999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.9e-41  Score=298.58  Aligned_cols=239  Identities=23%  Similarity=0.392  Sum_probs=187.0

Q ss_pred             cccccCcEEEEEEEeCC-------------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          132 CIGNGGHGSVYRAELPS-------------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      .||+|+||.||+|...+             ...|++|.+...    .......+.+|+.+++.++||||+++++++..+.
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            58999999999997532             225888887642    2223467889999999999999999999999999


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc-------EE
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE-------AH  271 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-------~k  271 (397)
                      ..++||||+++|+|..++....  ..+++..++.++.|+++||+|||+.   +++||||||+||+++.++.       ++
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence            9999999999999999886543  3589999999999999999999998   9999999999999987664       89


Q ss_pred             EeeeccccccCCCCCCcccccccccccCccccc-CCCCCcchhhHHHHHHHHHHH-hCCCCCCccccccccccccccccc
Q 016009          272 VADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELD  349 (397)
Q Consensus       272 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~  349 (397)
                      ++|||++......    ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+.......         ..
T Consensus       153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---------~~  219 (262)
T cd05077         153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---------KE  219 (262)
T ss_pred             eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---------HH
Confidence            9999998654322    2345778899999886 466899999999999999998 5888865322110         00


Q ss_pred             cccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...........    .....+.+++.+||+.||++||++.+|++.|+
T Consensus       220 ~~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         220 RFYEGQCMLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHhcCccCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            11111111111    11245889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.6e-41  Score=313.92  Aligned_cols=256  Identities=24%  Similarity=0.411  Sum_probs=197.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEec
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSH  196 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  196 (397)
                      .++|+..+.||+|+||.||+|..      .+++.||||+++....   ......+.+|+.++.++ +||||+++++++..
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC---hHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            45788999999999999999953      3578999999875322   12246788999999999 68999999998865


Q ss_pred             C-CeeeEEEEeccCCCHHHhhccccc------------------------------------------------------
Q 016009          197 A-RHSFLVYEFLKRGSLAAILSSDAA------------------------------------------------------  221 (397)
Q Consensus       197 ~-~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  221 (397)
                      . ...+++|||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 467899999999999999864210                                                      


Q ss_pred             ----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCC--cc
Q 016009          222 ----------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WT  289 (397)
Q Consensus       222 ----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~  289 (397)
                                ...+++.++..++.|++.||+|||+.   +++||||||+||++++++++||+|||++.........  ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                      12378889999999999999999998   9999999999999999999999999998765332221  12


Q ss_pred             cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCCCcchHHHH
Q 016009          290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-PRLPAPSRSVQEKL  367 (397)
Q Consensus       290 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  367 (397)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |..||........       ....+.+ .....+..    ..
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~----~~  308 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRLKEGTRMRAPDY----TT  308 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-------HHHHHhccCCCCCCCC----CC
Confidence            2345678999999988889999999999999999997 8989754321100       0000000 01111111    12


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          368 RSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       368 ~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+++..||+.||++|||+.+|+++|+
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~  337 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLG  337 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            35889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.9e-41  Score=305.88  Aligned_cols=248  Identities=27%  Similarity=0.419  Sum_probs=199.7

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.....   ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc---hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            355567799999999999965 4678999998764221   123567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++..    ..+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++.++++|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          82 EYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            99999999998854    3588999999999999999999998   9999999999999999999999999999866543


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      ........++..|+|||++.+..++.++||||||+++|||++|+.|+..........        .+.....+   ....
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------~~~~~~~~---~~~~  223 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--------LIPKNSPP---TLEG  223 (277)
T ss_pred             chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh--------hhhcCCCC---CCCc
Confidence            333334467889999999998889999999999999999999999976432211100        00001111   0111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.+++.+||+.+|++|||+.+++++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            234568899999999999999999999975

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.7e-41  Score=314.43  Aligned_cols=260  Identities=23%  Similarity=0.354  Sum_probs=195.2

Q ss_pred             HhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC---
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR---  198 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---  198 (397)
                      ..++|...+.||+|+||.||++.. .+|+.||+|++......  ......+.+|+.+++.++||||+++++++....   
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN--QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc--hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            346899999999999999999965 46899999998653222  223567889999999999999999999986443   


Q ss_pred             ---eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          199 ---HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       199 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                         ..++||||+++ +|.+.+.     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence               46999999976 5655553     2478899999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-------------cc
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-------------FL  342 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-------------~~  342 (397)
                      |++...... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||.........             ..
T Consensus       168 g~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         168 GLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             CCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            999754322 2223457899999999999999999999999999999999999998643211000             00


Q ss_pred             cc-ccccccccC--CCCC--------------CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          343 NT-DIELDEMLD--PRLP--------------APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       343 ~~-~~~~~~~~~--~~~~--------------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .. .........  +..+              ............+.+++.+||+.||++|||+.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00 000000000  0000              0000001123457899999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.7e-41  Score=300.47  Aligned_cols=258  Identities=29%  Similarity=0.446  Sum_probs=204.9

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||.|+||+||+|.. .++..+++|++.......   ..+.+.+|+++++.++|+|++++++.+..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT---SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch---HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence            4688899999999999999975 468899999986422211   467899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      +||+++++|.+++........+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++..+..
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            99999999999997644334689999999999999999999998   999999999999999999999999999877654


Q ss_pred             CCCC----cccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 016009          284 DSSN----WTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       284 ~~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      ....    .....++..|+|||.+... .++.++|+||||+++|||++|+.||............    .. ...+....
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~  229 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT----LQ-NDPPSLET  229 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH----hc-CCCCCcCC
Confidence            3322    1334688899999998876 7899999999999999999999998754332100000    00 00111111


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      . .........+.+++.+||+.||++|||+++++++
T Consensus       230 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         230 G-ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             c-cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            0 0012334568899999999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-41  Score=300.72  Aligned_cols=255  Identities=29%  Similarity=0.439  Sum_probs=204.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||++... +++.+++|.+.....    ...+.+.+|++++++++|||++++++++...+..++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch----hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            357888899999999999999654 678899999864322    245788999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      +|||+++++|.+++....  ..+++.++..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++....
T Consensus        78 ~~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             EEeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhh
Confidence            999999999999986542  3589999999999999999999998   99999999999999999999999999987655


Q ss_pred             CCCCCcccccccccccCcccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ..........++..|+|||...+.   .++.++||||||+++|||+||+.|+............   .......+..   
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~---  226 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI---SKSNFPPPKL---  226 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhccCCCccc---
Confidence            433233445678899999998776   7899999999999999999999998643321111000   0000000111   


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .........+.+++.+||+.+|.+|||+.+|+.+
T Consensus       227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             1122345668999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.2e-41  Score=300.77  Aligned_cols=252  Identities=21%  Similarity=0.310  Sum_probs=202.7

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|+||.+|++.. .+|+.|++|.+.....  .....+++.+|++++++++||||+++++++...+..++|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence            477788999999999999965 4789999999864221  1223567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++..... ..+++.+++.++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          79 DYCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             ecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            99999999999865432 3578999999999999999999998   9999999999999999999999999999866543


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      ........+++.|+|||...+..++.++|+||||+++++|++|+.|+......        .....+.....+..   ..
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~---~~  223 (256)
T cd08218         155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--------NLVLKIIRGSYPPV---SS  223 (256)
T ss_pred             hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--------HHHHHHhcCCCCCC---cc
Confidence            33333456788999999999888999999999999999999999997532210        01111111111111   11


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.+++.+||+.+|++||++.+|+++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            234468899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.7e-41  Score=299.91  Aligned_cols=248  Identities=27%  Similarity=0.437  Sum_probs=197.7

Q ss_pred             ccccccCcEEEEEEEeCC--C--CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEe
Q 016009          131 YCIGNGGHGSVYRAELPS--G--QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEF  206 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  206 (397)
                      +.||+|++|.||+|.+.+  +  ..||+|.+......   ...+.+..|++++++++||||+++++++.. ...++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            358999999999997543  3  36999998753322   346789999999999999999999999988 889999999


Q ss_pred             ccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC
Q 016009          207 LKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS  286 (397)
Q Consensus       207 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  286 (397)
                      +++++|.+++..... ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++........
T Consensus        77 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          77 APLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             cCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence            999999999976543 4689999999999999999999998   999999999999999999999999999987654322


Q ss_pred             C---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          287 N---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       287 ~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      .   .....++..|+|||...+..++.++||||||+++|||++ |+.||...........     ... .......+   
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-----~~~-~~~~~~~~---  223 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK-----IDK-EGERLERP---  223 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHh-cCCcCCCC---
Confidence            1   112356788999999998889999999999999999999 9999864332110000     000 00111111   


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       224 -~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         224 -EACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             123356889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.5e-41  Score=304.21  Aligned_cols=250  Identities=25%  Similarity=0.404  Sum_probs=197.2

Q ss_pred             CCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |+..+.||+|+||.||+|... ++..+++|.+...    .....+.+.+|+++++.++|||++++++++..++..++|+|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            556778999999999999765 5778899887542    12235678899999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |+++++|..++....  ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          83 FCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             ecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            999999998876432  3589999999999999999999998   99999999999999999999999999987654333


Q ss_pred             CCcccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          286 SNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      .......++..|+|||++.     +..++.++|||||||++|||++|+.||...........     ......+....+ 
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~-  231 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK-----IAKSEPPTLAQP-  231 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH-----HhhcCCCCCCCc-
Confidence            3334456889999999874     34578899999999999999999999864332110000     000001111111 


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ......+.+++.+||+.||++|||+.+++++
T Consensus       232 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         232 ---SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               1223468899999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7e-41  Score=304.49  Aligned_cols=252  Identities=25%  Similarity=0.414  Sum_probs=199.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +.|++.+.||+|+||.||+|... +++.+++|.+...    .....+.+..|+++++.++|||++++++++..++..++|
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            46888899999999999999764 5889999998642    223356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|..++.+..  ..+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          88 IEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999998875433  3589999999999999999999998   999999999999999999999999999875433


Q ss_pred             CCCCcccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 016009          284 DSSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      .........++..|+|||++.     ...++.++||||||+++|||++|+.||.........     ........+....
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~  237 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-----LKIAKSEPPTLSQ  237 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH-----HHHhcCCCccCCC
Confidence            333334456788999999875     345688999999999999999999998643321100     0000001111111


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +    ......+.+++.+||+.||++||+++++++.
T Consensus       238 ~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         238 P----SKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             C----cccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1    1233458899999999999999999999863

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.4e-41  Score=319.31  Aligned_cols=260  Identities=25%  Similarity=0.337  Sum_probs=196.2

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC-----e
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR-----H  199 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~  199 (397)
                      +|+..+.||+|+||.||++.. .+|+.||+|++.....  .....+.+.+|+++++.++||||+++++++...+     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ--NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc--chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence            477889999999999999975 4789999999864222  2223567889999999999999999999998776     7


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++|+||+. ++|.+.+...   ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             EEEEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccccee
Confidence            899999996 5787777543   3589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCC-CcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-----cc--ccc----
Q 016009          280 FLKPDSS-NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-----LN--TDI----  346 (397)
Q Consensus       280 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-----~~--~~~----  346 (397)
                      ....... ......++..|+|||.+.+. .++.++||||+||++|||++|+.||..........     ..  ...    
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            6543322 22334678899999998764 47899999999999999999999986433211000     00  000    


Q ss_pred             ---ccc-cccCCCCCCCC-----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ---ELD-EMLDPRLPAPS-----RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ---~~~-~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ... .+.......+.     ....+....+.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence               000 00000000000     0001123468899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-41  Score=299.29  Aligned_cols=245  Identities=30%  Similarity=0.467  Sum_probs=193.4

Q ss_pred             ccccccCcEEEEEEEeC--C--CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEe
Q 016009          131 YCIGNGGHGSVYRAELP--S--GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEF  206 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  206 (397)
                      +.||+|+||.||+|...  +  +..+|+|.+......   ...+++..|+++++.++|+|++++++++. .+..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            36999999999999643  2  268999998753222   24567899999999999999999999876 4567999999


Q ss_pred             ccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC
Q 016009          207 LKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS  286 (397)
Q Consensus       207 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  286 (397)
                      +++|+|.+++....   .+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        77 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          77 APLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            99999999997644   589999999999999999999998   999999999999999999999999999986644332


Q ss_pred             Ccc---cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          287 NWT---EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       287 ~~~---~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ...   ...++..|+|||...+..++.++||||||+++|||++ |..||+..........     ....  .....+   
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-----~~~~--~~~~~~---  220 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-----LESG--ERLPRP---  220 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-----HHcC--CcCCCC---
Confidence            211   1123467999999998889999999999999999998 9999865432110000     0000  001111   


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       221 -~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~  253 (257)
T cd05060         221 -EECPQEIYSIMLSCWKYRPEDRPTFSELESTFR  253 (257)
T ss_pred             -CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence             122346889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=317.52  Aligned_cols=258  Identities=26%  Similarity=0.444  Sum_probs=212.5

Q ss_pred             HHHHHHHhcCCCCCccccccCcEEEEEEEeCC-CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe
Q 016009          117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS  195 (397)
Q Consensus       117 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  195 (397)
                      ++.|+-...+....++||-|.||.||.|.++. .-.||||.++.+     .-..++|+.|+.+|+.++|||+|+++|+|.
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLkEAAvMKeikHpNLVqLLGVCT  333 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT  333 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence            35566555667777899999999999998764 567999998752     234789999999999999999999999999


Q ss_pred             cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          196 HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       196 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                      .+...|||.|||..|+|.++|++... ..++--..+.++.||+.||.||..+   ++|||||.++|+|+.++..+|++||
T Consensus       334 ~EpPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADF  409 (1157)
T KOG4278|consen  334 HEPPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADF  409 (1157)
T ss_pred             cCCCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeecc
Confidence            99999999999999999999986543 4577778899999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcc-cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC
Q 016009          276 GIAKFLKPDSSNWT-EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD  353 (397)
Q Consensus       276 g~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  353 (397)
                      |+++++..+....+ ...-.+.|.|||-+....++.|+|||+|||+|||+.| |..||.....-         .+..++.
T Consensus       410 GLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS---------qVY~LLE  480 (1157)
T KOG4278|consen  410 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------QVYGLLE  480 (1157)
T ss_pred             chhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH---------HHHHHHh
Confidence            99999875543322 1223678999999999999999999999999999999 88887643221         1122222


Q ss_pred             C--CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          354 P--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       354 ~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .  ++..+    ..++..+.+|+..||+.+|.+||++.|+-+.+|
T Consensus       481 kgyRM~~P----eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  481 KGYRMDGP----EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             ccccccCC----CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            2  22222    345567999999999999999999999988775

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.6e-42  Score=321.22  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=194.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||++... +++.||+|++..... ........+..|+.++.+++||||+++++.+.+.+..++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            46888899999999999999654 689999999864211 1112346788899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....   .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.....
T Consensus        80 ~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          80 MEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             EeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            99999999999986543   489999999999999999999998   999999999999999999999999999875422


Q ss_pred             CCC-----------------------------------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC
Q 016009          284 DSS-----------------------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK  328 (397)
Q Consensus       284 ~~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~  328 (397)
                      ...                                   ......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            100                                   011346899999999999999999999999999999999999


Q ss_pred             CCCCccccccccccccccccccccC--CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 016009          329 HPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT---MKIVSQQ  394 (397)
Q Consensus       329 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~~vl~~  394 (397)
                      .||........        ...+..  .....+...  .....+.+++.+++. ||++|++   +++++++
T Consensus       234 ~Pf~~~~~~~~--------~~~i~~~~~~~~~p~~~--~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         234 PPFCSETPQET--------YRKVMNWKETLVFPPEV--PISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCCHHHH--------HHHHHcCCCceecCCCC--CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            99864332110        011111  111111110  112346677777664 9999985   6777653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.5e-41  Score=307.56  Aligned_cols=255  Identities=24%  Similarity=0.416  Sum_probs=200.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEe--------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL--------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFC  194 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  194 (397)
                      .++|.+.+.||+|+||.||++..        .++..||+|.+.....   ....+.+.+|+.+++.+ +||||+++++++
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc---hHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            45677889999999999999963        1345799998764221   22356789999999999 899999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCc
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN  261 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  261 (397)
                      ......++||||+++|+|.+++.....             ...+++.++..++.|++.||+|||+.   +++|+||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence            999999999999999999999875321             13588999999999999999999998   99999999999


Q ss_pred             EEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccc
Q 016009          262 LLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS  338 (397)
Q Consensus       262 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  338 (397)
                      |++++++.+||+|||++.........  .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            99999999999999999866432221  122345678999999988889999999999999999998 788875332211


Q ss_pred             ccccccccccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          339 SSFLNTDIELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       339 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                              ....+... ....+    ......+.+++.+||+.+|++|||+.|+++.|+
T Consensus       248 --------~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~  294 (304)
T cd05101         248 --------LFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD  294 (304)
T ss_pred             --------HHHHHHcCCcCCCC----CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence                    00011011 11111    123456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.5e-41  Score=306.90  Aligned_cols=258  Identities=23%  Similarity=0.348  Sum_probs=199.6

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||++... ++..+++|.+.....   .....++.+|++++++++||||+++++++..++..++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK---PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence            36888899999999999999654 688899998764222   22356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++...   ..+++..+..++.|++.||.|||+.+  +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          78 MEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             eeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            9999999999999754   35889999999999999999999732  899999999999999999999999999875432


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-cccc-c---------------
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-LNTD-I---------------  346 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-~~~~-~---------------  346 (397)
                      ..  .....++..|+|||.+.+..++.++|+||||+++|||++|+.||.......... .... .               
T Consensus       153 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         153 SM--ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             cc--cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence            21  233568899999999988889999999999999999999999975322110000 0000 0               


Q ss_pred             -----------ccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 -----------ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                                 ....+.....+  ..........+.+++.+||+.||++|||+++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPP--KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCc--cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       00000000000  00001133468899999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=305.02  Aligned_cols=253  Identities=26%  Similarity=0.437  Sum_probs=202.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|++.+.||.|+||.||++... ++..+|+|.+...    .....+.+..|++++++++|||++++++++..+...++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            456888899999999999999764 6889999998642    22235678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++++|.+++....  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          80 LIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             EeeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            999999999999986543  3589999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCCcccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          283 PDSSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      ..........++..|+|||.+.     ...++.++|+||||+++|||++|+.||..........     .......+.+.
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~  229 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL-----KILKSEPPTLD  229 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH-----HHhcCCCCCcC
Confidence            4433334456889999999875     3446789999999999999999999986543211000     00000011111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .+    ......+.+++..||+.+|++||+++++++.
T Consensus       230 ~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         230 QP----SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             Cc----ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            11    1233458899999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.7e-41  Score=300.32  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=200.8

Q ss_pred             CCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCc--chhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD--QIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +|...+.||+|+||.||+|...+++.+|+|.+.......  .......+.+|++++++++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            467788899999999999988889999999986532211  122345688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      +||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999996543   478999999999999999999998   999999999999999999999999999876432


Q ss_pred             CC------CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          284 DS------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       284 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      ..      .......++..|+|||...+..++.++||||||+++|+|++|+.||.............   ......+..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~  231 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG---AHRGLMPRLP  231 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh---hccCCCCCCC
Confidence            11      11123467889999999998889999999999999999999999986433211100000   0000011111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                            ......+.+++.+||+.+|++||++.++++
T Consensus       232 ------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         232 ------DSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ------CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  123345889999999999999999999986

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.6e-41  Score=299.26  Aligned_cols=247  Identities=26%  Similarity=0.426  Sum_probs=196.9

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEE-ecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFC-SHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||++... |..+++|.++..      ...+.+.+|+.++++++|+|++++++++ ..++..+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence            46788899999999999999764 778999987542      1246789999999999999999999976 455678999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++..... ..+++..++.++.+++.||+|||+.   +++|+||||+||++++++.+||+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            999999999999875442 3588999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..   ....++..|+|||+..+..++.++||||||+++|||++ |+.||.......         ....+.....  ...
T Consensus       155 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---------~~~~~~~~~~--~~~  220 (256)
T cd05082         155 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGYK--MDA  220 (256)
T ss_pred             cC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHhcCCC--CCC
Confidence            22   22344568999999998889999999999999999998 999975322110         0000000000  000


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ....+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  254 (256)
T cd05082         221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE  254 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence            1123346889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-40  Score=301.53  Aligned_cols=259  Identities=23%  Similarity=0.391  Sum_probs=199.1

Q ss_pred             CCCCCccccccCcEEEEEEEe-----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC--C
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--R  198 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~  198 (397)
                      .|...+.||+|+||.||++..     .++..||+|.++....   ......+.+|++++++++|||++++.+++...  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc---HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            467788999999999999963     3578899999865322   22346789999999999999999999998765  5


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA  278 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  278 (397)
                      ..++||||+++++|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence            6899999999999999986543  3589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCC---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc---cccc----cc
Q 016009          279 KFLKPDSSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL---NTDI----EL  348 (397)
Q Consensus       279 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~---~~~~----~~  348 (397)
                      .........   .....++..|+|||.+.+..++.++||||||+++|||+|++.|............   ..+.    ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence            866533221   1234567789999999888899999999999999999998876432111000000   0000    00


Q ss_pred             ccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          349 DEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       349 ~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+. ..+.+    ...+..+.+++.+||+.+|++|||++++++.|+
T Consensus       237 ~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  281 (284)
T cd05079         237 RVLEEGKRLPRP----PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE  281 (284)
T ss_pred             HHHHcCccCCCC----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            000011 11111    123456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.1e-41  Score=302.40  Aligned_cols=252  Identities=27%  Similarity=0.363  Sum_probs=187.2

Q ss_pred             cccccCcEEEEEEEeCC---CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          132 CIGNGGHGSVYRAELPS---GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      .||+|+||.||+|...+   ...+++|.+....   .......+.+|+++++.++||||+++++++......++||||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            58999999999996543   3468888765422   12234678899999999999999999999999999999999999


Q ss_pred             CCCHHHhhccccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC
Q 016009          209 RGSLAAILSSDAA--AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS  286 (397)
Q Consensus       209 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  286 (397)
                      +|+|.+++.....  ....++.....++.|++.|++|||+.   +++||||||+||++++++.+||+|||++........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence            9999999976542  22356888899999999999999998   999999999999999999999999999865432221


Q ss_pred             --CcccccccccccCcccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 016009          287 --NWTEFAGTYGYVAPELAYT-------MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       287 --~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                        ......++..|+|||+...       ..++.++||||||+++|||++ |..||...........    ... ..+..+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~----~~~-~~~~~~  230 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ----VVR-EQDIKL  230 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH----Hhh-ccCccC
Confidence              1122345678999998642       356889999999999999999 7888764322110000    000 001111


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+ .........+.+++..|| .||++|||+++|++.|.
T Consensus       231 ~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111 111123345677888898 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=295.45  Aligned_cols=262  Identities=25%  Similarity=0.393  Sum_probs=201.6

Q ss_pred             hcCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec-----C
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH-----A  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~  197 (397)
                      ...|...+.||+|+||.|+.+. ..+|+.||||++.....  .....+...+|+++|+.++|+||+.+.+.+..     -
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~--~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE--NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh--chHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            3455557889999999999995 45899999999875333  33457788999999999999999999998844     4


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      +..|+|+|+| ..+|...++.+.   .++......++.|+++||.|+|+.   +|+||||||+|++++.+..+||+|||+
T Consensus        99 ~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence            6789999999 569999997653   489999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCC--CCCcccccccccccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------cccccc
Q 016009          278 AKFLKPD--SSNWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNTDIE  347 (397)
Q Consensus       278 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~~~~  347 (397)
                      |+.....  ....+..+.|..|.|||++. ...|+...||||.||++.||++|++-|.....+.+-.       ...++.
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            9987542  23346678899999999765 5679999999999999999999998876443321000       000111


Q ss_pred             ccc--------ccCCCCCCCCcc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          348 LDE--------MLDPRLPAPSRS----VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       348 ~~~--------~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +..        .+......+...    .+.......+|+.+||..||.+|+|++|.+++
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111        111111111111    11223457789999999999999999999874

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1e-40  Score=297.55  Aligned_cols=251  Identities=27%  Similarity=0.477  Sum_probs=200.3

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      .+|+..+.||+|+||.||++...+++.+++|.+....     ....++.+|++++++++|||++++++++......++||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-----MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-----CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            4677788999999999999987778899999876422     22467899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++....  ..+++..++.++.+++.|++|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  153 (256)
T cd05112          79 EFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence            9999999999986543  3588999999999999999999998   9999999999999999999999999998755322


Q ss_pred             CCC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          285 SSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       285 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ... .....++..|+|||...+..++.++||||||+++|||++ |+.||.......  ..   ..+......  ..+.  
T Consensus       154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~---~~~~~~~~~--~~~~--  224 (256)
T cd05112         154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VV---ETINAGFRL--YKPR--  224 (256)
T ss_pred             cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HH---HHHhCCCCC--CCCC--
Confidence            111 112234678999999998889999999999999999998 999986332110  00   000000000  0011  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        .....+.+++.+||+.+|++|||+.+++++|+
T Consensus       225 --~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 --LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             --CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence              12345889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4e-41  Score=302.42  Aligned_cols=251  Identities=28%  Similarity=0.539  Sum_probs=199.4

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CC---CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SG---QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      +|+..+.||+|+||.||+|... ++   ..|++|.+....   ......+|..|+.++++++||||+++++++..+...+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            5677889999999999999764 33   369999986532   2233578999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++++|.+++....  ..+++.+++.++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          82 IITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence            9999999999999987543  3589999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCC--cc-ccc--ccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccc-cCC
Q 016009          282 KPDSSN--WT-EFA--GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEM-LDP  354 (397)
Q Consensus       282 ~~~~~~--~~-~~~--g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~  354 (397)
                      ......  .. ...  .+..|+|||.+.+..++.++||||||+++||+++ |..||........        ...+ .+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~--------~~~i~~~~  228 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--------INAIEQDY  228 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH--------HHHHHcCC
Confidence            432221  11 111  2457999999998899999999999999999886 9999864332110        0000 011


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+.    +.+..+.+++..||+.+|++||++++|+..|+
T Consensus       229 ~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  266 (269)
T cd05065         229 RLPPPM----DCPTALHQLMLDCWQKDRNARPKFGQIVSTLD  266 (269)
T ss_pred             cCCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111111    23445889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9e-41  Score=299.80  Aligned_cols=251  Identities=28%  Similarity=0.459  Sum_probs=199.8

Q ss_pred             CCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcc-----hhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          127 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQ-----IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      |...+.||+|++|.||+|.. .+++.+|+|.+........     ....+.+.+|++++++++||||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            56678899999999999965 4688999998865333221     11235688999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      +++|||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            99999999999999996543   588999999999999999999998   999999999999999999999999999886


Q ss_pred             cCCCCC------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 016009          281 LKPDSS------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP  354 (397)
Q Consensus       281 ~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
                      ......      ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..........     .......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~  230 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-----KIGENASP  230 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH-----HHhccCCC
Confidence            653211      1122457889999999998889999999999999999999999987543211100     00111111


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+      ......+.+++.+||+.||++||++.++++.
T Consensus       231 ~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         231 EIP------SNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             cCC------cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            111      1233558899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.3e-41  Score=300.71  Aligned_cols=239  Identities=21%  Similarity=0.377  Sum_probs=185.3

Q ss_pred             cccccCcEEEEEEEeCC-------------------------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc
Q 016009          132 CIGNGGHGSVYRAELPS-------------------------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN  186 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n  186 (397)
                      .||+|+||.||+|....                         ...|++|.+...    .......+.+|+.+++.++|||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence            59999999999996421                         135888887542    1223457888999999999999


Q ss_pred             eeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC
Q 016009          187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL  266 (397)
Q Consensus       187 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  266 (397)
                      |+++++++......++||||+++|+|..++....  ..+++..+..++.|+++||+|||+.   +++||||||+||+++.
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~  152 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR  152 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence            9999999999999999999999999999986533  3588999999999999999999998   9999999999999976


Q ss_pred             CC-------cEEEeeeccccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHH-hCCCCCCccccc
Q 016009          267 EF-------EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVI-KGKHPRDFLSSI  337 (397)
Q Consensus       267 ~~-------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~-tg~~p~~~~~~~  337 (397)
                      .+       .++++|||++......    ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.|+......
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  228 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS  228 (274)
T ss_pred             cCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence            43       3799999987643221    22356788999998865 56899999999999999995 689987643221


Q ss_pred             cccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          338 SSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .         ...........+..    ....+.+++.+||+.+|++|||+.+|++.|.
T Consensus       229 ~---------~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 E---------KERFYEKKHRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             H---------HHHHHHhccCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1         01111111111111    1134889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.5e-41  Score=304.23  Aligned_cols=262  Identities=23%  Similarity=0.374  Sum_probs=200.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|++|.||+|... +|+.||+|++......  ....+.+.+|++++++++|||++++++++..+...++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD--PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC--ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence            36788889999999999999765 6899999988642211  12245688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|..+....   ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          79 FEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             EeccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            9999999888876543   2489999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc---------c-------ccc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL---------N-------TDI  346 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~---------~-------~~~  346 (397)
                      .........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........         .       ...
T Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            4333334567889999998875 4578999999999999999999999864332110000         0       000


Q ss_pred             ccccccCCCCCCCC---cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ELDEMLDPRLPAPS---RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .......+......   .........+.+++.+||+.+|++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            00000001000000   0011223568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.4e-41  Score=307.43  Aligned_cols=255  Identities=24%  Similarity=0.417  Sum_probs=199.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC--------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFC  194 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  194 (397)
                      .++|.+.+.||+|+||.||++...        ....+|+|.++....   ......+..|+++++++ +||||+++++++
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT---DKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC---hHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            457788899999999999999642        245789998764322   22356788999999999 699999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCc
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN  261 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  261 (397)
                      ...+..+++|||+++|+|.+++.....             ...+++.++..++.|++.||.|||+.   +++|+||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence            998999999999999999999965321             23589999999999999999999998   99999999999


Q ss_pred             EEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccc
Q 016009          262 LLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS  338 (397)
Q Consensus       262 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  338 (397)
                      |++++++.+||+|||+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999999865432211  111234467999999988889999999999999999999 888875432110


Q ss_pred             ccccccccccccccCCC-CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          339 SSFLNTDIELDEMLDPR-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       339 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                              ....+.... ...+.    .....+.+++.+||+.+|++|||+.++++.|+
T Consensus       245 --------~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~  291 (314)
T cd05099         245 --------LFKLLREGHRMDKPS----NCTHELYMLMRECWHAVPTQRPTFKQLVEALD  291 (314)
T ss_pred             --------HHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence                    000011111 11111    22345889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.5e-41  Score=304.27  Aligned_cols=255  Identities=23%  Similarity=0.362  Sum_probs=200.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||++... ++..||+|.+.....   ......+.+|++++++++||||+++++++...+..++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD---ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence            36778899999999999999765 789999998864221   22346789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|..++........+++..+..++.+++.||.|||+.+  +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence            999999999998876433346899999999999999999999642  899999999999999999999999999876532


Q ss_pred             CCCCcccccccccccCcccccCCC------CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMK------ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      ..  .....++..|+|||.+.+..      ++.++|+|||||++|||++|+.||.......  .   ......+.+...+
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~---~~~~~~~~~~~~~  228 (286)
T cd06622         156 SL--AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--I---FAQLSAIVDGDPP  228 (286)
T ss_pred             Cc--cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--H---HHHHHHHhhcCCC
Confidence            22  22346788999999886543      4789999999999999999999986322100  0   0011111121111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ....+....+.+++.+||+.+|++||++++++..
T Consensus       229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         229 ---TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             ---CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence               1112345568899999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.8e-41  Score=299.02  Aligned_cols=252  Identities=24%  Similarity=0.464  Sum_probs=201.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .++|...+.||+|+||.||++...++..+++|.+...     ....+.+.+|++++++++|+|++++.+++.. ...+++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence            3568888999999999999998877888999987642     1235678999999999999999999999887 778999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++..... ..+++.+++.++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EEeCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            999999999999976432 4588999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          284 DSSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       284 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      .... .....++..|+|||++....++.++|+||||+++|+++| |+.||..........     ....  +...+.+  
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-----~~~~--~~~~~~~--  225 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-----ALER--GYRMPRP--  225 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH-----HHhC--CCCCCCc--
Confidence            2211 122345677999999988889999999999999999999 899986432210000     0000  0011111  


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        ...+..+.+++.+|++.+|++||++.++.+.|+
T Consensus       226 --~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         226 --ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD  258 (260)
T ss_pred             --ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence              123346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.7e-41  Score=303.10  Aligned_cols=260  Identities=24%  Similarity=0.388  Sum_probs=203.5

Q ss_pred             cHHHHHHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEE
Q 016009          116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGF  193 (397)
Q Consensus       116 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  193 (397)
                      ++.++..+.+.|+..+.||+|+||.||+|.. .+++.+|+|.+...     .....++..|+.+++++ +|+|+++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~   81 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGA   81 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence            4455566778899999999999999999965 46889999987532     12345688899999999 69999999999


Q ss_pred             Eec------CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC
Q 016009          194 CSH------ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE  267 (397)
Q Consensus       194 ~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  267 (397)
                      +..      ....+++|||+++|+|.+++..... ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++++
T Consensus        82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~  157 (282)
T cd06636          82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             hhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            843      4578999999999999999865432 4588889999999999999999998   99999999999999999


Q ss_pred             CcEEEeeeccccccCCCCCCcccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc
Q 016009          268 FEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL  342 (397)
Q Consensus       268 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~  342 (397)
                      +.++|+|||++..............++..|+|||.+.     ...++.++||||||+++|||++|+.||.........  
T Consensus       158 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--  235 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--  235 (282)
T ss_pred             CCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh--
Confidence            9999999999876543333334456889999999875     345788999999999999999999998643321111  


Q ss_pred             ccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                            ..+......  ..........+.+++.+||+.||.+|||+.|+++.
T Consensus       236 ------~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         236 ------FLIPRNPPP--KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ------hhHhhCCCC--CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                  011111111  11112334568999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6e-41  Score=313.30  Aligned_cols=261  Identities=23%  Similarity=0.316  Sum_probs=196.4

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC---
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA---  197 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---  197 (397)
                      ...++|...+.||+|+||.||++.. ..++.||+|++......  ......+.+|+.+++.++||||+++++++...   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC--hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            3456899999999999999999965 46889999998753322  22356778999999999999999999988543   


Q ss_pred             ---CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEee
Q 016009          198 ---RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVAD  274 (397)
Q Consensus       198 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  274 (397)
                         ...++||||+++ +|.+.+.     ..+++.++..++.|+++||+|||+.   +++||||||+||+++.++.+||+|
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~D  162 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEee
Confidence               356999999975 5666653     2478899999999999999999998   999999999999999999999999


Q ss_pred             eccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-------------c
Q 016009          275 FGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-------------F  341 (397)
Q Consensus       275 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-------------~  341 (397)
                      ||+++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||.........             .
T Consensus       163 fg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         163 FGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             CcccccCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99998654322 223457899999999999989999999999999999999999998643211000             0


Q ss_pred             -ccccccccccc----------------CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          342 -LNTDIELDEML----------------DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       342 -~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       ...........                +...+............+.+++.+|++.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence             00000000000                000000000111123467899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.6e-41  Score=304.49  Aligned_cols=259  Identities=27%  Similarity=0.382  Sum_probs=202.2

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||+||++.. ++|+.||+|++.....   ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK---SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc---chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            4677788999999999999965 4688999998764221   22357889999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++...   +.+++..+..++.+++.||.|||+..  +++|+||+|+||++++++.++|+|||++.....
T Consensus        82 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          82 MEFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             EecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            9999999999988653   35899999999999999999999742  899999999999999999999999999865432


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc---cccccccccccCCCCCCCC
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF---LNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  360 (397)
                      ..  .....++..|+|||++.+..++.++|||||||++|+++||+.||..........   .........+.....+...
T Consensus       157 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd06620         157 SI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP  234 (284)
T ss_pred             hc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence            21  123468899999999988889999999999999999999999987433210000   0000011111111111100


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                        ..+....+.+++.+|++.||++|||+.|++++.
T Consensus       235 --~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         235 --SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             --chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence              112445688999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.2e-40  Score=299.04  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=186.3

Q ss_pred             cccccCcEEEEEEEeCCC---CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          132 CIGNGGHGSVYRAELPSG---QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      .||+|+||.||+|...++   ..+++|.+.....   ....+.+.+|+.+++.++||||+++++++......++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS---SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC---hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            599999999999965433   3456676553221   2235789999999999999999999999999999999999999


Q ss_pred             CCCHHHhhccccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC--
Q 016009          209 RGSLAAILSSDAA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--  285 (397)
Q Consensus       209 ~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--  285 (397)
                      +|+|.+++..... ....++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            9999999976432 23467778889999999999999998   99999999999999999999999999876432211  


Q ss_pred             CCcccccccccccCcccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 016009          286 SNWTEFAGTYGYVAPELAYT-------MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      .......++..|+|||+...       ..++.++||||||+++|||++ |..||.....................++.+.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence            11223467889999998753       245789999999999999997 5667753322100000000011112222222


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .      .....+.+++..|| .+|++||++++|++.|.
T Consensus       236 ~------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         236 L------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             C------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1      12345778888999 57999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.6e-41  Score=305.22  Aligned_cols=261  Identities=19%  Similarity=0.258  Sum_probs=197.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||+|... +++.||+|.+......   .....+.+|+.++++++||||+++++++..++..++|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc---CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence            46888899999999999999654 6889999998643221   1245677899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||++ ++|.+++....  ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.....
T Consensus        83 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          83 FEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             Eeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            99997 58988886543  3588999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-----c--ccccccccccc---
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-----F--LNTDIELDEML---  352 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-----~--~~~~~~~~~~~---  352 (397)
                      .........+++.|+|||.+.+. .++.++||||||+++|||+||+.||.........     .  .........+.   
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            33333345678899999987653 5788999999999999999999998643221000     0  00000000000   


Q ss_pred             ---CCCCCCC-Cc----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          353 ---DPRLPAP-SR----SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       353 ---~~~~~~~-~~----~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ....+.. ..    ........+.+++.+|++.||.+|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence               0000000 00    001123457899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.6e-41  Score=321.91  Aligned_cols=258  Identities=24%  Similarity=0.293  Sum_probs=188.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-----  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  197 (397)
                      ..+|...+.||+|+||.||+|.. .+++.||||++...        .....+|+.+++.++||||+++++++...     
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC--------cchHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            45788999999999999999965 46889999987531        12345799999999999999999886432     


Q ss_pred             ---CeeeEEEEeccCCCHHHhhccc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC-cEEE
Q 016009          198 ---RHSFLVYEFLKRGSLAAILSSD-AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF-EAHV  272 (397)
Q Consensus       198 ---~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl  272 (397)
                         ...++||||+++ +|.+++... .....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL  212 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL  212 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence               246789999985 676665432 1234689999999999999999999998   999999999999998665 7999


Q ss_pred             eeeccccccCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------ccc
Q 016009          273 ADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNT  344 (397)
Q Consensus       273 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~  344 (397)
                      +|||+++.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|.+||..........       ...
T Consensus       213 ~DFGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~  291 (440)
T PTZ00036        213 CDFGSAKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT  291 (440)
T ss_pred             eccccchhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99999986653322 2335679999999987654 68999999999999999999999986432211000       000


Q ss_pred             cccccc----ccCCCCCCC-Ccch-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          345 DIELDE----MLDPRLPAP-SRSV-----QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       345 ~~~~~~----~~~~~~~~~-~~~~-----~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......    ..+..++.. ....     ...+.++.+|+.+||+.||.+|||+.|++++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            000000    000000000 0000     0123468899999999999999999999864

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=298.98  Aligned_cols=247  Identities=27%  Similarity=0.433  Sum_probs=191.0

Q ss_pred             ccccccCcEEEEEEEeC-CCC--EEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEEEe
Q 016009          131 YCIGNGGHGSVYRAELP-SGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEF  206 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  206 (397)
                      +.||+|+||.||+|... ++.  .+++|.+.....   ....+.+.+|+++++++ +||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC---HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence            35899999999999765 343  468888763211   12346788999999999 899999999999999999999999


Q ss_pred             ccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEe
Q 016009          207 LKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVA  273 (397)
Q Consensus       207 ~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  273 (397)
                      +++|+|.+++.....             ...+++.++..++.|++.|++|||+.   +++|+||||+||++++++.+||+
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEEC
Confidence            999999999865321             13478999999999999999999998   99999999999999999999999


Q ss_pred             eeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc
Q 016009          274 DFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEML  352 (397)
Q Consensus       274 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  352 (397)
                      |||++....... .......+..|+|||+.....++.++||||||+++|||++ |..||.......        ....+.
T Consensus       155 dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~  225 (270)
T cd05047         155 DFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLP  225 (270)
T ss_pred             CCCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--------HHHHHh
Confidence            999985322111 1111233567999999988889999999999999999997 999985432110        000010


Q ss_pred             C-CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          353 D-PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       353 ~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      . .....+.    .....+.+++.+||+.+|.+|||+.++++.|+
T Consensus       226 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  266 (270)
T cd05047         226 QGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLN  266 (270)
T ss_pred             CCCCCCCCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence            0 0111111    22345889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-40  Score=302.71  Aligned_cols=261  Identities=26%  Similarity=0.361  Sum_probs=192.4

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc---cCCceeeeEEEEec-----
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI---RHRNIVKLYGFCSH-----  196 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----  196 (397)
                      +|+..+.||+|+||.||+|... +++.||+|.+.......  .....+.+|+++++.+   +||||+++++++..     
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~   78 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR   78 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence            4677889999999999999654 78999999987532221  1223456777777665   69999999998854     


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                      ....+++|||+++ +|.+++..... ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||
T Consensus        79 ~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          79 ETKVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             CceEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence            3457999999975 88888865432 4589999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc--cc-----ccccccc-
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--SF-----LNTDIEL-  348 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--~~-----~~~~~~~-  348 (397)
                      ++....... ......++..|+|||++.+..++.++||||+||++|||++|+.||........  ..     ....... 
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         154 LARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            998654322 22335678999999999988899999999999999999999999853321100  00     0000000 


Q ss_pred             ------ccccCCCCCCC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 ------DEMLDPRLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 ------~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                            .....+....+ .....+....+.+++.+|++.||++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  00000000000 00111233457899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-41  Score=337.74  Aligned_cols=258  Identities=23%  Similarity=0.355  Sum_probs=198.4

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec--C
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH--A  197 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~  197 (397)
                      ....++|.+.+.||+|+||+||++... ++..+|+|.+.....  .......+..|+.++++++||||+++++++..  .
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            344568999999999999999999654 677899998864322  22235678999999999999999999998854  4


Q ss_pred             CeeeEEEEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCceeccCCCCcEEeCCC-----
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCF----PPIVHRDISSKNLLLDLE-----  267 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~----~~ivH~dlk~~Nill~~~-----  267 (397)
                      ...++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+...    .+|+|+||||+|||++.+     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            56899999999999999986532 12469999999999999999999998521    259999999999999642     


Q ss_pred             ------------CcEEEeeeccccccCCCCCCcccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 016009          268 ------------FEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDF  333 (397)
Q Consensus       268 ------------~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~  333 (397)
                                  +.+||+|||++..+.... ......||+.|+|||++.+  ..++.++|||||||+||||+||+.||..
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                        348999999998654322 2234578999999998864  4588999999999999999999999864


Q ss_pred             ccccccccccccccccccc-CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          334 LSSISSSFLNTDIELDEML-DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      ......       .+..+. .+.++.     ......+.+||..||+.+|++||++.|++.
T Consensus       246 ~~~~~q-------li~~lk~~p~lpi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        246 ANNFSQ-------LISELKRGPDLPI-----KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCcHHH-------HHHHHhcCCCCCc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            322110       001110 111111     112345889999999999999999999985

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.9e-41  Score=303.69  Aligned_cols=262  Identities=26%  Similarity=0.412  Sum_probs=203.0

Q ss_pred             cHHHHHHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEE
Q 016009          116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGF  193 (397)
Q Consensus       116 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  193 (397)
                      ...++..++++|...+.||+|+||.||++.. .+++.+|+|.+....     .....+.+|+.+++++ +|||+++++++
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~   87 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGM   87 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence            3455566788999999999999999999965 478899999986421     1245678899999999 89999999999


Q ss_pred             EecC-----CeeeEEEEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC
Q 016009          194 CSHA-----RHSFLVYEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE  267 (397)
Q Consensus       194 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  267 (397)
                      +...     +..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.   +++|+||||+||+++++
T Consensus        88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~  164 (291)
T cd06639          88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE  164 (291)
T ss_pred             EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence            8653     35899999999999999886422 224689999999999999999999998   99999999999999999


Q ss_pred             CcEEEeeeccccccCCCCCCcccccccccccCcccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc
Q 016009          268 FEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL  342 (397)
Q Consensus       268 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~  342 (397)
                      +.++|+|||++..............++..|+|||.+...     .++.++||||||+++|||++|+.||.......... 
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-  243 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-  243 (291)
T ss_pred             CCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-
Confidence            999999999988655433333345688899999987643     36889999999999999999999986433211000 


Q ss_pred             ccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                          .......+.+..+    ......+.+++.+||+.+|++||++.|++++
T Consensus       244 ----~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         244 ----KIPRNPPPTLLHP----EKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ----HHhcCCCCCCCcc----cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                0000001111111    1233468899999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=294.62  Aligned_cols=246  Identities=30%  Similarity=0.474  Sum_probs=197.4

Q ss_pred             ccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCC
Q 016009          131 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRG  210 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  210 (397)
                      +.||+|+||.||++...+++.|++|.+......   .....+.+|++++++++|+||+++++++......++||||++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            358999999999998767999999988653322   23567899999999999999999999999999999999999999


Q ss_pred             CHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc--
Q 016009          211 SLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW--  288 (397)
Q Consensus       211 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--  288 (397)
                      +|.+++....  ..+++..++.++.+++.|++|||++   +++|+||+|+||+++.++.++|+|||++..........  
T Consensus        78 ~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          78 SLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            9999986543  3578999999999999999999998   99999999999999999999999999987654221111  


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--CCCCCCcchHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--RLPAPSRSVQE  365 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  365 (397)
                      .....+..|+|||.+.++.++.++|+||||+++|||+| |..||.......         ....+..  ....+    ..
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---------~~~~~~~~~~~~~~----~~  219 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---------TRERIESGYRMPAP----QL  219 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---------HHHHHhcCCCCCCC----cc
Confidence            11233567999999988889999999999999999999 888875432110         0111111  11111    12


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 016009          366 KLRSIVEVVFSCLNESPESRPTMKIVSQQLQI  397 (397)
Q Consensus       366 ~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le~  397 (397)
                      .+..+.+++.+|++.+|++|||+.|+++.|+.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            34468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.8e-40  Score=298.16  Aligned_cols=258  Identities=25%  Similarity=0.428  Sum_probs=201.2

Q ss_pred             CCCCCccccccCcEEEEEEEeCC--CCEEEEEecCCCCCC------cchhcHHHHHHHHHHHHh-ccCCceeeeEEEEec
Q 016009          126 DFDAQYCIGNGGHGSVYRAELPS--GQVVAIKKFHSPLPS------DQIVDKKEFLTEVEALTE-IRHRNIVKLYGFCSH  196 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~~--~~~vavK~~~~~~~~------~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  196 (397)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+......      .......++..|+.++.+ ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46778889999999999997654  688999987542211      112234567788988875 699999999999999


Q ss_pred             CCeeeEEEEeccCCCHHHhhccc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSD-AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                      ++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+.  .+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999987542 1224589999999999999999999963  18999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR  355 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  355 (397)
                      |.+....... ......++..|+|||...+..++.++||||||+++|||++|+.||.......        ....+.+..
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--------~~~~~~~~~  229 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--------LATKIVEAV  229 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--------HHHHHhhcc
Confidence            9998655433 3344568889999999998889999999999999999999999976432211        011111111


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ......  ......+.+++.+||+.||++||++.|+.++++
T Consensus       230 ~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 YEPLPE--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCcCCc--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111000  112345889999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.3e-40  Score=304.71  Aligned_cols=194  Identities=22%  Similarity=0.366  Sum_probs=158.8

Q ss_pred             CccccccCcEEEEEEEeC---CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec--CCeeeEEE
Q 016009          130 QYCIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH--ARHSFLVY  204 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  204 (397)
                      .+.||+|+||.||+|...   +++.||+|.+....      ....+.+|++++++++||||+++++++..  ....+++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            357999999999999754   56789999986421      12457789999999999999999998854  45689999


Q ss_pred             EeccCCCHHHhhcccc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe----CCCCcEEEee
Q 016009          205 EFLKRGSLAAILSSDA------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL----DLEFEAHVAD  274 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~D  274 (397)
                      ||+. ++|.+++....      ....+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            9986 48877765322      123588999999999999999999998   99999999999999    4567899999


Q ss_pred             eccccccCCCCC---CcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 016009          275 FGIAKFLKPDSS---NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDF  333 (397)
Q Consensus       275 fg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~  333 (397)
                      ||++........   ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            999987643321   22345789999999998764 589999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-40  Score=300.42  Aligned_cols=259  Identities=25%  Similarity=0.337  Sum_probs=199.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec--CCeee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH--ARHSF  201 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  201 (397)
                      ++|+..+.||.|++|.||++... +++.+|+|.+.....   ......+.+|++++++++||||+++++++..  .+..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN---PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc---hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence            36777889999999999999764 688999998864322   1235778999999999999999999999854  34689


Q ss_pred             EEEEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          202 LVYEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      +||||+++++|.+++.... ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence            9999999999998875322 224588999999999999999999998   999999999999999999999999999875


Q ss_pred             cCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccC---CCCC
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD---PRLP  357 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~  357 (397)
                      ......  ....++..|+|||...+..++.++||||+|+++|+|++|+.||+.........   ......+.+   +.+.
T Consensus       155 ~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~  229 (287)
T cd06621         155 LVNSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP---IELLSYIVNMPNPELK  229 (287)
T ss_pred             cccccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh---HHHHHHHhcCCchhhc
Confidence            432221  23457889999999998899999999999999999999999987542200000   000111111   1111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ............+.+++.+||+.+|++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            1111111234568999999999999999999999874

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.3e-42  Score=297.05  Aligned_cols=256  Identities=27%  Similarity=0.351  Sum_probs=190.8

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC-----e
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR-----H  199 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~  199 (397)
                      .|...+++|+|+||.||+|... +++.||||+...+....        -.|+++|+.++|||||+++-+|....     .
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            4666789999999999999654 57899999986533322        27999999999999999999885432     3


Q ss_pred             eeEEEEeccCCCHHHhhccc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC-CcEEEeeecc
Q 016009          200 SFLVYEFLKRGSLAAILSSD-AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGI  277 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~  277 (397)
                      ..+|||||+. +|.+.++.. ...+.++...+.-++.|+.+||+|||+.   +|+||||||.|+|+|.+ |.+||+|||.
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence            4589999987 888887642 1124577778888999999999999998   99999999999999987 8999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccc-------cccccccccc
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS-------SFLNTDIELD  349 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~-------~~~~~~~~~~  349 (397)
                      |+.+..+....+ ..-|-.|.|||.+.+. .|+.+.||||.||++.||+.|++-|...+....       -.....+++.
T Consensus       173 AK~L~~~epniS-YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  173 AKVLVKGEPNIS-YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             ceeeccCCCcee-EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            999877655533 3446789999988864 699999999999999999999988764333210       0000000111


Q ss_pred             -------cccCCCCCCCC--c-chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          350 -------EMLDPRLPAPS--R-SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       350 -------~~~~~~~~~~~--~-~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                             +...+.+....  . .......+..+|+.++++.+|++|.++.|++.+
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                   11111111110  0 112233568899999999999999999998864

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9e-41  Score=318.18  Aligned_cols=191  Identities=25%  Similarity=0.338  Sum_probs=164.9

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ..|.+.+.||+|+||.||++... +++.||||...          ...+.+|++++++++|+||+++++++..++..++|
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            36888899999999999999765 57889999632          23457899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      ||++. ++|.+++....  ..++|.+++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       239 ~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        239 LPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            99995 68888876433  3699999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 016009          284 DSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPR  331 (397)
Q Consensus       284 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~  331 (397)
                      ....  .....||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            2221  22356899999999999999999999999999999999987653

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.6e-41  Score=305.43  Aligned_cols=247  Identities=26%  Similarity=0.413  Sum_probs=197.6

Q ss_pred             CCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEe
Q 016009          128 DAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEF  206 (397)
Q Consensus       128 ~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  206 (397)
                      .....||+|+||.||++.. .++..||+|.+...    .....+.+.+|+.+++.++|+|++++++.+..++..++||||
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            3345699999999999965 46889999997542    123356788999999999999999999999999999999999


Q ss_pred             ccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC
Q 016009          207 LKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS  286 (397)
Q Consensus       207 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  286 (397)
                      +++++|.+++..    ..+++.++..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++........
T Consensus       101 ~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         101 LEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            999999998853    2488999999999999999999998   999999999999999999999999999876544333


Q ss_pred             CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHH
Q 016009          287 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK  366 (397)
Q Consensus       287 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (397)
                      ......++..|+|||...+..++.++||||||+++|||++|+.||..........     .......+.....    ...
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~----~~~  244 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-----RIRDNLPPRVKDS----HKV  244 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhcCCCccccc----ccc
Confidence            3344568899999999988889999999999999999999999986432211000     0111111111111    122


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          367 LRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       367 ~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+.+++..||+.||++|||+++++++
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            3457788999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.2e-40  Score=296.63  Aligned_cols=256  Identities=25%  Similarity=0.380  Sum_probs=201.7

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec--CCeeeE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH--ARHSFL  202 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  202 (397)
                      +|+..+.||.|+||.||++.. .+++.+++|.+.....  .....+.+..|++++++++|||++++++++..  +...++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence            467788899999999999954 5788999999864322  22345678899999999999999999998753  456799


Q ss_pred             EEEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDC--FPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      +|||+++++|.+++.... ....+++..++.++.+++.||.|||..+  ..+++|+||+|+||++++++.+||+|||++.
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence            999999999999986532 2246899999999999999999999321  2299999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      .............++..|+|||.+.+..++.++|+||||+++++|++|+.||.......        ....+.....+. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~-  229 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--------LASKIKEGKFRR-  229 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--------HHHHHhcCCCCC-
Confidence            76654432344578999999999998889999999999999999999999987432110        011111111111 


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        ........+.+++.+|++.+|++|||+++|+++
T Consensus       230 --~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         230 --IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              112334568899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-41  Score=313.59  Aligned_cols=243  Identities=24%  Similarity=0.280  Sum_probs=187.1

Q ss_pred             ccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc---cCCceeeeEEEEecCCeeeEEEEecc
Q 016009          133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI---RHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       133 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      ||+|+||+||+|... +++.||+|++...... .......+..|..++...   +||||+++++++...+..++||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence            699999999999654 6899999998531111 111233455677777665   69999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||++..........
T Consensus        80 ~g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~  153 (330)
T cd05586          80 GGELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT  153 (330)
T ss_pred             CChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence            99999988654   3589999999999999999999998   99999999999999999999999999987644333333


Q ss_pred             ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHH
Q 016009          289 TEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL  367 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (397)
                      ....||..|+|||.+.+. .++.++|||||||++|||+||+.||.......        ....+.......+..   ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~~---~~~  222 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--------MYRNIAFGKVRFPKN---VLS  222 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--------HHHHHHcCCCCCCCc---cCC
Confidence            456799999999998754 47899999999999999999999986422110        011111111111111   123


Q ss_pred             HHHHHHHHHccCCCCCCCC----CHHHHHH
Q 016009          368 RSIVEVVFSCLNESPESRP----TMKIVSQ  393 (397)
Q Consensus       368 ~~l~~l~~~cl~~~P~~RP----t~~~vl~  393 (397)
                      ..+.+++.+||+.||++||    ++.++++
T Consensus       223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            4577899999999999998    5666665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=293.07  Aligned_cols=259  Identities=27%  Similarity=0.426  Sum_probs=199.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc--cCCceeeeEEEEecC----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNIVKLYGFCSHA----  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~----  197 (397)
                      ..+....+.||+|.||.||+|.+ .|+.||||++..       .+.+...+|.++.+.+  +|+||+.+++.-..+    
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s-------rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS-------RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hheeEEEEEecCccccceeeccc-cCCceEEEEecc-------cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            34566778899999999999999 578899999874       1246788899998875  999999999876443    


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceeccCCCCcEEeCCCCcEEE
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD-----CFPPIVHRDISSKNLLLDLEFEAHV  272 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-----~~~~ivH~dlk~~Nill~~~~~~kl  272 (397)
                      .++|||.+|.+.|||.|+|..+    .++-...++++..+|.||++||..     ..|.|.|||||+.|||+..++...|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence            3679999999999999999763    488999999999999999999975     3478999999999999999999999


Q ss_pred             eeeccccccCCCCC----CcccccccccccCcccccCCC----C--CcchhhHHHHHHHHHHHhC----------CCCCC
Q 016009          273 ADFGIAKFLKPDSS----NWTEFAGTYGYVAPELAYTMK----I--TEKCDVYSFGVLALEVIKG----------KHPRD  332 (397)
Q Consensus       273 ~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~----~--~~~~Dv~s~G~~l~el~tg----------~~p~~  332 (397)
                      +|+|+|-.......    .....+||.+|||||++...-    +  -..+||||||.++||++-.          +.||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            99999976654422    235578999999999987532    1  2368999999999999752          35554


Q ss_pred             cccccccccccc-ccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          333 FLSSISSSFLNT-DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       333 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      +..+....+... .....+-+.|.++..+.. .+.+..+.+++..||..+|..|-|+-.+-+.|
T Consensus       438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s-~~~l~~m~klMkeCW~~Np~aRltALriKKtl  500 (513)
T KOG2052|consen  438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKS-DPALRVMAKLMKECWYANPAARLTALRIKKTL  500 (513)
T ss_pred             cCCCCCCCHHHHhcceeecccCCCCCccccc-CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence            443332222211 111122233444433333 46788899999999999999999987776654

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.9e-41  Score=305.06  Aligned_cols=246  Identities=26%  Similarity=0.415  Sum_probs=196.6

Q ss_pred             CCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEec
Q 016009          129 AQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       129 ~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  207 (397)
                      ....||+|+||.||++.. .+++.||+|.+....    ....+.+.+|+.+++.++|||++++++++..++..++|+||+
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc----cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            345699999999999965 478999999985421    123467889999999999999999999999999999999999


Q ss_pred             cCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCC
Q 016009          208 KRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN  287 (397)
Q Consensus       208 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  287 (397)
                      ++++|.+++..    ..+++.+++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus       101 ~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~  173 (297)
T cd06659         101 QGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK  173 (297)
T ss_pred             CCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence            99999998754    3489999999999999999999998   9999999999999999999999999998765443333


Q ss_pred             cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHH
Q 016009          288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL  367 (397)
Q Consensus       288 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (397)
                      .....++..|+|||++.+..++.++||||||+++|||++|+.||...........     +.....+...    ......
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~----~~~~~~  244 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-----LRDSPPPKLK----NAHKIS  244 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HhccCCCCcc----ccCCCC
Confidence            3445788999999999988899999999999999999999999864322110000     0000000111    111223


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          368 RSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       368 ~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+.+++.+||+.+|++||++++++++
T Consensus       245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         245 PVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            457889999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-41  Score=309.77  Aligned_cols=255  Identities=23%  Similarity=0.309  Sum_probs=194.0

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|++.+.||+|+||.||++... +++.||+|++.... .......+.+.+|..++..++|+||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE-MLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence            46888899999999999999754 68999999986311 11112345688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....  ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             EecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999999996532  3588999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCC-cccccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccC--CC
Q 016009          284 DSSN-WTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD--PR  355 (397)
Q Consensus       284 ~~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~  355 (397)
                      .... .....||+.|+|||++..     ..++.++|||||||++|||++|+.||........        ...+..  ..
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--------~~~i~~~~~~  226 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--------YGKIMNHKEH  226 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH--------HHHHHcCCCc
Confidence            3222 223468999999999863     4578899999999999999999999864322110        000100  00


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCC--CCCCCCHHHHHHH
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNES--PESRPTMKIVSQQ  394 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~--P~~RPt~~~vl~~  394 (397)
                      ...+.. .......+.+++.+|+..+  +..||++++++++
T Consensus       227 ~~~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         227 FQFPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ccCCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            110110 0112345677777766543  3347899998865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.9e-40  Score=300.44  Aligned_cols=250  Identities=26%  Similarity=0.413  Sum_probs=202.1

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||++.. .+++.|++|.+....    ....+.+.+|+.++++++|||++++++++...+..++|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            5788889999999999999964 478899999975321    22356789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      +||+++++|.+++...    .+++.++..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            9999999999998643    478999999999999999999998   999999999999999999999999999876654


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........+++.|+|||.+.+..++.++||||||+++|++++|+.||...........       ....+...  ....
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-------~~~~~~~~--~~~~  238 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNGTPE--LQNP  238 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-------hhcCCCCC--CCCc
Confidence            44333445688899999999888899999999999999999999999864332111000       00011100  1111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+.+++.+||+.+|++||++++++.+
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2233458899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.4e-40  Score=295.21  Aligned_cols=247  Identities=28%  Similarity=0.430  Sum_probs=188.9

Q ss_pred             ccccccCcEEEEEEEeC----CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe-cCCeeeEEEE
Q 016009          131 YCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS-HARHSFLVYE  205 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e  205 (397)
                      +.||+|+||.||+|...    ++..+|+|.+....   .....+.+.+|+.+++.++|||++++++++. .++..++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC---CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            35899999999999653    24579999875321   1223567889999999999999999999875 4556889999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |+.+|+|.+++....  ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.......
T Consensus        78 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          78 YMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            999999999986543  3467888899999999999999998   99999999999999999999999999987543221


Q ss_pred             ----CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCccccccccccccccccccccCCCCCCCC
Q 016009          286 ----SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG-KHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       286 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                          .......++..|+|||...+..++.++||||||+++|||++| ..|+.......        ....+.........
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~  224 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--------ITVYLLQGRRLLQP  224 (262)
T ss_pred             ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHhcCCCCCCC
Confidence                111223456789999999888899999999999999999995 55554322110        00111111111101


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         ...+..+.+++..||+.+|++||++.+|++.|+
T Consensus       225 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~  257 (262)
T cd05058         225 ---EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE  257 (262)
T ss_pred             ---CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence               112345889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.4e-40  Score=294.65  Aligned_cols=253  Identities=28%  Similarity=0.437  Sum_probs=206.3

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|++|.||++... +++.|++|++......   ...+.+.+|++.+++++|+|++++++++...+..++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            36788899999999999999765 5999999998753321   3367899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      |||+++++|.+++...   ..+++..++.++.|+++|++|||+ .   +++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          78 LEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             EEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999999754   358999999999999999999999 8   99999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..........++..|+|||...+..++.++|+||||+++|+|+||+.|+.......  .   ......+.....+...  
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~---~~~~~~~~~~~~~~~~--  224 (264)
T cd06623         152 NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--F---FELMQAICDGPPPSLP--  224 (264)
T ss_pred             cCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--H---HHHHHHHhcCCCCCCC--
Confidence            44433334567889999999998889999999999999999999999986543200  0   0011111111111111  


Q ss_pred             hHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQE-KLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~-~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .. .+..+.+++.+||+.+|++|||+++++++
T Consensus       225 -~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         225 -AEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             11 34568899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.9e-41  Score=299.16  Aligned_cols=255  Identities=24%  Similarity=0.380  Sum_probs=203.0

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|++|.||++... +++.+++|.+......   ...+++.+|++++++++||||+++++++...+..+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE---AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh---HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            35777888999999999999765 6899999998753221   3356789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      +||+++++|.+++....  ..+++..+..++.|++.|++|||+ .   +++|+||+|+||++++++.++|+|||.+....
T Consensus        78 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          78 MEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            99999999999987643  468899999999999999999999 7   99999999999999999999999999987654


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ....  ....++..|+|||...+..++.++||||||+++|+|++|+.|+...........   .....+.....+...  
T Consensus       153 ~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~--  225 (265)
T cd06605         153 NSLA--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF---ELLQYIVNEPPPRLP--  225 (265)
T ss_pred             HHHh--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHH---HHHHHHhcCCCCCCC--
Confidence            3221  125688899999999988999999999999999999999999864421110000   011111111111101  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .......+.+++.+||..||++|||+.+++.+
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            11144568899999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-40  Score=303.72  Aligned_cols=255  Identities=24%  Similarity=0.300  Sum_probs=202.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|++|.||++... +++.||+|.+..... ......+.+..|+++++.++|+||+++++.+......++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence            36778889999999999999765 589999999875322 1122456789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+.+++|.+++.... ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          80 MDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999999986543 24689999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCC-----------------------------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 016009          284 DSS-----------------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL  334 (397)
Q Consensus       284 ~~~-----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~  334 (397)
                      ...                             ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            211                             011235788999999999888999999999999999999999998643


Q ss_pred             ccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHH
Q 016009          335 SSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT----MKIVSQQ  394 (397)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt----~~~vl~~  394 (397)
                      ...        .....+.+.....+..  ......+.+++.+||+.||++|||    +++++..
T Consensus       236 ~~~--------~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         236 NRD--------ETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             chH--------HHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            321        1111222222211111  113456899999999999999999    8887763

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-40  Score=294.77  Aligned_cols=238  Identities=26%  Similarity=0.443  Sum_probs=188.0

Q ss_pred             ccccccCcEEEEEEEeCCCC-----------EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          131 YCIGNGGHGSVYRAELPSGQ-----------VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      +.||+|+||.||+|...+..           .+++|.+....    . ....+.+|+.++++++||||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----R-DSLAFFETASLMSQLSHKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----h-hHHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence            35899999999999765432           47777765321    1 15788999999999999999999999988 77


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC-------cEEE
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF-------EAHV  272 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-------~~kl  272 (397)
                      .++||||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++       .++|
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence            8999999999999999976542  589999999999999999999998   999999999999999888       7999


Q ss_pred             eeeccccccCCCCCCcccccccccccCcccccCC--CCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccc
Q 016009          273 ADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM--KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELD  349 (397)
Q Consensus       273 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  349 (397)
                      +|||++.....    .....++..|+|||++.+.  .++.++||||||+++|||++ |..|+..........     ...
T Consensus       150 ~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-----~~~  220 (259)
T cd05037         150 SDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-----FYQ  220 (259)
T ss_pred             CCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-----HHh
Confidence            99999886543    1223567789999998876  78999999999999999999 577765432110000     000


Q ss_pred             cccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        .....+.+.      ...+.+++.+||+.+|++|||+.+|++.|+
T Consensus       221 --~~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 --DQHRLPMPD------CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             --cCCCCCCCC------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              011111111      146889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.3e-40  Score=310.29  Aligned_cols=260  Identities=23%  Similarity=0.327  Sum_probs=195.6

Q ss_pred             HhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC----
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA----  197 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----  197 (397)
                      ..++|...+.||+|+||.||++.. ..++.||||++......  ....+.+.+|+.+++.++||||+++++++...    
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC--chhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence            356899999999999999999965 46889999998753322  22356788999999999999999999987543    


Q ss_pred             --CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          198 --RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       198 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                        ...++||||+++ +|.+.+.     ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       100 ~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         100 EFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             ccCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence              357999999975 6766663     2478899999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-------------cc
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-------------FL  342 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-------------~~  342 (397)
                      |++....... ......+|..|+|||++.+..++.++|||||||++|||++|+.||.........             ..
T Consensus       171 G~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         171 GLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             CCccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9998654322 223457899999999999999999999999999999999999998643221000             00


Q ss_pred             c-cccccccccC--------------CCC--CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          343 N-TDIELDEMLD--------------PRL--PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       343 ~-~~~~~~~~~~--------------~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      . ..........              +..  +............+.+++.+|++.||++|||++|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0 0000000000              000  00000001123467899999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-40  Score=296.56  Aligned_cols=249  Identities=28%  Similarity=0.473  Sum_probs=200.0

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc---CCceeeeEEEEecCCeee
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR---HRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~  201 (397)
                      .|+..+.||+|+||.||+|.. .+++.|++|.+.....   .....++.+|++++++++   |||++++++++..+...+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~   78 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP---DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW   78 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence            466778899999999999975 5789999999864322   123467889999999996   999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++++|.+++...    .+++..++.++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          79 IIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             EEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            999999999999998543    589999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      ...........|+..|+|||.+.++ .++.++|+||||+++|+|++|..||...........     ......+.+..  
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~--  224 (277)
T cd06917         152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-----IPKSKPPRLED--  224 (277)
T ss_pred             CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-----cccCCCCCCCc--
Confidence            5544334445788999999988654 468899999999999999999999864332111000     00001111111  


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ......+.+++.+||+.||++||++.+++++
T Consensus       225 ---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         225 ---NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence               1134568899999999999999999999864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.4e-40  Score=301.69  Aligned_cols=262  Identities=24%  Similarity=0.400  Sum_probs=200.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||+|..+ +++.||+|++.......  ...+.+.+|+++++.++||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK--MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc--hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence            36778899999999999999765 68999999986532221  2346788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      +||+++++|.++....   ..+++.++..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          79 FEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             EecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            9999999998876543   2489999999999999999999998   999999999999999999999999999887654


Q ss_pred             CCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccc---------ccccc-------cc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS---------SFLNT-------DI  346 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~---------~~~~~-------~~  346 (397)
                      .........++..|+|||+..+ ..++.++||||||+++|||++|+.||........         .....       ..
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            4333344567889999998875 4478899999999999999999998853221100         00000       00


Q ss_pred             ccccccCCCCCCCC---cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ELDEMLDPRLPAPS---RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....+..+......   .........+.+++.+||+.+|++||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00000001100000   0011224568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=317.34  Aligned_cols=252  Identities=27%  Similarity=0.404  Sum_probs=206.9

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCC-EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQ-VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +.|.++..||.|+||.||++..++.. ..|.|++..    ......++|+-|++||..++||+||++++.|...+.+|++
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil  107 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL  107 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence            35667788999999999999766544 445566543    2234578899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      .|||.||-.+..+-.-+  ..|++.++..+++|++.||.|||++   .|||||||+.|||++-+|.++|+|||.+.....
T Consensus       108 iEFC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             EeecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence            99999999988875433  5699999999999999999999999   999999999999999999999999999876555


Q ss_pred             CCCCcccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 016009          284 DSSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      .......+.||++|||||+..     ..+|+.++||||||++|.||..+.+|.....++..-.-..     .--.|.+. 
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia-----KSePPTLl-  256 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-----KSEPPTLL-  256 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh-----hcCCCccc-
Confidence            545556789999999999865     4578999999999999999999999988766654221111     00112222 


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         .+..+...+.+++..||.+||..||++.+++++
T Consensus       257 ---qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  257 ---QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ---CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence               234667789999999999999999999999875

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-40  Score=299.16  Aligned_cols=262  Identities=24%  Similarity=0.378  Sum_probs=201.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-----CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec--C
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH--A  197 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~  197 (397)
                      ++|...+.||+|+||.||++...     ++..+|+|.+......   ...+.+.+|+++++.++|+||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            35667788999999999999753     4678999998753322   235789999999999999999999999877  5


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...+++|||+++++|.+++....  ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  155 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL  155 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence            67899999999999999997644  2589999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCCc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc---c---cccccc
Q 016009          278 AKFLKPDSSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF---L---NTDIEL  348 (397)
Q Consensus       278 ~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~---~---~~~~~~  348 (397)
                      +..........   ....++..|+|||...+..++.++||||||++++||+||+.|+..........   .   ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL  235 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence            98765332211   11234567999999988889999999999999999999999975332111000   0   000001


Q ss_pred             ccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+.+......+.  ......++.+++.+||+.+|++|||+.||+++|+
T Consensus       236 ~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05038         236 LELLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD  281 (284)
T ss_pred             HHHHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence            111111111000  1122356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=319.33  Aligned_cols=247  Identities=28%  Similarity=0.502  Sum_probs=204.0

Q ss_pred             CCCCccccccCcEEEEEEE-eCCCC----EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          127 FDAQYCIGNGGHGSVYRAE-LPSGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~-~~~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ....++||+|+||+||+|. .+.|+    +||+|++......   ...+++++|+-+|.+++|||+++++|+|.... ..
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~---~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP---KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc---hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            3446789999999999994 44543    7899998753322   23578999999999999999999999998766 88


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      ||++||+.|+|.++++.++  ..+..+..+.|..|||+||.|||.+   +++||||.++|||+.+-..+||.|||+++.+
T Consensus       774 lvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            9999999999999998866  3688899999999999999999999   9999999999999999999999999999988


Q ss_pred             CCCCCCcccccc--cccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc--CCCC
Q 016009          282 KPDSSNWTEFAG--TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEML--DPRL  356 (397)
Q Consensus       282 ~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~  356 (397)
                      ..+........|  .+.|||-|.+....++.++|||||||.+||++| |..|++.....         ++.+.+  ..++
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~---------eI~dlle~geRL  919 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE---------EIPDLLEKGERL  919 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH---------HhhHHHhccccC
Confidence            876655444333  568999999999999999999999999999998 99998754421         111111  1234


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      +.|+    .+..+++.++.+||..|+..||+++++...+
T Consensus       920 sqPp----iCtiDVy~~mvkCwmid~~~rp~fkel~~~f  954 (1177)
T KOG1025|consen  920 SQPP----ICTIDVYMVMVKCWMIDADSRPTFKELAEEF  954 (1177)
T ss_pred             CCCC----CccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence            4444    3445689999999999999999999988764

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=299.04  Aligned_cols=256  Identities=27%  Similarity=0.425  Sum_probs=201.6

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCC-
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHAR-  198 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-  198 (397)
                      .++++|+..+.||+|++|.||+|... +++.+++|.+....     ...+++.+|+++++++ +|+||+++++++.... 
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP   77 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence            35688999999999999999999764 67899999976421     1346789999999999 7999999999996544 


Q ss_pred             -----eeeEEEEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEE
Q 016009          199 -----HSFLVYEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV  272 (397)
Q Consensus       199 -----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  272 (397)
                           ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEE
Confidence                 4899999999999999986532 124689999999999999999999998   9999999999999999999999


Q ss_pred             eeeccccccCCCCCCcccccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 016009          273 ADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE  347 (397)
Q Consensus       273 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~  347 (397)
                      +|||++..............++..|+|||.+..     ..++.++||||||+++|+|++|+.||........        
T Consensus       155 ~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------  226 (275)
T cd06608         155 VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--------  226 (275)
T ss_pred             CCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--------
Confidence            999998765443333344568899999998753     3467899999999999999999999864322110        


Q ss_pred             cccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          348 LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+.... .............+.+++.+||+.||++|||+.+++++
T Consensus       227 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         227 LFKIPRNP-PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             HHHhhccC-CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            01111100 10111112345678899999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.4e-40  Score=294.60  Aligned_cols=253  Identities=23%  Similarity=0.378  Sum_probs=195.5

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCC-cchhcHHHHHHHHHHHHhccCCceeeeEEEEec--CCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPS-DQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH--ARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  200 (397)
                      .+|...+.||+|+||.||++.. .++..|++|++...... ........+.+|+.++++++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688889999999999999965 46899999988643221 112234568899999999999999999998865  3577


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++++||+++++|.+++....   .+++...+.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999986543   488999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCC---CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          281 LKPDS---SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       281 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      .....   .......++..|+|||.+.+..++.++||||||+++|||++|+.||...........    .......+.++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~  231 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQPTNPQLP  231 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcCCCCCCCc
Confidence            53211   112234578899999999988899999999999999999999999864322110000    00000111111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                            ......+.+++ .||..+|++||+++||+++
T Consensus       232 ------~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         232 ------SHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ------hhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                  12233455666 6888999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.5e-40  Score=296.59  Aligned_cols=256  Identities=23%  Similarity=0.393  Sum_probs=200.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      ++|+....||+|+||.||+|..+      +.+.+++|.+....   .....+.+.+|++++++++|+|++++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            46788889999999999999753      34679999875421   1123567899999999999999999999999989


Q ss_pred             eeeEEEEeccCCCHHHhhcccccc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEE
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAA------QELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV  272 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  272 (397)
                      ..++||||+++|+|.+++......      ..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.+++
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEE
Confidence            999999999999999999755421      1589999999999999999999998   9999999999999999999999


Q ss_pred             eeeccccccCCCC-CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccccccc
Q 016009          273 ADFGIAKFLKPDS-SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE  350 (397)
Q Consensus       273 ~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  350 (397)
                      +|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......        ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--------~~~~  230 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--------VLNR  230 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--------HHHH
Confidence            9999987543221 12233456778999999988888999999999999999999 788875332211        0011


Q ss_pred             ccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ........+  .....+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       231 ~~~~~~~~~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         231 LQAGKLELP--VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHcCCcCCC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            111111100  00122346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.5e-40  Score=306.46  Aligned_cols=254  Identities=24%  Similarity=0.409  Sum_probs=198.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeC--------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCS  195 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  195 (397)
                      .+|.+.+.||+|+||.||++...        .+..||+|.++...   .....+++.+|+++++++ +||||+++++++.
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            46788899999999999999532        12368999876422   122356889999999999 7999999999999


Q ss_pred             cCCeeeEEEEeccCCCHHHhhcccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcE
Q 016009          196 HARHSFLVYEFLKRGSLAAILSSDA-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNL  262 (397)
Q Consensus       196 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni  262 (397)
                      ..+..++++||+++|+|.+++....             ....+++.++..++.|++.||+|||+.   +++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence            9999999999999999999986532             123588999999999999999999998   999999999999


Q ss_pred             EeCCCCcEEEeeeccccccCCCCCCc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccc
Q 016009          263 LLDLEFEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISS  339 (397)
Q Consensus       263 ll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~  339 (397)
                      ++++++.+||+|||+++.........  ....++..|+|||.+.+..++.++||||||+++|||++ |..||....... 
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-  244 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-  244 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence            99999999999999987654322111  12233567999999999889999999999999999998 888875432111 


Q ss_pred             cccccccccccccCCC-CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          340 SFLNTDIELDEMLDPR-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       340 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                             ....+.... ...+.    .....+.+++.+||+.+|++|||+.++++.|+
T Consensus       245 -------~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~  291 (334)
T cd05100         245 -------LFKLLKEGHRMDKPA----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLD  291 (334)
T ss_pred             -------HHHHHHcCCCCCCCC----CCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence                   011111111 11111    22345889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-40  Score=297.25  Aligned_cols=239  Identities=23%  Similarity=0.416  Sum_probs=186.6

Q ss_pred             cccccCcEEEEEEEeC-C-------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          132 CIGNGGHGSVYRAELP-S-------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .||+|+||.||+|... .       ...+++|.+...    .....+.+.+|+.+++.++|||++++++++..+...++|
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            5999999999999653 2       234888876431    122346788999999999999999999999998999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc--------EEEeee
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE--------AHVADF  275 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Df  275 (397)
                      |||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.        ++++||
T Consensus        78 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          78 QEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            99999999999997654  2589999999999999999999998   9999999999999987765        699999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCC-CCCCccccccccccccccccccccC
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGK-HPRDFLSSISSSFLNTDIELDEMLD  353 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~  353 (397)
                      |++......    ....++..|+|||.+.+. .++.++||||||+++|||++|. .|+........         .....
T Consensus       153 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---------~~~~~  219 (258)
T cd05078         153 GISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---------LQFYE  219 (258)
T ss_pred             ccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---------HHHHH
Confidence            988654321    234678889999998864 5789999999999999999985 55443221110         00111


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       354 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .....+..    ....+.+++.+||+.||++|||++++++.|+
T Consensus       220 ~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 DRHQLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ccccCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11111111    1235889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.4e-40  Score=297.37  Aligned_cols=248  Identities=28%  Similarity=0.461  Sum_probs=194.6

Q ss_pred             ccccccCcEEEEEEEeCC-------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          131 YCIGNGGHGSVYRAELPS-------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +.||+|+||.||+|...+       ++.+++|.+.....   ......+.+|+++++.++||||+++++++......++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT---DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc---hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            358999999999996542       25789998754221   12356789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhcccc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC-----cEEEee
Q 016009          204 YEFLKRGSLAAILSSDA----AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF-----EAHVAD  274 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-----~~kl~D  274 (397)
                      |||+++++|.+++....    ....+++.+++.++.|++.||+|||+.   +++|+||+|+||+++.++     .++++|
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999999999996532    123478999999999999999999998   999999999999999887     899999


Q ss_pred             eccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 016009          275 FGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       275 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      ||++........  ......++..|+|||.+.++.++.++||||||+++|||+| |+.||........        ...+
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~--------~~~~  226 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV--------LQHV  226 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH--------HHHH
Confidence            999876533221  1122345678999999999999999999999999999998 9999864322110        0000


Q ss_pred             cC-CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          352 LD-PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       352 ~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .. .....+    ...+..+.+++.+||+.+|++||++++|++.|+
T Consensus       227 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         227 TAGGRLQKP----ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             hcCCccCCc----ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            00 111111    123456889999999999999999999999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.1e-40  Score=298.56  Aligned_cols=253  Identities=28%  Similarity=0.452  Sum_probs=205.0

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      .++.|+..+.||+|++|.||+|..+ +++.+++|++.....     ..+.+.+|+++++.++|+|++++++++......+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            4556778888999999999999765 688999999864222     3577889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +++||+++++|.+++....  ..+++..++.++.+++.||+|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            9999999999999997654  3699999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ...........++..|+|||.+.+..++.++|+||||+++|+|++|+.|+........        ...+.....+ ...
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~-~~~  237 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--------LFLITTKGIP-PLK  237 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHhcCCC-CCc
Confidence            4433333334578899999999888899999999999999999999999864332110        0011111111 011


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ........+.+++.+||+.+|.+|||+.+++++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            111234568899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.5e-40  Score=294.69  Aligned_cols=246  Identities=27%  Similarity=0.463  Sum_probs=196.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|+..+.||+|+||.||++.. +++.||+|.++...      ..+.+.+|+.++++++|||++++++++... ..+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            4578889999999999999975 67889999976421      246789999999999999999999998654 479999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++..... ..+++..++.++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          78 ELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             ECCCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence            99999999999975432 3588999999999999999999998   9999999999999999999999999998754322


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .   .....+..|+|||.+.+..++.++|+||||+++|||++ |+.||........         ...........  ..
T Consensus       154 ~---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---------~~~~~~~~~~~--~~  219 (254)
T cd05083         154 V---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---------KECVEKGYRME--PP  219 (254)
T ss_pred             C---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---------HHHHhCCCCCC--CC
Confidence            1   12234568999999988889999999999999999998 9999864332110         00011111100  01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            123356889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.4e-40  Score=298.56  Aligned_cols=263  Identities=21%  Similarity=0.259  Sum_probs=196.3

Q ss_pred             HhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ++++|...+.||+|+||.||+|.. .+|+.|++|.+.......   ....+.+|+++++.++|+||+++.+++..++..+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   79 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG---VPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC---CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence            457888999999999999999965 468899999986532211   2346778999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +|+||+. ++|.+++....  ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        80 lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            9999996 67776664432  3478888999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc------------------
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL------------------  342 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~------------------  342 (397)
                      ...........++..|+|||.+.+. .++.++||||||+++|||++|+.||...........                  
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            4333333344578899999988754 578899999999999999999999864332100000                  


Q ss_pred             ccccccccccCCCCCCCCc---chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          343 NTDIELDEMLDPRLPAPSR---SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..............+....   ........+.+++.+|++.||++|||++|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            0000000000000000000   000113457889999999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-41  Score=312.03  Aligned_cols=191  Identities=23%  Similarity=0.354  Sum_probs=163.7

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ...+|+..+.||+|+||.||+|... +++.||+|....          .....|+.++++++||||+++++++......+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc----------cccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            3457999999999999999999765 577899997432          22356899999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +|+||+. ++|.+++....  ..+++.+++.++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus       134 lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        134 MVLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             EEEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            9999995 58888876433  4689999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP  330 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p  330 (397)
                      ... .......||..|+|||++.+..++.++|||||||++|||+++..|
T Consensus       208 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~  255 (357)
T PHA03209        208 VVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST  255 (357)
T ss_pred             ccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence            322 222345689999999999999999999999999999999986554

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.3e-41  Score=309.43  Aligned_cols=255  Identities=22%  Similarity=0.297  Sum_probs=196.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||++... +++.||+|.+.... .........+.+|..++..++|+||+++++++...+..++|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE-MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            46888899999999999999754 68899999986411 11122345678899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             EeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999997533  3588999999999999999999998   999999999999999999999999999976654


Q ss_pred             CCCC-cccccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccC--CC
Q 016009          284 DSSN-WTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD--PR  355 (397)
Q Consensus       284 ~~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~  355 (397)
                      .... .....|++.|+|||++.+     +.++.++||||||+++|||++|+.||.......        ....+..  .+
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~  226 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHEER  226 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH--------HHHHHHcCCCc
Confidence            3322 233568999999998875     467889999999999999999999986432211        0111111  11


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPES--RPTMKIVSQQ  394 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~~vl~~  394 (397)
                      .+.+ ....+....+.+++.+|+..++++  |+++++++++
T Consensus       227 ~~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 FQFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ccCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            1111 111123455788888988866554  4688888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=305.31  Aligned_cols=247  Identities=26%  Similarity=0.442  Sum_probs=202.7

Q ss_pred             CCccccccCcEEEEEEEeCC---CC--EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          129 AQYCIGNGGHGSVYRAELPS---GQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       129 ~~~~lg~G~~g~vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ..++||.|.||.||+|.+.+   |+  .||||.-+....   ..+.+.|+.|..+|++++||||++++|+|.. ...|+|
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t---~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv  468 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT---PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV  468 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC---hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence            44679999999999996532   33  588888765433   3347889999999999999999999999965 467999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      ||.++-|.|..+|..+..  .++......++.||+.||+|||+.   ..|||||..+|||+....-+||+|||+++.+..
T Consensus       469 mEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            999999999999987764  688889999999999999999999   999999999999999999999999999999886


Q ss_pred             CCCCccc-ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc-CCCCCCCC
Q 016009          284 DSSNWTE-FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEML-DPRLPAPS  360 (397)
Q Consensus       284 ~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  360 (397)
                      +...... ..-...|||||.+.-.+++.+||||.|||++||++. |..||........        +..+- ..+++.|+
T Consensus       544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------I~~iEnGeRlP~P~  615 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------IGHIENGERLPCPP  615 (974)
T ss_pred             cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------EEEecCCCCCCCCC
Confidence            6544332 233668999999999999999999999999999986 9999875443211        11111 23445444


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                          .++..+..|+.+||+.+|.+||++.++...|.
T Consensus       616 ----nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  616 ----NCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             ----CCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence                44556889999999999999999999988763

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6e-40  Score=296.06  Aligned_cols=248  Identities=27%  Similarity=0.413  Sum_probs=199.7

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      -|+..+.||+|+||.||+|.. .++..+|+|.+.....   ....+.+.+|++++++++||||+++++++..+...++||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            466678899999999999965 4788999998754221   123467889999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++..    ..+++..+..++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06641          82 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  154 (277)
T ss_pred             EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence            99999999999864    2488999999999999999999998   9999999999999999999999999998765543


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      ........++..|+|||.+.+..++.++|+||||+++|+|++|..|+.........        ..+.....+   ....
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~---~~~~  223 (277)
T cd06641         155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL--------FLIPKNNPP---TLEG  223 (277)
T ss_pred             hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH--------HHHhcCCCC---CCCc
Confidence            32333456788999999998888999999999999999999999998643321100        000000000   0111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.+++.+||+.+|++||++.+++++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            233558899999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-40  Score=308.56  Aligned_cols=255  Identities=23%  Similarity=0.311  Sum_probs=195.0

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||++..+ +++.+|+|.+..... ........+..|+.++..++|+||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence            36888899999999999999765 578899999753111 1112234578899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        80 ~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             EeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999997533  3589999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCC-CcccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC--C
Q 016009          284 DSS-NWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP--R  355 (397)
Q Consensus       284 ~~~-~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~  355 (397)
                      ... ......||+.|+|||++.     ...++.++|||||||++|||++|+.||........        ...+...  .
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~--------~~~i~~~~~~  226 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--------YGKIMNHKER  226 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH--------HHHHhCCCcc
Confidence            322 223357899999999886     34578999999999999999999999864332110        1111110  0


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPES--RPTMKIVSQQ  394 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~~vl~~  394 (397)
                      ...+ .........+.+++.+|+..+|++  ||++++++++
T Consensus       227 ~~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 FQFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ccCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            1111 111123345778888877654444  6899998765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.3e-40  Score=299.87  Aligned_cols=262  Identities=25%  Similarity=0.364  Sum_probs=197.2

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||.|++|.||+|... +|+.|++|++......  ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc--cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence            4777889999999999999654 7899999998643221  123457889999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+. ++|.+++..... ..+++.++..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          79 EFLH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             eccc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            9996 689888865432 4689999999999999999999998   9999999999999999999999999998765543


Q ss_pred             CCCcccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCcccccccccc------ccccc----cccccC
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL------NTDIE----LDEMLD  353 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~------~~~~~----~~~~~~  353 (397)
                      ........++..|+|||...+.. ++.++||||||+++|||+||+.||...........      .....    .....+
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence            33334445788999999887644 58899999999999999999999854322110000      00000    000000


Q ss_pred             --CCCCC-CCcch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          354 --PRLPA-PSRSV----QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       354 --~~~~~-~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        ...+. .....    ......+.+++.+||+.||++|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence              00000 00000    0122457789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.5e-40  Score=301.71  Aligned_cols=255  Identities=22%  Similarity=0.263  Sum_probs=196.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||++... +++.|++|.+..... ......+.+.+|+++++.++||||+++++.+..++..++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence            36888899999999999999654 678999998764221 1122346788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++....   .+++..+..++.+++.||+|||+.   +++|+||||+||+++.++.++|+|||+++....
T Consensus        80 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          80 MEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            99999999999996543   589999999999999999999998   999999999999999999999999998864211


Q ss_pred             CCC---------------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 016009          284 DSS---------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIEL  348 (397)
Q Consensus       284 ~~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  348 (397)
                      ...               ......++..|+|||.+.+..++.++|+||||+++|||++|..||......        ...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--------~~~  225 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--------ELF  225 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH
Confidence            100               011235678899999998888999999999999999999999998532210        001


Q ss_pred             ccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      ..........+... ...+..+.+++.+||+.||++||++.++.+.|
T Consensus       226 ~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll  271 (305)
T cd05609         226 GQVISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVK  271 (305)
T ss_pred             HHHHhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence            11111111111110 12334588999999999999999965554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.1e-40  Score=301.14  Aligned_cols=263  Identities=24%  Similarity=0.310  Sum_probs=199.2

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCc-chhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSD-QIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +|+..+.||+|++|.||+|... +|+.|++|.+....... .......+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3667788999999999999754 68999999987533221 111245677899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+ +++|.+++....  ..+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999997543  3589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-----cc--cccc------ccc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-----FL--NTDI------ELD  349 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-----~~--~~~~------~~~  349 (397)
                      .........++..|+|||.+.+ ..++.++||||||+++|||++|..||.........     ..  ....      ...
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            4333334456788999998864 45789999999999999999998776533321100     00  0000      000


Q ss_pred             cccCCCCCCC---CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          350 EMLDPRLPAP---SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       350 ~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .........+   ..........+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000000   00111224568899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.3e-40  Score=298.98  Aligned_cols=247  Identities=26%  Similarity=0.348  Sum_probs=200.3

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|++|.||++... +++.+|+|.+..... ......+.+.+|++++++++||||+++++++..++..++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence            36788899999999999999654 689999999864211 1122356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          80 MEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            9999999999998664   3589999999999999999999998   999999999999999999999999999887543


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .   .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.......        ....+.......+..  
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~--  220 (290)
T cd05580         154 R---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ--------IYEKILEGKVRFPSF--  220 (290)
T ss_pred             C---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCccCCcc--
Confidence            3   233468899999999988888999999999999999999999986433210        111111222221111  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRP-----TMKIVSQ  393 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~  393 (397)
                        ....+.+++.+||+.||++||     +++|+++
T Consensus       221 --~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         221 --FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             --CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              234588999999999999999     7788764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7e-40  Score=293.44  Aligned_cols=252  Identities=28%  Similarity=0.426  Sum_probs=200.5

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|...+.||+|+||.||+|.. .+++.|++|.++.....  ....+.+..|++++++++|+||+++++++.+.+..++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence            467778899999999999965 47899999998753322  234678999999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++....   .+++..+..++.+++.||+|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        79 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          79 EYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             ecCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            9999999999987543   478899999999999999999998   9999999999999999999999999998876543


Q ss_pred             CCCc----ccccccccccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          285 SSNW----TEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       285 ~~~~----~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      ....    ....++..|+|||++.+..   ++.++||||||++++|+++|+.||...........    .......+.++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~  228 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF----HVGAGHKPPIP  228 (264)
T ss_pred             CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH----HHhcCCCCCCC
Confidence            3221    1346788999999988766   88999999999999999999999864321100000    00111111121


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      ..    ......+.+++.+||+.+|++|||+.+++.
T Consensus       229 ~~----~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         229 DS----LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             cc----cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11    112345778999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.4e-40  Score=293.10  Aligned_cols=252  Identities=26%  Similarity=0.385  Sum_probs=199.7

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCC-cchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPS-DQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +|+..+.||+|++|.||+|... +++.|++|.+...... ......+.+.+|+++++.++|+|++++.+++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3666788999999999999765 7899999987642211 1122346789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      +||+++++|.+++....   .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999986543   488999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCcccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      .. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||...........     ...  ....+.   .
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-----~~~--~~~~~~---~  223 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-----IGR--SKELPP---I  223 (258)
T ss_pred             cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-----HHh--cccCCC---c
Confidence            32 223456788999999987766 89999999999999999999999864432111000     000  001110   0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .......+.+++.+||+.+|++||++.++++.
T Consensus       224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            11223457889999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.8e-40  Score=292.77  Aligned_cols=252  Identities=22%  Similarity=0.339  Sum_probs=196.9

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCC-cchhcHHHHHHHHHHHHhccCCceeeeEEEEecC--Cee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPS-DQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--RHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  200 (397)
                      ++|+..+.||+|+||.||+|.. .++..|++|.+...... ......+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4688889999999999999965 46899999987642221 1122346788999999999999999999988663  467


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      +++|||+++++|.+++....   .+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999986543   478889999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCC---CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccccc-CCCC
Q 016009          281 LKPDS---SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML-DPRL  356 (397)
Q Consensus       281 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~  356 (397)
                      .....   .......++..|+|||.+.+..++.++||||||+++|||++|+.||........        ..... .+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~~  227 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--------IFKIATQPTN  227 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--------HHHHhcCCCC
Confidence            54211   112334688899999999888899999999999999999999999864322110        01111 1111


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +   .........+.+++.+|+. +|++||+++||+++
T Consensus       228 ~---~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         228 P---VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             C---CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            1   1112334567788889985 99999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.3e-40  Score=299.91  Aligned_cols=261  Identities=21%  Similarity=0.295  Sum_probs=195.7

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|+||.||+|... +|+.+++|.+......  ......+.+|++++++++|||++++++++.+....++|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc--ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence            3677788999999999999664 7899999998643221  122356788999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||++ ++|.+++....  ..+++..++.++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          79 EYCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             ecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            9997 47877775433  3589999999999999999999998   9999999999999999999999999999865543


Q ss_pred             CCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc--------cccc---cccccc
Q 016009          285 SSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL--------NTDI---ELDEML  352 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~--------~~~~---~~~~~~  352 (397)
                      ........++..|+|||.+.+. .++.++||||||+++|||+||..|+...........        ....   ......
T Consensus       153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence            3333445678899999988764 468999999999999999999988532211100000        0000   000000


Q ss_pred             CC-CCCCCCc------chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          353 DP-RLPAPSR------SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       353 ~~-~~~~~~~------~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +. ..+....      ........+.+++.+||+.||.+|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            00 0000000      001223567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.3e-40  Score=291.95  Aligned_cols=251  Identities=22%  Similarity=0.347  Sum_probs=199.8

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|++|.||++.. .+++.+++|.+.....  .....+.+.+|++++++++|||++++++.+..++..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence            467788999999999999965 4788999999865322  2223578999999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC-CcEEEeeeccccccCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKP  283 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~  283 (397)
                      ||+++++|.+++..... ..+++..+..++.+++.|+.|||++   +++|+||+|+||+++++ +.++|+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          79 EYAPGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             ecCCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            99999999999976432 4589999999999999999999998   99999999999999865 4689999999986643


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||+......        ..............   
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~---  222 (256)
T cd08220         155 KS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--------LVLKIMSGTFAPIS---  222 (256)
T ss_pred             Cc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--------HHHHHHhcCCCCCC---
Confidence            32 2233467889999999998889999999999999999999999986432210        01111111111000   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+.+++.+||+.+|++|||++|++++
T Consensus       223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            1123458899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-40  Score=307.87  Aligned_cols=260  Identities=23%  Similarity=0.355  Sum_probs=194.6

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC---
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA---  197 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---  197 (397)
                      ...++|...+.||+|+||.||+|.. .+++.||||++.....  .....+.+.+|++++++++||||+++++++...   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            3457899999999999999999964 5788999999864321  122345678999999999999999999987533   


Q ss_pred             ---CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEee
Q 016009          198 ---RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVAD  274 (397)
Q Consensus       198 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  274 (397)
                         ...++++|++ +++|.+++..    ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence               4568999987 7899888753    3489999999999999999999998   999999999999999999999999


Q ss_pred             eccccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------ccccc
Q 016009          275 FGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNTDI  346 (397)
Q Consensus       275 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~~~  346 (397)
                      ||++......   .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..........       .....
T Consensus       162 fg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         162 FGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             CccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999865432   233468999999999876 568899999999999999999999986432210000       00000


Q ss_pred             ccccc-------cCCCCCC-CCcch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ELDEM-------LDPRLPA-PSRSV----QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~~~~~-------~~~~~~~-~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....+       ....++. +....    ......+.+++.+|++.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000       0000000 00000    0112347799999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-40  Score=295.21  Aligned_cols=251  Identities=26%  Similarity=0.453  Sum_probs=198.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCC----EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      .+|...+.||+|+||.||+|... +|.    .+|+|.+.....   ......+.+|+.++++++|||++++++++.. ..
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS---PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            46778899999999999999754 333    589998764322   2335678899999999999999999999987 78


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence            899999999999999997644  2489999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCCcc--cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CC
Q 016009          280 FLKPDSSNWT--EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-PR  355 (397)
Q Consensus       280 ~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~  355 (397)
                      ..........  ...++..|+|||......++.++|+||||+++||+++ |+.||+.......        ...+.. ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------~~~~~~~~~  229 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI--------PDLLEKGER  229 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH--------HHHHhCCCC
Confidence            7653322211  1223568999999988889999999999999999999 9999864322110        001111 11


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+.+..    ....+.+++.+||..+|++|||+.++++.|+
T Consensus       230 ~~~~~~----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~  266 (279)
T cd05057         230 LPQPPI----CTIDVYMVLVKCWMIDAESRPTFKELINEFS  266 (279)
T ss_pred             CCCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            111111    2235788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.6e-40  Score=297.41  Aligned_cols=249  Identities=25%  Similarity=0.393  Sum_probs=198.7

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      .|...+.||+|++|.||++.. .+++.+++|++....    ....+.+.+|+.+++.++|||++++++++...+..++++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            345567899999999999965 478899999875321    123466889999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++..    ..+++.++..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||.+......
T Consensus        96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          96 EFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             eccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            99999999999865    2488999999999999999999998   9999999999999999999999999988765433


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      ........|+..|+|||...+..++.++||||||+++|||++|+.||..........     .......+....+    .
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~----~  239 (285)
T cd06648         169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK-----RIRDNLPPKLKNL----H  239 (285)
T ss_pred             CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH-----HHHhcCCCCCccc----c
Confidence            333334568899999999988889999999999999999999999985432211000     0001111111111    1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.+++.+||+.+|++|||+.+++++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            133468899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.9e-40  Score=301.12  Aligned_cols=250  Identities=26%  Similarity=0.455  Sum_probs=195.8

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCC----EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      ++|+..+.||+|+||.||+|.. .+|.    .+|+|.+.....   .....++.+|+.+++.++||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG---PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            4677888999999999999965 3454    478888764221   22245688999999999999999999998754 4


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++++||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence            679999999999999986543  3588999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc--CC
Q 016009          280 FLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEML--DP  354 (397)
Q Consensus       280 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~  354 (397)
                      ........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......         ....+  ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---------~~~~~~~~~  228 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---------IPDLLEKGE  228 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHCCC
Confidence            66433221  122345678999999988889999999999999999997 899986432110         00111  11


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+.    .....+.+++..||..+|++||+++++++.|+
T Consensus       229 ~~~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~  266 (303)
T cd05110         229 RLPQPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFS  266 (303)
T ss_pred             CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111111    12345889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-40  Score=298.44  Aligned_cols=261  Identities=21%  Similarity=0.325  Sum_probs=195.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|++|.||+|..+ +++.||+|.+.......   ....+.+|++++++++|+||+++++++..++..++|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG---APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC---CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            57888899999999999999765 78999999986532211   134567899999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++ +|.+++....  ..+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          82 FEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             EecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            999985 9999886543  3588999999999999999999998   999999999999999999999999999875433


Q ss_pred             CCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc------c--cccccc------
Q 016009          284 DSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF------L--NTDIEL------  348 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~------~--~~~~~~------  348 (397)
                      .........++..|+|||...+ ..++.++||||+|+++|||++|+.||..........      .  ......      
T Consensus       156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence            2222233356788999998875 457899999999999999999999986433110000      0  000000      


Q ss_pred             ccccCCCCCCC-Ccch------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 DEMLDPRLPAP-SRSV------QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 ~~~~~~~~~~~-~~~~------~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ........... ....      ......+.+++.+|++.+|++|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            00000000000 0000      0011457789999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.3e-40  Score=295.89  Aligned_cols=252  Identities=26%  Similarity=0.411  Sum_probs=197.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeCC----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ++|...+.||+|+||.||+|...+    ...|++|.......   ....+.+.+|+.++++++|||++++++++.. ...
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS---PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            357778899999999999997543    24689998764321   2235678999999999999999999999875 457


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++|+|.+++....  ..+++.+++.++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence            89999999999999996543  3589999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCCCC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCC
Q 016009          281 LKPDSSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       281 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      ....... .....++..|+|||.+....++.++||||||+++||+++ |..||..........     ....  ....+.
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~-----~~~~--~~~~~~  229 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG-----RIEN--GERLPM  229 (270)
T ss_pred             cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-----HHHc--CCcCCC
Confidence            5433221 112234568999999988889999999999999999986 999986443211000     0000  011111


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.    ..+..+.+++.+|+..+|++|||+.++++.|+
T Consensus       230 ~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~  263 (270)
T cd05056         230 PP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS  263 (270)
T ss_pred             CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11    22346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.6e-40  Score=294.99  Aligned_cols=257  Identities=25%  Similarity=0.402  Sum_probs=198.4

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcc------hhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQ------IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      +|...+.||+|+||.||+|.. .+|+.+|+|.++.......      ....+.+..|++++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            356678899999999999964 4789999998754221111      111346788999999999999999999999999


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA  278 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  278 (397)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++++|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998765   3589999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCCC--CcccccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 016009          279 KFLKPDSS--NWTEFAGTYGYVAPELAYTMK--ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP  354 (397)
Q Consensus       279 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
                      ........  ......++..|+|||.+....  ++.++|+||||+++||+++|..|+..............    .  ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~--~~  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN----K--RS  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc----c--cc
Confidence            76442211  122345788999999887654  78999999999999999999999863322110000000    0  00


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....+.....+....+.+++.+||+.+|++|||+++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            0111111112334568899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.3e-40  Score=319.74  Aligned_cols=262  Identities=17%  Similarity=0.260  Sum_probs=191.5

Q ss_pred             HHHHHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC------Cceeee
Q 016009          118 DEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH------RNIVKL  190 (397)
Q Consensus       118 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~  190 (397)
                      +++...+++|.+.+.||+|+||+||+|.. .+++.||||+++...     .....+..|+++++.++|      ++++.+
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i  196 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKI  196 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence            34445678899999999999999999965 468899999986421     113445667777777754      458889


Q ss_pred             EEEEecC-CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCcEEeCCCC
Q 016009          191 YGFCSHA-RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHRDISSKNLLLDLEF  268 (397)
Q Consensus       191 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~  268 (397)
                      ++++... ...++|||++ +++|.+++...   ..+++..+..++.||+.||.|||+ .   +|+||||||+|||++.++
T Consensus       197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSD  269 (467)
T ss_pred             EEEEEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCC
Confidence            9988765 5788999987 77888888654   358999999999999999999997 5   899999999999998765


Q ss_pred             ----------------cEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 016009          269 ----------------EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD  332 (397)
Q Consensus       269 ----------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~  332 (397)
                                      .+||+|||.+....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~  346 (467)
T PTZ00284        270 TVVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD  346 (467)
T ss_pred             cccccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                            49999999876422   22234678999999999999999999999999999999999999996


Q ss_pred             ccccccc-------------ccccc--ccccccccC------CCCCCC-------Ccch--HHHHHHHHHHHHHccCCCC
Q 016009          333 FLSSISS-------------SFLNT--DIELDEMLD------PRLPAP-------SRSV--QEKLRSIVEVVFSCLNESP  382 (397)
Q Consensus       333 ~~~~~~~-------------~~~~~--~~~~~~~~~------~~~~~~-------~~~~--~~~~~~l~~l~~~cl~~~P  382 (397)
                      .......             .+...  ......+.+      +.....       ....  ......+.+|+.+||+.||
T Consensus       347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  426 (467)
T PTZ00284        347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR  426 (467)
T ss_pred             CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence            4332110             00000  000000000      000000       0000  0112457799999999999


Q ss_pred             CCCCCHHHHHHH
Q 016009          383 ESRPTMKIVSQQ  394 (397)
Q Consensus       383 ~~RPt~~~vl~~  394 (397)
                      ++|||++|++++
T Consensus       427 ~~R~ta~e~L~H  438 (467)
T PTZ00284        427 QKRLNARQMTTH  438 (467)
T ss_pred             hhCCCHHHHhcC
Confidence            999999999874

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-40  Score=311.42  Aligned_cols=255  Identities=22%  Similarity=0.262  Sum_probs=194.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC---CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ..+|.+.+.||+|+||.||++...   .+..|++|.+...         ....+|++++++++||||+++++++......
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            347889999999999999999643   4578999987531         2346899999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      +++||++. ++|.+++...   ..+++.+++.++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++..
T Consensus       162 ~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             EEEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            99999985 6888888432   4589999999999999999999998   999999999999999999999999999976


Q ss_pred             cCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccc----------------cccc
Q 016009          281 LKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS----------------SSFL  342 (397)
Q Consensus       281 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~----------------~~~~  342 (397)
                      .......  .....||..|+|||++.+..++.++|||||||++|||++|+.||.......                ..+.
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence            5543221  234578999999999999899999999999999999999999985332110                0000


Q ss_pred             ccc-c----c---cccccCCCCCCCCc-chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          343 NTD-I----E---LDEMLDPRLPAPSR-SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       343 ~~~-~----~---~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ... .    .   ......+....+.. ........+.+++.+||..||++|||+.|++.+
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000 0    0   00000000000000 000123457889999999999999999999864

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=298.11  Aligned_cols=248  Identities=22%  Similarity=0.357  Sum_probs=211.2

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      -|...+.||+|.|..|-++++ =+|..||||++.+..  ........+.+|++.|+.++|||||+++.+..+...+|||+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTK--lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTK--LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccc--cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            466677899999999998853 389999999997522  23345678999999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC-CCcEEEeeeccccccCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKP  283 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~  283 (397)
                      |.=++|+|.+++..+..  .+++....+++.||+.|+.|+|+.   .+|||||||+||.+.+ -|-+||+|||++..+.+
T Consensus        97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999977653  488999999999999999999999   8999999999998865 47899999999988775


Q ss_pred             CCCCcccccccccccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKIT-EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      +. ...+.+|+..|-|||++.+..|+ ++.|||||||+||.|++|+.||+....        .+.+..++|-....|   
T Consensus       172 G~-kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND--------SETLTmImDCKYtvP---  239 (864)
T KOG4717|consen  172 GK-KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND--------SETLTMIMDCKYTVP---  239 (864)
T ss_pred             cc-hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc--------hhhhhhhhcccccCc---
Confidence            54 44667999999999999998875 589999999999999999999975432        344556666655544   


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                       .....+..+||..||..||++|.+.++|+.
T Consensus       240 -shvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  240 -SHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence             355667899999999999999999999875

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-39  Score=290.28  Aligned_cols=249  Identities=29%  Similarity=0.489  Sum_probs=198.2

Q ss_pred             CCCccccccCcEEEEEEEeCC-----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          128 DAQYCIGNGGHGSVYRAELPS-----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       128 ~~~~~lg~G~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      ++.+.||.|+||.||++...+     +..||+|.+......   ...+.+..|+++++.++|+|++++++++...+..++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE---QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh---HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            456789999999999997653     388999998653221   135788999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      +|||+++++|.+++..... ..+++.++..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++....
T Consensus        79 i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence            9999999999999875432 2289999999999999999999999   99999999999999999999999999998665


Q ss_pred             CCCCCcc-cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCC
Q 016009          283 PDSSNWT-EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLPAP  359 (397)
Q Consensus       283 ~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  359 (397)
                      ....... ...++..|+|||...+..++.++||||+|+++++|++ |..|+.......        ....+... ....+
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~  226 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--------VLEYLKKGYRLPKP  226 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCCCCC
Confidence            4322111 2236789999999988889999999999999999998 788876422110        00111111 11111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      .    ..+..+.+++.+|++.||++|||+.|+++.|
T Consensus       227 ~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      227 E----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            1    1345688999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-39  Score=292.81  Aligned_cols=256  Identities=23%  Similarity=0.386  Sum_probs=200.8

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCc--chhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSD--QIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      +|+..+.||+|++|.||++.. .+++.||+|.+.......  .....+.+..|++++++++|+|++++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            467788899999999999964 578999999986433211  11235678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC-cEEEeeecccccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFL  281 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~  281 (397)
                      |+||+++++|.+++....   ++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999986543   588999999999999999999998   999999999999998776 5999999998776


Q ss_pred             CCCCC----CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          282 KPDSS----NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       282 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      .....    ......++..|+|||.+.+..++.++||||+|+++++|++|..||.........     ..........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~--  227 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL-----ALIFKIASAT--  227 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-----HHHHHHhccC--
Confidence            54321    112346788999999998888999999999999999999999998633211000     0000000000  


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ............+.+++.+|++.+|++|||+.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            0111112344568899999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.4e-39  Score=299.47  Aligned_cols=193  Identities=22%  Similarity=0.377  Sum_probs=157.7

Q ss_pred             ccccccCcEEEEEEEeC---CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe--cCCeeeEEEE
Q 016009          131 YCIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS--HARHSFLVYE  205 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e  205 (397)
                      ..||+|+||.||+|...   ++..||+|.+....      ....+.+|++++++++||||+++++++.  .+...++|||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            56999999999999764   45789999886421      1345788999999999999999999884  4567899999


Q ss_pred             eccCCCHHHhhcccc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe----CCCCcEEEeee
Q 016009          206 FLKRGSLAAILSSDA------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL----DLEFEAHVADF  275 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Df  275 (397)
                      |+.+ +|.+++....      ....+++..++.++.|++.||.|||+.   +++||||||+||++    +.++.+||+||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9875 7777664221      123588999999999999999999998   99999999999999    56678999999


Q ss_pred             ccccccCCCCC---CcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 016009          276 GIAKFLKPDSS---NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDF  333 (397)
Q Consensus       276 g~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~  333 (397)
                      |+++.......   ......+|..|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            99986643322   22345688999999988764 578999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.8e-39  Score=297.38  Aligned_cols=249  Identities=29%  Similarity=0.433  Sum_probs=196.1

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ..|...+.||+|+||.||+|... +++.||+|.+..... ......+.+.+|+++++.++|||++++.+++..++..++|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            45778889999999999999654 689999999864222 1222346788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||++ |++.+++....  ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        94 ~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 57777665433  3589999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCcccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          284 DSSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      .    ....++..|+|||.+.   ...++.++||||||+++|||+||+.|+..........        .+.....+  .
T Consensus       168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~--------~~~~~~~~--~  233 (307)
T cd06607         168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--------HIAQNDSP--T  233 (307)
T ss_pred             C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH--------HHhcCCCC--C
Confidence            2    2346788999999874   4568889999999999999999999976433211100        00000000  1


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+...+.+++.+||+.+|++||++.+|+.+
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            1112345568999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.7e-40  Score=292.84  Aligned_cols=252  Identities=23%  Similarity=0.338  Sum_probs=200.7

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|+||.||++... +|..+|+|.+.....  .....+.+.+|++++++++|+|++++++.+......++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence            4677788999999999999664 688999999864211  1123567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc-EEEeeeccccccCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE-AHVADFGIAKFLKP  283 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfg~~~~~~~  283 (397)
                      ||+++++|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++. ++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          79 EYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             ecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            99999999999865432 3579999999999999999999998   9999999999999998864 69999999887654


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........|++.|+|||...+..++.++|+||||++++||++|..|+.......        ..............   
T Consensus       155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~---  223 (257)
T cd08225         155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ--------LVLKICQGYFAPIS---  223 (257)
T ss_pred             CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHhcccCCCCC---
Confidence            3333334568889999999988889999999999999999999999986432111        01111111111100   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+.+++.+||+.+|++|||++|++++
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         224 PNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            1123458899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-40  Score=296.78  Aligned_cols=261  Identities=25%  Similarity=0.322  Sum_probs=197.0

Q ss_pred             CCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |+..+.||.|++|.||+|.. .+|..|++|++......  ......+.+|++++++++|||++++++++..++..+++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED--EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc--ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence            55678899999999999965 47999999998653221  1224568899999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |++ ++|.+++..... ..+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        79 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          79 FLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             ccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            995 689998865442 3589999999999999999999998   99999999999999999999999999997654333


Q ss_pred             CCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc-------cccc------cccc-
Q 016009          286 SNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL-------NTDI------ELDE-  350 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~-------~~~~------~~~~-  350 (397)
                      .......++..|+|||++.+. .++.++||||||+++|+|++|+.||...........       ....      ...+ 
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            333334568899999987654 578899999999999999999999864332110000       0000      0000 


Q ss_pred             ---ccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          351 ---MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       351 ---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ...................+.+++.+|++.||++|||++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               00000000000011223568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=295.89  Aligned_cols=261  Identities=26%  Similarity=0.400  Sum_probs=199.9

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|++|.||+|... +++.|++|.++....  .....+.+.+|++++++++|+||+++++++..++..+++|
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            6788889999999999999765 688999999864322  1223577899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||++++.+..+....   ..+++.++..++.+++.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          80 EYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            999987777665432   3489999999999999999999998   9999999999999999999999999998876544


Q ss_pred             CC-CcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccc----------------ccccc
Q 016009          285 SS-NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF----------------LNTDI  346 (397)
Q Consensus       285 ~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~----------------~~~~~  346 (397)
                      .. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||..........                .....
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            32 23345678899999999887 78999999999999999999999986432211000                00000


Q ss_pred             ccc--cccCCCCCC--CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ELD--EMLDPRLPA--PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~~~--~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...  ...+.....  ...........+.+++.+||+.+|++|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            000  000000000  000001124668999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.6e-39  Score=294.42  Aligned_cols=262  Identities=20%  Similarity=0.331  Sum_probs=198.9

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||.|++|.||+|... +|+.||+|.+......   .....+.+|++++++++|+|++++++++...+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence            4777889999999999999765 6889999998753321   22456788999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++ +|.+++........+++.++..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence            99985 8888886554335689999999999999999999998   9999999999999999999999999999765443


Q ss_pred             CCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccc--c-----ccccccccccc-----
Q 016009          285 SSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--S-----FLNTDIELDEM-----  351 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--~-----~~~~~~~~~~~-----  351 (397)
                      ........++..|++||.+.+. .++.++||||||+++|+|++|+.||........  .     ..........+     
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            3333344678899999987654 468899999999999999999999864322100  0     00000000000     


Q ss_pred             cCCCCCCCCc-----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          352 LDPRLPAPSR-----SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       352 ~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+....     ........+.+++.+|++.||++||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0001110000     001223567899999999999999999999863

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.7e-39  Score=287.22  Aligned_cols=250  Identities=32%  Similarity=0.494  Sum_probs=202.8

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|++|.||++... +++.+++|++.....    ...+.+.+|++++++++|+|++++++++......++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            4667788999999999999765 788999999875322    24578999999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++....  ..+++..+..++.+++.|+.|||+.   +++|+||+|+||++++++.++|+|||.+......
T Consensus        77 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          77 EFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             ecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            9999999999987653  4689999999999999999999998   9999999999999999999999999998876543


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      .. .....++..|+|||.+.+..++.++||||||+++++|++|+.|+............     ....-+.....    .
T Consensus       152 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~----~  221 (253)
T cd05122         152 KA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-----ATNGPPGLRNP----E  221 (253)
T ss_pred             cc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----HhcCCCCcCcc----c
Confidence            32 33456888999999998888999999999999999999999998644221110000     00000111111    1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.+++.+||+.||++|||+.|++++
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            123458899999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.3e-39  Score=293.84  Aligned_cols=246  Identities=24%  Similarity=0.292  Sum_probs=192.9

Q ss_pred             ccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCC
Q 016009          133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGS  211 (397)
Q Consensus       133 lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  211 (397)
                      ||+|+||+||++.. .+|+.+++|.+...... .......+..|++++++++|||++++++++...+..++||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            68999999999964 47899999998642211 11234567789999999999999999999999999999999999999


Q ss_pred             HHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcccc
Q 016009          212 LAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF  291 (397)
Q Consensus       212 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  291 (397)
                      |.+++..... ..+++.++..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+..... .......
T Consensus        80 L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~  154 (277)
T cd05577          80 LKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGR  154 (277)
T ss_pred             HHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccc
Confidence            9999875442 4589999999999999999999998   999999999999999999999999999876543 2222334


Q ss_pred             cccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccc-ccCCCCCCCCcchHHHHHHH
Q 016009          292 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE-MLDPRLPAPSRSVQEKLRSI  370 (397)
Q Consensus       292 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l  370 (397)
                      .++..|+|||...+..++.++||||||+++++|++|+.||........     ...+.. .......    ........+
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~~~  225 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-----KEELKRRTLEMAVE----YPDKFSPEA  225 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-----HHHHHhcccccccc----CCccCCHHH
Confidence            678899999999888899999999999999999999999864332100     000000 1111111    111224458


Q ss_pred             HHHHHHccCCCCCCCC-----CHHHHHH
Q 016009          371 VEVVFSCLNESPESRP-----TMKIVSQ  393 (397)
Q Consensus       371 ~~l~~~cl~~~P~~RP-----t~~~vl~  393 (397)
                      .+++.+||+.||++||     ++.++++
T Consensus       226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         226 KDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHccCChhHccCCCcccHHHHHh
Confidence            8999999999999999     6666765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.7e-39  Score=294.38  Aligned_cols=261  Identities=23%  Similarity=0.356  Sum_probs=199.5

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|++|.||+|.. .+|+.|++|++......  ......+.+|+.++++++|||++++++++..+...++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE--GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc--chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence            467788899999999999975 47899999998753321  123567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+ +++|.+++....  ..+++.+++.++.|+++||+|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        79 e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          79 EYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             ccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            999 999999986543  4689999999999999999999998   9999999999999999999999999998876543


Q ss_pred             CC-CcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccc--------------ccccc--cc
Q 016009          285 SS-NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--------------SFLNT--DI  346 (397)
Q Consensus       285 ~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--------------~~~~~--~~  346 (397)
                      .. ......++..|+|||.+.+. .++.++||||+|++++||+||..||........              .+...  ..
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence            21 23345688999999988654 468999999999999999999887753321100              00000  00


Q ss_pred             ccccccCCCCCC-C-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ELDEMLDPRLPA-P-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~~~~~~~~~~~~-~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....+..+.... + .....+....+.+++.+|++.+|++|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000000000 0 00001223678999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.9e-39  Score=295.28  Aligned_cols=262  Identities=23%  Similarity=0.288  Sum_probs=197.6

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC--Ceee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--RHSF  201 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  201 (397)
                      ++|+..+.||+|+||.||+|..+ +++.+++|.++.....  ......+.+|++++++++||||+++++++...  +..+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            46888899999999999999765 6889999998753322  12234677899999999999999999998777  8899


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++ +|.+++....  ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        83 lv~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             EEehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            99999974 9988886543  2589999999999999999999998   9999999999999999999999999998876


Q ss_pred             CCCCCCcccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCccccccccc-----cc--cc------cc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-----LN--TD------IE  347 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-----~~--~~------~~  347 (397)
                      ...........++..|+|||.+.+.. ++.++|+||||+++|||++|+.||..........     ..  ..      ..
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            54433334456788999999887544 6889999999999999999999986432211000     00  00      00


Q ss_pred             ccccc-----CCCCCCCCcchHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          348 LDEML-----DPRLPAPSRSVQE--KLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       348 ~~~~~-----~~~~~~~~~~~~~--~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +....     .............  ....+.+++.+||+.||++|||+.|++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00000     0000000000011  24457899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2e-39  Score=293.58  Aligned_cols=253  Identities=23%  Similarity=0.391  Sum_probs=193.0

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHH-HHhccCCceeeeEEEEecCCeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA-LTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      ++|++.+.||+|+||.||++... +|+.||+|.+.......   ...++..|+.+ ++..+|||++++++++..++..++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l   77 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ---EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI   77 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH---HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence            46888899999999999999664 69999999987532221   23456667665 566689999999999999999999


Q ss_pred             EEEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          203 VYEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +|||++ |+|.+++.... ....+++..++.++.|++.||+|||+++  +++||||||+||+++.++.+||+|||++...
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            999996 68887775422 2246899999999999999999999852  7999999999999999999999999998765


Q ss_pred             CCCCCCcccccccccccCcccccC----CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYT----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      .... ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||.......       ...........+
T Consensus       155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~  226 (283)
T cd06617         155 VDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-------QQLKQVVEEPSP  226 (283)
T ss_pred             cccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-------HHHHHHHhcCCC
Confidence            4221 1223467889999998764    446889999999999999999999986322100       011111111111


Q ss_pred             -CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 -APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 -~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .+.   ...+..+.+++.+||+.+|++||++.+++++
T Consensus       227 ~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         227 QLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             CCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             111   1234568899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=308.30  Aligned_cols=244  Identities=27%  Similarity=0.403  Sum_probs=199.7

Q ss_pred             cccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCC
Q 016009          132 CIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRG  210 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  210 (397)
                      +||+|.||+||-|+.. +...+|||.+....    ....+.+..|+.+-++++|.|||+++|.+..++..-+.||-++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD----SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc----chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            5999999999999655 45678999876422    233577899999999999999999999999999999999999999


Q ss_pred             CHHHhhccccccCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC-CCCcEEEeeeccccccCCCCCC
Q 016009          211 SLAAILSSDAAAQEL--GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD-LEFEAHVADFGIAKFLKPDSSN  287 (397)
Q Consensus       211 ~L~~~l~~~~~~~~l--~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~  287 (397)
                      ||.++|+..-  +++  ++..+-.+.+||++||.|||.+   .|||||||-+|||++ -.|.+||+|||-++.+..-...
T Consensus       658 SLSsLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  658 SLSSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             cHHHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence            9999997643  345  7788889999999999999999   999999999999994 5789999999999987765555


Q ss_pred             cccccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHH
Q 016009          288 WTEFAGTYGYVAPELAYTMK--ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE  365 (397)
Q Consensus       288 ~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (397)
                      ..+..||..|||||++..++  |..++|||||||++.||.||++||-.+...........  +. .+.|.+      +.+
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG--my-KvHP~i------Pee  803 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG--MY-KVHPPI------PEE  803 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc--ce-ecCCCC------cHH
Confidence            66788999999999998664  88999999999999999999999876554222111100  00 011222      245


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          366 KLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       366 ~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      ...+...+|.+|+.+||.+||+++++++
T Consensus       804 lsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            5667889999999999999999999985

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-40  Score=299.88  Aligned_cols=254  Identities=25%  Similarity=0.414  Sum_probs=203.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  202 (397)
                      ...|++.+.||+||.+.||++...+.+.+|+|++....  .+.....-|.+|+..|.+++ |.+|+++++|-..++.+|+
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            35688889999999999999998888999999876422  23344678999999999994 9999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      |||| ...+|..+|..... ....| .+..+..|++.|+.++|..   +|||.||||.|+|+ -.|.+||+|||.|..+.
T Consensus       438 vmE~-Gd~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  438 VMEC-GDIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAIQ  510 (677)
T ss_pred             Eeec-ccccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhcccC
Confidence            9996 46699999987653 22334 7788899999999999999   99999999999998 46789999999999877


Q ss_pred             CCCCC--cccccccccccCcccccCC-----------CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 016009          283 PDSSN--WTEFAGTYGYVAPELAYTM-----------KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD  349 (397)
Q Consensus       283 ~~~~~--~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  349 (397)
                      .+...  ....+||..||+||.+...           +.+.+|||||+||+||+|+.|+.||+....       ....+.
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~aKl~  583 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIAKLH  583 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHHHHH
Confidence            65433  3457899999999987643           256799999999999999999999875432       233456


Q ss_pred             cccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .+.||.-..+.....+ ..++.++++.||+.||++|||+.++|++
T Consensus       584 aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  584 AITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             hhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            6666643211111111 1228899999999999999999999874

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.7e-40  Score=304.67  Aligned_cols=194  Identities=24%  Similarity=0.386  Sum_probs=168.3

Q ss_pred             CCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-C-----CceeeeEEEEecCC
Q 016009          126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-H-----RNIVKLYGFCSHAR  198 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~  198 (397)
                      +|++.+.||+|+||.|.+| +.++++.||||+++...     .-..+-..|+.+|..|+ |     -|+|++++++...+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            7888999999999999999 56689999999998632     23466778999999996 4     48999999999999


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC--CcEEEeeec
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE--FEAHVADFG  276 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg  276 (397)
                      +.+||+|.+ ..+|.+++..+.. ..++...++.++.||+.||.+||+.   +|||+||||+||||.+-  ..+||+|||
T Consensus       262 HlciVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  262 HLCIVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             ceeeeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence            999999988 4599999988765 4599999999999999999999998   99999999999999654  379999999


Q ss_pred             cccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD  332 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~  332 (397)
                      .+++......   ...-+..|.|||++.+.+|+.+.|+|||||++.||++|.+-|.
T Consensus       337 SSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  337 SSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             cccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            9987543322   3456778999999999999999999999999999999976654

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.3e-39  Score=294.99  Aligned_cols=264  Identities=21%  Similarity=0.278  Sum_probs=195.3

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCe---
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARH---  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~---  199 (397)
                      ++|+..+.||+|+||.||+|... +++.||+|.+......  ......+.+|+.+++.++ ||||+++++++.....   
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE--EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc--cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            36888899999999999999754 7899999987653221  122457888999999995 6999999999876655   


Q ss_pred             --eeEEEEeccCCCHHHhhccccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC-CCcEEEee
Q 016009          200 --SFLVYEFLKRGSLAAILSSDAA--AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL-EFEAHVAD  274 (397)
Q Consensus       200 --~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~D  274 (397)
                        .++||||+++ +|.+++.....  ...+++..++.++.||+.||.|||+.   +++|+||+|+||+++. ++.++|+|
T Consensus        79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence              8999999986 78888764332  24689999999999999999999998   9999999999999998 88999999


Q ss_pred             eccccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc-------cccc
Q 016009          275 FGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL-------NTDI  346 (397)
Q Consensus       275 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~-------~~~~  346 (397)
                      ||++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........       ....
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9998765433222233456888999998765 4578999999999999999999999864322110000       0000


Q ss_pred             ccccc---c----CCCCCC--CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ELDEM---L----DPRLPA--PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~~~~~---~----~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....   .    .+....  ...........+.+++.+||+.||++|||+.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000   0    000000  000011234568899999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.8e-39  Score=294.94  Aligned_cols=244  Identities=26%  Similarity=0.414  Sum_probs=195.2

Q ss_pred             ccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccC
Q 016009          131 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKR  209 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  209 (397)
                      ..||+|+||.||++.. .+++.||+|++....    ......+.+|+.+++.++|+|++++++++...+..++||||+++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            5699999999999966 478999999875321    22356789999999999999999999999999999999999999


Q ss_pred             CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcc
Q 016009          210 GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT  289 (397)
Q Consensus       210 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  289 (397)
                      ++|.+++...    .+++.....++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++...........
T Consensus       102 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~  174 (292)
T cd06657         102 GALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  174 (292)
T ss_pred             CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence            9999987532    478999999999999999999998   999999999999999999999999999876544333333


Q ss_pred             cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHH
Q 016009          290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS  369 (397)
Q Consensus       290 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (397)
                      ...++..|+|||...+..++.++|+||+|+++|+|++|..||.........     ........+....    .......
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~  245 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-----KMIRDNLPPKLKN----LHKVSPS  245 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhhCCcccCC----cccCCHH
Confidence            456889999999998888899999999999999999999997632211000     0001111111111    1122345


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          370 IVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       370 l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +.+++.+||+.+|.+||++.+++++
T Consensus       246 l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         246 LKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             HHHHHHHHHhCCcccCcCHHHHhcC
Confidence            7889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.4e-39  Score=290.51  Aligned_cols=253  Identities=27%  Similarity=0.444  Sum_probs=194.7

Q ss_pred             CCCCccccccCcEEEEEEEeC----CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC----
Q 016009          127 FDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR----  198 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  198 (397)
                      |.+.+.||+|+||.||+|...    +++.||+|.+......  ....+++.+|++++++++|||++++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC--hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence            456778999999999999643    4688999998653322  223567899999999999999999999885432    


Q ss_pred             --eeeEEEEeccCCCHHHhhcccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEe
Q 016009          199 --HSFLVYEFLKRGSLAAILSSDA---AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVA  273 (397)
Q Consensus       199 --~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  273 (397)
                        ..++++||+++|+|.+++....   ....+++...+.++.|++.||+|||+.   +++|+||||+||+++.++.+||+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence              2478899999999998875322   112478999999999999999999998   99999999999999999999999


Q ss_pred             eeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccccccc
Q 016009          274 DFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE  350 (397)
Q Consensus       274 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  350 (397)
                      |||++........  ......++..|++||......++.++||||||+++|||++ |+.||.......        ....
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--------~~~~  227 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--------IYNY  227 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--------HHHH
Confidence            9999886543221  1122345678999999988889999999999999999999 888876432210        0000


Q ss_pred             ccC-CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          351 MLD-PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       351 ~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.. .....+.    .....+.+++.+||+.+|++|||+.++++.|+
T Consensus       228 ~~~~~~~~~~~----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~  270 (273)
T cd05074         228 LIKGNRLKQPP----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE  270 (273)
T ss_pred             HHcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            100 0111111    23346899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.8e-40  Score=292.58  Aligned_cols=251  Identities=27%  Similarity=0.354  Sum_probs=201.4

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|...+.||.|+||.||++... +++.|++|.+..... ......+.+.+|++++++++||||+++++++..+...++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence            4677889999999999999765 689999999864221 11123578899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+.+++|.+++...   ..+++.++..++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          80 DLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             eCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999999999998654   3588999999999999999999998   9999999999999999999999999998865433


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      . ......++..|+|||...+..++.++|+||||+++|+|++|+.||...........     ...........+    .
T Consensus       154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~----~  223 (258)
T cd05578         154 T-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI-----RAKQETADVLYP----A  223 (258)
T ss_pred             c-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH-----HHHhccccccCc----c
Confidence            2 22345678899999999888899999999999999999999999875432100000     011110111111    1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCH--HHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTM--KIVSQ  393 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~--~~vl~  393 (397)
                      .....+.+++.+||+.||.+||++  +|+++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             cCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            233568899999999999999999  77764

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=8.8e-39  Score=293.99  Aligned_cols=248  Identities=29%  Similarity=0.428  Sum_probs=194.9

Q ss_pred             CCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |+..+.||+|+||.||++.. .++..+|+|.+...... .......+.+|++++++++|||++++++++..++..++|||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            66678899999999999975 46889999998643222 22234678899999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |+++ +|.+.+....  ..+++.++..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...... 
T Consensus       106 ~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         106 YCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            9975 7777775433  3589999999999999999999998   9999999999999999999999999988754322 


Q ss_pred             CCcccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          286 SNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                         ....++..|+|||.+.   .+.++.++||||||+++|||++|+.||.......        ....+.....+.  ..
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~--~~  245 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPT--LQ  245 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHhccCCC--CC
Confidence               2346788999999874   4568899999999999999999999975432111        011111111110  01


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      .......+.+++.+||+.+|++||++.++++++
T Consensus       246 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            113344588999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4e-39  Score=290.82  Aligned_cols=245  Identities=20%  Similarity=0.241  Sum_probs=186.4

Q ss_pred             cccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHh---ccCCceeeeEEEEecCCeeeEEEEec
Q 016009          132 CIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE---IRHRNIVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~~~~~~~~~~~~~lv~e~~  207 (397)
                      .||+|+||.||++.. .+++.+|+|.+........ .....+.+|..+++.   .+|||++.+.+++...+..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence            389999999999965 4689999998865322211 112334445444443   47999999999999999999999999


Q ss_pred             cCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCC
Q 016009          208 KRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN  287 (397)
Q Consensus       208 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  287 (397)
                      ++|+|.+++....   .+++.++..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.......  
T Consensus        80 ~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          80 NGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            9999999886543   589999999999999999999998   99999999999999999999999999987543222  


Q ss_pred             cccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHH
Q 016009          288 WTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK  366 (397)
Q Consensus       288 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (397)
                      .....|+..|+|||...+ ..++.++||||+|+++|||++|..||.........      .......   ..........
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~---~~~~~~~~~~  222 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------EIDRMTL---TVNVELPDSF  222 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH------HHHHHhh---cCCcCCcccc
Confidence            223468999999998864 55889999999999999999999998643221100      0111100   0001111223


Q ss_pred             HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          367 LRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       367 ~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                      ...+.+++.+||+.||++||     |+++++++
T Consensus       223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            45688999999999999999     69999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9.6e-39  Score=284.90  Aligned_cols=251  Identities=27%  Similarity=0.392  Sum_probs=203.9

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC--CeeeE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--RHSFL  202 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  202 (397)
                      +|...+.||+|++|.||+|... +++.|++|++......  ....+.+.+|++++++++|||++++++.+...  +..++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence            3667788999999999999765 7899999998753322  23467889999999999999999999999888  89999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ++||+++++|.+++....   .+++.+++.++.++++||+|||+.   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        79 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            999999999999987644   689999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCCCCC
Q 016009          283 PDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD-PRLPAP  359 (397)
Q Consensus       283 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  359 (397)
                      ....  ......++..|+|||...+...+.++||||||+++++|++|..||........       ....... ....  
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~--  223 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-------ALYKIGSSGEPP--  223 (260)
T ss_pred             cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-------HHHhccccCCCc--
Confidence            4432  13345688899999999888899999999999999999999999875431100       0011111 0111  


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .........+.+++.+|++.+|++||++.++++.
T Consensus       224 -~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         224 -EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             -CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence             0111224568899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.2e-39  Score=294.12  Aligned_cols=253  Identities=26%  Similarity=0.394  Sum_probs=193.2

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeeeEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  203 (397)
                      +|...+.||+|+||.||++.. .+++.+|+|.+......   .....+.+|+.++.++. |+||+++++++..++..+++
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE---KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh---HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            455567899999999999965 46899999998643222   33567899999999996 99999999999999999999


Q ss_pred             EEeccCCCHHHhhcc--ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          204 YEFLKRGSLAAILSS--DAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      |||+.. ++.++...  ......+++..+..++.+++.||+|||+..  +++||||||+||+++.++.++|+|||++...
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            999864 55544321  111246899999999999999999999742  8999999999999999999999999998765


Q ss_pred             CCCCCCcccccccccccCcccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccC---CC
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD---PR  355 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~  355 (397)
                      ..... .....++..|+|||.+.+.   .++.++||||||+++|||++|+.||.......       ........   +.
T Consensus       159 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~  230 (288)
T cd06616         159 VDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-------DQLTQVVKGDPPI  230 (288)
T ss_pred             ccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-------HHHhhhcCCCCCc
Confidence            43222 1234678899999998766   68999999999999999999999986432110       00111111   11


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +.  ..........+.+++.+||+.+|++|||+++|++.
T Consensus       231 ~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         231 LS--NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CC--CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11  11112345568999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.6e-39  Score=286.48  Aligned_cols=243  Identities=27%  Similarity=0.364  Sum_probs=195.4

Q ss_pred             ccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCC
Q 016009          133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGS  211 (397)
Q Consensus       133 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  211 (397)
                      ||.|++|.||++... +++.+++|.+...... .....+.+.+|+++++.++||||+++++++.+++..++++||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            689999999999765 5899999998653221 12235679999999999999999999999999999999999999999


Q ss_pred             HHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcccc
Q 016009          212 LAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF  291 (397)
Q Consensus       212 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  291 (397)
                      |.+++....   .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        80 L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~  152 (262)
T cd05572          80 LWTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTF  152 (262)
T ss_pred             HHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccc
Confidence            999997543   488999999999999999999998   99999999999999999999999999998765432 22334


Q ss_pred             cccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCCcchHHHHHH
Q 016009          292 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLRS  369 (397)
Q Consensus       292 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  369 (397)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......      ......+.+  .....+.    .....
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~----~~~~~  222 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP------MEIYNDILKGNGKLEFPN----YIDKA  222 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH------HHHHHHHhccCCCCCCCc----ccCHH
Confidence            67889999999988889999999999999999999999986443100      001111111  1111111    11456


Q ss_pred             HHHHHHHccCCCCCCCCC-----HHHHHH
Q 016009          370 IVEVVFSCLNESPESRPT-----MKIVSQ  393 (397)
Q Consensus       370 l~~l~~~cl~~~P~~RPt-----~~~vl~  393 (397)
                      +.+++.+||+.+|++||+     ++|+++
T Consensus       223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         223 AKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            899999999999999999     888876

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-40  Score=306.74  Aligned_cols=247  Identities=22%  Similarity=0.373  Sum_probs=192.7

Q ss_pred             CccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe--eeEEEEe
Q 016009          130 QYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH--SFLVYEF  206 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~  206 (397)
                      ..+||+|+|-+||+|.. .+|..||--.++...........+.|..|+.+|+.|+||||++++.++.+...  .-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            45699999999999954 46777775544432223334446889999999999999999999999976654  7799999


Q ss_pred             ccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC-CcEEEeeeccccccCCCC
Q 016009          207 LKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       207 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~~~  285 (397)
                      +..|+|..++...+   ..+...+..|+.||++||.|||++ .|+|+|||||.+||+++.+ |.+||+|+|+|.......
T Consensus       125 ~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            99999999997765   488899999999999999999996 4699999999999999765 899999999999876544


Q ss_pred             CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHH
Q 016009          286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE  365 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (397)
                      ..  ...|||.|||||+.. ..|++..||||||++++||+|+..||..-.....-+        ..+-....+ .....-
T Consensus       201 ak--svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY--------KKV~SGiKP-~sl~kV  268 (632)
T KOG0584|consen  201 AK--SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY--------KKVTSGIKP-AALSKV  268 (632)
T ss_pred             cc--eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH--------HHHHcCCCH-HHhhcc
Confidence            33  378999999999887 689999999999999999999999986433211100        000000000 000000


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          366 KLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       366 ~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      .-.++.++|.+|+.. .++|||+.|+|+
T Consensus       269 ~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  269 KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            013488999999999 999999999986

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=303.13  Aligned_cols=244  Identities=27%  Similarity=0.454  Sum_probs=199.7

Q ss_pred             CccccccCcEEEEEEEeC--CCC--EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          130 QYCIGNGGHGSVYRAELP--SGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      .++||+|.||.|++|.+.  +|+  .||||.++......   ...+|++|+.+|.+|+|||+++++|+..+ ....+|+|
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~---~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA---IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch---hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            467999999999999664  454  68999998643322   46899999999999999999999999987 67889999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      .++.|||.+.|+. .....|-......++.|||.||+||.++   ++|||||..+|+++-..-.+||+|||+.+-+....
T Consensus       191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999987 3334577788899999999999999999   99999999999999999999999999999877554


Q ss_pred             CCcc---cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC--CCCCCC
Q 016009          286 SNWT---EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAP  359 (397)
Q Consensus       286 ~~~~---~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  359 (397)
                      ....   ...-...|.|||.+....++.+||||+|||++|||+| |..||-......         +-+.+|  ++++.+
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q---------IL~~iD~~erLpRP  337 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---------ILKNIDAGERLPRP  337 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH---------HHHhccccccCCCC
Confidence            4331   1223568999999999999999999999999999999 788875433211         111122  234444


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .    .+.+.+++++..||..+|++|||+..|.+.
T Consensus       338 k----~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  338 K----YCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             C----CChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            3    455679999999999999999999999744

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.3e-39  Score=295.90  Aligned_cols=263  Identities=28%  Similarity=0.336  Sum_probs=196.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC--Cee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--RHS  200 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  200 (397)
                      .++|+..+.||+|+||.||+|... +|+.||+|.+.......  .....+.+|+.++++++|+|++++++++...  +..
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD--GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC--CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            457888999999999999999654 68999999986432211  1123466899999999999999999998654  568


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+.+ +|.+++....  ..+++.++..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence            999999975 8888876533  4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-----cc-cc-ccc---cc
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-----FL-NT-DIE---LD  349 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-----~~-~~-~~~---~~  349 (397)
                      ............++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.........     .. .. ...   ..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            6544333333455788999998865 45789999999999999999999998643321100     00 00 000   00


Q ss_pred             ccc---CCCCC-CCCcch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          350 EML---DPRLP-APSRSV----QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       350 ~~~---~~~~~-~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..-   ..... .+....    ......+.+++.+|++.||++|||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000   00000 000000    1124567889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.1e-39  Score=291.63  Aligned_cols=263  Identities=23%  Similarity=0.326  Sum_probs=195.1

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|++|.||+|... +|+.|++|.+......  ....+.+.+|++++++++|||++++++++......++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED--EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc--ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            46888899999999999999764 7899999998643221  12346788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC-CCcEEEeeeccccccC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLK  282 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~  282 (397)
                      |||++ ++|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++. ++.+||+|||++....
T Consensus        80 ~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             Eeccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            99996 578777754332 3467888999999999999999998   9999999999999985 5679999999997654


Q ss_pred             CCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc------c-ccc------cc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL------N-TDI------EL  348 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~------~-~~~------~~  348 (397)
                      ..........+++.|+|||.+.+. .++.++||||+|+++|+|+||+.||...........      . ...      .+
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            333333344678899999988664 578999999999999999999999864322100000      0 000      00


Q ss_pred             cccc--CCCCCCCC--cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 DEML--DPRLPAPS--RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 ~~~~--~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....  .+......  .........+.+++.+|++.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000  00000000  0001123458899999999999999999999864

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-39  Score=287.57  Aligned_cols=245  Identities=24%  Similarity=0.288  Sum_probs=185.8

Q ss_pred             ccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHH-HhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEAL-TEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.||+|+||.||+|.. .+|+.||+|.+...... .......+..|..++ ...+|+|++++++++...+..++|+||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            4589999999999965 46899999998642111 111123345555544 44589999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +++|.+++....   .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....    .
T Consensus        81 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~  150 (260)
T cd05611          81 GGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----N  150 (260)
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----c
Confidence            999999986543   488999999999999999999998   999999999999999999999999998875432    2


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR  368 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (397)
                      ....++..|+|||...+..++.++||||||+++|||++|..||........        ...+.......+.........
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~  222 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--------FDNILSRRINWPEEVKEFCSP  222 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--------HHHHHhcccCCCCcccccCCH
Confidence            234678899999999888889999999999999999999999864322110        011111111101111112345


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          369 SIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       369 ~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .+.+++.+||+.+|++||++.++.+.
T Consensus       223 ~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         223 EAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             HHHHHHHHHccCCHHHccCCCcHHHH
Confidence            68899999999999999977544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=275.03  Aligned_cols=252  Identities=22%  Similarity=0.343  Sum_probs=198.7

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeeeEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  203 (397)
                      +......||+|..|.|++++.. +|...|||.+.....   ..+.+.++..++++...+ +|+||+.+|||..+...++.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N---kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic  169 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC  169 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC---HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence            4445667999999999999654 689999999976433   334677888888877774 99999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      ||.|. ..++.++....  +++++.-+-++...+..||.||..++  +|+|||+||+|||+|+.|++|++|||.+..+..
T Consensus       170 MelMs-~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  170 MELMS-TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHH-HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence            99884 46777775544  46888888899999999999999985  999999999999999999999999999987764


Q ss_pred             CCCCcccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          284 DSSNWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      +. ..+..+|.+.|||||.+.-   ..|+.++||||||+.++||.||+.||..-..-       -+.+..+++...+...
T Consensus       245 Sk-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-------Fe~ltkvln~ePP~L~  316 (391)
T KOG0983|consen  245 SK-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-------FEVLTKVLNEEPPLLP  316 (391)
T ss_pred             cc-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-------HHHHHHHHhcCCCCCC
Confidence            33 3355689999999998863   46889999999999999999999998642210       1112233332222111


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .....+..+.+++..||++|+.+||...+++++
T Consensus       317 -~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  317 -GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             -cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence             111255679999999999999999999999874

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-39  Score=284.41  Aligned_cols=249  Identities=27%  Similarity=0.415  Sum_probs=202.7

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|++|.||++... +++.|++|.+......  ....+.+.+|++++++++|+|++++++++.+.+..+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence            4677889999999999999654 6889999998764322  234578999999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++...   ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        79 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          79 EYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             ecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            999999999998654   3589999999999999999999998   9999999999999999999999999999876654


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      ........++..|+|||...+..++.++||||+|+++++|++|+.|+............     .....+..+  .    
T Consensus       153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~--~----  221 (254)
T cd06627         153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI-----VQDDHPPLP--E----  221 (254)
T ss_pred             cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-----hccCCCCCC--C----
Confidence            44334456888999999988878899999999999999999999998643321110000     000011111  1    


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      .....+.+++.+||+.+|++|||+.+++.
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         222 GISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            12345889999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-38  Score=284.07  Aligned_cols=253  Identities=25%  Similarity=0.388  Sum_probs=204.1

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|...+.||+|++|.||++... +++.+++|++.....  .....+.+..|+++++.++|||++++.+.+......++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence            4677788999999999999654 689999999865322  2234677899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          205 EFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      ||+++++|.+++.... ....+++.++..++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            9999999999987642 124689999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........+++.|+|||...+..++.++|+||+|+++++|++|+.||+......        ...............  
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~--  225 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--------LALKILKGQYPPIPS--  225 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--------HHHHHhcCCCCCCCC--
Confidence            4323344568889999999988889999999999999999999999986433111        001111111111111  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .....+.+++.+||+.+|++|||+.++++.
T Consensus       226 -~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         226 -QYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             223458899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.6e-39  Score=285.72  Aligned_cols=251  Identities=24%  Similarity=0.307  Sum_probs=202.7

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|+..+.||+|++|.||++.. .+++.+++|.+......  ......+.+|++++++++|+||+++.+++......++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS--QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc--HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence            467788899999999999954 47889999998643221  233567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          205 EFLKRGSLAAILSSDAA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      ||+++++|.+++..... ...+++..++.++.+++.||+|||+.   +++|+||+|+||++++++.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            99999999999865321 24589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .  ......++..|+|||...+..++.++|+||||+++|||++|+.||........        ...+.....+..   .
T Consensus       156 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~---~  222 (256)
T cd08530         156 N--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--------RYKVQRGKYPPI---P  222 (256)
T ss_pred             C--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHhcCCCCCC---c
Confidence            4  22234678899999999988899999999999999999999999864332110        011111111111   1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+.+++.+|++.+|++|||+.++++.
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            2344568999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=293.69  Aligned_cols=251  Identities=23%  Similarity=0.280  Sum_probs=202.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .+.|+.-++||+|+||.||-+.. .+|+.+|.|++.+..- .........++|-.+|.+++.+.||.+--.|++++.+++
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi-Kkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI-KKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH-HHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            35688889999999999999954 5799999999864221 112234557889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      |+..|.||+|.-++.+.+. ..++++.++.++.+|+.||++||+.   +||.|||||+|||+|+.|+++|+|+|+|..+.
T Consensus       263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            9999999999999987664 4599999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      .... ....+||.+|||||++.++.|+...|.||+||++|||+.|+.||.....-..     .+.++..+   +..+...
T Consensus       339 ~g~~-~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-----~eEvdrr~---~~~~~ey  409 (591)
T KOG0986|consen  339 EGKP-IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-----REEVDRRT---LEDPEEY  409 (591)
T ss_pred             CCCc-cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----HHHHHHHH---hcchhhc
Confidence            5433 3445999999999999999999999999999999999999999864332111     11111111   1112222


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTM  388 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~  388 (397)
                      ....+.+..++....|++||++|.-.
T Consensus       410 ~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  410 SDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             ccccCHHHHHHHHHHHccCHHHhccC
Confidence            23445567777889999999999643

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.1e-39  Score=288.44  Aligned_cols=246  Identities=26%  Similarity=0.367  Sum_probs=193.8

Q ss_pred             ccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCC
Q 016009          133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGS  211 (397)
Q Consensus       133 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  211 (397)
                      ||.|+||.||++... +|+.+++|.+..... ......+.+.+|++++++++|||++++++.+..+...+++|||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999776 599999999865322 112345678999999999999999999999999999999999999999


Q ss_pred             HHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC-----
Q 016009          212 LAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS-----  286 (397)
Q Consensus       212 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-----  286 (397)
                      |.+++....   .+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++........     
T Consensus        80 L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          80 LASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            999987543   589999999999999999999998   999999999999999999999999999876443311     


Q ss_pred             ---CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          287 ---NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       287 ---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                         ......++..|+|||.......+.++||||||+++||+++|+.||.......        ....+.......+... 
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~-  224 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--------IFQNILNGKIEWPEDV-  224 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCcCCCccc-
Confidence               2233467889999999988889999999999999999999999986433210        0111111111111110 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                       .....+.+++.+||+.+|++|||+..+.+.|
T Consensus       225 -~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         225 -EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             -cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence             1245688999999999999999994444433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.3e-38  Score=295.59  Aligned_cols=260  Identities=23%  Similarity=0.362  Sum_probs=195.5

Q ss_pred             HhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC----
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA----  197 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----  197 (397)
                      ..++|+..+.||+|+||.||++.. .+|+.||+|.+......  ......+.+|+.++++++||||+++++++...    
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN--VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC--hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence            456899999999999999999965 47899999998643221  22345678899999999999999999988543    


Q ss_pred             --CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          198 --RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       198 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                        ...++||||+.+ +|.+.+..     .+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.+||+||
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          92 EFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             ccCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence              356999999964 88877743     278899999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc-------------c--
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS-------------S--  340 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~-------------~--  340 (397)
                      |++........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........             .  
T Consensus       163 g~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         163 GLARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ccceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99986543222 2334678899999999999999999999999999999999999864321100             0  


Q ss_pred             ---------cccc-----ccccccccCCCC-CCC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          341 ---------FLNT-----DIELDEMLDPRL-PAP-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       341 ---------~~~~-----~~~~~~~~~~~~-~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                               +...     ............ +.. ..........+.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                     0000     000000000000 000 00011234567899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.4e-39  Score=290.23  Aligned_cols=255  Identities=24%  Similarity=0.313  Sum_probs=196.0

Q ss_pred             CCCCCccccccCcEEEEEEEe----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCee
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  200 (397)
                      +|+..+.||+|+||.||++..    .+|..||+|.+............+.+..|+++++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            366778899999999999965    378999999986532222222346788999999999 699999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999986543   588999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCCC-CcccccccccccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          281 LKPDSS-NWTEFAGTYGYVAPELAYTM--KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       281 ~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      ...... ......++..|+|||...+.  .++.++||||||+++|+|++|+.||.........    ......+.....+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~~~  230 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKSEPP  230 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH----HHHHHHhhccCCC
Confidence            543221 22234688899999998753  4678999999999999999999998632211000    0001111111111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                      .+    ......+.+++.+||+.||++||     ++++++.+
T Consensus       231 ~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         231 YP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             CC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            11    12334578999999999999997     77777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=283.53  Aligned_cols=253  Identities=21%  Similarity=0.315  Sum_probs=197.6

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCC-CcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC--Cee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLP-SDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--RHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  200 (397)
                      .+|...+.||+|+||.||+|.. .+++.|++|.+..... .........+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688889999999999999965 4689999998753221 11223456788999999999999999999998654  467


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++++||+++++|.+++....   .+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999986543   478999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCC---CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          281 LKPDS---SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       281 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      .....   .......++..|+|||.+.+..++.++|+||||+++|||++|+.||.......        ...........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~  227 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--------AIFKIATQPTK  227 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--------HHHHHHcCCCC
Confidence            53211   11223467889999999998889999999999999999999999986432211        01111100000


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        ...+......+.+++.+||+ +|..|||..+++.+
T Consensus       228 --~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         228 --PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             --CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence              11112334568899999999 57999999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.7e-38  Score=288.81  Aligned_cols=260  Identities=19%  Similarity=0.230  Sum_probs=182.9

Q ss_pred             cCCCCCccccccCcEEEEEEEeCC----CCEEEEEecCCCCCCcchh-------cHHHHHHHHHHHHhccCCceeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIV-------DKKEFLTEVEALTEIRHRNIVKLYGF  193 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~  193 (397)
                      ++|.+.+.||+|+||.||+|...+    +..+++|............       .......+...+..++|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            578889999999999999997654    3456666533211110000       00112233445566789999999997


Q ss_pred             EecCC----eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc
Q 016009          194 CSHAR----HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE  269 (397)
Q Consensus       194 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  269 (397)
                      +....    ..++++|++.. ++.+.+...   ...++..+..++.|++.||+|||+.   +++||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence            75443    34677777643 666665432   2357888999999999999999998   9999999999999999999


Q ss_pred             EEEeeeccccccCCCCC-------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc
Q 016009          270 AHVADFGIAKFLKPDSS-------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL  342 (397)
Q Consensus       270 ~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~  342 (397)
                      ++|+|||+++.+.....       ......||+.|+|||...+..++.++|||||||++|||++|+.||...........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            99999999986643221       11234689999999999999999999999999999999999999975422110000


Q ss_pred             c-cccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          343 N-TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       343 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      . .......+..+....     ......+.+++..|++.+|++||+++++++.|+
T Consensus       245 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        245 AAKCDFIKRLHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HhHHHHHHHhhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            0 000111111111111     122355889999999999999999999998874

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=293.46  Aligned_cols=264  Identities=21%  Similarity=0.289  Sum_probs=193.8

Q ss_pred             CCCCCccccccCcEEEEEEEeC---CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC--Cee
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--RHS  200 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  200 (397)
                      .|+..+.||+|+||.||+|...   +++.||+|.+..... ......+.+.+|+.++++++||||+++++++...  ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence            3667788999999999999764   478999999875321 1112235678899999999999999999999888  889


Q ss_pred             eEEEEeccCCCHHHhhccccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC----CCcEEEee
Q 016009          201 FLVYEFLKRGSLAAILSSDAA--AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL----EFEAHVAD  274 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~kl~D  274 (397)
                      ++||||+++ +|.+++.....  ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.    ++.+||+|
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D  155 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD  155 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence            999999975 66666643221  13688999999999999999999998   9999999999999999    89999999


Q ss_pred             eccccccCCCCC---CcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc-cccccc-
Q 016009          275 FGIAKFLKPDSS---NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL-NTDIEL-  348 (397)
Q Consensus       275 fg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~-  348 (397)
                      ||++........   ......++..|+|||.+.+. .++.++||||||++++||++|+.||........... .....+ 
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999986543322   12234678899999987664 578999999999999999999999864332110000 000000 


Q ss_pred             -----------------------ccc--cCCCCCCCCcchH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 -----------------------DEM--LDPRLPAPSRSVQ-------EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 -----------------------~~~--~~~~~~~~~~~~~-------~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                                             ...  .......+.....       .....+.+++.+|++.||++|||+.|++++
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                                   000  0000000000111       123458899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-38  Score=286.35  Aligned_cols=257  Identities=22%  Similarity=0.300  Sum_probs=191.1

Q ss_pred             CCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecC--CeeeE
Q 016009          127 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHA--RHSFL  202 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~l  202 (397)
                      |+..+.||+|+||.||+|.. .+++.||+|.++......   .......|+.+++++. |+|++++++++.+.  +..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence            45677899999999999965 478999999987532221   1234457899999985 99999999999887  88999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||++ ++|.+.+....  ..+++.+++.++.|++.||+|||+.   +++|+||+|+||+++. +.+||+|||++....
T Consensus        78 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          78 VFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             EEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            999997 57877776533  3589999999999999999999998   9999999999999999 999999999998664


Q ss_pred             CCCCCcccccccccccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc-----ccccc-cc------ccc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS-----SFLNT-DI------ELD  349 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~-----~~~~~-~~------~~~  349 (397)
                      .... .....++..|+|||... +..++.++|||||||++|||++|..||........     ..... ..      ...
T Consensus       151 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         151 SKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             cCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence            3322 22345788999999764 45578899999999999999999999864332110     00000 00      000


Q ss_pred             cccCCCCCCC-C----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          350 EMLDPRLPAP-S----RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       350 ~~~~~~~~~~-~----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+...+.. .    ......+..+.+++.+||+.+|++|||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0000000000 0    0011235679999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=287.07  Aligned_cols=260  Identities=25%  Similarity=0.331  Sum_probs=199.9

Q ss_pred             CCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |+..+.||+|++|.||++... +++.+++|.+......  ......+..|++++++++|+|++++++++..++..++|+|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES--EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence            456678999999999999664 7889999998753322  1235678899999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |+++ +|.+++....  ..+++.++..++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        79 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          79 FMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             ccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            9975 8888876543  4689999999999999999999998   99999999999999999999999999998765443


Q ss_pred             CCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccc-------cccccccccC----
Q 016009          286 SNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN-------TDIELDEMLD----  353 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~-------~~~~~~~~~~----  353 (397)
                      .......++..|+|||.+.+. .++.++|+||+|+++|+|+||+.||............       .........+    
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence            223334678889999998776 7899999999999999999999998643321100000       0000000000    


Q ss_pred             -------CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          354 -------PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       354 -------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                             ...........+....+.+++.+||+.||.+||++++++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                   00000011122345679999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-39  Score=297.25  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=204.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      ...|.+...||+|.|++|..+.. .++..||+|.+.+...  +....+.+.+|+++|+.++|||||+++.+......+|+
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            45788889999999999999954 4799999999876332  23334568999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+.+|.+.+++..+..   +.......++.|+..|++|||++   .|+|||||++||||+.+.++||+|||++.++.
T Consensus       133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence            9999999999999987764   55588889999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCCcccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      .. ....+.+|++.|.|||++.+.+| .+++|+||+|+++|-|+.|..||+...-..        -....+...+..+..
T Consensus       207 ~~-~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--------Lr~rvl~gk~rIp~~  277 (596)
T KOG0586|consen  207 YG-LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--------LRPRVLRGKYRIPFY  277 (596)
T ss_pred             cc-ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc--------ccchheeeeecccce
Confidence            43 34456799999999999998876 578999999999999999999998422110        011111112222211


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .    ..+..+++++++..+|.+|++++++-+.
T Consensus       278 m----s~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  278 M----SCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             e----echhHHHHHHhhccCccccCCHHHhhhh
Confidence            1    1236688889999999999999998654

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.6e-39  Score=291.41  Aligned_cols=257  Identities=23%  Similarity=0.311  Sum_probs=197.7

Q ss_pred             CCCCCccccccCcEEEEEEEe----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCee
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  200 (397)
                      +|+..+.||+|++|.||++..    .+++.||+|.++...........+.+.+|++++.++ +|||++++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            366778899999999999864    357889999986432222223346788999999999 599999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++|+|.+++...   ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999999998653   3588999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCCCC-cccccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          281 LKPDSSN-WTEFAGTYGYVAPELAYTMK--ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       281 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      ....... .....++..|+|||...+..  .+.++||||||+++|||++|..||.........    ......+.....+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~  230 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ----SEISRRILKSKPP  230 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH----HHHHHHHHccCCC
Confidence            5433221 22345788999999987655  788999999999999999999998532211100    0001111111111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+.    .....+.+++.+||+.||++|||+.++.+.|+
T Consensus       231 ~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         231 FPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             CCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            111    12345788999999999999999887766553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.1e-38  Score=283.16  Aligned_cols=250  Identities=22%  Similarity=0.329  Sum_probs=191.4

Q ss_pred             HHHHHHhcCCCCCccc--cccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEE
Q 016009          118 DEIVRATNDFDAQYCI--GNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGF  193 (397)
Q Consensus       118 ~~~~~~~~~~~~~~~l--g~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  193 (397)
                      .+.....++|++.+.+  |+|+||.||++.. .++..+|+|.+......       .  .|+.....+ +|||+++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-------~--~e~~~~~~~~~h~~iv~~~~~   77 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-------A--IEPMVHQLMKDNPNFIKLYYS   77 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-------h--hhHHHHHHhhcCCCEEEEEEE
Confidence            3444445677777766  9999999999965 47888999987642111       0  122222223 79999999999


Q ss_pred             EecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC-cEEE
Q 016009          194 CSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF-EAHV  272 (397)
Q Consensus       194 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl  272 (397)
                      +...+..++||||+++++|.+++....   .+++.++..++.|+++||.|||+.   +++|+||||+||+++.++ .++|
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         78 VTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             EecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEE
Confidence            999999999999999999999997543   689999999999999999999998   999999999999999998 9999


Q ss_pred             eeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 016009          273 ADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML  352 (397)
Q Consensus       273 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  352 (397)
                      +|||++......    ....++..|+|||++.+..++.++||||||+++|||++|+.||..........    .......
T Consensus       152 ~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~  223 (267)
T PHA03390        152 CDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL----ESLLKRQ  223 (267)
T ss_pred             ecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH----HHHHHhh
Confidence            999998765432    22367889999999998889999999999999999999999986332211000    0011111


Q ss_pred             CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 016009          353 DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT-MKIVSQQ  394 (397)
Q Consensus       353 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~~vl~~  394 (397)
                      .....    ........+.+++.+||+.+|.+||+ +++++++
T Consensus       224 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        224 QKKLP----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             cccCC----cccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            11111    11234456889999999999999996 6998863

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-38  Score=290.02  Aligned_cols=254  Identities=24%  Similarity=0.377  Sum_probs=193.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  201 (397)
                      .++|+..+.||+|++|.||+|... +++.||||.++.....   .....+..|+.++.+.. ||||+++++++..+...+
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK---EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh---HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            356788899999999999999876 4899999998653221   22456677887777774 999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      ++|||+. +++.+++....  ..+++..+..++.+++.||+|||+.  .+++|+||+|+||++++++.++|+|||++..+
T Consensus        91 ~v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          91 ICMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             EEeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            9999985 47777665432  3689999999999999999999973  18999999999999999999999999998765


Q ss_pred             CCCCCCcccccccccccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMK----ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      ..... .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||.......       .....+.+...+
T Consensus       166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~  237 (296)
T cd06618         166 VDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-------EVLTKILQEEPP  237 (296)
T ss_pred             cCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-------HHHHHHhcCCCC
Confidence            43222 22345788999999987553    7889999999999999999999986421100       001111111111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .... ......++.+++.+||+.||++||++++++++
T Consensus       238 ~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 SLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000 01233468899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4e-38  Score=289.02  Aligned_cols=247  Identities=28%  Similarity=0.414  Sum_probs=192.2

Q ss_pred             CCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |...+.||+|+||+||+|.. .+++.|++|.+...... .......+.+|+++++.++|||++++++++.+....++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            55567799999999999965 46889999998643221 22234578899999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |+. |++.+++....  ..+++.++..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++.....  
T Consensus       102 ~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         102 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             cCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            996 57777775433  3589999999999999999999998   999999999999999999999999998864322  


Q ss_pred             CCcccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          286 SNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                        .....++..|+|||.+.   ...++.++||||||+++|||++|..|+............     .....+...     
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~-----  241 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-----AQNDSPTLQ-----  241 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-----HhcCCCCCC-----
Confidence              22346788999999874   456888999999999999999999997643321100000     000001111     


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .......+.+++.+||+.+|++||++.++++.
T Consensus       242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11223458889999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-38  Score=284.26  Aligned_cols=260  Identities=25%  Similarity=0.363  Sum_probs=194.6

Q ss_pred             CCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc---cCCceeeeEEEEecCCe---
Q 016009          127 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI---RHRNIVKLYGFCSHARH---  199 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~---  199 (397)
                      |+..+.||+|+||.||+|..+ +++.+|+|.+.......  .....+.+|+.+++++   +|+|++++++++...+.   
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE--GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc--hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence            456788999999999999876 58999999987533221  1234566788877766   59999999999987766   


Q ss_pred             --eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          200 --SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       200 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                        .+++|||+.+ +|.+++..... ..+++.+++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||+
T Consensus        79 ~~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          79 LKLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             ceeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCc
Confidence              8999999975 89888865432 3589999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc--cc-----cccccc-c-
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--SF-----LNTDIE-L-  348 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--~~-----~~~~~~-~-  348 (397)
                      +........ .....++..|+|||.+.+..++.++|+||||+++|||++|+.||........  ..     ...... . 
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         154 ARIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ceeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            877643322 2233578899999999988899999999999999999999999864332110  00     000000 0 


Q ss_pred             -----ccccCCCCCC-CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 -----DEMLDPRLPA-PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 -----~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                           .......... ......+....+.+++.+||+.||++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                 0000000000 011112334567899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.9e-38  Score=290.35  Aligned_cols=256  Identities=18%  Similarity=0.238  Sum_probs=189.9

Q ss_pred             cccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCC
Q 016009          132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGS  211 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  211 (397)
                      .+|.|+++.+|++.. +++.||+|++.....  .....+.+.+|+++++.++|+||+++++++...+..+++|||+++|+
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            345555555555544 789999999875321  22345789999999999999999999999999999999999999999


Q ss_pred             HHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC-----
Q 016009          212 LAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS-----  286 (397)
Q Consensus       212 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-----  286 (397)
                      |.+++..... ..+++.....++.|++.||+|||+.   +|+|+||||+||+++.++.++++|||.+........     
T Consensus        86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9999975432 3588999999999999999999998   999999999999999999999999998865432211     


Q ss_pred             --CcccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc----------------ccccc
Q 016009          287 --NWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF----------------LNTDI  346 (397)
Q Consensus       287 --~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~----------------~~~~~  346 (397)
                        ......++..|+|||.+.+  ..++.++|+||||+++|||++|+.||..........                .....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence              1122356778999999875  358899999999999999999999987433211000                00000


Q ss_pred             cccc----ccCCCC--CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ELDE----MLDPRL--PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~~~~----~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....    ..++..  .............+.+++.+||+.||++|||+++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0000    000000  01111122334568899999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.2e-38  Score=290.18  Aligned_cols=249  Identities=28%  Similarity=0.427  Sum_probs=193.8

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      .|+..+.||+|+||.||+|... +++.+++|.+...... .....+++.+|+++++.++|+|++++.+++......++||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            4666788999999999999754 6788999988642111 1223457889999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+. |++.+.+....  ..+++.++..++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9996 57877765433  3588999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCCcccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          285 SSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                          ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+........        ...+.....+  ..
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~~--~~  234 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESP--AL  234 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--------HHHHhhcCCC--Cc
Confidence                2345788999999874   35678899999999999999999999754322110        0000000111  00


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      ........+.+++.+||+.+|++||+++++++.-
T Consensus       235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            0113345688999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.4e-38  Score=295.16  Aligned_cols=262  Identities=24%  Similarity=0.361  Sum_probs=195.6

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecC--C
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHA--R  198 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~  198 (397)
                      ..++|+..+.||+|+||.||+|... +++.+|+|++......  ......+..|+.+++++ +||||+++++++...  .
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN--ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc--chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            3467888899999999999999765 6889999988642221  12245677899999999 999999999998643  4


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA  278 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  278 (397)
                      ..++||||++ ++|.+++...    .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence            6899999997 5998888643    578999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCC-----CcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------cccc
Q 016009          279 KFLKPDSS-----NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNTD  345 (397)
Q Consensus       279 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~~  345 (397)
                      ........     ......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||..........       ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            86543321     2233467889999998764 457889999999999999999999986432211000       0000


Q ss_pred             c--------ccccccC----CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          346 I--------ELDEMLD----PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       346 ~--------~~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .        ....+.+    ................+.+++.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0        0000000    00000001111134568899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=286.72  Aligned_cols=260  Identities=25%  Similarity=0.373  Sum_probs=196.1

Q ss_pred             CCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC--CeeeEE
Q 016009          127 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--RHSFLV  203 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  203 (397)
                      |+..+.||+|++|.||+|... +++.+++|++....  ........+.+|++++++++|+|++++++++...  +..++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence            456778999999999999765 58899999987643  1122346788999999999999999999999887  889999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      +||+++ +|.+++....  ..+++.+++.++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        79 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          79 FEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             eccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            999975 8888886543  3589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCC-CcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccc-----c---ccccc--ccccc-
Q 016009          284 DSS-NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS-----S---FLNTD--IELDE-  350 (397)
Q Consensus       284 ~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~-----~---~~~~~--~~~~~-  350 (397)
                      ... ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||........     .   .....  ..... 
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            321 2233456788999997764 4578999999999999999999999864332110     0   00000  00000 


Q ss_pred             ----ccCCCCCCCC---cchHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          351 ----MLDPRLPAPS---RSVQE-KLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       351 ----~~~~~~~~~~---~~~~~-~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                          ...+....+.   ..... ....+.+++.+||+.+|++||+++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                0000000000   00001 14568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.6e-38  Score=288.99  Aligned_cols=265  Identities=24%  Similarity=0.342  Sum_probs=196.7

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC--
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR--  198 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  198 (397)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|.++.....  ......+.+|++++++++|||++++++++....  
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            45678999999999999999999765 6889999998653221  122456788999999999999999999987654  


Q ss_pred             --------eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcE
Q 016009          199 --------HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEA  270 (397)
Q Consensus       199 --------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  270 (397)
                              ..++|+||+++ ++.+.+....  ..+++.+++.++.|++.||+|||+.   +++|+||+|+||++++++.+
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence                    78999999986 6767665432  3589999999999999999999998   99999999999999999999


Q ss_pred             EEeeeccccccCCCCC-CcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-----c--
Q 016009          271 HVADFGIAKFLKPDSS-NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-----F--  341 (397)
Q Consensus       271 kl~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-----~--  341 (397)
                      ||+|||++........ ......++..|+|||.+.+ ..++.++||||||++++||++|+.||.........     .  
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999999987654332 1222345778999998764 35788999999999999999999998643321100     0  


Q ss_pred             cccccccccc--------cCCCCCC--C-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          342 LNTDIELDEM--------LDPRLPA--P-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       342 ~~~~~~~~~~--------~~~~~~~--~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .........+        .++....  . .......+..+.+++..||+.||++|||+++++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000000000        0000000  0 00001123568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.4e-38  Score=287.46  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=192.1

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR----  198 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  198 (397)
                      .++|+..+.||+|+||.||+|... +++.||+|.+.......  .....+.+|++++++++||||+++++++....    
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC--CchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            347888999999999999999654 78999999886432211  12345678999999999999999999986654    


Q ss_pred             ----eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEee
Q 016009          199 ----HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVAD  274 (397)
Q Consensus       199 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  274 (397)
                          ..++||||+.+ +|.+.+....  ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence                34999999964 7888775433  3589999999999999999999998   999999999999999999999999


Q ss_pred             eccccccCCCCCC----cccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccc----------
Q 016009          275 FGIAKFLKPDSSN----WTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS----------  339 (397)
Q Consensus       275 fg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~----------  339 (397)
                      ||++.........    .....++..|+|||.+.+. .++.++||||||+++|||+||+.||........          
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999765432211    1234567889999987664 368899999999999999999999854321100          


Q ss_pred             ---cccccccccccccCCCCCCCC-cchH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          340 ---SFLNTDIELDEMLDPRLPAPS-RSVQ------EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       340 ---~~~~~~~~~~~~~~~~~~~~~-~~~~------~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ............-....+... ....      .....+.+++.+||+.||++|||+++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence               000000000000000000000 0000      012356789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=296.04  Aligned_cols=260  Identities=23%  Similarity=0.369  Sum_probs=193.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-----  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  197 (397)
                      +++|+..+.||+|+||.||+|.. .+|+.||+|++.....   ......+.+|+.++++++||||+++++++...     
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH---QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc---chhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            46889999999999999999964 5789999999863211   12346678899999999999999999987543     


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...++++||+.+ +|.+.+..    +.+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        81 ~~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          81 NDVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             ceEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence            357999999975 88777743    3589999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCC---cccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-------cccccc
Q 016009          278 AKFLKPDSSN---WTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-------FLNTDI  346 (397)
Q Consensus       278 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-------~~~~~~  346 (397)
                      +.........   .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.........       ......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            8765432211   123467889999998654 46889999999999999999999998543211000       000000


Q ss_pred             ccccccCCC-------CCC-CCcc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ELDEMLDPR-------LPA-PSRS----VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~~~~~~~~~-------~~~-~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....+.+..       .+. +...    .......+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            011111000       000 0000    01123568899999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-38  Score=309.19  Aligned_cols=268  Identities=18%  Similarity=0.216  Sum_probs=186.4

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC--CCCEEEEEecCCC-------------CCCcchhcHHHHHHHHHHHHhccCCce
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP--SGQVVAIKKFHSP-------------LPSDQIVDKKEFLTEVEALTEIRHRNI  187 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~~-------------~~~~~~~~~~~~~~e~~~l~~l~h~ni  187 (397)
                      ..++|++.+.||+|+||+||++..+  ++...+.|.+...             ...........+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3568999999999999999998643  2222222211100             000111224568899999999999999


Q ss_pred             eeeEEEEecCCeeeEEEEeccCCCHHHhhccccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC
Q 016009          188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAA--AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD  265 (397)
Q Consensus       188 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  265 (397)
                      +++++++...+..++|+|++. ++|.+++.....  .......+...++.|++.||.|||+.   +|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            999999999999999999985 467666643321  12234667788999999999999998   999999999999999


Q ss_pred             CCCcEEEeeeccccccCCCCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC-CCcccccccc---
Q 016009          266 LEFEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-RDFLSSISSS---  340 (397)
Q Consensus       266 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p-~~~~~~~~~~---  340 (397)
                      .++.+||+|||++..+..... ......||..|+|||++.+..++.++|||||||++|||++|..+ +.........   
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999999987654322 22345789999999999999999999999999999999998754 4322111000   


Q ss_pred             ------------ccccccccccccC-CCCCCCCcchHH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          341 ------------FLNTDIELDEMLD-PRLPAPSRSVQE------KLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       341 ------------~~~~~~~~~~~~~-~~~~~~~~~~~~------~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                                  +......+...++ ............      ....+.+++.+|++.||++|||+.|++++
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                        0000000000000 000000000001      12346778899999999999999999874

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-38  Score=295.65  Aligned_cols=262  Identities=24%  Similarity=0.353  Sum_probs=196.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-----  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  197 (397)
                      .++|...+.||+|+||+||++.. .+++.||+|.+......  ......+..|+.+++.++|+||+++++++...     
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN--RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc--cchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            45788889999999999999964 47899999998753221  22345677899999999999999999988543     


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...++|+||+. ++|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence            35799999996 6888888653   3589999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccc--------------cc-
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--------------SF-  341 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--------------~~-  341 (397)
                      +..............++..|+|||.+.. ..++.++||||||+++|+|++|+.||........              .. 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            9866543333334467889999998764 4688999999999999999999999864321100              00 


Q ss_pred             cccccccccccC--CCCCCC--CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          342 LNTDIELDEMLD--PRLPAP--SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       342 ~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ............  +..+..  ..........+.+++.+||+.+|++|||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000000000000  000000  00011234568899999999999999999999875

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.2e-38  Score=289.33  Aligned_cols=255  Identities=23%  Similarity=0.306  Sum_probs=190.6

Q ss_pred             ccccc--CcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          132 CIGNG--GHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       132 ~lg~G--~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      .||+|  +||+||++.. .+|+.||+|.+......  ....+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT--EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            46666  8999999965 47999999998643222  2235678899999999999999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +++|.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+..........
T Consensus        83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          83 YGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9999999876432 3588999999999999999999998   99999999999999999999999997654322111110


Q ss_pred             -------ccccccccccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCcccccccc--cccc------c-----c
Q 016009          289 -------TEFAGTYGYVAPELAYTM--KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS--FLNT------D-----I  346 (397)
Q Consensus       289 -------~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~--~~~~------~-----~  346 (397)
                             ....++..|+|||++.+.  .++.++||||||+++|||++|+.||.........  ....      .     .
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                   112345679999998763  4789999999999999999999998643211000  0000      0     0


Q ss_pred             c---------------cc---------cccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 E---------------LD---------EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~---------------~~---------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .               ..         .+.+..+.  ..........+.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            0               00         00000010  11123455678999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-38  Score=295.08  Aligned_cols=262  Identities=25%  Similarity=0.371  Sum_probs=197.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec----CC
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH----AR  198 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~  198 (397)
                      .++|+..+.||+|++|.||+|.. .+|+.||+|++......  ....+.+.+|+.++++++||||+++.+++..    ..
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc--ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence            36888889999999999999965 47999999998753221  2235677889999999999999999998753    35


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA  278 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  278 (397)
                      ..++||||+. ++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~  154 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMA  154 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccc
Confidence            6899999995 68988886543   489999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCCCC----cccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-------------
Q 016009          279 KFLKPDSSN----WTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-------------  340 (397)
Q Consensus       279 ~~~~~~~~~----~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-------------  340 (397)
                      .........    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........             
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~  234 (334)
T cd07855         155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE  234 (334)
T ss_pred             eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence            765432211    123467889999998765 45889999999999999999999998643321100             


Q ss_pred             ccc--cccccccccC---CCCCCC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          341 FLN--TDIELDEMLD---PRLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       341 ~~~--~~~~~~~~~~---~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...  .........+   .....+ ..........+.+++.+||+.+|++|||+.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            000  0000000000   000000 00011234668999999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.8e-38  Score=283.18  Aligned_cols=245  Identities=19%  Similarity=0.244  Sum_probs=186.5

Q ss_pred             cccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHH---HHHhccCCceeeeEEEEecCCeeeEEEEec
Q 016009          132 CIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE---ALTEIRHRNIVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  207 (397)
                      .||+|+||.||++.. .+++.||+|.+........ .....+..|..   .++...|||++.+.+++...+..++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence            389999999999965 4688999999865322111 11222344443   344457999999999999999999999999


Q ss_pred             cCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCC
Q 016009          208 KRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN  287 (397)
Q Consensus       208 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  287 (397)
                      ++|+|.+++...   ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.......  
T Consensus        80 ~g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          80 NGGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            999999988643   3589999999999999999999998   99999999999999999999999999987553322  


Q ss_pred             cccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHH
Q 016009          288 WTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK  366 (397)
Q Consensus       288 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (397)
                      .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||............   .........++  .    ..
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~--~----~~  222 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTMAVELP--D----SF  222 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhhccCCCCC--C----cC
Confidence            2334689999999998754 6899999999999999999999998654221110000   00000111111  1    12


Q ss_pred             HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          367 LRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       367 ~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                      ...+.+++.+|++.+|.+||     ++.+++++
T Consensus       223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            35688999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.9e-38  Score=286.56  Aligned_cols=251  Identities=26%  Similarity=0.383  Sum_probs=201.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  202 (397)
                      ++|...+.||+|++|.||++... +|+.|++|++..... ......+.+..|.+++++++ ||||+++++++..++..++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence            36788889999999999999654 789999999865221 11223467889999999998 9999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++++|.+++....   .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        80 v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          80 VLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            999999999999997643   599999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCC--------------------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc
Q 016009          283 PDSS--------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL  342 (397)
Q Consensus       283 ~~~~--------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~  342 (397)
                      ....                    ......++..|+|||...+..++.++|+||||++++++++|+.|+.......    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----  229 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----  229 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----
Confidence            3221                    1123456889999999988889999999999999999999999987443211    


Q ss_pred             ccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 016009          343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTM----KIVSQQ  394 (397)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~----~~vl~~  394 (397)
                          ....+.+.....+.    .....+.+++.+||+.+|++|||+    ++++++
T Consensus       230 ----~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         230 ----TFQKILKLEYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ----HHHHHHhcCCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                01111111111111    223458899999999999999999    888764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=277.54  Aligned_cols=261  Identities=22%  Similarity=0.323  Sum_probs=209.5

Q ss_pred             HHHHHHhcCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeE
Q 016009          118 DEIVRATNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY  191 (397)
Q Consensus       118 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~  191 (397)
                      .++.....+++..-++.+|.||.||+|.+      .+.+.|.+|.++.....   .....++.|.-.+..+.|||+..+.
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~---iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ---IQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH---HHHHHHHHHHHHHhcCcCCCcccee
Confidence            34445556677777899999999999944      34567888888754332   2357789999999999999999999


Q ss_pred             EEEec-CCeeeEEEEeccCCCHHHhhc-----cccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC
Q 016009          192 GFCSH-ARHSFLVYEFLKRGSLAAILS-----SDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD  265 (397)
Q Consensus       192 ~~~~~-~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  265 (397)
                      +++.. ....+.+|.++.-|+|..+|.     +....+.++-.+...++.|++.|++|||+.   ++||.||.++|.++|
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence            99855 467789999999999999997     444456788889999999999999999999   999999999999999


Q ss_pred             CCCcEEEeeeccccccCCCCCCc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccc
Q 016009          266 LEFEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL  342 (397)
Q Consensus       266 ~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~  342 (397)
                      +..++||+|=.+++.+-+.+.+.  .....+..||+||.+....|+..+||||||++||||+| |+.|+....+.....+
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y  510 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY  510 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence            99999999999998776554432  33456778999999999999999999999999999998 9999876655322111


Q ss_pred             ccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      ..+       ..++..|.    +++.+++.++.-||+.+|++||+++|++..|
T Consensus       511 lkd-------GyRlaQP~----NCPDeLf~vMacCWallpeeRPsf~Qlv~cL  552 (563)
T KOG1024|consen  511 LKD-------GYRLAQPF----NCPDELFTVMACCWALLPEERPSFSQLVICL  552 (563)
T ss_pred             Hhc-------cceecCCC----CCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence            111       12333343    3445699999999999999999999998876

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-38  Score=282.55  Aligned_cols=259  Identities=25%  Similarity=0.399  Sum_probs=195.0

Q ss_pred             CCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeeeEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  204 (397)
                      |.+.+.||+|++|+||+|... +++.|++|++......   .......+|+..+++++ |+|++++++++..++..++||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   77 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF   77 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence            456788999999999999765 5789999998653321   12334567999999998 999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+ +|+|.+.+.... ...+++.++..++.|++.+|.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        78 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          78 EYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             ecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            999 889998886644 24589999999999999999999998   9999999999999999999999999999865432


Q ss_pred             CCCcccccccccccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------------ccccccccc
Q 016009          285 SSNWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------------LNTDIELDE  350 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------------~~~~~~~~~  350 (397)
                      .. .....++..|+|||.+. ...++.++|+||||++++||++|+.||..........             .........
T Consensus       153 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         153 PP-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CC-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            22 23346788999999875 4457899999999999999999999985433211000             000000000


Q ss_pred             ccCCCCCCCC-c----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          351 MLDPRLPAPS-R----SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       351 ~~~~~~~~~~-~----~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+...+... .    ........+.+++.+||+.||++|||++|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0111111000 0    000113568899999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=270.56  Aligned_cols=262  Identities=20%  Similarity=0.362  Sum_probs=211.7

Q ss_pred             HHHHHHHhcCCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEE
Q 016009          117 YDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFC  194 (397)
Q Consensus       117 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~  194 (397)
                      |+|+-+.|+     +.||+|+++.|-.+ ...+|.++|||++.+.    ....+..+.+|++++.+.+ |+||+.++++|
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefF  145 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFF  145 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence            567776664     45999999999988 5779999999998752    3456788999999999995 99999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC---cEE
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF---EAH  271 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~k  271 (397)
                      +++...|||||-|.||+|..++.++.   .+++.++.++..+|+.||.|||.+   +|.||||||+|||...-.   -+|
T Consensus       146 Edd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  146 EDDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             cccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCcee
Confidence            99999999999999999999998765   489999999999999999999999   999999999999996544   379


Q ss_pred             EeeeccccccCCC-------CCCcccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc
Q 016009          272 VADFGIAKFLKPD-------SSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS  339 (397)
Q Consensus       272 l~Dfg~~~~~~~~-------~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~  339 (397)
                      |+||.+.......       .....+.+|+..|||||+..     ...|+.++|.|||||++|-|++|.+||...-...-
T Consensus       220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC  299 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC  299 (463)
T ss_pred             eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence            9999887643221       11234568999999999753     23588999999999999999999999976554332


Q ss_pred             cccccc-------cccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          340 SFLNTD-------IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       340 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      .|-.++       .-.+.+-+.....|...+...+.+..+++...+..|+.+|.++.+++.
T Consensus       300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            222211       122334445555666667777788889999999999999999998876

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=311.26  Aligned_cols=260  Identities=27%  Similarity=0.448  Sum_probs=204.9

Q ss_pred             HHHHhcCCCCCccccccCcEEEEEEEeC--------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeee
Q 016009          120 IVRATNDFDAQYCIGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKL  190 (397)
Q Consensus       120 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~  190 (397)
                      ++...++..+.+.||+|.||.|++|...        ....||||.++.....   .+.+.+..|+++|+.+ +|+|++.+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~---~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS---SEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc---HHHHHHHHHHHHHHHhcCCcchhhh
Confidence            3444445556668999999999999642        1457999999864443   3578899999999999 79999999


Q ss_pred             EEEEecCCeeeEEEEeccCCCHHHhhcccc------c-----c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccC
Q 016009          191 YGFCSHARHSFLVYEFLKRGSLAAILSSDA------A-----A--QELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDI  257 (397)
Q Consensus       191 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~-----~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl  257 (397)
                      +|+|..++..++|+||+..|+|.++++..+      .     .  ..++..+.+.++.|||.||+||++.   +++||||
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDL  444 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDL  444 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhh
Confidence            999999999999999999999999998765      0     0  1388899999999999999999999   9999999


Q ss_pred             CCCcEEeCCCCcEEEeeeccccccCCCCCCc-ccccc--cccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCc
Q 016009          258 SSKNLLLDLEFEAHVADFGIAKFLKPDSSNW-TEFAG--TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDF  333 (397)
Q Consensus       258 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~g--~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~  333 (397)
                      .++|||++++..+||+|||+++......... ....+  ...|||||.+....|+.++||||||++||||+| |..|+..
T Consensus       445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            9999999999999999999998655443332 22222  456999999999999999999999999999999 8889764


Q ss_pred             cccccccccccccccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          334 LSSISSSFLNTDIELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .....       .....+.+. ++..|.    .+..++.+++..||+.+|++||++.++.+.|+
T Consensus       525 ~~~~~-------~l~~~l~~G~r~~~P~----~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~  577 (609)
T KOG0200|consen  525 IPPTE-------ELLEFLKEGNRMEQPE----HCSDEIYDLMKSCWNADPEDRPTFSECVEFFE  577 (609)
T ss_pred             CCcHH-------HHHHHHhcCCCCCCCC----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence            22100       001111111 222222    33456899999999999999999999998875

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.9e-38  Score=289.67  Aligned_cols=262  Identities=24%  Similarity=0.287  Sum_probs=192.4

Q ss_pred             CCC-CCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchh----------cHHHHHHHHHHHHhccCCceeeeEEE
Q 016009          126 DFD-AQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIV----------DKKEFLTEVEALTEIRHRNIVKLYGF  193 (397)
Q Consensus       126 ~~~-~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~  193 (397)
                      +|. ..+.||.|+||+||+|... +++.||+|++..........          ....+.+|++++++++|+||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            454 3467999999999999654 78999999986532221100          01257789999999999999999999


Q ss_pred             EecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEe
Q 016009          194 CSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVA  273 (397)
Q Consensus       194 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  273 (397)
                      +..++..++||||+. |+|.+++...   ..+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         89 YVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence            999999999999997 5899888643   3489999999999999999999998   99999999999999999999999


Q ss_pred             eeccccccCC--------------CCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccc
Q 016009          274 DFGIAKFLKP--------------DSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSIS  338 (397)
Q Consensus       274 Dfg~~~~~~~--------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~  338 (397)
                      |||++.....              .........++..|+|||.+.+. .++.++||||||+++|||++|+.||.......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999876541              11112233467889999988764 46899999999999999999999986433211


Q ss_pred             ccc-----c--cccccccc--------ccCCCCCCC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          339 SSF-----L--NTDIELDE--------MLDPRLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       339 ~~~-----~--~~~~~~~~--------~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...     .  ........        ......+.. ..........+.+++.+||+.+|++|||++|++.+
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            000     0  00000000        000000000 00001123568899999999999999999999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.9e-39  Score=313.54  Aligned_cols=255  Identities=26%  Similarity=0.413  Sum_probs=195.5

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec---
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH---  196 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---  196 (397)
                      .+-.++|+....||+||||.||+++.+ ||+.||||++....   .......+.+|+..|++|+|||||+++..+.+   
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            345578888999999999999999766 99999999997643   22335678999999999999999998732200   


Q ss_pred             --------------------------------------------------------------------------------
Q 016009          197 --------------------------------------------------------------------------------  196 (397)
Q Consensus       197 --------------------------------------------------------------------------------  196 (397)
                                                                                                      
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------C--------CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHH
Q 016009          197 ----------------------------A--------RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADA  240 (397)
Q Consensus       197 ----------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~  240 (397)
                                                  +        ..+|+=||||+..+|.++++.+....  .-...|+++.+|++|
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEG  709 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHH
Confidence                                        0        12467788998888888876654211  356789999999999


Q ss_pred             HHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC------------------CCCCCcccccccccccCccc
Q 016009          241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK------------------PDSSNWTEFAGTYGYVAPEL  302 (397)
Q Consensus       241 l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~------------------~~~~~~~~~~g~~~y~aPE~  302 (397)
                      |+|+|+.   ++|||||||.||++|++..+||+|||+++...                  .+....+..+||.-|+|||+
T Consensus       710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            9999999   99999999999999999999999999998621                  01113356789999999999


Q ss_pred             ccCCC---CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccC
Q 016009          303 AYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLN  379 (397)
Q Consensus       303 ~~~~~---~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  379 (397)
                      +.+..   |+.|+|+||+||+++||+.-   |+-  .+     ..-..+..+.++.++.+.+...+....=.++|.++++
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~T--sM-----ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGT--SM-----ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHhcc---CCc--hH-----HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhc
Confidence            87654   99999999999999999973   321  11     1111234444555655533344444556688999999


Q ss_pred             CCCCCCCCHHHHHH
Q 016009          380 ESPESRPTMKIVSQ  393 (397)
Q Consensus       380 ~~P~~RPt~~~vl~  393 (397)
                      .||.+|||+.|+|.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999986

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.9e-38  Score=281.59  Aligned_cols=254  Identities=21%  Similarity=0.276  Sum_probs=195.7

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCC-CcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLP-SDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +|.+.+.||+|+||.||++... .+..+++|.++.... ........++..|+.++++++|||++++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4677888999999999999654 345566666543211 11112234577899999999999999999999998999999


Q ss_pred             EEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          204 YEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      |||+++++|.+++.... ....+++.+++.++.|++.|+.|||+.   +++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999999886422 234689999999999999999999998   9999999999999975 569999999987765


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..........++..|+|||...+..++.++|+||||+++|+|++|..|+.......        ..........+.   .
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--------~~~~~~~~~~~~---~  225 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS--------VVLRIVEGPTPS---L  225 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHcCCCCC---C
Confidence            44333344567889999999888888999999999999999999999986322111        011111111111   1


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .......+.+++.+||+.+|++||++.++++.
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            12344568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-38  Score=291.75  Aligned_cols=260  Identities=25%  Similarity=0.365  Sum_probs=198.6

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC-----e
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR-----H  199 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~  199 (397)
                      +|.+.+.||+|++|.||+|... +++.|++|++.....  .....+.+.+|+++++.++|+||+++.+++....     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc--cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence            4677889999999999999765 589999999875322  1233567899999999999999999999987765     7


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .+++|||++ ++|.+++....   .+++..++.++.+++.||+|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             eEEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence            899999998 48888886543   689999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCC---CCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccc--------------c
Q 016009          280 FLKPDS---SNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS--------------F  341 (397)
Q Consensus       280 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~--------------~  341 (397)
                      ......   .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.........              .
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            765443   123344678899999999887 7899999999999999999999998643321000              0


Q ss_pred             c-ccccccccccCCCCCCCCc----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          342 L-NTDIELDEMLDPRLPAPSR----SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       342 ~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      . .........+.........    ...+....+.+++.+||+.+|++|||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0 0000000000000000000    001124568899999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=296.08  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=196.2

Q ss_pred             CCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC------e
Q 016009          127 FDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR------H  199 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  199 (397)
                      |...+.||+|+||.||+|+ ..+|+.||||.++....   ....+....|+++|++++|+|||++++.-++..      .
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~---~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS---LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcc---cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            4455679999999999997 56899999999986432   234677889999999999999999999765543      5


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC--CCCc--EEEeee
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD--LEFE--AHVADF  275 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~--~kl~Df  275 (397)
                      ..+|||||.+|||...+....+...|++.+.+.++.+++.||.|||++   +|+||||||.||++-  ++|+  -||+||
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence            689999999999999999888778899999999999999999999998   999999999999993  3343  699999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------cccccc
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNTDIE  347 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~~~~  347 (397)
                      |.|+.++.+. .....+||..|++||.... ..|+..+|.|||||++||++||..||..........       ......
T Consensus       169 G~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  169 GAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             cccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            9999887544 6677899999999999884 789999999999999999999999986433221000       000000


Q ss_pred             cccc----------cCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 016009          348 LDEM----------LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRP  386 (397)
Q Consensus       348 ~~~~----------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP  386 (397)
                      ....          ....++.+....+.....+...+..++..+|++|-
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            0000          11123333333444455566777777888888886

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.1e-38  Score=288.28  Aligned_cols=262  Identities=26%  Similarity=0.379  Sum_probs=196.5

Q ss_pred             HHHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec-C
Q 016009          120 IVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH-A  197 (397)
Q Consensus       120 ~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~  197 (397)
                      +...+++|+..+.||.|+||.||++.. .+++.||+|++......  ....+.+..|++++++++|||++++.+++.. .
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   82 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST--PVLAKRTYRELKLLKHLRHENIISLSDIFISPL   82 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc--cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence            345678899999999999999999964 47899999987643221  1234678899999999999999999999865 5


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...++++||+ +++|.+++...    .+++.....++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.
T Consensus        83 ~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~  154 (328)
T cd07856          83 EDIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGL  154 (328)
T ss_pred             CcEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccc
Confidence            6789999998 56898887542    478888899999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-----cc--ccccccc
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-----FL--NTDIELD  349 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-----~~--~~~~~~~  349 (397)
                      +......   .....++..|+|||.+.+ ..++.++||||||+++|+|+||+.||.........     ..  ..+....
T Consensus       155 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         155 ARIQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ccccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            8754322   123456888999998765 56899999999999999999999998643221000     00  0000000


Q ss_pred             cccCC-------CCC----CCC-cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          350 EMLDP-------RLP----APS-RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       350 ~~~~~-------~~~----~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+.       ..+    .+. .........+.+++.+||+.+|++|||+.+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000       000    000 0001123568899999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=275.50  Aligned_cols=242  Identities=27%  Similarity=0.352  Sum_probs=195.5

Q ss_pred             ccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCC
Q 016009          133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGS  211 (397)
Q Consensus       133 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  211 (397)
                      ||.|+||.||++... +++.+++|.+..... ........+..|++++++++|||++++++.+..+...++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            689999999999765 589999999865322 112235678999999999999999999999999999999999999999


Q ss_pred             HHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcccc
Q 016009          212 LAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF  291 (397)
Q Consensus       212 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  291 (397)
                      |.+++....   .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.............
T Consensus        80 L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (250)
T cd05123          80 LFSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF  153 (250)
T ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence            999997543   489999999999999999999998   99999999999999999999999999998765433333445


Q ss_pred             cccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHH
Q 016009          292 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV  371 (397)
Q Consensus       292 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  371 (397)
                      .++..|+|||...+...+.++|+||||+++|++++|+.||......        .....+.......+..    ....+.
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~----~~~~l~  221 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--------EIYEKILKDPLRFPEF----LSPEAR  221 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHhcCCCCCCCC----CCHHHH
Confidence            6788999999998888899999999999999999999998643210        0111111122222111    134578


Q ss_pred             HHHHHccCCCCCCCCCH---HHHHH
Q 016009          372 EVVFSCLNESPESRPTM---KIVSQ  393 (397)
Q Consensus       372 ~l~~~cl~~~P~~RPt~---~~vl~  393 (397)
                      +++.+||..||++||++   ++++.
T Consensus       222 ~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         222 DLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             HHHHHHhcCCHhhCCCcccHHHHHh
Confidence            99999999999999999   66654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-38  Score=299.43  Aligned_cols=260  Identities=24%  Similarity=0.419  Sum_probs=217.6

Q ss_pred             HHHHHHHhcCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEE
Q 016009          117 YDEIVRATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFC  194 (397)
Q Consensus       117 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  194 (397)
                      ++.+...++-|++.+++|.|.+|.||+++ .++|+..|+|++......     .+++..|.++|+.. .|||++.++|++
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-----deEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-----EEEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-----cHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            34445567788999999999999999995 457899999988753322     46778899999988 699999999998


Q ss_pred             e-----cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc
Q 016009          195 S-----HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE  269 (397)
Q Consensus       195 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  269 (397)
                      .     .++++|||||||.+||..|++.... +..+.|..+..|+..++.|+.+||..   .++|||+|-.|||++.++.
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence            4     4578999999999999999998766 57899999999999999999999999   9999999999999999999


Q ss_pred             EEEeeeccccccCCCCCCcccccccccccCcccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccc
Q 016009          270 AHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT  344 (397)
Q Consensus       270 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~  344 (397)
                      +||.|||++.+++.......+..||+.|||||++...     .|+..+|+||||++..||.-|.+|+-++.++..-+.. 
T Consensus       162 VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I-  240 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-  240 (953)
T ss_pred             EEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-
Confidence            9999999999888766666778999999999998754     3677999999999999999999998766654332221 


Q ss_pred             ccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          345 DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                              ....++....+..+..++.++|..|+.+|-++||++.+++++
T Consensus       241 --------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  241 --------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             --------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                    111122233456778899999999999999999999998864

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-38  Score=282.39  Aligned_cols=260  Identities=25%  Similarity=0.358  Sum_probs=198.3

Q ss_pred             CCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |+..+.||+|++|.||+|... +++.+++|.+.....  .....+.+..|++++++++|+|++++++++...+..++|||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc--cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence            455677999999999999765 589999999875331  12234677899999999999999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |++ ++|.+++....  ..+++.++..++.+++.||+|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        79 ~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          79 YCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             CcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            998 58999997653  3589999999999999999999998   99999999999999999999999999998765443


Q ss_pred             CCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-----cc--ccccc---cccc--c
Q 016009          286 SNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-----FL--NTDIE---LDEM--L  352 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-----~~--~~~~~---~~~~--~  352 (397)
                      .......++..|+|||.+.+. .++.++||||||++++|+++|+.||.........     ..  ..+..   ...+  .
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence            333334567789999998766 7899999999999999999999998643221000     00  00000   0000  0


Q ss_pred             CCCCCCCC-----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          353 DPRLPAPS-----RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       353 ~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +...+...     .........+.+++..||+.||++||++++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            00111000     0011124568999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=321.35  Aligned_cols=253  Identities=28%  Similarity=0.417  Sum_probs=200.7

Q ss_pred             hcCCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      +-+|.....||.|.||.||.| ...+|...|+|.++.....  ........+|+.++..++|||+|+++|+-.+.+..+|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            345667778999999999999 5668999999998754333  2335678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      .||||++|+|.+.+.-.+.   .++.....+..|++.|++|||+.   |||||||||.||+|+.+|.+|++|||.|..+.
T Consensus      1312 FMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence            9999999999999965443   55666677889999999999999   99999999999999999999999999998876


Q ss_pred             CCCCC----cccccccccccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 016009          283 PDSSN----WTEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR  355 (397)
Q Consensus       283 ~~~~~----~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  355 (397)
                      .....    .....||+.|||||++.+..   ...+.||||+|||.+||+||++||......-.-.+    .+...-.|.
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy----~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY----HVAAGHKPQ 1461 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh----HHhccCCCC
Confidence            54322    23468999999999998654   45578999999999999999999875432110000    011122233


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +|.      ....+=.+++..|+..||++|.++.|+++.
T Consensus      1462 ~P~------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 IPE------RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             Cch------hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            321      234456788889999999999999888764

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=269.03  Aligned_cols=254  Identities=22%  Similarity=0.281  Sum_probs=206.2

Q ss_pred             HhcCCCCC-ccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEec---
Q 016009          123 ATNDFDAQ-YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSH---  196 (397)
Q Consensus       123 ~~~~~~~~-~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---  196 (397)
                      .|++|++. ++||-|-.|.|-.+.. .+++.+|+|++..         .....+|+++--.. .|||||.++++|++   
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---------SPKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            35566544 5799999999999854 4789999999864         24456888876555 69999999999854   


Q ss_pred             -CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC---CCcEEE
Q 016009          197 -ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL---EFEAHV  272 (397)
Q Consensus       197 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl  272 (397)
                       ...+.+|||+|+||.|...+++++. +.+++.++..|+.||+.|+.|||+.   +|.||||||+|+|.+.   |..+||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence             4677899999999999999987664 6799999999999999999999999   9999999999999965   456999


Q ss_pred             eeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 016009          273 ADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML  352 (397)
Q Consensus       273 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  352 (397)
                      +|||+++.... .....+.+-|+.|.|||++...+|+...|+||+||++|-|++|.+||-.....    ....+....+.
T Consensus       206 tDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~----aispgMk~rI~  280 (400)
T KOG0604|consen  206 TDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKRRIR  280 (400)
T ss_pred             cccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc----cCChhHHhHhh
Confidence            99999986543 33345568899999999999999999999999999999999999997533221    11122233344


Q ss_pred             CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          353 DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       353 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......|...+.+.+....++|+..|..+|.+|.|++++..+
T Consensus       281 ~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  281 TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            444555666777888889999999999999999999999764

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-37  Score=289.06  Aligned_cols=256  Identities=23%  Similarity=0.381  Sum_probs=190.8

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC------
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA------  197 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  197 (397)
                      ++|...+.||+|+||.||+|.. .+|+.||+|++.......  .....+.+|++++++++||||+++++++...      
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE--IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc--cchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            6888889999999999999975 478999999987532221  2245688999999999999999999998654      


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...++|+||+.. +|..+..     ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            345899999964 7776642     2488999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------ccc-----
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNT-----  344 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~-----  344 (397)
                      +......   .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..........       ...     
T Consensus       164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         164 ARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8754322   223457888999998876 468899999999999999999999986432211000       000     


Q ss_pred             ---ccccccccC--CCCCCCC--cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          345 ---DIELDEMLD--PRLPAPS--RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       345 ---~~~~~~~~~--~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         .........  +..+...  .........+.+++.+||+.||++||++.+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               000000000  0000000  0001123457899999999999999999999864

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=275.77  Aligned_cols=243  Identities=26%  Similarity=0.304  Sum_probs=198.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..++||+|.||+|-+++. .+|+.+|+|++++..--. ......-+.|-++|+..+||.+..+--.++..+.+++
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-KDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-hHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            46889999999999999999964 479999999998643221 1223445678899999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||..||.|.-+|+..+   .+++...+.+-..|+.||.|||++   +||.||||.+|.|+|.+|++||+|||+.+.-.
T Consensus       246 VMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence            999999999999987644   488888888999999999999998   99999999999999999999999999998766


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccc-ccCCCCCCCCc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE-MLDPRLPAPSR  361 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  361 (397)
                      .........+||+.|+|||++....|....|.|.+||++|||++|+.||-.-..         +.+-+ ++-..+..|..
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---------~kLFeLIl~ed~kFPr~  390 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---------EKLFELILMEDLKFPRT  390 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---------hHHHHHHHhhhccCCcc
Confidence            566667789999999999999999999999999999999999999999742111         11111 11112222222


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCC
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRP  386 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RP  386 (397)
                          ...+...|+...+.+||.+|.
T Consensus       391 ----ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  391 ----LSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ----CCHHHHHHHHHHhhcChHhhc
Confidence                222356677789999999995

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9.9e-38  Score=286.35  Aligned_cols=263  Identities=24%  Similarity=0.310  Sum_probs=192.1

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-----  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  197 (397)
                      .++|+..+.||+|+||.||+|... +++.+++|++.......  .....+.+|++++++++||||+++++++...     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence            468889999999999999999754 68999999986432211  1134567899999999999999999987443     


Q ss_pred             ---CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEee
Q 016009          198 ---RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVAD  274 (397)
Q Consensus       198 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  274 (397)
                         ...++|+||+.+ +|...+....  ..+++.++..++.|+++||+|||+.   +++|+||||+||++++++.++|+|
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence               346999999875 6776665432  3589999999999999999999998   999999999999999999999999


Q ss_pred             eccccccCCCCCC-----------cccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-
Q 016009          275 FGIAKFLKPDSSN-----------WTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-  341 (397)
Q Consensus       275 fg~~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-  341 (397)
                      ||++.........           .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||.......... 
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~  238 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL  238 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999765432211           1223567889999987654 57899999999999999999999986433211000 


Q ss_pred             ------------ccccccccc----ccCCCCCCCC-cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          342 ------------LNTDIELDE----MLDPRLPAPS-RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       342 ------------~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                                  ......+..    ......+... .........+.+++.+|++.||++|||+.|++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence                        000000000    0000010000 0001122468899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-37  Score=288.13  Aligned_cols=265  Identities=23%  Similarity=0.341  Sum_probs=196.9

Q ss_pred             HHHHHHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe
Q 016009          117 YDEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS  195 (397)
Q Consensus       117 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  195 (397)
                      ..++...+++|...+.||+|+||.||++.. .+++.||+|++.....  .....+.+.+|++++++++||||+++.+++.
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            355667789999999999999999999964 5789999999865322  1223466888999999999999999999885


Q ss_pred             cC------CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc
Q 016009          196 HA------RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE  269 (397)
Q Consensus       196 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  269 (397)
                      ..      ...+++++++ +++|.+++..    ..+++..+..++.|+++||+|||+.   +++|+||||+||++++++.
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence            43      3467888876 7899888754    2489999999999999999999998   9999999999999999999


Q ss_pred             EEEeeeccccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccc--c-----c
Q 016009          270 AHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--S-----F  341 (397)
Q Consensus       270 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--~-----~  341 (397)
                      ++|+|||++.....   ......++..|+|||...+ ..++.++||||||+++|||++|+.||........  .     .
T Consensus       159 ~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         159 LKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             EEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999999875432   2233467889999998765 4678899999999999999999999853221100  0     0


Q ss_pred             cccccccccccC----------CCCCCC--CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          342 LNTDIELDEMLD----------PRLPAP--SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       342 ~~~~~~~~~~~~----------~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .........+.+          +..+..  ..........+.+++.+|++.||++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            000000000000          000000  00000123457899999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-37  Score=286.70  Aligned_cols=259  Identities=24%  Similarity=0.354  Sum_probs=194.1

Q ss_pred             HhcCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC---
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR---  198 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---  198 (397)
                      ..++|...+.||+|+||.||++. ..+|..||+|++.....  .......+.+|++++++++||||+++++++....   
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            45689899999999999999996 45789999999864322  1223456889999999999999999999986543   


Q ss_pred             ---eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          199 ---HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       199 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                         ..++||||+ +++|.+++..    ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence               358999998 7799888753    3589999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc--c----cccccc
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF--L----NTDIEL  348 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~--~----~~~~~~  348 (397)
                      |++......   .....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||..........  .    ......
T Consensus       163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         163 GLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            998765432   223456889999998875 458899999999999999999999986432210000  0    000000


Q ss_pred             ccccC--------CCCCCC-C----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 DEMLD--------PRLPAP-S----RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 ~~~~~--------~~~~~~-~----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+.        ..++.. .    .........+.+++.+|++.||++|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000        000000 0    0001223458899999999999999999999853

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.7e-37  Score=286.96  Aligned_cols=258  Identities=22%  Similarity=0.327  Sum_probs=189.6

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC------
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA------  197 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  197 (397)
                      .+|...+.||.|+||.||+|.. .+|+.||+|++.....    ...+.+.+|++++++++||||+++++++...      
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            5788889999999999999965 4689999999864222    2356788999999999999999999776543      


Q ss_pred             --------CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC-CCC
Q 016009          198 --------RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD-LEF  268 (397)
Q Consensus       198 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~  268 (397)
                              ...++||||++ ++|.+++..    ..+++..++.++.|++.||.|||+.   +++||||||+||+++ +++
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~  152 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence                    35789999997 588888753    2488999999999999999999998   999999999999997 456


Q ss_pred             cEEEeeeccccccCCCCC---CcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc---
Q 016009          269 EAHVADFGIAKFLKPDSS---NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF---  341 (397)
Q Consensus       269 ~~kl~Dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~---  341 (397)
                      .++++|||++........   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..........   
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            789999999876533211   1122357888999997654 557889999999999999999999986433211000   


Q ss_pred             ----cccccccccc-------cCCCCCCCCcch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          342 ----LNTDIELDEM-------LDPRLPAPSRSV----QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       342 ----~~~~~~~~~~-------~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                          ..........       ............    ......+.+++.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence                0000000000       000000000000    1123468899999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-37  Score=286.83  Aligned_cols=259  Identities=22%  Similarity=0.361  Sum_probs=194.3

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe--
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH--  199 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--  199 (397)
                      ..++|+..+.||+|++|.||+|... +++.||+|++......  ....+.+.+|+.++++++|||++++.+++...+.  
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch--hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            3567888999999999999999765 6889999998643221  2234567889999999999999999988765544  


Q ss_pred             ----eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          200 ----SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       200 ----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                          .++|+||+ +++|.+++..    ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+||
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence                89999998 6699998864    3589999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-----c--cccc-
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-----L--NTDI-  346 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-----~--~~~~-  346 (397)
                      |++......   .....++..|+|||...+ ..++.++||||||+++||+++|+.||..........     .  ..+. 
T Consensus       163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         163 GLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            999865432   233467888999998765 367899999999999999999999985332210000     0  0000 


Q ss_pred             -------ccccccCCCCCCCCcch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 -------ELDEMLDPRLPAPSRSV----QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 -------~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                             .....+...........    ......+.+++.+||+.||++|||+.+|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                   00000000000000000    1124568899999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.2e-36  Score=303.82  Aligned_cols=148  Identities=28%  Similarity=0.365  Sum_probs=130.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|.+.+.||+|+||.||+|... +++.||+|+++.... ........+..|+.+++.++||||+++++++......++|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            57888899999999999999765 789999999865222 1222346788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      |||+.+++|.+++....   .+++..++.++.||+.||.|||..   +|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999986543   488899999999999999999998   99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.5e-36  Score=280.92  Aligned_cols=259  Identities=24%  Similarity=0.338  Sum_probs=189.2

Q ss_pred             CCCCCccccccCcEEEEEEEeC-C--CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEec----C
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-S--GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSH----A  197 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~  197 (397)
                      +|+..+.||+|+||.||++... +  +..||+|++......  ....+.+.+|+++++++ +||||+++++++..    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   78 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF   78 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence            3667788999999999999754 4  788999998642221  12246788999999999 59999999987533    2


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...++++||+. ++|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||+
T Consensus        79 ~~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          79 NELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             CcEEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence            45788889886 6898888643   3589999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCC----CcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-------ccccc
Q 016009          278 AKFLKPDSS----NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-------FLNTD  345 (397)
Q Consensus       278 ~~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-------~~~~~  345 (397)
                      +........    ......|+..|+|||...+ ..++.++|+||+|+++|+|++|+.||.........       .....
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            986543221    1223468899999998765 46889999999999999999999998643211000       00000


Q ss_pred             cccccccCC----------CCC-CC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          346 IELDEMLDP----------RLP-AP-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       346 ~~~~~~~~~----------~~~-~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      .....+.++          ..+ .+ ..........+.+++.+|++.||++|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000          000 00 0000012346889999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.4e-36  Score=264.41  Aligned_cols=224  Identities=21%  Similarity=0.204  Sum_probs=176.8

Q ss_pred             cCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCCHHH
Q 016009          136 GGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAA  214 (397)
Q Consensus       136 G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  214 (397)
                      |.+|.||++.. .+++.+|+|++...         ..+..|...+....|||++++++++...+..++||||+++|+|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~---------~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKS---------SEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecch---------hhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            79999999965 57899999998642         123345555556679999999999999999999999999999999


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCccccccc
Q 016009          215 ILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT  294 (397)
Q Consensus       215 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  294 (397)
                      ++....   .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++++|||.+......   .....++
T Consensus        75 ~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~  145 (237)
T cd05576          75 HISKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVE  145 (237)
T ss_pred             HHHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcC
Confidence            986543   489999999999999999999998   9999999999999999999999999987654432   1223456


Q ss_pred             ccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHH
Q 016009          295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVV  374 (397)
Q Consensus       295 ~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  374 (397)
                      ..|+|||...+..++.++||||+|+++|||++|+.|+......          ........++  .    .....+.+++
T Consensus       146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~~--~----~~~~~~~~li  209 (237)
T cd05576         146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------INTHTTLNIP--E----WVSEEARSLL  209 (237)
T ss_pred             ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------cccccccCCc--c----cCCHHHHHHH
Confidence            7899999998888999999999999999999999886522110          0000000111  1    1234588899


Q ss_pred             HHccCCCCCCCCCH-----HHHHH
Q 016009          375 FSCLNESPESRPTM-----KIVSQ  393 (397)
Q Consensus       375 ~~cl~~~P~~RPt~-----~~vl~  393 (397)
                      .+|++.||++||++     ++++.
T Consensus       210 ~~~l~~dp~~R~~~~~~~~~~~~~  233 (237)
T cd05576         210 QQLLQFNPTERLGAGVAGVEDIKS  233 (237)
T ss_pred             HHHccCCHHHhcCCCccchHHHHc
Confidence            99999999999996     55553

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=281.14  Aligned_cols=247  Identities=25%  Similarity=0.352  Sum_probs=204.8

Q ss_pred             CccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          130 QYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      .++||+|.||+||-|. .++|+.||||++.+.....  ....++.+|+.||++++||.||.+...|++.+..++|||-+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~--kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT--KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCC--chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence            3679999999999995 4589999999987633222  234789999999999999999999999999999999999996


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC---CcEEEeeeccccccCCCC
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE---FEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~~~~~~  285 (397)
                      |.-|+-.|....  .++++.....++.||+.||.|||.+   +|+|+||||+|||+.+.   -.+||+|||+++.+. +.
T Consensus       647 GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg-Ek  720 (888)
T KOG4236|consen  647 GDMLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG-EK  720 (888)
T ss_pred             chHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc-hh
Confidence            655555555444  4688888889999999999999999   99999999999999654   369999999999876 34


Q ss_pred             CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHH
Q 016009          286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE  365 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (397)
                      +.....+||+.|+|||++....|...-|+||.|+++|--++|..||+.....          -+.+-+..+..|...+.+
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI----------ndQIQNAaFMyPp~PW~e  790 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI----------NDQIQNAAFMYPPNPWSE  790 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch----------hHHhhccccccCCCchhh
Confidence            4456679999999999999999999999999999999999999998743321          123334445555666778


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          366 KLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       366 ~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+||...++..-.+|.|.+.-+.+
T Consensus       791 is~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  791 ISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             cCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            88889999999999999999998876643

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.5e-37  Score=262.63  Aligned_cols=205  Identities=23%  Similarity=0.349  Sum_probs=168.4

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeC---C--CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELP---S--GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH  196 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  196 (397)
                      .....|+....||+|.||.||+|.-+   +  ...+|+|+++......  .--....+|+.+++.++|||++.+..++.+
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t--GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT--GISMSACREIALLRELKHPNVISLVKVFLS   98 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC--CcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence            33457888999999999999999432   2  2379999998643211  123567899999999999999999999866


Q ss_pred             -CCeeeEEEEeccCCCHHHhhcccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC----Cc
Q 016009          197 -ARHSFLVYEFLKRGSLAAILSSDA--AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE----FE  269 (397)
Q Consensus       197 -~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~  269 (397)
                       +...++++||.+. +|...++-+.  ..+.++-..+..|+.||+.|+.|||++   -|+||||||.|||+..+    |.
T Consensus        99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCe
Confidence             7889999999976 8888876443  235688889999999999999999998   89999999999999877    89


Q ss_pred             EEEeeeccccccCCCCCC---cccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCC
Q 016009          270 AHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRD  332 (397)
Q Consensus       270 ~kl~Dfg~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~  332 (397)
                      +||+|||+++.+...-..   ....+-|..|.|||.+.+. .||.+.|||+.||++.||+|-.+-|.
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            999999999987654322   2445779999999998876 48999999999999999999776553

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-38  Score=274.41  Aligned_cols=243  Identities=24%  Similarity=0.335  Sum_probs=199.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  202 (397)
                      .+|....+||+|+||.|-++..+ +.+.+|||++++..--+ ..+.+--+.|-++|... +-|.++.+..++++.+.+|+
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ-dDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeee-cCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            47888999999999999999654 56789999998743321 12233345677777766 67889999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+.||+|-.++++-+   .+.++.+..++.+||-||-+||++   +|+.||||..||++|.+|++||+|||+++.--
T Consensus       428 VMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence            999999999998887654   477788999999999999999999   99999999999999999999999999998766


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      .+.....+.+||+.|+|||++...+|...+|.|||||+||||+.|++||+....        ++-...+.+....-|.  
T Consensus       502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--------~elF~aI~ehnvsyPK--  571 (683)
T KOG0696|consen  502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQAIMEHNVSYPK--  571 (683)
T ss_pred             cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHHccCcCcc--
Confidence            666667788999999999999999999999999999999999999999984332        2223444454444332  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRP  386 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RP  386 (397)
                        ..+.+...+....+.+.|.+|.
T Consensus       572 --slSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  572 --SLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             --cccHHHHHHHHHHhhcCCcccc
Confidence              3344566778888999999994

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-39  Score=266.36  Aligned_cols=251  Identities=27%  Similarity=0.367  Sum_probs=193.8

Q ss_pred             CccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEEEec
Q 016009          130 QYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  207 (397)
                      ...||.|.||+|+|-. .+.|+..|||+++....   ..+.++++.|.+...+- +.||||+++|.+-.++..|+.||.|
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            4569999999999995 45899999999986332   23467888998865554 7999999999999999999999999


Q ss_pred             cCCCHHHhhccc--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          208 KRGSLAAILSSD--AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       208 ~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      . .||+.+...-  .....+++.-+-.|..-..+||.||....  .|+|||+||+|||+|..|.+||+|||.+..+..+-
T Consensus       146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence            5 4776665321  11235888888899999999999999874  89999999999999999999999999998765332


Q ss_pred             CCcccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccccc--CCCCCCCCc
Q 016009          286 SNWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML--DPRLPAPSR  361 (397)
Q Consensus       286 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  361 (397)
                       ..+.-+|...|||||.+..  ..|+.+|||||||++|||+.||+.|+.....+       -+.+..++  |+.......
T Consensus       223 -AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-------feql~~Vv~gdpp~l~~~~  294 (361)
T KOG1006|consen  223 -AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-------FEQLCQVVIGDPPILLFDK  294 (361)
T ss_pred             -HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-------HHHHHHHHcCCCCeecCcc
Confidence             2344578889999998863  34899999999999999999999997633221       11122222  222222233


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+....+..++..|+.+|-..||.+.++.++
T Consensus       295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            333566789999999999999999999998753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=281.84  Aligned_cols=240  Identities=24%  Similarity=0.299  Sum_probs=192.2

Q ss_pred             hcCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  201 (397)
                      +..|.....+|.|+|+.|-.+. ..+++..+||++....        .+-.+|+.++... +|||++++.+.+.++.+.|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc--------cccccccchhhhhcCCCcceeecceecCCceee
Confidence            5677888889999999998885 4578899999987531        2234677676666 7999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe-CCCCcEEEeeeccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL-DLEFEAHVADFGIAKF  280 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~~~~  280 (397)
                      +|||.+.|+-+.+.+....    ....++..|+.+++.|+.|||.+   ++|||||||+|||+ ++.++++|+|||.++.
T Consensus       393 ~v~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~  465 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE  465 (612)
T ss_pred             eeehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence            9999999998888775443    22277888999999999999998   99999999999999 6889999999999988


Q ss_pred             cCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      ...+   ....+-|..|.|||++....|++++|+||||++||+|++|+.||.....-       .+....+..+...   
T Consensus       466 ~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s---  532 (612)
T KOG0603|consen  466 LERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFS---  532 (612)
T ss_pred             Cchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCccc---
Confidence            7655   33446688999999999999999999999999999999999998633221       0111111111111   


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ...+....+|+.+||+.||.+||+|.++..+
T Consensus       533 ---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  533 ---ECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ---cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence               2344567888999999999999999998753

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-36  Score=235.67  Aligned_cols=261  Identities=21%  Similarity=0.295  Sum_probs=195.2

Q ss_pred             CCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|...++||+|.||+||+|+ .++++.||+|+++.....  ..-....++|+-+++.++|.|||++++....+..+-+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd--egvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC--CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            45556789999999999995 457889999998753332  223567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      |||.. +|..+...-.  ..++.+....++.|+.+||.|+|++   ++.||||||.|.+++.+|++|++|||+++-+.-.
T Consensus        81 e~cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             HHhhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            99965 8888876543  3588899999999999999999999   9999999999999999999999999999987765


Q ss_pred             CCCcccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHh-CCCCCCcccccc---c-------ccccccccccccc
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS---S-------SFLNTDIELDEML  352 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~---~-------~~~~~~~~~~~~~  352 (397)
                      -...+..+-|..|.+|.++.+.+ |+...|+||-||++.|+.. |++-|.......   .       ........+..+-
T Consensus       155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            55556667899999999998765 8999999999999999997 444443211100   0       0000000111111


Q ss_pred             CCCC-C--CCCcchHHHH----HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          353 DPRL-P--APSRSVQEKL----RSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       353 ~~~~-~--~~~~~~~~~~----~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      |-.. +  .....+.+..    ..=.+++...+.-+|.+|.++++.++.
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1110 0  1111222222    223466777888899999999988764

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-37  Score=299.00  Aligned_cols=257  Identities=24%  Similarity=0.293  Sum_probs=203.2

Q ss_pred             HHHHHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC
Q 016009          119 EIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA  197 (397)
Q Consensus       119 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  197 (397)
                      ++.-..++|.+.++||+|+||.|..++.+ +++.||.|++.+..- ....+..-|..|-++|..-+.+.|+.+.-.|++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eM-lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEM-LKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHH-hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            44455678999999999999999999765 688999999865211 1123356789999999999999999999999999


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      +.+|+|||||+||+|-.++....   .+++.-+..++..|+-||.-||+.   |+|||||||+|||+|..|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999999997765   588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC-CcccccccccccCccccc----C-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 016009          278 AKFLKPDSS-NWTEFAGTYGYVAPELAY----T-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       278 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~----~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      +-.+..+.. .....+|||.|++||++.    + +.|...+|.||+||++|||+.|..||-...-+. .       -..+
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve-T-------Y~KI  293 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE-T-------YGKI  293 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH-H-------HHHH
Confidence            887775443 456679999999999886    3 568999999999999999999999985332211 0       1111


Q ss_pred             cCC--CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 016009          352 LDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT---MKIVSQ  393 (397)
Q Consensus       352 ~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~~vl~  393 (397)
                      ++-  .+..|..  .+.+....+||...+. +|+.|..   ++++-.
T Consensus       294 m~hk~~l~FP~~--~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  294 MNHKESLSFPDE--TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hchhhhcCCCcc--cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            111  1222211  1234456777777666 7888877   777654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.9e-35  Score=258.19  Aligned_cols=240  Identities=29%  Similarity=0.452  Sum_probs=191.6

Q ss_pred             CcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCCHHHh
Q 016009          137 GHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAI  215 (397)
Q Consensus       137 ~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~  215 (397)
                      +||.||+|... +|+.+++|++........   .+.+.+|++.+++++|+|++++++++......++++||+++++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK---RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH---HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            58999999776 589999999875322211   57899999999999999999999999999999999999999999999


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcccccccc
Q 016009          216 LSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY  295 (397)
Q Consensus       216 l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  295 (397)
                      +....   .+++.+++.++.+++.++.|||+.   +++|+||+|+||++++++.++++|||.+....... ......++.
T Consensus        78 ~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~  150 (244)
T smart00220       78 LKKRG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTP  150 (244)
T ss_pred             HHhcc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCc
Confidence            86543   288999999999999999999998   99999999999999999999999999998765432 233456788


Q ss_pred             cccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHH
Q 016009          296 GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVF  375 (397)
Q Consensus       296 ~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  375 (397)
                      .|++||...+..++.++||||||++++++++|..||.......       ............. ..........+.+++.
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~  222 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-------ELFKKIGKPKPPF-PPPEWKISPEAKDLIR  222 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-------HHHHHHhccCCCC-ccccccCCHHHHHHHH
Confidence            9999999988889999999999999999999999986421110       0011111111110 0000003356889999


Q ss_pred             HccCCCCCCCCCHHHHHHH
Q 016009          376 SCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       376 ~cl~~~P~~RPt~~~vl~~  394 (397)
                      +|+..+|++||++.++++.
T Consensus       223 ~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      223 KLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HHccCCchhccCHHHHhhC
Confidence            9999999999999999863

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=257.78  Aligned_cols=252  Identities=25%  Similarity=0.341  Sum_probs=203.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  201 (397)
                      .++|...++||+|+|.+|..+++. +.+.+|+|++++..... ..+.+-...|-.+..+. +||.+|.+..+++++..++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd-dedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC-cccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            467889999999999999999764 67889999987654433 23455667788888777 7999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +|.||++||+|--+++..   +.++++.++.+...|+-||.|||++   ||+.||||..|||+|.+|++||+|||+.+.-
T Consensus       328 fvieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence            999999999998777554   3599999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      -......++.+||+.|+|||++++..|....|.|++|++++||+.|+.||+....-.......+--...++...+..|..
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs  481 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS  481 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence            65666667889999999999999999999999999999999999999999976632222111111223344444443322


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCC
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRP  386 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RP  386 (397)
                      .    +.....+++.-+++||.+|.
T Consensus       482 l----svkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  482 L----SVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             e----ehhhHHHHHHhhcCCcHHhc
Confidence            1    22344567788999999995

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.2e-35  Score=286.72  Aligned_cols=261  Identities=20%  Similarity=0.222  Sum_probs=168.8

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-C----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEE----
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-S----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGF----  193 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~----  193 (397)
                      ..++|...+.||+|+||.||+|... +    +..||+|++.....      .+....|  .++...+.++..+...    
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~------~e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA------VEIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch------hHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            4678999999999999999999764 4    68999998754111      1111111  1122222222222111    


Q ss_pred             --EecCCeeeEEEEeccCCCHHHhhcccccc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 016009          194 --CSHARHSFLVYEFLKRGSLAAILSSDAAA-----------------QELGWSQRMNVIKGVADALSYLHHDCFPPIVH  254 (397)
Q Consensus       194 --~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH  254 (397)
                        +......++||||+.+++|.+++......                 .......+..++.|++.||+|||+.   +|+|
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiH  278 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVH  278 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence              24567889999999999999998653210                 0112344668999999999999998   9999


Q ss_pred             ccCCCCcEEeCC-CCcEEEeeeccccccCCCCC-CcccccccccccCcccccCC----------------------CCCc
Q 016009          255 RDISSKNLLLDL-EFEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPELAYTM----------------------KITE  310 (397)
Q Consensus       255 ~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~----------------------~~~~  310 (397)
                      |||||+|||+++ ++.+||+|||+++.+..... ......+++.|+|||.+...                      .++.
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            999999999986 57999999999986543322 22445789999999965322                      2345


Q ss_pred             chhhHHHHHHHHHHHhCCCCCCcccccc-ccccccc---cccccccCCCCCCC----CcchHHHHHHHHHHHHHccCCCC
Q 016009          311 KCDVYSFGVLALEVIKGKHPRDFLSSIS-SSFLNTD---IELDEMLDPRLPAP----SRSVQEKLRSIVEVVFSCLNESP  382 (397)
Q Consensus       311 ~~Dv~s~G~~l~el~tg~~p~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~P  382 (397)
                      ++|||||||++|||+++..|++...... .......   ........+.....    ............+|+.+|++.||
T Consensus       359 k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            6799999999999999887754221100 0000000   00111111111000    00000011235689999999999


Q ss_pred             CCCCCHHHHHHH
Q 016009          383 ESRPTMKIVSQQ  394 (397)
Q Consensus       383 ~~RPt~~~vl~~  394 (397)
                      ++|||+++++++
T Consensus       439 ~kR~ta~e~L~H  450 (566)
T PLN03225        439 RQRISAKAALAH  450 (566)
T ss_pred             ccCCCHHHHhCC
Confidence            999999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=263.43  Aligned_cols=270  Identities=21%  Similarity=0.294  Sum_probs=201.8

Q ss_pred             CCcccHHHHHHHhcCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc--CC---
Q 016009          112 EGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR--HR---  185 (397)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~---  185 (397)
                      +|.+.|..--..+++|.+...+|+|.||.|..+. ...+..||+|+++...     .-.+..+-|+++|+++.  .|   
T Consensus        76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-----kYreAa~iEi~vLqki~~~DP~g~  150 (415)
T KOG0671|consen   76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-----KYREAALIEIEVLQKINESDPNGK  150 (415)
T ss_pred             CceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-----HHhhHHHHHHHHHHHHHhcCCCCc
Confidence            3444443333447889999999999999999994 4468899999987521     12455678999999993  23   


Q ss_pred             -ceeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe
Q 016009          186 -NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL  264 (397)
Q Consensus       186 -niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill  264 (397)
                       -++.+.+|+...++.++|+|.+ |-|+.+++..+.. .+++..+++.++.|++++++|||+.   +++|.||||+|||+
T Consensus       151 ~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILf  225 (415)
T KOG0671|consen  151 FRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILF  225 (415)
T ss_pred             eEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEE
Confidence             3777888899999999999987 6699999987654 5789999999999999999999999   99999999999999


Q ss_pred             CC--------------------CCcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHH
Q 016009          265 DL--------------------EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEV  324 (397)
Q Consensus       265 ~~--------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el  324 (397)
                      .+                    +..++|+|||.|++-.   ...+..+.|..|.|||++.+..++.++||||+||+|.|+
T Consensus       226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El  302 (415)
T KOG0671|consen  226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL  302 (415)
T ss_pred             eccceEEEeccCCccceeccCCCcceEEEecCCcceec---cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence            32                    3458999999998633   334667889999999999999999999999999999999


Q ss_pred             HhCCCCCCcccc-------------ccccccccc-------------------cccccccCCCCCC--CCcchHHHHHHH
Q 016009          325 IKGKHPRDFLSS-------------ISSSFLNTD-------------------IELDEMLDPRLPA--PSRSVQEKLRSI  370 (397)
Q Consensus       325 ~tg~~p~~~~~~-------------~~~~~~~~~-------------------~~~~~~~~~~~~~--~~~~~~~~~~~l  370 (397)
                      .||..-|.-...             .+.......                   .+.....++..+.  .......+...|
T Consensus       303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L  382 (415)
T KOG0671|consen  303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL  382 (415)
T ss_pred             eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence            999887642221             000000000                   0001111111110  001122344579


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHH
Q 016009          371 VEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       371 ~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ++|+..+|..||.+|+|+.|++.+
T Consensus       383 fDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  383 FDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHHHHHHccCccccccHHHHhcC
Confidence            999999999999999999999864

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-34  Score=274.65  Aligned_cols=267  Identities=17%  Similarity=0.226  Sum_probs=181.6

Q ss_pred             HhcCCCCCccccccCcEEEEEEEe-----------------CCCCEEEEEecCCCCCCcch----------hcHHHHHHH
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAEL-----------------PSGQVVAIKKFHSPLPSDQI----------VDKKEFLTE  175 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~-----------------~~~~~vavK~~~~~~~~~~~----------~~~~~~~~e  175 (397)
                      ..++|+..++||+|+||+||+|..                 .+++.||||++.........          ...+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999953                 24568999998642211000          011223457


Q ss_pred             HHHHHhccCCce-----eeeEEEEec--------CCeeeEEEEeccCCCHHHhhccccc---------------------
Q 016009          176 VEALTEIRHRNI-----VKLYGFCSH--------ARHSFLVYEFLKRGSLAAILSSDAA---------------------  221 (397)
Q Consensus       176 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  221 (397)
                      +.++.+++|.++     ++++++|..        ++..+|||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777788876654     677787743        3568999999999999999864211                     


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCC-cccccccccccCc
Q 016009          222 AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAP  300 (397)
Q Consensus       222 ~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~g~~~y~aP  300 (397)
                      ...++|..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......... .....+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            12356788999999999999999998   9999999999999999999999999999765432211 1122347899999


Q ss_pred             ccccCCCC----------------------CcchhhHHHHHHHHHHHhCCC-CCCccccccccccccccccc---cccCC
Q 016009          301 ELAYTMKI----------------------TEKCDVYSFGVLALEVIKGKH-PRDFLSSISSSFLNTDIELD---EMLDP  354 (397)
Q Consensus       301 E~~~~~~~----------------------~~~~Dv~s~G~~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~---~~~~~  354 (397)
                      |.+.....                      ..+.||||+||++++|++|.. |+..................   .....
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98754321                      134799999999999999875 65432211111100000000   00001


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESP---ESRPTMKIVSQQ  394 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P---~~RPt~~~vl~~  394 (397)
                      ...  ............+++.+++..+|   .+|+|++|++++
T Consensus       460 ~~~--~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        460 KYD--FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             CCC--cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            110  11112233557888999999766   689999999875

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=262.64  Aligned_cols=257  Identities=27%  Similarity=0.381  Sum_probs=192.5

Q ss_pred             CCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchh---cHHHHHHHHHHHHhccCCceeeeEEEEec-CCee
Q 016009          126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV---DKKEFLTEVEALTEIRHRNIVKLYGFCSH-ARHS  200 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  200 (397)
                      +|-..++||+|+|+.||++ .+...+.||||+-..........   --+...+|.+|-+.|.||.||++++|+.- .+..
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            3445567999999999999 56677889999754322222111   12346789999999999999999999964 4567


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC---CCCcEEEeeecc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD---LEFEAHVADFGI  277 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~  277 (397)
                      +-|+|||+|.+|+-+|..+.   .+++.+++.|+.||+.||.||... .++|||-||||.|||+-   ..|.+||+|||+
T Consensus       544 CTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             eeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            89999999999999998765   489999999999999999999986 45899999999999994   457899999999


Q ss_pred             ccccCCCCCC-------cccccccccccCcccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccc
Q 016009          278 AKFLKPDSSN-------WTEFAGTYGYVAPELAYTM----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDI  346 (397)
Q Consensus       278 ~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~  346 (397)
                      ++.+..+...       .+..+||..|++||.+.-+    +.+.|.||||.||++|.++.|+.||+....-. ..+... 
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dILqeN-  697 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DILQEN-  697 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HHHhhh-
Confidence            9988765433       2446799999999987643    47889999999999999999999997433211 111100 


Q ss_pred             ccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 016009          347 ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS  392 (397)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl  392 (397)
                      .+-....-.++..+    ....+...+|.+||+.--++|....++.
T Consensus       698 TIlkAtEVqFP~KP----vVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  698 TILKATEVQFPPKP----VVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             chhcceeccCCCCC----ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            01111111122211    1223467788999999999998877764

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-36  Score=247.72  Aligned_cols=262  Identities=24%  Similarity=0.391  Sum_probs=191.9

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec-------
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH-------  196 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------  196 (397)
                      +.|+...++|+|.||.||+|+. ++|+.||+|+...... . ..-....++|+++|..++|+|++.++..|..       
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-K-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-K-EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-c-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            3455567799999999999965 4678899987653211 1 1123456899999999999999999998843       


Q ss_pred             -CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          197 -ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       197 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                       ....|+||++|+. +|..+|....  ..++..++.+++.++..||.|+|..   .|+|||+|+.|+|++.++.+||+||
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence             2347999999976 8888887654  4689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCC----CcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccc------------
Q 016009          276 GIAKFLKPDSS----NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS------------  338 (397)
Q Consensus       276 g~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~------------  338 (397)
                      |+++.+.....    ..++.+-|..|.+||.+.+ ..++++.|||.-||++.||+||.+-+.......            
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            99977654322    2455677999999998775 468999999999999999999987765332211            


Q ss_pred             --ccccccc-ccc-ccccCCCCC-CCCcchHHHHH------HHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          339 --SSFLNTD-IEL-DEMLDPRLP-APSRSVQEKLR------SIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       339 --~~~~~~~-~~~-~~~~~~~~~-~~~~~~~~~~~------~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        ..|...+ -.+ ..+--+.++ .......+.+.      ...+|+..++..||.+|+++.+++.+
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence              0000000 000 000000011 00011112222      56788999999999999999999864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-35  Score=278.08  Aligned_cols=245  Identities=25%  Similarity=0.401  Sum_probs=189.5

Q ss_pred             CCCCccccccCcEE-EEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEE
Q 016009          127 FDAQYCIGNGGHGS-VYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       127 ~~~~~~lg~G~~g~-vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      |...+++|.|+-|+ ||+|.. +|+.||||++-..       ..+-..+|+..|+.- .|||||++++.-.+....|+..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            44556788988765 799988 6889999997531       234567899999998 6999999999999999999999


Q ss_pred             EeccCCCHHHhhccccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC---C--CcEEEeeeccc
Q 016009          205 EFLKRGSLAAILSSDAA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL---E--FEAHVADFGIA  278 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfg~~  278 (397)
                      |.|. .+|++++..... .....-...+.+..|++.||++||+.   +||||||||.||||+.   +  ..++|+|||++
T Consensus       583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls  658 (903)
T KOG1027|consen  583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLS  658 (903)
T ss_pred             hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccc
Confidence            9995 599999977411 01111134578899999999999998   9999999999999975   3  46899999999


Q ss_pred             cccCCCCCC---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCccccccccccccccccccccCC
Q 016009          279 KFLKPDSSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG-KHPRDFLSSISSSFLNTDIELDEMLDP  354 (397)
Q Consensus       279 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
                      +.+..+...   .....||.+|+|||++....-+..+||||+||++|+.++| .+||+....-..+.......+..+.. 
T Consensus       659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~-  737 (903)
T KOG1027|consen  659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEP-  737 (903)
T ss_pred             cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeecc-
Confidence            998766543   3456799999999999998888899999999999999995 99998654322222222222111110 


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                              ..++  ...+||.+|++++|..||++.+|+.+
T Consensus       738 --------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  738 --------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             --------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence                    1112  57789999999999999999999863

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=266.51  Aligned_cols=244  Identities=24%  Similarity=0.385  Sum_probs=197.1

Q ss_pred             CCCCCccccccCcEEEEEEEeCCCC-EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELPSGQ-VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +++....||-|+||.|=++..++.. .+|+|.+++..- ......+.+..|-.+|...+.|.||+++-.|.+....|++|
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI-VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI-VDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc-cchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            4445567999999999998765433 488888765222 12223566788999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      |-|-||.|...++.++   .++......++..+.+|++|||++   +||.|||||+|.++|.+|-+||.|||+++.+..+
T Consensus       500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999998765   488888889999999999999999   9999999999999999999999999999998866


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      ...+ +.+||+.|.|||++.....+..+|.||||+++|||++|.+||....++.-...... .++.+-   +|      .
T Consensus       574 ~KTw-TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk-Gid~i~---~P------r  642 (732)
T KOG0614|consen  574 RKTW-TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK-GIDKIE---FP------R  642 (732)
T ss_pred             Ccee-eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh-hhhhhh---cc------c
Confidence            6554 47999999999999999999999999999999999999999987666532221110 111111   11      1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCC
Q 016009          365 EKLRSIVEVVFSCLNESPESRPT  387 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt  387 (397)
                      ...+...+++.+.+..+|.+|.-
T Consensus       643 ~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  643 RITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ccchhHHHHHHHHHhcCcHhhhc
Confidence            22344678888989999999975

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-34  Score=264.83  Aligned_cols=213  Identities=23%  Similarity=0.334  Sum_probs=174.6

Q ss_pred             HHHHHHHh---cCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEE
Q 016009          117 YDEIVRAT---NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG  192 (397)
Q Consensus       117 ~~~~~~~~---~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~  192 (397)
                      |-.+.++.   .-|..++.||-|+||.|.++. .++...+|.|.+++.... ..........|-+||...+.+.||+|+-
T Consensus       618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl-~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL-MRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH-hhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            33444443   346677889999999999994 445678999998753221 1122345678999999999999999999


Q ss_pred             EEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEE
Q 016009          193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV  272 (397)
Q Consensus       193 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  272 (397)
                      .|++++.+|+||||++||++-.+|...+.   +.+..++.++.++++|+++.|..   |+|||||||+|||||.+|++||
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKL  770 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL  770 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceee
Confidence            99999999999999999999999976553   77888888999999999999999   9999999999999999999999


Q ss_pred             eeeccccccC---------CCCCC---------------------------------cccccccccccCcccccCCCCCc
Q 016009          273 ADFGIAKFLK---------PDSSN---------------------------------WTEFAGTYGYVAPELAYTMKITE  310 (397)
Q Consensus       273 ~Dfg~~~~~~---------~~~~~---------------------------------~~~~~g~~~y~aPE~~~~~~~~~  310 (397)
                      +|||++.-+.         .++..                                 ....+||+.|+|||++....++.
T Consensus       771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q  850 (1034)
T KOG0608|consen  771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ  850 (1034)
T ss_pred             eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence            9999975321         00000                                 02346999999999999999999


Q ss_pred             chhhHHHHHHHHHHHhCCCCCCcccc
Q 016009          311 KCDVYSFGVLALEVIKGKHPRDFLSS  336 (397)
Q Consensus       311 ~~Dv~s~G~~l~el~tg~~p~~~~~~  336 (397)
                      .+|.||.||+||||+.|+.||-...+
T Consensus       851 ~cdwws~gvil~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  851 LCDWWSVGVILYEMLVGQPPFLADTP  876 (1034)
T ss_pred             cchhhHhhHHHHHHhhCCCCccCCCC
Confidence            99999999999999999999875544

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=230.99  Aligned_cols=205  Identities=23%  Similarity=0.379  Sum_probs=168.7

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCC
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHAR  198 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  198 (397)
                      +.+.++......||+|++|.|-+-++ .+|+..|+|.+......   ...++.++|+++..+. .+|.+|.++|......
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~---q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS---QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh---HHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            33444555567799999999988854 58999999999865443   2357788899886665 7999999999999999


Q ss_pred             eeeEEEEeccCCCHHHhhccc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          199 HSFLVYEFLKRGSLAAILSSD-AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ..++.||.|. .||+.+...- .....+++..+-+|+..+..||.|||++.  .++|||+||+|||++.+|++|++|||.
T Consensus       119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGI  195 (282)
T KOG0984|consen  119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGI  195 (282)
T ss_pred             cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccc
Confidence            9999999995 4887776432 12346889999999999999999999984  899999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccC----CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYT----MKITEKCDVYSFGVLALEVIKGKHPRD  332 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~s~G~~l~el~tg~~p~~  332 (397)
                      +..+..+-. .+...|...|||||.+..    ..|+.+|||||||+.+.||.+++.||+
T Consensus       196 sG~L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  196 SGYLVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             ceeehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            987654322 233578889999998763    368999999999999999999999976

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=9.5e-32  Score=231.75  Aligned_cols=212  Identities=35%  Similarity=0.611  Sum_probs=184.1

Q ss_pred             ccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCC
Q 016009          133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGS  211 (397)
Q Consensus       133 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  211 (397)
                      ||+|.+|.||++... +++.+++|++.......   ..+.+.+|++.++.++|++++++++++......++++||+++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999775 48999999987532211   34779999999999999999999999999999999999999999


Q ss_pred             HHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC-CCcEEEeeeccccccCCCCCCccc
Q 016009          212 LAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKPDSSNWTE  290 (397)
Q Consensus       212 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~  290 (397)
                      |.+++....  ..+++..++.++.++++++.+||+.   +++|+||+|.||+++. ++.++|+|||.+............
T Consensus        78 l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (215)
T cd00180          78 LKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT  152 (215)
T ss_pred             HHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence            999987542  3588999999999999999999999   9999999999999999 899999999999876544322334


Q ss_pred             ccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHH
Q 016009          291 FAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS  369 (397)
Q Consensus       291 ~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (397)
                      ..+...|++||..... ..+.++|+|++|++++++                                           ..
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~  189 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PE  189 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HH
Confidence            5678899999998877 788999999999999999                                           34


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          370 IVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       370 l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      +.+++..|++.+|++||++.++++.+
T Consensus       190 ~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         190 LKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            88899999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-32  Score=244.32  Aligned_cols=133  Identities=26%  Similarity=0.430  Sum_probs=112.6

Q ss_pred             hcCCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-----C---CceeeeEEEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-----H---RNIVKLYGFC  194 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~  194 (397)
                      ..+|-..++||-|.|++||++ ...+.+.||+|+.+.     ...-.+..+.|+++|++++     |   ..||+|+++|
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            357888999999999999999 556788999999764     2233567889999999983     3   3699999999


Q ss_pred             e----cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC
Q 016009          195 S----HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD  265 (397)
Q Consensus       195 ~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  265 (397)
                      .    ++.++++|+|++ |.+|..++..... +.++...+.+|+.||+.||.|||..|  +|||.||||+|||+.
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence            4    567899999998 6688888876554 55999999999999999999999998  999999999999994

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=1.4e-33  Score=261.60  Aligned_cols=253  Identities=27%  Similarity=0.393  Sum_probs=205.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+....+|+|.+|.|||++. .+++..|+|.++....    .+.+-+.+|+-+++..+||||+.++|.+...+..++
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~----dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi   89 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG----DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI   89 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC----ccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence            45788889999999999999964 4789999999876322    234567789999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      .||||.+|+|++..+...   ++++.++..++++..+|+.|||+.   +-+|||||-.||++++.|.+|++|||.+..+.
T Consensus        90 cMEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             EEEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence            999999999999886544   699999999999999999999999   88999999999999999999999999998887


Q ss_pred             CCCCCcccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          283 PDSSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ..-.......||+.|||||+..   .+.|..++|||+.|+...|+-.-+.|-....++...++..    ....+|.-...
T Consensus       164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT----kS~~qpp~lkD  239 (829)
T KOG0576|consen  164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT----KSGFQPPTLKD  239 (829)
T ss_pred             hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh----ccCCCCCcccC
Confidence            7666667789999999999764   5679999999999999999988887744333333222211    11111111111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      .   ..+...+-++++.|+.++|++|||++-++.
T Consensus       240 k---~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  240 K---TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             C---ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1   233455888999999999999999987765

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.98  E-value=1.3e-32  Score=224.56  Aligned_cols=253  Identities=21%  Similarity=0.315  Sum_probs=192.4

Q ss_pred             hcCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecC--Ce
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHA--RH  199 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~  199 (397)
                      .++|++.+.+|+|.++.||.|. ..+.+.++||.++.       ..++.+.+|+.+|+.+. ||||+.+++...++  ..
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            4678888999999999999994 56788999999874       34688999999999997 99999999998665  45


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC-CcEEEeeeccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIA  278 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~  278 (397)
                      ..||+||+.+.+...+.      +.++...+...+.+++.||.|+|+.   ||.|||+||.|+++|.. -.++|+|+|+|
T Consensus       110 paLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             chhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence            68999999999888776      3477888999999999999999999   99999999999999865 46999999999


Q ss_pred             cccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccc-------------------
Q 016009          279 KFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS-------------------  338 (397)
Q Consensus       279 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~-------------------  338 (397)
                      .++.+.... ...+.+..|..||.+.. ..|+..-|+|||||++..|+..+.||-......                   
T Consensus       181 EFYHp~~eY-nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  181 EFYHPGKEY-NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             hhcCCCcee-eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            988765443 33456777889998875 457889999999999999999999973221110                   


Q ss_pred             -ccccccccccccccCCCCCCCC------cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          339 -SSFLNTDIELDEMLDPRLPAPS------RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       339 -~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                       ......+.....++......++      +.-.-...+..+++.+.+..|-++|||++|...
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence             0000001111111111110000      000011245788999999999999999999865

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-33  Score=233.30  Aligned_cols=258  Identities=26%  Similarity=0.380  Sum_probs=192.0

Q ss_pred             CCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-----CeeeE
Q 016009          129 AQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-----RHSFL  202 (397)
Q Consensus       129 ~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l  202 (397)
                      ..+-||-|+||.||.+..+ +|+.|+.|++..-.  ......+.+.+|+++|...+|.|++..++..+-.     .+.|+
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf--q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF--QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHH--HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            3566999999999999654 89999999986422  2334567899999999999999999998876543     35678


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      +.|.|.. +|.+.+-..   +.++-+.+.-+..||++||.|||+.   +|.||||||.|.|++.|-.+||+|||+++..+
T Consensus       135 ~TELmQS-DLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHh-hhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence            8888854 788777543   4588888999999999999999998   99999999999999999999999999999876


Q ss_pred             CCCC-CcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc---------------ccc
Q 016009          283 PDSS-NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL---------------NTD  345 (397)
Q Consensus       283 ~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~---------------~~~  345 (397)
                      .+.. ..+..+-|..|.|||.+++. .|+...||||.||++.|++..+.-|...+++..-..               .-+
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            5443 44556789999999999875 589999999999999999998877764443220000               001


Q ss_pred             cccccccCCCCCCCC-------cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          346 IELDEMLDPRLPAPS-------RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       346 ~~~~~~~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      +....++......|.       ........+-..+...++..||++|.+.++.+..+
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            111111111111111       01112223455677789999999999998887654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=227.09  Aligned_cols=257  Identities=23%  Similarity=0.343  Sum_probs=187.8

Q ss_pred             cCCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe------cC
Q 016009          125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS------HA  197 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~------~~  197 (397)
                      .+|...+.+|.|.- .|..+ ..-.+++||+|++..+...  ....+...+|...+..+.|+|+++++.++.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n--~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN--QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc--CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            35666677888877 55555 3336899999998776332  334566789999999999999999999883      23


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      .+.|+|||+|.. +|...+..     +++-..+..|..|++.|++|||+.   +|+||||||+||++..+..+||.|||+
T Consensus        94 ~e~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   94 QEVYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             HhHHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence            467999999954 78777752     366678899999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccc-------------------
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS-------------------  338 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~-------------------  338 (397)
                      ++.-... -..+..+.+-.|.|||++.+..+.+.+||||.||++.||++|+.-|.......                   
T Consensus       165 ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  165 ARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             hcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            9854433 23455677889999999999889999999999999999999987654211100                   


Q ss_pred             -----ccccc-cc----ccccc-ccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          339 -----SSFLN-TD----IELDE-MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       339 -----~~~~~-~~----~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                           ..+.. .+    ....+ .-|..++.......-......+++.+||..||++|.+++++|++
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                 00000 00    00000 11111111111111123457788999999999999999999874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=8.8e-30  Score=222.14  Aligned_cols=199  Identities=32%  Similarity=0.532  Sum_probs=170.6

Q ss_pred             CCCCccccccCcEEEEEEEeCC-CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |...+.||+|++|.||++...+ ++.+++|.+......   ...+.+.+|++.+++++|+|++++++++......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence            4556789999999999997764 889999998753322   236788999999999999999999999999899999999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS  285 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  285 (397)
                      |+++++|.+++.....  .+++..+..++.+++.++.+||+.   +++|+|++|+||+++.++.++|+|||.+.......
T Consensus        78 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       78 YCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             ccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            9999999999875432  278999999999999999999998   99999999999999999999999999988765432


Q ss_pred             -CCcccccccccccCcccc-cCCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 016009          286 -SNWTEFAGTYGYVAPELA-YTMKITEKCDVYSFGVLALEVIKGKHPRDF  333 (397)
Q Consensus       286 -~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~  333 (397)
                       .......++..|++||.. ....++.++|+|+||++++||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence             122334677889999998 666788899999999999999999999853

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-31  Score=241.02  Aligned_cols=199  Identities=25%  Similarity=0.353  Sum_probs=167.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchh----cHHHHHHHHHHHHhcc---CCceeeeEEEEec
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIV----DKKEFLTEVEALTEIR---HRNIVKLYGFCSH  196 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~----~~~~~~~e~~~l~~l~---h~niv~~~~~~~~  196 (397)
                      .+|...+.+|.|+||.|+.+.++ +...|+||.+.+..--....    ..-.+-.|++||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46888899999999999999665 56789999886532111100    1123567999999997   9999999999999


Q ss_pred             CCeeeEEEEec-cCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          197 ARHSFLVYEFL-KRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       197 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                      ++..||+||-. ++-+|.+++....   .+++.+...|+.||+.|+++||++   +|||||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence            99999999965 4668999997654   589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCC
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPR  331 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~  331 (397)
                      |.+.....  ..+...+||.+|.|||++.+.+| ...-|||++|++||-++....||
T Consensus       715 gsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  715 GSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             cchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            99876543  33566799999999999999887 45689999999999999888885

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=1.9e-30  Score=234.45  Aligned_cols=201  Identities=26%  Similarity=0.299  Sum_probs=167.6

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc------CCceeeeEEE
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR------HRNIVKLYGF  193 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~  193 (397)
                      +..-+.|.+....|+|-|++|.+|.. ..|+.||||++...     ..-.+.=+.|+++|++|.      -.|.++++-.
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            34456788888999999999999954 46889999999752     222355678999999995      3588999999


Q ss_pred             EecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC-cEEE
Q 016009          194 CSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF-EAHV  272 (397)
Q Consensus       194 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl  272 (397)
                      |...+++|||+|-+ ..+|.+.|...+..-.|....+..++.|+.-||..|...   +|+|.||||.|||+++.- .+||
T Consensus       503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeee
Confidence            99999999999977 569999998776555688899999999999999999998   999999999999998764 5899


Q ss_pred             eeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 016009          273 ADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD  332 (397)
Q Consensus       273 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~  332 (397)
                      ||||.|.......  .+...-+--|.|||++.|..|+...|+||.||+||||.||+..|.
T Consensus       579 CDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp  636 (752)
T KOG0670|consen  579 CDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP  636 (752)
T ss_pred             ccCcccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence            9999997654322  222334557999999999999999999999999999999997764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.4e-30  Score=214.79  Aligned_cols=250  Identities=20%  Similarity=0.364  Sum_probs=183.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEE-EecCCeee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGF-CSHARHSF  201 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~  201 (397)
                      +.|.+.+.||+|.||.+-+++++ +.+.+++|.+..+.     ...++|.+|...--.| .|.||+.-++. |++.+...
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            46888899999999999999765 56789999887533     3467899998776666 58999987764 57777888


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe-CC-CCcEEEeeecccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL-DL-EFEAHVADFGIAK  279 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill-~~-~~~~kl~Dfg~~~  279 (397)
                      +++||++.|+|.+-+...+    +.+....+++.|++.|+.|+|++   ++||||||.+|||+ +. ..++||+|||..+
T Consensus        99 F~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             EeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence            9999999999998886643    66777889999999999999999   99999999999999 33 3479999999987


Q ss_pred             ccCCCCCCcccccccccccCcccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP  354 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
                      ..+.   .......+..|.+||.....     ...+.+|||.||++++.++||+.||.........+..... ......+
T Consensus       172 k~g~---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~-w~~rk~~  247 (378)
T KOG1345|consen  172 KVGT---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ-WLKRKNP  247 (378)
T ss_pred             ccCc---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH-HhcccCc
Confidence            5432   22223345678899976432     3577899999999999999999999844433333322211 1122223


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      ..+...   ......+.++..+-+..+|++|=...++.+
T Consensus       248 ~~P~~F---~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  248 ALPKKF---NPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             cCchhh---cccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence            333221   223344667777899999999955554443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=5.7e-29  Score=208.81  Aligned_cols=165  Identities=23%  Similarity=0.260  Sum_probs=124.8

Q ss_pred             CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcc
Q 016009          210 GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT  289 (397)
Q Consensus       210 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  289 (397)
                      |+|.+++...+  ..+++.+++.++.|++.||+|||+.   +      ||+||+++.++.+++  ||++.......    
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            68999997543  4599999999999999999999998   4      999999999999999  99987654322    


Q ss_pred             cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHH-
Q 016009          290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR-  368 (397)
Q Consensus       290 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  368 (397)
                       ..|++.|+|||++.+..++.++|||||||++|||+||+.||.............   .... .+..+........... 
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~  138 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEIL---LNGM-PADDPRDRSNLESVSAA  138 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHH---HHHh-ccCCccccccHHHHHhh
Confidence             267899999999999999999999999999999999999986443221111000   0000 0110100011122222 


Q ss_pred             -HHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          369 -SIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       369 -~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       .+.+++.+||+.+|++|||+.|+++++.
T Consensus       139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      139 RSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             hhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence             5899999999999999999999998864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.1e-29  Score=259.76  Aligned_cols=195  Identities=18%  Similarity=0.197  Sum_probs=139.4

Q ss_pred             hccC-CceeeeEEEE-------ecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 016009          181 EIRH-RNIVKLYGFC-------SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI  252 (397)
Q Consensus       181 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i  252 (397)
                      .++| +||.++++++       ......++++||+ +++|.+++....  ..+++.+++.++.||++||.|||++   +|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            4555 5788888877       2334567888987 669999996532  4589999999999999999999998   99


Q ss_pred             eeccCCCCcEEeCC-------------------CCcEEEeeeccccccCCCC----------------CCcccccccccc
Q 016009          253 VHRDISSKNLLLDL-------------------EFEAHVADFGIAKFLKPDS----------------SNWTEFAGTYGY  297 (397)
Q Consensus       253 vH~dlk~~Nill~~-------------------~~~~kl~Dfg~~~~~~~~~----------------~~~~~~~g~~~y  297 (397)
                      +||||||+|||++.                   ++.+|++|||+++......                .......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999964                   4456666666665321100                000113578889


Q ss_pred             cCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHc
Q 016009          298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSC  377 (397)
Q Consensus       298 ~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  377 (397)
                      +|||++.+..++.++|||||||+||||++|..|+..........      ......+..       ........+++.+|
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~------~~~~~~~~~-------~~~~~~~~~~~~~~  248 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSL------RHRVLPPQI-------LLNWPKEASFCLWL  248 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHH------HHhhcChhh-------hhcCHHHHHHHHHh
Confidence            99999999999999999999999999999998865321110000      000111110       01122356788899


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 016009          378 LNESPESRPTMKIVSQQ  394 (397)
Q Consensus       378 l~~~P~~RPt~~~vl~~  394 (397)
                      |+++|.+|||+.|++++
T Consensus       249 L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        249 LHPEPSCRPSMSELLQS  265 (793)
T ss_pred             CCCChhhCcChHHHhhc
Confidence            99999999999999874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1.3e-28  Score=218.19  Aligned_cols=200  Identities=28%  Similarity=0.424  Sum_probs=166.2

Q ss_pred             HHHHHHhcCCCCCccccccCcEEEEEEEeC----CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEE
Q 016009          118 DEIVRATNDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYG  192 (397)
Q Consensus       118 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~  192 (397)
                      +++....+.|...++||.|.|++||++...    ..+.||+|.+....      ....+.+|+++|..+ -+.||+++.+
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~  102 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNG  102 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchh
Confidence            344455677889999999999999999543    46789999987522      246689999999999 5999999999


Q ss_pred             EEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC-CcEE
Q 016009          193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAH  271 (397)
Q Consensus       193 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~k  271 (397)
                      ++...+...+|+||++.....+++.      .++..++...+..+..||+++|++   ||||||+||+|++.+.. +.-.
T Consensus       103 ~~rnnd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~  173 (418)
T KOG1167|consen  103 CFRNNDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGV  173 (418)
T ss_pred             hhccCCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCce
Confidence            9999999999999999999999884      377889999999999999999999   99999999999999754 5688


Q ss_pred             EeeeccccccC-----------------C-CC--------------------------CCcccccccccccCcccccC-C
Q 016009          272 VADFGIAKFLK-----------------P-DS--------------------------SNWTEFAGTYGYVAPELAYT-M  306 (397)
Q Consensus       272 l~Dfg~~~~~~-----------------~-~~--------------------------~~~~~~~g~~~y~aPE~~~~-~  306 (397)
                      |.|||++....                 . ..                          ......+||++|.|||++.. .
T Consensus       174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~  253 (418)
T KOG1167|consen  174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP  253 (418)
T ss_pred             EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence            99999987210                 0 00                          00123469999999998875 4


Q ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCC
Q 016009          307 KITEKCDVYSFGVLALEVIKGKHPRD  332 (397)
Q Consensus       307 ~~~~~~Dv~s~G~~l~el~tg~~p~~  332 (397)
                      .-++++||||.|++++-+++++.||-
T Consensus       254 ~QttaiDiws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  254 RQTTAIDIWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             CcCCccceeeccceeehhhccccccc
Confidence            57889999999999999999999973

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.9e-27  Score=197.40  Aligned_cols=245  Identities=20%  Similarity=0.320  Sum_probs=183.9

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccC
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKR  209 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  209 (397)
                      ..+|.....|..|+|+++. ..+++|++...  .....-.++|..|.-.|+-..||||.+++|.|..+....++..||+.
T Consensus       195 ~tkl~e~hsgelwrgrwqg-ndivakil~vr--~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQG-NDIVAKILNVR--EVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhccCCCcccccccccC-cchhhhhhhhh--hcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            3457788899999999964 45677776531  12222246788899999999999999999999999999999999999


Q ss_pred             CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEe--eeccccccCCCCCC
Q 016009          210 GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVA--DFGIAKFLKPDSSN  287 (397)
Q Consensus       210 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~--Dfg~~~~~~~~~~~  287 (397)
                      |||...+++... -..+-.+..+++.++|+|++|||+.. +-|.---|.+..|++|++.+++|+  |--++.+   .   
T Consensus       272 gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq---e---  343 (448)
T KOG0195|consen  272 GSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---E---  343 (448)
T ss_pred             hHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee---c---
Confidence            999999987653 34667789999999999999999973 223344689999999999988873  3222211   0   


Q ss_pred             cccccccccccCcccccCCCCC---cchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          288 WTEFAGTYGYVAPELAYTMKIT---EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       288 ~~~~~g~~~y~aPE~~~~~~~~---~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                       ....-.+.||+||.+...+.+   ..+|+|||++++||+.|...||.+.+++.-..-..    -+.+.+.++  +    
T Consensus       344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia----leglrv~ip--p----  412 (448)
T KOG0195|consen  344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA----LEGLRVHIP--P----  412 (448)
T ss_pred             -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh----hccccccCC--C----
Confidence             112346789999998876543   47899999999999999999998877654332221    111222222  1    


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .....+.+++.-|++.||.+||.+..|+-.||
T Consensus       413 gis~hm~klm~icmnedpgkrpkfdmivpile  444 (448)
T KOG0195|consen  413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILE  444 (448)
T ss_pred             CccHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence            22345889999999999999999999988776

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.6e-25  Score=204.94  Aligned_cols=168  Identities=20%  Similarity=0.211  Sum_probs=128.9

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeC--CCCEEEEEecCCCCCC-cchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELP--SGQVVAIKKFHSPLPS-DQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      ...++|...+.||+|+||+||+|...  +++.||||++...... ......+.+.+|+++|++++|+|+++.+..+   +
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            34567999999999999999999654  5778899987532110 1122356799999999999999998533322   4


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccC-CCCcEEeCCCCcEEEeeecc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDI-SSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~  277 (397)
                      ..++||||++|++|... ..      ..   ...++.+++++|.|||+.   +|+|||| ||+|||++.++.++|+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            57999999999999732 11      11   146788999999999998   9999999 99999999999999999999


Q ss_pred             ccccCCCCCC--------cccccccccccCcccccC
Q 016009          278 AKFLKPDSSN--------WTEFAGTYGYVAPELAYT  305 (397)
Q Consensus       278 ~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~  305 (397)
                      ++.+......        .....++..|+|||++..
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9976543311        134567888999998764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-24  Score=199.40  Aligned_cols=254  Identities=21%  Similarity=0.254  Sum_probs=187.7

Q ss_pred             CCCCCccccccCcEEEEEEEeCCC--CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC----CceeeeEEEE-ecCC
Q 016009          126 DFDAQYCIGNGGHGSVYRAELPSG--QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH----RNIVKLYGFC-SHAR  198 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~  198 (397)
                      +|.+.+.||+|+||.||.+...+.  ..+|+|.........    ...+..|..++..+..    +++..+++.. ..+.
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC----CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence            788999999999999999976543  478888765422211    1257788999988863    6888999888 5777


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC-----CcEEEe
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-----FEAHVA  273 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-----~~~kl~  273 (397)
                      ..++||+.+ |.+|.++..... .+.++..+...|+.|++.+|.++|+.   |++||||||.|+.+...     ..+.|.
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEE
Confidence            889999976 889999886555 46799999999999999999999999   99999999999999765     469999


Q ss_pred             eecccc--ccCCCCC-------C-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccc
Q 016009          274 DFGIAK--FLKPDSS-------N-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN  343 (397)
Q Consensus       274 Dfg~~~--~~~~~~~-------~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~  343 (397)
                      |||+++  .+.....       . .....||..|.++..+.+...+.+.|+||++.++.|+..|..||............
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~  249 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF  249 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence            999998  3211111       1 12356999999999999999999999999999999999999998654432110000


Q ss_pred             cccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          344 TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      ...........    ...   ..+..+.++...+-..+..++|....+...|
T Consensus       250 ~~~~~~~~~~~----~~~---~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l  294 (322)
T KOG1164|consen  250 EKDPRKLLTDR----FGD---LKPEEFAKILEYIDSLDYEDKPDYEKLAELL  294 (322)
T ss_pred             HHHhhhhcccc----ccC---CChHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence            00000111110    001   1123455666666668999999998887765

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=6.8e-23  Score=189.23  Aligned_cols=260  Identities=28%  Similarity=0.424  Sum_probs=193.9

Q ss_pred             CCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCC-ceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR-NIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e  205 (397)
                      |.....||.|+||.||++...  ..+++|.+........ .....+.+|+.+++.+.|+ +++++.+++......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch-hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            455677999999999999776  7899999876433321 2367899999999999988 79999999977777899999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC-cEEEeeeccccccCCC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPD  284 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~  284 (397)
                      ++.++++.+++........++......++.+++.++.|+|..   +++|||+||+||+++..+ .++++|||.+......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            999999997765443112588899999999999999999999   899999999999999998 7999999999865543


Q ss_pred             CC------CcccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 016009          285 SS------NWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR  355 (397)
Q Consensus       285 ~~------~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  355 (397)
                      ..      ......++..|+|||...+   ...+...|+||+|++++++++|..|+....... ..............+.
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~  234 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-ATSQTLKIILELPTPS  234 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc-cHHHHHHHHHhcCCcc
Confidence            32      2355689999999999987   578899999999999999999999965443200 0000000000000000


Q ss_pred             CC--CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          356 LP--APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       356 ~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      ..  ............+.+++..|+..+|..|.+..+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            00  000000112245778888999999999998887654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=4.3e-25  Score=215.12  Aligned_cols=254  Identities=21%  Similarity=0.299  Sum_probs=185.9

Q ss_pred             CCccccccCcEEEEEEEe-CCCCEEEEEecCC---CCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          129 AQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHS---PLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       129 ~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ..+.+|.|.+|.|+.... ......+.|....   +....... ...+..|+.+-..++|||++..+..+.+.....-.|
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~-~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKY-NYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHH-hhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            456799999997777643 3344444444331   11111111 122667888888899999988887777666666669


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      |||++ +|..++....   .++..++..++.|+..|+.|+|+.   ++.|||+|++|++++.+|.+||+|||.+..+...
T Consensus       401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9999986542   477788999999999999999999   9999999999999999999999999999876544


Q ss_pred             CC----CcccccccccccCcccccCCCCCc-chhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          285 SS----NWTEFAGTYGYVAPELAYTMKITE-KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       285 ~~----~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ..    .....+|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||.........+.. ......  ......+
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-~~~~~~--~~~~~~~  550 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-NNYSDQ--RNIFEGP  550 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-hccccc--cccccCh
Confidence            33    235578999999999999999876 589999999999999999998755443222100 000000  0001112


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      .......+.....++.++++.||.+|.|+++|++
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            2233445566888999999999999999999986

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=4.7e-25  Score=215.58  Aligned_cols=246  Identities=21%  Similarity=0.239  Sum_probs=182.7

Q ss_pred             CCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      ++...+.||++.|=+|.+|+.+.|. |+||++-+...........+-+.|++ ...++|||.+++.-+-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5666788999999999999998887 99999865443333222333344444 455689999999888888888899999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc--CC
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL--KP  283 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~--~~  283 (397)
                      |..+ +|.|.+..+.-   +...+...|+.|+..|+..+|..   +|+|||||.+|||++.-.-+.|+||...+..  ..
T Consensus       102 yvkh-nLyDRlSTRPF---L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRPF---LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhccchH---HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9865 89999976543   67778888999999999999999   9999999999999999999999999765432  21


Q ss_pred             CC-CCc----ccccccccccCcccccCC-----------CCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccc---c
Q 016009          284 DS-SNW----TEFAGTYGYVAPELAYTM-----------KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL---N  343 (397)
Q Consensus       284 ~~-~~~----~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~---~  343 (397)
                      ++ ..+    .+...-.+|+|||.+...           ..+++.||||+||++.||++ |++||+..+-......   .
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~  254 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD  254 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence            11 111    233445689999976531           15788999999999999998 7888875544322111   1


Q ss_pred             cccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          344 TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .+..++.+-|+              .++.++..|++.||.+|.++++.|+.
T Consensus       255 ~e~~Le~Ied~--------------~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  255 PEQLLEKIEDV--------------SLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHHhCcCc--------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence            11112222221              37889999999999999999999975

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-22  Score=175.20  Aligned_cols=250  Identities=17%  Similarity=0.249  Sum_probs=188.8

Q ss_pred             CCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEE
Q 016009          126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .|.+.++||+|.||.++.| .+-++++||||.-..  .+    +.-++..|....+.| ..++|...+-+...+.+-.||
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc--cC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            6888999999999999999 466899999997432  11    245788999999988 578999888888888888999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC-----CcEEEeeeccc
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-----FEAHVADFGIA  278 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~~  278 (397)
                      +|.+ |-||+|++.-.+  +.++.+++..+|.|++.-++|+|++   .+|.|||||+|.||..-     ..+.++|||++
T Consensus       103 idLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            9987 789999885433  5799999999999999999999999   99999999999999643     35899999999


Q ss_pred             cccCCCCCC-------cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 016009          279 KFLKPDSSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       279 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      +.+......       .....||.+||+-..+.+.+-+.+.|.=|+|-++++.+-|..||..+..-...     ..-..+
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-----~kYeKI  251 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-----EKYEKI  251 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-----HHHHHh
Confidence            987654332       23467999999999999999999999999999999999999999865431100     011111


Q ss_pred             cCCCCC-CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 016009          352 LDPRLP-APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS  392 (397)
Q Consensus       352 ~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl  392 (397)
                      -+..-. .........+.++..-+.-.=..+-++-|..+-+.
T Consensus       252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr  293 (449)
T KOG1165|consen  252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLR  293 (449)
T ss_pred             ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHH
Confidence            121111 11112223344555555555556667777765443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=1.8e-23  Score=178.01  Aligned_cols=174  Identities=13%  Similarity=0.138  Sum_probs=133.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHH------HHHHHHHHHhccCCceeeeEEEEecC
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKE------FLTEVEALTEIRHRNIVKLYGFCSHA  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~  197 (397)
                      .++|...+++|.|+||.||.... ++..+|+|.++....... .....      +.+|++.+.++.|++|..+..++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~-~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTE-RFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchH-HHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            57899999999999999999766 577899999976443322 11222      67999999999999999999886532


Q ss_pred             --------CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc
Q 016009          198 --------RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE  269 (397)
Q Consensus       198 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  269 (397)
                              ...+++|||++|.+|.++..       ++.    ....+++.++..+|+.   +++|||++|+||++++++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence                    35789999999999988732       222    2456899999999999   999999999999999988 


Q ss_pred             EEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh
Q 016009          270 AHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK  326 (397)
Q Consensus       270 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t  326 (397)
                      ++|+|||.......+.. ..           .+.....+..++|+|+||+.+.....
T Consensus       173 i~liDfg~~~~~~e~~a-~d-----------~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKA-KD-----------RIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEEECCCcccccchhh-HH-----------HHHHHhHhcccccccceeEeehHHHH
Confidence            99999998765421111 00           02333346678999999999877653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=8.6e-23  Score=172.13  Aligned_cols=143  Identities=22%  Similarity=0.210  Sum_probs=108.6

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchh----------------------cHHHHHHHHHHHHhccCCce
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIV----------------------DKKEFLTEVEALTEIRHRNI  187 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~ni  187 (397)
                      ...||+|+||.||+|..++|+.||||+++.........                      .......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            35699999999999988899999999997532211100                      01223459999999988776


Q ss_pred             eeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceeccCCCCcEEeCC
Q 016009          188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDL  266 (397)
Q Consensus       188 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~~~~ivH~dlk~~Nill~~  266 (397)
                      .....+...  ..++||||++++++.......   ..+++.+...++.|++.+|.++ |+.   +|+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            443333222  238999999998776543222   3588999999999999999999 677   999999999999998 


Q ss_pred             CCcEEEeeecccccc
Q 016009          267 EFEAHVADFGIAKFL  281 (397)
Q Consensus       267 ~~~~kl~Dfg~~~~~  281 (397)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=2.8e-23  Score=171.35  Aligned_cols=255  Identities=19%  Similarity=0.292  Sum_probs=192.9

Q ss_pred             hcCCCCCccccccCcEEEEEE-EeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC-CceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH-RNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~  201 (397)
                      ...|...+.||+|+||.+|.| ...+|..||+|.-.....      -.++..|..+.+.+++ ..|..+..|..+...-.
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~------hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK------HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC------CcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            347888999999999999999 567899999998554222      3467889999999974 67777888888888889


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC---CcEEEeeeccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE---FEAHVADFGIA  278 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~  278 (397)
                      +|||.. |-||++++.-..  +.++..+++-++-|++.-++|+|.+   +++||||||+|.|+.-+   ..+.++|||++
T Consensus        88 lVMdLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eeeecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence            999987 789999986433  4689999999999999999999999   99999999999999654   46899999999


Q ss_pred             cccCCCCCC-------cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 016009          279 KFLKPDSSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       279 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      +.+......       ..+..||..|.+--.+.+..-+.+.|+=|+|.+|.++--|..||..........     .-+.+
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q-----KyEkI  236 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ-----KYEKI  236 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-----HHHHH
Confidence            876543221       245679999998888877778889999999999999999999998655422111     11122


Q ss_pred             cCCCCCCCCc-chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          352 LDPRLPAPSR-SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       352 ~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      ....+..+.+ .....+.++.-.+.-|=..--++-|...-+-+.+
T Consensus       237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            2222222111 1123345566777778887788888776665544

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.89  E-value=2.8e-23  Score=193.50  Aligned_cols=209  Identities=27%  Similarity=0.475  Sum_probs=158.8

Q ss_pred             HHhccCCceeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc-eeccC
Q 016009          179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI-VHRDI  257 (397)
Q Consensus       179 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i-vH~dl  257 (397)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+....  ..++|.-...++.+++.||+|+|+.   +| +|+.|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            457899999999999999999999999999999999998743  4689999999999999999999997   44 99999


Q ss_pred             CCCcEEeCCCCcEEEeeeccccccCC--CCCCcccccccccccCcccccCCC-------CCcchhhHHHHHHHHHHHhCC
Q 016009          258 SSKNLLLDLEFEAHVADFGIAKFLKP--DSSNWTEFAGTYGYVAPELAYTMK-------ITEKCDVYSFGVLALEVIKGK  328 (397)
Q Consensus       258 k~~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Dv~s~G~~l~el~tg~  328 (397)
                      +++|.++|....+|++|||+......  .........-..-|.|||.+....       .+.++||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999887642  111122233456799999987641       467899999999999999999


Q ss_pred             CCCCccccccccccccccccccccC-CC-CCCCCcc-hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          329 HPRDFLSSISSSFLNTDIELDEMLD-PR-LPAPSRS-VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       329 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~-~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .||+........    .+....+.+ .. ...|.-. ..+....+..++..||..+|++||++++|-..++
T Consensus       156 ~~~~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~  222 (484)
T KOG1023|consen  156 GPFDLRNLVEDP----DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL  222 (484)
T ss_pred             CccccccccCCh----HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence            998753322111    001111111 11 0111111 1133346889999999999999999999987664

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=5.6e-22  Score=167.91  Aligned_cols=144  Identities=21%  Similarity=0.217  Sum_probs=111.1

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcch----------------------hcHHHHHHHHHHHHhccCCce
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQI----------------------VDKKEFLTEVEALTEIRHRNI  187 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~ni  187 (397)
                      ...||+|++|.||+|...+|+.||||+++........                      .....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4569999999999998778999999998764221000                      001224578999999999987


Q ss_pred             eeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCcEEeCC
Q 016009          188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHRDISSKNLLLDL  266 (397)
Q Consensus       188 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~  266 (397)
                      .....+...  ..++||||++++++.......   ..++..+...++.+++.++.++|+ .   +++||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence            554444333  248999999988654332221   247788899999999999999999 7   999999999999998 


Q ss_pred             CCcEEEeeeccccccC
Q 016009          267 EFEAHVADFGIAKFLK  282 (397)
Q Consensus       267 ~~~~kl~Dfg~~~~~~  282 (397)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=6.4e-22  Score=164.90  Aligned_cols=185  Identities=12%  Similarity=0.062  Sum_probs=137.3

Q ss_pred             CCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeeeEEEEec
Q 016009          129 AQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       129 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  207 (397)
                      ....|++|+||+||.+.. .+.+++.+.+..............+.+|+++|+++. |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            456799999999998766 677888777764222111112235789999999995 5889999886    3469999999


Q ss_pred             cCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccC-CCCcEEeCCCCcEEEeeeccccccCCCCC
Q 016009          208 KRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDI-SSKNLLLDLEFEAHVADFGIAKFLKPDSS  286 (397)
Q Consensus       208 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~~~~~~~~~~  286 (397)
                      .|.+|...+..          ....++.+++++|.++|+.   +|+|||| ||+||+++.++.++|+|||++........
T Consensus        81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            99998754321          1135778999999999999   9999999 79999999999999999999986554332


Q ss_pred             C-----c--------ccccccccccCcccccCC-CCC-cchhhHHHHHHHHHHHhCCCCC
Q 016009          287 N-----W--------TEFAGTYGYVAPELAYTM-KIT-EKCDVYSFGVLALEVIKGKHPR  331 (397)
Q Consensus       287 ~-----~--------~~~~g~~~y~aPE~~~~~-~~~-~~~Dv~s~G~~l~el~tg~~p~  331 (397)
                      .     .        .-...++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            1     0        011246677777654322 233 4678899999999999999884

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.1e-23  Score=193.24  Aligned_cols=227  Identities=26%  Similarity=0.336  Sum_probs=178.6

Q ss_pred             cccccCcEEEEEEE----eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeeeEEEEe
Q 016009          132 CIGNGGHGSVYRAE----LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSFLVYEF  206 (397)
Q Consensus       132 ~lg~G~~g~vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  206 (397)
                      ++|+|.||.|+.++    ...|.-+|.|++++.......  +.....|..++..++ ||.++++.-.++.+...+++++|
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~--~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD--RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccc--ccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence            37899999999873    234777899988764332221  225567888999996 99999999999999999999999


Q ss_pred             ccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC
Q 016009          207 LKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS  286 (397)
Q Consensus       207 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  286 (397)
                      ..+|.|...+....   .+++.........++-+++++|+.   +++|+|+|++||+++.+|++++.|||+++..-....
T Consensus        79 ~rgg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~  152 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI  152 (612)
T ss_pred             cccchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence            99999998887654   366667777788899999999999   999999999999999999999999999986543322


Q ss_pred             CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHH
Q 016009          287 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK  366 (397)
Q Consensus       287 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (397)
                          .+||..|||||++.  .....+|.||||++++||+||..||..            +....+....+..|    .+.
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~~~p----~~l  210 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAELEMP----REL  210 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhccCCc----hhh
Confidence                28999999999998  457789999999999999999999863            12233333233322    344


Q ss_pred             HHHHHHHHHHccCCCCCCCCCH
Q 016009          367 LRSIVEVVFSCLNESPESRPTM  388 (397)
Q Consensus       367 ~~~l~~l~~~cl~~~P~~RPt~  388 (397)
                      .....+++..++..+|..|.-.
T Consensus       211 ~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  211 SAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hHHHHHHHHHHHhhCHHHHhcc
Confidence            4556777778888899888644

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=1.4e-21  Score=171.53  Aligned_cols=234  Identities=21%  Similarity=0.287  Sum_probs=147.2

Q ss_pred             CCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc----------CCceeeeEEEE--
Q 016009          128 DAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR----------HRNIVKLYGFC--  194 (397)
Q Consensus       128 ~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~----------h~niv~~~~~~--  194 (397)
                      .....||.|+++.||.+... +|+++|+|++.... .......+++.+|.-....+.          |-.++-.++..  
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            34567999999999999765 68999999987644 333344667777765554432          21222222211  


Q ss_pred             -------ecC---C-----eeeEEEEeccCCCHHHhhcc---ccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 016009          195 -------SHA---R-----HSFLVYEFLKRGSLAAILSS---DAA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHR  255 (397)
Q Consensus       195 -------~~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~  255 (397)
                             ...   .     ..+++|+-+ .++|.+++..   ... ...+....++.+..|+++.+++||+.   |++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                   111   1     235677766 5688887642   111 12244556678889999999999999   99999


Q ss_pred             cCCCCcEEeCCCCcEEEeeeccccccCCCCCCcccccccccccCcccccC--------CCCCcchhhHHHHHHHHHHHhC
Q 016009          256 DISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT--------MKITEKCDVYSFGVLALEVIKG  327 (397)
Q Consensus       256 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~s~G~~l~el~tg  327 (397)
                      ||+|+|++++.+|.+.|+||+.......   .......+..|.+||....        ..++.+.|.|++|+++|.|++|
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTE---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCc---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999999999999999987654322   1111344577899997643        2478899999999999999999


Q ss_pred             CCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCC
Q 016009          328 KHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESR  385 (397)
Q Consensus       328 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R  385 (397)
                      +.||+..........            .+   ..+. +.+..+.+||..+|+.||++|
T Consensus       247 ~lPf~~~~~~~~~~~------------~f---~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW------------DF---SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG------------GG---TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc------------cc---hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999985433211100            11   1122 455668899999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=3.7e-20  Score=157.46  Aligned_cols=138  Identities=20%  Similarity=0.267  Sum_probs=105.5

Q ss_pred             CCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-----cCCceeeeEEEEecCC---
Q 016009          127 FDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-----RHRNIVKLYGFCSHAR---  198 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---  198 (397)
                      ++....||+|+||.||. .-.++. .+||++.....    ...+.+.+|+++++.+     .||||++++|+++++.   
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcC-eEEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            34467899999999996 333444 47998764221    1356789999999999     5799999999998874   


Q ss_pred             eee-EEEEe--ccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCceeccCCCCcEEeCC----CCcE
Q 016009          199 HSF-LVYEF--LKRGSLAAILSSDAAAQELGWSQRMNVIKGVADAL-SYLHHDCFPPIVHRDISSKNLLLDL----EFEA  270 (397)
Q Consensus       199 ~~~-lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~  270 (397)
                      ..+ +|+||  +.+|+|.+++.+.    .+++.  ..++.+++.++ +|||++   +|+||||||+||+++.    ++.+
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcE
Confidence            333 78999  5589999999653    25544  35677888777 999999   9999999999999974    3479


Q ss_pred             EEee-ecccc
Q 016009          271 HVAD-FGIAK  279 (397)
Q Consensus       271 kl~D-fg~~~  279 (397)
                      +|+| ||...
T Consensus       149 ~LiDg~G~~~  158 (210)
T PRK10345        149 VVCDNIGEST  158 (210)
T ss_pred             EEEECCCCcc
Confidence            9999 55443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=8.4e-20  Score=181.89  Aligned_cols=202  Identities=22%  Similarity=0.238  Sum_probs=158.2

Q ss_pred             HHHHHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          119 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       119 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      +.+.....|.+.+.+|+|+||+||+|...+|+.||+|+-+.+.. .+.+-..+++..++ ...  -+-|..+...+.-.+
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~-WEfYI~~q~~~RLk-~~~--~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP-WEFYICLQVMERLK-PQM--LPSIMHISSAHVFQN  767 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc-eeeeehHHHHHhhc-hhh--hcchHHHHHHHccCC
Confidence            33444567888899999999999999888899999998665333 22222333333333 111  123344444445567


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC-------CCCcEE
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD-------LEFEAH  271 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-------~~~~~k  271 (397)
                      ..+||+||.+.|+|.+++...   +.++|..+..++.|+++.+..||..   +|||+||||+|.+|.       ++.-++
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             cceeeeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence            789999999999999999743   4599999999999999999999999   999999999999994       234589


Q ss_pred             EeeeccccccC--CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 016009          272 VADFGIAKFLK--PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP  330 (397)
Q Consensus       272 l~Dfg~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p  330 (397)
                      |+|||.+.-+.  ++...+...++|-.+-.+|+..|..++.+.|.|.++.+++-|+.|+.-
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99999986543  234456677889999999999999999999999999999999999864

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=1.7e-19  Score=157.24  Aligned_cols=147  Identities=21%  Similarity=0.231  Sum_probs=112.3

Q ss_pred             cCCCCCccccccCcEEEEEEE--eCCCCEEEEEecCCCCCCcc------------------h--hcHHHHHHHHHHHHhc
Q 016009          125 NDFDAQYCIGNGGHGSVYRAE--LPSGQVVAIKKFHSPLPSDQ------------------I--VDKKEFLTEVEALTEI  182 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~--~~~~~~vavK~~~~~~~~~~------------------~--~~~~~~~~e~~~l~~l  182 (397)
                      ..|.+.+.||+|++|.||+|.  ..+|+.||+|+++.......                  .  .....+..|++.++++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            347778899999999999997  56899999999875321100                  0  0113467899999999


Q ss_pred             cCC--ceeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceeccCCC
Q 016009          183 RHR--NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP-IVHRDISS  259 (397)
Q Consensus       183 ~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~-ivH~dlk~  259 (397)
                      .+.  .+.+++++    ...++||||+++++|.......   ..+...+...++.|++.++++||+.   + ++|+||||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            753  34444543    2358999999998887664322   2355667789999999999999999   8 99999999


Q ss_pred             CcEEeCCCCcEEEeeeccccccC
Q 016009          260 KNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       260 ~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      +||+++ +++++|+|||.+....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=3.5e-19  Score=153.82  Aligned_cols=138  Identities=17%  Similarity=0.324  Sum_probs=114.6

Q ss_pred             ccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcc----hhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEe
Q 016009          131 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQ----IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEF  206 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  206 (397)
                      +.||+|++|.||+|.. +|..+++|+.........    ......+.+|++++..++|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4699999999999987 677899998654222111    11234678899999999999988877777777888999999


Q ss_pred             ccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          207 LKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       207 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++|++|.+++....      + .+..++.+++.+|.++|+.   +++|+|++|.||+++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999985421      2 7889999999999999998   999999999999999 78999999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=5.6e-19  Score=150.78  Aligned_cols=149  Identities=19%  Similarity=0.198  Sum_probs=113.9

Q ss_pred             HHHHHHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcch------------------hcHHHHHHHHHHH
Q 016009          118 DEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQI------------------VDKKEFLTEVEAL  179 (397)
Q Consensus       118 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~~~~e~~~l  179 (397)
                      .++.+....|...+.||+|+||.||++..++|+.||||++.........                  .....+..|..++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            3445555457778899999999999998888999999987643211000                  0122367889999


Q ss_pred             HhccCC--ceeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccC
Q 016009          180 TEIRHR--NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDI  257 (397)
Q Consensus       180 ~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl  257 (397)
                      ..+.|+  .++..++.    ...++||||+++++|.+....         .....++.+++.++.++|+.   +++|+||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl  151 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDL  151 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence            999887  44444442    345899999999999765421         23467889999999999998   9999999


Q ss_pred             CCCcEEeCCCCcEEEeeeccccccC
Q 016009          258 SSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       258 k~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      +|+||++++++.++|+|||++....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=2.1e-20  Score=171.22  Aligned_cols=174  Identities=22%  Similarity=0.378  Sum_probs=134.5

Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA  278 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  278 (397)
                      ..|+.|++|...+|.+|+.........++.....++.|++.|+.|   +   +.+|+|+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999877766788999999999999999999   5   8899999999999999999999999998


Q ss_pred             cccCCCC------CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 016009          279 KFLKPDS------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       279 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      .......      ...+...||..||+||.+.+..|+.|+||||||++|+|+++ =..+++-           .....++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-----------~~t~~d~  472 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-----------IATLTDI  472 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------HHhhhhh
Confidence            7665433      23456789999999999999999999999999999999998 2222210           1122333


Q ss_pred             cCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 016009          352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS  392 (397)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl  392 (397)
                      -|..++  +....+++. =..|+.+++.+.|.+||++.++.
T Consensus       473 r~g~ip--~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  473 RDGIIP--PEFLQDYPE-EYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             hcCCCC--hHHhhcCcH-HHHHHHHhcCCCcccCchHHHHh
Confidence            333333  111122222 23677799999999999655543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=1.3e-18  Score=148.91  Aligned_cols=134  Identities=17%  Similarity=0.347  Sum_probs=107.9

Q ss_pred             cccccCcEEEEEEEeCCCCEEEEEecCCCCCCc----chhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEec
Q 016009          132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD----QIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  207 (397)
                      .||+|++|.||+|.. +|..+++|.........    .......+.+|+++++.++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 67889999865322111    1122466788999999999887665555566667779999999


Q ss_pred             cCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          208 KRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       208 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      +|++|.+.+.....          .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988754210          7899999999999998   999999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=5.8e-19  Score=155.96  Aligned_cols=195  Identities=25%  Similarity=0.351  Sum_probs=135.0

Q ss_pred             cCCceeeeEEEEec---------------------------CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHH
Q 016009          183 RHRNIVKLYGFCSH---------------------------ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIK  235 (397)
Q Consensus       183 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~  235 (397)
                      +|||||++.++|.+                           +..+|+||.-++. +|..++..+.    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            59999999887632                           3456899987755 8888886543    55666777899


Q ss_pred             HHHHHHHHHHhCCCCCceeccCCCCcEEe--CCCC--cEEEeeeccccccCCC------CCCcccccccccccCcccccC
Q 016009          236 GVADALSYLHHDCFPPIVHRDISSKNLLL--DLEF--EAHVADFGIAKFLKPD------SSNWTEFAGTYGYVAPELAYT  305 (397)
Q Consensus       236 ~i~~~l~~Lh~~~~~~ivH~dlk~~Nill--~~~~--~~kl~Dfg~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~  305 (397)
                      |+++|+.|||.+   +|.|||+|++|||+  |+|+  .+.|+|||.+---...      .+......|...-||||+...
T Consensus       349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            999999999999   99999999999999  4444  4789999976421110      111233467788999998764


Q ss_pred             CC------CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccC
Q 016009          306 MK------ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLN  379 (397)
Q Consensus       306 ~~------~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  379 (397)
                      .+      --.|+|.|+.|.+.||+++...||-.-..+--..       ...-...++.-+   ...+..+.+++...++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-------r~Yqe~qLPalp---~~vpp~~rqlV~~lL~  495 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-------RTYQESQLPALP---SRVPPVARQLVFDLLK  495 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-------hhhhhhhCCCCc---ccCChHHHHHHHHHhc
Confidence            32      1258999999999999999999974311111000       001111122111   1223447889999999


Q ss_pred             CCCCCCCCHHHHHHHh
Q 016009          380 ESPESRPTMKIVSQQL  395 (397)
Q Consensus       380 ~~P~~RPt~~~vl~~L  395 (397)
                      .||.+|++..-....|
T Consensus       496 r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  496 RDPSKRVSPNIAANVL  511 (598)
T ss_pred             CCccccCCccHHHhHH
Confidence            9999999876555444

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=1.6e-18  Score=169.74  Aligned_cols=142  Identities=18%  Similarity=0.298  Sum_probs=113.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEec-CCCCCCc---chhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKF-HSPLPSD---QIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~-~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      ...|...+.||+|+||+||+|.+.+.. +++|+. .......   .....+.+.+|+++++.++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            344566788999999999999875443 444432 2211111   11224568899999999999999988888877778


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++++|.+++.           ....++.+++++|.+||+.   +++||||||+||++ +++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999998874           3467899999999999998   99999999999999 67899999999997


Q ss_pred             cc
Q 016009          280 FL  281 (397)
Q Consensus       280 ~~  281 (397)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            53

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.74  E-value=1.4e-18  Score=170.54  Aligned_cols=207  Identities=24%  Similarity=0.315  Sum_probs=137.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+.++.+..|++|.||.++++ +.+.+|.| +++    +     .-+++-  ++.....|.+|              
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNk----q-----~lilRn--ilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INK----Q-----NLILRN--ILTFAGNPFVV--------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccc----c-----chhhhc--cccccCCccee--------------
Confidence            458899999999999999999776 45677874 332    1     111110  22223333333              


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                             |+-...+...+   .++..        ++.+++|||+.   +|+|||+||+|.+++.-|++|++|||+++...
T Consensus       136 -------gDc~tllk~~g---~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 -------GDCATLLKNIG---PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             -------chhhhhcccCC---CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhh
Confidence                   44444443322   23222        27789999998   99999999999999999999999999987532


Q ss_pred             CCCC---------------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 016009          283 PDSS---------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE  347 (397)
Q Consensus       283 ~~~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~  347 (397)
                      ....               .....+||+.|+|||++....|...+|+|++|+++||.+.|..||....+..        -
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee--------l  266 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--------L  266 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH--------H
Confidence            1100               0123589999999999999999999999999999999999999986442210        0


Q ss_pred             cccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 016009          348 LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRP  386 (397)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP  386 (397)
                      +..++...+.-+.. ......+..+++.+.++.+|.+|-
T Consensus       267 fg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  267 FGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             Hhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence            01111000000000 112223477888899999999994

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=5.4e-17  Score=132.26  Aligned_cols=134  Identities=18%  Similarity=0.201  Sum_probs=113.2

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC--CceeeeEEEEecCCeeeEEEEec
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH--RNIVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~  207 (397)
                      .+.||+|.++.||++...+ ..+++|.......      ...+..|+..++.++|  .++++++++....+..+++|||+
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            4679999999999998755 7899998764221      4578899999999976  58999999888888899999999


Q ss_pred             cCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          208 KRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       208 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      +++.+..+          +......++.+++++++++|.....+++|+|++|+||++++++.+++.|||.+..
T Consensus        76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            98877543          4566778899999999999996444799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=6.6e-17  Score=136.83  Aligned_cols=140  Identities=22%  Similarity=0.233  Sum_probs=99.3

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcH--------------------HHHHHHHHHHHhccCCc--e
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDK--------------------KEFLTEVEALTEIRHRN--I  187 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~--------------------~~~~~e~~~l~~l~h~n--i  187 (397)
                      .+.||+|+||.||+|...+|+.||||+++...........                    .....|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4569999999999998878999999998653221111000                    01135666666665433  4


Q ss_pred             eeeEEEEecCCeeeEEEEeccCCCHHHh-hccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCcEEeC
Q 016009          188 VKLYGFCSHARHSFLVYEFLKRGSLAAI-LSSDAAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHRDISSKNLLLD  265 (397)
Q Consensus       188 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~  265 (397)
                      .+.+++    ...++||||++++++... +....    .. .+...++.+++.++.++|. .   +++|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            444443    245899999999554321 11110    11 5678899999999999999 7   999999999999999


Q ss_pred             CCCcEEEeeeccccccC
Q 016009          266 LEFEAHVADFGIAKFLK  282 (397)
Q Consensus       266 ~~~~~kl~Dfg~~~~~~  282 (397)
                       ++.++++|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8899999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=1.6e-16  Score=138.88  Aligned_cols=140  Identities=15%  Similarity=0.257  Sum_probs=106.5

Q ss_pred             Ccccc-ccCcEEEEEEEeCCCCEEEEEecCCCCC-----C----cchhcHHHHHHHHHHHHhccCCce--eeeEEEEecC
Q 016009          130 QYCIG-NGGHGSVYRAELPSGQVVAIKKFHSPLP-----S----DQIVDKKEFLTEVEALTEIRHRNI--VKLYGFCSHA  197 (397)
Q Consensus       130 ~~~lg-~G~~g~vy~~~~~~~~~vavK~~~~~~~-----~----~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  197 (397)
                      ...|| .|+.|+||++... +..+++|.+.....     .    ........+.+|++++.+++|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8999999999874 67899988753110     0    011234668899999999998774  6777765433


Q ss_pred             C----eeeEEEEeccC-CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEE
Q 016009          198 R----HSFLVYEFLKR-GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV  272 (397)
Q Consensus       198 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  272 (397)
                      .    ..++||||++| .+|.+++...    +++..    .+.+++.++.+||+.   ||+|+||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 6999887542    24443    356899999999999   9999999999999999999999


Q ss_pred             eeecccccc
Q 016009          273 ADFGIAKFL  281 (397)
Q Consensus       273 ~Dfg~~~~~  281 (397)
                      +|||.+...
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999988764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=4.7e-18  Score=166.03  Aligned_cols=253  Identities=23%  Similarity=0.303  Sum_probs=185.2

Q ss_pred             CCCCCccccccCcEEEEEEEeC--CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeeeE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP--SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  202 (397)
                      .|...+.||+|.|+.|-.....  ....+|+|.+....  ...........|..+-+.+. |+|++.+++...+.+..++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4666777999999999887553  34456666665432  11222344556777777776 9999999999999999999


Q ss_pred             EEEeccCCCHHHhh-ccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceeccCCCCcEEeCCCC-cEEEeeecccc
Q 016009          203 VYEFLKRGSLAAIL-SSDAAAQELGWSQRMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~  279 (397)
                      ..||..++++.+-+ ....  ...+....-..+.|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||++.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            99999999999888 4332  13455666788999999999999 76   999999999999999999 99999999998


Q ss_pred             ccCC-CCC--Ccccccc-cccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 016009          280 FLKP-DSS--NWTEFAG-TYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP  354 (397)
Q Consensus       280 ~~~~-~~~--~~~~~~g-~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
                      .+.. ...  .....+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++........+...       ...
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~-------~~~  246 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW-------KSN  246 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee-------ccc
Confidence            8765 322  2344677 9999999998874 45678999999999999999999987655433221111       111


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS  392 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl  392 (397)
                      ........+........+++.+++..+|..|.+.+++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence            00000111122233466777789999999999988764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=4.2e-16  Score=134.91  Aligned_cols=201  Identities=21%  Similarity=0.363  Sum_probs=139.9

Q ss_pred             HHHHhccCCceeeeEEEEec-----CCeeeEEEEeccCCCHHHhhccccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 016009          177 EALTEIRHRNIVKLYGFCSH-----ARHSFLVYEFLKRGSLAAILSSDAA-AQELGWSQRMNVIKGVADALSYLHHDCFP  250 (397)
Q Consensus       177 ~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~  250 (397)
                      .-|-++-|.|||++..|+.+     .....++.|||..|++..+|++... ...+......+|+.||..||.|||+ |.|
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            34555679999999998854     3456889999999999999976542 3457778888999999999999999 677


Q ss_pred             CceeccCCCCcEEeCCCCcEEEeeeccccccCCC-----CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHH
Q 016009          251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-----SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI  325 (397)
Q Consensus       251 ~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~  325 (397)
                      +++|+++..+.|++..++-+|++-- ........     ........+-++|.+||+-...+.+..+|||+||+..+||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            9999999999999999998887432 11111110     00112234678999999988888889999999999999998


Q ss_pred             hCCCC-CCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          326 KGKHP-RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       326 tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .|..- .+..+.     ...++.....+-    ...+.      .-..++..|++..|..||+|++++.+
T Consensus       277 ilEiq~tnseS~-----~~~ee~ia~~i~----~len~------lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  277 ILEIQSTNSESK-----VEVEENIANVII----GLENG------LQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HheeccCCCcce-----eehhhhhhhhee----eccCc------cccCcCcccccCCCCCCcchhhhhcC
Confidence            87543 111111     110111111000    00000      02346678999999999999998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=9.2e-15  Score=138.71  Aligned_cols=146  Identities=21%  Similarity=0.262  Sum_probs=101.3

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhc------------------------------------HHHHH
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVD------------------------------------KKEFL  173 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~------------------------------------~~~~~  173 (397)
                      .+.||+|++|.||+|++.+|+.||||+.+......-..+                                    .-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            357999999999999999999999999865321110000                                    01245


Q ss_pred             HHHHHHHhcc----CCceeeeEEEE-ecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 016009          174 TEVEALTEIR----HRNIVKLYGFC-SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVAD-ALSYLHHD  247 (397)
Q Consensus       174 ~e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~Lh~~  247 (397)
                      .|+..+.+++    |.+-+.+-..+ ......+|||||++|++|.+.......  ..   .+..++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence            5666555552    22223332233 233457999999999999887643211  12   23456666666 46788987


Q ss_pred             CCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       248 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                         +++|+|++|.||+++++++++++|||++..+..
T Consensus       277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence               999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=2.9e-13  Score=130.04  Aligned_cols=147  Identities=17%  Similarity=0.229  Sum_probs=93.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeCC-CCEEEEEecCCCCCCc-------------------------ch-----hcHH---
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSD-------------------------QI-----VDKK---  170 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~-------------------------~~-----~~~~---  170 (397)
                      .+|+. +.||+|++|.||+|.+++ |+.||||+.+......                         ..     .-.+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35665 689999999999999887 9999999997542110                         00     0011   


Q ss_pred             ---HHHHHHHHHHhcc----CCceeeeEEEEec-CCeeeEEEEeccCCCHHHhh--cccc-ccCCCCHHHHHHHHHHHHH
Q 016009          171 ---EFLTEVEALTEIR----HRNIVKLYGFCSH-ARHSFLVYEFLKRGSLAAIL--SSDA-AAQELGWSQRMNVIKGVAD  239 (397)
Q Consensus       171 ---~~~~e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~-~~~~l~~~~~~~i~~~i~~  239 (397)
                         ++..|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.+.-  ...+ ....+.......++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence               2344444444442    3333333333322 35678999999999998742  2211 00112222223333333  


Q ss_pred             HHHHHHhCCCCCceeccCCCCcEEeCCCC----cEEEeeeccccccC
Q 016009          240 ALSYLHHDCFPPIVHRDISSKNLLLDLEF----EAHVADFGIAKFLK  282 (397)
Q Consensus       240 ~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~~~~  282 (397)
                           ...   |++|+|++|.||+++.++    ++++.|||+...++
T Consensus       277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 345   999999999999999988    99999999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=7.9e-14  Score=130.71  Aligned_cols=247  Identities=25%  Similarity=0.283  Sum_probs=176.5

Q ss_pred             CCCCccccc--cCcEEEEEEEe---CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCee
Q 016009          127 FDAQYCIGN--GGHGSVYRAEL---PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       127 ~~~~~~lg~--G~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  200 (397)
                      |.....+|.  |.+|.+|.+..   .++..+|+|+-+......  .....=.+|+...+.+ .|+|.++....+...+..
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p--~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP--LDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc--cccccccchhhcccccCccccccccCcccccCCcc
Confidence            455677999  99999999965   468889999854433211  1122234566666666 499999988889999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCceeccCCCCcEEeCCC-CcEEEeee
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVAD----ALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADF  275 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Df  275 (397)
                      ++-.|++. .+|..+-+....  .++....+....+...    |+.++|..   .++|-|+||.||++..+ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            99999885 688877765432  3566777777777777    99999998   99999999999999999 78999999


Q ss_pred             ccccccCCCCCCc-----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 016009          276 GIAKFLKPDSSNW-----TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE  350 (397)
Q Consensus       276 g~~~~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  350 (397)
                      |+...+....-..     ....+...|++||...+ -++..+|+|++|.+.++..+|..+....      +.........
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g------~~~~W~~~r~  340 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVG------KNSSWSQLRQ  340 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCC------CCCCcccccc
Confidence            9998776544221     12257788999998765 4688899999999999999987764311      0010111111


Q ss_pred             ccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      +.     .+.+....-..++...+..+++.+|..|++.+.+..
T Consensus       341 ~~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  341 GY-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cc-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            11     111122222334556888999999999999887764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=5.8e-13  Score=110.75  Aligned_cols=130  Identities=21%  Similarity=0.187  Sum_probs=95.2

Q ss_pred             ccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCcee-eeEEEEecCCeeeEEEEeccC
Q 016009          131 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV-KLYGFCSHARHSFLVYEFLKR  209 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~  209 (397)
                      +.++.|.++.||++... +..+++|.......     ....+..|+.+++.+.+.+++ +++.+.  ....++||||++|
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G   75 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG   75 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence            45888999999999874 77899998754221     123467899999998655544 444443  2345899999999


Q ss_pred             CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          210 GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC--FPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       210 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      .++.+.-        .   ....++.+++++|+.||+..  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        76 ~~l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          76 SELLTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             Ccccccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            8876430        0   11345678999999999983  12359999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.43  E-value=1.5e-12  Score=123.47  Aligned_cols=169  Identities=18%  Similarity=0.236  Sum_probs=125.6

Q ss_pred             EeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCC
Q 016009          145 ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQE  224 (397)
Q Consensus       145 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~  224 (397)
                      +..++.+|.|...+....    .......+-++.|+.++||||++++..++..+..|||+|-+.  .|..++.+      
T Consensus        33 ~k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------  100 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------  100 (690)
T ss_pred             eeccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------
Confidence            445788888888765222    123556677889999999999999999999999999999773  56666643      


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcccccccccccCccccc
Q 016009          225 LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY  304 (397)
Q Consensus       225 l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~  304 (397)
                      ++.......+.||+.||.|||+.|  +++|++|....|++++.|+.||++|.++..............--..|..|+.+.
T Consensus       101 l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  101 LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID  178 (690)
T ss_pred             hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence            334566678899999999999775  899999999999999999999999988764332221111112223456666543


Q ss_pred             CCCCCcchhhHHHHHHHHHHHhCCC
Q 016009          305 TMKITEKCDVYSFGVLALEVIKGKH  329 (397)
Q Consensus       305 ~~~~~~~~Dv~s~G~~l~el~tg~~  329 (397)
                      ...  -..|.|-||++++|++.|..
T Consensus       179 ~s~--~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  179 PSE--WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             ccc--cchhhhhHHHHHHHHhCccc
Confidence            322  34699999999999999943

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.42  E-value=4.1e-12  Score=106.23  Aligned_cols=139  Identities=22%  Similarity=0.236  Sum_probs=98.4

Q ss_pred             ccccccCcEEEEEEEeCC-------CCEEEEEecCCCCCCc---------c---------hhcHHHH----HHHHHHHHh
Q 016009          131 YCIGNGGHGSVYRAELPS-------GQVVAIKKFHSPLPSD---------Q---------IVDKKEF----LTEVEALTE  181 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~-------~~~vavK~~~~~~~~~---------~---------~~~~~~~----~~e~~~l~~  181 (397)
                      ..||.|.-+.||.|...+       +..+|||+.+.....-         .         ....+.+    .+|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999996543       4789999875322100         0         0012233    389999999


Q ss_pred             ccC--CceeeeEEEEecCCeeeEEEEeccCCCHHH-hhccccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceeccC
Q 016009          182 IRH--RNIVKLYGFCSHARHSFLVYEFLKRGSLAA-ILSSDAAAQELGWSQRMNVIKGVADALSYL-HHDCFPPIVHRDI  257 (397)
Q Consensus       182 l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~~~~ivH~dl  257 (397)
                      +..  -++..++++    ..-++||||+.++.+.. .+.+    ..++..+...+..+++.+|..+ |..   +++|+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            953  466667764    45689999997754422 2221    1244456677889999999999 777   9999999


Q ss_pred             CCCcEEeCCCCcEEEeeecccccc
Q 016009          258 SSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       258 k~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      ++.||+++ ++.+.|+|||.+...
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeC
Confidence            99999997 467999999988644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=2.4e-11  Score=98.11  Aligned_cols=134  Identities=19%  Similarity=0.320  Sum_probs=100.2

Q ss_pred             cccccCcEEEEEEEeCCCCEEEEEec-CCCCCCc---chhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEec
Q 016009          132 CIGNGGHGSVYRAELPSGQVVAIKKF-HSPLPSD---QIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~~~~vavK~~-~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  207 (397)
                      .+++|+-+.+|.+.+.+ .++++|.- .+.....   +......-.+|+.++.+++--.|.-..=+..+.+...++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            47899999999997744 34666642 2222211   1112345678999999997655555555566777888999999


Q ss_pred             cCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          208 KRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       208 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      +|-.|.+.+...          ...++..+-.-+.-||..   +|+|+||.++||++..+. +.++|||++.+
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999898654          245677777788889999   999999999999997765 99999999975

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.32  E-value=2.7e-11  Score=105.30  Aligned_cols=143  Identities=20%  Similarity=0.259  Sum_probs=109.2

Q ss_pred             ccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC--CceeeeEEEEecCC---eeeEEEE
Q 016009          131 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH--RNIVKLYGFCSHAR---HSFLVYE  205 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~---~~~lv~e  205 (397)
                      +.|+.|..+.+|++...+|+.+++|........   .....+..|.++++.+++  .++.+++.+.....   ..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            458899999999998877789999987643221   124568899999999965  44677787776542   5689999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC-------------------------------------  248 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-------------------------------------  248 (397)
                      |++|.++.+.+..    ..++..++..++.+++++|..||+..                                     
T Consensus        81 ~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          81 RVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             EeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            9999988776532    23667777788888888888888531                                     


Q ss_pred             ----------------CCCceeccCCCCcEEeCC--CCcEEEeeeccccc
Q 016009          249 ----------------FPPIVHRDISSKNLLLDL--EFEAHVADFGIAKF  280 (397)
Q Consensus       249 ----------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~  280 (397)
                                      ...++|+|+.+.||++++  ++.+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            135799999999999998  66789999988763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.30  E-value=8.8e-11  Score=94.42  Aligned_cols=148  Identities=21%  Similarity=0.270  Sum_probs=105.5

Q ss_pred             CCccccccCcEEEEEEEeCCCCEEEEEecCC-CCC---CcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          129 AQYCIGNGGHGSVYRAELPSGQVVAIKKFHS-PLP---SDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       129 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~-~~~---~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ....+-+|+-+.|+++.+ .|+...||.-.. ...   -++...++...+|++.|.+++--.|.-..=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            456788999999999988 577777765321 111   112223566789999999986545444444555666667999


Q ss_pred             EeccC-CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC---cEEEeeeccccc
Q 016009          205 EFLKR-GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF---EAHVADFGIAKF  280 (397)
Q Consensus       205 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~~  280 (397)
                      ||++| -++.+++...... +.........+..|-+.+.-||.+   +++|+||.++||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 4777777654332 222233378888999999999999   999999999999996654   358999999865


Q ss_pred             c
Q 016009          281 L  281 (397)
Q Consensus       281 ~  281 (397)
                      .
T Consensus       166 s  166 (229)
T KOG3087|consen  166 S  166 (229)
T ss_pred             c
Confidence            3

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=2.7e-12  Score=120.53  Aligned_cols=248  Identities=21%  Similarity=0.207  Sum_probs=172.2

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEe--CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCC
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAEL--PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHAR  198 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  198 (397)
                      ..+.+|..+..||.|.|+.|++...  .++..+++|.+.......  .+...-+.|+.+...+ .|.++++....+...+
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~--~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF--ASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch--HhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            3455788888999999999999843  467889999876533221  1222234566666666 5888888877777777


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC-CcEEEeeecc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGI  277 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~  277 (397)
                      ..|+=-||+.++++.....-   ...++...++++..+++.++.++|+.   .++|+|++|+||++..+ +.-+++|||.
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             cccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence            77899999999998776622   23467788899999999999999988   99999999999999876 7889999998


Q ss_pred             ccccCCCCCCccccccccccc--CcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 016009          278 AKFLKPDSSNWTEFAGTYGYV--APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR  355 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  355 (397)
                      ...+....   ......-++.  +++......+..+.|+||||.-+.|.++|..--....           ....+....
T Consensus       414 ~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----------~~~~i~~~~  479 (524)
T KOG0601|consen  414 WTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----------QSLTIRSGD  479 (524)
T ss_pred             ccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-----------cceeeeccc
Confidence            86422211   1112233344  4555555667889999999999999999875421110           111122222


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                      .+....    ....+..+...+..+++..||.+.+...+.
T Consensus       480 ~p~~~~----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  480 TPNLPG----LKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             ccCCCc----hHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            221111    114466677788999999999998876543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.21  E-value=5.1e-10  Score=103.46  Aligned_cols=215  Identities=16%  Similarity=0.194  Sum_probs=149.8

Q ss_pred             cEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe----cCCeeeEEEEeccC-CC
Q 016009          138 HGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS----HARHSFLVYEFLKR-GS  211 (397)
Q Consensus       138 ~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-g~  211 (397)
                      -.+.|++. ..||..|+.|+++.... .   .......-++.++++.|+|+|++..++.    .+..+++||+|.++ ++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~-~---~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRD-Q---STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccc-c---CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            36789994 45899999999953211 1   1122345678999999999999998886    34578999999985 57


Q ss_pred             HHHhhccccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          212 LAAILSSDAA------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       212 L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      |.+.......            ....++..+|.++.|++.||.++|+.   |+..+-|.+.+|+++.+.+++|+..|...
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence            7666533211            12367789999999999999999999   99999999999999999999999998887


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      .+..+..              |.+.   --.+-|.=.||.+++.|.||..-...-     .... ...+..         
T Consensus       442 vl~~d~~--------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~-----d~~~-~s~~~~---------  489 (655)
T KOG3741|consen  442 VLQEDPT--------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRT-----DSTQ-SSHLTR---------  489 (655)
T ss_pred             eecCCCC--------------cchh---HHhhhhHHHHHHHHHHHhhcccccccc-----cchH-HHHHHH---------
Confidence            6654431              1111   134569999999999999996541100     0000 000010         


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        -...+..++.+++......++++ -++++++.+
T Consensus       490 --I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  490 --ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             --hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence              01234456777888888888876 577777655

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.19  E-value=1.7e-09  Score=97.68  Aligned_cols=253  Identities=17%  Similarity=0.238  Sum_probs=152.4

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEE------ecC-Ceee
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFC------SHA-RHSF  201 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~------~~~-~~~~  201 (397)
                      .+.||+|+-+.+|..-.-.  ..+.|+++.+....    ..   +.+..|... .||-+-.-+.+=      -+. ...-
T Consensus        16 gr~LgqGgea~ly~l~e~~--d~VAKIYh~Pppa~----~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          16 GRPLGQGGEADLYTLGEVR--DQVAKIYHAPPPAA----QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CccccCCccceeeecchhh--chhheeecCCCchH----HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            4569999999999652211  23556666533211    11   122333333 566443312211      112 2245


Q ss_pred             EEEEeccCC-CHHHhhccc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          202 LVYEFLKRG-SLAAILSSD---AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       202 lv~e~~~~g-~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ++|..+.+. ....+++..   .......|+-.++.+..+|.+.+.||..   |.+-+|++++|+|+++++.+.|.|-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence            677776654 233333221   1223478999999999999999999999   999999999999999999999998654


Q ss_pred             ccccCCCCCCcccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhC-CCCCCccccccccccccccc----
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLALEVIKG-KHPRDFLSSISSSFLNTDIE----  347 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg-~~p~~~~~~~~~~~~~~~~~----  347 (397)
                      -... .........+|...|++||.-.     +-.-+..+|-|.+|+++++++.| ++||.........-...+..    
T Consensus       164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            3322 3344455678999999999654     33457789999999999999886 99987543221100000000    


Q ss_pred             -cc---cccCCCCCCCCc-chHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHh
Q 016009          348 -LD---EMLDPRLPAPSR-SVQEKLRSIVEVVFSCLNE--SPESRPTMKIVSQQL  395 (397)
Q Consensus       348 -~~---~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~--~P~~RPt~~~vl~~L  395 (397)
                       ..   +.-.+..+.|.. .+.-...++.-+..+|+..  ++.-|||++-.+..|
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl  297 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL  297 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence             00   000011111111 1112223455556678775  366899999888765

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.17  E-value=6.5e-12  Score=124.37  Aligned_cols=251  Identities=21%  Similarity=0.262  Sum_probs=163.5

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ..+.+.+.+-+.+|.++.++.+.-. .|...+.|.... .......+.+....+-.++-..+||-+++..--+.-....+
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~-ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGL-APKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhcc-chhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            3456666777888999988877432 333333333221 11111111233333434444445666665554444556789


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      |+++|..+++|...++...   ..+..-....+..+..+++|||..   .+.|+|++|.|.+...++..+++|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence            9999999999999987655   244444555666788899999997   7899999999999999999999999832211


Q ss_pred             C---------------------CCC----------CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 016009          282 K---------------------PDS----------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP  330 (397)
Q Consensus       282 ~---------------------~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p  330 (397)
                      .                     ...          .......+|+.|.+||...+......+|+|+.|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            0                     000          001234689999999999999999999999999999999999999


Q ss_pred             CCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 016009          331 RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK  389 (397)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~  389 (397)
                      |+....-.        ....+....++- .....+......+++...+..+|.+|-.+.
T Consensus      1035 ~na~tpq~--------~f~ni~~~~~~~-p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQ--------IFENILNRDIPW-PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchhh--------hhhccccCCCCC-CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            87554321        112222222221 112223334567777788899999997664

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.10  E-value=3.5e-09  Score=93.69  Aligned_cols=139  Identities=22%  Similarity=0.192  Sum_probs=98.5

Q ss_pred             CcEEEEEEEeCCCCEEEEEecCCCCCCc---c----hhcHHHHHHHHHHHHhccCC--ceeeeEEEEec-----CCeeeE
Q 016009          137 GHGSVYRAELPSGQVVAIKKFHSPLPSD---Q----IVDKKEFLTEVEALTEIRHR--NIVKLYGFCSH-----ARHSFL  202 (397)
Q Consensus       137 ~~g~vy~~~~~~~~~vavK~~~~~~~~~---~----~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~-----~~~~~l  202 (397)
                      ....|++..+ +|+.+.||.........   .    ......+.+|...+.++...  ..+.++++...     ....+|
T Consensus        34 ~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         34 EGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             CCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence            3344667766 67789999764322100   0    01122478899999888433  33445556543     235789


Q ss_pred             EEEeccCC-CHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC-------CCcEEEee
Q 016009          203 VYEFLKRG-SLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL-------EFEAHVAD  274 (397)
Q Consensus       203 v~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-------~~~~kl~D  274 (397)
                      |+|++++. +|.+++..... .+.+...+..++.+++..+.-||..   |++|+|++++|||++.       ++.+.++|
T Consensus       113 Vte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID  188 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVID  188 (268)
T ss_pred             EEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence            99999986 89998853221 3355677789999999999999999   9999999999999975       46899999


Q ss_pred             eccccc
Q 016009          275 FGIAKF  280 (397)
Q Consensus       275 fg~~~~  280 (397)
                      |+.+..
T Consensus       189 l~r~~~  194 (268)
T PRK15123        189 LHRAQI  194 (268)
T ss_pred             CCcccc
Confidence            998853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.08  E-value=1.4e-09  Score=90.78  Aligned_cols=129  Identities=25%  Similarity=0.345  Sum_probs=83.0

Q ss_pred             EEEEEEeCCCCEEEEEecCCCCCC----------------------cchhcHHHHHHHHHHHHhccCC--ceeeeEEEEe
Q 016009          140 SVYRAELPSGQVVAIKKFHSPLPS----------------------DQIVDKKEFLTEVEALTEIRHR--NIVKLYGFCS  195 (397)
Q Consensus       140 ~vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~  195 (397)
                      .||.|...+|..+|+|..+.....                      ..........+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            389998889999999987542111                      0111134467899999999755  566666553 


Q ss_pred             cCCeeeEEEEecc--CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCceeccCCCCcEEeCCCCcEEE
Q 016009          196 HARHSFLVYEFLK--RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY-LHHDCFPPIVHRDISSKNLLLDLEFEAHV  272 (397)
Q Consensus       196 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  272 (397)
                         .-.+||||++  |..+..+....     ++......++.+++..+.. +|..   +++|+||.+.||+++++ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence               3479999998  65554433221     1123445677777776665 4676   99999999999999888 9999


Q ss_pred             eeecccccc
Q 016009          273 ADFGIAKFL  281 (397)
Q Consensus       273 ~Dfg~~~~~  281 (397)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=99.00  E-value=1.8e-08  Score=84.52  Aligned_cols=142  Identities=19%  Similarity=0.180  Sum_probs=105.0

Q ss_pred             ccccCcEEEEEEEeCCCCEEEEEecCCCCCCc--chhcHHHHHHHHHHHHhccC--CceeeeEEEEe-c----CCeeeEE
Q 016009          133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD--QIVDKKEFLTEVEALTEIRH--RNIVKLYGFCS-H----ARHSFLV  203 (397)
Q Consensus       133 lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~-~----~~~~~lv  203 (397)
                      -|+||.+.|++..+. |+.+-+|+-.......  .......|.+|...|.++..  -.+.+.. ++. .    ....+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            567888889998774 4579999865322211  13357889999999999953  3344544 332 1    1235799


Q ss_pred             EEeccC-CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc--EEEeeeccccc
Q 016009          204 YEFLKR-GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE--AHVADFGIAKF  280 (397)
Q Consensus       204 ~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~~  280 (397)
                      +|-++| -+|.+++.+... .+.+..++..++.+++..++-||+.   ++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997764 589888865432 3567778889999999999999999   9999999999999986666  99999976653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.93  E-value=1.2e-08  Score=87.66  Aligned_cols=137  Identities=23%  Similarity=0.239  Sum_probs=94.8

Q ss_pred             CCCccccccCcEEEEEEEeCCCCEEEEEecCCCCC------------------CcchhcHHHHHHHHHHHHhccCC--ce
Q 016009          128 DAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLP------------------SDQIVDKKEFLTEVEALTEIRHR--NI  187 (397)
Q Consensus       128 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~~~~~e~~~l~~l~h~--ni  187 (397)
                      .+...||-|.-+.||.|..+.|.++|||.=+....                  +..........+|.++|.++...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            34567999999999999999999999996321110                  00111234567899999999654  67


Q ss_pred             eeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC
Q 016009          188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE  267 (397)
Q Consensus       188 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  267 (397)
                      .+.+++    +.-.+||||++|-.|...-        ++-...-.++..|++-+.-+-..   |+||+|+++-||++++|
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d  238 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence            777664    3457999999986665432        11222233444444444444455   99999999999999999


Q ss_pred             CcEEEeeecccc
Q 016009          268 FEAHVADFGIAK  279 (397)
Q Consensus       268 ~~~kl~Dfg~~~  279 (397)
                      |.+.++||--+.
T Consensus       239 g~~~vIDwPQ~v  250 (304)
T COG0478         239 GDIVVIDWPQAV  250 (304)
T ss_pred             CCEEEEeCcccc
Confidence            999999996554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.89  E-value=2.7e-08  Score=85.21  Aligned_cols=128  Identities=22%  Similarity=0.285  Sum_probs=93.8

Q ss_pred             CCCEEEEEecCCCCCCc---chhcHHHHHHHHHHHHhcc--CCceeeeEEEEecCC----eeeEEEEeccCC-CHHHhhc
Q 016009          148 SGQVVAIKKFHSPLPSD---QIVDKKEFLTEVEALTEIR--HRNIVKLYGFCSHAR----HSFLVYEFLKRG-SLAAILS  217 (397)
Q Consensus       148 ~~~~vavK~~~~~~~~~---~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~  217 (397)
                      .++.+.+|.+.......   .........+|...+..+.  .-.+++.+++.....    ..++|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            45566666543222111   1123456788998888885  334566677665432    458999999984 8999986


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC---cEEEeeecccccc
Q 016009          218 SDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF---EAHVADFGIAKFL  281 (397)
Q Consensus       218 ~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~~~  281 (397)
                      ....   .+......++.+++..++-||..   +++|+|+++.|||++.+.   .+.++||+-++..
T Consensus       111 ~~~~---~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  111 QWEQ---LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hhcc---cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            5332   55567789999999999999999   999999999999998887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.85  E-value=7.3e-10  Score=105.94  Aligned_cols=149  Identities=22%  Similarity=0.332  Sum_probs=99.4

Q ss_pred             HHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCC----c-----ccccccccccCccccc
Q 016009          234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN----W-----TEFAGTYGYVAPELAY  304 (397)
Q Consensus       234 ~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~----~-----~~~~g~~~y~aPE~~~  304 (397)
                      +.+++.|+.|+|..  +++||++|.|++|.++.++..||+.|+++.........    +     ....-...|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34566999999997  58999999999999999999999999987543321111    0     1112355799999999


Q ss_pred             CCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccc-ccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCC
Q 016009          305 TMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS-SSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESP  382 (397)
Q Consensus       305 ~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P  382 (397)
                      +...+.++|+||+|+++|.+.. |+.-+....... ..+..      ...+.......   .+.+.++.+=+.+.+..++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~------~~~~~~~~~~s---~~~p~el~~~l~k~l~~~~  253 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR------NLLNAGAFGYS---NNLPSELRESLKKLLNGDS  253 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh------ccccccccccc---ccCcHHHHHHHHHHhcCCc
Confidence            9888999999999999999995 444333221111 00000      00011111001   2233446666778899999


Q ss_pred             CCCCCHHHHHH
Q 016009          383 ESRPTMKIVSQ  393 (397)
Q Consensus       383 ~~RPt~~~vl~  393 (397)
                      .-||++.++..
T Consensus       254 ~~rp~~~~l~~  264 (700)
T KOG2137|consen  254 AVRPTLDLLLS  264 (700)
T ss_pred             ccCcchhhhhc
Confidence            99998877653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.82  E-value=4.1e-08  Score=94.19  Aligned_cols=144  Identities=22%  Similarity=0.264  Sum_probs=93.7

Q ss_pred             ccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcH------------------------------H------HHHH
Q 016009          131 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDK------------------------------K------EFLT  174 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~------------------------------~------~~~~  174 (397)
                      +-|+.++-|.||+|++++|+.||||+.+......-..+.                              +      ++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            569999999999999999999999998765432211111                              0      1334


Q ss_pred             HHHHHHhcc-----CCceeeeEEEE-ecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 016009          175 EVEALTEIR-----HRNIVKLYGFC-SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADA-LSYLHHD  247 (397)
Q Consensus       175 e~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~-l~~Lh~~  247 (397)
                      |..-+.+++     .+++ .+=..+ +-.+...|+|||++|-.+.+...-...  ..+.+   .++..++++ +..+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k---~ia~~~~~~f~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRK---ELAELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHH---HHHHHHHHHHHHHHHhc
Confidence            444444442     3333 222223 334667899999999988887432221  24422   333333332 2222223


Q ss_pred             CCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       248 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                         +++|+|..|.||+++.++++.+.|||+...+..
T Consensus       285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               899999999999999999999999999876653

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.61  E-value=2.7e-06  Score=71.36  Aligned_cols=104  Identities=22%  Similarity=0.259  Sum_probs=82.5

Q ss_pred             HHHHHHHhccC-CceeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 016009          174 TEVEALTEIRH-RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI  252 (397)
Q Consensus       174 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i  252 (397)
                      .|.-+++.+++ +++++++|+|-    .+++.||...+++......-......+|..|.+|+.++++.+.++++.....+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            57888888865 69999999993    36789999887664321100011246899999999999999999999655568


Q ss_pred             eeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          253 VHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       253 vH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      ...|++++|+-+++++++|+.|.+.....
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            89999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.60  E-value=1.5e-06  Score=75.43  Aligned_cols=138  Identities=17%  Similarity=0.241  Sum_probs=85.1

Q ss_pred             ccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc--eeeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      ..||+|..+.||+.   .|..+++|......      ......+|.++++.+..-.  +.+.+++....+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            45899999999984   25567788865311      2455788999999986433  4677888877777889999999


Q ss_pred             CCC-HHHhhc---------------------cccccCCCCHHHHHH-H---HH-------HHHH-HHHHHHhC-CCCCce
Q 016009          209 RGS-LAAILS---------------------SDAAAQELGWSQRMN-V---IK-------GVAD-ALSYLHHD-CFPPIV  253 (397)
Q Consensus       209 ~g~-L~~~l~---------------------~~~~~~~l~~~~~~~-i---~~-------~i~~-~l~~Lh~~-~~~~iv  253 (397)
                      |.+ +...+.                     .-.. ...+...... +   +.       .+.. ...+|... ..+.++
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            863 221111                     1000 0111111110 0   00       0111 12223221 123578


Q ss_pred             eccCCCCcEEeCCCCcEEEeeecccc
Q 016009          254 HRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       254 H~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      |+|+.|.||++++++ +.++||+.+.
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcC
Confidence            999999999999888 9999998875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.58  E-value=5.5e-07  Score=75.98  Aligned_cols=139  Identities=17%  Similarity=0.192  Sum_probs=89.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHH------HHHHHHHHHHhccC---CceeeeEEEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKK------EFLTEVEALTEIRH---RNIVKLYGFC  194 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~~e~~~l~~l~h---~niv~~~~~~  194 (397)
                      ..+|...+++-......|.+-.. +|+.+++|..+......+ ....      ...+++..+.+++.   .....++...
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~e-r~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPE-RRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHH-HHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            45677777777777667766666 578899998765332211 1111      12334444444432   2222323222


Q ss_pred             e-----cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc
Q 016009          195 S-----HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE  269 (397)
Q Consensus       195 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  269 (397)
                      .     -....+++|||++|..|.+...       ++.    .++..+++++.-+|..   |++|+|..|.|+++++++ 
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-
Confidence            2     2234568999999988876532       222    2456677889999999   999999999999998655 


Q ss_pred             EEEeeecccc
Q 016009          270 AHVADFGIAK  279 (397)
Q Consensus       270 ~kl~Dfg~~~  279 (397)
                      +++.||+..+
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.58  E-value=8.5e-07  Score=75.67  Aligned_cols=156  Identities=21%  Similarity=0.277  Sum_probs=101.4

Q ss_pred             ccHHHHHHHhcCCCCCc---cccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchh---------------cHH-----H
Q 016009          115 LVYDEIVRATNDFDAQY---CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIV---------------DKK-----E  171 (397)
Q Consensus       115 ~~~~~~~~~~~~~~~~~---~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~---------------~~~-----~  171 (397)
                      .+.+.+....+...+..   .|++|.-+.||+|...++..+|||+++.........               ...     -
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            34455555555554444   466788899999988889999999986532211100               011     1


Q ss_pred             HHHHHHHHHhcc--CCceeeeEEEEecCCeeeEEEEeccCCC-HHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 016009          172 FLTEVEALTEIR--HRNIVKLYGFCSHARHSFLVYEFLKRGS-LAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC  248 (397)
Q Consensus       172 ~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~  248 (397)
                      ...|..-|+++.  +-.+.+.+++..    -.|||||+.... -.-.|..-    ++...+...+..++++.+.-|-..+
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHhc
Confidence            346777777773  445555665543    369999996531 11111111    1233356677778888888877732


Q ss_pred             CCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       249 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                        ++||+||+.-|||+. ++.+.++|+|-+...
T Consensus       187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             --CcccccchhhheEEE-CCeEEEEECcccccc
Confidence              999999999999999 889999999987643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.52  E-value=1.1e-08  Score=97.16  Aligned_cols=184  Identities=20%  Similarity=0.156  Sum_probs=134.2

Q ss_pred             CCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc-eeeeEEEEecCCeeeEEEEec
Q 016009          129 AQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN-IVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       129 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~  207 (397)
                      .-+-+++|++++++|.+-.-.+....+.+..         .....-++++|.+++||| .++.++-++.+...+++++++
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~---------~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ---------TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeecc---------chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            3345788999999988644334444555432         134557889999999999 777777777788889999999


Q ss_pred             cCC-CHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC
Q 016009          208 KRG-SLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS  286 (397)
Q Consensus       208 ~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  286 (397)
                      .++ +-..-..  .....+...+...+...-+++++++|+.   .-+|+|    ||+..+ +..+..||+....+.... 
T Consensus       317 s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-  385 (829)
T KOG0576|consen  317 STGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-  385 (829)
T ss_pred             cCCccccccCC--hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc-
Confidence            877 2211111  1111244455666777778899999986   458888    777765 678999999988776543 


Q ss_pred             CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 016009          287 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD  332 (397)
Q Consensus       287 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~  332 (397)
                      ......+++.++|||+.....+..+.|+|+.|.--.++.-|-+|-.
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            3455678999999999999999999999999988778888877743

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.38  E-value=8.2e-06  Score=71.97  Aligned_cols=139  Identities=16%  Similarity=0.153  Sum_probs=84.8

Q ss_pred             ccccCc-EEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeeeEEEEeccCC
Q 016009          133 IGNGGH-GSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSFLVYEFLKRG  210 (397)
Q Consensus       133 lg~G~~-g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  210 (397)
                      |..|.. ..||+.... +..+++|......       ...+..|+++++.+. +--+.+++++....+..++|||+++|.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            344444 788999764 4678888865321       235678999988883 445667788777666789999999998


Q ss_pred             CHHHhhc-------------------cccc-cCCCC--HHHHHHHHH--------------------HHHHHHHHHHhC-
Q 016009          211 SLAAILS-------------------SDAA-AQELG--WSQRMNVIK--------------------GVADALSYLHHD-  247 (397)
Q Consensus       211 ~L~~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~i~~~l~~Lh~~-  247 (397)
                      ++.....                   .-.. ..++.  .........                    .+......|-.. 
T Consensus        78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  157 (244)
T cd05150          78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR  157 (244)
T ss_pred             cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence            8765421                   1000 00111  000010000                    011122222211 


Q ss_pred             ---CCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          248 ---CFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       248 ---~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                         ..+.++|+|+.|.||+++++....|+||+.+.
T Consensus       158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence               12468999999999999998778899998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.37  E-value=3.6e-06  Score=80.73  Aligned_cols=145  Identities=19%  Similarity=0.225  Sum_probs=89.5

Q ss_pred             ccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcH---------------------------H------HHHHHHH
Q 016009          131 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDK---------------------------K------EFLTEVE  177 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------------~------~~~~e~~  177 (397)
                      +.||.-+.|.||+|++++|+.||||+-+......-..+.                           +      +|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            569999999999999999999999997764432211110                           1      1344444


Q ss_pred             HHHhc----cCCc---eeeeEEEE-ecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 016009          178 ALTEI----RHRN---IVKLYGFC-SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF  249 (397)
Q Consensus       178 ~l~~l----~h~n---iv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~  249 (397)
                      -..+.    +|-+   -|.+=.++ .......|+||||+|..+.+.-.-..  ..++...   ++..+.++..  +.-..
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~---i~~~l~~~~~--~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHD---ILNKLVEAYL--EQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHH---HHHHHHHHHH--HHHHh
Confidence            33333    3444   11122222 22346789999999987766532111  1244443   3333333321  11111


Q ss_pred             CCceeccCCCCcEEeCC----CCcEEEeeeccccccC
Q 016009          250 PPIVHRDISSKNLLLDL----EFEAHVADFGIAKFLK  282 (397)
Q Consensus       250 ~~ivH~dlk~~Nill~~----~~~~kl~Dfg~~~~~~  282 (397)
                      .|.+|+|=.|.||+++.    ++++.+-|||+...+.
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            28999999999999984    6789999999987654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.34  E-value=9.5e-06  Score=70.90  Aligned_cols=142  Identities=17%  Similarity=0.251  Sum_probs=83.5

Q ss_pred             ccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCC--ceeeeEEEEec---CCeeeEEEE
Q 016009          131 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR--NIVKLYGFCSH---ARHSFLVYE  205 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e  205 (397)
                      +.++.|..+.||+....+ ..+++|.....      .....+..|..+++.+...  .+.+++.+...   ....+++|+
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            458899999999998877 58999986531      2356788999999988533  35666665432   234689999


Q ss_pred             eccCCCHHH----------------hh---cccc-ccCCCCHHH---------HHHH------------HHHHHH-HHHH
Q 016009          206 FLKRGSLAA----------------IL---SSDA-AAQELGWSQ---------RMNV------------IKGVAD-ALSY  243 (397)
Q Consensus       206 ~~~~g~L~~----------------~l---~~~~-~~~~l~~~~---------~~~i------------~~~i~~-~l~~  243 (397)
                      +++|..+..                .+   +... ......+..         ....            ...+.+ .+..
T Consensus        76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (239)
T PF01636_consen   76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE  155 (239)
T ss_dssp             EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence            999988877                11   0110 001111100         0000            111222 3333


Q ss_pred             HHh----CCCCCceeccCCCCcEEeC-CCCcEEEeeecccc
Q 016009          244 LHH----DCFPPIVHRDISSKNLLLD-LEFEAHVADFGIAK  279 (397)
Q Consensus       244 Lh~----~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~  279 (397)
                      ++.    .....++|+|+.+.||+++ +++.+.|.||+.+.
T Consensus       156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            332    1234699999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.34  E-value=2.9e-05  Score=65.43  Aligned_cols=138  Identities=20%  Similarity=0.284  Sum_probs=95.3

Q ss_pred             CCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCc------------chhcHHHHHHHHHHHHhcc------CCceeee
Q 016009          129 AQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD------------QIVDKKEFLTEVEALTEIR------HRNIVKL  190 (397)
Q Consensus       129 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~~~e~~~l~~l~------h~niv~~  190 (397)
                      ....||+|+.-.||.  +++.....||++.......            .....++..+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            355699999988885  5556678899887643000            0112466777777776665      8899999


Q ss_pred             EEEEecCCeeeEEEEeccC------CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe
Q 016009          191 YGFCSHARHSFLVYEFLKR------GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL  264 (397)
Q Consensus       191 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill  264 (397)
                      +|+.+++....+|+|.+.+      -+|.+++....    ++. ..   ...+-+-..||-..   .|+.+|++|+||++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~---~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-EL---RQALDEFKRYLLDH---HIVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HH---HHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence            9999999999999998753      36777774432    444 33   33334445677777   89999999999999


Q ss_pred             CCCC----cEEEee-ecccc
Q 016009          265 DLEF----EAHVAD-FGIAK  279 (397)
Q Consensus       265 ~~~~----~~kl~D-fg~~~  279 (397)
                      ..+.    .+.|+| ||...
T Consensus       152 ~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             EecCCCceEEEEEeCCCCcc
Confidence            5332    577777 56544

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.33  E-value=7.4e-06  Score=66.17  Aligned_cols=128  Identities=20%  Similarity=0.271  Sum_probs=86.1

Q ss_pred             CCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          129 AQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       129 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      ..+.|++|++|.||+|.+. |..+|+|+-+.+.      ....+..|+++|..++-.++.+=+-.+.   .-++.|||+.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds------~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~   95 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS------PRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYID   95 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCc------chhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhc
Confidence            3566999999999999885 4588999865432      3577899999999998766654332222   2234599999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCC--CcEEeCCCCcEEEeeeccccc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISS--KNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~--~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      |-.|.+.-...      +-++.    ..+++.---|...   ||-|+.|.-  .||++.++ .+.|+||..|+.
T Consensus        96 G~~L~~~~~~~------~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~  155 (201)
T COG2112          96 GRPLGKLEIGG------DRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDR-DVYIIDFDSATF  155 (201)
T ss_pred             Ccchhhhhhcc------cHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence            98888775421      11222    3344442223333   888888864  56666554 999999998874

>PLN02876 acyl-CoA dehydrogenase

Probab=98.26  E-value=2.6e-05  Score=80.72  Aligned_cols=149  Identities=17%  Similarity=0.289  Sum_probs=92.1

Q ss_pred             CccccccCcEEEEEEEeCCC---CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCce--eeeEEEEecC---Cee
Q 016009          130 QYCIGNGGHGSVYRAELPSG---QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNI--VKLYGFCSHA---RHS  200 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~  200 (397)
                      .+.++.|.+..+|+....++   ..+++|+......   ......+.+|.++++.+. |.++  .+++.+|.+.   +..
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~---~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL---LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc---CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            45588899999999876654   3677776532111   112457889999999995 6654  7788888664   467


Q ss_pred             eEEEEeccCCCHHHh-----------------------hccccc--------cCCCCH--HHHHHHH-------------
Q 016009          201 FLVYEFLKRGSLAAI-----------------------LSSDAA--------AQELGW--SQRMNVI-------------  234 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~-----------------------l~~~~~--------~~~l~~--~~~~~i~-------------  234 (397)
                      |+||||++|..+.+.                       |+.-..        ..+..+  .++..|.             
T Consensus       120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~  199 (822)
T PLN02876        120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP  199 (822)
T ss_pred             eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence            899999998653221                       111000        001111  1111111             


Q ss_pred             --HHHHHHHHHHHhCCC--------CCceeccCCCCcEEeCCC-Cc-EEEeeecccccc
Q 016009          235 --KGVADALSYLHHDCF--------PPIVHRDISSKNLLLDLE-FE-AHVADFGIAKFL  281 (397)
Q Consensus       235 --~~i~~~l~~Lh~~~~--------~~ivH~dlk~~Nill~~~-~~-~kl~Dfg~~~~~  281 (397)
                        ..+.+.+.+|..+..        +.+||+|+++.||+++.+ .. .-|.||+++..-
T Consensus       200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence              123344667755322        259999999999999853 33 578999987653

>PRK10593 hypothetical protein; Provisional

Probab=98.15  E-value=5.3e-05  Score=68.72  Aligned_cols=76  Identities=17%  Similarity=0.172  Sum_probs=56.5

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC---CceeeeEEEEec---CCeeeEE
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH---RNIVKLYGFCSH---ARHSFLV  203 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv  203 (397)
                      .+.||.|..+.||+....+++ +++|..+. .     .....+..|.+.|+.+.-   -.+.+++++|..   .+..++|
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGN-PMPLMARS-F-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             eeecCCccceeEEEEEcCCCC-EEEEEecc-c-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            456999999999999776664 66676432 1     123578899999999842   468888888754   3668999


Q ss_pred             EEeccCCCH
Q 016009          204 YEFLKRGSL  212 (397)
Q Consensus       204 ~e~~~~g~L  212 (397)
                      ||+++++++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.09  E-value=4e-05  Score=67.11  Aligned_cols=73  Identities=14%  Similarity=0.214  Sum_probs=45.0

Q ss_pred             ccccccCcE-EEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCC---ceeeeEEEEecC---CeeeEE
Q 016009          131 YCIGNGGHG-SVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR---NIVKLYGFCSHA---RHSFLV  203 (397)
Q Consensus       131 ~~lg~G~~g-~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv  203 (397)
                      +.++.|+.. .||+.    +..+++|.....      .....+..|.++++.+...   .+.+.++.....   ...+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc------chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            346666665 58875    235777764421      1245788999999888532   344445444332   234889


Q ss_pred             EEeccCCCHH
Q 016009          204 YEFLKRGSLA  213 (397)
Q Consensus       204 ~e~~~~g~L~  213 (397)
                      |++++|.++.
T Consensus        73 ~~~i~G~~l~   82 (235)
T cd05155          73 YRWLEGETAT   82 (235)
T ss_pred             EEeecCCCCC
Confidence            9999997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN03150 hypothetical protein; Provisional

Probab=98.09  E-value=6.7e-06  Score=82.21  Aligned_cols=48  Identities=25%  Similarity=0.567  Sum_probs=29.5

Q ss_pred             CCCCCEEecCCCcccccCCCCCc--cccCCcccccCCCCCCCCCCCCCCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNSTA--FRNASVEALEGNKGLCGGVKGMQPCK   49 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~~~--~~~~~~~~~~gN~~lcg~~~~~~~c~   49 (397)
                      |++|++||||+|+|+|.+|....  +.+.....+.+|+.+||.+. ...|.
T Consensus       489 L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~-l~~C~  538 (623)
T PLN03150        489 LTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG-LRACG  538 (623)
T ss_pred             CCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCC-CCCCc
Confidence            35566666666666666665321  12233457889999998653 45674

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.09  E-value=5.5e-05  Score=63.27  Aligned_cols=129  Identities=25%  Similarity=0.410  Sum_probs=89.0

Q ss_pred             cCCCCCccccccCc-EEEEEEEeCCCCEEEEEecCC---CCC--------Ccch------hcHHHHHHHHHHHHhcc---
Q 016009          125 NDFDAQYCIGNGGH-GSVYRAELPSGQVVAIKKFHS---PLP--------SDQI------VDKKEFLTEVEALTEIR---  183 (397)
Q Consensus       125 ~~~~~~~~lg~G~~-g~vy~~~~~~~~~vavK~~~~---~~~--------~~~~------~~~~~~~~e~~~l~~l~---  183 (397)
                      .+++..+.||.|.- |.||+++. +|+.+|+|.+..   ...        ....      .-...|..|.+...+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888899999999 99999998 677999999321   000        0000      12346888999888884   


Q ss_pred             CCce--eeeEEEEecC------------------CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHH
Q 016009          184 HRNI--VKLYGFCSHA------------------RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY  243 (397)
Q Consensus       184 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~  243 (397)
                      +.++  |+.+||..-.                  ....+|.||++...            .++..    -+.++.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHH
Confidence            4455  8999987221                  12357777776533            12222    34456666788


Q ss_pred             HHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccc
Q 016009          244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA  278 (397)
Q Consensus       244 Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  278 (397)
                      +|..   +|+-+|+++.|..     .-+|+|||.+
T Consensus       180 ~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            9998   9999999999985     3578899864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.03  E-value=9.5e-05  Score=64.75  Aligned_cols=141  Identities=17%  Similarity=0.203  Sum_probs=80.2

Q ss_pred             ccccccCcEEEEEEEeCC--CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc-eeeeEEEEecCCeeeEEEEec
Q 016009          131 YCIGNGGHGSVYRAELPS--GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN-IVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~  207 (397)
                      +.|..|-...+|+....+  +..+++|....... .    ......|+.+++.+...+ .+++++...    -.++|||+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i   74 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-L----IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFI   74 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-c----eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEee
Confidence            346777788999997764  67888997653211 1    122347888888885333 344444332    24799999


Q ss_pred             cCCCHHHh-----------------hcccccc--------CCCC-HHHHHHHHH----------------------HHHH
Q 016009          208 KRGSLAAI-----------------LSSDAAA--------QELG-WSQRMNVIK----------------------GVAD  239 (397)
Q Consensus       208 ~~g~L~~~-----------------l~~~~~~--------~~l~-~~~~~~i~~----------------------~i~~  239 (397)
                      +|.++...                 ++.....        .... |..+..+..                      .+..
T Consensus        75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  154 (235)
T cd05157          75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD  154 (235)
T ss_pred             CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence            98776321                 0111100        0111 222212211                      1111


Q ss_pred             HHHHH----HhC-CCCCceeccCCCCcEEeCC-CCcEEEeeeccccc
Q 016009          240 ALSYL----HHD-CFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKF  280 (397)
Q Consensus       240 ~l~~L----h~~-~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~  280 (397)
                      .+..|    ... ....++|+|+.+.||++++ ++.+.++||..+..
T Consensus       155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            11222    211 1236899999999999998 57899999987753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.00  E-value=4e-05  Score=78.36  Aligned_cols=195  Identities=18%  Similarity=0.204  Sum_probs=132.4

Q ss_pred             HHHHHHHHHhccCCceeeeEEEEecCCee----eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Q 016009          172 FLTEVEALTEIRHRNIVKLYGFCSHARHS----FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD  247 (397)
Q Consensus       172 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~  247 (397)
                      ...|.+.+.+..|+|++.++.|-......    .+..|++..-++...+..-.   ..+....+.+..+..+|+.|+|+.
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHHh
Confidence            45577778888999999999987554322    34457777778877775433   478888999999999999999998


Q ss_pred             CCCCceeccCCCC---cEEeCCCCcEEEe--eeccccccCCCCCCcccccccccccCcccccCCCCCc--chhhHHHHHH
Q 016009          248 CFPPIVHRDISSK---NLLLDLEFEAHVA--DFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE--KCDVYSFGVL  320 (397)
Q Consensus       248 ~~~~ivH~dlk~~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~Dv~s~G~~  320 (397)
                         ...|.-|..+   +.-.+.++...++  ||+.+..+........ ..-+..+.+||......+..  ..|+|++|..
T Consensus       306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~-~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS-DLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh-hcCccccccccccccccchhhhhhHHHHHHHH
Confidence               5556555555   5555666777776  8888776543322222 23345677888766554443  4799999999


Q ss_pred             HHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          321 ALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       321 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+..|..+-....           ....+.+....          ..+.+....|+..++++|++..+++.+
T Consensus       382 ~~~~~~~~~i~~~~~-----------~~~~~l~~~~~----------~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSA-----------VPVSLLDVLST----------SELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HhhhhhcCccccccc-----------chhhhhccccc----------hhhhhhhhhhcchhhhhccchhhhhhc
Confidence            999999876622111           01111111110          136677779999999999999999865

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.92  E-value=0.00028  Score=66.06  Aligned_cols=80  Identities=21%  Similarity=0.222  Sum_probs=55.3

Q ss_pred             CccccccCcEEEEEEEeCCC-CEEEEEecCCCCCC--cc-hhcHHHHHHHHHHHHhcc---CCceeeeEEEEecCCeeeE
Q 016009          130 QYCIGNGGHGSVYRAELPSG-QVVAIKKFHSPLPS--DQ-IVDKKEFLTEVEALTEIR---HRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~-~~vavK~~~~~~~~--~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  202 (397)
                      .+.||.|.+..||++...+| +.++||.-......  .. ....+....|.+.|+.+.   -.++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35689999999999988777 48999985422111  11 124567778888888873   2456667766  3455789


Q ss_pred             EEEeccCCC
Q 016009          203 VYEFLKRGS  211 (397)
Q Consensus       203 v~e~~~~g~  211 (397)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.86  E-value=0.00017  Score=63.99  Aligned_cols=138  Identities=14%  Similarity=0.099  Sum_probs=77.7

Q ss_pred             ccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCce-eeeEEEEecCCeeeEEEEeccCCC
Q 016009          133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI-VKLYGFCSHARHSFLVYEFLKRGS  211 (397)
Q Consensus       133 lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~  211 (397)
                      +..|-.+.+|+... +++.+++|.........    .-....|.++++.+....+ .++++...    -++||||++|..
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL----GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccc----cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence            45677788998874 56678888754321110    0134678889998854333 34444432    368999999876


Q ss_pred             HHHh-----------------hccccc-cCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCceeccCC
Q 016009          212 LAAI-----------------LSSDAA-AQELGWSQR-MNVIKG---------VADALSYLHHD-----CFPPIVHRDIS  258 (397)
Q Consensus       212 L~~~-----------------l~~~~~-~~~l~~~~~-~~i~~~---------i~~~l~~Lh~~-----~~~~ivH~dlk  258 (397)
                      +...                 ++.... ..+++.... .....+         +...+..+...     ..+.++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            5421                 111111 112222211 111111         11112222221     12358999999


Q ss_pred             CCcEEeCCCCcEEEeeeccccc
Q 016009          259 SKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       259 ~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      |.||++++++ +.++||+.+..
T Consensus       155 ~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       155 AYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCcEEEeCCC-CEEEeccccCc
Confidence            9999999877 78999988764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.83  E-value=0.00023  Score=64.75  Aligned_cols=142  Identities=21%  Similarity=0.213  Sum_probs=85.4

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc--eeeeEEE------EecCCeee
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVKLYGF------CSHARHSF  201 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~  201 (397)
                      .+.+..|....+|+....++ .+++|....       .....+..|++++..+.+..  +.+++..      ....+..+
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~-------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK-------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCC-------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            44577777789999876544 688888653       12356677888888885332  4444432      12344568


Q ss_pred             EEEEeccCCCHHH----hh----------ccc----cc----cCCCCHHHHH----------HHHHHHHHHHHHHHh---
Q 016009          202 LVYEFLKRGSLAA----IL----------SSD----AA----AQELGWSQRM----------NVIKGVADALSYLHH---  246 (397)
Q Consensus       202 lv~e~~~~g~L~~----~l----------~~~----~~----~~~l~~~~~~----------~i~~~i~~~l~~Lh~---  246 (397)
                      +|++|++|..+..    ..          +..    ..    .....|....          .....+..++.++..   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999999876532    00          100    00    0112232211          111223344555553   


Q ss_pred             -CCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          247 -DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       247 -~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                       ....+++|+|+.|.||+++++....|.||+.+.
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence             122479999999999999998778899998775

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.72  E-value=0.00087  Score=61.62  Aligned_cols=155  Identities=17%  Similarity=0.215  Sum_probs=83.3

Q ss_pred             HHHHHHHhcCCCC-----CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCC--ceee
Q 016009          117 YDEIVRATNDFDA-----QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR--NIVK  189 (397)
Q Consensus       117 ~~~~~~~~~~~~~-----~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~  189 (397)
                      .+++......|..     .+.++.|....+|+....+| .+++|++.. .      ..+.+..|.++++.+...  .+.+
T Consensus         9 ~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~-~------~~~~l~~~~~~l~~L~~~glpvP~   80 (319)
T PRK05231          9 DDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER-L------TAEDLPFFLGLMQHLAARGVPVPA   80 (319)
T ss_pred             HHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc-C------ChHHhHHHHHHHHHHHHCCCCCCc
Confidence            3444444344533     24466677788999877665 688887641 1      123445566666666322  2333


Q ss_pred             eEE------EEecCCeeeEEEEeccCCCHHH-----h---------hcccc--------ccCCCCH-HHHHH--------
Q 016009          190 LYG------FCSHARHSFLVYEFLKRGSLAA-----I---------LSSDA--------AAQELGW-SQRMN--------  232 (397)
Q Consensus       190 ~~~------~~~~~~~~~lv~e~~~~g~L~~-----~---------l~~~~--------~~~~l~~-~~~~~--------  232 (397)
                      .+.      +....+..++++||++|..+..     .         ++...        ....+.| .....        
T Consensus        81 ~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (319)
T PRK05231         81 PVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLAD  160 (319)
T ss_pred             ceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccCh
Confidence            332      1123456789999999875421     1         11100        0001112 11111        


Q ss_pred             ----HHHH-HHHHHHHHHhC----CCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          233 ----VIKG-VADALSYLHHD----CFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       233 ----i~~~-i~~~l~~Lh~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                          .+.+ +...+..+...    ...+++|+|+.+.||+++++...-|.||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        161 EQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             hHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                1111 11222333311    23489999999999999876656899999875

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.70  E-value=0.0004  Score=63.29  Aligned_cols=140  Identities=22%  Similarity=0.276  Sum_probs=81.6

Q ss_pred             cccccCcEEEEEEEeCC-------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc-eeeeEEEEecCCeeeEE
Q 016009          132 CIGNGGHGSVYRAELPS-------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN-IVKLYGFCSHARHSFLV  203 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv  203 (397)
                      .+..|-...+|+....+       ++.+++|.......     .......|.++++.+.... ..++++++..    .+|
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-----LLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            35556667899987655       57899998654221     1234568888888885333 3445555532    358


Q ss_pred             EEeccCCCHHHh-h----------------ccccccC------CC--CHHHHHHH-------------------------
Q 016009          204 YEFLKRGSLAAI-L----------------SSDAAAQ------EL--GWSQRMNV-------------------------  233 (397)
Q Consensus       204 ~e~~~~g~L~~~-l----------------~~~~~~~------~l--~~~~~~~i-------------------------  233 (397)
                      +||++|..+... +                +......      ..  -|.....+                         
T Consensus        76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (302)
T cd05156          76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL  155 (302)
T ss_pred             hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence            999998776431 1                1111100      00  01111111                         


Q ss_pred             -HHHHHHHHHHHHh------CCCCCceeccCCCCcEEeCCC----CcEEEeeeccccc
Q 016009          234 -IKGVADALSYLHH------DCFPPIVHRDISSKNLLLDLE----FEAHVADFGIAKF  280 (397)
Q Consensus       234 -~~~i~~~l~~Lh~------~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~  280 (397)
                       ...+...+.++..      .....++|+|+.+.||+++++    +.+.++||..+..
T Consensus       156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence             1122223344432      133478999999999999985    8899999988753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.67  E-value=0.0016  Score=59.46  Aligned_cols=143  Identities=20%  Similarity=0.201  Sum_probs=82.6

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc--eeeeEEEE------ecCCeee
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVKLYGFC------SHARHSF  201 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~------~~~~~~~  201 (397)
                      .+.++.|....+|+....+| .+++|..+...      ..+.+..|.+++..|....  +.+++...      ...+..+
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~------~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV------KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC------CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            34567777789999876555 57788764311      1345566777777774322  34444321      2235578


Q ss_pred             EEEEeccCCCHHHh--------------hcccccc---------CCCCHHHHH------------HHHHHHHHHHHHHHh
Q 016009          202 LVYEFLKRGSLAAI--------------LSSDAAA---------QELGWSQRM------------NVIKGVADALSYLHH  246 (397)
Q Consensus       202 lv~e~~~~g~L~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~i~~~l~~Lh~  246 (397)
                      +++||++|..+...              ++.....         ..-.|....            .....+.+.++++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            99999988653210              1110000         001122111            011123344555543


Q ss_pred             ----CCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          247 ----DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       247 ----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                          ....+++|+|+.+.||++++++...|.||+.+.
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                223589999999999999988877899998875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.56  E-value=0.0008  Score=61.03  Aligned_cols=144  Identities=24%  Similarity=0.287  Sum_probs=95.9

Q ss_pred             CCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCc--------------------chhc--HHHHHHHHHHHHhccCC
Q 016009          128 DAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD--------------------QIVD--KKEFLTEVEALTEIRHR  185 (397)
Q Consensus       128 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~--~~~~~~e~~~l~~l~h~  185 (397)
                      .+..+|..|.-+.||.+...+|..+|||+++...-.-                    ++..  +.-...|++-|++++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3456788999999999999999999999875432100                    0000  11235678888888654


Q ss_pred             ceeeeEEEEecCCeeeEEEEeccCCCH-HHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe
Q 016009          186 NIVKLYGFCSHARHSFLVYEFLKRGSL-AAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL  264 (397)
Q Consensus       186 niv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill  264 (397)
                      .|.-.--...  ..-.|||+|+....- .-.|..    ..++...+...-.+++.-|.-|-+.|  ++||.||.--|+|+
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCccccc----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence            4332111111  123689999853221 111111    24667778888889999999888887  89999999999999


Q ss_pred             CCCCcEEEeeeccccc
Q 016009          265 DLEFEAHVADFGIAKF  280 (397)
Q Consensus       265 ~~~~~~kl~Dfg~~~~  280 (397)
                      . +|.+.++|.+-+..
T Consensus       299 h-dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  299 H-DGKLYIIDVSQSVE  313 (520)
T ss_pred             E-CCEEEEEEcccccc
Confidence            5 45889999877653

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.53  E-value=0.0018  Score=58.59  Aligned_cols=146  Identities=18%  Similarity=0.304  Sum_probs=82.4

Q ss_pred             ccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC--CceeeeEEEEecCC--eeeEEEEecc
Q 016009          133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH--RNIVKLYGFCSHAR--HSFLVYEFLK  208 (397)
Q Consensus       133 lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~  208 (397)
                      ...|..-.+|..... ++.+++. ...  ............+|..+++.+.-  --+...+++|..+.  ..+.||+|++
T Consensus        33 ~~~G~sn~t~~~~~~-~~~~vlR-~P~--~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve  108 (321)
T COG3173          33 ISGGWSNDTFRLGDT-GQKYVLR-KPP--RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE  108 (321)
T ss_pred             ccCCcccceEEEecC-CceEEEe-cCC--ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence            333433444444432 7778877 221  11222234566788888888742  34455677776665  7799999998


Q ss_pred             CCCHHHhhccccc-----------------------------------cCCCCHHHHHHHH--------HHHHHHHHHHH
Q 016009          209 RGSLAAILSSDAA-----------------------------------AQELGWSQRMNVI--------KGVADALSYLH  245 (397)
Q Consensus       209 ~g~L~~~l~~~~~-----------------------------------~~~l~~~~~~~i~--------~~i~~~l~~Lh  245 (397)
                      |..+.+.+.....                                   .+--.|...++.+        -....-..||+
T Consensus       109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~  188 (321)
T COG3173         109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE  188 (321)
T ss_pred             ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence            8433222211000                                   0001111111100        01122345555


Q ss_pred             hCCC-----CCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          246 HDCF-----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       246 ~~~~-----~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      .+..     +.++|+|+.+.|++++++.-+-|.||+++..-.
T Consensus       189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            4432     468999999999999999889999999987643

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.47  E-value=2.1e-05  Score=82.27  Aligned_cols=162  Identities=14%  Similarity=0.063  Sum_probs=115.1

Q ss_pred             HHHHHHHHHHHhccCCceeeeEEEEe--cCCeeeEEEEeccCCCHHHhhccccc-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 016009          170 KEFLTEVEALTEIRHRNIVKLYGFCS--HARHSFLVYEFLKRGSLAAILSSDAA-AQELGWSQRMNVIKGVADALSYLHH  246 (397)
Q Consensus       170 ~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~  246 (397)
                      +....|.+-++...|+++.....-..  ...+.+.+++|+.+|.+.+.+-.+.. ...+...-+.....+......-.|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            34455555666678988776655442  33466889999999999999865432 1223333233333332444444444


Q ss_pred             CCC--CCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHH
Q 016009          247 DCF--PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEV  324 (397)
Q Consensus       247 ~~~--~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el  324 (397)
                      ...  .-.+|++||+-|.++..+..++++++|+.+...+.........+++.|++|+......++.++|+|..|+.+|+.
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence            321  236899999999999999999999999998444444445556788899999999888899999999999999999


Q ss_pred             HhCCCCC
Q 016009          325 IKGKHPR  331 (397)
Q Consensus       325 ~tg~~p~  331 (397)
                      .-|..++
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8888775

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.42  E-value=0.00033  Score=62.34  Aligned_cols=136  Identities=14%  Similarity=0.123  Sum_probs=91.0

Q ss_pred             CCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCC------------------CcchhcHHHHHHHHHHHHhccC--Cc
Q 016009          127 FDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLP------------------SDQIVDKKEFLTEVEALTEIRH--RN  186 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~~~~~e~~~l~~l~h--~n  186 (397)
                      ++..+.||-|.-+.+|.+...+|++.++|.=+....                  +......-...+|...|+.+..  --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            456778999999999999999999998885221000                  0011112234678888888843  33


Q ss_pred             eeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC
Q 016009          187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL  266 (397)
Q Consensus       187 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  266 (397)
                      +.+.++++    .-++|||++.+-.|...-+-      .+.++   +...+..-+.-|..+   |+||+|.+-=||++++
T Consensus       174 VPkpiD~~----RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  174 VPKPIDHN----RHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCccccc----ceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHHc---CceecccchheeEEec
Confidence            55555543    45789999988777654321      12222   333344445556666   9999999999999999


Q ss_pred             CCcEEEeeeccc
Q 016009          267 EFEAHVADFGIA  278 (397)
Q Consensus       267 ~~~~kl~Dfg~~  278 (397)
                      ++.++++||--.
T Consensus       238 d~~i~vIDFPQm  249 (465)
T KOG2268|consen  238 DDKIVVIDFPQM  249 (465)
T ss_pred             CCCEEEeechHh
Confidence            999999999644

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.28  E-value=0.0022  Score=57.54  Aligned_cols=73  Identities=22%  Similarity=0.322  Sum_probs=48.0

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc---CCceeeeEEEEecCCeeeEEEEe
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR---HRNIVKLYGFCSHARHSFLVYEF  206 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~  206 (397)
                      .+.++.|....+|+.. .+++.+.||.-.       ......|..|.+-|+.|.   --.+++++++....+..+||+||
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~-------~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS-------ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEE-------GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecC-------hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            4558888899999987 577889999843       122457888999888883   44577889988877788999999


Q ss_pred             ccCC
Q 016009          207 LKRG  210 (397)
Q Consensus       207 ~~~g  210 (397)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            9876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.27  E-value=0.0046  Score=55.40  Aligned_cols=31  Identities=26%  Similarity=0.431  Sum_probs=25.7

Q ss_pred             CCceeccCCCCcEEeCCCCc-EEEeeeccccc
Q 016009          250 PPIVHRDISSKNLLLDLEFE-AHVADFGIAKF  280 (397)
Q Consensus       250 ~~ivH~dlk~~Nill~~~~~-~kl~Dfg~~~~  280 (397)
                      +.++|+|+.+.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 46999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.19  E-value=0.0097  Score=55.75  Aligned_cols=77  Identities=18%  Similarity=0.207  Sum_probs=50.7

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCc-c--hhcHHHHHHHHHHHHhcc---CCceeeeEEEEecCCeeeEE
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD-Q--IVDKKEFLTEVEALTEIR---HRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~-~--~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  203 (397)
                      .+.+|.|....||+.... +..++||.-....... .  ......-..|.+.|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            456899999999998764 4569999854222110 0  112344455677776663   247888888887  446789


Q ss_pred             EEeccC
Q 016009          204 YEFLKR  209 (397)
Q Consensus       204 ~e~~~~  209 (397)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PLN02236 choline kinase

Probab=97.15  E-value=0.0082  Score=55.71  Aligned_cols=139  Identities=19%  Similarity=0.309  Sum_probs=78.9

Q ss_pred             ccccCcEEEEEEEeCC-----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCce-eeeEEEEecCCeeeEEEEe
Q 016009          133 IGNGGHGSVYRAELPS-----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI-VKLYGFCSHARHSFLVYEF  206 (397)
Q Consensus       133 lg~G~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~  206 (397)
                      +..|-...+|+....+     ++.|++|......  ...   -.-.+|..+++.+...++ .++++.+..+    .|.||
T Consensus        44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~---idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ef  114 (344)
T PLN02236         44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELF---FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEF  114 (344)
T ss_pred             cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Cee---echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEe
Confidence            4446667888886532     3678888765422  111   122578888888854333 3456665432    58999


Q ss_pred             ccCCCHHHh-----------------hccccc--cC-CCCHHHHHHHHHHH-----------------HHHHHHH----H
Q 016009          207 LKRGSLAAI-----------------LSSDAA--AQ-ELGWSQRMNVIKGV-----------------ADALSYL----H  245 (397)
Q Consensus       207 ~~~g~L~~~-----------------l~~~~~--~~-~l~~~~~~~i~~~i-----------------~~~l~~L----h  245 (397)
                      +++.++...                 ++....  .. ...|.++.++..++                 ...+..|    .
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            987766421                 111110  01 11233333333221                 1112222    2


Q ss_pred             h-CCCCCceeccCCCCcEEeCC-CCcEEEeeeccccc
Q 016009          246 H-DCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKF  280 (397)
Q Consensus       246 ~-~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~  280 (397)
                      . .....++|+|+++.||++++ ++.+.++||..+..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            1 12236899999999999986 46899999988864

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=97.13  E-value=0.01  Score=50.48  Aligned_cols=134  Identities=22%  Similarity=0.278  Sum_probs=82.1

Q ss_pred             cccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc---CCceeeeEEEEecCCeeeEEEEecc
Q 016009          132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR---HRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      .+.-|..-..|.... +..++.||.=.       ......|..|+.-|..+.   .-++.+++.+-....+.|+|+||++
T Consensus        23 ~v~gG~inea~~v~d-g~~~~FvK~n~-------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~   94 (286)
T COG3001          23 EVSGGDINEAWRLRD-GTDPFFVKCNQ-------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP   94 (286)
T ss_pred             ccCCccccceeEeec-CCcceEEEecc-------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence            344444444444433 45789999732       223467888888777773   4568888888889999999999999


Q ss_pred             CCCHHH--h---------hccccc---------------cCCCCHH---------HHHHHHHHH--------------HH
Q 016009          209 RGSLAA--I---------LSSDAA---------------AQELGWS---------QRMNVIKGV--------------AD  239 (397)
Q Consensus       209 ~g~L~~--~---------l~~~~~---------------~~~l~~~---------~~~~i~~~i--------------~~  239 (397)
                      -|.+..  .         |+....               .++-+|.         +|+-+..++              +.
T Consensus        95 ~~~~d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~  174 (286)
T COG3001          95 TGPLDAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVE  174 (286)
T ss_pred             CCCCCchhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHH
Confidence            876651  1         111110               0111222         233333333              33


Q ss_pred             HHHHHHhCCC--CCceeccCCCCcEEeCCCCcEEEee
Q 016009          240 ALSYLHHDCF--PPIVHRDISSKNLLLDLEFEAHVAD  274 (397)
Q Consensus       240 ~l~~Lh~~~~--~~ivH~dlk~~Nill~~~~~~kl~D  274 (397)
                      .+..+-..+.  |..+|+||-..|..+..+| +.+-|
T Consensus       175 ~v~elL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fD  210 (286)
T COG3001         175 KIQELLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFD  210 (286)
T ss_pred             HHHHHHhcCCCCcceeecccccccccccCCC-Ceeec
Confidence            4444433333  6899999999999999998 66655

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.07  E-value=0.0077  Score=55.40  Aligned_cols=76  Identities=14%  Similarity=0.152  Sum_probs=48.5

Q ss_pred             cccccCcEEEEEEEeCCC-CEEEEEecCCCCC---CcchhcHHHHHHHHHHHHhcc--CCc-eeeeEEEEecCCeeeEEE
Q 016009          132 CIGNGGHGSVYRAELPSG-QVVAIKKFHSPLP---SDQIVDKKEFLTEVEALTEIR--HRN-IVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~~-~~vavK~~~~~~~---~~~~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~  204 (397)
                      .||.|....||++..++| +.|+||.-..-..   ..-....++..-|.+.|+...  -|. +++++.  .++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            479999999999987655 5899997542221   111233455667778887763  343 444443  3445567899


Q ss_pred             EeccC
Q 016009          205 EFLKR  209 (397)
Q Consensus       205 e~~~~  209 (397)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.89  E-value=0.019  Score=52.59  Aligned_cols=29  Identities=31%  Similarity=0.387  Sum_probs=25.3

Q ss_pred             CCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          250 PPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       250 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 578999998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=96.82  E-value=0.00032  Score=36.09  Aligned_cols=18  Identities=39%  Similarity=0.719  Sum_probs=16.3

Q ss_pred             CCCEEecCCCcccccCCCC
Q 016009            3 GLSVIDISDNQLQGPVPNS   21 (397)
Q Consensus         3 ~L~~ldls~N~l~G~iP~~   21 (397)
                      +|++||||+|+|+ .||..
T Consensus         1 ~L~~Ldls~n~l~-~ip~~   18 (22)
T PF00560_consen    1 NLEYLDLSGNNLT-SIPSS   18 (22)
T ss_dssp             TESEEEETSSEES-EEGTT
T ss_pred             CccEEECCCCcCE-eCChh
Confidence            5899999999999 99974

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.62  E-value=0.015  Score=54.23  Aligned_cols=78  Identities=19%  Similarity=0.169  Sum_probs=51.0

Q ss_pred             CccccccCcEEEEEEEeCC-CCEEEEEecCCCCC--CcchhcHHHHHHHHHHHHhcc--CCc-eeeeEEEEecCCeeeEE
Q 016009          130 QYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLP--SDQIVDKKEFLTEVEALTEIR--HRN-IVKLYGFCSHARHSFLV  203 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv  203 (397)
                      .+.||.|....||++..++ ++.|+||.-..-..  ..-....++..-|.+.|+...  -|. +++++.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4568999999999998753 56799997543222  111334566777888888763  454 4445433  44556788


Q ss_pred             EEeccC
Q 016009          204 YEFLKR  209 (397)
Q Consensus       204 ~e~~~~  209 (397)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>PLN03150 hypothetical protein; Provisional

Probab=96.58  E-value=0.0048  Score=61.99  Aligned_cols=36  Identities=31%  Similarity=0.582  Sum_probs=22.8

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |++|+.||||+|+|+|.||.. ..+.++....+.+|.
T Consensus       465 l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~  501 (623)
T PLN03150        465 ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS  501 (623)
T ss_pred             CCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCc
Confidence            456777777777777777763 234445555566664

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.51  E-value=0.046  Score=50.11  Aligned_cols=136  Identities=21%  Similarity=0.280  Sum_probs=81.3

Q ss_pred             CcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc------eeeeEEE----EecCCeeeEEEEe
Q 016009          137 GHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN------IVKLYGF----CSHARHSFLVYEF  206 (397)
Q Consensus       137 ~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~----~~~~~~~~lv~e~  206 (397)
                      .-..+|+....+|+. ++|.....      ....++..|...+..+.-..      +..+=|-    ...+...+-+++|
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~------~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG------WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC------CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            456789998877776 88887642      23567788888888883211      2222221    1222367789999


Q ss_pred             ccCCCHHH-hh--------------c----cc----c-ccCCCCHHH-------------HHHHHHHHHHHHHHHHhCC-
Q 016009          207 LKRGSLAA-IL--------------S----SD----A-AAQELGWSQ-------------RMNVIKGVADALSYLHHDC-  248 (397)
Q Consensus       207 ~~~g~L~~-~l--------------~----~~----~-~~~~l~~~~-------------~~~i~~~i~~~l~~Lh~~~-  248 (397)
                      ++|..+.. ..              +    ..    . ......|..             ......++...+..+.+.. 
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99988873 11              0    00    0 111234431             0112233444444444432 


Q ss_pred             ---CCC---ceeccCCCCcEEeCCCCc-EEEeeecccc
Q 016009          249 ---FPP---IVHRDISSKNLLLDLEFE-AHVADFGIAK  279 (397)
Q Consensus       249 ---~~~---ivH~dlk~~Nill~~~~~-~kl~Dfg~~~  279 (397)
                         ...   +||+|+.|.||+++++.. ..+.||+-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               123   899999999999999885 8999998775

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.45  E-value=0.039  Score=50.90  Aligned_cols=139  Identities=17%  Similarity=0.261  Sum_probs=76.4

Q ss_pred             ccccCcEEEEEEEeCC----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCce-eeeEEEEecCCeeeEEEEec
Q 016009          133 IGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI-VKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       133 lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~  207 (397)
                      |..|-...+|+....+    +..|++|.......  ..   -.-.+|..+++.+..-++ .++++++.++    +|.+|+
T Consensus        22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~---IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi   92 (330)
T PLN02421         22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YV---IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFI   92 (330)
T ss_pred             eCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eE---echHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhh
Confidence            4446667788886543    23788887654221  11   223578888888865444 3456655322    589999


Q ss_pred             cCCCHHHh-----------------hccccc--cC-CCCHHHHHHHHHHH----------------------HHHHHHHH
Q 016009          208 KRGSLAAI-----------------LSSDAA--AQ-ELGWSQRMNVIKGV----------------------ADALSYLH  245 (397)
Q Consensus       208 ~~g~L~~~-----------------l~~~~~--~~-~l~~~~~~~i~~~i----------------------~~~l~~Lh  245 (397)
                      ++..|..-                 ++....  .. .--|..+.++..++                      ..-+..+.
T Consensus        93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  172 (330)
T PLN02421         93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK  172 (330)
T ss_pred             cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence            87665321                 111110  01 11233332222221                      11122211


Q ss_pred             ----hC-CCCCceeccCCCCcEEeCC-CCcEEEeeeccccc
Q 016009          246 ----HD-CFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKF  280 (397)
Q Consensus       246 ----~~-~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~  280 (397)
                          .. ...-.+|+|+.+.||++++ ++.++++||..+..
T Consensus       173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                11 1123689999999999975 57899999998864

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.42  E-value=0.095  Score=48.25  Aligned_cols=72  Identities=17%  Similarity=0.183  Sum_probs=45.5

Q ss_pred             cCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCC--ceeeeE---E--EEecCCeeeEEEEecc
Q 016009          136 GGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR--NIVKLY---G--FCSHARHSFLVYEFLK  208 (397)
Q Consensus       136 G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~---~--~~~~~~~~~lv~e~~~  208 (397)
                      +.-..||+...++|..+++|..+...     ....++..|.+.+..+...  .++...   |  ....++..+.++++++
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~  110 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG  110 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence            44577999988888889999865311     2356677888888777321  122211   1  1223456788999998


Q ss_pred             CCCH
Q 016009          209 RGSL  212 (397)
Q Consensus       209 ~g~L  212 (397)
                      |...
T Consensus       111 G~~~  114 (325)
T PRK11768        111 GRAP  114 (325)
T ss_pred             CCCC
Confidence            7643

>PRK06148 hypothetical protein; Provisional

Probab=96.30  E-value=0.075  Score=56.59  Aligned_cols=141  Identities=17%  Similarity=0.242  Sum_probs=78.3

Q ss_pred             cccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-------CCceeeeE-E----EEec-CC
Q 016009          132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-------HRNIVKLY-G----FCSH-AR  198 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-------h~niv~~~-~----~~~~-~~  198 (397)
                      .|+ |..-.+|+....+|+.+++|+.+...      .......|.+.|..+.       -|.+++-. |    .... ++
T Consensus        32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~------~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G  104 (1013)
T PRK06148         32 PLD-GERDLNFRLTTDDGADYILKIVNPSE------PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDG  104 (1013)
T ss_pred             ecC-CcCCceEEEEeCCCCeEEEEEcCCcc------chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCC
Confidence            454 45577899888888899999987521      1234445556666552       22333221 1    1111 12


Q ss_pred             --eeeEEEEeccCCCHHHhhc---------------------c--c-cccCCCCHHH-----------------HHHHHH
Q 016009          199 --HSFLVYEFLKRGSLAAILS---------------------S--D-AAAQELGWSQ-----------------RMNVIK  235 (397)
Q Consensus       199 --~~~lv~e~~~~g~L~~~l~---------------------~--~-~~~~~l~~~~-----------------~~~i~~  235 (397)
                        ..+-+++|++|..+.+...                     .  . ...+.+.|..                 ...++.
T Consensus       105 ~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~  184 (1013)
T PRK06148        105 EPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVE  184 (1013)
T ss_pred             ceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHH
Confidence              4567899999987765110                     0  0 0012233321                 112222


Q ss_pred             HHHHHHH-----HHHhCCCCCceeccCCCCcEEeCCCC--cEE-Eeeeccccc
Q 016009          236 GVADALS-----YLHHDCFPPIVHRDISSKNLLLDLEF--EAH-VADFGIAKF  280 (397)
Q Consensus       236 ~i~~~l~-----~Lh~~~~~~ivH~dlk~~Nill~~~~--~~k-l~Dfg~~~~  280 (397)
                      ++.+...     .+.+ ....+||+|+.+.||+++.++  ++. |+|||.+..
T Consensus       185 ~~~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        185 RFLARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            2322221     1222 234799999999999999875  454 999998753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.24  E-value=0.014  Score=50.07  Aligned_cols=29  Identities=28%  Similarity=0.472  Sum_probs=20.8

Q ss_pred             CceeccCCCCcEEe-CCCCcEEEeeecccc
Q 016009          251 PIVHRDISSKNLLL-DLEFEAHVADFGIAK  279 (397)
Q Consensus       251 ~ivH~dlk~~Nill-~~~~~~kl~Dfg~~~  279 (397)
                      .++|+|+.+.||++ +.++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            57899999999999 888999999998875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PTZ00384 choline kinase; Provisional

Probab=96.16  E-value=0.039  Score=51.80  Aligned_cols=29  Identities=28%  Similarity=0.282  Sum_probs=24.4

Q ss_pred             CceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          251 PIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       251 ~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ..+|.|+-+.||+.+++ .+.++||..+..
T Consensus       228 VfCHNDL~~gNIL~~~~-~l~lID~EYA~~  256 (383)
T PTZ00384        228 LFCHNDLFFTNILDFNQ-GIYFIDFDFAGF  256 (383)
T ss_pred             eeeeccCCcccEEecCC-CEEEEEeccccC
Confidence            57899999999997654 699999988764

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.83  E-value=0.08  Score=44.99  Aligned_cols=151  Identities=15%  Similarity=0.151  Sum_probs=87.4

Q ss_pred             CcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEeccCCCHHHhh
Q 016009          137 GHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAIL  216 (397)
Q Consensus       137 ~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l  216 (397)
                      +-.+.-.+..+-| +..+|++....-   .....-|..+.+++++++  .|+++..=  +....-++.|+|..-.     
T Consensus        74 gNsTl~~~kt~iG-~L~lKKi~slp~---~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----  140 (308)
T PF07387_consen   74 GNSTLLIGKTKIG-PLFLKKIRSLPC---CINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----  140 (308)
T ss_pred             CceEEEEeccccc-hhhhhhccCCCc---ccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----
Confidence            3344444433333 456666653111   112355678888888885  46666621  3334568889874311     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCccccccccc
Q 016009          217 SSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG  296 (397)
Q Consensus       217 ~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~  296 (397)
                                ....-.|..+ ..+|.-.|+.. .+.+|+|-.|+||+-|..|.+||.|-+.--  +          .+..
T Consensus       141 ----------i~~~N~i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~----------~~V~  196 (308)
T PF07387_consen  141 ----------INFSNFITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--E----------NQVN  196 (308)
T ss_pred             ----------cchhHHHHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhh--h----------heee
Confidence                      0111122222 35677788654 389999999999999999999999976432  1          0111


Q ss_pred             ccCcccccCCCCCcchhhHHHHHHHHHHHhC
Q 016009          297 YVAPELAYTMKITEKCDVYSFGVLALEVIKG  327 (397)
Q Consensus       297 y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg  327 (397)
                      |.--|+   ...|+++.+-+|=.-++++...
T Consensus       197 ~vN~~Y---~~lT~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  197 MVNIEY---ESLTQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             EEeeec---cccChHHHHHHHHHHHHHHHHH
Confidence            222111   2346777777777777777663

The function of this family is unknown.

>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D

Probab=95.72  E-value=0.0062  Score=28.96  Aligned_cols=14  Identities=36%  Similarity=0.646  Sum_probs=10.0

Q ss_pred             CCCCEEecCCCccc
Q 016009            2 HGLSVIDISDNQLQ   15 (397)
Q Consensus         2 ~~L~~ldls~N~l~   15 (397)
                      ++|+.||||+|+|+
T Consensus         1 ~~L~~L~l~~n~L~   14 (17)
T PF13504_consen    1 PNLRTLDLSNNRLT   14 (17)
T ss_dssp             TT-SEEEETSS--S
T ss_pred             CccCEEECCCCCCC
Confidence            57999999999986

...

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	397
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-38
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-37
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-30
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-30
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-29
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-28
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-28
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-25
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-21
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-20
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-09
3soa_A	444	Full-Length Human Camkii Length = 444		4e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		8e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		9e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 94/289 (32%), Positives = 144/289 (49%), Gaps = 16/289 (5%)
Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA 178
           E+  A+++F  +  +G GG G VY+  L  G +VA+K+          +   +F TEVE 
Sbjct: 32  ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL---QFQTEVEM 88
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE-LGWSQRMNVIKGV 237
           ++   HRN+++L GFC       LVY ++  G            Q  L W +R  +  G 
Sbjct: 89  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 148
Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK-PDSSNWTEFAGTYG 296
           A  L+YLH  C P I+HRD+ + N+LLD EFEA V DFG+AK +   D        GT G
Sbjct: 149 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIG 208
Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS---------SFLNTDIE 347
           ++APE   T K +EK DV+ +GV+ LE+I G+   D     +            L  + +
Sbjct: 209 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 268
Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           L+ ++D  L    +   E++  +++V   C   SP  RP M  V + L+
Sbjct: 269 LEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 93/289 (32%), Positives = 143/289 (49%), Gaps = 16/289 (5%)
Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA 178
           E+  A+++F  +  +G GG G VY+  L  G +VA+K+            + +F TEVE 
Sbjct: 24  ELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQG---GELQFQTEVEM 80
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE-LGWSQRMNVIKGV 237
           ++   HRN+++L GFC       LVY ++  G            Q  L W +R  +  G 
Sbjct: 81  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK-PDSSNWTEFAGTYG 296
           A  L+YLH  C P I+HRD+ + N+LLD EFEA V DFG+AK +   D        G  G
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIG 200
Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS---------FLNTDIE 347
           ++APE   T K +EK DV+ +GV+ LE+I G+   D     +            L  + +
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260
Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           L+ ++D  L    +   E++  +++V   C   SP  RP M  V + L+
Sbjct: 261 LEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 97/290 (33%), Positives = 147/290 (50%), Gaps = 23/290 (7%)
Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA 178
           ++  ATN+FD ++ IG+G  G VY+  L  G  VA+K+  +P  S      +EF TE+E 
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQ---GIEEFETEIET 88
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-XQELGWSQRMNVIKGV 237
           L+  RH ++V L GFC       L+Y++++ G               + W QR+ +  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA----G 293
           A  L YLH      I+HRD+ S N+LLD  F   + DFGI+K  K    + T       G
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLXXVVKG 203
Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKH------PRDFLSSISSSF-LNTDI 346
           T GY+ PE     ++TEK DVYSFGV+  EV+  +       PR+ ++    +   + + 
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 347 ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +L++++DP L    R   E LR   +    CL  S E RP+M  V  +L+
Sbjct: 264 QLEQIVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 97/290 (33%), Positives = 146/290 (50%), Gaps = 23/290 (7%)
Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA 178
           ++  ATN+FD ++ IG+G  G VY+  L  G  VA+K+  +P  S      +EF TE+E 
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQ---GIEEFETEIET 88
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-XQELGWSQRMNVIKGV 237
           L+  RH ++V L GFC       L+Y++++ G               + W QR+ +  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA----G 293
           A  L YLH      I+HRD+ S N+LLD  F   + DFGI+K  K      T       G
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXVVKG 203
Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKH------PRDFLSSISSSF-LNTDI 346
           T GY+ PE     ++TEK DVYSFGV+  EV+  +       PR+ ++    +   + + 
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 347 ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +L++++DP L    R   E LR   +    CL  S E RP+M  V  +L+
Sbjct: 264 QLEQIVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 139/293 (47%), Gaps = 24/293 (8%)
Query: 119 EIVRATNDFDAQYC------IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEF 172
           E+   TN+FD +        +G GG G VY+  + +   VA+KK  + +       K++F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMN 232
             E++ + + +H N+V+L GF S      LVY ++  G              L W  R  
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK--PDSSNWTE 290
           + +G A+ +++LH +     +HRDI S N+LLD  F A ++DFG+A+  +    +   + 
Sbjct: 138 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSR 194
Query: 291 FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG-------KHPRDFLSSISSSFLN 343
             GT  Y+APE A   +IT K D+YSFGV+ LE+I G       + P+  L         
Sbjct: 195 IVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 253
Query: 344 TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                D +      A S SV+    ++  V   CL+E    RP +K V Q LQ
Sbjct: 254 EKTIEDYIDKKMNDADSTSVE----AMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 138/293 (47%), Gaps = 24/293 (8%)
Query: 119 EIVRATNDFDAQYC------IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEF 172
           E+   TN+FD +        +G GG G VY+  + +   VA+KK  + +       K++F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMN 232
             E++ + + +H N+V+L GF S      LVY ++  G              L W  R  
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK--PDSSNWTE 290
           + +G A+ +++LH +     +HRDI S N+LLD  F A ++DFG+A+  +    +     
Sbjct: 138 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXR 194
Query: 291 FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG-------KHPRDFLSSISSSFLN 343
             GT  Y+APE A   +IT K D+YSFGV+ LE+I G       + P+  L         
Sbjct: 195 IVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 253
Query: 344 TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                D +      A S SV+    ++  V   CL+E    RP +K V Q LQ
Sbjct: 254 EKTIEDYIDKKMNDADSTSVE----AMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 138/293 (47%), Gaps = 24/293 (8%)
Query: 119 EIVRATNDFDAQYC------IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEF 172
           E+   TN+FD +        +G GG G VY+  + +   VA+KK  + +       K++F
Sbjct: 13  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 71
Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMN 232
             E++ + + +H N+V+L GF S      LVY ++  G              L W  R  
Sbjct: 72  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 131
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTE 290
           + +G A+ +++LH +     +HRDI S N+LLD  F A ++DFG+A+  +  +       
Sbjct: 132 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXR 188
Query: 291 FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG-------KHPRDFLSSISSSFLN 343
             GT  Y+APE A   +IT K D+YSFGV+ LE+I G       + P+  L         
Sbjct: 189 IVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 247
Query: 344 TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                D +      A S SV+    ++  V   CL+E    RP +K V Q LQ
Sbjct: 248 EKTIEDYIDKKMNDADSTSVE----AMYSVASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 133/293 (45%), Gaps = 24/293 (8%)
Query: 119 EIVRATNDFDAQYC------IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEF 172
           E+   TN+FD +         G GG G VY+  + +   VA+KK  + +       K++F
Sbjct: 10  ELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 68
Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMN 232
             E++   + +H N+V+L GF S      LVY +   G              L W  R  
Sbjct: 69  DQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCK 128
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK--PDSSNWTE 290
           + +G A+ +++LH +     +HRDI S N+LLD  F A ++DFG+A+  +        + 
Sbjct: 129 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSR 185
Query: 291 FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG-------KHPRDFLSSISSSFLN 343
             GT  Y APE A   +IT K D+YSFGV+ LE+I G       + P+  L         
Sbjct: 186 IVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 244
Query: 344 TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                D +      A S SV+    +   V   CL+E    RP +K V Q LQ
Sbjct: 245 EKTIEDYIDKKXNDADSTSVE----AXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 139/297 (46%), Gaps = 32/297 (10%)
Query: 109 LNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIK-----KFHSPLPS 163
           L F+G +  D++     D + +  IG G  G+V+RAE   G  VA+K      FH+    
Sbjct: 21  LYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA---- 75
Query: 164 DQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQ 223
           +++    EFL EV  +  +RH NIV   G  +   +  +V E+L RG            +
Sbjct: 76  ERV---NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 132
Query: 224 ELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP 283
           +L   +R+++   VA  ++YLH+   PPIVHRD+ S NLL+D ++   V DFG+++    
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
Query: 284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSS----ISS 339
                   AGT  ++APE+       EK DVYSFGV+  E+   + P   L+      + 
Sbjct: 192 XFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251
Query: 340 SFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            F    +E+   L+P++ A              ++  C    P  RP+   +   L+
Sbjct: 252 GFKCKRLEIPRNLNPQVAA--------------IIEGCWTNEPWKRPSFATIMDLLR 294

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 140/297 (47%), Gaps = 32/297 (10%)
Query: 109 LNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIK-----KFHSPLPS 163
           L F+G +  D++     D + +  IG G  G+V+RAE   G  VA+K      FH+    
Sbjct: 21  LYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA---- 75
Query: 164 DQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQ 223
           +++    EFL EV  +  +RH NIV   G  +   +  +V E+L RG            +
Sbjct: 76  ERV---NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 132
Query: 224 ELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP 283
           +L   +R+++   VA  ++YLH+   PPIVHR++ S NLL+D ++   V DFG+++    
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
Query: 284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSS----ISS 339
              +    AGT  ++APE+       EK DVYSFGV+  E+   + P   L+      + 
Sbjct: 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251
Query: 340 SFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            F    +E+   L+P++ A              ++  C    P  RP+   +   L+
Sbjct: 252 GFKCKRLEIPRNLNPQVAA--------------IIEGCWTNEPWKRPSFATIMDLLR 294

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 135/284 (47%), Gaps = 27/284 (9%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELPSGQ-VVAIKKF---HSPLPSDQIVDKKEFLTEVEA 178
           A N+ + +  IG GG G V++  L   + VVAIK      S   ++ I   +EF  EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA 238
           ++ + H NIVKLYG   +     +V EF+  G              + WS ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIA 132
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFE-----AHVADFGIAKFLKPDSSNWTEFAG 293
             + Y+ +   PPIVHRD+ S N+ L    E     A VADFG+++       + +   G
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---QSVHSVSGLLG 188
Query: 294 TYGYVAPEL--AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM 351
            + ++APE   A     TEK D YSF ++   ++ G+ P D  S     F+N   E  E 
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE--EG 246
Query: 352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           L P +P        +LR+++E+   C +  P+ RP    + ++L
Sbjct: 247 LRPTIP---EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 134/284 (47%), Gaps = 27/284 (9%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELPSGQ-VVAIKKF---HSPLPSDQIVDKKEFLTEVEA 178
           A N+ + +  IG GG G V++  L   + VVAIK      S   ++ I   +EF  EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA 238
           ++ + H NIVKLYG   +     +V EF+  G              + WS ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIA 132
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFE-----AHVADFGIAKFLKPDSSNWTEFAG 293
             + Y+ +   PPIVHRD+ S N+ L    E     A VADFG ++       + +   G
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ---QSVHSVSGLLG 188
Query: 294 TYGYVAPEL--AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM 351
            + ++APE   A     TEK D YSF ++   ++ G+ P D  S     F+N   E  E 
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE--EG 246
Query: 352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           L P +P        +LR+++E+   C +  P+ RP    + ++L
Sbjct: 247 LRPTIP---EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 126/261 (48%), Gaps = 27/261 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G+G  G V   +      VA+K     +  +  + + EF  E + + ++ H  +VK YG
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVK-----MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            CS     ++V E++  G             E   SQ + +   V + +++L    F   
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP--SQLLEMCYDVCEGMAFLESHQF--- 125
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSNWTEFAGTYGYVAPELAYTMKIT 309
           +HRD++++N L+D +    V+DFG+ +++  D   SS  T+F   +   APE+ +  K +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS--APEVFHYFKYS 183
Query: 310 EKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
            K DV++FG+L  EV   GK P D        + N+++ L      RL  P  +      
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDL-------YTNSEVVLKVSQGHRLYRPHLASD---- 232
Query: 369 SIVEVVFSCLNESPESRPTMK 389
           +I ++++SC +E PE RPT +
Sbjct: 233 TIYQIMYSCWHELPEKRPTFQ 253

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 134/284 (47%), Gaps = 27/284 (9%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELPSGQ-VVAIKKF---HSPLPSDQIVDKKEFLTEVEA 178
           A N+ + +  IG GG G V++  L   + VVAIK      S   ++ I   +EF  EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA 238
           ++ + H NIVKLYG   +     +V EF+  G              + WS ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIA 132
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFE-----AHVADFGIAKFLKPDSSNWTEFAG 293
             + Y+ +   PPIVHRD+ S N+ L    E     A VADF +++       + +   G
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---QSVHSVSGLLG 188
Query: 294 TYGYVAPEL--AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM 351
            + ++APE   A     TEK D YSF ++   ++ G+ P D  S     F+N   E  E 
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE--EG 246
Query: 352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           L P +P        +LR+++E+   C +  P+ RP    + ++L
Sbjct: 247 LRPTIP---EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 124/273 (45%), Gaps = 29/273 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDK--KEFLTEVEALTEIRHRNIVKL 190
           IG GG G VYRA     +V      H P   D+ + +  +    E +    ++H NI+ L
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDP---DEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
            G C    +  LV EF + G             ++     +N    +A  ++YLH +   
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI----LVNWAVQIARGMNYLHDEAIV 127
Query: 251 PIVHRDISSKNLLLDLEFE--------AHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           PI+HRD+ S N+L+  + E          + DFG+A+     +      AG Y ++APE+
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYAWMAPEV 185
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
                 ++  DV+S+GVL  E++ G+ P   +  ++ ++    + ++++    LP PS +
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY---GVAMNKL---ALPIPS-T 238
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             E    ++E    C N  P SRP+   +  QL
Sbjct: 239 CPEPFAKLME---DCWNPDPHSRPSFTNILDQL 268

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 24/277 (8%)
Query: 114 KLVYDEIVRATND-FDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE 171
           KL  D + +   + FD    +G G +GSVY+A    +GQ+VAIK+   P+ SD     +E
Sbjct: 17  KLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDL----QE 70
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
            + E+  + +    ++VK YG        ++V E+   G            + L   +  
Sbjct: 71  IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC--GAGSVSDIIRLRNKTLTEDEIA 128
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
            +++     L YLH   F   +HRDI + N+LL+ E  A +ADFG+A  L    +     
Sbjct: 129 TILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXV 185
Query: 292 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM 351
            GT  ++APE+   +      D++S G+ A+E+ +GK P   +  + + F+         
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI-------- 237
Query: 352 LDPRLPAPS-RSVQEKLRSIVEVVFSCLNESPESRPT 387
             P  P P+ R  +    +  + V  CL +SPE R T
Sbjct: 238 --PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT 272

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 68
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+  RG             E    +    I  +A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE---QRTATYITELANA 125
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T   GT  Y+ P
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 180
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 63
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  TE  GT  Y+ P
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPP 175
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 68
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+  RG             E    +    I  +A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE---QRTATYITELANA 125
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS      GT  Y+ P
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPP 180
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 64
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 121
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T+  GT  Y+ P
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPP 176
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 63
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T+  GT  Y+ P
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPP 175
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 63
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T+  GT  Y+ P
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPP 175
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 68
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 125
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T+  GT  Y+ P
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPP 180
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 68
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 125
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T   GT  Y+ P
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 180
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 63
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T   GT  Y+ P
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 175
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 67
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 124
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T   GT  Y+ P
Sbjct: 125 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 179
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 35/294 (11%)
Query: 118 DEIVRA-TNDFDAQYC-----IGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIV 167
           +E VR    + D  Y      IG G  G V R  L +       VAIK         Q  
Sbjct: 3   NEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-- 60
Query: 168 DKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW 227
            ++EFL+E   + +  H NI++L G  +++    ++ EF++ G             +   
Sbjct: 61  -RREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG--QFTV 117
Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
            Q + +++G+A  + YL    +   VHRD++++N+L++      V+DFG+++FL+ +SS+
Sbjct: 118 IQLVGMLRGIASGMRYLAEMSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD 174
Query: 288 WTEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSF 341
            TE +   G     + APE     K T   D +S+G++  EV+  G+ P      +S+  
Sbjct: 175 PTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP---YWDMSNQD 231
Query: 342 LNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           +   IE D  L P    P+        S+ +++  C  +   +RP    V   L
Sbjct: 232 VINAIEQDYRLPPPPDCPT--------SLHQLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 89
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 146
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T   GT  Y+ P
Sbjct: 147 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 201
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 66
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 123
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T   GT  Y+ P
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 178
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 63
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T   GT  Y+ P
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPP 175
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 80
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 137
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T   GT  Y+ P
Sbjct: 138 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 192
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 62
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 119
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T   GT  Y+ P
Sbjct: 120 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 174
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 66
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 123
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T   GT  Y+ P
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 178
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 136/294 (46%), Gaps = 29/294 (9%)
Query: 109 LNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIV 167
           L F+G   YD+      D   ++ +G G +G VY        + VA+K        +  +
Sbjct: 10  LYFQGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTM 64
Query: 168 DKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW 227
           + +EFL E   + EI+H N+V+L G C+     +++ EF+  G            QE+  
Sbjct: 65  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVNA 123
Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
              + +   ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  
Sbjct: 124 VVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-- 178
Query: 288 WTEFAGT---YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
           +T  AG      + APE LAY  K + K DV++FGVL  E+   G  P   +       L
Sbjct: 179 YTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------L 231
Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +   EL E  D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 232 SQVYELLEK-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 280

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 64
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 121
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +      SS  T  +GT  Y+ P
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPP 176
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 124/266 (46%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V   +      VAIK     +  +  + + EF+ E + +  + H  +V+LYG
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C+  R  F++ E++  G             +    Q + + K V +A+ YL    F   
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQF--- 141
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 306
           +HRD++++N L++ +    V+DFG+++++  D     E+  + G      +  PE+    
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLMYS 196
Query: 307 KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
           K + K D+++FGVL  E+   GK P +        F N++         RL  P  + ++
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYE-------RFTNSETAEHIAQGLRLYRPHLASEK 249
Query: 366 KLRSIVEVVFSCLNESPESRPTMKIV 391
               +  +++SC +E  + RPT KI+
Sbjct: 250 ----VYTIMYSCWHEKADERPTFKIL 271

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 124/266 (46%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V   +      VAIK     +  +  + + EF+ E + +  + H  +V+LYG
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C+  R  F++ E++  G             +    Q + + K V +A+ YL    F   
Sbjct: 78  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQF--- 132
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 306
           +HRD++++N L++ +    V+DFG+++++  D     E+  + G      +  PE+    
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLMYS 187
Query: 307 KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
           K + K D+++FGVL  E+   GK P +        F N++         RL  P  + ++
Sbjct: 188 KFSSKSDIWAFGVLMWEIYSLGKMPYE-------RFTNSETAEHIAQGLRLYRPHLASEK 240
Query: 366 KLRSIVEVVFSCLNESPESRPTMKIV 391
               +  +++SC +E  + RPT KI+
Sbjct: 241 ----VYTIMYSCWHEKADERPTFKIL 262

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 125/263 (47%), Gaps = 27/263 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V   +      VAIK     +  +  + + EF+ E + +  + H  +V+LYG
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C+  R  F++ E++  G             +    Q + + K V +A+ YL    F   
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQF--- 126
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSNWTEFAGTYGYVAPELAYTMKIT 309
           +HRD++++N L++ +    V+DFG+++++  D   SS  ++F   +    PE+    K +
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWS--PPEVLMYSKFS 184
Query: 310 EKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
            K D+++FGVL  E+   GK P +        F N++         RL  P  + ++   
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYE-------RFTNSETAEHIAQGLRLYRPHLASEK--- 234
Query: 369 SIVEVVFSCLNESPESRPTMKIV 391
            +  +++SC +E  + RPT KI+
Sbjct: 235 -VYTIMYSCWHEKADERPTFKIL 256

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 124/266 (46%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V   +      VAIK     +  +  + + EF+ E + +  + H  +V+LYG
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C+  R  F++ E++  G             +    Q + + K V +A+ YL    F   
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQF--- 126
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 306
           +HRD++++N L++ +    V+DFG+++++  D     E+  + G      +  PE+    
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLMYS 181
Query: 307 KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
           K + K D+++FGVL  E+   GK P +        F N++         RL  P  + ++
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPYE-------RFTNSETAEHIAQGLRLYRPHLASEK 234
Query: 366 KLRSIVEVVFSCLNESPESRPTMKIV 391
               +  +++SC +E  + RPT KI+
Sbjct: 235 ----VYTIMYSCWHEKADERPTFKIL 256

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 124/266 (46%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V   +      VAIK     +  +  + + EF+ E + +  + H  +V+LYG
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C+  R  F++ E++  G             +    Q + + K V +A+ YL    F   
Sbjct: 71  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQF--- 125
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 306
           +HRD++++N L++ +    V+DFG+++++  D     E+  + G      +  PE+    
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLMYS 180
Query: 307 KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
           K + K D+++FGVL  E+   GK P +        F N++         RL  P  + ++
Sbjct: 181 KFSSKSDIWAFGVLMWEIYSLGKMPYE-------RFTNSETAEHIAQGLRLYRPHLASEK 233
Query: 366 KLRSIVEVVFSCLNESPESRPTMKIV 391
               +  +++SC +E  + RPT KI+
Sbjct: 234 ----VYTIMYSCWHEKADERPTFKIL 255

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 68
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 125
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T   GT  Y+ P
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 180
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E        EK D++S GVL  E + GK P
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 89
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 146
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS   +  GT  Y+ P
Sbjct: 147 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPP 201
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 66
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 123
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS   +  GT  Y+ P
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPP 178
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 123/266 (46%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V   +      VAIK     +  +  + + EF+ E + +  + H  +V+LYG
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C+  R  F++ E++  G                  Q + + K V +A+ YL    F   
Sbjct: 67  VCTKQRPIFIITEYMANG--CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF--- 121
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 306
           +HRD++++N L++ +    V+DFG+++++  D     E+  + G      +  PE+    
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLMYS 176
Query: 307 KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
           K + K D+++FGVL  E+   GK P +        F N++         RL  P  + ++
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYE-------RFTNSETAEHIAQGLRLYRPHLASEK 229
Query: 366 KLRSIVEVVFSCLNESPESRPTMKIV 391
               +  +++SC +E  + RPT KI+
Sbjct: 230 ----VYTIMYSCWHEKADERPTFKIL 251

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALTEI 182
            DFD    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  + +
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGV--EHQLRREVEIQSHL 69
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
           RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+ALS
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRTATYITELANALS 126
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T   GT  Y+ PE+
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 181
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHP 330
                  EK D++S GVL  E + G  P
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 8/208 (3%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           A  DF+    +G G  G+VY A     + +   K       ++   + +   EVE  + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
           RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+ALS
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 119
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      ++HRDI  +NLLL    E  +ADFG +  +   SS  T   GT  Y+ PE+
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 174
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHP 330
                  EK D++S GVL  E + GK P
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 65
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 122
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +A+FG +  +   SS  T   GT  Y+ P
Sbjct: 123 LSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPP 177
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 125/263 (47%), Gaps = 27/263 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V   +      VAIK     +  +  + + EF+ E + +  + H  +V+LYG
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C+  R  F++ E++  G             +    Q + + K V +A+ YL    F   
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQF--- 141
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSNWTEFAGTYGYVAPELAYTMKIT 309
           +HRD++++N L++ +    V+DFG+++++  D   SS  ++F   +    PE+    K +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWS--PPEVLMYSKFS 199
Query: 310 EKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
            K D+++FGVL  E+   GK P +        F N++         RL  P  + ++   
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYE-------RFTNSETAEHIAQGLRLYRPHLASEK--- 249
Query: 369 SIVEVVFSCLNESPESRPTMKIV 391
            +  +++SC +E  + RPT KI+
Sbjct: 250 -VYTIMYSCWHEKADERPTFKIL 271

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 66
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 123
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +A+FG +  +   SS  T   GT  Y+ P
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPP 178
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 66
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 123
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS      GT  Y+ P
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPP 178
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 65
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 122
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS      GT  Y+ P
Sbjct: 123 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPP 177
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 63
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS      GT  Y+ P
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPP 175
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 63
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS      GT  Y+ P
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPP 175
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 66
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 123
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS      GT  Y+ P
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPP 178
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 64
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+A
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 121
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS      GT  Y+ P
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPP 176
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 102/243 (41%), Gaps = 30/243 (12%)
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS 228
           ++ FL EV+ +  + H N++K  G     +    + E++K G             +  WS
Sbjct: 51  QRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD--SQYPWS 108
Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL------- 281
           QR++  K +A  ++YLH      I+HRD++S N L+       VADFG+A+ +       
Sbjct: 109 QRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165
Query: 282 -------KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDF 333
                  KPD        G   ++APE+       EK DV+SFG++  E+I +     D+
Sbjct: 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225
Query: 334 LSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ 393
           L       LN    LD    P  P           S   +   C +  PE RP+   +  
Sbjct: 226 LPRTMDFGLNVRGFLDRYCPPNCPP----------SFFPITVRCCDLDPEKRPSFVKLEH 275
Query: 394 QLQ 396
            L+
Sbjct: 276 WLE 278

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G+VY A ++ +GQ VAI++ +      Q   K+  + E+  + E ++ NIV   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                    ++V E+L  G            +     Q   V +    AL +LH +    
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN---Q 136
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           ++HRDI S N+LL ++    + DFG    + P+ S  +E  GT  ++APE+        K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 312 CDVYSFGVLALEVIKGKHP 330
            D++S G++A+E+I+G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 123/264 (46%), Gaps = 29/264 (10%)
Query: 133 IGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G V R  L +       VAIK         Q   ++EFL+E   + +  H NI+
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ---RREFLSEASIMGQFEHPNII 78
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  +++    ++ EF++ G             +    Q + +++G+A  + YL    
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDG--QFTVIQLVGMLRGIASGMRYLAEMS 136
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG-----YVAPELA 303
           +   VHRD++++N+L++      V+DFG+++FL+ +SS+ T  +   G     + APE  
Sbjct: 137 Y---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 304 YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
              K T   D +S+G++  EV+  G+ P      +S+  +   IE D  L P    P+  
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMSFGERP---YWDMSNQDVINAIEQDYRLPPPPDCPT-- 248
Query: 363 VQEKLRSIVEVVFSCLNESPESRP 386
                 S+ +++  C  +   +RP
Sbjct: 249 ------SLHQLMLDCWQKDRNARP 266

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 124/268 (46%), Gaps = 29/268 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G V+     +   VAIK       S++     +F+ E E + ++ H  +V+LYG
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQLYG 72
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C       LV+EF++ G                    + +   V + ++YL   C   +
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEAC---V 127
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSNWTEFAGTYGYVAPELAYTMKIT 309
           +HRD++++N L+       V+DFG+ +F+  D   SS  T+F     + +PE+    + +
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSRYS 185
Query: 310 EKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELD-EMLDPRLPAPSRSVQEKL 367
            K DV+SFGVL  EV  +GK P +   + S+S +  DI     +  PRL +         
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLYKPRLAST-------- 234
Query: 368 RSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + +++  C  E PE RP    + +QL
Sbjct: 235 -HVYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 124/268 (46%), Gaps = 29/268 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G V+     +   VAIK       S++     +F+ E E + ++ H  +V+LYG
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQLYG 69
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C       LV+EF++ G                    + +   V + ++YL   C   +
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEAC---V 124
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSNWTEFAGTYGYVAPELAYTMKIT 309
           +HRD++++N L+       V+DFG+ +F+  D   SS  T+F     + +PE+    + +
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSRYS 182
Query: 310 EKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELD-EMLDPRLPAPSRSVQEKL 367
            K DV+SFGVL  EV  +GK P +   + S+S +  DI     +  PRL +         
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLYKPRLAST-------- 231
Query: 368 RSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + +++  C  E PE RP    + +QL
Sbjct: 232 -HVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 124/268 (46%), Gaps = 29/268 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G V+     +   VAIK       S++     +F+ E E + ++ H  +V+LYG
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQLYG 67
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C       LV+EF++ G                    + +   V + ++YL   C   +
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSNWTEFAGTYGYVAPELAYTMKIT 309
           +HRD++++N L+       V+DFG+ +F+  D   SS  T+F     + +PE+    + +
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSRYS 180
Query: 310 EKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELD-EMLDPRLPAPSRSVQEKL 367
            K DV+SFGVL  EV  +GK P +   + S+S +  DI     +  PRL +         
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLYKPRLAST-------- 229
Query: 368 RSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + +++  C  E PE RP    + +QL
Sbjct: 230 -HVYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALT 180
           A  DF+    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGV--EHQLRREVEIQS 63
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI++LYG+   +   +L+ E+   G             E    +    I  +A+A
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANA 120
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LSY H      ++HRDI  +NLLL    E  +ADFG +  +   SS      GT  Y+ P
Sbjct: 121 LSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPP 175
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E+       EK D++S GVL  E + GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 64
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMAT 123
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 179 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 231
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 232 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G V+ AE           +VA+K    P     +  +K+F  E E LT ++H +
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEH 78
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXX-------------XXXXQELGWSQRMNV 233
           IVK YG C       +V+E++K G                          ELG SQ +++
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG 293
              +A  + YL    F   VHRD++++N L+       + DFG+++ +   S+++    G
Sbjct: 139 ASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGG 193
Query: 294 ----TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIEL 348
                  ++ PE     K T + DV+SFGV+  E+   GK P   LS       NT++ +
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-------NTEV-I 245
Query: 349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           + +   R+    R      + + +V+  C    P+ R  +K + + L 
Sbjct: 246 ECITQGRVLERPRVCP---KEVYDVMLGCWQREPQQRLNIKEIYKILH 290

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 63
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMAT 122
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 123 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 177
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 178 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 230
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 231 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 271

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 64
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMAT 123
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 179 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 231
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 232 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALTEI 182
            DFD    +G G  G+VY A E  S  ++A+K  F + L    +  + +   EVE  + +
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGV--EHQLRREVEIQSHL 69
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
           RH NI++LYG+   A   +L+ E+   G             E    +    I  +A+ALS
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRTATYITELANALS 126
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      ++HRDI  +NLLL    E  +ADFG +  +   SS      GT  Y+ PE+
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEM 181
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHP 330
                  EK D++S GVL  E + G  P
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 59
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYG-NLLDYLRECNRQEVSAVVLLYMAT 118
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 174 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 226
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 227 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 59
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMAT 118
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 174 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 226
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 227 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 59
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYG-NLLDYLRECNRQEVSAVVLLYMAT 118
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 174 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 226
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 227 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 59
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMAT 118
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 174 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 226
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 227 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 59
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMAT 118
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 174 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 226
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 227 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 59
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMAT 118
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 174 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 226
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 227 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 64
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMAT 123
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 179 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 231
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 232 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 131/286 (45%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 64
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMAT 123
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+   T  AG  
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAK 178
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 179 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 231
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 232 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 61
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMAT 120
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 121 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 175
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 176 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 228
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 229 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 64
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYG-NLLDYLRECNRQEVNAVVLLYMAT 123
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 179 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 231
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 232 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 131/286 (45%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 60
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYG-NLLDYLRECNRQEVNAVVLLYMAT 119
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+   T  AG  
Sbjct: 120 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAK 174
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 175 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 227
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 228 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 61
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMAT 120
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 121 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 175
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 176 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 228
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 229 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 125/267 (46%), Gaps = 29/267 (10%)
Query: 130 QYCIGNGGHGSVYRA--ELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR 185
           +  IG G  G V     +LP  +   VAIK   S     Q   +++FL+E   + +  H 
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ---RRDFLSEASIMGQFDHP 94
Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           N++ L G  + +    ++ EF++ G             +    Q + +++G+A  + YL 
Sbjct: 95  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLA 152
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG-----YVAP 300
              +   VHRD++++N+L++      V+DFG+++FL+ D+S+ T  +   G     + AP
Sbjct: 153 DMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 209
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           E     K T   DV+S+G++  EV+  G+ P  +    +   +N  IE D  L P +  P
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTNQDVINA-IEQDYRLPPPMDCP 266
Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRP 386
           S        ++ +++  C  +    RP
Sbjct: 267 S--------ALHQLMLDCWQKDRNHRP 285

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 29/268 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G V+     +   VAIK        +  + + +F+ E E + ++ H  +V+LYG
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTI-----KEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C       LV+EF++ G                    + +   V + ++YL   C   +
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEAC---V 144
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSNWTEFAGTYGYVAPELAYTMKIT 309
           +HRD++++N L+       V+DFG+ +F+  D   SS  T+F     + +PE+    + +
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSRYS 202
Query: 310 EKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELD-EMLDPRLPAPSRSVQEKL 367
            K DV+SFGVL  EV  +GK P +   + S+S +  DI     +  PRL +         
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLYKPRLAST-------- 251
Query: 368 RSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + +++  C  E PE RP    + +QL
Sbjct: 252 -HVYQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 305
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMAT 364
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HR+++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 365 QISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 419
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 420 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 472
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 473 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 513

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 121/272 (44%), Gaps = 40/272 (14%)
Query: 130 QYCIGNGGHGSVYRAELPSGQ-----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           Q  IG G  G VY+  L +        VAIK   +     Q VD   FL E   + +  H
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD---FLGEAGIMGQFSH 105
Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
            NI++L G  S  +   ++ E+++ G             E    Q + +++G+A  + YL
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYL 163
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGTYG--YVAPE 301
            +  +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + APE
Sbjct: 164 ANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 302 LAYTMKITEKCDVYSFGVLALEVIK-GKHP------RDFLSSISSSFLNTDIELDEMLDP 354
                K T   DV+SFG++  EV+  G+ P       + + +I+  F             
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------------- 267
Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRP 386
           RLP P     +   +I +++  C  +    RP
Sbjct: 268 RLPTP----MDCPSAIYQLMMQCWQQERARRP 295

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 61
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMAT 120
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 121 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAK 175
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 176 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 228
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 229 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 60
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMAT 119
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 120 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAK 174
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 175 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 227
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 228 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY        + VA+K        +  ++ +EFL E
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 266
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G            QE+     + +  
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMAT 325
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT- 294
            ++ A+ YL    F   +HR+++++N L+       VADFG+++ +  D+  +T  AG  
Sbjct: 326 QISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 380
Query: 295 --YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDE 350
               + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E
Sbjct: 381 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLE 433
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             D R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 434 K-DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 474

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 29/268 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G V+     +   VAIK       S++     +F+ E E + ++ H  +V+LYG
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQLYG 70
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C       LV EF++ G                    + +   V + ++YL   C   +
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEAC---V 125
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSNWTEFAGTYGYVAPELAYTMKIT 309
           +HRD++++N L+       V+DFG+ +F+  D   SS  T+F     + +PE+    + +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSRYS 183
Query: 310 EKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELD-EMLDPRLPAPSRSVQEKL 367
            K DV+SFGVL  EV  +GK P +   + S+S +  DI     +  PRL +         
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLYKPRLAST-------- 232
Query: 368 RSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + +++  C  E PE RP    + +QL
Sbjct: 233 -HVYQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G+VY A ++ +GQ VAI++ +      Q   K+  + E+  + E ++ NIV   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                    ++V E+L  G            +     Q   V +    AL +LH +    
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN---Q 136
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           ++HRDI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 312 CDVYSFGVLALEVIKGKHP 330
            D++S G++A+E+I+G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G+VY A ++ +GQ VAI++ +      Q   K+  + E+  + E ++ NIV   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                    ++V E+L  G            +     Q   V +    AL +LH +    
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN---Q 136
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           ++HRDI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 312 CDVYSFGVLALEVIKGKHP 330
            D++S G++A+E+I+G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G+VY A ++ +GQ VAI++ +      Q   K+  + E+  + E ++ NIV   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                    ++V E+L  G            +     Q   V +    AL +LH +    
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN---Q 137
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           ++HRDI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        K
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 312 CDVYSFGVLALEVIKGKHP 330
            D++S G++A+E+I+G+ P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 78  VVSE-EPIYIVTEYMNKGSLLDFLKGETG-KYLRLPQLVDMSAQIASGMAYVERMNY--- 132
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           VHRD+ + N+L+       VADFG+A+ +  + + WT   G      + APE A   + T
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFT 190
Query: 310 EKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P   
Sbjct: 191 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPEC 237
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +    S+ +++  C  + PE RPT + +   L+
Sbjct: 238 PE----SLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 126/278 (45%), Gaps = 29/278 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
            D   ++ +G G +G VY        + VA+K        +  ++ +EFL E   + EI+
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIK 65
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           H N+V+L G C+     +++ EF+  G            QE+     + +   ++ A+ Y
Sbjct: 66  HPNLVQLLGVCTREPPFYIIIEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAP 300
           L    F   +HRD++++N L+       VADFG+++ +  D+   T  AG      + AP
Sbjct: 125 LEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAP 179
Query: 301 E-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           E LAY  K + K DV++FGVL  E+   G  P      I  S +   +E D  ++     
Sbjct: 180 ESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP---YPGIDPSQVYELLEKDYRMERPEGC 235
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           P +        + E++ +C   +P  RP+   + Q  +
Sbjct: 236 PEK--------VYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 14/232 (6%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKK--FHSPLPSDQIVDKKEFLTEVEALTEI 182
           +DFD    +G G  G+VY A     + +   K  F S L  + +  + +   E+E  + +
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV--EHQLRREIEIQSHL 72
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
           RH NI+++Y +    +  +L+ EF  RG             E    +    ++ +ADAL 
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADALH 129
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      ++HRDI  +NLL+  + E  +ADFG +  +   S       GT  Y+ PE+
Sbjct: 130 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEM 184
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--SFLNTDIELDEML 352
                  EK D++  GVL  E + G  P D  S   +    +N D++    L
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 236

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 140/318 (44%), Gaps = 59/318 (18%)
Query: 109 LNFEGKL----------VYDEIVRATNDFDAQY---------CIGNGGHGSVY--RAELP 147
           L F+GKL           Y+E  RA   F  +           IG+G  G V   R  +P
Sbjct: 14  LYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVP 73
Query: 148 SGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE 205
             +   VAIK   +     Q   +++FL+E   + +  H NI++L G  +  R + +V E
Sbjct: 74  GQRDVPVAIKALKAGYTERQ---RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130
Query: 206 FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD 265
           +++ G             +    Q + +++GV   + YL    +   VHRD++++N+L+D
Sbjct: 131 YMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVD 185
Query: 266 LEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLAL 322
                 V+DFG+++ L+ D  + +T   G     + APE       +   DV+SFGV+  
Sbjct: 186 SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMW 245
Query: 323 EVIK-GKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVF 375
           EV+  G+ P      RD +SS+   +             RLPAP         ++ +++ 
Sbjct: 246 EVLAYGERPYWNMTNRDVISSVEEGY-------------RLPAPMGCPH----ALHQLML 288
Query: 376 SCLNESPESRPTM-KIVS 392
            C ++    RP   +IVS
Sbjct: 289 DCWHKDRAQRPRFSQIVS 306

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 14/234 (5%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKK--FHSPLPSDQIVDKKEFLTEVEALT 180
             +DFD    +G G  G+VY A     + +   K  F S L  + +  + +   E+E  +
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV--EHQLRREIEIQS 69
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            +RH NI+++Y +    +  +L+ EF  RG             E    +    ++ +ADA
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADA 126
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           L Y H      ++HRDI  +NLL+  + E  +ADFG +  +   S       GT  Y+ P
Sbjct: 127 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPP 181
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--SFLNTDIELDEML 352
           E+       EK D++  GVL  E + G  P D  S   +    +N D++    L
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 235

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 129/295 (43%), Gaps = 43/295 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRAE----LPS--GQVVAIKKFHSPLPSDQIVDKKEFLTEVEA 178
            D   ++ +G G  G V+ AE    LP     +VA+K       S     +++F  E E 
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA----RQDFQREAEL 96
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRG------------XXXXXXXXXXXXQELG 226
           LT ++H++IV+ +G C+  R   +V+E+++ G                          LG
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS 286
             Q + V   VA  + YL    F   VHRD++++N L+       + DFG+++ +   S+
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--ST 211
Query: 287 NWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSF 341
           ++    G       ++ PE     K T + DV+SFGV+  E+   GK P   LS+  +  
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-- 269
Query: 342 LNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           ++   +  E+  PR   P          +  ++  C    P+ R ++K V  +LQ
Sbjct: 270 IDCITQGRELERPRACPP---------EVYAIMRGCWQREPQQRHSIKDVHARLQ 315

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 123/268 (45%), Gaps = 29/268 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G V+     +   VAIK       S++     +F+ E E + ++ H  +V+LYG
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQLYG 69
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C       LV+EF++ G                    + +   V + ++YL       +
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEE---ASV 124
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSNWTEFAGTYGYVAPELAYTMKIT 309
           +HRD++++N L+       V+DFG+ +F+  D   SS  T+F     + +PE+    + +
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSRYS 182
Query: 310 EKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELD-EMLDPRLPAPSRSVQEKL 367
            K DV+SFGVL  EV  +GK P +   + S+S +  DI     +  PRL +         
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLYKPRLAST-------- 231
Query: 368 RSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + +++  C  E PE RP    + +QL
Sbjct: 232 -HVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 127/278 (45%), Gaps = 29/278 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
            D   ++ +G G +G VY        + VA+K        +  ++ +EFL E   + EI+
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIK 65
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           H N+V+L G C+     +++ EF+  G            QE+     + +   ++ A+ Y
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAP 300
           L    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG      + AP
Sbjct: 125 LEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--FTAHAGAKFPIKWTAP 179
Query: 301 E-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           E LAY  K + K DV++FGVL  E+   G  P      I  S +   +E D  ++     
Sbjct: 180 ESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP---YPGIDPSQVYELLEKDYRMERPEGC 235
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           P +        + E++ +C   +P  RP+   + Q  +
Sbjct: 236 PEK--------VYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 123/264 (46%), Gaps = 29/264 (10%)
Query: 133 IGNGGHGSVYRA--ELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G V     +LP  +   VAIK   S     Q   +++FL+E   + +  H N++
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ---RRDFLSEASIMGQFDHPNVI 71
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
            L G  + +    ++ EF++ G             +    Q + +++G+A  + YL    
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN 129
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG-----YVAPELA 303
           +   VHR ++++N+L++      V+DFG+++FL+ D+S+ T  +   G     + APE  
Sbjct: 130 Y---VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 304 YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
              K T   DV+S+G++  EV+  G+ P  +    +   +N  IE D  L P +  PS  
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTNQDVINA-IEQDYRLPPPMDCPS-- 241
Query: 363 VQEKLRSIVEVVFSCLNESPESRP 386
                 ++ +++  C  +    RP
Sbjct: 242 ------ALHQLMLDCWQKDRNHRP 259

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRAE----LPS--GQVVAIKKFHSPLPSDQIVDKKEFLTEVEA 178
            D   ++ +G G  G V+ AE    LP     +VA+K       S     +++F  E E 
Sbjct: 18  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA----RQDFQREAEL 73
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE------------LG 226
           LT ++H++IV+ +G C+  R   +V+E+++ G             +            LG
Sbjct: 74  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 133
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS 286
             Q + V   VA  + YL    F   VHRD++++N L+       + DFG+++ +   S+
Sbjct: 134 LGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--ST 188
Query: 287 NWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSF 341
           ++    G       ++ PE     K T + DV+SFGV+  E+   GK P   LS+  +  
Sbjct: 189 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-- 246
Query: 342 LNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           ++   +  E+  PR   P          +  ++  C    P+ R ++K V  +LQ
Sbjct: 247 IDCITQGRELERPRACPP---------EVYAIMRGCWQREPQQRHSIKDVHARLQ 292

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 140/318 (44%), Gaps = 59/318 (18%)
Query: 109 LNFEGKL----------VYDEIVRATNDFDAQY---------CIGNGGHGSVY--RAELP 147
           L F+GKL           Y+E  RA   F  +           IG+G  G V   R  +P
Sbjct: 14  LYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVP 73
Query: 148 SGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYE 205
             +   VAIK   +     Q   +++FL+E   + +  H NI++L G  +  R + +V E
Sbjct: 74  GQRDVPVAIKALKAGYTERQ---RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130
Query: 206 FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD 265
           +++ G             +    Q + +++GV   + YL    +   VHRD++++N+L+D
Sbjct: 131 YMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVD 185
Query: 266 LEFEAHVADFGIAKFLK--PDSSNWTEFAGT-YGYVAPELAYTMKITEKCDVYSFGVLAL 322
                 V+DFG+++ L+  PD++  T        + APE       +   DV+SFGV+  
Sbjct: 186 SNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMW 245
Query: 323 EVIK-GKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVF 375
           EV+  G+ P      RD +SS+   +             RLPAP         ++ +++ 
Sbjct: 246 EVLAYGERPYWNMTNRDVISSVEEGY-------------RLPAPMGCPH----ALHQLML 288
Query: 376 SCLNESPESRPTM-KIVS 392
            C ++    RP   +IVS
Sbjct: 289 DCWHKDRAQRPRFSQIVS 306

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRAE----LPS--GQVVAIKKFHSPLPSDQIVDKKEFLTEVEA 178
            D   ++ +G G  G V+ AE    LP     +VA+K       S     +++F  E E 
Sbjct: 12  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA----RQDFQREAEL 67
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE------------LG 226
           LT ++H++IV+ +G C+  R   +V+E+++ G             +            LG
Sbjct: 68  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 127
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS 286
             Q + V   VA  + YL    F   VHRD++++N L+       + DFG+++ +   S+
Sbjct: 128 LGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--ST 182
Query: 287 NWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSF 341
           ++    G       ++ PE     K T + DV+SFGV+  E+   GK P   LS+  +  
Sbjct: 183 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-- 240
Query: 342 LNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           ++   +  E+  PR   P          +  ++  C    P+ R ++K V  +LQ
Sbjct: 241 IDCITQGRELERPRACPP---------EVYAIMRGCWQREPQQRHSIKDVHARLQ 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 124/281 (44%), Gaps = 32/281 (11%)
Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           +D++ Q  IG+G    V  A   P  + VAIK+ +  L   Q     E L E++A+++  
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQ-TSMDELLKEIQAMSQCH 66
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE-----LGWSQRMNVIKGVA 238
           H NIV  Y         +LV + L  G             E     L  S    +++ V 
Sbjct: 67  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-----SSNWTEFAG 293
           + L YLH +     +HRD+ + N+LL  +    +ADFG++ FL        +     F G
Sbjct: 127 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 294 TYGYVAPELAYTMKITE-KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML 352
           T  ++APE+   ++  + K D++SFG+ A+E+  G  P      +    L          
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN------ 237
Query: 353 DPRLPAPSRSVQEKL------RSIVEVVFSCLNESPESRPT 387
           DP  P+    VQ+K       +S  +++  CL + PE RPT
Sbjct: 238 DP--PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 276

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 108/241 (44%), Gaps = 35/241 (14%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G+VY A ++ +GQ VAI++ +      Q   K+  + E+  + E ++ NIV   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                    ++V E+L  G            +     Q   V +    AL +LH +    
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN---Q 137
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           ++HR+I S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        K
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 197
Query: 312 CDVYSFGVLALEVIKGKHPR-----------------------DFLSSISSSFLNTDIEL 348
            D++S G++A+E+I+G+ P                        + LS+I   FLN  +E+
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 257
Query: 349 D 349
           D
Sbjct: 258 D 258

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 124/281 (44%), Gaps = 32/281 (11%)
Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           +D++ Q  IG+G    V  A   P  + VAIK+ +  L   Q     E L E++A+++  
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQ-TSMDELLKEIQAMSQCH 71
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE-----LGWSQRMNVIKGVA 238
           H NIV  Y         +LV + L  G             E     L  S    +++ V 
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-----SSNWTEFAG 293
           + L YLH +     +HRD+ + N+LL  +    +ADFG++ FL        +     F G
Sbjct: 132 EGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 294 TYGYVAPELAYTMKITE-KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML 352
           T  ++APE+   ++  + K D++SFG+ A+E+  G  P      +    L          
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN------ 242
Query: 353 DPRLPAPSRSVQEKL------RSIVEVVFSCLNESPESRPT 387
           DP  P+    VQ+K       +S  +++  CL + PE RPT
Sbjct: 243 DP--PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 29/278 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
            D   ++ +G G  G VY        + VA+K        +  ++ +EFL E   + EI+
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIK 65
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           H N+V+L G C+     +++ EF+  G            QE+     + +   ++ A+ Y
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAP 300
           L    F   +HRD++++N L+       VADFG+++ +  D+   T  AG      + AP
Sbjct: 125 LEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAP 179
Query: 301 E-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           E LAY  K + K DV++FGVL  E+   G  P      I  S +   +E D  ++     
Sbjct: 180 ESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP---YPGIDPSQVYELLEKDYRMERPEGC 235
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           P +        + E++ +C   +P  RP+   + Q  +
Sbjct: 236 PEK--------VYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 115/260 (44%), Gaps = 26/260 (10%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G V++  +  + QVVAIK        D+I D ++   E+  L++     + K Y
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSSYVTKYY 87
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G        +++ E+L  G            +     Q   ++K +   L YLH +    
Sbjct: 88  GSYLKGSKLWIIMEYLGGGSALDLLRAGPFDE----FQIATMLKEILKGLDYLHSE---K 140
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
            +HRDI + N+LL  + +  +ADFG+A  L         F GT  ++APE+        K
Sbjct: 141 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 200
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA--PSRSVQEKLRS 369
            D++S G+ A+E+ KG+ P   +  +   FL             +P   P   V +  +S
Sbjct: 201 ADIWSLGITAIELAKGEPPNSDMHPMRVLFL-------------IPKNNPPTLVGDFTKS 247
Query: 370 IVEVVFSCLNESPESRPTMK 389
             E + +CLN+ P  RPT K
Sbjct: 248 FKEFIDACLNKDPSFRPTAK 267

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 118/266 (44%), Gaps = 22/266 (8%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
            + + +  +G G  G V +A+    + VAIK+  S        ++K F+ E+  L+ + H
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE------SERKAFIVELRQLSRVNH 61
Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
            NIVKLYG C +     LV E+ + G                 +  M+     +  ++YL
Sbjct: 62  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           H      ++HRD+   NLLL        + DFG A  ++   ++ T   G+  ++APE+ 
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVF 176
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
                +EKCDV+S+G++  EVI  + P D    I          +     P L      +
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPFD---EIGGPAFRIMWAVHNGTRPPL------I 227
Query: 364 QEKLRSIVEVVFSCLNESPESRPTMK 389
           +   + I  ++  C ++ P  RP+M+
Sbjct: 228 KNLPKPIESLMTRCWSKDPSQRPSME 253

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 35/272 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +GNG  G V+         VAIK           +  + FL E + + +++H  +V+LY 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKP-----GTMSPESFLEEAQIMKKLKHDKLVQLYA 71
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L     +++   VA  ++Y+    +   
Sbjct: 72  VVSE-EPIYIVTEYMNKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMNY--- 126
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ S N+L+       +ADFG+A+ ++ +     + A     + APE A   + T K
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 312 CDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ 364
            DV+SFG+L  E++ KG+ P      R+ L  +   +             R+P P    Q
Sbjct: 187 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-------------RMPCP----Q 229
Query: 365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +   S+ E++  C  + PE RPT + +   L+
Sbjct: 230 DCPISLHELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 118/266 (44%), Gaps = 22/266 (8%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
            + + +  +G G  G V +A+    + VAIK+  S        ++K F+ E+  L+ + H
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE------SERKAFIVELRQLSRVNH 60
Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
            NIVKLYG C +     LV E+ + G                 +  M+     +  ++YL
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           H      ++HRD+   NLLL        + DFG A  ++   ++ T   G+  ++APE+ 
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVF 175
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
                +EKCDV+S+G++  EVI  + P D    I          +     P L      +
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFD---EIGGPAFRIMWAVHNGTRPPL------I 226
Query: 364 QEKLRSIVEVVFSCLNESPESRPTMK 389
           +   + I  ++  C ++ P  RP+M+
Sbjct: 227 KNLPKPIESLMTRCWSKDPSQRPSME 252

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + +IRH  +V+LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKIRHEKLVQLYA 80
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 81  VVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           VHRD+ + N+L+       VADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 310 EKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P   
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPEC 240
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +    S+ +++  C  + PE RPT + +   L+
Sbjct: 241 PE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 121/274 (44%), Gaps = 39/274 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 81  VVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           VHRD+++ N+L+       VADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 310 EKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P   
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPEC 240
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +    S+ +++  C  + PE RPT + +   L+
Sbjct: 241 PE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 119/272 (43%), Gaps = 35/272 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 81  VVSE-EPIYIVIEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           VHRD+ + N+L+       VADFG+A+ ++ +     + A     + APE A   + T K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 312 CDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ 364
            DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P    +
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPECPE 242
Query: 365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
               S+ +++  C  + PE RPT + +   L+
Sbjct: 243 ----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 81  VVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           VHRD+ + N+L+       VADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 310 EKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P   
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPEC 240
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +    S+ +++  C  + PE RPT + +   L+
Sbjct: 241 PE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 130/265 (49%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKF-HSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL 190
           IG+G  G+VY A ++ + +VVAIKK  +S   S++    ++ + EV  L ++RH N ++ 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE--KWQDIIKEVRFLQKLRHPNTIQY 119
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH-HDCF 249
            G       ++LV E+                QE+   +   V  G    L+YLH H+  
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV---EIAAVTHGALQGLAYLHSHN-- 174
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM--- 306
             ++HRD+ + N+LL       + DFG A  + P +     F GT  ++APE+   M   
Sbjct: 175 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEG 228
Query: 307 KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
           +   K DV+S G+  +E+ + K P   ++++S+ +      + +   P L +   S  E 
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HIAQNESPALQSGHWS--EY 281
Query: 367 LRSIVEVVFSCLNESPESRPTMKIV 391
            R+ V+   SCL + P+ RPT +++
Sbjct: 282 FRNFVD---SCLQKIPQDRPTSEVL 303

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 69
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 70  VVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 124
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           VHRD+ + N+L+       VADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 182
Query: 310 EKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P   
Sbjct: 183 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPEC 229
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +    S+ +++  C  + PE RPT + +   L+
Sbjct: 230 PE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 71
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 72  VVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 126
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           VHRD+ + N+L+       VADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 184
Query: 310 EKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P   
Sbjct: 185 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPEC 231
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +    S+ +++  C  + PE RPT + +   L+
Sbjct: 232 PE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 81  VVSE-EPIYIVMEYMSKGCLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           VHRD+ + N+L+       VADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 310 EKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P   
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPEC 240
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +    S+ +++  C  + PE RPT + +   L+
Sbjct: 241 PE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 73
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 74  VVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 128
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           VHRD+ + N+L+       VADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 186
Query: 310 EKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P   
Sbjct: 187 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPEC 233
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +    S+ +++  C  + PE RPT + +   L+
Sbjct: 234 PE----SLHDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 81  VVSE-EPIYIVIEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           VHRD+ + N+L+       VADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 310 EKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P   
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPEC 240
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +    S+ +++  C  + PE RPT + +   L+
Sbjct: 241 PE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 81  VVSE-EPIYIVCEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           VHRD+ + N+L+       VADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 310 EKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P   
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPEC 240
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +    S+ +++  C  + PE RPT + +   L+
Sbjct: 241 PE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 130/265 (49%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKF-HSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL 190
           IG+G  G+VY A ++ + +VVAIKK  +S   S++    ++ + EV  L ++RH N ++ 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE--KWQDIIKEVRFLQKLRHPNTIQY 80
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH-HDCF 249
            G       ++LV E+                QE+   +   V  G    L+YLH H+  
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV---EIAAVTHGALQGLAYLHSHN-- 135
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM--- 306
             ++HRD+ + N+LL       + DFG A  + P +     F GT  ++APE+   M   
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEG 189
Query: 307 KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
           +   K DV+S G+  +E+ + K P   ++++S+ +      + +   P L +   S  E 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HIAQNESPALQSGHWS--EY 242
Query: 367 LRSIVEVVFSCLNESPESRPTMKIV 391
            R+ V+   SCL + P+ RPT +++
Sbjct: 243 FRNFVD---SCLQKIPQDRPTSEVL 264

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 81  VVSE-EPIYIVTEYMSKGCLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           VHRD+ + N+L+       VADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 310 EKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P   
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPEC 240
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +    S+ +++  C  + PE RPT + +   L+
Sbjct: 241 PE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 45/277 (16%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 384
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 306
           VHRD+ + N+L+       VADFG+A+ ++ +     E+    G      + APE A   
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 439
Query: 307 KITEKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           + T K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCP 486
Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                E   S+ +++  C  + PE RPT + +   L+
Sbjct: 487 P----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 120/277 (43%), Gaps = 45/277 (16%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK       S +      FL E + + ++RH  +V+LY 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQVMKKLRHEKLVQLYA 246
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 301
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 306
           VHRD+ + N+L+       VADFG+A+ ++ +     E+    G      + APE A   
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 356
Query: 307 KITEKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           + T K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCP 403
Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                E   S+ +++  C  + PE RPT + +   L+
Sbjct: 404 P----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 78  VVSE-EPIYIVTEYMNKGSLLDFLKGETG-KYLRLPQLVDMSAQIASGMAYVERMNY--- 132
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTMKIT 309
           VHRD+ + N+L+       VADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 190
Query: 310 EKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P   
Sbjct: 191 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPEC 237
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +    S+ +++  C  + PE RPT + +   L+
Sbjct: 238 PE----SLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 120/277 (43%), Gaps = 45/277 (16%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK       S +      FL E + + ++RH  +V+LY 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQVMKKLRHEKLVQLYA 246
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 301
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 306
           VHRD+ + N+L+       VADFG+A+ ++ +     E+    G      + APE A   
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 356
Query: 307 KITEKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           + T K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCP 403
Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                E   S+ +++  C  + PE RPT + +   L+
Sbjct: 404 P----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 120/277 (43%), Gaps = 45/277 (16%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK       S +      FL E + + ++RH  +V+LY 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQVMKKLRHEKLVQLYA 246
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 247 VVSE-EPIYIVGEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 301
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 306
           VHRD+ + N+L+       VADFG+A+ ++ +     E+    G      + APE A   
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 356
Query: 307 KITEKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           + T K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCP 403
Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                E   S+ +++  C  + PE RPT + +   L+
Sbjct: 404 P----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 35/272 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 70
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S      +V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 71  VVSE-EPIXIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 125
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           VHRD+ + N+L+       VADFG+A+ ++ +     + A     + APE A   + T K
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 312 CDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ 364
            DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P    +
Sbjct: 186 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPECPE 232
Query: 365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
               S+ +++  C  + PE RPT + +   L+
Sbjct: 233 ----SLHDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 121/277 (43%), Gaps = 45/277 (16%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VAIK      P +  +  + FL E + + ++RH  +V+LY 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGN--MSPEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             S     ++V E++ +G            + L   Q +++   +A  ++Y+    +   
Sbjct: 248 VVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 302
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 306
           VHRD+ + N+L+       VADFG+ + ++ +     E+    G      + APE A   
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDN-----EYTARQGAKFPIKWTAPEAALYG 357
Query: 307 KITEKCDVYSFGVLALEV-IKGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           + T K DV+SFG+L  E+  KG+ P      R+ L  +   +             R+P P
Sbjct: 358 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCP 404
Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                E   S+ +++  C  + PE RPT + +   L+
Sbjct: 405 P----ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 28/296 (9%)
Query: 109 LNFEGKLVYDEIVRATNDFDAQYCIG---NGGHGSVYRAELPSGQVVAIKKFHSPLPSDQ 165
           L F+    Y+ + R  N  D    IG   +G  G VY+A+     V+A  K       ++
Sbjct: 18  LYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 77
Query: 166 IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQEL 225
           + D   ++ E++ L    H NIVKL     +  + +++ EF   G            + L
Sbjct: 78  LED---YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPL 132
Query: 226 GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS 285
             SQ   V K   DAL+YLH +    I+HRD+ + N+L  L+ +  +ADFG++       
Sbjct: 133 TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXI 189
Query: 286 SNWTEFAGTYGYVAPELAYTMKITE-----KCDVYSFGVLALEVIKGKHPRDFLSSISSS 340
                F GT  ++APE+       +     K DV+S G+  +E+ + + P   L+     
Sbjct: 190 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---- 245
Query: 341 FLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +   +++ +   P L  PSR       +  + +  CL ++ ++R T    SQ LQ
Sbjct: 246 -MRVLLKIAKSEPPTLAQPSRWSS----NFKDFLKKCLEKNVDARWT---TSQLLQ 293

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 28/296 (9%)
Query: 109 LNFEGKLVYDEIVRATNDFDAQYCIG---NGGHGSVYRAELPSGQVVAIKKFHSPLPSDQ 165
           L F+    Y+ + R  N  D    IG   +G  G VY+A+     V+A  K       ++
Sbjct: 18  LYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 77
Query: 166 IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQEL 225
           + D   ++ E++ L    H NIVKL     +  + +++ EF   G            + L
Sbjct: 78  LED---YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPL 132
Query: 226 GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS 285
             SQ   V K   DAL+YLH +    I+HRD+ + N+L  L+ +  +ADFG++       
Sbjct: 133 TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 189
Query: 286 SNWTEFAGTYGYVAPELAYTMKITE-----KCDVYSFGVLALEVIKGKHPRDFLSSISSS 340
                F GT  ++APE+       +     K DV+S G+  +E+ + + P   L+     
Sbjct: 190 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---- 245
Query: 341 FLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +   +++ +   P L  PSR       +  + +  CL ++ ++R T    SQ LQ
Sbjct: 246 -MRVLLKIAKSEPPTLAQPSRWSS----NFKDFLKKCLEKNVDARWT---TSQLLQ 293

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 28/296 (9%)
Query: 109 LNFEGKLVYDEIVRATNDFDAQYCIG---NGGHGSVYRAELPSGQVVAIKKFHSPLPSDQ 165
           L F+    Y+ + R  N  D    IG   +G  G VY+A+     V+A  K       ++
Sbjct: 18  LYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 77
Query: 166 IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQEL 225
           + D   ++ E++ L    H NIVKL     +  + +++ EF   G            + L
Sbjct: 78  LED---YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPL 132
Query: 226 GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS 285
             SQ   V K   DAL+YLH +    I+HRD+ + N+L  L+ +  +ADFG++       
Sbjct: 133 TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXI 189
Query: 286 SNWTEFAGTYGYVAPELAYTMKITE-----KCDVYSFGVLALEVIKGKHPRDFLSSISSS 340
                F GT  ++APE+       +     K DV+S G+  +E+ + + P   L+     
Sbjct: 190 QRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---- 245
Query: 341 FLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +   +++ +   P L  PSR       +  + +  CL ++ ++R T    SQ LQ
Sbjct: 246 -MRVLLKIAKSEPPTLAQPSRWSS----NFKDFLKKCLEKNVDARWT---TSQLLQ 293

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 129/271 (47%), Gaps = 32/271 (11%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V   R +LPS +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 109
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E+++ G             +    Q + +++G+A  + YL    
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+A+ L+ D  + +T   G     + +PE    
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI--ELDEMLDPRLPAPSRS 362
            K T   DV+S+G++  EV+  G+ P   +S       N D+   +DE    RLP P   
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDEGY--RLPPP--- 272
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTM-KIVS 392
             +   ++ +++  C  +   +RP   +IVS
Sbjct: 273 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 129/271 (47%), Gaps = 32/271 (11%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V   R +LPS +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 109
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E+++ G             +    Q + +++G+A  + YL    
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           F   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + +PE    
Sbjct: 168 F---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI--ELDEMLDPRLPAPSRS 362
            K T   DV+S+G++  EV+  G+ P   +S       N D+   +DE    RLP P   
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDEGY--RLPPP--- 272
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTM-KIVS 392
             +   ++ +++  C  +   +RP   +IVS
Sbjct: 273 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 114/258 (44%), Gaps = 22/258 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G V++  +  + +VVAIK        D+I D ++   E+  L++     + K Y
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 91
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G        +++ E+L  G              L  +Q   +++ +   L YLH +    
Sbjct: 92  GSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---K 144
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
            +HRDI + N+LL    E  +ADFG+A  L         F GT  ++APE+        K
Sbjct: 145 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 204
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            D++S G+ A+E+ +G+ P   L  +   FL        +     P    +  + L+  V
Sbjct: 205 ADIWSLGITAIELARGEPPHSELHPMKVLFL--------IPKNNPPTLEGNYSKPLKEFV 256
Query: 372 EVVFSCLNESPESRPTMK 389
           E   +CLN+ P  RPT K
Sbjct: 257 E---ACLNKEPSFRPTAK 271

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 127 FDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRH 184
            D+   IG G  G V  A E  SG+ VA+K     L   Q   ++E L  EV  + + +H
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQ---RRELLFNEVVIMRDYQH 101
Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
            N+V++Y         +++ EFL+ G            +E    Q   V + V  AL+YL
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE----QIATVCEAVLQALAYL 157
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
           H      ++HRDI S ++LL L+    ++DFG    +  D        GT  ++APE+  
Sbjct: 158 HAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVIS 214
Query: 305 TMKITEKCDVYSFGVLALEVIKGKHP 330
                 + D++S G++ +E++ G+ P
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 24/261 (9%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G+G  G VY+A+      +A  K       +++ D   ++ E+E L    H  IVKL G
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED---YIVEIEILATCDHPYIVKLLG 75
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
              H    +++ EF   G            + L   Q   V + + +AL++LH      I
Sbjct: 76  AYYHDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RI 130
Query: 253 VHRDISSKNLLLDLEFEAHVADFGI-AKFLKPDSSNWTEFAGTYGYVAPELAY--TMKIT 309
           +HRD+ + N+L+ LE +  +ADFG+ AK LK        F GT  ++APE+    TMK T
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMCETMKDT 189
Query: 310 E---KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
               K D++S G+  +E+ + + P   L+      +   +++ +   P L  PS+   E 
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSDPPTLLTPSKWSVE- 243
Query: 367 LRSIVEVVFSCLNESPESRPT 387
            R  +++    L+++PE+RP+
Sbjct: 244 FRDFLKI---ALDKNPETRPS 261

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 41/285 (14%)
Query: 133 IGNGGHGSVYRAEL----PSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G V+ AE     P     +VA+K       SD    +K+F  E E LT ++H +
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNA--RKDFHREAELLTNLQHEH 76
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXX----------XXXXXXXXXXQELGWSQRMNVIKG 236
           IVK YG C       +V+E++K G                       EL  SQ +++ + 
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG--- 293
           +A  + YL    F   VHRD++++N L+       + DFG+++ +   S+++    G   
Sbjct: 137 IAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY--STDYYRVGGHTM 191
Query: 294 -TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEM 351
               ++ PE     K T + DV+S GV+  E+   GK P   LS+      N  IE   +
Sbjct: 192 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIEC--I 243
Query: 352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              R+    R+  ++   + E++  C    P  R  +K +   LQ
Sbjct: 244 TQGRVLQRPRTCPQE---VYELMLGCWQREPHMRKNIKGIHTLLQ 285

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 114/258 (44%), Gaps = 22/258 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G V++  +  + +VVAIK        D+I D ++   E+  L++     + K Y
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 86
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G        +++ E+L  G              L  +Q   +++ +   L YLH +    
Sbjct: 87  GSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---K 139
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
            +HRDI + N+LL    E  +ADFG+A  L         F GT  ++APE+        K
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSK 199
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            D++S G+ A+E+ +G+ P   L  +   FL        +     P    +  + L+  V
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHPMKVLFL--------IPKNNPPTLEGNYSKPLKEFV 251
Query: 372 EVVFSCLNESPESRPTMK 389
           E   +CLN+ P  RPT K
Sbjct: 252 E---ACLNKEPSFRPTAK 266

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 114/277 (41%), Gaps = 41/277 (14%)
Query: 133 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G V+   L +   +VA+K     LP D    K +FL E   L +  H NIV+L 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 178
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G C+  +  ++V E ++ G              L     + ++   A  + YL   C   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG-----------YVAP 300
            +HRD++++N L+  +    ++DFG+++          E  G Y            + AP
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR---------EEADGVYAASGGLRQVPVKWTAP 284
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           E     + + + DV+SFG+L  E    G  P   LS+  +       E  E    RLP P
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR------EFVEK-GGRLPCP 337
Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                    ++  ++  C    P  RP+   + Q+LQ
Sbjct: 338 ELCPD----AVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 114/258 (44%), Gaps = 22/258 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G V++  +  + +VVAIK        D+I D ++   E+  L++     + K Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 71
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G        +++ E+L  G            +    +Q   +++ +   L YLH +    
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATILREILKGLDYLHSE---K 124
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
            +HRDI + N+LL    E  +ADFG+A  L         F GT  ++APE+        K
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 184
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            D++S G+ A+E+ +G+ P   L  +   FL        +     P    +  + L+  V
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHPMKVLFL--------IPKNNPPTLEGNYSKPLKEFV 236
Query: 372 EVVFSCLNESPESRPTMK 389
           E   +CLN+ P  RPT K
Sbjct: 237 E---ACLNKEPSFRPTAK 251

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           ++ +  Q  +G G  G V    +  +GQ  A+K   S     Q  DK+  L EV+ L ++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQL 83
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NI+KLY F     + +LV E    G             E+  ++   +I+ V   ++
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 243 YLHHDCFPPIVHRDISSKNLLLD---LEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           Y+H +    IVHRD+  +NLLL+    +    + DFG++   +  S    +  GT  Y+A
Sbjct: 141 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIA 196
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 197 PEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 24/261 (9%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G+G  G VY+A+      +A  K       +++ D   ++ E+E L    H  IVKL G
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED---YIVEIEILATCDHPYIVKLLG 83
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
              H    +++ EF   G            + L   Q   V + + +AL++LH      I
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 253 VHRDISSKNLLLDLEFEAHVADFGI-AKFLKPDSSNWTEFAGTYGYVAPE--LAYTMKIT 309
           +HRD+ + N+L+ LE +  +ADFG+ AK LK        F GT  ++APE  +  TMK T
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMCETMKDT 197
Query: 310 E---KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
               K D++S G+  +E+ + + P   L+      +   +++ +   P L  PS+   E 
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSDPPTLLTPSKWSVE- 251
Query: 367 LRSIVEVVFSCLNESPESRPT 387
            R  +++    L+++PE+RP+
Sbjct: 252 FRDFLKI---ALDKNPETRPS 269

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 32/271 (11%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V   R +LPS +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 97
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E+++ G             +    Q + +++G+A  + YL    
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 155
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + +PE    
Sbjct: 156 Y---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 212
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI--ELDEMLDPRLPAPSRS 362
            K T   DV+S+G++  EV+  G+ P   +S       N D+   +DE    RLP P   
Sbjct: 213 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDEGY--RLPPP--- 260
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTM-KIVS 392
             +   ++ +++  C  +   +RP   +IVS
Sbjct: 261 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 290

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           ++ +  Q  +G G  G V    +  +GQ  A+K   S     Q  DK+  L EV+ L ++
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQL 107
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NI+KLY F     + +LV E    G             E+  ++   +I+ V   ++
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 164
Query: 243 YLHHDCFPPIVHRDISSKNLLLD---LEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           Y+H +    IVHRD+  +NLLL+    +    + DFG++   +  S    +  GT  Y+A
Sbjct: 165 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIA 220
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 221 PEVLHGT-YDEKCDVWSTGVILYILLSGCPP 250

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 114/258 (44%), Gaps = 22/258 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G V++  +  + +VVAIK        D+I D ++   E+  L++     + K Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 71
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G        +++ E+L  G            +    +Q   +++ +   L YLH +    
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATILREILKGLDYLHSE---K 124
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
            +HRDI + N+LL    E  +ADFG+A  L         F GT  ++APE+        K
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSK 184
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            D++S G+ A+E+ +G+ P   L  +   FL        +     P    +  + L+  V
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHPMKVLFL--------IPKNNPPTLEGNYSKPLKEFV 236
Query: 372 EVVFSCLNESPESRPTMK 389
           E   +CLN+ P  RPT K
Sbjct: 237 E---ACLNKEPSFRPTAK 251

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 32/271 (11%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V   R +LPS +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 80
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E+++ G             +    Q + +++G+A  + YL    
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + +PE    
Sbjct: 139 Y---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI--ELDEMLDPRLPAPSRS 362
            K T   DV+S+G++  EV+  G+ P   +S       N D+   +DE    RLP P   
Sbjct: 196 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDEGY--RLPPP--- 243
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTM-KIVS 392
             +   ++ +++  C  +   +RP   +IVS
Sbjct: 244 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 273

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           ++ +  Q  +G G  G V    +  +GQ  A+K   S     Q  DK+  L EV+ L ++
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQL 106
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NI+KLY F     + +LV E    G             E+  ++   +I+ V   ++
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 163
Query: 243 YLHHDCFPPIVHRDISSKNLLLD---LEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           Y+H +    IVHRD+  +NLLL+    +    + DFG++   +  S    +  GT  Y+A
Sbjct: 164 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIA 219
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 220 PEVLHGT-YDEKCDVWSTGVILYILLSGCPP 249

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 111/262 (42%), Gaps = 23/262 (8%)
Query: 133 IGNGGHGSVYRAEL--PSGQVVAIK-KFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G  G V R E   PSG+ V++  K   P    Q     +F+ EV A+  + HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 190 LYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
           LYG         +V E    G              LG   R  V   VA+ + YL    F
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 136
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTM 306
              +HRD++++NLLL       + DFG+ + L  +  ++         + + APE   T 
Sbjct: 137 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 307 KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
             +   D + FGV   E+   G+ P  ++    S  L+   +  E    RLP P    Q+
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE----RLPRPEDCPQD 247
Query: 366 KLRSIVEVVFSCLNESPESRPT 387
               I  V+  C    PE RPT
Sbjct: 248 ----IYNVMVQCWAHKPEDRPT 265

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 111/262 (42%), Gaps = 23/262 (8%)
Query: 133 IGNGGHGSVYRAEL--PSGQVVAIK-KFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G  G V R E   PSG+ V++  K   P    Q     +F+ EV A+  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 190 LYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
           LYG         +V E    G              LG   R  V   VA+ + YL    F
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 142
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTM 306
              +HRD++++NLLL       + DFG+ + L  +  ++         + + APE   T 
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 307 KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
             +   D + FGV   E+   G+ P  ++    S  L+   +  E    RLP P    Q+
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE----RLPRPEDCPQD 253
Query: 366 KLRSIVEVVFSCLNESPESRPT 387
               I  V+  C    PE RPT
Sbjct: 254 ----IYNVMVQCWAHKPEDRPT 271

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 111/262 (42%), Gaps = 23/262 (8%)
Query: 133 IGNGGHGSVYRAEL--PSGQVVAIK-KFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G  G V R E   PSG+ V++  K   P    Q     +F+ EV A+  + HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 190 LYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
           LYG         +V E    G              LG   R  V   VA+ + YL    F
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 136
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTM 306
              +HRD++++NLLL       + DFG+ + L  +  ++         + + APE   T 
Sbjct: 137 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 307 KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
             +   D + FGV   E+   G+ P  ++    S  L+   +  E    RLP P    Q+
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE----RLPRPEDCPQD 247
Query: 366 KLRSIVEVVFSCLNESPESRPT 387
               I  V+  C    PE RPT
Sbjct: 248 ----IYNVMVQCWAHKPEDRPT 265

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           ++ +  Q  +G G  G V    +  +GQ  A+K   S     Q  DK+  L EV+ L ++
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQL 89
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NI+KLY F     + +LV E    G             E+  ++   +I+ V   ++
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 146
Query: 243 YLHHDCFPPIVHRDISSKNLLLD---LEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           Y+H +    IVHRD+  +NLLL+    +    + DFG++   +  S    +  GT  Y+A
Sbjct: 147 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIA 202
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 203 PEVLHGT-YDEKCDVWSTGVILYILLSGCPP 232

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 111/262 (42%), Gaps = 23/262 (8%)
Query: 133 IGNGGHGSVYRAEL--PSGQVVAIK-KFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G  G V R E   PSG+ V++  K   P    Q     +F+ EV A+  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 190 LYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
           LYG         +V E    G              LG   R  V   VA+ + YL    F
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 132
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTM 306
              +HRD++++NLLL       + DFG+ + L  +  ++         + + APE   T 
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 307 KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
             +   D + FGV   E+   G+ P  ++    S  L+   +  E    RLP P    Q+
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE----RLPRPEDCPQD 243
Query: 366 KLRSIVEVVFSCLNESPESRPT 387
               I  V+  C    PE RPT
Sbjct: 244 ----IYNVMVQCWAHKPEDRPT 261

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 32/271 (11%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V   R +LPS +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 109
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E+++ G             +    Q + +++G+A  + YL    
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + +PE    
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI--ELDEMLDPRLPAPSRS 362
            K T   DV+S+G++  EV+  G+ P   +S       N D+   +DE    RLP P   
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDEGY--RLPPP--- 272
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTM-KIVS 392
             +   ++ +++  C  +   +RP   +IVS
Sbjct: 273 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 111/262 (42%), Gaps = 23/262 (8%)
Query: 133 IGNGGHGSVYRAEL--PSGQVVAIK-KFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G  G V R E   PSG+ V++  K   P    Q     +F+ EV A+  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 190 LYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
           LYG         +V E    G              LG   R  V   VA+ + YL    F
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 132
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTM 306
              +HRD++++NLLL       + DFG+ + L  +  ++         + + APE   T 
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 307 KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
             +   D + FGV   E+   G+ P  ++    S  L+   +  E    RLP P    Q+
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE----RLPRPEDCPQD 243
Query: 366 KLRSIVEVVFSCLNESPESRPT 387
               I  V+  C    PE RPT
Sbjct: 244 ----IYNVMVQCWAHKPEDRPT 261

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 32/271 (11%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V   R +LPS +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 109
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E+++ G             +    Q + +++G+A  + YL    
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + +PE    
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI--ELDEMLDPRLPAPSRS 362
            K T   DV+S+G++  EV+  G+ P   +S       N D+   +DE    RLP P   
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDEGY--RLPPP--- 272
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTM-KIVS 392
             +   ++ +++  C  +   +RP   +IVS
Sbjct: 273 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 32/271 (11%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V   R +LPS +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 109
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E+++ G             +    Q + +++G+A  + YL    
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + +PE    
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI--ELDEMLDPRLPAPSRS 362
            K T   DV+S+G++  EV+  G+ P   +S       N D+   +DE    RLP P   
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDEGY--RLPPP--- 272
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTM-KIVS 392
             +   ++ +++  C  +   +RP   +IVS
Sbjct: 273 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 115/258 (44%), Gaps = 22/258 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G VY+  +  + +VVAIK        D+I D ++   E+  L++     I + +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYF 83
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G    +   +++ E+L  G            +    +    +++ +   L YLH +    
Sbjct: 84  GSYLKSTKLWIIMEYLGGGSALDLLKPGPLEE----TYIATILREILKGLDYLHSER--- 136
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
            +HRDI + N+LL  + +  +ADFG+A  L         F GT  ++APE+        K
Sbjct: 137 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFK 196
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            D++S G+ A+E+ KG+ P   L  +   FL           P+   P+   Q   +   
Sbjct: 197 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLI----------PKNSPPTLEGQHS-KPFK 245
Query: 372 EVVFSCLNESPESRPTMK 389
           E V +CLN+ P  RPT K
Sbjct: 246 EFVEACLNKDPRFRPTAK 263

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 32/271 (11%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V   R +LPS +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 109
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E+++ G             +    Q + +++G+A  + YL    
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + +PE    
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI--ELDEMLDPRLPAPSRS 362
            K T   DV+S+G++  EV+  G+ P   +S       N D+   +DE    RLP P   
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDEGY--RLPPP--- 272
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTM-KIVS 392
             +   ++ +++  C  +   +RP   +IVS
Sbjct: 273 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 32/271 (11%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V   R +LPS +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 107
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E+++ G             +    Q + +++G+A  + YL    
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 165
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + +PE    
Sbjct: 166 Y---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 222
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI--ELDEMLDPRLPAPSRS 362
            K T   DV+S+G++  EV+  G+ P   +S       N D+   +DE    RLP P   
Sbjct: 223 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDEGY--RLPPP--- 270
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTM-KIVS 392
             +   ++ +++  C  +   +RP   +IVS
Sbjct: 271 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 300

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 128/271 (47%), Gaps = 32/271 (11%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V   R +LPS +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 109
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E+++ G             +    Q + +++G+A  + YL    
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+ + L+ D  + +T   G     + +PE    
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI--ELDEMLDPRLPAPSRS 362
            K T   DV+S+G++  EV+  G+ P   +S       N D+   +DE    RLP P   
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDEGY--RLPPP--- 272
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTM-KIVS 392
             +   ++ +++  C  +   +RP   +IVS
Sbjct: 273 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 14/245 (5%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPSDQIVDKKEFLTEVEALTEI 182
           +DF+    +G G  G+VY A E  S  +VA+K  F S +  + +  + +   E+E    +
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGV--EHQLRREIEIQAHL 80
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NI++LY +    R  +L+ E+  RG             E    +   +++ +ADAL 
Sbjct: 81  HHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDE---QRTATIMEELADALM 137
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      ++HRDI  +NLLL L+ E  +ADFG +  +   S       GT  Y+ PE+
Sbjct: 138 YCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEM 192
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
                  EK D++  GVL  E++ G  P  F S+  +      +++D      +P  ++ 
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVGNPP--FESASHNETYRRIVKVDLKFPASVPTGAQD 250
Query: 363 VQEKL 367
           +  KL
Sbjct: 251 LISKL 255

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 8/205 (3%)
Query: 126 DFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           D++  Y IG G +G   +    S G+++  K+      ++   +K+  ++EV  L E++H
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKH 64
Query: 185 RNIVKLYGFCSHARHS--FLVYEFLKRGXXXXXXXX-XXXXQELGWSQRMNVIKGVADAL 241
            NIV+ Y       ++  ++V E+ + G             Q L     + V+  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 242 SYLHH--DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              H   D    ++HRD+   N+ LD +    + DFG+A+ L  D     EF GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMS 184
Query: 300 PELAYTMKITEKCDVYSFGVLALEV 324
           PE    M   EK D++S G L  E+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 8/205 (3%)
Query: 126 DFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           D++  Y IG G +G   +    S G+++  K+      ++   +K+  ++EV  L E++H
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKH 64
Query: 185 RNIVKLYGFCSHARHS--FLVYEFLKRGXXXXXXXX-XXXXQELGWSQRMNVIKGVADAL 241
            NIV+ Y       ++  ++V E+ + G             Q L     + V+  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 242 SYLHH--DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              H   D    ++HRD+   N+ LD +    + DFG+A+ L  D+S    F GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 300 PELAYTMKITEKCDVYSFGVLALEV 324
           PE    M   EK D++S G L  E+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 8/205 (3%)
Query: 126 DFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           D++  Y IG G +G   +    S G+++  K+      ++   +K+  ++EV  L E++H
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKH 64
Query: 185 RNIVKLYGFCSHARHS--FLVYEFLKRGXXXXXXXX-XXXXQELGWSQRMNVIKGVADAL 241
            NIV+ Y       ++  ++V E+ + G             Q L     + V+  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 242 SYLHH--DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              H   D    ++HRD+   N+ LD +    + DFG+A+ L  D+S    F GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 184
Query: 300 PELAYTMKITEKCDVYSFGVLALEV 324
           PE    M   EK D++S G L  E+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 115/271 (42%), Gaps = 29/271 (10%)
Query: 133 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G V+   L +   +VA+K     LP D    K +FL E   L +  H NIV+L 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 178
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G C+  +  ++V E ++ G              L     + ++   A  + YL   C   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-----TYGYVAPELAYTM 306
            +HRD++++N L+  +    ++DFG++   + ++      +G        + APE     
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMS---REEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 307 KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
           + + + DV+SFG+L  E    G  P   LS+  +       E  E    RLP P      
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR------EFVEK-GGRLPCPELCPD- 342
Query: 366 KLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              ++  ++  C    P  RP+   + Q+LQ
Sbjct: 343 ---AVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRHRNIVKL 190
           IG G  G V  A +  SG++VA+KK    L   Q   ++E L  EV  + + +H N+V++
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQ---RRELLFNEVVIMRDYQHENVVEM 93
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y         ++V EFL+ G            +E    Q   V   V  ALS LH     
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG-- 147
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            ++HRDI S ++LL  +    ++DFG    +  +        GT  ++APEL   +    
Sbjct: 148 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 206
Query: 311 KCDVYSFGVLALEVIKGKHP 330
           + D++S G++ +E++ G+ P
Sbjct: 207 EVDIWSLGIMVIEMVDGEPP 226

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRHRNIVKL 190
           IG G  G V  A +  SG++VA+KK    L   Q   ++E L  EV  + + +H N+V++
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQ---RRELLFNEVVIMRDYQHENVVEM 91
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y         ++V EFL+ G            +E    Q   V   V  ALS LH     
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG-- 145
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            ++HRDI S ++LL  +    ++DFG    +  +        GT  ++APEL   +    
Sbjct: 146 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 204
Query: 311 KCDVYSFGVLALEVIKGKHP 330
           + D++S G++ +E++ G+ P
Sbjct: 205 EVDIWSLGIMVIEMVDGEPP 224

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRHRNIVKL 190
           IG G  G V  A +  SG++VA+KK    L   Q   ++E L  EV  + + +H N+V++
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQ---RRELLFNEVVIMRDYQHENVVEM 82
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y         ++V EFL+ G            +E    Q   V   V  ALS LH     
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG-- 136
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            ++HRDI S ++LL  +    ++DFG    +  +        GT  ++APEL   +    
Sbjct: 137 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 195
Query: 311 KCDVYSFGVLALEVIKGKHP 330
           + D++S G++ +E++ G+ P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 128/271 (47%), Gaps = 32/271 (11%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V   R +LPS +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 80
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E ++ G             +    Q + +++G+A  + YL    
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + +PE    
Sbjct: 139 Y---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI--ELDEMLDPRLPAPSRS 362
            K T   DV+S+G++  EV+  G+ P   +S       N D+   +DE    RLP P   
Sbjct: 196 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDEGY--RLPPP--- 243
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTM-KIVS 392
             +   ++ +++  C  +   +RP   +IVS
Sbjct: 244 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 273

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 122/268 (45%), Gaps = 39/268 (14%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G V   R +LP  +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 86
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
            L G  + ++   +V E+++ G             +    Q + +++G++  + YL    
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDG--QFTVIQLVGMLRGISAGMKYLSDMG 144
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGTYG--YVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + APE    
Sbjct: 145 Y---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHP------RDFLSSISSSFLNTDIELDEMLDPRLPA 358
            K T   DV+S+G++  EV+  G+ P      +D + ++   +             RLP+
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGY-------------RLPS 248
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRP 386
           P     +   ++ +++  C  +   SRP
Sbjct: 249 P----MDCPAALYQLMLDCWQKERNSRP 272

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 110/262 (41%), Gaps = 23/262 (8%)
Query: 133 IGNGGHGSVYRAEL--PSGQVVAIK-KFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G  G V R E   PSG+ V++  K   P    Q     +F+ EV A+  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 190 LYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
           LYG         +V E    G              LG   R  V   VA+ + YL    F
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 142
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTM 306
              +HRD++++NLLL       + DFG+ + L  +  +          + + APE   T 
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 307 KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
             +   D + FGV   E+   G+ P  ++    S  L+   +  E    RLP P    Q+
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE----RLPRPEDCPQD 253
Query: 366 KLRSIVEVVFSCLNESPESRPT 387
               I  V+  C    PE RPT
Sbjct: 254 ----IYNVMVQCWAHKPEDRPT 271

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 110/262 (41%), Gaps = 23/262 (8%)
Query: 133 IGNGGHGSVYRAEL--PSGQVVAIK-KFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G  G V R E   PSG+ V++  K   P    Q     +F+ EV A+  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 190 LYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
           LYG         +V E    G              LG   R  V   VA+ + YL    F
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 132
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTM 306
              +HRD++++NLLL       + DFG+ + L  +  +          + + APE   T 
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 307 KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
             +   D + FGV   E+   G+ P  ++    S  L+   +  E    RLP P    Q+
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE----RLPRPEDCPQD 243
Query: 366 KLRSIVEVVFSCLNESPESRPT 387
               I  V+  C    PE RPT
Sbjct: 244 ----IYNVMVQCWAHKPEDRPT 261

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 119/268 (44%), Gaps = 39/268 (14%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G V   R +LP  +   VAIK         Q   +++FL E   + +  H N+V
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ---RRDFLCEASIMGQFDHPNVV 107
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
            L G  +  +   +V EF++ G             +    Q + +++G+A  + YL    
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG--QFTVIQLVGMLRGIAAGMRYLADMG 165
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ ++ D  + +T   G     + APE    
Sbjct: 166 Y---VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHP------RDFLSSISSSFLNTDIELDEMLDPRLPA 358
            K T   DV+S+G++  EV+  G+ P      +D + +I   +             RLPA
Sbjct: 223 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY-------------RLPA 269
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRP 386
           P     +    + +++  C  +    RP
Sbjct: 270 P----MDCPAGLHQLMLDCWQKERAERP 293

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRHRNIVKL 190
           IG G  G V  A +  SG++VA+KK    L   Q   ++E L  EV  + + +H N+V++
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQ---RRELLFNEVVIMRDYQHENVVEM 136
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y         ++V EFL+ G            +E    Q   V   V  ALS LH     
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG-- 190
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            ++HRDI S ++LL  +    ++DFG    +  +        GT  ++APEL   +    
Sbjct: 191 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 249
Query: 311 KCDVYSFGVLALEVIKGKHP 330
           + D++S G++ +E++ G+ P
Sbjct: 250 EVDIWSLGIMVIEMVDGEPP 269

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRHRNIVKL 190
           IG G  G V  A +  SG++VA+KK    L   Q   ++E L  EV  + + +H N+V++
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQ---RRELLFNEVVIMRDYQHENVVEM 213
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y         ++V EFL+ G            +E    Q   V   V  ALS LH     
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG-- 267
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            ++HRDI S ++LL  +    ++DFG    +  +        GT  ++APEL   +    
Sbjct: 268 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 326
Query: 311 KCDVYSFGVLALEVIKGKHP 330
           + D++S G++ +E++ G+ P
Sbjct: 327 EVDIWSLGIMVIEMVDGEPP 346

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRHRNIVKL 190
           IG G  G V  A +  SG++VA+KK    L   Q   ++E L  EV  + + +H N+V++
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQ---RRELLFNEVVIMRDYQHENVVEM 86
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y         ++V EFL+ G            +E    Q   V   V  ALS LH     
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG-- 140
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            ++HRDI S ++LL  +    ++DFG    +  +        GT  ++APEL   +    
Sbjct: 141 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 199
Query: 311 KCDVYSFGVLALEVIKGKHP 330
           + D++S G++ +E++ G+ P
Sbjct: 200 EVDIWSLGIMVIEMVDGEPP 219

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 128/271 (47%), Gaps = 32/271 (11%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V   R +LPS +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 109
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E ++ G             +    Q + +++G+A  + YL    
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + +PE    
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI--ELDEMLDPRLPAPSRS 362
            K T   DV+S+G++  EV+  G+ P   +S       N D+   +DE    RLP P   
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDEGY--RLPPP--- 272
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTM-KIVS 392
             +   ++ +++  C  +   +RP   +IVS
Sbjct: 273 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFL---------TE 175
           DF     +G G    VYRAE + +G  VAIK          ++DKK             E
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIK----------MIDKKAMYKAGMVQRVQNE 61
Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK 235
           V+   +++H +I++LY +   + + +LV E    G            +    ++  + + 
Sbjct: 62  VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMH 119
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK-PDSSNWTEFAGT 294
            +   + YLH      I+HRD++  NLLL       +ADFG+A  LK P   ++T   GT
Sbjct: 120 QIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGT 175
Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD 332
             Y++PE+A       + DV+S G +   ++ G+ P D
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 29/278 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
            D   ++ +G G +G VY        + VA+K        +  ++ +EFL E   + EI+
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIK 86
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           H N+V+L G C+     ++V E++  G            +E+     + +   ++ A+ Y
Sbjct: 87  HPNLVQLLGVCTLEPPFYIVTEYMPYG-NLLDYLRECNREEVTAVVLLYMATQISSAMEY 145
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAP 300
           L    F   +HRD++++N L+       VADFG+++ +  D+  +T  AG      + AP
Sbjct: 146 LEKKNF---IHRDLAARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAP 200
Query: 301 E-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           E LAY    + K DV++FGVL  E+   G  P      I  S +   +E    ++     
Sbjct: 201 ESLAYN-TFSIKSDVWAFGVLLWEIATYGMSP---YPGIDLSQVYDLLEKGYRMEQPEGC 256
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           P +        + E++ +C   SP  RP+     Q  +
Sbjct: 257 PPK--------VYELMRACWKWSPADRPSFAETHQAFE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G +G VY+A+   G+  A+KK       + I      + E+  L E++H NIVKLY 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLYD 67
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQEL-GWSQRMNVIKGVADALSYLHHDCFPP 251
                +   LV+E L +             + +   S  + ++ G+A    Y H      
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA----YCHDR---R 120
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITE 310
           ++HRD+  +NLL++ E E  +ADFG+A+        +T    T  Y AP+ L  + K + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 311 KCDVYSFGVLALEVIKG 327
             D++S G +  E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G +G VY+A+   G+  A+KK       + I      + E+  L E++H NIVKLY 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLYD 67
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQEL-GWSQRMNVIKGVADALSYLHHDCFPP 251
                +   LV+E L +             + +   S  + ++ G+A    Y H      
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA----YCHDR---R 120
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITE 310
           ++HRD+  +NLL++ E E  +ADFG+A+        +T    T  Y AP+ L  + K + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 311 KCDVYSFGVLALEVIKG 327
             D++S G +  E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           ++ +  Q  +G G  G V   +   +GQ  A+K   S     Q  DK+  L EV+ L ++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQL 83
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NI KLY F     + +LV E    G             E+  ++   +I+ V   ++
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 243 YLHHDCFPPIVHRDISSKNLLLD---LEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           Y H +    IVHRD+  +NLLL+    +    + DFG++   +  S    +  GT  Y+A
Sbjct: 141 YXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKXKDKIGTAYYIA 196
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 197 PEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRHRNIVKL 190
           IG G  G V  A E  +G+ VA+KK    L   Q   ++E L  EV  + +  H N+V +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQ---RRELLFNEVVIMRDYHHDNVVDM 107
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y         ++V EFL+ G            +E    Q   V   V  ALSYLH+    
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLSVLRALSYLHNQG-- 161
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
            ++HRDI S ++LL  +    ++DFG    +  +        GT  ++APE+   +    
Sbjct: 162 -VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGT 220
Query: 311 KCDVYSFGVLALEVIKGKHP 330
           + D++S G++ +E+I G+ P
Sbjct: 221 EVDIWSLGIMVIEMIDGEPP 240

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 127/292 (43%), Gaps = 37/292 (12%)
Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNIVK 189
           C+G G +G V+R     G+ VA+K F S        D+K +  E E    +  RH NI+ 
Sbjct: 44  CVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 95
Query: 190 LYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
                  +RHS      +                 L     + ++  +A  L++LH + F
Sbjct: 96  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 250 -----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA-----GTYGYVA 299
                P I HRD+ SKN+L+    +  +AD G+A  +   S+N  +       GT  Y+A
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 300 PE-LAYTMKIT-----EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT---DIELDE 350
           PE L  T+++      ++ D+++FG++  EV +       +      F +    D   ++
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 274
Query: 351 M-----LDPRLP-APSRSVQE-KLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           M     +D + P  P+R   +  L S+ +++  C  ++P +R T   + + L
Sbjct: 275 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 326

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G +G VY+A+   G+  A+KK       + I      + E+  L E++H NIVKLY 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLYD 67
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQEL-GWSQRMNVIKGVADALSYLHHDCFPP 251
                +   LV+E L +             + +   S  + ++ G+A    Y H      
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA----YCHDR---R 120
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITE 310
           ++HRD+  +NLL++ E E  +ADFG+A+        +T    T  Y AP+ L  + K + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 311 KCDVYSFGVLALEVIKG 327
             D++S G +  E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 127/271 (46%), Gaps = 32/271 (11%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V   R +LPS +   VAIK         Q   +++FL E   + +  H NI+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 109
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E ++ G             +    Q + +++G+A  + YL    
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD-- 165
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
               VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + +PE    
Sbjct: 166 -MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI--ELDEMLDPRLPAPSRS 362
            K T   DV+S+G++  EV+  G+ P   +S       N D+   +DE    RLP P   
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDEGY--RLPPP--- 272
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTM-KIVS 392
             +   ++ +++  C  +   +RP   +IVS
Sbjct: 273 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 9/197 (4%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G +G VY+A+   G++VA+K+       + I      + E+  L E+ H NIV L  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKELHHPNIVSLID 86
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
                R   LV+EF+++             Q+   SQ    +  +   +++ H      I
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDENKTGLQD---SQIKIYLYQLLRGVAHCHQH---RI 140
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITEK 311
           +HRD+  +NLL++ +    +ADFG+A+       ++T    T  Y AP+ L  + K +  
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 312 CDVYSFGVLALEVIKGK 328
            D++S G +  E+I GK
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 127/292 (43%), Gaps = 37/292 (12%)
Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNIVK 189
           C+G G +G V+R     G+ VA+K F S        D+K +  E E    +  RH NI+ 
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 66
Query: 190 LYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
                  +RHS      +                 L     + ++  +A  L++LH + F
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 250 -----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA-----GTYGYVA 299
                P I HRD+ SKN+L+    +  +AD G+A  +   S+N  +       GT  Y+A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 300 PE-LAYTMKIT-----EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT---DIELDE 350
           PE L  T+++      ++ D+++FG++  EV +       +      F +    D   ++
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 351 M-----LDPRLP-APSRSVQE-KLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           M     +D + P  P+R   +  L S+ +++  C  ++P +R T   + + L
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 9/197 (4%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G +G VY+A+   G++VA+K+       + I      + E+  L E+ H NIV L  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKELHHPNIVSLID 86
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
                R   LV+EF+++             Q+   SQ    +  +   +++ H      I
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDENKTGLQD---SQIKIYLYQLLRGVAHCHQH---RI 140
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITEK 311
           +HRD+  +NLL++ +    +ADFG+A+       ++T    T  Y AP+ L  + K +  
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 312 CDVYSFGVLALEVIKGK 328
            D++S G +  E+I GK
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 9/208 (4%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G GG  +VY AE     + VAIK    P P ++    K F  EV   +++ H+NIV + 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                    +LV E+++                L     +N    + D + + H      
Sbjct: 78  DVDEEDDCYYLVMEYIE---GPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD---MR 131
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA-GTYGYVAPELAYTMKITE 310
           IVHRDI  +N+L+D      + DFGIAK L   S   T    GT  Y +PE A      E
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 311 KCDVYSFGVLALEVIKGKHPRDFLSSIS 338
             D+YS G++  E++ G+ P +  +++S
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVS 219

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 127/292 (43%), Gaps = 37/292 (12%)
Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNIVK 189
           C+G G +G V+R     G+ VA+K F S        D+K +  E E    +  RH NI+ 
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 66
Query: 190 LYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
                  +RHS      +                 L     + ++  +A  L++LH + F
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 250 -----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA-----GTYGYVA 299
                P I HRD+ SKN+L+    +  +AD G+A  +   S+N  +       GT  Y+A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 300 PE-LAYTMKIT-----EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT---DIELDE 350
           PE L  T+++      ++ D+++FG++  EV +       +      F +    D   ++
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 351 M-----LDPRLP-APSRSVQE-KLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           M     +D + P  P+R   +  L S+ +++  C  ++P +R T   + + L
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 133 IGNGGHGSVYRAELPSG------QVVAIKKFHSPLPSD--QIVDK--KEFLTEVEALTEI 182
           +G+G +G V   +  +G      +V+   +F     SD  + ++K  +E   E+  L  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NI+KL+      ++ +LV EF + G             E   +   N++K +   + 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---NIMKQILSGIC 160
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLE---FEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           YLH      IVHRDI  +N+LL+ +       + DFG++ F   D     +  GT  Y+A
Sbjct: 161 YLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRLGTAYYIA 216
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+    K  EKCDV+S GV+   ++ G  P
Sbjct: 217 PEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G +G V +     +G++VAIKKF      D++V KK  + E++ L ++RH N+V L 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLES-DDDKMV-KKIAMREIKLLKQLRHENLVNLL 90
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH-HDCFP 250
             C   +  +LV+EF+                 L +      +  + + + + H H+   
Sbjct: 91  EVCKKKKRWYLVFEFVDH---TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY-TMKIT 309
            I+HRDI  +N+L+       + DFG A+ L      + +   T  Y APEL    +K  
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 310 EKCDVYSFGVLALEVIKGK 328
           +  DV++ G L  E+  G+
Sbjct: 204 KAVDVWAIGCLVTEMFMGE 222

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G V   R ++P  +   VAIK   +     Q   +++FL+E   + +  H NI+
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ---RRDFLSEASIMGQFDHPNII 78
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
            L G  +  +   ++ E+++ G              +   Q + +++G+   + YL    
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMS 136
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + APE    
Sbjct: 137 Y---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHP 330
            K T   DV+S+G++  EV+  G+ P
Sbjct: 194 RKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G V   R ++P  +   VAIK   +     Q   +++FL+E   + +  H NI+
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ---RRDFLSEASIMGQFDHPNII 72
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
            L G  +  +   ++ E+++ G              +   Q + +++G+   + YL    
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMS 130
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
           +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + APE    
Sbjct: 131 Y---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHP 330
            K T   DV+S+G++  EV+  G+ P
Sbjct: 188 RKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 119/276 (43%), Gaps = 38/276 (13%)
Query: 127 FDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RH 184
           F+    +GNG +G VY+   + +GQ+ AIK     +  D+   ++E   E+  L +   H
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDE---EEEIKQEINMLKKYSHH 80
Query: 185 RNIVKLYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA 238
           RNI   YG              +LV EF   G              L       + + + 
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREIL 139
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
             LS+LH      ++HRDI  +N+LL    E  + DFG++  L         F GT  ++
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 299 APELAYTMKITE-----KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD 353
           APE+    +  +     K D++S G+ A+E+ +G  P   +  + + FL           
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---------- 246
Query: 354 PRLPAP---SRSVQEKLRSIVEVVFSCLNESPESRP 386
           PR PAP   S+   +K +S +E   SCL ++   RP
Sbjct: 247 PRNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRP 279

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 81/163 (49%), Gaps = 11/163 (6%)
Query: 171 EFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQR 230
           + L EV  L  + H NI+KLY F    R+ +LV E  K G             E+  +  
Sbjct: 82  KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV- 140
Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD-LEFEA--HVADFGIAKFLKPDSSN 287
             +IK V   ++YLH      IVHRD+  +NLLL+  E +A   + DFG++   + +   
Sbjct: 141 --IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKK 194
Query: 288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
             E  GT  Y+APE+    K  EKCDV+S GV+   ++ G  P
Sbjct: 195 MKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 76
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ EFL  G            + +   + +     +   + YL 
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 134
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 135 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 251
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 252 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 283

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 16/206 (7%)
Query: 133 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G V   R ++P  +   VAIK   +     Q   +++FL+E   + +  H NI+
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ---RRDFLSEASIMGQFDHPNII 93
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
            L G  +  +   ++ E+++ G              +   Q + +++G+   + YL    
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSD-- 149
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGT--YGYVAPELAYT 305
               VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + APE    
Sbjct: 150 -MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHP 330
            K T   DV+S+G++  EV+  G+ P
Sbjct: 209 RKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 113/265 (42%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 56  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + YL   
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 170
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS----SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +         N T       ++A E  
Sbjct: 171 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 228 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 280
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 281 PD----PLYEVMLKCWHPKAEMRPS 301

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 115/265 (43%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 37  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + YL   
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 151
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSS--NWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+  + K   S  N T       ++A E  
Sbjct: 152 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 261
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 262 PD----PLYEVMLKCWHPKAEMRPS 282

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 115/265 (43%), Gaps = 23/265 (8%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+ A       VA+K      P    V+   FL E   +  ++H  +VKL+ 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA--FLAEANVMKTLQHDKLVKLHA 77
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ EF+ +G            ++    + ++    +A+ ++++    +   
Sbjct: 78  VVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY--- 132
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 312 CDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSI 370
            DV+SFG+L +E++  G+ P   +S       N ++        R+P P    +E    +
Sbjct: 193 SDVWSFGILLMEIVTYGRIPYPGMS-------NPEVIRALERGYRMPRPENCPEE----L 241
Query: 371 VEVVFSCLNESPESRPTMKIVSQQL 395
             ++  C    PE RPT + +   L
Sbjct: 242 YNIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 115/265 (43%), Gaps = 23/265 (8%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+ A       VA+K      P    V+   FL E   +  ++H  +VKL+ 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA--FLAEANVMKTLQHDKLVKLHA 250
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ EF+ +G            ++    + ++    +A+ ++++    +   
Sbjct: 251 VVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY--- 305
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 312 CDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSI 370
            DV+SFG+L +E++  G+ P   +S       N ++        R+P P    +E    +
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMS-------NPEVIRALERGYRMPRPENCPEE----L 414
Query: 371 VEVVFSCLNESPESRPTMKIVSQQL 395
             ++  C    PE RPT + +   L
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 113/265 (42%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 30  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + YL   
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 144
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS----SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +         N T       ++A E  
Sbjct: 145 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 202 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 254
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 255 PD----PLYEVMLKCWHPKAEMRPS 275

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 113/265 (42%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 57  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + YL   
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 171
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS----SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +         N T       ++A E  
Sbjct: 172 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 229 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 281
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 282 PD----PLYEVMLKCWHPKAEMRPS 302

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 113/265 (42%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + YL   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 152
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS----SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +         N T       ++A E  
Sbjct: 153 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 262
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 263 PD----PLYEVMLKCWHPKAEMRPS 283

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 113/265 (42%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 35  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + YL   
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 149
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS----SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +         N T       ++A E  
Sbjct: 150 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 259
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 260 PD----PLYEVMLKCWHPKAEMRPS 280

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 116/253 (45%), Gaps = 21/253 (8%)
Query: 127 FDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFL-TEVEALTEIRH 184
           F+ +  +G G    V  AE   +G++ A+K     +P   +  K+  +  E+  L +I+H
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVK----CIPKKALKGKESSIENEIAVLRKIKH 79
Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
            NIV L        H +LV + +  G             E   S    +I+ V DA+ YL
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS---TLIRQVLDAVYYL 136
Query: 245 HHDCFPPIVHRDISSKNLLL---DLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
           H      IVHRD+  +NLL    D E +  ++DFG++K ++      +   GT GYVAPE
Sbjct: 137 HR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACGTPGYVAPE 192
Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           +      ++  D +S GV+A  ++ G  P   +  S +    L  + E D    P     
Sbjct: 193 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFD---SPYWDDI 249
Query: 360 SRSVQEKLRSIVE 372
           S S ++ +R+++E
Sbjct: 250 SDSAKDFIRNLME 262

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 91
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 149
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 150 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 266
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 267 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 298

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 113/265 (42%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 37  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + YL   
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 151
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS----SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +         N T       ++A E  
Sbjct: 152 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 261
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 262 PD----PLYEVMLKCWHPKAEMRPS 282

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 113/265 (42%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 36  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + YL   
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 150
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS----SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +         N T       ++A E  
Sbjct: 151 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 260
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 261 PD----PLYEVMLKCWHPKAEMRPS 281

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 113/265 (42%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + YL   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 152
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS----SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +         N T       ++A E  
Sbjct: 153 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 262
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 263 PD----PLYEVMLKCWHPKAEMRPS 283

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 118/280 (42%), Gaps = 40/280 (14%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 73
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 131
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF-------AGTYGYV 298
              +   +HRD++++N+L++ E    + DFG+ K L  D     EF            + 
Sbjct: 132 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EFFKVKEPGESPIFWY 184
Query: 299 APELAYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEM 351
           APE     K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 352 L--DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           L  + RLP P     E    I  ++  C N +   RP+ +
Sbjct: 245 LKNNGRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 280

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 113/265 (42%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 33  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 147
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS----SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +         N T       ++A E  
Sbjct: 148 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 257
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 258 PD----PLYEVMLKCWHPKAEMRPS 278

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 91
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 149
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 150 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 266
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 267 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 298

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 80
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 138
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 139 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 255
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 256 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 287

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 104
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 162
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 163 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 280 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 311

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 79
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 137
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 138 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 254
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 255 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 286

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 73
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 131
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 132 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 249 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 280

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 76
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 134
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 135 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 251
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 252 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 283

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 71
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 129
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 130 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 246
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 247 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 278

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 77
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 135
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 136 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 252
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 253 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 284

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 78
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 136
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 137 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 253
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 254 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 285

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 72
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 130
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 131 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 247
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 248 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 279

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 73
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 131
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 132 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 249 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 280

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 76
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHA--ERIDHIKLLQYTSQICKGMEYLG 134
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HRD++++N+L++ E    + DFG+ K L  D               + APE 
Sbjct: 135 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 251
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 252 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 283

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 75
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 76  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 130
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  
Sbjct: 131 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 188
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 189 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 228
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 229 TPDEVVWPGVTSMPDYKPSFPKWARQ 254

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 75
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 76  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 130
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  
Sbjct: 131 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 188
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 189 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 228
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 229 TPDEVVWPGVTSMPDYKPSFPKWARQ 254

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
           + F+    +G G  G V+  +  SG    Q+ A+K       + ++ D+     E + L 
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA--TLKVRDRVRTKMERDILV 82
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
           E+ H  IVKL Y F +  +  +L+ +FL+ G             E         +  +A 
Sbjct: 83  EVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYLAELAL 138
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           AL +LH      I++RD+  +N+LLD E    + DFG++K           F GT  Y+A
Sbjct: 139 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 195
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+      T+  D +SFGVL  E++ G  P
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 117/276 (42%), Gaps = 32/276 (11%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 74
Query: 188 VKLYGFCSHA--RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A  R+  L+ E+L  G            + +   + +     +   + YL 
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 132
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPEL 302
              +   +HR+++++N+L++ E    + DFG+ K L  D   +           + APE 
Sbjct: 133 TKRY---IHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 303 AYTMKITEKCDVYSFGVLALEVI----KGKH-PRDFLSSISSSFLNTDI--ELDEML--D 353
               K +   DV+SFGV+  E+     K K  P +F+  I +      I   L E+L  +
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 249
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     E    I  ++  C N +   RP+ +
Sbjct: 250 GRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFR 281

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 72
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 73  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 127
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  
Sbjct: 128 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 185
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 186 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 225
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 226 TPDEVVWPGVTSMPDYKPSFPKWARQ 251

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
           + F+    +G G  G V+  +  SG    Q+ A+K       + ++ D+     E + L 
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA--TLKVRDRVRTKMERDILV 81
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
           E+ H  IVKL Y F +  +  +L+ +FL+ G             E         +  +A 
Sbjct: 82  EVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYLAELAL 137
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           AL +LH      I++RD+  +N+LLD E    + DFG++K           F GT  Y+A
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+      T+  D +SFGVL  E++ G  P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 182 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 221
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 222 TPDEVVWPGVTSMPDYKPSFPKWARQ 247

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 97  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 211
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL---KPDS-SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +   + DS  N T       ++A E  
Sbjct: 212 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 321
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 322 PD----PLYEVMLKCWHPKAEMRPS 342

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 59
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 120 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 172
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 215
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 216 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 248

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 181
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 182 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 221
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 222 TPDEVVWPGVTSMPDYKPSFPKWARQ 247

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 67
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 122
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 181 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 220
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQ 246

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 182 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 221
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 222 TPDEVVWPGVTSMPDYKPSFPKWARQ 247

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 67
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 122
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 181 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 220
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQ 246

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
           + F+    +G G  G V+  +  SG    Q+ A+K       + ++ D+     E + L 
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA--TLKVRDRVRTKMERDILV 81
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
           E+ H  IVKL Y F +  +  +L+ +FL+ G             E         +  +A 
Sbjct: 82  EVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYLAELAL 137
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           AL +LH      I++RD+  +N+LLD E    + DFG++K           F GT  Y+A
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+      T+  D +SFGVL  E++ G  P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 39  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + +L   
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 153
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL---KPDS-SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +   + DS  N T       ++A E  
Sbjct: 154 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 263
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 264 PD----PLYEVMLKCWHPKAEMRPS 284

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G    LS+ H    
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LSFCHSHR- 123
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 182 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 221
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 222 TPDEVVWPGVTSMPDYKPSFPKWARQ 247

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + +L   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 152
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL---KPDS-SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +   + DS  N T       ++A E  
Sbjct: 153 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 262
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 263 PD----PLYEVMLKCWHPKAEMRPS 283

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V++     +GQ+VAIKKF      D  V KK  L E+  L +++H N+V L 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLES--EDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQR---MNVIKGVA----DALSYL 244
                 R   LV+E+                 EL   QR    +++K +      A+++ 
Sbjct: 69  EVFRRKRRLHLVFEYCDH----------TVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 245 H-HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           H H+C    +HRD+  +N+L+       + DFG A+ L   S  + +   T  Y +PEL 
Sbjct: 119 HKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL 174
Query: 304 Y-TMKITEKCDVYSFGVLALEVIKG 327
               +     DV++ G +  E++ G
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 39  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + +L   
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 153
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL---KPDS-SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +   + DS  N T       ++A E  
Sbjct: 154 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 263
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 264 PD----PLYEVMLKCWHPKAEMRPS 284

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + +L   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 152
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL---KPDS-SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +   + DS  N T       ++A E  
Sbjct: 153 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 262
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 263 PD----PLYEVMLKCWHPKAEMRPS 283

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 36  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + +L   
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 150
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL---KPDS-SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +   + DS  N T       ++A E  
Sbjct: 151 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 260
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 261 PD----PLYEVMLKCWHPKAEMRPS 281

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 29/265 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKE---FLTEVEALTEIRHRNIV 188
           IG G  G VY   L        KK H  + S ++I D  E   FLTE   + +  H N++
Sbjct: 43  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 189 KLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G              +     +     VA  + +L   
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 157
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL---KPDS-SNWTEFAGTYGYVAPELA 303
            F   VHRD++++N +LD +F   VADFG+A+ +   + DS  N T       ++A E  
Sbjct: 158 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
            T K T K DV+SFGVL  E++ +G  P   +++        DI +  +   RL  P   
Sbjct: 215 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYC 267
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
                  + EV+  C +   E RP+
Sbjct: 268 PD----PLYEVMLKCWHPKAEMRPS 288

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 123/269 (45%), Gaps = 39/269 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      VA+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 87
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + S A    +V ++ +               E+   + +++ +  A  + YLH      I
Sbjct: 88  Y-STAPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---I 141
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT------EFAGTYGYVAPELAYTM 306
           +HRD+ S N+ L  +    + DFG+A     + S W+      + +G+  ++APE+    
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 307 K---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
                + + DVY+FG++  E++ G+ P         S +N   ++ EM+     +P  S 
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP--------YSNINNRDQIIEMVGRGSLSPDLS- 248
Query: 364 QEKLRS-----IVEVVFSCLNESPESRPT 387
             K+RS     +  ++  CL +  + RP+
Sbjct: 249 --KVRSNCPKRMKRLMAECLKKKRDERPS 275

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 118/265 (44%), Gaps = 32/265 (12%)
Query: 133 IGNGGHGSVYRAELPSGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G+G  G V+  E  S      +  I K  S +P +QI        E+E L  + H NI+
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE------AEIEVLKSLDHPNII 83
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXX-QELGWSQRMNVIKGVADALSYLHHD 247
           K++       + ++V E  + G             + L       ++K + +AL+Y H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAH----VADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
               +VH+D+  +N+L   +   H    + DFG+A+  K D  + T  AGT  Y+APE+ 
Sbjct: 144 ---HVVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKSDEHS-TNAAGTALYMAPEV- 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDI-ELDEMLDPRLPAPSRS 362
           +   +T KCD++S GV+   ++ G  P          F  T + E+ +    + P  +  
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTGCLP----------FTGTSLEEVQQKATYKEPNYAVE 247
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
            +      V+++   L + PE RP+
Sbjct: 248 CRPLTPQAVDLLKQMLTKDPERRPS 272

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 110/263 (41%), Gaps = 34/263 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+     +   VA+K       S Q      FL E   +  ++H  +V+LY 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-----AFLEEANLMKTLQHDKLVRLYA 74
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ EF+ +G            + L   + ++    +A+ ++Y+    +   
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY--- 130
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190
Query: 312 CDVYSFGVLALEVIK-------GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ 364
            +V+SFG+L  E++        G+   D +S++S  +             R+P       
Sbjct: 191 SNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGY-------------RMPRMENCPD 237
Query: 365 EKLRSIVEVVFSCLNESPESRPT 387
           E    + +++  C  E  E RPT
Sbjct: 238 E----LYDIMKMCWKEKAEERPT 256

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 106/277 (38%), Gaps = 32/277 (11%)
Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVD------KKEFLTEVEA 178
           +F  +  IG G    VYRA  L  G  VA+KK        QI D      + + + E++ 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV-------QIFDLMDAKARADCIKEIDL 85
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA 238
           L ++ H N++K Y          +V E    G            + L       V K   
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL--IPERTVWKYFV 143
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
              S L H     ++HRDI   N+ +       + D G+ +F    ++      GT  Y+
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP----RDFLSSISSSFLNTDIELDEMLDP 354
           +PE  +      K D++S G L  E+   + P    +  L S+       D         
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP------- 256
Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIV 391
             P PS    E+LR +V +   C+N  PE RP +  V
Sbjct: 257 --PLPSDHYSEELRQLVNM---CINPDPEKRPDVTYV 288

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G GG G V R     +G+ VAIK+    L      +++ +  E++ + ++ H N+V   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK---NRERWCLEIQIMKKLNHPNVVSAR 78
Query: 192 ----GFCSHARHSF--LVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
               G    A +    L  E+ + G              L       ++  ++ AL YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 246 HDCFPPIVHRDISSKNLLLD---LEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
            +    I+HRD+  +N++L          + D G AK L       TEF GT  Y+APEL
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAPEL 194
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHP 330
               K T   D +SFG LA E I G  P
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G GG G V R     +G+ VAIK+    L      +++ +  E++ + ++ H N+V   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK---NRERWCLEIQIMKKLNHPNVVSAR 79
Query: 192 ----GFCSHARHSF--LVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
               G    A +    L  E+ + G              L       ++  ++ AL YLH
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139
Query: 246 HDCFPPIVHRDISSKNLLLD---LEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
            +    I+HRD+  +N++L          + D G AK L       TEF GT  Y+APEL
Sbjct: 140 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAPEL 195
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHP 330
               K T   D +SFG LA E I G  P
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/264 (22%), Positives = 111/264 (42%), Gaps = 31/264 (11%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+ A       VA+K      P    V+   FL E   +  ++H  +VKL+ 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA--FLAEANVMKTLQHDKLVKLHA 244
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ EF+ +G            ++    + ++    +A+ ++++    +   
Sbjct: 245 VVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY--- 299
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKC 312
           +HRD+ + N+L+       +ADFG+A+        WT         APE       T K 
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT---------APEAINFGSFTIKS 350
Query: 313 DVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
           DV+SFG+L +E++  G+ P   +S       N ++        R+P P    +E    + 
Sbjct: 351 DVWSFGILLMEIVTYGRIPYPGMS-------NPEVIRALERGYRMPRPENCPEE----LY 399
Query: 372 EVVFSCLNESPESRPTMKIVSQQL 395
            ++  C    PE RPT + +   L
Sbjct: 400 NIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 120/270 (44%), Gaps = 35/270 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G  G V   +   G  VA+K   +   +      + FL E   +T++RH N+V+L G
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA------QAFLAEASVMTQLRHSNLVQLLG 253
Query: 193 FCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                +   ++V E++ +G              LG    +     V +A+ YL  + F  
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF-- 310
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYTMKIT 309
            VHRD++++N+L+  +  A V+DFG+ K      ++ T+  G     + APE     K +
Sbjct: 311 -VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 310 EKCDVYSFGVLALEVI---KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
            K DV+SFG+L  E+    +  +PR  L  +        +E    +D     P       
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDAPDGCPP------ 413
Query: 367 LRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             ++ +V+ +C +    +RPT   + +QL+
Sbjct: 414 --AVYDVMKNCWHLDAATRPTFLQLREQLE 441

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 120/269 (44%), Gaps = 30/269 (11%)
Query: 127 FDAQYCIGNGGHGSVYRAELPSGQ-VVAIKKFHSPLPSDQIVDKKE--FLTEVEALTEIR 183
           +D +  +G G    V  AE    Q +VAIK       + + ++ KE     E+  L +I+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-----AKEALEGKEGSMENEIAVLHKIK 74
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           H NIV L        H +L+ + +  G             E   S+   +I  V DA+ Y
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKY 131
Query: 244 LHHDCFPPIVHRDISSKNLL---LDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LH      IVHRD+  +NLL   LD + +  ++DFG++K   P S   T   GT GYVAP
Sbjct: 132 LHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAP 187
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLNTDIELDEMLDPRLPA 358
           E+      ++  D +S GV+A  ++ G  P   +  + +    L  + E D    P    
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS---PYWDD 244
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPT 387
            S S ++ +R ++E       + PE R T
Sbjct: 245 ISDSAKDFIRHLME-------KDPEKRFT 266

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 124/269 (46%), Gaps = 39/269 (14%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      VA+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 87
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + +  + + +V ++ +               E+   + +++ +  A  + YLH      I
Sbjct: 88  YSTKPQLA-IVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---I 141
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT------EFAGTYGYVAPELAYTM 306
           +HRD+ S N+ L  +    + DFG+A     + S W+      + +G+  ++APE+    
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 307 K---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
                + + DVY+FG++  E++ G+ P         S +N   ++ EM+     +P  S 
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP--------YSNINNRDQIIEMVGRGSLSPDLS- 248
Query: 364 QEKLRS-----IVEVVFSCLNESPESRPT 387
             K+RS     +  ++  CL +  + RP+
Sbjct: 249 --KVRSNCPKRMKRLMAECLKKKRDERPS 275

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 120/269 (44%), Gaps = 30/269 (11%)
Query: 127 FDAQYCIGNGGHGSVYRAELPSGQ-VVAIKKFHSPLPSDQIVDKKE--FLTEVEALTEIR 183
           +D +  +G G    V  AE    Q +VAIK       + + ++ KE     E+  L +I+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-----AKEALEGKEGSMENEIAVLHKIK 74
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           H NIV L        H +L+ + +  G             E   S+   +I  V DA+ Y
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKY 131
Query: 244 LHHDCFPPIVHRDISSKNLL---LDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LH      IVHRD+  +NLL   LD + +  ++DFG++K   P S   T   GT GYVAP
Sbjct: 132 LHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAP 187
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLNTDIELDEMLDPRLPA 358
           E+      ++  D +S GV+A  ++ G  P   +  + +    L  + E D    P    
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS---PYWDD 244
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPT 387
            S S ++ +R ++E       + PE R T
Sbjct: 245 ISDSAKDFIRHLME-------KDPEKRFT 266

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 122/265 (46%), Gaps = 31/265 (11%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      VA+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 75
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + +  + + +V ++ +               E+   + +++ +  A  + YLH      I
Sbjct: 76  YSTKPQLA-IVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---I 129
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIA--KFLKPDSSNWTEFAGTYGYVAPELAYTMK--- 307
           +HRD+ S N+ L  +    + DFG+A  K     S  + + +G+  ++APE+        
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 308 ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM-----LDPRLPAPSRS 362
            + + DVY+FG++  E++ G+ P         S +N   ++ EM     L P L     +
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQLP--------YSNINNRDQIIEMVGRGSLSPDLSKVRSN 241
Query: 363 VQEKLRSIVEVVFSCLNESPESRPT 387
             ++++ ++     CL +  + RP+
Sbjct: 242 CPKRMKRLMA---ECLKKKRDERPS 263

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 110/263 (41%), Gaps = 34/263 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+     +   VA+K       S Q      FL E   +  ++H  +V+LY 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-----FLEEANLMKTLQHDKLVRLYA 75
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E++ +G            + L   + ++    +A+ ++Y+    +   
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY--- 131
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 312 CDVYSFGVLALEVIK-------GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ 364
            DV+SFG+L  E++        G+   D ++++S  +             R+P       
Sbjct: 192 SDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGY-------------RMPRVENCPD 238
Query: 365 EKLRSIVEVVFSCLNESPESRPT 387
           E    + +++  C  E  E RPT
Sbjct: 239 E----LYDIMKMCWKEKAEERPT 257

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 120/269 (44%), Gaps = 30/269 (11%)
Query: 127 FDAQYCIGNGGHGSVYRAELPSGQ-VVAIKKFHSPLPSDQIVDKKE--FLTEVEALTEIR 183
           +D +  +G G    V  AE    Q +VAIK       + + ++ KE     E+  L +I+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-----AKEALEGKEGSMENEIAVLHKIK 74
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           H NIV L        H +L+ + +  G             E   S+   +I  V DA+ Y
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKY 131
Query: 244 LHHDCFPPIVHRDISSKNLL---LDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LH      IVHRD+  +NLL   LD + +  ++DFG++K   P S   T   GT GYVAP
Sbjct: 132 LHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAP 187
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLNTDIELDEMLDPRLPA 358
           E+      ++  D +S GV+A  ++ G  P   +  + +    L  + E D    P    
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS---PYWDD 244
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPT 387
            S S ++ +R ++E       + PE R T
Sbjct: 245 ISDSAKDFIRHLME-------KDPEKRFT 266

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 120/269 (44%), Gaps = 30/269 (11%)
Query: 127 FDAQYCIGNGGHGSVYRAELPSGQ-VVAIKKFHSPLPSDQIVDKKE--FLTEVEALTEIR 183
           +D +  +G G    V  AE    Q +VAIK       + + ++ KE     E+  L +I+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-----AKKALEGKEGSMENEIAVLHKIK 74
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           H NIV L        H +L+ + +  G             E   S+   +I  V DA+ Y
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKY 131
Query: 244 LHHDCFPPIVHRDISSKNLL---LDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           LH      IVHRD+  +NLL   LD + +  ++DFG++K   P S   T   GT GYVAP
Sbjct: 132 LHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAP 187
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLNTDIELDEMLDPRLPA 358
           E+      ++  D +S GV+A  ++ G  P   +  + +    L  + E D    P    
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS---PYWDD 244
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPT 387
            S S ++ +R ++E       + PE R T
Sbjct: 245 ISDSAKDFIRHLME-------KDPEKRFT 266

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 35/270 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G  G V   +   G  VA+K   +   +      + FL E   +T++RH N+V+L G
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA------QAFLAEASVMTQLRHSNLVQLLG 66
Query: 193 FCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                +   ++V E++ +G              LG    +     V +A+ YL  + F  
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF-- 123
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYTMKIT 309
            VHRD++++N+L+  +  A V+DFG+ K      ++ T+  G     + APE     K +
Sbjct: 124 -VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 310 EKCDVYSFGVLALEVI---KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
            K DV+SFG+L  E+    +  +PR  L  +        +E    +D     P       
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDAPDGCPP------ 226
Query: 367 LRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             ++ EV+ +C +     RP+   + +QL+
Sbjct: 227 --AVYEVMKNCWHLDAAMRPSFLQLREQLE 254

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 106/234 (45%), Gaps = 26/234 (11%)
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS 228
           K E L E   + ++ +  IV++ G C  A    LV E  + G            ++    
Sbjct: 415 KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 470
Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
             + ++  V+  + YL    F   VHRD++++N+LL  +  A ++DFG++K L+ D + +
Sbjct: 471 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 527
Query: 289 TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
              A T+G     + APE     K + K DV+SFGVL  E    G+ P      +  S +
Sbjct: 528 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEV 582
Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              +E  E    R+  P+   +E    + +++  C     E+RP    V  +L+
Sbjct: 583 TAMLEKGE----RMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 628

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 123/270 (45%), Gaps = 29/270 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFH---SPLPSDQIVDKKEFLTEVEALT 180
           +DF+    +G G  G V++ +  PSG V+A K  H    P   +QI+       E++ L 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII------RELQVLH 62
Query: 181 EIRHRNIVKLYG-FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
           E     IV  YG F S    S  +                   +++     + VIKG   
Sbjct: 63  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--- 119
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
            L+YL       I+HRD+   N+L++   E  + DFG++  L  + +N  EF GT  Y++
Sbjct: 120 -LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN--EFVGTRSYMS 174
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           PE       + + D++S G+  +E+  G++PR  +    + F   D  ++E   P+LP+ 
Sbjct: 175 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPM----AIFELLDYIVNEP-PPKLPSA 229
Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
             S++ +     + V  CL ++P  R  +K
Sbjct: 230 VFSLEFQ-----DFVNKCLIKNPAERADLK 254

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS 228
           K E L E   + ++ +  IV++ G C  A    LV E  + G            ++    
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 111
Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
             + ++  V+  + YL    F   VHRD++++N+LL  +  A ++DFG++K L+ D + +
Sbjct: 112 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY 168
Query: 289 TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
              A T+G     + APE     K + K DV+SFGVL  E    G+ P      +  S +
Sbjct: 169 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEV 223
Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              +E  E    R+  P+       R + +++  C     E+RP    V  +L+
Sbjct: 224 TAMLEKGE----RMGCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLR 269

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 106/234 (45%), Gaps = 26/234 (11%)
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS 228
           K E L E   + ++ +  IV++ G C  A    LV E  + G            ++    
Sbjct: 414 KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 469
Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
             + ++  V+  + YL    F   VHRD++++N+LL  +  A ++DFG++K L+ D + +
Sbjct: 470 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526
Query: 289 TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
              A T+G     + APE     K + K DV+SFGVL  E    G+ P      +  S +
Sbjct: 527 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEV 581
Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              +E  E    R+  P+   +E    + +++  C     E+RP    V  +L+
Sbjct: 582 TAMLEKGE----RMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 627

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 35/270 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G  G V   +   G  VA+K   +   +      + FL E   +T++RH N+V+L G
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA------QAFLAEASVMTQLRHSNLVQLLG 81
Query: 193 FCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                +   ++V E++ +G              LG    +     V +A+ YL  + F  
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF-- 138
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYTMKIT 309
            VHRD++++N+L+  +  A V+DFG+ K      ++ T+  G     + APE     K +
Sbjct: 139 -VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 310 EKCDVYSFGVLALEVI---KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
            K DV+SFG+L  E+    +  +PR  L  +        +E    +D     P       
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDAPDGCPP------ 241
Query: 367 LRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             ++ EV+ +C +     RP+   + +QL+
Sbjct: 242 --AVYEVMKNCWHLDAAMRPSFLQLREQLE 269

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 61
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 122 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 217
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 218 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 250

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           H NIVKL+       H+FLV E L  G             E   ++   +++ +  A+S+
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSE---TEASYIMRKLVSAVSH 121
Query: 244 LHHDCFPPIVHRDISSKNLLLDLE---FEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           +H      +VHRD+  +NLL   E    E  + DFG A+   PD+        T  Y AP
Sbjct: 122 MHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           EL       E CD++S GV+   ++ G+ P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS 228
           K E L E   + ++ +  IV++ G C  A    LV E  + G            ++    
Sbjct: 50  KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 105
Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
             + ++  V+  + YL    F   VHRD++++N+LL  +  A ++DFG++K L+ D + +
Sbjct: 106 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 162
Query: 289 TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
              A T+G     + APE     K + K DV+SFGVL  E    G+ P      +  S +
Sbjct: 163 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEV 217
Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              +E  E    R+  P+       R + +++  C     E+RP    V  +L+
Sbjct: 218 TAMLEKGE----RMGCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLR 263

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 61
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 122 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 217
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 218 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 250

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 61
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 122 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 217
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 218 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 250

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 60
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 121 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 216
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 217 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 249

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 62
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 123 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 175
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 218
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 219 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 251

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS 228
           K E L E   + ++ +  IV++ G C  A    LV E  + G            ++    
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 111
Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
             + ++  V+  + YL    F   VHRD++++N+LL  +  A ++DFG++K L+ D + +
Sbjct: 112 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 168
Query: 289 TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
              A T+G     + APE     K + K DV+SFGVL  E    G+ P      +  S +
Sbjct: 169 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEV 223
Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              +E  E    R+  P+       R + +++  C     E+RP    V  +L+
Sbjct: 224 TAMLEKGE----RMGCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLR 269

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      VA+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 71
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + S A    +V ++ +               E+   + +++ +  A  + YLH      I
Sbjct: 72  Y-STAPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 125
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIA--KFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD+ S N+ L  +    + DFG+A  K     S  + + +G+  ++APE+   +++ +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 182
Query: 311 K------CDVYSFGVLALEVIKGKHP 330
           K       DVY+FG++  E++ G+ P
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      VA+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 91
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + +  + + +V ++ +               E+   + +++ +  A  + YLH      I
Sbjct: 92  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 145
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT------EFAGTYGYVAPELAYTM 306
           +HRD+ S N+ L  +    + DFG+A     + S W+      + +G+  ++APE+   +
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLAT----EKSRWSGSHQFEQLSGSILWMAPEV---I 198
Query: 307 KITEK------CDVYSFGVLALEVIKGKHP 330
           ++ +K       DVY+FG++  E++ G+ P
Sbjct: 199 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 60
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 121 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 216
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 217 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 249

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 114/266 (42%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 69
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 70  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 124
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  
Sbjct: 125 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 183 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 222
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 223 TPDEVVWPGVTSMPDYKPSFPKWARQ 248

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      VA+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 71
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + +  + + +V ++ +               E+   + +++ +  A  + YLH      I
Sbjct: 72  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 125
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT------EFAGTYGYVAPELAYTM 306
           +HRD+ S N+ L  +    + DFG+A     + S W+      + +G+  ++APE+   +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLAT----EKSRWSGSHQFEQLSGSILWMAPEV---I 178
Query: 307 KITEK------CDVYSFGVLALEVIKGKHP 330
           ++ +K       DVY+FG++  E++ G+ P
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      VA+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 99
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + +  + + +V ++ +               E+   + +++ +  A  + YLH      I
Sbjct: 100 YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 153
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT------EFAGTYGYVAPELAYTM 306
           +HRD+ S N+ L  +    + DFG+A     + S W+      + +G+  ++APE+   +
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLAT----EKSRWSGSHQFEQLSGSILWMAPEV---I 206
Query: 307 KITEK------CDVYSFGVLALEVIKGKHP 330
           ++ +K       DVY+FG++  E++ G+ P
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS 228
           K E L E   + ++ +  IV++ G C  A    LV E  + G            ++    
Sbjct: 52  KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 107
Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
             + ++  V+  + YL    F   VHRD++++N+LL  +  A ++DFG++K L+ D + +
Sbjct: 108 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164
Query: 289 TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
              A T+G     + APE     K + K DV+SFGVL  E    G+ P      +  S +
Sbjct: 165 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEV 219
Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              +E  E    R+  P+       R + +++  C     E+RP    V  +L+
Sbjct: 220 TAMLEKGE----RMGCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLR 265

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 59
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 120 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 215
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 216 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 248

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 58
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 119 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 214
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 215 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS 228
           K E L E   + ++ +  IV++ G C  A    LV E  + G            ++    
Sbjct: 70  KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 125
Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
             + ++  V+  + YL    F   VHRD++++N+LL  +  A ++DFG++K L+ D + +
Sbjct: 126 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 182
Query: 289 TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
              A T+G     + APE     K + K DV+SFGVL  E    G+ P      +  S +
Sbjct: 183 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEV 237
Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              +E  E    R+  P+       R + +++  C     E+RP    V  +L+
Sbjct: 238 TAMLEKGE----RMGCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLR 283

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 58
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 119 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 214
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 215 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 114/266 (42%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 67
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 122
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 181 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 220
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQ 246

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 114/266 (42%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+ K      ++ +      + E+  L E+ H NIVKL 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 182 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 221
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 222 TPDEVVWPGVTSMPDYKPSFPKWARQ 247

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS 228
           K E L E   + ++ +  IV++ G C  A    LV E  + G            ++    
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 117
Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
             + ++  V+  + YL    F   VHRD++++N+LL  +  A ++DFG++K L+ D + +
Sbjct: 118 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174
Query: 289 TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
              A T+G     + APE     K + K DV+SFGVL  E    G+ P      +  S +
Sbjct: 175 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEV 229
Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              +E  E    R+  P+       R + +++  C     E+RP    V  +L+
Sbjct: 230 TAMLEKGE----RMGCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLR 275

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 114/266 (42%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+ K      ++ +      + E+  L E+ H NIVKL 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 67
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 122
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 181 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 220
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQ 246

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 114/266 (42%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 67
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 122
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 181 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 220
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQ 246

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 58
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 119 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 214
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 215 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 84
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 85  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 139
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 200 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 249
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 250 QLMRLCWKERPEDRPTFDYLRSVLE 274

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      VA+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 76
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + +  + + +V ++ +               E+   + +++ +  A  + YLH      I
Sbjct: 77  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 130
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIA--KFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD+ S N+ L  +    + DFG+A  K     S  + + +G+  ++APE+   +++ +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 187
Query: 311 K------CDVYSFGVLALEVIKGKHP 330
           K       DVY+FG++  E++ G+ P
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 114/266 (42%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+EFL +               L    S    +++G+A   S+      
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 182 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 221
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 222 TPDEVVWPGVTSMPDYKPSFPKWARQ 247

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      VA+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 71
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + +  + + +V ++ +               E+   + +++ +  A  + YLH      I
Sbjct: 72  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 125
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIA--KFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD+ S N+ L  +    + DFG+A  K     S  + + +G+  ++APE+   +++ +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 182
Query: 311 K------CDVYSFGVLALEVIKGKHP 330
           K       DVY+FG++  E++ G+ P
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   ++++ H+N
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKLNHQN 109
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    +++    G      
Sbjct: 170 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPV 224
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 282
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 283 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 60
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 121 CHSHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 216
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 217 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 249

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 11/228 (4%)
Query: 116 VYDEIVRATND-FDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLT 174
           V+DE      D F+    IG G  G V   +    + +   K+ +     +  + +    
Sbjct: 5   VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVI 234
           E++ +  + H  +V L+         F+V + L  G            +E   + ++ + 
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE--TVKLFIC 122
Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT 294
           + V  AL YL +     I+HRD+   N+LLD     H+ DF IA  L P  +  T  AGT
Sbjct: 123 ELVM-ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITTMAGT 177
Query: 295 YGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISS 339
             Y+APE+  + K    +   D +S GV A E+++G+ P    SS SS
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      VA+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 76
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + +  + + +V ++ +               E+   + +++ +  A  + YLH      I
Sbjct: 77  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 130
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIA--KFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD+ S N+ L  +    + DFG+A  K     S  + + +G+  ++APE+   +++ +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 187
Query: 311 K------CDVYSFGVLALEVIKGKHP 330
           K       DVY+FG++  E++ G+ P
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      VA+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 98
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + +  + + +V ++ +               E+   + +++ +  A  + YLH      I
Sbjct: 99  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 152
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIA--KFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD+ S N+ L  +    + DFG+A  K     S  + + +G+  ++APE+   +++ +
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 209
Query: 311 K------CDVYSFGVLALEVIKGKHP 330
           K       DVY+FG++  E++ G+ P
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      VA+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 99
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + +  + + +V ++ +               E+   + +++ +  A  + YLH      I
Sbjct: 100 YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 153
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIA--KFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD+ S N+ L  +    + DFG+A  K     S  + + +G+  ++APE+   +++ +
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 210
Query: 311 K------CDVYSFGVLALEVIKGKHP 330
           K       DVY+FG++  E++ G+ P
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 59
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 120 CHSHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 215
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 216 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 248

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 130
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 191 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 240
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      VA+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 73
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + +  + + +V ++ +               E+   + +++ +  A  + YLH      I
Sbjct: 74  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 127
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIA--KFLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD+ S N+ L  +    + DFG+A  K     S  + + +G+  ++APE+   +++ +
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 184
Query: 311 K------CDVYSFGVLALEVIKGKHP 330
           K       DVY+FG++  E++ G+ P
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   ++++ H+N
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKLNHQN 95
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    +++    G      
Sbjct: 156 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPV 210
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 268
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 269 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS 228
           K E L E   + ++ +  IV++ G C  A    LV E  + G            ++    
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 127
Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
             + ++  V+  + YL    F   VHRD++++N+LL  +  A ++DFG++K L+ D + +
Sbjct: 128 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 289 TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
              A T+G     + APE     K + K DV+SFGVL  E    G+ P      +  S +
Sbjct: 185 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEV 239
Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              +E  E    R+  P+       R + +++  C     E+RP    V  +L+
Sbjct: 240 TAMLEKGE----RMGCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLR 285

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS 228
           K E L E   + ++ +  IV++ G C  A    LV E  + G            ++    
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 127
Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
             + ++  V+  + YL    F   VHRD++++N+LL  +  A ++DFG++K L+ D + +
Sbjct: 128 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 289 TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
              A T+G     + APE     K + K DV+SFGVL  E    G+ P      +  S +
Sbjct: 185 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEV 239
Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              +E  E    R+  P+       R + +++  C     E+RP    V  +L+
Sbjct: 240 TAMLEKGE----RMGCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLR 285

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 77
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 78  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 132
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 193 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 242
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 243 QLMRLCWKERPEDRPTFDYLRSVLE 267

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 82  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 136
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 197 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 246
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 247 QLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 83
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 84  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 138
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 199 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 248
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 249 QLMRLCWKERPEDRPTFDYLRSVLE 273

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 112/271 (41%), Gaps = 38/271 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           NDFD    +G G  G V    E  +G+  A+K     L  + I+ K E    +TE   L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMK----ILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG-VA 238
             RH  +  L Y F +H R  F V E+   G             E    +R       + 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYGAEIV 115
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
            AL YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD----IELDEMLDP 354
           APE+          D +  GV+  E++ G+ P          F N D     EL  M + 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHERLFELILMEEI 222
Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
           R P   R++  + +S++      L + P+ R
Sbjct: 223 RFP---RTLSPEAKSLLA---GLLKKDPKQR 247

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 112/271 (41%), Gaps = 38/271 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           NDFD    +G G  G V    E  +G+  A+K     L  + I+ K E    +TE   L 
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMK----ILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG-VA 238
             RH  +  L Y F +H R  F V E+   G             E    +R       + 
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYGAEIV 118
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
            AL YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+
Sbjct: 119 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 175
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD----IELDEMLDP 354
           APE+          D +  GV+  E++ G+ P          F N D     EL  M + 
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHERLFELILMEEI 225
Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
           R P   R++  + +S++      L + P+ R
Sbjct: 226 RFP---RTLSPEAKSLLA---GLLKKDPKQR 250

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 112/271 (41%), Gaps = 38/271 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           NDFD    +G G  G V    E  +G+  A+K     L  + I+ K E    +TE   L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMK----ILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG-VA 238
             RH  +  L Y F +H R  F V E+   G             E    +R       + 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYGAEIV 115
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
            AL YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD----IELDEMLDP 354
           APE+          D +  GV+  E++ G+ P          F N D     EL  M + 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHERLFELILMEEI 222
Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
           R P   R++  + +S++      L + P+ R
Sbjct: 223 RFP---RTLSPEAKSLLA---GLLKKDPKQR 247

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 130
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 191 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 240
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 76
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 77  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 131
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 192 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 241
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 242 QLMRLCWKERPEDRPTFDYLRSVLE 266

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 112/271 (41%), Gaps = 38/271 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           NDFD    +G G  G V    E  +G+  A+K     L  + I+ K E    +TE   L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMK----ILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG-VA 238
             RH  +  L Y F +H R  F V E+   G             E    +R       + 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYGAEIV 115
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
            AL YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYL 172
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD----IELDEMLDP 354
           APE+          D +  GV+  E++ G+ P          F N D     EL  M + 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHERLFELILMEEI 222
Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
           R P   R++  + +S++      L + P+ R
Sbjct: 223 RFP---RTLSPEAKSLLA---GLLKKDPKQR 247

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 11/162 (6%)
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
            L EV  L ++ H NI+KLY F    R+ +LV E  + G             E+  +   
Sbjct: 51  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-- 108
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGIAKFLKPDSSNW 288
            ++K V    +YLH      IVHRD+  +NLLL+ +       + DFG++   +      
Sbjct: 109 -IMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGKM 163
Query: 289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            E  GT  Y+APE+    K  EKCDV+S GV+   ++ G  P
Sbjct: 164 KERLGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 116/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 61
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL                 L    S    +++G+A 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 122 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 217
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 218 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 250

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 94
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    +++    G      
Sbjct: 155 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPV 209
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 267
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 268 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 112/271 (41%), Gaps = 38/271 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           NDFD    +G G  G V    E  +G+  A+K     L  + I+ K E    +TE   L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMK----ILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG-VA 238
             RH  +  L Y F +H R  F V E+   G             E    +R       + 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYGAEIV 115
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
            AL YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYL 172
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD----IELDEMLDP 354
           APE+          D +  GV+  E++ G+ P          F N D     EL  M + 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHERLFELILMEEI 222
Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
           R P   R++  + +S++      L + P+ R
Sbjct: 223 RFP---RTLSPEAKSLLA---GLLKKDPKQR 247

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 58
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL +               L    S    +++G+A 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 119 CHSHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 214
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 215 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 116/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 61
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL                 L    S    +++G+A 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 122 CHSHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 217
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 218 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 250

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 11/162 (6%)
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
            L EV  L ++ H NI+KLY F    R+ +LV E  + G             E+  +   
Sbjct: 68  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-- 125
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGIAKFLKPDSSNW 288
            ++K V    +YLH      IVHRD+  +NLLL+ +       + DFG++   +      
Sbjct: 126 -IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGKM 180
Query: 289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            E  GT  Y+APE+    K  EKCDV+S GV+   ++ G  P
Sbjct: 181 KERLGTAYYIAPEVL-RKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 116/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 60
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL                 L    S    +++G+A 
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 121 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 216
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 217 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 249

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 86
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 87  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 146
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    +++    G      
Sbjct: 147 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPV 201
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 202 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 259
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 260 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 85
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 86  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 140
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 200
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 201 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 250
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 251 QLMRLCWKERPEDRPTFDYLRSVLE 275

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 102/249 (40%), Gaps = 35/249 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           NDFD    +G G  G V    E  +G+  A+K     L  + I+ K E    +TE   L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMK----ILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG-VA 238
             RH  +  L Y F +H R  F V E+   G             E    +R       + 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYGAEIV 115
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
            AL YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+
Sbjct: 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYL 172
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE-------LDEM 351
           APE+          D +  GV+  E++ G+ P          F N D E       ++E+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHERLFELILMEEI 222
Query: 352 LDPRLPAPS 360
             PR  +P 
Sbjct: 223 RFPRTLSPE 231

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 109
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 110 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    +++    G      
Sbjct: 170 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPV 224
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 282
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 283 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/265 (21%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K       S        FL E   + +++H+ +V+LY 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-----PDAFLAEANLMKQLQHQRLVRLYA 70
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 71  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 125
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 185
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 186 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 235
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 236 QLMRLCWKERPEDRPTFDYLRSVLE 260

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 94
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 95  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    +++    G      
Sbjct: 155 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPV 209
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 267
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 268 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           NDFD    +G G  G V    E  +G+  A+K     L  + I+ K E    +TE   L 
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMK----ILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG-VA 238
             RH  +  L Y F +H R  F V E+   G             E    +R       + 
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYGAEIV 120
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
            AL YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+
Sbjct: 121 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYL 177
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           APE+          D +  GV+  E++ G+ P
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 82  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 136
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 197 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 246
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 247 QLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 95
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    +++    G      
Sbjct: 156 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPV 210
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 268
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 269 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 130
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 191 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 240
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 116/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 59
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+EFL                 L    S    +++G+A 
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 120 CHSHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 215
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 216 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 248

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 12/211 (5%)
Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           T+++     +G G    V R  ++P+GQ  A K  ++   S +  D ++   E      +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSAR--DHQKLEREARICRLL 60
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
           +H NIV+L+   S     +LV++ +  G             E   S   + I+ + ++++
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESVN 117
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEA---HVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           + H      IVHRD+  +NLLL  + +     +ADFG+A  ++ D   W  FAGT GY++
Sbjct: 118 HCH---LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+       +  D+++ GV+   ++ G  P
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 12/211 (5%)
Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           T+++     +G G    V R  ++P+GQ  A K  ++   S +  D ++   E      +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSAR--DHQKLEREARICRLL 60
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
           +H NIV+L+   S     +LV++ +  G             E   S   + I+ + ++++
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESVN 117
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEA---HVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           + H      IVHRD+  +NLLL  + +     +ADFG+A  ++ D   W  FAGT GY++
Sbjct: 118 HCH---LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+       +  D+++ GV+   ++ G  P
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 111
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 112 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 171
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    +++    G      
Sbjct: 172 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPV 226
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 227 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 284
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 285 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 80
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 81  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 135
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 195
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 196 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 245
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 246 QLMRLCWKERPEDRPTFDYLRSVLE 270

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 120/270 (44%), Gaps = 25/270 (9%)
Query: 125 NDFDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFH---SPLPSDQIVDKKEFLTEVEALT 180
           +DF+    +G G  G V++ +  PSG V+A K  H    P   +QI+       E++ L 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII------RELQVLH 78
Query: 181 EIRHRNIVKLYG-FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
           E     IV  YG F S    S  +                   +++     + VIKG   
Sbjct: 79  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--- 135
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
            L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 136 -LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 190
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           PE       + + D++S G+  +E+  G++P    S   + F   D  ++E   P+LP+ 
Sbjct: 191 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEP-PPKLPSG 249
Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
             S++ +     + V  CL ++P  R  +K
Sbjct: 250 VFSLEFQ-----DFVNKCLIKNPAERADLK 274

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 101
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 102 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 161
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    +++    G      
Sbjct: 162 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPV 216
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 217 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 274
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 275 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 135
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    + +    G      
Sbjct: 196 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYRKGGCAMLPV 250
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 308
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 309 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 112
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 113 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 172
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    + +    G      
Sbjct: 173 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYRKGGCAMLPV 227
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 228 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 285
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 286 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 118/270 (43%), Gaps = 35/270 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G  G V   +   G  VA+K   +   +      + FL E   +T++RH N+V+L G
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA------QAFLAEASVMTQLRHSNLVQLLG 72
Query: 193 FCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                +   ++V E++ +G              LG    +     V +A+ YL  + F  
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF-- 129
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYTMKIT 309
            VHRD++++N+L+  +  A V+DFG+ K      ++ T+  G     + APE       +
Sbjct: 130 -VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFS 183
Query: 310 EKCDVYSFGVLALEVI---KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
            K DV+SFG+L  E+    +  +PR  L  +        +E    +D     P       
Sbjct: 184 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDAPDGCPP------ 232
Query: 367 LRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             ++ EV+ +C +     RP+   + +QL+
Sbjct: 233 --AVYEVMKNCWHLDAAMRPSFLQLREQLE 260

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VYSEQ--DELDFLMEALIISKFNHQN 109
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    +++    G      
Sbjct: 170 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPV 224
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 282
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 283 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 15/217 (6%)
Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIV---DKKEFLT 174
           +I     DF+    +G G  G V+ AE   + Q  AIK     L  D ++   D +  + 
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIK----ALKKDVVLMDDDVECTMV 67
Query: 175 EVEALT-EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNV 233
           E   L+    H  +  ++       + F V E+L  G             +   S+    
Sbjct: 68  EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFY 124
Query: 234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG 293
              +   L +LH      IV+RD+   N+LLD +    +ADFG+ K      +   EF G
Sbjct: 125 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCG 181
Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           T  Y+APE+    K     D +SFGVL  E++ G+ P
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 121
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 122 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 181
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    +++    G      
Sbjct: 182 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPV 236
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 237 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 294
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 295 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 39/283 (13%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 95
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXX----XXXXXXXXQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G                  L     ++V + +A    
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVA---DFGIAKFLKPDSSNWTEFAGT----Y 295
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    +++    G      
Sbjct: 156 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIY--RASYYRKGGCAMLPV 210
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP 354
            ++ PE       T K D +SFGVL  E+   G  P  + S  +   L        M  P
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 268
Query: 355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P P          +  ++  C    PE RP   I+ ++++
Sbjct: 269 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 132 CIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDK--------KEFLTEVEALTEI 182
            IG G    V  A  + +G+ VA++          I+DK        ++   EV  +  +
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVR----------IIDKTQLNSSSLQKLFREVRIMKVL 70
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NIVKL+      +  +LV E+   G            +E    +     + +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIVSAVQ 127
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      IVHRD+ ++NLLLD +    +ADFG +       +   EF G+  Y APEL
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDEFCGSPPYAAPEL 183
Query: 303 AYTMKIT-EKCDVYSFGVLALEVIKGKHPRD 332
               K    + DV+S GV+   ++ G  P D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 112/283 (39%), Gaps = 40/283 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           ND   Q  IG G  G V +A +    +    AIK+       D   D ++F  E+E L +
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 71
Query: 182 IRHR-NIVKLYGFCSHARHSFLVYEFLKRGXXX-------------XXXXXXXXXQELGW 227
           + H  NI+ L G C H  + +L  E+   G                           L  
Sbjct: 72  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 131
Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
            Q ++    VA  + YL    F   +HRD++++N+L+   + A +ADFG+++  +     
Sbjct: 132 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 188
Query: 288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI 346
                         L Y++  T   DV+S+GVL  E++  G  P   +         T  
Sbjct: 189 TMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTPYCGM---------TCA 238
Query: 347 ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
           EL E L    RL  P     E    + +++  C  E P  RP+
Sbjct: 239 ELYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPS 277

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 116/265 (43%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 130
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HRD+ + N+L+       +ADFG+A+ ++       E A     + APE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 191 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 240
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 121/263 (46%), Gaps = 35/263 (13%)
Query: 152 VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYE----- 205
           VA+K   S   +D   +K+  ++E++ ++ + +H NIV L G C+H     ++ E     
Sbjct: 79  VAVKMLKSTAHAD---EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 206 ----FLKR----GXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL-HHDCFPPIVHRD 256
               FL+R    G            ++L     ++    VA  +++L   +C    +HRD
Sbjct: 136 DLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC----IHRD 191
Query: 257 ISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYTMKITEKCDV 314
           ++++N+LL     A + DFG+A+ +  DS+   +        ++APE  +    T + DV
Sbjct: 192 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 251
Query: 315 YSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEV 373
           +S+G+L  E+   G +P   +  ++S F     +  +M  P   AP        ++I  +
Sbjct: 252 WSYGILLWEIFSLGLNPYPGI-LVNSKFYKLVKDGYQMAQPAF-AP--------KNIYSI 301
Query: 374 VFSCLNESPESRPTMKIVSQQLQ 396
           + +C    P  RPT + +   LQ
Sbjct: 302 MQACWALEPTHRPTFQQICSFLQ 324

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 112/283 (39%), Gaps = 40/283 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           ND   Q  IG G  G V +A +    +    AIK+       D   D ++F  E+E L +
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 81
Query: 182 IRHR-NIVKLYGFCSHARHSFLVYEFLKRGXXX-------------XXXXXXXXXQELGW 227
           + H  NI+ L G C H  + +L  E+   G                           L  
Sbjct: 82  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
            Q ++    VA  + YL    F   +HRD++++N+L+   + A +ADFG+++  +     
Sbjct: 142 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI 346
                         L Y++  T   DV+S+GVL  E++  G  P   +         T  
Sbjct: 199 TMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGM---------TCA 248
Query: 347 ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
           EL E L    RL  P     E    + +++  C  E P  RP+
Sbjct: 249 ELYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPS 287

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 14/263 (5%)
Query: 126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           DFD    IG G +  V    L  + ++ A+K     L +D   D     TE     +   
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASN 68
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           H  +V L+         F V E++  G             E            ++ AL+Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---EHARFYSAEISLALNY 125
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYGYVAPEL 302
           LH      I++RD+   N+LLD E    + D+G+ K  L+P  +  + F GT  Y+APE+
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIAPEI 181
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
                     D ++ GVL  E++ G+ P D + S  +   NT+  L +++  +     RS
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241
Query: 363 VQEKLRSIVEVVFSCLNESPESR 385
           +  K  S+++   S LN+ P+ R
Sbjct: 242 LSVKAASVLK---SFLNKDPKER 261

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 14/263 (5%)
Query: 126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           DFD    IG G +  V    L  + ++ A+K     L +D   D     TE     +   
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASN 64
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           H  +V L+         F V E++  G             E            ++ AL+Y
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---EHARFYSAEISLALNY 121
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYGYVAPEL 302
           LH      I++RD+   N+LLD E    + D+G+ K  L+P  +  + F GT  Y+APE+
Sbjct: 122 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIAPEI 177
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
                     D ++ GVL  E++ G+ P D + S  +   NT+  L +++  +     RS
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 237
Query: 363 VQEKLRSIVEVVFSCLNESPESR 385
           +  K  S+++   S LN+ P+ R
Sbjct: 238 LSVKAASVLK---SFLNKDPKER 257

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 14/263 (5%)
Query: 126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           DFD    IG G +  V    L  + ++ A+K     L +D   D     TE     +   
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASN 79
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           H  +V L+         F V E++  G             E            ++ AL+Y
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---EHARFYSAEISLALNY 136
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYGYVAPEL 302
           LH      I++RD+   N+LLD E    + D+G+ K  L+P  +  + F GT  Y+APE+
Sbjct: 137 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIAPEI 192
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
                     D ++ GVL  E++ G+ P D + S  +   NT+  L +++  +     RS
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 252
Query: 363 VQEKLRSIVEVVFSCLNESPESR 385
           +  K  S+++   S LN+ P+ R
Sbjct: 253 MSVKAASVLK---SFLNKDPKER 272

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDK--------KEFLTEV 176
           ++  Q  IG G    V  A  + +G+ VA+K          I+DK        ++   EV
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVK----------IIDKTQLNPTSLQKLFREV 65
Query: 177 EALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG 236
             +  + H NIVKL+      +  +LV E+   G            +E    +     + 
Sbjct: 66  RIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQ 122
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
           +  A+ Y H      IVHRD+ ++NLLLD +    +ADFG +       +    F G+  
Sbjct: 123 IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTV-GNKLDTFCGSPP 178
Query: 297 YVAPELAYTMKIT-EKCDVYSFGVLALEVIKGKHPRD 332
           Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 114/266 (42%), Gaps = 33/266 (12%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H NIVKL 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 67
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVADALSYLHHDCF 249
                    +LV+E + +               L    S    +++G+A   S+      
Sbjct: 68  DVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 122
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-I 308
             ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
           +   D++S G +  E++  +           +    D E+D++           +   L 
Sbjct: 181 STAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF---------RIFRTLG 220
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQ 394
           +  EVV+  +   P+ +P+    ++Q
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQ 246

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 152 VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYE----- 205
           VA+K   S   +D+   K+  ++E++ ++ + +H NIV L G C+H     ++ E     
Sbjct: 71  VAVKMLKSTAHADE---KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 127
Query: 206 ----FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL-HHDCFPPIVHRDISSK 260
               FL+R              EL     ++    VA  +++L   +C    +HRD++++
Sbjct: 128 DLLNFLRRKAEADLDKEDGRPLEL--RDLLHFSSQVAQGMAFLASKNC----IHRDVAAR 181
Query: 261 NLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYTMKITEKCDVYSFG 318
           N+LL     A + DFG+A+ +  DS+   +        ++APE  +    T + DV+S+G
Sbjct: 182 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 241
Query: 319 VLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSC 377
           +L  E+   G +P   +  ++S F     +  +M  P   AP        ++I  ++ +C
Sbjct: 242 ILLWEIFSLGLNPYPGI-LVNSKFYKLVKDGYQMAQPAF-AP--------KNIYSIMQAC 291
Query: 378 LNESPESRPTMKIVSQQLQ 396
               P  RPT + +   LQ
Sbjct: 292 WALEPTHRPTFQQICSFLQ 310

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 16/264 (6%)
Query: 126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           DFD    IG G +  V    L  + ++ A++     L +D   D     TE     +   
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEKHVFEQASN 111
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           H  +V L+         F V E++  G            ++L           ++ AL+Y
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNY 168
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYGYVAPEL 302
           LH      I++RD+   N+LLD E    + D+G+ K  L+P  +  T F GT  Y+APE+
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEI 224
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT-DIELDEMLDPRLPAPSR 361
                     D ++ GVL  E++ G+ P D + S  +   NT D     +L+ ++  P R
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-R 283
Query: 362 SVQEKLRSIVEVVFSCLNESPESR 385
           S+  K  S+++   S LN+ P+ R
Sbjct: 284 SLSVKAASVLK---SFLNKDPKER 304

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    + +    F  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    + +    F  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 22/223 (9%)
Query: 114 KLVYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF 172
           ++VY+     ++DF  +  +G G +G V  A   P+G++VAIKK     P D+ +     
Sbjct: 4   RIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRT 56
Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMN 232
           L E++ L   +H NI+ ++              ++ +             Q L       
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS------- 285
            I     A+  LH      ++HRD+   NLL++   +  V DFG+A+ +   +       
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 286 ---SNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEV 324
              S  TE+  T  Y APE+  T  K +   DV+S G +  E+
Sbjct: 174 GQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 132 CIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDK--------KEFLTEVEALTEI 182
            IG G    V  A  + +G+ VAIK          I+DK        ++   EV  +  +
Sbjct: 19  TIGKGNFAKVKLARHILTGREVAIK----------IIDKTQLNPTSLQKLFREVRIMKIL 68
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NIVKL+      +  +L+ E+   G            +E    +  +  + +  A+ 
Sbjct: 69  NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE---KEARSKFRQIVSAVQ 125
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      IVHRD+ ++NLLLD +    +ADFG +            F G+  Y APEL
Sbjct: 126 YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDTFCGSPPYAAPEL 181
Query: 303 AYTMKIT-EKCDVYSFGVLALEVIKGKHPRD 332
               K    + DV+S GV+   ++ G  P D
Sbjct: 182 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 114/265 (43%), Gaps = 33/265 (12%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +      V I K   P P       + F  EV  L + RH NI+   G
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQ----FQAFRNEVAVLRKTRHVNILLFMG 99
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + +    + +V ++ +               ++   Q +++ +  A  + YLH      I
Sbjct: 100 YMTKDNLA-IVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGMDYLHAKN---I 153
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT------EFAGTYGYVAPELAYTM 306
           +HRD+ S N+ L       + DFG+A       S W+      +  G+  ++APE+    
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATV----KSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 307 K---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP--SR 361
                + + DVYS+G++  E++ G+ P         S +N   ++  M+     +P  S+
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTGELP--------YSHINNRDQIIFMVGRGYASPDLSK 261
Query: 362 SVQEKLRSIVEVVFSCLNESPESRP 386
             +   +++  +V  C+ +  E RP
Sbjct: 262 LYKNCPKAMKRLVADCVKKVKEERP 286

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/265 (20%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 71
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +     +++ E+++ G            + L  ++ +++   +A+ ++++    +   
Sbjct: 72  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 126
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEK 311
           +HR++ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 186
Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            DV+SFG+L  E++   H R     +++  +  ++E       R+  P    +E    + 
Sbjct: 187 SDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEE----LY 236
Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
           +++  C  E PE RPT   +   L+
Sbjct: 237 QLMRLCWKERPEDRPTFDYLRSVLE 261

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 119/273 (43%), Gaps = 29/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE-ALTEI 182
           +D +    +G G +G V +   +PSGQ++A+K+  + + S +   +K  L +++ ++  +
Sbjct: 51  DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDLDISMRTV 107
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
                V  YG        ++  E +               Q +       +   +  AL 
Sbjct: 108 DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 167
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           +LH      ++HRD+   N+L++   +  + DFGI+ +L  DS   T  AG   Y+APE 
Sbjct: 168 HLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DSVAKTIDAGCKPYMAPER 224
Query: 303 --------AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP 354
                    Y++    K D++S G+  +E+   + P D   S  + F     ++ E   P
Sbjct: 225 INPELNQKGYSV----KSDIWSLGITMIELAILRFPYD---SWGTPFQQLK-QVVEEPSP 276
Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
           +LPA   S +      V+    CL ++ + RPT
Sbjct: 277 QLPADKFSAE-----FVDFTSQCLKKNSKERPT 304

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 89/214 (41%), Gaps = 33/214 (15%)
Query: 132 CIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDK--------KEFLTEVEALTEI 182
            IG G    V  A  + +G+ VA+K          I+DK        ++   EV  +  +
Sbjct: 14  TIGKGNFAKVKLARHILTGKEVAVK----------IIDKTQLNSSSLQKLFREVRIMKVL 63
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNV---IKGVAD 239
            H NIVKL+      +  +LV E+   G               GW +        + +  
Sbjct: 64  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH------GWMKEKEARAKFRQIVS 117
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           A+ Y H      IVHRD+ ++NLLLD +    +ADFG +       +    F G+  Y A
Sbjct: 118 AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDTFCGSPPYAA 173
Query: 300 PELAYTMKIT-EKCDVYSFGVLALEVIKGKHPRD 332
           PEL    K    + DV+S GV+   ++ G  P D
Sbjct: 174 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 152 VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYE----- 205
           VA+K   S   +D+   K+  ++E++ ++ + +H NIV L G C+H     ++ E     
Sbjct: 79  VAVKMLKSTAHADE---KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 206 ----FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL-HHDCFPPIVHRDISSK 260
               FL+R              EL     ++    VA  +++L   +C    +HRD++++
Sbjct: 136 DLLNFLRRKAEADLDKEDGRPLEL--RDLLHFSSQVAQGMAFLASKNC----IHRDVAAR 189
Query: 261 NLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYTMKITEKCDVYSFG 318
           N+LL     A + DFG+A+ +  DS+   +        ++APE  +    T + DV+S+G
Sbjct: 190 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 249
Query: 319 VLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSC 377
           +L  E+   G +P   +  ++S F     +  +M  P   AP        ++I  ++ +C
Sbjct: 250 ILLWEIFSLGLNPYPGI-LVNSKFYKLVKDGYQMAQPAF-AP--------KNIYSIMQAC 299
Query: 378 LNESPESRPTMKIVSQQLQ 396
               P  RPT + +   LQ
Sbjct: 300 WALEPTHRPTFQQICSFLQ 318

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 84  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 139
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    + +    F  T  Y APE+    M
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVATRWYRAPEIMLNWM 194
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 13/183 (7%)
Query: 148 SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH--ARHSFLVYE 205
           +G+ VA+K        + I D K+   E+E L  + H NIVK  G C+        L+ E
Sbjct: 49  TGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105
Query: 206 FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD 265
           FL  G             ++   Q++     +   + YL    +   VHRD++++N+L++
Sbjct: 106 FLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVE 160
Query: 266 LEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKITEKCDVYSFGVLAL 322
            E +  + DFG+ K ++ D    T   +      + APE     K     DV+SFGV   
Sbjct: 161 SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220
Query: 323 EVI 325
           E++
Sbjct: 221 ELL 223

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 32/267 (11%)
Query: 133 IGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G+G  G+VY+   +P G+ V    AIK  +        V   EF+ E   +  + H ++
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV---EFMDEALIMASMDHPHL 102
Query: 188 VKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
           V+L G C       LV + +  G              +G    +N    +A  + YL   
Sbjct: 103 VRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER 159
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYT 305
               +VHRD++++N+L+       + DFG+A+ L+ D   +    G     ++A E  + 
Sbjct: 160 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 216
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--RLPAPSRS 362
            K T + DV+S+GV   E++  G  P D + +          E+ ++L+   RLP P   
Sbjct: 217 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------REIPDLLEKGERLPQPPIC 267
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMK 389
             +    +  V+  C     +SRP  K
Sbjct: 268 TID----VYMVMVKCWMIDADSRPKFK 290

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 32/267 (11%)
Query: 133 IGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G+G  G+VY+   +P G+ V    AIK  +        V   EF+ E   +  + H ++
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV---EFMDEALIMASMDHPHL 79
Query: 188 VKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
           V+L G C       LV + +  G              +G    +N    +A  + YL   
Sbjct: 80  VRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER 136
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYT 305
               +VHRD++++N+L+       + DFG+A+ L+ D   +    G     ++A E  + 
Sbjct: 137 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 193
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--RLPAPSRS 362
            K T + DV+S+GV   E++  G  P D + +          E+ ++L+   RLP P   
Sbjct: 194 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------REIPDLLEKGERLPQPPIC 244
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMK 389
             +    +  V+  C     +SRP  K
Sbjct: 245 TID----VYMVMVKCWMIDADSRPKFK 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 132 CIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDK--------KEFLTEVEALTEI 182
            IG G    V  A  + +G+ VA+K          I+DK        ++   EV  +  +
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVK----------IIDKTQLNSSSLQKLFREVRIMKVL 70
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NIVKL+      +  +LV E+   G            +E    +     + +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIVSAVQ 127
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      IVHRD+ ++NLLLD +    +ADFG +       +    F G+  Y APEL
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPEL 183
Query: 303 AYTMKIT-EKCDVYSFGVLALEVIKGKHPRD 332
               K    + DV+S GV+   ++ G  P D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 33/261 (12%)
Query: 152 VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYE----- 205
           VA+K   S   +D+   K+  ++E++ ++ + +H NIV L G C+H     ++ E     
Sbjct: 79  VAVKMLKSTAHADE---KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 206 ----FLKRGXXXXXXXXXXXXQELGWSQR--MNVIKGVADALSYL-HHDCFPPIVHRDIS 258
               FL+R                  S R  ++    VA  +++L   +C    +HRD++
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNC----IHRDVA 191
Query: 259 SKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYTMKITEKCDVYS 316
           ++N+LL     A + DFG+A+ +  DS+   +        ++APE  +    T + DV+S
Sbjct: 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251
Query: 317 FGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVF 375
           +G+L  E+   G +P   +  ++S F     +  +M  P   AP        ++I  ++ 
Sbjct: 252 YGILLWEIFSLGLNPYPGI-LVNSKFYKLVKDGYQMAQPAF-AP--------KNIYSIMQ 301
Query: 376 SCLNESPESRPTMKIVSQQLQ 396
           +C    P  RPT + +   LQ
Sbjct: 302 ACWALEPTHRPTFQQICSFLQ 322

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 27/211 (12%)
Query: 132 CIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDK--------KEFLTEVEALTEI 182
            IG G    V  A  + +G+ VAIK          I+DK        ++   EV  +  +
Sbjct: 22  TIGKGNFAKVKLARHILTGREVAIK----------IIDKTQLNPTSLQKLFREVRIMKIL 71
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NIVKL+      +  +L+ E+   G            +E    +  +  + +  A+ 
Sbjct: 72  NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE---KEARSKFRQIVSAVQ 128
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      IVHRD+ ++NLLLD +    +ADFG +            F G   Y APEL
Sbjct: 129 YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFCGAPPYAAPEL 184
Query: 303 AYTMKIT-EKCDVYSFGVLALEVIKGKHPRD 332
               K    + DV+S GV+   ++ G  P D
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 132 CIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDK--------KEFLTEVEALTEI 182
            IG G    V  A  + +G+ VA+K          I+DK        ++   EV  +  +
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVK----------IIDKTQLNSSSLQKLFREVRIMKVL 70
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NIVKL+      +  +LV E+   G            +E    +     + +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIVSAVQ 127
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      IVHRD+ ++NLLLD +    +ADFG +       +    F G+  Y APEL
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPEL 183
Query: 303 AYTMKIT-EKCDVYSFGVLALEVIKGKHPRD 332
               K    + DV+S GV+   ++ G  P D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 192 GFCSHARHSFLVYE--FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
              + AR S   +   +L               Q+L       +I  +   L Y+H    
Sbjct: 108 DVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 163
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKI 308
             I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M  
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHY 220
Query: 309 TEKCDVYSFGVLALEVIKGK 328
            +  D++S G +  E++ G+
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S      +VY     +++               Q L        +  +  +L+Y+H
Sbjct: 80  YFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 195
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 97/235 (41%), Gaps = 41/235 (17%)
Query: 121 VRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKF-HSPLPSDQIVDKKEFLTEVEA 178
           +R  +DF+    +G G  G V +A      +  AIKK  H+      I      L+EV  
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI------LSEVML 55
Query: 179 LTEIRHRNIVKLYGFCSHARH-------------SFLVYEFLKRGXXXXXXXXXXXXQEL 225
           L  + H+ +V+ Y      R+              F+  E+ + G            Q+ 
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 226 GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK------ 279
               R+   + + +ALSY+H      I+HRD+   N+ +D      + DFG+AK      
Sbjct: 116 DEYWRL--FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 280 -FLKPDSS-------NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI 325
             LK DS        N T   GT  YVA E L  T    EK D+YS G++  E+I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 13/183 (7%)
Query: 148 SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH--ARHSFLVYE 205
           +G+ VA+K        + I D K+   E+E L  + H NIVK  G C+        L+ E
Sbjct: 37  TGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGICTEDGGNGIKLIME 93
Query: 206 FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD 265
           FL  G             ++   Q++     +   + YL    +   VHRD++++N+L++
Sbjct: 94  FLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVE 148
Query: 266 LEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKITEKCDVYSFGVLAL 322
            E +  + DFG+ K ++ D    T   +      + APE     K     DV+SFGV   
Sbjct: 149 SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 208
Query: 323 EVI 325
           E++
Sbjct: 209 ELL 211

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVE- 177
           +  DF     +G G  G V+      +G+  A+K           V KKE    L +VE 
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMK-----------VLKKEIVVRLKQVEH 52
Query: 178 ------ALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
                  L+ + H  I++++G    A+  F++ ++++ G              L  SQR 
Sbjct: 53  TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL---------LRKSQRF 103
Query: 232 N--VIKGVAD----ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS 285
              V K  A     AL YLH      I++RD+  +N+LLD      + DFG AK++ PD 
Sbjct: 104 PNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDV 159
Query: 286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +      GT  Y+APE+  T    +  D +SFG+L  E++ G  P
Sbjct: 160 T--YXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 97
Query: 192 GFCSHARHSFLVYE--FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
              + AR S   +   +L               Q+L       +I  +   L Y+H    
Sbjct: 98  DVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 153
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKI 308
             I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M  
Sbjct: 154 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHY 210
Query: 309 TEKCDVYSFGVLALEVIKGK 328
            +  D++S G +  E++ G+
Sbjct: 211 NQTVDIWSVGCIMAELLTGR 230

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYE--FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
              + AR S   +   +L               Q+L       +I  +   L Y+H    
Sbjct: 88  DVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKI 308
             I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 309 TEKCDVYSFGVLALEVIKGK 328
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 33/261 (12%)
Query: 152 VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYE----- 205
           VA+K   S   +D+   K+  ++E++ ++ + +H NIV L G C+H     ++ E     
Sbjct: 79  VAVKMLKSTAHADE---KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 206 ----FLKRGXXXXXXXXXXXXQELGWSQR--MNVIKGVADALSYL-HHDCFPPIVHRDIS 258
               FL+R                  S R  ++    VA  +++L   +C    +HRD++
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC----IHRDVA 191
Query: 259 SKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYTMKITEKCDVYS 316
           ++N+LL     A + DFG+A+ +  DS+   +        ++APE  +    T + DV+S
Sbjct: 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251
Query: 317 FGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVF 375
           +G+L  E+   G +P   +  ++S F     +  +M  P   AP        ++I  ++ 
Sbjct: 252 YGILLWEIFSLGLNPYPGI-LVNSKFYKLVKDGYQMAQPAF-AP--------KNIYSIMQ 301
Query: 376 SCLNESPESRPTMKIVSQQLQ 396
           +C    P  RPT + +   LQ
Sbjct: 302 ACWALEPTHRPTFQQICSFLQ 322

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 192 GFCSHARHSFLVYE--FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
              + AR S   +   +L               Q+L       +I  +   L Y+H    
Sbjct: 107 DVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 162
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKI 308
             I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M  
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHY 219
Query: 309 TEKCDVYSFGVLALEVIKGK 328
            +  D++S G +  E++ G+
Sbjct: 220 NQTVDIWSVGCIMAELLTGR 239

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 93  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 148
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 149 --ADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 203
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGR 225

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 112/283 (39%), Gaps = 40/283 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           ND   Q  IG G  G V +A +    +    AIK+       D   D ++F  E+E L +
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 78
Query: 182 IRHR-NIVKLYGFCSHARHSFLVYEFLKRGXXX-------------XXXXXXXXXQELGW 227
           + H  NI+ L G C H  + +L  E+   G                           L  
Sbjct: 79  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 138
Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
            Q ++    VA  + YL    F   +HR+++++N+L+   + A +ADFG+++  +     
Sbjct: 139 QQLLHFAADVARGMDYLSQKQF---IHRNLAARNILVGENYVAKIADFGLSRGQEVYVKK 195
Query: 288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI 346
                         L Y++  T   DV+S+GVL  E++  G  P   +         T  
Sbjct: 196 TMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTPYCGM---------TCA 245
Query: 347 ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
           EL E L    RL  P     E    + +++  C  E P  RP+
Sbjct: 246 ELYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPS 284

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 95  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 150
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+     +   T +  T  Y APE+    M
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TADEMTGYVATRWYRAPEIMLNWM 205
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGR 227

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 16/159 (10%)
Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE 290
           + VI     AL++ H +    I+HRD+   N+++       V DFGIA+ +    ++ T+
Sbjct: 136 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 192
Query: 291 FA---GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE 347
            A   GT  Y++PE A    +  + DVYS G +  EV+ G+ P    S +S ++ +   +
Sbjct: 193 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 252
Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVE-VVFSCLNESPESR 385
                    P P  +  E L + ++ VV   L ++PE+R
Sbjct: 253 ---------PIPPSARHEGLSADLDAVVLKALAKNPENR 282

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 22/223 (9%)
Query: 114 KLVYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF 172
           ++VY+     ++DF  +  +G G +G V  A   P+G++VAIKK     P D+ +     
Sbjct: 4   RIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRT 56
Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMN 232
           L E++ L   +H NI+ ++              ++ +             Q L       
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS------- 285
            I     A+  LH      ++HRD+   NLL++   +  V DFG+A+ +   +       
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 286 ---SNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEV 324
              S   EF  T  Y APE+  T  K +   DV+S G +  E+
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 192 GFCSHARHSFLVYE--FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
              + AR S   +   +L               Q+L       +I  +   L Y+H    
Sbjct: 84  DVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 139
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKI 308
             I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M  
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHY 196
Query: 309 TEKCDVYSFGVLALEVIKGK 328
            +  D++S G +  E++ G+
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 16/159 (10%)
Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE 290
           + VI     AL++ H +    I+HRD+   N+++       V DFGIA+ +    ++ T+
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 291 FA---GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE 347
            A   GT  Y++PE A    +  + DVYS G +  EV+ G+ P    S +S ++ +   +
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 235
Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVE-VVFSCLNESPESR 385
                    P P  +  E L + ++ VV   L ++PE+R
Sbjct: 236 ---------PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 192 GFCSHARHSFLVYE--FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
              + AR S   +   +L               Q+L       +I  +   L Y+H    
Sbjct: 94  DVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 149
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKI 308
             I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M  
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHY 206
Query: 309 TEKCDVYSFGVLALEVIKGK 328
            +  D++S G +  E++ G+
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 16/159 (10%)
Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE 290
           + VI     AL++ H +    I+HRD+   N+++       V DFGIA+ +    ++ T+
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 291 FA---GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE 347
            A   GT  Y++PE A    +  + DVYS G +  EV+ G+ P    S +S ++ +   +
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 235
Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVE-VVFSCLNESPESR 385
                    P P  +  E L + ++ VV   L ++PE+R
Sbjct: 236 ---------PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 16/159 (10%)
Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE 290
           + VI     AL++ H +    I+HRD+   N+++       V DFGIA+ +    ++ T+
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 291 FA---GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE 347
            A   GT  Y++PE A    +  + DVYS G +  EV+ G+ P    S +S ++ +   +
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 235
Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVE-VVFSCLNESPESR 385
                    P P  +  E L + ++ VV   L ++PE+R
Sbjct: 236 ---------PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 103/246 (41%), Gaps = 14/246 (5%)
Query: 127 FDAQYCIGNGGHGSVYRAE----LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           F+    +G GG+G V++        +G++ A+K     +      D      E   L E+
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 183 RHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADAL 241
           +H  IV L Y F +  +  +L+ E+L  G             E         +  ++ AL
Sbjct: 79  KHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME---DTACFYLAEISMAL 134
Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
            +LH      I++RD+  +N++L+ +    + DFG+ K    D +    F GT  Y+APE
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191
Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR 361
           +          D +S G L  +++ G  P  F        ++  ++    L P L   +R
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP--FTGENRKKTIDKILKCKLNLPPYLTQEAR 249
Query: 362 SVQEKL 367
            + +KL
Sbjct: 250 DLLKKL 255

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 95  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 150
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+     +   T +  T  Y APE+    M
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TADEMTGYVATRWYRAPEIMLNWM 205
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGR 227

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 103/246 (41%), Gaps = 14/246 (5%)
Query: 127 FDAQYCIGNGGHGSVYRAE----LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           F+    +G GG+G V++        +G++ A+K     +      D      E   L E+
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 183 RHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADAL 241
           +H  IV L Y F +  +  +L+ E+L  G             E         +  ++ AL
Sbjct: 79  KHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME---DTACFYLAEISMAL 134
Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
            +LH      I++RD+  +N++L+ +    + DFG+ K    D +    F GT  Y+APE
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE 191
Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR 361
           +          D +S G L  +++ G  P  F        ++  ++    L P L   +R
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP--FTGENRKKTIDKILKCKLNLPPYLTQEAR 249
Query: 362 SVQEKL 367
            + +KL
Sbjct: 250 DLLKKL 255

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 119/274 (43%), Gaps = 29/274 (10%)
Query: 124 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE-ALTE 181
            +D +    +G G +G V +   +PSGQ++A+K+  + + S +   +K  L +++ ++  
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDLDISMRT 62
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADAL 241
           +     V  YG        ++  E +               Q +       +   +  AL
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
            +LH      ++HRD+   N+L++   +  + DFGI+ +L  D +   + AG   Y+APE
Sbjct: 123 EHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-AGCKPYMAPE 179
Query: 302 L--------AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD 353
                     Y++    K D++S G+  +E+   + P D   S  + F     ++ E   
Sbjct: 180 RINPELNQKGYSV----KSDIWSLGITMIELAILRFPYD---SWGTPFQQLK-QVVEEPS 231
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
           P+LPA   S +      V+    CL ++ + RPT
Sbjct: 232 PQLPADKFSAE-----FVDFTSQCLKKNSKERPT 260

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 95  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 150
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+     +   T +  T  Y APE+    M
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVATRWYRAPEIMLNWM 205
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGR 227

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 126/298 (42%), Gaps = 47/298 (15%)
Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNIVK 189
           C+G G +G V+R  L  G+ VA+K F S        D++ +  E E    +  RH NI+ 
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAVKIFSSR-------DEQSWFRETEIYNTVLLRHDNILG 66
Query: 190 LYGFCSHARHS----FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
                  +R+S    +L+  + + G              L     + +    A  L++LH
Sbjct: 67  FIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAACGLAHLH 122
Query: 246 HDCF-----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA-----GTY 295
            + F     P I HRD  S+N+L+    +  +AD G+A  +    S++ +       GT 
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTK 181
Query: 296 GYVAPELAYTMKITEKC-------DVYSFGVLALEVIKGKHPRDFLSSISSSFLNT---D 345
            Y+APE+    +I   C       D+++FG++  E+ +       +      F +    D
Sbjct: 182 RYMAPEV-LDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPND 240
Query: 346 IELDEM-----LDPRLPA-PSR-SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              ++M     +D + P  P+R +    L  + +++  C   +P +R T   + + LQ
Sbjct: 241 PSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQ 298

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 27/211 (12%)
Query: 132 CIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDK--------KEFLTEVEALTEI 182
            IG G    V  A  + +G+ VA+K          I+DK        ++   EV  +  +
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVK----------IIDKTQLNSSSLQKLFREVRIMKVL 70
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NIVKL+      +  +LV E+   G            +E    +     + +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIVSAVQ 127
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      IVHRD+ ++NLLLD +    +ADFG +       +    F G   Y APEL
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPEL 183
Query: 303 AYTMKIT-EKCDVYSFGVLALEVIKGKHPRD 332
               K    + DV+S GV+   ++ G  P D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 24/224 (10%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKF---HSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G   +VY+A +  + Q+VAIKK    H     D I   +  L E++ L E+ H NI+
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI--NRTALREIKLLQELSHPNII 75
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
            L     H  +  LV++F++                L  S     +      L YLH   
Sbjct: 76  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI 308
              I+HRD+   NLLLD      +ADFG+AK     +  +     T  Y APEL +  ++
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARM 189
Query: 309 TE-KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM 351
                D+++ G +  E++           +   FL  D +LD++
Sbjct: 190 YGVGVDMWAVGCILAELL-----------LRVPFLPGDSDLDQL 222

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 100 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 155
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 156 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 210
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGR 232

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 108/256 (42%), Gaps = 37/256 (14%)
Query: 120 IVRAT-NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LT 174
           + R T N+F+    +G G  G V    E  +G+  A+K     L  + IV K E    LT
Sbjct: 3   MARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLT 58
Query: 175 EVEALTEIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNV 233
           E   L   RH  +  L Y F +H R  F V E+   G            +E  +S+    
Sbjct: 59  ENRVLQNSRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLS-----RERVFSEDRAR 112
Query: 234 IKG--VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
             G  +  AL YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +    F
Sbjct: 113 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 170
Query: 292 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE---- 347
            GT  Y+APE+          D +  GV+  E++ G+ P          F N D E    
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHEKLFE 220
Query: 348 ---LDEMLDPRLPAPS 360
              ++E+  PR   P 
Sbjct: 221 LILMEEIRFPRTLGPE 236

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 127 FDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFH---SPLPSDQIVDKKEFLT-EVEALTE 181
           +D +  IG G    V R     +G   A+K        L  +Q+ + +E    E   L +
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 182 IR-HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
           +  H +I+ L      +   FLV++ +++G             E    +  ++++ + +A
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE---KETRSIMRSLLEA 212
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           +S+LH +    IVHRD+  +N+LLD   +  ++DFG +  L+P      E  GT GY+AP
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELCGTPGYLAP 268
Query: 301 E-LAYTMKIT-----EKCDVYSFGVLALEVIKGKHP 330
           E L  +M  T     ++ D+++ GV+   ++ G  P
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 111/255 (43%), Gaps = 27/255 (10%)
Query: 148 SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL--VYE 205
           +G++VA+K   +          K+   E++ L  + H +I+K  G C  A  + L  V E
Sbjct: 59  TGEMVAVKALKADAGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115
Query: 206 FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD 265
           ++  G              +G +Q +   + + + ++YLH   +   +HRD++++N+LLD
Sbjct: 116 YVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQHY---IHRDLAARNVLLD 168
Query: 266 LEFEAHVADFGIAKFLKPDSSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLAL 322
            +    + DFG+AK +      +    +      + APE     K     DV+SFGV   
Sbjct: 169 NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 323 EVI-----KGKHPRDFLSSIS-SSFLNTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVV 374
           E++         P  FL  I  +    T + L E+L+   RLP P +   E    +  ++
Sbjct: 229 ELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAE----VYHLM 284
Query: 375 FSCLNESPESRPTMK 389
            +C       RPT +
Sbjct: 285 KNCWETEASFRPTFE 299

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 12/211 (5%)
Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           T+++     IG G    V R  +L +G   A K  ++   S +  D ++   E      +
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSAR--DHQKLEREARICRLL 60
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
           +H NIV+L+   S     +LV++ +  G             E   S   + I+ + +A+ 
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAVL 117
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEA---HVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           + H      +VHRD+  +NLLL  + +     +ADFG+A  ++ D   W  FAGT GY++
Sbjct: 118 HCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+       +  D+++ GV+   ++ G  P
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY-TM 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNAM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 105/250 (42%), Gaps = 36/250 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           N+F+    +G G  G V    E  +G+  A+K     L  + IV K E    LTE   L 
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG--V 237
             RH  +  L Y F +H R  F V E+   G            +E  +S+      G  +
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLS-----RERVFSEDRARFYGAEI 117
Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGY 297
             AL YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  Y
Sbjct: 118 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEY 175
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE-------LDE 350
           +APE+          D +  GV+  E++ G+ P          F N D E       ++E
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHEKLFELILMEE 225
Query: 351 MLDPRLPAPS 360
           +  PR   P 
Sbjct: 226 IRFPRTLGPE 235

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 93  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 148
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 149 --ADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 203
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 100 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 155
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 156 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 210
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 100 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 155
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 156 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 210
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGR 232

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/302 (22%), Positives = 118/302 (39%), Gaps = 77/302 (25%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKK--EFLTEVEALTEIRHRNIVKL 190
           +G G  GSV    L      ++K     +  D    ++  EFL+E   + +  H N+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 191 YGFCSHAR-------------------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
            G C                       H++L+Y  L+ G            + +     +
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP-----------KHIPLQTLL 150
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
             +  +A  + YL +  F   +HRD++++N +L  +    VADFG++K +         +
Sbjct: 151 KFMVDIALGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKI---------Y 198
Query: 292 AGTY-----------GYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLSSISS 339
           +G Y            ++A E       T K DV++FGV   E+  +G  P         
Sbjct: 199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY-------- 250
Query: 340 SFLNTDIELDEMLD-----PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
                 ++  EM D      RL  P   + E    + E+++SC    P  RPT  ++  Q
Sbjct: 251 ----PGVQNHEMYDYLLHGHRLKQPEDCLDE----LYEIMYSCWRTDPLDRPTFSVLRLQ 302
Query: 395 LQ 396
           L+
Sbjct: 303 LE 304

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 99  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 154
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 155 --ADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 209
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGR 231

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 90  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 145
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 146 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 200
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGR 222

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V +  +  + Q  A+K  +     ++  D    L EVE L ++ H NI+KL+
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK--DTSTILREVELLKKLDHPNIMKLF 87
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                +   ++V E    G             E   ++   +IK V   ++Y+H      
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHK---HN 141
Query: 252 IVHRDISSKNLLL---DLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI 308
           IVHRD+  +N+LL   + + +  + DFG++   + + +   +  GT  Y+APE+      
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT-Y 199
Query: 309 TEKCDVYSFGVLALEVIKGKHP 330
            EKCDV+S GV+   ++ G  P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 13/211 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  SG+ VAIKK   P  S +I  K+ +  E+  L  ++H N++ L 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAY-RELLLLKHMQHENVIGLL 107
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
              + A      Y+F                 E    +   ++  +   L Y+H      
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG--- 164
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITE 310
           +VHRD+   NL ++ + E  + DFG+A+      +  T +  T  Y APE+  + M   +
Sbjct: 165 VVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRAPEVILSWMHYNQ 221
Query: 311 KCDVYSFGVLALEVIKGK---HPRDFLSSIS 338
             D++S G +  E++ GK     +D+L  ++
Sbjct: 222 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 252

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 108 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 163
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 164 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 218
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 95  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 150
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 205
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGR 227

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 93  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 148
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 149 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 203
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 132 CIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDK--------KEFLTEVEALTEI 182
            IG G    V  A  + +G+ VA++          I+DK        ++   EV  +  +
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVR----------IIDKTQLNSSSLQKLFREVRIMKVL 70
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NIVKL+      +  +LV E+   G            +E    +     + +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIVSAVQ 127
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      IVHRD+ ++NLLLD +    +ADFG +       +    F G+  Y APEL
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDTFCGSPPYAAPEL 183
Query: 303 AYTMKIT-EKCDVYSFGVLALEVIKGKHPRD 332
               K    + DV+S GV+   ++ G  P D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 99  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 154
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 155 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 209
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGR 231

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 107 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 162
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 163 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 217
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGR 239

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 93  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 148
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 149 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 203
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 86
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 87  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 142
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 143 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 197
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 198 HYNQTVDIWSVGCIMAELLTGR 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 94  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 149
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 150 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 204
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 90  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 145
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 146 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 200
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 192 GFCSHARHSFLVYE--FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
              + AR S   +   +L               Q+L       +I  +   L Y+H    
Sbjct: 90  DVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 145
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKI 308
             I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M  
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHY 202
Query: 309 TEKCDVYSFGVLALEVIKGK 328
            +  D++S G +  E++ G+
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 111 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 166
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M
Sbjct: 167 --ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVATRWYRAPEIMLNWM 221
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGR 243

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 105/250 (42%), Gaps = 36/250 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           N+F+    +G G  G V    E  +G+  A+K     L  + IV K E    LTE   L 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG--V 237
             RH  +  L Y F +H R  F V E+   G            +E  +S+      G  +
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLS-----RERVFSEDRARFYGAEI 257
Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGY 297
             AL YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  Y
Sbjct: 258 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 315
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE-------LDE 350
           +APE+          D +  GV+  E++ G+ P          F N D E       ++E
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHEKLFELILMEE 365
Query: 351 MLDPRLPAPS 360
           +  PR   P 
Sbjct: 366 IRFPRTLGPE 375

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 105/250 (42%), Gaps = 36/250 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           N+F+    +G G  G V    E  +G+  A+K     L  + IV K E    LTE   L 
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG--V 237
             RH  +  L Y F +H R  F V E+   G            +E  +S+      G  +
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLS-----RERVFSEDRARFYGAEI 119
Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGY 297
             AL YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  Y
Sbjct: 120 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEY 177
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE-------LDE 350
           +APE+          D +  GV+  E++ G+ P          F N D E       ++E
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHEKLFELILMEE 227
Query: 351 MLDPRLPAPS 360
           +  PR   P 
Sbjct: 228 IRFPRTLGPE 237

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 85
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 86  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 141
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 142 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 196
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 197 HYNQTVDIWSVGCIMAELLTGR 218

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/276 (22%), Positives = 116/276 (42%), Gaps = 33/276 (11%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           +  +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKE 61
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW--SQRMNVIKGVAD 239
           + H NIVKL          +LV+E + +               L    S    +++G+A 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
             S+        ++HRD+  +NLL++ E    +ADFG+A+        +     T  Y A
Sbjct: 122 CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           PE+    K  +   D++S G +  E++  +           +    D E+D++       
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR-----------ALFPGDSEIDQLF------ 217
Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   L +  EVV+  +   P+ +P+    ++Q
Sbjct: 218 ---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 250

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 87
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 144
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 84  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 139
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 194
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 85  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 140
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 141 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 195
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGR 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE 290
           + VI     AL++ H +    I+HRD+   N+++       V DFGIA+ +    ++ T+
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 291 FA---GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE 347
            A   GT  Y++PE A    +  + DVYS G +  EV+ G+ P  F      S     + 
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPDSVAYQHVR 233
Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVE-VVFSCLNESPESR 385
            D       P P  +  E L + ++ VV   L ++PE+R
Sbjct: 234 ED-------PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 105/250 (42%), Gaps = 36/250 (14%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           N+F+    +G G  G V    E  +G+  A+K     L  + IV K E    LTE   L 
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG--V 237
             RH  +  L Y F +H R  F V E+   G            +E  +S+      G  +
Sbjct: 207 NSRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLS-----RERVFSEDRARFYGAEI 260
Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGY 297
             AL YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  Y
Sbjct: 261 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 318
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE-------LDE 350
           +APE+          D +  GV+  E++ G+ P          F N D E       ++E
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHEKLFELILMEE 368
Query: 351 MLDPRLPAPS 360
           +  PR   P 
Sbjct: 369 IRFPRTLGPE 378

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 90  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 145
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 146 --ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 200
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 85  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 140
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 141 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 195
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGR 217

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 127 FDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           F+ +  +G G    VYR +    Q     K ++     + VDKK   TE+  L  + H N
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQ-----KPYALKVLKKTVDKKIVRTEIGVLLRLSHPN 109
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHH 246
           I+KL           LV E +  G             E       + +K + +A++YLH 
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE---RDAADAVKQILEAVAYLHE 166
Query: 247 DCFPPIVHRDISSKNLLLDL---EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           +    IVHRD+  +NLL      +    +ADFG++K ++      T   GT GY APE+ 
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-VCGTPGYCAPEIL 222
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
                  + D++S G++   ++ G  P
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 94  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 149
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M
Sbjct: 150 --ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 204
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGR 226

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 229
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKL 190
           +G G +G V+++ +  +G+VVA+KK      +    D +    E+  LTE+  H NIV L
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS--TDAQRTFREIMILTELSGHENIVNL 74
Query: 191 YGF--CSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
                  + R  +LV+++++                L    +  V+  +   + YLH   
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIRANI-----LEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAK--------------FLKPDSSNW------ 288
              ++HRD+   N+LL+ E    VADFG+++               +  ++ N+      
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 289 -TEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLALEVIKGK 328
            T++  T  Y APE+   + K T+  D++S G +  E++ GK
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFH-SPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL 190
           +G G  G V   E   +G  VA+K  +   + S  +V K +   E++ L   RH +I+KL
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKL 76
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y   S     F+V E++  G            +E+   +   + + +  A+ Y H     
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM---EARRLFQQILSAVDYCHRHM-- 131
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKIT 309
            +VHRD+  +N+LLD    A +ADFG++  +  D     +  G+  Y APE ++  +   
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRDSCGSPNYAAPEVISGRLYAG 189
Query: 310 EKCDVYSFGVLALEVIKGKHPRD 332
            + D++S GV+   ++ G  P D
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFD 212

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 22/223 (9%)
Query: 114 KLVYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF 172
           ++VY+     ++DF  +  +G G +G V  A   P+G++VAIKK     P D+ +     
Sbjct: 4   RIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRT 56
Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMN 232
           L E++ L   +H NI+ ++              ++ +             Q L       
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS------- 285
            I     A+  LH      ++HRD+   NLL++   +  V DFG+A+ +   +       
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 286 ---SNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEV 324
              S  TE   T  Y APE+  T  K +   DV+S G +  E+
Sbjct: 174 GQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 192 GFCSHARHSFLVYE--FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
              + AR S   +   +L               Q+L       +I  +   L Y+H    
Sbjct: 94  DVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 149
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKI 308
             I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+    M  
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHY 206
Query: 309 TEKCDVYSFGVLALEVIKGK 328
            +  D++S G +  E++ G+
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 87
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 144
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 91
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 207
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 91
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 207
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 95
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 152
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 212
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 213 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 248

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 87
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 144
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 89
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 146
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 36/211 (17%)
Query: 136 GGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE--ALTEIRHRNIVKLYGF 193
           G  G V++A+L + + VA+K F        I DK+ +  E E  +L  ++H NI++  G 
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIF-------PIQDKQSWQNEYEVYSLPGMKHENILQFIG- 85
Query: 194 CSHARHS------FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            +  R +      +L+  F ++G              + W++  ++ + +A  L+YLH D
Sbjct: 86  -AEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHED 140
Query: 248 C-------FPPIVHRDISSKNLLLDLEFEAHVADFGIA-KFLKPDSSNWTEF-AGTYGYV 298
                    P I HRDI SKN+LL     A +ADFG+A KF    S+  T    GT  Y+
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 299 APE-----LAYTMKITEKCDVYSFGVLALEV 324
           APE     + +      + D+Y+ G++  E+
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 98
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 99  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 159 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 214
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 215 GATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK     P +     +  L E++ L   RH NI+ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 148
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 87
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 144
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 83
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 84  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 144 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 199
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 200 GATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 195
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 80
Query: 191 YGFCSHAR-----HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S        +  LV +++               Q L        +  +  +L+Y+H
Sbjct: 81  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 140
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 141 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 196
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 197 GATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 133 IGNGGHGSVYRA--ELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G G  GSV +    +   Q+ VAIK         +  D +E + E + + ++ +  IV+
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ---GTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 190 LYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
           L G C  A    LV E    G            +E+  S    ++  V+  + YL    F
Sbjct: 75  LIGVC-QAEALMLVMEMA--GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT-EFAGTY--GYVAPELAYTM 306
              VHRD++++N+LL     A ++DFG++K L  D S +T   AG +   + APE     
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 307 KITEKCDVYSFGVLALEVIK-GKHP 330
           K + + DV+S+GV   E +  G+ P
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 87
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 88  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 148 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 203
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 204 GATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 16/159 (10%)
Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE 290
           + VI     AL++ H +    I+HRD+   N+L+       V DFGIA+ +    ++  +
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQ 175
Query: 291 FA---GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE 347
            A   GT  Y++PE A    +  + DVYS G +  EV+ G+ P    S +S ++ +   +
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 235
Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVE-VVFSCLNESPESR 385
                    P P  +  E L + ++ VV   L ++PE+R
Sbjct: 236 ---------PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 107
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 164
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 165 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 91
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 148
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 14/214 (6%)
Query: 121 VRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEAL 179
           + +++ F     +GNG + +VY+     +G  VA+K+    L S++       + E+  +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK--LDSEEGTPSTA-IREISLM 57
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK---- 235
            E++H NIV+LY          LV+EF+                  G    +N++K    
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRG--LELNLVKYFQW 115
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY 295
            +   L++ H +    I+HRD+  +NLL++   +  + DFG+A+      + ++    T 
Sbjct: 116 QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 296 GYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGK 328
            Y AP+ L  +   +   D++S G +  E+I GK
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 195
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 107
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 108 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 168 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 223
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 224 GATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLAFRHENIIGIN 89
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 146
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 117
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 178 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 233
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 234 GATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 85
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 142
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 203 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 238

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 115
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 176 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 231
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 232 GATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 229
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 158
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 219 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 274
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 275 GATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 92
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 93  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 153 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 208
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 209 GATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 84
Query: 191 YGFCSHARHSFLVY-----EFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S       VY     +++               Q L        +  +  +L+Y+H
Sbjct: 85  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 145 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 200
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 201 GATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 92
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 149
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 209
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 210 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 245

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 85
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 142
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 203 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 238

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 93
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 150
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 151 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 210
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 211 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 246

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 84
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 141
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 142 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 201
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 202 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 237

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 91
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 148
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 87
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 115/267 (43%), Gaps = 25/267 (9%)
Query: 133 IGNGGHGSVYR-AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN---IV 188
           IG G +GSV +    PSGQ++A+K+  S +   +   +K+ L +++ +  +R  +   IV
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE---QKQLLMDLDVV--MRSSDCPYIV 84
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK-GVADALSYLHHD 247
           + YG        ++  E +                ++   + +  I      AL++L  +
Sbjct: 85  QFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL----A 303
               I+HRDI   N+LLD      + DFGI+  L  DS   T  AG   Y+APE     A
Sbjct: 145 L--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDPSA 201
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
                  + DV+S G+   E+  G+ P    +S+         +L +++    P  S S 
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QLTQVVKGDPPQLSNSE 254
Query: 364 QEKLR-SIVEVVFSCLNESPESRPTMK 389
           + +   S +  V  CL +    RP  K
Sbjct: 255 EREFSPSFINFVNLCLTKDESKRPKYK 281

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 43/225 (19%)
Query: 133 IGNGGHGSVYRAELPS------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           IG G  G V++A  P         +VA+K       +D   D   F  E   + E  + N
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD---FQREAALMAEFDNPN 111
Query: 187 IVKLYGFCSHARHSFLVYEFLKRG---------------------XXXXXXXXXXXXQEL 225
           IVKL G C+  +   L++E++  G                                   L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 226 GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI------AK 279
             ++++ + + VA  ++YL    F   VHRD++++N L+       +ADFG+      A 
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEV 324
           + K D ++    A    ++ PE  +  + T + DV+++GV+  E+
Sbjct: 229 YYKADGND----AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G    V R  ++ +GQ  A K  ++   S +  D ++   E      ++H NIV+L+
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSAR--DHQKLEREARICRLLKHPNIVRLH 87
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
              S   H +L+++ +  G             E   S   + I+ + +A+ + H      
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAVLHCHQ---MG 141
Query: 252 IVHRDISSKNLLLDLEFEA---HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI 308
           +VHRD+  +NLLL  + +     +ADFG+A  ++ +   W  FAGT GY++PE+      
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 201
Query: 309 TEKCDVYSFGVLALEVIKGKHP 330
            +  D+++ GV+   ++ G  P
Sbjct: 202 GKPVDLWACGVILYILLVGYPP 223

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           IGNG  G VY+A+L  SG++VAIKK         + DK+    E++ + ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 191 YGFCSHAR-----HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           Y F S        +  LV +++               Q L        +  +  +L+Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
                 I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL +
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 195
Query: 305 -TMKITEKCDVYSFGVLALEVIKGK 328
                T   DV+S G +  E++ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 23/225 (10%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPSDQIVD 168
           V DE   A         +G G  G VY   +  G V       VAIK  +    +  + +
Sbjct: 1   VPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNE---AASMRE 56
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE---- 224
           + EFL E   + E    ++V+L G  S  + + ++ E + RG             E    
Sbjct: 57  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 116
Query: 225 ---LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL 281
                 S+ + +   +AD ++YL+ + F   VHRD++++N ++  +F   + DFG+ + +
Sbjct: 117 LAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDI 173
Query: 282 KPDSSNWTEFAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEV 324
                      G     +++PE       T   DV+SFGV+  E+
Sbjct: 174 XETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 192 GFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
              + AR        +LV   +                 + +     +I  +   L Y+H
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF-----LIYQILRGLKYIH 138
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
                 I+HRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE+   
Sbjct: 139 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLN 192
Query: 306 -MKITEKCDVYSFGVLALEVIKGK 328
            M   +  D++S G +  E++ G+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFH-SPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL 190
           +G G  G V   E   +G  VA+K  +   + S  +V K +   E++ L   RH +I+KL
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKL 76
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y   S     F+V E++  G            +E+   +   + + +  A+ Y H     
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM---EARRLFQQILSAVDYCHRHM-- 131
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKIT 309
            +VHRD+  +N+LLD    A +ADFG++  +  D        G+  Y APE ++  +   
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSCGSPNYAAPEVISGRLYAG 189
Query: 310 EKCDVYSFGVLALEVIKGKHPRD 332
            + D++S GV+   ++ G  P D
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFD 212

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 24/220 (10%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSP--------LPSDQIVDKKEFL 173
           AT+ ++    IG G +G+VY+A  P SG  VA+K    P        LP    V +   L
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPI-STVREVALL 65
Query: 174 TEVEALTEIRHRNIVKLYGFCSHARHS-----FLVYEFLKRGXXXXXXXXXXXXQELGWS 228
             +EA     H N+V+L   C+ +R        LV+E + +               L   
Sbjct: 66  RRLEAF---EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAE 120
Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
              ++++     L +LH +C   IVHRD+  +N+L+       +ADFG+A+      +  
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-L 176
Query: 289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 328
           T    T  Y APE+          D++S G +  E+ + K
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V +  +  + Q  A+K  +     ++  D    L EVE L ++ H NI+KL+
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK--DTSTILREVELLKKLDHPNIMKLF 87
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                +   ++V E    G             E        +IK V   ++Y+H      
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAARIIKQVFSGITYMHKH---N 141
Query: 252 IVHRDISSKNLLL---DLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI 308
           IVHRD+  +N+LL   + + +  + DFG++   + + +   +  GT  Y+APE+      
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT-Y 199
Query: 309 TEKCDVYSFGVLALEVIKGKHP 330
            EKCDV+S GV+   ++ G  P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 107
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   +L               Q L        +  +   L Y+H      
Sbjct: 108 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 164
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 165 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 91
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS---AN 148
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLAFRHENIIGIN 89
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 146
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 147 VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 111 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 166
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +      +  T  Y APE+    M
Sbjct: 167 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG---YVATRWYRAPEIMLNWM 221
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGR 243

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V +  +  + Q  A+K  +     ++  D    L EVE L ++ H NI+KL+
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK--DTSTILREVELLKKLDHPNIMKLF 87
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                +   ++V E    G             E        +IK V   ++Y+H      
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAARIIKQVFSGITYMHKH---N 141
Query: 252 IVHRDISSKNLLL---DLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI 308
           IVHRD+  +N+LL   + + +  + DFG++   + + +   +  GT  Y+APE+      
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT-Y 199
Query: 309 TEKCDVYSFGVLALEVIKGKHP 330
            EKCDV+S GV+   ++ G  P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 152 VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYE----- 205
           VA+K   S   +D+   K+  ++E++ ++ + +H NIV L G C+H     ++ E     
Sbjct: 64  VAVKMLKSTAHADE---KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 120
Query: 206 ----FLKRGXXXXXXXXXXXXQE-----------LGWSQRMNVIKGVADALSYL-HHDCF 249
               FL+R             Q+           L     ++    VA  +++L   +C 
Sbjct: 121 DLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC- 179
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYTMK 307
              +HRD++++N+LL     A + DFG+A+ +  DS+   +        ++APE  +   
Sbjct: 180 ---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV 236
Query: 308 ITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
            T + DV+S+G+L  E+   G +P   +  ++S F     +  +M  P   AP       
Sbjct: 237 YTVQSDVWSYGILLWEIFSLGLNPYPGI-LVNSKFYKLVKDGYQMAQPAF-AP------- 287
Query: 367 LRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            ++I  ++ +C    P  RPT + +   LQ
Sbjct: 288 -KNIYSIMQACWALEPTHRPTFQQICSFLQ 316

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + D+G+A+         T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDYGLARHT---DDEMTGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 21/225 (9%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTE 175
           +D      ++++    IGNG +G V  A    +GQ VAIKK   P   D + + K  L E
Sbjct: 47  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI--PNAFDVVTNAKRTLRE 104
Query: 176 VEALTEIRHRNIVKLYGFCSHA------RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQ 229
           ++ L   +H NI+ +             +  ++V + ++              Q L    
Sbjct: 105 LKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME----SDLHQIIHSSQPLTLEH 160
Query: 230 RMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL--KPDSSN 287
               +  +   L Y+H      ++HRD+   NLL++   E  + DFG+A+ L   P    
Sbjct: 161 VRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ 217
Query: 288 W--TEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKH 329
           +  TE+  T  Y APEL  ++ + T+  D++S G +  E++  + 
Sbjct: 218 YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 23/225 (10%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPSDQIVD 168
           V DE   A         +G G  G VY   +  G V       VAIK  +    +  + +
Sbjct: 10  VPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNE---AASMRE 65
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE---- 224
           + EFL E   + E    ++V+L G  S  + + ++ E + RG             E    
Sbjct: 66  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 125
Query: 225 ---LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL 281
                 S+ + +   +AD ++YL+ + F   VHRD++++N ++  +F   + DFG+ + +
Sbjct: 126 LAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDI 182
Query: 282 KPDSSNWTEFAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEV 324
                      G     +++PE       T   DV+SFGV+  E+
Sbjct: 183 XETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 121/274 (44%), Gaps = 27/274 (9%)
Query: 125 NDFDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           +DF+    +G G  G V++ +  PSG V+A K  H  +   +   + + + E++ L E  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 62
Query: 184 HRNIVKLYG-FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
              IV  YG F S    S  +                   +++     + VIKG    L+
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 118
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE 
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 174
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD-------PR 355
                 + + D++S G+  +E+  G++P     +   S     + + E+LD       P+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDS--RPPMAIFELLDYIVNEPPPK 232
Query: 356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           LP+   S++ +     + V  CL ++P  R  +K
Sbjct: 233 LPSGVFSLEFQ-----DFVNKCLIKNPAERADLK 261

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 87
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDET--CTRFYTAE-IVSA 144
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 201
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL      ++  D+++ G +  +++ G  P
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 21/221 (9%)
Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTE 175
           +D      ++++    IGNG +G V  A    +GQ VAIKK   P   D + + K  L E
Sbjct: 46  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI--PNAFDVVTNAKRTLRE 103
Query: 176 VEALTEIRHRNIVKLYGFCSHA------RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQ 229
           ++ L   +H NI+ +             +  ++V + ++              Q L    
Sbjct: 104 LKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME----SDLHQIIHSSQPLTLEH 159
Query: 230 RMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL--KPDSSN 287
               +  +   L Y+H      ++HRD+   NLL++   E  + DFG+A+ L   P    
Sbjct: 160 VRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ 216
Query: 288 W--TEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVI 325
           +  TE+  T  Y APEL  ++ + T+  D++S G +  E++
Sbjct: 217 YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+ +    +    T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM---TGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 15/217 (6%)
Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIV---DKKEFLT 174
           +I     DF     +G G  G V+ AE   + Q  AIK     L  D ++   D +  + 
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIK----ALKKDVVLMDDDVECTMV 66
Query: 175 EVEALT-EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNV 233
           E   L+    H  +  ++       + F V E+L  G             +   S+    
Sbjct: 67  EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFY 123
Query: 234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG 293
              +   L +LH      IV+RD+   N+LLD +    +ADFG+ K      +    F G
Sbjct: 124 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCG 180
Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           T  Y+APE+    K     D +SFGVL  E++ G+ P
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + DFG+A+    +    T    T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGXVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAI+K  SP        +   L E++ L   RH NI+ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 91
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 148
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    K 
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 115/287 (40%), Gaps = 39/287 (13%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G +VA+K+     P  Q    ++F  E++ L  +    I
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILKALHSDFI 74
Query: 188 VKLYGFC-SHARHSF-LVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL- 244
           VK  G      R S  LV E+L  G              L  S+ +     +   + YL 
Sbjct: 75  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLG 132
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPE 301
              C    VHRD++++N+L++ E    +ADFG+AK L  D   +           + APE
Sbjct: 133 SRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 188
Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN-TDIELD----------E 350
                  + + DV+SFGV+  E+       D   S S+ FL     E D           
Sbjct: 189 SLSDNIFSRQSDVWSFGVVLYELFTYC---DKSCSPSAEFLRMMGCERDVPALCRLLELL 245
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI 397
               RLPAP     E    + E++  C   SP+ RP+   +  QL +
Sbjct: 246 EEGQRLPAPPACPAE----VHELMKLCWAPSPQDRPSFSALGPQLDM 288

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 16/216 (7%)
Query: 121 VRATNDFDAQYCIGNGGHGSVYRA--ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA 178
            R T+D+     +G G    V R   + P+ Q  A K  ++   S +  D ++   E   
Sbjct: 27  TRFTDDYQLFEELGKGAFSVVRRCVKKTPT-QEYAAKIINTKKLSAR--DHQKLEREARI 83
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA 238
              ++H NIV+L+   S     +LV++ +  G             E   S   + I  + 
Sbjct: 84  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIHQIL 140
Query: 239 DALSYLH-HDCFPPIVHRDISSKNLLLDLEFEA---HVADFGIAKFLKPDSSNWTEFAGT 294
           ++++++H HD    IVHRD+  +NLLL  + +     +ADFG+A  ++ +   W  FAGT
Sbjct: 141 ESVNHIHQHD----IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGT 196
Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            GY++PE+       +  D+++ GV+   ++ G  P
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 127 FDAQYCIGNGGHGSVY---RAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           F+    +G G  G V+   +   P SG + A+K       + ++ D+     E + L ++
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKA--TLKVRDRVRTKMERDILADV 87
Query: 183 RHRNIVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADAL 241
            H  +VKL Y F +  +  +L+ +FL+ G             E         +  +A  L
Sbjct: 88  NHPFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYLAELALGL 143
Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
            +LH      I++RD+  +N+LLD E    + DFG++K           F GT  Y+APE
Sbjct: 144 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPE 200
Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +      +   D +S+GVL  E++ G  P
Sbjct: 201 VVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 27/227 (11%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPSDQIVD 168
           V DE   A         +G G  G VY   +  G V       VAIK  +    +  + +
Sbjct: 9   VPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNE---AASMRE 64
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE---- 224
           + EFL E   + E    ++V+L G  S  + + ++ E + RG             E    
Sbjct: 65  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 124
Query: 225 ---LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL 281
                 S+ + +   +AD ++YL+ + F   VHRD++++N ++  +F   + DFG+ + +
Sbjct: 125 LAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDI 181
Query: 282 KPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEV 324
               +++    G       +++PE       T   DV+SFGV+  E+
Sbjct: 182 Y--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 115/287 (40%), Gaps = 39/287 (13%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G +VA+K+     P  Q    ++F  E++ L  +    I
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILKALHSDFI 86
Query: 188 VKLYGFC-SHARHSF-LVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL- 244
           VK  G      R S  LV E+L  G              L  S+ +     +   + YL 
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLG 144
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPE 301
              C    VHRD++++N+L++ E    +ADFG+AK L  D   +           + APE
Sbjct: 145 SRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN-TDIELD----------E 350
                  + + DV+SFGV+  E+       D   S S+ FL     E D           
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYC---DKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI 397
               RLPAP     E    + E++  C   SP+ RP+   +  QL +
Sbjct: 258 EEGQRLPAPPACPAE----VHELMKLCWAPSPQDRPSFSALGPQLDM 300

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVI 234
           E+     + H+++V  +GF       F+V E  +R             + L   +    +
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR---RSLLELHKRRKALTEPEARYYL 123
Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT 294
           + +     YLH +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT
Sbjct: 124 RQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP 354
             Y+APE+      + + DV+S G +   ++ GK P +  S +  ++L   I+ +E   P
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLR--IKKNEYSIP 237
Query: 355 RLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTM 388
           +   P + S+ +K+          L   P +RPT+
Sbjct: 238 KHINPVAASLIQKM----------LQTDPTARPTI 262

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVI 234
           E+     + H+++V  +GF       F+V E  +R             + L   +    +
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR---RSLLELHKRRKALTEPEARYYL 123
Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT 294
           + +     YLH +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT
Sbjct: 124 RQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP 354
             Y+APE+      + + DV+S G +   ++ GK P +  S +  ++L   I+ +E   P
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLR--IKKNEYSIP 237
Query: 355 RLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTM 388
           +   P + S+ +K+          L   P +RPT+
Sbjct: 238 KHINPVAASLIQKM----------LQTDPTARPTI 262

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 27/227 (11%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPSDQIVD 168
           V DE   A         +G G  G VY   +  G V       VAIK  +    +  + +
Sbjct: 3   VPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNE---AASMRE 58
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE---- 224
           + EFL E   + E    ++V+L G  S  + + ++ E + RG             E    
Sbjct: 59  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 118
Query: 225 ---LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL 281
                 S+ + +   +AD ++YL+ + F   VHRD++++N ++  +F   + DFG+ + +
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDI 175
Query: 282 KPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEV 324
               +++    G       +++PE       T   DV+SFGV+  E+
Sbjct: 176 Y--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 87
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 144
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 133 IGNGGHGSVYRA--ELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G G  GSV +    +   Q+ VAIK         +  D +E + E + + ++ +  IV+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ---GTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 190 LYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
           L G C  A    LV E    G            +E+  S    ++  V+  + YL    F
Sbjct: 401 LIGVC-QAEALMLVMEMA--GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT-EFAGTY--GYVAPELAYTM 306
              VHR+++++N+LL     A ++DFG++K L  D S +T   AG +   + APE     
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 307 KITEKCDVYSFGVLALEVIK-GKHP 330
           K + + DV+S+GV   E +  G+ P
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 27/227 (11%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPSDQIVD 168
           V DE   A         +G G  G VY   +  G V       VAIK  +    +  + +
Sbjct: 16  VPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNE---AASMRE 71
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE---- 224
           + EFL E   + E    ++V+L G  S  + + ++ E + RG             E    
Sbjct: 72  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 131
Query: 225 ---LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL 281
                 S+ + +   +AD ++YL+ + F   VHRD++++N ++  +F   + DFG+ + +
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDI 188
Query: 282 KPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEV 324
               +++    G       +++PE       T   DV+SFGV+  E+
Sbjct: 189 Y--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 98/228 (42%), Gaps = 27/228 (11%)
Query: 115 LVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPSDQIV 167
            V DE   A         +G G  G VY   +  G V       VAIK  +    +  + 
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNE---AASMR 61
Query: 168 DKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE--- 224
           ++ EFL E   + E    ++V+L G  S  + + ++ E + RG             E   
Sbjct: 62  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 121
Query: 225 ----LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF 280
                  S+ + +   +AD ++YL+ + F   VHRD++++N ++  +F   + DFG+ + 
Sbjct: 122 VLAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRD 178
Query: 281 LKPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEV 324
           +    +++    G       +++PE       T   DV+SFGV+  E+
Sbjct: 179 IY--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 87
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 144
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 88
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 145
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 146 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 65
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 122
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 123 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 90
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 91  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 147
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 148 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSP-----LPSDQIVDKKEFLTEV 176
           AT+ ++    IG G +G+VY+A  P SG  VA+K    P     LP    V +   L  +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI-STVREVALLRRL 60
Query: 177 EALTEIRHRNIVKLYGFCSHARHS-----FLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           EA     H N+V+L   C+ +R        LV+E + +               L      
Sbjct: 61  EAF---EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIK 115
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
           ++++     L +LH +C   IVHRD+  +N+L+       +ADFG+A+      + +   
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVV 172
Query: 292 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 328
             T  Y APE+          D++S G +  E+ + K
Sbjct: 173 V-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSP-----LPSDQIVDKKEFLTEV 176
           AT+ ++    IG G +G+VY+A  P SG  VA+K    P     LP    V +   L  +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI-STVREVALLRRL 60
Query: 177 EALTEIRHRNIVKLYGFCSHARHS-----FLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           EA     H N+V+L   C+ +R        LV+E + +               L      
Sbjct: 61  EAF---EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIK 115
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
           ++++     L +LH +C   IVHRD+  +N+L+       +ADFG+A+      +     
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LAPV 171
Query: 292 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 328
             T  Y APE+          D++S G +  E+ + K
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFH-SPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G  G   V + EL +G  VA+K  +   + S  +V K     E++ L   RH +I+KLY
Sbjct: 26  VGTFGKVKVGKHEL-TGHKVAVKILNRQKIRSLDVVGK--IRREIQNLKLFRHPHIIKLY 82
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
              S     F+V E++  G             E    +   + + +   + Y H      
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDE---KESRRLFQQILSGVDYCHRHM--- 136
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITE 310
           +VHRD+  +N+LLD    A +ADFG++  +  D        G+  Y APE ++  +    
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRXSCGSPNYAAPEVISGRLYAGP 195
Query: 311 KCDVYSFGVLALEVIKGKHPRD 332
           + D++S GV+   ++ G  P D
Sbjct: 196 EVDIWSSGVILYALLCGTLPFD 217

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 96/235 (40%), Gaps = 41/235 (17%)
Query: 121 VRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKF-HSPLPSDQIVDKKEFLTEVEA 178
           +R  +DF+    +G G  G V +A      +  AIKK  H+      I      L+EV  
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI------LSEVML 55
Query: 179 LTEIRHRNIVKLYGFCSHARH-------------SFLVYEFLKRGXXXXXXXXXXXXQEL 225
           L  + H+ +V+ Y      R+              F+  E+ +              Q+ 
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQR 115
Query: 226 GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK------ 279
               R+   + + +ALSY+H      I+HRD+   N+ +D      + DFG+AK      
Sbjct: 116 DEYWRL--FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 280 -FLKPDSS-------NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI 325
             LK DS        N T   GT  YVA E L  T    EK D+YS G++  E+I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVI 234
           E+     + H+++V  +GF       F+V E  +R             + L   +    +
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR---RSLLELHKRRKALTEPEARYYL 127
Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT 294
           + +     YLH +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT
Sbjct: 128 RQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 184
Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP 354
             Y+APE+      + + DV+S G +   ++ GK P +  S +  ++L   I+ +E   P
Sbjct: 185 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLR--IKKNEYSIP 241
Query: 355 RLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTM 388
           +   P + S+ +K+          L   P +RPT+
Sbjct: 242 KHINPVAASLIQKM----------LQTDPTARPTI 266

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 88
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 145
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 146 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--- 181
           D+D    +G G +G V  A    + + VA+K          IVD K  +   E + +   
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIC 57
Query: 182 ----IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 116
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 117 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 92
Query: 181 EIRHRNIVKLYGFCSHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
            + H   VKLY FC       +    + K G             E     R    + +  
Sbjct: 93  RLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVS 148
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGY 297
           AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  Y
Sbjct: 149 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           V+PEL       +  D+++ G +  +++ G  P
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 88/211 (41%), Gaps = 27/211 (12%)
Query: 132 CIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDK--------KEFLTEVEALTEI 182
            IG G    V  A  + +G+ VA+K          I+DK        ++   EV     +
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVK----------IIDKTQLNSSSLQKLFREVRIXKVL 70
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
            H NIVKL+      +  +LV E+   G            +E    +     + +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKE---KEARAKFRQIVSAVQ 127
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      IVHRD+ ++NLLLD +    +ADFG +       +    F G   Y APEL
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPEL 183
Query: 303 AYTMKIT-EKCDVYSFGVLALEVIKGKHPRD 332
               K    + DV+S GV+   ++ G  P D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 115/287 (40%), Gaps = 39/287 (13%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G +VA+K+     P  Q    ++F  E++ L  +    I
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILKALHSDFI 73
Query: 188 VKLYGFC-SHARHSF-LVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL- 244
           VK  G      R S  LV E+L  G              L  S+ +     +   + YL 
Sbjct: 74  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLG 131
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPE 301
              C    VHRD++++N+L++ E    +ADFG+AK L  D   +           + APE
Sbjct: 132 SRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 187
Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN-----------TDIELDE 350
                  + + DV+SFGV+  E+       D   S S+ FL            + +    
Sbjct: 188 SLSDNIFSRQSDVWSFGVVLYELFTYC---DKSCSPSAEFLRMMGSERDVPALSRLLELL 244
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI 397
               RLPAP     E    + E++  C   SP+ RP+   +  QL +
Sbjct: 245 EEGQRLPAPPACPAE----VHELMKLCWAPSPQDRPSFSALGPQLDM 287

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 27/227 (11%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPSDQIVD 168
           V DE   A         +G G  G VY   +  G V       VAIK  +    +  + +
Sbjct: 10  VPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNE---AASMRE 65
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE---- 224
           + EFL E   + E    ++V+L G  S  + + ++ E + RG             E    
Sbjct: 66  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 125
Query: 225 ---LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL 281
                 S+ + +   +AD ++YL+ + F   VHRD++++N ++  +F   + DFG+ + +
Sbjct: 126 LAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDI 182
Query: 282 KPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEV 324
               +++    G       +++PE       T   DV+SFGV+  E+
Sbjct: 183 Y--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           ++++D +  +G G    V R     +G   A K  ++   S +   K E   E     ++
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE--REARICRKL 85
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
           +H NIV+L+         +LV++ +  G             E   S   + I+ + ++++
Sbjct: 86  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIA 142
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEA---HVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           Y H +    IVHR++  +NLLL  + +     +ADFG+A  +  DS  W  FAGT GY++
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLS 198
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+      ++  D+++ GV+   ++ G  P
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 87
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 144
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--- 181
           D+D    +G G +G V  A    + + VA+K          IVD K  +   E + +   
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIC 56
Query: 182 ----IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 115
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 116 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 27/227 (11%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPSDQIVD 168
           V DE   A         +G G  G VY   +  G V       VAIK  +    +  + +
Sbjct: 9   VPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNE---AASMRE 64
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE---- 224
           + EFL E   + E    ++V+L G  S  + + ++ E + RG             E    
Sbjct: 65  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 124
Query: 225 ---LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL 281
                 S+ + +   +AD ++YL+ + F   VHRD++++N ++  +F   + DFG+ + +
Sbjct: 125 LAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDI 181
Query: 282 KPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEV 324
               +++    G       +++PE       T   DV+SFGV+  E+
Sbjct: 182 Y--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 85
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 142
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 87
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 144
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 192 GFCSHARHSFLVYE--FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
              + AR S   +   +L               Q+L       +I  +   L Y+H    
Sbjct: 108 DVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 163
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKI 308
             I+HRD+   NL ++ + E  + DFG+A+    +         T  Y APE+    M  
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG---XVATRWYRAPEIMLNWMHY 220
Query: 309 TEKCDVYSFGVLALEVIKGK 328
            +  D++S G +  E++ G+
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 64
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 121
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 122 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 87
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 144
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 85
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 142
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 127 FDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR 185
           +D    +G G  G V+R  E  +G   A K   +P  SD+   +KE    ++ ++ +RH 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE----IQTMSVLRHP 214
Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
            +V L+          ++YEF+  G             ++   + +  ++ V   L ++H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGG--ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 246 HDCFPPIVHRDISSKNLLLDLEF--EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
            + +   VH D+  +N++   +   E  + DFG+   L P  S      GT  + APE+A
Sbjct: 273 ENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVA 328
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
               +    D++S GVL+  ++ G  P
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 62
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 119
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 120 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 100/236 (42%), Gaps = 24/236 (10%)
Query: 101 NPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSP 160
           +P+ +  +L  +GK      +  TN       IGNG  G V++A+L     VAIKK    
Sbjct: 20  DPNKVIKVLASDGKTGEQREIAYTN----CKVIGNGSFGVVFQAKLVESDEVAIKKV--- 72
Query: 161 LPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFC----SHARHSFL--VYEFLKRGXXXX 214
                + DK+    E++ +  ++H N+V L  F           FL  V E++       
Sbjct: 73  -----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRA 127
Query: 215 XXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEA-HVA 273
                   Q +        +  +  +L+Y+H      I HRDI  +NLLLD       + 
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLI 184
Query: 274 DFGIAKFLKPDSSNWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLALEVIKGK 328
           DFG AK L     N +     Y Y APEL +     T   D++S G +  E+++G+
Sbjct: 185 DFGSAKILIAGEPNVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 85
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 142
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYE--FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
              + AR S   +   +L               Q+L       +I  +   L Y+H    
Sbjct: 88  DVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKI 308
             I+HRD+   NL ++ + E  + DF +A+         T +  T  Y APE+    M  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFYLARHT---DDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 309 TEKCDVYSFGVLALEVIKGK 328
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 122/285 (42%), Gaps = 29/285 (10%)
Query: 113 GKLVYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIV 167
           G +    I++ T +F     +G+G  G+VY+   +P G+ V    AIK+           
Sbjct: 1   GAMALLRILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-- 57
Query: 168 DKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW 227
             KE L E   +  + + ++ +L G C  +    L+ + +  G              +G 
Sbjct: 58  -NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGS 113
Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
              +N    +A+ ++YL       +VHRD++++N+L+       + DFG+AK L  +   
Sbjct: 114 QYLLNWCVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 170
Query: 288 WTEFAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNT 344
           +    G     ++A E       T + DV+S+GV   E++  G  P D    I +S +++
Sbjct: 171 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISS 227
Query: 345 DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            +E  E    RLP P     +    +  ++  C     +SRP  +
Sbjct: 228 ILEKGE----RLPQPPICTID----VYMIMVKCWMIDADSRPKFR 264

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 63
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 120
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSP-----LPSDQIVDKKEFLTEV 176
           AT+ ++    IG G +G+VY+A  P SG  VA+K    P     LP    V +   L  +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI-STVREVALLRRL 60
Query: 177 EALTEIRHRNIVKLYGFCSHARHS-----FLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           EA     H N+V+L   C+ +R        LV+E + +               L      
Sbjct: 61  EAF---EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIK 115
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
           ++++     L +LH +C   IVHRD+  +N+L+       +ADFG+A+      +     
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LDPV 171
Query: 292 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 328
             T  Y APE+          D++S G +  E+ + K
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 35/287 (12%)
Query: 123 ATNDFDAQY-------CIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKE 171
           +T D++ Q        CIG G  G V++    S       VAIK   +   SD + +K  
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREK-- 57
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           FL E   + +  H +IVKL G  +     +++ E    G             +L  +  +
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--ASLI 114
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
                ++ AL+YL    F   VHRDI+++N+L+       + DFG++++++ DS+ +   
Sbjct: 115 LYAYQLSTALAYLESKRF---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKAS 170
Query: 292 AGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIEL 348
            G     ++APE     + T   DV+ FGV   E++  G  P      + ++ +   IE 
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP---FQGVKNNDVIGRIEN 227
Query: 349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            E    RLP P         ++  ++  C    P  RP    +  QL
Sbjct: 228 GE----RLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 170 KEFLTEVEALTEIRHRNIVKLYGFCS--HARHSFLVYEFLKRGXXXXXXXXXXXXQELGW 227
           ++   E+  L ++ H N+VKL       +  H ++V+E + +G            ++   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
               ++IKG+     YLH   +  I+HRDI   NLL+  +    +ADFG++   K   + 
Sbjct: 141 FYFQDLIKGI----EYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 288 WTEFAGTYGYVAPE-LAYTMKI--TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT 344
            +   GT  ++APE L+ T KI   +  DV++ GV     + G+ P  F+       L++
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP--FMDE-RIMCLHS 250
Query: 345 DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESR---PTMKI 390
            I+   +  P  P     + E L+ ++      L+++PESR   P +K+
Sbjct: 251 KIKSQALEFPDQP----DIAEDLKDLIT---RMLDKNPESRIVVPEIKL 292

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 29/219 (13%)
Query: 126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE---- 181
           D+D    +G G +G V          +A+ +      + +IVD K  +   E + +    
Sbjct: 8   DWDLVQTLGEGAYGEVQ---------LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 58
Query: 182 ---IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIKG 236
              + H N+VK YG        +L  E+   G             E   +QR    ++ G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAG 117
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGT 294
           V     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT
Sbjct: 118 VV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 295 YGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
             YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 29/219 (13%)
Query: 126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE---- 181
           D+D    +G G +G V          +A+ +      + +IVD K  +   E + +    
Sbjct: 8   DWDLVQTLGEGAYGEVQ---------LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 58
Query: 182 ---IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIKG 236
              + H N+VK YG        +L  E+   G             E   +QR    ++ G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAG 117
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGT 294
           V     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT
Sbjct: 118 VV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 295 YGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
             YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVI 234
           E+     + H+++V  +GF       F+V E  +R             + L   +    +
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR---RSLLELHKRRKALTEPEARYYL 121
Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT 294
           + +     YLH +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT
Sbjct: 122 RQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP 354
             Y+APE+      + + DV+S G +   ++ GK P +  S +  ++L   I+ +E   P
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLR--IKKNEYSIP 235
Query: 355 RLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTM 388
           +   P + S+ +K+          L   P +RPT+
Sbjct: 236 KHINPVAASLIQKM----------LQTDPTARPTI 260

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 29/219 (13%)
Query: 126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE---- 181
           D+D    +G G +G V          +A+ +      + +IVD K  +   E + +    
Sbjct: 8   DWDLVQTLGEGAYGEVQ---------LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 58
Query: 182 ---IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIKG 236
              + H N+VK YG        +L  E+   G             E   +QR    ++ G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAG 117
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGT 294
           V     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT
Sbjct: 118 VV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 295 YGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
             YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +G+V  A +  +G  VAIKK + P  S+     K    E+  L  +RH N++ L 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA--KRAYRELRLLKHMRHENVIGLL 90
Query: 192 G-FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
             F            +L               ++LG  +   ++  +   L Y+H     
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG-- 148
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG---TYGYVAPELAYT-M 306
            I+HRD+   NL ++ + E  + DFG+A+  + DS    E  G   T  Y APE+    M
Sbjct: 149 -IIHRDLKPGNLAVNEDCELKILDFGLAR--QADS----EMXGXVVTRWYRAPEVILNWM 201
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
           + T+  D++S G +  E+I GK
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGK 223

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLT-EVEALTEIRHRNIVKL 190
           IGNG  G VY+A+L  SG++VAIKK         ++  K F   E++ + ++ H NIV+L
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK---------VLQGKAFKNRELQIMRKLDHCNIVRL 78
Query: 191 -YGFCSHAR-----HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
            Y F S        +  LV +++               Q L        +  +  +L+Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           H      I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL 
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELI 194
Query: 304 Y-TMKITEKCDVYSFGVLALEVIKGK 328
           +     T   DV+S G +  E++ G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL-------TEVE 177
           D+D    +G G +G V  A    + + VA+K          IVD K  +        E+ 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIX 57
Query: 178 ALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 116
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 117 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 169
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLT-EVEALTEIRHRNIVKL 190
           IGNG  G VY+A+L  SG++VAIKK         ++  K F   E++ + ++ H NIV+L
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK---------VLQGKAFKNRELQIMRKLDHCNIVRL 78
Query: 191 -YGFCSHAR-----HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
            Y F S        +  LV +++               Q L        +  +  +L+Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           H      I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL 
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELI 194
Query: 304 Y-TMKITEKCDVYSFGVLALEVIKGK 328
           +     T   DV+S G +  E++ G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL-------TEVE 177
           D+D    +G G +G V  A    + + VA+K          IVD K  +        E+ 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIX 56
Query: 178 ALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 115
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 116 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 13/211 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  SG+ VAIKK   P  S +I  K+ +  E+  L  ++H N++ L 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAY-RELLLLKHMQHENVIGLL 89
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
              + A      Y+F                 +    +   ++  +   L Y+H      
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG--- 146
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITE 310
           +VHRD+   NL ++ + E  + DFG+A+      +  T +  T  Y APE+  + M   +
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRAPEVILSWMHYNQ 203
Query: 311 KCDVYSFGVLALEVIKGK---HPRDFLSSIS 338
             D++S G +  E++ GK     +D+L  ++
Sbjct: 204 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 234

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLT-EVEALTEIRHRNIVKL 190
           IGNG  G VY+A+L  SG++VAIKK         ++  K F   E++ + ++ H NIV+L
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK---------VLQGKAFKNRELQIMRKLDHCNIVRL 78
Query: 191 -YGFCSHAR-----HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
            Y F S        +  LV +++               Q L        +  +  +L+Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           H      I HRDI  +NLLLD +     + DFG AK L     N +     Y Y APEL 
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELI 194
Query: 304 Y-TMKITEKCDVYSFGVLALEVIKGK 328
           +     T   DV+S G +  E++ G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 33/286 (11%)
Query: 123 ATNDFDAQY-------CIGNGGHGSVYRAELPSGQ----VVAIKKFHSPLPSDQIVDKKE 171
           +T D++ Q        CIG G  G V++    S +     VAIK   +   SD + +K  
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREK-- 62
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           FL E   + +  H +IVKL G  +     +++ E    G             +L  +  +
Sbjct: 63  FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLI 119
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
                ++ AL+YL    F   VHRDI+++N+L+       + DFG++++++ DS+ +   
Sbjct: 120 LYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKAS 175
Query: 292 AGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD 349
            G     ++APE     + T   DV+ FGV   E++   H       + ++ +   IE  
Sbjct: 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL--MHGVKPFQGVKNNDVIGRIENG 233
Query: 350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           E    RLP P         ++  ++  C    P  RP    +  QL
Sbjct: 234 E----RLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQL 271

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL-------TEVE 177
           D+D    +G G +G V  A    + + VA+K          IVD K  +        E+ 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIX 56
Query: 178 ALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 115
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 116 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 33/286 (11%)
Query: 123 ATNDFDAQY-------CIGNGGHGSVYRAELPSGQ----VVAIKKFHSPLPSDQIVDKKE 171
           +T D++ Q        CIG G  G V++    S +     VAIK   +   SD + +K  
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREK-- 59
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           FL E   + +  H +IVKL G  +     +++ E    G             +L  +  +
Sbjct: 60  FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLI 116
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
                ++ AL+YL    F   VHRDI+++N+L+       + DFG++++++ DS+ +   
Sbjct: 117 LYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKAS 172
Query: 292 AGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD 349
            G     ++APE     + T   DV+ FGV   E++   H       + ++ +   IE  
Sbjct: 173 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL--MHGVKPFQGVKNNDVIGRIENG 230
Query: 350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           E    RLP P         ++  ++  C    P  RP    +  QL
Sbjct: 231 E----RLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQL 268

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 127 FDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR 185
           +D    +G G  G V+R  E  +G   A K   +P  SD+   +KE    ++ ++ +RH 
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE----IQTMSVLRHP 108
Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
            +V L+          ++YEF+  G             ++   + +  ++ V   L ++H
Sbjct: 109 TLVNLHDAFEDDNEMVMIYEFMSGG--ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 246 HDCFPPIVHRDISSKNLLLDLEF--EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
            + +   VH D+  +N++   +   E  + DFG+   L P  S      GT  + APE+A
Sbjct: 167 ENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVA 222
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
               +    D++S GVL+  ++ G  P
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 33/286 (11%)
Query: 123 ATNDFDAQY-------CIGNGGHGSVYRAELPSGQ----VVAIKKFHSPLPSDQIVDKKE 171
           +T D++ Q        CIG G  G V++    S +     VAIK   +   SD + +K  
Sbjct: 29  STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREK-- 85
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           FL E   + +  H +IVKL G  +     +++ E    G             +L  +  +
Sbjct: 86  FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLI 142
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
                ++ AL+YL    F   VHRDI+++N+L+       + DFG++++++ DS+ +   
Sbjct: 143 LYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKAS 198
Query: 292 AGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD 349
            G     ++APE     + T   DV+ FGV   E++   H       + ++ +   IE  
Sbjct: 199 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL--MHGVKPFQGVKNNDVIGRIENG 256
Query: 350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           E    RLP P         ++  ++  C    P  RP    +  QL
Sbjct: 257 E----RLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQL 294

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVI 234
           E+     + H+++V  +GF       F+V E  +R             + L   +    +
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR---RSLLELHKRRKALTEPEARYYL 145
Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT 294
           + +     YLH +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT
Sbjct: 146 RQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 202
Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP 354
             Y+APE+      + + DV+S G +   ++ GK P +  S +  ++L   I+ +E   P
Sbjct: 203 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLR--IKKNEYSIP 259
Query: 355 RLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTM 388
           +   P + S+ +K+          L   P +RPT+
Sbjct: 260 KHINPVAASLIQKM----------LQTDPTARPTI 284

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 33/286 (11%)
Query: 123 ATNDFDAQY-------CIGNGGHGSVYRAELPSGQ----VVAIKKFHSPLPSDQIVDKKE 171
           +T D++ Q        CIG G  G V++    S +     VAIK   +   SD + +K  
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREK-- 60
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           FL E   + +  H +IVKL G  +     +++ E    G             +L  +  +
Sbjct: 61  FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLI 117
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
                ++ AL+YL    F   VHRDI+++N+L+       + DFG++++++ DS+ +   
Sbjct: 118 LYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKAS 173
Query: 292 AGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD 349
            G     ++APE     + T   DV+ FGV   E++   H       + ++ +   IE  
Sbjct: 174 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL--MHGVKPFQGVKNNDVIGRIENG 231
Query: 350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           E    RLP P         ++  ++  C    P  RP    +  QL
Sbjct: 232 E----RLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQL 269

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 35/287 (12%)
Query: 123 ATNDFDAQY-------CIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKE 171
           +T D++ Q        CIG G  G V++    S       VAIK   +   SD + +K  
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREK-- 57
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           FL E   + +  H +IVKL G  +     +++ E    G             +L  +  +
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLI 114
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
                ++ AL+YL    F   VHRDI+++N+L+       + DFG++++++ DS+ +   
Sbjct: 115 LYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKAS 170
Query: 292 AGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIEL 348
            G     ++APE     + T   DV+ FGV   E++  G  P      + ++ +   IE 
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP---FQGVKNNDVIGRIEN 227
Query: 349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            E    RLP P         ++  ++  C    P  RP    +  QL
Sbjct: 228 GE----RLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVI 234
           E+     + H+++V  +GF       F+V E  +R             + L   +    +
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR---RSLLELHKRRKALTEPEARYYL 147
Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT 294
           + +     YLH +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT
Sbjct: 148 RQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 204
Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP 354
             Y+APE+      + + DV+S G +   ++ GK P +  S +  ++L   I+ +E   P
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLR--IKKNEYSIP 261
Query: 355 RLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTM 388
           +   P + S+ +K+          L   P +RPT+
Sbjct: 262 KHINPVAASLIQKM----------LQTDPTARPTI 286

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 104/249 (41%), Gaps = 18/249 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIK----ILEKRHIIKENKVPYVTRERDVMS 84
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 141
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           +PEL       +  D+++ G +  +++ G  P  F +          I+L+     +   
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEKFFP 256
Query: 359 PSRSVQEKL 367
            +R + EKL
Sbjct: 257 KARDLVEKL 265

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDK------KEFLTEVEALTEIRHR 185
           +G+G  G+V++   +P G+ + I     P+    I DK      +     + A+  + H 
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKI-----PVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 93
Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           +IV+L G C  +    LV ++L  G              LG    +N    +A  + YL 
Sbjct: 94  HIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAKGMYYLE 150
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELA 303
                 +VHR+++++N+LL    +  VADFG+A  L PD     ++E      ++A E  
Sbjct: 151 EHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 207
Query: 304 YTMKITEKCDVYSFGVLALEVI 325
           +  K T + DV+S+GV   E++
Sbjct: 208 HFGKYTHQSDVWSYGVTVWELM 229

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--- 181
           D+D    +G G +G V  A    + + VA+K          IVD K  +   E + +   
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIC 55
Query: 182 ----IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 56  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 114
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 115 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 167
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--- 181
           D+D    +G G +G V  A    + + VA+K          IVD K  +   E + +   
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIC 56
Query: 182 ----IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 115
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 116 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--- 181
           D+D    +G G +G V  A    + + VA+K          IVD K  +   E + +   
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIC 57
Query: 182 ----IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 116
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 117 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 104/249 (41%), Gaps = 18/249 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIK----ILEKRHIIKENKVPYVTRERDVMS 84
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 141
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           +PEL       +  D+++ G +  +++ G  P  F +          I+L+     +   
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEKFFP 256
Query: 359 PSRSVQEKL 367
            +R + EKL
Sbjct: 257 KARDLVEKL 265

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGT 294
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--- 181
           D+D    +G G +G V  A    + + VA+K          IVD K  +   E + +   
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIC 57
Query: 182 ----IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 116
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 117 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 104/249 (41%), Gaps = 18/249 (7%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV--DKKEFLT-EVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+  +K  ++T E + ++
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIK----ILEKRHIIKENKVPYVTRERDVMS 69
Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G             E     R    + +  A
Sbjct: 70  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE-IVSA 126
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT  YV
Sbjct: 127 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           +PEL       +  D+++ G +  +++ G  P  F +          I+L+     +   
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEKFFP 241
Query: 359 PSRSVQEKL 367
            +R + EKL
Sbjct: 242 KARDLVEKL 250

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--- 181
           D+D    +G G +G V  A    + + VA+K          IVD K  +   E + +   
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIC 56
Query: 182 ----IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 115
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 116 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 13/208 (6%)
Query: 125 NDFDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           +DF+    +G G  G V++ +  PSG V+A K  H  +   +   + + + E++ L E  
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 124
Query: 184 HRNIVKLYG-FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
              IV  YG F S    S  +                   +++     + VIKG    L+
Sbjct: 125 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 180
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE 
Sbjct: 181 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 236
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHP 330
                 + + D++S G+  +E+  G++P
Sbjct: 237 LQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 27/227 (11%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPSDQIVD 168
           V DE   A         +G G  G VY   +  G V       VAIK  +    +  + +
Sbjct: 38  VPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNE---AASMRE 93
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE---- 224
           + EFL E   + E    ++V+L G  S  + + ++ E + RG             E    
Sbjct: 94  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 153
Query: 225 ---LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL 281
                 S+ + +   +AD ++YL+ + F   VHRD++++N ++  +F   + DFG+ + +
Sbjct: 154 LAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDI 210
Query: 282 KPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEV 324
               +++    G       +++PE       T   DV+SFGV+  E+
Sbjct: 211 Y--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 33/286 (11%)
Query: 123 ATNDFDAQY-------CIGNGGHGSVYRAELPSGQ----VVAIKKFHSPLPSDQIVDKKE 171
           +T D++ Q        CIG G  G V++    S +     VAIK   +   SD + +K  
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREK-- 57
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           FL E   + +  H +IVKL G  +     +++ E    G             +L  +  +
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLI 114
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
                ++ AL+YL    F   VHRDI+++N+L+       + DFG++++++ DS+ +   
Sbjct: 115 LYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKAS 170
Query: 292 AGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD 349
            G     ++APE     + T   DV+ FGV   E++   H       + ++ +   IE  
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL--MHGVKPFQGVKNNDVIGRIENG 228
Query: 350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           E    RLP P         ++  ++  C    P  RP    +  QL
Sbjct: 229 E----RLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--- 181
           D+D    +G G +G V  A    + + VA+K          IVD K  +   E + +   
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIC 56
Query: 182 ----IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 115
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 116 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--- 181
           D+D    +G G +G V  A    + + VA+K          IVD K  +   E + +   
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIC 56
Query: 182 ----IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 115
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 116 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  +  FG+A+    +    T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 125 NDFDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFH---SPLPSDQIVDKKEFLTEVEALT 180
           +DF+    +G G  G V++ +  PSG V+A K  H    P   +QI+       E++ L 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII------RELQVLH 86
Query: 181 EIRHRNIVKLYG-FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
           E     IV  YG F S    S  +                   +++     + VIKG   
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--- 143
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
            L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 144 -LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 198
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE       + + D++S G+  +E+  G++P
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--- 181
           D+D    +G G +G V  A    + + VA+K          IVD K  +   E + +   
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIC 56
Query: 182 ----IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 115
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 116 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--- 181
           D+D    +G G +G V  A    + + VA+K          IVD K  +   E + +   
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIC 56
Query: 182 ----IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 115
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 116 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--- 181
           D+D    +G G +G V  A    + + VA+K          IVD K  +   E + +   
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIC 56
Query: 182 ----IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 115
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 116 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 97/229 (42%), Gaps = 31/229 (13%)
Query: 122 RATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
           R   DF+   C+G GG G V+ A+        AIK+    LP+ ++  +K  + EV+AL 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR--LPNRELAREK-VMREVKALA 58
Query: 181 EIRHRNIVKLYGF------------CSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS 228
           ++ H  IV+ +               S   + ++  +  ++             +E   S
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
             +++   +A+A+ +LH      ++HRD+   N+   ++    V DFG+   +  D    
Sbjct: 119 VCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 289 TEFA------------GTYGYVAPELAYTMKITEKCDVYSFGVLALEVI 325
           T               GT  Y++PE  +    + K D++S G++  E++
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--- 181
           D+D    +G G +G V  A    + + VA+K          IVD K  +   E + +   
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEIC 56
Query: 182 ----IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIK 235
               + H N+VK YG        +L  E+   G             E   +QR    ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA 115
Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAG 293
           GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  G
Sbjct: 116 GVV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 294 TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
           T  YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 125 NDFDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFH---SPLPSDQIVDKKEFLTEVEALT 180
           +DF+    +G G  G V++ +  PSG V+A K  H    P   +QI+       E++ L 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII------RELQVLH 59
Query: 181 EIRHRNIVKLYG-FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
           E     IV  YG F S    S  +                   +++     + VIKG   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--- 116
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
            L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 117 -LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 171
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE       + + D++S G+  +E+  G++P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 125 NDFDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFH---SPLPSDQIVDKKEFLTEVEALT 180
           +DF+    +G G  G V++ +  PSG V+A K  H    P   +QI+       E++ L 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII------RELQVLH 59
Query: 181 EIRHRNIVKLYG-FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
           E     IV  YG F S    S  +                   +++     + VIKG   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--- 116
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
            L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 117 -LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 171
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE       + + D++S G+  +E+  G++P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 29/219 (13%)
Query: 126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE---- 181
           D+D    +G G +G V          +A+ +      + +IVD K  +   E + +    
Sbjct: 8   DWDLVQTLGEGAYGEVQ---------LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 58
Query: 182 ---IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIKG 236
              + H N+VK YG        +L  E+   G             E   +QR    ++ G
Sbjct: 59  NAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAG 117
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGT 294
           V     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT
Sbjct: 118 VV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 295 YGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
             YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDK------KEFLTEVEALTEIRHR 185
           +G+G  G+V++   +P G+ + I     P+    I DK      +     + A+  + H 
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKI-----PVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           +IV+L G C  +    LV ++L  G              LG    +N    +A  + YL 
Sbjct: 76  HIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAKGMYYLE 132
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELA 303
                 +VHR+++++N+LL    +  VADFG+A  L PD     ++E      ++A E  
Sbjct: 133 EHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 304 YTMKITEKCDVYSFGVLALEVI 325
           +  K T + DV+S+GV   E++
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELM 211

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 74
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 131
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 132 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 241
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 242 PQPPICTID----VYMIMVKCWMIDADSRPKFR 270

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 49/293 (16%)
Query: 133 IGNGGHGSVYRA------ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A      +  +   VA+K      PS  + +++  ++E++ L+ +  H 
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 110
Query: 186 NIVKLYGFCSHARHSFLVYE---------FLKR----------GXXXXXXXXXXXXQELG 226
           NIV L G C+    + ++ E         FL+R                        E  
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS 286
            S    V KG+A   S    +C    +HRD++++N+LL       + DFG+A+ +K DS+
Sbjct: 171 LSFSYQVAKGMAFLAS---KNC----IHRDLAARNILLTHGRITKICDFGLARHIKNDSN 223
Query: 287 NWTEFAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLN 343
              +        ++APE  +    T + DV+S+G+   E+   G  P   +  + S F  
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSKFYK 282
Query: 344 TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              E   ML P   AP+         + +++ +C +  P  RPT K + Q ++
Sbjct: 283 MIKEGFRMLSPE-HAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 13/208 (6%)
Query: 125 NDFDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           +DF+    +G G  G V++ +  PSG V+A K  H  +   +   + + + E++ L E  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 62
Query: 184 HRNIVKLYG-FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
              IV  YG F S    S  +                   +++     + VIKG    L+
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 118
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE 
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 174
Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHP 330
                 + + D++S G+  +E+  G++P
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 125 NDFDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFH---SPLPSDQIVDKKEFLTEVEALT 180
           +DF+    +G G  G V++ +  PSG V+A K  H    P   +QI+       E++ L 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII------RELQVLH 59
Query: 181 EIRHRNIVKLYG-FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
           E     IV  YG F S    S  +                   +++     + VIKG   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--- 116
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
            L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 117 -LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 171
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE       + + D++S G+  +E+  G++P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 111/256 (43%), Gaps = 29/256 (11%)
Query: 148 SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--RHSFLVYE 205
           +G++VA+K   +          K+   E++ L  + H +I+K  G C     +   LV E
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVME 98
Query: 206 FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD 265
           ++  G              +G +Q +   + + + ++YLH   +   +HR+++++N+LLD
Sbjct: 99  YVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHSQHY---IHRNLAARNVLLD 151
Query: 266 LEFEAHVADFGIAKFLKPDSSNWTEFA----GTYGYVAPELAYTMKITEKCDVYSFGVLA 321
            +    + DFG+AK + P+   +            + APE     K     DV+SFGV  
Sbjct: 152 NDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 210
Query: 322 LEVI-----KGKHPRDFLSSIS-SSFLNTDIELDEMLD--PRLPAPSRSVQEKLRSIVEV 373
            E++         P  FL  I  +    T + L E+L+   RLP P +   E    +  +
Sbjct: 211 YELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCE----VYHL 266
Query: 374 VFSCLNESPESRPTMK 389
           + +C       RPT +
Sbjct: 267 MKNCWETEASFRPTFE 282

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + D G+A+    +    T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM---TGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 35/287 (12%)
Query: 123 ATNDFDAQY-------CIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKE 171
           +T D++ Q        CIG G  G V++    S       VAIK   +   SD + +K  
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREK-- 437
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           FL E   + +  H +IVKL G  +     +++ E    G             +L  +  +
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--ASLI 494
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
                ++ AL+YL    F   VHRDI+++N+L+       + DFG++++++ DS+ +   
Sbjct: 495 LYAYQLSTALAYLESKRF---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKAS 550
Query: 292 AGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIEL 348
            G     ++APE     + T   DV+ FGV   E++  G  P      + ++ +   IE 
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP---FQGVKNNDVIGRIEN 607
Query: 349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            E    RLP P         ++  ++  C    P  RP    +  QL
Sbjct: 608 GE----RLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQL 646

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 73
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 130
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 240
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 241 PQPPICTID----VYMIMVKCWMIDADSRPKFR 269

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           ++++D +  +G G    V R     +G   A K  ++   S +   K E   E     ++
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE--REARICRKL 62
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
           +H NIV+L+         +LV++ +  G             E   S   + I+ + ++++
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIA 119
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEA---HVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           Y H +    IVHR++  +NLLL  + +     +ADFG+A  +  DS  W  FAGT GY++
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLS 175
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+      ++  D+++ GV+   ++ G  P
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           ++++D +  +G G    V R     +G   A K  ++   S +   K E   E     ++
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE--REARICRKL 62
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
           +H NIV+L+         +LV++ +  G             E   +   + I+ + ++++
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---ADASHCIQQILESIA 119
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEA---HVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           Y H +    IVHR++  +NLLL  + +     +ADFG+A  +  DS  W  FAGT GY++
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLS 175
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+      ++  D+++ GV+   ++ G  P
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 75
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 132
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 133 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 242
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 243 PQPPICTID----VYMIMVKCWMIDADSRPKFR 271

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 71
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 128
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 238
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 239 PQPPICTID----VYMIMVKCWMIDADSRPKFR 267

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 111/256 (43%), Gaps = 29/256 (11%)
Query: 148 SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--RHSFLVYE 205
           +G++VA+K   +          K+   E++ L  + H +I+K  G C     +   LV E
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVME 98
Query: 206 FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD 265
           ++  G              +G +Q +   + + + ++YLH   +   +HR+++++N+LLD
Sbjct: 99  YVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQHY---IHRNLAARNVLLD 151
Query: 266 LEFEAHVADFGIAKFLKPDSSNWTEFA----GTYGYVAPELAYTMKITEKCDVYSFGVLA 321
            +    + DFG+AK + P+   +            + APE     K     DV+SFGV  
Sbjct: 152 NDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 210
Query: 322 LEVI-----KGKHPRDFLSSIS-SSFLNTDIELDEMLD--PRLPAPSRSVQEKLRSIVEV 373
            E++         P  FL  I  +    T + L E+L+   RLP P +   E    +  +
Sbjct: 211 YELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCE----VYHL 266
Query: 374 VFSCLNESPESRPTMK 389
           + +C       RPT +
Sbjct: 267 MKNCWETEASFRPTFE 282

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 74
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 131
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 132 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 241
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 242 PQPPICTID----VYMIMVKCWMIDADSRPKFR 270

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 78
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 135
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 136 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 245
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 246 PQPPICTID----VYMIMVKCWMIDADSRPKFR 274

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYE--FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
              + AR S   +   +L               Q+L       +I  +   L Y+H    
Sbjct: 88  DVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 143
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKI 308
             I+HRD+   NL ++ + E  + D G+A+         T +  T  Y APE+    M  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDRGLARHT---DDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 309 TEKCDVYSFGVLALEVIKGK 328
            +  D++S G +  E++ G+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 116/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 72
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHK--DNIGSQYLLNWCVQIAK 129
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 130 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 239
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 240 PQPPICTID----VYMIMVKCWMIDADSRPKFR 268

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 72
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 129
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 130 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 239
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 240 PQPPICTID----VYMIMVKCWMIDADSRPKFR 268

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 79/339 (23%), Positives = 143/339 (42%), Gaps = 61/339 (17%)
Query: 86  RKRNSDSGDRQRSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAE 145
           RKR S  G + R ++    + +I NFE  L         N   ++  +G G  G+V    
Sbjct: 6   RKRGSRGGKKGRKSR----IANIPNFEQSL--------KNLVVSEKILGYGSSGTVVFQG 53
Query: 146 LPSGQVVAIKKFHSPLPSDQIVDKKEF-LTEVEALTEIR-HRNIVKLYGFCSHARHSFLV 203
              G+ VA+K+         ++D  +  L E++ LTE   H N+++ Y   +  R  ++ 
Sbjct: 54  SFQGRPVAVKRM--------LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 105
Query: 204 YEFLKRGXXXXXXXXXXXXQELGWSQRMN---VIKGVADALSYLHHDCFPPIVHRDISSK 260
            E                 + L   +  N   +++ +A  +++LH      I+HRD+  +
Sbjct: 106 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQ 162
Query: 261 NLLLDL--EFEAH-----------VADFGIAKFLKPDSS----NWTEFAGTYGYVAPEL- 302
           N+L+     F A            ++DFG+ K L         N    +GT G+ APEL 
Sbjct: 163 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELL 222
Query: 303 --AYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP 359
             +   ++T   D++S G +   ++ KGKHP     S  S+ +     LDEM        
Sbjct: 223 EESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEM-------- 274
Query: 360 SRSVQEK--LRSIVEVVFSCLNESPESRPT-MKIVSQQL 395
            + + ++  +    +++   ++  P  RPT MK++   L
Sbjct: 275 -KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 79/339 (23%), Positives = 143/339 (42%), Gaps = 61/339 (17%)
Query: 86  RKRNSDSGDRQRSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAE 145
           RKR S  G + R ++    + +I NFE  L         N   ++  +G G  G+V    
Sbjct: 6   RKRGSRGGKKGRKSR----IANIPNFEQSL--------KNLVVSEKILGYGSSGTVVFQG 53
Query: 146 LPSGQVVAIKKFHSPLPSDQIVDKKEF-LTEVEALTEIR-HRNIVKLYGFCSHARHSFLV 203
              G+ VA+K+         ++D  +  L E++ LTE   H N+++ Y   +  R  ++ 
Sbjct: 54  SFQGRPVAVKRM--------LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 105
Query: 204 YEFLKRGXXXXXXXXXXXXQELGWSQRMN---VIKGVADALSYLHHDCFPPIVHRDISSK 260
            E                 + L   +  N   +++ +A  +++LH      I+HRD+  +
Sbjct: 106 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQ 162
Query: 261 NLLLDL--EFEAH-----------VADFGIAKFLKPDSS----NWTEFAGTYGYVAPEL- 302
           N+L+     F A            ++DFG+ K L         N    +GT G+ APEL 
Sbjct: 163 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELL 222
Query: 303 --AYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP 359
             +   ++T   D++S G +   ++ KGKHP     S  S+ +     LDEM        
Sbjct: 223 EESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEM-------- 274
Query: 360 SRSVQEK--LRSIVEVVFSCLNESPESRPT-MKIVSQQL 395
            + + ++  +    +++   ++  P  RPT MK++   L
Sbjct: 275 -KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 74
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 131
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 132 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 241
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 242 PQPPICTID----VYMIMVKCWMIDADSRPKFR 270

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           ++++D +  +G G    V R     +G   A K  ++   S +   K E   E     ++
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE--REARICRKL 61
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALS 242
           +H NIV+L+         +LV++ +  G             E   S   + I+ + ++++
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIA 118
Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEA---HVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           Y H +    IVHR++  +NLLL  + +     +ADFG+A  +  DS  W  FAGT GY++
Sbjct: 119 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLS 174
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+      ++  D+++ GV+   ++ G  P
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 27/227 (11%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPSDQIVD 168
           V DE   A         +G G  G VY   +  G V       VAIK  +    +  + +
Sbjct: 3   VPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNE---AASMRE 58
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE---- 224
           + EFL E   + E    ++V+L G  S  + + ++ E + RG             E    
Sbjct: 59  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 118
Query: 225 ---LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL 281
                 S+ + +   +AD ++YL+ + F   VHRD++++N  +  +F   + DFG+ + +
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCXVAEDFTVKIGDFGMTRDI 175
Query: 282 KPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEV 324
               +++    G       +++PE       T   DV+SFGV+  E+
Sbjct: 176 Y--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 116/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 71
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHK--DNIGSQYLLNWCVQIAK 128
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 238
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 239 PQPPICTID----VYMIMVKCWMIDADSRPKFR 267

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 73
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 130
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 240
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 241 PQPPICTID----VYMIMVKCWMIDADSRPKFR 269

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  +G  VA+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 192 GFCSHARHSFLVYEF----LKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
              + AR    + EF    L               Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-M 306
               I+HRD+   NL ++ + E  + D G+A+         T +  T  Y APE+    M
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDGGLARHT---DDEMTGYVATRWYRAPEIMLNWM 198
Query: 307 KITEKCDVYSFGVLALEVIKGK 328
              +  D++S G +  E++ G+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 71
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 128
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 238
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 239 PQPPICTID----VYMIMVKCWMIDADSRPKFR 267

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 116/270 (42%), Gaps = 26/270 (9%)
Query: 132 CIGNGGHGSVYRAELPSGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           CIG G  G V++    S +     VAIK   +   SD + +K  FL E   + +  H +I
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREK--FLQEALTMRQFDHPHI 70
Query: 188 VKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
           VKL G  +     +++ E    G             +L  +  +     ++ AL+YL   
Sbjct: 71  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESK 127
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYT 305
            F   VHRDI+++N+L+       + DFG++++++ DS+ +    G     ++APE    
Sbjct: 128 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 183
Query: 306 MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
            + T   DV+ FGV   E++   H       + ++ +   IE  E    RLP P      
Sbjct: 184 RRFTSASDVWMFGVCMWEIL--MHGVKPFQGVKNNDVIGRIENGE----RLPMPPNCPP- 236
Query: 366 KLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
              ++  ++  C    P  RP    +  QL
Sbjct: 237 ---TLYSLMTKCWAYDPSRRPRFTELKAQL 263

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 35/287 (12%)
Query: 123 ATNDFDAQY-------CIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKE 171
           +T D++ Q        CIG G  G V++    S       VAIK   +   SD + +K  
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREK-- 437
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           FL E   + +  H +IVKL G  +     +++ E    G             +L  +  +
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--ASLI 494
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
                ++ AL+YL    F   VHRDI+++N+L+       + DFG++++++ DS+ +   
Sbjct: 495 LYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKAS 550
Query: 292 AGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIEL 348
            G     ++APE     + T   DV+ FGV   E++  G  P      + ++ +   IE 
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP---FQGVKNNDVIGRIEN 607
Query: 349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            E    RLP P         ++  ++  C    P  RP    +  QL
Sbjct: 608 GE----RLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQL 646

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 77
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 78  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 134
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 135 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 244
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 245 PQPPICTID----VYMIMVKCWMIDADSRPKFR 273

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G+V++A+   + ++VA+K+    L  D        L E+  L E++H+NIV+L+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQ-ELGWSQRMNVIKGVADALSYLHHDCFP 250
                 +   LV+EF  +               E+  S    ++KG    L + H     
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG----LGFCHSR--- 120
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI-T 309
            ++HRD+  +NLL++   E  +ADFG+A+        ++    T  Y  P++ +  K+ +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 310 EKCDVYSFGVLALEVIKGKHP 330
              D++S G +  E+     P
Sbjct: 181 TSIDMWSAGCIFAELANAARP 201

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 96
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 97  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 153
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 154 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 263
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 264 PQPPICTID----VYMIMVKCWMIDADSRPKFR 292

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/302 (21%), Positives = 123/302 (40%), Gaps = 46/302 (15%)
Query: 118 DEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIV--DKKEFLTE 175
           ++++     F     +G G  GSV  A+L       +K     L +D I   D +EFL E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 176 VEALTEIRHRNIVKLYGFCSHARHS------FLVYEFLKRGXXXXXXXXXXXXQE---LG 226
              + E  H ++ KL G    +R         ++  F+K G            +    L 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS 286
               +  +  +A  + YL    F   +HRD++++N +L  +    VADFG+++ +     
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKI----- 187
Query: 287 NWTEFAGTY-----------GYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFL 334
               ++G Y            ++A E       T   DV++FGV   E++ +G+ P    
Sbjct: 188 ----YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP---- 239
Query: 335 SSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
               +   N +I    +   RL  P   ++E    + ++++ C +  P+ RP+   +  +
Sbjct: 240 ---YAGIENAEIYNYLIGGNRLKQPPECMEE----VYDLMYQCWSADPKQRPSFTCLRME 292
Query: 395 LQ 396
           L+
Sbjct: 293 LE 294

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 49/293 (16%)
Query: 133 IGNGGHGSVYRA------ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A      +  +   VA+K      PS  + +++  ++E++ L+ +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 186 NIVKLYGFCSHARHSFLVYE---------FLKR----------GXXXXXXXXXXXXQELG 226
           NIV L G C+    + ++ E         FL+R                        E  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS 286
            S    V KG+A   S    +C    +HRD++++N+LL       + DFG+A+ +K DS+
Sbjct: 148 LSFSYQVAKGMAFLAS---KNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 287 NWTEFAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLN 343
              +        ++APE  +    T + DV+S+G+   E+   G  P   +  + S F  
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSKFYK 259
Query: 344 TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              E   ML P   AP+         + +++ +C +  P  RPT K + Q ++
Sbjct: 260 MIKEGFRMLSPE-HAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 29/219 (13%)
Query: 126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE---- 181
           D+D    +G G  G V          +A+ +      + +IVD K  +   E + +    
Sbjct: 7   DWDLVQTLGEGAAGEVQ---------LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 57
Query: 182 ---IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM--NVIKG 236
              + H N+VK YG        +L  E+   G             E   +QR    ++ G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAG 116
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGT 294
           V     YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT
Sbjct: 117 VV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 295 YGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 332
             YVAPEL    +   E  DV+S G++   ++ G+ P D
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 35/287 (12%)
Query: 123 ATNDFDAQY-------CIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKE 171
           +T D++ Q        CIG G  G V++    S       VAIK   +   SD + +K  
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREK-- 57
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           FL E   + +  H +IVKL G  +     +++ E    G             +L  +  +
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--ASLI 114
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
                ++ AL+YL    F   VHRDI+++N+L+       + DFG++++++ DS+     
Sbjct: 115 LYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKAS 170
Query: 292 AGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIEL 348
            G     ++APE     + T   DV+ FGV   E++  G  P      + ++ +   IE 
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP---FQGVKNNDVIGRIEN 227
Query: 349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            E    RLP P         ++  ++  C    P  RP    +  QL
Sbjct: 228 GE----RLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 49/293 (16%)
Query: 133 IGNGGHGSVYRA------ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A      +  +   VA+K      PS  + +++  ++E++ L+ +  H 
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 103
Query: 186 NIVKLYGFCSHARHSFLVYE---------FLKR----------GXXXXXXXXXXXXQELG 226
           NIV L G C+    + ++ E         FL+R                        E  
Sbjct: 104 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS 286
            S    V KG+A   S    +C    +HRD++++N+LL       + DFG+A+ +K DS+
Sbjct: 164 LSFSYQVAKGMAFLAS---KNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN 216
Query: 287 NWTEFAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLN 343
              +        ++APE  +    T + DV+S+G+   E+   G  P   +  + S F  
Sbjct: 217 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSKFYK 275
Query: 344 TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              E   ML P   AP+         + +++ +C +  P  RPT K + Q ++
Sbjct: 276 MIKEGFRMLSPE-HAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 37/283 (13%)
Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           +D +    +G G +G V +   +PSGQ+ A+K+  + + S +   +K  L +++    I 
Sbjct: 34  DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQE---QKRLLXDLD----IS 86
Query: 184 HRNI-----VKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA 238
            R +     V  YG        ++  E                 Q +       +   + 
Sbjct: 87  XRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 146
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
            AL +LH      ++HRD+   N+L++   +    DFGI+ +L  D +   + AG   Y 
Sbjct: 147 KALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-AGCKPYX 203
Query: 299 APEL--------AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE 350
           APE          Y++    K D++S G+  +E+   + P D   S  + F     ++ E
Sbjct: 204 APERINPELNQKGYSV----KSDIWSLGITXIELAILRFPYD---SWGTPFQQLK-QVVE 255
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ 393
              P+LPA   S +      V+    CL ++ + RPT   + Q
Sbjct: 256 EPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 49/293 (16%)
Query: 133 IGNGGHGSVYRA------ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A      +  +   VA+K      PS  + +++  ++E++ L+ +  H 
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 105
Query: 186 NIVKLYGFCSHARHSFLVYE---------FLKR----------GXXXXXXXXXXXXQELG 226
           NIV L G C+    + ++ E         FL+R                        E  
Sbjct: 106 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS 286
            S    V KG+A   S    +C    +HRD++++N+LL       + DFG+A+ +K DS+
Sbjct: 166 LSFSYQVAKGMAFLAS---KNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN 218
Query: 287 NWTEFAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLN 343
              +        ++APE  +    T + DV+S+G+   E+   G  P   +  + S F  
Sbjct: 219 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSKFYK 277
Query: 344 TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              E   ML P   AP+         + +++ +C +  P  RPT K + Q ++
Sbjct: 278 MIKEGFRMLSPE-HAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 65
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 122
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 232
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 233 PQPPICTID----VYMIMVKCWMIDADSRPKFR 261

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 97/227 (42%), Gaps = 27/227 (11%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPSDQIVD 168
           V DE   A         +G G  G VY   +  G V       VAIK  +    +  + +
Sbjct: 16  VPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNE---AASMRE 71
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE---- 224
           + EFL E   + E    ++V+L G  S  + + ++ E + RG                  
Sbjct: 72  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 225 ---LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL 281
                 S+ + +   +AD ++YL+ + F   VHRD++++N ++  +F   + DFG+ + +
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDI 188
Query: 282 KPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEV 324
               +++    G       +++PE       T   DV+SFGV+  E+
Sbjct: 189 Y--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/204 (22%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 133 IGNGGHGSVYR------AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G GG    Y        E+ +G+VV       P        K++  TE+     + + +
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPH------QKEKMSTEIAIHKSLDNPH 87
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHH 246
           +V  +GF       ++V E  +R              E    +    ++     + YLH+
Sbjct: 88  VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---PEARYFMRQTIQGVQYLHN 144
Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM 306
           +    ++HRD+   NL L+ + +  + DFG+A  ++ D     +  GT  Y+APE+    
Sbjct: 145 N---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKK 201
Query: 307 KITEKCDVYSFGVLALEVIKGKHP 330
             + + D++S G +   ++ GK P
Sbjct: 202 GHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 49/293 (16%)
Query: 133 IGNGGHGSVYRA------ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A      +  +   VA+K      PS  + +++  ++E++ L+ +  H 
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 110
Query: 186 NIVKLYGFCSHARHSFLVYE---------FLKR----------GXXXXXXXXXXXXQELG 226
           NIV L G C+    + ++ E         FL+R                        E  
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS 286
            S    V KG+A   S    +C    +HRD++++N+LL       + DFG+A+ +K DS+
Sbjct: 171 LSFSYQVAKGMAFLAS---KNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN 223
Query: 287 NWTEFAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLN 343
              +        ++APE  +    T + DV+S+G+   E+   G  P   +  + S F  
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSKFYK 282
Query: 344 TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              E   ML P   AP+         + +++ +C +  P  RPT K + Q ++
Sbjct: 283 MIKEGFRMLSPE-HAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFH---SPLPSDQIVDKKEFLTEVEALT 180
           +DF+    +G G  G V + +  PSG ++A K  H    P   +QI+       E++ L 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQII------RELQVLH 69
Query: 181 EIRHRNIVKLYG-FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
           E     IV  YG F S    S  +                   +E+     + V++G   
Sbjct: 70  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG--- 126
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
            L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y+A
Sbjct: 127 -LAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMA 181
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE       + + D++S G+  +E+  G++P
Sbjct: 182 PERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 12/214 (5%)
Query: 121 VRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            R T ++     +G G    V R  ++ +GQ  A    ++   S +  D ++   E    
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR--DHQKLEREARIC 64
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             ++H NIV+L+   S   H +L+++ +  G             E   S   + I+ + +
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQQILE 121
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEA---HVADFGIAKFLKPDSSNWTEFAGTYG 296
           A+ + H      +VHR++  +NLLL  + +     +ADFG+A  ++ +   W  FAGT G
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y++PE+       +  D+++ GV+   ++ G  P
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 17/230 (7%)
Query: 127 FDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR 185
           +D    +G+G  G V+R  E  +G+V   K  ++P P    +DK     E+  + ++ H 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP----LDKYTVKNEISIMNQLHHP 108
Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
            ++ L+          L+ EFL  G             ++  ++ +N ++   + L ++H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMH 166
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVA--DFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
                 IVH DI  +N++ + +  + V   DFG+A  L PD       A T  + APE+ 
Sbjct: 167 EHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA-TAEFAAPEIV 222
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP---RDFLSSISSSFLNTDIELDE 350
               +    D+++ GVL   ++ G  P    D L ++  +    D E DE
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-QNVKRCDWEFDE 271

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 71
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 128
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 238
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 239 PQPPICTID----VYMIMRKCWMIDADSRPKFR 267

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL 190
           +G+G    V+   +  +G++ A+K    SP   D  ++      E+  L +I+H NIV L
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-----NEIAVLKKIKHENIVTL 71
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
                   H +LV + +  G             E   S    VI+ V  A+ YLH +   
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---VIQQVLSAVKYLHEN--- 125
Query: 251 PIVHRDISSKNLLL---DLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK 307
            IVHRD+  +NLL    +   +  + DFG++K     +   +   GT GYVAPE+     
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTACGTPGYVAPEVLAQKP 183
Query: 308 ITEKCDVYSFGVLALEVIKGKHP 330
            ++  D +S GV+   ++ G  P
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPP 206

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 74
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 131
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 132 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 241
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 242 PQPPICTID----VYMIMRKCWMIDADSRPKFR 270

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 97/227 (42%), Gaps = 27/227 (11%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPSDQIVD 168
           V DE   A         +G G  G VY   +  G V       VAIK  +    +  + +
Sbjct: 6   VPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNE---AASMRE 61
Query: 169 KKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE---- 224
           + EFL E   + E    ++V+L G  S  + + ++ E + RG                  
Sbjct: 62  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 121
Query: 225 ---LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL 281
                 S+ + +   +AD ++YL+ + F   VHRD++++N ++  +F   + DFG+ + +
Sbjct: 122 LAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDI 178
Query: 282 KPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEV 324
               +++    G       +++PE       T   DV+SFGV+  E+
Sbjct: 179 Y--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 20/205 (9%)
Query: 133 IGNGGHGSVYR------AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G GG    Y        E+ +G+VV       P        K++  TE+     + + +
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPH------QKEKMSTEIAIHKSLDNPH 103
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM-NVIKGVADALSYLH 245
           +V  +GF       ++V E  +R              E      M   I+GV     YLH
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGV----QYLH 159
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
           ++    ++HRD+   NL L+ + +  + DFG+A  ++ D     +  GT  Y+APE+   
Sbjct: 160 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK 216
Query: 306 MKITEKCDVYSFGVLALEVIKGKHP 330
              + + D++S G +   ++ GK P
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 88/216 (40%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 91
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 148
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +     E   T  Y APE+    K 
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 208
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 88/216 (40%), Gaps = 17/216 (7%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A     +V VAIKK  SP        +   L E++ L   RH NI+ + 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT--LREIKILLRFRHENIIGIN 92
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   ++ +             Q L        +  +   L Y+H      
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 149
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYTMK- 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +     E   T  Y APE+    K 
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 209
Query: 308 ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            T+  D++S G +  E++       GKH  D L+ I
Sbjct: 210 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 245

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  + ++ SG  +A+KK   P  S  I+  K    E+  L  ++H N++ L 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 116
Query: 192 GFCSHARHSFLVYE--FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
              + A  S   +   +L               Q+L       +I  +   L Y+H    
Sbjct: 117 DVFTPAT-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 172
Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKI 308
             I+HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M  
Sbjct: 173 ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHY 229
Query: 309 TEKCDVYSFGVLALEVIKGK 328
               D++S G +  E++ G+
Sbjct: 230 NMTVDIWSVGCIMAELLTGR 249

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 18/219 (8%)
Query: 130 QYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           QY IG G +G V  A +      VAIKK  SP        +   L E++ L   RH N++
Sbjct: 49  QY-IGEGAYGMVSSAYDHVRKTRVAIKKI-SPFEHQTYCQRT--LREIQILLRFRHENVI 104
Query: 189 KLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
            +      +    +   ++ +             Q+L        +  +   L Y+H   
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYT 305
              ++HRD+   NLL++   +  + DFG+A+   P+  +    TE   T  Y APE+   
Sbjct: 165 ---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221
Query: 306 MK-ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 337
            K  T+  D++S G +  E++       GKH  D L+ I
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 45/81 (55%)
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           I++RD+   N++LD E    +ADFG+ K    D     EF GT  Y+APE+       + 
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKS 200
Query: 312 CDVYSFGVLALEVIKGKHPRD 332
            D +++GVL  E++ G+ P D
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFD 221

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 81
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 82  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 138
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 139 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 248
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 249 PQPPICTID----VYMIMRKCWMIDADSRPKFR 277

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 94/235 (40%), Gaps = 41/235 (17%)
Query: 121 VRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKF-HSPLPSDQIVDKKEFLTEVEA 178
           +R  +DF+    +G G  G V +A      +  AIKK  H+      I      L+EV  
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI------LSEVXL 55
Query: 179 LTEIRHRNIVKLYGFCSHARH-------------SFLVYEFLKRGXXXXXXXXXXXXQEL 225
           L  + H+ +V+ Y      R+              F+  E+ +              Q+ 
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQR 115
Query: 226 GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK------ 279
               R+   + + +ALSY+H      I+HR++   N+ +D      + DFG+AK      
Sbjct: 116 DEYWRL--FRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 280 -FLKPDSS-------NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI 325
             LK DS        N T   GT  YVA E L  T    EK D YS G++  E I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 113/287 (39%), Gaps = 39/287 (13%)
Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G +VA+K+     P  Q    ++F  E++ L  +    I
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILKALHSDFI 70
Query: 188 VKLYG--FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL- 244
           VK  G  +        LV E+L  G              L  S+ +     +   + YL 
Sbjct: 71  VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLG 128
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPE 301
              C    VHRD++++N+L++ E    +ADFG+AK L  D               + APE
Sbjct: 129 SRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE 184
Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN-TDIELD----------E 350
                  + + DV+SFGV+  E+       D   S S+ FL     E D           
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYELFTYC---DKSCSPSAEFLRMMGCERDVPALCRLLELL 241
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI 397
               RLPAP     E    + E++  C   SP+ RP+   +  QL +
Sbjct: 242 EEGQRLPAPPACPAE----VHELMKLCWAPSPQDRPSFSALGPQLDM 284

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 23/162 (14%)
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
           VA  + YL    F   VHRD++++N +LD  F   VADFG+A+ +  D   ++     + 
Sbjct: 133 VARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHRHA 188
Query: 297 -----YVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSIS-SSFLNTDIELD 349
                + A E   T + T K DV+SFGVL  E++ +G  P   +     + FL       
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ----- 243
Query: 350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIV 391
                RLP P         S+ +V+  C    P  RPT +++
Sbjct: 244 ---GRRLPQPEYCPD----SLYQVMQQCWEADPAVRPTFRVL 278

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/276 (22%), Positives = 117/276 (42%), Gaps = 34/276 (12%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAI-------KKFHSPLPSDQIVDKKEFLTEV 176
            +F     +G+G  G+VY+   +P G+ V I       ++  SP  +      KE L E 
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKAN------KEILDEA 102
Query: 177 EALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG 236
             +  + + ++ +L G C  +    L+ + +  G              +G    +N    
Sbjct: 103 YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQ 159
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY- 295
           +A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G   
Sbjct: 160 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 296 -GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD 353
             ++A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E   
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE--- 270
Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            RLP P     +    +  ++  C     +SRP  +
Sbjct: 271 -RLPQPPICTID----VYMIMVKCWMIDADSRPKFR 301

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 29/263 (11%)
Query: 148 SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--RHSFLVYE 205
           +G++VA+K         Q+  +  +  E+E L  + H +IVK  G C     +   LV E
Sbjct: 36  TGEMVAVKALKEGC-GPQL--RSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVME 92
Query: 206 FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD 265
           ++  G              +G +Q +   + + + ++YLH   +   +HR ++++N+LLD
Sbjct: 93  YVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLHAQHY---IHRALAARNVLLD 145
Query: 266 LEFEAHVADFGIAKFLKPDSSNWTEFA----GTYGYVAPELAYTMKITEKCDVYSFGVLA 321
            +    + DFG+AK + P+   +            + APE     K     DV+SFGV  
Sbjct: 146 NDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTL 204
Query: 322 LEVI----KGKHPRDFLSSI--SSSFLNTDIELDEMLD--PRLPAPSRSVQEKLRSIVEV 373
            E++      + P    + +   +    T + L E+L+   RLP P R   E    I  +
Sbjct: 205 YELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCE----IYHL 260
Query: 374 VFSCLNESPESRPTMKIVSQQLQ 396
           + +C       RPT + +   LQ
Sbjct: 261 MKNCWETEASFRPTFQNLVPILQ 283

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 114/273 (41%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 73
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 130
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG AK L  +   +    G     +
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 240
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 241 PQPPICTID----VYMIMVKCWMIDADSRPKFR 269

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 29/263 (11%)
Query: 148 SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--RHSFLVYE 205
           +G++VA+K         Q+  +  +  E+E L  + H +IVK  G C     +   LV E
Sbjct: 37  TGEMVAVKALKEGC-GPQL--RSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVME 93
Query: 206 FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD 265
           ++  G              +G +Q +   + + + ++YLH   +   +HR ++++N+LLD
Sbjct: 94  YVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLHAQHY---IHRALAARNVLLD 146
Query: 266 LEFEAHVADFGIAKFLKPDSSNWTEFA----GTYGYVAPELAYTMKITEKCDVYSFGVLA 321
            +    + DFG+AK + P+   +            + APE     K     DV+SFGV  
Sbjct: 147 NDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTL 205
Query: 322 LEVI----KGKHPRDFLSSI--SSSFLNTDIELDEMLD--PRLPAPSRSVQEKLRSIVEV 373
            E++      + P    + +   +    T + L E+L+   RLP P R   E    I  +
Sbjct: 206 YELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCE----IYHL 261
Query: 374 VFSCLNESPESRPTMKIVSQQLQ 396
           + +C       RPT + +   LQ
Sbjct: 262 MKNCWETEASFRPTFQNLVPILQ 284

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 114/273 (41%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 75
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 132
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG AK L  +   +    G     +
Sbjct: 133 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 242
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 243 PQPPICTID----VYMIMVKCWMIDADSRPKFR 271

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 20/205 (9%)
Query: 133 IGNGGHGSVYR------AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G GG    Y        E+ +G+VV       P        K++  TE+     + + +
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPH------QKEKMSTEIAIHKSLDNPH 103
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM-NVIKGVADALSYLH 245
           +V  +GF       ++V E  +R              E      M   I+GV     YLH
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGV----QYLH 159
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
           ++    ++HRD+   NL L+ + +  + DFG+A  ++ D        GT  Y+APE+   
Sbjct: 160 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCK 216
Query: 306 MKITEKCDVYSFGVLALEVIKGKHP 330
              + + D++S G +   ++ GK P
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 20/205 (9%)
Query: 133 IGNGGHGSVYR------AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G GG    Y        E+ +G+VV       P        K++  TE+     + + +
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPH------QKEKMSTEIAIHKSLDNPH 103
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM-NVIKGVADALSYLH 245
           +V  +GF       ++V E  +R              E      M   I+GV     YLH
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGV----QYLH 159
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
           ++    ++HRD+   NL L+ + +  + DFG+A  ++ D        GT  Y+APE+   
Sbjct: 160 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCK 216
Query: 306 MKITEKCDVYSFGVLALEVIKGKHP 330
              + + D++S G +   ++ GK P
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 114/273 (41%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 78
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 135
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG AK L  +   +    G     +
Sbjct: 136 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 245
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 246 PQPPICTID----VYMIMVKCWMIDADSRPKFR 274

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 114/273 (41%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 71
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 128
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG AK L  +   +    G     +
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 238
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 239 PQPPICTID----VYMIMVKCWMIDADSRPKFR 267

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 15/213 (7%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEA 178
             ++F+    +G G  G V  A +  +G + A+K     L  D I+   +    +TE   
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV----LKKDVILQDDDVECTMTEKRI 76
Query: 179 LTEIR-HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGV 237
           L+  R H  + +L+         F V EF+  G             E   ++       +
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE---ARARFYAAEI 133
Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGY 297
             AL +LH      I++RD+   N+LLD E    +ADFG+ K    +      F GT  Y
Sbjct: 134 ISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY 190
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +APE+   M      D ++ GVL  E++ G  P
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 114/273 (41%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     + +G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 78
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 135
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 136 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 245
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 246 PQPPICTID----VYMIMVKCWMIDADSRPKFR 274

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 12/209 (5%)
Query: 126 DFDAQYCIGNG-GHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           D +  Y + N  G GS    ++   +   I++    +P   + D   F  E+E +  + H
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH 65
Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
            NI++LY         +LV E    G            +E   S    ++K V  A++Y 
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE---SDAARIMKDVLSAVAYC 122
Query: 245 HHDCFPPIVHRDISSKNLLL---DLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
           H      + HRD+  +N L      +    + DFG+A   KP     T+  GT  YV+P+
Sbjct: 123 HKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK-VGTPYYVSPQ 178
Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +   +   E CD +S GV+   ++ G  P
Sbjct: 179 VLEGLYGPE-CDEWSAGVMMYVLLCGYPP 206

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 122/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K        + + D    ++E+E +  I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSD---LVSEMEMMKMIGK 99
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------------XQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         +++ +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 160 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------FTLGGSPYPG 262
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  P+    E    +  ++  C +  P  RPT K + + L
Sbjct: 263 IPVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 12/209 (5%)
Query: 126 DFDAQYCIGNG-GHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           D +  Y + N  G GS    ++   +   I++    +P   + D   F  E+E +  + H
Sbjct: 23  DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH 82
Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
            NI++LY         +LV E    G            +E   S    ++K V  A++Y 
Sbjct: 83  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE---SDAARIMKDVLSAVAYC 139
Query: 245 HHDCFPPIVHRDISSKNLLL---DLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
           H      + HRD+  +N L      +    + DFG+A   KP     T+  GT  YV+P+
Sbjct: 140 HKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK-VGTPYYVSPQ 195
Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +   +   E CD +S GV+   ++ G  P
Sbjct: 196 VLEGLYGPE-CDEWSAGVMMYVLLCGYPP 223

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 37/215 (17%)
Query: 134 GNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--IRHRNIVKLY 191
             G  G V++A+L     VA+K F  PL      DK+ + +E E  +   ++H N+++  
Sbjct: 24  ARGRFGCVWKAQL-MNDFVAVKIF--PLQ-----DKQSWQSEREIFSTPGMKHENLLQF- 74
Query: 192 GFCSHARHS------FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
              +  R S      +L+  F  +G              + W++  +V + ++  LSYLH
Sbjct: 75  -IAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLH 129
Query: 246 HDC--------FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA--GTY 295
            D          P I HRD  SKN+LL  +  A +ADFG+A   +P           GT 
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR 189
Query: 296 GYVAPE-----LAYTMKITEKCDVYSFGVLALEVI 325
            Y+APE     + +      + D+Y+ G++  E++
Sbjct: 190 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G +GSV   Y A L   Q VA+KK   P  S  ++  +    E+  L  ++H N++ 
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQS--LIHARRTYRELRLLKHLKHENVIG 91
Query: 190 LYGFCSHARHSFLVYE-FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           L    + A       E +L               Q L       ++  +   L Y+H   
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MK 307
              I+HRD+   N+ ++ + E  + DFG+A   +      T +  T  Y APE+    M 
Sbjct: 152 ---IIHRDLKPSNVAVNEDSELRILDFGLA---RQADEEMTGYVATRWYRAPEIMLNWMH 205
Query: 308 ITEKCDVYSFGVLALEVIKGK 328
             +  D++S G +  E+++GK
Sbjct: 206 YNQTVDIWSVGCIMAELLQGK 226

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 114/273 (41%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 73
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 130
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG AK L  +   +    G     +
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 240
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 241 PQPPICTID----VYMIMRKCWMIDADSRPKFR 269

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G+V++A+   + ++VA+K+    L  D        L E+  L E++H+NIV+L+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQ-ELGWSQRMNVIKGVADALSYLHHDCFP 250
                 +   LV+EF  +               E+  S    ++KG    L + H     
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG----LGFCHSR--- 120
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI-T 309
            ++HRD+  +NLL++   E  +A+FG+A+        ++    T  Y  P++ +  K+ +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 310 EKCDVYSFGVLALEVIKGKHP 330
              D++S G +  E+     P
Sbjct: 181 TSIDMWSAGCIFAELANAGRP 201

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 114/273 (41%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     + +G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 78
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 135
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 136 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 245
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 246 PQPPICTID----VYMIMVKCWMIDADSRPKFR 274

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K          + D    ++E+E +  I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 99
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------------XQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         +++ +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 160 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------FTLGGSPYPG 262
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  P+    E    +  ++  C +  P  RPT K + + L
Sbjct: 263 IPVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 114/273 (41%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     +G+G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 73
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 130
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG AK L  +   +    G     +
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 240
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 241 PQPPICTID----VYMIMRKCWMIDADSRPKFR 269

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 110/267 (41%), Gaps = 32/267 (11%)
Query: 133 IGNGGHGSVYRA-ELPSGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G+G  G+VY+   +P G+     VAIK              KE L E   +  +    +
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA---NKEILDEAYVMAGVGSPYV 81
Query: 188 VKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
            +L G C  +    LV + +  G              LG    +N    +A  +SYL   
Sbjct: 82  SRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRG--RLGSQDLLNWCMQIAKGMSYLED- 137
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYT 305
               +VHRD++++N+L+       + DFG+A+ L  D + +    G     ++A E    
Sbjct: 138 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILR 195
Query: 306 MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--RLPAPSRS 362
            + T + DV+S+GV   E++  G  P D + +          E+ ++L+   RLP P   
Sbjct: 196 RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---------REIPDLLEKGERLPQPPIC 246
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMK 389
             +    +  ++  C     E RP  +
Sbjct: 247 TID----VYMIMVKCWMIDSECRPRFR 269

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 114/273 (41%), Gaps = 28/273 (10%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVV----AIKKFHSPLPSDQIVDKKEFLTEVEAL 179
            +F     + +G  G+VY+   +P G+ V    AIK+             KE L E   +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVM 71
Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVAD 239
             + + ++ +L G C  +    L+ + +  G              +G    +N    +A 
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 128
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GY 297
            ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G     +
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           +A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E    RL
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE----RL 238
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           P P     +    +  ++  C     +SRP  +
Sbjct: 239 PQPPICTID----VYMIMVKCWMIDADSRPKFR 267

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K          + D    ++E+E +  I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 99
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------------XQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         +++ +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 160 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGLAR----DINNID 211
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------FTLGGSPYPG 262
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  P+    E    +  ++  C +  P  RPT K + + L
Sbjct: 263 IPVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G +GSV   Y A L   Q VA+KK   P  S  ++  +    E+  L  ++H N++ 
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQS--LIHARRTYRELRLLKHLKHENVIG 83
Query: 190 LYGFCSHARHSFLVYE-FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           L    + A       E +L               Q L       ++  +   L Y+H   
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS-- 141
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MK 307
              I+HRD+   N+ ++ + E  + DFG+A   +      T +  T  Y APE+    M 
Sbjct: 142 -AGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADEEMTGYVATRWYRAPEIMLNWMH 197
Query: 308 ITEKCDVYSFGVLALEVIKGK 328
             +  D++S G +  E+++GK
Sbjct: 198 YNQTVDIWSVGCIMAELLQGK 218

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 13/173 (7%)
Query: 165 QIVDK--KEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX 221
           +++DK  ++   E+E L    +H NI+ L       +H +LV E ++ G           
Sbjct: 58  KVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF 117
Query: 222 XQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE----AHVADFGI 277
             E    +   V+  +   + YLH      +VHRD+   N+L   E        + DFG 
Sbjct: 118 FSE---REASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGF 171
Query: 278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           AK L+ ++        T  +VAPE+       E CD++S G+L   ++ G  P
Sbjct: 172 AKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G +GSV   Y A L   Q VA+KK   P  S  ++  +    E+  L  ++H N++ 
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQS--LIHARRTYRELRLLKHLKHENVIG 91
Query: 190 LYGFCSHARHSFLVYE-FLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDC 248
           L    + A       E +L               Q L       ++  +   L Y+H   
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MK 307
              I+HRD+   N+ ++ + E  + DFG+A   +      T +  T  Y APE+    M 
Sbjct: 152 ---IIHRDLKPSNVAVNEDSELRILDFGLA---RQADEEMTGYVATRWYRAPEIMLNWMH 205
Query: 308 ITEKCDVYSFGVLALEVIKGK 328
             +  D++S G +  E+++GK
Sbjct: 206 YNQTVDIWSVGCIMAELLQGK 226

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/251 (21%), Positives = 103/251 (41%), Gaps = 38/251 (15%)
Query: 170 KEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------- 221
           ++ L+E   L ++ H +++KLYG CS      L+ E+ K G                   
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 222 -------------XQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF 268
                         + L     ++    ++  + YL       +VHRD++++N+L+    
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGR 187
Query: 269 EAHVADFGIAKFLKPDSSNWTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK 326
           +  ++DFG+++ +  + S      G     ++A E  +    T + DV+SFGVL  E++ 
Sbjct: 188 KMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 327 -GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
            G +P      I    L   ++       R+  P    +E  R    ++  C  + P+ R
Sbjct: 248 LGGNP---YPGIPPERLFNLLKTGH----RMERPDNCSEEMYR----LMLQCWKQEPDKR 296
Query: 386 PTMKIVSQQLQ 396
           P    +S+ L+
Sbjct: 297 PVFADISKDLE 307

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K          + D    ++E+E +  I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 99
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXX-------------XXXQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         +++ +   
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 160 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------FTLGGSPYPG 262
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  P+    E    +  ++  C +  P  RPT K + + L
Sbjct: 263 IPVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 13/173 (7%)
Query: 165 QIVDK--KEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX 221
           +++DK  ++   E+E L    +H NI+ L       +H +LV E ++ G           
Sbjct: 58  KVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF 117
Query: 222 XQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE----AHVADFGI 277
             E    +   V+  +   + YLH      +VHRD+   N+L   E        + DFG 
Sbjct: 118 FSE---REASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGF 171
Query: 278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           AK L+ ++        T  +VAPE+       E CD++S G+L   ++ G  P
Sbjct: 172 AKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/251 (21%), Positives = 103/251 (41%), Gaps = 38/251 (15%)
Query: 170 KEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------- 221
           ++ L+E   L ++ H +++KLYG CS      L+ E+ K G                   
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 222 -------------XQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF 268
                         + L     ++    ++  + YL       +VHRD++++N+L+    
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGR 187
Query: 269 EAHVADFGIAKFLKPDSSNWTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK 326
           +  ++DFG+++ +  + S      G     ++A E  +    T + DV+SFGVL  E++ 
Sbjct: 188 KMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 327 -GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
            G +P      I    L   ++       R+  P    +E  R    ++  C  + P+ R
Sbjct: 248 LGGNP---YPGIPPERLFNLLKTGH----RMERPDNCSEEMYR----LMLQCWKQEPDKR 296
Query: 386 PTMKIVSQQLQ 396
           P    +S+ L+
Sbjct: 297 PVFADISKDLE 307

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K          + D    ++E+E +  I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 99
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXX-------------XXXQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         +++ +   
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 160 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------FTLGGSPYPG 262
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  P+    E    +  ++  C +  P  RPT K + + L
Sbjct: 263 IPVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 88/207 (42%), Gaps = 21/207 (10%)
Query: 133 IGNGGHGSVYRA---ELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G VY     ++  G+    VA+K  +    S  + ++ EFL E   +      +
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE---SASLRERIEFLNEASVMKGFTCHH 78
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG-------WSQRMNVIKGVAD 239
           +V+L G  S  + + +V E +  G             E           + + +   +AD
Sbjct: 79  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 138
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG--Y 297
            ++YL+   F   VHRD++++N ++  +F   + DFG+ + +           G     +
Sbjct: 139 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 195
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEV 324
           +APE       T   D++SFGV+  E+
Sbjct: 196 MAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 88/207 (42%), Gaps = 21/207 (10%)
Query: 133 IGNGGHGSVYRA---ELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G VY     ++  G+    VA+K  +    S  + ++ EFL E   +      +
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE---SASLRERIEFLNEASVMKGFTCHH 81
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG-------WSQRMNVIKGVAD 239
           +V+L G  S  + + +V E +  G             E           + + +   +AD
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG--Y 297
            ++YL+   F   VHRD++++N ++  +F   + DFG+ + +           G     +
Sbjct: 142 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEV 324
           +APE       T   D++SFGV+  E+
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 88/207 (42%), Gaps = 21/207 (10%)
Query: 133 IGNGGHGSVYRA---ELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G VY     ++  G+    VA+K  +    S  + ++ EFL E   +      +
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE---SASLRERIEFLNEASVMKGFTCHH 81
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG-------WSQRMNVIKGVAD 239
           +V+L G  S  + + +V E +  G             E           + + +   +AD
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG--Y 297
            ++YL+   F   VHRD++++N ++  +F   + DFG+ + +           G     +
Sbjct: 142 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEV 324
           +APE       T   D++SFGV+  E+
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/268 (23%), Positives = 107/268 (39%), Gaps = 40/268 (14%)
Query: 133 IGNGGHG-SVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G ++       G+   IK+ +    S +  +++E   EV  L  ++H NIV+  
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK--EREESRREVAVLANMKHPNIVQYR 89
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA----DALSYLHHD 247
                    ++V ++ + G                  +R+N  KGV       L +    
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLF---------------KRINAQKGVLFQEDQILDWFVQI 134
Query: 248 CFP-------PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           C          I+HRDI S+N+ L  +    + DFGIA+ L           GT  Y++P
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSP 194
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
           E+        K D+++ G +  E+   KH  +     + S  N  +++   +    P  S
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHAFE-----AGSMKNLVLKI---ISGSFPPVS 246
Query: 361 RSVQEKLRSIVEVVFSCLNESPESRPTM 388
                 LRS+V  +F     +P  RP++
Sbjct: 247 LHYSYDLRSLVSQLF---KRNPRDRPSV 271

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 43/79 (54%)
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           I++RD+   N++LD E    +ADFG+ K    D      F GT  Y+APE+       + 
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 522
Query: 312 CDVYSFGVLALEVIKGKHP 330
            D ++FGVL  E++ G+ P
Sbjct: 523 VDWWAFGVLLYEMLAGQAP 541

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K          + D    ++E+E +  I +
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 86
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXX-------------XXXQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         +++ +   
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 147 VSCTYQLARGMEYLASQKC----IHRDLTARNVLVTENNVMKIADFGLAR----DINNID 198
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------FTLGGSPYPG 249
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  P+    E    +  ++  C +  P  RPT K + + L
Sbjct: 250 IPVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 300

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 20/225 (8%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V+R    S +   + KF     +DQ++ KK    E+  L   RHRNI+ L+ 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILNIARHRNILHLHE 68
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH-HDCFPP 251
                    +++EF+                EL   + ++ +  V +AL +LH H+    
Sbjct: 69  SFESMEELVMIFEFI--SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---- 122
Query: 252 IVHRDISSKNLLLDLEFEA--HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKIT 309
           I H DI  +N++      +   + +FG A+ LKP   N+        Y APE+     ++
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 310 EKCDVYSFGVLALEVIKGKHPRDFLS----SISSSFLNTDIELDE 350
              D++S G L   ++ G +P  FL+     I  + +N +   DE
Sbjct: 182 TATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDE 224

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/251 (21%), Positives = 103/251 (41%), Gaps = 38/251 (15%)
Query: 170 KEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------- 221
           ++ L+E   L ++ H +++KLYG CS      L+ E+ K G                   
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 222 -------------XQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF 268
                         + L     ++    ++  + YL       +VHRD++++N+L+    
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGR 187
Query: 269 EAHVADFGIAKFLKPDSSNWTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK 326
           +  ++DFG+++ +  + S      G     ++A E  +    T + DV+SFGVL  E++ 
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 327 -GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
            G +P      I    L   ++       R+  P    +E  R    ++  C  + P+ R
Sbjct: 248 LGGNP---YPGIPPERLFNLLKTGH----RMERPDNCSEEMYR----LMLQCWKQEPDKR 296
Query: 386 PTMKIVSQQLQ 396
           P    +S+ L+
Sbjct: 297 PVFADISKDLE 307

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K          + D    ++E+E +  I +
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 91
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRG-------------XXXXXXXXXXXXQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         +++ +   
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 152 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNID 203
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
            +  T        ++APE  +    T + DV+SFGVL  E+   G  P   +        
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------ 257
Query: 343 NTDIELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
               EL ++L    R+  P+    E    +  ++  C +  P  RPT K + + L
Sbjct: 258 ---EELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 305

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 43/79 (54%)
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           I++RD+   N++LD E    +ADFG+ K    D      F GT  Y+APE+       + 
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 201
Query: 312 CDVYSFGVLALEVIKGKHP 330
            D ++FGVL  E++ G+ P
Sbjct: 202 VDWWAFGVLLYEMLAGQAP 220

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 40/221 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K          + D    ++E+E +  I +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 145
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------------XQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         +++ +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 206 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNID 257
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEV 324
            +  T        ++APE  +    T + DV+SFGVL  E+
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K          + D    ++E+E +  I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 99
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRG-------------XXXXXXXXXXXXQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         +++ +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 160 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
               T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------FTLGGSPYPG 262
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  P+    E    +  ++  C +  P  RPT K + + L
Sbjct: 263 IPVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 119/296 (40%), Gaps = 59/296 (19%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIK----KFHSPLPSDQIVDKKEFLTEVEALTEI 182
           +G    G VY+  L         Q VAIK    K   PL       ++EF  E      +
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-------REEFRHEAMLRARL 69
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG------ 236
           +H N+V L G  +  +   +++ +   G             ++G +     +K       
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 237 -------VADALSYL--HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
                  +A  + YL  HH     +VH+D++++N+L+  +    ++D G+  F +  +++
Sbjct: 130 FVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGL--FREVYAAD 182
Query: 288 WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
           + +  G       ++APE     K +   D++S+GV+  EV   G  P          + 
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-------YCGYS 235
Query: 343 NTDIELDEMLDPR--LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           N D+   EM+  R  LP P          +  ++  C NE P  RP  K +  +L+
Sbjct: 236 NQDVV--EMIRNRQVLPCPDDCPA----WVYALMIECWNEFPSRRPRFKDIHSRLR 285

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K          + D    ++E+E +  I +
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 88
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRG-------------XXXXXXXXXXXXQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         +++ +   
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 149 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNID 200
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------FTLGGSPYPG 251
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  P+    E    +  ++  C +  P  RPT K + + L
Sbjct: 252 IPVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 302

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 48/291 (16%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P+    VA+K   S      + D    ++E+E +  I +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD---LISEMEMMKMIGK 92
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------------XQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         ++L     
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK--PDSSN 287
           ++    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+ +        
Sbjct: 153 VSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDI- 346
            T       ++APE  +    T + DV+SFGVL  E+          +   S +    + 
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI---------FTLGGSPYPGVPVE 259
Query: 347 ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           EL ++L    R+  PS    E    +  ++  C +  P  RPT K + + L
Sbjct: 260 ELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 133 IGNGGHGSVYRA---ELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G VY     ++  G+    VA+K  +    S  + ++ EFL E   +      +
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE---SASLRERIEFLNEASVMKGFTCHH 80
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG-------WSQRMNVIKGVAD 239
           +V+L G  S  + + +V E +  G             E           + + +   +AD
Sbjct: 81  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 140
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT----Y 295
            ++YL+   F   VHRD++++N ++  +F   + DFG+ + +    +++    G      
Sbjct: 141 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 195
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEV 324
            ++APE       T   D++SFGV+  E+
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/306 (21%), Positives = 131/306 (42%), Gaps = 56/306 (18%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTE--VEALTEIRHRNIVKL 190
           IG G +G+VY+  L   + VA+K F          +++ F+ E  +  +  + H NI + 
Sbjct: 21  IGRGRYGAVYKGSLDE-RPVAVKVF-------SFANRQNFINEKNIYRVPLMEHDNIARF 72
Query: 191 Y----GFCSHARHSFL-VYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
                   +  R  +L V E+   G                W     +   V   L+YLH
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLH 128
Query: 246 HDC------FPPIVHRDISSKNLLLDLEFEAHVADFGIA------KFLKP---DSSNWTE 290
            +        P I HRD++S+N+L+  +    ++DFG++      + ++P   D++  +E
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 291 FAGTYGYVAPEL---AYTMKITE----KCDVYSFGVLALEVIKG-----------KHPRD 332
             GT  Y+APE+   A  ++  E    + D+Y+ G++  E+              ++   
Sbjct: 189 -VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
Query: 333 FLSSISSSFLNTDIEL---DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           F + + +     D+++    E   P+ P   +     +RS+ E +  C ++  E+R T +
Sbjct: 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ 307
Query: 390 IVSQQL 395
              +++
Sbjct: 308 XAEERM 313

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 15/247 (6%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKE---FLTEVEALTE 181
           +DF     IG G  G V  A   + +V    K    L    I+ KKE    ++E   L +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV---LQKKAILKKKEEKHIMSERNVLLK 94
Query: 182 -IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
            ++H  +V L+     A   + V +++  G             E    +       +A A
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE---PRARFYAAEIASA 151
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           L YLH      IV+RD+  +N+LLD +    + DFG+ K     +S  + F GT  Y+AP
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAP 208
Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
           E+ +        D +  G +  E++ G  P  F S  ++   +  +     L P +   +
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPP--FYSRNTAEMYDNILNKPLQLKPNITNSA 266
Query: 361 RSVQEKL 367
           R + E L
Sbjct: 267 RHLLEGL 273

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 119/296 (40%), Gaps = 59/296 (19%)
Query: 133 IGNGGHGSVYRAEL------PSGQVVAIK----KFHSPLPSDQIVDKKEFLTEVEALTEI 182
           +G    G VY+  L         Q VAIK    K   PL       ++EF  E      +
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-------REEFRHEAMLRARL 86
Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG------ 236
           +H N+V L G  +  +   +++ +   G             ++G +     +K       
Sbjct: 87  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 146
Query: 237 -------VADALSYL--HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
                  +A  + YL  HH     +VH+D++++N+L+  +    ++D G+  F +  +++
Sbjct: 147 FVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGL--FREVYAAD 199
Query: 288 WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFL 342
           + +  G       ++APE     K +   D++S+GV+  EV   G  P          + 
Sbjct: 200 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-------YCGYS 252
Query: 343 NTDIELDEMLDPR--LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           N D+   EM+  R  LP P          +  ++  C NE P  RP  K +  +L+
Sbjct: 253 NQDVV--EMIRNRQVLPCPDDCPA----WVYALMIECWNEFPSRRPRFKDIHSRLR 302

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 120/295 (40%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K          + D    ++E+E +  I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 99
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------------XQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         +++ +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 160 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
               T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------FTLGGSPYPG 262
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  P+    E    +  ++  C +  P  RPT K + + L
Sbjct: 263 IPVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 55/303 (18%)
Query: 130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNI 187
           Q  IG G  G V+R +   G+ VA+K F S        +++ +  E E    +  RH NI
Sbjct: 11  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENI 62
Query: 188 VKLYGFCSHARHS-------FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
           +   GF +            +LV ++ + G             E      + +    A  
Sbjct: 63  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 115
Query: 241 LSYLHHDCF-----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT------ 289
           L++LH +       P I HRD+ SKN+L+       +AD G+A  ++ DS+  T      
Sbjct: 116 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 173
Query: 290 EFAGTYGYVAPEL---AYTMKITE---KCDVYSFGVLALEV-----IKGKHP------RD 332
              GT  Y+APE+   +  MK  E   + D+Y+ G++  E+     I G H        D
Sbjct: 174 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 233
Query: 333 FLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
            + S  S      +  ++ L P +P   +S  E LR + +++  C   +  +R T   + 
Sbjct: 234 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIK 292
Query: 393 QQL 395
           + L
Sbjct: 293 KTL 295

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 55/303 (18%)
Query: 130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNI 187
           Q  IG G  G V+R +   G+ VA+K F S        +++ +  E E    +  RH NI
Sbjct: 14  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENI 65
Query: 188 VKLYGFCSHARHS-------FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
           +   GF +            +LV ++ + G             E      + +    A  
Sbjct: 66  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 118
Query: 241 LSYLHHDCF-----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT------ 289
           L++LH +       P I HRD+ SKN+L+       +AD G+A  ++ DS+  T      
Sbjct: 119 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 176
Query: 290 EFAGTYGYVAPEL---AYTMKITE---KCDVYSFGVLALEV-----IKGKHP------RD 332
              GT  Y+APE+   +  MK  E   + D+Y+ G++  E+     I G H        D
Sbjct: 177 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 236
Query: 333 FLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
            + S  S      +  ++ L P +P   +S  E LR + +++  C   +  +R T   + 
Sbjct: 237 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIK 295
Query: 393 QQL 395
           + L
Sbjct: 296 KTL 298

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/300 (22%), Positives = 126/300 (42%), Gaps = 53/300 (17%)
Query: 129 AQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEF-LTEVEALTEIR-HRN 186
           ++  +G G  G+V       G+ VA+K+         ++D  +  L E++ LTE   H N
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRM--------LIDFCDIALMEIKLLTESDDHPN 70
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMN---VIKGVADALSY 243
           +++ Y   +  R  ++  E                 + L   +  N   +++ +A  +++
Sbjct: 71  VIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 244 LHHDCFPPIVHRDISSKNLLLDL--EFEAH-----------VADFGIAKFLKPDSS---- 286
           LH      I+HRD+  +N+L+     F A            ++DFG+ K L    S    
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 287 NWTEFAGTYGYVAPEL-------AYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSIS 338
           N    +GT G+ APEL           ++T   D++S G +   ++ KGKHP     S  
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 339 SSFLNTDIELDEMLDPRLPAPSRSVQEK--LRSIVEVVFSCLNESPESRPT-MKIVSQQL 395
           S+ +     LDEM         + + ++  +    +++   ++  P  RPT MK++   L
Sbjct: 248 SNIIRGIFSLDEM---------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P+    VA+K   S      + D    ++E+E +  I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD---LISEMEMMKMIGK 133
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXX-------------XXXQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         ++L     
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+    D  +  
Sbjct: 194 VSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 245
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI---------FTLGGSPYPG 296
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  PS    E    +  ++  C +  P  RPT K + + L
Sbjct: 297 VPVEELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 347

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 133 IGNGGHGSVYRA---ELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G VY     ++  G+    VA+K  +    S  + ++ EFL E   +      +
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE---SASLRERIEFLNEASVMKGFTCHH 81
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG-------WSQRMNVIKGVAD 239
           +V+L G  S  + + +V E +  G             E           + + +   +AD
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT----Y 295
            ++YL+   F   VHRD++++N ++  +F   + DFG+ + +    +++    G      
Sbjct: 142 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 196
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEV 324
            ++APE       T   D++SFGV+  E+
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 55/303 (18%)
Query: 130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNI 187
           Q  IG G  G V+R +   G+ VA+K F S        +++ +  E E    +  RH NI
Sbjct: 9   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENI 60
Query: 188 VKLYGFCSHARHS-------FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
           +   GF +            +LV ++ + G             E      + +    A  
Sbjct: 61  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 113
Query: 241 LSYLHHDCF-----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT------ 289
           L++LH +       P I HRD+ SKN+L+       +AD G+A  ++ DS+  T      
Sbjct: 114 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 171
Query: 290 EFAGTYGYVAPEL---AYTMKITE---KCDVYSFGVLALEV-----IKGKHP------RD 332
              GT  Y+APE+   +  MK  E   + D+Y+ G++  E+     I G H        D
Sbjct: 172 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 231
Query: 333 FLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
            + S  S      +  ++ L P +P   +S  E LR + +++  C   +  +R T   + 
Sbjct: 232 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIK 290
Query: 393 QQL 395
           + L
Sbjct: 291 KTL 293

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P+    VA+K   S      + D    ++E+E +  I +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD---LISEMEMMKMIGK 92
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------------XQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         ++L     
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+    D  +  
Sbjct: 153 VSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 204
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI---------FTLGGSPYPG 255
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  PS    E    +  ++  C +  P  RPT K + + L
Sbjct: 256 VPVEELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 55/303 (18%)
Query: 130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNI 187
           Q  IG G  G V+R +   G+ VA+K F S        +++ +  E E    +  RH NI
Sbjct: 34  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENI 85
Query: 188 VKLYGFCSHARHS-------FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
           +   GF +            +LV ++ + G             E      + +    A  
Sbjct: 86  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 138
Query: 241 LSYLHHDCF-----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT------ 289
           L++LH +       P I HRD+ SKN+L+       +AD G+A  ++ DS+  T      
Sbjct: 139 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 196
Query: 290 EFAGTYGYVAPEL---AYTMKITE---KCDVYSFGVLALEV-----IKGKHP------RD 332
              GT  Y+APE+   +  MK  E   + D+Y+ G++  E+     I G H        D
Sbjct: 197 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 256
Query: 333 FLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
            + S  S      +  ++ L P +P   +S  E LR + +++  C   +  +R T   + 
Sbjct: 257 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIK 315
Query: 393 QQL 395
           + L
Sbjct: 316 KTL 318

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 55/303 (18%)
Query: 130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNI 187
           Q  IG G  G V+R +   G+ VA+K F S        +++ +  E E    +  RH NI
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENI 98
Query: 188 VKLYGFCSHARHS-------FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
           +   GF +            +LV ++ + G             E      + +    A  
Sbjct: 99  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 151
Query: 241 LSYLHHDCF-----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT------ 289
           L++LH +       P I HRD+ SKN+L+       +AD G+A  ++ DS+  T      
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 209
Query: 290 EFAGTYGYVAPEL---AYTMKITE---KCDVYSFGVLALEV-----IKGKHPR------D 332
              GT  Y+APE+   +  MK  E   + D+Y+ G++  E+     I G H        D
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 333 FLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
            + S  S      +  ++ L P +P   +S  E LR + +++  C   +  +R T   + 
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIK 328
Query: 393 QQL 395
           + L
Sbjct: 329 KTL 331

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P+    VA+K   S      + D    ++E+E +  I +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD---LISEMEMMKMIGK 92
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------------XQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         ++L     
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+    D  +  
Sbjct: 153 VSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 204
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI---------FTLGGSPYPG 255
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  PS    E    +  ++  C +  P  RPT K + + L
Sbjct: 256 VPVEELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 55/303 (18%)
Query: 130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNI 187
           Q  IG G  G V+R +   G+ VA+K F S        +++ +  E E    +  RH NI
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENI 59
Query: 188 VKLYGFCSHARHS-------FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
           +   GF +            +LV ++ + G             E      + +    A  
Sbjct: 60  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 112
Query: 241 LSYLHHDCF-----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT------ 289
           L++LH +       P I HRD+ SKN+L+       +AD G+A  ++ DS+  T      
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 170
Query: 290 EFAGTYGYVAPEL---AYTMKITE---KCDVYSFGVLALEV-----IKGKHP------RD 332
              GT  Y+APE+   +  MK  E   + D+Y+ G++  E+     I G H        D
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230
Query: 333 FLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
            + S  S      +  ++ L P +P   +S  E LR + +++  C   +  +R T   + 
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIK 289
Query: 393 QQL 395
           + L
Sbjct: 290 KTL 292

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P+    VA+K   S      + D    ++E+E +  I +
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD---LISEMEMMKMIGK 77
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------------XQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         ++L     
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+    D  +  
Sbjct: 138 VSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 189
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI---------FTLGGSPYPG 240
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  PS    E    +  ++  C +  P  RPT K + + L
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 291

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 117/269 (43%), Gaps = 36/269 (13%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVKL 190
           IG+GG   V++      Q+ AIK  +     +Q +D   +  E+  L +++  +  I++L
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 77
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y +    ++ ++V E    G                W +R +  K + +A+  +H     
Sbjct: 78  YDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIHQHG-- 131
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA--GTYGYVAPELAYTMKI 308
            IVH D+   N L+ ++    + DFGIA  ++PD+++  + +  GT  Y+ PE    M  
Sbjct: 132 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 189
Query: 309 TEK-----------CDVYSFGVLALEVIKGKHP-RDFLSSISSSFLNTDIELDEMLDPRL 356
           + +            DV+S G +   +  GK P +  ++ IS        +L  ++DP  
Sbjct: 190 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------KLHAIIDPNH 241
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESR 385
                 + EK   + +V+  CL   P+ R
Sbjct: 242 EIEFPDIPEK--DLQDVLKCCLKRDPKQR 268

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P+    VA+K   S      + D    ++E+E +  I +
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD---LISEMEMMKMIGK 81
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------------XQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         ++L     
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+    D  +  
Sbjct: 142 VSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 193
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI---------FTLGGSPYPG 244
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  PS    E    +  ++  C +  P  RPT K + + L
Sbjct: 245 VPVEELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 295

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P+    VA+K   S      + D    ++E+E +  I +
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD---LISEMEMMKMIGK 84
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------------XQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         ++L     
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+    D  +  
Sbjct: 145 VSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 196
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI---------FTLGGSPYPG 247
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  PS    E    +  ++  C +  P  RPT K + + L
Sbjct: 248 VPVEELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 298

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P+    VA+K   S      + D    ++E+E +  I +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD---LISEMEMMKMIGK 92
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------------XQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         ++L     
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+    D  +  
Sbjct: 153 VSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 204
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI---------FTLGGSPYPG 255
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  PS    E    +  ++  C +  P  RPT K + + L
Sbjct: 256 VPVEELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P+    VA+K   S      + D    ++E+E +  I +
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD---LISEMEMMKMIGK 85
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX-------------XQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G                         ++L     
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+    D  +  
Sbjct: 146 VSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 197
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI---------FTLGGSPYPG 248
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  PS    E    +  ++  C +  P  RPT K + + L
Sbjct: 249 VPVEELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 299

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 89/207 (42%), Gaps = 21/207 (10%)
Query: 133 IGNGGHGSVYRA---ELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G VY     ++  G+    VA+K  +    S  + ++ EFL E   +      +
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE---SASLRERIEFLNEASVMKGFTCHH 81
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG-------WSQRMNVIKGVAD 239
           +V+L G  S  + + +V E +  G             E           + + +   +AD
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG--Y 297
            ++YL+   F   VHRD++++N ++  +F   + DFG+ + +   +       G     +
Sbjct: 142 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRW 198
Query: 298 VAPELAYTMKITEKCDVYSFGVLALEV 324
           +APE       T   D++SFGV+  E+
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G   +V+R     +G + AIK F++ +   + VD +  + E E L ++ H+NIVKL+
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNN-ISFLRPVDVQ--MREFEVLKKLNHKNIVKLF 73
Query: 192 GF--CSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
                +  RH  L+ EF   G              L  S+ + V++ V   +++L  +  
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 250 PPIVHRDISSKNLLL----DLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA-- 303
             IVHR+I   N++     D +    + DFG A+ L+ D   +    GT  Y+ P++   
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVXLYGTEEYLHPDMYER 189
Query: 304 ------YTMKITEKCDVYSFGVLALEVIKGKHP 330
                 +  K     D++S GV       G  P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 117/269 (43%), Gaps = 36/269 (13%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVKL 190
           IG+GG   V++      Q+ AIK  +     +Q +D   +  E+  L +++  +  I++L
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 73
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y +    ++ ++V E    G                W +R +  K + +A+  +H     
Sbjct: 74  YDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIHQHG-- 127
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA--GTYGYVAPELAYTMKI 308
            IVH D+   N L+ ++    + DFGIA  ++PD+++  + +  GT  Y+ PE    M  
Sbjct: 128 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 185
Query: 309 TEK-----------CDVYSFGVLALEVIKGKHP-RDFLSSISSSFLNTDIELDEMLDPRL 356
           + +            DV+S G +   +  GK P +  ++ IS        +L  ++DP  
Sbjct: 186 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------KLHAIIDPNH 237
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESR 385
                 + EK   + +V+  CL   P+ R
Sbjct: 238 EIEFPDIPEK--DLQDVLKCCLKRDPKQR 264

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 117/269 (43%), Gaps = 36/269 (13%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVKL 190
           IG+GG   V++      Q+ AIK  +     +Q +D   +  E+  L +++  +  I++L
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 121
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y +    ++ ++V E    G                W +R +  K + +A+  +H     
Sbjct: 122 YDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIHQHG-- 175
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA--GTYGYVAPELAYTMKI 308
            IVH D+   N L+ ++    + DFGIA  ++PD+++  + +  GT  Y+ PE    M  
Sbjct: 176 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 309 TEK-----------CDVYSFGVLALEVIKGKHP-RDFLSSISSSFLNTDIELDEMLDPRL 356
           + +            DV+S G +   +  GK P +  ++ IS        +L  ++DP  
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------KLHAIIDPNH 285
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESR 385
                 + EK   + +V+  CL   P+ R
Sbjct: 286 EIEFPDIPEK--DLQDVLKCCLKRDPKQR 312

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 19/206 (9%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA----LTEIRHRNI 187
           +G G  G V  A    + Q VA+K       S Q++ K +    VE     L  +RH +I
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALK-----FISRQLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 188 VKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
           +KLY   +      +V E+                ++ G        + +  A+ Y H  
Sbjct: 72  IKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEG----RRFFQQIICAIEYCHRH 127
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY-TM 306
               IVHRD+  +NLLLD      +ADFG++  +  D +      G+  Y APE+    +
Sbjct: 128 ---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVINGKL 183
Query: 307 KITEKCDVYSFGVLALEVIKGKHPRD 332
               + DV+S G++   ++ G+ P D
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 11/202 (5%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V  A    +GQ VA+K  +  + +   +  +    E+  L  +RH +I+KLY
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 80
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +V E+                 ++   +     + +  A+ Y H      
Sbjct: 81  DVIKSKDEIIMVIEY----AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---K 133
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITE 310
           IVHRD+  +NLLLD      +ADFG++  +  D +      G+  Y APE ++  +    
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGP 192
Query: 311 KCDVYSFGVLALEVIKGKHPRD 332
           + DV+S GV+   ++  + P D
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFD 214

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 117/269 (43%), Gaps = 36/269 (13%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVKL 190
           IG+GG   V++      Q+ AIK  +     +Q +D   +  E+  L +++  +  I++L
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 93
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y +    ++ ++V E    G                W +R +  K + +A+  +H     
Sbjct: 94  YDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIHQHG-- 147
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA--GTYGYVAPELAYTMKI 308
            IVH D+   N L+ ++    + DFGIA  ++PD+++  + +  GT  Y+ PE    M  
Sbjct: 148 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 309 TEK-----------CDVYSFGVLALEVIKGKHP-RDFLSSISSSFLNTDIELDEMLDPRL 356
           + +            DV+S G +   +  GK P +  ++ IS        +L  ++DP  
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------KLHAIIDPNH 257
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESR 385
                 + EK   + +V+  CL   P+ R
Sbjct: 258 EIEFPDIPEK--DLQDVLKCCLKRDPKQR 284

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 11/202 (5%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V  A    +GQ VA+K  +  + +   +  +    E+  L  +RH +I+KLY
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 70
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +V E+                 ++   +     + +  A+ Y H      
Sbjct: 71  DVIKSKDEIIMVIEY----AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---K 123
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITE 310
           IVHRD+  +NLLLD      +ADFG++  +  D +      G+  Y APE ++  +    
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGP 182
Query: 311 KCDVYSFGVLALEVIKGKHPRD 332
           + DV+S GV+   ++  + P D
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFD 204

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 11/202 (5%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V  A    +GQ VA+K  +  + +   +  +    E+  L  +RH +I+KLY
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 79
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +V E+                 ++   +     + +  A+ Y H      
Sbjct: 80  DVIKSKDEIIMVIEY----AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---K 132
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITE 310
           IVHRD+  +NLLLD      +ADFG++  +  D +      G+  Y APE ++  +    
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGP 191
Query: 311 KCDVYSFGVLALEVIKGKHPRD 332
           + DV+S GV+   ++  + P D
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFD 213

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 14/165 (8%)
Query: 173 LTEVEALTEIR-HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           L EV+ L ++  H NI++L          FLV++ +K+G             E    + M
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 117
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
             +  V  AL  L+      IVHRD+  +N+LLD +    + DFG +  L P      E 
Sbjct: 118 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREV 170
Query: 292 AGTYGYVAPELAYTMK------ITEKCDVYSFGVLALEVIKGKHP 330
            GT  Y+APE+             ++ D++S GV+   ++ G  P
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G   +V+R     +G + AIK F++ +   + VD +  + E E L ++ H+NIVKL+
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNN-ISFLRPVDVQ--MREFEVLKKLNHKNIVKLF 73
Query: 192 GF--CSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCF 249
                +  RH  L+ EF   G              L  S+ + V++ V   +++L  +  
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 250 PPIVHRDISSKNLLL----DLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA-- 303
             IVHR+I   N++     D +    + DFG A+ L+ D   +    GT  Y+ P++   
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHPDMYER 189
Query: 304 ------YTMKITEKCDVYSFGVLALEVIKGKHP 330
                 +  K     D++S GV       G  P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 11/202 (5%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V  A    +GQ VA+K  +  + +   +  +    E+  L  +RH +I+KLY
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 74
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +V E+                 ++   +     + +  A+ Y H      
Sbjct: 75  DVIKSKDEIIMVIEY----AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---K 127
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITE 310
           IVHRD+  +NLLLD      +ADFG++  +  D +      G+  Y APE ++  +    
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGP 186
Query: 311 KCDVYSFGVLALEVIKGKHPRD 332
           + DV+S GV+   ++  + P D
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFD 208

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 117/269 (43%), Gaps = 36/269 (13%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVKL 190
           IG+GG   V++      Q+ AIK  +     +Q +D   +  E+  L +++  +  I++L
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 74
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y +    ++ ++V E    G                W +R +  K + +A+  +H     
Sbjct: 75  YDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIHQHG-- 128
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA--GTYGYVAPELAYTMKI 308
            IVH D+   N L+ ++    + DFGIA  ++PD+++  + +  GT  Y+ PE    M  
Sbjct: 129 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 309 TEK-----------CDVYSFGVLALEVIKGKHP-RDFLSSISSSFLNTDIELDEMLDPRL 356
           + +            DV+S G +   +  GK P +  ++ IS        +L  ++DP  
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------KLHAIIDPNH 238
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESR 385
                 + EK   + +V+  CL   P+ R
Sbjct: 239 EIEFPDIPEK--DLQDVLKCCLKRDPKQR 265

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/295 (22%), Positives = 120/295 (40%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K          + D    ++E+E +  I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 99
Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXX-------------XXXQELGWSQR 230
           H+NI+ L G C+     +++  +  +G                         +++ +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 160 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------FTLGGSPYPG 262
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  P+    E    +  ++  C +  P  RPT K + + L
Sbjct: 263 IPVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 117/269 (43%), Gaps = 36/269 (13%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVKL 190
           IG+GG   V++      Q+ AIK  +     +Q +D   +  E+  L +++  +  I++L
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 121
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y +    ++ ++V E    G                W +R +  K + +A+  +H     
Sbjct: 122 YDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIHQHG-- 175
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA--GTYGYVAPELAYTMKI 308
            IVH D+   N L+ ++    + DFGIA  ++PD+++  + +  GT  Y+ PE    M  
Sbjct: 176 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 309 TEK-----------CDVYSFGVLALEVIKGKHP-RDFLSSISSSFLNTDIELDEMLDPRL 356
           + +            DV+S G +   +  GK P +  ++ IS        +L  ++DP  
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------KLHAIIDPNH 285
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESR 385
                 + EK   + +V+  CL   P+ R
Sbjct: 286 EIEFPDIPEK--DLQDVLKCCLKRDPKQR 312

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 122/295 (41%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAEL-------PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE        P   V VA+K          + D    ++E+E +  I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 99
Query: 184 HRNIVKLYGFCSHARHSFLVY---------EFLKR----GXXXXXXXXXXXXQELGWSQR 230
           H+NI+ L G C+     +++          E+L+     G            +++ +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 231 MNVIKGVADALSYL-HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
           ++    +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N  
Sbjct: 160 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 290 EFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN 343
            +  T        ++APE  +    T + DV+SFGVL  E+          +   S +  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------FTLGGSPYPG 262
Query: 344 TDI-ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             + EL ++L    R+  P+    E    +  ++  C +  P  RPT K + + L
Sbjct: 263 IPVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 14/165 (8%)
Query: 173 LTEVEALTEIR-HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           L EV+ L ++  H NI++L          FLV++ +K+G             E    + M
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
             +  V  AL  L+      IVHRD+  +N+LLD +    + DFG +  L P      E 
Sbjct: 131 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREV 183
Query: 292 AGTYGYVAPELAYTMK------ITEKCDVYSFGVLALEVIKGKHP 330
            GT  Y+APE+             ++ D++S GV+   ++ G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 58/107 (54%), Gaps = 11/107 (10%)
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLL--DLEFEAHVADFGIAK-FLKPDSSNW 288
           N+++ +  AL YLH+     I HRDI  +N L   +  FE  + DFG++K F K ++  +
Sbjct: 172 NIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 289 ---TEFAGTYGYVAPELAYTMKIT--EKCDVYSFGVLALEVIKGKHP 330
              T  AGT  +VAPE+  T   +   KCD +S GVL   ++ G  P
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/290 (21%), Positives = 120/290 (41%), Gaps = 48/290 (16%)
Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           DF     IG+GG G V++A+    G+   IK+           + ++   EV+AL ++ H
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK--------YNNEKAEREVKALAKLDH 63
Query: 185 RNIVKLYGFC-----------------SHARHSFLVYEFLKRGXXXXXXXXXXXXQELGW 227
            NIV  Y  C                 S  +  F+  EF  +G            ++L  
Sbjct: 64  VNIVH-YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDK 121
Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
              + + + +   + Y+H      +++RD+   N+ L    +  + DFG+   LK D   
Sbjct: 122 VLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE 347
                GT  Y++PE   +    ++ D+Y+ G++  E++   H  D  ++  +S   TD+ 
Sbjct: 179 -XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCD--TAFETSKFFTDLR 232
Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI 397
            D ++        +++ +KL          L++ PE RP    + + L +
Sbjct: 233 -DGIISDIFDKKEKTLLQKL----------LSKKPEDRPNTSEILRTLTV 271

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 127/302 (42%), Gaps = 57/302 (18%)
Query: 129 AQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEF-LTEVEALTEIR-HRN 186
           ++  +G G  G+V       G+ VA+K+         ++D  +  L E++ LTE   H N
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRM--------LIDFCDIALMEIKLLTESDDHPN 70
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMN---VIKGVADALSY 243
           +++ Y   +  R  ++  E                 + L   +  N   +++ +A  +++
Sbjct: 71  VIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 244 LHHDCFPPIVHRDISSKNLLLDL--EFEAH-----------VADFGIAKFLKPDS----- 285
           LH      I+HRD+  +N+L+     F A            ++DFG+ K  K DS     
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXF 185
Query: 286 -SNWTEFAGTYGYVAPEL-------AYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSS 336
             N    +GT G+ APEL           ++T   D++S G +   ++ KGKHP     S
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 337 ISSSFLNTDIELDEMLDPRLPAPSRSVQEK--LRSIVEVVFSCLNESPESRPT-MKIVSQ 393
             S+ +     LDEM         + + ++  +    +++   ++  P  RPT MK++  
Sbjct: 246 RESNIIRGIFSLDEM---------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296
Query: 394 QL 395
            L
Sbjct: 297 PL 298

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 117/286 (40%), Gaps = 42/286 (14%)
Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G GG   V   E L  G   A+K+    L  +Q  D++E   E +      H NI++L 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRI---LCHEQ-QDREEAQREADMHRLFNHPNILRLV 92
Query: 192 GFCSHAR----HSFLVYEFLKRGXXXXXXXXXXXXQE-LGWSQRMNVIKGVADALSYLHH 246
            +C   R     ++L+  F KRG               L   Q + ++ G+   L  +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSS-------NWTEFAGTYGY 297
             +    HRD+   N+LL  E +  + D G      +  + S       +W     T  Y
Sbjct: 153 KGY---AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 298 VAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFL----SSISSSFLNTDIELDE 350
            APEL        I E+ DV+S G +   ++ G+ P D +     S++ +  N      +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN------Q 263
Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  P+ P  S ++ + L S++ V        P  RP + ++  QL+
Sbjct: 264 LSIPQSPRHSSALWQLLNSMMTV-------DPHQRPHIPLLLSQLE 302

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 114/291 (39%), Gaps = 52/291 (17%)
Query: 133 IGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A+        + + VA+K         +    +  ++E++ L  I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSE---HRALMSELKILIHIGHHL 91
Query: 186 NIVKLYGFCSHARHSFLV-YEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG---VADAL 241
           N+V L G C+      +V  EF K G                 S+R   +       D L
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR----------SKRNEFVPYKDLYKDFL 141
Query: 242 SYLHHDCFP-------------PIVHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSS 286
           +  H  C+                +HRD++++N+LL  +    + DFG+A+  +  PD  
Sbjct: 142 TLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 201
Query: 287 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDI 346
              +      ++APE  +    T + DV+SFGVL  E+         L +     +  D 
Sbjct: 202 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGVKIDE 254
Query: 347 ELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
           E    L    R+ AP  +  E  +++++    C +  P  RPT   + + L
Sbjct: 255 EFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 301

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 13/173 (7%)
Query: 165 QIVDK--KEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX 221
           +I+DK  ++   E+E L    +H NI+ L       ++ ++V E +K G           
Sbjct: 53  KIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF 112
Query: 222 XQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF----EAHVADFGI 277
             E    +   V+  +   + YLH      +VHRD+   N+L   E        + DFG 
Sbjct: 113 FSE---REASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGF 166
Query: 278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           AK L+ ++        T  +VAPE+         CD++S GVL   ++ G  P
Sbjct: 167 AKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/209 (22%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 133 IGNGGHGSVYRA---ELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G VY     ++  G+    VA+K  +    S  + ++ EFL E   +      +
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE---SASLRERIEFLNEASVMKGFTCHH 81
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG-------WSQRMNVIKGVAD 239
           +V+L G  S  + + +V E +  G             E           + + +   +AD
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT----Y 295
            ++YL+   F   VHR+++++N ++  +F   + DFG+ + +    +++    G      
Sbjct: 142 GMAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 196
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEV 324
            ++APE       T   D++SFGV+  E+
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
           +   L +LH      I++RD+  +N+LLD +    ++D G+A  LK   +    +AGT G
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           ++APEL    +     D ++ GV   E+I  + P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/209 (22%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 133 IGNGGHGSVYRA---ELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G VY     ++  G+    VA+K  +    S  + ++ EFL E   +      +
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE---SASLRERIEFLNEASVMKGFTCHH 82
Query: 187 IVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG-------WSQRMNVIKGVAD 239
           +V+L G  S  + + +V E +  G             E           + + +   +AD
Sbjct: 83  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 142
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT----Y 295
            ++YL+   F   VHR+++++N ++  +F   + DFG+ + +    +++    G      
Sbjct: 143 GMAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 197
Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEV 324
            ++APE       T   D++SFGV+  E+
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
           +   L +LH      I++RD+  +N+LLD +    ++D G+A  LK   +    +AGT G
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           ++APEL    +     D ++ GV   E+I  + P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
           +   L +LH      I++RD+  +N+LLD +    ++D G+A  LK   +    +AGT G
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           ++APEL    +     D ++ GV   E+I  + P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
           +   L +LH      I++RD+  +N+LLD +    ++D G+A  LK   +    +AGT G
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           ++APEL    +     D ++ GV   E+I  + P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G +G VY     S QV +AIK+    +P       +    E+     ++H+NIV+  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKE----IPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXX-----XXXQELGWSQRMNVIKGVADALSYLHH 246
           G  S      +  E +  G                 Q +G+       K + + L YLH 
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-----YTKQILEGLKYLHD 140
Query: 247 DCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL--A 303
           +    IVHRDI   N+L++       ++DFG +K L   +     F GT  Y+APE+   
Sbjct: 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
                 +  D++S G   +E+  GK P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 104/260 (40%), Gaps = 28/260 (10%)
Query: 118 DEIVRATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEV 176
           +E+  AT+    Q  +G G  G V+R E   +G   A+KK          V + E L   
Sbjct: 90  EEVHWATH----QLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLE------VFRAEELMAC 139
Query: 177 EALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG 236
             LT  R   IV LYG         +  E L+ G             E    + +  +  
Sbjct: 140 AGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPE---DRALYYLGQ 193
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSSNWTEFAGTY 295
             + L YLH      I+H D+ + N+LL  +   A + DFG A  L+PD    +   G Y
Sbjct: 194 ALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250
Query: 296 -----GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD--FLSSISSSFLNTDIEL 348
                 ++APE+        K DV+S   + L ++ G HP    F   +     +    +
Sbjct: 251 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPV 310
Query: 349 DEMLDPRLPAPSRSVQEKLR 368
            E+     P  ++++QE LR
Sbjct: 311 REIPPSCAPLTAQAIQEGLR 330

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 152 VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFL--- 207
           VA+K       S +   ++  ++E++ +T++  H NIV L G C+ +   +L++E+    
Sbjct: 78  VAVKMLKEKADSSE---REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 134
Query: 208 --------KRGXXXXXXXXXXXXQELGWSQRMNVIK---------GVADALSYLHHDCFP 250
                   KR             + L   + +NV+           VA  + +L    F 
Sbjct: 135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FK 191
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYTMKI 308
             VHRD++++N+L+       + DFG+A+ +  DS+            ++APE  +    
Sbjct: 192 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 251
Query: 309 TEKCDVYSFGVLALEVIK-GKHP 330
           T K DV+S+G+L  E+   G +P
Sbjct: 252 TIKSDVWSYGILLWEIFSLGVNP 274

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 27/153 (17%)
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD++++N+LL       + DFG+A+  +  PD     +      ++APE  +    + 
Sbjct: 221 IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYST 280
Query: 311 KCDVYSFGVLALEVIK-GKHP-------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
           K DV+S+GVL  E+   G  P        DF S +                 R+ AP  S
Sbjct: 281 KSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGM-------------RMRAPEYS 327
Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             E    I +++  C +  P+ RP    + ++L
Sbjct: 328 TPE----IYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 11/168 (6%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V ++E   EV  L EIRH NI+ L+    +     L+ E +  G            + L 
Sbjct: 71  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGG---ELFDFLAEKESLT 127
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + D + YLH      I H D+  +N +LLD         + DFGIA  ++
Sbjct: 128 EDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 184
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
              + +    GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 185 A-GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 11/168 (6%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V ++E   EV  L EIRH NI+ L+    +     L+ E +  G             E  
Sbjct: 50  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE 109
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
            +Q    +K + D + YLH      I H D+  +N +LLD         + DFGIA  ++
Sbjct: 110 ATQ---FLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
              + +    GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 164 A-GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 114/288 (39%), Gaps = 43/288 (14%)
Query: 133 IGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A+        + + VA+K         +    +  ++E++ L  I  H 
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGHHL 92
Query: 186 NIVKLYGFCSHARHSFLV-YEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
           N+V L G C+      +V  EF K G            + + +    ++ K   D L+  
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN-EFVPYKTPEDLYK---DFLTLE 148
Query: 245 HHDCFP-------------PIVHRDISSKNLLLDLEFEAHVADFGIAKFL--KPDSSNWT 289
           H  C+                +HRD++++N+LL  +    + DFG+A+ +   PD     
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD 349
           +      ++APE  +    T + DV+SFGVL  E+         L +     +  D E  
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFC 261
Query: 350 EMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             L    R+ AP  +  E    + + +  C +  P  RPT   + + L
Sbjct: 262 RRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 104/262 (39%), Gaps = 30/262 (11%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G +G VY     S QV +AIK+    +P       +    E+     ++H+NIV+  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKE----IPERDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXX-----XXXQELGWSQRMNVIKGVADALSYLHH 246
           G  S      +  E +  G                 Q +G+       K + + L YLH 
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-----YTKQILEGLKYLHD 126
Query: 247 DCFPPIVHRDISSKNLLLDLEFEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL--A 303
           +    IVHRDI   N+L++       ++DFG +K L   +     F GT  Y+APE+   
Sbjct: 127 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 183
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
                 +  D++S G   +E+  GK P   L    ++     +     + P +P  S S 
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM---FKVHPEIPE-SMSA 239
Query: 364 QEKLRSIVEVVFSCLNESPESR 385
           + K       +  C    P+ R
Sbjct: 240 EAK-----AFILKCFEPDPDKR 256

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 11/168 (6%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V ++E   EV  L EIRH NI+ L+    +     L+ E +  G            + L 
Sbjct: 57  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGG---ELFDFLAEKESLT 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + D + YLH      I H D+  +N +LLD         + DFGIA  ++
Sbjct: 114 EDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 170
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
              + +    GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 A-GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 66/147 (44%), Gaps = 15/147 (10%)
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD++++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 166 IHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 225
Query: 311 KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLR 368
           + DV+SFGVL  E+         L +     +  D E    L    R+ AP  +  E   
Sbjct: 226 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPE--- 275
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQL 395
            + + +  C +  P  RPT   + + L
Sbjct: 276 -MYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/269 (22%), Positives = 116/269 (43%), Gaps = 36/269 (13%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVKL 190
           IG+GG   V++      Q+ AIK  +     +Q +D   +  E+  L +++  +  I++L
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 121
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y +    ++ ++V E    G                W +R +  K + +A+  +H     
Sbjct: 122 YDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIHQHG-- 175
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA--GTYGYVAPELAYTMKI 308
            IVH D+   N L+ ++    + DFGIA  ++PD+++  + +  G   Y+ PE    M  
Sbjct: 176 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 309 TEK-----------CDVYSFGVLALEVIKGKHP-RDFLSSISSSFLNTDIELDEMLDPRL 356
           + +            DV+S G +   +  GK P +  ++ IS        +L  ++DP  
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------KLHAIIDPNH 285
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESR 385
                 + EK   + +V+  CL   P+ R
Sbjct: 286 EIEFPDIPEK--DLQDVLKCCLKRDPKQR 312

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A+        + + VA+K         +    +  ++E++ L  I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGHHL 91
Query: 186 NIVKLYGFCSHARHSFLV-YEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK-GVA----- 238
           N+V L G C+      +V  EF K G                 S+R   +   VA     
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR----------SKRNEFVPYKVAPEDLY 141
Query: 239 -DALSYLHHDCFP-------------PIVHRDISSKNLLLDLEFEAHVADFGIAK--FLK 282
            D L+  H  C+                +HRD++++N+LL  +    + DFG+A+  +  
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL 342
           PD     +      ++APE  +    T + DV+SFGVL  E+         L +     +
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGV 254
Query: 343 NTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             D E    L    R+ AP  +  E    + + +  C +  P  RPT   + + L
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A+        + + VA+K         +    +  ++E++ L  I  H 
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGHHL 128
Query: 186 NIVKLYGFCSHARHSFLV-YEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK-GVA----- 238
           N+V L G C+      +V  EF K G                 S+R   +   VA     
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR----------SKRNEFVPYKVAPEDLY 178
Query: 239 -DALSYLHHDCFP-------------PIVHRDISSKNLLLDLEFEAHVADFGIAK--FLK 282
            D L+  H  C+                +HRD++++N+LL  +    + DFG+A+  +  
Sbjct: 179 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 238
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL 342
           PD     +      ++APE  +    T + DV+SFGVL  E+         L +     +
Sbjct: 239 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGV 291
Query: 343 NTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             D E    L    R+ AP  +  E    + + +  C +  P  RPT   + + L
Sbjct: 292 KIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 114/269 (42%), Gaps = 36/269 (13%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVKL 190
           IG+GG   V++      Q+ AIK  +     +Q +D   +  E+  L +++  +  I++L
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 93
Query: 191 YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y +    ++ ++V E    G                W +R +  K + +A+  +H     
Sbjct: 94  YDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIHQHG-- 147
Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA--GTYGYVAPELAYTMKI 308
            IVH D+   N L+ ++    + DFGIA  ++PD     + +  GT  Y+ PE    M  
Sbjct: 148 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 309 TEK-----------CDVYSFGVLALEVIKGKHP-RDFLSSISSSFLNTDIELDEMLDPRL 356
           + +            DV+S G +   +  GK P +  ++ IS        +L  ++DP  
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------KLHAIIDPNH 257
Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESR 385
                 + EK   + +V+  CL   P+ R
Sbjct: 258 EIEFPDIPEK--DLQDVLKCCLKRDPKQR 284

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A+        + + VA+K         +    +  ++E++ L  I  H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGHHL 82
Query: 186 NIVKLYGFCSHARHSFLVY-EFLKRGXXXXXXXXXXXXQELGWSQRMNVIK-GVA----- 238
           N+V L G C+      +V  EF K G                 S+R   +   VA     
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLR----------SKRNEFVPYKVAPEDLY 132
Query: 239 -DALSYLHHDCFP-------------PIVHRDISSKNLLLDLEFEAHVADFGIAK--FLK 282
            D L+  H  C+                +HRD++++N+LL  +    + DFG+A+  +  
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL 342
           PD     +      ++APE  +    T + DV+SFGVL  E+         L +     +
Sbjct: 193 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGV 245
Query: 343 NTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             D E    L    R+ AP  +  E    + + +  C +  P  RPT   + + L
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/303 (21%), Positives = 121/303 (39%), Gaps = 61/303 (20%)
Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           DF     IG+GG G V++A+    G+   I++           + ++   EV+AL ++ H
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVK--------YNNEKAEREVKALAKLDH 64
Query: 185 RNIVKLYGFC------------------------------SHARHSFLVYEFLKRGXXXX 214
            NIV  Y  C                              S  +  F+  EF  +G    
Sbjct: 65  VNIVH-YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQ 123
Query: 215 XXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVAD 274
                   ++L     + + + +   + Y+H      ++HRD+   N+ L    +  + D
Sbjct: 124 WIEKRRG-EKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGD 179
Query: 275 FGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL 334
           FG+   LK D    T   GT  Y++PE   +    ++ D+Y+ G++  E++   H  D  
Sbjct: 180 FGLVTSLKNDGKR-TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCD-- 233
Query: 335 SSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ 394
           ++  +S   TD+  D ++        +++ +KL          L++ PE RP    + + 
Sbjct: 234 TAFETSKFFTDLR-DGIISDIFDKKEKTLLQKL----------LSKKPEDRPNTSEILRT 282
Query: 395 LQI 397
           L +
Sbjct: 283 LTV 285

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 111/288 (38%), Gaps = 42/288 (14%)
Query: 133 IGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A+        + + VA+K         +    +  ++E++ L  I  H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGHHL 93
Query: 186 NIVKLYGFCSHARHSFLV-YEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
           N+V L G C+      +V  EF K G                     ++ K   D L+  
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYK---DFLTLE 150
Query: 245 HHDCFP-------------PIVHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSSNWT 289
           H  C+                +HRD++++N+LL  +    + DFG+A+  +  PD     
Sbjct: 151 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD 349
           +      ++APE  +    T + DV+SFGVL  E+         L +     +  D E  
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFC 263
Query: 350 EMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             L    R+ AP  +  E    + + +  C +  P  RPT   + + L
Sbjct: 264 RRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A+        + + VA+K         +    +  ++E++ L  I  H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGHHL 82
Query: 186 NIVKLYGFCSHARHSFLVY-EFLKRGXXXXXXXXXXXXQELGWSQRMNVIK-GVA----- 238
           N+V L G C+      +V  EF K G                 S+R   +   VA     
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLR----------SKRNEFVPYKVAPEDLY 132
Query: 239 -DALSYLHHDCFP-------------PIVHRDISSKNLLLDLEFEAHVADFGIAK--FLK 282
            D L+  H  C+                +HRD++++N+LL  +    + DFG+A+  +  
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL 342
           PD     +      ++APE  +    T + DV+SFGVL  E+         L +     +
Sbjct: 193 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGV 245
Query: 343 NTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             D E    L    R+ AP  +  E    + + +  C +  P  RPT   + + L
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 103/260 (39%), Gaps = 28/260 (10%)
Query: 118 DEIVRATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEV 176
           +E+  AT+    Q  +G G  G V+R E   +G   A+KK          V + E L   
Sbjct: 71  EEVHWATH----QLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLE------VFRAEELMAC 120
Query: 177 EALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG 236
             LT  R   IV LYG         +  E L+ G             E    + +  +  
Sbjct: 121 AGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPE---DRALYYLGQ 174
Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSSNWTEFAGTY 295
             + L YLH      I+H D+ + N+LL  +   A + DFG A  L+PD        G Y
Sbjct: 175 ALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY 231
Query: 296 -----GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD--FLSSISSSFLNTDIEL 348
                 ++APE+        K DV+S   + L ++ G HP    F   +     +    +
Sbjct: 232 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPV 291
Query: 349 DEMLDPRLPAPSRSVQEKLR 368
            E+     P  ++++QE LR
Sbjct: 292 REIPPSCAPLTAQAIQEGLR 311

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A+        + + VA+K         +    +  ++E++ L  I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGHHL 91
Query: 186 NIVKLYGFCSHARHSFLV-YEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK-GVA----- 238
           N+V L G C+      +V  EF K G                 S+R   +   VA     
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR----------SKRNEFVPYKVAPEDLY 141
Query: 239 -DALSYLHHDCFP-------------PIVHRDISSKNLLLDLEFEAHVADFGIAK--FLK 282
            D L+  H  C+                +HRD++++N+LL  +    + DFG+A+  +  
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL 342
           PD     +      ++APE  +    T + DV+SFGVL  E+         L +     +
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGV 254
Query: 343 NTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             D E    L    R+ AP  +  E    + + +  C +  P  RPT   + + L
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 14/165 (8%)
Query: 173 LTEVEALTEIR-HRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           L EV+ L ++  H NI++L          FLV++ +K+G             E    + M
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
             +  V  AL  L+      IVHRD+  +N+LLD +    + DFG +  L P        
Sbjct: 131 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLRSV 183
Query: 292 AGTYGYVAPELAYTMK------ITEKCDVYSFGVLALEVIKGKHP 330
            GT  Y+APE+             ++ D++S GV+   ++ G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 66/147 (44%), Gaps = 15/147 (10%)
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD++++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 222 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 281
Query: 311 KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLR 368
           + DV+SFGVL  E+         L +     +  D E    L    R+ AP  +  E   
Sbjct: 282 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 331
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQL 395
            + + +  C +  P  RPT   + + L
Sbjct: 332 -MYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 66/147 (44%), Gaps = 15/147 (10%)
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD++++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 213 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 272
Query: 311 KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLR 368
           + DV+SFGVL  E+         L +     +  D E    L    R+ AP  +  E   
Sbjct: 273 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 322
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQL 395
            + + +  C +  P  RPT   + + L
Sbjct: 323 -MYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 101/230 (43%), Gaps = 21/230 (9%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V++ E  +     +K     + +  + DK+E   E+  + ++ H N+++LY 
Sbjct: 97  LGGGRFGQVHKCEETA---TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 193 FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
                    LV E++  G              L     +  +K + + + ++H      I
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESY--NLTELDTILFMKQICEGIRHMHQ---MYI 208
Query: 253 VHRDISSKNLLL---DLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKIT 309
           +H D+  +N+L    D + +  + DFG+A+  KP       F GT  ++APE+     ++
Sbjct: 209 LHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFVS 266
Query: 310 EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT------DIELDEMLD 353
              D++S GV+A  ++ G  P  FL    +  LN       D+E +E  D
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSP--FLGDNDAETLNNILACRWDLEDEEFQD 314

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 66/147 (44%), Gaps = 15/147 (10%)
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD++++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 311 KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLR 368
           + DV+SFGVL  E+         L +     +  D E    L    R+ AP  +  E   
Sbjct: 275 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 324
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQL 395
            + + +  C +  P  RPT   + + L
Sbjct: 325 -MYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 66/147 (44%), Gaps = 15/147 (10%)
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD++++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 279
Query: 311 KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLR 368
           + DV+SFGVL  E+         L +     +  D E    L    R+ AP  +  E   
Sbjct: 280 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 329
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQL 395
            + + +  C +  P  RPT   + + L
Sbjct: 330 -MYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K   + WT   GT  Y+A
Sbjct: 174 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GATWT-LCGTPEYLA 227
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 1/79 (1%)
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           IV+RD+  +N+LLD      ++D G+A  + P+        GT GY+APE+    + T  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 312 CDVYSFGVLALEVIKGKHP 330
            D ++ G L  E+I G+ P
Sbjct: 366 PDWWALGCLLYEMIAGQSP 384

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 1/79 (1%)
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           IV+RD+  +N+LLD      ++D G+A  + P+        GT GY+APE+    + T  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 312 CDVYSFGVLALEVIKGKHP 330
            D ++ G L  E+I G+ P
Sbjct: 366 PDWWALGCLLYEMIAGQSP 384

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 98/248 (39%), Gaps = 31/248 (12%)
Query: 97  RSNQNPHGLFSILNFEGKLVYDEIVRA-------TNDFDAQYCIGNGGHGSVYRAELPSG 149
           R N+N      I NF  +  Y++IV+          D+D    IG G  G V      + 
Sbjct: 48  RKNKN------IDNFLNR--YEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKAS 99
Query: 150 QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKR 209
           Q V   K  S     +  D   F  E + +       +V+L+      ++ ++V E++  
Sbjct: 100 QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 159
Query: 210 GXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE 269
           G            ++  W++       V  AL  +H      ++HRD+   N+LLD    
Sbjct: 160 GDLVNLMSNYDVPEK--WAKFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGH 212
Query: 270 AHVADFGIAKFLKPDSSNWTE---FAGTYGYVAPELAYTMK----ITEKCDVYSFGVLAL 322
             +ADFG    +K D +         GT  Y++PE+  +         +CD +S GV   
Sbjct: 213 LKLADFGTC--MKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 270
Query: 323 EVIKGKHP 330
           E++ G  P
Sbjct: 271 EMLVGDTP 278

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A+        + + VA+K         +    +  ++E++ L  I  H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGHHL 82
Query: 186 NIVKLYGFCSHARHSFLV-YEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK-GVA----- 238
           N+V L G C+      +V  EF K G                 S+R   +   VA     
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR----------SKRNEFVPYKVAPEDLY 132
Query: 239 -DALSYLHHDCFP-------------PIVHRDISSKNLLLDLEFEAHVADFGIAKFLK-- 282
            D L+  H  C+                +HRD++++N+LL  +    + DFG+A+ +   
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL 342
           PD     +      ++APE  +    T + DV+SFGVL  E+         L +     +
Sbjct: 193 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGV 245
Query: 343 NTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             D E    L    R+ AP  +  E    + + +  C +  P  RPT   + + L
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A+        + + VA+K         +    +  ++E++ L  I  H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGHHL 82
Query: 186 NIVKLYGFCSHARHSFLVY-EFLKRGXXXXXXXXXXXXQELGWSQRMNVIK-GVA----- 238
           N+V L G C+      +V  EF K G                 S+R   +   VA     
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLR----------SKRNEFVPYKVAPEDLY 132
Query: 239 -DALSYLHHDCFP-------------PIVHRDISSKNLLLDLEFEAHVADFGIAKFLK-- 282
            D L+  H  C+                +HRD++++N+LL  +    + DFG+A+ +   
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL 342
           PD     +      ++APE  +    T + DV+SFGVL  E+         L +     +
Sbjct: 193 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGV 245
Query: 343 NTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             D E    L    R+ AP  +  E    + + +  C +  P  RPT   + + L
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 56/295 (18%)
Query: 133 IGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A+        + + VA+K         +    +  ++E++ L  I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGHHL 91
Query: 186 NIVKLYGFCSHARHSFLV-YEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK-GVA----- 238
           N+V L G C+      +V  EF K G                 S+R   +   VA     
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR----------SKRNEFVPYKVAPEDLY 141
Query: 239 -DALSYLHHDCFP-------------PIVHRDISSKNLLLDLEFEAHVADFGIAKFL--K 282
            D L+  H  C+                +HRD++++N+LL  +    + DFG+A+ +   
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL 342
           PD     +      ++APE  +    T + DV+SFGVL  E+         L +     +
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGV 254
Query: 343 NTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
             D E    L    R+ AP  +  E    + + +  C +  P  RPT   + + L
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 15/213 (7%)
Query: 126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR 185
           DF+    IG G  G V   +L +   V   K  +     +  +   F  E + L     +
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXX--QELGWSQRMNVIKGVADALSY 243
            I  L+       + +LV ++   G              +E+       ++  + D++  
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI-DSVHQ 193
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA-GTYGYVAPEL 302
           LH+      VHRDI   N+L+D+     +ADFG    L  D +  +  A GT  Y++PE+
Sbjct: 194 LHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 303 AYTM-----KITEKCDVYSFGVLALEVIKGKHP 330
              M     +   +CD +S GV   E++ G+ P
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 13/173 (7%)
Query: 165 QIVDK--KEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXX 221
           +I+DK  ++   E+E L    +H NI+ L       ++ ++V E  K G           
Sbjct: 53  KIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF 112
Query: 222 XQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF----EAHVADFGI 277
             E    +   V+  +   + YLH      +VHRD+   N+L   E        + DFG 
Sbjct: 113 FSE---REASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGF 166
Query: 278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           AK L+ ++        T  +VAPE+         CD++S GVL    + G  P
Sbjct: 167 AKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 66/147 (44%), Gaps = 15/147 (10%)
Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFL--KPDSSNWTEFAGTYGYVAPELAYTMKITE 310
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 311 KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLR 368
           + DV+SFGVL  E+         L +     +  D E    L    R+ AP  +  E   
Sbjct: 230 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 279
Query: 369 SIVEVVFSCLNESPESRPTMKIVSQQL 395
            + + +  C +  P  RPT   + + L
Sbjct: 280 -MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA-GTYGY 297
           D++  LH+      VHRDI   N+LLD+     +ADFG    +  D +  +  A GT  Y
Sbjct: 205 DSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 258
Query: 298 VAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHP 330
           ++PE+   M     K   +CD +S GV   E++ G+ P
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA-GTYGY 297
           D++  LH+      VHRDI   N+LLD+     +ADFG    +  D +  +  A GT  Y
Sbjct: 189 DSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 242
Query: 298 VAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHP 330
           ++PE+   M     K   +CD +S GV   E++ G+ P
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     WT   GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPEYLA 207
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     WT   GT  Y+A
Sbjct: 139 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPEYLA 192
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 193 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 17/192 (8%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V ++E   EV  L ++ H N++ L+    +     L+ E +  G            + L 
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLS 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +  + IK + D ++YLH      I H D+  +N +LLD         + DFG+A  ++
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSS 336
            D   +    GT  +VAPE+     +  + D++S GV+   ++ G  P      ++ L++
Sbjct: 171 -DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229
Query: 337 ISSSFLNTDIEL 348
           I+S   + D E 
Sbjct: 230 ITSVSYDFDEEF 241

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W   AGT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LAGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 23/204 (11%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVVAAYDAILERN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKVVNHKNIIG 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        ++V E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ------MELDHERMSYLLYQMLVGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M   E  D++S GV+  E+IKG
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 23/204 (11%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKVVNHKNIIG 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        ++V E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ------MELDHERMSYLLYQMLVGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M   E  D++S GV+  E+IKG
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 17/192 (8%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V ++E   EV  L ++ H N++ L+    +     L+ E +  G            + L 
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLS 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +  + IK + D ++YLH      I H D+  +N +LLD         + DFG+A  ++
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSS 336
            D   +    GT  +VAPE+     +  + D++S GV+   ++ G  P      ++ L++
Sbjct: 171 -DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229
Query: 337 ISSSFLNTDIEL 348
           I+S   + D E 
Sbjct: 230 ITSVSYDFDEEF 241

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 11/168 (6%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V ++E   EV  L ++ H N++ L+    +     L+ E +  G            + L 
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLS 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +  + IK + D ++YLH      I H D+  +N +LLD         + DFG+A  ++
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D   +    GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 -DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 118 DEIVRATNDFDAQYCIGNGGHGSVYRAE--LPSGQVVAIKKF-----HSPLPSDQIVDKK 170
           D + RA   ++    IG G +G V++A      G+ VA+K+         +P   I +  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-- 61
Query: 171 EFLTEVEALTEIRHRNIVKLYGFCSHARHS-----FLVYEFLKRGXXXXXXXXXX--XXQ 223
             +  +  L    H N+V+L+  C+ +R        LV+E + +                
Sbjct: 62  --VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 119
Query: 224 ELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP 283
           E        +++G    L +LH      +VHRD+  +N+L+    +  +ADFG+A+    
Sbjct: 120 ETIKDMMFQLLRG----LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
Query: 284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 328
             +  T    T  Y APE+          D++S G +  E+ + K
Sbjct: 173 QMA-LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 17/192 (8%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V ++E   EV  L ++ H N++ L+    +     L+ E +  G            + L 
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLS 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +  + IK + D ++YLH      I H D+  +N +LLD         + DFG+A  ++
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSS 336
            D   +    GT  +VAPE+     +  + D++S GV+   ++ G  P      ++ L++
Sbjct: 171 -DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229
Query: 337 ISSSFLNTDIEL 348
           I+S   + D E 
Sbjct: 230 ITSVSYDFDEEF 241

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 11/168 (6%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V ++E   EV  L ++ H N++ L+    +     L+ E +  G            + L 
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLS 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +  + IK + D ++YLH      I H D+  +N +LLD         + DFG+A  ++
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D   +    GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 -DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 13/239 (5%)
Query: 97  RSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKK 156
           R N+N     S        + D  ++A  D++    IG G  G V      S + V   K
Sbjct: 47  RKNKNIDNFLSRYKDTINKIRDLRMKA-EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 105
Query: 157 FHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXX 216
             S     +  D   F  E + +       +V+L+      R+ ++V E++  G      
Sbjct: 106 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 165
Query: 217 XXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG 276
                 ++  W++       V  AL  +H   F   +HRD+   N+LLD      +ADFG
Sbjct: 166 SNYDVPEK--WARFYTA--EVVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFG 218
Query: 277 IAKFLKPDSSNWTEFA-GTYGYVAPELAYTM----KITEKCDVYSFGVLALEVIKGKHP 330
               +  +     + A GT  Y++PE+  +         +CD +S GV   E++ G  P
Sbjct: 219 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 118 DEIVRATNDFDAQYCIGNGGHGSVYRAE--LPSGQVVAIKKFH-----SPLPSDQIVDKK 170
           D + RA   ++    IG G +G V++A      G+ VA+K+         +P   I +  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-- 61
Query: 171 EFLTEVEALTEIRHRNIVKLYGFCSHARHS-----FLVYEFLKRGXXXXXXXXXX--XXQ 223
             +  +  L    H N+V+L+  C+ +R        LV+E + +                
Sbjct: 62  --VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 119
Query: 224 ELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP 283
           E        +++G    L +LH      +VHRD+  +N+L+    +  +ADFG+A+    
Sbjct: 120 ETIKDMMFQLLRG----LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
Query: 284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 328
             +  T    T  Y APE+          D++S G +  E+ + K
Sbjct: 173 QMA-LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 118 DEIVRATNDFDAQYCIGNGGHGSVYRAE--LPSGQVVAIKKFH-----SPLPSDQIVDKK 170
           D + RA   ++    IG G +G V++A      G+ VA+K+         +P   I +  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-- 61
Query: 171 EFLTEVEALTEIRHRNIVKLYGFCSHARHS-----FLVYEFLKRGXXXXXXXXXX--XXQ 223
             +  +  L    H N+V+L+  C+ +R        LV+E + +                
Sbjct: 62  --VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 119
Query: 224 ELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP 283
           E        +++G    L +LH      +VHRD+  +N+L+    +  +ADFG+A+    
Sbjct: 120 ETIKDMMFQLLRG----LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
Query: 284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 328
             +  T    T  Y APE+          D++S G +  E+ + K
Sbjct: 173 QMA-LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG+G  G V  A +   G  VA+KK   P   +Q   K+ +  E+  L  + H+NI+ L 
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAY-RELVLLKCVNHKNIISLL 87
Query: 192 GFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
              +  +        +LV E +                EL   +   ++  +   + +LH
Sbjct: 88  NVFTPQKTLEEFQDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLH 141
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAPELA 303
                 I+HRD+   N+++  +    + DFG+A+     S+N+  T +  T  Y APE+ 
Sbjct: 142 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYYRAPEVI 195
Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M   E  D++S G +  E++KG
Sbjct: 196 LGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    VADFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    VADFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    VADFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G +G VY+A +  + + VAIK+    L  ++       + EV  L E++HRNI++L 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH-HDCFP 250
               H     L++E+ +                +  S    +I GV    ++ H   C  
Sbjct: 100 SVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGV----NFCHSRRC-- 153
Query: 251 PIVHRDISSKNLLLDLEFEAH-----VADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAY 304
             +HRD+  +NLLL +   +      + DFG+A+        +T    T  Y  PE L  
Sbjct: 154 --LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 305 TMKITEKCDVYSFGVLALEVI 325
           +   +   D++S   +  E++
Sbjct: 212 SRHYSTSVDIWSIACIWAEML 232

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    VADFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 120/303 (39%), Gaps = 61/303 (20%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G +G V+  +   G+ VA+K F +   +    +     TE+     +RH NI+   G
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE-----TEIYQTVLMRHENIL---G 95
Query: 193 FCS-------HARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           F +            +L+ ++ + G              L     + +       L +LH
Sbjct: 96  FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLH 151
Query: 246 HDCF-----PPIVHRDISSKNLLLDLEFEAHVADFGIA-KFLKPDSSNWTEF-----AGT 294
            + F     P I HRD+ SKN+L+       +AD G+A KF+    +N  +       GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI--SDTNEVDIPPNTRVGT 209
Query: 295 YGYVAPEL-----------AYTMKITEKCDVYSFGVLALEVIKG----------KHP-RD 332
             Y+ PE+           +Y M      D+YSFG++  EV +           + P  D
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIM-----ADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 333 FLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
            + S  S     +I   + L P  P    S  E LR + +++  C   +P SR T   V 
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPN-RWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
Query: 393 QQL 395
           + L
Sbjct: 324 KTL 326

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 13/239 (5%)
Query: 97  RSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKK 156
           R N+N     S        + D  ++A  D++    IG G  G V      S + V   K
Sbjct: 47  RKNKNIDNFLSRYKDTINKIRDLRMKA-EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 105
Query: 157 FHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXX 216
             S     +  D   F  E + +       +V+L+      R+ ++V E++  G      
Sbjct: 106 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 165
Query: 217 XXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG 276
                 ++  W++       V  AL  +H   F   +HRD+   N+LLD      +ADFG
Sbjct: 166 SNYDVPEK--WARFYTA--EVVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFG 218
Query: 277 IAKFLKPDSSNWTEFA-GTYGYVAPELAYTM----KITEKCDVYSFGVLALEVIKGKHP 330
               +  +     + A GT  Y++PE+  +         +CD +S GV   E++ G  P
Sbjct: 219 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 13/239 (5%)
Query: 97  RSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKK 156
           R N+N     S        + D  ++A  D++    IG G  G V      S + V   K
Sbjct: 42  RKNKNIDNFLSRYKDTINKIRDLRMKA-EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 100
Query: 157 FHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXX 216
             S     +  D   F  E + +       +V+L+      R+ ++V E++  G      
Sbjct: 101 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 217 XXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG 276
                 ++  W++       V  AL  +H   F   +HRD+   N+LLD      +ADFG
Sbjct: 161 SNYDVPEK--WARFYTA--EVVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFG 213
Query: 277 IAKFLKPDSSNWTEFA-GTYGYVAPELAYTM----KITEKCDVYSFGVLALEVIKGKHP 330
               +  +     + A GT  Y++PE+  +         +CD +S GV   E++ G  P
Sbjct: 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/235 (22%), Positives = 95/235 (40%), Gaps = 32/235 (13%)
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           F      ++++ H+++V  YG C     + LV EF+K G              + W  ++
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE--------AHVADFGIAKFLKP 283
            V K +A A+ +L  +    ++H ++ +KN+LL  E +          ++D GI+  + P
Sbjct: 117 EVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 284 DSSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSF 341
                        +V PE     K +    D +SFG    E+   G  P   L S     
Sbjct: 174 KDI----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229
Query: 342 LNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              D         +LPAP      K   +  ++ +C++  P+ RP+ + + + L 
Sbjct: 230 FYEDRH-------QLPAP------KAAELANLINNCMDYEPDHRPSFRAIIRDLN 271

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 83/204 (40%), Gaps = 15/204 (7%)
Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G   +VY+  L +   V +             +++ F  E E L  ++H NIV+ Y 
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 193 FCSHA----RHSFLVYEFLKRGXXXXXXXXXXXXQ-ELGWSQRMNVIKGVADALSYLHHD 247
                    +   LV E    G            + ++  S    ++KG    L +LH  
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKG----LQFLHTR 148
Query: 248 CFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM 306
             PPI+HRD+   N+ +        + D G+A   +  +S      GT  + APE  Y  
Sbjct: 149 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFXAPE-XYEE 204
Query: 307 KITEKCDVYSFGVLALEVIKGKHP 330
           K  E  DVY+FG   LE    ++P
Sbjct: 205 KYDESVDVYAFGXCXLEXATSEYP 228

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 41/278 (14%)
Query: 74  LVSMTLVAIFILRKRNSDSGDRQRSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCI 133
            V+  LV     R  N++S      ++N   +F  L  + + VY + +R  +++     +
Sbjct: 86  FVNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTL 143
Query: 134 GNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL--------------TEVEA 178
           G+G  G V  A E  + + VAI+          I+ K++F               TE+E 
Sbjct: 144 GSGACGEVKLAFERKTCKKVAIR----------IISKRKFAIGSAREADPALNVETEIEI 193
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA 238
           L ++ H  I+K+  F   A   ++V E ++ G            +E   + ++   + + 
Sbjct: 194 LKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEA--TCKLYFYQMLL 250
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGIAKFLKPDSSNWTEFAGTY 295
            A+ YLH +    I+HRD+  +N+LL  + E     + DFG +K L  ++S      GT 
Sbjct: 251 -AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 305
Query: 296 GYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHP 330
            Y+APE+     T       D +S GV+    + G  P
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKK------EFLTEVEALTEIR-H 184
           +G G +  V  A  L +G+  A+K          I++K+          EVE L + + +
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVK----------IIEKQAGHSRSRVFREVETLYQCQGN 70
Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
           +NI++L  F       +LV+E L+ G             E    +   V++ VA AL +L
Sbjct: 71  KNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNE---REASRVVRDVAAALDFL 127
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEA---HVADFGIAKFLKPDSS-------NWTEFAGT 294
           H      I HRD+  +N+L +   +     + DF +   +K ++S         T   G+
Sbjct: 128 HTK---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGS 184
Query: 295 YGYVAPELA--YTMKIT---EKCDVYSFGVLALEVIKGKHP 330
             Y+APE+   +T + T   ++CD++S GV+   ++ G  P
Sbjct: 185 AEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKXVNHKNIIS 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ------MELDHERMSYLLYQMLXGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK 328
             M   E  D++S G +  E+++ K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 41/278 (14%)
Query: 74  LVSMTLVAIFILRKRNSDSGDRQRSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCI 133
            V+  LV     R  N++S      ++N   +F  L  + + VY + +R  +++     +
Sbjct: 100 FVNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTL 157
Query: 134 GNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL--------------TEVEA 178
           G+G  G V  A E  + + VAI+          I+ K++F               TE+E 
Sbjct: 158 GSGACGEVKLAFERKTCKKVAIR----------IISKRKFAIGSAREADPALNVETEIEI 207
Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA 238
           L ++ H  I+K+  F   A   ++V E ++ G            +E   + ++   + + 
Sbjct: 208 LKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEA--TCKLYFYQMLL 264
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGIAKFLKPDSSNWTEFAGTY 295
            A+ YLH +    I+HRD+  +N+LL  + E     + DFG +K L  ++S      GT 
Sbjct: 265 -AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 319
Query: 296 GYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHP 330
            Y+APE+     T       D +S GV+    + G  P
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 112/279 (40%), Gaps = 29/279 (10%)
Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKE---FLT 174
           E+    +DF+    IG G    V   ++  +GQV A+K  +       ++ + E   F  
Sbjct: 55  EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW----DMLKRGEVSCFRE 110
Query: 175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVI 234
           E + L     R I +L+       + +LV E+   G            + +        +
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYL 168
Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA-G 293
             +  A+  +H   +   VHRDI   N+LLD      +ADFG    L+ D +  +  A G
Sbjct: 169 AEIVMAIDSVHRLGY---VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG 225
Query: 294 TYGYVAPELAYTMKITE-------KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDI 346
           T  Y++PE+   +           +CD ++ GV A E+  G+ P  F +  ++      +
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP--FYADSTAETYGKIV 283
Query: 347 ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
              E L   LP     V E+ R  ++ +       PE+R
Sbjct: 284 HYKEHLS--LPLVDEGVPEEARDFIQRLLC----PPETR 316

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 174 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 227
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LXGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 20/215 (9%)
Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           ND +    +G+G  G V++     +G V+A+K+      S    + K  L +++ + +  
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR---SGNKEENKRILMDLDVVLKSH 81
Query: 184 H-RNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE--LGWSQRMNVIKGVADA 240
               IV+ +G        F+  E +                E  LG   +M V   +  A
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG---KMTV--AIVKA 136
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           L YL       ++HRD+   N+LLD   +  + DFGI+  L  D +     AG   Y+AP
Sbjct: 137 LYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCAAYMAP 193
Query: 301 ELAYTMKITE-----KCDVYSFGVLALEVIKGKHP 330
           E       T+     + DV+S G+  +E+  G+ P
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 148 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 201
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 239
Query: 312 CDVYSFGVLALEVIKGKHP 330
            D ++ GVL  E+  G  P
Sbjct: 240 VDWWALGVLIYEMAAGYPP 258

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/235 (22%), Positives = 95/235 (40%), Gaps = 32/235 (13%)
Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRM 231
           F      ++++ H+++V  YG C     + LV EF+K G              + W  ++
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE--------AHVADFGIAKFLKP 283
            V K +A A+ +L  +    ++H ++ +KN+LL  E +          ++D GI+  + P
Sbjct: 117 EVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 284 DSSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSF 341
                        +V PE     K +    D +SFG    E+   G  P   L S     
Sbjct: 174 KDI----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229
Query: 342 LNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              D         +LPAP      K   +  ++ +C++  P+ RP+ + + + L 
Sbjct: 230 FYEDRH-------QLPAP------KAAELANLINNCMDYEPDHRPSFRAIIRDLN 271

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKVVNHKNIIG 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        ++V E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ------MELDHERMSYLLYQMLVGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M   E  D++S G +  E+IKG
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 11/168 (6%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V ++E   EV  L ++ H NI+ L+    +     L+ E +  G            + L 
Sbjct: 57  VCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLS 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +  + IK + D ++YLH      I H D+  +N +LLD         + DFG+A  ++
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D   +    GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 171 -DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NL++D +    V DFG+AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 146 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 199
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 146 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 199
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 41/236 (17%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL- 173
           VY + +R  +++     +G+G  G V  A E  + + VAIK          I+ K++F  
Sbjct: 9   VYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIK----------IISKRKFAI 56
Query: 174 -------------TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXX 220
                        TE+E L ++ H  I+K+  F   A   ++V E ++ G          
Sbjct: 57  GSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK 115
Query: 221 XXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGI 277
             +E   + ++   + +  A+ YLH +    I+HRD+  +N+LL  + E     + DFG 
Sbjct: 116 RLKEA--TCKLYFYQMLL-AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 169
Query: 278 AKFLKPDSSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHP 330
           +K L  ++S      GT  Y+APE+     T       D +S GV+    + G  P
Sbjct: 170 SKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 41/236 (17%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL- 173
           VY + +R  +++     +G+G  G V  A E  + + VAIK          I+ K++F  
Sbjct: 3   VYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIK----------IISKRKFAI 50
Query: 174 -------------TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXX 220
                        TE+E L ++ H  I+K+  F   A   ++V E ++ G          
Sbjct: 51  GSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK 109
Query: 221 XXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGI 277
             +E   + ++   + +  A+ YLH +    I+HRD+  +N+LL  + E     + DFG 
Sbjct: 110 RLKEA--TCKLYFYQMLL-AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163
Query: 278 AKFLKPDSSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHP 330
           +K L  ++S      GT  Y+APE+     T       D +S GV+    + G  P
Sbjct: 164 SKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 105/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKXVNHKNIIS 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 249
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 250 KKLQPTVRNYVE 261

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKXVNHKNIIS 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 249
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 250 KKLQPTVRNYVE 261

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 41/236 (17%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL- 173
           VY + +R  +++     +G+G  G V  A E  + + VAIK          I+ K++F  
Sbjct: 3   VYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIK----------IISKRKFAI 50
Query: 174 -------------TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXX 220
                        TE+E L ++ H  I+K+  F   A   ++V E ++ G          
Sbjct: 51  GSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK 109
Query: 221 XXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGI 277
             +E   + ++   + +  A+ YLH +    I+HRD+  +N+LL  + E     + DFG 
Sbjct: 110 RLKEA--TCKLYFYQMLL-AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163
Query: 278 AKFLKPDSSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHP 330
           +K L  ++S      GT  Y+APE+     T       D +S GV+    + G  P
Sbjct: 164 SKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 140 TFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 193
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKVVNHKNIIG 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        ++V E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M   E  D++S G +  E+IKG
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 41/236 (17%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL- 173
           VY + +R  +++     +G+G  G V  A E  + + VAIK          I+ K++F  
Sbjct: 2   VYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIK----------IISKRKFAI 49
Query: 174 -------------TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXX 220
                        TE+E L ++ H  I+K+  F   A   ++V E ++ G          
Sbjct: 50  GSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK 108
Query: 221 XXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGI 277
             +E   + ++   + +  A+ YLH +    I+HRD+  +N+LL  + E     + DFG 
Sbjct: 109 RLKEA--TCKLYFYQMLL-AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 162
Query: 278 AKFLKPDSSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHP 330
           +K L  ++S      GT  Y+APE+     T       D +S GV+    + G  P
Sbjct: 163 SKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 105/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIS 80
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ------MELDHERMSYLLYQMLXGIKH 134
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 242
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 243 KKLQPTVRNYVE 254

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIG 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        ++V E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M   E  D++S G +  E+IKG
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 51/101 (50%), Gaps = 7/101 (6%)
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWT 289
           ++K + +A+ YLH      I HRD+  +NLL   +    +    DFG AK     +S  T
Sbjct: 120 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 175
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           E   T  YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 176 EPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIG 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        ++V E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M   E  D++S G +  E+IKG
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 41/236 (17%)
Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL- 173
           VY + +R  +++     +G+G  G V  A E  + + VAIK          I+ K++F  
Sbjct: 3   VYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIK----------IISKRKFAI 50
Query: 174 -------------TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXX 220
                        TE+E L ++ H  I+K+  F   A   ++V E ++ G          
Sbjct: 51  GSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK 109
Query: 221 XXQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGI 277
             +E   + ++   + +  A+ YLH +    I+HRD+  +N+LL  + E     + DFG 
Sbjct: 110 RLKEA--TCKLYFYQMLL-AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163
Query: 278 AKFLKPDSSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHP 330
           +K L  ++S      GT  Y+APE+     T       D +S GV+    + G  P
Sbjct: 164 SKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NL++D +    V DFG+AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 18/216 (8%)
Query: 125 NDFDAQYCIGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
            +F+    +G G +G V+     SG    ++ A+K         +    +   TE + L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 181 EIRHRN-IVKL-YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKG-V 237
            IR    +V L Y F +  +   L+ +++  G             E      + +  G +
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEI 168
Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNWTEFAGTYG 296
             AL +LH      I++RDI  +N+LLD      + DFG++K F+  ++    +F GT  
Sbjct: 169 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 297 YVAPELAYTMKI--TEKCDVYSFGVLALEVIKGKHP 330
           Y+AP++         +  D +S GVL  E++ G  P
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 33  IGSGAQGIVCAAYDAILERN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIG 88
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        ++V E +                EL   +   ++  +   + +
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 142
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 143 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 198
Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M   E  D++S G +  E+IKG
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 105/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIS 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ------MELDHERMSYLLYQMLXGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 249
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 250 KKLQPTVRNYVE 261

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 11/162 (6%)
Query: 175 EVEALTEIRHRNIVKLYG--FCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMN 232
           E++ L  +RH+N+++L    +    +  ++V E+   G            +     Q   
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHG 113
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT--E 290
               + D L YLH      IVH+DI   NLLL       ++  G+A+ L P +++ T   
Sbjct: 114 YFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 291 FAGTYGYVAPELAYTMKITE--KCDVYSFGVLALEVIKGKHP 330
             G+  +  PE+A  +      K D++S GV    +  G +P
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIG 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        ++V E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M   E  D++S G +  E+IKG
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIG 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        ++V E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M   E  D++S G +  E+IKG
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 37/226 (16%)
Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKL 190
           +  GG   VY A+ + SG+  A+K+    L S++    +  + EV  + ++  H NIV+ 
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKR----LLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ- 90
Query: 191 YGFCSHA----------RHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADA 240
             FCS A          +  FL+   L +G              L     + +      A
Sbjct: 91  --FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK--PDSSNWT--------- 289
           + ++H    PPI+HRD+  +NLLL  +    + DFG A  +   PD S W+         
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS-WSAQRRALVEE 206
Query: 290 --EFAGTYGYVAPE---LAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                 T  Y  PE   L     I EK D+++ G +   +   +HP
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 107/263 (40%), Gaps = 30/263 (11%)
Query: 133 IGNGGHGSVYRA---ELPSGQVVAIKKFHSPLPSDQIVDKK--EFLTEVEALTEIRHRNI 187
           +G+G  G V+ A   E     VV   K    L    I D K  +   E+  L+ + H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 188 VKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHD 247
           +K+     +     LV E  K G              L       + + +  A+ YL   
Sbjct: 92  IKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR-- 147
Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK 307
               I+HRDI  +N+++  +F   + DFG A +L+     +T F GT  Y APE+     
Sbjct: 148 -LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAPEVLMGNP 205
Query: 308 IT-EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
               + +++S GV    ++  ++P                EL+E ++  +  P   V ++
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEENPF--------------CELEETVEAAI-HPPYLVSKE 250
Query: 367 LRSIVEVVFSCLNESPESRPTMK 389
           L S+V      L   PE R T++
Sbjct: 251 LMSLVS---GLLQPVPERRTTLE 270

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  ++  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIS 125
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 179
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 180 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 235
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 287
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 288 KKLQPTVRNYVE 299

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWT 289
           ++K + +A+ YLH      I HRD+  +NLL   +    +    DFG AK     +S  T
Sbjct: 136 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 192
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 193 PCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 232

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 23/204 (11%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 34  IGSGAQGIVCAAYDAILERN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIG 89
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        ++V E +                EL   +   ++  +   + +
Sbjct: 90  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKH 143
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S     F  T  Y APE+ 
Sbjct: 144 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMVPFVVTRYYRAPEVI 199
Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M   E  D++S G +  E+IKG
Sbjct: 200 LGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWT 289
           ++K + +A+ YLH      I HRD+  +NLL   +    +    DFG AK     +S  T
Sbjct: 128 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 184
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 185 PCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 224

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWT 289
           ++K + +A+ YLH      I HRD+  +NLL   +    +    DFG AK     +S  T
Sbjct: 126 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 182
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 183 PCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 222

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWT 289
           ++K + +A+ YLH      I HRD+  +NLL   +    +    DFG AK     +S  T
Sbjct: 127 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 183
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 184 PCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 223

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 98/245 (40%), Gaps = 24/245 (9%)
Query: 133 IGNGGHGSVYR-AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V+R  +  +G   A+KK          V + E L     L+  R   IV LY
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPR---IVPLY 116
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G         +  E L+ G             E    + +  +    + L YLH      
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR---R 170
Query: 252 IVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSSNWTEFAGTY-----GYVAPELAYT 305
           I+H D+ + N+LL  +   A + DFG A  L+PD    +   G Y      ++APE+   
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 306 MKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
                K D++S   + L ++ G HP  + F   +     +    + E+     P  ++++
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290
Query: 364 QEKLR 368
           QE LR
Sbjct: 291 QEGLR 295

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIS 80
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 134
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 242
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 243 KKLQPTVRNYVE 254

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIS 81
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 135
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 136 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 191
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 192 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 243
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 244 KKLQPTVRNYVE 255

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIS 81
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 135
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 136 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 191
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 192 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 243
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 244 KKLQPTVRNYVE 255

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWT 289
           ++K + +A+ YLH      I HRD+  +NLL   +    +    DFG AK     +S  T
Sbjct: 166 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 223 PCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWT 289
           ++K + +A+ YLH      I HRD+  +NLL   +    +    DFG AK     +S  T
Sbjct: 172 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 228
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 229 PCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 268

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWT 289
           ++K + +A+ YLH      I HRD+  +NLL   +    +    DFG AK     +S  T
Sbjct: 120 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 176
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 177 PCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 98/245 (40%), Gaps = 24/245 (9%)
Query: 133 IGNGGHGSVYR-AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V+R  +  +G   A+KK          V + E L     L+  R   IV LY
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPR---IVPLY 130
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G         +  E L+ G             E    + +  +    + L YLH      
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR---R 184
Query: 252 IVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSSNWTEFAGTY-----GYVAPELAYT 305
           I+H D+ + N+LL  +   A + DFG A  L+PD    +   G Y      ++APE+   
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 306 MKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
                K D++S   + L ++ G HP  + F   +     +    + E+     P  ++++
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 304
Query: 364 QEKLR 368
           QE LR
Sbjct: 305 QEGLR 309

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWT 289
           ++K + +A+ YLH      I HRD+  +NLL   +    +    DFG AK     +S  T
Sbjct: 121 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 177
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 178 PCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 217

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 91/208 (43%), Gaps = 31/208 (14%)
Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFH------SPLPSDQIVDKKEFLTEVEALTEIRHR 185
           +G G + +VY+ +   +  +VA+K+        +P  +         + EV  L +++H 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA---------IREVSLLKDLKHA 60
Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIK----GVADAL 241
           NIV L+      +   LV+E+L +              + G    M+ +K     +   L
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYL-------DDCGNIINMHNVKLFLFQLLRGL 113
Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
           +Y H      ++HRD+  +NLL++   E  +ADFG+A+     +  +     T  Y  P+
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPD 170
Query: 302 -LAYTMKITEKCDVYSFGVLALEVIKGK 328
            L  +   + + D++  G +  E+  G+
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIS 125
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 179
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 180 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 235
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 287
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 288 KKLQPTVRNYVE 299

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIS 88
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 89  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 142
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 143 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 198
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 250
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 251 KKLQPTVRNYVE 262

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 98/245 (40%), Gaps = 24/245 (9%)
Query: 133 IGNGGHGSVYR-AELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V+R  +  +G   A+KK          V + E L     L+  R   IV LY
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPR---IVPLY 132
Query: 192 GFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G         +  E L+ G             E    + +  +    + L YLH      
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR---R 186
Query: 252 IVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSSNWTEFAGTY-----GYVAPELAYT 305
           I+H D+ + N+LL  +   A + DFG A  L+PD    +   G Y      ++APE+   
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 306 MKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
                K D++S   + L ++ G HP  + F   +     +    + E+     P  ++++
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 306
Query: 364 QEKLR 368
           QE LR
Sbjct: 307 QEGLR 311

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 31  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIS 86
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 87  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 140
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 141 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 196
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 197 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 248
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 249 KKLQPTVRNYVE 260

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIS 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 249
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 250 KKLQPTVRNYVE 261

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWT 289
           ++K + +A+ YLH      I HRD+  +NLL   +    +    DFG AK     +S  T
Sbjct: 122 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 178
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 179 PCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIS 88
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 89  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 142
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 143 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 198
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 250
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 251 KKLQPTVRNYVE 262

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 34/252 (13%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIS 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        +LV E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+ 
Sbjct: 142 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKGK--HP-RDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
             M   E  D++S G +  E+++ K   P RD++   +           E L    P   
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--------EQLGTPCPEFM 249
Query: 361 RSVQEKLRSIVE 372
           + +Q  +R+ VE
Sbjct: 250 KKLQPTVRNYVE 261

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWT 289
           ++K + +A+ YLH      I HRD+  +NLL   +    +    DFG AK     +S  T
Sbjct: 122 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 178
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 179 PCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKK------EFLTEVEALTEIR-H 184
           +G G H  V     L + Q  A+K          I++K+          EVE L + + H
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVK----------IIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
           RN+++L  F       +LV+E ++ G             EL  S    V++ VA AL +L
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFL 127
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGIAKFLKPD-------SSNWTEFAGT 294
           H+     I HRD+  +N+L +   +     + DFG+   +K +       +       G+
Sbjct: 128 HNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 295 YGYVAPEL--AYTMKIT---EKCDVYSFGVLALEVIKGKHP 330
             Y+APE+  A++ + +   ++CD++S GV+   ++ G  P
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 13/169 (7%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G             E  
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-- 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 114 -EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 167
Query: 283 PDSSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N +    GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 168 IDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSD--QIVDKKEFLTEVEALTEIRH--RNI 187
           +G+GG GSVY     S  + VAIK       SD  ++ +      EV  L ++      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 188 VKLYGFCSHARHSFLVYEFLK--RGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
           ++L  +        L+ E ++  +             +EL  S    V++ V        
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC----- 130
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 131 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 186
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           P +  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 23/204 (11%)
Query: 133 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           IG+G  G V   Y A L     VAIKK   P   +Q   K+ +  E+  +  + H+NI+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPF-QNQTHAKRAY-RELVLMKCVNHKNIIG 87
Query: 190 LYGFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSY 243
           L    +  +        ++V E +                EL   +   ++  +   + +
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH 141
Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      I+HRD+   N+++  +    + DFG+A+          E    Y Y APE+ 
Sbjct: 142 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRY-YRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M   E  D++S G +  E+IKG
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 23/204 (11%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG+G  G V  A +   G  VA+KK   P   +Q   K+ +  E+  L  + H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAY-RELVLLKCVNHKNIISLL 89
Query: 192 GFCSHAR------HSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYLH 245
              +  +        +LV E +                EL   +   ++  +   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLH 143
Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAPELA 303
                 I+HRD+   N+++  +    + DFG+A   +   +N+  T +  T  Y APE+ 
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPYVVTRYYRAPEVI 197
Query: 304 YTMKITEKCDVYSFGVLALEVIKG 327
             M      D++S G +  E++KG
Sbjct: 198 LGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 17/171 (9%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G             E  
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-- 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 114 -EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 167
Query: 283 PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 17/171 (9%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G             E  
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-- 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 114 -EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 167
Query: 283 PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 17/171 (9%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G             E  
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-- 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 114 -EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 167
Query: 283 PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 100/249 (40%), Gaps = 43/249 (17%)
Query: 109 LNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIV 167
           L F+G ++ +  V+  ++++ ++ IG G +G VY A +  + + VAIKK +     + ++
Sbjct: 14  LYFQGAIIKN--VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMF--EDLI 69
Query: 168 DKKEFLTEVEALTEIRHRNIVKLYGFCS-----HARHSFLVYEFLKRGXXXXXXXXXXXX 222
           D K  L E+  L  ++   I++L+              ++V E                 
Sbjct: 70  DCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLT 129
Query: 223 QELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK 282
           ++   +   N++ G      ++H      I+HRD+   N LL+ +    + DFG+A+ + 
Sbjct: 130 EQHVKTILYNLLLGE----KFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTIN 182
Query: 283 PDSS-------------------------NWTEFAGTYGYVAPELAYTMK-ITEKCDVYS 316
            D                             T    T  Y APEL    +  T   D++S
Sbjct: 183 SDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWS 242
Query: 317 FGVLALEVI 325
            G +  E++
Sbjct: 243 TGCIFAELL 251

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 17/171 (9%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G            + L 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLT 112
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 113 EEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 167
Query: 283 PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 27/161 (16%)
Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKE-----FLTEVEALTEIRHRN 186
           IG G  G V++A    +GQ VA+KK         + ++KE      L E++ L  ++H N
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV-------LMENEKEGFPITALREIKILQLLKHEN 78
Query: 187 IVKLYGFC-------SHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA 238
           +V L   C       +  + S +LV++F +               +   S+   V++ + 
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLL 135
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK 279
           + L Y+H +    I+HRD+ + N+L+  +    +ADFG+A+
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 17/171 (9%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G            + L 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLT 112
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 113 EEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 167
Query: 283 PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 27/161 (16%)
Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKE-----FLTEVEALTEIRHRN 186
           IG G  G V++A    +GQ VA+KK         + ++KE      L E++ L  ++H N
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV-------LMENEKEGFPITALREIKILQLLKHEN 78
Query: 187 IVKLYGFCSHARHSF--------LVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA 238
           +V L   C      +        LV++F +               +   S+   V++ + 
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLL 135
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK 279
           + L Y+H +    I+HRD+ + N+L+  +    +ADFG+A+
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 17/171 (9%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G            + L 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLT 112
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 113 EEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 167
Query: 283 PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 17/171 (9%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G             E  
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-- 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 114 -EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 167
Query: 283 PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 17/171 (9%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G             E  
Sbjct: 55  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-- 112
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 113 -EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 166
Query: 283 PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 167 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 17/171 (9%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G             E  
Sbjct: 55  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-- 112
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 113 -EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 166
Query: 283 PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 167 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 17/171 (9%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G             E  
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-- 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 114 -EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 167
Query: 283 PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 17/171 (9%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G             E  
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-- 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 114 -EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 167
Query: 283 PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 27/161 (16%)
Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKE-----FLTEVEALTEIRHRN 186
           IG G  G V++A    +GQ VA+KK         + ++KE      L E++ L  ++H N
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV-------LMENEKEGFPITALREIKILQLLKHEN 78
Query: 187 IVKLYGFC-------SHARHS-FLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA 238
           +V L   C       +  + S +LV++F +               +   S+   V++ + 
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLL 135
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK 279
           + L Y+H +    I+HRD+ + N+L+  +    +ADFG+A+
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 132 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 187
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 17/171 (9%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G            + L 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLT 112
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 113 EEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 167
Query: 283 PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 7/101 (6%)
Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWT 289
           + K + +A+ YLH      I HRD+  +NLL   +    +    DFG AK     +S  T
Sbjct: 166 IXKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222
Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                Y YVAPE+    K  + CD +S GV+   ++ G  P
Sbjct: 223 PCYTPY-YVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPP 262

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 179 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 234
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCGDIP 261

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 27/161 (16%)
Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKE-----FLTEVEALTEIRHRN 186
           IG G  G V++A    +GQ VA+KK         + ++KE      L E++ L  ++H N
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKV-------LMENEKEGFPITALREIKILQLLKHEN 77
Query: 187 IVKLYGFCSHARHSF--------LVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVA 238
           +V L   C      +        LV++F +               +   S+   V++ + 
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLL 134
Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK 279
           + L Y+H +    I+HRD+ + N+L+  +    +ADFG+A+
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 154 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 209
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIP 236

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 83/169 (49%), Gaps = 27/169 (15%)
Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF---EAHVADFGIAKFLKPDSSN 287
           + +IK + + + YLH +    IVH D+  +N+LL   +   +  + DFG+++ +   +  
Sbjct: 134 IRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACE 189
Query: 288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS-SSFLN-TD 345
             E  GT  Y+APE+     IT   D+++ G++A  ++    P  F+   +  ++LN + 
Sbjct: 190 LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP--FVGEDNQETYLNISQ 247
Query: 346 IELDEMLDPRLPAPSRSVQEKLRSIVEV----VFSCLNESPESRPTMKI 390
           + +D              +E   S+ ++    + S L ++PE RPT +I
Sbjct: 248 VNVD------------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEI 284

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/221 (19%), Positives = 93/221 (42%), Gaps = 31/221 (14%)
Query: 122 RATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPL----------PSDQIVDKK- 170
           +  ND+     +  G    +   E    +  A+KK+   L           +D+I  K  
Sbjct: 28  KYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86
Query: 171 --EFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQE---- 224
             +F  E++ +T+I++   +   G  ++    +++YE+++               +    
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 225 -LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP 283
            +       +IK V ++ SY+H++    I HRD+   N+L+D      ++DFG ++++  
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 284 DSSNWTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFGV 319
                +   GTY ++ PE      +Y      K D++S G+
Sbjct: 205 KKIKGSR--GTYEFMPPEFFSNESSYN---GAKVDIWSLGI 240

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 131 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 186
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 132 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 187
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 160 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 215
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 159 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 214
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 174 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 229
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 160 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 215
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 174 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 229
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 159 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 214
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 159 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 214
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 160 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 215
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 130 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 185
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIP 212

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 132 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 187
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 159 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 214
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 166 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 221
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIP 248

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 146 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 201
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIP 228

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 146 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 201
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIP 228

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 147 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 202
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 147 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 202
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 160 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 215
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 174 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 229
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 147 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 202
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 127 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 182
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H+C   ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 127 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 182
Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y         V+S G+L  +++ G  P
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT   +A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEALA 206
Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 95/234 (40%), Gaps = 38/234 (16%)
Query: 121 VRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEAL 179
           V   +++  ++ IG G +G VY A +  + + VAIKK +     + ++D K  L E+  L
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITIL 79
Query: 180 TEIRHRNIVKLYGFCS-----HARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVI 234
             ++   I++LY              ++V E                 +E   +   N++
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLL 139
Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK------------ 282
            G     +++H      I+HRD+   N LL+ +    V DFG+A+ +             
Sbjct: 140 LGE----NFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 283 ------PDSSN----WTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVI 325
                 P + N     T    T  Y APEL    +  T+  D++S G +  E++
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 17/171 (9%)
Query: 167 VDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG 226
           V +++   EV  L EI+H N++ L+    +     L+ E +  G             E  
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTE-- 113
Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN-LLLDLEF---EAHVADFGIAKFLK 282
             +    +K + + + YLH      I H D+  +N +LLD         + DFG+A   K
Sbjct: 114 -EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--K 167
Query: 283 PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
            D  N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 64/281 (22%), Positives = 111/281 (39%), Gaps = 48/281 (17%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKE-FLTEVEALTE 181
           A  D      +G G  G VY     + +   I         D  +D KE F++E   +  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG--WSQRMNVIK---- 235
           + H +IVKL G       ++++ E    G             ELG    +  N +K    
Sbjct: 70  LDHPHIVKLIGIIEE-EPTWIIMELYPYG-------------ELGHYLERNKNSLKVLTL 115
Query: 236 -----GVADALSYLHH-DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
                 +  A++YL   +C    VHRDI+ +N+L+       + DFG+++++  +  ++ 
Sbjct: 116 VLYSLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYY 169
Query: 290 EFAGT---YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTD 345
           + + T     +++PE     + T   DV+ F V   E++  GK P  +L        N D
Sbjct: 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------NKD 222
Query: 346 IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRP 386
           +        RLP P          +  ++  C +  P  RP
Sbjct: 223 VIGVLEKGDRLPKPDLCPP----VLYTLMTRCWDYDPSDRP 259

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 64/279 (22%), Positives = 108/279 (38%), Gaps = 44/279 (15%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKE-FLTEVEALTE 181
           A  D      +G G  G VY     + +   I         D  +D KE F++E   +  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG--WSQRMNVIK---- 235
           + H +IVKL G       ++++ E    G             ELG    +  N +K    
Sbjct: 82  LDHPHIVKLIGIIEE-EPTWIIMELYPYG-------------ELGHYLERNKNSLKVLTL 127
Query: 236 -----GVADALSYLHH-DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK-PDSSNW 288
                 +  A++YL   +C    VHRDI+ +N+L+       + DFG++++++  D    
Sbjct: 128 VLYSLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 183
Query: 289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIE 347
           +       +++PE     + T   DV+ F V   E++  GK P  +L        N D+ 
Sbjct: 184 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------NKDVI 236
Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRP 386
                  RLP P          +  ++  C +  P  RP
Sbjct: 237 GVLEKGDRLPKPDLCPP----VLYTLMTRCWDYDPSDRP 271

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 64/281 (22%), Positives = 111/281 (39%), Gaps = 48/281 (17%)
Query: 123 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKE-FLTEVEALTE 181
           A  D      +G G  G VY     + +   I         D  +D KE F++E   +  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELG--WSQRMNVIK---- 235
           + H +IVKL G       ++++ E    G             ELG    +  N +K    
Sbjct: 66  LDHPHIVKLIGIIEE-EPTWIIMELYPYG-------------ELGHYLERNKNSLKVLTL 111
Query: 236 -----GVADALSYLHH-DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
                 +  A++YL   +C    VHRDI+ +N+L+       + DFG+++++  +  ++ 
Sbjct: 112 VLYSLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYY 165
Query: 290 EFAGT---YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTD 345
           + + T     +++PE     + T   DV+ F V   E++  GK P  +L        N D
Sbjct: 166 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------NKD 218
Query: 346 IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRP 386
           +        RLP P          +  ++  C +  P  RP
Sbjct: 219 VIGVLEKGDRLPKPDLCPP----VLYTLMTRCWDYDPSDRP 255

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 252 IVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKIT 309
           ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y     
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHG 188
Query: 310 EKCDVYSFGVLALEVIKGKHP 330
               V+S G+L  +++ G  P
Sbjct: 189 RSAAVWSLGILLYDMVCGDIP 209

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 39/221 (17%)
Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKK------EFLTEVEALTEIR-H 184
           +G G H  V     L + Q  A+K          I++K+          EVE L + + H
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVK----------IIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWSQRMNVIKGVADALSYL 244
           RN+++L  F       +LV+E ++ G             EL  S    V++ VA AL +L
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFL 127
Query: 245 HHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGIAKFLKPD-------SSNWTEFAGT 294
           H+     I HRD+  +N+L +   +     + DF +   +K +       +       G+
Sbjct: 128 HNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 295 YGYVAPEL--AYTMKIT---EKCDVYSFGVLALEVIKGKHP 330
             Y+APE+  A++ + +   ++CD++S GV+   ++ G  P
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 42/225 (18%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           NDF     IG GG G VY   +  +G++ A+K           +DKK    +      + 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK----------CLDKKRIKMKQGETLALN 238
Query: 184 HRNIVKL-------------YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS-Q 229
            R ++ L             Y F +  + SF++ + +  G             E      
Sbjct: 239 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFY 297
Query: 230 RMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA---KFLKPDSS 286
              +I G    L ++H+     +V+RD+   N+LLD      ++D G+A      KP +S
Sbjct: 298 AAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 287 NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                 GT+GY+APE L   +      D +S G +  ++++G  P
Sbjct: 351 -----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 42/225 (18%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           NDF     IG GG G VY   +  +G++ A+K           +DKK    +      + 
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK----------CLDKKRIKMKQGETLALN 237
Query: 184 HRNIVKL-------------YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS-Q 229
            R ++ L             Y F +  + SF++ + +  G             E      
Sbjct: 238 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFY 296
Query: 230 RMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA---KFLKPDSS 286
              +I G    L ++H+     +V+RD+   N+LLD      ++D G+A      KP +S
Sbjct: 297 AAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 349
Query: 287 NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                 GT+GY+APE L   +      D +S G +  ++++G  P
Sbjct: 350 -----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 42/225 (18%)
Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           NDF     IG GG G VY   +  +G++ A+K           +DKK    +      + 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK----------CLDKKRIKMKQGETLALN 238
Query: 184 HRNIVKL-------------YGFCSHARHSFLVYEFLKRGXXXXXXXXXXXXQELGWS-Q 229
            R ++ L             Y F +  + SF++ + +  G             E      
Sbjct: 239 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFY 297
Query: 230 RMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL---KPDSS 286
              +I G    L ++H+     +V+RD+   N+LLD      ++D G+A      KP +S
Sbjct: 298 AAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 287 NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                 GT+GY+APE L   +      D +S G +  ++++G  P
Sbjct: 351 -----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	397
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-98
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-89
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-83
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-71
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-65
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-64
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-64
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-62
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-56
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-51
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-51
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-49
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-35
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-35
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-35
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-35
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-35
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-33
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-33
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-33
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-33
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-32
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-32
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-32
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-32
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-32
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-32
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-32
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-32
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-31
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-31
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-31
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-31
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-31
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-30
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-30
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-29
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-29
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-28
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-28
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-28
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-28
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-28
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-27
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-27
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-26
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-26
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-26
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-26
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-26
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-25
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-25
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-24
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-23
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-22
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-22
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-21
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-12
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-09
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-05
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	5e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  295 bits (757), Expect = 2e-98
 Identities = 94/286 (32%), Positives = 147/286 (51%), Gaps = 16/286 (5%)

Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEV 176
             E+  A+++F  +  +G GG G VY+  L  G +VA+K+        Q  +  +F TEV
Sbjct: 22  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE--RTQGGEL-QFQTEV 78

Query: 177 EALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLA-AILSSDAAAQELGWSQRMNVIK 235
           E ++   HRN+++L GFC       LVY ++  GS+A  +     +   L W +R  +  
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN-WTEFAGT 294
           G A  L+YLH  C P I+HRD+ + N+LLD EFEA V DFG+AK +    ++  T   GT
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198

Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN---------TD 345
            G++APE   T K +EK DV+ +GV+ LE+I G+   D     +   +           +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 346 IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIV 391
            +L+ ++D  L        E++  +++V   C   SP  RP M  V
Sbjct: 259 KKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  271 bits (696), Expect = 3e-89
 Identities = 101/321 (31%), Positives = 154/321 (47%), Gaps = 25/321 (7%)

Query: 89  NSDSGDRQRSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPS 148
           +  S      N      + +     ++   ++  ATN+FD ++ IG+G  G VY+  L  
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 149 GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLK 208
           G  VA+K+      S Q    +EF TE+E L+  RH ++V L GFC       L+Y++++
Sbjct: 63  GAKVALKRRTPE--SSQ--GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118

Query: 209 RGSLAAILS-SDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE 267
            G+L   L  SD     + W QR+ +  G A  L YLH      I+HRD+ S N+LLD  
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN 175

Query: 268 FEAHVADFGIAKFLKPDSSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEV 324
           F   + DFGI+K    +       T   GT GY+ PE     ++TEK DVYSFGV+  EV
Sbjct: 176 FVPKITDFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234

Query: 325 IKGKHPRDFLSSISSSFLN---------TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVF 375
           +  +       S+    +N          + +L++++DP L    +   E LR   +   
Sbjct: 235 LCARSAIV--QSLPREMVNLAEWAVESHNNGQLEQIVDPNL--ADKIRPESLRKFGDTAV 290

Query: 376 SCLNESPESRPTMKIVSQQLQ 396
            CL  S E RP+M  V  +L+
Sbjct: 291 KCLALSSEDRPSMGDVLWKLE 311

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  256 bits (656), Expect = 2e-83
 Identities = 90/295 (30%), Positives = 146/295 (49%), Gaps = 24/295 (8%)

Query: 117 YDEIVRATNDFDAQYC------IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKK 170
           + E+   TN+FD +        +G GG G VY+  +     VA+KK  + +       K+
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQ 75

Query: 171 EFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQR 230
           +F  E++ + + +H N+V+L GF S      LVY ++  GSL   LS       L W  R
Sbjct: 76  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135

Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW-- 288
             + +G A+ +++LH +     +HRDI S N+LLD  F A ++DFG+A+      +    
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQTVM 191

Query: 289 -TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDF------LSSISSSF 341
            +   GT  Y+APE A   +IT K D+YSFGV+ LE+I G    D       L  I    
Sbjct: 192 TSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 250

Query: 342 LNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            + +  +++ +D ++   + +    + ++  V   CL+E    RP +K V Q LQ
Sbjct: 251 EDEEKTIEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  225 bits (576), Expect = 3e-71
 Identities = 68/310 (21%), Positives = 121/310 (39%), Gaps = 41/310 (13%)

Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEV 176
            + +   +           G  G V++A+L   + VA+K F       Q     +   EV
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIF-----PIQDKQSWQNEYEV 69

Query: 177 EALTEIRHRNIVKLYGFCSHARHS----FLVYEFLKRGSLAAILSSDAAAQELGWSQRMN 232
            +L  ++H NI++  G            +L+  F ++GSL+  L +      + W++  +
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCH 125

Query: 233 VIKGVADALSYLHHDCF-------PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS 285
           + + +A  L+YLH D         P I HRDI SKN+LL     A +ADFG+A   +   
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 286 SNW--TEFAGTYGYVAPELA-----YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS 338
           S        GT  Y+APE+      +      + D+Y+ G++  E+       D      
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 339 ----SSFLNTDIELDEM--------LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRP 386
                  +     L++M          P L          +  + E +  C +   E+R 
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR-DYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 387 TMKIVSQQLQ 396
           +   V +++ 
Sbjct: 305 SAGCVGERIT 314

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  207 bits (528), Expect = 9e-65
 Identities = 77/272 (28%), Positives = 123/272 (45%), Gaps = 25/272 (9%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG GG G VYRA    G  VA+K        D     +    E +    ++H NI+ L G
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C    +  LV EF + G L  +LS     + +     +N    +A  ++YLH +   PI
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 253 VHRDISSKNLLLDLEFEAH--------VADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
           +HRD+ S N+L+  + E          + DFG+A+     +      AG Y ++APE+  
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYAWMAPEVIR 187

Query: 305 TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ 364
               ++  DV+S+GVL  E++ G+ P   +  ++ ++     +L       LP PS +  
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL------ALPIPS-TCP 240

Query: 365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           E    ++E    C N  P SRP+   +  QL 
Sbjct: 241 EPFAKLME---DCWNPDPHSRPSFTNILDQLT 269

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  207 bits (530), Expect = 1e-64
 Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 22/265 (8%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V +A+    + VAIK+  S        ++K F+ E+  L+ + H NIVKLYG
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESES------ERKAFIVELRQLSRVNHPNIVKLYG 68

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C +     LV E+ + GSL  +L           +  M+     +  ++YLH      +
Sbjct: 69  ACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 253 VHRDISSKNLLLDLEFE-AHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           +HRD+   NLLL        + DFG A  ++   ++ T   G+  ++APE+      +EK
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFEGSNYSEK 183

Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
           CDV+S+G++  EVI  + P D +   +   +            R P    ++ + + S++
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-----GTRPPLIK-NLPKPIESLM 237

Query: 372 EVVFSCLNESPESRPTMKIVSQQLQ 396
                C ++ P  RP+M+ + + + 
Sbjct: 238 T---RCWSKDPSQRPSMEEIVKIMT 259

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  207 bits (529), Expect = 2e-64
 Identities = 83/264 (31%), Positives = 128/264 (48%), Gaps = 14/264 (5%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G  G+V+RAE   G  VA+K         + V   EFL EV  +  +RH NIV   G
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERV--NEFLREVAIMKRLRHPNIVLFMG 101

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
             +   +  +V E+L RGSL  +L    A ++L   +R+++   VA  ++YLH+   PPI
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKC 312
           VHR++ S NLL+D ++   V DFG+++       +    AGT  ++APE+       EK 
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220

Query: 313 DVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVE 372
           DVYSFGV+  E+   + P   L+                   RL  P  ++  ++ +I+E
Sbjct: 221 DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK------RLEIPR-NLNPQVAAIIE 273

Query: 373 VVFSCLNESPESRPTMKIVSQQLQ 396
               C    P  RP+   +   L+
Sbjct: 274 ---GCWTNEPWKRPSFATIMDLLR 294

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  200 bits (510), Expect = 6e-62
 Identities = 81/275 (29%), Positives = 125/275 (45%), Gaps = 27/275 (9%)

Query: 133 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDK---KEFLTEVEALTEIRHRNIV 188
           IG GG G V++  L     VVAIK         +       +EF  EV  ++ + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           KLYG   +     +V EF+  G L   L     A  + WS ++ ++  +A  + Y+ +  
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN-Q 141

Query: 249 FPPIVHRDISSKNLLLDLEFE-----AHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
            PPIVHRD+ S N+ L    E     A VADFG+++     S   +   G + ++APE  
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSV--SGLLGNFQWMAPETI 198

Query: 304 YTMKI--TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR 361
              +   TEK D YSF ++   ++ G+ P D  S     F+N   E       R   P  
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL----RPTIPE- 253

Query: 362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
               +LR+++E    C +  P+ RP    + ++L 
Sbjct: 254 DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  196 bits (500), Expect = 6e-60
 Identities = 65/322 (20%), Positives = 119/322 (36%), Gaps = 54/322 (16%)

Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEV 176
             E     ++      IG G +G+VY+  L   + VA+K F          +++ F+ E 
Sbjct: 5   ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-------NRQNFINEK 56

Query: 177 E--ALTEIRHRNIVKLYGFCSHARHS-----FLVYEFLKRGSLAAILSSDAAAQELGWSQ 229
               +  + H NI +                 LV E+   GSL   LS         W  
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVS 112

Query: 230 RMNVIKGVADALSYLHHD------CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP 283
              +   V   L+YLH +        P I HRD++S+N+L+  +    ++DFG++  L  
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 284 DSSNWTEF--------AGTYGYVAPE-------LAYTMKITEKCDVYSFGVLALEVIKGK 328
           +                GT  Y+APE       L       ++ D+Y+ G++  E+    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 329 HPRDFLSSIS------SSFLNTDIELDEMLD--------PRLPAPSRSVQEKLRSIVEVV 374
                  S+        + +      ++M          P+ P   +     +RS+ E +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 375 FSCLNESPESRPTMKIVSQQLQ 396
             C ++  E+R T +   +++ 
Sbjct: 293 EDCWDQDAEARLTAQXAEERMA 314

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  187 bits (477), Expect = 1e-56
 Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 33/279 (11%)

Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G   +     +G+V+ +K+        Q    + FL EV+ +  + H N++K  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ----RTFLKEVKVMRCLEHPNVLKFI 73

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G     +    + E++K G+L  I+ S     +  WSQR++  K +A  ++YLH      
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MN 128

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFL--------------KPDSSNWTEFAGTYGY 297
           I+HRD++S N L+       VADFG+A+ +              KPD        G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP 357
           +APE+       EK DV+SFG++  E+I   +               D  L+        
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP-----RTMDFGLNVRGFLDRY 243

Query: 358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            P  +       I      C +  PE RP+   +   L+
Sbjct: 244 CPP-NCPPSFFPI---TVRCCDLDPEKRPSFVKLEHWLE 278

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  185 bits (471), Expect = 2e-56
 Identities = 51/269 (18%), Positives = 105/269 (39%), Gaps = 25/269 (9%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +     G +++     G  + +K       S +    ++F  E   L    H N++ + G
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKS--RDFNEECPRLRIFSHPNVLPVLG 74

Query: 193 FCSH--ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
            C    A H  L+  ++  GSL  +L        +  SQ +     +A  +++LH    P
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHT-LEP 132

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL---AYTMK 307
            I    ++S+++++D +  A ++   +    +              +VAPE         
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEALQKKPEDT 187

Query: 308 ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL 367
                D++SF VL  E++  + P   LS++        + L+ +   R   P   +   +
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLSNMEIGM---KVALEGL---RPTIPP-GISPHV 240

Query: 368 RSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             +++    C+NE P  RP   ++   L+
Sbjct: 241 SKLMK---ICMNEDPAKRPKFDMIVPILE 266

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  180 bits (458), Expect = 5e-54
 Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 43/296 (14%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE--ALTEIRHRNIVK 189
           C+G G +G V+R     G+ VA+K F S        D+K +  E E      +RH NI+ 
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 66

Query: 190 LYGFCSHARHS----FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
                  +RHS    +L+  + + GSL   L        L     + ++  +A  L++LH
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLH 122

Query: 246 HDCF-----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS----NWTEFAGTYG 296
            + F     P I HRD+ SKN+L+    +  +AD G+A      ++          GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 297 YVAPEL------AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF---LNTDIE 347
           Y+APE+             ++ D+++FG++  EV +       +      F   +  D  
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 348 LDEMLDP------RLPAPSRSVQEK-LRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            ++M         R   P+R   +  L S+ +++  C  ++P +R T   + + L 
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  176 bits (448), Expect = 3e-52
 Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 43/296 (14%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE--ALTEIRHRNIVK 189
            IG G +G V+  +   G+ VA+K F +        ++  +  E E      +RH NI+ 
Sbjct: 44  QIGKGRYGEVWMGKW-RGEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHENILG 95

Query: 190 LYGFCSHARHS----FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
                     S    +L+ ++ + GSL   L S      L     + +       L +LH
Sbjct: 96  FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLH 151

Query: 246 HDCF-----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW----TEFAGTYG 296
            + F     P I HRD+ SKN+L+       +AD G+A     D++          GT  
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211

Query: 297 YVAPE-LAYTMKI-----TEKCDVYSFGVLALEVIKGKHPRDFLSSI---SSSFLNTDIE 347
           Y+ PE L  ++           D+YSFG++  EV +       +          + +D  
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271

Query: 348 LDEMLDP------RLPAPSRSVQEK-LRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            ++M +       R   P+R   ++ LR + +++  C   +P SR T   V + L 
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  175 bits (445), Expect = 7e-52
 Identities = 55/278 (19%), Positives = 105/278 (37%), Gaps = 34/278 (12%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G  G VY      G+V AI+       ++  +  K F  EV A  + RH N+V   G
Sbjct: 41  IGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQL--KAFKREVMAYRQTRHENVVLFMG 96

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C    H  ++    K  +L +++    A   L  ++   + + +   + YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAK-----FLKPDSSNWTEFAGTYGYVAPELAYTMK 307
           +H+D+ SKN+  D   +  + DFG+                    G   ++APE+   + 
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 308 I---------TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
                     ++  DV++ G +  E+   + P     + +  +      +   +  +   
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ-----MGTGM--KPNL 263

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
               + +++  I+     C     E RPT   +   L+
Sbjct: 264 SQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLE 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  174 bits (443), Expect = 2e-51
 Identities = 64/296 (21%), Positives = 118/296 (39%), Gaps = 43/296 (14%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE--ALTEIRHRNIVK 189
            IG G  G V+R +   G+ VA+K F S        +++ +  E E      +RH NI+ 
Sbjct: 49  SIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILG 100

Query: 190 LYGFCSHARHS----FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
                +    +    +LV ++ + GSL   L+       +     + +    A  L++LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLH 156

Query: 246 HDCF-----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS----NWTEFAGTYG 296
            +       P I HRD+ SKN+L+       +AD G+A      +           GT  
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 297 YVAPEL------AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF---LNTDIE 347
           Y+APE+          +  ++ D+Y+ G++  E+ +              +   + +D  
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276

Query: 348 LDEMLDP------RLPAPSR-SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           ++EM         R   P+R    E LR + +++  C   +  +R T   + + L 
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  172 bits (437), Expect = 4e-51
 Identities = 60/269 (22%), Positives = 126/269 (46%), Gaps = 21/269 (7%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G+VY+ +   G V A+K  +   P+ Q +  + F  EV  L + RH NI+   G
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 87

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
           + +  + + +V ++ +  SL   L +     +    + +++ +  A  + YLH      I
Sbjct: 88  YSTAPQLA-IVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHA---KSI 141

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLK--PDSSNWTEFAGTYGYVAPEL---AYTMK 307
           +HRD+ S N+ L  +    + DFG+A        S  + + +G+  ++APE+     +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 308 ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL 367
            + + DVY+FG++  E++ G+ P   +++               L P L     +  +++
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG---RGSLSPDLSKVRSNCPKRM 258

Query: 368 RSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           + ++     CL +  + RP+   +  +++
Sbjct: 259 KRLMA---ECLKKKRDERPSFPRILAEIE 284

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  140 bits (356), Expect = 3e-39
 Identities = 56/263 (21%), Positives = 105/263 (39%), Gaps = 26/263 (9%)

Query: 132 CIGNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
            IG G   +VY+  +  +   VA  +     L   +    + F  E E L  ++H NIV+
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER---QRFKEEAEMLKGLQHPNIVR 89

Query: 190 LYG----FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
            Y          +   LV E +  G+L   L      + +      +  + +   L +LH
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH 146

Query: 246 HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
               PPI+HRD+   N+ +        + D G+A   +   +      GT  ++APE+ Y
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEM-Y 202

Query: 305 TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ 364
             K  E  DVY+FG+  LE+   ++P     + +  +         +         +   
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFD---KVAI 256

Query: 365 EKLRSIVEVVFSCLNESPESRPT 387
            +++ I+E    C+ ++ + R +
Sbjct: 257 PEVKEIIE---GCIRQNKDERYS 276

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  140 bits (356), Expect = 2e-38
 Identities = 69/277 (24%), Positives = 110/277 (39%), Gaps = 41/277 (14%)

Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G V+   L +    VA+K     LP D    K +FL E   L +  H NIV+L 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 178

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G C+  +  ++V E ++ G     L ++     L     + ++   A  + YL   C   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKCC-- 234

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN-----------WTEFAGTYGYVAP 300
            +HRD++++N L+  +    ++DFG+++                   WT         AP
Sbjct: 235 -IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT---------AP 284

Query: 301 ELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           E     + + + DV+SFG+L  E    G  P   LS       N           RLP P
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-------NQQTREFVEKGGRLPCP 337

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                     +  ++  C    P  RP+   + Q+LQ
Sbjct: 338 ELCPDA----VFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  135 bits (341), Expect = 5e-37
 Identities = 58/285 (20%), Positives = 113/285 (39%), Gaps = 46/285 (16%)

Query: 122 RATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
           R   DF     IG+GG G V++A+    G+   IK+           + ++   EV+AL 
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK--------YNNEKAEREVKALA 59

Query: 181 EIRHRNIVKLYGF----------------CSHARHSFLVYEFLKRGSLAAILSSDAAAQE 224
           ++ H NIV   G                  S  +  F+  EF  +G+L   +      ++
Sbjct: 60  KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEK 118

Query: 225 LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD 284
           L     + + + +   + Y+H      +++RD+   N+ L    +  + DFG+   LK D
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175

Query: 285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT 344
                   GT  Y++PE   +    ++ D+Y+ G++  E++                  T
Sbjct: 176 GKRTR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT----------AFET 224

Query: 345 DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
                ++ D  +        +K +++++     L++ PE RP   
Sbjct: 225 SKFFTDLRDGIISD---IFDKKEKTLLQ---KLLSKKPEDRPNTS 263

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  131 bits (332), Expect = 1e-35
 Identities = 61/293 (20%), Positives = 123/293 (41%), Gaps = 44/293 (15%)

Query: 122 RATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
           R   DF+   C+G GG G V+ A+        AIK+    LP+ + + +++ + EV+AL 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR--IRLPNRE-LAREKVMREVKALA 58

Query: 181 EIRHRNIVKLYGFC------------SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWS 228
           ++ H  IV+ +               S   + ++  +  ++ +L   ++     +E   S
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK------ 282
             +++   +A+A+ +LH      ++HRD+   N+   ++    V DFG+   +       
Sbjct: 119 VCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 283 ------PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSS 336
                 P  +  T   GT  Y++PE  +    + K D++S G++  E++   +P  F + 
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP--FSTQ 230

Query: 337 ISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           +      TD+      + + P            +V+     L+ SP  RP   
Sbjct: 231 MERVRTLTDVR-----NLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAI 275

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  131 bits (332), Expect = 1e-35
 Identities = 67/277 (24%), Positives = 113/277 (40%), Gaps = 21/277 (7%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFH-SPLPSDQIVDKKEFLTEVEALTEI 182
            +F  +  IG G    VYRA  L  G  VA+KK     L   +   + + + E++ L ++
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK--ARADCIKEIDLLKQL 89

Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQE-LGWSQRMNVIKGVADAL 241
            H N++K Y          +V E    G L+ ++      +  +           +  AL
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
            ++H      ++HRDI   N+ +       + D G+ +F    ++      GT  Y++PE
Sbjct: 150 EHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS-SFLNTDIELDEMLDPRLPAPS 360
             +      K D++S G L  E+   + P  F     +   L   IE  +   P LP+  
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDY--PPLPSDH 262

Query: 361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI 397
            S  E+LR +V     C+N  PE RP    V+    +
Sbjct: 263 YS--EELRQLVN---MCINPDPEKRPD---VTYVYDV 291

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  130 bits (329), Expect = 3e-35
 Identities = 72/265 (27%), Positives = 121/265 (45%), Gaps = 26/265 (9%)

Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLT-EVEALTEIR 183
            F     IG G  G V++  +  + +VVAIK     +  ++  D+ E +  E+  L++  
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI----IDLEEAEDEIEDIQQEITVLSQCD 78

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
              + K YG        +++ E+L  GS   +L        L  +Q   +++ +   L Y
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDY 134

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH +     +HRDI + N+LL    E  +ADFG+A  L         F GT  ++APE+ 
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
                  K D++S G+ A+E+ +G+ P   L  +   FL   I       P+   P  ++
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL---I-------PKNNPP--TL 239

Query: 364 QEKL-RSIVEVVFSCLNESPESRPT 387
           +    + + E V +CLN+ P  RPT
Sbjct: 240 EGNYSKPLKEFVEACLNKEPSFRPT 264

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  130 bits (330), Expect = 4e-35
 Identities = 74/306 (24%), Positives = 127/306 (41%), Gaps = 30/306 (9%)

Query: 89  NSDSGDRQRSNQNPHGLFSILNFEGKLVYDEIVRATN---DFDAQYCIGNGGHGSVYRA- 144
           +  SG    +         + + + K     +V   +     D+   IG G  G V  A 
Sbjct: 6   HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65

Query: 145 ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL-- 202
           E  SG+ VA+K     L   Q   ++    EV  + + +H N+V++Y   S+     L  
Sbjct: 66  EKHSGRQVAVKMM--DLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYK--SYLVGEELWV 119

Query: 203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNL 262
           + EFL+ G+L  I+S       L   Q   V + V  AL+YLH      ++HRDI S ++
Sbjct: 120 LMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI 172

Query: 263 LLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLAL 322
           LL L+    ++DFG    +  D        GT  ++APE+        + D++S G++ +
Sbjct: 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232

Query: 323 EVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL-RSIVEVVFSCLNES 381
           E++ G+ P    S + +      +          P P      K+   + + +   L   
Sbjct: 233 EMVDGEPPYFSDSPVQAMKR---L-------RDSPPPKLKNSHKVSPVLRDFLERMLVRD 282

Query: 382 PESRPT 387
           P+ R T
Sbjct: 283 PQERAT 288

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  131 bits (331), Expect = 4e-35
 Identities = 62/266 (23%), Positives = 106/266 (39%), Gaps = 22/266 (8%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
             +     IG G  G     +    G+   IK+ +    S +  +++E   EV  L  ++
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK--EREESRREVAVLANMK 81

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAA--QELGWSQRMNVIKGVADAL 241
           H NIV+           ++V ++ + G L   +++      QE    Q ++    +  AL
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE---DQILDWFVQICLAL 138

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
            ++H      I+HRDI S+N+ L  +    + DFGIA+ L           GT  Y++PE
Sbjct: 139 KHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR 361
           +        K D+++ G +  E+   KH   F  + S   L   I       P +     
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHA--F-EAGSMKNLVLKIISGSF--PPVSL--- 247

Query: 362 SVQEKLRSIVEVVFSCLNESPESRPT 387
                LRS+V         +P  RP+
Sbjct: 248 HYSYDLRSLVS---QLFKRNPRDRPS 270

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  130 bits (329), Expect = 7e-35
 Identities = 60/272 (22%), Positives = 99/272 (36%), Gaps = 33/272 (12%)

Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
            +    Q  +G G  G V+R  +  +G   A+KK    +   +         E+ A   +
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---------ELVACAGL 107

Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALS 242
               IV LYG         +  E L+ GSL  ++       E    + +  +    + L 
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLE 164

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSSNWTE-----FAGTYG 296
           YLH      I+H D+ + N+LL  +   A + DFG A  L+PD    +        GT  
Sbjct: 165 YLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           ++APE+        K D++S   + L ++ G HP               I          
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK---I-------ASE 271

Query: 357 PAPSRSVQEKL-RSIVEVVFSCLNESPESRPT 387
           P P R +         + +   L + P  R +
Sbjct: 272 PPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 303

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  129 bits (326), Expect = 8e-35
 Identities = 67/281 (23%), Positives = 129/281 (45%), Gaps = 29/281 (10%)

Query: 117 YDEIVRATN---DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF 172
           Y+ + R  +    ++    +G+G  G VY+A    +G + A K       S++  + +++
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEE--ELEDY 63

Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN 232
           + E+E L    H  IVKL G   H    +++ EF   G++ AI+      + L   Q   
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQV 121

Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA 292
           V + + +AL++LH      I+HRD+ + N+L+ LE +  +ADFG++            F 
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178

Query: 293 GTYGYVAPELAYTMKITE-----KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE 347
           GT  ++APE+     + +     K D++S G+  +E+ + + P   L+ +        I 
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK---I- 234

Query: 348 LDEMLDPRLPAPSRSVQEKL-RSIVEVVFSCLNESPESRPT 387
                  +   P+     K      + +   L+++PE+RP+
Sbjct: 235 ------AKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPS 269

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  129 bits (327), Expect = 8e-35
 Identities = 77/276 (27%), Positives = 128/276 (46%), Gaps = 26/276 (9%)

Query: 117 YDEIVRATN---DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF 172
            DE          FD    +G G +GSVY+A    +GQ+VAIK+    +P +   D +E 
Sbjct: 18  LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ----VPVES--DLQEI 71

Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN 232
           + E+  + +    ++VK YG        ++V E+   GS++ I+      + L   +   
Sbjct: 72  IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIAT 129

Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA 292
           +++     L YLH       +HRDI + N+LL+ E  A +ADFG+A  L    +      
Sbjct: 130 ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 186

Query: 293 GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML 352
           GT  ++APE+   +      D++S G+ A+E+ +GK P   +  + + F+   I      
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM---I------ 237

Query: 353 DPRLPAPSRSVQEKL-RSIVEVVFSCLNESPESRPT 387
            P  P P+    E    +  + V  CL +SPE R T
Sbjct: 238 -PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT 272

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  128 bits (325), Expect = 1e-34
 Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 27/268 (10%)

Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
              +     IG G  G+VY A ++ +GQ VAI++    L       K+  + E+  + E 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQP--KKELIINEILVMREN 74

Query: 183 RHRNIVKLYGFCSHARHSFL--VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADA 240
           ++ NIV      S+     L  V E+L  GSL  +++       +   Q   V +    A
Sbjct: 75  KNPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQA 128

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           L +LH +    ++HRDI S N+LL ++    + DFG    + P+ S  +   GT  ++AP
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 301 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
           E+        K D++S G++A+E+I+G+ P    + + + +L   I            P 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---I-------ATNGTPE 235

Query: 361 RSVQEKL-RSIVEVVFSCLNESPESRPT 387
               EKL     + +  CL    E R +
Sbjct: 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGS 263

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  128 bits (324), Expect = 1e-34
 Identities = 69/269 (25%), Positives = 120/269 (44%), Gaps = 19/269 (7%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
            D++  Y IG G +G   +      G+++  K+      ++   +K+  ++EV  L E++
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELK 63

Query: 184 HRNIVKLYG--FCSHARHSFLVYEFLKRGSLAAILSSDAAAQE-LGWSQRMNVIKGVADA 240
           H NIV+ Y           ++V E+ + G LA++++     ++ L     + V+  +  A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 241 LSYLH--HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
           L   H   D    ++HRD+   N+ LD +    + DFG+A+ L  D+S    F GT  Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           +PE    M   EK D++S G L  E+     P  F +  S   L   I   +    R+P 
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAF-SQKELAGKIREGKF--RRIPY 238

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPT 387
                 ++L  I+      LN     RP+
Sbjct: 239 ---RYSDELNEIIT---RMLNLKDYHRPS 261

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  131 bits (331), Expect = 2e-34
 Identities = 61/282 (21%), Positives = 112/282 (39%), Gaps = 45/282 (15%)

Query: 126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLT----EVEALTE 181
            F  +  +G+G  G++    +   + VA+K+              E  +    EV+ L E
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI-----------LPECFSFADREVQLLRE 73

Query: 182 I-RHRNIVKLYGFCSHARHSFLVYEFLKRGSLA-AILSSDAAAQELGWSQRMNVIKGVAD 239
              H N+++ +      +  ++  E L   +L   +   D A   L   + + +++    
Sbjct: 74  SDEHPNVIRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGL---EPITLLQQTTS 129

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLL-----DLEFEAHVADFGIAKFLKPDSS---NWTEF 291
            L++LH      IVHRD+   N+L+       + +A ++DFG+ K L          +  
Sbjct: 130 GLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186

Query: 292 AGTYGYVAPEL---AYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIE 347
            GT G++APE+         T   D++S G +   VI +G HP        ++ L     
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS 246

Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           LD         P +      R ++E     +   P+ RP+ K
Sbjct: 247 LD------CLHPEKHEDVIARELIE---KMIAMDPQKRPSAK 279

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  128 bits (323), Expect = 3e-34
 Identities = 61/292 (20%), Positives = 108/292 (36%), Gaps = 38/292 (13%)

Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
            +     +G GG   V   E L  G   A+K+       D    ++E   E +      H
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD----REEAQREADMHRLFNH 85

Query: 185 RNIVKLYGFCSHARHS----FLVYEFLKRGSLAAILSSDAAAQELGWSQR--MNVIKGVA 238
            NI++L  +C   R +    +L+  F KRG+L   +           ++   + ++ G+ 
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGIC 144

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---------WT 289
             L  +H        HRD+   N+LL  E +  + D G                    W 
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201

Query: 290 EFAGTYGYVAPEL----AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD 345
               T  Y APEL    ++ + I E+ DV+S G +   ++ G+ P  +            
Sbjct: 202 AQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVAL 258

Query: 346 IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI 397
              +++  P+ P  S      L  ++    S +   P  RP + ++  QL+ 
Sbjct: 259 AVQNQLSIPQSPRHS----SALWQLLN---SMMTVDPHQRPHIPLLLSQLEA 303

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  125 bits (317), Expect = 1e-33
 Identities = 64/291 (21%), Positives = 110/291 (37%), Gaps = 48/291 (16%)

Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  G V           +G+ VA+K        +      +   E+E L  + H NI
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH---IADLKKEIEILRNLYHENI 85

Query: 188 VKLYGFCSHARHS--FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
           VK  G C+    +   L+ EFL  GSL   L  +    ++   Q++     +   + YL 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLG 143

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN------------WTEFAG 293
              +   VHRD++++N+L++ E +  + DFG+ K ++ D               W     
Sbjct: 144 SRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY---- 196

Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLN-----TDIE 347
                APE     K     DV+SFGV   E++         ++             T   
Sbjct: 197 -----APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251

Query: 348 LDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           L   L    RLP P     E    + +++  C    P +R + + + +  +
Sbjct: 252 LVNTLKEGKRLPCPPNCPDE----VYQLMRKCWEFQPSNRTSFQNLIEGFE 298

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  125 bits (317), Expect = 2e-33
 Identities = 68/310 (21%), Positives = 112/310 (36%), Gaps = 75/310 (24%)

Query: 122 RATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE-----FLTE 175
           R  +DF+    +G G  G V +A      +  AIK           +   E      L+E
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIK----------KIRHTEEKLSTILSE 52

Query: 176 VEALTEIRHRNIVKLYGFCSHARHS-------------FLVYEFLKRGSLA-AILSSDAA 221
           V  L  + H+ +V+ Y      R+              F+  E+ + G+L   I S +  
Sbjct: 53  VMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN 112

Query: 222 AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL 281
            Q     +   + + + +ALSY+H      I+HRD+   N+ +D      + DFG+AK +
Sbjct: 113 QQR---DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166

Query: 282 KPDSSNW--------------TEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK 326
                                T   GT  YVA E L  T    EK D+YS G++  E+I 
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

Query: 327 GKHPRDFLSSISSSFLNTDIELDEML------DPRLPAP-SRSVQEKLRSIVEVVFSCLN 379
                           +T +E   +L          P     +  +  + I+      ++
Sbjct: 227 P--------------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR---LLID 269

Query: 380 ESPESRPTMK 389
             P  RP  +
Sbjct: 270 HDPNKRPGAR 279

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  129 bits (326), Expect = 2e-33
 Identities = 69/285 (24%), Positives = 130/285 (45%), Gaps = 33/285 (11%)

Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVE 177
           E+ R   D   ++ +G G +G VY        + VA+K        +  ++ +EFL E  
Sbjct: 216 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAA 268

Query: 178 ALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGV 237
            + EI+H N+V+L G C+     +++ EF+  G+L   L      QE+     + +   +
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQI 327

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---SSNWTEFAGT 294
           + A+ YL    F   +HR+++++N L+       VADFG+++ +  D   +    +F   
Sbjct: 328 SSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-- 382

Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLD 353
             + APE     K + K DV++FGVL  E+   G  P   +            ++ E+L+
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---------DLSQVYELLE 433

Query: 354 P--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 434 KDYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 474

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  124 bits (313), Expect = 3e-33
 Identities = 71/277 (25%), Positives = 123/277 (44%), Gaps = 45/277 (16%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG+G  G V+     +   VAIK        +  + +++F+ E E + ++ H  +V+LYG
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C       LV EF++ G L+  L +            + +   V + ++YL   C    
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEACV--- 125

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD----SSN------WTEFAGTYGYVAPEL 302
           +HRD++++N L+       V+DFG+ +F+  D    S+       W          +PE+
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA---------SPEV 176

Query: 303 AYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDP--RLPAP 359
               + + K DV+SFGVL  EV  +GK P +  S       N+++   E +    RL  P
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVV--EDISTGFRLYKP 227

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             +       + +++  C  E PE RP    + +QL 
Sbjct: 228 RLASTH----VYQIMNHCWRERPEDRPAFSRLLRQLA 260

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  125 bits (316), Expect = 4e-33
 Identities = 72/291 (24%), Positives = 111/291 (38%), Gaps = 49/291 (16%)

Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G +VA+K+    L       +++F  E++ L  +    I
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQ----LQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 188 VKLYGFCSHARHS--FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
           VK  G           LV E+L  G L   L    A   L  S+ +     +   + YL 
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLG 144

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS------------NWTEFAG 293
                  VHRD++++N+L++ E    +ADFG+AK L  D               W     
Sbjct: 145 SRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY---- 197

Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLN-----TDIE 347
                APE       + + DV+SFGV+  E+           +                 
Sbjct: 198 -----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252

Query: 348 LDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           L E+L+   RLPAP     E    + E++  C   SP+ RP+   +  QL 
Sbjct: 253 LLELLEEGQRLPAPPACPAE----VHELMKLCWAPSPQDRPSFSALGPQLD 299

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  124 bits (313), Expect = 5e-33
 Identities = 68/286 (23%), Positives = 111/286 (38%), Gaps = 57/286 (19%)

Query: 133 IGNGGHGSVYRAEL--PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G G  GSV +        Q+ VAIK         +  D +E + E + + ++ +  IV+
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
           L G C       LV E    G L   L      +E+  S    ++  V+  + YL    F
Sbjct: 75  LIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKNF 131

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN------------WTEFAGTYGY 297
              VHRD++++N+LL     A ++DFG++K L  D S             W         
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-------- 180

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELDE 350
            APE     K + + DV+S+GV   E +  G+ P       + ++ I             
Sbjct: 181 -APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------- 230

Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
               R+  P     E    +  ++  C     E RP    V Q+++
Sbjct: 231 ----RMECPPECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMR 268

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  124 bits (313), Expect = 5e-33
 Identities = 69/292 (23%), Positives = 113/292 (38%), Gaps = 50/292 (17%)

Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 73

Query: 188 VKLYGFCSHARHS--FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A      L+ E+L  GSL   L      + +   + +     +   + YL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG 131

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN------------WTEFAG 293
              +   +HRD++++N+L++ E    + DFG+ K L  D               W     
Sbjct: 132 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY---- 184

Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN-------TDI 346
                APE     K +   DV+SFGV+  E+           +     +           
Sbjct: 185 -----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239

Query: 347 ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            L E+L    RLP P     E    I  ++  C N +   RP+ + ++ ++ 
Sbjct: 240 HLIELLKNNGRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFRDLALRVD 287

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  124 bits (313), Expect = 6e-33
 Identities = 69/257 (26%), Positives = 116/257 (45%), Gaps = 18/257 (7%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G GG  +VY AE       VAIK    P    +   K+ F  EV   +++ H+NIV + 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVSMI 77

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                    +LV E+++  +L+  + S      L     +N    + D + + H      
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM---R 131

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA-GTYGYVAPELAYTMKITE 310
           IVHRDI  +N+L+D      + DFGIAK L   S   T    GT  Y +PE A      E
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191

Query: 311 KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL-RS 369
             D+YS G++  E++ G+ P +  +++S       I +  + D  +P  +  V++ + +S
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQDS-VPNVTTDVRKDIPQS 243

Query: 370 IVEVVFSCLNESPESRP 386
           +  V+     +   +R 
Sbjct: 244 LSNVILRATEKDKANRY 260

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  124 bits (313), Expect = 9e-33
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 57/287 (19%)

Query: 133 IGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG+G  G V    L         VAIK   +     Q   +++FL+E   + +  H NI+
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ---RRDFLSEASIMGQFDHPNII 113

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  +  R + +V E+++ GSL   L +     +    Q + +++GV   + YL    
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG 171

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN------------WTEFAGTYG 296
           +   VHRD++++N+L+D      V+DFG+++ L+ D               WT       
Sbjct: 172 Y---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT------- 221

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELD 349
             APE       +   DV+SFGV+  EV+  G+ P      RD +SS+   +        
Sbjct: 222 --APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY-------- 271

Query: 350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                RLPAP          + +++  C ++    RP    +   L 
Sbjct: 272 -----RLPAPMGCPHA----LHQLMLDCWHKDRAQRPRFSQIVSVLD 309

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  123 bits (311), Expect = 1e-32
 Identities = 67/282 (23%), Positives = 119/282 (42%), Gaps = 49/282 (17%)

Query: 133 IGNGGHGSVYRAELPSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G  G+V +      +V   VA+K   +         K E L E   + ++ +  IV+
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA--LKDELLAEANVMQQLDNPYIVR 82

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
           + G C       LV E  + G L   L  +   + +     + ++  V+  + YL    F
Sbjct: 83  MIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN------------WTEFAGTYGY 297
              VHRD++++N+LL  +  A ++DFG++K L+ D +             W         
Sbjct: 139 ---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-------- 187

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDP-- 354
            APE     K + K DV+SFGVL  E    G+ P   +         +++    ML+   
Sbjct: 188 -APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVT--AMLEKGE 237

Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           R+  P+   +E    + +++  C     E+RP    V  +L+
Sbjct: 238 RMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 275

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  123 bits (311), Expect = 1e-32
 Identities = 75/283 (26%), Positives = 123/283 (43%), Gaps = 36/283 (12%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           +D++ Q  IG+G    V  A   P  + VAIK+    L   Q     E L E++A+++  
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQT-SMDELLKEIQAMSQCH 71

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN------VIKGV 237
           H NIV  Y         +LV + L  GS+  I+     A+    S  ++      +++ V
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKH-IVAKGEHKSGVLDESTIATILREV 130

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE-----FA 292
            + L YLH +     +HRD+ + N+LL  +    +ADFG++ FL              F 
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 293 GTYGYVAPEL-----AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE 347
           GT  ++APE+      Y      K D++SFG+ A+E+  G  P      +    L    +
Sbjct: 188 GTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243

Query: 348 LDEMLDPRLPAPSRSVQEKLR---SIVEVVFSCLNESPESRPT 387
                 P L    +  +   +   S  +++  CL + PE RPT
Sbjct: 244 -----PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  123 bits (311), Expect = 1e-32
 Identities = 58/261 (22%), Positives = 105/261 (40%), Gaps = 28/261 (10%)

Query: 133 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G GG G VY AE     ++VA+K     L SD +   +    E      ++  ++V ++
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEPHVVPIH 100

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
            F       ++    +    LAA+L        L   + + +++ +  AL   H      
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---G 154

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE---FAGTYGYVAPELAYTMKI 308
             HRD+  +N+L+  +  A++ DFGIA          T+     GT  Y+APE       
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLS---SISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
           T + D+Y+   +  E + G  P  +     S+  + +N  I     + P +P        
Sbjct: 213 TYRADIYALTCVLYECLTGSPP--YQGDQLSVMGAHINQAIPRPSTVRPGIPV------- 263

Query: 366 KLRSIVEVVFSCLNESPESRP 386
              +   V+   + ++PE R 
Sbjct: 264 ---AFDAVIARGMAKNPEDRY 281

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  123 bits (311), Expect = 2e-32
 Identities = 69/292 (23%), Positives = 113/292 (38%), Gaps = 50/292 (17%)

Query: 133 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  GSV           +G+VVA+KK             ++F  E+E L  ++H NI
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNI 104

Query: 188 VKLYGFCSHARHS--FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
           VK  G C  A      L+ E+L  GSL   L      + +   + +     +   + YL 
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG 162

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN------------WTEFAG 293
              +   +HRD++++N+L++ E    + DFG+ K L  D               W     
Sbjct: 163 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY---- 215

Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN-------TDI 346
                APE     K +   DV+SFGV+  E+           +     +           
Sbjct: 216 -----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270

Query: 347 ELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            L E+L    RLP P     E    I  ++  C N +   RP+ + ++ ++ 
Sbjct: 271 HLIELLKNNGRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFRDLALRVD 318

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  122 bits (309), Expect = 3e-32
 Identities = 72/279 (25%), Positives = 122/279 (43%), Gaps = 32/279 (11%)

Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
              F+    +GNG +G VY+   + +GQ+ AIK     +  D   +++E   E+  L + 
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGD---EEEEIKQEINMLKKY 77

Query: 183 -RHRNIVKLYG------FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIK 235
             HRNI   YG              +LV EF   GS+  ++ +      L       + +
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICR 136

Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY 295
            +   LS+LH      ++HRDI  +N+LL    E  + DFG++  L         F GT 
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 193

Query: 296 GYVAPELAYTMKITE-----KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE 350
            ++APE+    +  +     K D++S G+ A+E+ +G  P   +  + + FL   I    
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---I---- 246

Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
              PR PAP    ++  +     + SCL ++   RP  +
Sbjct: 247 ---PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATE 282

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  122 bits (309), Expect = 4e-32
 Identities = 66/291 (22%), Positives = 116/291 (39%), Gaps = 50/291 (17%)

Query: 133 IGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G G  G V           +G++VA+K             +  +  E++ L  + H +I
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 188 VKLYGFCSHARHS--FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
           +K  G C  A  +   LV E++  GSL   L        +G +Q +   + + + ++YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLH 151

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN------------WTEFAG 293
              +   +HRD++++N+LLD +    + DFG+AK +                  W     
Sbjct: 152 AQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY---- 204

Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLN-----TDIE 347
                APE     K     DV+SFGV   E++      +   +             T + 
Sbjct: 205 -----APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259

Query: 348 LDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           L E+L+   RLP P +   E    +  ++ +C       RPT + +   L+
Sbjct: 260 LTELLERGERLPRPDKCPAE----VYHLMKNCWETEASFRPTFENLIPILK 306

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  122 bits (307), Expect = 4e-32
 Identities = 63/262 (24%), Positives = 113/262 (43%), Gaps = 24/262 (9%)

Query: 132 CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL 190
            +G G +G VY   +L +   +AIK+   P    +    +    E+     ++H+NIV+ 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYS--QPLHEEIALHKHLKHKNIVQY 84

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
            G  S      +  E +  GSL+A+L S     +          K + + L YLH +   
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 142

Query: 251 PIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI 308
            IVHRDI   N+L++  +   +  +DFG +K L   +     F GT  Y+APE+      
Sbjct: 143 -IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200

Query: 309 --TEKCDVYSFGVLALEVIKGKHP-RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
              +  D++S G   +E+  GK P  +     ++ F    + + + + P +P    S+  
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK---VGMFK-VHPEIPE---SMSA 253

Query: 366 KLRSIVEVVFSCLNESPESRPT 387
           + ++ +     C    P+ R  
Sbjct: 254 EAKAFIL---KCFEPDPDKRAC 272

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  121 bits (307), Expect = 4e-32
 Identities = 66/282 (23%), Positives = 117/282 (41%), Gaps = 53/282 (18%)

Query: 133 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G +G VY        + VA+K        +  ++ +EFL E   + EI+H N+V+L 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G C+     +++ EF+  G+L   L      QE+     + +   ++ A+ YL    F  
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNF-- 132

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD----SSN------WTEFAGTYGYVAPE 301
            +HRD++++N L+       VADFG+++ +  D     +       WT         APE
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------APE 182

Query: 302 LAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELDEMLDP 354
                K + K DV++FGVL  E+   G  P            +   +             
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------- 229

Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           R+  P    +     + E++ +C   +P  RP+   + Q  +
Sbjct: 230 RMERP----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  121 bits (305), Expect = 4e-32
 Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 53/281 (18%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G+G  G V   +      VA+K             + EF  E + + ++ H  +VK YG
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            CS     ++V E++  G L   L S    + L  SQ + +   V + +++L    F   
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQF--- 125

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD----SSN------WTEFAGTYGYVAPEL 302
           +HRD++++N L+D +    V+DFG+ +++  D    S        W+         APE+
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS---------APEV 176

Query: 303 AYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELDEMLDPR 355
            +  K + K DV++FG+L  EV   GK P       + +  +S                R
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-------------R 223

Query: 356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           L  P     + +  I+    SC +E PE RPT + +   ++
Sbjct: 224 LYRP-HLASDTIYQIMY---SCWHELPEKRPTFQQLLSSIE 260

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  122 bits (309), Expect = 5e-32
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 58/288 (20%)

Query: 133 IGNGGHGSVYRAEL--PSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           IG G  G VY+  L   SG+    VAIK   +     Q   + +FL E   + +  H NI
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ---RVDFLGEAGIMGQFSHHNI 108

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           ++L G  S  +   ++ E+++ G+L   L       E    Q + +++G+A  + YL + 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM 166

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN------------WTEFAGTY 295
            +   VHRD++++N+L++      V+DFG+++ L+ D               WT      
Sbjct: 167 NY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT------ 217

Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIEL 348
              APE     K T   DV+SFG++  EV+  G+ P       + + +I+  F       
Sbjct: 218 ---APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------- 267

Query: 349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                 RLP P          I +++  C  +    RP    +   L 
Sbjct: 268 ------RLPTPMDCPSA----IYQLMMQCWQQERARRPKFADIVSILD 305

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  121 bits (305), Expect = 7e-32
 Identities = 55/289 (19%), Positives = 108/289 (37%), Gaps = 58/289 (20%)

Query: 133 IGNGGHGSVYRAEL--------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           +G G    +++                V +K     L        + F      ++++ H
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKV----LDKAHRNYSESFFEAASMMSKLSH 71

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
           +++V  YG C     + LV EF+K GSL   L  +     +    ++ V K +A A+ +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFL 129

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAH--------VADFGIAKFLKPDSS-----NWTEF 291
             +     +H ++ +KN+LL  E +          ++D GI+  + P         W   
Sbjct: 130 EENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV-- 184

Query: 292 AGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELD 349
                   PE +     +    D +SFG    E+   G  P   L        +      
Sbjct: 185 -------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-------SQRKL-- 228

Query: 350 EMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +  +   +LPAP  +       +  ++ +C++  P+ RP+ + + + L 
Sbjct: 229 QFYEDRHQLPAPKAA------ELANLINNCMDYEPDHRPSFRAIIRDLN 271

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  121 bits (307), Expect = 8e-32
 Identities = 60/282 (21%), Positives = 109/282 (38%), Gaps = 50/282 (17%)

Query: 133 IGNGGHGSVYRAEL--PSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G+G  G+VY+        +V   VAIK+      +      KE L E   +  + + ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
            +L G C       L+ + +  G L   +        +G    +N    +A  ++YL   
Sbjct: 80  CRLLGICL-TSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS-----------NWTEFAGTYG 296
                VHRD++++N+L+       + DFG+AK L  +              W        
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------- 186

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDP- 354
             A E       T + DV+S+GV   E++  G  P D +         ++I    +L+  
Sbjct: 187 --ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEIS--SILEKG 235

Query: 355 -RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            RLP P     +    +  ++  C     +SRP  + +  + 
Sbjct: 236 ERLPQPPICTID----VYMIMRKCWMIDADSRPKFRELIIEF 273

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  124 bits (313), Expect = 8e-32
 Identities = 71/275 (25%), Positives = 120/275 (43%), Gaps = 43/275 (15%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
            IG G  G V   +   G  VA+K     + +D     + FL E   +T++RH N+V+L 
Sbjct: 200 TIGKGEFGDVMLGDY-RGNKVAVKC----IKND--ATAQAFLAEASVMTQLRHSNLVQLL 252

Query: 192 GFCSHARHSF-LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
           G     +    +V E++ +GSL   L S      LG    +     V +A+ YL  + F 
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 310

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN------WTEFAGTYGYVAPELAY 304
             VHRD++++N+L+  +  A V+DFG+ K              WT         APE   
Sbjct: 311 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALR 359

Query: 305 TMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDP--RLPAPSR 361
             K + K DV+SFG+L  E+   G+ P   +            ++   ++   ++ AP  
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---------PLKDVVPRVEKGYKMDAPDG 410

Query: 362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                   + +V+ +C +    +RPT   + +QL+
Sbjct: 411 CPPA----VYDVMKNCWHLDAATRPTFLQLREQLE 441

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  120 bits (302), Expect = 2e-31
 Identities = 70/281 (24%), Positives = 118/281 (41%), Gaps = 53/281 (18%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           +G G  G V   +      VAIK             + EF+ E + +  + H  +V+LYG
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
            C+  R  F++ E++  G L   L            Q + + K V +A+ YL    F   
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQF--- 141

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPD----SSN------WTEFAGTYGYVAPEL 302
           +HRD++++N L++ +    V+DFG+++++  D    S        W+          PE+
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS---------PPEV 192

Query: 303 AYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELDEMLDPR 355
               K + K D+++FGVL  E+   GK P       +    I+                R
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-------------R 239

Query: 356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           L  P     EK+ +I+    SC +E  + RPT KI+   + 
Sbjct: 240 LYRP-HLASEKVYTIMY---SCWHEKADERPTFKILLSNIL 276

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  120 bits (302), Expect = 2e-31
 Identities = 71/282 (25%), Positives = 107/282 (37%), Gaps = 45/282 (15%)

Query: 133 IGNGGHGSVYRAEL--PSGQV--VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G+G  G V R E   PSG+   VA+K     + S       +F+ EV A+  + HRN++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA-MDDFIREVNAMHSLDHRNLI 84

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           +LYG         +V E    GSL   L                    VA+ + YL    
Sbjct: 85  RLYGVVL-TPPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR 141

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN------------WTEFAGTYG 296
           F   +HRD++++NLLL       + DFG+ + L  +  +            W        
Sbjct: 142 F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC------- 191

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTD-IELDEMLDP 354
             APE   T   +   D + FGV   E+   G+ P   L+        +  +   +    
Sbjct: 192 --APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKEGE 242

Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           RLP P        + I  V+  C    PE RPT   +   L 
Sbjct: 243 RLPRPEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  123 bits (310), Expect = 2e-31
 Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 45/278 (16%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
            +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQLY 245

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
              S     ++V E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +  
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY-- 301

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN----------WTEFAGTYGYVAPE 301
            VHRD+ + N+L+       VADFG+A+ ++ +             WT         APE
Sbjct: 302 -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---------APE 351

Query: 302 LAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDP--RLPA 358
            A   + T K DV+SFG+L  E+  KG+ P   +          + E+ + ++   R+P 
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---------VNREVLDQVERGYRMPC 402

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           P     E   S+ +++  C  + PE RPT + +   L+
Sbjct: 403 P----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  124 bits (313), Expect = 2e-31
 Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 39/277 (14%)

Query: 133 IGNGGHGSVYRAEL--PSGQV-VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G G  GSV +        Q+ VAIK              +E + E + + ++ +  IV+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD---TEEMMREAQIMHQLDNPYIVR 400

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
           L G C       LV E    G L   L      +E+  S    ++  V+  + YL    F
Sbjct: 401 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKNF 457

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT---YGYVAPELAYTM 306
              VHR+++++N+LL     A ++DFG++K L  D S +T  +       + APE     
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514

Query: 307 KITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           K + + DV+S+GV   E +  G+ P       + ++ I                 R+  P
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-------------RMECP 561

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                E    +  ++  C     E RP    V Q+++
Sbjct: 562 ----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  120 bits (303), Expect = 2e-31
 Identities = 61/271 (22%), Positives = 97/271 (35%), Gaps = 31/271 (11%)

Query: 122 RATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
                F     +G+G +G V++      G++ A+K+  S  P     D+   L EV +  
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR--SMSPFRGPKDRARKLAEVGSHE 111

Query: 181 EI-RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVAD 239
           ++ +H   V+L          +L  E     SL       A    L  +Q    ++    
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCE--AWGASLPEAQVWGYLRDTLL 168

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           AL++LH      +VH D+   N+ L       + DFG+   L    +      G   Y+A
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMA 224

Query: 300 PEL---AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           PEL   +Y        DV+S G+  LEV                           L P  
Sbjct: 225 PELLQGSY----GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG-------YLPPEF 273

Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
            A    +  +LRS++      L   P+ R T
Sbjct: 274 TA---GLSSELRSVLV---MMLEPDPKLRAT 298

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  122 bits (308), Expect = 3e-31
 Identities = 61/275 (22%), Positives = 119/275 (43%), Gaps = 39/275 (14%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
            +G G  G V+ A       VA+K           +  + FL E   +  ++H  +VKL+
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSVEAFLAEANVMKTLQHDKLVKLH 249

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
              +     +++ EF+ +GSL   L SD    +    + ++    +A+ ++++    +  
Sbjct: 250 AVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNY-- 305

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV---APELAYTMKI 308
            +HRD+ + N+L+       +ADFG+A+ ++ +   +T   G    +   APE       
Sbjct: 306 -IHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSF 362

Query: 309 TEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPAPSR 361
           T K DV+SFG+L +E++  G+ P       + + ++   +             R+P P  
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-------------RMPRPEN 409

Query: 362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             +E    +  ++  C    PE RPT + +   L 
Sbjct: 410 CPEE----LYNIMMRCWKNRPEERPTFEYIQSVLD 440

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  120 bits (302), Expect = 3e-31
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 24/214 (11%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLT-EVEALTEIRHRNIVKL 190
           +G G   +V+R     +G + AIK F     +   +   +    E E L ++ H+NIVKL
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVF----NNISFLRPVDVQMREFEVLKKLNHKNIVKL 72

Query: 191 YGF--CSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           +     +  RH  L+ EF   GSL  +L   + A  L  S+ + V++ V   +++L  + 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132

Query: 249 FPPIVHRDISSKNLLLDLEFEAH----VADFGIAKFLKPDSSNWTEFAGTYGYVAPEL-- 302
              IVHR+I   N++  +  +      + DFG A+ L+ D   +    GT  Y+ P++  
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYE 188

Query: 303 ------AYTMKITEKCDVYSFGVLALEVIKGKHP 330
                  +  K     D++S GV       G  P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  119 bits (300), Expect = 3e-31
 Identities = 71/278 (25%), Positives = 118/278 (42%), Gaps = 51/278 (18%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G  G V   +   G  VA+K   +          + FL E   +T++RH N+V+L G
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 193 FCSHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                +   ++V E++ +GSL   L S      LG    +     V +A+ YL  + F  
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF-- 138

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN------WTEFAGTYGYVAPELAYT 305
            VHRD++++N+L+  +  A V+DFG+ K              WT         APE    
Sbjct: 139 -VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALRE 188

Query: 306 MKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELDEMLDPRLPA 358
            K + K DV+SFG+L  E+   G+ P      +D +  +   +             ++ A
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------KMDA 235

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           P          + EV+ +C +     RP+   + +QL+
Sbjct: 236 PDGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLE 269

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  123 bits (310), Expect = 4e-31
 Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 45/278 (16%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
            +G G  G V+         VAIK           +  + FL E + + ++RH  +V+LY
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQLY 328

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
              S     ++V E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +  
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY-- 384

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN----------WTEFAGTYGYVAPE 301
            VHRD+ + N+L+       VADFG+A+ ++ +             WT         APE
Sbjct: 385 -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---------APE 434

Query: 302 LAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDP--RLPA 358
            A   + T K DV+SFG+L  E+  KG+ P   +          + E+ + ++   R+P 
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---------VNREVLDQVERGYRMPC 485

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           P     E   S+ +++  C  + PE RPT + +   L+
Sbjct: 486 P----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  119 bits (301), Expect = 4e-31
 Identities = 63/279 (22%), Positives = 113/279 (40%), Gaps = 46/279 (16%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVK 189
            IG+GG   V++      Q+ AIK     L          +  E+  L +++  +  I++
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH-HDC 248
           LY +    ++ ++V E      L + L    +       +R +  K + +A+  +H H  
Sbjct: 93  LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG- 147

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAPEL---- 302
              IVH D+   N L+  +    + DFGIA  ++PD+++       GT  Y+ PE     
Sbjct: 148 ---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 303 -------AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR 355
                      KI+ K DV+S G +   +  GK P  F        +N   +L  ++DP 
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISKLHAIIDPN 256

Query: 356 LPAP-----SRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
                     + +Q+ L+        CL   P+ R ++ 
Sbjct: 257 HEIEFPDIPEKDLQDVLK-------CCLKRDPKQRISIP 288

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  120 bits (304), Expect = 5e-31
 Identities = 65/287 (22%), Positives = 120/287 (41%), Gaps = 57/287 (19%)

Query: 133 IGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G V    L         VAIK         Q   +++FL E   + +  H NI+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 109

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           +L G  + ++   +V E+++ GSL + L    A  +    Q + +++G+A  + YL    
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 167

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN------------WTEFAGTYG 296
           +   VHRD++++N+L++      V+DFG+ + L+ D               WT       
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT------- 217

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELD 349
             +PE     K T   DV+S+G++  EV+  G+ P      +D + ++   +        
Sbjct: 218 --SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-------- 267

Query: 350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                RLP P          + +++  C  +   +RP  + +   L 
Sbjct: 268 -----RLPPPMDCPAA----LYQLMLDCWQKDRNNRPKFEQIVSILD 305

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  118 bits (298), Expect = 5e-31
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 40/222 (18%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLT--------- 174
            DF+    +G G  G+VY A E  S  ++A+K          ++ K +            
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALK----------VLFKAQLEKAGVEHQLRR 58

Query: 175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN-- 232
           EVE  + +RH NI++LYG+   A   +L+ E+   G++   L             + +  
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---------LSKFDEQ 109

Query: 233 ----VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
                I  +A+ALSY H      ++HRDI  +NLLL    E  +ADFG +    P S   
Sbjct: 110 RTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRT 165

Query: 289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
               GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 166 D-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (304), Expect = 5e-31
 Identities = 50/310 (16%), Positives = 101/310 (32%), Gaps = 52/310 (16%)

Query: 124 TNDFDAQYCIGNGGH--GSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
              ++    IG G     +V  A   P+G+ V +++    L +           E+    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSK 81

Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADA 240
              H NIV            ++V  F+  GS   ++ +      +       +++GV  A
Sbjct: 82  LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVLKA 140

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL-------KPDSSNWTEFAG 293
           L Y+HH      VHR + + ++L+ ++ + +++       +       +           
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 294 TYGYVAPELAYTMKI--TEKCDVYSFGVLALEVIKGK------HP--------------- 330
              +++PE+          K D+YS G+ A E+  G                        
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257

Query: 331 ------------RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKL-RSIVEVVFSC 377
                            S+++S L+  +           +PS              V  C
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317

Query: 378 LNESPESRPT 387
           L  +P++RP+
Sbjct: 318 LQRNPDARPS 327

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  119 bits (300), Expect = 1e-30
 Identities = 64/287 (22%), Positives = 115/287 (40%), Gaps = 62/287 (21%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKE--------FLTEVEALTEIR 183
            IG+GG   V++      Q+ AIK           V+ +E        +  E+  L +++
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIK----------YVNLEEADNQTLDSYRNEIAYLNKLQ 65

Query: 184 H--RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADAL 241
                I++LY +    ++ ++V E      L + L    +       +R +  K + +A+
Sbjct: 66  QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAV 121

Query: 242 SYLH-HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW--TEFAGTYGYV 298
             +H H     IVH D+   N L+  +    + DFGIA  ++PD+++       GT  Y+
Sbjct: 122 HTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 299 APEL-----------AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE 347
            PE                KI+ K DV+S G +   +  GK P  F        +N   +
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISK 229

Query: 348 LDEMLDPRLPAP-----SRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           L  ++DP           + +Q+ L+        CL   P+ R ++ 
Sbjct: 230 LHAIIDPNHEIEFPDIPEKDLQDVLK-------CCLKRDPKQRISIP 269

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  119 bits (300), Expect = 1e-30
 Identities = 50/313 (15%), Positives = 89/313 (28%), Gaps = 53/313 (16%)

Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEF 172
           E    +      + +G G    VY A         + Q   +K      P +  +  +  
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL- 117

Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQ--R 230
              +E L        +K Y        S LV E    G+L   ++      E    Q   
Sbjct: 118 ---MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH-----------VADFGIAK 279
           ++    +   +  +H      I+H DI   N +L   F              + D G + 
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 280 FLK--PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------- 330
            +K  P  + +T    T G+   E+        + D +        ++ G +        
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291

Query: 331 -------------RDFLSSISSSFLNTD-----IELDEMLDPRLPAPSRSVQEKLRSIVE 372
                         D  +      LN         LD +         +    K+R++  
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRN 351

Query: 373 VVFSCLNESPESR 385
            +   L E   SR
Sbjct: 352 RLIVLLLECKRSR 364

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  118 bits (297), Expect = 2e-30
 Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 31/266 (11%)

Query: 133 IGNGGHGSVYRAE---LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G GG   V+ A        + VA+K   + L  D     + F  E +    + H  IV 
Sbjct: 20  LGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 76

Query: 190 LY--GF--CSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
           +Y  G          ++V E++   +L  I+ ++     +   + + VI     AL++ H
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH 133

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA---GTYGYVAPEL 302
            +    I+HRD+   N+++       V DFGIA+ +    ++ T+ A   GT  Y++PE 
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190

Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF--LNTDIELDEMLDPRLPAPS 360
           A    +  + DVYS G +  EV+ G+ P    S +S ++  +  D          L A  
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA-- 248

Query: 361 RSVQEKLRSIVEVVFSCLNESPESRP 386
                    +  VV   L ++PE+R 
Sbjct: 249 --------DLDAVVLKALAKNPENRY 266

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  118 bits (298), Expect = 2e-30
 Identities = 64/288 (22%), Positives = 108/288 (37%), Gaps = 43/288 (14%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKL 190
           +  GG   VY A+ + SG+  A+K+  S          +  + EV  + ++  H NIV+ 
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN----RAIIQEVCFMKKLSGHPNIVQF 91

Query: 191 YGFCSHARHS-------FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
               S  +         FL+   L +G L   L    +   L     + +      A+ +
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN------------WTEF 291
           +H    PPI+HRD+  +NLLL  +    + DFG A  +                      
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 292 AGTYGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIEL 348
             T  Y  PE+        I EK D+++ G +   +   +HP  F        +N    +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FEDGAKLRIVNGKYSI 268

Query: 349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                P  P  ++       S++    + L  +PE R ++  V  QLQ
Sbjct: 269 -----P--PHDTQY--TVFHSLIR---AMLQVNPEERLSIAEVVHQLQ 304

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  118 bits (298), Expect = 2e-30
 Identities = 74/266 (27%), Positives = 125/266 (46%), Gaps = 27/266 (10%)

Query: 127 FDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDK-KEFLTEVEALTEIRH 184
           F     IG+G  G+VY A ++ + +VVAIKK        Q  +K ++ + EV  L ++RH
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
            N ++  G       ++LV E+   GS + +L  +   + L   +   V  G    L+YL
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
           H      ++HRD+ + N+LL       + DFG A  + P +S    F GT  ++APE+  
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVIL 223

Query: 305 TMKITE---KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR 361
            M   +   K DV+S G+  +E+ + K P   ++++S+ +    I        +  +P+ 
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---I-------AQNESPAL 273

Query: 362 SVQEKLRSIVEVVFSCLNESPESRPT 387
                       V SCL + P+ RPT
Sbjct: 274 QSGHWSEYFRNFVDSCLQKIPQDRPT 299

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  116 bits (294), Expect = 2e-30
 Identities = 58/282 (20%), Positives = 120/282 (42%), Gaps = 53/282 (18%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
            +G G  G V+         VA+K           +    FL E   + +++H+ +V+LY
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLVRLY 74

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
              +     +++ E+++ GSL   L +  +  +L  ++ +++   +A+ ++++    +  
Sbjct: 75  AVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD----SSN------WTEFAGTYGYVAPE 301
            +HRD+ + N+L+       +ADFG+A+ ++ +             WT         APE
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT---------APE 180

Query: 302 LAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELDEMLDP 354
                  T K DV+SFG+L  E++  G+ P       + + ++   +             
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------- 227

Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           R+  P    +E    + +++  C  E PE RPT   +   L+
Sbjct: 228 RMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE 265

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  119 bits (301), Expect = 2e-30
 Identities = 63/290 (21%), Positives = 116/290 (40%), Gaps = 54/290 (18%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALTEI-RHRNIV 188
           +G G  G+V       G+ VA+K           +        L E++ LTE   H N++
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVK----------RMLIDFCDIALMEIKLLTESDDHPNVI 72

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAIL----SSDAAAQELGWSQRMNVIKGVADALSYL 244
           + Y   +  R  ++  E L   +L  ++     SD   +       +++++ +A  +++L
Sbjct: 73  RYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAH-------------VADFGIAKFLKPDSSNWT-- 289
           H      I+HRD+  +N+L+                    ++DFG+ K L    S++   
Sbjct: 132 HSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 290 --EFAGTYGYVAPEL-------AYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISS 339
               +GT G+ APEL           ++T   D++S G +   ++ KGKHP     S  S
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248

Query: 340 SFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           + +     LDEM      +             +++   ++  P  RPT  
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEAT-------DLISQMIDHDPLKRPTAM 291

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  119 bits (299), Expect = 3e-30
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 24/214 (11%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLT-EVEALTEIRHRNIVKL 190
           +G G   +V+R     +G + AIK F     +   +   +    E E L ++ H+NIVKL
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVF----NNISFLRPVDVQMREFEVLKKLNHKNIVKL 72

Query: 191 YGF--CSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           +     +  RH  L+ EF   GSL  +L   + A  L  S+ + V++ V   +++L  + 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132

Query: 249 FPPIVHRDISSKNLLLDLEFEAH----VADFGIAKFLKPDSSNWTEFAGTYGYVAPEL-- 302
              IVHR+I   N++  +  +      + DFG A+ L+ D   +    GT  Y+ P++  
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYE 188

Query: 303 ------AYTMKITEKCDVYSFGVLALEVIKGKHP 330
                  +  K     D++S GV       G  P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  121 bits (305), Expect = 4e-30
 Identities = 55/262 (20%), Positives = 98/262 (37%), Gaps = 42/262 (16%)

Query: 132 CIGNGGHGSVYRAE--LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           CI +GG G +Y A     +G+ V +K       S     +   + E + L E+ H +IV+
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLV---HSGDAEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 190 LYGFCSHARHS-----FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
           ++ F  H         ++V E++   SL          Q+L  ++ +  +  +  ALSYL
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYL 198

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
           H      +V+ D+  +N++L  E +  + D G    +           GT G+ APE+  
Sbjct: 199 HSI---GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGY----LYGTPGFQAPEIVR 250

Query: 305 TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ 364
           T   T   D+Y+ G     +      R+                 + L    P       
Sbjct: 251 T-GPTVATDIYTVGRTLAALTLDLPTRNG-------------RYVDGLPEDDPVLKTY-- 294

Query: 365 EKLRSIVEVVFSCLNESPESRP 386
               S   ++   ++  P  R 
Sbjct: 295 ---DSYGRLLRRAIDPDPRQRF 313

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  118 bits (298), Expect = 4e-30
 Identities = 63/287 (21%), Positives = 115/287 (40%), Gaps = 62/287 (21%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKE--------FLTEVEALTEIR 183
            IG+GG   V++      Q+ AIK           V+ +E        +  E+  L +++
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIK----------YVNLEEADNQTLDSYRNEIAYLNKLQ 112

Query: 184 H--RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADAL 241
                I++LY +    ++ ++V E      L + L    +       +R +  K + +A+
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAV 168

Query: 242 SYLH-HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE--FAGTYGYV 298
             +H H     IVH D+   N L+  +    + DFGIA  ++PD+++  +    G   Y+
Sbjct: 169 HTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223

Query: 299 APEL-----------AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE 347
            PE                KI+ K DV+S G +   +  GK P  F        +N   +
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISK 276

Query: 348 LDEMLDPRLPAP-----SRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           L  ++DP           + +Q+ L+        CL   P+ R ++ 
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLK-------CCLKRDPKQRISIP 316

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (294), Expect = 8e-30
 Identities = 28/288 (9%), Positives = 67/288 (23%), Gaps = 44/288 (15%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +  G    V+   ++   +  A+K F     + +  + +       A   +   +  +  
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR-SELERLHEATFAAARLLGESPEEAR 128

Query: 192 GFCSHAR--------------------------HSFLVYEFLKRGSLAAILSSDAAAQE- 224
                                            +  L+        L  + S+       
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187

Query: 225 ---LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL 281
               G      +   +    + L       +VH   +  NL +  +    + D       
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL--- 241

Query: 282 KPDSSNWTEFAGTYGYVAPEL--AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS 339
               +     +    Y   E   A T   T   + +  G+    V     P   ++    
Sbjct: 242 WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301

Query: 340 SFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
                        D         + + +++++      LN     R  
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLL 346

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  115 bits (290), Expect = 2e-29
 Identities = 60/282 (21%), Positives = 109/282 (38%), Gaps = 50/282 (17%)

Query: 133 IGNGGHGSVYRAEL--PSGQV---VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G+G  G+VY+        +V   VAIK+      +      KE L E   +  + + ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
            +L G C       L+ + +  G L   +        +G    +N    +A  ++YL   
Sbjct: 80  CRLLGICL-TSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS-----------NWTEFAGTYG 296
                VHRD++++N+L+       + DFG+AK L  +              W        
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------- 186

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDP- 354
             A E       T + DV+S+GV   E++  G  P D +         ++I    +L+  
Sbjct: 187 --ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEIS--SILEKG 235

Query: 355 -RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            RLP P     +    +  ++  C     +SRP  + +  + 
Sbjct: 236 ERLPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEF 273

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  115 bits (290), Expect = 3e-29
 Identities = 62/267 (23%), Positives = 103/267 (38%), Gaps = 15/267 (5%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           +DF+    +G G  G V++    PSG V+A K  H  +       + + + E++ L E  
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECN 89

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
              IV  YG         +  E +  GSL  +L       E        V   V   L+Y
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTY 146

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           L       I+HRD+   N+L++   E  + DFG++  L  DS   + F GT  Y++PE  
Sbjct: 147 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-FVGTRSYMSPERL 202

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP----RDFLSSISSSFLNTDIELDEMLDPRLPAP 359
                + + D++S G+  +E+  G++P          +           +    PR P  
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRP 386
             +           +F  L+      P
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPP 289

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (288), Expect = 3e-29
 Identities = 61/277 (22%), Positives = 105/277 (37%), Gaps = 38/277 (13%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEAL-TEI 182
           ND +    +G+G  G V++     +G V+A+K+       +   + K  L +++ +    
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE---ENKRILMDLDVVLKSH 81

Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALS 242
               IV+ +G        F+  E +   +            E        +   +  AL 
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE---RILGKMTVAIVKALY 138

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           YL       ++HRD+   N+LLD   +  + DFGI+  L  D       AG   Y+APE 
Sbjct: 139 YLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPER 195

Query: 303 AYTMKITE-----KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD---- 353
                 T+     + DV+S G+  +E+  G+ P     +  + F        E+L     
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFP---YKNCKTDF--------EVLTKVLQ 244

Query: 354 ---PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
              P LP       +  +S V+    CL +    RP 
Sbjct: 245 EEPPLLPGHMGFSGD-FQSFVK---DCLTKDHRKRPK 277

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  114 bits (288), Expect = 4e-29
 Identities = 66/280 (23%), Positives = 110/280 (39%), Gaps = 39/280 (13%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE-ALTEI 182
            D      IG G +GSV +    PSGQ++A+K+  S +      ++K+ L +++  +   
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK---EQKQLLMDLDVVMRSS 78

Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM--NVIKGVADA 240
               IV+ YG        ++  E +   S         +  +    + +   +      A
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
           L++L  +    I+HRDI   N+LLD      + DFGI+  L  DS   T  AG   Y+AP
Sbjct: 138 LNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAP 194

Query: 301 E----LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           E     A       + DV+S G+   E+  G+ P    +S+         +    +  + 
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--------FDQLTQV-VKG 245

Query: 357 PAPSRSVQEKLRSIVEVVFS---------CLNESPESRPT 387
             P      +L +  E  FS         CL +    RP 
Sbjct: 246 DPP------QLSNSEEREFSPSFINFVNLCLTKDESKRPK 279

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  113 bits (286), Expect = 5e-29
 Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 26/208 (12%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE---------FLTEVEALTEI 182
           +G GG    +   +  + +V A K          IV K              E+     +
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGK----------IVPKSLLLKPHQREKMSMEISIHRSL 72

Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALS 242
            H+++V  +GF       F+V E  +R SL  +     A  E    +    ++ +     
Sbjct: 73  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQ 129

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           YLH +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  Y+APE+
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 186

Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHP 330
                 + + DV+S G +   ++ GK P
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  113 bits (285), Expect = 5e-29
 Identities = 58/289 (20%), Positives = 111/289 (38%), Gaps = 46/289 (15%)

Query: 122 RATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
           R T +F     IG+G  GSV++  +   G + AIK+  S  P    VD++  L EV A  
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHA 65

Query: 181 EI-RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQE-LGWSQRMNVIKGVA 238
            + +H ++V+ +   +   H  +  E+   GSLA  +S +         ++  +++  V 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLD-------------------LEFEAHVADFGIAK 279
             L Y+H      +VH DI   N+ +                     +    + D G   
Sbjct: 126 RGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 280 FLKPDSSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS 338
            +    S+     G   ++A E L        K D+++  +  +     +          
Sbjct: 183 RI----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-------- 230

Query: 339 SSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
               N D +  E+   RLP   + + ++   +++     ++  PE RP+
Sbjct: 231 --PRNGD-QWHEIRQGRLPRIPQVLSQEFTELLK---VMIHPDPERRPS 273

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  113 bits (284), Expect = 5e-29
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 40/222 (18%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLT--------- 174
           +DFD    +G G  G+VY A E  +  ++A+K          ++ K +            
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALK----------VLFKSQLEKEGVEHQLRR 63

Query: 175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN-- 232
           E+E  + +RH NI+++Y +    +  +L+ EF  RG L   L             R +  
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK---------HGRFDEQ 114

Query: 233 ----VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
                ++ +ADAL Y H      ++HRDI  +NLL+  + E  +ADFG +    P     
Sbjct: 115 RSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRR 170

Query: 289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           T   GT  Y+ PE+       EK D++  GVL  E + G  P
Sbjct: 171 T-MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  114 bits (287), Expect = 6e-29
 Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 38/214 (17%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE---------FLTEVEALTEI 182
           +G GG    +   +  + +V A K          IV K              E+     +
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGK----------IVPKSLLLKPHQREKMSMEISIHRSL 98

Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN------VIKG 236
            H+++V  +GF       F+V E  +R SL  +             + +        ++ 
Sbjct: 99  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR---------RKALTEPEARYYLRQ 149

Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
           +     YLH +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  
Sbjct: 150 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 206

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           Y+APE+      + + DV+S G +   ++ GK P
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  112 bits (283), Expect = 7e-29
 Identities = 62/282 (21%), Positives = 106/282 (37%), Gaps = 50/282 (17%)

Query: 133 IGNGGHGSVYRAEL--PSGQV--VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  G VY        G+   VA+K        D    K++F++E   +  + H +IV
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN---KEKFMSEAVIMKNLDHPHIV 76

Query: 189 KLYGFCSHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           KL G         +++ E    G L   L  +     L     +     +  A++YL   
Sbjct: 77  KLIGIIE--EEPTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESI 132

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN----------WTEFAGTYGY 297
                VHRDI+ +N+L+       + DFG++++++ +             W         
Sbjct: 133 NC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM-------- 181

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDP-- 354
            +PE     + T   DV+ F V   E++  GK P  +L        N D+    +L+   
Sbjct: 182 -SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------NKDVI--GVLEKGD 231

Query: 355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           RLP P          +  ++  C +  P  RP    +   L 
Sbjct: 232 RLPKPDLCPPV----LYTLMTRCWDYDPSDRPRFTELVCSLS 269

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  117 bits (294), Expect = 9e-29
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 17/208 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G GG G V R     +G+ VAIK+    L      +++ +  E++ + ++ H N+V   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK---NRERWCLEIQIMKKLNHPNVVSAR 78

Query: 192 ------GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
                    +      L  E+ + G L   L+       L       ++  ++ AL YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
            +    I+HRD+  +N++L    +     + D G AK L         F GT  Y+APEL
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVGTLQYLAPEL 194

Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHP 330
               K T   D +SFG LA E I G  P
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRP 222

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  112 bits (283), Expect = 1e-28
 Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 36/214 (16%)

Query: 122 RATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEV 176
             T +    +      G+G    V+   +  +G++ A+K                   E+
Sbjct: 2   MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI----KKSPAFRDSSLENEI 57

Query: 177 EALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL-AAILS------SDAAAQELGWSQ 229
             L +I+H NIV L        H +LV + +  G L   IL        DA+        
Sbjct: 58  AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS-------- 109

Query: 230 RMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLL-DLEFEAHV--ADFGIAKFLKPDS 285
              VI+ V  A+ YLH +     IVHRD+  +NLL    E  + +   DFG++K  +   
Sbjct: 110 --LVIQQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161

Query: 286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 319
              +   GT GYVAPE+      ++  D +S GV
Sbjct: 162 GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  113 bits (285), Expect = 2e-28
 Identities = 46/204 (22%), Positives = 82/204 (40%), Gaps = 29/204 (14%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL 190
           IG G    V R     +GQ  A+K    +   S   +  ++   E      ++H +IV+L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 191 YGFCSHARHSFLVYEFL----------KRGSLAAILSSDAAAQELGWSQRMNVIKGVADA 240
               S     ++V+EF+          KR     + S   A+         + ++ + +A
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS---------HYMRQILEA 142

Query: 241 LSYLH-HDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFLKPDSSNWTEFAGTYG 296
           L Y H ++    I+HRD+    +LL  +  +    +  FG+A  L           GT  
Sbjct: 143 LRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198

Query: 297 YVAPELAYTMKITEKCDVYSFGVL 320
           ++APE+       +  DV+  GV+
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVI 222

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  111 bits (280), Expect = 3e-28
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 36/221 (16%)

Query: 122 RATNDFDAQY----CIGNGGHGSVYRA-ELPSGQVVAIK-----KFHSPLPSDQIVDKKE 171
            +T+ F   Y     +G G    V R    P+ +  A+K        S    +    ++ 
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 172 FLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLKRGSL------AAILSSDAAAQE 224
            L EV+ L ++  H NI++L          FLV++ +K+G L         LS       
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-- 127

Query: 225 LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD 284
                   +++ + + +  LH      IVHRD+  +N+LLD +    + DFG +  L P 
Sbjct: 128 -------KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177

Query: 285 SSNWTEFAGTYGYVAPE-LAYTMKI-----TEKCDVYSFGV 319
                E  GT  Y+APE +  +M        ++ D++S GV
Sbjct: 178 EK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  111 bits (279), Expect = 3e-28
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 39/223 (17%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLT--------- 174
            DF     +G G    VYRA  + +G  VAIK          ++DKK             
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK----------MIDKKAMYKAGMVQRVQN 60

Query: 175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSS-------DAAAQELGW 227
           EV+   +++H +I++LY +   + + +LV E    G +   L +       + A      
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR----- 115

Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
               + +  +   + YLH      I+HRD++  NLLL       +ADFG+A  LK     
Sbjct: 116 ----HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168

Query: 288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
                GT  Y++PE+A       + DV+S G +   ++ G+ P
Sbjct: 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  113 bits (286), Expect = 3e-28
 Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 32/212 (15%)

Query: 124 TNDFDAQYC----IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA 178
              F  +Y     +G G    V R  ++ +GQ  A              D ++   E   
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMII--NTKKLSARDHQKLEREARI 63

Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLA-AILS------SDAAAQELGWSQRM 231
              ++H NIV+L+   S   H +L+++ +  G L   I++      +DA+          
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---------- 113

Query: 232 NVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFLKPDSSN 287
           + I+ + +A+ + H       +VHR++  +NLLL  + +     +ADFG+A  ++ +   
Sbjct: 114 HCIQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169

Query: 288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 319
           W  FAGT GY++PE+       +  D+++ GV
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV 201

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  112 bits (281), Expect = 4e-28
 Identities = 66/286 (23%), Positives = 106/286 (37%), Gaps = 58/286 (20%)

Query: 133 IGNGGHGSVYRAEL-PSGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G+G  G+V++    P G+     V IK         Q    +     + A+  + H +I
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQ--SFQAVTDHMLAIGSLDHAHI 77

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           V+L G C       LV ++L  GSL   +        LG    +N    +A  + YL   
Sbjct: 78  VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS-----------NWTEFAGTYG 296
                VHR+++++N+LL    +  VADFG+A  L PD              W        
Sbjct: 135 GM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM------- 184

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELD 349
             A E  +  K T + DV+S+GV   E++  G  P       +    +            
Sbjct: 185 --ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-------- 234

Query: 350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
                RL  P     +    +  V+  C       RPT K ++ + 
Sbjct: 235 -----RLAQPQICTID----VYMVMVKCWMIDENIRPTFKELANEF 271

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  110 bits (278), Expect = 4e-28
 Identities = 65/284 (22%), Positives = 107/284 (37%), Gaps = 56/284 (19%)

Query: 133 IGNGGHGSVYRAEL--PSGQV--VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G V++     P      VAIK   +         +++FL E   + +  H +IV
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPHIV 79

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           KL G  +     +++ E    G L + L        L  +  +     ++ AL+YL    
Sbjct: 80  KLIGVITENPV-WIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR 136

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD----SSN------WTEFAGTYGYV 298
           F   VHRDI+++N+L+       + DFG++++++      +S       W          
Sbjct: 137 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM--------- 184

Query: 299 APELAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELDEM 351
           APE     + T   DV+ FGV   E++  G  P       D +  I +            
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---------- 234

Query: 352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
              RLP P          +  ++  C    P  RP    +  QL
Sbjct: 235 ---RLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQL 271

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  114 bits (286), Expect = 5e-28
 Identities = 69/299 (23%), Positives = 107/299 (35%), Gaps = 57/299 (19%)

Query: 120 IVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIK---------KFHSPLPSDQ 165
           + +        Y      G+G +G V    E       AIK           +S    + 
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 166 IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL------AAILSSD 219
               +E   E+  L  + H NI+KL+      ++ +LV EF + G L             
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146

Query: 220 AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL---DLEFEAHVADFG 276
            AA         N++K +   + YLH      IVHRDI  +N+LL   +      + DFG
Sbjct: 147 DAA---------NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFG 194

Query: 277 IAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------ 330
           ++ F   D     +  GT  Y+APE     K  EKCDV+S GV+   ++ G  P      
Sbjct: 195 LSSFFSKDYK-LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQND 252

Query: 331 RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           +D +  +           D          S   +E ++         L      R T +
Sbjct: 253 QDIIKKV----EKGKYYFDF---NDWKNISDEAKELIK-------LMLTYDYNKRCTAE 297

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  110 bits (277), Expect = 6e-28
 Identities = 61/275 (22%), Positives = 115/275 (41%), Gaps = 33/275 (12%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE-ALTEI 182
           +D +    +G G +G V +   +PSGQ++A+K+  + + S    ++K  L +++ ++  +
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ---EQKRLLMDLDISMRTV 63

Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSS-DAAAQELGWSQRMNVIKGVADAL 241
                V  YG        ++  E +   SL           Q +       +   +  AL
Sbjct: 64  DCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
            +LH      ++HRD+   N+L++   +  + DFGI+ +L  D       AG   Y+APE
Sbjct: 123 EHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPE 179

Query: 302 --------LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-LNTDIELDEML 352
                     Y++    K D++S G+  +E+   + P     S  + F     +  +   
Sbjct: 180 RINPELNQKGYSV----KSDIWSLGITMIELAILRFP---YDSWGTPFQQLKQVVEEP-- 230

Query: 353 DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPT 387
            P+LPA   S   +          CL ++ + RPT
Sbjct: 231 SPQLPADKFS--AEFVDFTS---QCLKKNSKERPT 260

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  110 bits (278), Expect = 1e-27
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 44/225 (19%)

Query: 116 VYDEIVRATNDFDAQY----CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKK 170
           +  ++ R +  F   Y     IG G +    R     +    A+K          I+DK 
Sbjct: 9   IVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK----------IIDKS 58

Query: 171 --EFLTEVEAL-TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL-AAILS------SDA 220
             +   E+E L    +H NI+ L       ++ ++V E +K G L   IL        +A
Sbjct: 59  KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA 118

Query: 221 AAQELGWSQRMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAH----VADF 275
           +A          V+  +   + YLH       +VHRD+   N+L   E        + DF
Sbjct: 119 SA----------VLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDF 164

Query: 276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVL 320
           G AK L+ ++        T  +VAPE+         CD++S GVL
Sbjct: 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  110 bits (277), Expect = 1e-27
 Identities = 68/290 (23%), Positives = 119/290 (41%), Gaps = 53/290 (18%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQ--DELDFLMEALIISKFNHQN 94

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAIL----SSDAAAQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G L + L       +    L     ++V + +A    
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWTEFAGTYGYV- 298
           YL  + F   +HRDI+++N LL       V    DFG+A+ +    +++    G    + 
Sbjct: 155 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYR-KGGCAMLP 208

Query: 299 ----APE-LAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDI 346
                PE        T K D +SFGVL  E+   G  P      ++ L  ++S       
Sbjct: 209 VKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG----- 262

Query: 347 ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                   R+  P          +  ++  C    PE RP   I+ ++++
Sbjct: 263 --------RMDPPKNCPGP----VYRIMTQCWQHQPEDRPNFAIILERIE 300

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  112 bits (282), Expect = 2e-27
 Identities = 72/287 (25%), Positives = 113/287 (39%), Gaps = 43/287 (14%)

Query: 120 IVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPSDQIVDKKEFL 173
           +  +T  F  +Y      G G  G V    +  +GQ  A+K      +      DK+  L
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT--DKESLL 74

Query: 174 TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL------AAILSSDAAAQELGW 227
            EV+ L ++ H NI+KLY F     + +LV E    G L          S   AA     
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----- 129

Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL---DLEFEAHVADFGIAKFLKPD 284
                +I+ V   ++Y+H +    IVHRD+  +NLLL     +    + DFG++   +  
Sbjct: 130 ----RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182

Query: 285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFL 342
                +  GT  Y+APE+       EKCDV+S GV+   ++ G  P        I     
Sbjct: 183 KK-MKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240

Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
                 +    P+    S S ++ +R         L   P  R + +
Sbjct: 241 KGKYTFEL---PQWKKVSESAKDLIR-------KMLTYVPSMRISAR 277

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  108 bits (273), Expect = 2e-27
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)

Query: 124 TNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPSDQIVDKKEFLTEVE 177
              F  +Y I    G G  G V +  +  + Q  A+K  + +   +    D    L EVE
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTSTILREVE 73

Query: 178 ALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL-AAILS------SDAAAQELGWSQR 230
            L ++ H NI+KL+     +   ++V E    G L   I+        DAA         
Sbjct: 74  LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------- 124

Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFLKPDSSN 287
             +IK V   ++Y+H      IVHRD+  +N+LL+ + +     + DFG++   + ++  
Sbjct: 125 -RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179

Query: 288 WTEFAGTYGYVAPEL---AYTMKITEKCDVYSFGV 319
             +  GT  Y+APE+    Y     EKCDV+S GV
Sbjct: 180 MKDRIGTAYYIAPEVLRGTY----DEKCDVWSAGV 210

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  108 bits (272), Expect = 3e-27
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 35/213 (16%)

Query: 124 TNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPSDQIVDKKEFLTEVE 177
           +  F   Y +    G G    V R     +G   A K  +   L +    D ++   E  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREAR 57

Query: 178 ALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLA-AILS------SDAAAQELGWSQR 230
              +++H NIV+L+         +LV++ +  G L   I++      +DA+         
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--------- 108

Query: 231 MNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFE-AHV--ADFGIAKFLKPDSS 286
            + I+ + ++++Y H +     IVHR++  +NLLL  + + A V  ADFG+A  +    +
Sbjct: 109 -HCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163

Query: 287 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 319
            W  FAGT GY++PE+      ++  D+++ GV
Sbjct: 164 -WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  111 bits (280), Expect = 4e-27
 Identities = 72/290 (24%), Positives = 109/290 (37%), Gaps = 50/290 (17%)

Query: 120 IVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLT 174
           I          Y      G+G +G V    +  +    AIK       S       + L 
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII--RKTSVSTSSNSKLLE 85

Query: 175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL------AAILSSDAAAQELGWS 228
           EV  L  + H NI+KLY F    R+ +LV E  K G L          +   AA      
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA------ 139

Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL---DLEFEAHVADFGIAKFLKPDS 285
               +IK V   ++YLH      IVHRD+  +NLLL   + +    + DFG++   +   
Sbjct: 140 ---VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193

Query: 286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSSISS 339
               E  GT  Y+APE+    K  EKCDV+S GV+   ++ G  P      ++ L  +  
Sbjct: 194 K-MKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV-- 249

Query: 340 SFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
                    D    P     S   ++ ++         L    + R + +
Sbjct: 250 --EKGKYTFDS---PEWKNVSEGAKDLIK-------QMLQFDSQRRISAQ 287

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  110 bits (278), Expect = 4e-27
 Identities = 55/227 (24%), Positives = 87/227 (38%), Gaps = 35/227 (15%)

Query: 115 LVYDEIVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH----SPLPSDQ 165
           L  D+          +Y +    G+G  G V  A E  + + VAI+       +   + +
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180

Query: 166 IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL------AAILSSD 219
                   TE+E L ++ H  I+K+  F   A   ++V E ++ G L         L   
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEA 239

Query: 220 AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH---VADFG 276
                            +  A+ YLH +    I+HRD+  +N+LL  + E     + DFG
Sbjct: 240 TCK---------LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 287

Query: 277 IAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKI--TEKCDVYSFGVL 320
            +K L   S       GT  Y+APE L            D +S GV+
Sbjct: 288 HSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  109 bits (275), Expect = 4e-27
 Identities = 68/290 (23%), Positives = 118/290 (40%), Gaps = 53/290 (18%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G+G  G VY  ++      PS   VA+K     + S+Q  D+ +FL E   +++  H+N
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQ--DELDFLMEALIISKFNHQN 135

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSS----DAAAQELGWSQRMNVIKGVADALS 242
           IV+  G    +   F++ E +  G L + L       +    L     ++V + +A    
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHV---ADFGIAKFLKPDSSNWTEFAGTYGYV- 298
           YL  + F   +HRDI+++N LL       V    DFG+A+ +    + +    G    + 
Sbjct: 196 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYR-KGGCAMLP 249

Query: 299 ----APE-LAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDI 346
                PE        T K D +SFGVL  E+   G  P      ++ L  ++S       
Sbjct: 250 VKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG----- 303

Query: 347 ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                   R+  P          +  ++  C    PE RP   I+ ++++
Sbjct: 304 --------RMDPPKNCPGP----VYRIMTQCWQHQPEDRPNFAIILERIE 341

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  109 bits (275), Expect = 5e-27
 Identities = 68/277 (24%), Positives = 113/277 (40%), Gaps = 35/277 (12%)

Query: 133 IGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G VY   L          A+K  +         +  +FLTE   + +  H N++
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG---EVSQFLTEGIIMKDFSHPNVL 153

Query: 189 KLYGFCSHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G L   + ++           +     VA  + +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK 211

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV-----APEL 302
            F   VHRD++++N +LD +F   VADFG+A+ +     +      T   +     A E 
Sbjct: 212 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWMALES 267

Query: 303 AYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDP--RLPAP 359
             T K T K DV+SFGVL  E++ +G  P   +++          ++   L    RL  P
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---------FDITVYLLQGRRLLQP 318

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                     + EV+  C +   E RP+   +  ++ 
Sbjct: 319 EYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRIS 351

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  109 bits (274), Expect = 7e-27
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 35/219 (15%)

Query: 118 DEIVRATNDFDAQY----CIGNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPSDQIVDKKE 171
           + ++ A+  F   Y     +G G    V R     +G   A K  +   L +    D ++
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQK 74

Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLA-AILS------SDAAAQE 224
              E     +++H NIV+L+         +LV++ +  G L   I++      +DA+   
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--- 131

Query: 225 LGWSQRMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKF 280
                  + I+ + ++++Y H +     IVHR++  +NLLL  + +     +ADFG+A  
Sbjct: 132 -------HCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180

Query: 281 LKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 319
           +    + W  FAGT GY++PE+      ++  D+++ GV
Sbjct: 181 VNDSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  108 bits (271), Expect = 1e-26
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 35/213 (16%)

Query: 122 RATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEV 176
              +     + +    G G    VYR  +  + +  A+K         + VDKK   TE+
Sbjct: 46  SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL------KKTVDKKIVRTEI 99

Query: 177 EALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL-AAILS------SDAAAQELGWSQ 229
             L  + H NI+KL           LV E +  G L   I+        DAA        
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA-------- 151

Query: 230 RMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL-DLEFEAHV--ADFGIAKFLKPDSS 286
             + +K + +A++YLH +    IVHRD+  +NLL      +A +  ADFG++K ++    
Sbjct: 152 --DAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206

Query: 287 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 319
                 GT GY APE+        + D++S G+
Sbjct: 207 -MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  106 bits (268), Expect = 1e-26
 Identities = 69/285 (24%), Positives = 114/285 (40%), Gaps = 51/285 (17%)

Query: 133 IGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G VY   L          A+K  +         +  +FLTE   + +  H N++
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG---EVSQFLTEGIIMKDFSHPNVL 89

Query: 189 KLYGFCSHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G L   + ++           +     VA  + YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASK 147

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL-------KPDSSN------WTEFAGT 294
            F   VHRD++++N +LD +F   VADFG+A+ +         + +       W      
Sbjct: 148 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----- 199

Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLD 353
               A E   T K T K DV+SFGVL  E++ +G  P   +++          ++   L 
Sbjct: 200 ----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---------FDITVYLL 246

Query: 354 P--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              RL  P    +     + EV+  C +   E RP+   +  ++ 
Sbjct: 247 QGRRLLQP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  108 bits (271), Expect = 2e-26
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 37/221 (16%)

Query: 122 RATNDFDAQY----CIGNGGHGSVYRA-ELPSGQVVAIK----KFHSPLPSDQIVDKKEF 172
            A  +F  +Y     IG G    V R     +G   A+K          P      ++  
Sbjct: 87  AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146

Query: 173 LTEVEALTEIR-HRNIVKLYGFCSHARHSFLVYEFLKRGSL-AAILS------SDAAAQE 224
             E   L ++  H +I+ L      +   FLV++ +++G L   +         +     
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR--- 203

Query: 225 LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD 284
                  ++++ + +A+S+LH +    IVHRD+  +N+LLD   +  ++DFG +  L+P 
Sbjct: 204 -------SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253

Query: 285 SSNWTEFAGTYGYVAPE-LAYTMKITEK-----CDVYSFGV 319
                E  GT GY+APE L  +M  T        D+++ GV
Sbjct: 254 EK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  106 bits (266), Expect = 2e-26
 Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 42/217 (19%)

Query: 122 RATNDFDAQYCIGN----GGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEV 176
               D +  Y + N    G  G V  A +  +    A KK    +P   + D   F  E+
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK----IPKYFVEDVDRFKQEI 57

Query: 177 EALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL-AAILS------SDAAAQELGWSQ 229
           E +  + H NI++LY         +LV E    G L   ++       SDAA        
Sbjct: 58  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-------- 109

Query: 230 RMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFLKPDS 285
              ++K V  A++Y H  +    + HRD+  +N L   +       + DFG+A   KP  
Sbjct: 110 --RIMKDVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162

Query: 286 SNWTEFAGTYGYVAPEL---AYTMKITEKCDVYSFGV 319
                  GT  YV+P++    Y      +CD +S GV
Sbjct: 163 KMMRTKVGTPYYVSPQVLEGLY----GPECDEWSAGV 195

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  106 bits (266), Expect = 2e-26
 Identities = 67/295 (22%), Positives = 112/295 (37%), Gaps = 43/295 (14%)

Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLT 174
            I        +   IG G  G VY  E           AIK         ++   + FL 
Sbjct: 15  LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLR 71

Query: 175 EVEALTEIRHRNIVKLYGFCSHAR-HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNV 233
           E   +  + H N++ L G          ++  ++  G L   + S    +       ++ 
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISF 129

Query: 234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAG 293
              VA  + YL    F   VHRD++++N +LD  F   VADFG+A+ +  D   ++    
Sbjct: 130 GLQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQH 185

Query: 294 TYGYV-----APELAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSF 341
            +  +     A E   T + T K DV+SFGVL  E++ +G  P       D    ++   
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245

Query: 342 LNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                        RLP P          + +V+  C    P  RPT +++  +++
Sbjct: 246 -------------RLPQPEYCPDS----LYQVMQQCWEADPAVRPTFRVLVGEVE 283

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  107 bits (270), Expect = 3e-26
 Identities = 51/228 (22%), Positives = 87/228 (38%), Gaps = 35/228 (15%)

Query: 110 NFEGKLVYDEIVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSD 164
           +   K V   +          Y I    G+G  G V+R  E  +G+V   K     + + 
Sbjct: 32  DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF----INTP 87

Query: 165 QIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL-------AAILS 217
             +DK     E+  + ++ H  ++ L+          L+ EFL  G L          +S
Sbjct: 88  YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS 147

Query: 218 SDAAAQELGWSQRMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--AD 274
                         N ++   + L ++H H     IVH DI  +N++ + +  + V   D
Sbjct: 148 EAEVI---------NYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIID 194

Query: 275 FGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLA 321
           FG+A  L PD         T  + APE +     +    D+++ GVL 
Sbjct: 195 FGLATKLNPDEIVKVTT-ATAEFAAPEIVDREP-VGFYTDMWAIGVLG 240

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  106 bits (267), Expect = 3e-26
 Identities = 65/291 (22%), Positives = 115/291 (39%), Gaps = 54/291 (18%)

Query: 133 IGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  GSV  A+L     S   VA+K   + + +    D +EFL E   + E  H ++ 
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS--DIEEFLREAACMKEFDHPHVA 88

Query: 189 KLYGFCS------HARHSFLVYEFLKRGSLAAIL---SSDAAAQELGWSQRMNVIKGVAD 239
           KL G               ++  F+K G L A L           L     +  +  +A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS-----------NW 288
            + YL    F   +HRD++++N +L  +    VADFG+++ +                 W
Sbjct: 149 GMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205

Query: 289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIE 347
                     A E       T   DV++FGV   E++ +G+ P   + +          E
Sbjct: 206 L---------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN---------AE 247

Query: 348 LDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +   L    RL  P   ++E    + ++++ C +  P+ RP+   +  +L+
Sbjct: 248 IYNYLIGGNRLKQPPECMEE----VYDLMYQCWSADPKQRPSFTCLRMELE 294

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  106 bits (267), Expect = 3e-26
 Identities = 75/297 (25%), Positives = 123/297 (41%), Gaps = 63/297 (21%)

Query: 133 IGNGGHGSVYRAELPSG------QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G V+ AE  +        +VA+K     L       +++F  E E LT ++H++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQDFQREAELLTMLQHQH 104

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAIL------------SSDAAAQELGWSQRMNVI 234
           IV+ +G C+  R   +V+E+++ G L   L              D A   LG  Q + V 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL------KPDSSN- 287
             VA  + YL    F   VHRD++++N L+       + DFG+++ +      +      
Sbjct: 165 SQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221

Query: 288 ----WTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSF 341
               W           PE + Y  K T + DV+SFGV+  E+   GK P   LS      
Sbjct: 222 LPIRWM---------PPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLS------ 265

Query: 342 LNTDIELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
              + E  + +     L  P     E    +  ++  C    P+ R ++K V  +LQ
Sbjct: 266 ---NTEAIDCITQGRELERPRACPPE----VYAIMRGCWQREPQQRHSIKDVHARLQ 315

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  106 bits (266), Expect = 4e-26
 Identities = 65/294 (22%), Positives = 112/294 (38%), Gaps = 61/294 (20%)

Query: 133 IGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           +G G  GSV    L     +   VA+K       S +  + +EFL+E   + +  H N++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR--EIEEFLSEAACMKDFSHPNVI 99

Query: 189 KLYGFCS-----HARHSFLVYEFLKRGSLAAIL---SSDAAAQELGWSQRMNVIKGVADA 240
           +L G C            ++  F+K G L   L     +   + +     +  +  +A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS-----------NWT 289
           + YL +  F   +HRD++++N +L  +    VADFG++K +                 W 
Sbjct: 160 MEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216

Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFL 342
                    A E       T K DV++FGV   E+  +G  P       +    +     
Sbjct: 217 ---------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH- 266

Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                       RL  P   + E    + E+++SC    P  RPT  ++  QL+
Sbjct: 267 ------------RLKQPEDCLDE----LYEIMYSCWRTDPLDRPTFSVLRLQLE 304

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  105 bits (265), Expect = 5e-26
 Identities = 53/204 (25%), Positives = 81/204 (39%), Gaps = 31/204 (15%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFH----SPLPSDQIVDKKEFLTEVEALTEIRHRNI 187
           +G+G  G V  A E  + + VAIK       +   + +        TE+E L ++ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSL------AAILSSDAAAQELGWSQRMNVIKGVADAL 241
           +K+  F   A   ++V E ++ G L         L                    +  A+
Sbjct: 78  IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---------LYFYQMLLAV 127

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFLKPDSSNWTEFAGTYGYV 298
            YLH +    I+HRD+  +N+LL  + E     + DFG +K L   S       GT  Y+
Sbjct: 128 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYL 183

Query: 299 APE-LAYTMKI--TEKCDVYSFGV 319
           APE L            D +S GV
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGV 207

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  105 bits (265), Expect = 6e-26
 Identities = 56/203 (27%), Positives = 84/203 (41%), Gaps = 38/203 (18%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALTEIR-HRNI 187
           +G G      +     S Q  A+K          I+ K+       E+ AL     H NI
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVK----------IISKRMEANTQKEITALKLCEGHPNI 68

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSL-AAILS------SDAAAQELGWSQRMNVIKGVADA 240
           VKL+       H+FLV E L  G L   I        ++A+           +++ +  A
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS----------YIMRKLVSA 118

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFLKPDSSNWTEFAGTYGY 297
           +S++H      +VHRD+  +NLL   E +     + DFG A+   PD+        T  Y
Sbjct: 119 VSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175

Query: 298 VAPELAYTMKITEKCDVYSFGVL 320
            APEL       E CD++S GV+
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVI 198

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  108 bits (271), Expect = 6e-26
 Identities = 72/294 (24%), Positives = 117/294 (39%), Gaps = 54/294 (18%)

Query: 118 DEIVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPSDQIVDKKE 171
            E +     F  +Y I    G G  G V +  +  + Q  A+K  + +   +    D   
Sbjct: 11  RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTST 67

Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL-AAILS------SDAAAQE 224
            L EVE L ++ H NI+KL+     +   ++V E    G L   I+        DAA   
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--- 124

Query: 225 LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL---DLEFEAHVADFGIAKFL 281
                   +IK V   ++Y+H      IVHRD+  +N+LL   + + +  + DFG++   
Sbjct: 125 -------RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLS 335
           + ++    +  GT  Y+APE+       EKCDV+S GV+   ++ G  P       D L 
Sbjct: 175 QQNTK-MKDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232

Query: 336 SISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            +           D    P+    S   ++ +R         L   P  R T  
Sbjct: 233 RV----ETGKYAFDL---PQWRTISDDAKDLIR-------KMLTFHPSLRITAT 272

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  105 bits (265), Expect = 8e-26
 Identities = 41/227 (18%), Positives = 88/227 (38%), Gaps = 27/227 (11%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIK-------------KFHSPLPSDQIVDKKE 171
           ND+     +  G    +   E    +  A+K                +           +
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 172 FLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM 231
           F  E++ +T+I++   +   G  ++    +++YE+++  S+           +  ++  +
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFI 148

Query: 232 ------NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS 285
                  +IK V ++ SY+H+     I HRD+   N+L+D      ++DFG ++++  D 
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM-VDK 205

Query: 286 SNWTEFAGTYGYVAPELAYTMKIT--EKCDVYSFGVLALEVIKGKHP 330
                  GTY ++ PE           K D++S G+    +     P
Sbjct: 206 KIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  108 bits (270), Expect = 1e-25
 Identities = 64/280 (22%), Positives = 109/280 (38%), Gaps = 46/280 (16%)

Query: 133 IGNGGHGSVYRAEL--PSGQV--VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G V++     P      VAIK   +         +++FL E   + +  H +IV
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPHIV 454

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           KL G  +     +++ E    G L + L        L  +  +     ++ AL+YL    
Sbjct: 455 KLIGVIT-ENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR 511

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV-----APELA 303
           F   VHRDI+++N+L+       + DFG++++++  +     +  + G +     APE  
Sbjct: 512 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKLPIKWMAPESI 564

Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLSSISSSFLNTDIELDEMLDPRL 356
              + T   DV+ FGV   E++  G  P       D +  I +               RL
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------RL 611

Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           P P          +  ++  C    P  RP    +  QL 
Sbjct: 612 PMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLS 647

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  105 bits (264), Expect = 1e-25
 Identities = 47/207 (22%), Positives = 88/207 (42%), Gaps = 29/207 (14%)

Query: 126 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
                  +G G  G V++  E  +G  +A K     + +  + DK+E   E+  + ++ H
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKI----IKTRGMKDKEEVKNEISVMNQLDH 145

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSL-------AAILSSDAAAQELGWSQRMNVIKGV 237
            N+++LY          LV E++  G L       +  L+                +K +
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI---------LFMKQI 196

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKPDSSNWTEFAGTY 295
            + + ++H      I+H D+  +N+L        +   DFG+A+  KP       F GT 
Sbjct: 197 CEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTP 252

Query: 296 GYVAPE-LAYTMKITEKCDVYSFGVLA 321
            ++APE + Y   ++   D++S GV+A
Sbjct: 253 EFLAPEVVNYD-FVSFPTDMWSVGVIA 278

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  104 bits (262), Expect = 2e-25
 Identities = 53/339 (15%), Positives = 111/339 (32%), Gaps = 91/339 (26%)

Query: 122 RATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKK------------------FHSPLP 162
           R   DF+   C+G GG G V+ A+        AIK+                    + L 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 163 SDQIV------------------------------------DKKEFLTEVEALTEIRHRN 186
              IV                                           ++  +     +N
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH 246
            V      S   + ++  +  ++ +L   ++   + ++      +++   +A+A+ +LH 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS------------NWTEFAGT 294
                ++HRD+   N+   ++    V DFG+   +  D                T   GT
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML-- 352
             Y++PE  +    + K D++S G++  E++   +             +T +E   ++  
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YS-----------FSTQMERVRIITD 285

Query: 353 --DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
             + + P        +   +V+     L+ SP  RP   
Sbjct: 286 VRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEAT 321

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  103 bits (259), Expect = 2e-25
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 28/203 (13%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIK--KFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G    V +  +  +G+  A K  K      S + V ++E   EV  L EIRH NI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 190 LYGFCSHARHSFLVYEFLKRGSL------AAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           L+    +     L+ E +  G L         L+ D A            +K + D + Y
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT---------QFLKQILDGVHY 123

Query: 244 LHHDCFPPIVHRDISSKNLLL-DLEFEAH---VADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           LH      I H D+  +N++L D         + DFGIA  ++  +  +    GT  +VA
Sbjct: 124 LHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVA 179

Query: 300 PE-LAYTMKITEKCDVYSFGVLA 321
           PE + Y   +  + D++S GV+ 
Sbjct: 180 PEIVNYE-PLGLEADMWSIGVIT 201

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  104 bits (262), Expect = 2e-25
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 32/216 (14%)

Query: 124 TNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH--SPLPSDQIVDKKEFLTEV 176
               +  Y I    G+G    V +  E  +G   A K         S + V ++E   EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 177 EALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL------AAILSSDAAAQELGWSQR 230
             L ++ H NI+ L+    +     L+ E +  G L         LS + A         
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------- 118

Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL-DLEFEAH---VADFGIAKFLKPDSS 286
            + IK + D ++YLH      I H D+  +N++L D         + DFG+A  ++    
Sbjct: 119 -SFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 287 NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLA 321
            +    GT  +VAPE + Y   +  + D++S GV+ 
Sbjct: 175 -FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 208

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (261), Expect = 2e-25
 Identities = 57/261 (21%), Positives = 94/261 (36%), Gaps = 54/261 (20%)

Query: 112 EGKLVYDEIVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPSDQ 165
            G+        +  +   +Y +    G G +G V  A E  +  + AIK  + + +    
Sbjct: 9   SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68

Query: 166 IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL------------- 212
             D +   TEV  + ++ H NI +LY      ++  LV E    G L             
Sbjct: 69  PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128

Query: 213 ----------------------AAILSSDAAAQELGWSQRM--NVIKGVADALSYLHHDC 248
                                    +     + +    +++  N+++ +  AL YLH+  
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ- 187

Query: 249 FPPIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKP----DSSNWTEFAGTYGYVAPEL 302
              I HRDI  +N L        +   DFG++K        +    T  AGT  +VAPE+
Sbjct: 188 --GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245

Query: 303 --AYTMKITEKCDVYSFGVLA 321
                     KCD +S GVL 
Sbjct: 246 LNTTNESYGPKCDAWSAGVLL 266

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  103 bits (259), Expect = 3e-25
 Identities = 75/298 (25%), Positives = 122/298 (40%), Gaps = 64/298 (21%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G V+ AE           +VA+K     L    +  +K+F  E E LT ++H +
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKA----LKDPTLAARKDFQREAELLTNLQHEH 78

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSL-------------AAILSSDAAAQELGWSQRMNV 233
           IVK YG C       +V+E++K G L                     A  ELG SQ +++
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL------KPDSSN 287
              +A  + YL    F   VHRD++++N L+       + DFG+++ +      +     
Sbjct: 139 ASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 288 -----WTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSS 340
                W           PE + Y  K T + DV+SFGV+  E+   GK P   LS     
Sbjct: 196 MLPIRWM---------PPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLS----- 240

Query: 341 FLNTDIELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
               + E+ E +     L  P R   +++  ++     C    P+ R  +K + + L 
Sbjct: 241 ----NTEVIECITQGRVLERP-RVCPKEVYDVML---GCWQREPQQRLNIKEIYKILH 290

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  106 bits (266), Expect = 3e-25
 Identities = 50/246 (20%), Positives = 93/246 (37%), Gaps = 31/246 (12%)

Query: 90  SDSGDRQRSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCI----GNGGHGSVYRA- 144
                R +   + +    + +   +     +    +     Y I    G G  G V+R  
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT 177

Query: 145 ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY 204
           E  +G   A K     + +    DK+    E++ ++ +RH  +V L+          ++Y
Sbjct: 178 ERATGNNFAAKF----VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233

Query: 205 EFLKRGSL-------AAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDI 257
           EF+  G L          +S D A            ++ V   L ++H +     VH D+
Sbjct: 234 EFMSGGELFEKVADEHNKMSEDEAV---------EYMRQVCKGLCHMHEN---NYVHLDL 281

Query: 258 SSKNLLLDLEFEAHV--ADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVY 315
             +N++   +    +   DFG+   L P   +     GT  + APE+A    +    D++
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 340

Query: 316 SFGVLA 321
           S GVL+
Sbjct: 341 SVGVLS 346

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  103 bits (259), Expect = 3e-25
 Identities = 70/301 (23%), Positives = 115/301 (38%), Gaps = 74/301 (24%)

Query: 133 IGNGGHGSVYRAEL---PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIV 188
           IG G  G V +A +         AIK+       D   D ++F  E+E L ++  H NI+
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCKLGHHPNII 89

Query: 189 KLYGFCSHARHSFLVYEFLKRGSL-------------AAILSSDAAAQELGWSQRMNVIK 235
            L G C H  + +L  E+   G+L              A   +++ A  L   Q ++   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN-------- 287
            VA  + YL    F   +HRD++++N+L+   + A +ADFG+++                
Sbjct: 150 DVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 202

Query: 288 ----WTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDFLS 335
               W          A E L Y+   T   DV+S+GVL  E++  G  P       +   
Sbjct: 203 LPVRWM---------AIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252

Query: 336 SISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            +   +             RL  P     E    + +++  C  E P  RP+   +   L
Sbjct: 253 KLPQGY-------------RLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSL 295

Query: 396 Q 396
            
Sbjct: 296 N 296

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  103 bits (259), Expect = 4e-25
 Identities = 60/291 (20%), Positives = 117/291 (40%), Gaps = 55/291 (18%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G VY               VAIK   +   S +  ++ EFL E   + E    +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMR--ERIEFLNEASVMKEFNCHH 89

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAIL-------SSDAAAQELGWSQRMNVIKGVAD 239
           +V+L G  S  + + ++ E + RG L + L       +++        S+ + +   +AD
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL------KPDSSN-----W 288
            ++YL+ + F   VHRD++++N ++  +F   + DFG+ + +      +          W
Sbjct: 150 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206

Query: 289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIE 347
                     +PE       T   DV+SFGV+  E+    + P   LS         + +
Sbjct: 207 M---------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---------NEQ 248

Query: 348 LDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +   +     L  P  +  + L  ++     C   +P+ RP+   +   ++
Sbjct: 249 VLRFVMEGGLLDKP-DNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 295

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (259), Expect = 4e-25
 Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 34/220 (15%)

Query: 121 VRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH--SPLPSDQIVDKKEFL 173
           V    + D  Y      G+G    V +  E  +G   A K         S + V +++  
Sbjct: 3   VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62

Query: 174 TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL------AAILSSDAAAQELGW 227
            EV  L EI+H N++ L+    +     L+ E +  G L         L+ + A      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT----- 117

Query: 228 SQRMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLL-DLEFEAH---VADFGIAKFLK 282
                 +K + + + YLH       I H D+  +N++L D         + DFG+A  + 
Sbjct: 118 ----EFLKQILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169

Query: 283 PDSSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLA 321
             +  +    GT  +VAPE + Y   +  + D++S GV+ 
Sbjct: 170 FGNE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  103 bits (258), Expect = 5e-25
 Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 32/216 (14%)

Query: 124 TNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH--SPLPSDQIVDKKEFLTEV 176
               +  Y I    G+G    V +  E  +G   A K         S + V ++E   EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 177 EALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL------AAILSSDAAAQELGWSQR 230
             L ++ H N++ L+    +     L+ E +  G L         LS + A         
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------- 118

Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL-DLEFEAH---VADFGIAKFLKPDSS 286
            + IK + D ++YLH      I H D+  +N++L D         + DFG+A  ++    
Sbjct: 119 -SFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 287 NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLA 321
            +    GT  +VAPE + Y   +  + D++S GV+ 
Sbjct: 175 -FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 208

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  100 bits (252), Expect = 2e-24
 Identities = 27/258 (10%), Positives = 66/258 (25%), Gaps = 46/258 (17%)

Query: 132 CIGNGGHGSVYRAE---LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
             G       ++A    L   + VA+               +E L+    L+ I    + 
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPD-DVLQETLSRTLRLSRIDKPGVA 94

Query: 189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC 248
           ++           +V E+++ GSL  +               +  ++ +A A    H   
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRA- 148

Query: 249 FPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI 308
              +         + + ++ +  +A                        +          
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA------- 179

Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
             + D+   G     ++  + P     +   S L      +     +   P+   ++   
Sbjct: 180 NPQDDIRGIGASLYALLVNRWP--LPEAGVRSGLAP---AERDTAGQPIEPADIDRDIPF 234

Query: 369 SIVEVVFSCLNESPESRP 386
            I  V    +      R 
Sbjct: 235 QISAVAARSVQGDGGIRS 252

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  100 bits (252), Expect = 2e-24
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 23/208 (11%)

Query: 124 TNDFDAQYC----IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE-FLTEVE 177
               D  +     +G+G  G V+   E  SG    IK     +  D+     E    E+E
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT----INKDRSQVPMEQIEAEIE 72

Query: 178 ALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL-AAILSSDAAAQELGWSQRMNVIKG 236
            L  + H NI+K++       + ++V E  + G L   I+S+ A  + L       ++K 
Sbjct: 73  VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132

Query: 237 VADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFLKPDSSNWTEFA 292
           + +AL+Y H       +VH+D+  +N+L           + DFG+A+  K D    T  A
Sbjct: 133 MMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAA 187

Query: 293 GTYGYVAPE-LAYTMKITEKCDVYSFGV 319
           GT  Y+APE       +T KCD++S GV
Sbjct: 188 GTALYMAPEVFKR--DVTFKCDIWSAGV 213

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  102 bits (255), Expect = 3e-24
 Identities = 40/294 (13%), Positives = 84/294 (28%), Gaps = 59/294 (20%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSP--LPSDQIVDKKEFLTEVEALTEIRH----- 184
           +G     +   A    +G+   +   +     PS+ I   KE +  +  L  I++     
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 185 --------------RNIVKLYGFCSHARHSFLVYEFLKR-------GSLAAILSSDAAAQ 223
                             K+       R  +++  F           +   +L S ++  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 224 E-LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK 282
           + L    R+ +   V   L+ LHH     +VH  +   +++LD      +  F      +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 260

Query: 283 PDSSNWTEFAGTYG---YVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFL 334
             +S  +     +      A  +          +T   D ++ G+    +     P    
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NT 318

Query: 335 SSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTM 388
              +        E        +P P R+          ++   L    E R   
Sbjct: 319 DDAALG----GSEWIFRSCKNIPQPVRA----------LLEGFLRYPKEDRLLP 358

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  100 bits (252), Expect = 3e-24
 Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 35/221 (15%)

Query: 120 IVRATNDFDAQYCI-----GNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL 173
             ++  +F+  Y +     G G    V +     +GQ  A K             + E L
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD--CRAEIL 76

Query: 174 TEVEALTEIRHR-NIVKLYGFCSHARHSFLVYEFLKRGSL--------AAILSSDAAAQE 224
            E+  L   +    ++ L+    +     L+ E+   G +        A ++S +     
Sbjct: 77  HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI-- 134

Query: 225 LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFL 281
                   +IK + + + YLH +    IVH D+  +N+LL   +      + DFG+++ +
Sbjct: 135 -------RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184

Query: 282 KPDSSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLA 321
                   E  GT  Y+APE L Y   IT   D+++ G++A
Sbjct: 185 GHACE-LREIMGTPEYLAPEILNYD-PITTATDMWNIGIIA 223

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  100 bits (251), Expect = 4e-24
 Identities = 47/201 (23%), Positives = 80/201 (39%), Gaps = 32/201 (15%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V+R  E  S +    K         +  D+     E+  L   RHRNI+ L+
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISILNIARHRNILHLH 67

Query: 192 GFCSHARHSFLVYEFLKRGSL-------AAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
                     +++EF+    +       A  L+              + +  V +AL +L
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV---------SYVHQVCEALQFL 118

Query: 245 H-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
           H H+    I H DI  +N++      + +   +FG A+ LKP  +    F     Y APE
Sbjct: 119 HSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEYYAPE 173

Query: 302 -LAYTMKITEKCDVYSFGVLA 321
              + + ++   D++S G L 
Sbjct: 174 VHQHDV-VSTATDMWSLGTLV 193

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  100 bits (251), Expect = 5e-24
 Identities = 52/226 (23%), Positives = 91/226 (40%), Gaps = 46/226 (20%)

Query: 124 TNDFDAQY-----CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE 177
           +  F+  Y      +G G H  V     L + Q  A+K     +       +     EVE
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKI----IEKQPGHIRSRVFREVE 62

Query: 178 ALTEIR-HRNIVKLYGFCSHARHSFLVYEFLKRGSL-AAILS------SDAAAQELGWSQ 229
            L + + HRN+++L  F       +LV+E ++ GS+ + I         +A+        
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-------- 114

Query: 230 RMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFLKPDSS 286
              V++ VA AL +LH      I HRD+  +N+L +   +     + DF +   +K +  
Sbjct: 115 --VVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169

Query: 287 -------NWTEFAGTYGYVAPE-----LAYTMKITEKCDVYSFGVL 320
                        G+  Y+APE             ++CD++S GV+
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 63/301 (20%), Positives = 115/301 (38%), Gaps = 69/301 (22%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A         +   VA+K            +K+  ++E++ ++ + +H 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHAD--EKEALMSELKIMSHLGQHE 110

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSLAAIL-----------SSDAAAQELGWSQRMNVI 234
           NIV L G C+H     ++ E+   G L   L           +   A         ++  
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS-----SN-- 287
             VA  +++L        +HRD++++N+LL     A + DFG+A+ +  DS      N  
Sbjct: 171 SQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 288 ----WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP-------RDFLS 335
               W          APE  +    T + DV+S+G+L  E+   G +P         F  
Sbjct: 228 LPVKWM---------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278

Query: 336 SISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            +   +             ++  P+ + +     I  ++ +C    P  RPT + +   L
Sbjct: 279 LVKDGY-------------QMAQPAFAPKN----IYSIMQACWALEPTHRPTFQQICSFL 321

Query: 396 Q 396
           Q
Sbjct: 322 Q 322

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 47/219 (21%), Positives = 82/219 (37%), Gaps = 45/219 (20%)

Query: 124 TNDFDAQY-----CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE 177
                  Y      +G G +G V       +GQ  A+K          + D  +   EV+
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---------LLYDSPKARQEVD 73

Query: 178 ALTEI-RHRNIVKLYGFCSHARHS----FLVYEFLKRGSL--------AAILSSDAAAQE 224
              +     +IV +     +  H      ++ E ++ G L            +   AA+ 
Sbjct: 74  HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE- 132

Query: 225 LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFL 281
                   +++ +  A+ +LH      I HRD+  +NLL   + +     + DFG AK  
Sbjct: 133 --------IMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181

Query: 282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVL 320
             ++        T  YVAPE+    K  + CD++S GV+
Sbjct: 182 TQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 97.3 bits (243), Expect = 3e-23
 Identities = 60/303 (19%), Positives = 110/303 (36%), Gaps = 73/303 (24%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G    G VY+  L         Q VAIK             ++EF  E      ++H N
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGP--LREEFRHEAMLRARLQHPN 73

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSL-------------AAILSSDAAAQELGWSQRMNV 233
           +V L G  +  +   +++ +   G L              +          L     +++
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 234 IKGVADALSYL--HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL------KPDS 285
           +  +A  + YL  HH     +VH+D++++N+L+  +    ++D G+ + +      K   
Sbjct: 134 VAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 286 SN-----WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP------RDF 333
           ++     W          APE     K +   D++S+GV+  EV   G  P      +D 
Sbjct: 189 NSLLPIRWM---------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239

Query: 334 LSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ 393
           +  I +                LP P          +  ++  C NE P  RP  K +  
Sbjct: 240 VEMIRNRQ-------------VLPCPDDCPAW----VYALMIECWNEFPSRRPRFKDIHS 282

Query: 394 QLQ 396
           +L+
Sbjct: 283 RLR 285

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 41/206 (19%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKL 190
           +G G +G V +     + +  A+K          + D  +   EVE      +  +IV++
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALK---------MLQDCPKARREVELHWRASQCPHIVRI 120

Query: 191 YGFC----SHARHSFLVYEFLKRGSL-AAILS--------SDAAAQELGWSQRMNVIKGV 237
                   +  +   +V E L  G L + I           +A+           ++K +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS----------EIMKSI 170

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFLKPDSSNWTEFAGT 294
            +A+ YLH      I HRD+  +NLL   +       + DFG AK     +S  T    T
Sbjct: 171 GEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYT 226

Query: 295 YGYVAPELAYTMKITEKCDVYSFGVL 320
             YVAPE+    K  + CD++S GV+
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVI 252

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 63/300 (21%), Positives = 119/300 (39%), Gaps = 63/300 (21%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A         +   VA+K      PS  + +++  ++E++ L+ +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG--------- 236
           NIV L G C+    + ++ E+   G L   L     +     +    +            
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 237 ------VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-----S 285
                 VA  +++L        +HRD++++N+LL       + DFG+A+ +K D      
Sbjct: 148 LSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 286 SN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSIS 338
            N      W          APE  +    T + DV+S+G+   E+   G  P   +    
Sbjct: 205 GNARLPVKWM---------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--- 252

Query: 339 SSFLNTDIELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                 D +  +M+    R+ +P  +  E    + +++ +C +  P  RPT K + Q ++
Sbjct: 253 -----VDSKFYKMIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLIE 303

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 61/304 (20%), Positives = 118/304 (38%), Gaps = 72/304 (23%)

Query: 133 IGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE              VA+K       +++  D  + ++E+E +  I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEK--DLSDLVSEMEMMKMIGK 99

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSL-------------AAILSSDAAAQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G+L              +   +    +++ +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 231 MNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-----S 285
           ++    +A  + YL        +HRD++++N+L+       +ADFG+A+ +        +
Sbjct: 160 VSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 286 SN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP------RD 332
           +N      W          APE  +    T + DV+SFGVL  E+   G  P       +
Sbjct: 217 TNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267

Query: 333 FLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
               +                 R+  P  +   +L  ++     C +  P  RPT K + 
Sbjct: 268 LFKLLKEGH-------------RMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFKQLV 310

Query: 393 QQLQ 396
           + L 
Sbjct: 311 EDLD 314

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 65/308 (21%), Positives = 119/308 (38%), Gaps = 75/308 (24%)

Query: 133 IGNGGHGSVYRAELPSG------QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           IG G  G V++A  P         +VA+K       S     + +F  E   + E  + N
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASAD--MQADFQREAALMAEFDNPN 111

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSL---------------------AAILSSDAAAQEL 225
           IVKL G C+  +   L++E++  G L                          S      L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 226 GWSQRMNVIKGVADALSYL--HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL-- 281
             ++++ + + VA  ++YL          VHRD++++N L+       +ADFG+++ +  
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 282 ----KPDSSN-----WTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI-KGKHP 330
               K D ++     W           PE + Y  + T + DV+++GV+  E+   G  P
Sbjct: 227 ADYYKADGNDAIPIRWM---------PPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276

Query: 331 RDFLSSISSSFLNTDIELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTM 388
              ++           E+   +     L  P     E    +  ++  C ++ P  RP+ 
Sbjct: 277 YYGMA---------HEEVIYYVRDGNILACPENCPLE----LYNLMRLCWSKLPADRPSF 323

Query: 389 KIVSQQLQ 396
             + + LQ
Sbjct: 324 CSIHRILQ 331

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 95.5 bits (238), Expect = 6e-22
 Identities = 64/304 (21%), Positives = 115/304 (37%), Gaps = 72/304 (23%)

Query: 133 IGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE              VA+K       +++  D  + ++E+E +  I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEK--DLSDLISEMEMMKMIGK 133

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG------- 236
           H+NI+ L G C+     +++ E+  +G+L   L +             +  +        
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 237 ------VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-----S 285
                 VA  + YL        +HRD++++N+L+  +    +ADFG+A+ +        +
Sbjct: 194 VSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 286 SN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP------RD 332
           +N      W          APE  +    T + DV+SFGVL  E+   G  P       +
Sbjct: 251 TNGRLPVKWM---------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301

Query: 333 FLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
               +                 R+  PS    E    +  ++  C +  P  RPT K + 
Sbjct: 302 LFKLLKEGH-------------RMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLV 344

Query: 393 QQLQ 396
           + L 
Sbjct: 345 EDLD 348

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 93.9 bits (234), Expect = 8e-22
 Identities = 67/299 (22%), Positives = 113/299 (37%), Gaps = 62/299 (20%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A+        + + VA+K       +    + +  ++E++ L  I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHS--EHRALMSELKILIHIGHHL 91

Query: 186 NIVKLYGFCSHA-RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG-------- 236
           N+V L G C+       ++ EF K G+L+  L S             ++ K         
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 237 -----VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS----- 286
                VA  + +L        +HRD++++N+LL  +    + DFG+A+ +  D       
Sbjct: 152 CYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208

Query: 287 ------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISS 339
                  W          APE  +    T + DV+SFGVL  E+   G  P         
Sbjct: 209 DARLPLKWM---------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--------Y 251

Query: 340 SFLNTDIELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             +  D E    L    R+ AP  +  E    + + +  C +  P  RPT   + + L 
Sbjct: 252 PGVKIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLG 306

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 94.7 bits (235), Expect = 9e-22
 Identities = 37/301 (12%), Positives = 88/301 (29%), Gaps = 70/301 (23%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSD------------------------QIV 167
           +G     +   A +  +G+   +   +                              Q  
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 168 DKKEFLTEVEALTEIRHRNIVKLYGFCSH--ARHSFLVYEFLK--RGSLAAILSSDAAAQ 223
               F+   + + + + + ++++            F +Y  ++    +   +L S ++  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 224 E-LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK 282
           + L    R+ +   V   L+ LHH     +VH  +   +++LD      +  F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256

Query: 283 PDSSNWTEFAGTYGYVAPEL-----------AYTMKITEKCDVYSFGVLALEVIKGKHPR 331
                    + + G+  PEL                +T   D ++ G++   +     P 
Sbjct: 257 ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312

Query: 332 DFLSSISSSFLNTDIELDEML---DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTM 388
                      +  +   E +      +P P       +R+++E     L    E R   
Sbjct: 313 -I-------TKDAALGGSEWIFRSCKNIPQP-------VRALLE---GFLRYPKEDRLLP 354

Query: 389 K 389
            
Sbjct: 355 L 355

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 61/306 (19%), Positives = 118/306 (38%), Gaps = 76/306 (24%)

Query: 133 IGNGGHGSVYRAEL--------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-R 183
           +G G  G V  AE              VA+K       +++  D  + ++E+E +  I +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEK--DLSDLVSEMEMMKMIGK 145

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSL-------------AAILSSDAAAQELGWSQR 230
           H+NI+ L G C+     +++ E+  +G+L              +   +    +++ +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 231 MNVIKGVADALSYL--HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD---- 284
           ++    +A  + YL          +HRD++++N+L+       +ADFG+A+ +       
Sbjct: 206 VSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260

Query: 285 -SSN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP------ 330
            ++N      W          APE  +    T + DV+SFGVL  E+   G  P      
Sbjct: 261 KTTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311

Query: 331 RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKI 390
            +    +                 R+  P  +   +L  ++     C +  P  RPT K 
Sbjct: 312 EELFKLLKEGH-------------RMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFKQ 354

Query: 391 VSQQLQ 396
           + + L 
Sbjct: 355 LVEDLD 360

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 66/312 (21%), Positives = 115/312 (36%), Gaps = 83/312 (26%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G  G V +A             VA+K       S    + ++ L+E   L ++ H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASPS--ELRDLLSEFNVLKQVNHPH 87

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAIL--SSDAAAQELGWSQRMNVIKG-------- 236
           ++KLYG CS      L+ E+ K GSL   L  S       LG     N            
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 237 -----------VADALSYL--HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP 283
                      ++  + YL         +VHRD++++N+L+    +  ++DFG+++ +  
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 284 D-----SSN------WTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI------ 325
           +      S       W          A E L      T + DV+SFGVL  E++      
Sbjct: 203 EDSYVKRSQGRIPVKWM---------AIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP 252

Query: 326 -KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPES 384
             G  P    + + +               R+  P    +E    +  ++  C  + P+ 
Sbjct: 253 YPGIPPERLFNLLKTGH-------------RMERPDNCSEE----MYRLMLQCWKQEPDK 295

Query: 385 RPTMKIVSQQLQ 396
           RP    +S+ L+
Sbjct: 296 RPVFADISKDLE 307

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 56/201 (27%), Positives = 85/201 (42%), Gaps = 33/201 (16%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEF--------LTEVEALTEIR 183
           IG G    V  A  + +G+ VAIK          I+DK +           EV  +  + 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIK----------IIDKTQLNPTSLQKLFREVRIMKILN 72

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           H NIVKL+      +  +L+ E+   G +   L +    +E    +  +  + +  A+ Y
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE---KEARSKFRQIVSAVQY 129

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL- 302
            H      IVHRD+ ++NLLLD +    +ADFG +            F G   Y APEL 
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPELF 185

Query: 303 ---AYTMKITEKCDVYSFGVL 320
               Y      + DV+S GV+
Sbjct: 186 QGKKYDGP---EVDVWSLGVI 203

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 55/224 (24%), Positives = 88/224 (39%), Gaps = 40/224 (17%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
            DF     +G G   +V  A EL + +  AIK     L    I+ + +      E + ++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 85

Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGSL------AAILSSDAA----AQELGWSQR 230
            + H   VKLY         +    + K G L                   A+       
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE------- 138

Query: 231 MNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN-- 287
                 +  AL YLH       I+HRD+  +N+LL+ +    + DFG AK L P+S    
Sbjct: 139 ------IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188

Query: 288 -WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
             + F GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 189 ANS-FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 92.4 bits (230), Expect = 6e-21
 Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 40/224 (17%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           + F+    IG G  G V   +   + ++ A+K     +   + V++ E      E++ + 
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKY----MNKQKCVERNEVRNVFKELQIMQ 70

Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGSL------AAILSSDAA---AQELGWSQR 230
            + H  +V L Y F       F+V + L  G L            +       EL     
Sbjct: 71  GLEHPFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL----- 124

Query: 231 MNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
                    AL YL        I+HRD+   N+LLD     H+ DF IA  L  ++   T
Sbjct: 125 -------VMALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173

Query: 290 EFAGTYGYVAPELAYTMKI---TEKCDVYSFGVLALEVIKGKHP 330
             AGT  Y+APE+  + K    +   D +S GV A E+++G+ P
Sbjct: 174 -MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 92.0 bits (229), Expect = 6e-21
 Identities = 61/307 (19%), Positives = 114/307 (37%), Gaps = 72/307 (23%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G+G  G V  A             VA+K            +++  ++E++ +T++  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSS--EREALMSELKMMTQLGSHE 109

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSL--------------------AAILSSDAAAQEL 225
           NIV L G C+ +   +L++E+   G L                       L  +     L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 226 GWSQRMNVIKGVADALSYL--HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP 283
            +   +     VA  + +L          VHRD++++N+L+       + DFG+A+ +  
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 284 D-----SSN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPR 331
           D       N      W          APE  +    T K DV+S+G+L  E+   G +P 
Sbjct: 225 DSNYVVRGNARLPVKWM---------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP- 274

Query: 332 DFLSSISSSFLNTDIELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
                     +  D    +++    ++  P  + +E    I  ++ SC       RP+  
Sbjct: 275 -------YPGIPVDANFYKLIQNGFKMDQPFYATEE----IYIIMQSCWAFDSRKRPSFP 323

Query: 390 IVSQQLQ 396
            ++  L 
Sbjct: 324 NLTSFLG 330

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 18/202 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G +G V +     +G++VAIKKF      D  + KK  + E++ L ++RH N+V L 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFL--ESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
             C   +  +LV+EF+   ++   L  +     L +      +  + + + + H      
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSHN--- 144

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL-----AYTM 306
           I+HRDI  +N+L+       + DFG A+ L      + +   T  Y APEL      Y  
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGK 204

Query: 307 KITEKCDVYSFGVLALEVIKGK 328
            +    DV++ G L  E+  G+
Sbjct: 205 AV----DVWAIGCLVTEMFMGE 222

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 54/219 (24%), Positives = 83/219 (37%), Gaps = 43/219 (19%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
            G G  G+V    E  +G  VAIKK            +   L  ++ L  + H NIV+L 
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKVI-----QDPRFRNRELQIMQDLAVLHHPNIVQLQ 85

Query: 191 YGFCSHARHSF------LVYEF----LKRGSLAAILSSDAAAQELGWSQRMNVIKG---- 236
             F +            +V E+    L R       +               +IK     
Sbjct: 86  SYFYTLGERDRRDIYLNVVMEYVPDTLHR----CCRNYYRRQVAP----PPILIKVFLFQ 137

Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSSNWTEFAGTY 295
           +  ++  LH      + HRDI   N+L++       + DFG AK L P   N   +  + 
Sbjct: 138 LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYICSR 195

Query: 296 GYVAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 328
            Y APEL      YT  +    D++S G + A E++ G+
Sbjct: 196 YYRAPELIFGNQHYTTAV----DIWSVGCIFA-EMMLGE 229

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 89.5 bits (223), Expect = 2e-20
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 18/202 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V++     +GQ+VAIKKF      D  V KK  L E+  L +++H N+V L 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFL--ESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                 R   LV+E+    ++   L  D   + +      ++      A+++ H      
Sbjct: 69  EVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKHN--- 122

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL-----AYTM 306
            +HRD+  +N+L+       + DFG A+ L   S  + +   T  Y +PEL      Y  
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182

Query: 307 KITEKCDVYSFGVLALEVIKGK 328
            +    DV++ G +  E++ G 
Sbjct: 183 PV----DVWAIGCVFAELLSGV 200

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 69/219 (31%), Positives = 99/219 (45%), Gaps = 49/219 (22%)

Query: 133 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IGNG  G VY+A+L  SG++VAIKK           DK+    E++ + ++ H NIV+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVL--------QDKRFKNRELQIMRKLDHCNIVRLR 113

Query: 192 GFCSHARHSF------LVYEF----LKRGSLAAILSSDAAAQELGWSQRMNVIKG----V 237
            F   +          LV ++    + R           A Q L     +  +K     +
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYR----VARHYSRAKQTLP----VIYVKLYMYQL 165

Query: 238 ADALSYLH-HDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSSNWTEFAGTY 295
             +L+Y+H       I HRDI  +NLLLD +     + DFG AK L     N   +  + 
Sbjct: 166 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSR 220

Query: 296 GYVAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 328
            Y APEL      YT  I    DV+S G VLA E++ G+
Sbjct: 221 YYRAPELIFGATDYTSSI----DVWSAGCVLA-ELLLGQ 254

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 59/278 (21%), Positives = 108/278 (38%), Gaps = 60/278 (21%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIK---KFHSPLPSDQIVDKKEFLT---EVEALTEIRHR 185
           +G+G  G V+ A      + V +K   K    +  D  ++  +      E+  L+ + H 
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKK--EKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRG-------SLAAILSSDAAAQELGWSQRMNVIKGVA 238
           NI+K+     +     LV E    G            L    A+          + + + 
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS---------YIFRQLV 140

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
            A+ YL       I+HRDI  +N+++  +F   + DFG A +L+     +T F GT  Y 
Sbjct: 141 SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYC 196

Query: 299 APEL----AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP 354
           APE+     Y      + +++S GV    ++  ++P                EL+E ++ 
Sbjct: 197 APEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFC--------------ELEETVEA 239

Query: 355 RLPAP---SRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
            +  P   S+ +   +  +       L   PE R T++
Sbjct: 240 AIHPPYLVSKELMSLVSGL-------LQPVPERRTTLE 270

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 48/218 (22%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IGNG  G V++A+L     VAIKK           DK+    E++ +  ++H N+V L  
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQ--------DKRFKNRELQIMRIVKHPNVVDLKA 99

Query: 193 FCSHARHS------FLVYEF----LKRGSLAAILSSDAAAQELGWSQRMNVIKG----VA 238
           F              LV E+    + R    A        Q +     M +IK     + 
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYR----ASRHYAKLKQTMP----MLLIKLYMYQLL 151

Query: 239 DALSYLH-HDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
            +L+Y+H       I HRDI  +NLLLD       + DFG AK L     N   +  +  
Sbjct: 152 RSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYICSRY 206

Query: 297 YVAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 328
           Y APEL      YT  I    D++S G V+A E+++G+
Sbjct: 207 YRAPELIFGATNYTTNI----DIWSTGCVMA-ELMQGQ 239

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 34/202 (16%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLT---------EVEALTEI 182
           +G G  G V   E   +G  VA+K          I+++++  +         E++ L   
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVK----------ILNRQKIRSLDVVGKIKREIQNLKLF 68

Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALS 242
           RH +I+KLY   S     F+V E++  G L   +      +E    +   + + +  A+ 
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE---MEARRLFQQILSAVD 125

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      +VHRD+  +N+LLD    A +ADFG++  +       T   G+  Y APE+
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEV 181

Query: 303 ----AYTMKITEKCDVYSFGVL 320
                Y      + D++S GV+
Sbjct: 182 ISGRLYA---GPEVDIWSCGVI 200

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 50/220 (22%), Positives = 75/220 (34%), Gaps = 62/220 (28%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLT------------EVEAL 179
           +G GG G+V+    L     VAIK          ++ +   L             EV  L
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIK----------VIPRNRVLGWSPLSDSVTCPLEVALL 88

Query: 180 TEIR----HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQEL----GWSQRM 231
            ++     H  +++L  +        LV E                 Q+L         +
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA------------QDLFDYITEKGPL 136

Query: 232 ------NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPD 284
                      V  A+ + H      +VHRDI  +N+L+DL    A + DFG    L   
Sbjct: 137 GEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-- 191

Query: 285 SSNWTEFAGTYGYVAPEL----AYTMKITEKCDVYSFGVL 320
              +T+F GT  Y  PE      Y         V+S G+L
Sbjct: 192 DEPYTDFDGTRVYSPPEWISRHQYHAL---PATVWSLGIL 228

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 67/273 (24%), Positives = 110/273 (40%), Gaps = 37/273 (13%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           N F     +G GG G V   ++  +G++ A KK    L   +I  +K     L E + L 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKK----LEKKRIKKRKGEAMALNEKQILE 239

Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG--V 237
           ++  R +V L Y + +      LV   +  G L   +       + G+ +   V     +
Sbjct: 240 KVNSRFVVSLAYAYETKD-ALCLVLTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEI 295

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKPDSSNWTEFAGTY 295
              L  LH +    IV+RD+  +N+LLD     H+  +D G+A  +    +      GT 
Sbjct: 296 CCGLEDLHRER---IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKG-RVGTV 349

Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR 355
           GY+APE+    + T   D ++ G L  E+I G+ P  F            I+ +E+    
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP--FQQR------KKKIKREEVERLV 401

Query: 356 LPAP---SRSVQEKLRSIVEVVFSCLNESPESR 385
              P   S     + RS+       L + P  R
Sbjct: 402 KEVPEEYSERFSPQARSLCS---QLLCKDPAER 431

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 58/233 (24%), Positives = 92/233 (39%), Gaps = 51/233 (21%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKE---FLTEVEALT 180
           +DF+    IG G    V   ++  +GQV A+K     +    ++ + E   F  E + L 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI----MNKWDMLKRGEVSCFREERDVLV 116

Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGSLAAILSSDA-----------AAQELGWS 228
               R I +L + F     + +LV E+   G L  +LS               A+     
Sbjct: 117 NGDRRWITQLHFAFQD-ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE----- 170

Query: 229 QRMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKPDS 285
                   +  A+  +H        VHRDI   N+LLD     H+  ADFG    L+ D 
Sbjct: 171 --------IVMAIDSVHRLG----YVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADG 216

Query: 286 SNWTE-FAGTYGYVAPELAYTMKITEK-------CDVYSFGVLALEVIKGKHP 330
           +  +    GT  Y++PE+   +            CD ++ GV A E+  G+ P
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 54/219 (24%), Positives = 85/219 (38%), Gaps = 62/219 (28%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLT------------EVEAL 179
           +G+GG GSVY    +     VAIK           V+K                 EV  L
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIK----------HVEKDRISDWGELPNGTRVPMEVVLL 100

Query: 180 TEIRHR--NIVKLYGFCSHARHSFLVYEF-----------LKRGSLAAILSSDAAAQELG 226
            ++      +++L  +        L+ E             +RG+L      +  A+   
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL-----QEELARSFF 155

Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDS 285
           W Q       V +A+ + H+     ++HRDI  +N+L+DL   E  + DFG    LK   
Sbjct: 156 W-Q-------VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--D 202

Query: 286 SNWTEFAGTYGYVAPEL----AYTMKITEKCDVYSFGVL 320
           + +T+F GT  Y  PE      Y  +      V+S G+L
Sbjct: 203 TVYTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGIL 238

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 84.0 bits (208), Expect = 6e-18
 Identities = 51/227 (22%), Positives = 89/227 (39%), Gaps = 44/227 (19%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE---FLTEVEALT 180
            D++    IG G  G V       + +V A+K     L   +++ + +   F  E + + 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL----LSKFEMIKRSDSAFFWEERDIMA 124

Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILS------SDA---AAQELGWSQRM 231
                 +V+L+      R+ ++V E++  G L  ++S        A    A+        
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE-------- 176

Query: 232 NVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKPDSSNW 288
                V  AL  +H        +HRD+   N+LLD     H+  ADFG    +  +    
Sbjct: 177 -----VVLALDAIHSMG----FIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVR 225

Query: 289 TE-FAGTYGYVAPEL----AYTMKITEKCDVYSFGVLALEVIKGKHP 330
            +   GT  Y++PE+            +CD +S GV   E++ G  P
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 56/221 (25%), Positives = 88/221 (39%), Gaps = 39/221 (17%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           + FD    +G G  G V   +   SG   A+K     L   ++V  K+    L E   L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI----LDKQKVVKLKQIEHTLNEKRILQ 96

Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDA----------AAQELGWSQR 230
            +    +VKL        + ++V E++  G + + L              AAQ       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ------- 149

Query: 231 MNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
                 +     YLH  D    +++RD+  +NLL+D +    V DFG AK  +     WT
Sbjct: 150 ------IVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWT 197

Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
              GT   +APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 198 -LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 81.9 bits (203), Expect = 9e-18
 Identities = 49/215 (22%), Positives = 85/215 (39%), Gaps = 35/215 (16%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIK------------KFHSPLPSDQIVDKKEFLT----- 174
           IG G +G V  A         A+K                P P          +      
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 175 -----EVEALTEIRHRNIVKLYGFCSHA--RHSFLVYEFLKRGSLAAILSSDAAAQELGW 227
                E+  L ++ H N+VKL          H ++V+E + +G +  + +    +++   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140

Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
               ++IKG+     YLH+     I+HRDI   NLL+  +    +ADFG++   K   + 
Sbjct: 141 FYFQDLIKGI----EYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193

Query: 288 WTEFAGTYGYVAPELAYTMKIT---EKCDVYSFGV 319
            +   GT  ++APE     +     +  DV++ GV
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 58/231 (25%), Positives = 92/231 (39%), Gaps = 49/231 (21%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKE---FLTEVEALT 180
            DF+    IG G  G V   +L  + +V A+K     L   +++ + E   F  E + L 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI----LNKWEMLKRAETACFREERDVLV 129

Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGSLAAILSSDA-----------AAQELGWS 228
               + I  L Y F     + +LV ++   G L  +LS               A+     
Sbjct: 130 NGDSKWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE----- 183

Query: 229 QRMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKPDS 285
                   +  A+  +H        VHRDI   N+L+D     H+  ADFG    L  D 
Sbjct: 184 --------MVIAIDSVHQLH----YVHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDG 229

Query: 286 SNWTE-FAGTYGYVAPELAYTMKITEK-----CDVYSFGVLALEVIKGKHP 330
           +  +    GT  Y++PE+   M+  +      CD +S GV   E++ G+ P
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 52/208 (25%), Positives = 77/208 (37%), Gaps = 50/208 (24%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLT-----EVEALTEIRHRN 186
           IG+G  G         + ++VA+K           +++   +      E+     +RH N
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVK----------YIERGAAIDENVQREIINHRSLRHPN 77

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSL------AAILSSDAAA---QELGWSQRMNVIKGV 237
           IV+         H  ++ E+   G L      A   S D A    Q+L            
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------------ 125

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH--VADFGIAKFLKPDSSNWTEFAGTY 295
              +SY H      I HRD+  +N LLD        + DFG +K     S   +   GT 
Sbjct: 126 LSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTP 181

Query: 296 GYVAPEL----AYTMKITEKCDVYSFGV 319
            Y+APE+     Y  K     DV+S GV
Sbjct: 182 AYIAPEVLLRQEYDGK---IADVWSCGV 206

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 32/211 (15%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE-----FLTEVEALTEIRHRN 186
           +GNG + +VY+     +G  VA+K+          +D +E      + E+  + E++H N
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVK--------LDSEEGTPSTAIREISLMKELKHEN 64

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA----DALS 242
           IV+LY          LV+EF+    L   +              +N++K         L+
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           + H +    I+HRD+  +NLL++   +  + DFG+A+      + ++    T  Y AP++
Sbjct: 123 FCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179

Query: 303 -----AYTMKITEKCDVYSFGVLALEVIKGK 328
                 Y+  I    D++S G +  E+I GK
Sbjct: 180 LMGSRTYSTSI----DIWSCGCILAEMITGK 206

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 52/214 (24%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLT----------EVEALTE 181
           +G G +G V       +    A+K          I+ KK+             E++ L  
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVK----------ILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 182 IRHRNIVKLYGFCSHA--RHSFLVYEFLKRGS---LAAI----LSSDAAA---QELGWSQ 229
           +RH+N+++L     +   +  ++V E+   G    L ++         A     +L    
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL---- 118

Query: 230 RMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT 289
                    D L YLH      IVH+DI   NLLL       ++  G+A+ L P +++ T
Sbjct: 119 --------IDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167

Query: 290 --EFAGTYGYVAPELAYTMKITE--KCDVYSFGV 319
                G+  +  PE+A  +      K D++S GV
Sbjct: 168 CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGV 201

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 80.2 bits (199), Expect = 3e-17
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 27/206 (13%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKE-----FLTEVEALTEIRHRNI 187
           IG G +G VY+A+   G+  A+KK         +  + E      + E+  L E++H NI
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR-------LEKEDEGIPSTTIREISILKELKHSNI 62

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           VKLY      +   LV+E L +  L  +L  D     L      + +  + + ++Y H  
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL----- 302
               ++HRD+  +NLL++ E E  +ADFG+A+        +T    T  Y AP++     
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 303 AYTMKITEKCDVYSFGVLALEVIKGK 328
            Y+  I    D++S G +  E++ G 
Sbjct: 177 KYSTTI----DIWSVGCIFAEMVNGT 198

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 62/271 (22%), Positives = 112/271 (41%), Gaps = 30/271 (11%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           + F     +G GG G V+  ++  +G++ A KK    L   ++  +K +   + E + L 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK----LNKKRLKKRKGYQGAMVEKKILA 240

Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG--V 237
           ++  R IV L Y F +      LV   +  G +   + +       G+ +   +     +
Sbjct: 241 KVHSRFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYN-VDEDNPGFQEPRAIFYTAQI 298

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGY 297
              L +LH      I++RD+  +N+LLD +    ++D G+A  LK   +    +AGT G+
Sbjct: 299 VSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP 357
           +APEL    +     D ++ GV   E+I  + P  F +          +E  E+    L 
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGP--FRAR------GEKVENKELKQRVLE 407

Query: 358 AP---SRSVQEKLRSIVEVVFSCLNESPESR 385
                        +   E +   L + PE R
Sbjct: 408 QAVTYPDKFSPASKDFCEAL---LQKDPEKR 435

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 81.8 bits (202), Expect = 4e-17
 Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 34/202 (16%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLT---------EVEALTEI 182
           +G G  G V   +   +G  VA+K          I+++++  +         E++ L   
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVK----------ILNRQKIRSLDVVGKIRREIQNLKLF 73

Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALS 242
           RH +I+KLY   S     F+V E++  G L   +  +    E    +   + + +   + 
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE---KESRRLFQQILSGVD 130

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      +VHRD+  +N+LLD    A +ADFG++  +       T   G+  Y APE+
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEV 186

Query: 303 ----AYTMKITEKCDVYSFGVL 320
                Y      + D++S GV+
Sbjct: 187 ISGRLYA---GPEVDIWSSGVI 205

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 81.4 bits (201), Expect = 4e-17
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 19/203 (9%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG+G  G V  A +    + VAIKK   P         K    E+  +  + H+NI+ L 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLL 127

Query: 192 ------GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
                       +  +LV E +   +L  ++       EL   +   ++  +   + +LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 181

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
                 I+HRD+   N+++  +    + DFG+A+     S   T +  T  Y APE+   
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 237

Query: 306 MKITEKCDVYSFGVLALEVIKGK 328
           M   E  D++S G +  E+++ K
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHK 260

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 79.5 bits (197), Expect = 5e-17
 Identities = 57/212 (26%), Positives = 81/212 (38%), Gaps = 55/212 (25%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLT-------EVEALTEIRH 184
           +G G +G V  A    + + VA+K          IVD K  +        E+     + H
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEICINKMLNH 64

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN----------VI 234
            N+VK YG        +L  E+   G L   +  D           M           ++
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLM 115

Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW---TEF 291
            GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++         
Sbjct: 116 AGV----VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-M 167

Query: 292 AGTYGYVAPEL----AYTMKITEKCDVYSFGV 319
            GT  YVAPEL     +     E  DV+S G+
Sbjct: 168 CGTLPYVAPELLKRREFH---AEPVDVWSCGI 196

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 81.0 bits (200), Expect = 6e-17
 Identities = 48/212 (22%), Positives = 90/212 (42%), Gaps = 43/212 (20%)

Query: 133 IGNGGHGSVYRA---ELPSGQVVAIKKFHS---PLPSDQIVDKKEFLTEVEALTEIRHRN 186
           +G G +G VY+A   +    +  A+K+       + +           E+  L E++H N
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---------CREIALLRELKHPN 79

Query: 187 IVKLYG-FCSHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRMN--VIKGVA---- 238
           ++ L   F SHA    +L++++ +   L  I+    A++      ++   ++K +     
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH----VADFGIAKFLKPDSSNWTEFAG- 293
           D + YLH +    ++HRD+   N+L+  E        +AD G A+          +    
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 294 --TYGYVAPEL-----AYTMKITEKCDVYSFG 318
             T+ Y APEL      YT  I    D+++ G
Sbjct: 196 VVTFWYRAPELLLGARHYTKAI----DIWAIG 223

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 81.3 bits (201), Expect = 6e-17
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 37/222 (16%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           N+F+    +G G  G V   +   +G+  A+K     L  + IV K E    LTE   L 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI----LKKEVIVAKDEVAHTLTENRVLQ 203

Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGSLAAILSSDA----------AAQELGWSQ 229
             RH  +  L Y F +H      V E+   G L   LS +            A+      
Sbjct: 204 NSRHPFLTALKYSFQTHD-RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------ 256

Query: 230 RMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDSSNW 288
                  +  AL YLH +    +V+RD+  +NL+LD +    + DFG+ K  +K  ++  
Sbjct: 257 -------IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307

Query: 289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           T F GT  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 308 T-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 80.0 bits (198), Expect = 7e-17
 Identities = 46/212 (21%), Positives = 83/212 (39%), Gaps = 39/212 (18%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKL 190
           +G G +  V+ A  + + + V +K           V KK+   E++ L  +R   NI+ L
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRGGPNIITL 96

Query: 191 YGFCSHARHSF---LVYEFLKRGSLAAILS--SDAAAQELGWSQRMNVIKGVADALSYLH 245
                    S    LV+E +       +    +D   +          +  +  AL Y H
Sbjct: 97  AD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY--------MYEILKALDYCH 147

Query: 246 -HDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL- 302
                  I+HRD+   N+++D E  +  + D+G+A+F  P    +     +  +  PEL 
Sbjct: 148 SMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELL 202

Query: 303 ----AYTMKITEKCDVYSFGVLALEVIKGKHP 330
                Y   +    D++S G +   +I  K P
Sbjct: 203 VDYQMYDYSL----DMWSLGCMLASMIFRKEP 230

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 80.0 bits (198), Expect = 7e-17
 Identities = 47/207 (22%), Positives = 91/207 (43%), Gaps = 29/207 (14%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE-----FLTEVEALTEIRHRN 186
           +G G + +VY+     +  +VA+K+          ++ +E      + EV  L +++H N
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIR--------LEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH 246
           IV L+      +   LV+E+L +  L   L  D     +        +  +   L+Y H 
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHR 118

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL---- 302
                ++HRD+  +NLL++   E  +ADFG+A+     +  +     T  Y  P++    
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175

Query: 303 -AYTMKITEKCDVYSFGVLALEVIKGK 328
             Y+ +I    D++  G +  E+  G+
Sbjct: 176 TDYSTQI----DMWGVGCIFYEMATGR 198

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 21/213 (9%)

Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
              +     +G+G +G+V  A +  +G  VAIKK + P      +  K    E+  L  +
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHM 81

Query: 183 RHRNIVKLY------GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG 236
           RH N++ L                +LV  F+    L  ++      ++LG  +   ++  
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKH----EKLGEDRIQFLVYQ 136

Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
           +   L Y+H      I+HRD+   NL ++ + E  + DFG+A   +   S  T +  T  
Sbjct: 137 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRW 190

Query: 297 YVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 328
           Y APE+    M+ T+  D++S G +  E+I GK
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 52/243 (21%), Positives = 83/243 (34%), Gaps = 65/243 (26%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL- 190
           +G G  G V    ++ SG+  A+KK           D +    E++ +  + H NI+KL 
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVL--------QDPRYKNRELDIMKVLDHVNIIKLV 66

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM------------------N 232
             F +         +     +     ++                                
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 233 VIKGVAD-------------------ALSYLH-HDCFPPIVHRDISSKNLLLDLE-FEAH 271
           V+K                       A+ ++H       I HRDI  +NLL++ +     
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG----ICHRDIKPQNLLVNSKDNTLK 182

Query: 272 VADFGIAKFLKPDSSNWTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFG-VLALEVI 325
           + DFG AK L P   +   +  +  Y APEL      YT  I    D++S G V   E+I
Sbjct: 183 LCDFGSAKKLIPSEPS-VAYICSRFYRAPELMLGATEYTPSI----DLWSIGCVFG-ELI 236

Query: 326 KGK 328
            GK
Sbjct: 237 LGK 239

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 50/202 (24%), Positives = 81/202 (40%), Gaps = 35/202 (17%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLT---------EVEALTEI 182
           +G G  G V  A    + Q VA+K           + ++             E+  L  +
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALK----------FISRQLLKKSDMHMRVEREISYLKLL 66

Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALS 242
           RH +I+KLY   +      +V E+   G L   +       E    +     + +  A+ 
Sbjct: 67  RHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTE---DEGRRFFQQIICAIE 122

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           Y H      IVHRD+  +NLLLD      +ADFG++  +   +   T   G+  Y APE+
Sbjct: 123 YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEV 178

Query: 303 ----AYTMKITEKCDVYSFGVL 320
                Y      + DV+S G++
Sbjct: 179 INGKLYA---GPEVDVWSCGIV 197

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 24/216 (11%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTE---VE 177
           NDF     IG GG G VY      +G++ A+K     L   +I  K+     L E   + 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC----LDKKRIKMKQGETLALNERIMLS 244

Query: 178 ALTEIRHRNIVKL-YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNV-IK 235
            ++      IV + Y F +       + + +  G L   LS      E      M     
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAA 299

Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY 295
            +   L ++H+     +V+RD+   N+LLD      ++D G+A        +     GT+
Sbjct: 300 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASVGTH 354

Query: 296 GYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           GY+APE L   +      D +S G +  ++++G  P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 78.3 bits (194), Expect = 2e-16
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 28/209 (13%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKE-----FLTEVEALTEIRHRN 186
           IG G +G+V++A    + ++VA+K+         + D  E      L E+  L E++H+N
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVR-------LDDDDEGVPSSALREICLLKELKHKN 62

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH 246
           IV+L+      +   LV+EF  +  L      D+   +L      + +  +   L + H 
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL---- 302
                ++HRD+  +NLL++   E  +A+FG+A+        ++    T  Y  P++    
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 303 -AYTMKITEKCDVYSFGVLALEVIKGKHP 330
             Y+  I    D++S G +  E+     P
Sbjct: 177 KLYSTSI----DMWSAGCIFAELANAGRP 201

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 19/212 (8%)

Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
              +     IG+G  G V  A +    + VAIKK   P         K    E+  +  +
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCV 81

Query: 183 RHRNIVKLY------GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG 236
            H+NI+ L             +  ++V E +   +L  ++       EL   +   ++  
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQ 135

Query: 237 VADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYG 296
           +   + +LH      I+HRD+   N+++  +    + DFG+A+         T +  T  
Sbjct: 136 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRY 191

Query: 297 YVAPELAYTMKITEKCDVYSFGVLALEVIKGK 328
           Y APE+   M   E  D++S G +  E+IKG 
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 27/206 (13%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKE-----FLTEVEALTEIRHRNI 187
           +G G +G VY+A+   G++VA+K+         +  + E      + E+  L E+ H NI
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIR-------LDAEDEGIPSTAIREISLLKELHHPNI 81

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           V L       R   LV+EF+++  L  +L  D     L  SQ    +  +   +++ H  
Sbjct: 82  VSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQH 138

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL----- 302
               I+HRD+  +NLL++ +    +ADFG+A+       ++T    T  Y AP++     
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 303 AYTMKITEKCDVYSFGVLALEVIKGK 328
            Y+  +    D++S G +  E+I GK
Sbjct: 196 KYSTSV----DIWSIGCIFAEMITGK 217

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 45/213 (21%), Positives = 91/213 (42%), Gaps = 36/213 (16%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF------LTEVEALTEIRHR 185
           +G G +G VY+A +  + + VAIK+          ++ +E       + EV  L E++HR
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIR--------LEHEEEGVPGTAIREVSLLKELQHR 93

Query: 186 NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
           NI++L     H     L++E+ +   L   +       ++      + +  + + +++ H
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCH 149

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAH-----VADFGIAKFLKPDSSNWTEFAGTYGYVAP 300
                  +HRD+  +NLLL +   +      + DFG+A+        +T    T  Y  P
Sbjct: 150 SRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPP 206

Query: 301 EL-----AYTMKITEKCDVYSFGVLALEVIKGK 328
           E+      Y+  +    D++S   +  E++   
Sbjct: 207 EILLGSRHYSTSV----DIWSIACIWAEMLMKT 235

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 57/212 (26%), Positives = 81/212 (38%), Gaps = 55/212 (25%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLT-------EVEALTEIRH 184
           +G G +G V  A    + + VA+K          IVD K  +        E+     + H
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK----------IVDMKRAVDCPENIKKEICINKMLNH 64

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN----------VI 234
            N+VK YG        +L  E+   G L   +  D           M           ++
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLM 115

Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW---TEF 291
            GV     YLH      I HRDI  +NLLLD      ++DFG+A   + ++         
Sbjct: 116 AGV----VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-M 167

Query: 292 AGTYGYVAPEL----AYTMKITEKCDVYSFGV 319
            GT  YVAPEL     +     E  DV+S G+
Sbjct: 168 CGTLPYVAPELLKRREFH---AEPVDVWSCGI 196

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 49/219 (22%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEF--------LTEVEALTEIR 183
           +G G   +VY+A +  + Q+VAIKK         +  + E         L E++ L E+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIK-------LGHRSEAKDGINRTALREIKLLQELS 70

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           H NI+ L     H  +  LV++F++   L  I+     +  L  S     +      L Y
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYMLMTLQGLEY 127

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF----LKPDSSN----WTEFAGTY 295
           LH      I+HRD+   NLLLD      +ADFG+AK      +  +      W       
Sbjct: 128 LHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRW------- 177

Query: 296 GYVAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 328
            Y APEL      Y + +    D+++ G +LA E++   
Sbjct: 178 -YRAPELLFGARMYGVGV----DMWAVGCILA-ELLLRV 210

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 77.2 bits (191), Expect = 5e-16
 Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 43/223 (19%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
            DF     +G G  G V+      +G+  A+K     L  + +V  K+      E   L+
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV----LKKEIVVRLKQVEHTNDERLMLS 61

Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDA----------AAQELGWSQR 230
            + H  I++++G    A+  F++ ++++ G L ++L              AA+       
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE------- 114

Query: 231 MNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKPDSSN 287
                 V  AL YLH  D    I++RD+  +N+LLD     H+   DFG AK        
Sbjct: 115 ------VCLALEYLHSKD----IIYRDLKPENILLD--KNGHIKITDFGFAK--YVPDVT 160

Query: 288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +T   GT  Y+APE+  T    +  D +SFG+L  E++ G  P
Sbjct: 161 YT-LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.3 bits (191), Expect = 6e-16
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 22/204 (10%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G+G +GSV  A +  SG+ VAIKK   P      +  K    E+  L  ++H N++ L 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLL 89

Query: 192 G-FCSHARHS-----FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
             F   +        +LV  F++   L  I+       +    +   ++  +   L Y+H
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIH 143

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
                 +VHRD+   NL ++ + E  + DFG+A   +   +  T +  T  Y APE+  +
Sbjct: 144 S---AGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILS 197

Query: 306 -MKITEKCDVYSFGVLALEVIKGK 328
            M   +  D++S G +  E++ GK
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 54/243 (22%), Positives = 90/243 (37%), Gaps = 42/243 (17%)

Query: 112 EGKLVYDEIVRATNDFDAQY----CIGNGGHGSVYRAELPSGQVVAIKKFHSPL------ 161
           +G+    +++   +   + Y     I +G +G+V       G  VAIK+  + +      
Sbjct: 5   KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV 64

Query: 162 -PSDQIVDKKEFLTEVEALTEIRHRNIVKLYG-FCSHARHSF----LVYEFLKRGSLAAI 215
                    K  L E+  L    H NI+ L   F      +     LV E ++   LA +
Sbjct: 65  NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQV 123

Query: 216 LSSDAAAQELGWSQRMNVI-----KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEA 270
           +            Q +         G    L  LH      +VHRD+   N+LL    + 
Sbjct: 124 IHDQRIVIS---PQHIQYFMYHILLG----LHVLHE---AGVVHRDLHPGNILLADNNDI 173

Query: 271 HVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFGVLALEVI 325
            + DF +A+    D +N T +     Y APEL      +T  +    D++S G +  E+ 
Sbjct: 174 TICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLV----DMWSAGCVMAEMF 228

Query: 326 KGK 328
             K
Sbjct: 229 NRK 231

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 44/232 (18%)

Query: 122 RATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK--FHSPLPSDQIVDKKEF----LT 174
              + ++    IG G  G V++A    +GQ VA+KK    +        +K+ F    L 
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--------EKEGFPITALR 65

Query: 175 EVEALTEIRHRNIVKLYGFCSHARHS--------FLVYEFLKRGSLAAILSSDAAAQELG 226
           E++ L  ++H N+V L   C              +LV++F +   LA +L       +  
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFT 122

Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA-KFLKPDS 285
            S+   V++ + + L Y+H +    I+HRD+ + N+L+  +    +ADFG+A  F    +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 286 SNWTEFAG---TYGYVAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 328
           S    +     T  Y  PEL      Y   I    D++  G ++A E+    
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMA-EMWTRS 226

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 132 CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL 190
            +G+G +GSV  A +  +G  VA+KK   P     I+  K    E+  L  ++H N++ L
Sbjct: 36  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGL 93

Query: 191 YGFC--SHARHSF----LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
                 + +   F    LV   +    L  I+      Q+L       +I  +   L Y+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKC----QKLTDDHVQFLIYQILRGLKYI 148

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY 304
           H      I+HRD+   NL ++ + E  + DFG+A   +  +   T +  T  Y APE+  
Sbjct: 149 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRAPEIML 202

Query: 305 T-MKITEKCDVYSFGVLALEVIKGK 328
             M   +  D++S G +  E++ G+
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 31/211 (14%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A +  +   VAIKK     P +     +  L E++ L   RH NI+ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 91

Query: 192 G-FCSHARHSF----LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH 246
               +          +V + ++   L  +L +    Q L        +  +   L Y+H 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 146

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPEL- 302
                ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+ 
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

Query: 303 ----AYTMKITEKCDVYSFG-VLALEVIKGK 328
                YT  I    D++S G +LA E++  +
Sbjct: 204 LNSKGYTKSI----DIWSVGCILA-EMLSNR 229

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.8 bits (182), Expect = 6e-15
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 40/220 (18%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G GG+G V+ A +    + VAIKK    +        K  L E++ +  + H NIVK++
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKK----IVLTDPQSVKHALREIKIIRRLDHDNIVKVF 74

Query: 192 ----------GFCSHARHSF----LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGV 237
                          +        +V E+++   LA +L        L        +  +
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQL 129

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSN---WTEFAG 293
              L Y+H      ++HRD+   NL ++ E     + DFG+A+ + P  S+    +E   
Sbjct: 130 LRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186

Query: 294 TYGYVAPEL-----AYTMKITEKCDVYSFGVLALEVIKGK 328
           T  Y +P L      YT  I    D+++ G +  E++ GK
Sbjct: 187 TKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.2 bits (183), Expect = 7e-15
 Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 42/224 (18%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           NDFD    +G G  G V       +G+  A+K     L  + I+ K E    +TE   L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKI----LRKEVIIAKDEVAHTVTESRVLQ 60

Query: 181 EIRHRNIVKL-YGFCSHARHSFLVYEFLKRGSL------AAILSSDAA---AQELGWSQR 230
             RH  +  L Y F +H      V E+   G L        + + + A     E      
Sbjct: 61  NTRHPFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSRERVFTEERARFYGAE------ 113

Query: 231 MNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAK-FLKPDSS 286
                 +  AL YLH  D    +V+RDI  +NL+LD   + H+   DFG+ K  +   ++
Sbjct: 114 ------IVSALEYLHSRD----VVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGAT 161

Query: 287 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
             T F GT  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 162 MKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 42/207 (20%), Positives = 74/207 (35%), Gaps = 64/207 (30%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKL 190
           +G G +G V +     + +  A+K          + D  +   EVE      +  +IV++
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALK---------MLQDCPKARREVELHWRASQCPHIVRI 76

Query: 191 YGFC----SHARHSFLVYEFLKRGSL-AAILS--------SDAAAQELGWSQRMNVIKGV 237
                   +  +   +V E L  G L + I           +A+           ++K +
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE----------IMKSI 126

Query: 238 ADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFLKPDSSNWTEFAG 293
            +A+ YLH  +    I HRD+  +NLL   +       + DFG AK              
Sbjct: 127 GEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET---------TGE 173

Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVL 320
            Y              + CD++S GV+
Sbjct: 174 KYD-------------KSCDMWSLGVI 187

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 46/227 (20%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEF--LTEVEA 178
           + F+    +G G  G V+  +      + Q+ A+K     L    +  +       E + 
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV----LKKATLKVRDRVRTKMERDI 79

Query: 179 LTEIRHRNIVKL-YGFCSHARHSFLVYEFLKRGSLAAILSSDA----------AAQELGW 227
           L E+ H  IVKL Y F +  +  +L+ +FL+ G L   LS +            A+    
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE---- 134

Query: 228 SQRMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAK-FLKP 283
                    +A AL +LH       I++RD+  +N+LLD   E H+   DFG++K  +  
Sbjct: 135 ---------LALALDHLHSLG----IIYRDLKPENILLD--EEGHIKLTDFGLSKESIDH 179

Query: 284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +   ++ F GT  Y+APE+      T+  D +SFGVL  E++ G  P
Sbjct: 180 EKKAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 36/226 (15%)

Query: 124 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           ++DF  +  +G G +G V  A   P+G++VAIKK     P D+ +     L E++ L   
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHF 66

Query: 183 RHRNIVKLYG-FCSHARHSF----LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGV 237
           +H NI+ ++      +  +F    ++ E ++   L  ++S+    Q L        I   
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST----QMLSDDHIQYFIYQT 121

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---------- 287
             A+  LH      ++HRD+   NLL++   +  V DFG+A+ +   +++          
Sbjct: 122 LRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178

Query: 288 WTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFGVLALEVIKGK 328
             EF  T  Y APE+      Y+  +    DV+S G +  E+   +
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 69.1 bits (170), Expect = 2e-13
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLT---EVEALTEIR---HR 185
           IG G +G+VY+A +  SG  VA+K     +P+         ++   EV  L  +    H 
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 186 NIVKLYGFCSHARHS-----FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADA 240
           N+V+L   C+ +R        LV+E + +  L   L   A    L      ++++     
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPGLPAETIKDLMRQFLRG 132

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF 280
           L +LH +C   IVHRD+  +N+L+       +ADFG+A+ 
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 68.7 bits (169), Expect = 4e-13
 Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 46/228 (20%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKE----FLTEV 176
             F+    +G GG+G V++        +G++ A+K     L    IV   +       E 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKV----LKKAMIVRNAKDTAHTKAER 72

Query: 177 EALTEIRHRNIVKL-YGFCSHARHSFLVYEFLKRGSL------AAILSSDAA---AQELG 226
             L E++H  IV L Y F +  +  +L+ E+L  G L        I   D A     E  
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAE-- 129

Query: 227 WSQRMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAK-FLK 282
                     ++ AL +LH       I++RD+  +N++L+   + HV   DFG+ K  + 
Sbjct: 130 ----------ISMALGHLHQKG----IIYRDLKPENIMLNH--QGHVKLTDFGLCKESIH 173

Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
             +   T F GT  Y+APE+          D +S G L  +++ G  P
Sbjct: 174 DGTVTHT-FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 58/286 (20%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
            DFD    IG G +  V    L  + ++ A+K     +  + + D ++     TE     
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV----VKKELVNDDEDIDWVQTEKHVFE 64

Query: 181 EI-RHRNIVKL-YGFCSHARHSFLVYEFLKRGSL------AAILSSDAA---AQELGWSQ 229
           +   H  +V L   F + +R  F V E++  G L         L  + A   + E     
Sbjct: 65  QASNHPFLVGLHSCFQTESRL-FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 118

Query: 230 RMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAK-FLKPDS 285
                  ++ AL+YLH       I++RD+   N+LLD   E H+   D+G+ K  L+P  
Sbjct: 119 -------ISLALNYLHERG----IIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGD 165

Query: 286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD 345
           +  T F GT  Y+APE+          D ++ GVL  E++ G+ P  F    SS   + +
Sbjct: 166 TTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP--FDIVGSSDNPDQN 222

Query: 346 IELDEMLD------PRLPAPSRSVQEKLRSIVEVVFSCLNESPESR 385
            E D +         R+P   RS+  K  S+++   S LN+ P+ R
Sbjct: 223 TE-DYLFQVILEKQIRIP---RSLSVKAASVLK---SFLNKDPKER 261

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 68.4 bits (168), Expect = 6e-13
 Identities = 63/225 (28%), Positives = 90/225 (40%), Gaps = 43/225 (19%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEAL- 179
            DF     +G G  G V+ AE   + Q  AIK     L  D ++   +    + E   L 
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA----LKKDVVLMDDDVECTMVEKRVLS 72

Query: 180 TEIRHRNIVKL-YGFCSHARHSFLVYEFLKRGSL------AAILSSDAA---AQELGWSQ 229
               H  +  +   F +     F V E+L  G L              A   A E     
Sbjct: 73  LAWEHPFLTHMFCTFQTKENL-FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE----- 126

Query: 230 RMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAK-FLKPDS 285
                  +   L +LH       IV+RD+   N+LLD +   H+  ADFG+ K  +  D+
Sbjct: 127 -------IILGLQFLHSKG----IVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDA 173

Query: 286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
              T F GT  Y+APE+    K     D +SFGVL  E++ G+ P
Sbjct: 174 KTNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 50/225 (22%), Positives = 83/225 (36%), Gaps = 53/225 (23%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A +    +VVAIKK       + ++D K  L E+  L  + H ++VK+ 
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKIL--RVFEDLIDCKRILREIAILNRLNHDHVVKVL 118

Query: 192 G-FCSHARHSF----LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH- 245
                     F    +V E         +  +      L       ++  +   + Y+H 
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHS 174

Query: 246 HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTY---------- 295
                 I+HRD+   N L++ +    V DFG+A+ +    +  ++   +           
Sbjct: 175 AG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230

Query: 296 -----------GYV------APEL-----AYTMKITEKCDVYSFG 318
                      G+V      APEL      YT  I    DV+S G
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----DVWSIG 271

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 68.1 bits (167), Expect = 8e-13
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 43/225 (19%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           +DF     IG G  G V  A         A+K     L    I+ KKE    ++E   L 
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV----LQKKAILKKKEEKHIMSERNVLL 93

Query: 181 E-IRHRNIVKL-YGFCSHARHSFLVYEFLKRGSL------AAILSSDAA---AQELGWSQ 229
           + ++H  +V L + F +  +  + V +++  G L              A   A E     
Sbjct: 94  KNVKHPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLEPRARFYAAE----- 147

Query: 230 RMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAK-FLKPDS 285
                  +A AL YLH  +    IV+RD+  +N+LLD   + H+   DFG+ K  ++ +S
Sbjct: 148 -------IASALGYLHSLN----IVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNS 194

Query: 286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +  T F GT  Y+APE+ +        D +  G +  E++ G  P
Sbjct: 195 TTST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 52/283 (18%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
            DFD    IG G +  V    L  + ++ A++     +  + + D ++     TE     
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRV----VKKELVNDDEDIDWVQTEKHVFE 107

Query: 181 EI-RHRNIVKL-YGFCSHARHSFLVYEFLKRGSL------AAILSSDAA---AQELGWSQ 229
           +   H  +V L   F + +R  F V E++  G L         L  + A   + E     
Sbjct: 108 QASNHPFLVGLHSCFQTESRL-FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 161

Query: 230 RMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAK-FLKPDS 285
                  ++ AL+YLH       I++RD+   N+LLD   E H+   D+G+ K  L+P  
Sbjct: 162 -------ISLALNYLHERG----IIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGD 208

Query: 286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD 345
           +  T F GT  Y+APE+          D ++ GVL  E++ G+ P  F    SS   + +
Sbjct: 209 TTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP--FDIVGSSDNPDQN 265

Query: 346 IELDEMLDPRLPAP---SRSVQEKLRSIVEVVFSCLNESPESR 385
            E D +    L       RS+  K  S+++   S LN+ P+ R
Sbjct: 266 TE-DYLFQVILEKQIRIPRSLSVKAASVLK---SFLNKDPKER 304

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 41/224 (18%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
            DF+    +G G  G V  +E   + ++ A+K     L  D ++   +    + E   L 
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI----LKKDVVIQDDDVECTMVEKRVLA 396

Query: 181 EI-RHRNIVKLYGFCSH-ARHSFLVYEFLKRGSL------AAILSSDAA---AQELGWSQ 229
              +   + +L+  C       + V E++  G L              A   A E     
Sbjct: 397 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE----- 450

Query: 230 RMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAK-FLKPDSS 286
                  +A  L +L       I++RD+   N++LD   E H+  ADFG+ K  +    +
Sbjct: 451 -------IAIGLFFLQSK---GIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVT 498

Query: 287 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
             T F GT  Y+APE+       +  D ++FGVL  E++ G+ P
Sbjct: 499 TKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 48/231 (20%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEF----LTEV 176
            +F+    +G G +G V+         +G++ A+K     L    IV K +      TE 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV----LKKATIVQKAKTTEHTRTER 109

Query: 177 EALTEIRHRN-IVKL-YGFCSHARHSFLVYEFLKRGSL------AAILSSDAA---AQEL 225
           + L  IR    +V L Y F +  +   L+ +++  G L          +         E+
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168

Query: 226 GWSQRMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLK 282
                         AL +LH       I++RDI  +N+LLD     HV   DFG++K   
Sbjct: 169 ------------VLALEHLHKLG----IIYRDIKLENILLDS--NGHVVLTDFGLSKEFV 210

Query: 283 PDSSNWTE-FAGTYGYVAPELAYTMKI--TEKCDVYSFGVLALEVIKGKHP 330
            D +     F GT  Y+AP++         +  D +S GVL  E++ G  P
Sbjct: 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 43/225 (19%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
           ++F+    +G G  G V  A +  +G + A+K     L  D I+   +    +TE   L+
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV----LKKDVILQDDDVECTMTEKRILS 78

Query: 181 EI-RHRNIVKL-YGFCSHARHSFLVYEFLKRGSL------AAILSSDAA---AQELGWSQ 229
               H  + +L   F +  R  F V EF+  G L      +       A   A E     
Sbjct: 79  LARNHPFLTQLFCCFQTPDRL-FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE----- 132

Query: 230 RMNVIKGVADALSYLH-HDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAK-FLKPDS 285
                  +  AL +LH       I++RD+   N+LLD   E H   ADFG+ K  +    
Sbjct: 133 -------IISALMFLHDKG----IIYRDLKLDNVLLDH--EGHCKLADFGMCKEGICNGV 179

Query: 286 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
           +  T F GT  Y+APE+   M      D ++ GVL  E++ G  P
Sbjct: 180 TTAT-FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 41/224 (18%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEF---LTEVEALT 180
            DF+    +G G  G V  +E   + ++ A+K     L  D ++   +    + E   L 
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI----LKKDVVIQDDDVECTMVEKRVLA 75

Query: 181 EI-RHRNIVKL-YGFCSHARHSFLVYEFLKRGSL------AAILSSDAA---AQELGWSQ 229
              +   + +L   F +  R  + V E++  G L              A   A E     
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRL-YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE----- 129

Query: 230 RMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAK-FLKPDSS 286
                  +A  L +L       I++RD+   N++LD   E H+  ADFG+ K  +    +
Sbjct: 130 -------IAIGLFFLQSK---GIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVT 177

Query: 287 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 330
             T F GT  Y+APE+       +  D ++FGVL  E++ G+ P
Sbjct: 178 TKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 64.9 bits (159), Expect = 6e-12
 Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 38/227 (16%)

Query: 122 RATNDFDAQYCIGNGGHGSVYRA--ELPSGQVVAIKKFHSPLPSDQIVDKKE-----FLT 174
           RA   ++    IG G +G V++A      G+ VA+K+    + +      +E      + 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTG-----EEGMPLSTIR 60

Query: 175 EVEALTEIR---HRNIVKLYGFCSHARHS-----FLVYEFLKRGSLAAILSSDAAAQELG 226
           EV  L  +    H N+V+L+  C+ +R        LV+E + +  L   L        + 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK-VPEPGVP 118

Query: 227 WSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK-FLKPDS 285
                +++  +   L +LH      +VHRD+  +N+L+    +  +ADFG+A+ +     
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173

Query: 286 SNWTEFAGTYGYVAPEL----AYTMKITEKCDVYSFGVLALEVIKGK 328
              T    T  Y APE+    +Y   +    D++S G +  E+ + K
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 59/282 (20%), Positives = 103/282 (36%), Gaps = 59/282 (20%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G VY A +  + + VAIKK +     + ++D K  L E+  L  ++   I++LY
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYIIRLY 91

Query: 192 G-FCSHARHSF----LVYEFLKRGSLAAILSSDAAAQELGWSQRM-----NVIKGVADAL 241
                     F    +V E      L  +  +      L   + +     N++ G     
Sbjct: 92  DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP---IFLT-EEHIKTILYNLLLG----E 142

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN-------------- 287
           +++H      I+HRD+   N LL+ +    V DFG+A+ +  +                 
Sbjct: 143 NFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199

Query: 288 --------WTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGKHPRDF 333
                    T    T  Y APEL      YT  I    D++S G + A E++        
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFA-ELLNMLQSHIN 254

Query: 334 LSSISSS-FLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVV 374
             +     F  +                +S +++L  I  ++
Sbjct: 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNII 296

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 59/351 (16%), Positives = 103/351 (29%), Gaps = 116/351 (33%)

Query: 133 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHR 185
           +G G  G V  A+        + + VA+K            + +  ++E++ L  I  H 
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---EHRALMSELKILIHIGHHL 86

Query: 186 NIVKLYGFCSHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKG-------- 236
           N+V L G C+       ++ EF K G+L+  L S         ++     +G        
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 237 ----------------------------VADALSYLHHDCFPPIVHRD------------ 256
                                         +            +                
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 257 --ISSKNL----------LLDLEFEAHVADFGIAKFLKPDSSN-----------WTEFAG 293
             ++S+            LL  +    + DFG+A+ +  D              W     
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM---- 262

Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP-------RDFLSSISSSFLNTD 345
                APE  +    T + DV+SFGVL  E+   G  P        +F   +        
Sbjct: 263 -----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---- 313

Query: 346 IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                    R+ AP  +  E    + + +  C +  P  RPT   + + L 
Sbjct: 314 ---------RMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLG 351

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 47/227 (20%), Positives = 88/227 (38%), Gaps = 50/227 (22%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEF----LTEVEALTEIR---- 183
           +G G   +V+ A+ + +   VA+K          +   K +      E++ L  +     
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMK---------IVRGDKVYTEAAEDEIKLLQRVNDADN 77

Query: 184 -------HRNIVKLYGFCSH----ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN 232
                    +I+KL    +H      H  +V+E L   +L A++      +  G    + 
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIP--LI 131

Query: 233 VIKGVA----DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH------VADFGIAKFLK 282
            +K ++      L Y+H  C   I+H DI  +N+L+++           +AD G A +  
Sbjct: 132 YVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-- 187

Query: 283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKH 329
               ++T    T  Y +PE+          D++S   L  E+I G  
Sbjct: 188 -YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 60.3 bits (147), Expect = 5e-10
 Identities = 16/62 (25%), Positives = 24/62 (38%), Gaps = 2/62 (3%)

Query: 1   MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKGFLSHKQNSGA 60
           +  L+ ID+S+N L GP+P    F          N GLCG    +  C    +       
Sbjct: 703 LTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP--LPRCDPSNADGYAHHQ 760

Query: 61  KR 62
           + 
Sbjct: 761 RS 762

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 56/232 (24%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKL 190
           +G G +G V+++ +  +G+VVA+KK           D +    E+  LTE+  H NIV L
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNL 74

Query: 191 Y------GFCSHARHSFLVYEFLKRGS-LAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
                        R  +LV++++   + L A++ +      L    +  V+  +   + Y
Sbjct: 75  LNVLRADND----RDVYLVFDYM--ETDLHAVIRA----NILEPVHKQYVVYQLIKVIKY 124

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---------------- 287
           LH      ++HRD+   N+LL+ E    VADFG+++                        
Sbjct: 125 LHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181

Query: 288 -----WTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 328
                 T++  T  Y APE+      YT  I    D++S G +L  E++ GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILG-EILCGK 228

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.0 bits (139), Expect = 2e-09
 Identities = 37/254 (14%), Positives = 65/254 (25%), Gaps = 57/254 (22%)

Query: 123 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
            T        IG G  G V++        VAIK     +    +V+     T  E L EI
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKII--AIEGPDLVNGSHQKTFEEILPEI 74

Query: 183 ---------------RHRNIVKLYGF--CSHARHSFLVYEFL----KRGSLAAILSSDAA 221
                          R    + L        +    L+  +      +GS          
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 222 AQ--------------------ELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN 261
            Q                        +   +++  +  +L+           HRD+   N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGN 192

Query: 262 LLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK--CDVYSFGV 319
           +LL       +      K              + G     + YT+   E+    V+    
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTI---------PSCGLQVSIIDYTLSRLERDGIVVFCDVS 243

Query: 320 LALEVIKGKHPRDF 333
           +  ++  G     F
Sbjct: 244 MDEDLFTGDGDYQF 257

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 14/48 (29%), Positives = 21/48 (43%), Gaps = 2/48 (4%)

Query: 1   MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPC 48
           +  L  +++S N L G +P     +   V A   NK LCG    +  C
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS--PLPAC 312

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.0 bits (134), Expect = 1e-08
 Identities = 61/377 (16%), Positives = 113/377 (29%), Gaps = 99/377 (26%)

Query: 84  ILRKRNSDSGDRQRSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYR 143
           I+  +++ SG  +        LF  L  + + +  + V      + ++ +      S  +
Sbjct: 54  IIMSKDAVSGTLR--------LFWTLLSKQEEMVQKFVEEVLRINYKFLM------SPIK 99

Query: 144 AEL--PSGQVVAIKKFHSPLPSD-QIVDK------KEFLTEVEALTEIRHRNIVKLYGF- 193
            E   PS       +    L +D Q+  K      + +L   +AL E+R    V + G  
Sbjct: 100 TEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159

Query: 194 -----------CS----HARHSFLVYEFLKRG-------------SLAAILSSDAAAQEL 225
                      C       +  F ++ +L                 L   +  +  ++  
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIF-WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218

Query: 226 GWSQRMNVIKGVADALSYL-----HHDCFPPIVHRDISSKNLLLDLEFE---------AH 271
             S     I  +   L  L     + +C   +V  ++ +                     
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENCL--LVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276

Query: 272 VADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPR 331
           V DF  A      S +             E      +  K        L  EV+   +PR
Sbjct: 277 VTDFLSAATTTHISLDHHS----MTLTPDE---VKSLLLKYLDCRPQDLPREVLTT-NPR 328

Query: 332 DFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ-EKLRSIVEVVFSCLNESPESR----- 385
             LS I+ S       + + L        + V  +KL +I+E   + L E  E R     
Sbjct: 329 -RLSIIAES-------IRDGLA--TWDNWKHVNCDKLTTIIESSLNVL-EPAEYRKMFDR 377

Query: 386 -----PTMKIVSQQLQI 397
                P+  I +  L +
Sbjct: 378 LSVFPPSAHIPTILLSL 394

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 3e-05
 Identities = 44/294 (14%), Positives = 93/294 (31%), Gaps = 79/294 (26%)

Query: 145 ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE-IRHRNIVKLYGFCSHARHSFL- 202
           +LP  +V+      +P     I    E + +  A  +  +H N  KL    +    S L 
Sbjct: 317 DLPR-EVLTT----NPRRLSIIA---ESIRDGLATWDNWKHVNCDKL----TTIIESSLN 364

Query: 203 ---------VYEFLKRGSLAAILSSDA--AAQELG--WSQR--------MN-------VI 234
                    +++ L      ++    A      L   W           +N       V 
Sbjct: 365 VLEPAEYRKMFDRL------SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418

Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGT 294
           K   ++   +        ++ ++  K   L+ E+  H     +  +  P + +  +    
Sbjct: 419 KQPKESTISIPS------IYLELKVK---LENEYALH--RSIVDHYNIPKTFDSDDLIPP 467

Query: 295 Y--GYVAPELAYTMKI---TEKCDVYSFGVLALEVIKGKHPRDFLS-SISSSFLNTDIEL 348
           Y   Y    + + +K     E+  ++    L    ++ K   D  + + S S LNT  +L
Sbjct: 468 YLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQL 527

Query: 349 D---EMLDPRLPAPSRSVQEKLRSIVEVVFSC---LNESPESRPTMKIVSQQLQ 396
                 +    P   R     + +I++ +      L  S  +     ++   L 
Sbjct: 528 KFYKPYICDNDPKYER----LVNAILDFLPKIEENLICSKYTD----LLRIALM 573

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 40/181 (22%), Positives = 73/181 (40%), Gaps = 39/181 (21%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIK---------KFHSPLPSD----QIVDKKEFLTEVEAL 179
           IG GG G +Y A++ S + V              + PL ++    Q   K E + +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 180 TEIRHRNIVKLYGFCSH----ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIK 235
            ++++  + K +G   H      + F++ +      L  I  ++        ++R +  K
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEAN--------AKRFS-RK 152

Query: 236 GVA-------DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKPDSS 286
            V        D L Y+H   +   VH DI + NLLL+ +    V   D+G+A    P+  
Sbjct: 153 TVLQLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209

Query: 287 N 287
           +
Sbjct: 210 H 210

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 39/178 (21%), Positives = 66/178 (37%), Gaps = 39/178 (21%)

Query: 133 IGNGGHGSVYRAE---------LPSGQVVAIK--KFHSPLPSD----QIVDKKEFLTEVE 177
                 G +Y A           P  Q  ++K       L ++    Q   K   + + +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 178 ALTEIRHRNIVKLYGFCSH-ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNV-IK 235
            L       I    GF  H  ++ FLV   L R SL + L           S +  +  +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALD---------VSPKHVLSER 159

Query: 236 GVA-------DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKPD 284
            V        DAL +LH + +   VH +++++N+ +D E ++ V  A +G A    P 
Sbjct: 160 SVLQVACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 41/179 (22%), Positives = 69/179 (38%), Gaps = 38/179 (21%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIK------KFHSPLPSD----QIVDKKEFLTEVEALTE 181
           IG+GG G +Y A      +  A        + + PL S+    Q V KK+ + +     +
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 182 IRHRNIVKLYGFCSHA----RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGV 237
           + +  I   YG          + F+V E L    L  I            +        V
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISG---------QNGTFK-KSTV 153

Query: 238 A-------DALSYLHHDCFPPIVHRDISSKNLLLDLEFE--AHVADFGIAKFLKPDSSN 287
                   D L Y+H + +   VH DI + NLLL  +     ++AD+G++    P+ ++
Sbjct: 154 LQLGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 50/221 (22%), Positives = 78/221 (35%), Gaps = 52/221 (23%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEF----LTEVEALTEIRHR-- 185
           IG G  G V +A      + VAIK          I +KK F      EV  L  +     
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIK---------IIKNKKAFLNQAQIEVRLLELMNKHDT 112

Query: 186 ----NIVKLYGFCSHARHSFLV--------YEFLKRGSLAAILSSDAAAQELGWSQRMNV 233
                IV L        H  LV        Y+ L+                 G S  +N+
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNT------------NFRGVS--LNL 158

Query: 234 IKGVA----DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH--VADFGIAKFLKPDSSN 287
            +  A     AL +L       I+H D+  +N+LL     +   + DFG +         
Sbjct: 159 TRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQR 214

Query: 288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 328
             ++  +  Y +PE+   M      D++S G + +E+  G+
Sbjct: 215 IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 58/223 (26%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEF----LTEVEALTEIRHR-- 185
           IG G  G V +A      Q VA+K          + ++K F      E+  L  +R +  
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALK---------MVRNEKRFHRQAAEEIRILEHLRKQDK 155

Query: 186 ----NIVKLYGFCSHARHSFLV--------YEFLKRGSLAAILSSDAAAQELGWSQRMNV 233
               N++ +    +   H  +         YE +K+                G+S  + +
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQ------------GFS--LPL 201

Query: 234 IKGVA----DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH--VADFGIAKFLKPDSSN 287
           ++  A      L  LH      I+H D+  +N+LL  +  +   V DFG + +       
Sbjct: 202 VRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT 258

Query: 288 W--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 328
           +  + F     Y APE+    +     D++S G +  E++ G 
Sbjct: 259 YIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 43/185 (23%), Positives = 64/185 (34%), Gaps = 38/185 (20%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G ++    L + Q VAIK       + Q+ D+      +   T      I  +Y
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT-----GIPNVY 72

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA-------DALSYL 244
            F     H+ LV + L   SL  +L             R   +K VA         +  +
Sbjct: 73  YFGQEGLHNVLVIDLLGP-SLEDLLD---------LCGRKFSVKTVAMAAKQMLARVQSI 122

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEA-----HVADFGIAKFLKPDSSNW-------TEFA 292
           H       V+RDI   N L+           +V DFG+ KF +   +            +
Sbjct: 123 HEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 179

Query: 293 GTYGY 297
           GT  Y
Sbjct: 180 GTARY 184

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 49/301 (16%), Positives = 96/301 (31%), Gaps = 82/301 (27%)

Query: 120 IVRATNDFDAQYCI----GNGGHGSVYRAE-LPSGQVVAIKKF-HSPLPSDQIVDKKEFL 173
           +V+  + F+ +Y +    G G   +V+ +  +   + VA+K    +   ++  +D     
Sbjct: 28  LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----- 82

Query: 174 TEVEALTEIRHRNIVKL-YGFCSHARHSF-----------LVYEFLKRGSLAAILSSDAA 221
            E+  L  +R+ +               F           +V+E L    L   +   + 
Sbjct: 83  -EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK-SN 139

Query: 222 AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-------------- 267
            Q L       +I+ V   L YLH  C   I+H DI  +N+LL +               
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEW 197

Query: 268 -----------------------------------FEAHVADFGIAKFLKPDSSNWTEFA 292
                                               +  +AD G A ++       TE  
Sbjct: 198 QRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDI 254

Query: 293 GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML 352
            T  Y + E+          D++S   +A E+  G +   F       +   +  +  ++
Sbjct: 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL--FEPHSGEEYTRDEDHIALII 312

Query: 353 D 353
           +
Sbjct: 313 E 313

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 33/160 (20%), Positives = 60/160 (37%), Gaps = 31/160 (19%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G +   + L + + VAIK       + Q+  +  F  ++ +        I ++Y
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS-----GDGIPQVY 71

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA-------DALSYL 244
            F    +++ +V E L   SL  +              R   +K V          + Y+
Sbjct: 72  YFGPCGKYNAMVLELLGP-SLEDLFD---------LCDRTFSLKTVLMIAIQLISRMEYV 121

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEA-----HVADFGIAK 279
           H       ++RD+  +N L+           H+ DF +AK
Sbjct: 122 HSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 38/184 (20%), Positives = 68/184 (36%), Gaps = 38/184 (20%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH-RNIVKL 190
           IG+G  G +Y    + +G+ VAIK         Q+        E +    ++    I  +
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI------ESKIYKMMQGGVGIPTI 70

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA-------DALSY 243
               +   ++ +V E L   SL  + +         +  R   +K V          + Y
Sbjct: 71  RWCGAEGDYNVMVMELLGP-SLEDLFN---------FCSRKFSLKTVLLLADQMISRIEY 120

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFLKPDSSNW-------TEFAG 293
           +H   F   +HRD+   N L+ L  + +   + DFG+AK  +   ++            G
Sbjct: 121 IHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177

Query: 294 TYGY 297
           T  Y
Sbjct: 178 TARY 181

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 40/184 (21%), Positives = 71/184 (38%), Gaps = 38/184 (20%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKL 190
           IG+G  G +Y    + + + VAIK  +      Q++       E +    ++    I  +
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY------ESKIYRILQGGTGIPNV 68

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA-------DALSY 243
             F     ++ LV + L   SL  + +         +  R   +K V        + + +
Sbjct: 69  RWFGVEGDYNVLVMDLLGP-SLEDLFN---------FCSRKLSLKTVLMLADQMINRVEF 118

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAH---VADFGIAKFLKPDSSNW-------TEFAG 293
           +H   F   +HRDI   N L+ L   A+   + DFG+AK  +  S++            G
Sbjct: 119 VHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175

Query: 294 TYGY 297
           T  Y
Sbjct: 176 TARY 179

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 40.7 bits (95), Expect = 5e-04
 Identities = 29/206 (14%), Positives = 66/206 (32%), Gaps = 46/206 (22%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPS-DQIVDKKEFL-------------TEVE 177
            +G G   +V+           +K       S  ++ +K+++               E  
Sbjct: 97  LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 156

Query: 178 ALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAA--QELGWSQRMNVIK 235
           AL +++   + K+Y +  +A    ++ E +    L  +   +       +         +
Sbjct: 157 ALQKLQGLAVPKVYAWEGNA----VLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 212

Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA---------KFLKPDSS 286
           G               IVH D+S  N+L+  E    + DF  +         + L+ D  
Sbjct: 213 G---------------IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVR 256

Query: 287 NWTEFAGTYGYVAPELAYTMK-ITEK 311
           N   +         ++   +  I ++
Sbjct: 257 NIITYFSRTYRTEKDINSAIDRILQE 282

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	397
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.44
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.06
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.86
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.64
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.63
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.54
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.49
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.24
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	98.21
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.14
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.97
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.94
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.73
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.66
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.65
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.56
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.55
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.51
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.5
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.4
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.16
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.09
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.92
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	96.63
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	95.8
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.77
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	94.72
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.98
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	93.7
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	93.6
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	93.22
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	93.19
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	93.07
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	92.94
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	92.66
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	91.52
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	91.21
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	91.01
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	90.94
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	90.81
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	90.03
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	89.8
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	89.61
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	89.51
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	89.34
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	89.28
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	89.22
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	88.89
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	88.79
3m19_A	251	Variable lymphocyte receptor A diversity region; a	88.51
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	88.17
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	88.15
3e6j_A	229	Variable lymphocyte receptor diversity region; var	88.11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	87.81
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	87.59
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	87.06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	86.93
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	86.82
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	86.09
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	85.55
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	85.2
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	84.74
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	84.48
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	84.48
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	84.16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	84.04
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.99
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	83.91
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	83.68
3e6j_A	229	Variable lymphocyte receptor diversity region; var	83.24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	82.88
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	82.49
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	82.38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	82.37
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	82.31
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	82.14
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	81.68
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	81.34
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	80.4
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	80.32

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.6e-60  Score=430.07  Aligned_cols=253  Identities=22%  Similarity=0.367  Sum_probs=207.4

Q ss_pred             CCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      ++++.+.||+|+||+||+|.+.      +++.||||+++....   ....++|.+|+.++++++|||||+++|+|.+++.
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~---~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE---GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC---C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC---hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence            4555678999999999999762      567899999975332   2346789999999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC
Q 016009          200 SFLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL  266 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  266 (397)
                      .+||||||++|+|.++|.....             ...++|.+++.|+.|||+||+|||++   +||||||||+|||+++
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence            9999999999999999965321             23599999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccc
Q 016009          267 EFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLN  343 (397)
Q Consensus       267 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~  343 (397)
                      ++++||+|||+++.......  ......||+.|||||++.++.++.++|||||||++|||+| |+.||.......     
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-----  255 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-----  255 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-----
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence            99999999999987643322  2345679999999999999999999999999999999999 899987543211     


Q ss_pred             cccccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          344 TDIELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       344 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         ....+.+. ..+.+.    +++..+.+|+.+||+.||++||||.||+++|+
T Consensus       256 ---~~~~i~~~~~~~~p~----~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~  302 (308)
T 4gt4_A          256 ---VVEMIRNRQVLPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIHSRLR  302 (308)
T ss_dssp             ---HHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---HHHHHHcCCCCCCcc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence               11111111 122222    33456889999999999999999999999986

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-60  Score=425.53  Aligned_cols=257  Identities=23%  Similarity=0.403  Sum_probs=201.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .+++...+.||+|+||+||+|.+.+  .||||+++....  .....+.|.+|++++++++|||||+++|++.. +..+||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDP--TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            3467778899999999999998754  599999875322  23346789999999999999999999999864 568999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      ||||++|+|.+++....  ..++|.+++.|+.|||+||+|||++   +||||||||+|||+++++++||+|||+|+....
T Consensus       110 mEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             EECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             EEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            99999999999997544  3699999999999999999999998   999999999999999999999999999987653


Q ss_pred             CC--CCcccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 016009          284 DS--SNWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       284 ~~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      ..  ......+||+.|||||++.+   +.|+.++|||||||++|||+||+.||...........   ........|.++ 
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~---~~~~~~~~p~~~-  260 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF---MVGRGYASPDLS-  260 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH---HHHTTCCCCCST-
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH---HHhcCCCCCCcc-
Confidence            32  22345689999999999864   4589999999999999999999999975432110000   000111122221 


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        ....+++..+.+|+.+||+.||++||||.||+++||
T Consensus       261 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le  296 (307)
T 3omv_A          261 --KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE  296 (307)
T ss_dssp             --TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred             --cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence              111234456889999999999999999999999886

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9.4e-60  Score=430.30  Aligned_cols=253  Identities=28%  Similarity=0.489  Sum_probs=201.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      ++|...++||+|+||+||+|++.      +++.||||+++..    .....++|.+|+++|++++|||||+++|+|.+++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            35666788999999999999764      4788999999752    2334678999999999999999999999999999


Q ss_pred             eeeEEEEeccCCCHHHhhccccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAA------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL  266 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  266 (397)
                      ..+||||||++|+|.++++....            ..+++|.+++.|+.|||+||+|||+.   +|+||||||+|||+++
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence            99999999999999999976431            23699999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccc
Q 016009          267 EFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLN  343 (397)
Q Consensus       267 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~  343 (397)
                      ++.+||+|||+++.......  ......||+.|||||++.+..++.++|||||||++|||+| |+.||........    
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~----  269 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA----  269 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH----
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH----
Confidence            99999999999987654332  2234679999999999999999999999999999999999 9999875433110    


Q ss_pred             cccccccccC-CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          344 TDIELDEMLD-PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       344 ~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                          ...+.. .+++.+.    .++..+.+|+.+||+.||++||||+||+++|+
T Consensus       270 ----~~~i~~g~~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~  315 (329)
T 4aoj_A          270 ----IDCITQGRELERPR----ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ  315 (329)
T ss_dssp             ----HHHHHHTCCCCCCT----TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred             ----HHHHHcCCCCCCcc----cccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence                111111 1222222    23345889999999999999999999999986

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2e-60  Score=428.94  Aligned_cols=253  Identities=27%  Similarity=0.461  Sum_probs=206.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      ++|...+.||+|+||+||+|.+.      +++.||||+++..    .....++|.+|+++|++++|||||+++|+|.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            46777889999999999999753      4778999999752    2234678999999999999999999999999999


Q ss_pred             eeeEEEEeccCCCHHHhhcccc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC
Q 016009          199 HSFLVYEFLKRGSLAAILSSDA----------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF  268 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  268 (397)
                      ..+||||||++|+|.+++....          ....++|.+++.++.|||+||+|||++   +|+||||||+|||+++++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence            9999999999999999997542          234699999999999999999999998   999999999999999999


Q ss_pred             cEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 016009          269 EAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTD  345 (397)
Q Consensus       269 ~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~  345 (397)
                      .+||+|||+++........  .....||+.|||||++.+..++.++|||||||++|||+| |+.||.......       
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------  238 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------  238 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            9999999999876543322  123468999999999999999999999999999999999 999987543211       


Q ss_pred             cccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          346 IELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       346 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ....+... ..+.+.    .++..+.+|+.+||+.||++|||++||++.|+
T Consensus       239 -~~~~i~~~~~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~  285 (299)
T 4asz_A          239 -VIECITQGRVLQRPR----TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ  285 (299)
T ss_dssp             -HHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -HHHHHHcCCCCCCCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence             11111111 122222    23346889999999999999999999998885

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.2e-59  Score=427.96  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=204.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||+||+|.. .+|+.||||++......  ....+.+.+|++++++++|||||++++++.+++..||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS--SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC--HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            36899999999999999999965 57999999999753322  2346789999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      |||||+||+|.+++..... ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       101 VmEy~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EEeCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            9999999999999975442 4578999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      .........+||+.|||||++.+..|+.++|||||||++|||+||+.||.......        ....+.....+...  
T Consensus       177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~~~~~--  246 (350)
T 4b9d_A          177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--------LVLKIISGSFPPVS--  246 (350)
T ss_dssp             HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCCCCC--
T ss_pred             CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcCCCCCCC--
Confidence            33333345689999999999999999999999999999999999999997433211        11122222222111  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       ...+.++.+|+.+||++||++|||++|++++
T Consensus       247 -~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          247 -LHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             1233458899999999999999999999863

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.7e-59  Score=424.57  Aligned_cols=250  Identities=26%  Similarity=0.410  Sum_probs=209.0

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +.|+..+.||+|+||+||+|.. .+|+.||||++....    ....+.+.+|+++|++++|||||++++++.+++..|||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG----CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4588888999999999999976 479999999986422    12345688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      ||||+||+|.+++..    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus       150 mEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          150 MEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             ECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            999999999999864    2499999999999999999999999   999999999999999999999999999998776


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      ........+||+.|||||++.+..|+.++|||||||++|||++|+.||..........     .+.....+.+.    ..
T Consensus       223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-----~i~~~~~~~~~----~~  293 (346)
T 4fih_A          223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-----MIRDNLPPRLK----NL  293 (346)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHSSCCCCS----CG
T ss_pred             CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-----HHHcCCCCCCC----cc
Confidence            6555667899999999999999999999999999999999999999996433211000     01111111111    12


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+.++.+|+.+||+.||++|||++|++++
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            2334568899999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-57  Score=425.84  Aligned_cols=250  Identities=26%  Similarity=0.405  Sum_probs=209.6

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +.|+..+.||+|+||.||+|.. .+|+.||||++.....    ...+.+.+|+++|++++|||||++++++.+++..|||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            5688999999999999999965 4799999999975322    2245688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      ||||+||+|.+++...    .+++.++..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+++.+..
T Consensus       227 mEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          227 MEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            9999999999998642    499999999999999999999999   999999999999999999999999999998776


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      ........+||+.|||||++.+..|+.++|||||||++|||++|+.||..........     .+.....+.+...    
T Consensus       300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-----~i~~~~~~~~~~~----  370 (423)
T 4fie_A          300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-----MIRDNLPPRLKNL----  370 (423)
T ss_dssp             SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHSCCCCCSCT----
T ss_pred             CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-----HHHcCCCCCCccc----
Confidence            6555667899999999999999999999999999999999999999986443221100     0111111222211    


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+.+|+.+||+.||++|||++|++++
T Consensus       371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1233458899999999999999999999874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.3e-58  Score=412.75  Aligned_cols=249  Identities=22%  Similarity=0.321  Sum_probs=206.7

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++..... ......+.+.+|+++|++++|||||++++++++++..|+|
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4699999999999999999965 5799999999863110 1122357799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||++||+|.+++...+   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       111 mEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            99999999999997643   599999999999999999999999   999999999999999999999999999998754


Q ss_pred             CC--CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          284 DS--SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       284 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ..  ......+||+.|||||++.+..|+.++||||+||++|||+||+.||......        .....+.......+..
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~~~~p~~  256 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--------LIFAKIIKLEYDFPEK  256 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCCCTT
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCCcc
Confidence            33  2345678999999999999999999999999999999999999999643221        1111222222222222


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVS  392 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl  392 (397)
                          ...++.+|+.+||++||++|||++|++
T Consensus       257 ----~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          257 ----FFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ----CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ----cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                234588999999999999999999863

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.4e-58  Score=417.55  Aligned_cols=248  Identities=23%  Similarity=0.291  Sum_probs=200.2

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +.|...++||+|+||+||+|.. .+|+.||||+++....         ..+|+.++++++|||||++++++.+++..|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4577778899999999999975 4799999999875221         24699999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC-cEEEeeeccccccC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLK  282 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~  282 (397)
                      ||||+||+|.+++...+   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++ ++||+|||+++.+.
T Consensus       129 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             EeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            99999999999997543   599999999999999999999999   999999999999999987 69999999998775


Q ss_pred             CCCCC-----cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          283 PDSSN-----WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       283 ~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      .....     ....+||+.|||||++.+..|+.++|||||||++|||+||+.||........        ...+.....+
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--------~~~i~~~~~~  274 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--------CLKIASEPPP  274 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--------HHHHHHSCCG
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--------HHHHHcCCCC
Confidence            43221     2335799999999999999999999999999999999999999974332110        1111111100


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ....+...+..+.+++.+||++||++|||+.|++++|+
T Consensus       275 -~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~  312 (336)
T 4g3f_A          275 -IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG  312 (336)
T ss_dssp             -GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence             00011123345889999999999999999999998764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4e-57  Score=404.51  Aligned_cols=249  Identities=22%  Similarity=0.363  Sum_probs=196.4

Q ss_pred             CCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec----CCeeeE
Q 016009          128 DAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH----ARHSFL  202 (397)
Q Consensus       128 ~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  202 (397)
                      +..+.||+|+||+||+|.. .+++.||+|++.....  .....+.|.+|++++++++|||||++++++.+    +...+|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            4456799999999999965 4789999999864222  22346789999999999999999999999865    356899


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC-CCcEEEeeecccccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFL  281 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~  281 (397)
                      |||||++|+|.+++...   ..+++..+..++.||+.||+|||++. ++|+||||||+|||++. ++.+||+|||+|+..
T Consensus       107 vmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            99999999999999754   35999999999999999999999981 13999999999999984 799999999999864


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ..  ......+||+.|||||++.+ +|+.++|||||||++|||+||+.||........-       ...+.....+  ..
T Consensus       183 ~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~-------~~~i~~~~~~--~~  250 (290)
T 3fpq_A          183 RA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------YRRVTSGVKP--AS  250 (290)
T ss_dssp             CT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-------HHHHTTTCCC--GG
T ss_pred             CC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH-------HHHHHcCCCC--CC
Confidence            32  33455789999999998865 6999999999999999999999999643321100       0111111111  01


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.++.+|+.+||+.||++|||++|++++
T Consensus       251 ~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111122358899999999999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.4e-57  Score=399.76  Aligned_cols=249  Identities=22%  Similarity=0.330  Sum_probs=191.5

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||+||+|.. .+|+.||+|++...... .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            5899999999999999999975 47999999998753322 223356799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+ +|+|.+++....   .+++.++..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+....
T Consensus        92 mEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             EeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9999 679999987543   599999999999999999999999   999999999999999999999999999987553


Q ss_pred             CCCCcccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      . ......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||.......        ....+.+.....+.. 
T Consensus       165 ~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~--------~~~~i~~~~~~~p~~-  234 (275)
T 3hyh_A          165 G-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV--------LFKNISNGVYTLPKF-  234 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCCTT-
T ss_pred             C-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCCCCCCC-
Confidence            3 23345689999999999998876 579999999999999999999997432210        111122222222221 


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         .+..+.+|+.+||+.||++|||++|++++
T Consensus       235 ---~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          235 ---LSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ---SCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ---CCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               23458899999999999999999999874

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.2e-57  Score=409.92  Aligned_cols=260  Identities=23%  Similarity=0.335  Sum_probs=197.2

Q ss_pred             CCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC----eee
Q 016009          126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR----HSF  201 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~  201 (397)
                      +|...+.||+|+||+||+|++ +|+.||||++...     ......+..|+..+.+++|||||+++|+|..++    ..+
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~-----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc-----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            466678899999999999988 6899999998631     111222344566667889999999999997653    579


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC-----FPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                      ||||||++|+|.++++..    .++|.++.+++.|+++||+|||+++     .++|+||||||+|||+++++++||+|||
T Consensus        78 lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            999999999999999753    4899999999999999999999862     4589999999999999999999999999


Q ss_pred             cccccCCCCCC----cccccccccccCcccccCC------CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccc--
Q 016009          277 IAKFLKPDSSN----WTEFAGTYGYVAPELAYTM------KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT--  344 (397)
Q Consensus       277 ~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~--  344 (397)
                      +++........    ....+||+.|||||++.+.      .++.++|||||||++|||+||+.|+.........+...  
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99876543322    2345799999999998754      46789999999999999999998875433221111100  


Q ss_pred             -----ccc----cccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          345 -----DIE----LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       345 -----~~~----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                           +..    .....+|.++... ...+.+..+.+|+.+||+.||++||||.||+++|+
T Consensus       234 ~~~~~~~~~~~~~~~~~rp~~p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  293 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             ccchHHHHHHHHhcccCCCCCCccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence                 000    1112223332111 12355677999999999999999999999999885

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-57  Score=418.26  Aligned_cols=262  Identities=24%  Similarity=0.384  Sum_probs=211.1

Q ss_pred             HHHHHHhcCCCCCccccccCcEEEEEEEeCC------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC-Cceeee
Q 016009          118 DEIVRATNDFDAQYCIGNGGHGSVYRAELPS------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH-RNIVKL  190 (397)
Q Consensus       118 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~  190 (397)
                      ++++...++|+..+.||+|+||+||+|.+..      ++.||||++.....   ....+.|.+|+++|++++| ||||++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~---~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC---hHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4566667889999999999999999997532      35799999975322   2335789999999999965 899999


Q ss_pred             EEEEecC-CeeeEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecc
Q 016009          191 YGFCSHA-RHSFLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRD  256 (397)
Q Consensus       191 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~d  256 (397)
                      +|+|... +..++|||||++|+|.++|+....             ...++|.+++.++.|||+||+|||++   +|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            9999664 568999999999999999975432             23589999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCc
Q 016009          257 ISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDF  333 (397)
Q Consensus       257 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~  333 (397)
                      |||+|||+++++.+||+|||+|+.+..+...  .....||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876544332  244678999999999999999999999999999999998 9999875


Q ss_pred             cccccccccccccccccccC-CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          334 LSSISSSFLNTDIELDEMLD-PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ......       ....+.+ .+++.+..    ++.++.+++.+||+.||++|||+.||+++|+
T Consensus       291 ~~~~~~-------~~~~i~~g~~~~~p~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~  343 (353)
T 4ase_A          291 VKIDEE-------FCRRLKEGTRMRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  343 (353)
T ss_dssp             CCCSHH-------HHHHHHHTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHHHH-------HHHHHHcCCCCCCCcc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence            432110       0011111 12222222    2345889999999999999999999999885

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-57  Score=409.17  Aligned_cols=249  Identities=25%  Similarity=0.352  Sum_probs=198.5

Q ss_pred             cCCCCCccccccCcEEEEEEEe----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ++|+..+.||+|+||+||+|+.    .+++.||+|+++.....  ......+.+|++++++++|||||++++++.+++..
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK--VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE--EEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC--hHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            4799999999999999999965    25789999998653211  12234688999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      |+|||||+||+|.+++....   .+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+.
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            99999999999999997643   599999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      ...........+||+.|||||++.+..++.++||||+||++|||+||+.||.......        ....+.......+.
T Consensus       176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~~~p~  247 (304)
T 3ubd_A          176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--------TMTMILKAKLGMPQ  247 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCT
T ss_pred             ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--------HHHHHHcCCCCCCC
Confidence            6554445556789999999999999999999999999999999999999997433211        11122222222222


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPT-----MKIVSQ  393 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~~vl~  393 (397)
                      .    .+.++.+|+.+||++||++|||     ++|+++
T Consensus       248 ~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          248 F----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             T----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             c----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            2    2345889999999999999998     467765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.1e-55  Score=395.73  Aligned_cols=251  Identities=23%  Similarity=0.414  Sum_probs=193.1

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC-----
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR-----  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  198 (397)
                      ++|+..+.||+|+||+||+|.. .+|+.||||+++...   .....+.+.+|+++|++++|||||++++++.+.+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            4688899999999999999975 479999999986432   2234577999999999999999999999986544     


Q ss_pred             -------eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEE
Q 016009          199 -------HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH  271 (397)
Q Consensus       199 -------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  271 (397)
                             ..|+|||||++|+|.+++.........++..++.++.||+.||+|||++   +|+||||||+|||++.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence                   3689999999999999998766555677888999999999999999999   999999999999999999999


Q ss_pred             EeeeccccccCCCCCC------------cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc
Q 016009          272 VADFGIAKFLKPDSSN------------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS  339 (397)
Q Consensus       272 l~Dfg~~~~~~~~~~~------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~  339 (397)
                      |+|||+|+.+......            .+..+||+.|||||++.+..|+.++|||||||++|||++   ||......  
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--  233 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--  233 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--
Confidence            9999999876543221            233579999999999999999999999999999999997   66421110  


Q ss_pred             cccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          340 SFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                           ...+..+.+...+   ....+....+.+|+.+||+.||++|||+.|++++
T Consensus       234 -----~~~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          234 -----VRTLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             -----HHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----HHHHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 0011111222221   1223444557789999999999999999999873

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-52  Score=388.60  Aligned_cols=261  Identities=23%  Similarity=0.351  Sum_probs=199.8

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec------C
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH------A  197 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~  197 (397)
                      ++|+..+.||+|+||+||+|.. .+|+.||||+++....  .....+.+.+|+++|++++|||||++++++..      .
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD--VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc--chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            5788999999999999999965 5799999999975332  22345678899999999999999999998754      3


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      +..|||||||+ |+|.+++...   +.+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence            67899999996 6899998754   3599999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCC----CCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------cccc
Q 016009          278 AKFLKPD----SSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNTD  345 (397)
Q Consensus       278 ~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~~  345 (397)
                      ++.+...    .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||..........       ....
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9876432    2233457899999999998875 46999999999999999999999996433211000       0000


Q ss_pred             c--------ccccccCCCCCCCCcchH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          346 I--------ELDEMLDPRLPAPSRSVQ----EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       346 ~--------~~~~~~~~~~~~~~~~~~----~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .        .....+..........+.    .....+.+|+.+||+.||++|||++|++++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0        000000000000000011    113457899999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.1e-51  Score=376.62  Aligned_cols=201  Identities=25%  Similarity=0.375  Sum_probs=171.8

Q ss_pred             HHHHHHHhcCCCCCccccccCcEEEEEEEeC----CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeE
Q 016009          117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLY  191 (397)
Q Consensus       117 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~  191 (397)
                      ++.+....+.|++.+.||+|+||+||+|..+    +++.||+|++....      ...++.+|+++|+.+ +||||++++
T Consensus        13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~   86 (361)
T 4f9c_A           13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVK   86 (361)
T ss_dssp             HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCS
T ss_pred             HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEE
Confidence            3344455688999999999999999999642    46789999986421      246788999999998 699999999


Q ss_pred             EEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC-CcE
Q 016009          192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEA  270 (397)
Q Consensus       192 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~  270 (397)
                      +++.+.+..++||||+++|+|.+++.      .+++.++..++.|++.||+|||++   +|+||||||+|||++.+ +.+
T Consensus        87 ~~~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~  157 (361)
T 4f9c_A           87 YCFRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKY  157 (361)
T ss_dssp             EEEEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEE
T ss_pred             EEEEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeE
Confidence            99999999999999999999999983      489999999999999999999999   99999999999999877 799


Q ss_pred             EEeeeccccccCCCCC----------------------------CcccccccccccCcccccCC-CCCcchhhHHHHHHH
Q 016009          271 HVADFGIAKFLKPDSS----------------------------NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLA  321 (397)
Q Consensus       271 kl~Dfg~~~~~~~~~~----------------------------~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l  321 (397)
                      ||+|||+|+.......                            .....+||+.|+|||++.+. .++.++||||+||++
T Consensus       158 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il  237 (361)
T 4f9c_A          158 ALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF  237 (361)
T ss_dssp             EECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred             EECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHH
Confidence            9999999976532211                            12345799999999998875 489999999999999


Q ss_pred             HHHHhCCCCCC
Q 016009          322 LEVIKGKHPRD  332 (397)
Q Consensus       322 ~el~tg~~p~~  332 (397)
                      |||+||+.||.
T Consensus       238 ~ell~G~~Pf~  248 (361)
T 4f9c_A          238 LSLLSGRYPFY  248 (361)
T ss_dssp             HHHHHTCSSSS
T ss_pred             HHHHHCCCCCC
Confidence            99999999984

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.4e-51  Score=399.73  Aligned_cols=253  Identities=21%  Similarity=0.344  Sum_probs=209.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++...    .....+.+.+|+++|+.++|||||++++++.+.+..++
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  231 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  231 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            36799999999999999999965 47999999998652    22346778999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC--CcEEEeeeccccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE--FEAHVADFGIAKF  280 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~~~~  280 (397)
                      |||||+||+|.+++....  ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+++.
T Consensus       232 v~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            999999999999986543  3589999999999999999999999   99999999999999854  8999999999998


Q ss_pred             cCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      +... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.......        .+..+.......+.
T Consensus       307 ~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~  377 (573)
T 3uto_A          307 LDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--------TLRNVKSCDWNMDD  377 (573)
T ss_dssp             CCTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHTTCCCCCS
T ss_pred             ccCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHhCCCCCCc
Confidence            7643 33345689999999999999999999999999999999999999997443211        11112111222112


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .........+.+|+.+||+.||++|||++|++++
T Consensus       378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2222334568899999999999999999999874

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.7e-50  Score=368.76  Aligned_cols=279  Identities=34%  Similarity=0.626  Sum_probs=229.2

Q ss_pred             CcccHHHHHHHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEE
Q 016009          113 GKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG  192 (397)
Q Consensus       113 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~  192 (397)
                      ..+++.++..++++|+..+.||+|+||.||+|...+|+.||||++.......   ....+.+|++++++++||||+++++
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG---GELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch---HHHHHHHHHHHHHhccCCCccceEE
Confidence            4678899999999999999999999999999988889999999987533221   1236899999999999999999999


Q ss_pred             EEecCCeeeEEEEeccCCCHHHhhccccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEE
Q 016009          193 FCSHARHSFLVYEFLKRGSLAAILSSDAA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH  271 (397)
Q Consensus       193 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  271 (397)
                      ++...+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+.++++||||||+||+++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999976543 34599999999999999999999998777999999999999999999999


Q ss_pred             EeeeccccccCCCCCC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc---------c
Q 016009          272 VADFGIAKFLKPDSSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS---------F  341 (397)
Q Consensus       272 l~Dfg~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~---------~  341 (397)
                      |+|||++......... .....||+.|+|||.+.+..++.++||||||+++|||+||+.||+........         .
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            9999999876543332 33456999999999999888999999999999999999999998632211100         0


Q ss_pred             cccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          342 LNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .........+.+....  .....+....+.+++.+||+.||++|||+.||+++|+
T Consensus       255 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TTSSCCSTTSSCTTCT--TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             HhhchhhhhhcChhhc--cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            0111223333444333  2334577788999999999999999999999999996

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.4e-51  Score=396.30  Aligned_cols=253  Identities=19%  Similarity=0.241  Sum_probs=199.1

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHH---HHHHHHhccCCceeeeEEEEecCCe
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLT---EVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      .++|++.++||+|+||+||+|... +|+.||+|++..... ........+.+   ++.+++.++|||||++++++.+.+.
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i-~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHc-chhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence            367999999999999999999654 799999999853110 00111223333   4666777899999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      +|+|||||+||+|.+++...+   .+++..+..++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+
T Consensus       267 lylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence            999999999999999997643   599999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      .+....  ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||.........     .....+.......
T Consensus       341 ~~~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-----~i~~~i~~~~~~~  413 (689)
T 3v5w_A          341 DFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRMTLTMAVEL  413 (689)
T ss_dssp             ECSSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-----HHHHHHHHCCCCC
T ss_pred             ecCCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHHhhcCCCCCC
Confidence            765432  344689999999999864 57999999999999999999999999643221100     0011112222222


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPT-----MKIVSQQ  394 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~~vl~~  394 (397)
                      +.    ..+..+.+|+.+||+.||++|++     ++||+++
T Consensus       414 p~----~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          414 PD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             CT----TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             Cc----cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            22    22345889999999999999998     6777653

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.9e-49  Score=363.25  Aligned_cols=273  Identities=34%  Similarity=0.553  Sum_probs=222.5

Q ss_pred             ccHHHHHHHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEE
Q 016009          115 LVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFC  194 (397)
Q Consensus       115 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  194 (397)
                      +.+.++..++++|+..+.||+|+||.||+|...+|+.||+|++....    ....+.+.+|++++++++||||+++++++
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  104 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES----SQGIEEFETEIETLSFCRHPHLVSLIGFC  104 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            33445556788999999999999999999998889999999986532    22367899999999999999999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEe
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVA  273 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  273 (397)
                      ...+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEEC
T ss_pred             cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEe
Confidence            999999999999999999999976542 23589999999999999999999998   99999999999999999999999


Q ss_pred             eeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------ccc
Q 016009          274 DFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNT  344 (397)
Q Consensus       274 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~  344 (397)
                      |||++........  ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..........       ...
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  261 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN  261 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence            9999986543221  2234568999999999998899999999999999999999999986433211000       001


Q ss_pred             ccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          345 DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .......+++....  ....+....+.+++.+||+.||++|||+.||+++|+
T Consensus       262 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          262 NGQLEQIVDPNLAD--KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             TTCCCSSSSSSCTT--CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccHHHhcChhhcc--ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            11233344444432  233567788999999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.4e-48  Score=351.26  Aligned_cols=276  Identities=32%  Similarity=0.543  Sum_probs=226.2

Q ss_pred             CcccHHHHHHHhcCCCCC------ccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc
Q 016009          113 GKLVYDEIVRATNDFDAQ------YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN  186 (397)
Q Consensus       113 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n  186 (397)
                      ..+++.++..++++|...      +.||+|+||.||+|.. +++.||+|++............+.+.+|++++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            467889999999999877      8899999999999987 688999999876443333344678999999999999999


Q ss_pred             eeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC
Q 016009          187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL  266 (397)
Q Consensus       187 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  266 (397)
                      |+++++++...+..++||||+++++|.+++........+++..++.++.|++.||.|||+.   +++|+||||+||++++
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence            9999999999999999999999999999997655556799999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc-----
Q 016009          267 EFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS-----  339 (397)
Q Consensus       267 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~-----  339 (397)
                      ++.+||+|||++.........  .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........     
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK  247 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence            999999999999865543222  233578999999998765 589999999999999999999999875432110     


Q ss_pred             -cccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          340 -SFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       340 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ........+...+++.+..   ........+.+++.+||+.||++|||+++|+++|+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~  302 (307)
T 2nru_A          248 EEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ  302 (307)
T ss_dssp             HHHHTTSCCHHHHSCSSCSC---CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             HHhhhhhhhhhhhccccccc---cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence             0001111223334444332   23466778999999999999999999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.7e-49  Score=361.14  Aligned_cols=263  Identities=30%  Similarity=0.454  Sum_probs=203.2

Q ss_pred             HHHHHHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC
Q 016009          118 DEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA  197 (397)
Q Consensus       118 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  197 (397)
                      .++....++|+..+.||+|+||+||+|.. +|+.||||++.....  .....+.+.+|++++++++||||+++++++...
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            33344456888899999999999999977 688999999875332  223456799999999999999999999999999


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeccCCCCcEEeCCCCcEEEeee
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP--IVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                      +..++||||+++|+|.+++........+++..++.++.|++.||+|||+.   +  ++||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence            99999999999999999998755444599999999999999999999998   7  999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR  355 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  355 (397)
                      |++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||...........      .......
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~------~~~~~~~  257 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA------VGFKCKR  257 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH------HHHSCCC
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhcCCC
Confidence            9998655443334456799999999999999999999999999999999999999875432110000      0001111


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...+.    .....+.+++.+||+.||++|||++++++.|+
T Consensus       258 ~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~  294 (309)
T 3p86_A          258 LEIPR----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR  294 (309)
T ss_dssp             CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11111    22345889999999999999999999999885

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-48  Score=354.78  Aligned_cols=251  Identities=26%  Similarity=0.425  Sum_probs=208.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||+||+|.. .+|+.||+|++....    ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG----CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            35799999999999999999975 578999999986422    2235778999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|.+++...    .+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        95 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            99999999999999653    489999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..........||+.|+|||.+.+..++.++||||||+++|||+||+.||...........     ......+....    
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----~~~~~~~~~~~----  238 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-----IATNGTPELQN----  238 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHHCSCCCSC----
T ss_pred             CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhCCCCCCCC----
Confidence            555555667899999999999999999999999999999999999999864332111000     00001111111    


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .......+.+++.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            12234458899999999999999999999874

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.8e-48  Score=355.49  Aligned_cols=263  Identities=25%  Similarity=0.400  Sum_probs=214.6

Q ss_pred             CCcccHHHHHHHhcC----------CCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHH
Q 016009          112 EGKLVYDEIVRATND----------FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT  180 (397)
Q Consensus       112 ~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~  180 (397)
                      .+.++++++..+++.          |+..+.||+|+||.||+|... +|+.||||++.....    ...+.+.+|+.+++
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~   97 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMR   97 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHHHHHHHHHHHT
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHHHHHHHHHHHH
Confidence            356788888888865          566678999999999999765 799999999865322    23577899999999


Q ss_pred             hccCCceeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCC
Q 016009          181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSK  260 (397)
Q Consensus       181 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~  260 (397)
                      +++||||+++++++...+..++||||+++++|.+++..    ..+++.++..++.|++.||+|||+.   +++||||||+
T Consensus        98 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~  170 (321)
T 2c30_A           98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSD  170 (321)
T ss_dssp             TCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred             hCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHH
Confidence            99999999999999999999999999999999999864    2489999999999999999999998   9999999999


Q ss_pred             cEEeCCCCcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc
Q 016009          261 NLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS  340 (397)
Q Consensus       261 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~  340 (397)
                      ||+++.++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus       171 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~  250 (321)
T 2c30_A          171 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM  250 (321)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             HEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999999987665444445568999999999999999999999999999999999999998643321100


Q ss_pred             ccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          341 FLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                           ..+.....+....    .......+.+++.+||+.||++|||++|++++
T Consensus       251 -----~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          251 -----KRLRDSPPPKLKN----SHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             -----HHHHHSSCCCCTT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -----HHHhcCCCCCcCc----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0011111111111    11233458899999999999999999999874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=350.44  Aligned_cols=254  Identities=26%  Similarity=0.454  Sum_probs=205.6

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||+||+|... +++.||+|++..    ......+.+.+|++++++++||||+++++++.+++..++|
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            46788899999999999999764 689999998854    2233467899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            99999999999997643  4599999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCc--------------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 016009          284 DSSNW--------------TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD  349 (397)
Q Consensus       284 ~~~~~--------------~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  349 (397)
                      .....              ....||+.|+|||.+.+..++.++||||||+++|||++|..|+...........   ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---~~~~  237 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---LNVR  237 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS---BCHH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh---hhhh
Confidence            32211              145789999999999999999999999999999999999999764332111111   0111


Q ss_pred             cccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...+...+.      ..+..+.+++.+||+.||++|||+.++++.|+
T Consensus       238 ~~~~~~~~~------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~  278 (310)
T 3s95_A          238 GFLDRYCPP------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE  278 (310)
T ss_dssp             HHHHHTCCT------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccccccCCC------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            111111111      11234889999999999999999999999885

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.5e-48  Score=354.93  Aligned_cols=250  Identities=24%  Similarity=0.381  Sum_probs=206.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|...+.||+|+||.||+|.. .+|+.||||++.....  .....+.+.+|+++++.++||||+++++++...+..++
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            35788899999999999999976 5899999999864222  22345678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        92 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             EECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            999999999999996543   589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKIT-EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      .. .......||+.|+|||.+.+..++ .++||||+||++|||++|+.||.......        ....+.......+..
T Consensus       166 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~p~~  236 (328)
T 3fe3_A          166 VG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--------LRERVLRGKYRIPFY  236 (328)
T ss_dssp             SS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTT
T ss_pred             CC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCCC
Confidence            43 234556899999999999888765 79999999999999999999987433211        111111222222221


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                          ....+.+++.+||+.||++|||++|++++
T Consensus       237 ----~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          237 ----MSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ----SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                22357889999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.3e-47  Score=353.37  Aligned_cols=252  Identities=24%  Similarity=0.295  Sum_probs=206.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||++... +|+.||+|+++.... ........+.+|+++++.++||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            357888999999999999999765 799999999864210 112235678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|.+++....   .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        83 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            999999999999987543   589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..........||+.|+|||++.+..++.++||||||+++|||++|+.||.......        ....+.......+.  
T Consensus       157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~p~--  226 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEEIRFPR--  226 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCT--
T ss_pred             cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCCCC--
Confidence            44444556789999999999999999999999999999999999999986432210        11111111222121  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                        .....+.+++.+||+.||++||     +++|++++
T Consensus       227 --~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          227 --TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence              1234588999999999999999     89999864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-47  Score=356.45  Aligned_cols=256  Identities=21%  Similarity=0.288  Sum_probs=208.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCc--chhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSD--QIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      .+.|...+.||+|+||.||++... +|+.||+|.+.......  .....+.+.+|++++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            457888999999999999999765 78999999987533221  112357899999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC----cEEEeeec
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF----EAHVADFG  276 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg  276 (397)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+.   +|+||||||+||++++++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            9999999999999999654   3599999999999999999999999   999999999999998877    79999999


Q ss_pred             cccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      ++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......        .....+.....
T Consensus       165 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--------~~~~~i~~~~~  235 (361)
T 2yab_A          165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITAVSY  235 (361)
T ss_dssp             SCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCC
T ss_pred             CceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcCC
Confidence            998765432 234567999999999999989999999999999999999999998643221        11111212121


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+...+......+.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          236 DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11111112234568899999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=365.49  Aligned_cols=256  Identities=21%  Similarity=0.298  Sum_probs=208.0

Q ss_pred             HhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ..++|+..+.||+|+||.||++.. .+|+.+|+|++.....  .....+.+.+|++++++++||||+++++++.+++..+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            356789999999999999999965 5789999999875322  2234567899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC---CCCcEEEeeeccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD---LEFEAHVADFGIA  278 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~  278 (397)
                      +||||+++|+|.+.+....   .+++.++..++.|++.||.|||+.   +|+||||||+|||++   .++.+||+|||++
T Consensus        87 lv~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            9999999999999987643   589999999999999999999999   999999999999998   4678999999999


Q ss_pred             cccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 016009          279 KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       279 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      ..............||+.|+|||++.+..++.++||||+||++|+|++|..||.......        ....+.......
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~~  232 (444)
T 3soa_A          161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--------LYQQIKAGAYDF  232 (444)
T ss_dssp             BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCCC
T ss_pred             EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHhCCCCC
Confidence            877655554556789999999999999899999999999999999999999986432211        011111111111


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +...+......+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          233 PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            111112334568899999999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.7e-47  Score=357.81  Aligned_cols=255  Identities=24%  Similarity=0.421  Sum_probs=206.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEe--------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL--------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFC  194 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  194 (397)
                      .++|...+.||+|+||.||+|..        .++..||||+++...   .....+.+.+|+++++++ +||||+++++++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            35788889999999999999964        235679999987532   223457899999999999 899999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCc
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN  261 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  261 (397)
                      ...+..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+.   +|+||||||+|
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N  233 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  233 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence            999999999999999999999976432             23589999999999999999999999   99999999999


Q ss_pred             EEeCCCCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccc
Q 016009          262 LLLDLEFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS  338 (397)
Q Consensus       262 ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  338 (397)
                      ||++.++.+||+|||++........  ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999999999986654322  2233456889999999999999999999999999999999 999986433211


Q ss_pred             ccccccccccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          339 SSFLNTDIELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       339 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                              ....+... ....+.    .....+.+++.+||+.||++|||+.|+++.|+
T Consensus       314 --------~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~  360 (370)
T 2psq_A          314 --------LFKLLKEGHRMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  360 (370)
T ss_dssp             --------HHHHHHTTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --------HHHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                    01111111 111111    23345889999999999999999999999986

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-47  Score=352.12  Aligned_cols=252  Identities=22%  Similarity=0.288  Sum_probs=207.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|...+.||+|+||.||++... +++.||+|.+...     ......+.+|+++++.++||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            357888999999999999999765 6889999998642     1235678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC--CCcEEEeeeccccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL--EFEAHVADFGIAKF  280 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~  280 (397)
                      ||||+++|+|.+++....  ..+++.+++.++.|++.||.|||+.   +++||||||+||+++.  ++.+||+|||++..
T Consensus        79 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           79 IFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            999999999999996543  3589999999999999999999999   9999999999999987  78999999999987


Q ss_pred             cCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      .... .......||+.|+|||++.+..++.++||||||+++|||++|..||......        .....+.......+.
T Consensus       154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~~~~  224 (321)
T 1tki_A          154 LKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEYTFDE  224 (321)
T ss_dssp             CCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCCCH
T ss_pred             CCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHcCCCCCCh
Confidence            6543 2334567899999999999888999999999999999999999998643221        111222222222111


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....+.+..+.+++.+||+.||++|||+.|++++
T Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1112334568899999999999999999999874

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3e-47  Score=350.13  Aligned_cols=252  Identities=26%  Similarity=0.471  Sum_probs=202.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC----CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ++|...+.||+|+||.||+|...    .+..||||++.....   ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT---ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            46777899999999999999764    344699999875322   23457899999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            99999999999999996543  3599999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-C
Q 016009          281 LKPDSSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-R  355 (397)
Q Consensus       281 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~  355 (397)
                      ........   ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......        ....+... .
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~  272 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--------VISSVEEGYR  272 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------HHHHHHTTCC
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHcCCC
Confidence            65432221   22345778999999998899999999999999999999 999986433211        01111111 1


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+.+.    ..+..+.+++.+||+.||++|||+.+|++.|+
T Consensus       273 ~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~  309 (325)
T 3kul_A          273 LPAPM----GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD  309 (325)
T ss_dssp             CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCC----CcCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11111    22345889999999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=345.48  Aligned_cols=264  Identities=23%  Similarity=0.297  Sum_probs=209.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC--eee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR--HSF  201 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~  201 (397)
                      ++|...+.||+|+||+||+|... +++.||||++....   .....+.+.+|++++++++||||+++++++....  ..+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS---FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG---GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc---ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            46888899999999999999765 58999999986422   1223577889999999999999999999997655  779


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe----CCCCcEEEeeecc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL----DLEFEAHVADFGI  277 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~  277 (397)
                      +||||+++++|.+++........+++.+++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            9999999999999998765545599999999999999999999999   99999999999999    8888899999999


Q ss_pred             ccccCCCCCCcccccccccccCccccc--------CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccc------
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAY--------TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN------  343 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~------  343 (397)
                      +....... ......||+.|+|||++.        +..++.++||||||+++|||+||+.||............      
T Consensus       163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            98765433 233457999999999876        567899999999999999999999998632221100000      


Q ss_pred             -----------cccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 016009          344 -----------TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL  395 (397)
Q Consensus       344 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~L  395 (397)
                                 .......-..+.++............+.+++.+||+.||++|||++|++++.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence                       0000000011222333344466777899999999999999999999999875

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=349.93  Aligned_cols=255  Identities=21%  Similarity=0.301  Sum_probs=206.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCc--chhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSD--QIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      +.|...+.||+|+||.||++... +|+.||+|.+.......  .....+.+.+|++++++++||||+++++++......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46888899999999999999764 68999999986533221  1224678999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC----cEEEeeecc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF----EAHVADFGI  277 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~  277 (397)
                      +||||+++|+|.+++...   ..+++.+++.++.|++.||.|||+.   +++||||||+||+++.++    .+||+|||+
T Consensus        91 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            999999999999999654   3589999999999999999999998   999999999999999887    899999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      +....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......        ....+......
T Consensus       165 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~~~~~~~~  235 (326)
T 2y0a_A          165 AHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANVSAVNYE  235 (326)
T ss_dssp             CEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHTCCC
T ss_pred             CeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHHhcCCC
Confidence            98765332 2344579999999999998899999999999999999999999986432210        01111111111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .+..........+.+++.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111111223468899999999999999999999975

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=355.91  Aligned_cols=252  Identities=23%  Similarity=0.337  Sum_probs=201.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  201 (397)
                      .++|+..+.||+|+||.||+|... +|+.||+|+++.... ......+.+..|.++++.+ +||||+++++++.+.+..+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~-~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh-cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            468999999999999999999764 689999999864111 1122356788999999998 7999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++|+|.+++....   .+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999999999999997643   599999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ..........+||+.|+|||++.+..++.++|||||||++|||++|+.||......        .....+.......+..
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~p~~  246 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILNDEVVYPTW  246 (353)
T ss_dssp             CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCTT
T ss_pred             ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCCCC
Confidence            54444455678999999999999888999999999999999999999998643321        1112222222222221


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTM------KIVSQQ  394 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~------~~vl~~  394 (397)
                          ....+.+++.+||+.||++||++      +|++++
T Consensus       247 ----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          247 ----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                22458889999999999999998      777653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.1e-47  Score=346.44  Aligned_cols=257  Identities=26%  Similarity=0.419  Sum_probs=198.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHh--ccCCceeeeEEEEec----C
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--IRHRNIVKLYGFCSH----A  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~  197 (397)
                      .++|+..+.||+|+||+||+|.. +++.||||++..       .....+..|.+++..  ++||||+++++++..    .
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS-------RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG-------GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc-------ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            45788899999999999999987 689999999853       134566777887777  799999999998644    3


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceeccCCCCcEEeCCCCc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH--------HDCFPPIVHRDISSKNLLLDLEFE  269 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~~~~ivH~dlk~~Nill~~~~~  269 (397)
                      ...++||||+++|+|.+++..    ..+++..++.++.|++.||+|||        +.   +++||||||+|||++.++.
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred             ceeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence            568999999999999999954    35899999999999999999999        76   9999999999999999999


Q ss_pred             EEEeeeccccccCCCCCC----cccccccccccCcccccCC------CCCcchhhHHHHHHHHHHHhC----------CC
Q 016009          270 AHVADFGIAKFLKPDSSN----WTEFAGTYGYVAPELAYTM------KITEKCDVYSFGVLALEVIKG----------KH  329 (397)
Q Consensus       270 ~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~el~tg----------~~  329 (397)
                      +||+|||++.........    .....||+.|+|||.+.+.      .++.++||||||+++|||+||          +.
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            999999999765543322    2234789999999998876      456799999999999999999          66


Q ss_pred             CCCcccccccccccccc-ccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          330 PRDFLSSISSSFLNTDI-ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       330 p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ||............... .......+..+. ..........+.+++.+||+.||++|||+.+|++.|+
T Consensus       232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  298 (301)
T 3q4u_A          232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPN-RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT  298 (301)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCG-GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cccccCCCCcchhhhhHHHhccCCCCCCCh-hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence            65432211110000000 000011111110 1112346678999999999999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.7e-47  Score=355.99  Aligned_cols=259  Identities=25%  Similarity=0.339  Sum_probs=204.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  201 (397)
                      .++|+..+.||+|+||.||+++.. +++.||+|+++..... .....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            357889999999999999999765 6789999998753221 112234578899999887 8999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++|+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       130 lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            9999999999999997543   599999999999999999999999   9999999999999999999999999999864


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccc-ccccccccCCCCCCCC
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT-DIELDEMLDPRLPAPS  360 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  360 (397)
                      ..........+||+.|+|||++.+..++.++|||||||++|||++|+.||............. ......+.......+.
T Consensus       204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~  283 (396)
T 4dc2_A          204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR  283 (396)
T ss_dssp             CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred             ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence            444444556789999999999999999999999999999999999999996432211100000 0011122222222222


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTM------KIVSQ  393 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~------~~vl~  393 (397)
                      .    ....+.+|+.+||+.||++||++      +|+++
T Consensus       284 ~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          284 S----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             T----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             c----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            2    23458899999999999999995      56665

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.2e-47  Score=346.27  Aligned_cols=257  Identities=26%  Similarity=0.391  Sum_probs=202.7

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||++.. .+++.||+|.+..... ......+.+.+|+.++++++||||+++++++...+..++|
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            4788899999999999999965 4789999999865332 2233467899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999997543   599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC-Cc
Q 016009          284 DSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP-SR  361 (397)
Q Consensus       284 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  361 (397)
                      ... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.........       .. ......+.. ..
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-------~~-~~~~~~~~~~~~  235 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-------IK-HIQDSVPNVTTD  235 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-------HH-HHSSCCCCHHHH
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-------HH-HhhccCCCcchh
Confidence            322 223457899999999999999999999999999999999999998754321100       00 001111100 00


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRP-TMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RP-t~~~vl~~Le  396 (397)
                      ...+.+..+.+++.+||+.||++|| +++++.+.|+
T Consensus       236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence            0112235688999999999999998 8999888775

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.5e-47  Score=353.75  Aligned_cols=254  Identities=22%  Similarity=0.335  Sum_probs=206.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|...+.||+|+||.||+|... +|+.||+|++.....  .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            467899999999999999999664 689999999875332  22345778999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC---cEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF---EAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~  279 (397)
                      ||||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++   .+||+|||++.
T Consensus       106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999999986543   589999999999999999999999   999999999999998654   59999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......        ....+.......+
T Consensus       180 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------~~~~i~~~~~~~~  250 (362)
T 2bdw_A          180 EVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYAQIKAGAYDYP  250 (362)
T ss_dssp             CCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCC
T ss_pred             EecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCCCC
Confidence            76533 23345679999999999999899999999999999999999999986432210        0111111111111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+......+.+++.+||+.||++|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            22222334568899999999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.3e-47  Score=356.21  Aligned_cols=258  Identities=21%  Similarity=0.268  Sum_probs=206.2

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCC-CCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPL-PSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      ++|+..+.||+|+||.||+|.. .+|+.||+|++.... ........+.+.+|+++++.++||||+++++++...+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4688899999999999999965 478999999975311 00111235789999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc---EEEeeeccc
Q 016009          203 VYEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGIA  278 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~  278 (397)
                      ||||+++|+|.+.+.... ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            999999999988876543 223589999999999999999999999   9999999999999987655   999999999


Q ss_pred             cccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 016009          279 KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       279 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      ..............||+.|+|||++.+..++.++|||||||++|||++|+.||.....         .....+.......
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~i~~~~~~~  251 (351)
T 3c0i_A          181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLFEGIIKGKYKM  251 (351)
T ss_dssp             EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHHHHHHHTCCCC
T ss_pred             eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHHHHHHcCCCCC
Confidence            8776544444556899999999999999999999999999999999999999864321         0111111111111


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +...+......+.+++.+||+.||++|||+.|++++
T Consensus       252 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            111111234568899999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.1e-47  Score=346.53  Aligned_cols=263  Identities=22%  Similarity=0.298  Sum_probs=201.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .++|+..+.||+|+||+||+|...+|+.||+|++.....  .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            357888999999999999999988899999999875322  222356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++ +|.+.+....  ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        98 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            999985 7888876543  3589999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc-------------ccccccc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL-------------NTDIELD  349 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~-------------~~~~~~~  349 (397)
                      .........+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........             .......
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence            4444555678999999999876 5689999999999999999999999864332110000             0000000


Q ss_pred             cccCCCCCCCC-cc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          350 EMLDPRLPAPS-RS----VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       350 ~~~~~~~~~~~-~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+....... ..    ......++.+|+.+||+.||++|||++|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            00000000000 00    01123468899999999999999999999874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.4e-47  Score=348.28  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=195.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEe----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      .++|+..+.||+|+||.||++..    .+|+.||+|+++.............+.+|++++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35788899999999999999976    47899999999764322222345668899999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++|+|.+++....   .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999997543   589999999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      .............||+.|+|||.+.+..++.++||||||+++|||++|+.||......        .....+.......+
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~~~p  241 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--------KTIDKILKCKLNLP  241 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCCCCC
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCCCCC
Confidence            6544333344567999999999999989999999999999999999999998643321        11111222222222


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                      ..    ....+.+++.+||+.||++||     +++|++++
T Consensus       242 ~~----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          242 PY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             TT----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             CC----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            21    234588999999999999999     77888764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.2e-47  Score=338.27  Aligned_cols=251  Identities=27%  Similarity=0.483  Sum_probs=206.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .++|+..+.||+|+||.||+|...++..||+|++....     ...+++.+|++++++++||||+++++++...+..++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-----MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-----BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-----CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            45788889999999999999999888899999987422     2356799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++....  ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            99999999999997643  3589999999999999999999999   999999999999999999999999999986654


Q ss_pred             CCCC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 016009          284 DSSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLPAPS  360 (397)
Q Consensus       284 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  360 (397)
                      .... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+.......        ...+... ....+.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~  228 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV--------VLKVSQGHRLYRPH  228 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--------HHHHHTTCCCCCCT
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH--------HHHHHcCCCCCCCC
Confidence            3221 223456778999999998889999999999999999999 9999864432110        0111111 111111


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .    ....+.+++.+||+.||++|||+.++++.|+
T Consensus       229 ~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  260 (268)
T 3sxs_A          229 L----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIE  260 (268)
T ss_dssp             T----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHG
T ss_pred             c----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1    1235889999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.5e-47  Score=358.50  Aligned_cols=251  Identities=25%  Similarity=0.473  Sum_probs=194.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeC----CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ++|+..+.||+|+||.||+|...    ++..||||+++...   .....+.+.+|++++++++||||+++++++...+..
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            47888999999999999999764    57789999987532   223457899999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            99999999999999997543  3689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCCc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--
Q 016009          281 LKPDSSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--  354 (397)
Q Consensus       281 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  354 (397)
                      ........   ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......         ....+..  
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---------~~~~i~~~~  267 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---------VIKAVDEGY  267 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---------HHHHHHTTE
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcCC
Confidence            65432211   12235678999999999999999999999999999998 999986433211         0011111  


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+.    ..+..+.+++.+||+.||++|||+++|+++|+
T Consensus       268 ~~~~~~----~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~  305 (373)
T 2qol_A          268 RLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVSILD  305 (373)
T ss_dssp             ECCCCT----TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCc----cccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence            111111    22345889999999999999999999999885

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.4e-47  Score=339.30  Aligned_cols=251  Identities=27%  Similarity=0.460  Sum_probs=206.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .++|+..+.||+|+||.||+|...+++.||+|++....     ...+++.+|++++++++||||+++++++.+.+..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-----cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence            35788889999999999999998889999999987522     2346799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             EECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            99999999999996544  3589999999999999999999999   999999999999999999999999999986543


Q ss_pred             CC-CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 016009          284 DS-SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLPAPS  360 (397)
Q Consensus       284 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  360 (397)
                      .. .......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.......        ....+... ....+.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~  230 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRLYKPR  230 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCCCT
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHhcCccCCCCC
Confidence            21 11233456788999999998899999999999999999999 999986433211        01111111 111111


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                          .....+.+++.+||+.||++|||+.+++++|+
T Consensus       231 ----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~  262 (269)
T 4hcu_A          231 ----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLA  262 (269)
T ss_dssp             ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----cCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence                12345889999999999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.3e-47  Score=351.48  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=201.1

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||+|.. .+++.||+|++..... ........+.+|+++++.++||||+++++++.+++..++|
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc-cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            5788899999999999999975 5789999999853110 1111235788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+ +|+|.+++....   .+++.+++.++.|++.||.|||+.   +++||||||+||++++++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 789988886543   599999999999999999999999   999999999999999999999999999986654


Q ss_pred             CCCCcccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      .. ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||+......        ....+.......+.  
T Consensus       161 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------~~~~i~~~~~~~p~--  229 (336)
T 3h4j_B          161 GN-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--------LFKKVNSCVYVMPD--  229 (336)
T ss_dssp             SB-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--------CBCCCCSSCCCCCT--
T ss_pred             Cc-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHcCCCCCcc--
Confidence            32 2344579999999999988776 789999999999999999999987432211        01111111111111  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        .....+.+++.+||+.||++|||++|++++
T Consensus       230 --~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          230 --FLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             --TSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             --cCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence              123458899999999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.4e-47  Score=338.36  Aligned_cols=255  Identities=29%  Similarity=0.472  Sum_probs=193.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|+..+.||+|+||.||+|... ++.||||++............+.+.+|+++++.++||||+++++++...+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57888899999999999999874 88999999876443333344678999999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC--------CCcEEEeeec
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL--------EFEAHVADFG  276 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Dfg  276 (397)
                      ||+++++|.+++..    +.+++..++.++.|++.||+|||+....+++||||||+||+++.        ++.+||+|||
T Consensus        86 e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           86 EFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             ECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            99999999999853    35899999999999999999999982223999999999999986        6789999999


Q ss_pred             cccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      ++........  ....||+.|+|||.+.+..++.++||||||+++|||++|+.||............    ...  ....
T Consensus       162 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~--~~~~  233 (271)
T 3dtc_A          162 LAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV----AMN--KLAL  233 (271)
T ss_dssp             C---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH----HTS--CCCC
T ss_pred             cccccccccc--cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh----hcC--CCCC
Confidence            9986543322  2457899999999999889999999999999999999999998754321110000    000  0011


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+.    .....+.+++.+||+.||++|||++|++++|+
T Consensus       234 ~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~  269 (271)
T 3dtc_A          234 PIPS----TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT  269 (271)
T ss_dssp             CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCc----ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence            1111    22345889999999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-47  Score=360.08  Aligned_cols=253  Identities=26%  Similarity=0.443  Sum_probs=205.7

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ..++|...+.||+|+||.||+|... +++.||||.++....   ....+.+.+|++++++++||||+++++++...+..+
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP---PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC---HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC---HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence            3457888899999999999999875 789999999875321   223457889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus       189 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            9999999999999997543  3589999999999999999999999   9999999999999999999999999999864


Q ss_pred             CCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC--CCC
Q 016009          282 KPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD--PRL  356 (397)
Q Consensus       282 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~  356 (397)
                      ......  .....++..|+|||.+.+..++.++||||||+++|||+| |..||.......         ....+.  ..+
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---------~~~~~~~~~~~  334 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---------TREFVEKGGRL  334 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---------HHHHHHTTCCC
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcCCCC
Confidence            332111  112235778999999998899999999999999999998 999987543211         011111  112


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+..    .+..+.+++.+||+.||++|||++++++.|+
T Consensus       335 ~~~~~----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  370 (377)
T 3cbl_A          335 PCPEL----CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ  370 (377)
T ss_dssp             CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            22221    2345889999999999999999999999886

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.1e-47  Score=348.77  Aligned_cols=252  Identities=21%  Similarity=0.387  Sum_probs=203.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR----  198 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  198 (397)
                      .++|+..+.||+|+||.||+|... +|+.||||++.....   ....+.+.+|++++++++||||+++++++.+..    
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR---ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST---TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            457888999999999999999775 799999999875332   224678999999999999999999999985543    


Q ss_pred             -----------------------------------------------------eeeEEEEeccCCCHHHhhccccccCCC
Q 016009          199 -----------------------------------------------------HSFLVYEFLKRGSLAAILSSDAAAQEL  225 (397)
Q Consensus       199 -----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l  225 (397)
                                                                           ..++||||+++++|.+++.........
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 379999999999999999877665667


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC------------Ccccccc
Q 016009          226 GWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS------------NWTEFAG  293 (397)
Q Consensus       226 ~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~g  293 (397)
                      ++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........            ......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            8888999999999999999998   999999999999999999999999999987654421            2233579


Q ss_pred             cccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHH
Q 016009          294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEV  373 (397)
Q Consensus       294 ~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  373 (397)
                      |+.|+|||.+.+..++.++||||||+++|||++|..|+.....          ..........   ..........+.++
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~----------~~~~~~~~~~---~~~~~~~~~~~~~l  305 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR----------IITDVRNLKF---PLLFTQKYPQEHMM  305 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH----------HHHHHHTTCC---CHHHHHHCHHHHHH
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH----------HHHHhhccCC---CcccccCChhHHHH
Confidence            9999999999999999999999999999999999887432111          0111111111   12223445667899


Q ss_pred             HHHccCCCCCCCCCHHHHHHH
Q 016009          374 VFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       374 ~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +.+||+.||++|||++|++++
T Consensus       306 i~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          306 VQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHccCCCCcCCCHHHHhhc
Confidence            999999999999999999974

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.7e-46  Score=347.43  Aligned_cols=258  Identities=26%  Similarity=0.345  Sum_probs=204.9

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  202 (397)
                      ++|+..+.||+|+||.||++... +++.||+|++..... ......+.+..|..+++++ +||||+++++++.+.+..++
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            47888999999999999999765 688999999875322 1223356788999999998 89999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            999999999999997543   599999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccc-ccccccccCCCCCCCCc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT-DIELDEMLDPRLPAPSR  361 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  361 (397)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||............. ......+.......+. 
T Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~-  240 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-  240 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT-
T ss_pred             CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC-
Confidence            44444456689999999999999999999999999999999999999996432211000000 0011112222222222 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTM------KIVSQ  393 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~------~~vl~  393 (397)
                         .....+.+++.+||+.||++||++      +|+++
T Consensus       241 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          241 ---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             ---TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             ---CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence               123458899999999999999995      66664

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.7e-47  Score=349.25  Aligned_cols=263  Identities=24%  Similarity=0.368  Sum_probs=202.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC----e
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR----H  199 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  199 (397)
                      .++|+..+.||+|+||+||+|... ++.||||++...     ......+..|+.++++++||||+++++++....    .
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence            357888999999999999999875 789999998631     223455667899999999999999999997744    4


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCceeccCCCCcEEeCCCCcEEE
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC-------FPPIVHRDISSKNLLLDLEFEAHV  272 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-------~~~ivH~dlk~~Nill~~~~~~kl  272 (397)
                      .++||||+++|+|.+++...    .+++..++.++.|++.||+|||+.+       .++|+||||||+||+++.++.+||
T Consensus        97 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence            69999999999999999653    4899999999999999999999861       238999999999999999999999


Q ss_pred             eeeccccccCCCCC--CcccccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc---
Q 016009          273 ADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL---  342 (397)
Q Consensus       273 ~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~---  342 (397)
                      +|||++........  ......||+.|+|||++.+     ..++.++||||||+++|||+||+.||...........   
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999987654332  2234578999999999886     3466789999999999999999999864322110000   


Q ss_pred             ----cccccccc-ccCCCCCC-CCc--chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          343 ----NTDIELDE-MLDPRLPA-PSR--SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       343 ----~~~~~~~~-~~~~~~~~-~~~--~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                          ........ ........ ...  ........+.+++.+||+.||++|||+.||++.|+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  314 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT  314 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                00000111 11111111 011  11234566999999999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=341.07  Aligned_cols=254  Identities=22%  Similarity=0.329  Sum_probs=197.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcc----------------------hhcHHHHHHHHHHHH
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQ----------------------IVDKKEFLTEVEALT  180 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~e~~~l~  180 (397)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++........                      ....+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            35788899999999999999965 4788999999865321110                      112356889999999


Q ss_pred             hccCCceeeeEEEEec--CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCC
Q 016009          181 EIRHRNIVKLYGFCSH--ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDIS  258 (397)
Q Consensus       181 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk  258 (397)
                      +++||||+++++++..  ....++||||+++++|.+++..    ..+++.+++.++.|++.||+|||+.   +++|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            9999999999999976  5688999999999999887543    3599999999999999999999999   99999999


Q ss_pred             CCcEEeCCCCcEEEeeeccccccCCCCCCcccccccccccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCccc
Q 016009          259 SKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLS  335 (397)
Q Consensus       259 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~el~tg~~p~~~~~  335 (397)
                      |+||+++.++.+||+|||++..............||+.|+|||.+.+..   ++.++||||||+++|||++|+.||....
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            9999999999999999999987665444445568999999999988765   4788999999999999999999986432


Q ss_pred             cccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          336 SISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....        ...+.......+.  .......+.+++.+||+.||++|||+.|++++
T Consensus       245 ~~~~--------~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          245 IMCL--------HSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HHHH--------HHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HHHH--------HHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            2110        0001111111000  01123458899999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-46  Score=339.96  Aligned_cols=262  Identities=25%  Similarity=0.354  Sum_probs=199.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|+..+.||+|+||.||+|...+|+.||+|++.....  .....+.+.+|++++++++||||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            46888899999999999999888899999999875322  2223467889999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++ +|.+++....  ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        80 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             ECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             EecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            99986 8998886543  3589999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccc--------cc----cccccccc
Q 016009          285 SSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF--------LN----TDIELDEM  351 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~--------~~----~~~~~~~~  351 (397)
                      ........+|+.|+|||.+.+. .++.++||||||+++|||++|+.||..........        ..    ........
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence            3444456789999999998764 58999999999999999999999986433211000        00    00000000


Q ss_pred             cCCCCCC----CC-cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          352 LDPRLPA----PS-RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       352 ~~~~~~~----~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .++....    +. .........+.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1111110    00 0001223458899999999999999999999874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-46  Score=352.01  Aligned_cols=253  Identities=21%  Similarity=0.333  Sum_probs=205.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|... +|+.||+|.+....    ......+.+|++++++++||||+++++++.+....++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence            357888999999999999999664 78999999986422    2235678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC--CCcEEEeeeccccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL--EFEAHVADFGIAKF  280 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~  280 (397)
                      ||||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.  ++.+||+|||++..
T Consensus       126 v~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEeccccee
Confidence            999999999999997543  3589999999999999999999999   9999999999999974  47799999999987


Q ss_pred             cCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........        ...+.......+.
T Consensus       201 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--------~~~i~~~~~~~~~  271 (387)
T 1kob_A          201 LNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--------LQNVKRCDWEFDE  271 (387)
T ss_dssp             CCTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--------HHHHHHCCCCCCS
T ss_pred             cCCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH--------HHHHHhCCCCCCc
Confidence            65432 23445799999999999999999999999999999999999999874332110        1111111111111


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .........+.+++.+||+.||++|||+.|++++
T Consensus       272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            1112233458899999999999999999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.6e-47  Score=350.11  Aligned_cols=253  Identities=25%  Similarity=0.325  Sum_probs=204.5

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCe
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARH  199 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  199 (397)
                      ...++|...+.||+|+||.||+|... +|+.||+|+++.... ......+.+..|.++++.+ +||||+++++++.+.+.
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh-hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            34568999999999999999999765 689999999864210 0112356688899999987 89999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++|+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            999999999999999997543   589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ............+||+.|+|||++.+..++.++||||||+++|||++|+.||.......        ....+.......+
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~p  238 (345)
T 1xjd_A          167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSIRMDNPFYP  238 (345)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCC
T ss_pred             hcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHhCCCCCC
Confidence            65444444456789999999999999999999999999999999999999986432210        0111111111111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMK-IVSQ  393 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-~vl~  393 (397)
                      .    .....+.+++.+||+.||++||++. ++++
T Consensus       239 ~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          239 R----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             T----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             c----ccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence            1    1234588999999999999999997 6654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.2e-47  Score=354.27  Aligned_cols=265  Identities=24%  Similarity=0.384  Sum_probs=209.2

Q ss_pred             cHHHHHHHhcCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCcee
Q 016009          116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIV  188 (397)
Q Consensus       116 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv  188 (397)
                      ...++....++|...+.||+|+||.||+|..      .+++.||||++.....   ....+.+.+|+++++++ +||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC---HHHHHHHHHHHHHHHhhcCCccee
Confidence            3455666778999999999999999999963      3567899999975322   22356799999999999 799999


Q ss_pred             eeEEEEecCC-eeeEEEEeccCCCHHHhhccccc----------------------------------------------
Q 016009          189 KLYGFCSHAR-HSFLVYEFLKRGSLAAILSSDAA----------------------------------------------  221 (397)
Q Consensus       189 ~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------  221 (397)
                      ++++++...+ ..++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            9999997755 48999999999999999976432                                              


Q ss_pred             -----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          222 -----------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       222 -----------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                                       ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                             11288999999999999999999999   9999999999999999999999999999866443


Q ss_pred             CC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          285 SS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       285 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ..  ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||..........    ......  .....+. 
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~~~--~~~~~~~-  319 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC----RRLKEG--TRMRAPD-  319 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH----HHHHHT--CCCCCCT-
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH----HHHHcC--CCCCCCC-
Confidence            32  2234568899999999999999999999999999999998 999986433211000    000000  0111111 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         .....+.+++.+||+.||++|||+.|++++|+
T Consensus       320 ---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  351 (359)
T 3vhe_A          320 ---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  351 (359)
T ss_dssp             ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence               12345889999999999999999999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-46  Score=345.92  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=201.9

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|... +++.||+|++......   ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc---chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            357888999999999999999765 7899999998643221   124568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|.+++....   .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..+.
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            999999999999996543   499999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCC--CCcccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          283 PDS--SNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       283 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ...  .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..........       .......... 
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~~~~~~~~~~-  228 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-------SDWKEKKTYL-  228 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-------HHHHTTCTTS-
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-------HHHhcccccC-
Confidence            322  22345679999999999987775 778999999999999999999987543211110       0111111110 


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .........+.+|+.+||+.||++|||++|++++
T Consensus       229 -~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence             0112233457899999999999999999999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-46  Score=345.63  Aligned_cols=251  Identities=24%  Similarity=0.335  Sum_probs=183.7

Q ss_pred             CccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeeeEEEEec
Q 016009          130 QYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  207 (397)
                      .+.||+|+||.||+|... +++.||||++..       .....+.+|+.+++.+. ||||+++++++.+....++||||+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~   88 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK-------RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL   88 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG-------GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh-------hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence            477999999999999764 689999999853       13467889999999997 999999999999999999999999


Q ss_pred             cCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC---cEEEeeeccccccCCC
Q 016009          208 KRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF---EAHVADFGIAKFLKPD  284 (397)
Q Consensus       208 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~~~~~~  284 (397)
                      ++|+|.+++...   ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++   .+||+|||++......
T Consensus        89 ~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           89 NGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             CSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            999999999764   3599999999999999999999999   999999999999997665   8999999999876655


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchH
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQ  364 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (397)
                      ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .........+.......+...+.
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~  241 (325)
T 3kn6_A          163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKIKKGDFSFEGEAWK  241 (325)
T ss_dssp             ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHHTTTCCCCCSHHHH
T ss_pred             CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHHHcCCCCCCccccc
Confidence            54455667899999999999999999999999999999999999998743321000 00011122223333332333333


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          365 EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       365 ~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.+++.+||+.||++|||++|++++
T Consensus       242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             TSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            445678999999999999999999998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=338.91  Aligned_cols=252  Identities=25%  Similarity=0.409  Sum_probs=183.8

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||+|.. .+|+.||+|.+..... ......+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM-YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh-hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            5788889999999999999976 5799999999853110 1112246789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++....  ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            99999999999997543  4689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........||+.|+|||.+.+..++.++||||||+++|||++|+.||.......        ....+.......+.   
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~---  233 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--------TLNKVVLADYEMPS---  233 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCCCCCT---
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--------HHHHHhhcccCCcc---
Confidence            4333345678999999999998889999999999999999999999986433211        11111111111111   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .....+.+++.+||+.||++|||+++++++
T Consensus       234 -~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          234 -FLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             -TSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -ccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence             123458899999999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.4e-46  Score=337.46  Aligned_cols=262  Identities=21%  Similarity=0.285  Sum_probs=200.9

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||+||+|... +++.||+|++......  ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS--TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc--CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            46888899999999999999764 6899999998753322  22357788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++ ++.+.+....  ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             EecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            999986 5555554322  3599999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCcccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCcccccccc-----------ccccccccccc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-----------FLNTDIELDEM  351 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-----------~~~~~~~~~~~  351 (397)
                      .........+|+.|+|||.+.+.. ++.++||||||+++|||++|..|+.........           ...........
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence            544455668899999999988766 799999999999999999998885322111000           00000000000


Q ss_pred             cC-------CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          352 LD-------PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       352 ~~-------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .+       +...............+.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00       00000001111233568899999999999999999999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.2e-46  Score=337.89  Aligned_cols=251  Identities=25%  Similarity=0.469  Sum_probs=203.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .++|+..+.||+|+||.||++...++..||+|++....     ...+++.+|++++++++||||+++++++.+.+..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   97 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   97 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-----CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence            45788889999999999999999888899999987522     2346799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++....  ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           98 TEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             ECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999997643  3599999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-CCCCC
Q 016009          284 DSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPR-LPAPS  360 (397)
Q Consensus       284 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  360 (397)
                      ... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||........        ...+.... ...+.
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~  244 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--------AEHIAQGLRLYRPH  244 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--------HHHHHTTCCCCCCT
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--------HHHHhcccCCCCCC
Confidence            211 1223456788999999998899999999999999999998 9999875432110        11111111 11111


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                          .....+.+++.+||+.||++|||+++++++|+
T Consensus       245 ----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  276 (283)
T 3gen_A          245 ----LASEKVYTIMYSCWHEKADERPTFKILLSNIL  276 (283)
T ss_dssp             ----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ----cCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence                11245889999999999999999999999885

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-46  Score=341.37  Aligned_cols=260  Identities=26%  Similarity=0.428  Sum_probs=200.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-  197 (397)
                      .++|+..+.||+|+||+||+|.+     .+++.||||++...    .....+.+.+|++++++++||||+++++++... 
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            35788889999999999999974     36889999998742    223457899999999999999999999998543 


Q ss_pred             -CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          198 -RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       198 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                       ...++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence             56899999999999999997654  3589999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCC---CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccc----c---c
Q 016009          277 IAKFLKPDSS---NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT----D---I  346 (397)
Q Consensus       277 ~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~----~---~  346 (397)
                      ++........   ......++..|+|||.+.+..++.++||||||+++|||+||..|+.............    .   .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            9987654322   1223456778999999999999999999999999999999999976432110000000    0   0


Q ss_pred             cccccc--CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          347 ELDEML--DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       347 ~~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .....+  ....+.+.    ..+..+.+++.+||+.||++|||++|++++|+
T Consensus       240 ~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~  287 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVD  287 (295)
T ss_dssp             HHHHHHHTTCCCCCCT----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHhccCcCCCCc----CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            000111  11112122    23356889999999999999999999999885

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-46  Score=342.44  Aligned_cols=248  Identities=23%  Similarity=0.368  Sum_probs=204.1

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||++... +|+.||+|++..... ......+.+.+|..+++.++||||+++++++.+....++|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            57888999999999999999764 799999999864111 1112356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999997543   589999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .   .....||+.|+|||++.+..++.++||||||+++|||++|+.||......        .....+.......+..  
T Consensus       159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~~~p~~--  225 (318)
T 1fot_A          159 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNAELRFPPF--  225 (318)
T ss_dssp             C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHCCCCCCTT--
T ss_pred             c---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCCC--
Confidence            2   23457999999999999999999999999999999999999998643221        1111222222222221  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                        ....+.+++.+||+.||++||     +++|++++
T Consensus       226 --~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          226 --FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             --SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence              224588999999999999999     89998754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-46  Score=349.87  Aligned_cols=255  Identities=25%  Similarity=0.412  Sum_probs=206.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC--------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFC  194 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  194 (397)
                      .++|...+.||+|+||.||+|...        ++..||+|++.....   ....+.+.+|+++++++ +||||+++++++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC---HHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            457888899999999999999642        335799999875322   23457899999999999 999999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCc
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN  261 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  261 (397)
                      ...+..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+.   +|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            999999999999999999999976432             23589999999999999999999999   99999999999


Q ss_pred             EEeCCCCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccc
Q 016009          262 LLLDLEFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS  338 (397)
Q Consensus       262 ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  338 (397)
                      |++++++.+||+|||++........  ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987654322  2234467889999999999999999999999999999999 999986433211


Q ss_pred             ccccccccccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          339 SSFLNTDIELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       339 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                              ....+... ....+.    .....+.+++.+||+.||++|||++||++.|+
T Consensus       302 --------~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  348 (382)
T 3tt0_A          302 --------LFKLLKEGHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  348 (382)
T ss_dssp             --------HHHHHHTTCCCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --------HHHHHHcCCCCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                    01111111 111111    22345889999999999999999999999985

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-46  Score=348.40  Aligned_cols=259  Identities=24%  Similarity=0.404  Sum_probs=207.9

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEE
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFC  194 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  194 (397)
                      ....++|+..+.||+|+||.||+|...      +++.||+|+++....   ....+.+.+|++++++++||||+++++++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            344578999999999999999999764      347899999875322   23357899999999999999999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAA---------------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIV  253 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iv  253 (397)
                      ...+..++||||+++|+|.+++.....                     ...+++.+++.++.|++.||.|||+.   +++
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv  196 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  196 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            999999999999999999999976421                     14689999999999999999999999   999


Q ss_pred             eccCCCCcEEeCCCCcEEEeeeccccccCCCC--CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 016009          254 HRDISSKNLLLDLEFEAHVADFGIAKFLKPDS--SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP  330 (397)
Q Consensus       254 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p  330 (397)
                      ||||||+||+++.++.+||+|||++.......  .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            99999999999999999999999997654322  12234567899999999998899999999999999999999 9999


Q ss_pred             CCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          331 RDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      |.......        ....+.+.......   ......+.+++.+||+.||++|||+.++++.|+
T Consensus       277 ~~~~~~~~--------~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~  331 (343)
T 1luf_A          277 YYGMAHEE--------VIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ  331 (343)
T ss_dssp             TTTSCHHH--------HHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCChHH--------HHHHHhCCCcCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence            86433211        11111111111111   122345889999999999999999999999885

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-46  Score=347.82  Aligned_cols=252  Identities=21%  Similarity=0.298  Sum_probs=205.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  201 (397)
                      .++|+..+.||+|+||.||+|... +|+.||+|+++.... ......+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            468999999999999999999765 588999999864211 1112356788999999988 8999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++|+|.+++....   .+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999997543   599999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ..........+||+.|+|||++.+..++.++||||||+++|||++|+.||......        .....+.......+. 
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~p~-  242 (353)
T 2i0e_A          172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHNVAYPK-  242 (353)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCT-
T ss_pred             ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhCCCCCCC-
Confidence            44444445678999999999999999999999999999999999999998643221        111222222222222 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPT-----MKIVSQQ  394 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~~vl~~  394 (397)
                         .....+.+++.+||+.||++||+     +++++++
T Consensus       243 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          243 ---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ---TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               22345889999999999999995     5777653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=350.80  Aligned_cols=247  Identities=22%  Similarity=0.314  Sum_probs=196.9

Q ss_pred             CccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          130 QYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      .+.||+|+||.||+|.. .+|+.||+|++...    .....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  169 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD  169 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc----ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            56799999999999965 47899999998752    12346789999999999999999999999999999999999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe--CCCCcEEEeeeccccccCCCCC
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL--DLEFEAHVADFGIAKFLKPDSS  286 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfg~~~~~~~~~~  286 (397)
                      +++|.+++....  ..+++..++.++.|++.||+|||+.   +|+||||||+|||+  ++++.+||+|||++....... 
T Consensus       170 ~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-  243 (373)
T 2x4f_A          170 GGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-  243 (373)
T ss_dssp             TCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence            999999886543  3589999999999999999999999   99999999999999  677899999999998765432 


Q ss_pred             CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHH
Q 016009          287 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK  366 (397)
Q Consensus       287 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (397)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......        ..+..+.......+.......
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~~~~~~~~~~~~  315 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--------ETLNNILACRWDLEDEEFQDI  315 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCSCSGGGTTS
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhccCCCChhhhccC
Confidence            223457999999999999889999999999999999999999998643321        111122222222111222233


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          367 LRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       367 ~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+.+|+.+||+.||++|||++|++++
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            4568899999999999999999999874

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=347.41  Aligned_cols=251  Identities=25%  Similarity=0.340  Sum_probs=189.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|... +++.||||++....      ..+.+.+|++++++++||||+++++++...+..++
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            467888999999999999999765 68899999987522      24568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC---CCcEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL---EFEAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~  279 (397)
                      ||||+++|+|.+++....   .+++.+++.++.|++.||.|||+.   +++||||||+||+++.   ++.+||+|||++.
T Consensus       126 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             EECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            999999999999997543   489999999999999999999999   9999999999999975   8899999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......       .....+.......+
T Consensus       200 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~i~~~~~~~~  271 (349)
T 2w4o_A          200 IVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-------FMFRRILNCEYYFI  271 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-------HHHHHHHTTCCCCC
T ss_pred             ccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-------HHHHHHHhCCCccC
Confidence            65432 22334578999999999999899999999999999999999999986432211       01111111111111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+....+.+++.+||+.||++|||+.|++++
T Consensus       272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11112334568899999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1e-46  Score=361.94  Aligned_cols=254  Identities=23%  Similarity=0.451  Sum_probs=207.5

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      +...++|...+.||+|+||.||+|...++..||||+++...     ...+.|.+|++++++++||||+++++++. .+..
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            34456788889999999999999999888999999987522     23678999999999999999999999986 5678


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             EEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            999999999999999975432 3588999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc-CCCCC
Q 016009          281 LKPDSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEML-DPRLP  357 (397)
Q Consensus       281 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~  357 (397)
                      ...... ......++..|+|||.+....++.++||||||+++|||+| |+.||........        ...+. ..+++
T Consensus       334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~--------~~~i~~~~~~~  405 (454)
T 1qcf_A          334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--------IRALERGYRMP  405 (454)
T ss_dssp             BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--------HHHHHHTCCCC
T ss_pred             cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHHcCCCCC
Confidence            643211 1122346788999999998899999999999999999999 9999864432110        00110 11122


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+.    ..+..+.+++.+||+.||++|||+++|++.|+
T Consensus       406 ~~~----~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~  440 (454)
T 1qcf_A          406 RPE----NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD  440 (454)
T ss_dssp             CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            222    23345889999999999999999999999886

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.4e-46  Score=346.04  Aligned_cols=250  Identities=24%  Similarity=0.438  Sum_probs=197.1

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCC----EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      ++|+..+.||+|+||+||+|... +++    +||+|.+.....   ....+.+.+|+.++++++||||+++++++.... 
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            46888899999999999999753 444    368888764222   234578999999999999999999999998754 


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++|+||+.+|+|.+++....  ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence            789999999999999997644  3699999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--
Q 016009          280 FLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--  354 (397)
Q Consensus       280 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  354 (397)
                      ........  .....+|..|+|||.+.+..++.++||||||+++|||+| |+.||.......         ....+..  
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---------~~~~~~~~~  236 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGE  236 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------HHHHHHTTC
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---------HHHHHHcCC
Confidence            76544332  233456889999999999999999999999999999999 999987433211         1111111  


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+.    .....+.+++.+||+.||++|||+.+++++|+
T Consensus       237 ~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~  274 (327)
T 3poz_A          237 RLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             CCCCCT----TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             CCCCCc----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            111122    22345889999999999999999999999875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=350.98  Aligned_cols=255  Identities=24%  Similarity=0.400  Sum_probs=204.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  197 (397)
                      .++|...+.||+|+||.||+|...      +++.||||++.....   ......+.+|+.++++++||||+++++++...
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS---EQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            356888899999999999999743      467899999864222   23356789999999999999999999999999


Q ss_pred             CeeeEEEEeccCCCHHHhhccccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC---cE
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAA----AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF---EA  270 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~  270 (397)
                      ...++||||+++|+|.+++.....    ...+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++   .+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence            999999999999999999976432    23589999999999999999999999   999999999999999555   59


Q ss_pred             EEeeeccccccCCCC--CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 016009          271 HVADFGIAKFLKPDS--SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIE  347 (397)
Q Consensus       271 kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  347 (397)
                      ||+|||+++......  .......+|+.|+|||.+.+..++.++|||||||++|||+| |..||.......        .
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--------~  295 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--------V  295 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------H
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------H
Confidence            999999997543221  22234567899999999999999999999999999999998 999986433211        0


Q ss_pred             cccccCCC-CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          348 LDEMLDPR-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       348 ~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...+.... ...+.    .....+.+++.+||+.||++|||+.+|+++|+
T Consensus       296 ~~~i~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~  341 (367)
T 3l9p_A          296 LEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  341 (367)
T ss_dssp             HHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCc----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            11111111 11111    22345889999999999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.4e-46  Score=345.89  Aligned_cols=248  Identities=21%  Similarity=0.279  Sum_probs=204.3

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||++... +|+.||+|++.... .......+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH-hccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            57888899999999999999765 78999999985311 01122356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....   .+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            99999999999997543   589999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .   .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......        ....+.......+..  
T Consensus       194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~p~~--  260 (350)
T 1rdq_E          194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKVRFPSH--  260 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTT--
T ss_pred             C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--------HHHHHHcCCCCCCCC--
Confidence            2   234579999999999999999999999999999999999999986432211        111122222222221  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPT-----MKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt-----~~~vl~~  394 (397)
                        ....+.+++.+||+.||++||+     ++|++++
T Consensus       261 --~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence              2345889999999999999998     8888764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.3e-46  Score=350.04  Aligned_cols=265  Identities=18%  Similarity=0.256  Sum_probs=203.3

Q ss_pred             hcCCCCCcccccc--CcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          124 TNDFDAQYCIGNG--GHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       124 ~~~~~~~~~lg~G--~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      .++|+..+.||+|  +||.||+|... +|+.||||++......  ....+.+.+|++++++++||||+++++++...+..
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS--NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC--hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            4578889999999  99999999765 7999999998753221  23456788999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.+..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            999999999999999976532 4589999999999999999999999   999999999999999999999999998865


Q ss_pred             cCCCC-------CCcccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 016009          281 LKPDS-------SNWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       281 ~~~~~-------~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      .....       .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||...................+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence            42211       11223478999999999987  5799999999999999999999999865332211000000000000


Q ss_pred             cCCC---------------------------CC-------CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          352 LDPR---------------------------LP-------APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       352 ~~~~---------------------------~~-------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .+..                           ..       ............+.+|+.+||+.||++|||++|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            0000                           00       0000112234568899999999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=348.50  Aligned_cols=252  Identities=25%  Similarity=0.385  Sum_probs=202.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||++... +++.||+|++.... .......+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK-CVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh-cccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            57888999999999999999654 68899999985311 01122356789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+.+|+|.+++....   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999997643   599999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCCcccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          284 DSSNWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      . .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||.........     .....+.......+.
T Consensus       168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-----~~~~~~~~~~~~~p~  241 (384)
T 4fr4_A          168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK-----EIVHTFETTVVTYPS  241 (384)
T ss_dssp             T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH-----HHHHHHHHCCCCCCT
T ss_pred             C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH-----HHHHHHhhcccCCCC
Confidence            3 33355689999999999874   45899999999999999999999998643221100     001111111111111


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPT-MKIVSQ  393 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~~vl~  393 (397)
                          .....+.+++.+||+.||++||+ ++++++
T Consensus       242 ----~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          242 ----AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ----TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ----cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                22345889999999999999998 777764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.4e-46  Score=341.41  Aligned_cols=256  Identities=20%  Similarity=0.297  Sum_probs=206.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCc--chhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSD--QIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      .++|+..+.||+|+||.||+|... +|+.||+|.+.......  .....+.+.+|++++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            356888999999999999999765 68999999986533221  112467899999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC----cEEEeeec
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF----EAHVADFG  276 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg  276 (397)
                      ++||||+++++|.+++...   ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            9999999999999999754   3589999999999999999999999   999999999999999888    79999999


Q ss_pred             cccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      ++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......        ....+.....
T Consensus       165 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~~  235 (321)
T 2a2a_A          165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANITSVSY  235 (321)
T ss_dssp             TCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHTTCC
T ss_pred             cceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhccc
Confidence            998765432 2344578999999999999999999999999999999999999986432210        1111111111


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+..........+.+++.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11111111223458899999999999999999999874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.2e-46  Score=360.97  Aligned_cols=252  Identities=23%  Similarity=0.291  Sum_probs=196.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++..... ........+.+|+++++.++||||+++++++...+..++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            46789999999999999999965 4789999999864211 111224567889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+++..
T Consensus       226 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            999999999999996543   58999999999999999999998 7   9999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|+.||.......        ....+.......+..
T Consensus       300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~p~~  371 (446)
T 4ejn_A          300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMEEIRFPRT  371 (446)
T ss_dssp             CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTT
T ss_pred             cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--------HHHHHHhCCCCCCcc
Confidence            544444556789999999999999999999999999999999999999986433211        111111112221211


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                          ....+.+++.+||+.||++||     |++|++++
T Consensus       372 ----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          372 ----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                224588999999999999999     99999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-46  Score=347.08  Aligned_cols=257  Identities=23%  Similarity=0.392  Sum_probs=205.3

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEE
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFC  194 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  194 (397)
                      ...++|...+.||+|+||.||+|..      .++..||+|.+.....   ....+.+.+|+++++++ +||||+++++++
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD---SSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC---HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            3457888899999999999999975      2456899999975322   22346799999999999 899999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhcccccc--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAAA--------------------QELGWSQRMNVIKGVADALSYLHHDCFPPIVH  254 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH  254 (397)
                      ...+..++||||+++|+|.+++......                    ..+++..++.++.|++.||+|||+.   +++|
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH  195 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  195 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence            9999999999999999999999764321                    2489999999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 016009          255 RDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPR  331 (397)
Q Consensus       255 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~  331 (397)
                      |||||+||+++.++.+||+|||++.........  .....+|+.|+|||.+.+..++.++||||||+++|||+| |..||
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999999999999999999866543322  233467889999999998899999999999999999998 99998


Q ss_pred             CccccccccccccccccccccCCC--CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          332 DFLSSISSSFLNTDIELDEMLDPR--LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .......        .....+...  ...+.    .....+.+++.+||+.||++|||+.+++++|+
T Consensus       276 ~~~~~~~--------~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          276 PGIPVDA--------NFYKLIQNGFKMDQPF----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             TTCCCSH--------HHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccCCcHH--------HHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            6543211        011111111  11111    12345889999999999999999999999885

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1e-45  Score=354.54  Aligned_cols=248  Identities=27%  Similarity=0.445  Sum_probs=202.1

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC-eee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR-HSF  201 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~  201 (397)
                      ..++|+..+.||+|+||.||+|... |+.||||+++...      ..+.|.+|++++++++||||+++++++.... ..+
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence            3467888899999999999999884 7899999997532      2467999999999999999999999987655 789


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++|+|.+++..... ..+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus       264 iv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            99999999999999976432 3479999999999999999999999   9999999999999999999999999999854


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCC
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-PRLPAP  359 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  359 (397)
                      ...   .....++..|+|||.+.+..++.++||||||+++|||+| |+.||........        ...+.. .++..+
T Consensus       340 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--------~~~i~~~~~~~~p  408 (450)
T 1k9a_A          340 SST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--------VPRVEKGYKMDAP  408 (450)
T ss_dssp             C---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--------HHHHHTTCCCCCC
T ss_pred             ccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHHcCCCCCCC
Confidence            322   122356889999999999999999999999999999998 9999875432110        111111 111222


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .    .++..+.+++.+||+.||++|||+.++++.|+
T Consensus       409 ~----~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~  441 (450)
T 1k9a_A          409 D----GCPPAVYDVMKNCWHLDAATRPTFLQLREQLE  441 (450)
T ss_dssp             T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            2    23346889999999999999999999999885

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7e-46  Score=334.68  Aligned_cols=254  Identities=22%  Similarity=0.338  Sum_probs=204.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|... +|+.||+|++.....  .....+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            467888999999999999999654 689999999864322  22335678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc---EEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~~  279 (397)
                      ||||+++++|.+.+....   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.   +||+|||++.
T Consensus        83 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            999999999999886543   589999999999999999999999   9999999999999987655   9999999997


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........        ...+.......+
T Consensus       157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~~  227 (284)
T 3kk8_A          157 EVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--------YAQIKAGAYDYP  227 (284)
T ss_dssp             ECCSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHHTCCCCC
T ss_pred             EcccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH--------HHHHHhccccCC
Confidence            655332 23446789999999999999999999999999999999999999864332110        011111111111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..........+.+++.+||+.||++|||++|++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            11111233458899999999999999999999874

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.6e-46  Score=331.63  Aligned_cols=250  Identities=20%  Similarity=0.327  Sum_probs=201.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC--CeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--RHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  202 (397)
                      ++|...+.||+|+||.||+|... ++.||+|++.....  .....+.+.+|++++++++||||+++++++...  ...++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTC--CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            46888899999999999999884 88999999875322  223457799999999999999999999999877  78899


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP--IVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.   +  ++|+||||+||+++.++.++|+|||++..
T Consensus        87 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             eecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence            9999999999999976442 3589999999999999999999998   7  99999999999999999999999988764


Q ss_pred             cCCCCCCcccccccccccCcccccCCCCCc---chhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYTMKITE---KCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      ...     ....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||...........    .......+..+
T Consensus       163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~  233 (271)
T 3kmu_A          163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK----VALEGLRPTIP  233 (271)
T ss_dssp             TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH----HHHSCCCCCCC
T ss_pred             ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH----HHhcCCCCCCC
Confidence            322     2346899999999988765544   79999999999999999999874432111000    00011111111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        .    .....+.+++.+||+.||++|||++++++.|+
T Consensus       234 --~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~  266 (271)
T 3kmu_A          234 --P----GISPHVSKLMKICMNEDPAKRPKFDMIVPILE  266 (271)
T ss_dssp             --T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence              1    22345889999999999999999999999885

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.9e-46  Score=363.56  Aligned_cols=252  Identities=26%  Similarity=0.457  Sum_probs=207.3

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ..++|...+.||+|+||.||+|... ++..||||.++...     ...+.|.+|++++++++||||++++++|......+
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence            4456778889999999999999776 48899999987522     23678999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++|+|.+++..... ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       293 lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence            99999999999999975432 4589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--CCC
Q 016009          282 KPDSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--RLP  357 (397)
Q Consensus       282 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~  357 (397)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.......         ....+..  ++.
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---------~~~~~~~~~~~~  439 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELLEKDYRME  439 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---------HHHHHHTTCCCC
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcCCCCC
Confidence            43321 1223346788999999998899999999999999999999 999986433211         1111111  111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+.    ..+..+.+|+.+||+.||++|||+.+|++.|+
T Consensus       440 ~~~----~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~  474 (495)
T 1opk_A          440 RPE----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE  474 (495)
T ss_dssp             CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC----CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence            122    22345889999999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2e-45  Score=336.89  Aligned_cols=264  Identities=22%  Similarity=0.345  Sum_probs=190.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|... +|+.||+|++......   ...+.+.+|++++++++||||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE---GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTT---CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            457889999999999999999754 6899999998753321   224678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhcccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDA---AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      ||||++ |+|.+++....   ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccce
Confidence            999998 59999886532   123589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccc--c------ccc--cccc
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS--F------LNT--DIEL  348 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~--~------~~~--~~~~  348 (397)
                      .............+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.........  .      ...  ....
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            765444444556789999999998764 6899999999999999999999998643321100  0      000  0000


Q ss_pred             cc--ccCCCCCC-CCcchH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 DE--MLDPRLPA-PSRSVQ---------EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 ~~--~~~~~~~~-~~~~~~---------~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..  ...+.... +.....         .....+.+++.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            00  00000000 000000         123468899999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.6e-46  Score=346.73  Aligned_cols=258  Identities=24%  Similarity=0.415  Sum_probs=206.3

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEeC-CC-----CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEE
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAELP-SG-----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGF  193 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  193 (397)
                      ....++|...+.||+|+||.||+|... ++     ..||+|.+....   .....+.+.+|+++++++ +||||++++++
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            344578889999999999999999754 23     479999987532   223457799999999999 89999999999


Q ss_pred             EecCCeeeEEEEeccCCCHHHhhccccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcE
Q 016009          194 CSHARHSFLVYEFLKRGSLAAILSSDAA-----------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNL  262 (397)
Q Consensus       194 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni  262 (397)
                      +...+..++||||+++|+|.+++.....           ...+++..++.++.|++.||+|||+.   +++||||||+||
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  195 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNV  195 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGC
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceE
Confidence            9999999999999999999999875421           23589999999999999999999999   999999999999


Q ss_pred             EeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccc
Q 016009          263 LLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISS  339 (397)
Q Consensus       263 ll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~  339 (397)
                      +++.++.+||+|||++.........  .....+|+.|+|||.+.+..++.++||||||+++|||+| |..||....... 
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-  274 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-  274 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-
Confidence            9999999999999999865433221  233456889999999998899999999999999999999 999986432211 


Q ss_pred             cccccccccccccCCC--CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          340 SFLNTDIELDEMLDPR--LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       340 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                             .........  ...+.    .....+.+++.+||+.||++|||+.+|++.|+
T Consensus       275 -------~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  322 (333)
T 2i1m_A          275 -------KFYKLVKDGYQMAQPA----FAPKNIYSIMQACWALEPTHRPTFQQICSFLQ  322 (333)
T ss_dssp             -------HHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -------HHHHHHhcCCCCCCCC----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence                   001111100  11111    11345889999999999999999999999885

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=8.7e-46  Score=338.44  Aligned_cols=247  Identities=23%  Similarity=0.271  Sum_probs=194.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  202 (397)
                      ++|+..+.||+|+||+||+|... +|+.||||++......  ......+..|+..+.++ +||||+++++++.+++..++
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG--PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC--hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            57888999999999999999765 7999999998653332  22344556666666665 89999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+ +++|.+++....  ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       135 v~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            99999 679998886543  4699999999999999999999998   99999999999999999999999999988764


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+......           ..+.....+  ...
T Consensus       209 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----------~~~~~~~~~--~~~  273 (311)
T 3p1a_A          209 TAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-----------QQLRQGYLP--PEF  273 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-----------HHHTTTCCC--HHH
T ss_pred             cCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----------HHHhccCCC--ccc
Confidence            332 2334568999999998876 7899999999999999999997664322111           111111111  111


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .......+.+++.+||+.||++|||++|++++
T Consensus       274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          274 TAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            11223568899999999999999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.1e-46  Score=339.34  Aligned_cols=257  Identities=23%  Similarity=0.412  Sum_probs=207.1

Q ss_pred             hcCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEec
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSH  196 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  196 (397)
                      .++|+..+.||+|+||.||+|..      .+++.||+|.+....   .....+.+.+|+++++++ +||||+++++++..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            45788889999999999999974      356789999987532   223457899999999999 99999999999999


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCc
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAA---------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN  261 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  261 (397)
                      .+..++||||+++|+|.+++.....               ...+++.+++.++.|++.||+|||+.   +++||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence            9999999999999999999976432               12489999999999999999999999   99999999999


Q ss_pred             EEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccc
Q 016009          262 LLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS  338 (397)
Q Consensus       262 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  338 (397)
                      |+++.++.+||+|||++.........  .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            99999999999999999876544322  223457789999999998899999999999999999999 999986433211


Q ss_pred             ccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          339 SSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...    ..........  .+.    .....+.+++.+||+.||++|||+.|++++|+
T Consensus       256 ~~~----~~~~~~~~~~--~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  303 (313)
T 1t46_A          256 KFY----KMIKEGFRML--SPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE  303 (313)
T ss_dssp             HHH----HHHHHTCCCC--CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH----HHhccCCCCC--Ccc----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            000    0001111111  111    22345889999999999999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3e-45  Score=331.13  Aligned_cols=254  Identities=31%  Similarity=0.502  Sum_probs=200.7

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchh---cHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIV---DKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++..........   ..+.+.+|++++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            5788889999999999999976 478999999987543322211   1267899999999999999999999997655  


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeccCCCCcEEeCCCCc-----EEEe
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP--IVHRDISSKNLLLDLEFE-----AHVA  273 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~-----~kl~  273 (397)
                      ++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +  ++||||||+||+++.++.     +||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            69999999999999886543  4699999999999999999999998   7  999999999999988776     9999


Q ss_pred             eeccccccCCCCCCcccccccccccCccccc--CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 016009          274 DFGIAKFLKPDSSNWTEFAGTYGYVAPELAY--TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       274 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      |||++.....   ......||+.|+|||.+.  ...++.++||||||+++|||++|+.||............  ......
T Consensus       172 Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~~  246 (287)
T 4f0f_A          172 DFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN--MIREEG  246 (287)
T ss_dssp             CCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH--HHHHSC
T ss_pred             CCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH--HHhccC
Confidence            9999975332   234467899999999984  456789999999999999999999998743321110000  000011


Q ss_pred             cCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+..+      ......+.+++.+||+.||++|||++|+++.|+
T Consensus       247 ~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  285 (287)
T 4f0f_A          247 LRPTIP------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS  285 (287)
T ss_dssp             CCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCC------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            111111      122345889999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=340.46  Aligned_cols=251  Identities=27%  Similarity=0.472  Sum_probs=195.0

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|+..+.||+|+||.||++... ++.||+|++...      ...+.+.+|++++++++||||+++++++.+  ..++||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~   78 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM   78 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence            46788899999999999999874 788999998641      235789999999999999999999998874  479999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc-EEEeeeccccccCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE-AHVADFGIAKFLKP  283 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfg~~~~~~~  283 (397)
                      ||+++|+|.+++........+++..++.++.|+++||+|||+.+..+++||||||+||+++.++. +||+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            99999999999987654446889999999999999999999943238999999999999988886 79999999975542


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .   .....||+.|+|||.+.+..++.++||||||+++|||+||+.||..........      .........+.   ..
T Consensus       159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~~~~---~~  226 (307)
T 2eva_A          159 H---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI------MWAVHNGTRPP---LI  226 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH------HHHHHTTCCCC---CB
T ss_pred             c---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH------HHHHhcCCCCC---cc
Confidence            2   233468999999999999999999999999999999999999987432211000      00000101110   01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ......+.+++.+||+.||++|||++++++.|+
T Consensus       227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  259 (307)
T 2eva_A          227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT  259 (307)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            122345889999999999999999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.6e-46  Score=341.18  Aligned_cols=258  Identities=24%  Similarity=0.426  Sum_probs=191.3

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeCCC----CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA  197 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  197 (397)
                      ...++|+..+.||+|+||.||+|.....    ..||||++......  ....+.+.+|++++++++||||+++++++...
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA--SSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC--HHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            3456799999999999999999976533    27999998753222  23367899999999999999999999999877


Q ss_pred             Cee------eEEEEeccCCCHHHhhcccccc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC
Q 016009          198 RHS------FLVYEFLKRGSLAAILSSDAAA---QELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF  268 (397)
Q Consensus       198 ~~~------~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  268 (397)
                      ...      ++||||+++|+|.+++......   ..+++.+++.++.|++.||+|||+.   +++||||||+||++++++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence            655      9999999999999998654321   2589999999999999999999999   999999999999999999


Q ss_pred             cEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 016009          269 EAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTD  345 (397)
Q Consensus       269 ~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~  345 (397)
                      .+||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......       
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------  247 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------  247 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-------
Confidence            999999999987644322  1223456788999999999999999999999999999999 999987433211       


Q ss_pred             cccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          346 IELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       346 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ....+... ....+.    .....+.+++.+||+.||++|||+.++++.|+
T Consensus       248 -~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  294 (323)
T 3qup_A          248 -IYNYLIGGNRLKQPP----ECMEEVYDLMYQCWSADPKQRPSFTCLRMELE  294 (323)
T ss_dssp             -HHHHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -HHHHHhcCCCCCCCC----ccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence             11111111 111111    22345889999999999999999999998875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.5e-46  Score=339.33  Aligned_cols=255  Identities=23%  Similarity=0.432  Sum_probs=206.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  197 (397)
                      .++|...+.||+|+||.||+|..      .+++.||+|++....   .....+.+.+|++++++++||||+++++++...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            45788889999999999999964      345789999987532   223457889999999999999999999999999


Q ss_pred             CeeeEEEEeccCCCHHHhhccccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAA---------------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRD  256 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~d  256 (397)
                      +..++||||+++|+|.+++.....                     ...+++.+++.++.|++.||+|||+.   +++|||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d  175 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD  175 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence            999999999999999999976432                     13488999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCc
Q 016009          257 ISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDF  333 (397)
Q Consensus       257 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~  333 (397)
                      |||+||++++++.+||+|||++.........  .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876543322  233456788999999998889999999999999999999 9999864


Q ss_pred             cccccccccccccccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          334 LSSISSSFLNTDIELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ......        ...+... ....+.    .....+.+++.+||+.||++|||+.+++++|+
T Consensus       256 ~~~~~~--------~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~  307 (314)
T 2ivs_A          256 IPPERL--------FNLLKTGHRMERPD----NCSEEMYRLMLQCWKQEPDKRPVFADISKDLE  307 (314)
T ss_dssp             CCGGGH--------HHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHHHH--------HHHhhcCCcCCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            332110        0111111 111111    22345889999999999999999999999886

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.6e-46  Score=349.94  Aligned_cols=252  Identities=23%  Similarity=0.293  Sum_probs=191.4

Q ss_pred             cCCCCC-ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEec----C
Q 016009          125 NDFDAQ-YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSH----A  197 (397)
Q Consensus       125 ~~~~~~-~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~  197 (397)
                      ++|... +.||+|+||+||++... +|+.||||++..         ...+.+|++++.++ +||||+++++++..    .
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~  131 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR  131 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence            456655 68999999999999654 789999999853         24567888887554 89999999999865    5


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC---CCcEEEee
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL---EFEAHVAD  274 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~D  274 (397)
                      ...++||||+++|+|.+++..... ..+++.+++.++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|
T Consensus       132 ~~~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          132 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             cEEEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence            678999999999999999976432 4599999999999999999999998   9999999999999998   78999999


Q ss_pred             eccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 016009          275 FGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP  354 (397)
Q Consensus       275 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
                      ||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........    ......+...
T Consensus       208 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~i~~~  282 (400)
T 1nxk_A          208 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRMG  282 (400)
T ss_dssp             CTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC----CSHHHHHHHT
T ss_pred             cccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc----HHHHHHHHcC
Confidence            9999865432 2234567899999999999999999999999999999999999998643321100    0000111111


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....+...+......+.+|+.+||+.||++|||+.|++++
T Consensus       283 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1111111112234568899999999999999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.4e-46  Score=348.34  Aligned_cols=248  Identities=24%  Similarity=0.292  Sum_probs=193.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHH-HHhccCCceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA-LTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      .++|+..+.||+|+||.||+++.. +++.||+|++...... .......+..|..+ ++.++||||+++++++.+.+..+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            357888999999999999999765 6889999998652211 11224556677776 56789999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++|+|.+++....   .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       116 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            9999999999999997543   589999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ..........+||+.|+|||++.+..++.++|||||||++|||++|+.||......        .....+.......+..
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~~  261 (373)
T 2r5t_A          190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNKPLQLKPN  261 (373)
T ss_dssp             BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--------HHHHHHHHSCCCCCSS
T ss_pred             ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhcccCCCCC
Confidence            44444445678999999999999999999999999999999999999998643221        1111222222222221


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKI  390 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~  390 (397)
                          ....+.+++.+||+.||++||++.+
T Consensus       262 ----~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          262 ----ITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             ----SCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             ----CCHHHHHHHHHHcccCHHhCCCCCC
Confidence                2245889999999999999999853

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-46  Score=347.53  Aligned_cols=264  Identities=25%  Similarity=0.301  Sum_probs=203.2

Q ss_pred             HHHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCC-CcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC
Q 016009          120 IVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLP-SDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA  197 (397)
Q Consensus       120 ~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  197 (397)
                      +....++|...+.||+|+||.||+|.. .+++.||+|++..... .......+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            345667899999999999999999965 4788999999753210 01122357899999999999999999999999999


Q ss_pred             CeeeEEEEeccCCCHHHhhccccc-------------------------------------cCCCCHHHHHHHHHHHHHH
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAA-------------------------------------AQELGWSQRMNVIKGVADA  240 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~~  240 (397)
                      +..++||||+++|+|.+++.....                                     ...+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999999852110                                     1124567888999999999


Q ss_pred             HHHHHhCCCCCceeccCCCCcEEeCCCC--cEEEeeeccccccCCCCC----CcccccccccccCcccccC--CCCCcch
Q 016009          241 LSYLHHDCFPPIVHRDISSKNLLLDLEF--EAHVADFGIAKFLKPDSS----NWTEFAGTYGYVAPELAYT--MKITEKC  312 (397)
Q Consensus       241 l~~Lh~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~--~~~~~~~  312 (397)
                      |+|||+.   +++||||||+||+++.++  .+||+|||++..+.....    ......||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999   999999999999998776  899999999986543211    2345678999999999875  6789999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 016009          313 DVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS  392 (397)
Q Consensus       313 Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl  392 (397)
                      ||||||+++|||++|+.||.......        ....+.......+..........+.+++.+||+.||++|||+.|++
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l  329 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDAD--------TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL  329 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHH--------HHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            99999999999999999986443211        1122222222211222223345688999999999999999999998


Q ss_pred             HH
Q 016009          393 QQ  394 (397)
Q Consensus       393 ~~  394 (397)
                      ++
T Consensus       330 ~h  331 (345)
T 3hko_A          330 QH  331 (345)
T ss_dssp             HS
T ss_pred             cC
Confidence            74

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.7e-46  Score=354.95  Aligned_cols=250  Identities=23%  Similarity=0.369  Sum_probs=204.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||+|... +|+.||||++..... ........+.+|+++++.++||||+++++++.+.+..++|
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH-HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            46888899999999999999765 799999999863110 1112346789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++...   ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        95 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            9999999999999754   3599999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      . ......+||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+.....        .....+.+.....+.. 
T Consensus       169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~p~~-  238 (476)
T 2y94_A          169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------TLFKKICDGIFYTPQY-  238 (476)
T ss_dssp             T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--------HHHHHHHTTCCCCCTT-
T ss_pred             c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcCCcCCCcc-
Confidence            3 23345679999999999988765 68999999999999999999998743221        1111222222222221 


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ....+.+++.+||+.||++|||++|++++
T Consensus       239 ---~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          239 ---LNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             ---CCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ---CCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence               22358899999999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.2e-47  Score=359.03  Aligned_cols=257  Identities=20%  Similarity=0.311  Sum_probs=205.2

Q ss_pred             HHHHHHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec
Q 016009          118 DEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH  196 (397)
Q Consensus       118 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  196 (397)
                      .++....++|+..+.||+|+||+||+|... +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh-hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            344455688999999999999999999765 688999999853110 001112347899999999999999999999999


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                      .+..++||||+++|+|.+++...    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence            99999999999999999998643    489999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCC-CcccccccccccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 016009          277 IAKFLKPDSS-NWTEFAGTYGYVAPELAYTMK----ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       277 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      +++....... .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.......        ....+
T Consensus       214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i  285 (410)
T 3v8s_A          214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKI  285 (410)
T ss_dssp             TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHH
T ss_pred             eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh--------HHHHH
Confidence            9987654332 223568999999999988655    7899999999999999999999986433211        01111


Q ss_pred             cC----CCCCCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 016009          352 LD----PRLPAPSRSVQEKLRSIVEVVFSCLNESPES--RPTMKIVSQQ  394 (397)
Q Consensus       352 ~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~~vl~~  394 (397)
                      ..    ...+...    .....+.+|+.+||+.+|++  ||+++||+++
T Consensus       286 ~~~~~~~~~p~~~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          286 MNHKNSLTFPDDN----DISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HTHHHHCCCCTTC----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             HhccccccCCCcc----cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            11    1112111    12245888999999999998  9999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8.2e-47  Score=345.33  Aligned_cols=255  Identities=24%  Similarity=0.358  Sum_probs=195.2

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe----
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH----  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  199 (397)
                      ++|+..+.||+|+||.||++.. .+++.||||++...... .......+.+|++++++++||||+++++++.....    
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT-SHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC-CHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            5788899999999999999975 57899999999763332 22345678999999999999999999999876543    


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++++|.+++....   .+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            399999999999999997543   589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC---CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 016009          280 FLKPDSS---NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       280 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      .......   ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.........        ........
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--------~~~~~~~~  236 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--------YQHVREDP  236 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--------HHHHHCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--------HHHhcCCC
Confidence            6654322   123356899999999999999999999999999999999999998644321110        00111111


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+..........+.+++.+||+.||++||+..++++.
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence            10000011123458899999999999999987777653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.8e-46  Score=355.96  Aligned_cols=253  Identities=27%  Similarity=0.480  Sum_probs=201.7

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ...++|...+.||+|+||.||+|...++..||||+++...     ...+.|.+|++++++++||||+++++++.. +..+
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            3456788889999999999999999888889999987532     235789999999999999999999999876 6789


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++..
T Consensus       255 iv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EEehhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            99999999999999975332 4589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCC
Q 016009          282 KPDSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-PRLPA  358 (397)
Q Consensus       282 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  358 (397)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.......        ....+.. .+++.
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~~  402 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERGYRMPC  402 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCCC
T ss_pred             CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCC
Confidence            53321 1223456789999999998899999999999999999999 999986433211        0111111 11222


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.    ..+..+.+++.+||+.||++|||++++++.|+
T Consensus       403 ~~----~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~  436 (452)
T 1fmk_A          403 PP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE  436 (452)
T ss_dssp             CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            22    23345889999999999999999999999886

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.5e-46  Score=332.61  Aligned_cols=251  Identities=23%  Similarity=0.329  Sum_probs=203.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|...+.||+|+||.||+|... ++..||+|++.....    ...+.+.+|++++++++||||+++++++...+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence            356888999999999999999765 577999999864222    236789999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe---CCCCcEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL---DLEFEAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~  279 (397)
                      ||||+++++|.+++....   .+++.+++.++.|++.||+|||+.   +++|+||||+||++   +.++.++|+|||++.
T Consensus        84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            999999999999886543   589999999999999999999999   99999999999999   788999999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ...... ......+|+.|+|||.+.+. ++.++||||||+++|||++|+.||.......        ....+.......+
T Consensus       158 ~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  227 (277)
T 3f3z_A          158 RFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--------VMLKIREGTFTFP  227 (277)
T ss_dssp             ECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCC
T ss_pred             eccCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCCCC
Confidence            765432 33445789999999988654 8999999999999999999999986433211        1111111122211


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..........+.+++.+||+.||++|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11111234568899999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.9e-45  Score=333.53  Aligned_cols=252  Identities=21%  Similarity=0.351  Sum_probs=207.1

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|...+.||+|+||.||++... +++.||+|.+..... ......+.+.+|++++++++||||+++++++...+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            357888899999999999999765 688999999864222 122346778999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++++|.+++...   ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus        93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999999988654   3589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..........|++.|+|||.+.+..++.++||||||+++|||++|+.||.......        ....+.......+.. 
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~-  237 (294)
T 2rku_A          167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNEYSIPKH-  237 (294)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCCCCCTT-
T ss_pred             cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhhccCCCccc-
Confidence            44444455678999999999998889999999999999999999999986433211        011111111111111 


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ....+.+++.+||+.||++|||++|++++
T Consensus       238 ---~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          238 ---INPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence               22358889999999999999999999874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-45  Score=342.57  Aligned_cols=249  Identities=29%  Similarity=0.442  Sum_probs=199.8

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +.|+..+.||+|+||.||+|.. .+|+.||||++..... ......+.+.+|++++++++||||+++++++..++..++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            4578889999999999999975 5789999999875322 2223456789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+. |+|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus       133 ~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 68888775433  4699999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCcccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          284 DSSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      .    ....||+.|+|||++.   ...++.++||||||+++|||++|+.||...........     ......+...  .
T Consensus       207 ~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-----~~~~~~~~~~--~  275 (348)
T 1u5q_A          207 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----IAQNESPALQ--S  275 (348)
T ss_dssp             B----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSCCCCCC--C
T ss_pred             C----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-----HHhcCCCCCC--C
Confidence            2    2357899999999884   56789999999999999999999999864332111000     0000011111  1


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ......+.+++.+||+.||++|||+++++++
T Consensus       276 ---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          276 ---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ---CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence               1123458899999999999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9e-46  Score=338.43  Aligned_cols=262  Identities=23%  Similarity=0.346  Sum_probs=198.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||+||+|... +|+.||+|++.....  .....+.+.+|++++++++||||+++++++...+..++|
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED--DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            57888999999999999999765 689999999865322  223356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             EECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            99999999999886543   489999999999999999999999   999999999999999999999999999987665


Q ss_pred             CCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccc-------------cccc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD-------------IELD  349 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~-------------~~~~  349 (397)
                      .........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||..............             ....
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence            4444455678999999999876 5689999999999999999999999865432110000000             0000


Q ss_pred             cccCCCCCCCCc------chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          350 EMLDPRLPAPSR------SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       350 ~~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .......+.+..      ........+.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000001111000      001223458899999999999999999999864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.3e-46  Score=344.29  Aligned_cols=252  Identities=22%  Similarity=0.312  Sum_probs=201.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  201 (397)
                      .++|+..+.||+|+||.||++... +|+.||+|++.....        ...+|++++.++ +||||+++++++.+++..+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            457888999999999999999764 688999999865321        234688888888 7999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC----CcEEEeeecc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE----FEAHVADFGI  277 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~  277 (397)
                      +||||+++|+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+||++.++    +.+||+|||+
T Consensus        93 lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            9999999999999997543   589999999999999999999999   99999999999998543    3599999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      +..............||+.|+|||++.+..++.++||||||+++|||++|+.||........     ......+......
T Consensus       167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~~~~~i~~~~~~  241 (342)
T 2qr7_A          167 AKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-----EEILARIGSGKFS  241 (342)
T ss_dssp             CEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH-----HHHHHHHHHCCCC
T ss_pred             cccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH-----HHHHHHHccCCcc
Confidence            98776554445566889999999999888899999999999999999999999864221100     0011111111222


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .+...+......+.+++.+||+.||++|||+.+++++
T Consensus       242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1111122334568899999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-45  Score=335.91  Aligned_cols=260  Identities=24%  Similarity=0.369  Sum_probs=203.0

Q ss_pred             cCCCCCccccccCcEEEEEEEe-----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC--
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA--  197 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--  197 (397)
                      +.|+..+.||+|+||.||+|.+     .+++.||+|++.....   ....+.+.+|++++++++||||+++++++...  
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc---chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            3577889999999999999983     4688999999875332   22457899999999999999999999999776  


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             ceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence            66899999999999999996543  3589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC---CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc------ccccccccc
Q 016009          278 AKFLKPDSS---NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------SFLNTDIEL  348 (397)
Q Consensus       278 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~  348 (397)
                      +........   ......+|..|+|||.+.+..++.++||||||+++|||+||..|+........      .........
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            987665432   12345678889999999998999999999999999999999998643221100      000000001


Q ss_pred             cccc-C-CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          349 DEML-D-PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       349 ~~~~-~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...+ . ...+.+.    .....+.+++.+||+.||++|||++++++.|+
T Consensus       253 ~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  298 (302)
T 4e5w_A          253 VNTLKEGKRLPCPP----NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE  298 (302)
T ss_dssp             HHHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhccCCCCCCC----CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            1111 1 1111111    22345889999999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.6e-46  Score=343.96  Aligned_cols=255  Identities=16%  Similarity=0.219  Sum_probs=203.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  201 (397)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++.....      .+.+.+|+++++++ +||||+++++++...+..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            35788899999999999999975 5789999999865322      23578999999999 9999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc-----EEEeeec
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE-----AHVADFG  276 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg  276 (397)
                      +||||+ +++|.+++....  ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.     +||+|||
T Consensus        82 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             EEEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            999999 999999997542  4699999999999999999999999   9999999999999999887     9999999


Q ss_pred             cccccCCCCCC-------cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 016009          277 IAKFLKPDSSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD  349 (397)
Q Consensus       277 ~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  349 (397)
                      ++.........       .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........     ....
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~-----~~~~  230 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK-----ERYQ  230 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH-----HHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH-----HHHH
Confidence            99876443221       23567999999999999999999999999999999999999998753221100     0001


Q ss_pred             cccCCCCCCCCcc-hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          350 EMLDPRLPAPSRS-VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       350 ~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+.+.....+... ....+ .+.+++..||+.||.+||++++|++.|+
T Consensus       231 ~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          231 KIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             HHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             HHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence            1100000000000 00112 6899999999999999999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=340.58  Aligned_cols=246  Identities=22%  Similarity=0.356  Sum_probs=203.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcc----hhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQ----IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      .++|+..+.||+|+||.||+|.. .+++.||||++........    ....+.+.+|++++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            46799999999999999999964 5789999999875332111    112345778999999999999999999999999


Q ss_pred             eeeEEEEeccCC-CHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          199 HSFLVYEFLKRG-SLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       199 ~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ..++||||+.+| +|.+++....   .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            999999999777 9999997643   599999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      +....... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....              ......
T Consensus       177 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------~~~~~~  241 (335)
T 3dls_A          177 AAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------TVEAAI  241 (335)
T ss_dssp             CEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------GTTTCC
T ss_pred             ceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------HHhhcc
Confidence            98765433 2344679999999999988776 7899999999999999999999864321              111111


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+..    ....+.+++.+||+.||++|||+++++++
T Consensus       242 ~~~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          242 HPPYL----VSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             CCCcc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11111    22358899999999999999999999975

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.9e-45  Score=331.64  Aligned_cols=255  Identities=22%  Similarity=0.331  Sum_probs=202.6

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCC--cchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPS--DQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ++|+..+.||+|+||.||++... +|+.||+|.+......  ......+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46888899999999999999765 7899999998653221  11224678999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC----cEEEeeecc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF----EAHVADFGI  277 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~  277 (397)
                      +||||+++++|.+++...   ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            999999999999999653   3589999999999999999999999   999999999999998877    899999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      +....... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......        ....+......
T Consensus       159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~  229 (283)
T 3bhy_A          159 AHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--------TLTNISAVNYD  229 (283)
T ss_dssp             CEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCCC
T ss_pred             ceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--------HHHHhHhcccC
Confidence            98765332 2334578999999999998899999999999999999999999986433211        01111111111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .+..........+.+++.+||+.||++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            1111111223458899999999999999999999874

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.9e-46  Score=356.40  Aligned_cols=261  Identities=21%  Similarity=0.287  Sum_probs=206.8

Q ss_pred             HHHHHHHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe
Q 016009          117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS  195 (397)
Q Consensus       117 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  195 (397)
                      +.++...+++|+..+.||+|+||+||+|... +++.||+|++..... ........+.+|..++..++||||+++++++.
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh-hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            3455556789999999999999999999765 578999999853110 01111234789999999999999999999999


Q ss_pred             cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          196 HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       196 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                      +.+..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence            9999999999999999999997633  3599999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCC-cccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 016009          276 GIAKFLKPDSSN-WTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD  349 (397)
Q Consensus       276 g~~~~~~~~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  349 (397)
                      |+++........ ....+||+.|+|||++.     ...++.++|||||||++|||++|+.||........        ..
T Consensus       220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~--------~~  291 (437)
T 4aw2_A          220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--------YG  291 (437)
T ss_dssp             TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HH
T ss_pred             hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH--------HH
Confidence            999876543332 23468999999999987     56789999999999999999999999864332110        11


Q ss_pred             cccC----CCCCCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 016009          350 EMLD----PRLPAPSRSVQEKLRSIVEVVFSCLNESPES--RPTMKIVSQQ  394 (397)
Q Consensus       350 ~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~~vl~~  394 (397)
                      .++.    ..++...   ......+.+|+.+||..+|++  ||+++|++++
T Consensus       292 ~i~~~~~~~~~p~~~---~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          292 KIMNHKERFQFPTQV---TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHTHHHHCCCCSSC---CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hhhhccccccCCccc---ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            1110    1111110   112345888999999998888  9999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-45  Score=329.58  Aligned_cols=250  Identities=27%  Similarity=0.453  Sum_probs=205.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|+..+.||+|+||.||++...+++.||+|.+....     ...+.+.+|++++++++||||+++++++...+..++||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            5688889999999999999998888999999987532     13468999999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++....  ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        83 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            9999999999997543  3589999999999999999999999   9999999999999999999999999999865432


Q ss_pred             C-CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCc
Q 016009          285 S-SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLPAPSR  361 (397)
Q Consensus       285 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  361 (397)
                      . .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......        ....+... ....+. 
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~i~~~~~~~~~~-  228 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRLYKPR-  228 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCCCT-
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--------HHHHHhcCCcCCCCc-
Confidence            1 11123456788999999998889999999999999999999 899986432211        01111111 111111 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         .....+.+++.+||+.||++|||+.+++++|+
T Consensus       229 ---~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  260 (267)
T 3t9t_A          229 ---LASTHVYQIMNHCWRERPEDRPAFSRLLRQLA  260 (267)
T ss_dssp             ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---cCcHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence               12345889999999999999999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.2e-46  Score=338.66  Aligned_cols=255  Identities=25%  Similarity=0.434  Sum_probs=208.2

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ...++|+..+.||+|+||.||+|... ++..||+|.+...     ....+.+.+|++++++++||||+++++++...+..
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            34567888999999999999999765 5889999998642     12357899999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             EEEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            999999999999999976432 4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCC
Q 016009          281 LKPDSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       281 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.........     .......  ....
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~-----~~~~~~~--~~~~  233 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----ELLEKDY--RMER  233 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-----HHHHTTC--CCCC
T ss_pred             ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHhccC--CCCC
Confidence            654332 2233456788999999998899999999999999999999 99998643321100     0011111  1111


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.    ..+..+.+++.+||+.||++|||+.++++.|+
T Consensus       234 ~~----~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~  267 (288)
T 3kfa_A          234 PE----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE  267 (288)
T ss_dssp             CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CC----CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence            11    22345889999999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-45  Score=334.38  Aligned_cols=257  Identities=23%  Similarity=0.426  Sum_probs=192.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .++|+..+.||+|+||.||+|...+  .||+|+++....  .....+.+.+|++++++++||||+++++++ .....++|
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCC--CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            4578889999999999999998643  599999875332  233467899999999999999999999965 45668999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999999996543  4689999999999999999999999   999999999999999999999999999976543


Q ss_pred             C--CCCcccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 016009          284 D--SSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       284 ~--~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      .  ........||+.|+|||.+.   +..++.++||||||+++|||++|+.||...........   ........+... 
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~-  248 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE---MVGRGSLSPDLS-  248 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHH---HHHHTSCCCCTT-
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHH---HhcccccCcchh-
Confidence            2  12234457899999999886   56788899999999999999999999865332110000   000001111111 


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        ......+..+.+++.+||+.||++|||+.+++++|+
T Consensus       249 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  284 (289)
T 3og7_A          249 --KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE  284 (289)
T ss_dssp             --SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence              111223456899999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-45  Score=336.95  Aligned_cols=262  Identities=26%  Similarity=0.391  Sum_probs=198.0

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc--cCCceeeeEEEEecC--
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNIVKLYGFCSHA--  197 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~--  197 (397)
                      ...++|+..+.||+|+||.||+|... ++.||||++..       .....+..|.+++...  +||||+++++++...  
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-------~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT-------TEEASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG-------GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec-------cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            34568999999999999999999875 88999999853       1234556666666655  899999999999877  


Q ss_pred             --CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceeccCCCCcEEeCCCCcE
Q 016009          198 --RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC-----FPPIVHRDISSKNLLLDLEFEA  270 (397)
Q Consensus       198 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~~ivH~dlk~~Nill~~~~~~  270 (397)
                        ...++||||+++|+|.+++...    .+++.+++.++.|++.||+|||+.+     .++++||||||+||+++.++.+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence              7889999999999999999643    4899999999999999999999862     2389999999999999999999


Q ss_pred             EEeeeccccccCCCCCC----cccccccccccCcccccCCCCCcc------hhhHHHHHHHHHHHhCCC----------C
Q 016009          271 HVADFGIAKFLKPDSSN----WTEFAGTYGYVAPELAYTMKITEK------CDVYSFGVLALEVIKGKH----------P  330 (397)
Q Consensus       271 kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~------~Dv~s~G~~l~el~tg~~----------p  330 (397)
                      ||+|||++.........    .....||+.|+|||.+.+...+.+      +||||||+++|||+||..          |
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            99999999766543322    124578999999999987766655      999999999999999954          4


Q ss_pred             CCcccccccccccccc-ccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          331 RDFLSSISSSFLNTDI-ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       331 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      |............... .......+..+. .....+....+.+++.+||+.||++|||+.+|+++|+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  327 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCIKKLRPSFPN-RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA  327 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCG-GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HhhhcCCCCchhhhHHHHhhhccCccccc-cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence            4322111100000000 000111111111 1112366778999999999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.7e-45  Score=331.75  Aligned_cols=252  Identities=24%  Similarity=0.395  Sum_probs=192.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCC----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      .++|+..+.||+|+||.||+|....    +..||+|.+....   .....+.+.+|+.++++++||||+++++++. .+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            3578888999999999999997642    4579999986522   2234577999999999999999999999984 567


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             cEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence            899999999999999997543  3589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-C
Q 016009          280 FLKPDSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPR-L  356 (397)
Q Consensus       280 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~  356 (397)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......        ....+.... .
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--------~~~~i~~~~~~  236 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERL  236 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCCC
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--------HHHHHHcCCCC
Confidence            7654322 1233456789999999998899999999999999999997 999987433211        011111111 1


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+.    ..+..+.+++.+||+.||++|||+.+++++|+
T Consensus       237 ~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  272 (281)
T 1mp8_A          237 PMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  272 (281)
T ss_dssp             CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1111    22345889999999999999999999999885

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-45  Score=339.90  Aligned_cols=255  Identities=24%  Similarity=0.423  Sum_probs=204.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEe--------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL--------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFC  194 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  194 (397)
                      .++|...+.||+|+||.||+|..        .++..||+|++....   .....+.+.+|+++++++ +||||+++++++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            46788899999999999999975        356789999987532   223457789999999999 899999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCc
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN  261 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  261 (397)
                      ...+..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+.   +++|+||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence            999999999999999999999976542             13489999999999999999999999   99999999999


Q ss_pred             EEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccc
Q 016009          262 LLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS  338 (397)
Q Consensus       262 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  338 (397)
                      |+++.++.+||+|||++.........  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            99999999999999999876543221  223456789999999988889999999999999999999 999986432211


Q ss_pred             ccccccccccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          339 SSFLNTDIELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       339 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .        ...+... ....+.    .....+.+++.+||+.||++|||++|+++.|+
T Consensus       268 ~--------~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  314 (334)
T 2pvf_A          268 L--------FKLLKEGHRMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  314 (334)
T ss_dssp             H--------HHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H--------HHHHhcCCCCCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            0        0001000 111111    22345889999999999999999999999885

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.6e-45  Score=340.92  Aligned_cols=253  Identities=21%  Similarity=0.282  Sum_probs=192.9

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|...+.||+|+||+||++... +++.||+|++.....     ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            357888999999999999999765 789999999865222     23568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc--EEEeeeccccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE--AHVADFGIAKF  280 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~~  280 (397)
                      ||||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.  +||+|||+++.
T Consensus        94 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           94 IMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            999999999999986543   599999999999999999999998   9999999999999987765  99999999975


Q ss_pred             cCCCCCCcccccccccccCcccccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYTMKITEK-CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      .... .......||+.|+|||++.+..++.+ +||||||+++|||++|+.||.........    ......+.......+
T Consensus       168 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~  242 (361)
T 3uc3_A          168 SVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY----RKTIQRILSVKYSIP  242 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH----HHHHHHHHTTCCCCC
T ss_pred             cccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH----HHHHHHHhcCCCCCC
Confidence            3322 22234579999999999988887665 89999999999999999998743321100    001111222221111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..  ......+.+|+.+||+.||++|||+.|++++
T Consensus       243 ~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          243 DD--IRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             TT--SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             Cc--CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            10  0122458899999999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.3e-45  Score=332.11  Aligned_cols=250  Identities=28%  Similarity=0.445  Sum_probs=200.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|... +++.||+|++.... .........+.+|++++++++||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc-cchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            467888999999999999999654 67899999975311 1112235678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            999999999999986543   589999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......        ....+.......+.. 
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~-  229 (279)
T 3fdn_A          161 SS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVEFTFPDF-  229 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCCCCCTT-
T ss_pred             cc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--------HHHHHHhCCCCCCCc-
Confidence            22  2244578999999999999899999999999999999999999986432211        011111111111111 


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ....+.+++.+||+.||++|||++|++++
T Consensus       230 ---~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          230 ---VTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ---SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ---CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               22457899999999999999999999975

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.1e-46  Score=342.38  Aligned_cols=262  Identities=23%  Similarity=0.383  Sum_probs=209.2

Q ss_pred             HHHHHHhcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeE
Q 016009          118 DEIVRATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY  191 (397)
Q Consensus       118 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~  191 (397)
                      +++....++|+..+.||+|+||.||+|...      +++.||+|.+....   .......+.+|++++++++||||++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            344556678999999999999999999653      46789999987432   223356789999999999999999999


Q ss_pred             EEEecCCeeeEEEEeccCCCHHHhhccccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe
Q 016009          192 GFCSHARHSFLVYEFLKRGSLAAILSSDAA-------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL  264 (397)
Q Consensus       192 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill  264 (397)
                      +++.+.+..++||||+++|+|.+++.....       ...+++..++.++.|++.||+|||+.   +++||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence            999999999999999999999999975321       13579999999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccc
Q 016009          265 DLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSF  341 (397)
Q Consensus       265 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~  341 (397)
                      +.++.+||+|||++.........  .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......   
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  248 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---  248 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---
Confidence            99999999999999765432221  123456889999999998899999999999999999999 899986433211   


Q ss_pred             cccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          342 LNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                           ....+.........   ......+.+++.+||+.||++|||+.|+++.|+
T Consensus       249 -----~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~  295 (322)
T 1p4o_A          249 -----VLRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  295 (322)
T ss_dssp             -----HHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred             -----HHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence                 01111111111111   122345889999999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=342.65  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=196.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC--CceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH--RNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~  201 (397)
                      .++|+..+.||+|+||.||++...+++.||||++.....  .....+.+.+|++++++++|  |||+++++++..++..+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc--chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            346888999999999999999888899999999875322  22345778999999999976  99999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||| +.+++|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||++...
T Consensus        86 lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           86 MVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            9999 56889999997643   589999999999999999999999   999999999999997 678999999999876


Q ss_pred             CCCCC--CcccccccccccCcccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 016009          282 KPDSS--NWTEFAGTYGYVAPELAYT-----------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIEL  348 (397)
Q Consensus       282 ~~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  348 (397)
                      .....  ......||+.|+|||++.+           ..++.++||||||+++|||++|+.||.......       ...
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~  230 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------SKL  230 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------HHH
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-------HHH
Confidence            54332  2234679999999999864           678999999999999999999999986432110       111


Q ss_pred             ccccCCCCC--CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 DEMLDPRLP--APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 ~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..++++...  .+..    ....+.+++.+||+.||++|||+.|++++
T Consensus       231 ~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          231 HAIIDPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHCTTSCCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhcCCcccCCccc----CCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            222222211  1111    12358899999999999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.3e-45  Score=339.20  Aligned_cols=252  Identities=21%  Similarity=0.351  Sum_probs=206.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|...+.||+|+||.||++... +++.||+|++..... ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            357888899999999999999765 688999999864222 122346778999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++++|.+++...   ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus       119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            99999999999998654   3589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..........|+..|+|||.+.+..++.++||||||+++|||++|+.||.......        ....+.......+.. 
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~-  263 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNEYSIPKH-  263 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCCCCCTT-
T ss_pred             cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHhcCCCCCCcc-
Confidence            44444455678999999999999899999999999999999999999986432211        011111111111111 


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ....+.+++.+||+.||++|||++|++++
T Consensus       264 ---~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          264 ---INPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               22357889999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-45  Score=337.43  Aligned_cols=257  Identities=22%  Similarity=0.326  Sum_probs=196.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|...+.||+|+||.||+|... +++.||+|++..... ......+.+.+|++++++++||||+++++++..++..++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            468899999999999999999764 788999999864221 122235778999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++++|.+++....   .+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            999999999999997543   589999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCC-CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          283 PDS-SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       283 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ... .......+++.|+|||.+.+..++.++||||||+++|||++|+.||.......         ....+....+.+..
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~  256 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---------MGAHINQAIPRPST  256 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---------HHHHHHSCCCCGGG
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---------HHHHhccCCCCccc
Confidence            432 22234578999999999999899999999999999999999999987433210         00011111110001


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRP-TMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RP-t~~~vl~~Le  396 (397)
                      .....+..+.+++.+||+.||++|| |++++++.|+
T Consensus       257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~  292 (309)
T 2h34_A          257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH  292 (309)
T ss_dssp             TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence            1112233588999999999999999 9999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.2e-45  Score=335.66  Aligned_cols=261  Identities=21%  Similarity=0.304  Sum_probs=195.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++..... ......+.+.+|++++++++||||+++++++...+..++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            34788899999999999999975 5799999999875222 223346778999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          203 VYEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      ||||+++++|.+++.... ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999999986532 224589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ...........+++.|+|||.+.+..++.++||||||+++|||++|+.||.........      ....+.....+... 
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~-  259 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS------LCKKIEQCDYPPLP-  259 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH------HHHHHHTTCSCCCC-
T ss_pred             cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH------HHHHhhcccCCCCc-
Confidence            54433334557899999999999989999999999999999999999998532211000      00111111111000 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       .......+.+++.+||+.||++|||+++|++.|+
T Consensus       260 -~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~  293 (310)
T 2wqm_A          260 -SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK  293 (310)
T ss_dssp             -TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence             0122345889999999999999999999999885

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.6e-46  Score=334.45  Aligned_cols=257  Identities=25%  Similarity=0.388  Sum_probs=204.1

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe--cCCee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS--HARHS  200 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~  200 (397)
                      .++|+..+.||+|+||.||++... +++.||+|.+.....  .....+.+.+|++++++++||||+++++++.  .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            357888999999999999999764 789999999875322  2234678999999999999999999999874  46788


Q ss_pred             eEEEEeccCCCHHHhhccccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----ceeccCCCCcEEeCCCCcEEEee
Q 016009          201 FLVYEFLKRGSLAAILSSDAA-AQELGWSQRMNVIKGVADALSYLHHDCFPP-----IVHRDISSKNLLLDLEFEAHVAD  274 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~-----ivH~dlk~~Nill~~~~~~kl~D  274 (397)
                      ++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.   +     ++|+||||+||+++.++.+||+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~d  159 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGD  159 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence            999999999999999975432 23589999999999999999999998   7     99999999999999999999999


Q ss_pred             eccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 016009          275 FGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP  354 (397)
Q Consensus       275 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
                      ||++..............|++.|+|||.+.+..++.++||||||+++|||++|+.||.......        ....+...
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~i~~~  231 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREG  231 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHT
T ss_pred             CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--------HHHHHhhc
Confidence            9999876543333344578999999999999899999999999999999999999987543211        00111111


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ......   ......+.+++.+||+.||++|||++|+++.+.
T Consensus       232 ~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          232 KFRRIP---YRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             CCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ccccCC---cccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            111001   122345889999999999999999999998765

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.4e-45  Score=339.14  Aligned_cols=252  Identities=26%  Similarity=0.385  Sum_probs=197.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCE----EEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQV----VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      ++|+..+.||+|+||.||+|... +++.    |++|.+......   ...+.+.+|+.++++++||||+++++++. .+.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR---QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC---SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            46888899999999999999754 4544    888887543221   12345778999999999999999999986 456


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             cEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence            889999999999999997653  3588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 016009          280 FLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       280 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      .......  ......++..|+|||.+.+..++.++||||||+++|||+| |+.||..........     .+...  ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-----~~~~~--~~~  236 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-----LLEKG--ERL  236 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-----HHHTT--CBC
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-----HHHcC--CCC
Confidence            7654432  2344567889999999998999999999999999999999 999987543211000     00000  011


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+..    ....+.+++.+||+.||++|||+++++++|+
T Consensus       237 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~  272 (325)
T 3kex_A          237 AQPQI----CTIDVYMVMVKCWMIDENIRPTFKELANEFT  272 (325)
T ss_dssp             CCCTT----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred             CCCCc----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111    1224778999999999999999999999885

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.9e-46  Score=349.14  Aligned_cols=262  Identities=18%  Similarity=0.251  Sum_probs=197.9

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCC------CCEEEEEecCCCCCCcc-------hhcHHHHHHHHHHHHhccCCceeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPS------GQVVAIKKFHSPLPSDQ-------IVDKKEFLTEVEALTEIRHRNIVKL  190 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~  190 (397)
                      .++|...+.||+|+||.||+|...+      ++.||||++........       ......+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4578899999999999999997754      47899999865221000       0001223455666777789999999


Q ss_pred             EEEEecC----CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC-
Q 016009          191 YGFCSHA----RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD-  265 (397)
Q Consensus       191 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-  265 (397)
                      ++++...    ...++||||+ +++|.+++....  ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence            9998764    4589999999 999999997643  4699999999999999999999999   999999999999998 


Q ss_pred             -CCCcEEEeeeccccccCCCCCC-------cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccc
Q 016009          266 -LEFEAHVADFGIAKFLKPDSSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSI  337 (397)
Q Consensus       266 -~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~  337 (397)
                       .++.+||+|||+++.+......       .....||+.|+|||++.+..++.++||||||+++|||+||+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999875432211       13345999999999999999999999999999999999999999743221


Q ss_pred             cccc----cccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          338 SSSF----LNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       338 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ....    ......+..+.++.++..     ..+..+.+++..||+.||++||++++|++.|+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~  325 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAA-----NAPGEIAKYMETVKLLDYTEKPLYENLRDILL  325 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTT-----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhcccc-----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence            1000    000011222222222110     11345889999999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.6e-45  Score=340.83  Aligned_cols=263  Identities=23%  Similarity=0.399  Sum_probs=208.1

Q ss_pred             HHHHHHHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcc----hhcHHHHHHHHHHHHhc-cCCceeee
Q 016009          117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQ----IVDKKEFLTEVEALTEI-RHRNIVKL  190 (397)
Q Consensus       117 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~  190 (397)
                      ........++|...+.||+|+||.||+|... +|+.||||++........    ....+.+.+|+.+++++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3344455678999999999999999999775 799999999875332211    11245688999999999 79999999


Q ss_pred             EEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcE
Q 016009          191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEA  270 (397)
Q Consensus       191 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  270 (397)
                      ++++......++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            99999999999999999999999999754   3599999999999999999999998   99999999999999999999


Q ss_pred             EEeeeccccccCCCCCCcccccccccccCcccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccc
Q 016009          271 HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT  344 (397)
Q Consensus       271 kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~  344 (397)
                      ||+|||++..+.... ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||.......      
T Consensus       240 kl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------  312 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------  312 (365)
T ss_dssp             EECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------
T ss_pred             EEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH------
Confidence            999999998765432 2345679999999998863      358899999999999999999999986432210      


Q ss_pred             ccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          345 DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        ....+.......+...+......+.+++.+||+.||++|||+.|++++
T Consensus       313 --~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          313 --MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             --HHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --HHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              011111111111110111223458899999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=347.60  Aligned_cols=265  Identities=23%  Similarity=0.312  Sum_probs=208.6

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC--eee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR--HSF  201 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~  201 (397)
                      ++|...+.||+|+||+||+|... +|+.||||++....   .....+.+.+|++++++++||||+++++++....  ..+
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS---FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG---GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc---ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            46888899999999999999765 58999999986422   1223577889999999999999999999997655  679


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe----CCCCcEEEeeecc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL----DLEFEAHVADFGI  277 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~  277 (397)
                      +||||+++|+|.+++........+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            9999999999999998765545599999999999999999999999   99999999999999    7888899999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccC--------CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc------cc
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYT--------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF------LN  343 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~------~~  343 (397)
                      +....... ......||+.|+|||++.+        ..++.++||||||+++|||++|+.||..........      ..
T Consensus       163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            98765432 2234578999999998865        467889999999999999999999986322110000      00


Q ss_pred             c--cc---ccc------cccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          344 T--DI---ELD------EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       344 ~--~~---~~~------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .  ..   ...      .-.....+............+.+++.+||+.||++|||++|+++.++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~  305 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence            0  00   000      00111223233334567778999999999999999999999988764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.6e-45  Score=344.28  Aligned_cols=249  Identities=23%  Similarity=0.373  Sum_probs=197.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc--CCceeeeEEEEecCCeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR--HRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~l  202 (397)
                      ++|+..+.||+|+||.||++...+++.||||++.....  .....+.+.+|++++++++  ||||+++++++...+..++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            45888999999999999999888899999999865322  2234678999999999996  5999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||| +.+++|.+++....   .+++.+++.++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||++....
T Consensus       134 v~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             EEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            999 67889999997643   589999999999999999999998   999999999999995 5799999999998765


Q ss_pred             CCCC--CcccccccccccCcccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 016009          283 PDSS--NWTEFAGTYGYVAPELAYT-----------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD  349 (397)
Q Consensus       283 ~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  349 (397)
                      ....  ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......       ...+.
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~  278 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLH  278 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHH
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------HHHHH
Confidence            4322  2234579999999999865           36889999999999999999999998643211       01122


Q ss_pred             cccCCCCC--CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          350 EMLDPRLP--APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       350 ~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .++++...  .+...    ...+.+|+.+||+.||++|||+.|++++
T Consensus       279 ~~~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          279 AIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhCccccCCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            22222221  11111    2358899999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.1e-45  Score=332.69  Aligned_cols=256  Identities=18%  Similarity=0.250  Sum_probs=203.9

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  201 (397)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++.....      .+.+.+|+++++.+ +|+|++++++++......+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   82 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   82 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence            35788899999999999999975 5789999999864221      24578899999999 7999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc-----EEEeeec
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE-----AHVADFG  276 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg  276 (397)
                      +||||+ +++|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.     +||+|||
T Consensus        83 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence            999999 999999997543  3599999999999999999999998   9999999999999987776     9999999


Q ss_pred             cccccCCCCC-------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 016009          277 IAKFLKPDSS-------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD  349 (397)
Q Consensus       277 ~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  349 (397)
                      ++........       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........     ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~-----~~  231 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK-----YE  231 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH-----HH
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH-----HH
Confidence            9987654322       12345789999999999999999999999999999999999999875432110000     00


Q ss_pred             cccCCCCCCC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          350 EMLDPRLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       350 ~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+.......+ .......+..+.+++.+||+.||++|||+++|++.|+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~  279 (298)
T 1csn_A          232 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  279 (298)
T ss_dssp             HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             HHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            0000000000 0000122346889999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.7e-45  Score=331.36  Aligned_cols=252  Identities=22%  Similarity=0.445  Sum_probs=204.3

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      ..++|+..+.||+|+||.||+|...+++.||+|.+....     ...+.+.+|++++++++||||+++++++.. +..++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            345788889999999999999998888899999987522     235789999999999999999999999864 56899


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++++|.+++..... ..+++.+++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++....
T Consensus        85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            9999999999999975432 3589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCC
Q 016009          283 PDSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLPAP  359 (397)
Q Consensus       283 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  359 (397)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......        ....+... ....+
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~  232 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--------VIQNLERGYRMVRP  232 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCCCC
T ss_pred             CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--------HHHHHhcccCCCCc
Confidence            4321 1223456788999999998889999999999999999999 999986432211        00111110 11111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .    .....+.+++.+||+.||++|||++++++.|+
T Consensus       233 ~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  265 (279)
T 1qpc_A          233 D----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (279)
T ss_dssp             T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             c----cccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            1    22345889999999999999999999999885

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-45  Score=336.19  Aligned_cols=252  Identities=27%  Similarity=0.474  Sum_probs=197.0

Q ss_pred             cCCCCCccccccCcEEEEEEEeCC-----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPS-----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      ++|...+.||+|+||.||+|....     +..||+|.+.....   ......+.+|++++++++||||+++++++...+.
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT---EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            356667889999999999996542     23599999875322   2335678999999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence            999999999999999997543  3689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-
Q 016009          280 FLKPDSSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-  354 (397)
Q Consensus       280 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  354 (397)
                      ........   .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......        ....+.+. 
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------~~~~~~~~~  267 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------VMKAINDGF  267 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHCCC
Confidence            76543221   122345788999999999899999999999999999999 999986433211        01111111 


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+.    .....+.+++.+||+.||++||++.+++++|+
T Consensus       268 ~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  305 (333)
T 1mqb_A          268 RLPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILD  305 (333)
T ss_dssp             CCCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             cCCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111111    22345889999999999999999999999885

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.1e-46  Score=361.19  Aligned_cols=257  Identities=21%  Similarity=0.262  Sum_probs=205.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|...+.||+|+||.||+|... +|+.||+|++..... ........+.+|++++++++||||+++++++.+.+..++
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~-~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh-hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            456888899999999999999764 799999999853110 112235678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       262 VmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            9999999999999876442 3589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........    ......+.......+   
T Consensus       338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~----~~i~~~i~~~~~~~p---  409 (576)
T 2acx_A          338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKEVPEEYS---  409 (576)
T ss_dssp             TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH----HHHHHHHHHCCCCCC---
T ss_pred             cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH----HHHHHHhhcccccCC---
Confidence            432 234458999999999999989999999999999999999999998753221000    000011111111111   


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                       ......+.+|+.+||+.||++||     +++||+++
T Consensus       410 -~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          410 -ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence             12234588999999999999999     78888764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.9e-46  Score=359.55  Aligned_cols=257  Identities=21%  Similarity=0.293  Sum_probs=206.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||++... +|+.||+|++..... ......+.+..|++++++++||||+++++++.+....++|
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~-~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh-hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            57888889999999999999765 799999999854111 1112356788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          204 YEFLKRGSLAAILSSDAA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      |||++||+|.+++..... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999875432 24699999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..........||+.|+|||++.+..++.++|||||||++|||+||+.||.........    ......+.......+.  
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~----~~~~~~i~~~~~~~p~--  414 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRVLEQAVTYPD--  414 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH----HHHHHHHHHCCCCCCT--
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH----HHHHHHHhhcccCCCc--
Confidence            5444444568999999999999999999999999999999999999998643211000    0011112222222221  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTM-----KIVSQ  393 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~-----~~vl~  393 (397)
                        .....+.+++.+||+.||++||++     +++++
T Consensus       415 --~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          415 --KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             --TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             --ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence              223458899999999999999975     56654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.9e-45  Score=356.40  Aligned_cols=254  Identities=26%  Similarity=0.403  Sum_probs=207.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|... +|+.||||++..... ......+.+.+|++++++++||||+++++++...+..++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV-KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhc-ccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            357888999999999999999765 789999999865322 223346789999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe---CCCCcEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL---DLEFEAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~  279 (397)
                      ||||+.+|+|.+++....   .+++..++.++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||++.
T Consensus       104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999987543   589999999999999999999999   99999999999999   567899999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.......        ....+.......+
T Consensus       178 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~~  247 (484)
T 3nyv_A          178 HFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--------ILKKVEKGKYTFE  247 (484)
T ss_dssp             HBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCC
T ss_pred             Eccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCCCCC
Confidence            765433 3345679999999999876 68999999999999999999999987443211        1111111111111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+...+..+.+++.+||+.||++|||+.|++++
T Consensus       248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            22222344568899999999999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.3e-45  Score=335.43  Aligned_cols=260  Identities=21%  Similarity=0.337  Sum_probs=197.2

Q ss_pred             cCCCCC-ccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeee
Q 016009          125 NDFDAQ-YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       125 ~~~~~~-~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  201 (397)
                      +.|.+. +.||+|+||.||+|.. .+++.||||++....    ....+.+.+|++++.++ +||||+++++++.+.+..+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            456664 6799999999999975 478999999986532    22357889999999995 7999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc---EEEeeeccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGIA  278 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~  278 (397)
                      +||||+++|+|.+++....   .+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.   +||+|||++
T Consensus        88 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             EEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            9999999999999997643   589999999999999999999999   9999999999999998776   999999998


Q ss_pred             cccCCCCC-------CcccccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccc--
Q 016009          279 KFLKPDSS-------NWTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT--  344 (397)
Q Consensus       279 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~--  344 (397)
                      ........       ......||+.|+|||.+.+     ..++.++||||||+++|||++|+.||.........+...  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            76542211       1223468999999999875     458899999999999999999999987543211111000  


Q ss_pred             -----ccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          345 -----DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       345 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                           ......+.......+..........+.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                 00011111122221111111234568899999999999999999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-45  Score=343.41  Aligned_cols=267  Identities=22%  Similarity=0.290  Sum_probs=205.6

Q ss_pred             ccHHHHHHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-----CCcee
Q 016009          115 LVYDEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-----HRNIV  188 (397)
Q Consensus       115 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv  188 (397)
                      +++.+.....++|...+.||+|+||+||+|.. .+++.||||++..     .....+.+..|+++++.++     ||||+
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            33444445567899999999999999999976 5789999999863     1223566788999999996     99999


Q ss_pred             eeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC--
Q 016009          189 KLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL--  266 (397)
Q Consensus       189 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--  266 (397)
                      ++++++...+..++||||+ +++|.+++..... ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.  
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccc
Confidence            9999999999999999999 9999999976543 3589999999999999999999998   9999999999999976  


Q ss_pred             -----------------------CCcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHH
Q 016009          267 -----------------------EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALE  323 (397)
Q Consensus       267 -----------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~e  323 (397)
                                             ++.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++||
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                   789999999999864432   234578999999999999999999999999999999


Q ss_pred             HHhCCCCCCccccccc-------------ccccc--ccccccc-----cCCCCCCCCcchHH--------------HHHH
Q 016009          324 VIKGKHPRDFLSSISS-------------SFLNT--DIELDEM-----LDPRLPAPSRSVQE--------------KLRS  369 (397)
Q Consensus       324 l~tg~~p~~~~~~~~~-------------~~~~~--~~~~~~~-----~~~~~~~~~~~~~~--------------~~~~  369 (397)
                      |+||+.||........             .....  .......     .....+........              ....
T Consensus       252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            9999999864322100             00000  0000000     00001111110000              1145


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          370 IVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       370 l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +.+|+.+||+.||++|||++|++++
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhcC
Confidence            7799999999999999999999874

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=352.79  Aligned_cols=260  Identities=24%  Similarity=0.281  Sum_probs=205.3

Q ss_pred             HHHHHHHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe
Q 016009          117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS  195 (397)
Q Consensus       117 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  195 (397)
                      +.+.....++|+..+.||+|+||.||++... +|+.||+|+++.... ......+.+.+|.+++..++||||+++++++.
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~-~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM-LKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            3444556788999999999999999999764 799999999853110 01112345789999999999999999999999


Q ss_pred             cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          196 HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       196 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                      +.+..++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++++||+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence            9999999999999999999997543  3589999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCC-cccccccccccCccccc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 016009          276 GIAKFLKPDSSN-WTEFAGTYGYVAPELAY-------TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE  347 (397)
Q Consensus       276 g~~~~~~~~~~~-~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~  347 (397)
                      |+++........ ....+||+.|+|||++.       ...++.++|||||||++|||++|+.||.......        .
T Consensus       207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~  278 (412)
T 2vd5_A          207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--------T  278 (412)
T ss_dssp             TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------H
T ss_pred             hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--------H
Confidence            999876544332 23458999999999987       3568999999999999999999999986433211        0


Q ss_pred             cccccC----CCCCCCCcchHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 016009          348 LDEMLD----PRLPAPSRSVQEKLRSIVEVVFSCLNESPESR---PTMKIVSQQ  394 (397)
Q Consensus       348 ~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---Pt~~~vl~~  394 (397)
                      ...+..    ...+..   ....+..+.+++.+||. +|++|   |+++|++++
T Consensus       279 ~~~i~~~~~~~~~p~~---~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          279 YGKIVHYKEHLSLPLV---DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHHHTHHHHCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHHHhcccCcCCCcc---ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            111111    011100   01223458899999999 99998   699998764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2e-45  Score=332.50  Aligned_cols=246  Identities=23%  Similarity=0.425  Sum_probs=197.1

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CC-------CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SG-------QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH  196 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  196 (397)
                      ++|...+.||+|+||.||+|... ++       ..||+|.+..    ......+.+.+|++++++++||||+++++++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK----AHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECG----GGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccc----ccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            56888899999999999999654 33       4799999864    223346789999999999999999999999999


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc-------
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE-------  269 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-------  269 (397)
                      ++..++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.       
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence            999999999999999999997643  3489999999999999999999999   9999999999999998887       


Q ss_pred             -EEEeeeccccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCC-CCCcccccccccccccc
Q 016009          270 -AHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKH-PRDFLSSISSSFLNTDI  346 (397)
Q Consensus       270 -~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~-p~~~~~~~~~~~~~~~~  346 (397)
                       +||+|||++.....    .....+++.|+|||.+.+ ..++.++||||||+++|||++|.. |+...........    
T Consensus       159 ~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~----  230 (289)
T 4fvq_A          159 FIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF----  230 (289)
T ss_dssp             EEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----
T ss_pred             eeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH----
Confidence             99999999865432    233467889999999987 678999999999999999999654 4432221100000    


Q ss_pred             ccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          347 ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ..  .....+...      ...+.+++.+||+.||++|||++++++.|+
T Consensus       231 -~~--~~~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  271 (289)
T 4fvq_A          231 -YE--DRHQLPAPK------AAELANLINNCMDYEPDHRPSFRAIIRDLN  271 (289)
T ss_dssp             -HH--TTCCCCCCS------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             -hh--ccCCCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence             00  011111111      123788999999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-45  Score=331.81  Aligned_cols=253  Identities=26%  Similarity=0.394  Sum_probs=196.9

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||++.. .++..+|+|++.....   ....+.+.+|++++++++||||+++++++.+....++|
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            4688889999999999999965 4689999999865322   22467899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe---CCCCcEEEeeecccc
Q 016009          204 YEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL---DLEFEAHVADFGIAK  279 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~  279 (397)
                      |||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +++||||||+||++   +.++.+||+|||++.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            99999999999886532 224699999999999999999999999   99999999999999   456789999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ...... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||..........      ......+.....
T Consensus       176 ~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~------~~~~~~~~~~~~  247 (285)
T 3is5_A          176 LFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ------KATYKEPNYAVE  247 (285)
T ss_dssp             C-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCCCCCC-
T ss_pred             ecCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh------hhccCCcccccc
Confidence            655332 234457899999999876 568999999999999999999999986433211000      000001111100


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..   .....+.+++.+||+.||++|||+.|++++
T Consensus       248 ~~---~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          248 CR---PLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             -C---CCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cC---cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00   122457899999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.3e-45  Score=338.04  Aligned_cols=265  Identities=20%  Similarity=0.302  Sum_probs=206.0

Q ss_pred             ccHHHHHHHhcCCCCC-ccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeE
Q 016009          115 LVYDEIVRATNDFDAQ-YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLY  191 (397)
Q Consensus       115 ~~~~~~~~~~~~~~~~-~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~  191 (397)
                      +.+.......+.|... +.||+|+||.||+|... +++.||+|++......  ......+.+|+.+++.+ +||||++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG--QDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT--EECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            3344445556667766 78999999999999665 6899999998753222  22367899999999999 569999999


Q ss_pred             EEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC---CC
Q 016009          192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL---EF  268 (397)
Q Consensus       192 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~  268 (397)
                      +++...+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.   +++||||||+||+++.   ++
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence            99999999999999999999999986543 24699999999999999999999999   9999999999999988   78


Q ss_pred             cEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 016009          269 EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIEL  348 (397)
Q Consensus       269 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  348 (397)
                      .+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........        .
T Consensus       172 ~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--------~  242 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--------Y  242 (327)
T ss_dssp             CEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------H
T ss_pred             cEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--------H
Confidence            99999999998765332 22345799999999999999999999999999999999999999864332110        0


Q ss_pred             ccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+.......+..........+.+++.+||+.||++|||+++++++
T Consensus       243 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          243 LNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            0111111111111112234558899999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.4e-45  Score=348.74  Aligned_cols=258  Identities=22%  Similarity=0.293  Sum_probs=192.9

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCC----cchhcHHHHHHHHHHHHhccCCceeeeEEEEec
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPS----DQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH  196 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  196 (397)
                      ...++|...+.||+|+||.||+|.. .+++.||+|++......    ........+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4467899999999999999999965 46899999998642110    111122357899999999999999999999864


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC---cEEEe
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF---EAHVA  273 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~  273 (397)
                       +..++||||+++|+|.+++....   .+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++   .+||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence             45799999999999999986543   599999999999999999999999   999999999999997544   59999


Q ss_pred             eeccccccCCCCCCcccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 016009          274 DFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE  350 (397)
Q Consensus       274 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  350 (397)
                      |||+++..... .......||+.|+|||++.+   ..++.++||||||+++|||++|+.||........       ....
T Consensus       285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-------~~~~  356 (419)
T 3i6u_A          285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-------LKDQ  356 (419)
T ss_dssp             CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-------HHHH
T ss_pred             ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-------HHHH
Confidence            99999876532 22345679999999999863   5678899999999999999999999864322100       0011


Q ss_pred             ccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +..................+.+++.+||+.||++|||++|++++
T Consensus       357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            11111111111112234568899999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.5e-45  Score=339.42  Aligned_cols=261  Identities=25%  Similarity=0.351  Sum_probs=205.1

Q ss_pred             cCCCCCccccccCcEEEEEEEe-----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe--cC
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS--HA  197 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~  197 (397)
                      ++|+..+.||+|+||.||++.+     .+++.||||++...    .....+.+.+|++++++++||||+++++++.  ..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            4788889999999999999973     46889999998752    2234567999999999999999999999886  45


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...++||||+++++|.+++....  ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             ceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence            67899999999999999997643  3589999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCC---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc------cccccc
Q 016009          278 AKFLKPDSSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL------NTDIEL  348 (397)
Q Consensus       278 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~------~~~~~~  348 (397)
                      +.........   .....+|..|+|||.+.+..++.++||||||+++|+|++|+.||...........      ......
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            9876543321   2334678889999999988899999999999999999999999754322100000      000001


Q ss_pred             ccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          349 DEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...+......+  ........+.+++.+||+.||++|||+++++++|+
T Consensus       254 ~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  299 (327)
T 3lxl_A          254 LELLEEGQRLP--APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD  299 (327)
T ss_dssp             HHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhhcccCCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111111100  01123355889999999999999999999999886

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=334.38  Aligned_cols=266  Identities=26%  Similarity=0.326  Sum_probs=199.4

Q ss_pred             HhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCC-cchhcHHHHHHHHHHHHhcc---CCceeeeEEEEecC
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPS-DQIVDKKEFLTEVEALTEIR---HRNIVKLYGFCSHA  197 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~  197 (397)
                      .+++|+..+.||+|+||+||+|.. .+++.||+|++...... ........+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999975 57899999998642211 11112346677888877775   99999999999765


Q ss_pred             C-----eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEE
Q 016009          198 R-----HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV  272 (397)
Q Consensus       198 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  272 (397)
                      .     ..++||||+. ++|.+++..... ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence            4     5799999997 599999976543 3489999999999999999999999   9999999999999999999999


Q ss_pred             eeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc------------
Q 016009          273 ADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS------------  340 (397)
Q Consensus       273 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~------------  340 (397)
                      +|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........            
T Consensus       162 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          162 ADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             CSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9999998665332 334567899999999999999999999999999999999999998643321100            


Q ss_pred             --ccccccccccccCCCCCCCC-cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          341 --FLNTDIELDEMLDPRLPAPS-RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       341 --~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        +............+..+.+. ....+....+.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence              00000000000000000000 0001223568899999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.8e-45  Score=334.96  Aligned_cols=263  Identities=24%  Similarity=0.387  Sum_probs=208.5

Q ss_pred             HHHHHHHhcCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceee
Q 016009          117 YDEIVRATNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVK  189 (397)
Q Consensus       117 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~  189 (397)
                      ...+....++|...+.||+|+||.||+|..      .+++.||+|++.....   ....+.+.+|+++++++ +||||++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC---cHHHHHHHHHHHHHHhcccCCCeee
Confidence            345555667899999999999999999963      3568999999875322   22356789999999999 7999999


Q ss_pred             eEEEEecCC-eeeEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 016009          190 LYGFCSHAR-HSFLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHR  255 (397)
Q Consensus       190 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~  255 (397)
                      +++++...+ ..++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+.   +++||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            999987654 58999999999999999976542             12278999999999999999999999   99999


Q ss_pred             cCCCCcEEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 016009          256 DISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRD  332 (397)
Q Consensus       256 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~  332 (397)
                      ||||+||+++.++.+||+|||++.........  .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999999999999999876543322  234567889999999999899999999999999999998 999986


Q ss_pred             ccccccccccccccccccccC-CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          333 FLSSISSSFLNTDIELDEMLD-PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .......       ....+.. .....+.    .....+.+++.+||+.||++|||+.|++++|+
T Consensus       253 ~~~~~~~-------~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  306 (316)
T 2xir_A          253 GVKIDEE-------FCRRLKEGTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  306 (316)
T ss_dssp             TCCCSHH-------HHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccchhHH-------HHHHhccCccCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            4332110       0000000 0111111    12345889999999999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.9e-45  Score=336.06  Aligned_cols=258  Identities=24%  Similarity=0.368  Sum_probs=202.1

Q ss_pred             CCCCccccccCcEEEEEEEeC-----CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec--CCe
Q 016009          127 FDAQYCIGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH--ARH  199 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~  199 (397)
                      |+..+.||+|+||+||++.+.     +++.||||++....   .....+.+.+|++++++++||||+++++++..  ...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            477889999999999988542     68899999997532   22346779999999999999999999999977  467


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++|+|.+++...    .+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence            89999999999999999653    389999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc---ccc---ccccccc
Q 016009          280 FLKPDSSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS---FLN---TDIELDE  350 (397)
Q Consensus       280 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~---~~~---~~~~~~~  350 (397)
                      ........   .....++..|+|||.+.+..++.++||||||+++|||+||+.||.........   ...   .......
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE  262 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence            76544321   23346788899999999888999999999999999999999998643211000   000   0001111


Q ss_pred             ccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+......+  .....+..+.+++.+||+.||++|||++|+++.|+
T Consensus       263 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  306 (318)
T 3lxp_A          263 LLERGERLP--RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK  306 (318)
T ss_dssp             HHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhcccCCC--CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            111111100  01123356889999999999999999999999886

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.3e-45  Score=336.14  Aligned_cols=260  Identities=25%  Similarity=0.382  Sum_probs=203.0

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHh--ccCCceeeeEEEEecCC
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--IRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~  198 (397)
                      ....++|...+.||+|+||.||+|.. +|+.||+|++..       ...+.+..|.++++.  ++||||+++++++....
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS-------REERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG-------GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc-------hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            44567899999999999999999987 589999999853       134678889999988  68999999999998775


Q ss_pred             ----eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceeccCCCCcEEeCC
Q 016009          199 ----HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH--------HDCFPPIVHRDISSKNLLLDL  266 (397)
Q Consensus       199 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~~~~ivH~dlk~~Nill~~  266 (397)
                          ..++||||+++|+|.+++...    .+++.+++.++.|++.||+|||        +.   +++||||||+||+++.
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK  182 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred             CccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence                789999999999999999643    4899999999999999999999        66   9999999999999999


Q ss_pred             CCcEEEeeeccccccCCCCCC----cccccccccccCcccccCC------CCCcchhhHHHHHHHHHHHhC---------
Q 016009          267 EFEAHVADFGIAKFLKPDSSN----WTEFAGTYGYVAPELAYTM------KITEKCDVYSFGVLALEVIKG---------  327 (397)
Q Consensus       267 ~~~~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~el~tg---------  327 (397)
                      ++.+||+|||++.........    .....||+.|+|||.+.+.      .++.++||||||+++|||+||         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            999999999999876543321    2345789999999998765      334789999999999999999         


Q ss_pred             -CCCCCcccccccccccc-ccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          328 -KHPRDFLSSISSSFLNT-DIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       328 -~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ..||............. .........+.++.. ....+....+.+++.+||+.||++|||+++|+++|+
T Consensus       263 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cccCccccCcCcccHHHHHHHHHHHHhCCCCccc-ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence             56664332111000000 000011112222110 012356677999999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-45  Score=341.99  Aligned_cols=251  Identities=27%  Similarity=0.430  Sum_probs=189.9

Q ss_pred             CCCCCccccccCcEEEEEEEeC--CC--CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe-cCCee
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP--SG--QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS-HARHS  200 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~  200 (397)
                      .|...+.||+|+||.||+|...  ++  ..||+|.+....   .....+.+.+|+.++++++||||+++++++. .++..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS---CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            3556678999999999999653  22  368999986422   2234678999999999999999999999875 45678


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++|+|.+++....  ..+++.+++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~  241 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  241 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccc
Confidence            99999999999999997543  3588999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCC----CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-C
Q 016009          281 LKPDSS----NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-P  354 (397)
Q Consensus       281 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~  354 (397)
                      ......    ......+++.|+|||.+.+..++.++||||||+++|||+| |..||........        ...+.. .
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--------~~~~~~~~  313 (373)
T 3c1x_A          242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--------TVYLLQGR  313 (373)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--------HHHHHTTC
T ss_pred             ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--------HHHHHcCC
Confidence            543221    1233456789999999999999999999999999999999 6777754332110        001111 1


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ....+.    ..+..+.+++.+||+.||++|||++|+++.|+
T Consensus       314 ~~~~p~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~  351 (373)
T 3c1x_A          314 RLLQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  351 (373)
T ss_dssp             CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111111    12345889999999999999999999999885

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=336.98  Aligned_cols=250  Identities=24%  Similarity=0.434  Sum_probs=195.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCE----EEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQV----VAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      ++|+..+.||+|+||.||+|... +++.    |++|.+.....   ....+.+.+|+.++++++||||+++++++.... 
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS---CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            57888999999999999999753 4553    57787754222   234678999999999999999999999998765 


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++|+||+.+|+|.+++....  ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            789999999999999997654  3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC--C
Q 016009          280 FLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD--P  354 (397)
Q Consensus       280 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~--~  354 (397)
                      ........  .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......         ....+.  .
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---------~~~~~~~~~  236 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGE  236 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------HHHHHHTTC
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---------HHHHHHcCC
Confidence            76543222  233456789999999999999999999999999999999 999987543211         111111  1


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+.    .....+.+++.+||+.||++|||++|+++.|+
T Consensus       237 ~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  274 (327)
T 3lzb_A          237 RLPQPP----ICTIDVYMIMRKCWMIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             CCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            111122    12345889999999999999999999999885

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.7e-45  Score=331.07  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=199.0

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      +|.....||+|+||.||+|.. .+++.||+|.+....    ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            455566899999999999975 578899999987532    123577899999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC-CCcEEEeeeccccccCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL-EFEAHVADFGIAKFLKP  283 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~  283 (397)
                      ||+++++|.+++........+++..+..++.|++.||+|||+.   +++|+||||+||+++. ++.+||+|||++.....
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            9999999999997654444578999999999999999999999   9999999999999987 89999999999987654


Q ss_pred             CCCCcccccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMK--ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      .........|++.|+|||.+.+..  ++.++||||||+++|||++|+.||............   .......+.++  . 
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~--~-  249 (295)
T 2clq_A          176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK---VGMFKVHPEIP--E-  249 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH---HHHHCCCCCCC--T-
T ss_pred             CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh---hcccccccccc--c-
Confidence            333344567899999999987653  789999999999999999999998643221100000   00000111111  1 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         .....+.+++.+||+.||++|||+.+++++
T Consensus       250 ---~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          250 ---SMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ---TSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ---cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               223458899999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-44  Score=328.93  Aligned_cols=249  Identities=28%  Similarity=0.451  Sum_probs=205.9

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +.|+..+.||+|+||.||+|.. .+++.||+|.+......   ...+.+.+|+.++++++||||+++++++......++|
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS---TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            4688889999999999999965 47899999998753322   2367899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++..    ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        99 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            999999999999864    3589999999999999999999999   999999999999999999999999999987665


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........|++.|+|||.+.+..++.++||||||+++|||++|+.||...........     ......+...  .   
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~--~---  241 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-----IPKNNPPTLE--G---  241 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSCCCCCC--S---
T ss_pred             cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-----hhcCCCCCCc--c---
Confidence            44444556789999999999999999999999999999999999999874432111000     0000011111  1   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .....+.+++.+||+.||++|||+.+++++
T Consensus       242 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          242 -NYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             -SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             -ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             123458899999999999999999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.8e-45  Score=332.00  Aligned_cols=251  Identities=24%  Similarity=0.349  Sum_probs=201.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|...+.||+|+||.||++... +|+.||+|.+.....    ...+.+.+|++++++++||||+++++++...+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            357888899999999999999764 789999999875321    224678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe---CCCCcEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL---DLEFEAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~  279 (397)
                      ||||+++++|.+++....   .+++.+++.++.|++.||.|||+.   +++|+||||+||++   ++++.++|+|||++.
T Consensus        84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           84 VMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            999999999999986543   589999999999999999999999   99999999999999   788999999999987


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      .....  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......        ....+.......+
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~~~~~  227 (304)
T 2jam_A          158 MEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--------LFEKIKEGYYEFE  227 (304)
T ss_dssp             CCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHCCCCCC
T ss_pred             ecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCCCCC
Confidence            54322  2334568999999999999999999999999999999999999986432210        0111111111111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..........+.+++.+||+.||++|||++|++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11111233568899999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=327.49  Aligned_cols=250  Identities=26%  Similarity=0.396  Sum_probs=201.1

Q ss_pred             CCCCCc-cccccCcEEEEEEEeC---CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          126 DFDAQY-CIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       126 ~~~~~~-~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      +|.... .||+|+||.||+|...   ++..||+|+++...   .....+.+.+|++++++++||||+++++++ ..+..+
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc---chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            455555 8999999999999753   57789999987532   223467899999999999999999999999 456689


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++++|.+++....  ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus        86 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            9999999999999996543  4589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCC---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CC
Q 016009          282 KPDSSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RL  356 (397)
Q Consensus       282 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~  356 (397)
                      ......   .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||........        ...+... ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--------~~~i~~~~~~  232 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--------MAFIEQGKRM  232 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--------HHHHHTTCCC
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--------HHHHhcCCcC
Confidence            543322   123356889999999998889999999999999999999 9999864332110        0111111 11


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.    ..+..+.+++..||+.||++|||+.+++++|+
T Consensus       233 ~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          233 ECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             CCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCC----CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111    22345889999999999999999999999885

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.1e-45  Score=335.86  Aligned_cols=263  Identities=24%  Similarity=0.389  Sum_probs=199.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|... +|+.||+|++.....  .....+.+.+|++++++++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD--DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC--chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            357888899999999999999765 589999999865322  22335678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++++|.+++....   .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus       102 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EEECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EEecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            999999999998865433   489999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccc----------------cccc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF----------------LNTD  345 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~----------------~~~~  345 (397)
                      ..........+++.|+|||.+.+. .++.++||||||+++|||++|+.||..........                ....
T Consensus       176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            544444556789999999998875 68999999999999999999999986543211000                0000


Q ss_pred             cccccccCCCCCCCCc---chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          346 IELDEMLDPRLPAPSR---SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       346 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ........+.......   ........+.+++.+||+.||++|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000011111110000   001224568999999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8e-46  Score=340.64  Aligned_cols=261  Identities=18%  Similarity=0.270  Sum_probs=192.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||+||+|... +++.||+|++.......   ....+.+|++++++++||||+++++++...+..++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc---cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            46888899999999999999765 78999999986532211   112345799999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||++ |+|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        79 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             EECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             ecccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            99997 58988886543  3589999999999999999999999   999999999999999999999999999986654


Q ss_pred             CCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc--------------ccc--ccc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS--------------FLN--TDI  346 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~--------------~~~--~~~  346 (397)
                      .........+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.........              +..  ...
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence            4444455678999999999876 56899999999999999999999998653321100              000  000


Q ss_pred             ccccccCCCCCCCC--cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ELDEMLDPRLPAPS--RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .......+......  .........+.+|+.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00000000000000  0001123457899999999999999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.5e-45  Score=332.27  Aligned_cols=259  Identities=25%  Similarity=0.419  Sum_probs=195.3

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEeC----CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH  196 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  196 (397)
                      ....++|...+.||+|+||.||+|...    +++.||+|.+.....  .....+.+.+|++++++++||||+++++++..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            344567888899999999999999653    345899999875322  22335779999999999999999999999976


Q ss_pred             CC-----eeeEEEEeccCCCHHHhhcccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC
Q 016009          197 AR-----HSFLVYEFLKRGSLAAILSSDA---AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF  268 (397)
Q Consensus       197 ~~-----~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  268 (397)
                      ..     ..++||||+++|+|.+++....   ....+++.+++.++.|++.||.|||+.   +++||||||+||+++.++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence            54     3499999999999999985322   234699999999999999999999998   999999999999999999


Q ss_pred             cEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 016009          269 EAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTD  345 (397)
Q Consensus       269 ~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~  345 (397)
                      .+||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......       
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------  257 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-------  257 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------
Confidence            999999999986643321  1233457889999999999999999999999999999999 888986433211       


Q ss_pred             cccccccCCC-CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          346 IELDEMLDPR-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       346 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ....+.... ...+    ......+.+++.+||+.||++|||+.+++++|+
T Consensus       258 -~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  304 (313)
T 3brb_A          258 -MYDYLLHGHRLKQP----EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE  304 (313)
T ss_dssp             -HHHHHHTTCCCCCB----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -HHHHHHcCCCCCCC----ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence             011111111 1111    122345889999999999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.5e-45  Score=339.61  Aligned_cols=264  Identities=20%  Similarity=0.300  Sum_probs=192.7

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ...++|+..+.||+|+||+||+|.. .+++.||+|++.....  .....+.+.+|++++++++||||+++++++...+..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            3456899999999999999999964 4789999999875332  222346678999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe-----CCCCcEEEeee
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL-----DLEFEAHVADF  275 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill-----~~~~~~kl~Df  275 (397)
                      ++||||+++ +|.+++....   .+++..++.++.|++.||+|||+.   +|+||||||+||++     ++++.+||+||
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            999999985 9999987654   489999999999999999999999   99999999999999     45566999999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc-------ccccc
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL-------NTDIE  347 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~-------~~~~~  347 (397)
                      |++..............+|+.|+|||++.+. .++.++|||||||++|||++|+.||...........       .....
T Consensus       182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            9998766544444556789999999998875 489999999999999999999999864332110000       00000


Q ss_pred             ---cccc--cCCCCCC-CCcchHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          348 ---LDEM--LDPRLPA-PSRSVQE-----KLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       348 ---~~~~--~~~~~~~-~~~~~~~-----~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ....  .....+. .......     ....+.+|+.+||+.||++|||++|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence               0000  0000000 0001111     23568899999999999999999999874

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-45  Score=338.95  Aligned_cols=266  Identities=24%  Similarity=0.299  Sum_probs=198.0

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcc-hhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQ-IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ..++|...+.||+|+||.||+|... +|+.||+|++........ ....+.+.+|++++++++||||+++++++...+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3568999999999999999999765 689999999875322111 11124678999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++ +|.+++....  ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999986 8888886543  3588899999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------cccccccc---
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNTDIELD---  349 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~~~~~~---  349 (397)
                      ............+|+.|+|||.+.+. .++.++||||||+++|||++|..||..........       ........   
T Consensus       162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            75544444556889999999998754 48899999999999999999999986433211000       00000000   


Q ss_pred             ---ccc-CCCCCCCC--cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          350 ---EML-DPRLPAPS--RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       350 ---~~~-~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         +.. ....+...  .........+.+++.+||+.||++|||++|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence               000 00000000  0001223568999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.7e-45  Score=358.58  Aligned_cols=252  Identities=27%  Similarity=0.485  Sum_probs=204.8

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      ..++|+..+.||+|+||.||+|.+.++..||||+++...     ...+.|.+|++++++++||||+++++++.. +..++
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            345677888999999999999999888889999987532     235789999999999999999999999876 67899


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|.+++..... ..+++.+++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++...
T Consensus       339 v~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             eeehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            9999999999999975332 4589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCC
Q 016009          283 PDSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-PRLPAP  359 (397)
Q Consensus       283 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  359 (397)
                      .... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.......        ....+.. .+++.+
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~~~  486 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERGYRMPCP  486 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--------HHHHHHTTCCCCCC
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCC
Confidence            3211 1122346788999999998899999999999999999999 999986433211        0111111 111212


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .    .+...+.+|+.+||+.||++|||+++|+++|+
T Consensus       487 ~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  519 (535)
T 2h8h_A          487 P----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE  519 (535)
T ss_dssp             T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            2    23345889999999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9e-45  Score=353.16  Aligned_cols=255  Identities=24%  Similarity=0.327  Sum_probs=202.1

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcc---------hhcHHHHHHHHHHHHhccCCceeeeEEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQ---------IVDKKEFLTEVEALTEIRHRNIVKLYGF  193 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~~~~~  193 (397)
                      .++|...+.||+|+||+||+|... +++.||+|++........         ....+.+.+|++++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            568999999999999999999764 688999999875322110         1235678999999999999999999999


Q ss_pred             EecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC---cE
Q 016009          194 CSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF---EA  270 (397)
Q Consensus       194 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~  270 (397)
                      +.+....++||||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999999986543   599999999999999999999999   999999999999998776   69


Q ss_pred             EEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 016009          271 HVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE  350 (397)
Q Consensus       271 kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  350 (397)
                      ||+|||++....... ......||+.|+|||++. +.++.++||||+|+++|+|++|..||......        .....
T Consensus       189 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~  258 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------DIIKK  258 (504)
T ss_dssp             EECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHH
T ss_pred             EEEECCCCEEcCCCC-ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence            999999998765432 334567999999999887 46899999999999999999999998743321        11111


Q ss_pred             ccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +.......+...+...+..+.+++.+||+.||++|||++|++++
T Consensus       259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          259 VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11122211111112234568899999999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=338.50  Aligned_cols=261  Identities=20%  Similarity=0.238  Sum_probs=195.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeC----CCCEEEEEecCCCCCCcc-------hhcHHHHHHHHHHHHhccCCceeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQ-------IVDKKEFLTEVEALTEIRHRNIVKLYGF  193 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~  193 (397)
                      ++|...+.||+|+||.||+|...    ++..+|+|++........       ......+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57888999999999999999765    578899999875322100       0112346788899999999999999999


Q ss_pred             Eec----CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC-
Q 016009          194 CSH----ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF-  268 (397)
Q Consensus       194 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-  268 (397)
                      +..    ....++||||+ +++|.+++....   .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++ 
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence            977    77899999999 999999997654   599999999999999999999999   999999999999998887 


Q ss_pred             -cEEEeeeccccccCCCC-------CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc
Q 016009          269 -EAHVADFGIAKFLKPDS-------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS  340 (397)
Q Consensus       269 -~~kl~Dfg~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~  340 (397)
                       .+||+|||+++.+....       .......||+.|+|||.+.+..++.++||||||+++|||+||+.||.........
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             99999999998764321       1124457899999999999999999999999999999999999998532111100


Q ss_pred             ccccccccccccCCCCCCCC---cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          341 FLNTDIELDEMLDPRLPAPS---RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...    ......+.++...   ......+..+.+++..||+.||++|||+++|++.|+
T Consensus       270 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  324 (345)
T 2v62_A          270 VQT----AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILN  324 (345)
T ss_dssp             HHH----HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred             HHH----HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence            000    0000000110000   000012346889999999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8e-45  Score=327.80  Aligned_cols=249  Identities=27%  Similarity=0.420  Sum_probs=203.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||+|... +++.||+|++..... ......+.+.+|++++++++||||+++++++...+..++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc-chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            57888899999999999999765 678899999853110 1112346789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++....   .+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999997543   589999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......        ....+.......+..  
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~--  234 (284)
T 2vgo_A          167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--------THRRIVNVDLKFPPF--  234 (284)
T ss_dssp             S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCCCCCTT--
T ss_pred             c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--------HHHHHhccccCCCCc--
Confidence            2  2234578999999999999999999999999999999999999986433211        111111122221111  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        ....+.+++.+||+.||++|||+++++++
T Consensus       235 --~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          235 --LSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             --SCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             --CCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence              23458899999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.4e-44  Score=347.28  Aligned_cols=259  Identities=22%  Similarity=0.315  Sum_probs=194.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-----  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  197 (397)
                      .++|+..+.||+|+||+||+|.. .+|+.||||++....  ......+.+.+|+.+++.++||||+++++++...     
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            46789999999999999999965 478999999987532  2233467789999999999999999999999654     


Q ss_pred             -CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          198 -RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       198 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                       ...++||||++++ |.+.+.     ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       139 ~~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          139 FQDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CCEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CCeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence             4569999999865 555553     2489999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc--------------cc
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS--------------FL  342 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~--------------~~  342 (397)
                      +++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.........              ..
T Consensus       210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          210 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             CC-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eeeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            99876533 2334568999999999999999999999999999999999999999643321000              00


Q ss_pred             ccccccccccCCC----------------CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          343 NTDIELDEMLDPR----------------LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       343 ~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .........+...                .+............+.+|+.+||+.||++|||++|++++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000000000                011111112235678999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1e-44  Score=326.53  Aligned_cols=252  Identities=23%  Similarity=0.381  Sum_probs=199.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCC----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      .++|...+.||+|+||.||+|...+    +..||+|.+....   .....+.+.+|++++++++||||+++++++.+ +.
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence            4578888999999999999996532    3369999987532   22346789999999999999999999999865 45


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             CEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence            689999999999999997543  3589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCC
Q 016009          280 FLKPDSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-PRL  356 (397)
Q Consensus       280 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~  356 (397)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||........        ...+.. ...
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--------~~~~~~~~~~  233 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--------IGVLEKGDRL  233 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--------HHHHHHTCCC
T ss_pred             ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--------HHHHhcCCCC
Confidence            7654322 2233456889999999998899999999999999999998 9999864332110        000000 111


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+.    .....+.+++.+||+.||++|||+.|++++|+
T Consensus       234 ~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  269 (281)
T 3cc6_A          234 PKPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS  269 (281)
T ss_dssp             CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence            1111    12345889999999999999999999999885

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.5e-45  Score=359.98  Aligned_cols=244  Identities=26%  Similarity=0.408  Sum_probs=195.1

Q ss_pred             cccccCcEEEEEEEeC---CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEecc
Q 016009          132 CIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      .||+|+||.||+|...   ++..||||+++....   ....+++.+|++++++++||||+++++++.. +..++||||++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~  418 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG  418 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS---STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCC
Confidence            6999999999999653   466799999975322   2246789999999999999999999999976 56899999999


Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      +|+|.+++....  ..+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       419 ~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          419 GGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             TCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             CCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            999999996543  4699999999999999999999999   99999999999999999999999999998765432211


Q ss_pred             ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCCCcch
Q 016009          289 ---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-PRLPAPSRSV  363 (397)
Q Consensus       289 ---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  363 (397)
                         ....+++.|+|||++.+..++.++|||||||++|||+| |+.||........        ...+.. .++..+.   
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--------~~~i~~~~~~~~p~---  562 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--------MAFIEQGKRMECPP---  562 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH--------HHHHHTTCCCCCCT---
T ss_pred             eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--------HHHHHcCCCCCCCC---
Confidence               22345688999999998999999999999999999998 9999875432110        111111 1122222   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       .++..+.+++..||+.||++|||+.+|++.|+
T Consensus       563 -~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  594 (613)
T 2ozo_A          563 -ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  594 (613)
T ss_dssp             -TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred             -cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence             23356889999999999999999999999885

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.1e-45  Score=353.02  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=199.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .+.|...+.||+|+||+||+|... ++..||+|++.......  .....+.+|+++++.++||||+++++++.+....++
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            346888999999999999999765 78899999987533211  235678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC---CcEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE---FEAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~  279 (397)
                      ||||+++|+|.+.+....   .+++..++.++.|++.||+|||+.   +|+||||||+||+++.+   +.+||+|||++.
T Consensus       114 v~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            999999999999886543   589999999999999999999999   99999999999999764   459999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ...... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.......        ....+.......+
T Consensus       188 ~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~~  257 (494)
T 3lij_A          188 VFENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--------ILRKVEKGKYTFD  257 (494)
T ss_dssp             ECBTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCC
T ss_pred             ECCCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCC
Confidence            765432 234467999999999876 469999999999999999999999987433211        1111111111111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+...+..+.+++.+||+.||++|||+.|++++
T Consensus       258 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            12222334568899999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.5e-45  Score=352.27  Aligned_cols=253  Identities=23%  Similarity=0.373  Sum_probs=203.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|...+.||+|+||+||+|... +++.||||++....  ........+.+|++++++++||||+++++++......++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS--AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHH--HBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            357888999999999999999764 78999999985311  112235789999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC---CCCcEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD---LEFEAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~  279 (397)
                      ||||+.+|+|.+.+....   .+++.++..++.|++.||.|||+.   +|+||||||+||+++   .++.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999999886543   589999999999999999999999   999999999999995   45679999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.......        ....+.......+
T Consensus       173 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~~  242 (486)
T 3mwu_A          173 CFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--------ILKRVETGKYAFD  242 (486)
T ss_dssp             TBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCSC
T ss_pred             ECCCCC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCC
Confidence            765432 2344579999999999876 58999999999999999999999986433211        1111111222211


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            22223334568899999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=331.87  Aligned_cols=252  Identities=28%  Similarity=0.441  Sum_probs=201.3

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ..++|+..+.||+|+||.||+|... +|+.||+|.+....      ..+.+.+|++++++++||||+++++++...+..+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            3467889999999999999999765 68999999986521      2467899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++++|.+++....  ..+++..++.++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus       101 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            9999999999999986432  4689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ...........|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........     ......+...    
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~----  246 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-----IPTNPPPTFR----  246 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSCCCCCS----
T ss_pred             hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-----HhcCCCcccC----
Confidence            5443444456789999999999998999999999999999999999999875432211000     0000011111    


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ........+.+++.+||+.||++|||+.+++++
T Consensus       247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            111223468899999999999999999999863

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.9e-44  Score=327.63  Aligned_cols=252  Identities=27%  Similarity=0.423  Sum_probs=197.1

Q ss_pred             cCCCCCccccccCcEEEEEEEeCC----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEE-ecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFC-SHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~  199 (397)
                      .+|...+.||+|+||.||+|...+    ...+|+|.+....   .....+.+.+|+.++++++||||+++++++ ..++.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC---CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            457778899999999999997542    2358999987522   223457899999999999999999999986 45567


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             eEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence            899999999999999996543  4589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC----CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC
Q 016009          280 FLKPDS----SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP  354 (397)
Q Consensus       280 ~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
                      ......    .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||........        ...+...
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--------~~~~~~~  248 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--------TVYLLQG  248 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--------HHHHHTT
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--------HHHHhcC
Confidence            654322    11233467789999999999999999999999999999999 5555543322110        0111111


Q ss_pred             C-CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 R-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      . ...+.    .....+.+++.+||+.||++|||++|++++|+
T Consensus       249 ~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  287 (298)
T 3f66_A          249 RRLLQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  287 (298)
T ss_dssp             CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1 11111    12245889999999999999999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-44  Score=324.51  Aligned_cols=253  Identities=24%  Similarity=0.362  Sum_probs=203.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|... +++.||+|++.....   ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            457888999999999999999765 789999999864222   1235778999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++++|.+++...   ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus        83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            99999999999998654   3589999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCC--CCcccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          283 PDS--SNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       283 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ...  .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.........       ........... 
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~-  228 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTYL-  228 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-------HHHHHTTCTTS-
T ss_pred             CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHhhhccccc-
Confidence            322  12344578999999999987765 77999999999999999999998753321100       01111111000 


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .........+.+++.+||+.||++|||++|++++
T Consensus       229 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence             0111233458899999999999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-46  Score=345.63  Aligned_cols=257  Identities=23%  Similarity=0.326  Sum_probs=201.0

Q ss_pred             cCCCCCccccccCcEEEEEEEe----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  199 (397)
                      ++|+..+.||+|+||.||++..    .+|+.||||+++...........+.+.+|+++++++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5788899999999999999976    478999999986422111122345677899999999 69999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++|+|.+++....   .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            999999999999999997543   589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CcccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 016009          280 FLKPDSS-NWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       280 ~~~~~~~-~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      ....... ......||+.|+|||++.+  ..++.++||||||+++|||++|+.||.........    ......+.....
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~~~~~~  283 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKSEP  283 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHHCCC
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH----HHHHHHHhccCC
Confidence            6543222 2234579999999999885  34789999999999999999999998643221100    000111111111


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRP-----TMKIVSQQL  395 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~L  395 (397)
                      +.+.    +....+.+++.+||+.||++||     |++|++++.
T Consensus       284 ~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          284 PYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             CCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             CCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            1111    2234588999999999999999     999998764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.1e-45  Score=336.12  Aligned_cols=261  Identities=25%  Similarity=0.387  Sum_probs=194.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHH--HHhccCCceeeeEEEEe-----c
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA--LTEIRHRNIVKLYGFCS-----H  196 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~-----~  196 (397)
                      .++|+..+.||+|+||.||+|.. +++.||||++..       .....+..|.++  +..++||||+++++.+.     .
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF-------ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEG-------GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeec-------cchhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence            35788899999999999999977 689999999853       123445555555  44589999999998653     2


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCceeccCCCCcEEeCCCCcE
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC------FPPIVHRDISSKNLLLDLEFEA  270 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------~~~ivH~dlk~~Nill~~~~~~  270 (397)
                      ....++||||+++|+|.+++....    .++..++.++.|++.||+|||+.+      .++|+||||||+|||++.++.+
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             CceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            336789999999999999996543    589999999999999999999863      2389999999999999999999


Q ss_pred             EEeeeccccccCCCC--------CCcccccccccccCcccccC-------CCCCcchhhHHHHHHHHHHHhCCCCCCccc
Q 016009          271 HVADFGIAKFLKPDS--------SNWTEFAGTYGYVAPELAYT-------MKITEKCDVYSFGVLALEVIKGKHPRDFLS  335 (397)
Q Consensus       271 kl~Dfg~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~  335 (397)
                      ||+|||++.......        .......||+.|+|||++.+       ..++.++||||||+++|||++|..|+....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            999999998764321        11234569999999999886       456789999999999999999987753222


Q ss_pred             cccccccc---------cccc-----cccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          336 SISSSFLN---------TDIE-----LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       336 ~~~~~~~~---------~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ........         ....     ......+.++............+.+++.+||+.||++|||++|+++.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            11100000         0000     0111122222222223345667999999999999999999999999885

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.9e-45  Score=363.47  Aligned_cols=251  Identities=22%  Similarity=0.310  Sum_probs=206.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  201 (397)
                      .++|+..+.||+|+||.||+|... +++.||||+++.... ......+.+..|..++..+ +||+|+.+++++.+.+..|
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH-HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            467888999999999999999754 688999999864110 1112346688899999988 7999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++|+|.+++....   .+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999997643   599999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ...........||+.|+|||++.+..++.++||||||+++|||++|+.||.....        ......+.......+. 
T Consensus       493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~-  563 (674)
T 3pfq_A          493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPK-  563 (674)
T ss_dssp             CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSSCCCCCT-
T ss_pred             ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCCCCCCc-
Confidence            5444455667899999999999999999999999999999999999999874322        1112223333333222 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTM-----KIVSQ  393 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~-----~~vl~  393 (397)
                         .....+.+|+.+||+.||++||++     +||++
T Consensus       564 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          564 ---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ---TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ---cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence               223458899999999999999997     77765

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.9e-45  Score=343.78  Aligned_cols=263  Identities=23%  Similarity=0.380  Sum_probs=190.7

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCC-
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHAR-  198 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-  198 (397)
                      ...++|+..+.||+|+||.||+|.. .+|+.||||++.....  .....+.+.+|+.+++++. ||||+++++++...+ 
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ--NSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C--CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            3457899999999999999999965 5799999999865322  2334677889999999997 999999999997543 


Q ss_pred             -eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          199 -HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       199 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                       ..++||||++ ++|.+++..    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence             7899999997 589988865    3589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCC---------------------CCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccc
Q 016009          278 AKFLKPD---------------------SSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLS  335 (397)
Q Consensus       278 ~~~~~~~---------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~  335 (397)
                      ++.....                     ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9865321                     111234579999999999876 678999999999999999999999986433


Q ss_pred             ccccccc-------ccccccccccCC---------------CCCCCCcchH-------------HHHHHHHHHHHHccCC
Q 016009          336 SISSSFL-------NTDIELDEMLDP---------------RLPAPSRSVQ-------------EKLRSIVEVVFSCLNE  380 (397)
Q Consensus       336 ~~~~~~~-------~~~~~~~~~~~~---------------~~~~~~~~~~-------------~~~~~l~~l~~~cl~~  380 (397)
                      .......       .....+..+..+               ..........             .....+.+|+.+||+.
T Consensus       236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            2110000       000000000000               0000000000             1134588999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 016009          381 SPESRPTMKIVSQQ  394 (397)
Q Consensus       381 ~P~~RPt~~~vl~~  394 (397)
                      ||++|||++|++++
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-44  Score=324.53  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=194.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|...+.||+|+||.||+|... +|+.||+|.+.... .......+.+.+|+++++.++||||+++++++...+..++|
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK-IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc-ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            57888899999999999999765 79999999985311 01122356789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++....   .+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999999997543   589999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCCcccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      .. ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.......        ....+.......+.. 
T Consensus       164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~-  233 (276)
T 2h6d_A          164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--------LFKKIRGGVFYIPEY-  233 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTT-
T ss_pred             Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--------HHHHhhcCcccCchh-
Confidence            32 2234578999999999987765 689999999999999999999986432110        011111111111111 


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ....+.+++.+||+.||++|||++|++++
T Consensus       234 ---~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          234 ---LNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               22458899999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-44  Score=324.71  Aligned_cols=251  Identities=25%  Similarity=0.394  Sum_probs=197.4

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CC---CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee-
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SG---QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS-  200 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-  200 (397)
                      .|...+.||+|+||+||+|... ++   ..||+|.+....   .....+.+.+|++++++++||||+++++++...+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT---EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc---cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            3455678999999999999643 33   379999987522   223467889999999999999999999999776655 


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+.+|+|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             EEEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            99999999999999997643  4689999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCC----CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC-CCccccccccccccccccccccCC-
Q 016009          281 LKPDS----SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-RDFLSSISSSFLNTDIELDEMLDP-  354 (397)
Q Consensus       281 ~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~-  354 (397)
                      .....    .......+++.|+|||.+.+..++.++||||||+++|||++|..| +........        ...+... 
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~--------~~~~~~~~  245 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL--------THFLAQGR  245 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH--------HHHHHTTC
T ss_pred             ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH--------HHHhhcCC
Confidence            54321    122345678899999999999999999999999999999996555 432221110        0001111 


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+.    .....+.+++.+||+.||++|||+++++++|+
T Consensus       246 ~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  283 (298)
T 3pls_A          246 RLPQPE----YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE  283 (298)
T ss_dssp             CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCc----cchHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            111111    12345889999999999999999999999886

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.9e-44  Score=327.22  Aligned_cols=258  Identities=17%  Similarity=0.278  Sum_probs=198.3

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEE-ecCCe
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFC-SHARH  199 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~  199 (397)
                      ...++|+..+.||+|+||.||+|.. .+++.||+|++.....      .+.+..|+++++.++|++++..++++ ...+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence            3457899999999999999999975 5789999998654222      23578899999999988877776666 66778


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe---CCCCcEEEeeec
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL---DLEFEAHVADFG  276 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg  276 (397)
                      .++||||+ +++|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+||++   ++++.+||+|||
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg  153 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred             eEEEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence            89999999 999999997433  3599999999999999999999999   99999999999999   788999999999


Q ss_pred             cccccCCCCC-------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 016009          277 IAKFLKPDSS-------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD  349 (397)
Q Consensus       277 ~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  349 (397)
                      ++........       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........     ..
T Consensus       154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~  228 (296)
T 4hgt_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-----YE  228 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH-----HH
T ss_pred             cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh-----hh
Confidence            9987654322       12345789999999999999999999999999999999999999875432211000     00


Q ss_pred             cccCCCCCCCC-cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          350 EMLDPRLPAPS-RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       350 ~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+.......+. ......+..+.+++..||+.||++|||+++|++.|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (296)
T 4hgt_A          229 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             hhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence            10000000000 000112346889999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-44  Score=345.85  Aligned_cols=195  Identities=26%  Similarity=0.386  Sum_probs=154.6

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec-----CC
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH-----AR  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~  198 (397)
                      ++|+..+.||+|+||+||+|... +++.||||++.....  .....+.+.+|++++++++||||+++++++..     ..
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE--DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc--CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            57899999999999999999654 789999999865322  23346789999999999999999999999943     35


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA  278 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  278 (397)
                      ..|+||||+ +++|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            789999998 56999998654   3599999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC---------------------------CcccccccccccCcccc-cCCCCCcchhhHHHHHHHHHHHhCC
Q 016009          279 KFLKPDSS---------------------------NWTEFAGTYGYVAPELA-YTMKITEKCDVYSFGVLALEVIKGK  328 (397)
Q Consensus       279 ~~~~~~~~---------------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~el~tg~  328 (397)
                      +.......                           .....+||+.|+|||++ .+..++.++|||||||++|||+||.
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            87643211                           12345789999999976 5667999999999999999999943

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=335.07  Aligned_cols=247  Identities=16%  Similarity=0.192  Sum_probs=198.7

Q ss_pred             hcCCCCCccccccCcEEEEEEE------eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc---CCceeeeEEEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR---HRNIVKLYGFC  194 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~  194 (397)
                      .++|...+.||+|+||+||+|.      ..+++.||+|++...       ...++..|+++++.++   |+|++++++++
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------NPWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            4578888999999999999993      457899999998642       2467788888888886   99999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhcccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC------
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDA--AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL------  266 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~------  266 (397)
                      ...+..++||||+++|+|.+++....  ....+++.+++.++.|++.||+|||+.   +|+||||||+|||++.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence            99999999999999999999997532  234699999999999999999999998   9999999999999998      


Q ss_pred             -----CCcEEEeeeccccccCC--CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc
Q 016009          267 -----EFEAHVADFGIAKFLKP--DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS  339 (397)
Q Consensus       267 -----~~~~kl~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~  339 (397)
                           ++.+||+|||++..+..  .........||+.|+|||++.+..++.++|||||||++|||+||+.||......  
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--  291 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--  291 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT--
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC--
Confidence                 89999999999975432  222334567999999999999999999999999999999999999997532211  


Q ss_pred             cccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHhc
Q 016009          340 SFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESR-PTMKIVSQQLQ  396 (397)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-Pt~~~vl~~Le  396 (397)
                           ...    .........     ....+.+++..|++.+|.+| |+++++.+.|+
T Consensus       292 -----~~~----~~~~~~~~~-----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~  335 (365)
T 3e7e_A          292 -----ECK----PEGLFRRLP-----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK  335 (365)
T ss_dssp             -----EEE----ECSCCTTCS-----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred             -----cee----echhccccC-----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence                 000    111111111     12346678889999999999 67777776654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.6e-44  Score=327.02  Aligned_cols=251  Identities=25%  Similarity=0.413  Sum_probs=199.1

Q ss_pred             cCCCCCc-cccccCcEEEEEEEe---CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          125 NDFDAQY-CIGNGGHGSVYRAEL---PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~-~lg~G~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ++|...+ .||+|+||.||+|..   .+++.||||++.....  .....+.+.+|+++++.++||||+++++++ ..+..
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            4566666 899999999999953   2468899999875322  222367899999999999999999999999 56678


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++++|.+++....   .+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            99999999999999997643   589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-C
Q 016009          281 LKPDSSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-R  355 (397)
Q Consensus       281 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~  355 (397)
                      ........   ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||........        ...+... .
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------~~~~~~~~~  238 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--------TAMLEKGER  238 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------HHHHHTTCC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--------HHHHHcCCC
Confidence            65443221   22345788999999998889999999999999999999 9999875432110        0001010 1


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...+.    .....+.+++.+||+.||++|||+.++++.|+
T Consensus       239 ~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  275 (291)
T 1xbb_A          239 MGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLR  275 (291)
T ss_dssp             CCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111    22345889999999999999999999999885

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.6e-45  Score=345.66  Aligned_cols=246  Identities=14%  Similarity=0.135  Sum_probs=189.9

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHH---HHHhccCCceeeeE-------E
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVE---ALTEIRHRNIVKLY-------G  192 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~niv~~~-------~  192 (397)
                      .++|...+.||+|+||.||+|.. .+|+.||||++..... ......+.+.+|++   ++++++||||++++       +
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC--CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc-cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            45788889999999999999975 5799999999874222 12234578899994   55556899999998       6


Q ss_pred             EEecCC-----------------eeeEEEEeccCCCHHHhhccccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 016009          193 FCSHAR-----------------HSFLVYEFLKRGSLAAILSSDAA----AQELGWSQRMNVIKGVADALSYLHHDCFPP  251 (397)
Q Consensus       193 ~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~  251 (397)
                      ++...+                 ..++||||+ +|+|.+++.....    ...+++..++.++.|++.||+|||+.   +
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            665553                 278999999 6899999975432    12244688899999999999999999   9


Q ss_pred             ceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcccccccccccCcccccCC-----------CCCcchhhHHHHHH
Q 016009          252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM-----------KITEKCDVYSFGVL  320 (397)
Q Consensus       252 ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~s~G~~  320 (397)
                      |+||||||+|||++.++.+||+|||+++...   .......| +.|+|||++.+.           .++.++|||||||+
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999998533   23344567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          321 ALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       321 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +|||+||+.||.......        ....+.. ..   .    .....+.+++.+||+.||++|||+.|++++
T Consensus       303 l~elltg~~Pf~~~~~~~--------~~~~~~~-~~---~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          303 IYWIWCADLPITKDAALG--------GSEWIFR-SC---K----NIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHSSCCC------C--------CSGGGGS-SC---C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHCCCCCccccccc--------chhhhhh-hc---c----CCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            999999999986433211        0111111 11   1    112358899999999999999999999863

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.5e-44  Score=327.86  Aligned_cols=256  Identities=17%  Similarity=0.278  Sum_probs=200.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEE-ecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFC-SHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~  201 (397)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++.....      .+.+.+|+++++.++|++++..+.++ ......+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            46788999999999999999975 6899999999865322      24688999999999988877666665 5667889


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC---CCCcEEEeeeccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD---LEFEAHVADFGIA  278 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~  278 (397)
                      +||||+ +++|.+++....  ..+++.+++.++.|++.||+|||+.   +++||||||+||+++   .++.+||+|||++
T Consensus        82 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            999999 999999996433  3699999999999999999999999   999999999999994   8889999999999


Q ss_pred             cccCCCCCC-------cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 016009          279 KFLKPDSSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       279 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      .........       .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..........     ....+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~  230 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-----KYERI  230 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-----HHHHH
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh-----hhhhh
Confidence            876543321       234578999999999999999999999999999999999999987543211100     00000


Q ss_pred             cCCCCCCCC-cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          352 LDPRLPAPS-RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       352 ~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .......+. ......+..+.+++.+||+.||++|||+++|++.|+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  276 (296)
T 3uzp_A          231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             cccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence            000000000 000112345889999999999999999999999885

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.9e-44  Score=324.60  Aligned_cols=249  Identities=22%  Similarity=0.341  Sum_probs=199.9

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  200 (397)
                      ..++|+..+.||+|+||.||+|... +++.||+|++.......  ....++.+|+..+..+ +||||+++++++.+.+..
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS--VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS--HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            3467889999999999999999765 79999999987533322  2457788999999999 999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC------------
Q 016009          201 FLVYEFLKRGSLAAILSSDAA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE------------  267 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~------------  267 (397)
                      ++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.   +++||||||+||+++.+            
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence            999999999999999976432 24589999999999999999999999   99999999999999844            


Q ss_pred             -------CcEEEeeeccccccCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccc
Q 016009          268 -------FEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS  339 (397)
Q Consensus       268 -------~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~  339 (397)
                             ..+||+|||.+.......    ...||+.|+|||.+.+. .++.++||||||+++|||++|..|+.....   
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             ccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                   479999999998765432    23589999999998765 566899999999999999999987542221   


Q ss_pred             cccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          340 SFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                              ...+.....+....   .....+.+++.+||+.||++|||+.|++++
T Consensus       237 --------~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 --------WHEIRQGRLPRIPQ---VLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             --------HHHHHTTCCCCCSS---CCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             --------HHHHHcCCCCCCCc---ccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence                    11111111111111   123458899999999999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=330.60  Aligned_cols=255  Identities=27%  Similarity=0.438  Sum_probs=196.5

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEec--
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSH--  196 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~--  196 (397)
                      ....++|+..+.||+|+||.||+|.. .+|+.||+|++.....     ..+.+.+|+.+++++ +||||+++++++..  
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            34567889999999999999999976 4789999999864221     246788999999999 89999999999976  


Q ss_pred             ----CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEE
Q 016009          197 ----ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHV  272 (397)
Q Consensus       197 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  272 (397)
                          .+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence                467899999999999999997653 24689999999999999999999999   9999999999999999999999


Q ss_pred             eeeccccccCCCCCCcccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 016009          273 ADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE  347 (397)
Q Consensus       273 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~  347 (397)
                      +|||++..............|++.|+|||.+.     +..++.++||||||+++|||++|+.||...........     
T Consensus       171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----  245 (326)
T 2x7f_A          171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-----  245 (326)
T ss_dssp             CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----
T ss_pred             eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-----
Confidence            99999987654333334557899999999987     56689999999999999999999999864432211000     


Q ss_pred             cccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          348 LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+...  .   ......+.+++.+||+.||++|||+.+++++
T Consensus       246 ~~~~~~~~~~--~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          246 IPRNPAPRLK--S---KKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HHHSCCCCCS--C---SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhcCccccCC--c---cccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000011111  0   1123458899999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.2e-44  Score=326.52  Aligned_cols=245  Identities=23%  Similarity=0.398  Sum_probs=201.5

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec-----
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH-----  196 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----  196 (397)
                      ..++|+..+.||+|+||.||+|... +++.||+|.+....        +.+.+|++++++++||||+++++++..     
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            3457888999999999999999775 79999999986421        346789999999999999999998854     


Q ss_pred             -----------CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC
Q 016009          197 -----------ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD  265 (397)
Q Consensus       197 -----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  265 (397)
                                 ....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.   +++|+||||+||+++
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~  156 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV  156 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence                       4557999999999999999975432 4689999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccc
Q 016009          266 LEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD  345 (397)
Q Consensus       266 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~  345 (397)
                      +++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++|..|+......        
T Consensus       157 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--------  227 (284)
T 2a19_B          157 DTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF--------  227 (284)
T ss_dssp             ETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH--------
T ss_pred             CCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH--------
Confidence            99999999999998765432 223457899999999999999999999999999999999999886422111        


Q ss_pred             cccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          346 IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        ...+.+..++.      .....+.+++.+||+.||++|||+.|++++|+
T Consensus       228 --~~~~~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~  270 (284)
T 2a19_B          228 --FTDLRDGIISD------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT  270 (284)
T ss_dssp             --HHHHHTTCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --HHHhhcccccc------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence              11111111111      11234788999999999999999999999885

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9e-45  Score=360.70  Aligned_cols=245  Identities=26%  Similarity=0.419  Sum_probs=194.8

Q ss_pred             ccccccCcEEEEEEEeC---CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEec
Q 016009          131 YCIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  207 (397)
                      +.||+|+||.||+|.+.   +++.||||+++...  ......+++.+|++++++++||||+++++++.. +..++||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence            46999999999999542   46789999987532  222346789999999999999999999999965 4578999999


Q ss_pred             cCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCC
Q 016009          208 KRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN  287 (397)
Q Consensus       208 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  287 (397)
                      ++|+|.+++...   ..+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+......
T Consensus       452 ~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          452 ELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             TTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             CCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            999999999654   3589999999999999999999999   9999999999999999999999999999876543321


Q ss_pred             ---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCcc
Q 016009          288 ---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLPAPSRS  362 (397)
Q Consensus       288 ---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  362 (397)
                         .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||........        ...+... ....+.  
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--------~~~i~~~~~~~~p~--  595 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--------TAMLEKGERMGCPA--  595 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------HHHHHTTCCCCCCT--
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHHcCCCCCCCC--
Confidence               223456788999999999999999999999999999998 9999875432110        0111111 111111  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        ..+..+.+++..||+.||++|||+.+|+++|+
T Consensus       596 --~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  627 (635)
T 4fl3_A          596 --GCPREMYDLMNLCWTYDVENRPGFAAVELRLR  627 (635)
T ss_dssp             --TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             --CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence              23356889999999999999999999999885

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.5e-44  Score=332.76  Aligned_cols=255  Identities=25%  Similarity=0.412  Sum_probs=200.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  197 (397)
                      .++|...+.||+|+||.||+|..      .+++.||||.+....   ......++.+|+.++++++||||+++++++...
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            45788899999999999999973      357789999986422   223456789999999999999999999999999


Q ss_pred             CeeeEEEEeccCCCHHHhhccccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC---CCcE
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAA----AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL---EFEA  270 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~  270 (397)
                      ...++||||+++++|.+++.....    ...+++.+++.++.|++.||.|||+.   +++||||||+||+++.   +..+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence            999999999999999999976532    13589999999999999999999999   9999999999999984   4469


Q ss_pred             EEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 016009          271 HVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIE  347 (397)
Q Consensus       271 kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  347 (397)
                      ||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.......        .
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~  254 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--------V  254 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------H
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--------H
Confidence            9999999875433221  2233567889999999998899999999999999999998 999986432211        0


Q ss_pred             cccccCCC-CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          348 LDEMLDPR-LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       348 ~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ...+.... ...+.    .....+.+++.+||+.||++|||+.+++++|+
T Consensus       255 ~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  300 (327)
T 2yfx_A          255 LEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  300 (327)
T ss_dssp             HHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhcCCCCCCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            11111111 11111    22345889999999999999999999999885

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.1e-44  Score=342.57  Aligned_cols=200  Identities=25%  Similarity=0.391  Sum_probs=168.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-----  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  197 (397)
                      .++|...+.||+|+||.||+|.. .+++.||||++.....  .....+.+.+|++++++++||||+++++++...     
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE--DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc--ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            35788899999999999999965 4688999999975322  233467899999999999999999999999765     


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...++||||+. |+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          103 DELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             CCEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CeEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            57899999986 5999999654   3599999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC----------------------CcccccccccccCcccc-cCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 016009          278 AKFLKPDSS----------------------NWTEFAGTYGYVAPELA-YTMKITEKCDVYSFGVLALEVIKGKHPRD  332 (397)
Q Consensus       278 ~~~~~~~~~----------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~el~tg~~p~~  332 (397)
                      ++.......                      ......||+.|+|||++ ....++.++||||+||++|||++|..|+.
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            987653321                      12456789999999985 56679999999999999999999776654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.3e-44  Score=325.27  Aligned_cols=256  Identities=23%  Similarity=0.346  Sum_probs=204.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCc-----chhcHHHHHHHHHHHHhcc-CCceeeeEEEEec
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSD-----QIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSH  196 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  196 (397)
                      .++|...+.||+|+||.||+|... +|+.||+|.+.......     .....+.+.+|++++++++ ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            457888999999999999999764 68999999986532111     1123467889999999995 9999999999999


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                      .+..++||||+++++|.+++...   ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence            99999999999999999999754   3589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccCccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAY------TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE  350 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  350 (397)
                      ++....... ......+++.|+|||.+.      ...++.++||||||+++|||++|+.||.......        ....
T Consensus       170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~  240 (298)
T 1phk_A          170 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------MLRM  240 (298)
T ss_dssp             TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHH
T ss_pred             chhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--------HHHH
Confidence            998765432 234457899999999875      4568899999999999999999999986432211        0111


Q ss_pred             ccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +.......+..........+.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            11111111111122344568899999999999999999999863

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.6e-45  Score=335.18  Aligned_cols=250  Identities=23%  Similarity=0.344  Sum_probs=183.6

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEe-------
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCS-------  195 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~-------  195 (397)
                      .+|+..+.||+|+||.||+|.. .+++.||+|++...    .....+.+.+|+.+++++. ||||+++++++.       
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            4788889999999999999975 47899999998542    2234577899999999996 999999999983       


Q ss_pred             -cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeccCCCCcEEeCCCCcEEE
Q 016009          196 -HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP--IVHRDISSKNLLLDLEFEAHV  272 (397)
Q Consensus       196 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl  272 (397)
                       .....++||||+. |+|.+++........+++.+++.++.|++.||+|||+.   +  ++||||||+||+++.++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence             3455799999996 79999887644445699999999999999999999998   7  999999999999999999999


Q ss_pred             eeeccccccCCCCCC------------cccccccccccCcccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCccccc
Q 016009          273 ADFGIAKFLKPDSSN------------WTEFAGTYGYVAPELA---YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSI  337 (397)
Q Consensus       273 ~Dfg~~~~~~~~~~~------------~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~  337 (397)
                      +|||++.........            .....+|+.|+|||.+   .+..++.++||||||+++|||+||+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            999999876543221            1134589999999998   5667899999999999999999999998643221


Q ss_pred             cccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          338 SSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .            +.......+..  ......+.+++.+||+.||++|||+.|++++|+
T Consensus       260 ~------------~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          260 R------------IVNGKYSIPPH--DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ------------------CCCCTT--CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             H------------hhcCcccCCcc--cccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1            11111110000  011123778999999999999999999999885

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.3e-44  Score=334.71  Aligned_cols=261  Identities=23%  Similarity=0.332  Sum_probs=198.2

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec-------
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH-------  196 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------  196 (397)
                      ++|+..+.||+|+||.||+|.. .+|+.||+|++.......  .....+.+|++++++++||||+++++++..       
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc--cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            5788899999999999999976 578999999986533222  234578899999999999999999999976       


Q ss_pred             -CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          197 -ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       197 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                       .+..++||||+++ +|.+.+....  ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence             4468999999985 7777775543  3599999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCC----CCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccc------------
Q 016009          276 GIAKFLKPDS----SNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS------------  338 (397)
Q Consensus       276 g~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~------------  338 (397)
                      |++.......    .......||+.|+|||++.+ ..++.++||||||+++|||+||+.||.......            
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9998764321    22344578999999998876 458999999999999999999999987433210            


Q ss_pred             -cccccccc--ccccccCCCCCCCCcchHHH------HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          339 -SSFLNTDI--ELDEMLDPRLPAPSRSVQEK------LRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       339 -~~~~~~~~--~~~~~~~~~~~~~~~~~~~~------~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       ........  ........ .........+.      ...+.+|+.+||+.||++|||++|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCC-CSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             Chhhccccccchhhccccc-ccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence             00000000  00000000 00001111111      2358899999999999999999999874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.6e-44  Score=324.75  Aligned_cols=247  Identities=27%  Similarity=0.440  Sum_probs=194.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-CeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-RHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~l  202 (397)
                      .++|+..+.||+|+||.||++.. +|+.||+|.++...      ..+.+.+|++++++++||||+++++++... +..++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            45788899999999999999987 48899999986421      357789999999999999999999997544 57899


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++++|.+++..... ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus        93 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            9999999999999975432 2488999999999999999999999   99999999999999999999999999987544


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RLPAPS  360 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  360 (397)
                      ..   .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.......        ....+... ....+.
T Consensus       169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~  237 (278)
T 1byg_A          169 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAPD  237 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTCCCCCCT
T ss_pred             cc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCCCCcc
Confidence            32   223357889999999998899999999999999999998 999986432211        00111111 111111


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                          ..+..+.+++.+||+.||++|||+.++++.|+
T Consensus       238 ----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  269 (278)
T 1byg_A          238 ----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE  269 (278)
T ss_dssp             ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence                22345889999999999999999999999885

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.9e-44  Score=331.95  Aligned_cols=253  Identities=27%  Similarity=0.441  Sum_probs=199.3

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCE--EEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQV--VAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  200 (397)
                      ++|...+.||+|+||.||+|... ++..  +++|.+.....   ....+.+.+|+++++++ +||||+++++++...+..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc---hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            57888899999999999999654 5654  49998864222   12346789999999999 899999999999999999


Q ss_pred             eEEEEeccCCCHHHhhcccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC
Q 016009          201 FLVYEFLKRGSLAAILSSDA-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE  267 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  267 (397)
                      ++||||+++|+|.+++....             ....+++.+++.++.|++.||+|||+.   +++||||||+||+++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence            99999999999999997643             124689999999999999999999999   99999999999999999


Q ss_pred             CcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 016009          268 FEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDI  346 (397)
Q Consensus       268 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~  346 (397)
                      +.+||+|||++...... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||........       
T Consensus       179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------  250 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------  250 (327)
T ss_dssp             GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------
T ss_pred             CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-------
Confidence            99999999998743321 11233456889999999998889999999999999999998 9999864332110       


Q ss_pred             ccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          347 ELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       347 ~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ...+... ....+.    .....+.+++.+||+.||++|||++++++.|+
T Consensus       251 -~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  296 (327)
T 1fvr_A          251 -YEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLN  296 (327)
T ss_dssp             -HHHGGGTCCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -HHHhhcCCCCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence             0111111 111111    22345889999999999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.1e-45  Score=331.03  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=197.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|... +++.||+|.+....    ....+.+.+|++++++++||||+++++++...+..++
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            457888999999999999999765 68999999986532    2346789999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++++|.+++....  ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus        94 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999999986533  3589999999999999999999999   99999999999999999999999999875432


Q ss_pred             CCCCCcccccccccccCcccc-----cCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          283 PDSSNWTEFAGTYGYVAPELA-----YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      ..........|++.|+|||.+     .+..++.++||||||+++|||++|+.||..........     .......+...
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~  243 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-----KIAKSDPPTLL  243 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHSCCCCCS
T ss_pred             ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH-----HHhccCCcccC
Confidence            111122334689999999988     36678999999999999999999999987543211000     00000001111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                          ........+.+++.+||+.||++|||+.+++++
T Consensus       244 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          244 ----TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ----SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ----CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                112233458899999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=329.79  Aligned_cols=257  Identities=23%  Similarity=0.367  Sum_probs=199.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe----cCC
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS----HAR  198 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~  198 (397)
                      .++|+..+.||+|+||.||++.. .+++.||+|++...    .....+.+.+|+++++.++||||+++++++.    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            35788899999999999999976 57999999988541    2234678899999999999999999999986    345


Q ss_pred             eeeEEEEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            7899999999999999987532 124689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC---------cccccccccccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccc
Q 016009          278 AKFLKPDSSN---------WTEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTD  345 (397)
Q Consensus       278 ~~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~  345 (397)
                      +.........         .....||+.|+|||.+.+..   ++.++||||||+++|||++|+.||............  
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--  258 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL--  258 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH--
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH--
Confidence            8754321111         12345689999999987554   689999999999999999999998642211000000  


Q ss_pred             cccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          346 IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                       ....  ....+...    .....+.+++.+||+.||++|||+++++++|+
T Consensus       259 -~~~~--~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  302 (317)
T 2buj_A          259 -AVQN--QLSIPQSP----RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE  302 (317)
T ss_dssp             -HHHC--C--CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -Hhhc--cCCCCccc----cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence             0000  01111111    22345889999999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=340.51  Aligned_cols=253  Identities=18%  Similarity=0.254  Sum_probs=198.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeCC---------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceee------
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPS---------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK------  189 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~------  189 (397)
                      ++|...+.||+|+||.||+|....         ++.||+|.+...         +.+.+|++++++++||||++      
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            578889999999999999997653         789999998642         35789999999999999987      


Q ss_pred             ---------eEEEEec-CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCC
Q 016009          190 ---------LYGFCSH-ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISS  259 (397)
Q Consensus       190 ---------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~  259 (397)
                               +++++.. ....++||||+ +++|.+++.... ...+++.+++.++.|++.||+|||+.   +++||||||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp  187 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA  187 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence                     6777765 67889999999 999999997652 24699999999999999999999999   999999999


Q ss_pred             CcEEeCCCC--cEEEeeeccccccCCCCC-------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 016009          260 KNLLLDLEF--EAHVADFGIAKFLKPDSS-------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP  330 (397)
Q Consensus       260 ~Nill~~~~--~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p  330 (397)
                      +||+++.++  .+||+|||++........       ......||+.|+|||.+.+..++.++||||||+++|||++|+.|
T Consensus       188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999998  899999999986643221       12334789999999999998999999999999999999999999


Q ss_pred             CCccccccccccccc----cccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          331 RDFLSSISSSFLNTD----IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       331 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      |..............    .......+...     ........+.+++.+||+.||++|||+++|++.|+
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  332 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCG-----HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE  332 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTS-----CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhcc-----ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence            875431110000000    00011111000     00112345889999999999999999999999885

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=330.78  Aligned_cols=259  Identities=26%  Similarity=0.417  Sum_probs=202.9

Q ss_pred             cCCCCCccccccCcEEEEEEEe-----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC-
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR-  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-  198 (397)
                      ++|+..+.||+|+||.||++..     .+++.||+|++...    .....+.+.+|++++++++||||+++++++...+ 
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            4678889999999999999973     46889999998752    2234578999999999999999999999986543 


Q ss_pred             -eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          199 -HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       199 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                       ..++||||+++++|.+++....  ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence             7899999999999999997653  3589999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCC---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccc-------ccc
Q 016009          278 AKFLKPDSSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNT-------DIE  347 (397)
Q Consensus       278 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~-------~~~  347 (397)
                      +.........   .....++..|+|||.+.+..++.++||||||+++|||+||..|+.............       ...
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            9876543321   123456778999999998889999999999999999999999875321100000000       000


Q ss_pred             cccccCC--CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          348 LDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       348 ~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+.+..  ..+.+.    ..+..+.+++.+||+.||++|||+.|+++.|+
T Consensus       272 ~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~  318 (326)
T 2w1i_A          272 LIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVD  318 (326)
T ss_dssp             HHHHHHTTCCCCCCT----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCC----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111111  111111    23345889999999999999999999999885

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.1e-44  Score=323.51  Aligned_cols=249  Identities=21%  Similarity=0.341  Sum_probs=196.4

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec----CCee
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH----ARHS  200 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  200 (397)
                      .|...+.||+|+||.||+|.. .++..||+|.+.....  .....+.+.+|++++++++||||+++++++..    ....
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            366677899999999999965 4688999999864222  22346779999999999999999999999865    4568


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeccCCCCcEEeC-CCCcEEEeeecc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP--IVHRDISSKNLLLD-LEFEAHVADFGI  277 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~  277 (397)
                      ++||||+++++|.+++...   ..+++..++.++.|++.||.|||+.   +  ++|+||||+||+++ +++.+||+|||+
T Consensus       105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            9999999999999999654   3589999999999999999999998   7  99999999999998 789999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      +......  ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.........       ...+.....+
T Consensus       179 ~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~~  248 (290)
T 1t4h_A          179 ATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------YRRVTSGVKP  248 (290)
T ss_dssp             GGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-------HHHHTTTCCC
T ss_pred             ccccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-------HHHHhccCCc
Confidence            9754332  2344578999999998764 5899999999999999999999998643321110       0111111000


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        ..........+.+++.+||+.||++|||++|++++
T Consensus       249 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          249 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence              00111112458899999999999999999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.9e-44  Score=331.25  Aligned_cols=256  Identities=24%  Similarity=0.309  Sum_probs=196.1

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCC----cchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPS----DQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      .++|...+.||+|+||.||+|... +++.||||.+......    ........+.+|++++++++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            457889999999999999999654 6889999998653211    11122345889999999999999999999997655


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc---EEEeee
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADF  275 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df  275 (397)
                       .++||||+++++|.+++...   ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.   +||+||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             -eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence             89999999999999998654   3589999999999999999999999   9999999999999987664   999999


Q ss_pred             ccccccCCCCCCcccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML  352 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  352 (397)
                      |++...... .......||+.|+|||.+.   ...++.++||||||+++|||++|+.||........       ....+.
T Consensus       162 g~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~  233 (322)
T 2ycf_A          162 GHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-------LKDQIT  233 (322)
T ss_dssp             TTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-------HHHHHH
T ss_pred             ccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-------HHHHHH
Confidence            999865432 1223457899999999864   56789999999999999999999999864322100       000111


Q ss_pred             CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          353 DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       353 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .................+.+++.+||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          234 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            111111111111234568899999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=325.47  Aligned_cols=254  Identities=20%  Similarity=0.292  Sum_probs=197.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEE--ecCCee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFC--SHARHS  200 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~  200 (397)
                      .++|...+.||+|+||.||++... +++.||+|++............+.+.+|++++++++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999764 78899999986421111122357799999999999999999999998  445688


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||++++ |.+++.... ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999877 777765433 24699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCC--CCcccccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 016009          281 LKPDS--SNWTEFAGTYGYVAPELAYTMK--ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       281 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      .....  .......|++.|+|||.+.+..  ++.++||||||+++|||++|+.||.......        ....+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~i~~~~~  230 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--------LFENIGKGSY  230 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--------HHHHHhcCCC
Confidence            65322  2223456899999999987644  4789999999999999999999987432211        0111111111


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+..    ....+.+++.+||+.||++|||++|++++
T Consensus       231 ~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 AIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             CCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11111    23458899999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-44  Score=327.58  Aligned_cols=253  Identities=28%  Similarity=0.440  Sum_probs=193.6

Q ss_pred             cCCCCCccccccCcEEEEEEEeC--CCC--EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP--SGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ++|+..+.||+|+||.||+|.+.  +++  .||+|+++..... .....+.+.+|++++++++||||+++++++.... .
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            47888899999999999999753  333  6899998753221 2234678999999999999999999999998765 8


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++++|.+++....  ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence            89999999999999997643  3589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCC---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC--C
Q 016009          281 LKPDSSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD--P  354 (397)
Q Consensus       281 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~--~  354 (397)
                      .......   .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......        ....+..  .
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~  242 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEGE  242 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSCC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--------HHHHHHccCC
Confidence            6544322   223457788999999998889999999999999999999 999986433211        0111111  1


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ..+.+.    ..+..+.+++.+||+.||++|||+.++++.|+
T Consensus       243 ~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  280 (291)
T 1u46_A          243 RLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  280 (291)
T ss_dssp             CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCc----CcCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            111111    23345889999999999999999999999885

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.2e-45  Score=332.00  Aligned_cols=261  Identities=27%  Similarity=0.428  Sum_probs=185.5

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ...++|...+.||+|+||.||+|.. .+++.||+|.+.....   ....+.+.+|++++++++||||+++++++...+..
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            3356899999999999999999965 4789999999864321   12356788999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccc-----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          201 FLVYEFLKRGSLAAILSSD-----AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                      ++||||+++++|.+++...     .....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEec
Confidence            9999999999999998641     1124589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCC-----CcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 016009          276 GIAKFLKPDSS-----NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD  349 (397)
Q Consensus       276 g~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  349 (397)
                      |++........     ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..................
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  245 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP  245 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence            99876543221     1234578999999998875 56899999999999999999999998754332110000000000


Q ss_pred             ----cccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          350 ----EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       350 ----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                          ...++...      ......+.+++.+||+.||++|||+.+++++
T Consensus       246 ~~~~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          246 SLETGVQDKEML------KKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             CTTC-----CCC------CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ccccccccchhh------hhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                00001110      1123458899999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-44  Score=335.50  Aligned_cols=258  Identities=24%  Similarity=0.343  Sum_probs=193.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR----  198 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  198 (397)
                      .++|...+.||+|+||.||+|.. .+|+.||||++.....  .....+.+.+|++++++++||||+++++++....    
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc--CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            35788899999999999999976 5799999999865332  2234577899999999999999999999997653    


Q ss_pred             --eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          199 --HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       199 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                        ..++||||+ +++|.+++..    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             CceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence              459999999 8899999865    3589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------ccccccc
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNTDIEL  348 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~~~~~  348 (397)
                      +++.....   .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||..........       .......
T Consensus       174 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          174 LARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             TCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99875432   334578999999999877 679999999999999999999999986433211000       0000000


Q ss_pred             c--------cccC--CCCCC-C-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 D--------EMLD--PRLPA-P-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 ~--------~~~~--~~~~~-~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .        ..+.  +.... . ..........+.+|+.+||+.||++|||++|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0        0000  00000 0 00001223458899999999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.3e-44  Score=337.12  Aligned_cols=258  Identities=10%  Similarity=0.010  Sum_probs=183.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc--cCCceeeeE-------EE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI--RHRNIVKLY-------GF  193 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~-------~~  193 (397)
                      ..+|...+.||+|+||.||+|... +|+.||+|++..... ......+.+.+|+++++.+  +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            345788899999999999999754 789999999986432 2233456778886555555  699988755       44


Q ss_pred             EecC-----------------CeeeEEEEeccCCCHHHhhccccccCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 016009          194 CSHA-----------------RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQR------MNVIKGVADALSYLHHDCFP  250 (397)
Q Consensus       194 ~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~Lh~~~~~  250 (397)
                      +...                 ...++||||++ |+|.+++.....  .+++..+      +.++.|++.||+|||++   
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---  213 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---  213 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence            4332                 34799999999 899999976432  3455566      78889999999999999   


Q ss_pred             CceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCC
Q 016009          251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLALEVIKGK  328 (397)
Q Consensus       251 ~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~  328 (397)
                      +|+||||||+|||++.++.+||+|||+++....   ......+|+.|+|||++.+  ..++.++|||||||++|||+||+
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999986542   2224466799999999987  67999999999999999999999


Q ss_pred             CCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          329 HPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       329 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .||............. .............+  ........+.+++.+||+.||++|||+.+++++
T Consensus       291 ~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          291 LPFGLVTPGIKGSWKR-PSLRVPGTDSLAFG--SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             CSTTBCCTTCTTCCCB-CCTTSCCCCSCCCT--TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCCCcCcccccchhh-hhhhhccccccchh--hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9987543221111000 00000111111111  011223458899999999999999999999763

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-43  Score=331.62  Aligned_cols=259  Identities=22%  Similarity=0.308  Sum_probs=192.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR----  198 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  198 (397)
                      .++|...+.||+|+||.||+|.. .+++.||||++.....  .....+.+.+|+.+++.++||||+++++++....    
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC--ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            35788899999999999999965 4789999999875322  2234577889999999999999999999997654    


Q ss_pred             --eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          199 --HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       199 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                        ..++||||+++ +|.+.+.     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          102 FQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             CCEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ccceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence              78999999975 7877774     2488999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc--cc-----------
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF--LN-----------  343 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~--~~-----------  343 (397)
                      ++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........  ..           
T Consensus       173 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          173 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             C-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             cccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99865432 22344578999999999999999999999999999999999999986433211000  00           


Q ss_pred             -ccc---------------ccccccC-CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          344 -TDI---------------ELDEMLD-PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       344 -~~~---------------~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       ...               ....... ...+............+.+|+.+||+.||++|||++|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence             000               0000000 00011111122335678999999999999999999999874

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.2e-44  Score=337.86  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=201.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||++... +++.||+|++....   .....+.+.+|++++++++||||+++++++..++..++|
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            57888899999999999999765 78999999987532   223457899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++....   .+++..+..++.+++.||+|||+.+  +++|+||||+||+++.++.+||+|||++.....
T Consensus       110 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999997543   5899999999999999999999831  799999999999999999999999999875432


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccc--------------------
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN--------------------  343 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~--------------------  343 (397)
                      .  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............                    
T Consensus       185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence            2  123357899999999999999999999999999999999999998643221000000                    


Q ss_pred             --------------cccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          344 --------------TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       344 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                                    .......+.....+...  .......+.+|+.+||+.||++|||++|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCC--cccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                          00000000001000000  01123458899999999999999999999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.3e-43  Score=331.04  Aligned_cols=272  Identities=22%  Similarity=0.284  Sum_probs=200.2

Q ss_pred             cHHHHHHHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcc-------hhcHHHHHHHHHHHHhccCCcee
Q 016009          116 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQ-------IVDKKEFLTEVEALTEIRHRNIV  188 (397)
Q Consensus       116 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv  188 (397)
                      ...++....++|...+.||+|+||.||+|...+|+.||||++........       ....+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            45677888999999999999999999999888899999999865332211       11247899999999999999999


Q ss_pred             eeEEEEec-----CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEE
Q 016009          189 KLYGFCSH-----ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLL  263 (397)
Q Consensus       189 ~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil  263 (397)
                      ++++++..     ....++||||++ |+|.+.+....  ..+++..++.++.|++.||+|||+.   +++||||||+||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence            99999843     346799999998 58888876543  3689999999999999999999999   9999999999999


Q ss_pred             eCCCCcEEEeeeccccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc
Q 016009          264 LDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL  342 (397)
Q Consensus       264 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~  342 (397)
                      ++.++.+||+|||++....... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  245 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK  245 (362)
T ss_dssp             ECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             EcCCCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999997544322 2344578999999998876 6789999999999999999999999875332110000


Q ss_pred             --------c-------cccccccccCCCCC-CCCcch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          343 --------N-------TDIELDEMLDPRLP-APSRSV----QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       343 --------~-------~~~~~~~~~~~~~~-~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                              .       .............. .+....    ......+.+++.+||+.||++|||+.|++++
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence                    0       00000000000000 011111    1123458899999999999999999999874

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.6e-44  Score=321.54  Aligned_cols=253  Identities=23%  Similarity=0.370  Sum_probs=202.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|... +++.||+|++......  ....+.+.+|++++++++||||+++++++...+..++
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            467999999999999999999765 7899999998642221  2346789999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC---CcEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE---FEAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~  279 (397)
                      ||||+++++|.+++....   .+++.+++.++.|++.||.|||+.   +++|+||||+||+++.+   +.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            999999999999886543   589999999999999999999999   99999999999999764   469999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ...... ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......        ....+.......+
T Consensus       173 ~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  242 (287)
T 2wei_A          173 CFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--------ILKRVETGKYAFD  242 (287)
T ss_dssp             TBCCCS-SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCC
T ss_pred             eecCCC-ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCCC
Confidence            665332 2233468999999998875 48999999999999999999999986433211        0111111111111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..........+.+++.+||+.||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            11112233468899999999999999999999874

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4e-43  Score=334.35  Aligned_cols=198  Identities=20%  Similarity=0.294  Sum_probs=171.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc------cCCceeeeEEEEec
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI------RHRNIVKLYGFCSH  196 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~  196 (397)
                      ..+|+..+.||+|+||.||+|... +++.||||++...     ....+++.+|+++++.+      .|+||+++++++..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            357888999999999999999654 6899999998641     22346778899888887      46799999999999


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc--EEEee
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE--AHVAD  274 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~D  274 (397)
                      .+..++||||+. ++|.+++..... ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.  +||+|
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence            999999999996 699998876543 4589999999999999999999999   9999999999999999987  99999


Q ss_pred             eccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 016009          275 FGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL  334 (397)
Q Consensus       275 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~  334 (397)
                      ||++......   .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       246 FG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          246 FGSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CTTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            9999764432   23457899999999999999999999999999999999999998643

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=328.14  Aligned_cols=255  Identities=22%  Similarity=0.346  Sum_probs=197.5

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ...++|+..+.||+|+||.||+|...+  .+|+|++......  ....+.+.+|+.++++++||||+++++++...+..+
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDN--EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA  105 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCC--CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCC--HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence            345688899999999999999998754  4999998753222  122355778999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++++|.+++....  ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++ ++.+||+|||++...
T Consensus       106 iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             EEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            9999999999999997643  3589999999999999999999999   999999999999998 679999999998754


Q ss_pred             CCC-----CCCcccccccccccCcccccC---------CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 016009          282 KPD-----SSNWTEFAGTYGYVAPELAYT---------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE  347 (397)
Q Consensus       282 ~~~-----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~  347 (397)
                      ...     ........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||..........     .
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~  254 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-----Q  254 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH-----H
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----H
Confidence            321     122234568999999998874         357889999999999999999999987433211000     0


Q ss_pred             cccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          348 LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ......+.....     .....+.+++.+||+.||++|||+.+++++|+
T Consensus       255 ~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~  298 (319)
T 2y4i_B          255 MGTGMKPNLSQI-----GMGKEISDILLFCWAFEQEERPTFTKLMDMLE  298 (319)
T ss_dssp             HHTTCCCCCCCS-----SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred             hccCCCCCCCcC-----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            001111111110     11234889999999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.9e-44  Score=332.75  Aligned_cols=264  Identities=19%  Similarity=0.339  Sum_probs=202.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcch-------------hcHHHHHHHHHHHHhccCCceeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQI-------------VDKKEFLTEVEALTEIRHRNIVKL  190 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~  190 (397)
                      .++|...+.||+|+||.||+|.. +|+.||+|.+.........             ...+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            35788999999999999999988 8999999998642111100             012789999999999999999999


Q ss_pred             EEEEecCCeeeEEEEeccCCCHHHh------hccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCcEE
Q 016009          191 YGFCSHARHSFLVYEFLKRGSLAAI------LSSDAAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHRDISSKNLL  263 (397)
Q Consensus       191 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nil  263 (397)
                      ++++.+.+..++||||+++|+|.++      +.... ...+++..++.++.|++.||.|||+ .   +++|+||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence            9999999999999999999999998      54321 3569999999999999999999999 7   9999999999999


Q ss_pred             eCCCCcEEEeeeccccccCCCCCCcccccccccccCcccccCC-CCCc-chhhHHHHHHHHHHHhCCCCCCccccccc--
Q 016009          264 LDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM-KITE-KCDVYSFGVLALEVIKGKHPRDFLSSISS--  339 (397)
Q Consensus       264 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--  339 (397)
                      ++.++.+||+|||++......  ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||........  
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            999999999999999875433  33445789999999999877 6666 99999999999999999999874432100  


Q ss_pred             -ccccc----ccccccccCCCCCCC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          340 -SFLNT----DIELDEMLDPRLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       340 -~~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .....    .........+..... ..........+.+++.+||+.||++|||+.|++++
T Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             00000    000000000000000 00001233568899999999999999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.3e-43  Score=325.19  Aligned_cols=253  Identities=21%  Similarity=0.307  Sum_probs=197.3

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEec--CCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSH--ARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~  200 (397)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++..       ...+.+.+|++++++++ ||||+++++++..  ....
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-------CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-------cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            5788899999999999999965 5789999999863       12577899999999997 9999999999987  6678


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC-cEEEeeecccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAK  279 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~  279 (397)
                      ++||||+++++|.+++.      .+++.++..++.|++.||+|||+.   +++||||||+||+++.++ .+||+|||++.
T Consensus       109 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             EEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            99999999999999884      388999999999999999999999   999999999999999776 89999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc------------------
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS------------------  340 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~------------------  340 (397)
                      ....... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........                  
T Consensus       180 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          180 FYHPGQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             ECCTTCC-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             EcCCCCc-cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            7654332 344578999999999876 66899999999999999999999998432110000                  


Q ss_pred             --ccccccccccccCCCCC------CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          341 --FLNTDIELDEMLDPRLP------APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       341 --~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        .................      ............+.+|+.+||+.||++|||++|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              00000000000000000      0000111134568899999999999999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.1e-44  Score=336.54  Aligned_cols=258  Identities=24%  Similarity=0.292  Sum_probs=192.5

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC------
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR------  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  198 (397)
                      .+|...+.||+|+||+||+|....+..||+|++......        ..+|+++++.++||||+++++++....      
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            468889999999999999999877777999988642221        236999999999999999999995443      


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC-CCCcEEEeeecc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD-LEFEAHVADFGI  277 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~  277 (397)
                      ..++||||++++.+............+++..++.++.|+++||+|||+.   +|+||||||+|||++ .++.+||+|||+
T Consensus       112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            3789999998765554443222335699999999999999999999999   999999999999998 799999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc-------cccccc-
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL-------NTDIEL-  348 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~-------~~~~~~-  348 (397)
                      ++....... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...........       .....+ 
T Consensus       189 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          189 AKILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CEECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            987654332 2345789999999988764 589999999999999999999999975432110000       000000 


Q ss_pred             ---ccccCCCCCCC-CcchH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 ---DEMLDPRLPAP-SRSVQ-----EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 ---~~~~~~~~~~~-~~~~~-----~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ........+.. .....     .....+.+|+.+||+.||++|||+.|++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence               00000111100 00000     123468899999999999999999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.5e-43  Score=322.21  Aligned_cols=251  Identities=25%  Similarity=0.400  Sum_probs=191.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec------
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH------  196 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------  196 (397)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|.+..     .....+.+.+|++++++++||||+++++++..      
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            45788899999999999999976 4789999999853     22345778999999999999999999998854      


Q ss_pred             -------CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc
Q 016009          197 -------ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE  269 (397)
Q Consensus       197 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  269 (397)
                             ....++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence                   457799999999999999997543  3578899999999999999999999   9999999999999999999


Q ss_pred             EEEeeeccccccCCCC--------------CCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 016009          270 AHVADFGIAKFLKPDS--------------SNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFL  334 (397)
Q Consensus       270 ~kl~Dfg~~~~~~~~~--------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~  334 (397)
                      +||+|||++.......              .......|++.|+|||.+.+. .++.++||||||+++|||++   |+...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            9999999998654221              122345689999999998764 68999999999999999998   43311


Q ss_pred             ccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          335 SSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....       .....+.......+..........+.+++.+||+.||++|||+++++++
T Consensus       232 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          232 MERV-------NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHH-------HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hhHH-------HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            1000       0011111111111111112334458899999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3e-43  Score=338.27  Aligned_cols=256  Identities=18%  Similarity=0.290  Sum_probs=200.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC-CceeeeEEEEecCCeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH-RNIVKLYGFCSHARHSF  201 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~  201 (397)
                      .++|...+.||+|+||.||+|.. .+++.||||++.....      ..++..|+++++.++| +++..+..++...+..+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS------SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            46789999999999999999975 5799999998764322      2347899999999976 55666666677888899


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe---CCCCcEEEeeeccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL---DLEFEAHVADFGIA  278 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~  278 (397)
                      +||||+ +++|.+++....  ..+++.+++.++.||+.||+|||+.   +|+||||||+|||+   +.++.+||+|||++
T Consensus        80 lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            999999 999999997433  4699999999999999999999999   99999999999999   58899999999999


Q ss_pred             cccCCCCCC-------cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 016009          279 KFLKPDSSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       279 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      +........       .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...........     ...+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~-----~~~i  228 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-----YEKI  228 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH-----HHHH
T ss_pred             eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH-----HHHH
Confidence            876543321       1256799999999999999999999999999999999999999875432110000     0000


Q ss_pred             cCCCCCCC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          352 LDPRLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       352 ~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ........ ..........+.+++..||+.||++||++++|++.|+
T Consensus       229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~  274 (483)
T 3sv0_A          229 SEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR  274 (483)
T ss_dssp             HHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             hhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            00000000 0000112346899999999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.2e-43  Score=329.24  Aligned_cols=267  Identities=21%  Similarity=0.230  Sum_probs=187.4

Q ss_pred             HHHHHHhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec
Q 016009          118 DEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH  196 (397)
Q Consensus       118 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  196 (397)
                      .+.....++|...+.||+|+||.||+|... +|+.||||++.....     ....+.+|++.++.++||||+++++++..
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~h~niv~~~~~~~~   90 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIMQDLAVLHHPNIVQLQSYFYT   90 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-----CCCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-----ccHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence            445677789999999999999999999764 789999999864222     12456788888999999999999999965


Q ss_pred             CCe-------eeEEEEeccCCCHHHhhcc-ccccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCceeccCCCCcEEeCC
Q 016009          197 ARH-------SFLVYEFLKRGSLAAILSS-DAAAQELGWSQRMNVIKGVADALSYLH--HDCFPPIVHRDISSKNLLLDL  266 (397)
Q Consensus       197 ~~~-------~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~Lh--~~~~~~ivH~dlk~~Nill~~  266 (397)
                      ...       .++||||+++ +|.+.+.. ......+++..+..++.|++.||.|||  +.   +|+||||||+||+++.
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEET
T ss_pred             cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeC
Confidence            433       7899999987 44443322 122346899999999999999999999  77   9999999999999996


Q ss_pred             -CCcEEEeeeccccccCCCCCCcccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCccccccccccc-
Q 016009          267 -EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN-  343 (397)
Q Consensus       267 -~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~-  343 (397)
                       ++.+||+|||++........ .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||............ 
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  245 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV  245 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCcEEEeeCCCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence             89999999999987654332 23457899999999886554 899999999999999999999998753321100000 


Q ss_pred             -----cccccccccCCCCC------CCC--------cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          344 -----TDIELDEMLDPRLP------APS--------RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       344 -----~~~~~~~~~~~~~~------~~~--------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                           .........++...      ...        .........+.+|+.+||+.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                 00000000000000      000        0001134568999999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-43  Score=329.35  Aligned_cols=258  Identities=23%  Similarity=0.345  Sum_probs=182.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-----  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  197 (397)
                      .++|...+.||+|+||.||+|.. .+|+.||||++.....  .....+.+.+|+++++.++||||+++++++...     
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            35788899999999999999964 5789999999875332  233467788999999999999999999998654     


Q ss_pred             -CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          198 -RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       198 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                       ...++|+||+ +++|.+++..    +.+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence             5679999998 7899988864    3599999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------ccccc--
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNTDI--  346 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~~~--  346 (397)
                      +++.....   .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||..........       .....  
T Consensus       178 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          178 LARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99865422   334578999999999876 678999999999999999999999986543211000       00000  


Q ss_pred             ------ccccccCCCCCCCCcchH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ------ELDEMLDPRLPAPSRSVQ----EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ------~~~~~~~~~~~~~~~~~~----~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                            .....+......+.....    .....+.+|+.+||+.||++|||+.|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                  000000000000011111    113458899999999999999999999874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.6e-43  Score=322.40  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=196.2

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc--CCceeeeEEEEecCCee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR--HRNIVKLYGFCSHARHS  200 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~  200 (397)
                      ..++|+..+.||+|+||.||++...+++.||+|++.....  .....+.+.+|++++++++  ||||+++++++...+..
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            3567888999999999999999888899999999865322  2234678899999999997  59999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||| +.+++|.+++....   .+++.+++.++.|++.||.|||+.   +++||||||+||++++ +.+||+|||++..
T Consensus       104 ~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~  175 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred             EEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccc
Confidence            99999 66889999997643   589999999999999999999999   9999999999999964 8999999999987


Q ss_pred             cCCCCC--CcccccccccccCcccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 016009          281 LKPDSS--NWTEFAGTYGYVAPELAYT-----------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE  347 (397)
Q Consensus       281 ~~~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~  347 (397)
                      ......  ......|++.|+|||.+.+           ..++.++||||||+++|||++|+.||.......       ..
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-------~~  248 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------SK  248 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------HH
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-------HH
Confidence            654322  1234578999999999875           468889999999999999999999986432110       11


Q ss_pred             cccccCCCCC--CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          348 LDEMLDPRLP--APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       348 ~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....++...  .+..    ....+.+++.+||+.||++|||+.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          249 LHAIIDPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHHHCTTSCCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhcccccCCccc----chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            1122222111  1111    12358899999999999999999999874

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.6e-43  Score=330.54  Aligned_cols=260  Identities=22%  Similarity=0.298  Sum_probs=198.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-----  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  197 (397)
                      .++|+..+.||+|+||.||+|... +++.||+|++....   .....+.+.+|++++++++||||+++++++...     
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  102 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM  102 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc---CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence            457889999999999999999654 78899999987422   223357789999999999999999999999654     


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...++||||+. |+|.+++..    ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          103 KDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             CCEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence            36899999997 599998864    3489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC---CcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc-------cccc
Q 016009          278 AKFLKPDSS---NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL-------NTDI  346 (397)
Q Consensus       278 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~-------~~~~  346 (397)
                      +........   ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........       ....
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  254 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            987653322   1234578999999998654 4589999999999999999999999864432110000       0000


Q ss_pred             cccc--------ccCCCCCCCCcch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ELDE--------MLDPRLPAPSRSV----QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ~~~~--------~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....        .............    ......+.+|+.+||+.||++|||+.|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000        0000000000000    1123458899999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4e-43  Score=323.00  Aligned_cols=265  Identities=21%  Similarity=0.325  Sum_probs=199.1

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEe--CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc---cCCceeeeEEEEe-
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAEL--PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI---RHRNIVKLYGFCS-  195 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-  195 (397)
                      ++.++|+..+.||+|+||.||+|..  .+|+.||+|++.......  .....+.+|+.+++.+   +||||+++++++. 
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            3457899999999999999999976  468899999986422211  1123456777777766   8999999999987 


Q ss_pred             ----cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEE
Q 016009          196 ----HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH  271 (397)
Q Consensus       196 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  271 (397)
                          .....++||||+. |+|.+++..... ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence                5677899999998 699999876442 3589999999999999999999999   999999999999999999999


Q ss_pred             EeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc------------
Q 016009          272 VADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------------  339 (397)
Q Consensus       272 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~------------  339 (397)
                      |+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........            
T Consensus       161 l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          161 LADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             ECSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EecCcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999997654221 22345789999999999998999999999999999999999999874332110            


Q ss_pred             --cccccccccccccCC-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          340 --SFLNTDIELDEMLDP-RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       340 --~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        .+............. ...............+.+++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              000000000000000 0000000011223458899999999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-43  Score=320.94  Aligned_cols=255  Identities=22%  Similarity=0.365  Sum_probs=186.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||++.. .+|+.||+|++.....  .....+.+.++...++.++||||+++++++..++..++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C--HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC--cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            46788899999999999999975 5789999999875322  12223444555556788899999999999999999999


Q ss_pred             EEEeccCCCHHHhhccc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          203 VYEFLKRGSLAAILSSD-AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      ||||+++ +|.+++... .....+++..++.++.|++.||+|||+++  +++||||||+||+++.++.+||+|||++...
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9999974 887777542 12246999999999999999999999852  8999999999999999999999999999866


Q ss_pred             CCCCCCcccccccccccCcccc----cCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          282 KPDSSNWTEFAGTYGYVAPELA----YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      .... ......||+.|+|||.+    .+..++.++||||||+++|||+||+.||.......       ...........+
T Consensus       161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~  232 (290)
T 3fme_A          161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-------QQLKQVVEEPSP  232 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-------HHHHHHHHSCCC
T ss_pred             cccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-------HHHHHHhccCCC
Confidence            5332 22334789999999995    56678999999999999999999999986422110       011111111111


Q ss_pred             -CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 -APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 -~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .+.   ......+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          233 QLPA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             CCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             Cccc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence             111   1223458899999999999999999999863

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.6e-43  Score=332.08  Aligned_cols=258  Identities=22%  Similarity=0.294  Sum_probs=198.7

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc--------CCceeeeEEEEe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR--------HRNIVKLYGFCS  195 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~  195 (397)
                      ++|...+.||+|+||+||+|.. .+++.||||++...     ....+.+.+|++++++++        |+||+++++++.
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            5788999999999999999965 57889999998641     233577899999999996        788999999987


Q ss_pred             ----cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC---
Q 016009          196 ----HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF---  268 (397)
Q Consensus       196 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---  268 (397)
                          .....++||||+ +++|.+.+..... ..+++..++.++.|++.||+|||+++  +|+||||||+|||++.++   
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence                566889999999 5566666644322 45999999999999999999999963  899999999999999775   


Q ss_pred             ----------------------------------------------cEEEeeeccccccCCCCCCcccccccccccCccc
Q 016009          269 ----------------------------------------------EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL  302 (397)
Q Consensus       269 ----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~  302 (397)
                                                                    .+||+|||++......   .....||+.|+|||+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence                                                          7999999999875432   234578999999999


Q ss_pred             ccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-----------------------------ccccccccccccC
Q 016009          303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-----------------------------FLNTDIELDEMLD  353 (397)
Q Consensus       303 ~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-----------------------------~~~~~~~~~~~~~  353 (397)
                      +.+..++.++|||||||++|||+||+.||.........                             +.........+.+
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            99999999999999999999999999998643321100                             0000000000000


Q ss_pred             CCCC-------CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          354 PRLP-------APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       354 ~~~~-------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....       .......+....+.+|+.+||+.||++|||++|++++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            0000       0011234556789999999999999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.1e-43  Score=322.50  Aligned_cols=253  Identities=21%  Similarity=0.269  Sum_probs=172.5

Q ss_pred             hcCCCCCc-cccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec----C
Q 016009          124 TNDFDAQY-CIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH----A  197 (397)
Q Consensus       124 ~~~~~~~~-~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~  197 (397)
                      .++|...+ .||+|+||.||+|... +|+.||+|++...        ..........++.++||||+++++++..    .
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            45787744 6999999999999765 7999999998541        1222223334566799999999999876    4


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC---CCcEEEee
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL---EFEAHVAD  274 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~D  274 (397)
                      ...++||||+++|+|.+++..... ..+++.+++.++.|++.||.|||+.   +++||||||+||+++.   ++.+||+|
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence            568999999999999999976543 4699999999999999999999999   9999999999999976   45599999


Q ss_pred             eccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 016009          275 FGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP  354 (397)
Q Consensus       275 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
                      ||++......  ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...........    ....+...
T Consensus       175 fg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~  248 (336)
T 3fhr_A          175 FGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG----MKRRIRLG  248 (336)
T ss_dssp             CTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh----HHHhhhcc
Confidence            9999865432  22345789999999999888899999999999999999999999864332111000    00011111


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....+..........+.+++.+||+.||++|||++|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1111111112234568899999999999999999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=334.09  Aligned_cols=198  Identities=22%  Similarity=0.371  Sum_probs=153.2

Q ss_pred             CCCC-CccccccCcEEEEEEEeC---CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe--cCCe
Q 016009          126 DFDA-QYCIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS--HARH  199 (397)
Q Consensus       126 ~~~~-~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~  199 (397)
                      .|+. .++||+|+||+||+|...   +++.||+|++.....      ...+.+|++++++++||||+++++++.  ....
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            4554 457999999999999865   578999999864221      246889999999999999999999994  4678


Q ss_pred             eeEEEEeccCCCHHHhhcccc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe----CCCCc
Q 016009          200 SFLVYEFLKRGSLAAILSSDA------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL----DLEFE  269 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~  269 (397)
                      .++||||+.+ +|.+++....      ....+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.
T Consensus        95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence            9999999975 7877775322      112489999999999999999999999   99999999999999    77889


Q ss_pred             EEEeeeccccccCCCC---CCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 016009          270 AHVADFGIAKFLKPDS---SNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDF  333 (397)
Q Consensus       270 ~kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~  333 (397)
                      +||+|||++.......   .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            9999999998765322   223446789999999998874 589999999999999999999999853

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.1e-43  Score=322.44  Aligned_cols=258  Identities=18%  Similarity=0.285  Sum_probs=200.4

Q ss_pred             hcCCCCCccccccCcEEEEEEEe--CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc------eeeeEEEEe
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL--PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN------IVKLYGFCS  195 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~  195 (397)
                      .++|+..+.||+|+||.||+|..  .+++.||+|++...     ....+.+.+|+++++.++|++      ++++++++.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            35788899999999999999975  36889999998641     223567889999999997664      999999999


Q ss_pred             cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC---------
Q 016009          196 HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL---------  266 (397)
Q Consensus       196 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---------  266 (397)
                      ..+..++||||+ +++|.+++..... ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.         
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence            999999999999 8899999876542 4589999999999999999999999   9999999999999987         


Q ss_pred             ----------CCcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccc
Q 016009          267 ----------EFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSS  336 (397)
Q Consensus       267 ----------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~  336 (397)
                                ++.+||+|||++......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                      668999999999864432   2345789999999999999999999999999999999999999864332


Q ss_pred             cccccc------cccc------cccccc-C-------------------CCCCCCCcchHHHHHHHHHHHHHccCCCCCC
Q 016009          337 ISSSFL------NTDI------ELDEML-D-------------------PRLPAPSRSVQEKLRSIVEVVFSCLNESPES  384 (397)
Q Consensus       337 ~~~~~~------~~~~------~~~~~~-~-------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~  384 (397)
                      ......      ....      ...... .                   ................+.+++.+||+.||++
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            110000      0000      000000 0                   0000000011234567899999999999999


Q ss_pred             CCCHHHHHHH
Q 016009          385 RPTMKIVSQQ  394 (397)
Q Consensus       385 RPt~~~vl~~  394 (397)
                      |||+.|++++
T Consensus       320 Rpt~~ell~h  329 (339)
T 1z57_A          320 RITLREALKH  329 (339)
T ss_dssp             SCCHHHHTTS
T ss_pred             ccCHHHHhcC
Confidence            9999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-43  Score=331.52  Aligned_cols=259  Identities=23%  Similarity=0.271  Sum_probs=192.7

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec---
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH---  196 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---  196 (397)
                      ....++|+..+.||+|+||.||+|.. .+|+.||+|++.....        ...+|+++++.++||||+++++++..   
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~E~~il~~l~hpnIv~l~~~~~~~~~   74 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLDHVNIIKLVDYFYTTGD   74 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHHcCCCCccchhheeeecCc
Confidence            34567899999999999999999965 5799999999864322        12369999999999999999999843   


Q ss_pred             -----------------------------------CCeeeEEEEeccCCCHHHhhccc-cccCCCCHHHHHHHHHHHHHH
Q 016009          197 -----------------------------------ARHSFLVYEFLKRGSLAAILSSD-AAAQELGWSQRMNVIKGVADA  240 (397)
Q Consensus       197 -----------------------------------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~  240 (397)
                                                         ....++||||++ |+|.+.+... .....+++..+..++.|+++|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a  153 (383)
T 3eb0_A           75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA  153 (383)
T ss_dssp             -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence                                               234789999998 4877776532 122469999999999999999


Q ss_pred             HHHHHhCCCCCceeccCCCCcEEeC-CCCcEEEeeeccccccCCCCCCcccccccccccCcccccCC-CCCcchhhHHHH
Q 016009          241 LSYLHHDCFPPIVHRDISSKNLLLD-LEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFG  318 (397)
Q Consensus       241 l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G  318 (397)
                      |+|||+.   +|+||||||+||+++ .++.+||+|||++........ .....+|..|+|||.+.+. .++.++||||+|
T Consensus       154 L~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (383)
T 3eb0_A          154 VGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPELMLGATEYTPSIDLWSIG  229 (383)
T ss_dssp             HHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence            9999998   999999999999997 688999999999987654332 2345789999999988765 489999999999


Q ss_pred             HHHHHHHhCCCCCCcccccccccc-------ccc-------cccccccCCCCCCCCcch-----HHHHHHHHHHHHHccC
Q 016009          319 VLALEVIKGKHPRDFLSSISSSFL-------NTD-------IELDEMLDPRLPAPSRSV-----QEKLRSIVEVVFSCLN  379 (397)
Q Consensus       319 ~~l~el~tg~~p~~~~~~~~~~~~-------~~~-------~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~  379 (397)
                      |++|||++|+.||...........       ...       .......-+...  ...+     ......+.+|+.+||+
T Consensus       230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~  307 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK--AKDWRKILPEGTPSLAIDLLEQILR  307 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCC--CCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccC--cccHHhhCCCCCCHHHHHHHHHHcc
Confidence            999999999999875432110000       000       000000001100  0000     0123458899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 016009          380 ESPESRPTMKIVSQQ  394 (397)
Q Consensus       380 ~~P~~RPt~~~vl~~  394 (397)
                      .||++|||+.|++++
T Consensus       308 ~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          308 YEPDLRINPYEAMAH  322 (383)
T ss_dssp             SSGGGSCCHHHHHTS
T ss_pred             CChhhCCCHHHHhcC
Confidence            999999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.6e-43  Score=328.16  Aligned_cols=257  Identities=23%  Similarity=0.349  Sum_probs=195.1

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee--
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS--  200 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--  200 (397)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++......  ....+.+.+|+.+++.++||||+++++++...+..  
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc--hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            35788899999999999999965 47899999998753322  23357889999999999999999999999877655  


Q ss_pred             ----eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          201 ----FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       201 ----~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                          ++||||+. ++|.+.+.     ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             ceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence                99999997 58888873     2489999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------ccccc--
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNTDI--  346 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~~~--  346 (397)
                      ++......   .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..........       .....  
T Consensus       190 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          190 LARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             CC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            99865432   234578999999999887 678999999999999999999999997533211000       00000  


Q ss_pred             ------ccccccCCCCCCCCcch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          347 ------ELDEMLDPRLPAPSRSV----QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       347 ------~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                            ............+....    ......+.+|+.+||+.||++|||+.|++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                  00000000000001111    1123568899999999999999999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.8e-43  Score=334.60  Aligned_cols=254  Identities=26%  Similarity=0.315  Sum_probs=189.6

Q ss_pred             CCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC------C
Q 016009          126 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA------R  198 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  198 (397)
                      +|+..+.||+|+||.||+|... +|+.||||++.....        ...+|++++++++||||+++++++...      .
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            5778899999999999999765 699999999864221        223699999999999999999998432      2


Q ss_pred             eeeEEEEeccCCCHHHhhccc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC-CcEEEeeec
Q 016009          199 HSFLVYEFLKRGSLAAILSSD-AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFG  276 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg  276 (397)
                      ..++||||+++ +|.+.+... .....+++..++.++.||++||+|||+.   +|+||||||+|||++.+ +.+||+|||
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence            36799999986 565555321 2234699999999999999999999998   99999999999999965 678999999


Q ss_pred             cccccCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccccc--c-----cccccc
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF--L-----NTDIEL  348 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~--~-----~~~~~~  348 (397)
                      +++....... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||........-.  .     .....+
T Consensus       203 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          203 SAKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             TCEECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9987654332 2345789999999998764 78999999999999999999999987543211000  0     000000


Q ss_pred             -------ccccCCCCCCCCcchH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 -------DEMLDPRLPAPSRSVQ-----EKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 -------~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                             .+...+.+.  ...+.     .....+.+|+.+||+.||++|||+.|++++
T Consensus       282 ~~~~~~~~~~~~p~~~--~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIK--AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHCSCCCCCCCCCCC--CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhChhhhhhccCccC--CCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence                   000011110  00011     123468899999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=321.49  Aligned_cols=258  Identities=23%  Similarity=0.351  Sum_probs=190.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe--------
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS--------  195 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--------  195 (397)
                      ++|...+.||+|+||.||+|... +++.||+|++...    .....+.+.+|++++++++||||+++++++.        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            57888999999999999999765 5899999998642    2234678899999999999999999999873        


Q ss_pred             ------cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC-CCC
Q 016009          196 ------HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD-LEF  268 (397)
Q Consensus       196 ------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~  268 (397)
                            .....++||||++ |+|.+++..    ..+++..++.++.|++.||+|||+.   +++||||||+||+++ +++
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence                  3467899999998 599999864    3589999999999999999999999   999999999999997 567


Q ss_pred             cEEEeeeccccccCCCC---CCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc--
Q 016009          269 EAHVADFGIAKFLKPDS---SNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL--  342 (397)
Q Consensus       269 ~~kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~--  342 (397)
                      .+||+|||++.......   .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........  
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999998764321   12234467889999998765 6789999999999999999999999875432110000  


Q ss_pred             -----cccccccccc-------CCCCCCCCcch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          343 -----NTDIELDEML-------DPRLPAPSRSV----QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       343 -----~~~~~~~~~~-------~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                           .......++.       ......+....    ......+.+++.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence                 0000000000       00000000000    1123568899999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.4e-43  Score=349.83  Aligned_cols=253  Identities=24%  Similarity=0.399  Sum_probs=199.7

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC----CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      ..++|+..+.||+|+||.||+|...    .+..||+|.+....   .....+.+.+|+.++++++||||+++++++. .+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            3456778889999999999999764    24579999986522   2233578999999999999999999999985 46


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA  278 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  278 (397)
                      ..++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence            6899999999999999997543  3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CC
Q 016009          279 KFLKPDSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-PR  355 (397)
Q Consensus       279 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~  355 (397)
                      ........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||........        ...+.+ ..
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--------~~~i~~~~~  610 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--------IGRIENGER  610 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------HHHHHHTCC
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH--------HHHHHcCCC
Confidence            87654322 1223456789999999998899999999999999999997 9999864332110        111111 11


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+.+.    ..+..+.+++.+||+.||++|||+.++++.|+
T Consensus       611 ~~~~~----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~  647 (656)
T 2j0j_A          611 LPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  647 (656)
T ss_dssp             CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            11111    22345889999999999999999999999885

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=9.8e-43  Score=323.97  Aligned_cols=260  Identities=24%  Similarity=0.354  Sum_probs=196.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-----  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  197 (397)
                      .++|...+.||+|+||.||+|... +|+.||||++...   ........+.+|++++++++||||+++++++...     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            457888999999999999999765 7899999998642   1223356788999999999999999999988654     


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...++||||+. ++|.+++..    ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            67899999997 589998865    3589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC----------cccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-----
Q 016009          278 AKFLKPDSSN----------WTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-----  341 (397)
Q Consensus       278 ~~~~~~~~~~----------~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-----  341 (397)
                      +.........          .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..........     
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  238 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI  238 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence            9876532211          123468999999998764 678999999999999999999999986433210000     


Q ss_pred             ---cccc--------cccccccCCCCCCCCcc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          342 ---LNTD--------IELDEMLDPRLPAPSRS----VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       342 ---~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ....        ....+........+...    .......+.+++.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence               0000        00000000000000000    01223568899999999999999999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.8e-43  Score=344.20  Aligned_cols=261  Identities=26%  Similarity=0.326  Sum_probs=200.9

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec------C
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH------A  197 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~  197 (397)
                      ++|+..+.||+|+||.||+|.. .+|+.||||++....   .....+.+.+|++++++++||||+++++++..      .
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC---CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            5799999999999999999965 478999999987532   22346779999999999999999999999765      6


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc---EEEee
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE---AHVAD  274 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~D  274 (397)
                      +..++||||+++|+|.+++........+++..++.++.+++.||+|||+.   +++||||||+||+++.++.   +||+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence            77899999999999999998765545689999999999999999999998   9999999999999987765   99999


Q ss_pred             eccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccc-----------ccccc
Q 016009          275 FGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS-----------SSFLN  343 (397)
Q Consensus       275 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~-----------~~~~~  343 (397)
                      ||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......           .....
T Consensus       168 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          168 LGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            99998765432 2344678999999999999999999999999999999999999985321100           00000


Q ss_pred             ccc-ccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 016009          344 TDI-ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS  392 (397)
Q Consensus       344 ~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl  392 (397)
                      ... .-........+.+..........+.+++..||+.||++|||+.+++
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            000 0000111122222333344567799999999999999999998754

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.2e-43  Score=333.65  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=186.4

Q ss_pred             CCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEEE
Q 016009          127 FDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYE  205 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  205 (397)
                      |...+.||+|+||+||.+...+|+.||||++..       ...+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~-------~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG-------GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH-------HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            444578999999999877677899999999753       1245678999999987 89999999999999999999999


Q ss_pred             eccCCCHHHhhccccccCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC-------------C
Q 016009          206 FLKRGSLAAILSSDAAAQE----LGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE-------------F  268 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~----l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-------------~  268 (397)
                      |+. |+|.+++........    .++..++.++.|++.||+|||+.   +|+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCce
Confidence            996 699999976542111    13345678999999999999999   99999999999999654             4


Q ss_pred             cEEEeeeccccccCCCCCC----cccccccccccCcccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCcccc
Q 016009          269 EAHVADFGIAKFLKPDSSN----WTEFAGTYGYVAPELAYT-------MKITEKCDVYSFGVLALEVIK-GKHPRDFLSS  336 (397)
Q Consensus       269 ~~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~  336 (397)
                      .+||+|||++.........    .....||+.|+|||++.+       ..++.++|||||||++|||+| |+.||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            8999999999876543321    234579999999999875       568999999999999999999 9999864322


Q ss_pred             ccccccccccccccccC-CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          337 ISSSFLNTDIELDEMLD-PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       337 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....      ...... +...  ..........+.+++.+||+.||++|||+.+|+++
T Consensus       246 ~~~~i------~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          246 RESNI------IRGIFSLDEMK--CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             HHHHH------HHTCCCCCCCT--TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hHHHH------hcCCCCccccc--ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            11000      011111 1111  11123556779999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=323.16  Aligned_cols=256  Identities=22%  Similarity=0.323  Sum_probs=193.9

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe----
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH----  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  199 (397)
                      ++|...+.||+|+||.||+|.. .+|+.||||++.....  .....+.+.+|+.++++++||||+++++++.....    
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ--SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            5788889999999999999975 4789999999875332  22335778999999999999999999999977654    


Q ss_pred             --eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          200 --SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       200 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                        .++||||+. ++|.+++.     ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence              499999997 58888773     2489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------cccccc--
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNTDIE--  347 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~~~~--  347 (397)
                      +......   .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..........       ......  
T Consensus       173 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          173 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             TTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             ccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9864422   234578999999998876 678999999999999999999999987543211000       000000  


Q ss_pred             ----------cccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          348 ----------LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       348 ----------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                                ...+..................+.+++.+||+.||++|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                      00000000000000111234568899999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.2e-42  Score=322.99  Aligned_cols=201  Identities=23%  Similarity=0.274  Sum_probs=170.4

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CC-----ceeeeEEEEe
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HR-----NIVKLYGFCS  195 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~  195 (397)
                      ..++|+..+.||+|+||+||+|... +++.||||++...     ....+++..|+.+++.++ |+     +++++++++.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            3568999999999999999999654 6889999998641     223567788999998885 54     4999999999


Q ss_pred             cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC--CCCcEEEe
Q 016009          196 HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD--LEFEAHVA  273 (397)
Q Consensus       196 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~  273 (397)
                      ..+..++||||++ |+|.+++..... ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+
T Consensus       127 ~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          127 FRNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             ETTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             cCCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            9999999999996 599999876542 4589999999999999999999952 12899999999999994  57889999


Q ss_pred             eeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 016009          274 DFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL  334 (397)
Q Consensus       274 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~  334 (397)
                      |||++......   .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       204 DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          204 DFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999876432   23457899999999999999999999999999999999999999743

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.7e-42  Score=319.00  Aligned_cols=256  Identities=25%  Similarity=0.356  Sum_probs=177.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHH-HHHhccCCceeeeEEEEecCCeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVE-ALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      ++|...+.||+|+||.||+|... +|+.||||++.....   .....++..|+. +++.++||||+++++++...+..++
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC---HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC---chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            57888999999999999999764 789999999875322   123445666666 6777899999999999999999999


Q ss_pred             EEEeccCCCHHHhhccc--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          203 VYEFLKRGSLAAILSSD--AAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ||||+++ +|.+++...  .....+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++..
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            9999985 887777531  1124689999999999999999999995  2899999999999999999999999999986


Q ss_pred             cCCCCCCcccccccccccCcccc----cCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELA----YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      ..... ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||........       ....+.....
T Consensus       176 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~  247 (327)
T 3aln_A          176 LVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QLTQVVKGDP  247 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCC
T ss_pred             ccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------HHHHHhcCCC
Confidence            64332 22334789999999998    456789999999999999999999999874322110       0111111111


Q ss_pred             C-CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          357 P-APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       357 ~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      + .+..........+.+++.+||+.||++|||+.++++.
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            1 0010011223458899999999999999999999764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.4e-43  Score=321.81  Aligned_cols=246  Identities=24%  Similarity=0.353  Sum_probs=198.5

Q ss_pred             HhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCc--chhcHHHHHHHHHHHHhcc--CCceeeeEEEEecC
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSD--QIVDKKEFLTEVEALTEIR--HRNIVKLYGFCSHA  197 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~  197 (397)
                      ..++|...+.||+|+||.||+|.. .+++.||||.+.......  .....+.+.+|+.++++++  |+||+++++++..+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            356788999999999999999965 578999999986532211  0112245678999999996  59999999999999


Q ss_pred             CeeeEEEEeccC-CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC-CCCcEEEeee
Q 016009          198 RHSFLVYEFLKR-GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD-LEFEAHVADF  275 (397)
Q Consensus       198 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Df  275 (397)
                      +..++|||++.+ ++|.+++...   ..+++..++.++.|++.||+|||+.   +++||||||+||+++ +++.+||+||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999986 8999998754   3589999999999999999999998   999999999999998 7899999999


Q ss_pred             ccccccCCCCCCcccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 016009          276 GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP  354 (397)
Q Consensus       276 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
                      |++......  ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......              ..
T Consensus       195 g~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------------~~  258 (320)
T 3a99_A          195 GSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------RG  258 (320)
T ss_dssp             TTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HC
T ss_pred             ccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh--------------cc
Confidence            999876532  2334578999999999887665 678999999999999999999986432211              00


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....+..    ....+.+++.+||+.||++|||++|+++.
T Consensus       259 ~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          259 QVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111111    12358899999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=318.24  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=191.7

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcc--hhcHHHHHHHHHHHHhc----cCCceeeeEEE
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQ--IVDKKEFLTEVEALTEI----RHRNIVKLYGF  193 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l----~h~niv~~~~~  193 (397)
                      ....++|...+.||+|+||.||+|.. .+++.||+|++........  ......+.+|+.+++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34456899999999999999999965 4789999999865322110  11233466799999998    89999999999


Q ss_pred             EecCCeeeEEEEe-ccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC-CCCcEE
Q 016009          194 CSHARHSFLVYEF-LKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD-LEFEAH  271 (397)
Q Consensus       194 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~k  271 (397)
                      +...+..++|||| +.+++|.+++....   .+++.+++.++.|++.||+|||+.   +++||||||+||+++ .++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 78999999997643   589999999999999999999999   999999999999998 889999


Q ss_pred             EeeeccccccCCCCCCcccccccccccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 016009          272 VADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKIT-EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE  350 (397)
Q Consensus       272 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  350 (397)
                      |+|||++......  ......|+..|+|||.+.+..+. .++||||||+++|||++|+.||......             
T Consensus       181 l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------------  245 (312)
T 2iwi_A          181 LIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------------  245 (312)
T ss_dssp             ECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------------
T ss_pred             EEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-------------
Confidence            9999999876533  23445789999999998876664 5899999999999999999998643211             


Q ss_pred             ccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .+.....+.    .....+.+++.+||+.||++|||++|++++
T Consensus       246 -~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          246 -LEAELHFPA----HVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -HHTCCCCCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -hhhccCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             111111111    123458899999999999999999999974

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=330.81  Aligned_cols=248  Identities=22%  Similarity=0.313  Sum_probs=186.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .+|...+.||+|+||+||.....+|+.||||++.....       ..+.+|+++++++ +||||+++++++.+....++|
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            46778889999999997666666899999999864221       2346899999999 799999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC-----CCcEEEeeeccc
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL-----EFEAHVADFGIA  278 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~~  278 (397)
                      |||+. |+|.+++.....  .+.+..++.++.|++.||+|||+.   +|+||||||+||+++.     ...+||+|||++
T Consensus        97 ~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            99996 599999976542  344556778999999999999999   9999999999999953     336889999999


Q ss_pred             cccCCCC---CCcccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 016009          279 KFLKPDS---SNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       279 ~~~~~~~---~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      .......   .......||+.|+|||++.   ...++.++|||||||++|||+| |..||.........         ..
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~---------~~  241 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN---------IL  241 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH---------HH
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH---------HH
Confidence            8765432   2234467999999999987   4567889999999999999999 99998533211100         00


Q ss_pred             cCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..................+.+|+.+||+.||++|||++||+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            0000000001112334557899999999999999999999864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=317.39  Aligned_cols=251  Identities=23%  Similarity=0.334  Sum_probs=178.9

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|... +|+.||||++.....  .....+.+..+..+++.++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence            457888899999999999999765 789999999875322  12223444555567888899999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      ||||+ ++.+..+.....  ..+++..++.++.|++.||.|||+ .   +++|+||||+||+++.++.+||+|||++...
T Consensus       102 v~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            99999 556655554322  468999999999999999999998 5   8999999999999999999999999999765


Q ss_pred             CCCCCCcccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccccc---C
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML---D  353 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~  353 (397)
                      .... ......+++.|+|||.+.     ...++.++||||||+++|||++|+.||.......       .....+.   .
T Consensus       176 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~  247 (318)
T 2dyl_A          176 VDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-------EVLTKVLQEEP  247 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------HHHHHHHHSCC
T ss_pred             cCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-------HHHHHHhccCC
Confidence            4332 223457899999999984     4568899999999999999999999986422110       0011111   1


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       354 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      +..+...    .....+.+++.+||+.||++|||+++++++
T Consensus       248 ~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          248 PLLPGHM----GFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             CCCCSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCCCccC----CCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1111111    123458899999999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.1e-42  Score=323.03  Aligned_cols=258  Identities=21%  Similarity=0.286  Sum_probs=197.0

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-----------CCceeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-----------HRNIVKLYG  192 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~  192 (397)
                      ++|...+.||+|+||.||+|.. .+++.||||++..     .....+.+.+|++++++++           ||||+++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            4788899999999999999975 5789999999863     1223567889999999886           899999999


Q ss_pred             EEecCC----eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC---
Q 016009          193 FCSHAR----HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD---  265 (397)
Q Consensus       193 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---  265 (397)
                      ++...+    ..++||||+ +++|.+++..... ..+++..++.++.|++.||+|||+++  +|+||||||+|||++   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence            997654    789999999 8999999976442 45899999999999999999999952  899999999999994   


Q ss_pred             ---CCCcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc-
Q 016009          266 ---LEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-  341 (397)
Q Consensus       266 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-  341 (397)
                         ..+.+||+|||++......   .....||+.|+|||++.+..++.++||||||+++|||+||+.||.......... 
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence               4458999999999865432   233578999999999999999999999999999999999999987433110000 


Q ss_pred             ----------------------------cccccccccccCCCC-------CCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 016009          342 ----------------------------LNTDIELDEMLDPRL-------PAPSRSVQEKLRSIVEVVFSCLNESPESRP  386 (397)
Q Consensus       342 ----------------------------~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP  386 (397)
                                                  .........+.....       .............+.+|+.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence                                        000000000000000       000112245667899999999999999999


Q ss_pred             CHHHHHHH
Q 016009          387 TMKIVSQQ  394 (397)
Q Consensus       387 t~~~vl~~  394 (397)
                      |++|++++
T Consensus       327 t~~ell~h  334 (373)
T 1q8y_A          327 DAGGLVNH  334 (373)
T ss_dssp             CHHHHHTC
T ss_pred             CHHHHhhC
Confidence            99999874

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.8e-41  Score=315.49  Aligned_cols=258  Identities=19%  Similarity=0.264  Sum_probs=197.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CC-CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc------eeeeEEEEe
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SG-QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN------IVKLYGFCS  195 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~  195 (397)
                      .++|+..+.||+|+||.||+|... ++ +.||+|+++..     ....+.+.+|++++++++|++      ++.+.+++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            357888999999999999999764 44 68999998641     223567889999999998766      899999999


Q ss_pred             cCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEe-----------
Q 016009          196 HARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLL-----------  264 (397)
Q Consensus       196 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill-----------  264 (397)
                      ..+..++||||+ +++|.+++..... ..+++.+++.++.|++.||+|||+.   +|+||||||+|||+           
T Consensus        93 ~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           93 FHGHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eCCeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence            999999999999 6677777655432 4689999999999999999999998   99999999999999           


Q ss_pred             --------CCCCcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccc
Q 016009          265 --------DLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSS  336 (397)
Q Consensus       265 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~  336 (397)
                              +.++.+||+|||++......   .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                    56789999999999864432   2345789999999999999999999999999999999999999864332


Q ss_pred             cccc-------------ccccccccccccCCC--CC-----------------CCCcchHHHHHHHHHHHHHccCCCCCC
Q 016009          337 ISSS-------------FLNTDIELDEMLDPR--LP-----------------APSRSVQEKLRSIVEVVFSCLNESPES  384 (397)
Q Consensus       337 ~~~~-------------~~~~~~~~~~~~~~~--~~-----------------~~~~~~~~~~~~l~~l~~~cl~~~P~~  384 (397)
                      ....             ...............  ..                 ............+.+|+.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            1000             000000000000000  00                 000011233457889999999999999


Q ss_pred             CCCHHHHHHH
Q 016009          385 RPTMKIVSQQ  394 (397)
Q Consensus       385 RPt~~~vl~~  394 (397)
                      |||+.|++++
T Consensus       325 Rpt~~e~l~h  334 (355)
T 2eu9_A          325 RITLAEALLH  334 (355)
T ss_dssp             SCCHHHHTTS
T ss_pred             CcCHHHHhcC
Confidence            9999999864

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.2e-41  Score=302.71  Aligned_cols=230  Identities=11%  Similarity=0.067  Sum_probs=180.9

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||+|... +|+.||+|++....... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP-DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC-HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            46888899999999999999765 58999999997643322 23457899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++++|.+++...     ....++..++.|++.||+|||+.   +|+||||||+||+++.++.+||++++       
T Consensus       110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999999998532     35567889999999999999999   99999999999999999999998543       


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                                   |++       .++.++||||||+++|||+||+.||...........     ...........+....
T Consensus       175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  229 (286)
T 3uqc_A          175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----AERDTAGQPIEPADID  229 (286)
T ss_dssp             -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----CCBCTTSCBCCHHHHC
T ss_pred             -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----HHHHhccCCCChhhcc
Confidence                         233       268899999999999999999999875433210000     0000111111000011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+....+.+++.+||+.||++| |+.|+++.|+
T Consensus       230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~  261 (286)
T 3uqc_A          230 RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQ  261 (286)
T ss_dssp             TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHH
Confidence            1223458899999999999999 9999999885

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.1e-41  Score=304.20  Aligned_cols=231  Identities=22%  Similarity=0.296  Sum_probs=179.1

Q ss_pred             cCCCCC-ccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHH-HhccCCceeeeEEEEec----C
Q 016009          125 NDFDAQ-YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEAL-TEIRHRNIVKLYGFCSH----A  197 (397)
Q Consensus       125 ~~~~~~-~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~  197 (397)
                      ++|... +.||+|+||.||++.. .+++.||+|++..         ...+.+|++++ +..+||||+++++++..    .
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            456666 6799999999999965 5789999999853         24677899888 55599999999999876    6


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC---CCcEEEee
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL---EFEAHVAD  274 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~D  274 (397)
                      ...++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.   ++.+||+|
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             ceEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence            788999999999999999976542 4699999999999999999999999   9999999999999998   78999999


Q ss_pred             eccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 016009          275 FGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP  354 (397)
Q Consensus       275 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
                      ||++....                      +..++.++||||||+++|||+||+.||...........    ....+...
T Consensus       164 fg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~----~~~~~~~~  217 (299)
T 3m2w_A          164 FGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----MKTRIRMG  217 (299)
T ss_dssp             CTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC----SCCSSCTT
T ss_pred             cccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH----HHHHHhhc
Confidence            99986432                      13467899999999999999999999864332111000    00111111


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....+..........+.+++.+||+.||++|||+.|++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            1111111111234568999999999999999999999874

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-40  Score=335.67  Aligned_cols=236  Identities=25%  Similarity=0.372  Sum_probs=189.4

Q ss_pred             cCCCCCccccccCcEEEEEEEeC--CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe---
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP--SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH---  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  199 (397)
                      ++|++.+.||+|+||.||+|...  +|+.||||++....   .......+.+|++++++++||||+++++++...+.   
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG---DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC---CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            57889999999999999999764  68999999986422   22335678999999999999999999999987655   


Q ss_pred             --eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          200 --SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       200 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                        .|+||||+++++|.+++..     .+++.+++.++.||+.||.|||+.   +|+||||||+||+++.+ .+||+|||+
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence              6999999999999987643     589999999999999999999999   99999999999999986 899999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      +......    ....||+.|+|||++.+.. +.++||||||+++|||++|..|+.....            .     .++
T Consensus       228 a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~------------~-----~~~  285 (681)
T 2pzi_A          228 VSRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV------------D-----GLP  285 (681)
T ss_dssp             CEETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC------------S-----SCC
T ss_pred             chhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc------------c-----ccc
Confidence            9876533    3457999999999987654 8999999999999999999888652110            0     001


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHh
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPT-MKIVSQQL  395 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~~vl~~L  395 (397)
                       ...........+.+++.+||+.||++||+ ++++...|
T Consensus       286 -~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  323 (681)
T 2pzi_A          286 -EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL  323 (681)
T ss_dssp             -TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             -ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence             01112233456889999999999999996 44454443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-40  Score=315.56  Aligned_cols=245  Identities=14%  Similarity=0.117  Sum_probs=179.3

Q ss_pred             hcCCCCCccccccCcEEEEEEE-eCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC-Ccee---------e---
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH-RNIV---------K---  189 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv---------~---  189 (397)
                      +.+|...+.||+|+||+||+|. ..+|+.||||++...... .....+.+.+|+.+++.++| +|..         .   
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3456677889999999999997 457999999998743222 22335779999999999977 2211         1   


Q ss_pred             ---------eEEEEec-----CCeeeEEEEeccCCCHHHhhccc----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 016009          190 ---------LYGFCSH-----ARHSFLVYEFLKRGSLAAILSSD----AAAQELGWSQRMNVIKGVADALSYLHHDCFPP  251 (397)
Q Consensus       190 ---------~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~  251 (397)
                               +..++..     ....+++|+++ +++|.+++...    .....+++..++.++.|+++||+|||+.   +
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence                     1111111     12346666654 68999988421    1123578899999999999999999999   9


Q ss_pred             ceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCcccccccccccCcccc----------cCCCCCcchhhHHHHHHH
Q 016009          252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA----------YTMKITEKCDVYSFGVLA  321 (397)
Q Consensus       252 ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dv~s~G~~l  321 (397)
                      |+||||||+|||++.++.+||+|||+++.....   .....| +.|+|||++          .+..++.++|||||||++
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            999999999999999999999999998764432   344567 999999998          555688999999999999


Q ss_pred             HHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          322 LEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       322 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                      |||+||+.||.......        ....++....    .    .+..+.+|+.+||+.||++|||+.++++
T Consensus       308 ~elltg~~Pf~~~~~~~--------~~~~~~~~~~----~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALG--------GSEWIFRSCK----N----IPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHSSCCCCTTGGGS--------CSGGGGSSCC----C----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHCCCCCCCcchhh--------hHHHHHhhcc----c----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999999986433211        1111111111    1    1245889999999999999999988865

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.2e-40  Score=306.03  Aligned_cols=248  Identities=18%  Similarity=0.175  Sum_probs=187.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCC----cchhcHHHHHHHHHHHHhcc---------CCceeee
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPS----DQIVDKKEFLTEVEALTEIR---------HRNIVKL  190 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~---------h~niv~~  190 (397)
                      .++|+..+.||+|+||+||+|.. +|+.||||++......    ......+.+.+|++++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688899999999999999987 7899999999754321    12233578899999999886         7777777


Q ss_pred             EEEE-----------------ec-------------CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHH
Q 016009          191 YGFC-----------------SH-------------ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADA  240 (397)
Q Consensus       191 ~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~  240 (397)
                      .+.+                 .+             .+..++||||+++|++.+.+..    ..+++.+++.++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            6654                 22             6789999999999977666643    358999999999999999


Q ss_pred             HHHHH-hCCCCCceeccCCCCcEEeCCCC--------------------cEEEeeeccccccCCCCCCcccccccccccC
Q 016009          241 LSYLH-HDCFPPIVHRDISSKNLLLDLEF--------------------EAHVADFGIAKFLKPDSSNWTEFAGTYGYVA  299 (397)
Q Consensus       241 l~~Lh-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~a  299 (397)
                      |+||| +.   +|+||||||+|||++.++                    .+||+|||+++.....     ...||+.|+|
T Consensus       174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a  245 (336)
T 2vuw_A          174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred             HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence            99999 88   999999999999999887                    8999999999876532     3479999999


Q ss_pred             cccccCCCCCcchhhHHHHHH-HHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHcc
Q 016009          300 PELAYTMKITEKCDVYSFGVL-ALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCL  378 (397)
Q Consensus       300 PE~~~~~~~~~~~Dv~s~G~~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  378 (397)
                      ||++.+.. +.++||||+|++ .+++++|..||....+...  .. ......... ...............+.+|+.+||
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~--~~-~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY--LT-DKMLKQMTF-KTKCNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH--HH-HHHHHTCCC-SSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH--HH-Hhhhhhhcc-CcccchhhhhhcCHHHHHHHHHHh
Confidence            99998766 889999998777 7778899999753211000  00 000000000 111112234566788999999999


Q ss_pred             CCCCCCCCCHHHHH-HH
Q 016009          379 NESPESRPTMKIVS-QQ  394 (397)
Q Consensus       379 ~~~P~~RPt~~~vl-~~  394 (397)
                      +.|     |++|++ ++
T Consensus       321 ~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          321 NFS-----SATDLLCQH  332 (336)
T ss_dssp             GSS-----SHHHHHHHC
T ss_pred             ccC-----CHHHHHhcC
Confidence            976     999998 53

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.2e-34  Score=282.13  Aligned_cols=188  Identities=19%  Similarity=0.163  Sum_probs=133.3

Q ss_pred             ccccCcEEEEEE-EeCCCCEEEEEecCCCCCC------cchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCeeeEEE
Q 016009          133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPS------DQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       133 lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      .+.|+.|.+..+ +.-.|+.+++|.+......      ......++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            455666665554 3346889999998653221      1123356799999999999 7999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||++|++|.+++...+   +++..   +|+.||+.||+|+|++   +||||||||+|||+++++.+||+|||+++.....
T Consensus       322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999997654   46554   5889999999999999   9999999999999999999999999999887665


Q ss_pred             CCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 016009          285 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP  330 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p  330 (397)
                      .......+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            555566789999999999875 467789999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.4e-29  Score=246.85  Aligned_cols=186  Identities=15%  Similarity=0.214  Sum_probs=147.2

Q ss_pred             CCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcc----hhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          129 AQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQ----IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       129 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ..+.||+|+||.||++.. .++.+++|+.........    ....+.+.+|++++++++||||+++..++...+..++||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            356899999999999954 578899998654222211    112456899999999999999997777776778889999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++++|.+++..           +..++.|+++||+|||++   +|+||||||+|||+++  .+||+|||+++.....
T Consensus       419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            99999999999864           458999999999999999   9999999999999998  9999999999976543


Q ss_pred             CCC-------cccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 016009          285 SSN-------WTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPR  331 (397)
Q Consensus       285 ~~~-------~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~tg~~p~  331 (397)
                      ...       .....||+.|+|||++..  ..|+..+|+|+..+-.++-+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            221       135679999999999886  56888899999999999988877765

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=7.8e-26  Score=202.55  Aligned_cols=156  Identities=16%  Similarity=0.143  Sum_probs=121.4

Q ss_pred             HHHHHHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcc----h----------hcHHHHHHHHHHHHhcc
Q 016009          118 DEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQ----I----------VDKKEFLTEVEALTEIR  183 (397)
Q Consensus       118 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~----~----------~~~~~~~~e~~~l~~l~  183 (397)
                      ..+......|...+.||+|+||.||+|...+|+.||+|.++.......    .          .....+.+|++++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344455566777799999999999999888899999999864221110    0          13567899999999999


Q ss_pred             CCceeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEE
Q 016009          184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLL  263 (397)
Q Consensus       184 h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil  263 (397)
                        | +++.+++.. +..++||||+++++|.+ +..         .....++.|++.||.|||+.   +|+||||||+|||
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL  225 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL  225 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence              4 566665543 56699999999999998 422         12447999999999999998   9999999999999


Q ss_pred             eCCCCcEEEeeeccccccCCCCCCcccccccccccCccccc
Q 016009          264 LDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY  304 (397)
Q Consensus       264 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~  304 (397)
                      ++ ++.+||+|||++..             +..+.|||++.
T Consensus       226 l~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVE-------------VGEEGWREILE  252 (282)
T ss_dssp             EE-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred             EE-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence            99 99999999999863             33467888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=5.6e-21  Score=168.95  Aligned_cols=140  Identities=19%  Similarity=0.200  Sum_probs=107.0

Q ss_pred             CCCCccccccCcEEEEEEEe-CCCCE--EEEEecCCCCCCc--------------------chhcHHHHHHHHHHHHhcc
Q 016009          127 FDAQYCIGNGGHGSVYRAEL-PSGQV--VAIKKFHSPLPSD--------------------QIVDKKEFLTEVEALTEIR  183 (397)
Q Consensus       127 ~~~~~~lg~G~~g~vy~~~~-~~~~~--vavK~~~~~~~~~--------------------~~~~~~~~~~e~~~l~~l~  183 (397)
                      |...+.||+|+||.||+|.. .+|+.  ||||+++......                    .......+.+|++++++++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56678899999999999977 68888  9999876432110                    0011246889999999998


Q ss_pred             CCce--eeeEEEEecCCeeeEEEEeccC-C----CHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceec
Q 016009          184 HRNI--VKLYGFCSHARHSFLVYEFLKR-G----SLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH-HDCFPPIVHR  255 (397)
Q Consensus       184 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~~~~ivH~  255 (397)
                      |+++  +.++++    +..+|||||+.+ |    +|.+....      .++..+..++.|++.||.||| +.   +|+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence            8864  344432    356899999942 4    67665432      224457789999999999999 87   99999


Q ss_pred             cCCCCcEEeCCCCcEEEeeecccccc
Q 016009          256 DISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       256 dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      ||||+|||+++  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=1.2e-18  Score=160.07  Aligned_cols=142  Identities=11%  Similarity=0.097  Sum_probs=101.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcc----------hhcHH--------HHHHHHHHHHhccCCc
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQ----------IVDKK--------EFLTEVEALTEIRHRN  186 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~----------~~~~~--------~~~~e~~~l~~l~h~n  186 (397)
                      .-|++.+.||+|++|.||+|...+|+.||||+++.......          .....        ....|...|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34888899999999999999988999999998764211100          00011        1234666777775544


Q ss_pred             eeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC
Q 016009          187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL  266 (397)
Q Consensus       187 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  266 (397)
                      +.-..-+...  ..+|||||++|++|..+...         +....++.|++.+|.+||+.   +||||||||.|||+++
T Consensus       175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE  240 (397)
T ss_dssp             CSCCCEEEEE--TTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred             CCCCeeeecc--CceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence            3222111111  23799999999988765421         12356889999999999998   9999999999999988


Q ss_pred             CC----------cEEEeeeccccc
Q 016009          267 EF----------EAHVADFGIAKF  280 (397)
Q Consensus       267 ~~----------~~kl~Dfg~~~~  280 (397)
                      ++          .+.|+||+-+..
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCcccccccccceEEEEeCCccc
Confidence            76          389999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.44  E-value=4.4e-13  Score=118.52  Aligned_cols=146  Identities=12%  Similarity=0.061  Sum_probs=112.4

Q ss_pred             HHHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCe
Q 016009          121 VRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARH  199 (397)
Q Consensus       121 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  199 (397)
                      ......|+....++.|+.+.||++... ++.+++|.......    .....+.+|+++++.+. +..+.++++++...+.
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~----~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC----CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            344457877777888888999999764 67899999763211    11235889999999984 6778899999988889


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC-------------------------------  248 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-------------------------------  248 (397)
                      .++||||++|.+|.+.+..        ..+...++.+++++++.||+..                               
T Consensus        85 ~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             eEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            9999999999999876421        1223478889999999999821                               


Q ss_pred             -------------------------CCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          249 -------------------------FPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       249 -------------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                                               .+.++|+|+++.||+++++..+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                     1358999999999999876666799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.32  E-value=3.2e-12  Score=112.70  Aligned_cols=128  Identities=18%  Similarity=0.144  Sum_probs=96.6

Q ss_pred             cccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc--eeeeEEEEecCCeeeEEEEeccCCC
Q 016009          134 GNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVKLYGFCSHARHSFLVYEFLKRGS  211 (397)
Q Consensus       134 g~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~  211 (397)
                      +.|..+.||++...+|+.+++|.....       ....+..|+++++.+.+.+  +.+++++...++..++||||++|.+
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~  101 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD  101 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence            456669999998877888999997542       1235778999999996544  5568888888788899999999988


Q ss_pred             HHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 016009          212 LAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC-------------------------------------------  248 (397)
Q Consensus       212 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-------------------------------------------  248 (397)
                      |.  ...      .+   ...++.++++.|+.||+..                                           
T Consensus       102 l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T 1nd4_A          102 LL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  170 (264)
T ss_dssp             TT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence            84  211      11   2256777888888888742                                           


Q ss_pred             ------------CCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          249 ------------FPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       249 ------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                                  ...++|+|++|.||+++++..+.|+|||.+.
T Consensus       171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                        0129999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=6.1e-11  Score=109.70  Aligned_cols=142  Identities=15%  Similarity=0.258  Sum_probs=106.3

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecC--CCCCCcchhcHHHHHHHHHHHHhcc--CCceeeeEEEEecC---CeeeE
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFH--SPLPSDQIVDKKEFLTEVEALTEIR--HRNIVKLYGFCSHA---RHSFL  202 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~l  202 (397)
                      .+.++.|.++.||+....+ ..+++|+..  ....   ......+.+|..+++.+.  +..++++++++.+.   +..++
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~---~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL---LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC---CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            4568899999999998754 578888765  2111   112356788999999996  45688899988766   45799


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC----------------------------------  248 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~----------------------------------  248 (397)
                      ||||++|..+.+..     ...++..++..++.++++.|+.||+..                                  
T Consensus       119 vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             EEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            99999998875421     124778888999999999999999831                                  


Q ss_pred             ---------------------CCCceeccCCCCcEEeCCCCc--EEEeeeccccc
Q 016009          249 ---------------------FPPIVHRDISSKNLLLDLEFE--AHVADFGIAKF  280 (397)
Q Consensus       249 ---------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~~  280 (397)
                                           .+.++|+|+++.||++++++.  +.|.||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 246899999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.06  E-value=1.2e-10  Score=105.20  Aligned_cols=185  Identities=23%  Similarity=0.233  Sum_probs=121.4

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCc--eeeeEEEEecCC---eeeEE
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRN--IVKLYGFCSHAR---HSFLV  203 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv  203 (397)
                      .+.++.|....||+..    ..+++|....      ......+..|.++++.+. +..  +.+++......+   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4558899999999863    5688888542      123567889999999883 332  445555543333   35899


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC-----------------------------------  248 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----------------------------------  248 (397)
                      ||+++|.+|.+...     ..++..++..++.++++.++.||+..                                   
T Consensus        95 m~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ  169 (304)
T ss_dssp             EECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred             EcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence            99999988865332     23677778888888888888888621                                   


Q ss_pred             --------------------CCCceeccCCCCcEEeCC--CCcEEEeeeccccccCCCCCCc--ccc---ccc-------
Q 016009          249 --------------------FPPIVHRDISSKNLLLDL--EFEAHVADFGIAKFLKPDSSNW--TEF---AGT-------  294 (397)
Q Consensus       249 --------------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~--~~~---~g~-------  294 (397)
                                          .+.++|+|+++.||++++  +..+.|+||+.+....+.....  ...   .+.       
T Consensus       170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence                                135799999999999988  4567899999887543210000  000   000       


Q ss_pred             ccc--cC-cccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 016009          295 YGY--VA-PELAYTMKITEKCDVYSFGVLALEVIKGKHPR  331 (397)
Q Consensus       295 ~~y--~a-PE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~  331 (397)
                      ..|  .. |+....  .....+.|+++.+++.+.+|..++
T Consensus       250 ~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          250 NHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            011  11 221111  112368999999999999999875

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.64  E-value=2.1e-07  Score=82.18  Aligned_cols=134  Identities=17%  Similarity=0.168  Sum_probs=94.0

Q ss_pred             ccccCcE-EEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeeeEEEEeccC
Q 016009          133 IGNGGHG-SVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSFLVYEFLKR  209 (397)
Q Consensus       133 lg~G~~g-~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  209 (397)
                      +..|..| .||+.... ++..+++|+-..       .....+..|...|+.+. +--+.++++++.+.+..++|||+++|
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence            4445444 68988654 566789998532       23567889999999884 44477889999998999999999999


Q ss_pred             CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 016009          210 GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC-----------------------------------------  248 (397)
Q Consensus       210 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----------------------------------------  248 (397)
                      .++.+......       .....+..+++..|+.||...                                         
T Consensus       105 ~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          105 KTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             EEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             ccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            88876543211       122344555555555555421                                         


Q ss_pred             --------------CCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          249 --------------FPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       249 --------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                                    .+.++|+|+.+.||++++++.+-|.||+.+..
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                          11378999999999999887778999988753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.63  E-value=4.3e-07  Score=81.74  Aligned_cols=137  Identities=18%  Similarity=0.148  Sum_probs=93.5

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCC---ceeeeEEEEe-cCCeeeEEEE
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHR---NIVKLYGFCS-HARHSFLVYE  205 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e  205 (397)
                      .+.++.|....||+.    |..+++|.-..      ......+..|.++|+.+.+.   .+.+.+.++. ..+..++|||
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            345788888899988    56788887431      12346789999999999642   3566777764 4556789999


Q ss_pred             eccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 016009          206 FLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD--------------------------------------  247 (397)
Q Consensus       206 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--------------------------------------  247 (397)
                      |++|.++.+...     ..++..+...++.++++.|+.||+.                                      
T Consensus        94 ~i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           94 KVQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             CCCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             ccCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            999988876321     1233444444555555555555542                                      


Q ss_pred             -------------------CCCCceeccCCCCcEEeCC---CCc-EEEeeecccccc
Q 016009          248 -------------------CFPPIVHRDISSKNLLLDL---EFE-AHVADFGIAKFL  281 (397)
Q Consensus       248 -------------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfg~~~~~  281 (397)
                                         ..+.++|+|+++.||++++   ++. ..|+||+.+..-
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                               1235699999999999987   455 489999987653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.49  E-value=3.8e-07  Score=83.97  Aligned_cols=83  Identities=5%  Similarity=0.021  Sum_probs=55.3

Q ss_pred             ccc-cccCcEEEEEEEeC-------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-C--CceeeeEEEEecC--
Q 016009          131 YCI-GNGGHGSVYRAELP-------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-H--RNIVKLYGFCSHA--  197 (397)
Q Consensus       131 ~~l-g~G~~g~vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~--  197 (397)
                      +.| +.|....+|+....       +++.+++|........ .......+..|..+++.+. +  -.+.++++++.+.  
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~-~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDV-PVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGC-CSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcc-ccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            456 78888999998664       2667888875431100 0001235678899988884 3  3577788887655  


Q ss_pred             -CeeeEEEEeccCCCHHH
Q 016009          198 -RHSFLVYEFLKRGSLAA  214 (397)
Q Consensus       198 -~~~~lv~e~~~~g~L~~  214 (397)
                       +..++||||++|.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.24  E-value=5.4e-06  Score=77.42  Aligned_cols=79  Identities=15%  Similarity=0.076  Sum_probs=49.8

Q ss_pred             CccccccCcEEEEEEEeC-CCCEEEEEecCCCCC---CcchhcHHHHHHHHHHHHhccC--Cc-eeeeEEEEecCCeeeE
Q 016009          130 QYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLP---SDQIVDKKEFLTEVEALTEIRH--RN-IVKLYGFCSHARHSFL  202 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h--~n-iv~~~~~~~~~~~~~l  202 (397)
                      .+.+|.|..+.||++... +++.+++|.......   .......+.+..|.++++.+..  +. +.+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            456899999999999654 568899998653211   0001123456789999988742  33 4455544  3445689


Q ss_pred             EEEeccCC
Q 016009          203 VYEFLKRG  210 (397)
Q Consensus       203 v~e~~~~g  210 (397)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.23  E-value=6.3e-06  Score=75.13  Aligned_cols=139  Identities=19%  Similarity=0.308  Sum_probs=79.7

Q ss_pred             cccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC--CceeeeEE------EEecCCeeeEE
Q 016009          132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH--RNIVKLYG------FCSHARHSFLV  203 (397)
Q Consensus       132 ~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~------~~~~~~~~~lv  203 (397)
                      .|+.|..+.+|+....+| .+++|....        ....+..|..+++.+..  -.+.+++.      +....+..+++
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~--------~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l  109 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHR--------PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV  109 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECS--------CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCC--------CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence            465567889999987655 488998764        12344456666666631  12333443      12345677899


Q ss_pred             EEeccCCCHH--------------Hhhccccc----c-------CCCCHHHHH---------------------------
Q 016009          204 YEFLKRGSLA--------------AILSSDAA----A-------QELGWSQRM---------------------------  231 (397)
Q Consensus       204 ~e~~~~g~L~--------------~~l~~~~~----~-------~~l~~~~~~---------------------------  231 (397)
                      |||++|.++.              ..++....    .       ..-.|...+                           
T Consensus       110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  189 (346)
T 2q83_A          110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL  189 (346)
T ss_dssp             EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred             EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence            9999986542              01111000    0       011332211                           


Q ss_pred             ----HHHHHHHHHHHHHHh----------CCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          232 ----NVIKGVADALSYLHH----------DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       232 ----~i~~~i~~~l~~Lh~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                          .+...+..++.+|+.          .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                111123345666653          023489999999999999888899999998775

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=98.21  E-value=5.8e-07  Score=91.48  Aligned_cols=48  Identities=33%  Similarity=0.595  Sum_probs=43.3

Q ss_pred             CCCCCEEecCCCcccccCCCCCccccCCcccccCCCCCCCCCCCCCCCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGGVKGMQPCKG   50 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~~~~~~~~~~~~~gN~~lcg~~~~~~~c~~   50 (397)
                      |++|++||||+|+|+|+||...+|.+++..+|.||++|||.+..  +|..
T Consensus       703 l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~--~C~~  750 (768)
T 3rgz_A          703 LTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP--RCDP  750 (768)
T ss_dssp             CCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC--CCCS
T ss_pred             CCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc--CCCC
Confidence            57899999999999999999999999999999999999998764  7853

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.14  E-value=1.8e-05  Score=70.94  Aligned_cols=138  Identities=17%  Similarity=0.206  Sum_probs=91.5

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc---CCceeeeEEEEecCCeeeEEEEe
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR---HRNIVKLYGFCSHARHSFLVYEF  206 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~  206 (397)
                      .+.|+.|....+|+... ++..+++|....       .....+..|.+.|+.+.   ...++++++++...+..++||||
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~-------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINER-------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEG-------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCc-------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            35688899999999976 467888998542       12567889999999884   35688899988888889999999


Q ss_pred             ccCCCHHH-----------hhccccc----c---------------CCCCHHHHH---HHH----------------HHH
Q 016009          207 LKRGSLAA-----------ILSSDAA----A---------------QELGWSQRM---NVI----------------KGV  237 (397)
Q Consensus       207 ~~~g~L~~-----------~l~~~~~----~---------------~~l~~~~~~---~i~----------------~~i  237 (397)
                      +++..+..           .++....    +               -.-+|....   ++.                ..+
T Consensus       113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l  192 (312)
T 3jr1_A          113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI  192 (312)
T ss_dssp             CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred             ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence            99876521           1121110    0               012454322   111                111


Q ss_pred             HHH-HHHHHh-CCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          238 ADA-LSYLHH-DCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       238 ~~~-l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                      ... ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            111 223432 2245799999999999999887 8899973

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.97  E-value=6.7e-05  Score=70.50  Aligned_cols=76  Identities=9%  Similarity=0.056  Sum_probs=46.2

Q ss_pred             CCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCccccc--ccccccCcccccCC---CCCcchhhHHHHHHHHHH
Q 016009          250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA--GTYGYVAPELAYTM---KITEKCDVYSFGVLALEV  324 (397)
Q Consensus       250 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~el  324 (397)
                      +.++|+|+++.||++++++ +++.||+.+..-.+.... ....  -...|.+|+.....   ......++......+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            4899999999999998876 999999988753321100 0001  12345666544311   112234555777777777


Q ss_pred             HhC
Q 016009          325 IKG  327 (397)
Q Consensus       325 ~tg  327 (397)
                      .++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            664

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.94  E-value=3.2e-05  Score=68.73  Aligned_cols=79  Identities=19%  Similarity=0.243  Sum_probs=56.1

Q ss_pred             CCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-C--CceeeeEEEEecCCeeeE
Q 016009          126 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-H--RNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l  202 (397)
                      +....+.+|.|..+.||+.+..||+.+++|+-.....    .....|..|...|+.+. .  -.+++++++.    ..++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP----ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC----CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc----chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence            3445667899999999999999999999998653221    12346788999999884 2  2344555542    3478


Q ss_pred             EEEeccCCCH
Q 016009          203 VYEFLKRGSL  212 (397)
Q Consensus       203 v~e~~~~g~L  212 (397)
                      ||||++++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999987653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.73  E-value=0.00022  Score=59.31  Aligned_cols=102  Identities=22%  Similarity=0.143  Sum_probs=66.8

Q ss_pred             CCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCCc
Q 016009          209 RGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW  288 (397)
Q Consensus       209 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  288 (397)
                      .-||.+.|...+  .+++++++|.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.+.+.+ +.+.         
T Consensus        32 ~vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           32 ALSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             cccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence            347999997655  589999999999999999877632110 1 1233456899999999988754 1110         


Q ss_pred             ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC
Q 016009          289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK  328 (397)
Q Consensus       289 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~  328 (397)
                         .....+.|||... ...+.+.-|||+|+++|..+-=.
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence               1123466888763 34578899999999999988633

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.66  E-value=0.00031  Score=62.69  Aligned_cols=71  Identities=11%  Similarity=0.071  Sum_probs=44.3

Q ss_pred             CccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCce-eeeEEEEecCCeeeEEEEec-
Q 016009          130 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI-VKLYGFCSHARHSFLVYEFL-  207 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-  207 (397)
                      .+.|+.|....+|+.     +.+++|+......  ..   .....|..+++.+....+ .+++++.  .+.-++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~--~~---~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE--EY---INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------C---CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcc--ce---eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            567888999999998     5688888654211  11   112468888887743333 4555543  33457899999 


Q ss_pred             cCCCH
Q 016009          208 KRGSL  212 (397)
Q Consensus       208 ~~g~L  212 (397)
                      ++.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.65  E-value=0.00024  Score=64.35  Aligned_cols=141  Identities=18%  Similarity=0.167  Sum_probs=73.1

Q ss_pred             cccccCcEE-EEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC--CceeeeEEEEecCCeeeEEEEecc
Q 016009          132 CIGNGGHGS-VYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH--RNIVKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       132 ~lg~G~~g~-vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~  208 (397)
                      .|+.|.... +|+....+|..+++|......       ...+..|+.+++.+..  -.+.+++.+....+  +++||++.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~   95 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG   95 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTT-------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCC-------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence            455554444 667765446778777643311       0223456777777642  23556676643333  78999998


Q ss_pred             CCCHHHhhccccc-----------------------cCCCCHHHHH-------HH-------------HHHHHHHHHHHH
Q 016009          209 RGSLAAILSSDAA-----------------------AQELGWSQRM-------NV-------------IKGVADALSYLH  245 (397)
Q Consensus       209 ~g~L~~~l~~~~~-----------------------~~~l~~~~~~-------~i-------------~~~i~~~l~~Lh  245 (397)
                      +.++.+++.....                       ...++.....       .+             ...+...+..+.
T Consensus        96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~  175 (333)
T 3csv_A           96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL  175 (333)
T ss_dssp             SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred             CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            7776554421100                       0111111100       00             011112222221


Q ss_pred             ---hCCCCCceeccCCCCcEEeCCC----CcEEEeeecccccc
Q 016009          246 ---HDCFPPIVHRDISSKNLLLDLE----FEAHVADFGIAKFL  281 (397)
Q Consensus       246 ---~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~~  281 (397)
                         ......++|+|+.+.||+++.+    +.+.|.||+.+..-
T Consensus       176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence               1123479999999999999875    67999999988653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.56  E-value=0.00032  Score=64.56  Aligned_cols=141  Identities=17%  Similarity=0.264  Sum_probs=83.5

Q ss_pred             ccccccCcEEEEEEEeC--------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeee
Q 016009          131 YCIGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  201 (397)
                      +.+..|-...+|+....        +++.+++|+... .    ......+.+|..+++.+. +.-..++++++.+    .
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-I----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-c----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            44666777889998764        247899998532 1    123456678999999884 3333566766654    2


Q ss_pred             EEEEeccCCCHHHh-----------------hcccc--ccCCCC--HHHHHHHHHHHHH-------------------HH
Q 016009          202 LVYEFLKRGSLAAI-----------------LSSDA--AAQELG--WSQRMNVIKGVAD-------------------AL  241 (397)
Q Consensus       202 lv~e~~~~g~L~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~i~~-------------------~l  241 (397)
                      +||||++|.+|..-                 ++...  ..+...  |.++.++..++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            89999998665321                 11110  112222  4555555544322                   22


Q ss_pred             HH----HHhC-CCCCceeccCCCCcEEeCCC----CcEEEeeeccccc
Q 016009          242 SY----LHHD-CFPPIVHRDISSKNLLLDLE----FEAHVADFGIAKF  280 (397)
Q Consensus       242 ~~----Lh~~-~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~  280 (397)
                      ..    |... ....++|+|+.+.||+++++    +.+.++||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33    3222 12358999999999999876    7899999988763

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.55  E-value=0.00028  Score=63.56  Aligned_cols=158  Identities=13%  Similarity=0.154  Sum_probs=87.6

Q ss_pred             ccHHHHHHHhcCCCCC-----ccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc--e
Q 016009          115 LVYDEIVRATNDFDAQ-----YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--I  187 (397)
Q Consensus       115 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--i  187 (397)
                      ++.+++......|...     +.|+.|....+|+....+| .+++|......      ....+..|..+++.+....  +
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~v   79 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSC   79 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCC
Confidence            3445555555566542     3356687889999987666 58889876421      1234567888887774222  2


Q ss_pred             eeeEEE------EecCCeeeEEEEeccCCCHHH--------------hhccc----ccc--CC---CCHHHHHHH-----
Q 016009          188 VKLYGF------CSHARHSFLVYEFLKRGSLAA--------------ILSSD----AAA--QE---LGWSQRMNV-----  233 (397)
Q Consensus       188 v~~~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~~~--~~---l~~~~~~~i-----  233 (397)
                      .+++..      ....+..+++++|++|..+..              .++..    ...  ..   ..|...+.-     
T Consensus        80 P~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~  159 (322)
T 2ppq_A           80 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA  159 (322)
T ss_dssp             CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred             CcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHH
Confidence            333321      122356789999999865321              01110    000  00   123221110     


Q ss_pred             -------HHHHHHHHHHHHhC----CCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          234 -------IKGVADALSYLHHD----CFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       234 -------~~~i~~~l~~Lh~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                             ...+...+++++..    ....++|+|+.+.||+++++..+.|+||+.+.
T Consensus       160 ~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          160 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                   01234455566532    12368999999999999887666899998775

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.51  E-value=0.0014  Score=59.16  Aligned_cols=142  Identities=13%  Similarity=0.185  Sum_probs=81.9

Q ss_pred             ccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc--eeeeEEE-----EecCCeeeEE
Q 016009          131 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN--IVKLYGF-----CSHARHSFLV  203 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv  203 (397)
                      ..++ |....||+....+|+.+++|......     .....+..|..+++.+....  +++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            3466 77789999887778789999976321     12456778888888884222  3444443     1223456789


Q ss_pred             EEeccCCCHHH-----h---------hcc----ccc--cCCCCHHHH----HHH---------------HHHHHHHHHHH
Q 016009          204 YEFLKRGSLAA-----I---------LSS----DAA--AQELGWSQR----MNV---------------IKGVADALSYL  244 (397)
Q Consensus       204 ~e~~~~g~L~~-----~---------l~~----~~~--~~~l~~~~~----~~i---------------~~~i~~~l~~L  244 (397)
                      |||++|..+..     .         ++.    ...  ....++...    ..+               ...+...++.+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            99998754321     0         111    000  011222211    001               11111223333


Q ss_pred             HhC----CCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          245 HHD----CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       245 h~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ...    ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            221    223688999999999999 4 899999987754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.50  E-value=0.00035  Score=65.68  Aligned_cols=72  Identities=21%  Similarity=0.357  Sum_probs=49.1

Q ss_pred             ccccccCcEEEEEEEeCC--------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCce-eeeEEEEecCCeee
Q 016009          131 YCIGNGGHGSVYRAELPS--------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI-VKLYGFCSHARHSF  201 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~  201 (397)
                      +.|+.|....+|+....+        ++.+++|+....   .   ....+..|..+++.+...++ .++++.+.+    .
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---E---TESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---C---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---C---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            457778889999998753        578999987431   1   12455689999998853333 567776543    2


Q ss_pred             EEEEeccCCCH
Q 016009          202 LVYEFLKRGSL  212 (397)
Q Consensus       202 lv~e~~~~g~L  212 (397)
                      +|+||++|.+|
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            89999987544

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.40  E-value=0.0012  Score=62.54  Aligned_cols=73  Identities=21%  Similarity=0.220  Sum_probs=46.6

Q ss_pred             ccccccCcEEEEEEEeCC-CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCce-eeeEEEEecCCeeeEEEEecc
Q 016009          131 YCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI-VKLYGFCSHARHSFLVYEFLK  208 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~  208 (397)
                      +.|+.|-...+|+....+ +..+++|+.....  ....+   ...|..+++.+...++ .++++.+.  +  .+||||++
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~  184 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIIN---REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD  184 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSC---HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence            457778889999998765 4778888864321  11111   2578899998864444 56777663  2  25999998


Q ss_pred             CCCH
Q 016009          209 RGSL  212 (397)
Q Consensus       209 ~g~L  212 (397)
                      |.+|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7554

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.16  E-value=0.00078  Score=61.94  Aligned_cols=73  Identities=15%  Similarity=0.160  Sum_probs=43.2

Q ss_pred             ccccccCcEEEEEEEeCC---------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCc-eeeeEEEEecCCee
Q 016009          131 YCIGNGGHGSVYRAELPS---------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN-IVKLYGFCSHARHS  200 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~  200 (397)
                      +.++.|....+|+....+         ++.+++|+.....  ..   ......|.++++.+...+ ..++++..  .  -
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~  109 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DE---LYNTISEFEVYKTMSKYKIAPQLLNTF--N--G  109 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GG---TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cc---eecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence            346778788999997654         2678888764311  11   112357888888885333 34666544  2  3


Q ss_pred             eEEEEeccCCCH
Q 016009          201 FLVYEFLKRGSL  212 (397)
Q Consensus       201 ~lv~e~~~~g~L  212 (397)
                      ++||||++|.++
T Consensus       110 ~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 GRIEEWLYGDPL  121 (369)
T ss_dssp             EEEEECCCSEEC
T ss_pred             cEEEEEecCCcC
Confidence            689999988544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.09  E-value=0.0022  Score=58.23  Aligned_cols=31  Identities=23%  Similarity=0.286  Sum_probs=27.5

Q ss_pred             CCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       250 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ..++|+|+.+.||++++++.+.|.||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3689999999999999888899999987764

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=96.63  E-value=2.6e-05  Score=74.83  Aligned_cols=30  Identities=20%  Similarity=0.073  Sum_probs=25.9

Q ss_pred             HHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 016009          169 KKEFLTEVEALTEIRHRNIVKLYGFCSHAR  198 (397)
Q Consensus       169 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  198 (397)
                      .++|..|++.+.+++|+|+|+++|||....
T Consensus       323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~  352 (487)
T 3oja_A          323 SETERLECERENQARQREIDALKEQYRTVI  352 (487)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence            568999999999999999999999997654

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=95.80  E-value=0.0046  Score=63.45  Aligned_cols=37  Identities=41%  Similarity=0.620  Sum_probs=25.5

Q ss_pred             CCCCEEecCCCcccccCCCCCccccCCcccccCCCCCCC
Q 016009            2 HGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCG   40 (397)
Q Consensus         2 ~~L~~ldls~N~l~G~iP~~~~~~~~~~~~~~gN~~lcg   40 (397)
                      ++|++||||+|+|+|.+|.  .|.++....+.||+-.|.
T Consensus       526 ~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~~C~  562 (844)
T 3j0a_A          526 ANLEILDISRNQLLAPNPD--VFVSLSVLDITHNKFICE  562 (844)
T ss_dssp             SCCCEEEEEEECCCCCCSC--CCSSCCEEEEEEECCCCS
T ss_pred             ccccEEECCCCcCCCCChh--HhCCcCEEEecCCCcccc
Confidence            3566677777777777775  345666677888988883

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.77  E-value=0.069  Score=49.73  Aligned_cols=140  Identities=10%  Similarity=0.119  Sum_probs=82.0

Q ss_pred             ccccccCcEEEEEEEeCC--------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeee
Q 016009          131 YCIGNGGHGSVYRAELPS--------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  201 (397)
                      +.+..|-...+|+....+        ++.+++++.....  ....   +..+|..+++.+. +.-..++++.+.    -+
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~i---dR~~E~~~l~~L~~~gi~P~l~~~~~----~~  146 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFY---DSKVELDVFRYLSNINIAPNIIADFP----EG  146 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCC---CHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhc---CHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence            346667778899997653        5789998854311  1111   2357888888884 333445565432    27


Q ss_pred             EEEEeccCCCHHH--h---------------hcccc----------ccCCCCHHHHHHHHHHH-----------------
Q 016009          202 LVYEFLKRGSLAA--I---------------LSSDA----------AAQELGWSQRMNVIKGV-----------------  237 (397)
Q Consensus       202 lv~e~~~~g~L~~--~---------------l~~~~----------~~~~l~~~~~~~i~~~i-----------------  237 (397)
                      +||||++|.+|..  +               ++...          ...+.-|.++.++..++                 
T Consensus       147 ~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~  226 (424)
T 3mes_A          147 RIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYS  226 (424)
T ss_dssp             EEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHH
T ss_pred             EEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHH
Confidence            8999999866421  0               01100          11111244444444322                 


Q ss_pred             --HHHHHHHHhC---------------------CCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          238 --ADALSYLHHD---------------------CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       238 --~~~l~~Lh~~---------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                        ...+.+|.+.                     ....++|+|+.+.||+ ++++.+.++||..+..
T Consensus       227 ~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          227 KILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence              2223333211                     1135899999999999 7788999999988763

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=94.72  E-value=0.1  Score=43.21  Aligned_cols=118  Identities=8%  Similarity=0.093  Sum_probs=81.6

Q ss_pred             cCCceeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcE
Q 016009          183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNL  262 (397)
Q Consensus       183 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni  262 (397)
                      .||++++. .+-...+...+.|+.-+  +...+-.    -+.++...+++++.+|+....+++..     +|--|.|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence            58888766 45566666666555433  2222211    13478899999999999988666654     8999999999


Q ss_pred             EeCCCCcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 016009          263 LLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL  334 (397)
Q Consensus       263 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~  334 (397)
                      ++|.++.+++.-.|+...+.                 |.     ..+...=.-.+=+++..+++++..|+..
T Consensus       111 ~f~~~~~p~i~~RGik~~l~-----------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l  160 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVD-----------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDAL  160 (215)
T ss_dssp             EECTTSCEEESCCEETTTBS-----------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred             EEcCCCCEEEEEccCccCCC-----------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            99999999998887654322                 21     1222333447788999999999998643

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.98  E-value=0.34  Score=44.72  Aligned_cols=29  Identities=24%  Similarity=0.430  Sum_probs=24.9

Q ss_pred             ceeccCCCCcEEe------CCCCcEEEeeeccccc
Q 016009          252 IVHRDISSKNLLL------DLEFEAHVADFGIAKF  280 (397)
Q Consensus       252 ivH~dlk~~Nill------~~~~~~kl~Dfg~~~~  280 (397)
                      ++|+|+.+.||++      +++..+.++||.++..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567799999998864

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=93.70  E-value=0.058  Score=43.21  Aligned_cols=36  Identities=19%  Similarity=0.282  Sum_probs=25.3

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |+.|++||||+|+|++..|.. ..+.++....+.+|.
T Consensus        53 l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~   89 (170)
T 3g39_A           53 LTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ   89 (170)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence            568899999999999765542 344556666777775

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=93.60  E-value=0.022  Score=57.76  Aligned_cols=19  Identities=21%  Similarity=0.621  Sum_probs=9.2

Q ss_pred             CCCCEEecCCCcccccCCC
Q 016009            2 HGLSVIDISDNQLQGPVPN   20 (397)
Q Consensus         2 ~~L~~ldls~N~l~G~iP~   20 (397)
                      +.|+.||||+|+|+|.||.
T Consensus       656 ~~L~~L~Ls~N~l~g~ip~  674 (768)
T 3rgz_A          656 PYLFILNLGHNDISGSIPD  674 (768)
T ss_dssp             TTCCEEECCSSCCCSCCCG
T ss_pred             ccCCEEeCcCCccCCCCCh
Confidence            3444455555555554443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=93.22  E-value=0.062  Score=43.97  Aligned_cols=36  Identities=8%  Similarity=0.160  Sum_probs=24.0

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |+.|++||||+|+|++..|.. ..+.++....+.+|.
T Consensus        77 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  113 (192)
T 1w8a_A           77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQ  113 (192)
T ss_dssp             CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSC
T ss_pred             cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCc
Confidence            467888888888888877752 234455555666664

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=93.19  E-value=0.075  Score=42.74  Aligned_cols=36  Identities=14%  Similarity=0.172  Sum_probs=26.0

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |+.|++||||+|+|++-.|.. ..+.++....+.+|.
T Consensus        56 l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~   92 (174)
T 2r9u_A           56 LVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH   92 (174)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence            578999999999999854442 345566667777775

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=93.07  E-value=0.26  Score=41.03  Aligned_cols=117  Identities=11%  Similarity=0.067  Sum_probs=78.9

Q ss_pred             cCCceeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCceeccCCCCc
Q 016009          183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALS-YLHHDCFPPIVHRDISSKN  261 (397)
Q Consensus       183 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~Lh~~~~~~ivH~dlk~~N  261 (397)
                      .||++  -...-.+.+...+.|+.-+++.=...+      +.++...+++++.+++.... +++..     +|--|.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCce
Confidence            57777  334446677777777754333222222      34788899999999988766 55544     888999999


Q ss_pred             EEeCCCCcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 016009          262 LLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL  334 (397)
Q Consensus       262 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~  334 (397)
                      +++|.++.+++.-.|+-..+                 +|.-     .+..-=.-++=+++..++.++..|+..
T Consensus       115 L~f~~~~~p~i~hRGi~~~l-----------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe~l  165 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESL-----------------PPDE-----WDDERLLREVKATVLALTEGEYRFDEY  165 (219)
T ss_dssp             EEECTTCCEEESCCEETTTB-----------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred             EEEeCCCcEEEEEcCCcccC-----------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            99999999999888765432                 3321     122222336778888999998887643

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=92.94  E-value=0.038  Score=32.61  Aligned_cols=28  Identities=29%  Similarity=0.446  Sum_probs=13.2

Q ss_pred             eEEEehhhHHHHHHHHHHH-hhhhhccCC
Q 016009           63 FAIVFPVLGALLVSMTLVA-IFILRKRNS   90 (397)
Q Consensus        63 ~~i~~~~~~~~~~~~~~~~-~~~~~~r~~   90 (397)
                      ..|+++++|+++++++++. ++++|||+.
T Consensus        12 ~~Ia~~vVGvll~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           12 TSIISAVVGILLVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred             cchHHHHHHHHHHHHHHHHHHhheehhhh
Confidence            3455566664444433333 444454443

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=92.66  E-value=0.081  Score=31.36  Aligned_cols=15  Identities=33%  Similarity=0.341  Sum_probs=8.3

Q ss_pred             eeEEEehhhHHHHHH
Q 016009           62 RFAIVFPVLGALLVS   76 (397)
Q Consensus        62 ~~~i~~~~~~~~~~~   76 (397)
                      ...|+++|++.++++
T Consensus        10 ~~~IA~gVVgGv~~~   24 (44)
T 2ks1_B           10 IPSIATGMVGALLLL   24 (44)
T ss_dssp             SSSSTHHHHHHHHHH
T ss_pred             cceEEeehhHHHHHH
Confidence            345666666654443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=91.52  E-value=0.14  Score=46.07  Aligned_cols=39  Identities=21%  Similarity=0.106  Sum_probs=24.7

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCCCCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNKGLCG   40 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~~lcg   40 (397)
                      |++|+.||||+|+|+|..|.. ..+.++....+.+|. |.+
T Consensus        55 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~   94 (347)
T 2ifg_A           55 LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA-LES   94 (347)
T ss_dssp             CCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC-CSC
T ss_pred             ccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc-cce
Confidence            567788888888888877752 334445555666665 443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=91.21  E-value=0.13  Score=42.99  Aligned_cols=36  Identities=14%  Similarity=0.228  Sum_probs=26.3

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |++|++||||+|++++..|.. ..+.++....+.+|.
T Consensus       104 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  140 (220)
T 2v70_A          104 LESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQ  140 (220)
T ss_dssp             CSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSC
T ss_pred             CcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCc
Confidence            578999999999999988863 234455566677775

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=91.01  E-value=0.099  Score=45.28  Aligned_cols=36  Identities=22%  Similarity=0.331  Sum_probs=24.6

Q ss_pred             CCCCCEEecCCCcccc--cCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQG--PVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G--~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |+.|+.||||+|+|+|  .||.. ..+.++....+++|.
T Consensus       169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~  207 (267)
T 3rw6_A          169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNE  207 (267)
T ss_dssp             CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSC
T ss_pred             CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCc
Confidence            5789999999999999  77742 234445555555554

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=90.94  E-value=0.12  Score=30.54  Aligned_cols=14  Identities=29%  Similarity=0.370  Sum_probs=7.8

Q ss_pred             eEEEehhhHHHHHH
Q 016009           63 FAIVFPVLGALLVS   76 (397)
Q Consensus        63 ~~i~~~~~~~~~~~   76 (397)
                      ..|+++|++.++++
T Consensus        10 ~aIA~gVVgGv~~v   23 (44)
T 2l2t_A           10 PLIAAGVIGGLFIL   23 (44)
T ss_dssp             HHHHHHHHHHHHHH
T ss_pred             ceEEEeehHHHHHH
Confidence            44666666654443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=90.81  E-value=0.18  Score=45.35  Aligned_cols=39  Identities=23%  Similarity=0.152  Sum_probs=27.8

Q ss_pred             CCCCCEEecCCCcccccCCCCCccccCCcccccCCCCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLC   39 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~~~~~~~~~~~~~gN~~lc   39 (397)
                      |++|++||||+|+|++..|......++....+.+|+--|
T Consensus        79 l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c  117 (347)
T 2ifg_A           79 TPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC  117 (347)
T ss_dssp             CSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred             CcCCCEEeCCCCccceeCHHHcccCCceEEEeeCCCccC
Confidence            678999999999999765543332335666777887555

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=90.03  E-value=0.2  Score=41.94  Aligned_cols=36  Identities=17%  Similarity=0.276  Sum_probs=26.1

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |++|++|||++|++++..|.. ..+.++....+.+|.
T Consensus       103 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  139 (220)
T 2v9t_B          103 LFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNK  139 (220)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCc
Confidence            578999999999999987763 234455566677775

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=89.80  E-value=0.26  Score=39.27  Aligned_cols=38  Identities=21%  Similarity=0.240  Sum_probs=28.2

Q ss_pred             CCCCEEecCCCcccccCCCC-CccccCCcccccCCCCCCC
Q 016009            2 HGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNKGLCG   40 (397)
Q Consensus         2 ~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~~lcg   40 (397)
                      +.|++|||++|++++..|.. ..+.++....+.+|. +.+
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~-l~~   68 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQ-LTV   68 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSC-CCC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCC-cCc
Confidence            57899999999999988863 345566667777775 444

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=89.61  E-value=0.27  Score=39.37  Aligned_cols=38  Identities=18%  Similarity=0.179  Sum_probs=28.5

Q ss_pred             CCCCEEecCCCcccccCCCC-CccccCCcccccCCCCCCC
Q 016009            2 HGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNKGLCG   40 (397)
Q Consensus         2 ~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~~lcg   40 (397)
                      +.|++||||+|+|++.+|.. ..+.++....+.+|. +-+
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~   71 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNK-LTA   71 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC-CCC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCC-CCc
Confidence            57999999999999998863 345566667777775 444

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=89.51  E-value=0.32  Score=38.83  Aligned_cols=39  Identities=21%  Similarity=0.286  Sum_probs=28.2

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCCCCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNKGLCG   40 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~~lcg   40 (397)
                      +++|++|||++|++++..|.. ..+.++....+.+|. +.+
T Consensus        75 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~  114 (177)
T 2o6r_A           75 LTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQ-LKS  114 (177)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC-CSC
T ss_pred             CCccCEEECCCCCccccCHHHhhCCcccCEEECcCCc-ceE
Confidence            578999999999999876653 344566666777775 444

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=89.34  E-value=0.25  Score=40.35  Aligned_cols=36  Identities=25%  Similarity=0.332  Sum_probs=26.6

Q ss_pred             CCCCCEEecCCCcccccCCC-CCccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPN-STAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~-~~~~~~~~~~~~~gN~   36 (397)
                      |+.|++||||+|++++..|. ...+.++....+.+|.
T Consensus        77 l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~  113 (193)
T 2wfh_A           77 MTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGND  113 (193)
T ss_dssp             CTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCC
Confidence            57899999999999988775 2334455666677775

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=89.28  E-value=0.25  Score=48.26  Aligned_cols=20  Identities=20%  Similarity=0.282  Sum_probs=11.6

Q ss_pred             CCCCCEEecCCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPN   20 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~   20 (397)
                      |++|++||||+|+|++..|.
T Consensus       517 l~~L~~L~Ls~N~l~~l~~~  536 (635)
T 4g8a_A          517 LSSLQVLNMSHNNFFSLDTF  536 (635)
T ss_dssp             CTTCCEEECTTSCCCBCCCG
T ss_pred             CCCCCEEECCCCcCCCCChh
Confidence            34566666666666665553

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=89.22  E-value=0.14  Score=44.27  Aligned_cols=39  Identities=23%  Similarity=0.439  Sum_probs=28.4

Q ss_pred             CCCCCEEecCCCcccccCCCCCccc--cCCcccccCCCCCCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNSTAFR--NASVEALEGNKGLCGG   41 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~~~~~--~~~~~~~~gN~~lcg~   41 (397)
                      |++|+.||||+|++++. .+...+.  ++....+.||+ +|+.
T Consensus       195 l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Np-l~~~  235 (267)
T 3rw6_A          195 APNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNS-LCDT  235 (267)
T ss_dssp             STTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTST-TGGG
T ss_pred             CCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCc-Cccc
Confidence            57899999999999985 2222233  56667888887 7764

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=88.89  E-value=0.11  Score=40.30  Aligned_cols=35  Identities=14%  Similarity=0.166  Sum_probs=19.6

Q ss_pred             CCCCCEEecCCCcccccCCCCCccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~~~~~~~~~~~~~gN~   36 (397)
                      ++.|++|||++|++++. +....+.++....+.+|.
T Consensus        41 l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~   75 (149)
T 2je0_A           41 FEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNR   75 (149)
T ss_dssp             CTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSC
T ss_pred             cCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCc
Confidence            35667777777777665 433334444445555554

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=88.79  E-value=0.32  Score=39.56  Aligned_cols=34  Identities=15%  Similarity=0.112  Sum_probs=16.9

Q ss_pred             CCCEEecCCCcccccCCC--CCccccCCcccccCCC
Q 016009            3 GLSVIDISDNQLQGPVPN--STAFRNASVEALEGNK   36 (397)
Q Consensus         3 ~L~~ldls~N~l~G~iP~--~~~~~~~~~~~~~gN~   36 (397)
                      .|+.|+|++|++++..|.  ...+.++....+.+|.
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~   65 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ   65 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCC
Confidence            456666666666555443  2233344444454443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=88.51  E-value=0.36  Score=41.11  Aligned_cols=36  Identities=22%  Similarity=0.259  Sum_probs=25.0

Q ss_pred             CCCCCEEecCCCcccccCCC-CCccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPN-STAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~-~~~~~~~~~~~~~gN~   36 (397)
                      +++|++||||+|+|++..|. ...+.++....+.+|.
T Consensus       130 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  166 (251)
T 3m19_A          130 LTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ  166 (251)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence            46788899999999876664 2344556666677775

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=88.17  E-value=0.4  Score=36.37  Aligned_cols=36  Identities=19%  Similarity=0.314  Sum_probs=25.0

Q ss_pred             CCCEEecCCCcccccCCCC--CccccCCcccccCCCCCC
Q 016009            3 GLSVIDISDNQLQGPVPNS--TAFRNASVEALEGNKGLC   39 (397)
Q Consensus         3 ~L~~ldls~N~l~G~iP~~--~~~~~~~~~~~~gN~~lc   39 (397)
                      +|+.||||+|+|+. ||..  ..+.++....+.+|+--|
T Consensus        32 ~l~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           32 DTTELVLTGNNLTA-LPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             TCSEEECTTSCCSS-CCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             CCCEEECCCCcCCc-cChhhhhhccccCEEEecCCCeec
Confidence            68999999999985 5542  223445556778887554

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=88.15  E-value=0.45  Score=41.10  Aligned_cols=39  Identities=26%  Similarity=0.228  Sum_probs=25.8

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCCCCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNKGLCG   40 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~~lcg   40 (397)
                      +++|+.|||++|++++..|.. ..+.++....+.+|. +.+
T Consensus       156 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~  195 (272)
T 3rfs_A          156 LTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ-LKS  195 (272)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC-CSC
T ss_pred             CccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc-CCc
Confidence            467888888888888766653 334555566666665 443

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=88.11  E-value=0.41  Score=40.20  Aligned_cols=35  Identities=20%  Similarity=0.277  Sum_probs=24.2

Q ss_pred             CCCCCEEecCCCcccccCCCCC-ccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNST-AFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~~-~~~~~~~~~~~gN~   36 (397)
                      |++|++|||++|+|+ .||... .+.++....+.+|.
T Consensus       111 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~  146 (229)
T 3e6j_A          111 LVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ  146 (229)
T ss_dssp             CTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSC
T ss_pred             chhhCeEeccCCccc-ccCcccccCCCCCEEECCCCc
Confidence            567888999999988 777632 33455556666664

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=87.81  E-value=0.35  Score=46.50  Aligned_cols=38  Identities=26%  Similarity=0.381  Sum_probs=26.1

Q ss_pred             CCCCCEEecCCCcccccCCCCCccccCCcccccCCCCCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCG   40 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~~~~~~~~~~~~~gN~~lcg   40 (397)
                      |++|++||||+|+|+ .||....+.++....+.+|. +.+
T Consensus       450 l~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~-l~~  487 (549)
T 2z81_A          450 LPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQ-LKS  487 (549)
T ss_dssp             CTTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSC-CCC
T ss_pred             CChhcEEECCCCccC-cCCCcccCccCCEEecCCCc-cCC
Confidence            467888888888888 77875445556666666664 444

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=87.59  E-value=0.54  Score=38.62  Aligned_cols=36  Identities=19%  Similarity=0.172  Sum_probs=24.8

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      +++|++|||++|++++..|.. ..+.++....+.+|.
T Consensus        99 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  135 (208)
T 2o6s_A           99 LTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQ  135 (208)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCc
Confidence            467899999999998766642 334555556666664

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=87.06  E-value=0.18  Score=39.94  Aligned_cols=34  Identities=24%  Similarity=0.354  Sum_probs=16.0

Q ss_pred             CCCCEEecCCCcccccCCCCCc-cccCCcccccCC
Q 016009            2 HGLSVIDISDNQLQGPVPNSTA-FRNASVEALEGN   35 (397)
Q Consensus         2 ~~L~~ldls~N~l~G~iP~~~~-~~~~~~~~~~gN   35 (397)
                      +.|++||||+|++++.+|.... +.++....+.+|
T Consensus        71 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  105 (168)
T 2ell_A           71 PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN  105 (168)
T ss_dssp             SSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSS
T ss_pred             CCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCC
Confidence            4555555555555555553211 333334444444

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=86.93  E-value=0.51  Score=38.45  Aligned_cols=36  Identities=19%  Similarity=0.244  Sum_probs=26.8

Q ss_pred             CCCCCEEecCCCcccccCCC-CCccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPN-STAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~-~~~~~~~~~~~~~gN~   36 (397)
                      |+.|++||||+|++++..|. ...+.++....+.+|.
T Consensus        53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            57899999999999987775 2344555666677775

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=86.82  E-value=0.3  Score=27.96  Aligned_cols=16  Identities=31%  Similarity=0.266  Sum_probs=8.4

Q ss_pred             eeEEEehhhHHHHHHH
Q 016009           62 RFAIVFPVLGALLVSM   77 (397)
Q Consensus        62 ~~~i~~~~~~~~~~~~   77 (397)
                      ..+|+.++++.++.++
T Consensus        10 ~GaIAGiVvG~v~gv~   25 (38)
T 2k1k_A           10 GGEIVAVIFGLLLGAA   25 (38)
T ss_dssp             HHHHHHHHHHHHHHHH
T ss_pred             CCceeeeehHHHHHHH
Confidence            4455666666554433

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=86.09  E-value=0.56  Score=39.07  Aligned_cols=36  Identities=17%  Similarity=0.251  Sum_probs=26.9

Q ss_pred             CCCCCEEecCCCcccccCCC-CCccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPN-STAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~-~~~~~~~~~~~~~gN~   36 (397)
                      |++|++||||+|++++..|. ...+.++....+.+|.
T Consensus        80 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  116 (220)
T 2v70_A           80 ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNR  116 (220)
T ss_dssp             CTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSC
T ss_pred             CCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCc
Confidence            57899999999999988775 2334556666777775

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=85.55  E-value=0.52  Score=41.39  Aligned_cols=36  Identities=17%  Similarity=0.192  Sum_probs=22.8

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      +++|+.|||++|++++..|.. ..+.++....+.+|.
T Consensus       198 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  234 (306)
T 2z66_A          198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH  234 (306)
T ss_dssp             CTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSC
T ss_pred             CCCCCEEECCCCccCccChhhccCcccCCEeECCCCC
Confidence            467888888888888765532 233445555666664

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=85.20  E-value=0.35  Score=45.94  Aligned_cols=39  Identities=26%  Similarity=0.242  Sum_probs=28.9

Q ss_pred             CCCCCEEecCCCcccccCCCCCccccCCcccccCCCCCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCG   40 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~~~~~~~~~~~~~gN~~lcg   40 (397)
                      +++|++||||+|+|+|..|....+.++....+.+|. +.+
T Consensus       190 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~-l~~  228 (487)
T 3oja_A          190 FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNK-LVL  228 (487)
T ss_dssp             CTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSC-CCE
T ss_pred             CCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCc-Ccc
Confidence            578999999999999977765555566667777775 444

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=84.74  E-value=0.76  Score=36.58  Aligned_cols=36  Identities=22%  Similarity=0.304  Sum_probs=26.7

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      ++.|++|||++|++++..|.. ..+.++....+.+|.
T Consensus        51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   87 (177)
T 2o6r_A           51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK   87 (177)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence            578999999999999766653 345566666777775

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=84.48  E-value=0.49  Score=45.91  Aligned_cols=35  Identities=26%  Similarity=0.394  Sum_probs=21.8

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |++|+.||||+|+|+ .||.. ..+.++....+++|.
T Consensus       462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~  497 (567)
T 1dce_A          462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA  497 (567)
T ss_dssp             GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSC
T ss_pred             cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCC
Confidence            457788888888887 77752 223444555566664

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=84.48  E-value=0.98  Score=40.23  Aligned_cols=15  Identities=20%  Similarity=0.432  Sum_probs=8.1

Q ss_pred             CCCCEEecCCCcccc
Q 016009            2 HGLSVIDISDNQLQG   16 (397)
Q Consensus         2 ~~L~~ldls~N~l~G   16 (397)
                      ++|++|||++|+++|
T Consensus       206 ~~L~~L~L~~N~l~~  220 (328)
T 4fcg_A          206 QNLKSLKIRNSPLSA  220 (328)
T ss_dssp             TTCCEEEEESSCCCC
T ss_pred             CCCCEEEccCCCCCc
Confidence            445555555555554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=84.16  E-value=0.8  Score=38.13  Aligned_cols=36  Identities=14%  Similarity=0.174  Sum_probs=25.2

Q ss_pred             CCCCCEEecCCCcccccCCC-CCccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPN-STAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~-~~~~~~~~~~~~~gN~   36 (397)
                      |++|++||||+|+|++-.|. ...+.++....+.+|.
T Consensus        79 l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~  115 (220)
T 2v9t_B           79 LRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANK  115 (220)
T ss_dssp             CSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCC
Confidence            57899999999999954333 2334556666777775

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=84.04  E-value=0.8  Score=41.17  Aligned_cols=38  Identities=29%  Similarity=0.408  Sum_probs=28.7

Q ss_pred             CCCCCEEecCCCcccccCCCC--CccccCCcccccCCCCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS--TAFRNASVEALEGNKGLC   39 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~--~~~~~~~~~~~~gN~~lc   39 (397)
                      +++|+.||||+|+++ .||..  ..+.++....+.+|+-.|
T Consensus       276 l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~  315 (353)
T 2z80_A          276 ISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC  315 (353)
T ss_dssp             CTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             ccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccC
Confidence            468999999999999 78863  345566677788887544

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.99  E-value=0.12  Score=48.90  Aligned_cols=61  Identities=10%  Similarity=-0.067  Sum_probs=16.7

Q ss_pred             CccccccCcEEEEEEEeCC-CCEEEE------EecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEe
Q 016009          130 QYCIGNGGHGSVYRAELPS-GQVVAI------KKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCS  195 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  195 (397)
                      .+.+|   ||.||+|.+.. ..+|||      |..+.....  ......+.+|..+++.++|||+++.+++..
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~--~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS--EKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCcccccccccc--ccccccccccccccccccccccCCCcceEE
Confidence            34565   99999997754 367888      665432111  123456888999999999999999988763

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=83.91  E-value=0.53  Score=41.66  Aligned_cols=36  Identities=14%  Similarity=0.299  Sum_probs=22.2

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |+.|++|||++|+++|.+|.. ..+.++....+.+|.
T Consensus       100 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~  136 (313)
T 1ogq_A          100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA  136 (313)
T ss_dssp             CTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred             CCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCc
Confidence            467778888888888777762 223344444555553

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=83.68  E-value=0.93  Score=38.97  Aligned_cols=36  Identities=17%  Similarity=0.239  Sum_probs=23.1

Q ss_pred             CCCCCEEecCCCcccccCCC-CCccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPN-STAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~-~~~~~~~~~~~~~gN~   36 (397)
                      |++|+.|+|++|++++..|. ...+.++....+.+|.
T Consensus       156 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  192 (270)
T 2o6q_A          156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ  192 (270)
T ss_dssp             CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CcccceeEecCCcCcEeChhHhccCCCcCEEECCCCc
Confidence            46788888888888876554 2233445555666664

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=83.24  E-value=0.91  Score=38.02  Aligned_cols=36  Identities=19%  Similarity=0.206  Sum_probs=23.3

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |+.|++|||++|+|++-.|.. ..+.++....+.+|.
T Consensus        63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~   99 (229)
T 3e6j_A           63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ   99 (229)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence            467888999999985443332 334555566677764

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=82.88  E-value=0.76  Score=42.82  Aligned_cols=36  Identities=17%  Similarity=0.107  Sum_probs=19.4

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |++|+.|+|++|++++..|.. ..+.++....+.+|.
T Consensus       230 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  266 (440)
T 3zyj_A          230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN  266 (440)
T ss_dssp             CTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSC
T ss_pred             CccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCC
Confidence            356667777777776665542 222334444455553

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=82.49  E-value=0.76  Score=40.49  Aligned_cols=36  Identities=19%  Similarity=0.083  Sum_probs=22.6

Q ss_pred             CCCCCEEecCCCcccccCCCCC-cc---ccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNST-AF---RNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~~-~~---~~~~~~~~~gN~   36 (397)
                      ++.|++||||+|++++.+|... .+   .++....+.+|.
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~  262 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAG  262 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSC
T ss_pred             CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCC
Confidence            4677888888888888776532 22   245555566664

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=82.38  E-value=0.93  Score=35.65  Aligned_cols=35  Identities=11%  Similarity=0.147  Sum_probs=28.0

Q ss_pred             CCCCEEecCCCccc-ccCCCC-CccccCCcccccCCC
Q 016009            2 HGLSVIDISDNQLQ-GPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         2 ~~L~~ldls~N~l~-G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      +.|+.|||++|+++ |.||.. ..+.++....+.+|.
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~   60 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVG   60 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSC
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCC
Confidence            57999999999999 999975 445666667777775

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=82.37  E-value=1.1  Score=39.91  Aligned_cols=36  Identities=11%  Similarity=0.021  Sum_probs=24.6

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |++|++|||++|++.|.+|.. ..+.++....+.+|.
T Consensus       228 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~  264 (328)
T 4fcg_A          228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS  264 (328)
T ss_dssp             CTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCT
T ss_pred             CCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCC
Confidence            467888888888888888863 334455555666654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=82.31  E-value=0.54  Score=37.48  Aligned_cols=33  Identities=21%  Similarity=0.324  Sum_probs=20.3

Q ss_pred             CCCEEecCCCcccccCCCCCccccCCcccccCCC
Q 016009            3 GLSVIDISDNQLQGPVPNSTAFRNASVEALEGNK   36 (397)
Q Consensus         3 ~L~~ldls~N~l~G~iP~~~~~~~~~~~~~~gN~   36 (397)
                      .|++||||+|++++. +....+.++....+.+|.
T Consensus        43 ~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~   75 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNR   75 (176)
T ss_dssp             CCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSC
T ss_pred             CCCEEECCCCCCCcc-cccccCCCCCEEECCCCc
Confidence            677778887777764 443444445555555554

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=82.14  E-value=0.57  Score=41.37  Aligned_cols=36  Identities=14%  Similarity=0.310  Sum_probs=27.9

Q ss_pred             CCCCCEEecCCCcccccCCCC---CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS---TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~---~~~~~~~~~~~~gN~   36 (397)
                      ++.|++|||++|+++|.+|..   ..+.++....+.+|.
T Consensus        94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~  132 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS  132 (312)
T ss_dssp             TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCB
T ss_pred             cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCC
Confidence            468999999999999999984   344556667777775

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=81.68  E-value=1.2  Score=34.18  Aligned_cols=35  Identities=6%  Similarity=0.104  Sum_probs=27.4

Q ss_pred             CCCCEEecCCCccc-ccCCCC-CccccCCcccccCCC
Q 016009            2 HGLSVIDISDNQLQ-GPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         2 ~~L~~ldls~N~l~-G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      +.|+.||+++|+++ |.+|.. ..+.++....+.+|.
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~   53 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG   53 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSC
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCC
Confidence            46999999999999 999974 445566667777774

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=81.34  E-value=0.92  Score=42.42  Aligned_cols=36  Identities=14%  Similarity=0.099  Sum_probs=21.9

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |++|+.|+|++|++++..|.. ..+.++....+.+|.
T Consensus       241 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  277 (452)
T 3zyi_A          241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN  277 (452)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             ccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCc
Confidence            456777777777777776652 223344455556664

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=80.40  E-value=0.5  Score=27.53  Aligned_cols=24  Identities=13%  Similarity=0.189  Sum_probs=9.3

Q ss_pred             EEehhhHHHHHHH-HHHHhhhhhcc
Q 016009           65 IVFPVLGALLVSM-TLVAIFILRKR   88 (397)
Q Consensus        65 i~~~~~~~~~~~~-~~~~~~~~~~r   88 (397)
                      |++++++++++++ +++.+++++||
T Consensus        15 I~~~vv~Gv~ll~~iv~~~~~~~rR   39 (41)
T 2k9y_A           15 VIGGVAVGVVLLLVLAGVGFFIHRR   39 (41)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred             EEeehhHHHHHHHHHHHHheeEeee
Confidence            3444444433333 33333444443

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=80.32  E-value=1.5  Score=38.29  Aligned_cols=36  Identities=17%  Similarity=0.211  Sum_probs=24.4

Q ss_pred             CCCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      +++|+.|||++|+|++-.|.. ..+.++....+.+|.
T Consensus       147 l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~  183 (290)
T 1p9a_G          147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS  183 (290)
T ss_dssp             CTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCc
Confidence            468999999999998543332 234556666677775

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	397
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-64
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-60
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-59
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-55
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-53
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-53
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-53
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-52
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-51
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-50
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-33
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-08

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 3e-64
 Identities = 61/277 (22%), Positives = 121/277 (43%), Gaps = 21/277 (7%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
                   IG+G  G+VY+ +      VA+K  +   P+ Q    + F  EV  L + RH
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRH 63

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
            NI+   G+ +      +V ++ +  SL   L       +    + +++ +  A  + YL
Sbjct: 64  VNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYL 120

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPEL 302
           H      I+HRD+ S N+ L  +    + DFG+A      S +  + + +G+  ++APE+
Sbjct: 121 HA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 303 AYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP 359
                    + + DVY+FG++  E++ G+ P    S+I++      +     L P L   
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKV 234

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             +  + ++ ++     CL +  + RP    +   ++
Sbjct: 235 RSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIE 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 3e-60
 Identities = 64/270 (23%), Positives = 120/270 (44%), Gaps = 19/270 (7%)

Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           D++  Y IG G +G   +      G+++  K+      ++   +K+  ++EV  L E++H
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELKH 62

Query: 185 RNIVKLYGFCSHARHS--FLVYEFLKRGSLAAILSSDAAAQE-LGWSQRMNVIKGVADAL 241
            NIV+ Y       ++  ++V E+ + G LA++++     ++ L     + V+  +  AL
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 242 SYLH--HDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
              H   D    ++HRD+   N+ LD +    + DFG+A+ L  D+S    F GT  Y++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP 359
           PE    M   EK D++S G L  E+     P    S              ++ + +    
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRRI 234

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
                ++L  I+      LN     RP+++
Sbjct: 235 PYRYSDELNEIIT---RMLNLKDYHRPSVE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 3e-59
 Identities = 55/273 (20%), Positives = 115/273 (42%), Gaps = 21/273 (7%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
                   +G G  G V+         VA+K           +    FL E   + +++H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQH 67

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
           + +V+LY   +     +++ E+++ GSL   L + +   +L  ++ +++   +A+ ++++
Sbjct: 68  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 125

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW-TEFAGTYGYVAPELA 303
                   +HRD+ + N+L+       +ADFG+A+ ++ +             + APE  
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
                T K DV+SFG+L  E++          +      N ++  +     R+  P    
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------NPEVIQNLERGYRMVRPDNCP 236

Query: 364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +E    + +++  C  E PE RPT   +   L+
Sbjct: 237 EE----LYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 9e-59
 Identities = 63/273 (23%), Positives = 117/273 (42%), Gaps = 21/273 (7%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           ++      IG+G  G V+     +   VAIK        +  + +++F+ E E + ++ H
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSH 59

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
             +V+LYG C       LV+EF++ G L+  L +            + +   V +    +
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEG---M 114

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE-FAGTYGYVAPELA 303
            +     ++HRD++++N L+       V+DFG+ +F+  D    +        + +PE+ 
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
              + + K DV+SFGVL  EV           S      N+++  D     RL  P  + 
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGFRLYKPRLAS 228

Query: 364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                 + +++  C  E PE RP    + +QL 
Sbjct: 229 TH----VYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-58
 Identities = 66/300 (22%), Positives = 113/300 (37%), Gaps = 43/300 (14%)

Query: 123 ATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
             +DF+    +G G  G V++    PSG V+A K  H      +   + + + E++ L E
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHE 60

Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADAL 241
                IV  YG         +  E +  GSL  +L     A  +       V   V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGL 117

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
           +YL       I+HRD+   N+L++   E  + DFG++  L    +    F GT  Y++PE
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE 173

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHP------------------------------R 331
                  + + D++S G+  +E+  G++P                               
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

Query: 332 DFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS--IVEVVFSCLNESPESRPTMK 389
               S         + + E+LD  +  P   +   + S    + V  CL ++P  R  +K
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 2e-57
 Identities = 65/274 (23%), Positives = 121/274 (44%), Gaps = 23/274 (8%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
            D      +G G  G V   +      VAIK        +  + + EF+ E + +  + H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSH 58

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
             +V+LYG C+  R  F++ E++  G L   L            Q + + K V +A+ YL
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYL 116

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPELA 303
                   +HRD++++N L++ +    V+DFG+++++  D             +  PE+ 
Sbjct: 117 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173

Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
              K + K D+++FGVL  E+   GK P +  +       N++         RL  P  +
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQGLRLYRPHLA 226

Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            ++    +  +++SC +E  + RPT KI+   + 
Sbjct: 227 SEK----VYTIMYSCWHEKADERPTFKILLSNIL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 8e-56
 Identities = 65/279 (23%), Positives = 114/279 (40%), Gaps = 23/279 (8%)

Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEA 178
           EI R       +  +G G  G V+         VAIK           +  + FL E + 
Sbjct: 13  EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQV 65

Query: 179 LTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
           + ++RH  +V+LY   S     ++V E++ +GSL   L  +   + L   Q +++   +A
Sbjct: 66  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIA 123

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD-SSNWTEFAGTYGY 297
             ++Y+        VHRD+ + N+L+       VADFG+A+ ++ +  +          +
Sbjct: 124 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP 357
            APE A   + T K DV+SFG+L  E+                    +        P  P
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 240

Query: 358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                      S+ +++  C  + PE RPT + +   L+
Sbjct: 241 ----------ESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (465), Expect = 9e-56
 Identities = 71/299 (23%), Positives = 128/299 (42%), Gaps = 38/299 (12%)

Query: 117 YDEIVRATNDFDAQY---------CIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPS 163
           +++   A  +F  +           IG G  G V    L         VAIK   S    
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 164 DQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQ 223
            Q   +++FL+E   + +  H N++ L G  + +    ++ EF++ GSL + L  +    
Sbjct: 69  KQ---RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125

Query: 224 ELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP 283
                Q + +++G+A  + YL        VHRD++++N+L++      V+DFG+++FL+ 
Sbjct: 126 T--VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 284 DSSNWTE-----FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSI 337
           D+S+ T            + APE     K T   DV+S+G++  EV+  G+ P   ++  
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-- 238

Query: 338 SSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                N D+      D RLP P          + +++  C  +    RP    +   L 
Sbjct: 239 -----NQDVINAIEQDYRLPPPMDCPSA----LHQLMLDCWQKDRNHRPKFGQIVNTLD 288

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 8e-55
 Identities = 62/297 (20%), Positives = 117/297 (39%), Gaps = 45/297 (15%)

Query: 132 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE--IRHRNIVK 189
            IG G  G V+R +   G+ VA+K F S        +++ +  E E      +RH NI+ 
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILG 61

Query: 190 LYGFCSHARHS----FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLH 245
                +    +    +LV ++ + GSL   L+       +     + +    A  L++LH
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLH 117

Query: 246 HDCF-----PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW----TEFAGTYG 296
            +       P I HRD+ SKN+L+       +AD G+A      +           GT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 297 YVAPELAYTM------KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN------- 343
           Y+APE+          +  ++ D+Y+ G++  E+ +              + +       
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 344 ----TDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                 +  ++ L P +P   +S  E LR + +++  C   +  +R T   + + L 
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 9e-55
 Identities = 70/274 (25%), Positives = 116/274 (42%), Gaps = 27/274 (9%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
            +      IG G  G V   +   G  VA+K   +          + FL E   +T++RH
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND------ATAQAFLAEASVMTQLRH 59

Query: 185 RNIVKLYGFCSHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
            N+V+L G     +   ++V E++ +GSL   L S      LG    +     V +A+ Y
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEY 118

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           L        VHRD++++N+L+  +  A V+DFG+ K     SS          + APE  
Sbjct: 119 LEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEAL 172

Query: 304 YTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
              K + K DV+SFG+L  E+   G+ P   +          D+        ++ AP   
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKMDAPDGC 225

Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                  + EV+ +C +     RP+   + +QL+
Sbjct: 226 PPA----VYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-54
 Identities = 76/266 (28%), Positives = 116/266 (43%), Gaps = 22/266 (8%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
            DF+    +G G  G+VY A    S  ++A+K           V + +   EVE  + +R
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 64

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           H NI++LYG+   A   +L+ E+   G++   L       +    +    I  +A+ALSY
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSY 121

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
            H      ++HRDI  +NLLL    E  +ADFG +      SS  T   GT  Y+ PE+ 
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMI 176

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
                 EK D++S GVL  E + GK P +          NT  E  + +          V
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE---------ANTYQETYKRISRVEFTFPDFV 227

Query: 364 QEKLRSIVEVVFSCLNESPESRPTMK 389
            E  R ++      L  +P  RP ++
Sbjct: 228 TEGARDLIS---RLLKHNPSQRPMLR 250

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  177 bits (450), Expect = 1e-53
 Identities = 67/284 (23%), Positives = 126/284 (44%), Gaps = 25/284 (8%)

Query: 117 YDEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTE 175
           YD+      D   ++ +G G +G VY          VA+K        +  ++ +EFL E
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 63

Query: 176 VEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIK 235
              + EI+H N+V+L G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMAT 122

Query: 236 GVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN-WTEFAGT 294
            ++ A+ YL        +HRD++++N L+       VADFG+++ +  D+          
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179

Query: 295 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP 354
             + APE     K + K DV++FGVL  E+            +S        ++ E+L+ 
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEK 231

Query: 355 --RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             R+  P    ++    + E++ +C   +P  RP+   + Q  +
Sbjct: 232 DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-53
 Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 31/273 (11%)

Query: 133 IGNGGHGSVYRAELP---SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G  G+V +         + VA+K   +   ++    K E L E   + ++ +  IV+
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
           + G C       LV E  + G L   L  +   + +     + ++  V+  + YL     
Sbjct: 73  MIGICEA-ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE--- 125

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW---TEFAGTYGYVAPELAYTM 306
              VHRD++++N+LL  +  A ++DFG++K L+ D + +   T       + APE     
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 307 KITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEML--DPRLPAPSRSV 363
           K + K DV+SFGVL  E    G+ P   +            E+  ML    R+  P+   
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGM---------KGSEVTAMLEKGERMGCPAGCP 236

Query: 364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +E    + +++  C     E+RP    V  +L+
Sbjct: 237 RE----MYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-53
 Identities = 67/273 (24%), Positives = 111/273 (40%), Gaps = 31/273 (11%)

Query: 133 IGNGGHGSVYRAEL---PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G G  GSV +           VAIK            D +E + E + + ++ +  IV+
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA---DTEEMMREAQIMHQLDNPYIVR 73

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
           L G C  A    LV E    G L   L      +E+  S    ++  V+  + YL     
Sbjct: 74  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE--- 127

Query: 250 PPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE---FAGTYGYVAPELAYTM 306
              VHRD++++N+LL     A ++DFG++K L  D S +T          + APE     
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187

Query: 307 KITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSV 363
           K + + DV+S+GV   E +  G+ P   +            E+   ++   R+  P    
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMK---------GPEVMAFIEQGKRMECPPECP 238

Query: 364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            E    +  ++  C     E RP    V Q+++
Sbjct: 239 PE----LYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-53
 Identities = 69/282 (24%), Positives = 126/282 (44%), Gaps = 27/282 (9%)

Query: 117 YDEIVRATN---DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEF 172
           Y+ + R  N    ++    +G+G  G VY+A+   +  + A K     + +    + +++
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV----IDTKSEEELEDY 56

Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN 232
           + E++ L    H NIVKL     +  + +++ EF   G++ A++      + L  SQ   
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQV 114

Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA 292
           V K   DAL+YLH      I+HRD+ + N+L  L+ +  +ADFG++            F 
Sbjct: 115 VCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171

Query: 293 GTYGYVAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE 347
           GT  ++APE+             K DV+S G+  +E+ + + P   L+ +         E
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE 231

Query: 348 LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
                 P L  PSR      +  ++    CL ++ ++R T  
Sbjct: 232 P-----PTLAQPSR-WSSNFKDFLK---KCLEKNVDARWTTS 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 3e-53
 Identities = 56/263 (21%), Positives = 111/263 (42%), Gaps = 24/263 (9%)

Query: 133 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G   +VY+     +   VA  +      +    +++ F  E E L  ++H NIV+ Y
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 192 GFC----SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
                     +   LV E +  G+L   L      + +      +  + +   L +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 248 CFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM 306
             PPI+HRD+   N+ +        + D G+A   +   +      GT  ++APE+ Y  
Sbjct: 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEM-YEE 187

Query: 307 KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEK 366
           K  E  DVY+FG+  LE+   ++P  +    +++ +   +        +  +  +    +
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRV----TSGVKPASFDKVAIPE 241

Query: 367 LRSIVEVVFSCLNESPESRPTMK 389
           ++ I+E    C+ ++ + R ++K
Sbjct: 242 VKEIIE---GCIRQNKDERYSIK 261

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 5e-53
 Identities = 68/258 (26%), Positives = 120/258 (46%), Gaps = 21/258 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G  G+VY A ++ +GQ VAI++ +      Q   K+  + E+  + E ++ NIV   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                    ++V E+L  GSL  +++       +   Q   V +    AL +LH +    
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ--- 136

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 311
           ++HRDI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 312 CDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIV 371
            D++S G++A+E+I+G+ P    + + + +L           P L  P + +    R  +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-----TPELQNPEK-LSAIFRDFL 250

Query: 372 EVVFSCLNESPESRPTMK 389
                CL+   E R + K
Sbjct: 251 N---RCLDMDVEKRGSAK 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (447), Expect = 5e-53
 Identities = 65/312 (20%), Positives = 127/312 (40%), Gaps = 47/312 (15%)

Query: 114 KLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIV 167
           KL+  E  R  N+ +    IG G  G V++A  P         +VA+K       +D   
Sbjct: 4   KLLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-- 59

Query: 168 DKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSS--------- 218
            + +F  E   + E  + NIVKL G C+  +   L++E++  G L   L S         
Sbjct: 60  -QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 219 ------------DAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL 266
                             L  ++++ + + VA  ++YL        VHRD++++N L+  
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGE 175

Query: 267 EFEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEV 324
                +ADFG+++ +            A    ++ PE  +  + T + DV+++GV+  E+
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235

Query: 325 IKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPES 384
                   +        +  +  +  + D  + A   +   +L +++     C ++ P  
Sbjct: 236 FSYGLQPYY-------GMAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPAD 285

Query: 385 RPTMKIVSQQLQ 396
           RP+   + + LQ
Sbjct: 286 RPSFCSIHRILQ 297

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (445), Expect = 1e-52
 Identities = 69/261 (26%), Positives = 118/261 (45%), Gaps = 25/261 (9%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG+G  G+VY A  + + +VVAIKK             ++ + EV  L ++RH N ++  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
           G       ++LV E+    +   +       + L   +   V  G    L+YLH      
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HN 135

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM---KI 308
           ++HRD+ + N+LL       + DFG A  + P +S    F GT  ++APE+   M   + 
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAMDEGQY 191

Query: 309 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLR 368
             K DV+S G+  +E+ + K P   ++++S+ +     E   +             E  R
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS-------EYFR 244

Query: 369 SIVEVVFSCLNESPESRPTMK 389
           + V+   SCL + P+ RPT +
Sbjct: 245 NFVD---SCLQKIPQDRPTSE 262

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 3e-52
 Identities = 65/318 (20%), Positives = 124/318 (38%), Gaps = 55/318 (17%)

Query: 114 KLVYD---EIVRATNDFDAQYCIGNGGHGSVYRAELPS------GQVVAIKKFHSPLPSD 164
           +  YD   E  R   + +    +G+G  G V  A             VA+K         
Sbjct: 25  EYEYDLKWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKA 79

Query: 165 QIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSS----- 218
              +++  ++E++ +T++  H NIV L G C+ +   +L++E+   G L   L S     
Sbjct: 80  DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 139

Query: 219 ---------------DAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLL 263
                          +     L +   +     VA  + +L        VHRD++++N+L
Sbjct: 140 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVL 196

Query: 264 LDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLA 321
           +       + DFG+A+ +  DS+            ++APE  +    T K DV+S+G+L 
Sbjct: 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256

Query: 322 LEVI-KGKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCL 378
            E+   G +P           +  D    +++    ++  P  + +E    I  ++ SC 
Sbjct: 257 WEIFSLGVNPYP--------GIPVDANFYKLIQNGFKMDQPFYATEE----IYIIMQSCW 304

Query: 379 NESPESRPTMKIVSQQLQ 396
                 RP+   ++  L 
Sbjct: 305 AFDSRKRPSFPNLTSFLG 322

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 3e-52
 Identities = 67/312 (21%), Positives = 127/312 (40%), Gaps = 48/312 (15%)

Query: 114 KLVYD---EIVRATNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSD 164
           +L YD   E  R  N       +G G  G V  A         +   VA+K      PS 
Sbjct: 11  QLPYDHKWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSA 65

Query: 165 QIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAIL------- 216
            + +++  ++E++ L+ +  H NIV L G C+    + ++ E+   G L   L       
Sbjct: 66  HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125

Query: 217 --------SSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF 268
                     +     L     ++    VA  +++L        +HRD++++N+LL    
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGR 182

Query: 269 EAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK 326
              + DFG+A+ +K DS+            ++APE  +    T + DV+S+G+   E+  
Sbjct: 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

Query: 327 GKHPRDFLSSISSSFLNTDIELDEMLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPES 384
                          +  D +  +M+    R+ +P  +  E    + +++ +C +  P  
Sbjct: 243 LGSSPYP-------GMPVDSKFYKMIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLK 291

Query: 385 RPTMKIVSQQLQ 396
           RPT K + Q ++
Sbjct: 292 RPTFKQIVQLIE 303

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-51
 Identities = 63/269 (23%), Positives = 104/269 (38%), Gaps = 22/269 (8%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
            D+D    +G G +G V  A    + + VA+K          +   +    E+     + 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKMLN 61

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           H N+VK YG        +L  E+   G L   +  D     +           +   + Y
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 118

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPE 301
           LH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  YVAPE
Sbjct: 119 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 302 LAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
           L    +   E  DV+S G++   ++ G+ P D  S     +       D         P 
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPW 229

Query: 361 RSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           + +     +++      L E+P +R T+ 
Sbjct: 230 KKIDSAPLALLH---KILVENPSARITIP 255

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 5e-51
 Identities = 66/273 (24%), Positives = 108/273 (39%), Gaps = 27/273 (9%)

Query: 133 IGNGGHGSVYRAELP----SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIV 188
           IG G  G VY   L          A+K  +       I +  +FLTE   + +  H N++
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 189 KLYGFCSHARHS-FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
            L G C  +  S  +V  ++K G L   + ++     +       +          +   
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFL 146

Query: 248 CFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDS----SNWTEFAGTYGYVAPELA 303
                VHRD++++N +LD +F   VADFG+A+ +         N T       ++A E  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
            T K T K DV+SFGVL  E++    P     +        DI +  +   RL  P    
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDITVYLLQGRRLLQPEYCP 260

Query: 364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
                 + EV+  C +   E RP+   +  ++ 
Sbjct: 261 DP----LYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-50
 Identities = 71/291 (24%), Positives = 117/291 (40%), Gaps = 38/291 (13%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELPSG---QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTE 181
           ND   Q  IG G  G V +A +         AIK+       D   D ++F  E+E L +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 66

Query: 182 I-RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAIL-------------SSDAAAQELGW 227
           +  H NI+ L G C H  + +L  E+   G+L   L              +++ A  L  
Sbjct: 67  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 228 SQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN 287
            Q ++    VA  + YL        +HRD++++N+L+   + A +ADFG+++  +     
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183

Query: 288 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE 347
                    ++A E       T   DV+S+GVL  E++          + +        E
Sbjct: 184 TM-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------E 234

Query: 348 LDEML--DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           L E L    RL  P     E    + +++  C  E P  RP+   +   L 
Sbjct: 235 LYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSLN 281

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-50
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 32/289 (11%)

Query: 118 DEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQ-----VVAIKKFHSPLPSDQIVDKKEF 172
            EI    +    Q  IG G  G VY+  L +        VAIK   +     Q   + +F
Sbjct: 2   TEI--HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ---RVDF 56

Query: 173 LTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMN 232
           L E   + +  H NI++L G  S  +   ++ E+++ G+L   L       E    Q + 
Sbjct: 57  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVG 114

Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW---T 289
           +++G+A   + + +      VHRD++++N+L++      V+DFG+++ L+ D       +
Sbjct: 115 MLRGIA---AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171

Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD 349
                  + APE     K T   DV+SFG++  EV+       +  S        + E+ 
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVM 223

Query: 350 EMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           + ++   RLP P          I +++  C  +    RP    +   L 
Sbjct: 224 KAINDGFRLPTPMDCPSA----IYQLMMQCWQQERARRPKFADIVSILD 268

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  170 bits (432), Expect = 3e-50
 Identities = 59/268 (22%), Positives = 109/268 (40%), Gaps = 21/268 (7%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           + +D    +G G  G V+R  E  +G   A K   +P  SD    K+    E++ ++ +R
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD----KETVRKEIQTMSVLR 81

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           H  +V L+          ++YEF+  G L   ++      ++   + +  ++ V   L +
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCH 139

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
           +H +     VH D+  +N++   +    +   DFG+   L P  S      GT  + APE
Sbjct: 140 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPE 195

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR 361
           +A    +    D++S GVL+  ++ G  P  F        L      D  +D    +   
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWNMDDSAFS--- 250

Query: 362 SVQEKLRSIVEVVFSCLNESPESRPTMK 389
            + E  +  +      L   P +R T+ 
Sbjct: 251 GISEDGKDFIR---KLLLADPNTRMTIH 275

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  168 bits (426), Expect = 2e-49
 Identities = 58/270 (21%), Positives = 115/270 (42%), Gaps = 25/270 (9%)

Query: 125 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           + +D    +G+G  G V+R  E  +G+V   K  ++P P    +DK     E+  + ++ 
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP----LDKYTVKNEISIMNQLH 84

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           H  ++ L+          L+ EFL  G L   ++++    ++  ++ +N ++   + L +
Sbjct: 85  HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKH 142

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
           +H      IVH DI  +N++ + +  + V   DFG+A  L PD         T  + APE
Sbjct: 143 MHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAPE 198

Query: 302 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS--SSFLNTDIELDEMLDPRLPAP 359
           +     +    D+++ GVL   ++ G  P      +    +    D E DE     +   
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258

Query: 360 SRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           ++          + + + L + P  R T+ 
Sbjct: 259 AK----------DFIKNLLQKEPRKRLTVH 278

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-49
 Identities = 68/280 (24%), Positives = 106/280 (37%), Gaps = 25/280 (8%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
            D      +G+G  G V R E  +       VA+K     + S       +F+ EV A+ 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-EAMDDFIREVNAMH 66

Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADA 240
            + HRN+++LYG         +V E    GSL   L                    VA+ 
Sbjct: 67  SLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEG 123

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW---TEFAGTYGY 297
           + YL        +HRD++++NLLL       + DFG+ + L  +  ++         + +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
            APE   T   +   D + FGV   E+   G+ P   L+          +   +    RL
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGERL 234

Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           P P    Q+    I  V+  C    PE RPT   +   L 
Sbjct: 235 PRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 1e-48
 Identities = 61/279 (21%), Positives = 103/279 (36%), Gaps = 22/279 (7%)

Query: 122 RATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
           +   DF     +G G   +V  A EL + +  AIK         +         E + ++
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-KVPYVTRERDVMS 63

Query: 181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADA 240
            + H   VKLY         +    + K G L   +           +        +  A
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSA 120

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW--TEFAGTYGYV 298
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S       F GT  YV
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           +PEL       +  D+++ G +  +++ G  P  F +       N  +   +++      
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAG------NEYLIFQKIIKLEYDF 229

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQI 397
           P +    K R +VE     L      R   + +     +
Sbjct: 230 PEK-FFPKARDLVE---KLLVLDATKRLGCEEMEGYGPL 264

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (411), Expect = 1e-47
 Identities = 68/272 (25%), Positives = 109/272 (40%), Gaps = 26/272 (9%)

Query: 124 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
            + +D +  +G G    V  AE   + ++VAIK             +     E+  L +I
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA---KKALEGKEGSMENEIAVLHKI 64

Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALS 242
           +H NIV L        H +L+ + +  G L   +                +I  V DA+ 
Sbjct: 65  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVK 121

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFE---AHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           YLH      IVHRD+  +NLL     E     ++DFG++K   P S   T   GT GYVA
Sbjct: 122 YLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVA 177

Query: 300 PELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSFLNTDIELDEMLDPRLP 357
           PE+      ++  D +S GV+A  ++ G  P   +  + +    L  + E D      + 
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237

Query: 358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
                      S  + +   + + PE R T +
Sbjct: 238 ----------DSAKDFIRHLMEKDPEKRFTCE 259

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 1e-47
 Identities = 63/288 (21%), Positives = 119/288 (41%), Gaps = 33/288 (11%)

Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAE-LPSGQV----VAIKKFHSPLPSDQIVDKKEFL 173
            I++ T +F     +G+G  G+VY+   +P G+     VAIK+      +      KE L
Sbjct: 4   RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEIL 59

Query: 174 TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNV 233
            E   +  + + ++ +L G C  +    L+ + +  G L   +        +G    +N 
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHK--DNIGSQYLLNW 116

Query: 234 IKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW--TEF 291
              +A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +     
Sbjct: 117 CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173

Query: 292 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDE 350
                ++A E       T + DV+S+GV   E++  G  P D              E+  
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---------GIPASEISS 224

Query: 351 MLD--PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +L+   RLP P     +    +  ++  C     +SRP  + +  +  
Sbjct: 225 ILEKGERLPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 4e-47
 Identities = 68/284 (23%), Positives = 115/284 (40%), Gaps = 28/284 (9%)

Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKEFLT 174
           EI R     +   CIG G  G V++    S       VAIK   +         +++FL 
Sbjct: 3   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQ 57

Query: 175 EVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVI 234
           E   + +  H +IVKL G  +     +++ E    G L + L        L  +  +   
Sbjct: 58  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYA 114

Query: 235 KGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS-NWTEFAG 293
             ++ AL+YL        VHRDI+++N+L+       + DFG++++++  +    ++   
Sbjct: 115 YQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 171

Query: 294 TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSFLNTDIELDEML 352
              ++APE     + T   DV+ FGV   E++  G  P   +        N D+      
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIEN 224

Query: 353 DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
             RLP P  +    L S++     C    P  RP    +  QL 
Sbjct: 225 GERLPMPP-NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLS 264

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 6e-47
 Identities = 64/267 (23%), Positives = 105/267 (39%), Gaps = 21/267 (7%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT-EI 182
            DF     +G G  G V+ AE   + Q  AIK     +      D +  + E   L+   
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-DVECTMVEKRVLSLAW 60

Query: 183 RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALS 242
            H  +  ++       + F V E+L  G L   + S     +   S+       +   L 
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQ 117

Query: 243 YLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 302
           +LH      IV+RD+   N+LLD +    +ADFG+ K      +    F GT  Y+APE+
Sbjct: 118 FLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174

Query: 303 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS 362
               K     D +SFGVL  E++ G+ P              + EL   +    P   R 
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---------QDEEELFHSIRMDNPFYPRW 225

Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMK 389
           ++++ + ++          PE R  ++
Sbjct: 226 LEKEAKDLLV---KLFVREPEKRLGVR 249

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-46
 Identities = 56/260 (21%), Positives = 106/260 (40%), Gaps = 22/260 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           +G G  G V+R  E  S +    K         +  D+     E+  L   RHRNI+ L+
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISILNIARHRNILHLH 67

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +++EF+    +   +++   A EL   + ++ +  V +AL +LH      
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HN 122

Query: 252 IVHRDISSKNLLLDLEFEAHV--ADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKIT 309
           I H DI  +N++      + +   +FG A+ LKP  +          Y APE+     ++
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQHDVVS 181

Query: 310 EKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRS 369
              D++S G L   ++ G +P  FL+            ++ +++        + +E    
Sbjct: 182 TATDMWSLGTLVYVLLSGINP--FLAE------TNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 370 IVEVVFSCLNESPESRPTMK 389
            ++ V   L +  +SR T  
Sbjct: 234 AMDFVDRLLVKERKSRMTAS 253

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  157 bits (397), Expect = 6e-46
 Identities = 66/284 (23%), Positives = 118/284 (41%), Gaps = 28/284 (9%)

Query: 124 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
           ++ ++    +G GG   V+ A  L   + VA+K   + L  D       F  E +    +
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPS-FYLRFRREAQNAAAL 64

Query: 183 RHRNIVKLYGFCSHARHS----FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
            H  IV +Y        +    ++V E++   +L  I+ ++     +   + + VI    
Sbjct: 65  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADAC 121

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTE---FAGTY 295
            AL++ H      I+HRD+   N+++       V DFGIA+ +    ++ T+     GT 
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF--LNTDIELDEMLD 353
            Y++PE A    +  + DVYS G +  EV+ G+ P    S +S ++  +  D        
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238

Query: 354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRP-TMKIVSQQLQ 396
             L A           +  VV   L ++PE+R  T   +   L 
Sbjct: 239 EGLSA----------DLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-45
 Identities = 60/305 (19%), Positives = 120/305 (39%), Gaps = 37/305 (12%)

Query: 111 FEGKLVYD----EIVRATNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSP 160
           F    VY     E+ R          +G G  G VY               VAIK  +  
Sbjct: 4   FSAADVYVPDEWEVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-- 59

Query: 161 LPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAIL---- 216
             +  + ++ EFL E   + E    ++V+L G  S  + + ++ E + RG L + L    
Sbjct: 60  -EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 118

Query: 217 ---SSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVA 273
              +++        S+ + +   +AD ++YL+       VHRD++++N ++  +F   + 
Sbjct: 119 PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175

Query: 274 DFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPR 331
           DFG+ + +          +      +++PE       T   DV+SFGV+  E+       
Sbjct: 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ- 234

Query: 332 DFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIV 391
                     L+ +  L  +++  L     +  + L  ++     C   +P+ RP+   +
Sbjct: 235 ------PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEI 285

Query: 392 SQQLQ 396
              ++
Sbjct: 286 ISSIK 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-44
 Identities = 68/304 (22%), Positives = 120/304 (39%), Gaps = 46/304 (15%)

Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRAELPS--------GQVVAIKKFHSPLPSDQIVDKK 170
           E+ R  +       +G G  G V  AE              VA+K   S        D  
Sbjct: 9   ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLS 63

Query: 171 EFLTEVEALTEI-RHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAIL------------- 216
           + ++E+E +  I +H+NI+ L G C+     +++ E+  +G+L   L             
Sbjct: 64  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 123

Query: 217 SSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG 276
            S    ++L     ++    VA  + YL        +HRD++++N+L+  +    +ADFG
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 180

Query: 277 IAKFLKPDSSNWT--EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL 334
           +A+ +                 ++APE  +    T + DV+SFGVL  E+          
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240

Query: 335 SSISSSFLNTDIELDEML--DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVS 392
             +         EL ++L    R+  PS    E    +  ++  C +  P  RPT K + 
Sbjct: 241 VPVE--------ELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLV 288

Query: 393 QQLQ 396
           + L 
Sbjct: 289 EDLD 292

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  149 bits (377), Expect = 5e-43
 Identities = 60/277 (21%), Positives = 113/277 (40%), Gaps = 28/277 (10%)

Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVD-----KKEFLTEVEAL 179
           +++ +  +G G    V R    P+ +  A+K            +     ++  L EV+ L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 180 TEIR-HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
            ++  H NI++L          FLV++ +K+G L   L+       L   +   +++ + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 120

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 298
           + +  LH      IVHRD+  +N+LLD +    + DFG +  L P      E  GT  Y+
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYL 176

Query: 299 APELAYTM------KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML 352
           APE+             ++ D++S GV+   ++ G  P  F            + L  ++
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHR------KQMLMLRMIM 228

Query: 353 DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
                  S    +   ++ ++V   L   P+ R T +
Sbjct: 229 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 265

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  151 bits (383), Expect = 5e-43
 Identities = 55/268 (20%), Positives = 96/268 (35%), Gaps = 21/268 (7%)

Query: 125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDK--KEFLTEVEALTE 181
           NDF     IG GG G VY      +G++ A+K         +  +         +  ++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 182 IRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADAL 241
                IV +            + + +  G L   LS      E   +        +   L
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---ADMRFYAAEIILGL 120

Query: 242 SYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE 301
            ++H+     +V+RD+   N+LLD      ++D G+A        + +   GT+GY+APE
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175

Query: 302 -LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS 360
            L   +      D +S G +  ++++G  P     +          E+D M         
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT------KDKHEIDRMTLTMAVELP 229

Query: 361 RSVQEKLRSIVEVVFSCLNESPESRPTM 388
            S   +LRS++E     L      R   
Sbjct: 230 DSFSPELRSLLE---GLLQRDVNRRLGC 254

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  149 bits (377), Expect = 6e-43
 Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 26/275 (9%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG 192
           IG G +G VY+A+   G+  A+KK       + I      + E+  L E++H NIVKLY 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI--PSTTIREISILKELKHSNIVKLYD 67

Query: 193 FCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 252
                +   LV+E L +     +   +     L      + +  + + ++Y H      +
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRV 121

Query: 253 VHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITEK 311
           +HRD+  +NLL++ E E  +ADFG+A+        +T    T  Y AP+ L  + K +  
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181

Query: 312 CDVYSFGVLALEVIKGKHP------RDFLSSISSSFLNTDIE----------LDEMLDPR 355
            D++S G +  E++ G          D L  I       + +           D      
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241

Query: 356 LPAPSRSVQEKL-RSIVEVVFSCLNESPESRPTMK 389
            P P  S  + L  S ++++   L   P  R T K
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-42
 Identities = 51/264 (19%), Positives = 101/264 (38%), Gaps = 22/264 (8%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFH--SPLPSDQIVDKKEFLTEVEALTEIRHRNIVK 189
           +G+G    V +  E  +G   A K         S + V +++   EV  L EI+H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 190 LYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCF 249
           L+    +     L+ E +  G L           E          + +   L+ +++   
Sbjct: 78  LHEVYENKTDVILILELVAGGEL------FDFLAEKESLTEEEATEFLKQILNGVYYLHS 131

Query: 250 PPIVHRDISSKNLLLDLE----FEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT 305
             I H D+  +N++L           + DFG+A  +   +  +    GT  +VAPE+   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 190

Query: 306 MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
             +  + D++S GV+   ++ G  P  FL       L     ++   +    +   +   
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEFEDEYFS---NTSA 245

Query: 366 KLRSIVEVVFSCLNESPESRPTMK 389
             +  +      L + P+ R T++
Sbjct: 246 LAKDFIR---RLLVKDPKKRMTIQ 266

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  147 bits (372), Expect = 7e-42
 Identities = 57/264 (21%), Positives = 105/264 (39%), Gaps = 23/264 (8%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
            DF     +G G  G V+      +G+  A+K     +        +    E   L+ + 
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVT 62

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           H  I++++G    A+  F++ ++++ G L ++L                     A+    
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA------AEVCLA 116

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           L +     I++RD+  +N+LLD      + DFG AK++           GT  Y+APE+ 
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVV 173

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
            T    +  D +SFG+L  E++ G  P  F  S      NT    +++L+  L  P    
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP--FYDS------NTMKTYEKILNAELRFPP-FF 224

Query: 364 QEKLRSIVEVVFSCLNESPESRPT 387
            E ++ ++      +      R  
Sbjct: 225 NEDVKDLLS---RLITRDLSQRLG 245

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 9e-42
 Identities = 67/301 (22%), Positives = 114/301 (37%), Gaps = 40/301 (13%)

Query: 119 EIVRATNDFDAQYCIGNGGHGSVYRA------ELPSGQVVAIKKFHSPLPSDQIVDKKEF 172
           E  R  +       +G G  G V  A      +  + + VA+K            + +  
Sbjct: 9   EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---EHRAL 63

Query: 173 LTEVEALTEIRHR-NIVKLYGFCSHARHS-FLVYEFLKRGSLAAILSS------------ 218
           ++E++ L  I H  N+V L G C+       ++ EF K G+L+  L S            
Sbjct: 64  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123

Query: 219 -DAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI 277
            D     L     +     VA  + +L        +HRD++++N+LL  +    + DFG+
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGL 180

Query: 278 AKFLKPDSSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLS 335
           A+ +  D       +      ++APE  +    T + DV+SFGVL  E+           
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240

Query: 336 SISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQL 395
            I   F     E       R+ AP  +  E    + + +  C +  P  RPT   + + L
Sbjct: 241 KIDEEFCRRLKE-----GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 396 Q 396
            
Sbjct: 292 G 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-41
 Identities = 64/279 (22%), Positives = 105/279 (37%), Gaps = 31/279 (11%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFH-SPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL 190
           +G G   +VY+A    + Q+VAIKK         +    +  L E++ L E+ H NI+ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
                H  +  LV++F++      I  +      L  S     +      L YLH     
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 251 PIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-IT 309
            I+HRD+   NLLLD      +ADFG+AK     +  +T    T  Y APEL +  +   
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 310 EKCDVYSFGVLALEVIKGKHP------RDFLSSI-------------SSSFLNTDIELDE 350
              D+++ G +  E++            D L+ I                 L   +    
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 351 MLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
                L     +  + L  +++        +P +R T  
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITAT 275

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 3e-41
 Identities = 64/267 (23%), Positives = 107/267 (40%), Gaps = 29/267 (10%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKL 190
           +G G +G V +     + +  A+K            D  +   EVE      +  +IV++
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRI 70

Query: 191 YGFCSHA----RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH 246
                +     +   +V E L  G L + +  D   Q     +   ++K + +A+ YLH 
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 247 DCFPPIVHRDISSKNLLLDLEFE---AHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
                I HRD+  +NLL   +       + DFG AK     +S  T    T  YVAPE+ 
Sbjct: 130 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPEVL 185

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS- 362
              K  + CD++S GV+   ++ G  P  F S+   +          M     P P  S 
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243

Query: 363 VQEKLRSIVEVVFSCLNESPESRPTMK 389
           V E+++ ++    + L   P  R T+ 
Sbjct: 244 VSEEVKMLIR---NLLKTEPTQRMTIT 267

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  145 bits (366), Expect = 4e-41
 Identities = 44/287 (15%), Positives = 98/287 (34%), Gaps = 26/287 (9%)

Query: 121 VRATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEAL 179
           +R  N +     IG+G  G +Y    + +G+ VAIK               +   E +  
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIY 56

Query: 180 TEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVAD 239
             ++    +    +C       ++   L   SL  + +  +  ++      + +   +  
Sbjct: 57  KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS--RKFSLKTVLLLADQMIS 114

Query: 240 ALSYLHHDCFPPIVHRDISSKNLL---LDLEFEAHVADFGIAKFLKPDSSN-------WT 289
            + Y+H       +HRD+   N L          ++ DFG+AK  +   ++         
Sbjct: 115 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171

Query: 290 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELD 349
              GT  Y +      ++ + + D+ S G + +    G  P   L + +       I   
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231

Query: 350 EMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
           +M  P +    +    +  + +     C +   + +P    + Q  +
Sbjct: 232 KMSTP-IEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 8e-41
 Identities = 60/264 (22%), Positives = 107/264 (40%), Gaps = 32/264 (12%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSD--QIVDKKEFLTEVEALTEIR--HRNI 187
           +G+GG GSVY    +     VAIK       SD  ++ +      EV  L ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71

Query: 188 VKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHD 247
           ++L  +        L+ E  +         ++     L      +    V +A+ + H+ 
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHN- 128

Query: 248 CFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYT 305
               ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y 
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYH 184

Query: 306 MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQE 365
                   V+S G+L  +++ G  P +                +E++  ++    R V  
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFE--------------HDEEIIRGQVFFRQR-VSS 229

Query: 366 KLRSIVEVVFSCLNESPESRPTMK 389
           + + ++     CL   P  RPT +
Sbjct: 230 ECQHLIR---WCLALRPSDRPTFE 250

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 66/283 (23%), Positives = 114/283 (40%), Gaps = 26/283 (9%)

Query: 126 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
           +F     IG G +G VY+A    +G+VVA+KK      ++ +      + E+  L E+ H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV--PSTAIREISLLKELNH 60

Query: 185 RNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYL 244
            NIVKL          +LV+EFL +     + +S      +      + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 118

Query: 245 HHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 303
           H      ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y APE L 
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSSISSSFLNTDIELDE------M 351
                +   D++S G +  E++  +         D L  I  +    D  +         
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 352 LDPRLPAPSRSVQEKL-----RSIVEVVFSCLNESPESRPTMK 389
             P  P  +R    K+          ++   L+  P  R + K
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-39
 Identities = 69/289 (23%), Positives = 107/289 (37%), Gaps = 36/289 (12%)

Query: 126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH 184
            +     IGNG  G VY+A+L  SG++VAIKK           DK+    E++ + ++ H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDH 72

Query: 185 RNIVKLYGFCSHA------RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVA 238
            NIV+L  F   +       +  LV +++             A Q L        +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLEFEAH-VADFGIAKFLKPDSSNWTEFAGTYGY 297
            +L+Y+H      I HRDI  +NLLLD +     + DFG AK L     N +     Y  
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSSISSSFLNTDIELDEM 351
               +      T   DV+S G +  E++ G+         D L  I         E    
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249

Query: 352 LDPRL---------PAPSRSVQEKLRS--IVEVVFSCLNESPESRPTMK 389
           ++P             P   V         + +    L  +P +R T  
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  139 bits (351), Expect = 4e-39
 Identities = 46/278 (16%), Positives = 91/278 (32%), Gaps = 30/278 (10%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN-IVKL 190
           IG G  G ++    L + Q VAIK            D  +   E      +     I  +
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 191 YGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFP 250
           Y F     H+ LV + L       +       ++          K +   +  +H     
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---K 120

Query: 251 PIVHRDISSKNLLLDLEFEAH-----VADFGIAKFLKPDSSN-------WTEFAGTYGYV 298
            +V+RDI   N L+      +     V DFG+ KF +   +            +GT  Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 299 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA 358
           +       + + + D+ + G + +  ++G  P   L + ++      I   +   P    
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240

Query: 359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ 396
            +   +E      + +    N + ++ P    +     
Sbjct: 241 CAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 7e-39
 Identities = 64/268 (23%), Positives = 104/268 (38%), Gaps = 24/268 (8%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           NDFD    +G G  G V       +G+  A+K     +   +  +    +TE   L   R
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTESRVLQNTR 63

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           H  +  L            V E+   G L   LS +    E             A+ +S 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE------ERARFYGAEIVSA 117

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           L +     +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+APE+ 
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIE--LDEMLDPRLPAPSR 361
                    D +  GV+  E++ G+ P          F N D E   + +L   +  P R
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQDHERLFELILMEEIRFP-R 226

Query: 362 SVQEKLRSIVEVVFSCLNESPESRPTMK 389
           ++  + +S++      L + P+ R    
Sbjct: 227 TLSPEAKSLLA---GLLKKDPKQRLGGG 251

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 1e-38
 Identities = 57/293 (19%), Positives = 109/293 (37%), Gaps = 33/293 (11%)

Query: 122 RATNDFDAQYCIGNGGHGSVYRAE--LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEAL 179
           RA   ++    IG G +G V++A      G+ VA+K+       +        + EV  L
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVL 61

Query: 180 TEI---RHRNIVKLYGFCSHAR-----HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM 231
             +    H N+V+L+  C+ +R        LV+E + +     +         +      
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIK 119

Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEF 291
           +++  +   L +LH      +VHRD+  +N+L+    +  +ADFG+A+      +  +  
Sbjct: 120 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-V 175

Query: 292 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-------------RDFLSSIS 338
             T  Y APE+          D++S G +  E+ + K                D +    
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235

Query: 339 SSFLNTDIELDEMLDPRLPAP--SRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
                 D+ L         A    + V +      +++  CL  +P  R +  
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 6e-38
 Identities = 60/284 (21%), Positives = 102/284 (35%), Gaps = 36/284 (12%)

Query: 133 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLY 191
           IG G +G V  A +  +   VAIKK     P +     +  L E++ L   RH NI+ + 
Sbjct: 16  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 72

Query: 192 GFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP 251
                     +   +L    + A L      Q L        +  +   L Y+H      
Sbjct: 73  DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 129

Query: 252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAPELAYT-MK 307
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+      
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189

Query: 308 ITEKCDVYSFGVLALEVIKGKHP----------------------RDFLSSISSSFLNTD 345
            T+  D++S G +  E++  +                         D    I+    N  
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249

Query: 346 IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           + L             +   K   +++     L  +P  R  ++
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVE 290

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 4e-37
 Identities = 55/285 (19%), Positives = 116/285 (40%), Gaps = 28/285 (9%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
             ++    IG G +G+V++A+   + ++VA+K+    L  D        L E+  L E++
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELK 59

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
           H+NIV+L+      +   LV+EF  +       S +      G      V   +   L  
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKG 113

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           L       ++HRD+  +NLL++   E  +A+FG+A+        ++    T  Y  P++ 
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 304 YTMKI-TEKCDVYSFGVLALEVIKGKHP--------------RDFLSSISSSFLNTDIEL 348
           +  K+ +   D++S G +  E+     P                 L + +     +  +L
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 349 DEMLDPRLPAPSRSVQEKLRSI----VEVVFSCLNESPESRPTMK 389
            +     +   + S+   +  +     +++ + L  +P  R + +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 3e-36
 Identities = 59/303 (19%), Positives = 119/303 (39%), Gaps = 42/303 (13%)

Query: 121 VRATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEAL 179
               + ++    IG G  G V++A    +GQ VA+KK    + +++       L E++ L
Sbjct: 6   CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKIL 63

Query: 180 TEIRHRNIVKLYGFCSHA--------RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRM 231
             ++H N+V L   C              +LV++F +      + +      +   S+  
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIK 120

Query: 232 NVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS----N 287
            V++ +   L+ L++     I+HRD+ + N+L+  +    +ADFG+A+      +     
Sbjct: 121 RVMQML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 288 WTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIKGKHP------RDFLSSISSS 340
           +T    T  Y  PEL    +      D++  G +  E+            +  L+ IS  
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 341 FLNTDIELDEMLDPR--------LPAPSRSVQEKLRSIV------EVVFSCLNESPESRP 386
             +   E+   +D          +    R V+++L++ V      +++   L   P  R 
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 387 TMK 389
              
Sbjct: 298 DSD 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 6e-36
 Identities = 56/272 (20%), Positives = 103/272 (37%), Gaps = 22/272 (8%)

Query: 125 NDFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT 180
            +F+    +G G +G V+         +G++ A+K         +    +   TE + L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 181 EIRHR-NIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVAD 239
            IR    +V L+          L+ +++  G L   LS      E      +       +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137

Query: 240 ALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWT-EFAGTYGYV 298
            +  L H     I++RDI  +N+LLD      + DFG++K    D +    +F GT  Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 299 APELAYTMK--ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL 356
           AP++         +  D +S GVL  E++ G  P  F      +            +P  
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSEPPY 255

Query: 357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTM 388
           P   + +    + +++     L + P+ R   
Sbjct: 256 P---QEMSALAKDLIQ---RLLMKDPKKRLGC 281

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (324), Expect = 1e-34
 Identities = 52/263 (19%), Positives = 89/263 (33%), Gaps = 23/263 (8%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           + FD    +G G  G V   +   SG   A+K              +  L E   L  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-QIEHTLNEKRILQAVN 99

Query: 184 HRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSY 243
              +VKL        + ++V E++  G + + L                    +     Y
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEY 156

Query: 244 LHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 303
           LH      +++RD+  +NLL+D +    V DFG AK             GT   +APE+ 
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEII 210

Query: 304 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV 363
            +    +  D ++ GVL  E+  G  P            +  I++ E +           
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFA---------DQPIQIYEKIVSGKVRFPSHF 261

Query: 364 QEKLRSIVEVVFSCLNESPESRP 386
              L+ ++    + L      R 
Sbjct: 262 SSDLKDLLR---NLLQVDLTKRF 281

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  123 bits (310), Expect = 6e-33
 Identities = 62/297 (20%), Positives = 108/297 (36%), Gaps = 49/297 (16%)

Query: 125 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR 183
           +D+     +G G +  V+ A  + + + V +K           V KK+   E++ L  +R
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLR 87

Query: 184 -HRNIVKLYGFCSHA--RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADA 240
              NI+ L         R   LV+E +       +       Q L        +  +  A
Sbjct: 88  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKA 141

Query: 241 LSYLHHDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 299
           L Y H      I+HRD+   N+++D E  +  + D+G+A+F  P    +     +  +  
Sbjct: 142 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 197

Query: 300 PELAYTMK-ITEKCDVYSFGVLALEVIKGKHP-------RDFLSSISSSF---------L 342
           PEL    +      D++S G +   +I  K P        D L  I+             
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257

Query: 343 NTDIELDEMLDPRLPAPSRSVQEKLRSI----------VEVVFSCLNESPESRPTMK 389
             +IELD   +  L   SR   E+              ++ +   L    +SR T +
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 6e-33
 Identities = 59/299 (19%), Positives = 109/299 (36%), Gaps = 38/299 (12%)

Query: 119 EIVRATNDFDAQY----CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFL 173
           E+ +   +  A Y     +G+G +G+V  A +  +G  VAIKK + P  S+     K   
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL--FAKRAY 65

Query: 174 TEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSD-AAAQELGWSQRMN 232
            E+  L  +RH N++ L    +         +F                 ++LG  +   
Sbjct: 66  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125

Query: 233 VIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFA 292
           ++  +   L Y+H        HRD+   NL ++ + E  + DFG+A+    DS       
Sbjct: 126 LVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTGYVV 180

Query: 293 GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP---------------------R 331
             +      +   M+ T+  D++S G +  E+I GK                        
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240

Query: 332 DFLSSISSSFLNTDIE-LDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMK 389
           +F+  + S      ++ L E+      +   +      +++E     L    E R T  
Sbjct: 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAG 296

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 6e-31
 Identities = 58/291 (19%), Positives = 100/291 (34%), Gaps = 36/291 (12%)

Query: 124 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI 182
              +     +G+G +GSV  A    +G  VA+KK   P  S      K    E+  L  +
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHM 74

Query: 183 RHRNIVKLYGFCSHAR-----HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGV 237
           +H N++ L    + AR     +   +   L    L  I+      Q+L       +I  +
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQI 130

Query: 238 ADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNWTEFAGTYGY 297
              L Y+H        HRD+   NL ++ + E  + DFG+A+    D       A  +  
Sbjct: 131 LRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYR 185

Query: 298 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSSISSSFLNTDIELDE- 350
               +   M   +  D++S G +  E++ G+         D L  I         EL + 
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245

Query: 351 --------MLDPRLPAPSRSVQEKLRSI----VEVVFSCLNESPESRPTMK 389
                    +      P  +            V+++   L    + R T  
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-30
 Identities = 61/311 (19%), Positives = 108/311 (34%), Gaps = 49/311 (15%)

Query: 116 VYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPSDQIVDKKEFLT 174
           V D        +     IG+G  G V  A +    + VAIKK   P  +      K    
Sbjct: 8   VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT--HAKRAYR 65

Query: 175 EVEALTEIRHRNIVKLYGFCSHARHS------FLVYEFLKRGSLAAILSSDAAAQELGWS 228
           E+  +  + H+NI+ L    +  +        +LV E +       I        EL   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHE 119

Query: 229 QRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSNW 288
           +   ++  +   + +LH       +HRD+   N+++  +    + DFG+A+     S   
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMM 175

Query: 289 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSSISSSFL 342
           T +  T  Y APE+   M   E  D++S G +  E+++ K         D  + +     
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235

Query: 343 NTDIELDEMLDPRL------------------------PAPSRSVQEKLRSIVEVVFSCL 378
               E  + L P +                        PA S   + K     +++   L
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295

Query: 379 NESPESRPTMK 389
              P  R ++ 
Sbjct: 296 VIDPAKRISVD 306

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 97.4 bits (241), Expect = 3e-23
 Identities = 45/254 (17%), Positives = 92/254 (36%), Gaps = 26/254 (10%)

Query: 133 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRN----- 186
           +G G   +V+ A+ + +   VA+K           V  +    E++ L  +   +     
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKED 75

Query: 187 ------IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWS--QRMNVIKGVA 238
                 I+KL    +H   + +    +       +L+     +  G        + K + 
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 239 DALSYLHHDCFPPIVHRDISSKNLLLDLE-FEAHVADFGIAKFLKPDSS--NWTEFAGTY 295
             L Y+H  C   I+H DI  +N+L+++     ++    IA          ++T    T 
Sbjct: 136 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 296 GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR 355
            Y +PE+          D++S   L  E+I G     F      S+   D  + ++++  
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIELL 251

Query: 356 LPAPSRSVQEKLRS 369
              PS  ++    +
Sbjct: 252 GELPSYLLRNGKYT 265

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.8 bits (214), Expect = 1e-20
 Identities = 30/183 (16%), Positives = 56/183 (30%), Gaps = 26/183 (14%)

Query: 133 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIV------DKKEFLTEVEALTEIRHRN 186
           +G G   +V+           +K       S + V          F            R 
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 187 IVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH 246
           + KL G      +++      +  ++   L        +       V+  + + ++  +H
Sbjct: 68  LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 247 DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK---------FLKPDSSNWTE-FAGTYG 296
                IVH D+S  N+L+  E    + DF  +           L+ D  N    F+ TY 
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYR 177

Query: 297 YVA 299
              
Sbjct: 178 TEK 180

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 51.3 bits (121), Expect = 6e-08
 Identities = 13/41 (31%), Positives = 19/41 (46%)

Query: 1   MHGLSVIDISDNQLQGPVPNSTAFRNASVEALEGNKGLCGG 41
           +  L  +++S N L G +P     +   V A   NK LCG 
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	397
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.67
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.24
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.92
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.34
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.17
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.03
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	92.35
d2ifga3	156	High affinity nerve growth factor receptor, N-term	89.95
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	89.85
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	89.44
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	87.66
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	85.99
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	85.13
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	80.36

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-58  Score=406.97  Aligned_cols=257  Identities=23%  Similarity=0.424  Sum_probs=200.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .++|+..+.||+|+||+||+|+.++  .||||+++.....  ....+.|.+|++++++++||||++++|++.. +..++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPT--PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCC--TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            4578889999999999999998643  5999998753322  2346789999999999999999999998754 568999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....  ..+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            99999999999997544  3599999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCC--CcccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 016009          284 DSS--NWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       284 ~~~--~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      ...  ......||+.|+|||++.+   ..++.++|||||||++|||+||+.||............   .......+... 
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~---~~~~~~~p~~~-  232 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLS-  232 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH---HHHTSCCCCGG-
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH---HhcCCCCCcch-
Confidence            322  2345679999999999864   35899999999999999999999998754322110000   00111111111 


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        ....+.+..+.+|+.+||+.||++|||++||+++||
T Consensus       233 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le  268 (276)
T d1uwha_         233 --KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE  268 (276)
T ss_dssp             --GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence              111123456889999999999999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-57  Score=399.24  Aligned_cols=250  Identities=26%  Similarity=0.445  Sum_probs=196.6

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|+..+.||+|+||+||+|.+.+++.||||+++...     ...++|.+|++++++++||||++++|+|..++..++||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-----CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            4678889999999999999999889999999987422     23578999999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++|+|.+++....  ..++|..++.++.|+|.||+|||+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus        80 E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             ECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             EecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC
Confidence            9999999999987543  4689999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCccccccccccccccccccccC-CCCCCCCc
Q 016009          285 SS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG-KHPRDFLSSISSSFLNTDIELDEMLD-PRLPAPSR  361 (397)
Q Consensus       285 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  361 (397)
                      .. ......||+.|+|||++.+..++.++|||||||++|||+|+ ++|+.......        ....+.. .+...+. 
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--------~~~~i~~~~~~~~p~-  225 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRLYKPR-  225 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--------HHHHHHHTCCCCCCT-
T ss_pred             CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHhcCCCCCcc-
Confidence            32 22345789999999999999999999999999999999995 55554322110        0111111 1111111 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         ..+..+.+++.+||+.||++|||++||+++|+
T Consensus       226 ---~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~  257 (263)
T d1sm2a_         226 ---LASTHVYQIMNHCWKERPEDRPAFSRLLRQLA  257 (263)
T ss_dssp             ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence               22345889999999999999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=401.99  Aligned_cols=250  Identities=26%  Similarity=0.429  Sum_probs=208.5

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++....    ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG----CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc----ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            4699999999999999999975 579999999986422    22357899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++...    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+++.+..
T Consensus        96 mEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            9999999999987542    489999999999999999999999   999999999999999999999999999998766


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .........||+.|+|||++.+..++.++||||+||++|||+||+.||...........     ......+.+..    .
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-----~~~~~~~~~~~----~  239 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-----IATNGTPELQN----P  239 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHHCSCCCSS----G
T ss_pred             ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH-----HHhCCCCCCCC----c
Confidence            55555667899999999999999999999999999999999999999864332211000     00000111111    1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+.+|+.+||+.||++|||++|++++
T Consensus       240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2234568899999999999999999999863

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-57  Score=397.03  Aligned_cols=249  Identities=28%  Similarity=0.444  Sum_probs=206.6

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||+||+|... +|+.||+|++.... .......+.+.+|++++++++||||+++++++.+++..++|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH-ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            47888999999999999999764 78999999985311 11122357789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        85 mEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             EeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            99999999999997543   599999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .  ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......        ....+.......+..  
T Consensus       159 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~~p~~--  226 (263)
T d2j4za1         159 S--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVEFTFPDF--  226 (263)
T ss_dssp             C--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCCCCCTT--
T ss_pred             C--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCCCcc--
Confidence            3  2345689999999999999999999999999999999999999987433211        111222222222221  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        .+..+.+|+.+||+.||++|||++|++++
T Consensus       227 --~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         227 --VTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             --SCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             --CCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence              23458889999999999999999999863

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-57  Score=405.83  Aligned_cols=263  Identities=26%  Similarity=0.504  Sum_probs=199.6

Q ss_pred             cccHHHHHHHhcCC---------CCCccccccCcEEEEEEEeC-CCC---EEEEEecCCCCCCcchhcHHHHHHHHHHHH
Q 016009          114 KLVYDEIVRATNDF---------DAQYCIGNGGHGSVYRAELP-SGQ---VVAIKKFHSPLPSDQIVDKKEFLTEVEALT  180 (397)
Q Consensus       114 ~~~~~~~~~~~~~~---------~~~~~lg~G~~g~vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~  180 (397)
                      .++|++...++.+|         +..+.||+|+||+||+|... +++   .||||++.....   ....+.|.+|+++|+
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~   82 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT---EKQRRDFLSEASIMG   82 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC---HHHHHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC---HHHHHHHHHHHHHHH
Confidence            34555555555444         45578999999999999764 332   589998865322   233578999999999


Q ss_pred             hccCCceeeeEEEEecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCC
Q 016009          181 EIRHRNIVKLYGFCSHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSK  260 (397)
Q Consensus       181 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~  260 (397)
                      +++|||||+++|+|..++..++|||||++|+|.+++....  ..++|.+++.++.|||+||+|||++   +|+||||||+
T Consensus        83 ~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~  157 (299)
T d1jpaa_          83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAAR  157 (299)
T ss_dssp             TCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             hCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccc
Confidence            9999999999999999999999999999999999887543  3599999999999999999999998   9999999999


Q ss_pred             cEEeCCCCcEEEeeeccccccCCCCCCc-----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 016009          261 NLLLDLEFEAHVADFGIAKFLKPDSSNW-----TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFL  334 (397)
Q Consensus       261 Nill~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~  334 (397)
                      |||++.++++||+|||+++.........     ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus       158 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~  237 (299)
T d1jpaa_         158 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM  237 (299)
T ss_dssp             GEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             eEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence            9999999999999999998765432211     22457899999999999999999999999999999998 89998754


Q ss_pred             cccccccccccccccccc-CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          335 SSISSSFLNTDIELDEML-DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ....        ....+. +.+.+.+.    +.+..+.+|+.+||+.||++|||+.||++.|+
T Consensus       238 ~~~~--------~~~~i~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~  288 (299)
T d1jpaa_         238 TNQD--------VINAIEQDYRLPPPM----DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD  288 (299)
T ss_dssp             CHHH--------HHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CHHH--------HHHHHHcCCCCCCCc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            3211        011111 11222222    23455889999999999999999999999885

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-57  Score=400.70  Aligned_cols=251  Identities=21%  Similarity=0.420  Sum_probs=204.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      .++|+..+.||+|+||+||+|.+++++.||||+++...     ...+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            45788889999999999999999888999999987422     235789999999999999999999998854 567999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++..... ..++|.+++.++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus        86 ~Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence            999999999998865443 4599999999999999999999998   999999999999999999999999999987754


Q ss_pred             CCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCC-CccccccccccccccccccccC-CCCCCCC
Q 016009          284 DSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPR-DFLSSISSSFLNTDIELDEMLD-PRLPAPS  360 (397)
Q Consensus       284 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  360 (397)
                      ... ......||+.|+|||++.+..++.++|||||||++|||+||..|+ .......        ....+.. .+...+.
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--------~~~~i~~~~~~~~p~  233 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--------VIQNLERGYRMVRPD  233 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCCCCT
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHhcCCCCCcc
Confidence            332 234457899999999999999999999999999999999965554 3221110        0111111 1111122


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                          ..+..+.+|+.+||+.||++||||++|++.|+
T Consensus       234 ----~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~  265 (272)
T d1qpca_         234 ----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (272)
T ss_dssp             ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence                22345889999999999999999999999886

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-57  Score=398.42  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=202.7

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++......   ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            5788899999999999999976 47999999998653221   1245689999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....   .+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            99999999999996543   599999999999999999999999   999999999999999999999999999987653


Q ss_pred             CC--CCcccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          284 DS--SNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       284 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      ..  ......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||..........       ..........  
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-------~~~~~~~~~~--  226 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-------SDWKEKKTYL--  226 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-------HHHHTTCTTS--
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-------HHHhcCCCCC--
Confidence            32  22345689999999999988776 578999999999999999999986433211110       1111111110  


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .........+.+|+.+||+.||++|||++|++++
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0111223457889999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-57  Score=400.42  Aligned_cols=257  Identities=25%  Similarity=0.387  Sum_probs=195.4

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec--CCeee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH--ARHSF  201 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  201 (397)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|.+.....  .....+.+.+|++++++++||||+++++++.+  .+..|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            5789999999999999999965 5799999999875332  22346779999999999999999999999854  45689


Q ss_pred             EEEEeccCCCHHHhhcccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceeccCCCCcEEeCCCCcEEEeeeccc
Q 016009          202 LVYEFLKRGSLAAILSSDA-AAQELGWSQRMNVIKGVADALSYLHHDC--FPPIVHRDISSKNLLLDLEFEAHVADFGIA  278 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  278 (397)
                      +||||+++|+|.+++.... ....+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||++
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            9999999999999986532 2346999999999999999999999862  124999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 016009          279 KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       279 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      +.............||+.|+|||++.+..++.++|||||||++|||+||+.||.......        ....+.+...+.
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--------~~~~i~~~~~~~  233 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRR  233 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCCC
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCCC
Confidence            987655544556789999999999999999999999999999999999999987433211        111111222211


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .+.   ..+.++.+|+.+||+.||++|||++|++++
T Consensus       234 ~~~---~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         234 IPY---RYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCc---ccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            111   223458899999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-56  Score=389.63  Aligned_cols=250  Identities=26%  Similarity=0.480  Sum_probs=210.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|+..+.||+|+||+||+|+.++++.||||+++...     ...++|.+|++++++++||||++++|+|.+++..++||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-----SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-----CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            5889999999999999999999888899999987522     23578999999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++|+|.+++....  ..+++..+++++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++.....
T Consensus        79 Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          79 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             ECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             EccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            9999999999976544  3689999999999999999999998   9999999999999999999999999999876544


Q ss_pred             CC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCCCc
Q 016009          285 SS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-PRLPAPSR  361 (397)
Q Consensus       285 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  361 (397)
                      .. ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||........        ...+.. .++..+..
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--------~~~i~~~~~~~~p~~  225 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--------AEHIAQGLRLYRPHL  225 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--------HHHHHTTCCCCCCTT
T ss_pred             CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH--------HHHHHhCCCCCCccc
Confidence            32 2334678999999999999999999999999999999998 8999875443211        111111 11222222


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                          .+..+.+|+.+||+.||++|||+++|+++|+
T Consensus       226 ----~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         226 ----ASEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             ----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ----ccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence                2345889999999999999999999999884

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-57  Score=404.48  Aligned_cols=253  Identities=26%  Similarity=0.437  Sum_probs=207.5

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      ..++|+..+.||+|+||+||+|.+. +|+.||||+++...     ...++|.+|++++++++|||||+++|+|.+++..+
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            3457888899999999999999765 68899999987522     23578999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++|+|.+++..... ..+++..++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++..
T Consensus        90 iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeec
Confidence            99999999999999975432 4699999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCC-cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC--CCCC
Q 016009          282 KPDSSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP--RLPA  358 (397)
Q Consensus       282 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  358 (397)
                      ...... .....|++.|+|||++.+..++.++|||||||++|||++|..|+.......        .+...+..  ..+.
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--------~~~~~i~~~~~~~~  237 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKDYRMER  237 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHHHTTCCCCC
T ss_pred             CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--------HHHHHHhcCCCCCC
Confidence            544332 233568899999999999999999999999999999999777653222111        11111111  1111


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.    ..+..+.+|+.+||+.||++|||++||++.|+
T Consensus       238 ~~----~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~  271 (287)
T d1opja_         238 PE----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE  271 (287)
T ss_dssp             CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             Cc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            22    22345889999999999999999999998875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-56  Score=399.52  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=204.5

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      +.|+..+.||+|+||+||+|.. .+|+.||||++....    ....+.+.+|++++++++|||||++++++.+++..++|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   87 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence            4678889999999999999975 478999999987532    12346789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++....  +.+++.++..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        88 mEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            99999999999976543  4599999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCCcccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 016009          284 DSSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPA  358 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (397)
                      .........||+.|+|||++.     +..++.++|||||||++|||+||+.||........        +..+.....+.
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--------~~~i~~~~~~~  234 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--------LLKIAKSEPPT  234 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--------HHHHHHSCCCC
T ss_pred             CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--------HHHHHcCCCCC
Confidence            322334568999999999874     45689999999999999999999999875433211        11111111110


Q ss_pred             CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          359 PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       359 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       .......+.++.+|+.+||+.||++|||++|++++
T Consensus       235 -~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         235 -LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             11112334568899999999999999999999873

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=393.67  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=202.2

Q ss_pred             CCCCCc-cccccCcEEEEEEEeC---CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          126 DFDAQY-CIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       126 ~~~~~~-~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      +|...+ +||+|+||+||+|.+.   ++..||||+++....   ....++|.+|+++|++++|||||+++|++.+ +..+
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC---HHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            455555 3999999999999653   355799999875322   2346789999999999999999999999965 4689


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      +||||+++|+|.+++....  ..+++.+++.++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++.+
T Consensus        85 lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence            9999999999999986543  4699999999999999999999998   9999999999999999999999999999877


Q ss_pred             CCCCCC---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCC
Q 016009          282 KPDSSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-PRL  356 (397)
Q Consensus       282 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~  356 (397)
                      ......   .....||+.|+|||++.++.++.++|||||||++|||+| |+.||........        ...+.. .++
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--------~~~i~~~~~~  231 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--------MAFIEQGKRM  231 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--------HHHHHTTCCC
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH--------HHHHHcCCCC
Confidence            644322   234568999999999999999999999999999999998 9999875432110        111111 111


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+.    ..+.++.+|+.+||+.||++|||+.+|++.|+
T Consensus       232 ~~p~----~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~  267 (285)
T d1u59a_         232 ECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  267 (285)
T ss_dssp             CCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCC----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            2222    23345889999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-55  Score=392.40  Aligned_cols=253  Identities=26%  Similarity=0.442  Sum_probs=196.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCC-----CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSG-----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      ++|+..++||+|+||.||+|.++++     ..||||+++....   .....+|.+|++++++++|||||+++|++.+.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT---EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC---hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            4677889999999999999976532     3799999865332   2235679999999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+.+|++.+.+....  ..++|.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence            999999999999999886544  4699999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCC---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC-C
Q 016009          280 FLKPDSSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDP-R  355 (397)
Q Consensus       280 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~  355 (397)
                      ........   .....||+.|+|||++.+..++.++|||||||++|||+||..|+......       ......+.+. +
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~~~  231 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFR  231 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCC
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-------HHHHHHHhccCC
Confidence            76543222   23356899999999999999999999999999999999976654321110       0011111111 1


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+.+.    +.+..+.+|+.+||+.||++||||.||+++|+
T Consensus       232 ~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~  268 (283)
T d1mqba_         232 LPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILD  268 (283)
T ss_dssp             CCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCch----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence            11122    23456889999999999999999999999885

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=401.83  Aligned_cols=255  Identities=23%  Similarity=0.402  Sum_probs=204.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCC-C-----CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEec
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPS-G-----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSH  196 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  196 (397)
                      .++|+..+.||+|+||+||+|.... +     ..||+|.+.....   ......+.+|+.+++++ +|||||++++++.+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD---SSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC---HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            3578888999999999999997542 2     3699999865322   22356789999999998 89999999999999


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecc
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAA--------------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRD  256 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~d  256 (397)
                      .+..++||||+++|+|.+++.....                    ...+++..++.++.||++||+|||++   +|+|||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence            9999999999999999999975431                    13589999999999999999999998   999999


Q ss_pred             CCCCcEEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCc
Q 016009          257 ISSKNLLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDF  333 (397)
Q Consensus       257 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~  333 (397)
                      |||+||+++.++.+||+|||+++........  .....||+.|+|||++.++.++.++|||||||++|||+| |+.||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876544332  234568999999999999999999999999999999998 8999864


Q ss_pred             cccccccccccccccccccCC--CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          334 LSSISSSFLNTDIELDEMLDP--RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .....        .+..++..  +++.+.    ..+..+.+|+.+||+.||++|||++||+++|.
T Consensus       270 ~~~~~--------~~~~~~~~~~~~~~p~----~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         270 IPVDA--------NFYKLIQNGFKMDQPF----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCCSH--------HHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHHH--------HHHHHHhcCCCCCCCC----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            33211        11111111  112222    22345889999999999999999999999985

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-55  Score=396.80  Aligned_cols=253  Identities=26%  Similarity=0.353  Sum_probs=190.9

Q ss_pred             hcCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .+.|+..+.||+|+||+||+|... +|+.||||++.......   ..+.+.+|++++++++||||+++++++.+++..|+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG---KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            356888999999999999999764 78999999987533221   24568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC---CCCcEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD---LEFEAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~  279 (397)
                      ||||++||+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+||+++   +++.+||+|||+++
T Consensus        85 vmE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence            999999999999997543   599999999999999999999999   999999999999994   57899999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ...... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||.......        ....+.......+
T Consensus       159 ~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~~~~~~~  229 (307)
T d1a06a_         159 MEDPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--------LFEQILKAEYEFD  229 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHTTCCCCC
T ss_pred             EccCCC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCCCCC
Confidence            665332 2344679999999999999999999999999999999999999986433211        0111111111111


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.+..+.+|+.+||+.||++|||++|++++
T Consensus       230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11112334568899999999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=390.18  Aligned_cols=245  Identities=26%  Similarity=0.413  Sum_probs=196.4

Q ss_pred             ccccccCcEEEEEEEeC---CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEec
Q 016009          131 YCIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  207 (397)
                      +.||+|+||+||+|.+.   +++.||||+++....  .....++|.+|++++++++|||||+++|+|..+ ..++||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC--CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcC
Confidence            46999999999999754   356899999975332  223457899999999999999999999999654 578999999


Q ss_pred             cCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCC
Q 016009          208 KRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN  287 (397)
Q Consensus       208 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  287 (397)
                      ++|+|.+++....   .+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus        90 ~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          90 ELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             TTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            9999999987543   599999999999999999999998   9999999999999999999999999999876544332


Q ss_pred             ---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCCCcc
Q 016009          288 ---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLD-PRLPAPSRS  362 (397)
Q Consensus       288 ---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  362 (397)
                         .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||........        ...+.. .+++.+.  
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--------~~~i~~~~~~~~p~--  233 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--------TAMLEKGERMGCPA--  233 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------HHHHHTTCCCCCCT--
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH--------HHHHHcCCCCCCCc--
Confidence               233578999999999999999999999999999999998 8999875432110        011111 1122222  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        ..+..+.+|+.+||+.||++|||+++|+++|+
T Consensus       234 --~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         234 --GCPREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             --TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             --ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence              23346889999999999999999999998875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=394.60  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=203.0

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++..... ......+.+.+|++++++++||||+++++++.+++..|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc-cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            4688999999999999999976 5799999999863111 1122356799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+++|+|.+++...+   .+++.+++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.+..
T Consensus        87 mEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            99999999999987543   599999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          284 DSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       284 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ...  ......||+.|+|||++.+..++.++||||+||++|||+||+.||.......        ....+.......+..
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~~~~~~p~~  232 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEK  232 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHTTCCCCCTT
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--------HHHHHHcCCCCCCcc
Confidence            322  2345679999999999999999999999999999999999999997433211        111122222222222


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                          ....+.+|+.+||+.||++|||++|+++
T Consensus       233 ----~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         233 ----FFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ----CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ----CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                2345889999999999999999998643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=385.09  Aligned_cols=247  Identities=22%  Similarity=0.346  Sum_probs=195.5

Q ss_pred             CCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec----CCeeeE
Q 016009          128 DAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH----ARHSFL  202 (397)
Q Consensus       128 ~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  202 (397)
                      +..+.||+|+||+||+|... +++.||+|++.....  .....+.+.+|++++++++||||+++++++.+    ....++
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            44567999999999999764 688999999865322  22345779999999999999999999999864    456799


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeccCCCCcEEeC-CCCcEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPP--IVHRDISSKNLLLD-LEFEAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~~~  279 (397)
                      ||||+++|+|.+++....   .+++..++.++.||+.||+|||++   +  |+||||||+|||++ +++.+||+|||+++
T Consensus        90 vmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            999999999999997543   599999999999999999999998   6  99999999999996 57899999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      ....  .......||+.|+|||++.+ +++.++|||||||++|||+||+.||........       ....+.....+  
T Consensus       164 ~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-------~~~~i~~~~~~--  231 (270)
T d1t4ha_         164 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-------IYRRVTSGVKP--  231 (270)
T ss_dssp             GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-------HHHHHTTTCCC--
T ss_pred             eccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-------HHHHHHcCCCC--
Confidence            6433  23345689999999998865 699999999999999999999999864322110       00111111110  


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .........++.+|+.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            11111223458899999999999999999999873

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.8e-55  Score=393.51  Aligned_cols=247  Identities=28%  Similarity=0.413  Sum_probs=200.9

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      .|+..+.||+|+||+||+|.. .+|+.||||++..... ......+.+.+|++++++++|||||++++++.+++..++||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            488889999999999999965 5788999999875332 22334567999999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      |||.+|+|..++...   ..+++.+++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            999999998776543   3599999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCCcccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          285 SSNWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                          ....||+.|+|||++.+   ..++.++|||||||++|||++|+.||........        +..+.....+....
T Consensus       169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--------~~~i~~~~~~~~~~  236 (309)
T d1u5ra_         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESPALQS  236 (309)
T ss_dssp             ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------HHHHHHSCCCCCSC
T ss_pred             ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--------HHHHHhCCCCCCCC
Confidence                34579999999999864   4589999999999999999999999864332110        11111111111000


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQ  393 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~  393 (397)
                        ...+..+.+|+.+||+.||++|||++|+++
T Consensus       237 --~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         237 --GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence              122345889999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.3e-54  Score=398.15  Aligned_cols=253  Identities=21%  Similarity=0.337  Sum_probs=208.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...    .....+.+.+|+++|++++|||||++++++.+++..++
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            35799999999999999999975 57999999998652    22346789999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC--CCCcEEEeeeccccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD--LEFEAHVADFGIAKF  280 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~~~~  280 (397)
                      |||||++|+|.+++....  ..+++.++..++.||+.||+|||++   +|+||||||+|||++  .++.+||+|||+++.
T Consensus       101 vmE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            999999999999986543  3599999999999999999999999   999999999999995  467899999999987


Q ss_pred             cCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPS  360 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (397)
                      +... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......        ..+..+.......+.
T Consensus       176 ~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~  246 (350)
T d1koaa2         176 LDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDWNMDD  246 (350)
T ss_dssp             CCTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCSCC
T ss_pred             cccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCc
Confidence            6543 3334568999999999999999999999999999999999999998643221        111122222222222


Q ss_pred             cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          361 RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       361 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ......+..+.+|+.+||+.||++|||++|++++
T Consensus       247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2222334568899999999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=398.91  Aligned_cols=258  Identities=24%  Similarity=0.372  Sum_probs=203.7

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|+..+.||+|+||+||+|.. .+|+.||+|+++....   ....+++.+|+++|++++|||||+++++|.+++..++
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC---TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56899999999999999999975 5789999999875332   2235789999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCcEEeCCCCcEEEeeecccccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFL  281 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  281 (397)
                      ||||+++|+|.+++....   .+++..+..++.|++.||.|||+ +   +|+||||||+|||+++++++||+|||+|...
T Consensus        82 VmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            999999999999997543   59999999999999999999997 5   8999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc-----ccc-----------
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL-----NTD-----------  345 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~-----~~~-----------  345 (397)
                      ...  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...........     ...           
T Consensus       156 ~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         156 IDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             HHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             CCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            432  22346899999999999999999999999999999999999999864321100000     000           


Q ss_pred             ------------------cccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          346 ------------------IELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       346 ------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                                        .....+.....+.  ......+.++.+|+.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCC--CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccchhHHHHHhhhhccCCcc--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                              0000000000000  0000123458899999999999999999999874

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=388.56  Aligned_cols=255  Identities=21%  Similarity=0.299  Sum_probs=207.9

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCC--cchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPS--DQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  201 (397)
                      +.|+..+.||+|+||+||+|.. .+|+.||||++......  ......+.+.+|+++|++++|||||++++++.+++..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5788999999999999999976 57999999998643221  22234678999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC----cEEEeeecc
Q 016009          202 LVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF----EAHVADFGI  277 (397)
Q Consensus       202 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~  277 (397)
                      +|||||++|+|.+++....   .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++    .+|++|||+
T Consensus        90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999997643   599999999999999999999999   999999999999998876    499999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLP  357 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
                      +....... ......||+.|+|||++.+..++.++||||+||++|||+||+.||.......        ....+......
T Consensus       164 a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~~~~~  234 (293)
T d1jksa_         164 AHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANVSAVNYE  234 (293)
T ss_dssp             CEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHTTCCC
T ss_pred             hhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--------HHHHHHhcCCC
Confidence            98765432 2344678999999999999999999999999999999999999987433211        11111111111


Q ss_pred             CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          358 APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       358 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .+.......+..+.+|+.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111112234568899999999999999999999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-55  Score=388.63  Aligned_cols=251  Identities=26%  Similarity=0.451  Sum_probs=198.8

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|++.+.||+|+||.||+|..++++.||||+++...     ...+.|.+|+.++++++|||||+++|+|.+ +..++||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-----CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence            5788899999999999999999888899999987422     235789999999999999999999999854 5689999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+++|+|..++..... +.++|.+++.++.||+.||+|||+.   +|+||||||+|||+|.++++||+|||+++.....
T Consensus        91 Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             CCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            99999999999876432 4599999999999999999999998   9999999999999999999999999999876533


Q ss_pred             C-CCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccccc-CCCCCCCCcc
Q 016009          285 S-SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML-DPRLPAPSRS  362 (397)
Q Consensus       285 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  362 (397)
                      . .......||+.|+|||++..+.++.++||||||+++|||+||..|+.......       ..+..+. ..+.+.+.  
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-------~~~~~i~~~~~~~~~~--  237 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYRMPCPP--  237 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCCCCT--
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhcCCCCCCc--
Confidence            2 23344678999999999999999999999999999999999766643222111       0011111 11111111  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                        +.+.++.+++.+||+.||++|||+++|+++|+
T Consensus       238 --~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  269 (285)
T d1fmka3         238 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE  269 (285)
T ss_dssp             --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHh
Confidence              23346889999999999999999999999886

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.9e-54  Score=396.11  Aligned_cols=252  Identities=21%  Similarity=0.335  Sum_probs=207.8

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++...    ....+.+.+|+++|++++||||+++++++.+++..|+|
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4688999999999999999965 579999999987522    23456788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeC--CCCcEEEeeecccccc
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLD--LEFEAHVADFGIAKFL  281 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~~~~~  281 (397)
                      |||+++|+|.+++....  ..+++.+++.++.||+.||+|||+.   +|+||||||+|||++  .++.+||+|||++...
T Consensus       105 mE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         105 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence            99999999998876543  3599999999999999999999998   999999999999997  6789999999999887


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      .... ......||+.|+|||++.+..++.++||||+||++|||+||+.||.......        .+..+.......+..
T Consensus       180 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~~  250 (352)
T d1koba_         180 NPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCDWEFDED  250 (352)
T ss_dssp             CTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHCCCCCCSS
T ss_pred             CCCC-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCcc
Confidence            6433 3345689999999999999999999999999999999999999986433211        111111111111111


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+..+.+|+.+||+.||++|||++|++++
T Consensus       251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            122334568899999999999999999999874

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=389.58  Aligned_cols=252  Identities=24%  Similarity=0.295  Sum_probs=209.2

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|+++.... ......+.+.+|+.+|++++||||+++++++.+++..|+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence            35799999999999999999975 5799999999864211 112235778999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|.+++....   .+++..++.++.|++.||+|||++   +|+||||||+|||++.+|.+||+|||+++...
T Consensus        83 v~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          83 VMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             ceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence            999999999999987654   589999999999999999999999   99999999999999999999999999999766


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      .........+||+.|+|||++.+..++.++||||+||++|||++|+.||.......        ....+....+..+.. 
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--------~~~~i~~~~~~~p~~-  227 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEEIRFPRT-  227 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTT-
T ss_pred             cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--------HHHHHhcCCCCCCcc-
Confidence            55555566789999999999999999999999999999999999999986443211        111122222222222 


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPT-----MKIVSQQ  394 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt-----~~~vl~~  394 (397)
                         .+.++.+|+.+||++||++||+     ++|++++
T Consensus       228 ---~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         228 ---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence               2345789999999999999995     8888763

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-54  Score=389.42  Aligned_cols=261  Identities=23%  Similarity=0.391  Sum_probs=209.0

Q ss_pred             HHHHHhcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEE
Q 016009          119 EIVRATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYG  192 (397)
Q Consensus       119 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~  192 (397)
                      +++...++|+..+.||+|+||+||+|+..      +++.||||+++....   ....++|.+|++++++++||||+++++
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC---HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC---hHHHHHHHHHHHHHHhcCCCCccccee
Confidence            44455678999999999999999999753      457899999875322   223578999999999999999999999


Q ss_pred             EEecCCeeeEEEEeccCCCHHHhhcccc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 016009          193 FCSHARHSFLVYEFLKRGSLAAILSSDA---------------------AAQELGWSQRMNVIKGVADALSYLHHDCFPP  251 (397)
Q Consensus       193 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~  251 (397)
                      +|...+..+++|||+++|+|.+++....                     ....+++.+++.++.|++.||+|||+.   +
T Consensus        84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~  160 (301)
T d1lufa_          84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K  160 (301)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---C
Confidence            9999999999999999999999986422                     123489999999999999999999998   9


Q ss_pred             ceeccCCCCcEEeCCCCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC-
Q 016009          252 IVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK-  328 (397)
Q Consensus       252 ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~-  328 (397)
                      ++||||||+|||+|.++++||+|||+++.......  ......+++.|+|||.+.+..++.++|||||||++|||++|. 
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence            99999999999999999999999999986543322  223457889999999999999999999999999999999985 


Q ss_pred             CCCCccccccccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          329 HPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       329 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +||.......        ....+.+...+..+   ...+.++.+|+.+||+.||++||||.||+++|+
T Consensus       241 ~p~~~~~~~e--------~~~~v~~~~~~~~p---~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~  297 (301)
T d1lufa_         241 QPYYGMAHEE--------VIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ  297 (301)
T ss_dssp             CTTTTSCHHH--------HHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCHHH--------HHHHHHcCCCCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            5665433211        11122222222111   122345889999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-54  Score=378.63  Aligned_cols=248  Identities=27%  Similarity=0.423  Sum_probs=194.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec-CCeeeE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH-ARHSFL  202 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l  202 (397)
                      .++|+..+.||+|+||.||+|.+ .|+.||||+++...      ..+.|.+|++++++++||||++++|+|.+ .+..++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence            35677888999999999999998 47889999986521      35779999999999999999999999854 566899


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|.+++..... ..++|..++.++.||+.||.|||+.   +++||||||+||+++.++.+|++|||+++...
T Consensus        79 v~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence            9999999999999975432 3589999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ..   .....++..|+|||++.+..++.++||||||+++|||+| |+.|+..........     .+.....+..  +. 
T Consensus       155 ~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~-----~i~~~~~~~~--~~-  223 (262)
T d1byga_         155 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----RVEKGYKMDA--PD-  223 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH-----HHTTTCCCCC--CT-
T ss_pred             CC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH-----HHHcCCCCCC--Cc-
Confidence            32   233467899999999999999999999999999999998 688776433211000     0111111112  11 


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                         .....+.+|+.+||+.||++|||+.+++++|+
T Consensus       224 ---~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~  255 (262)
T d1byga_         224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE  255 (262)
T ss_dssp             ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence               22345889999999999999999999999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.8e-53  Score=375.15  Aligned_cols=255  Identities=23%  Similarity=0.360  Sum_probs=206.8

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcc-----hhcHHHHHHHHHHHHhcc-CCceeeeEEEEecC
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQ-----IVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHA  197 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  197 (397)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++........     ....+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5788899999999999999975 5799999999875332211     112356889999999997 99999999999999


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      +..|+||||+++|+|.+++....   .+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999997543   599999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYT------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEM  351 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  351 (397)
                      ++...... ......||+.|+|||.+.+      ..++.++||||+||++|||+||+.||.......        ....+
T Consensus       157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--------~~~~i  227 (277)
T d1phka_         157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------MLRMI  227 (277)
T ss_dssp             CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHH
T ss_pred             eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--------HHHHH
Confidence            98776433 3345689999999998763      347889999999999999999999997543211        11111


Q ss_pred             cCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          352 LDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .......+.......+.++.+|+.+||+.||++|||++||+++
T Consensus       228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            2111111111222344568899999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5e-53  Score=382.74  Aligned_cols=248  Identities=23%  Similarity=0.370  Sum_probs=205.2

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++.... ......+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            5788999999999999999976 5799999999863111 1122357899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||++||+|..++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        83 mE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            99999999999987654   488999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .   ....+||+.|+|||++.+..++.++||||+||++|||+||+.||.......        ....+.......+..  
T Consensus       157 ~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~~~p~~--  223 (316)
T d1fota_         157 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAELRFPPF--  223 (316)
T ss_dssp             C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHCCCCCCTT--
T ss_pred             c---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH--------HHHHHHcCCCCCCCC--
Confidence            2   234689999999999999999999999999999999999999987433211        111222222222222  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                        ....+.+++.+||+.||.+||     |+++++++
T Consensus       224 --~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         224 --FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             --SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence              224588999999999999996     89999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=379.04  Aligned_cols=253  Identities=28%  Similarity=0.435  Sum_probs=194.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeC--CC--CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP--SG--QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ++|+..+.||+|+||.||+|+..  ++  ..||||++...... .....++|.+|++++++++||||++++|++.+ ...
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            46888899999999999999653  33  37899998753332 22345789999999999999999999999976 467


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      ++||||+++|++.+++....  ..+++..++.++.|+|.||.|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence            89999999999999887544  3599999999999999999999998   999999999999999999999999999998


Q ss_pred             cCCCCCC---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--
Q 016009          281 LKPDSSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP--  354 (397)
Q Consensus       281 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  354 (397)
                      .......   .....++..|+|||.+.+..++.++||||||+++|||+| |+.||.......        ....+...  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--------~~~~i~~~~~  232 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEGE  232 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSCC
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--------HHHHHHhCCC
Confidence            7544332   233467889999999999999999999999999999998 899986443221        11111111  


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +++.+.    ..+..+.+|+.+||+.||++|||+.||++.|+
T Consensus       233 ~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~  270 (273)
T d1u46a_         233 RLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  270 (273)
T ss_dssp             CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCcc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            111111    22345889999999999999999999999885

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=384.85  Aligned_cols=250  Identities=24%  Similarity=0.434  Sum_probs=198.9

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCC----EEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQ----VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      ++|+..+.||+|+||+||+|.+. +|+    +||+|+++....   ....++|.+|++++++++|||||+++|+|.++ .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence            46889999999999999999754 454    689998865322   22367899999999999999999999999865 5


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++++||+.+|+|.+++....  ..+++..++.++.|||.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             eeEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence            678899999999999887654  4699999999999999999999998   99999999999999999999999999999


Q ss_pred             ccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc--CC
Q 016009          280 FLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEML--DP  354 (397)
Q Consensus       280 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~  354 (397)
                      ........  .....||+.|+|||.+.++.++.++|||||||++|||+| |..||+......         +...+  ..
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---------~~~~i~~~~  230 (317)
T d1xkka_         160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGE  230 (317)
T ss_dssp             HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---------HHHHHHHTC
T ss_pred             ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---------HHHHHHcCC
Confidence            87654332  233468999999999999999999999999999999999 788887543211         11111  11


Q ss_pred             CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          355 RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       355 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +++.+.    ..+..+.+|+.+||+.||++|||++||+++|+
T Consensus       231 ~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         231 RLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             CCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCc----ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence            222222    22345889999999999999999999998874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3e-53  Score=378.66  Aligned_cols=258  Identities=24%  Similarity=0.358  Sum_probs=199.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR----  198 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  198 (397)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++..... .....+.+.+|++++++++||||+++++++...+    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            35788999999999999999965 57999999999764332 2234567999999999999999999999987643    


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA  278 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  278 (397)
                      ..|+||||++|++|.+++...+   .+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++..+++|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence            3789999999999999886543   599999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCCC---CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 016009          279 KFLKPDSS---NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPR  355 (397)
Q Consensus       279 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  355 (397)
                      ........   ......||+.|+|||++.+..++.++|||||||++|||+||+.||........        ....+...
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--------~~~~~~~~  230 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--------AYQHVRED  230 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------HHHHHHCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH--------HHHHHhcC
Confidence            76543322   23456799999999999999999999999999999999999999874432111        00111111


Q ss_pred             CCCCCcchHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhc
Q 016009          356 LPAPSRSVQEKLRSIVEVVFSCLNESPESRP-TMKIVSQQLQ  396 (397)
Q Consensus       356 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~~vl~~Le  396 (397)
                      ...+.....+.+..+.+++.+||++||++|| |++++++.|+
T Consensus       231 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            1101111112234588999999999999999 8999988764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=378.25  Aligned_cols=252  Identities=24%  Similarity=0.402  Sum_probs=193.8

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCC----CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCe
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARH  199 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  199 (397)
                      .++|+..+.||+|+||.||+|.+..    +..||||.++...   .....+.|.+|++++++++||||++++|++. .+.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence            3578888999999999999997642    3568999886422   2233578999999999999999999999995 467


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .++||||+++|+|.+++....  ..+++.+++.++.||++||+|||+.   +++||||||+||++++++.+||+|||+++
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence            899999999999999876543  4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CC
Q 016009          280 FLKPDSS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSFLNTDIELDEMLDP-RL  356 (397)
Q Consensus       280 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~  356 (397)
                      ....... ......||+.|+|||.+.+..++.++|||||||++|||+| |..||........        ...+.+. ..
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--------~~~i~~~~~~  228 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--------IGRIENGERL  228 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------HHHHHTTCCC
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--------HHHHHcCCCC
Confidence            7654332 2344568999999999999999999999999999999998 8999875443211        1111111 11


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+.    ..+..+.+|+.+||+.||++|||++||++.|+
T Consensus       229 ~~~~----~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~  264 (273)
T d1mp8a_         229 PMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  264 (273)
T ss_dssp             CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCC----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            2222    23345889999999999999999999999885

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=381.96  Aligned_cols=253  Identities=23%  Similarity=0.286  Sum_probs=201.7

Q ss_pred             hcCCCCCc-cccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEec----
Q 016009          124 TNDFDAQY-CIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSH----  196 (397)
Q Consensus       124 ~~~~~~~~-~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----  196 (397)
                      .++|.+.. .||+|+||+||+|.. .+++.||||+++.         ...+.+|++++.++ +||||+++++++.+    
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            35787764 699999999999965 5799999999863         35677899987665 89999999999865    


Q ss_pred             CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC---CCcEEEe
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL---EFEAHVA  273 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~  273 (397)
                      ....|+|||||+||+|.+++..... ..+++.+++.++.|++.||+|||+.   +|+||||||+|||+++   ++.+||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence            4678999999999999999976432 4699999999999999999999999   9999999999999985   4679999


Q ss_pred             eeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 016009          274 DFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD  353 (397)
Q Consensus       274 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  353 (397)
                      |||+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..........    .....+..
T Consensus       157 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~----~~~~~i~~  231 (335)
T d2ozaa1         157 DFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----GMKTRIRM  231 (335)
T ss_dssp             CCTTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCS
T ss_pred             ccceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH----HHHHHHhc
Confidence            999998765433 3345689999999999999999999999999999999999999986433211100    00111112


Q ss_pred             CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          354 PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       354 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+.......+.++.+|+.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            22222222334456679999999999999999999999874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=381.15  Aligned_cols=251  Identities=22%  Similarity=0.292  Sum_probs=206.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|++.+.||+|+||+||+|... +|+.||||+++...     .+...+.+|+++|++++||||+++++++.+++..|+|
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            57888999999999999999764 78899999987521     2345688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC--CcEEEeeecccccc
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE--FEAHVADFGIAKFL  281 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~~~~~  281 (397)
                      ||||+||+|.+++....  ..+++.+++.++.||+.||+|||+.   +|+||||||+|||++.+  ..+||+|||++...
T Consensus        80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            99999999999997643  3589999999999999999999998   99999999999999854  58999999999876


Q ss_pred             CCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 016009          282 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSR  361 (397)
Q Consensus       282 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
                      ... .......+|+.|+|||...+..++.++||||+||++|||++|+.||......        .....+.......+..
T Consensus       155 ~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~~  225 (321)
T d1tkia_         155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEYTFDEE  225 (321)
T ss_dssp             CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCCCHH
T ss_pred             ccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCChh
Confidence            533 2334567899999999999999999999999999999999999998643321        1112222222222211


Q ss_pred             chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          362 SVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       362 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .....+..+.+|+.+||+.||++|||++|++++
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            112234568899999999999999999999873

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=373.34  Aligned_cols=248  Identities=27%  Similarity=0.398  Sum_probs=197.3

Q ss_pred             CccccccCcEEEEEEEeCCC----CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec-CCeeeEEE
Q 016009          130 QYCIGNGGHGSVYRAELPSG----QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH-ARHSFLVY  204 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~  204 (397)
                      .++||+|+||+||+|.+.++    ..||||+++...   .....++|.+|++++++++||||++++|++.. ++..++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC---CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            45799999999999976532    258999986422   23346789999999999999999999999865 56899999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      |||++|+|.+++....  ..+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus       109 E~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             ECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EEeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            9999999999987544  3578899999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCC----cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCCCCC
Q 016009          285 SSN----WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLD-PRLPAP  359 (397)
Q Consensus       285 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  359 (397)
                      ...    .....||+.|+|||.+.+..++.++||||||+++|||+||..|+.......       .....+.. .+...+
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-------~~~~~i~~g~~~~~p  256 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQP  256 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCCCCC
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCCCCCCc
Confidence            221    233568999999999999999999999999999999999888764322110       00111111 111222


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .    .....+.+|+.+||+.||++||||+||+++|+
T Consensus       257 ~----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~  289 (311)
T d1r0pa_         257 E----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  289 (311)
T ss_dssp             T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             c----cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            2    22345889999999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=381.03  Aligned_cols=250  Identities=25%  Similarity=0.336  Sum_probs=204.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHH-hccCCceeeeEEEEecCCeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALT-EIRHRNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~l  202 (397)
                      ++|++.+.||+|+||+||+|... +|+.||||+++.... ......+.+..|..++. .++||||+++++++.+++..|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~-~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc-cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            57888999999999999999664 789999999863111 11123456777777765 6899999999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccC
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLK  282 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  282 (397)
                      ||||+++|+|.+++....   .+++.+++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++...
T Consensus        81 vmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            999999999999997543   589999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcc
Q 016009          283 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRS  362 (397)
Q Consensus       283 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (397)
                      ..........||+.|+|||++.+..++.++||||+||++|||+||+.||.......        ....+.......+.  
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~~~p~--  224 (320)
T d1xjda_         155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSIRMDNPFYPR--  224 (320)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCT--
T ss_pred             cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCCCc--
Confidence            65555566789999999999999999999999999999999999999997433211        01111111111111  


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 016009          363 VQEKLRSIVEVVFSCLNESPESRPTMK-IVSQ  393 (397)
Q Consensus       363 ~~~~~~~l~~l~~~cl~~~P~~RPt~~-~vl~  393 (397)
                        ..+..+.+|+.+||+.||++|||++ ++++
T Consensus       225 --~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         225 --WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence              1234588999999999999999996 6754

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=379.28  Aligned_cols=259  Identities=25%  Similarity=0.392  Sum_probs=195.0

Q ss_pred             HHhcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEE
Q 016009          122 RATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFC  194 (397)
Q Consensus       122 ~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  194 (397)
                      ...++|+..+.||+|+||.||+|...      +++.||||+++....   ....+.+..|..++.++ +|+||+.+++++
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC---cHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            33467888999999999999999643      346899999874322   22356788888888887 689999999998


Q ss_pred             ecC-CeeeEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCC
Q 016009          195 SHA-RHSFLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSK  260 (397)
Q Consensus       195 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~  260 (397)
                      ... ...++|||||++|+|.+++.....             ...+++.+++.++.||++||+|||++   +|+||||||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~  163 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR  163 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence            654 568999999999999999965431             23489999999999999999999998   9999999999


Q ss_pred             cEEeCCCCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCccccc
Q 016009          261 NLLLDLEFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK-HPRDFLSSI  337 (397)
Q Consensus       261 Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~-~p~~~~~~~  337 (397)
                      |||+++++.+||+|||+++.......  ......||+.|+|||.+.+..++.++|||||||++|||+||. .||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654332  234567999999999999999999999999999999999975 566533221


Q ss_pred             cccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          338 SSSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .. ..   ..+....  ....+.    ..+..+.+++.+||+.||++|||++||+++|+
T Consensus       244 ~~-~~---~~~~~~~--~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~  292 (299)
T d1ywna1         244 EE-FC---RRLKEGT--RMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  292 (299)
T ss_dssp             HH-HH---HHHHHTC--CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH-HH---HHHhcCC--CCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            10 00   0011111  111111    22345889999999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2e-52  Score=385.90  Aligned_cols=252  Identities=19%  Similarity=0.243  Sum_probs=198.2

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHH---HHHHHHhccCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLT---EVEALTEIRHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~  200 (397)
                      ++|++.+.||+|+||.||+|... +|+.||||++..... ........+.+   |+++++.++||||+++++++.+.+..
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHc-chhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            57999999999999999999764 799999999853110 11112233444   46677777899999999999999999


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKF  280 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  280 (397)
                      |+||||+++|+|.+++....   .+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999997643   588999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 016009          281 LKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAP  359 (397)
Q Consensus       281 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
                      .....  .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.........     .............+
T Consensus       157 ~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~  229 (364)
T d1omwa3         157 FSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRMTLTMAVELP  229 (364)
T ss_dssp             CSSSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-----HHHHHSSSCCCCCC
T ss_pred             cCCCc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhcccCCCCCC
Confidence            65432  244589999999999874 56899999999999999999999998743321100     00111111112212


Q ss_pred             CcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 016009          360 SRSVQEKLRSIVEVVFSCLNESPESRPT-----MKIVSQQ  394 (397)
Q Consensus       360 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~~vl~~  394 (397)
                      .    ..+..+.+|+.+||+.||++|||     ++|++++
T Consensus       230 ~----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         230 D----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             S----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             C----CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            2    22345889999999999999999     6888753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-52  Score=381.90  Aligned_cols=248  Identities=21%  Similarity=0.279  Sum_probs=205.3

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||.||+|.. .+|+.||||++.... .......+.+.+|+++|+.++||||+++++++......++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH-ccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            4788899999999999999976 479999999985311 11122356789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+.+|+|.+++....   .+++.+++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            99999999999997654   599999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCcch
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRLPAPSRSV  363 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
                      .   .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......        ....+.......+..  
T Consensus       194 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~~~p~~--  260 (350)
T d1rdqe_         194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKVRFPSH--  260 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTT--
T ss_pred             c---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH--------HHHHHhcCCCCCCcc--
Confidence            2   234689999999999999999999999999999999999999986433211        111122222222222  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          364 QEKLRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       364 ~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                        ....+.+++.+||+.||++|+     |++|++++
T Consensus       261 --~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence              234588999999999999994     89999863

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-52  Score=374.49  Aligned_cols=259  Identities=23%  Similarity=0.362  Sum_probs=196.1

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHH--HHHHHHhccCCceeeeEEEEecCC----
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLT--EVEALTEIRHRNIVKLYGFCSHAR----  198 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~~~~~~~~~~----  198 (397)
                      ++|...+.||+|+||.||+|++ +|+.||||+++..       ..+.+..  |+..+.+++||||++++++|...+    
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~-------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc-------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence            3556678899999999999987 6889999998631       1334444  445556789999999999997643    


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceeccCCCCcEEeCCCCcEEEe
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC-----FPPIVHRDISSKNLLLDLEFEAHVA  273 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~~ivH~dlk~~Nill~~~~~~kl~  273 (397)
                      ..++||||+++|+|.++++..    .++|.+++.++.|+|.||+|||+..     .++|+||||||+|||+++++.+||+
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~  150 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence            578999999999999999753    4899999999999999999999731     2489999999999999999999999


Q ss_pred             eeccccccCCCCC----CcccccccccccCcccccCC------CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccc
Q 016009          274 DFGIAKFLKPDSS----NWTEFAGTYGYVAPELAYTM------KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN  343 (397)
Q Consensus       274 Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~  343 (397)
                      |||+++.......    ......||+.|+|||++.+.      .++.++|||||||++|||+||..|+.........+..
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            9999987654332    22346799999999998754      2677999999999999999999887543322211111


Q ss_pred             c-------cccccccc----CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          344 T-------DIELDEML----DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       344 ~-------~~~~~~~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .       ........    +|.++... ...+....+.+|+.+||+.||++|||+.||+++|+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~  293 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGG-GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             cccccchHHHHHHHHhccccCCCCCccc-CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence            0       00111112    22222111 12345667999999999999999999999999885

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-52  Score=376.68  Aligned_cols=253  Identities=27%  Similarity=0.423  Sum_probs=199.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCC--EEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEecCCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQ--VVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSHARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  200 (397)
                      ++|+..+.||+|+||+||+|.+. +|.  .||||+++.....   ...+.|.+|+++|+++ +||||++++|+|.+++..
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh---HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            57888899999999999999765 444  5788887542222   2356799999999999 799999999999999999


Q ss_pred             eEEEEeccCCCHHHhhcccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCC
Q 016009          201 FLVYEFLKRGSLAAILSSDA-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLE  267 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  267 (397)
                      ++||||+++|+|.+++....             ....+++.+++.++.|||.||.|||+.   +++||||||+|||++.+
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC
Confidence            99999999999999997542             235699999999999999999999999   99999999999999999


Q ss_pred             CcEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCC-CCCcccccccccccccc
Q 016009          268 FEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKH-PRDFLSSISSSFLNTDI  346 (397)
Q Consensus       268 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~-p~~~~~~~~~~~~~~~~  346 (397)
                      +.+||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||.......        
T Consensus       164 ~~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--------  234 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------  234 (309)
T ss_dssp             GCEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------
T ss_pred             CceEEcccccccccccccc-ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--------
Confidence            9999999999986543222 234568999999999999999999999999999999999764 565332211        


Q ss_pred             ccccccC-CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          347 ELDEMLD-PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       347 ~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ....+.. .+...+.    ..+..+.+|+.+||+.||++||||+||++.|+
T Consensus       235 ~~~~i~~~~~~~~~~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~  281 (309)
T d1fvra_         235 LYEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLN  281 (309)
T ss_dssp             HHHHGGGTCCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            0111111 1122222    22345889999999999999999999999885

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-52  Score=377.05  Aligned_cols=257  Identities=23%  Similarity=0.407  Sum_probs=206.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEe------CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEEec
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFCSH  196 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  196 (397)
                      .++|+..+.||+|+||.||+|++      .+++.||||+++...   .......|.+|+.+++++ +|||||+++|+|.+
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            45788889999999999999964      346789999997532   223466899999999999 69999999999999


Q ss_pred             CCeeeEEEEeccCCCHHHhhcccc---------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCc
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDA---------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN  261 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  261 (397)
                      ++..++||||+++|+|.+++....               ....+++..+..++.||++||+|||++   +++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence            999999999999999999986543               123589999999999999999999999   99999999999


Q ss_pred             EEeCCCCcEEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccc
Q 016009          262 LLLDLEFEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS  338 (397)
Q Consensus       262 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  338 (397)
                      |+++.++.+|++|||+++........  .....||+.|+|||.+.++.++.++||||||+++|||+| |.+|+...... 
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-  254 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-  254 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-
Confidence            99999999999999999876543332  234578999999999999999999999999999999999 55555432221 


Q ss_pred             ccccccccccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          339 SSFLNTDIELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                             ..+..+++.......  ....+..+.+|+.+||+.||++|||+++|+++|+
T Consensus       255 -------~~~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~  303 (311)
T d1t46a_         255 -------SKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE  303 (311)
T ss_dssp             -------HHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -------HHHHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                   111112111111110  0122345889999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=376.97  Aligned_cols=257  Identities=23%  Similarity=0.374  Sum_probs=207.5

Q ss_pred             HhcCCCCCccccccCcEEEEEEEeC------CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec
Q 016009          123 ATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH  196 (397)
Q Consensus       123 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  196 (397)
                      ..++|...+.||+|+||+||+|.+.      +++.||||+++...   .......|.+|++++++++||||++++|+|..
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            3467888899999999999999653      35789999987532   22345679999999999999999999999999


Q ss_pred             CCeeeEEEEeccCCCHHHhhcccc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCc
Q 016009          197 ARHSFLVYEFLKRGSLAAILSSDA-------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFE  269 (397)
Q Consensus       197 ~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  269 (397)
                      ++..++||||+++|+|.+++....       ....+++.++..++.|+|+||.|||++   +|+||||||+|||++++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence            999999999999999999986432       223579999999999999999999998   9999999999999999999


Q ss_pred             EEEeeeccccccCCCCCC--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCcccccccccccccc
Q 016009          270 AHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK-HPRDFLSSISSSFLNTDI  346 (397)
Q Consensus       270 ~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~-~p~~~~~~~~~~~~~~~~  346 (397)
                      +||+|||+++........  .....+|+.|+|||.+.+..++.++||||||+++|||+||. .||......        .
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~--------~  243 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--------Q  243 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--------H
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH--------H
Confidence            999999999876543322  23346899999999999999999999999999999999985 666543221        1


Q ss_pred             ccccccCCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          347 ELDEMLDPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      ....+.+...+..+.   ..+..+.+++.+||+.||++|||+++|+++|+
T Consensus       244 ~~~~i~~~~~~~~p~---~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  290 (308)
T d1p4oa_         244 VLRFVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  290 (308)
T ss_dssp             HHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred             HHHHHHhCCCCCCcc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            122222322221111   22345899999999999999999999999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=370.37  Aligned_cols=255  Identities=25%  Similarity=0.413  Sum_probs=201.6

Q ss_pred             hcCCCCCccccccCcEEEEEEEeCC--------CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc-cCCceeeeEEEE
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAELPS--------GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI-RHRNIVKLYGFC  194 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  194 (397)
                      .++|+..+.||+|+||.||+|+...        +..||||+++....   .....++.+|...+.++ +||||++++++|
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC---hHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            3578888999999999999996532        24799999875332   22357889999999998 899999999999


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCc
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKN  261 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N  261 (397)
                      .+++..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+.   +|+||||||+|
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N  165 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  165 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence            999999999999999999999965431             24589999999999999999999999   99999999999


Q ss_pred             EEeCCCCcEEEeeeccccccCCCCC--CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccccc
Q 016009          262 LLLDLEFEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS  338 (397)
Q Consensus       262 ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~t-g~~p~~~~~~~~  338 (397)
                      ||++.++.+||+|||+++.......  ......+++.|+|||.+.++.++.++||||||+++|||++ |..||.......
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            9999999999999999987654322  2244578999999999999999999999999999999998 688876433211


Q ss_pred             ccccccccccccccC-CCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          339 SSFLNTDIELDEMLD-PRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       339 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                              ....+.+ ..+..+.    ..+..+.+|+.+||+.||++|||+.||++.|+
T Consensus       246 --------~~~~i~~~~~~~~p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~  292 (299)
T d1fgka_         246 --------LFKLLKEGHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  292 (299)
T ss_dssp             --------HHHHHHTTCCCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --------HHHHHHcCCCCCCCc----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence                    0111111 1111122    22345889999999999999999999999986

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-51  Score=368.67  Aligned_cols=259  Identities=24%  Similarity=0.268  Sum_probs=195.7

Q ss_pred             CccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcc-hhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEEEec
Q 016009          130 QYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQ-IVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVYEFL  207 (397)
Q Consensus       130 ~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  207 (397)
                      .++||+|+||+||+|.. .+|+.||||+++....... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            46799999999999976 4799999999865322211 111346889999999999999999999999999999999999


Q ss_pred             cCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCCCCC
Q 016009          208 KRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPDSSN  287 (397)
Q Consensus       208 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  287 (397)
                      .++++..+....   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........
T Consensus        83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             cchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            998887776433   3588899999999999999999999   9999999999999999999999999999877655555


Q ss_pred             cccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccc--------------ccccccccccccc
Q 016009          288 WTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--------------SFLNTDIELDEML  352 (397)
Q Consensus       288 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--------------~~~~~~~~~~~~~  352 (397)
                      .....||+.|+|||++.+. .++.++||||+||++|||+||+.||........              .+...........
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            5566899999999988754 579999999999999999999999864332110              0000000000000


Q ss_pred             CCCCCCCC--cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          353 DPRLPAPS--RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       353 ~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ....+...  .........+.+|+.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            00000000  0001123468899999999999999999999874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=371.09  Aligned_cols=263  Identities=25%  Similarity=0.346  Sum_probs=201.0

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||+||+|.. .+|+.||||+++....  .....+++.+|++++++++||||+++++++.+++..++|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            5789999999999999999965 5799999999965322  122357889999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      |||+.++.+........  ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~e~~~~~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          80 FEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             EECCSEEHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             EeecCCchhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccC
Confidence            99997655544433322  4599999999999999999999999   999999999999999999999999999988766


Q ss_pred             CCCCcccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCccccccccc-------ccccc---cccccc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF-------LNTDI---ELDEML  352 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~-------~~~~~---~~~~~~  352 (397)
                      .........||+.|+|||...... ++.++||||+||++|+|++|+.||..........       ...+.   ......
T Consensus       155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence            555556678999999999877655 5789999999999999999999986433211000       00000   000000


Q ss_pred             --CCCCCC-CCcc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          353 --DPRLPA-PSRS----VQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       353 --~~~~~~-~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                        ....+. ....    .......+.+|+.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence              000000 0000    01123568899999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.5e-51  Score=365.92  Aligned_cols=262  Identities=24%  Similarity=0.339  Sum_probs=200.7

Q ss_pred             cCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLVY  204 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  204 (397)
                      ++|+..+.||+|+||+||+|..++|+.||||+++....  .....+.+.+|+.+|++++||||+++++++..++..++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            57888999999999999999988999999999975322  2233578999999999999999999999999999999999


Q ss_pred             EeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCCC
Q 016009          205 EFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKPD  284 (397)
Q Consensus       205 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  284 (397)
                      ||+.++.+..+....   +.+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||.+......
T Consensus        80 e~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             ECCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             EeehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            999887777776543   4599999999999999999999998   9999999999999999999999999999887655


Q ss_pred             CCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccc----------ccccccccccc--
Q 016009          285 SSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS----------FLNTDIELDEM--  351 (397)
Q Consensus       285 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~----------~~~~~~~~~~~--  351 (397)
                      ........+++.|+|||.+.+. .++.++||||+||++|||++|+.||.........          ...........  
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence            4444556789999999988754 5689999999999999999999999644321100          00000000000  


Q ss_pred             cCCCCC----CC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          352 LDPRLP----AP-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       352 ~~~~~~----~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .+....    .+ ..........+.+|+.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000000    00 00011123468899999999999999999999863

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-51  Score=363.38  Aligned_cols=244  Identities=24%  Similarity=0.367  Sum_probs=196.4

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCc--chhcHHHHHHHHHHHHhcc--CCceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSD--QIVDKKEFLTEVEALTEIR--HRNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~  199 (397)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.......  ......++.+|++++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5788899999999999999965 579999999986422211  1112234678999999996  8999999999999999


Q ss_pred             eeEEEEeccC-CCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC-CCcEEEeeecc
Q 016009          200 SFLVYEFLKR-GSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL-EFEAHVADFGI  277 (397)
Q Consensus       200 ~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~  277 (397)
                      .++||||+.+ +++.+++...   ..+++.+++.++.|++.||+|||++   +|+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 6788877654   3599999999999999999999999   9999999999999985 47999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      +......  ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.......              ....
T Consensus       158 a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~--------------~~~~  221 (273)
T d1xwsa_         158 GALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------RGQV  221 (273)
T ss_dssp             CEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HCCC
T ss_pred             ceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh--------------hccc
Confidence            9865432  3345689999999999987765 567899999999999999999986432211              1111


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      ..+..    .+.++.+|+.+||+.||++|||++|++++
T Consensus       222 ~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         222 FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11111    12358899999999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-50  Score=361.45  Aligned_cols=263  Identities=20%  Similarity=0.304  Sum_probs=195.3

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CC-CCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhc---cCCceeeeEEEEec--
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PS-GQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEI---RHRNIVKLYGFCSH--  196 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~--  196 (397)
                      .++|++.+.||+|+||+||+|.. ++ ++.||||+++......  .....+.+|+++++.+   +||||+++++++..  
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            46899999999999999999975 44 5679999986432211  1123456777777766   79999999999853  


Q ss_pred             ---CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEe
Q 016009          197 ---ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVA  273 (397)
Q Consensus       197 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  273 (397)
                         ....+++|||+.++++........  ..+++..++.++.|++.||+|||++   +|+||||||+|||+++++.+||+
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeec
Confidence               356899999999887765544332  4589999999999999999999999   99999999999999999999999


Q ss_pred             eeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccc--------------c
Q 016009          274 DFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS--------------S  339 (397)
Q Consensus       274 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~--------------~  339 (397)
                      |||++...... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.......              .
T Consensus       159 dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         159 DFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             SCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             chhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            99998764422 23345689999999999999999999999999999999999999997443211              0


Q ss_pred             cccccccccccccCCCCC-CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          340 SFLNTDIELDEMLDPRLP-APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .+................ ............+.+|+.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000000000000000 0000011223457889999999999999999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-48  Score=347.83  Aligned_cols=262  Identities=20%  Similarity=0.272  Sum_probs=204.6

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCCeeeEE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  203 (397)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++....  .....+++.+|+.++++++||||+++++++.+....++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            5788899999999999999975 5789999999865332  223467899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccccccCC
Q 016009          204 YEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAKFLKP  283 (397)
Q Consensus       204 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  283 (397)
                      +|++.+++|..++...   +.+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.+.....
T Consensus        80 ~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          80 FEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eeeccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccC
Confidence            9999999998887654   3588999999999999999999999   999999999999999999999999999988765


Q ss_pred             CCCCcccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCccccccc--------------ccccccccc
Q 016009          284 DSSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--------------SFLNTDIEL  348 (397)
Q Consensus       284 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--------------~~~~~~~~~  348 (397)
                      .........++..|+|||.+.... ++.++||||+||++|||++|+.||........              .........
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            555555567788999999887655 68999999999999999999999632221100              000000000


Q ss_pred             cccc-CC---CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 DEML-DP---RLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 ~~~~-~~---~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .... .+   ...............+.+|+.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000 00   0000011111223458899999999999999999999874

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=349.21  Aligned_cols=261  Identities=22%  Similarity=0.304  Sum_probs=194.4

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec-------
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH-------  196 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------  196 (397)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++......  ....+++.+|+++|++++|||++++++++..       
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT--TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            5788899999999999999975 58999999998653322  2235778999999999999999999998854       


Q ss_pred             -CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeee
Q 016009          197 -ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADF  275 (397)
Q Consensus       197 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  275 (397)
                       .+..++||||+.++.+.......   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             cCceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence             34679999999888777655433   3588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCC----CcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccc---------c
Q 016009          276 GIAKFLKPDSS----NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS---------F  341 (397)
Q Consensus       276 g~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~---------~  341 (397)
                      |++........    ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.........         .
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99986653221    22335799999999998765 6899999999999999999999998643321100         0


Q ss_pred             c------ccccccccccCCCCCCCCcchHHH------HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          342 L------NTDIELDEMLDPRLPAPSRSVQEK------LRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       342 ~------~~~~~~~~~~~~~~~~~~~~~~~~------~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .      ........... ..........+.      ...+.+|+.+||+.||++|||++|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLE-LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CTTTSTTCCCC--------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             Chhhccccchhhhhhhhc-ccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            0      00000000000 000111111111      2357789999999999999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=356.80  Aligned_cols=257  Identities=26%  Similarity=0.290  Sum_probs=190.8

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC------C
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA------R  198 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  198 (397)
                      +|+..++||+|+||+||+|.. .+|+.||||++.....        .+.+|+++|++++||||+++++++...      .
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            577788999999999999976 4799999999875321        123799999999999999999998532      3


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC-cEEEeeecc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF-EAHVADFGI  277 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~  277 (397)
                      ..++||||++++.+..+.........+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence            4789999998775555443333335699999999999999999999998   999999999999999775 899999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc-------cccccc-
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL-------NTDIEL-  348 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~-------~~~~~~-  348 (397)
                      +........ .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||...........       ...... 
T Consensus       170 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         170 AKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             CEECCTTSC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hhhccCCcc-cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            987654332 344579999999998765 5689999999999999999999999864332110000       000000 


Q ss_pred             ---ccccCCCCCC---CC---cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          349 ---DEMLDPRLPA---PS---RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       349 ---~~~~~~~~~~---~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                         ....+...+.   ..   .........+.+|+.+||+.||++|||++|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               0000000000   00   0001123458899999999999999999999863

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=356.71  Aligned_cols=261  Identities=21%  Similarity=0.272  Sum_probs=194.0

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR----  198 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  198 (397)
                      +++|+..+.||+|+||+||+|.. .+|+.||||++....   .....+.+.+|+++|++++||||+++++++....    
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence            35688899999999999999964 589999999987522   2233567899999999999999999999996543    


Q ss_pred             eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeeccc
Q 016009          199 HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIA  278 (397)
Q Consensus       199 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  278 (397)
                      ..+++++|+.+|+|.+++...    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          84 KDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             CCEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence            234556677899999999643    599999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC---CcccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCccccccccccc-------c---
Q 016009          279 KFLKPDSS---NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLN-------T---  344 (397)
Q Consensus       279 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~-------~---  344 (397)
                      ........   ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||............       .   
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            86543322   2344678999999998854 46789999999999999999999998643321100000       0   


Q ss_pred             -------ccccccccCCCCCCCC--cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          345 -------DIELDEMLDPRLPAPS--RSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       345 -------~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                             .........+......  .........+.+|+.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   0000000000000000  0000112358899999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-48  Score=354.91  Aligned_cols=257  Identities=24%  Similarity=0.339  Sum_probs=191.5

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecCC----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHAR----  198 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  198 (397)
                      .++|+..+.||+|+||+||+|.. .+|+.||||+++....  .....+.+.+|+++|++++|||||+++++|...+    
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc--ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            35788899999999999999965 5799999999975332  2234578899999999999999999999997654    


Q ss_pred             --eeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeec
Q 016009          199 --HSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFG  276 (397)
Q Consensus       199 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  276 (397)
                        ..++||||+ +++|..+...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+|++|||
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence              569999999 5678777643    3599999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccc-------------cc
Q 016009          277 IAKFLKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-------------FL  342 (397)
Q Consensus       277 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~-------------~~  342 (397)
                      ++......   .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||.........             ..
T Consensus       167 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         167 LARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             TCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ceeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            99875432   3456799999999998764 5689999999999999999999998643321100             00


Q ss_pred             c-ccc----ccccccCCCCCC--CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          343 N-TDI----ELDEMLDPRLPA--PSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       343 ~-~~~----~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      . ...    ..... .+....  ...........+.+|+.+||+.||++|||++|++++
T Consensus       244 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         244 QRLQSDEAKNYMKG-LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HTCSCHHHHHHHHH-SCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhcchhhhhhhcc-CCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0 000    00000 000000  000001122457899999999999999999999974

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=358.18  Aligned_cols=256  Identities=23%  Similarity=0.321  Sum_probs=201.9

Q ss_pred             cCCCCCccccccCcEEEEEEEe----CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC-CceeeeEEEEecCCe
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH-RNIVKLYGFCSHARH  199 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  199 (397)
                      ++|++.+.||+|+||+||+|..    .+|+.||||.++...........+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5799999999999999999964    25889999998653222222335678899999999976 899999999999999


Q ss_pred             eeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          200 SFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       200 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                      .+++|||+.+|+|.+++....   .++......++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999997654   478899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC-CCcccccccccccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 016009          280 FLKPDS-SNWTEFAGTYGYVAPELAYTM--KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEMLDPRL  356 (397)
Q Consensus       280 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
                      .+.... .......|++.|+|||.+.+.  .++.++||||+||+||||+||+.||...........    ..........
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~----i~~~~~~~~~  253 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE----ISRRILKSEP  253 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH----HHHHHHHCCC
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHHhcccCCC
Confidence            764332 223456789999999998754  468899999999999999999999865433211100    0111111222


Q ss_pred             CCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 016009          357 PAPSRSVQEKLRSIVEVVFSCLNESPESRP-----TMKIVSQQ  394 (397)
Q Consensus       357 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~~vl~~  394 (397)
                      +.+.    +....+.+++.+||++||++||     |++|++++
T Consensus       254 ~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         254 PYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             CCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             CCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            2222    2344588999999999999999     47888863

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.4e-47  Score=345.23  Aligned_cols=253  Identities=21%  Similarity=0.303  Sum_probs=195.3

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEec--CCee
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSH--ARHS  200 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~  200 (397)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..       ..+++.+|+++|++++ ||||+++++++..  ....
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            5799999999999999999976 57999999998641       2567899999999995 9999999999974  4568


Q ss_pred             eEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCC-cEEEeeecccc
Q 016009          201 FLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEF-EAHVADFGIAK  279 (397)
Q Consensus       201 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~  279 (397)
                      ++||||+.+++|..+.      +.+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||++.
T Consensus       108 ~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             EEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             eEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence            9999999999998764      3589999999999999999999999   999999999999998654 69999999998


Q ss_pred             ccCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCccccccc-------------------
Q 016009          280 FLKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS-------------------  339 (397)
Q Consensus       280 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~-------------------  339 (397)
                      ...... ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||........                   
T Consensus       179 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         179 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             eccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            765433 23456789999999998765 479999999999999999999999864322100                   


Q ss_pred             -cccccccccccccCCCCC------CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          340 -SFLNTDIELDEMLDPRLP------APSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       340 -~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       ..................      ...........++.+|+.+||+.||++|||++|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             000000000000000000      0001111223468899999999999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=347.10  Aligned_cols=258  Identities=22%  Similarity=0.302  Sum_probs=191.1

Q ss_pred             cCCCCCccccccCcEEEEEEEeC-CCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEec------C
Q 016009          125 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSH------A  197 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~  197 (397)
                      ++|++.++||+|+||+||+|... +|+.||||++......  ....+.+.+|+.++++++||||+++++++..      .
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC--HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            57899999999999999999754 7999999999754332  2345678999999999999999999999953      4


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...|+||||+.++.+..+.      ..+++.+++.++.||+.||.|||+.   +|+||||||+|||++.++.+|++|||+
T Consensus        95 ~~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             CEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             ceeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence            6889999999776555442      3589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccc--------------cccc
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--------------SFLN  343 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~--------------~~~~  343 (397)
                      ++..... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||........              ....
T Consensus       166 ~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         166 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            8865432 233455789999999999999999999999999999999999999853321100              0000


Q ss_pred             ccccccc---------------cc-CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          344 TDIELDE---------------ML-DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       344 ~~~~~~~---------------~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                      .......               .. +................+.+|+.+||+.||++|||++|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000000               00 111111122233456778999999999999999999999864

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-47  Score=341.86  Aligned_cols=256  Identities=18%  Similarity=0.249  Sum_probs=192.1

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeee-EEEEecCCeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKL-YGFCSHARHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~-~~~~~~~~~~~l  202 (397)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++.....      .+++..|+++++.++|+|++.. .++....+..++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence            5688999999999999999965 5789999998765322      2347889999999987765554 555577788899


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC---CCcEEEeeecccc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL---EFEAHVADFGIAK  279 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~  279 (397)
                      ||||+ +++|.+.+....  +.+++..+..++.|++.||+|||++   +|+||||||+|||++.   +..+||+|||+++
T Consensus        81 vme~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          81 VMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EEEEc-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence            99998 556666654433  4699999999999999999999999   9999999999999864   4579999999998


Q ss_pred             ccCCCCC-------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 016009          280 FLKPDSS-------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDEML  352 (397)
Q Consensus       280 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  352 (397)
                      .+.....       ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.....................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  234 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence            7654322       123457999999999999999999999999999999999999998654332111100000000000


Q ss_pred             CCCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          353 DPRLPAPSRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       353 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      .+ .   .......+.++.+++..||+.||++||+++++.+.|+
T Consensus       235 ~~-~---~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~  274 (299)
T d1ckia_         235 TP-I---EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  274 (299)
T ss_dssp             SC-H---HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred             CC-h---hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            00 0   0000122355889999999999999999998877664

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.4e-46  Score=336.01  Aligned_cols=255  Identities=18%  Similarity=0.250  Sum_probs=198.8

Q ss_pred             cCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccC-CceeeeEEEEecCCeeeE
Q 016009          125 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRH-RNIVKLYGFCSHARHSFL  202 (397)
Q Consensus       125 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~l  202 (397)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.....      ...+.+|++.++.++| +|++.+++++..+...++
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            5788899999999999999975 4789999998754221      2346789999999965 899999999999999999


Q ss_pred             EEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCC-----CCcEEEeeecc
Q 016009          203 VYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDL-----EFEAHVADFGI  277 (397)
Q Consensus       203 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~  277 (397)
                      ||||+ +++|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.     ++.+||+|||+
T Consensus        79 vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence            99998 689999886544  4689999999999999999999999   9999999999999974     57899999999


Q ss_pred             ccccCCCCC-------CcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 016009          278 AKFLKPDSS-------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFLNTDIELDE  350 (397)
Q Consensus       278 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  350 (397)
                      ++.......       ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...........     ...
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~-----~~~  227 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK-----YER  227 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH-----HHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH-----HHH
Confidence            987653221       22346799999999999999999999999999999999999999974332211000     000


Q ss_pred             ccCCCCCCC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 016009          351 MLDPRLPAP-SRSVQEKLRSIVEVVFSCLNESPESRPTMKIVSQQLQ  396 (397)
Q Consensus       351 ~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~Le  396 (397)
                      +.+.....+ .......+.++.+++..|++.+|++||+++.+.+.|+
T Consensus       228 i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~  274 (293)
T d1csna_         228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  274 (293)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             HHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence            000000000 0000112345889999999999999999988877654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-46  Score=341.50  Aligned_cols=259  Identities=22%  Similarity=0.326  Sum_probs=193.9

Q ss_pred             hcCCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 016009          124 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNIVKLYGFCSHA-----  197 (397)
Q Consensus       124 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  197 (397)
                      .++|+..+.||+|+||+||+|.. .+|+.||||++.....  .....+.+.+|+++|++++|||++++++++...     
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence            45799999999999999999965 5799999999975332  223456789999999999999999999998643     


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEeeecc
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVADFGI  277 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  277 (397)
                      ...+++++|+.+|+|.+++..    +.+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             CceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence            344777888899999999854    3599999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccccccccc--------------
Q 016009          278 AKFLKPDSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSFL--------------  342 (397)
Q Consensus       278 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~~--------------  342 (397)
                      +....   .......|+..|+|||...+. .++.++||||+||++|+|++|+.||...........              
T Consensus       168 a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         168 ARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             --CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hcccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            87543   223446789999999987665 468899999999999999999999864322110000              


Q ss_pred             -ccccccccccCCCCCCCCcch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 016009          343 -NTDIELDEMLDPRLPAPSRSV----QEKLRSIVEVVFSCLNESPESRPTMKIVSQQ  394 (397)
Q Consensus       343 -~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~~vl~~  394 (397)
                       ................+....    ......+.+|+.+||+.||++|||++|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence             000000000000000001000    0123457899999999999999999999873

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-41  Score=313.84  Aligned_cols=258  Identities=19%  Similarity=0.231  Sum_probs=190.2

Q ss_pred             CCCCCccccccCcEEEEEEEe-CCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-----------CCceeeeEEE
Q 016009          126 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-----------HRNIVKLYGF  193 (397)
Q Consensus       126 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~  193 (397)
                      +|++.++||+|+||+||+|+. .+|+.||||+++..     ....+.+.+|++++++++           |+||++++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            488899999999999999975 57999999998741     223467788999988875           5789999988


Q ss_pred             Eec--CCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCcEEeCCCC--
Q 016009          194 CSH--ARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHRDISSKNLLLDLEF--  268 (397)
Q Consensus       194 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~--  268 (397)
                      +..  ....+++++++..+..............+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++  
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcc
Confidence            854  45667777777666544444333444568999999999999999999998 5   899999999999997665  


Q ss_pred             ----cEEEeeeccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccccccccc---
Q 016009          269 ----EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSF---  341 (397)
Q Consensus       269 ----~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~tg~~p~~~~~~~~~~~---  341 (397)
                          .++++|||.+......   .....||+.|+|||.+.+..++.++||||+||+++||++|+.||..........   
T Consensus       166 ~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence                3999999999865432   234579999999999999999999999999999999999999986432210000   


Q ss_pred             ----------------cccccccccccC-----CCCC------------CCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 016009          342 ----------------LNTDIELDEMLD-----PRLP------------APSRSVQEKLRSIVEVVFSCLNESPESRPTM  388 (397)
Q Consensus       342 ----------------~~~~~~~~~~~~-----~~~~------------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~  388 (397)
                                      ...........+     ..+.            ............+.+|+.+||..||++|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence                            000000000000     0000            0111234566789999999999999999999


Q ss_pred             HHHHHH
Q 016009          389 KIVSQQ  394 (397)
Q Consensus       389 ~~vl~~  394 (397)
                      +|++++
T Consensus       323 ~e~L~H  328 (362)
T d1q8ya_         323 GGLVNH  328 (362)
T ss_dssp             HHHHTC
T ss_pred             HHHhcC
Confidence            999874

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.6e-25  Score=186.92  Aligned_cols=172  Identities=15%  Similarity=0.148  Sum_probs=120.0

Q ss_pred             CCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCc--------------chhcHHHHHHHHHHHHhccCCceeeeEEEE
Q 016009          129 AQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSD--------------QIVDKKEFLTEVEALTEIRHRNIVKLYGFC  194 (397)
Q Consensus       129 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  194 (397)
                      +.+.||+|+||+||+|...+|+.||||+++......              ..........|...+.++.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            457899999999999988899999999876422110              011123456788899999999999887653


Q ss_pred             ecCCeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCcEEeCCCCcEEEee
Q 016009          195 SHARHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHRDISSKNLLLDLEFEAHVAD  274 (397)
Q Consensus       195 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  274 (397)
                      .    .+++|||+++..+.+          +++.....++.|++++++|||+.   +|+||||||+|||++++ .++|+|
T Consensus        84 ~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          84 G----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             T----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred             C----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence            2    379999998865533          33344567999999999999998   99999999999999865 589999


Q ss_pred             eccccccCCCCCCcccccccccccCcccccCCCCCcchhhHHHHHHH
Q 016009          275 FGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLA  321 (397)
Q Consensus       275 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l  321 (397)
                      ||.+.....+.... ....+... -.+. ....|+.++|+||..--+
T Consensus       146 FG~a~~~~~~~~~~-~l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWRE-ILERDVRN-IITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHHH-HHHHHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcHH-HHHHHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence            99997654221110 00000000 0111 135678899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.67  E-value=6.9e-08  Score=82.72  Aligned_cols=148  Identities=13%  Similarity=0.091  Sum_probs=96.9

Q ss_pred             HHHHHhcCCCCCccccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecC
Q 016009          119 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHA  197 (397)
Q Consensus       119 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  197 (397)
                      ++.+....|+..+..+.++.+.||+... +++.+++|+......    .....+.+|...++.+. +--+.+++.+...+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~----~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc----cchhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence            4455556666555444444578999865 556678887653211    12334678888888774 44467788888888


Q ss_pred             CeeeEEEEeccCCCHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 016009          198 RHSFLVYEFLKRGSLAAILSSDAAAQELGWSQRMNVIKGVADALSYLHHDC-----------------------------  248 (397)
Q Consensus       198 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----------------------------  248 (397)
                      +..++||++++|.++.+......        ....++.++++.++.||+..                             
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred             CceEEEEEecccccccccccccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence            89999999999988865542211        11223444455555555321                             


Q ss_pred             ---------------------------CCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          249 ---------------------------FPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       249 ---------------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                                                 .+.++|+|+.|.||++++++..-|.||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                       1137899999999999987667799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.24  E-value=1.2e-06  Score=74.21  Aligned_cols=140  Identities=15%  Similarity=0.092  Sum_probs=84.0

Q ss_pred             ccccC-cEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc--CCceeeeEEEEecCCeeeEEEEeccC
Q 016009          133 IGNGG-HGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR--HRNIVKLYGFCSHARHSFLVYEFLKR  209 (397)
Q Consensus       133 lg~G~-~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~  209 (397)
                      +..|. -+.||+....++..+++|.-....       ...+..|...++.+.  .-.+.+++++..+++..++||++++|
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            33443 367899988888888999754321       234667888888774  33466778888888889999999988


Q ss_pred             CCHHHhh-----------------cccc-ccCC--CCHHHHHHHH--------------------HHHHHHHHHHHhCC-
Q 016009          210 GSLAAIL-----------------SSDA-AAQE--LGWSQRMNVI--------------------KGVADALSYLHHDC-  248 (397)
Q Consensus       210 g~L~~~l-----------------~~~~-~~~~--l~~~~~~~i~--------------------~~i~~~l~~Lh~~~-  248 (397)
                      .++.+..                 +... ....  -.+.....-.                    ......+..+.... 
T Consensus        91 ~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  170 (255)
T d1nd4a_          91 QDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMP  170 (255)
T ss_dssp             EETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCC
T ss_pred             cccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCC
Confidence            6654321                 0000 0000  0011000000                    00112233333321 


Q ss_pred             ---CCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          249 ---FPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       249 ---~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                         .+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus       171 ~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         171 DGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             SSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence               1237999999999999987667899998765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.92  E-value=1.7e-05  Score=71.50  Aligned_cols=79  Identities=16%  Similarity=0.100  Sum_probs=48.0

Q ss_pred             ccccccCcEEEEEEEeCC-CCEEEEEecCCCCC---CcchhcHHHHHHHHHHHHhcc-C--CceeeeEEEEecCCeeeEE
Q 016009          131 YCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLP---SDQIVDKKEFLTEVEALTEIR-H--RNIVKLYGFCSHARHSFLV  203 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~lv  203 (397)
                      +.||.|....||+....+ ++.++||.-.....   ..-.........|.+.|+.+. +  ..+++++.+  ++...++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            458999999999997654 67899996432110   001112334556888887763 2  345555554  34556899


Q ss_pred             EEeccCCC
Q 016009          204 YEFLKRGS  211 (397)
Q Consensus       204 ~e~~~~g~  211 (397)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.34  E-value=0.00042  Score=60.41  Aligned_cols=69  Identities=12%  Similarity=0.169  Sum_probs=46.7

Q ss_pred             cEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCce--eeeEE-----EEecCCeeeEEEEeccCC
Q 016009          138 HGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI--VKLYG-----FCSHARHSFLVYEFLKRG  210 (397)
Q Consensus       138 ~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~g  210 (397)
                      .-.||++..++|+.+++|..+..     ....+++..|...+..|....+  +..+.     .....+..+.++++++|.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-----~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC-----CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            45899999999999999997642     1235778889999888853322  11111     123455678899998764


Q ss_pred             C
Q 016009          211 S  211 (397)
Q Consensus       211 ~  211 (397)
                      .
T Consensus       110 ~  110 (325)
T d1zyla1         110 Q  110 (325)
T ss_dssp             E
T ss_pred             C
Confidence            3

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.17  E-value=0.0011  Score=59.26  Aligned_cols=72  Identities=18%  Similarity=0.218  Sum_probs=47.8

Q ss_pred             ccccccCcEEEEEEEeCCC--------CEEEEEecCCCCCCcchhcHHHHHHHHHHHHhcc-CCceeeeEEEEecCCeee
Q 016009          131 YCIGNGGHGSVYRAELPSG--------QVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIR-HRNIVKLYGFCSHARHSF  201 (397)
Q Consensus       131 ~~lg~G~~g~vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  201 (397)
                      +.|+.|-.-.+|++..+++        +.|.+++.-. ..     ......+|..+++.+. +.-..++++++.+    .
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            4577788889999976543        4566666532 11     1234568999999885 4334577777753    5


Q ss_pred             EEEEeccCCCH
Q 016009          202 LVYEFLKRGSL  212 (397)
Q Consensus       202 lv~e~~~~g~L  212 (397)
                      +|+||++|.++
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            78999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.03  E-value=0.0013  Score=56.84  Aligned_cols=158  Identities=13%  Similarity=0.111  Sum_probs=83.3

Q ss_pred             ccHHHHHHHhcCCCCCcc-----ccccCcEEEEEEEeCCCCEEEEEecCCCCCCcchhcHHHHHHHHHHHHhccCCce--
Q 016009          115 LVYDEIVRATNDFDAQYC-----IGNGGHGSVYRAELPSGQVVAIKKFHSPLPSDQIVDKKEFLTEVEALTEIRHRNI--  187 (397)
Q Consensus       115 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--  187 (397)
                      ++.+++.....+|...+.     |..|---+.|+.+..+|+ +++|+......      .+++..|++++..+...++  
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~------~~~l~~~~~~l~~L~~~g~pv   75 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE------KNDLPFFLGLMQHLAAKGLSC   75 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---------CCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC------HHHHHHHHHHHHhhhhccccc
Confidence            556788888888876544     335556788999887665 88998754211      2345567777777743222  


Q ss_pred             eeeEE------EEecCCeeeEEEEeccCCCHHHh--------------hc----cccc--cCCCCH--------------
Q 016009          188 VKLYG------FCSHARHSFLVYEFLKRGSLAAI--------------LS----SDAA--AQELGW--------------  227 (397)
Q Consensus       188 v~~~~------~~~~~~~~~lv~e~~~~g~L~~~--------------l~----~~~~--~~~l~~--------------  227 (397)
                      ...+.      +.........++.+..+......              ++    ....  ......              
T Consensus        76 p~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (316)
T d2ppqa1          76 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA  155 (316)
T ss_dssp             CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred             cccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhh
Confidence            11111      11223445566666655332110              00    0000  000000              


Q ss_pred             ----HHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCcEEeCCCCcEEEeeecccc
Q 016009          228 ----SQRMNVIKGVADALSYLHHD-CFPPIVHRDISSKNLLLDLEFEAHVADFGIAK  279 (397)
Q Consensus       228 ----~~~~~i~~~i~~~l~~Lh~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  279 (397)
                          ......+......+...+.. ...++||+|+.+.||+++.+...-|.||+.+.
T Consensus       156 ~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         156 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence                01112222222222222221 22379999999999999988777899999875

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.35  E-value=0.05  Score=45.07  Aligned_cols=18  Identities=22%  Similarity=0.514  Sum_probs=8.6

Q ss_pred             CCCCEEecCCCcccccCCC
Q 016009            2 HGLSVIDISDNQLQGPVPN   20 (397)
Q Consensus         2 ~~L~~ldls~N~l~G~iP~   20 (397)
                      ++|++|||++|+|+ .||.
T Consensus       172 ~~L~~L~Ls~N~L~-~lp~  189 (266)
T d1p9ag_         172 ENLDTLLLQENSLY-TIPK  189 (266)
T ss_dssp             TTCCEEECCSSCCC-CCCT
T ss_pred             cccceeecccCCCc-ccCh
Confidence            34444555555544 4443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.95  E-value=0.14  Score=38.45  Aligned_cols=36  Identities=19%  Similarity=0.066  Sum_probs=21.0

Q ss_pred             CCCCCEEecCCCcccccCCC-CCccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPN-STAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~-~~~~~~~~~~~~~gN~   36 (397)
                      |+.|+.|+||+|+|++--|. +....++....+++|.
T Consensus        55 l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~   91 (156)
T d2ifga3          55 LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA   91 (156)
T ss_dssp             CCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred             ccccCcceeeccccCCcccccccccccccceeccCCC
Confidence            46777778888877765554 1222334445556664

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=89.85  E-value=0.04  Score=46.79  Aligned_cols=36  Identities=19%  Similarity=0.345  Sum_probs=20.0

Q ss_pred             CCCCCEEecCC-CcccccCCCC-CccccCCcccccCCC
Q 016009            1 MHGLSVIDISD-NQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~-N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      |+.|++||||+ |+|+|.||.. ..+.++....+.+|.
T Consensus        75 L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~  112 (313)
T d1ogqa_          75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN  112 (313)
T ss_dssp             CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEEC
T ss_pred             Cccccccccccccccccccccccccccccchhhhcccc
Confidence            45667777764 6677777652 223344444555553

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=89.44  E-value=0.13  Score=40.08  Aligned_cols=36  Identities=8%  Similarity=0.147  Sum_probs=23.7

Q ss_pred             CCCCCEEecCCCcccccCCC-CCccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPN-STAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~-~~~~~~~~~~~~~gN~   36 (397)
                      +++|++||||+|++++-.|. +..+.++....+.+|.
T Consensus        77 ~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~  113 (192)
T d1w8aa_          77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQ  113 (192)
T ss_dssp             CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSC
T ss_pred             ccccceeeeccccccccCHHHHhCCCcccccccCCcc
Confidence            46788888888888876665 2233445555666665

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=87.66  E-value=0.16  Score=36.37  Aligned_cols=35  Identities=26%  Similarity=0.363  Sum_probs=25.3

Q ss_pred             CCCCCEEecCCCcccccCCC-CCccccCCcccccCCC
Q 016009            1 MHGLSVIDISDNQLQGPVPN-STAFRNASVEALEGNK   36 (397)
Q Consensus         1 l~~L~~ldls~N~l~G~iP~-~~~~~~~~~~~~~gN~   36 (397)
                      |+.|++||||+|+++ .||. ...+.++....+.+|.
T Consensus        19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~   54 (124)
T d1dcea3          19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA   54 (124)
T ss_dssp             GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSC
T ss_pred             CCCCCEEECCCCccC-cchhhhhhhhccccccccccc
Confidence            468999999999998 5775 3344556666677775

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=85.99  E-value=0.19  Score=35.99  Aligned_cols=31  Identities=13%  Similarity=0.160  Sum_probs=21.9

Q ss_pred             CEEecCCCcccccCCCCCccccCCcccccCCC
Q 016009            5 SVIDISDNQLQGPVPNSTAFRNASVEALEGNK   36 (397)
Q Consensus         5 ~~ldls~N~l~G~iP~~~~~~~~~~~~~~gN~   36 (397)
                      ++||||+|+++ .+|....+.++....+++|.
T Consensus         1 R~L~Ls~n~l~-~l~~l~~l~~L~~L~ls~N~   31 (124)
T d1dcea3           1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNR   31 (124)
T ss_dssp             SEEECTTSCCS-SCCCGGGGTTCCEEECCSSC
T ss_pred             CEEEcCCCCCC-CCcccccCCCCCEEECCCCc
Confidence            57889999998 56654455566666777775

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.13  E-value=0.26  Score=37.04  Aligned_cols=34  Identities=9%  Similarity=0.110  Sum_probs=21.4

Q ss_pred             CCCCEEecCCCcccccCCCC-CccccCCcccccCCC
Q 016009            2 HGLSVIDISDNQLQGPVPNS-TAFRNASVEALEGNK   36 (397)
Q Consensus         2 ~~L~~ldls~N~l~G~iP~~-~~~~~~~~~~~~gN~   36 (397)
                      ..|+.|||++|+++. ||.. ..+..+....+++|.
T Consensus        18 ~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~   52 (162)
T d1a9na_          18 VRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNE   52 (162)
T ss_dssp             TSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSC
T ss_pred             CcCcEEECCCCCCCc-cCccccccccCCEEECCCCC
Confidence            457788888888764 4542 234455666677774

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=80.36  E-value=0.64  Score=35.74  Aligned_cols=35  Identities=14%  Similarity=0.121  Sum_probs=24.4

Q ss_pred             CCCCEEecCCCcccccCCCC--CccccCCcccccCCC
Q 016009            2 HGLSVIDISDNQLQGPVPNS--TAFRNASVEALEGNK   36 (397)
Q Consensus         2 ~~L~~ldls~N~l~G~iP~~--~~~~~~~~~~~~gN~   36 (397)
                      +.|++||||+|++++.+|..  ..+.++....+.+|.
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~   65 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ   65 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSC
T ss_pred             CCCCEEEeCCCCCcccccccccCCCceEeeeeccccc
Confidence            46889999999999877652  234455556666665